Citrus Sinensis ID: 037702
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 448 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LWM4 | 461 | CBL-interacting protein k | yes | no | 0.975 | 0.947 | 0.693 | 0.0 | |
| Q9FJ54 | 439 | CBL-interacting serine/th | yes | no | 0.941 | 0.961 | 0.700 | 0.0 | |
| Q7X996 | 443 | CBL-interacting protein k | no | no | 0.953 | 0.963 | 0.640 | 1e-167 | |
| Q5W736 | 457 | CBL-interacting protein k | no | no | 0.977 | 0.958 | 0.636 | 1e-166 | |
| Q9C562 | 479 | CBL-interacting serine/th | no | no | 0.995 | 0.931 | 0.604 | 1e-163 | |
| Q10LQ2 | 451 | CBL-interacting protein k | no | no | 0.982 | 0.975 | 0.6 | 1e-155 | |
| Q9LYQ8 | 456 | CBL-interacting serine/th | no | no | 0.982 | 0.964 | 0.596 | 1e-151 | |
| Q9SN43 | 489 | CBL-interacting serine/th | no | no | 0.955 | 0.875 | 0.587 | 1e-150 | |
| Q6H7U5 | 493 | CBL-interacting protein k | no | no | 0.997 | 0.906 | 0.554 | 1e-150 | |
| Q2QYM3 | 439 | CBL-interacting protein k | no | no | 0.975 | 0.995 | 0.575 | 1e-150 |
| >sp|Q9LWM4|CIPK5_ORYSJ CBL-interacting protein kinase 5 OS=Oryza sativa subsp. japonica GN=CIPK5 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 657 bits (1694), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 307/443 (69%), Positives = 371/443 (83%), Gaps = 6/443 (1%)
Query: 1 MEKKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKRE 60
MEKKA ILMN+YELGR+LGQGTFAKVYH RNL + QSVAIK++DKEK+ RVG+IDQIKRE
Sbjct: 1 MEKKASILMNRYELGRMLGQGTFAKVYHARNLASNQSVAIKVIDKEKVLRVGMIDQIKRE 60
Query: 61 ISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVD 120
IS+MRLVRHPNIVQL+EVMASK+KIYFAMEYVRGGELF++VA+G+L+E+ ARKYFQQL+
Sbjct: 61 ISIMRLVRHPNIVQLHEVMASKSKIYFAMEYVRGGELFSRVARGRLKEDAARKYFQQLIG 120
Query: 121 AVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAP 180
AV+FCHSRGVYHRDLKPENLL+DENG+LK+SDFGLSA +E +QDGLLHTTCGTPAYVAP
Sbjct: 121 AVDFCHSRGVYHRDLKPENLLVDENGNLKVSDFGLSAFKECQKQDGLLHTTCGTPAYVAP 180
Query: 181 EVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVR 240
E+INKRGYDGAKADIWSCGV+LFVLLAG LPF+DSNLME+Y+KI++ + K P WF +VR
Sbjct: 181 EIINKRGYDGAKADIWSCGVILFVLLAGYLPFHDSNLMEMYRKISKGDVKFPQWFTTDVR 240
Query: 241 KLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIETPESPRGQDRNKLISDIHAVFECESS 300
+LLSR+LDPNP+ R+T+ KL+E+ WF+KGYK P + + D+H F S+
Sbjct: 241 RLLSRLLDPNPNIRITVEKLVEHPWFKKGYKPAVMLSQPNESNN---LKDVHTAF---SA 294
Query: 301 SSRDTDPPTNSCRSPVRPSSFNAFDIISLSKGFNLSGLFEGDANSKLEARFTTTKPASAI 360
+D + S ++P S NAFDIISLSKGF+LSGLFE D K ++RF T KPASAI
Sbjct: 295 DHKDNEGKAKEPASSLKPVSLNAFDIISLSKGFDLSGLFENDKEQKADSRFMTQKPASAI 354
Query: 361 VSKFEEIAVTESCKFNKKDGTVKLQHNRQGRKGQLAVDAEIFEVTPAFHVVELKKAAGDT 420
VSK E+IA TES K K+DG VKLQ +++GRKGQLA+DAEIFEVTP+F VVE+KK+AGDT
Sbjct: 355 VSKLEQIAETESFKVKKQDGLVKLQGSKEGRKGQLAIDAEIFEVTPSFFVVEVKKSAGDT 414
Query: 421 MEYKDFCNQGLRPSLKDIVWTWQ 443
+EY+ FCN+GLRPSL+DI W Q
Sbjct: 415 LEYEKFCNKGLRPSLRDICWDGQ 437
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9FJ54|CIPKK_ARATH CBL-interacting serine/threonine-protein kinase 20 OS=Arabidopsis thaliana GN=CIPK20 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 655 bits (1690), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 313/447 (70%), Positives = 374/447 (83%), Gaps = 25/447 (5%)
Query: 1 MEKKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKRE 60
M+K +LM KYELGRLLGQGTFAKVYH RN+KTG+SVAIK++DK+K+ +VGLIDQIKRE
Sbjct: 1 MDKNGIVLMRKYELGRLLGQGTFAKVYHARNIKTGESVAIKVIDKQKVAKVGLIDQIKRE 60
Query: 61 ISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVD 120
ISVMRLVRHP++V L+EVMASKTKIYFAMEYV+GGELF+KV+KGKL+E +ARKYFQQL+
Sbjct: 61 ISVMRLVRHPHVVFLHEVMASKTKIYFAMEYVKGGELFDKVSKGKLKENIARKYFQQLIG 120
Query: 121 AVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAP 180
A+++CHSRGVYHRDLKPENLLLDENGDLKISDFGLSAL+ES +QDGLLHTTCGTPAYVAP
Sbjct: 121 AIDYCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALRESKQQDGLLHTTCGTPAYVAP 180
Query: 181 EVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVR 240
EVI K+GYDGAKAD+WSCGVVL+VLLAG LPF++ NL+E+Y+KIT+ EFKCPNWFPPEV+
Sbjct: 181 EVIGKKGYDGAKADVWSCGVVLYVLLAGFLPFHEQNLVEMYRKITKGEFKCPNWFPPEVK 240
Query: 241 KLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIETPESPRGQDRNKLISDIHAVFECESS 300
KLLSRILDPNP++R+ + K+MEN WF+KG+KKIETP+SP + LISD+HA F
Sbjct: 241 KLLSRILDPNPNSRIKIEKIMENSWFQKGFKKIETPKSPESHQIDSLISDVHAAF----- 295
Query: 301 SSRDTDPPTNSCRSPVRPSSFNAFDII-SLSKGFNLSGLFEGDANSKLEARFTTTKPASA 359
V+P S+NAFD+I SLS+GF+LSGLFE + S E++FTT K A
Sbjct: 296 --------------SVKPMSYNAFDLISSLSQGFDLSGLFEKEERS--ESKFTTKKDAKE 339
Query: 360 IVSKFEEIAVTESCKFN--KKDGTVKLQHNRQGRKGQLAVDAEIFEVTPAFHVVELKKAA 417
IVSKFEEIA T S +FN K D VK++ R+GRKG LA+D EIFEVT +FH+VE KK+
Sbjct: 340 IVSKFEEIA-TSSERFNLTKSDVGVKMEDKREGRKGHLAIDVEIFEVTNSFHMVEFKKSG 398
Query: 418 GDTMEYKDFCNQGLRPSLKDIVWTWQG 444
GDTMEYK FC++ LRPSLKDIVW WQG
Sbjct: 399 GDTMEYKQFCDRELRPSLKDIVWKWQG 425
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner (By similarity). Required for the abscisic acid-mediated (ABA) signaling pathway involved in seed germination and growth elongation inhibition. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7X996|CIPK2_ORYSJ CBL-interacting protein kinase 2 OS=Oryza sativa subsp. japonica GN=CIPK2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 587 bits (1512), Expect = e-167, Method: Compositional matrix adjust.
Identities = 283/442 (64%), Positives = 347/442 (78%), Gaps = 15/442 (3%)
Query: 2 EKKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREI 61
E++ +LM KYE+G+LLGQGTFAKVYH RN +T +SVAIK++DKEK+ + GL+DQIKREI
Sbjct: 3 EQRGNMLMKKYEMGKLLGQGTFAKVYHARNTETSESVAIKMIDKEKVLKGGLMDQIKREI 62
Query: 62 SVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDA 121
SVM+LVRHPNIVQLYEVMA+KTKIYF +E+V+GGELFNKV +G+L+E+ ARKYFQQL+ A
Sbjct: 63 SVMKLVRHPNIVQLYEVMATKTKIYFVLEHVKGGELFNKVQRGRLKEDAARKYFQQLICA 122
Query: 122 VEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPE 181
V+FCHSRGVYHRDLKPENLLLDEN +LK+SDFGLSAL + RQDGLLHTTCGTPAYVAPE
Sbjct: 123 VDFCHSRGVYHRDLKPENLLLDENSNLKVSDFGLSALADCKRQDGLLHTTCGTPAYVAPE 182
Query: 182 VINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRK 241
VIN+RGYDGAKADIWSCGV+LFVLLAG LPF+D NLM++YKKI +AEFKCP+WF +VR+
Sbjct: 183 VINRRGYDGAKADIWSCGVILFVLLAGYLPFHDKNLMDMYKKIGKAEFKCPSWFNTDVRR 242
Query: 242 LLSRILDPNPSTRVTMAKLMENYWFRKGYKKIETPESPRGQDRNKLISDIHAVFECESSS 301
LL RILDPNPSTR++M K+MEN WFRKG D L ++
Sbjct: 243 LLLRILDPNPSTRISMDKIMENPWFRKGL------------DAKLLRYNLQPKDAIPVDM 290
Query: 302 SRDTDPPTNSCRSPVRPSSFNAFDIISLSKGFNLSGLFEGDANSKLEARFTTTKPASAIV 361
S D D ++ +PS+ NAFDIISLS G +LSG+FE + K E++FT+T AS I+
Sbjct: 291 STDFDSFNSAPTLEKKPSNLNAFDIISLSTGLDLSGMFE--ESDKKESKFTSTSTASTII 348
Query: 362 SKFEEIAVTESCKFNKKD-GTVKLQHNRQGRKGQLAVDAEIFEVTPAFHVVELKKAAGDT 420
SK E+IA K KKD G +K++ ++ GRKG + +DAEIFEVTP FH+VELKK GDT
Sbjct: 349 SKIEDIAKGLRLKLTKKDGGLLKMEGSKPGRKGVMGIDAEIFEVTPNFHLVELKKTNGDT 408
Query: 421 MEYKDFCNQGLRPSLKDIVWTW 442
+EY+ NQ +RP+LKDIVW W
Sbjct: 409 LEYRKVLNQEMRPALKDIVWAW 430
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5W736|CIPKI_ORYSJ CBL-interacting protein kinase 18 OS=Oryza sativa subsp. japonica GN=CIPK18 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 584 bits (1506), Expect = e-166, Method: Compositional matrix adjust.
Identities = 291/457 (63%), Positives = 363/457 (79%), Gaps = 19/457 (4%)
Query: 1 MEKKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKRE 60
+EK IL+ +YE+G+LLGQGTFAKVYHGRN+ T QSVAIK++DK+KI +VGL+DQIKRE
Sbjct: 4 LEKNGNILLRRYEIGKLLGQGTFAKVYHGRNIVTSQSVAIKVIDKDKIFKVGLMDQIKRE 63
Query: 61 ISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVD 120
ISVM+LVRHPNIVQLYEVMA+K+KIYF +EYV+GGELFNKVAKG+L+E+ ARKYFQQLV
Sbjct: 64 ISVMKLVRHPNIVQLYEVMATKSKIYFVLEYVKGGELFNKVAKGRLKEDAARKYFQQLVS 123
Query: 121 AVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAP 180
AV+FCHSRGVYHRDLKPENLL+DENG+LKI+DFGLSAL ES RQDGLLHTTCGTPAYVAP
Sbjct: 124 AVDFCHSRGVYHRDLKPENLLVDENGNLKITDFGLSALAESRRQDGLLHTTCGTPAYVAP 183
Query: 181 EVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVR 240
EVI+++GYDG K D WSCGV+LFVL+AG LPF DSNLME+Y+KI +AEFKCP WF +VR
Sbjct: 184 EVISRKGYDGVKVDTWSCGVILFVLMAGYLPFQDSNLMEMYRKIGKAEFKCPAWFSSDVR 243
Query: 241 KLLSRILDPNPSTRVTMAKLMENYWFRKG------YKKIETPESPRGQDRNKLISDIHAV 294
KL+SRILDPNP +R+ + K+ME YWF+KG K +ET E ++D++ V
Sbjct: 244 KLVSRILDPNPRSRMPITKIMETYWFKKGLDSKLILKNVETNEPVTA------LADVNVV 297
Query: 295 FECESSSSRDTDPPTNSCRSPVRPSSFNAFDIISLSKGFNLSGLFEGDANSKLEARFTTT 354
F SSS T + + ++ NAFDIISLS+GF+LSGLFE + + K EARFT++
Sbjct: 298 FSSMGSSSS---KKTEEKQDAGKLTNLNAFDIISLSEGFDLSGLFE-ETDKKKEARFTSS 353
Query: 355 KPASAIVSKFEEIAVTESCKFNKKDGTV-KLQHNRQGRKGQLAVDAEIFEVTPAFHVVEL 413
+ ASAI+SK E++A KK+G V K++ +GRKG LA+DAEIFEVTP+FH+VE+
Sbjct: 354 QSASAIISKLEDVASCSKLTVKKKEGGVLKMEGASEGRKGVLAIDAEIFEVTPSFHLVEI 413
Query: 414 KKAAGDTMEYKDFCNQGLRPSLKDIVWTWQG--NDEQ 448
KK GDT+EY+ + ++P+LKDIVW WQG D+Q
Sbjct: 414 KKNNGDTLEYQHLWKEDMKPALKDIVWAWQGERQDQQ 450
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9C562|CIPKA_ARATH CBL-interacting serine/threonine-protein kinase 10 OS=Arabidopsis thaliana GN=CIPK10 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 574 bits (1480), Expect = e-163, Method: Compositional matrix adjust.
Identities = 275/455 (60%), Positives = 355/455 (78%), Gaps = 9/455 (1%)
Query: 1 MEKKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKRE 60
ME K +L +KY++GRLLGQGTFAKVY+GR++ T QSVAIK++DKEK+ +VGLI+QIKRE
Sbjct: 1 MENKPSVLTDKYDVGRLLGQGTFAKVYYGRSILTNQSVAIKMIDKEKVMKVGLIEQIKRE 60
Query: 61 ISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVD 120
ISVMR+ RHPN+V+LYEVMA+KT+IYF MEY +GGELFNKVAKGKLR++VA KYF QL++
Sbjct: 61 ISVMRIARHPNVVELYEVMATKTRIYFVMEYCKGGELFNKVAKGKLRDDVAWKYFYQLIN 120
Query: 121 AVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAP 180
AV+FCHSR VYHRD+KPENLLLD+N +LK+SDFGLSAL + RQDGLLHTTCGTPAYVAP
Sbjct: 121 AVDFCHSREVYHRDIKPENLLLDDNENLKVSDFGLSALADCKRQDGLLHTTCGTPAYVAP 180
Query: 181 EVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVR 240
EVIN++GYDG KADIWSCGVVLFVLLAG LPF+DSNLME+Y+KI +A+FK P+WF PEVR
Sbjct: 181 EVINRKGYDGTKADIWSCGVVLFVLLAGYLPFHDSNLMEMYRKIGKADFKAPSWFAPEVR 240
Query: 241 KLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIETPESPRGQDRNKLISDIHAVFECESS 300
+LL ++LDPNP TR+T+A++ E+ WFRKG + R ++ N + + E +
Sbjct: 241 RLLCKMLDPNPETRITIARIRESSWFRKGLHMKQKKMEKRVKEINSVEAGTAGTNENGAG 300
Query: 301 SSRDTDPPTNSCRSPV------RPSSFNAFDIISLSKGFNLSGLFEGDANSKLEARFTTT 354
S + P+ + P++ NAFD+I+LS GF+L+GLF GD N K E+RFT+
Sbjct: 301 PSENGAGPSENGDRVTEENHTDEPTNLNAFDLIALSAGFDLAGLF-GDDN-KRESRFTSQ 358
Query: 355 KPASAIVSKFEEIAVTESCKFNKKD-GTVKLQHNRQGRKGQLAVDAEIFEVTPAFHVVEL 413
KPAS I+SK EE+A K++ G KL+ ++GRKG L++DAEIF+VTP FH+VE+
Sbjct: 359 KPASVIISKLEEVAQRLKLSIRKREAGLFKLERLKEGRKGILSMDAEIFQVTPNFHLVEV 418
Query: 414 KKAAGDTMEYKDFCNQGLRPSLKDIVWTWQGNDEQ 448
KK+ GDT+EY+ + LRP+L DIVW WQG ++
Sbjct: 419 KKSNGDTLEYQKLVAEDLRPALSDIVWVWQGEKDE 453
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q10LQ2|CIPKA_ORYSJ CBL-interacting protein kinase 10 OS=Oryza sativa subsp. japonica GN=CIPK10 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 549 bits (1415), Expect = e-155, Method: Compositional matrix adjust.
Identities = 270/450 (60%), Positives = 350/450 (77%), Gaps = 10/450 (2%)
Query: 1 MEKKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKRE 60
+E+K ILM +YE+G+LLGQG+FAKVYHGRN+K QSVAIK++DKEKI + L+DQI+RE
Sbjct: 2 VEQKGNILMKRYEIGKLLGQGSFAKVYHGRNIKNSQSVAIKVIDKEKILKCELMDQIRRE 61
Query: 61 ISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVD 120
ISVM LVRHP IVQLYEVMA+KTKIYF +EYV+GGELFNKV +G+L+EEVARKYFQQL+
Sbjct: 62 ISVMNLVRHPCIVQLYEVMATKTKIYFILEYVKGGELFNKVRRGRLKEEVARKYFQQLIS 121
Query: 121 AVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAP 180
A++FCHSRGVYHRDLKPENLLLDEN +LKISDFGLSAL E RQDGLLHTTCGTPAYVAP
Sbjct: 122 AIDFCHSRGVYHRDLKPENLLLDENRNLKISDFGLSALAECKRQDGLLHTTCGTPAYVAP 181
Query: 181 EVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVR 240
EVIN++GYDGAKAD+W+CGV+L+VLLAG LPF D N++ +YKKI +AEFK P+WF ++R
Sbjct: 182 EVINRKGYDGAKADVWACGVILYVLLAGYLPFQDKNVINMYKKICKAEFKWPSWFSSDIR 241
Query: 241 KLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIETPESPRGQDRNKLIS-DIHAVFECES 299
KLL RILDPNP+TR++++++ME+ WFR G ++ +K++ D+ + F S
Sbjct: 242 KLLRRILDPNPATRISVSEIMEDPWFRVGLNSDLLNKTIPTDKVDKVVHVDMDSTFGNLS 301
Query: 300 SSSRDTDPPTNSCRSPVRPSSFNAFDIISLSKGFNLSGLFEGDANSKLEARFTTTKPASA 359
++ + + +S NAFDIISLS GF+LS +FE D NSK E++FT+T A+
Sbjct: 302 NNINEGKQEAENL------TSLNAFDIISLSSGFDLSAMFE-DENSKEESKFTSTNTATT 354
Query: 360 IVSKFEEIAVTESCKFNKKD-GTVKLQHNRQGRKGQLAVDAEIFEVTPAFHVVELKKAAG 418
I K E++A KF KK+ G +K++ ++ GRKG ++++AEIF++TP FH+VE K G
Sbjct: 355 ITKKLEDVAKNLRLKFLKKNGGLLKMEGSKPGRKGVMSINAEIFQITPDFHLVEFTKING 414
Query: 419 DTMEYKDFCNQGLRPSLKDIVWTWQGNDEQ 448
DT+EY+ Q +RP+LKDIVW WQG Q
Sbjct: 415 DTLEYQK-VKQEMRPALKDIVWAWQGEQPQ 443
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LYQ8|CIPK2_ARATH CBL-interacting serine/threonine-protein kinase 2 OS=Arabidopsis thaliana GN=CIPK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 535 bits (1379), Expect = e-151, Method: Compositional matrix adjust.
Identities = 268/449 (59%), Positives = 340/449 (75%), Gaps = 9/449 (2%)
Query: 1 MEKKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKRE 60
ME K +L +YE+GRLLGQGTFAKVY GR+ T +SVAIK++DK+K+ RVGL QIKRE
Sbjct: 1 MENKPSVLTERYEVGRLLGQGTFAKVYFGRSNHTNESVAIKMIDKDKVMRVGLSQQIKRE 60
Query: 61 ISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVD 120
ISVMR+ +HPN+V+LYEVMA+K++IYF +EY +GGELFNKVAKGKL+E+VA KYF QL+
Sbjct: 61 ISVMRIAKHPNVVELYEVMATKSRIYFVIEYCKGGELFNKVAKGKLKEDVAWKYFYQLIS 120
Query: 121 AVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAP 180
AV+FCHSRGVYHRD+KPENLLLD+N +LK+SDFGLSAL + RQDGLLHTTCGTPAYVAP
Sbjct: 121 AVDFCHSRGVYHRDIKPENLLLDDNDNLKVSDFGLSALADCKRQDGLLHTTCGTPAYVAP 180
Query: 181 EVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVR 240
EVIN++GY+G KADIWSCGVVLFVLLAG LPF+D+NLME+Y+KI +A+FKCP+WF PEV+
Sbjct: 181 EVINRKGYEGTKADIWSCGVVLFVLLAGYLPFHDTNLMEMYRKIGKADFKCPSWFAPEVK 240
Query: 241 KLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIETPESPRGQDRNKLISDIHAVFECESS 300
+LL ++LDPN TR+T+AK+ E+ WFRKG + + + + A E+
Sbjct: 241 RLLCKMLDPNHETRITIAKIKESSWFRKGLHLKQKKMEKMEKQQVR-----EATNPMEAG 295
Query: 301 SSRDTDPPTNSCRSPVRPSSFNAFDIISLSKGFNLSGLFEGDANSKLEARFTTTKPASAI 360
S + N P R ++ NAFDII+LS GF L+GLF GD K E+RF + KPAS I
Sbjct: 296 GSGQNENGEN--HEPPRLATLNAFDIIALSTGFGLAGLF-GDVYDKRESRFASQKPASEI 352
Query: 361 VSKFEEIAVTESCKFNKKD-GTVKLQHNRQGRKGQLAVDAEIFEVTPAFHVVELKKAAGD 419
+SK E+A K K+ G KL+ ++G+ G L +DAEIF+VTP FH+VE+KK GD
Sbjct: 353 ISKLVEVAKCLKLKIRKQGAGLFKLERVKEGKNGILTMDAEIFQVTPTFHLVEVKKCNGD 412
Query: 420 TMEYKDFCNQGLRPSLKDIVWTWQGNDEQ 448
TMEY+ + LRP+L DIVW WQG E+
Sbjct: 413 TMEYQKLVEEDLRPALADIVWVWQGEKEK 441
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SN43|CIPKC_ARATH CBL-interacting serine/threonine-protein kinase 12 OS=Arabidopsis thaliana GN=CIPK12 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 533 bits (1372), Expect = e-150, Method: Compositional matrix adjust.
Identities = 259/441 (58%), Positives = 328/441 (74%), Gaps = 13/441 (2%)
Query: 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMR 65
+++ +YE+G+LLG GTFAKVY RN+KT +SVAIK++DKEK+ + GLI IKREIS++R
Sbjct: 20 ALILGRYEMGKLLGHGTFAKVYLARNVKTNESVAIKVIDKEKVLKGGLIAHIKREISILR 79
Query: 66 LVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFC 125
VRHPNIVQL+EVMA+K KIYF MEYVRGGELFNKVAKG+L+EEVARKYFQQL+ AV FC
Sbjct: 80 RVRHPNIVQLFEVMATKAKIYFVMEYVRGGELFNKVAKGRLKEEVARKYFQQLISAVTFC 139
Query: 126 HSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINK 185
H+RGVYHRDLKPENLLLDENG+LK+SDFGLSA+ + RQDGL HT CGTPAYVAPEV+ +
Sbjct: 140 HARGVYHRDLKPENLLLDENGNLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLAR 199
Query: 186 RGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSR 245
+GYD AK DIWSCGV+LFVL+AG LPF+D N+M +YKKI R EF+CP WF E+ +LLS+
Sbjct: 200 KGYDAAKVDIWSCGVILFVLMAGYLPFHDRNVMAMYKKIYRGEFRCPRWFSTELTRLLSK 259
Query: 246 ILDPNPSTRVTMAKLMENYWFRKGYKKI----ETPESPRGQDRNKLISDIHAVFECESSS 301
+L+ NP R T ++MEN WF+KG+K I E + D ++L SD +V S+
Sbjct: 260 LLETNPEKRFTFPEIMENSWFKKGFKHIKFYVEDDKLCNVVDDDELESD--SVESDRDSA 317
Query: 302 SRDTD----PPTNSCRSPVRPSSFNAFDIISLSKGFNLSGLFEGDANSKLEARFTTTKPA 357
+ +++ P RP+S NAFDIIS S+GF+LSGLF+ D +RF + P
Sbjct: 318 ASESEIEYLEPRRRVGGLPRPASLNAFDIISFSQGFDLSGLFDDDGEG---SRFVSGAPV 374
Query: 358 SAIVSKFEEIAVTESCKFNKKDGTVKLQHNRQGRKGQLAVDAEIFEVTPAFHVVELKKAA 417
S I+SK EEIA S KKD V L+ +RQG KG L + AEIFE+TP+ VVE+KK
Sbjct: 375 SKIISKLEEIAKVVSFTVRKKDCRVSLEGSRQGVKGPLTIAAEIFELTPSLVVVEVKKKG 434
Query: 418 GDTMEYKDFCNQGLRPSLKDI 438
GD EY+DFCN L+P L+++
Sbjct: 435 GDKTEYEDFCNNELKPKLQNL 455
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6H7U5|CIPKQ_ORYSJ CBL-interacting protein kinase 26 OS=Oryza sativa subsp. japonica GN=CIPK26 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 532 bits (1371), Expect = e-150, Method: Compositional matrix adjust.
Identities = 260/469 (55%), Positives = 347/469 (73%), Gaps = 22/469 (4%)
Query: 1 MEKKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKRE 60
M+ + ILM++YE+GR LGQG FAKVY+ RNL +GQ+VAIK++DKEK+ RVGL+ QIKRE
Sbjct: 1 MDDRRTILMDRYEIGRQLGQGNFAKVYYARNLTSGQAVAIKMIDKEKVTRVGLMVQIKRE 60
Query: 61 ISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVD 120
IS+MRLV+HPNI+QL+EVMASK+KIYF +EY +GGELF K++KGK E+VAR+YF QL+
Sbjct: 61 ISIMRLVKHPNILQLFEVMASKSKIYFVLEYAKGGELFKKISKGKFSEDVARRYFHQLIS 120
Query: 121 AVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAP 180
+++CHSRGVYHRDLKPENLLLDEN LK+SDFGLSAL ES R DGLLHTTCGTPAYVAP
Sbjct: 121 GIDYCHSRGVYHRDLKPENLLLDENESLKVSDFGLSALSESKRHDGLLHTTCGTPAYVAP 180
Query: 181 EVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVR 240
EV+++RGYDGAKADIWSCGV+LFVL++G LPF+D+NL+E+Y+KI +AE+KCP F E++
Sbjct: 181 EVLSRRGYDGAKADIWSCGVILFVLVSGYLPFHDTNLIEMYRKIAKAEYKCPRSFSAELK 240
Query: 241 KLLSRILDPNPSTRVTMAKLMENYWFRKGY------KKIETPESPRGQDRNKLISDIHAV 294
LL +ILDP+PSTR+++ K+ + W+RK K ET + + + ++
Sbjct: 241 DLLYKILDPDPSTRISIPKIKRSAWYRKSSDVNALKSKHETGDKVYKGEATTSDTTECSI 300
Query: 295 FECESSSSRD----------TDPP----TNSCRSPVRPSSFNAFDIISLSKGFNLSGLFE 340
FE +SSRD +D P ++ ++ + + NAFDIISLS GF+LS LFE
Sbjct: 301 FEGNRASSRDKVYTNGEATTSDSPECSNSDGKQASLSLPNLNAFDIISLSTGFDLSNLFE 360
Query: 341 GDANSKLEARFTTTKPASAIVSKFEEIAVTESCKFNKKD-GTVKLQHNRQGRKGQLAVDA 399
+ + E RFTT +PA+AI +K E+A K KK+ G ++L ++G KG L +DA
Sbjct: 361 -ERYGRREERFTTRQPAAAIFAKLNELARRFKLKIKKKENGVLRLVAPKEGIKGLLELDA 419
Query: 400 EIFEVTPAFHVVELKKAAGDTMEYKDFCNQGLRPSLKDIVWTWQGNDEQ 448
E+FE+ P+FH+VE KK+ GDT+EY+ + +RP+LKDIVW WQG Q
Sbjct: 420 EVFELAPSFHLVEFKKSNGDTIEYQKLMKEDIRPALKDIVWAWQGGQHQ 468
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2QYM3|CIPKE_ORYSJ CBL-interacting protein kinase 14 OS=Oryza sativa subsp. japonica GN=CIPK14 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 531 bits (1368), Expect = e-150, Method: Compositional matrix adjust.
Identities = 258/448 (57%), Positives = 334/448 (74%), Gaps = 11/448 (2%)
Query: 1 MEKKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKRE 60
ME + ILM +YELGRLLG+GTF KV++ RNL++ QSVAIK++DK+++ +VGL +QI+RE
Sbjct: 1 MESRGKILMERYELGRLLGKGTFGKVHYARNLESNQSVAIKMMDKQQVLKVGLSEQIRRE 60
Query: 61 ISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLV 119
I+ MRLV H NIVQL+EVMA++ KIYF MEYV+GGELF KVAK GKL E VA KYFQQL+
Sbjct: 61 ITTMRLVAHKNIVQLHEVMATRNKIYFVMEYVKGGELFEKVAKRGKLTEVVAHKYFQQLI 120
Query: 120 DAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVA 179
AV++CHSRGVYHRDLKPENLLLDEN +LK+SDFGLSAL ES RQDGLLHTTCGTPAYVA
Sbjct: 121 SAVDYCHSRGVYHRDLKPENLLLDENENLKVSDFGLSALSESKRQDGLLHTTCGTPAYVA 180
Query: 180 PEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEV 239
PEVI+K GYDGAK+DIWSCGV+LFVL+AG LPF NLME+Y+KI EF+CP WF ++
Sbjct: 181 PEVISKIGYDGAKSDIWSCGVILFVLVAGYLPFQGPNLMEMYRKIQHGEFRCPGWFSRKL 240
Query: 240 RKLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIETPESPRGQDRNKLISDIHAVFECES 299
+KLL +I+DPNPSTR+++ K+ E+ WFRKG PE R L +
Sbjct: 241 QKLLYKIMDPNPSTRISIQKIKESTWFRKG------PEENRILKERTLNENTTKNVALVL 294
Query: 300 SSSRDTDPPTNSCRSPVRPSSFNAFDIISLSKGFNLSGLFEGDANSKLEARFTTTKPASA 359
R + + P+ ++ NAF+IIS SKGF+LSG+F + EARFT+ K AS
Sbjct: 295 GVRRKKNAHEDV--KPMSVTNLNAFEIISFSKGFDLSGMFI-VKEWRNEARFTSDKSAST 351
Query: 360 IVSKFEEIAVTESCKFNKKD-GTVKLQHNRQGRKGQLAVDAEIFEVTPAFHVVELKKAAG 418
I+SK E++A + + KKD G VK+Q ++GR G L D EIFEVT ++H++E+K+ +G
Sbjct: 352 IISKLEDVAKALNLRVRKKDNGVVKMQGRKEGRNGVLQFDIEIFEVTTSYHIIEMKQTSG 411
Query: 419 DTMEYKDFCNQGLRPSLKDIVWTWQGND 446
D++EY+ +G+RP+LKDIV W G++
Sbjct: 412 DSLEYRQLLEEGIRPALKDIVLAWHGDE 439
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 448 | ||||||
| 255562434 | 459 | CBL-interacting serine/threonine-protein | 0.997 | 0.973 | 0.767 | 0.0 | |
| 224116868 | 451 | predicted protein [Populus trichocarpa] | 0.993 | 0.986 | 0.728 | 0.0 | |
| 449464994 | 463 | PREDICTED: CBL-interacting protein kinas | 0.995 | 0.963 | 0.729 | 0.0 | |
| 225443776 | 450 | PREDICTED: CBL-interacting protein kinas | 0.979 | 0.975 | 0.728 | 0.0 | |
| 115435174 | 461 | Os01g0206700 [Oryza sativa Japonica Grou | 0.975 | 0.947 | 0.693 | 0.0 | |
| 15242509 | 439 | CBL-interacting serine/threonine-protein | 0.941 | 0.961 | 0.700 | 0.0 | |
| 297791135 | 439 | cbl-interacting protein kinase 20 [Arabi | 0.944 | 0.963 | 0.695 | 0.0 | |
| 326522302 | 464 | predicted protein [Hordeum vulgare subsp | 0.964 | 0.931 | 0.688 | 0.0 | |
| 357127243 | 460 | PREDICTED: CBL-interacting protein kinas | 0.977 | 0.952 | 0.664 | 1e-180 | |
| 242051653 | 455 | hypothetical protein SORBIDRAFT_03g00234 | 0.975 | 0.960 | 0.674 | 1e-180 |
| >gi|255562434|ref|XP_002522223.1| CBL-interacting serine/threonine-protein kinase, putative [Ricinus communis] gi|223538476|gb|EEF40081.1| CBL-interacting serine/threonine-protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 738 bits (1905), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 350/456 (76%), Positives = 400/456 (87%), Gaps = 9/456 (1%)
Query: 1 MEKKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKRE 60
MEKK ILMN+YELGRLLG+GTFAKVYH RNL++ QSVAIKI+DKEK+ + GLIDQIKRE
Sbjct: 1 MEKKGAILMNRYELGRLLGKGTFAKVYHARNLQSNQSVAIKIIDKEKVLKSGLIDQIKRE 60
Query: 61 ISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVD 120
ISVMRLVRHPNIVQLYEVMASKTKIYFAMEYV+GGELFNKVAKGKL+E+VARKYFQQL+
Sbjct: 61 ISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVKGGELFNKVAKGKLKEDVARKYFQQLIG 120
Query: 121 AVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAP 180
AVEFCHSRGVYHRD+KPENLLLDENGDLKISDFGLSAL ES +QDGLLHTTCGTPAYVAP
Sbjct: 121 AVEFCHSRGVYHRDIKPENLLLDENGDLKISDFGLSALHESRKQDGLLHTTCGTPAYVAP 180
Query: 181 EVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVR 240
E+INK+GYDGAKADIWSCGVVLFVLLAG LPF DSNLMELYKKI R EF+CPNWF PE R
Sbjct: 181 EIINKKGYDGAKADIWSCGVVLFVLLAGYLPFCDSNLMELYKKIIRGEFRCPNWFHPEAR 240
Query: 241 KLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIETPESPRGQDRNKLISDIHAVFECESS 300
KL+SRILDP+PSTR+TMA++M N WF+KGYK+IETP SP+G+ RN L+ D+HA F+ SS
Sbjct: 241 KLVSRILDPHPSTRITMARIMNNCWFKKGYKQIETPPSPQGKARNTLLKDVHAAFDSSSS 300
Query: 301 SSRD--------TDPPTNSCRSPVRPSSFNAFDIISLSKGFNLSGLFEGDANSKLEARFT 352
+ +D T + RSP+RP+++NAFDIISLSKGF+LSGLFE D+N + EARFT
Sbjct: 301 DNESINLQKEVASDDHTIT-RSPLRPTNYNAFDIISLSKGFDLSGLFEKDSNQRSEARFT 359
Query: 353 TTKPASAIVSKFEEIAVTESCKFNKKDGTVKLQHNRQGRKGQLAVDAEIFEVTPAFHVVE 412
+TKPAS IVSKF+EIA+TES FNKKDG VKLQ ++GRKGQL +DAEIFEVTP+F VVE
Sbjct: 360 STKPASTIVSKFQEIAMTESFSFNKKDGKVKLQGYKEGRKGQLGIDAEIFEVTPSFFVVE 419
Query: 413 LKKAAGDTMEYKDFCNQGLRPSLKDIVWTWQGNDEQ 448
+KK +GDT EYKDF +Q L+PSLKDIVW WQG+ EQ
Sbjct: 420 MKKTSGDTWEYKDFYDQELKPSLKDIVWAWQGSTEQ 455
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224116868|ref|XP_002317414.1| predicted protein [Populus trichocarpa] gi|116265940|gb|ABJ91218.1| CBL-interacting protein kinase 11 [Populus trichocarpa] gi|222860479|gb|EEE98026.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 696 bits (1797), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 328/450 (72%), Positives = 390/450 (86%), Gaps = 5/450 (1%)
Query: 1 MEKKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKRE 60
MEK ILMN+YELGRLLGQGTFAKVYH RNL++GQSVAIKI+DK K+ R GLIDQIKRE
Sbjct: 1 MEKMGPILMNRYELGRLLGQGTFAKVYHARNLQSGQSVAIKIIDKGKVLRSGLIDQIKRE 60
Query: 61 ISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVD 120
ISVMRLVRHPNIVQL EVMAS+TKIYF ME+V+GGELFN V+KGKL+E+VARKYFQQL+
Sbjct: 61 ISVMRLVRHPNIVQLNEVMASRTKIYFVMEFVKGGELFNLVSKGKLKEDVARKYFQQLIG 120
Query: 121 AVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAP 180
AV+FCHSRGVYHRDLKPENLLLDENGDLKI+DFGLSAL ES RQDGLLHTTCGTPAYVAP
Sbjct: 121 AVDFCHSRGVYHRDLKPENLLLDENGDLKITDFGLSALSESRRQDGLLHTTCGTPAYVAP 180
Query: 181 EVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVR 240
EVINK+GYDG KADIWSCGV+LFVLLAG LPF+D NLMELY+KIT+ EF+CPNWF PE +
Sbjct: 181 EVINKKGYDGPKADIWSCGVILFVLLAGFLPFHDQNLMELYRKITKGEFRCPNWFHPEAK 240
Query: 241 KLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIETPESPRGQDRNKLISDIHAVFECESS 300
KLLSRILDP+PS+R ++ K+ +N WFRKGYK+IETP SP+G R+ LI D+H+ F +S+
Sbjct: 241 KLLSRILDPHPSSRTSIEKITKNCWFRKGYKQIETPPSPQGHARSNLIKDVHSAF--DSA 298
Query: 301 SSRDTDPPTN---SCRSPVRPSSFNAFDIISLSKGFNLSGLFEGDANSKLEARFTTTKPA 357
S +++ N + RSP+RP+ +NAFDIISLSKGF+LSGLFE D N + EARFTTTK A
Sbjct: 299 SDNESNSRENVMVAPRSPLRPTCYNAFDIISLSKGFDLSGLFEKDKNRRQEARFTTTKSA 358
Query: 358 SAIVSKFEEIAVTESCKFNKKDGTVKLQHNRQGRKGQLAVDAEIFEVTPAFHVVELKKAA 417
S I+SKFE+IA+ ES F KKDGT+ L+ +R+GRKG LA+DAEI EVTP+F+VVE+KK +
Sbjct: 359 SMIMSKFEQIAMAESFSFKKKDGTLMLEGSREGRKGLLAIDAEICEVTPSFYVVEMKKKS 418
Query: 418 GDTMEYKDFCNQGLRPSLKDIVWTWQGNDE 447
GD+ EYK+FC+ L+PSLKDIVW WQG+++
Sbjct: 419 GDSFEYKEFCDHELKPSLKDIVWAWQGSEQ 448
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449464994|ref|XP_004150214.1| PREDICTED: CBL-interacting protein kinase 5-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 693 bits (1788), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 331/454 (72%), Positives = 386/454 (85%), Gaps = 8/454 (1%)
Query: 1 MEKKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKRE 60
MEKK ILM +YELGR+LGQGTFAKVYH RNLK+GQSVAIKI+DKEK+ RVGLIDQIKRE
Sbjct: 1 MEKKGSILMQRYELGRMLGQGTFAKVYHARNLKSGQSVAIKIIDKEKVLRVGLIDQIKRE 60
Query: 61 ISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVD 120
ISVMRLVRHPN+VQLYEVMAS+TKIYFAMEYVRGGELFNKVAKGKL+E+ ARKYFQQL+
Sbjct: 61 ISVMRLVRHPNVVQLYEVMASRTKIYFAMEYVRGGELFNKVAKGKLKEDAARKYFQQLIG 120
Query: 121 AVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAP 180
AV++CHSRGVYHRD+KPENLLLDE G+LKISDFGLSAL ES RQDGLLHTTCGTPAYVAP
Sbjct: 121 AVDYCHSRGVYHRDIKPENLLLDEYGNLKISDFGLSALAESRRQDGLLHTTCGTPAYVAP 180
Query: 181 EVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVR 240
EVINK+GYDGAKADIWS GVVLFVLLAG LPF+D NLME+Y+KI+R EFKCP WFPPEVR
Sbjct: 181 EVINKKGYDGAKADIWSSGVVLFVLLAGYLPFHDPNLMEMYRKISRGEFKCPQWFPPEVR 240
Query: 241 KLLSRILDPNPSTRVTMAKLMENYWFRKGYKK-IETPESPRGQD-------RNKLISDIH 292
KLLSRILDP+P TR+ MAKLMEN WF+KG+K+ + TP+ + + + SDI
Sbjct: 241 KLLSRILDPSPRTRINMAKLMENSWFKKGFKENVTTPKQLQNDEDMSSVSDVSSAFSDIS 300
Query: 293 AVFECESSSSRDTDPPTNSCRSPVRPSSFNAFDIISLSKGFNLSGLFEGDANSKLEARFT 352
+ S++ ++ P + R+P+R +SFNAFD+ISLS GF+LSGLFE D N +L++RFT
Sbjct: 301 SEGGSSVSNTNESGRPPTATRAPIRNNSFNAFDLISLSPGFDLSGLFESDVNERLQSRFT 360
Query: 353 TTKPASAIVSKFEEIAVTESCKFNKKDGTVKLQHNRQGRKGQLAVDAEIFEVTPAFHVVE 412
TTKPASAIVSK EEIA E K KKDG VKLQ ++QGRKGQLA+DAEIFEVTP+F VVE
Sbjct: 361 TTKPASAIVSKLEEIAEMERFKVMKKDGIVKLQGSKQGRKGQLAIDAEIFEVTPSFSVVE 420
Query: 413 LKKAAGDTMEYKDFCNQGLRPSLKDIVWTWQGND 446
+KK AGDT+EY+ F ++ +RP LKDIVWTW+GN+
Sbjct: 421 VKKTAGDTLEYRQFYDKDMRPCLKDIVWTWEGNE 454
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225443776|ref|XP_002271643.1| PREDICTED: CBL-interacting protein kinase 5 isoform 1 [Vitis vinifera] gi|229609833|gb|ACQ83532.1| CBL-interacting protein kinase 16 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 681 bits (1756), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 324/445 (72%), Positives = 379/445 (85%), Gaps = 6/445 (1%)
Query: 1 MEKKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKRE 60
MEKK ILM +YE+GR+LGQGTFAKVYH RNLK+GQSVAIK++DKEK+ +VGLIDQIKRE
Sbjct: 1 MEKKGVILMQRYEMGRMLGQGTFAKVYHARNLKSGQSVAIKMIDKEKVLKVGLIDQIKRE 60
Query: 61 ISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVD 120
ISVMRLVRHPN+VQLYEVMASKTKIYF MEYV+GGELFNKVAKGKL+E+ ARKYFQQL+
Sbjct: 61 ISVMRLVRHPNVVQLYEVMASKTKIYFVMEYVKGGELFNKVAKGKLKEDAARKYFQQLIG 120
Query: 121 AVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAP 180
AV+FCHSRGVYHRDLKPENLLLDENGDLK++DFGLSAL +S R DGLLHTTCGTPAYVAP
Sbjct: 121 AVDFCHSRGVYHRDLKPENLLLDENGDLKVTDFGLSALWDSRRHDGLLHTTCGTPAYVAP 180
Query: 181 EVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVR 240
EVINK+GYDGAKAD+WSCGV+LFVL+AG LPF+D NLME+Y+KI+R EFKCP WFP EVR
Sbjct: 181 EVINKKGYDGAKADMWSCGVILFVLMAGFLPFHDPNLMEMYRKISRGEFKCPQWFPLEVR 240
Query: 241 KLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIETPESPRGQDRNKLISDIHAVFECESS 300
KLLS+ILDP+PSTR+T+AKLM+N WF+KG+K I P+ +RN +SD+ AVF
Sbjct: 241 KLLSKILDPSPSTRITVAKLMDNPWFKKGFKPIVAPQP----NRNDSMSDVRAVFATHPE 296
Query: 301 SSRDTDPPTNSCRSPVRPSSFNAFDIISLSKGFNLSGLFEGDANSKLEARFTTTKPASAI 360
+ + + S ++P+ NAFDIISLS GF+LSGLFE D N + +ARFTT +PAS I
Sbjct: 297 GTSEEE--AEETTSSMKPTCLNAFDIISLSPGFDLSGLFEKDTNHRPDARFTTKQPASTI 354
Query: 361 VSKFEEIAVTESCKFNKKDGTVKLQHNRQGRKGQLAVDAEIFEVTPAFHVVELKKAAGDT 420
VSK EEIA E K KKDGTVKLQ +++GRKGQLA+DAEIFEVTP+ VVE+KK AGDT
Sbjct: 355 VSKLEEIAEMERFKVKKKDGTVKLQGSKEGRKGQLAIDAEIFEVTPSLFVVEVKKTAGDT 414
Query: 421 MEYKDFCNQGLRPSLKDIVWTWQGN 445
+EYK FCNQ L+PSLKDIVWTWQG+
Sbjct: 415 LEYKKFCNQDLKPSLKDIVWTWQGS 439
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|115435174|ref|NP_001042345.1| Os01g0206700 [Oryza sativa Japonica Group] gi|75335591|sp|Q9LWM4.1|CIPK5_ORYSJ RecName: Full=CBL-interacting protein kinase 5; AltName: Full=OsCIPK05 gi|7340882|dbj|BAA92972.1| putative CBL-interacting protein kinase 2 [Oryza sativa Japonica Group] gi|20804455|dbj|BAB92151.1| putative CBL-interacting protein kinase 2 [Oryza sativa Japonica Group] gi|113531876|dbj|BAF04259.1| Os01g0206700 [Oryza sativa Japonica Group] gi|125524847|gb|EAY72961.1| hypothetical protein OsI_00833 [Oryza sativa Indica Group] gi|125569457|gb|EAZ10972.1| hypothetical protein OsJ_00815 [Oryza sativa Japonica Group] gi|189099609|gb|ACD76976.1| CBL-interacting protein kinase 5 [Oryza sativa Japonica Group] gi|215686724|dbj|BAG89574.1| unnamed protein product [Oryza sativa Japonica Group] | Back alignment and taxonomy information |
|---|
Score = 657 bits (1694), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 307/443 (69%), Positives = 371/443 (83%), Gaps = 6/443 (1%)
Query: 1 MEKKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKRE 60
MEKKA ILMN+YELGR+LGQGTFAKVYH RNL + QSVAIK++DKEK+ RVG+IDQIKRE
Sbjct: 1 MEKKASILMNRYELGRMLGQGTFAKVYHARNLASNQSVAIKVIDKEKVLRVGMIDQIKRE 60
Query: 61 ISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVD 120
IS+MRLVRHPNIVQL+EVMASK+KIYFAMEYVRGGELF++VA+G+L+E+ ARKYFQQL+
Sbjct: 61 ISIMRLVRHPNIVQLHEVMASKSKIYFAMEYVRGGELFSRVARGRLKEDAARKYFQQLIG 120
Query: 121 AVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAP 180
AV+FCHSRGVYHRDLKPENLL+DENG+LK+SDFGLSA +E +QDGLLHTTCGTPAYVAP
Sbjct: 121 AVDFCHSRGVYHRDLKPENLLVDENGNLKVSDFGLSAFKECQKQDGLLHTTCGTPAYVAP 180
Query: 181 EVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVR 240
E+INKRGYDGAKADIWSCGV+LFVLLAG LPF+DSNLME+Y+KI++ + K P WF +VR
Sbjct: 181 EIINKRGYDGAKADIWSCGVILFVLLAGYLPFHDSNLMEMYRKISKGDVKFPQWFTTDVR 240
Query: 241 KLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIETPESPRGQDRNKLISDIHAVFECESS 300
+LLSR+LDPNP+ R+T+ KL+E+ WF+KGYK P + + D+H F S+
Sbjct: 241 RLLSRLLDPNPNIRITVEKLVEHPWFKKGYKPAVMLSQPNESNN---LKDVHTAF---SA 294
Query: 301 SSRDTDPPTNSCRSPVRPSSFNAFDIISLSKGFNLSGLFEGDANSKLEARFTTTKPASAI 360
+D + S ++P S NAFDIISLSKGF+LSGLFE D K ++RF T KPASAI
Sbjct: 295 DHKDNEGKAKEPASSLKPVSLNAFDIISLSKGFDLSGLFENDKEQKADSRFMTQKPASAI 354
Query: 361 VSKFEEIAVTESCKFNKKDGTVKLQHNRQGRKGQLAVDAEIFEVTPAFHVVELKKAAGDT 420
VSK E+IA TES K K+DG VKLQ +++GRKGQLA+DAEIFEVTP+F VVE+KK+AGDT
Sbjct: 355 VSKLEQIAETESFKVKKQDGLVKLQGSKEGRKGQLAIDAEIFEVTPSFFVVEVKKSAGDT 414
Query: 421 MEYKDFCNQGLRPSLKDIVWTWQ 443
+EY+ FCN+GLRPSL+DI W Q
Sbjct: 415 LEYEKFCNKGLRPSLRDICWDGQ 437
|
Source: Oryza sativa Japonica Group Species: Oryza sativa Genus: Oryza Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15242509|ref|NP_199394.1| CBL-interacting serine/threonine-protein kinase 20 [Arabidopsis thaliana] gi|75333940|sp|Q9FJ54.1|CIPKK_ARATH RecName: Full=CBL-interacting serine/threonine-protein kinase 20; AltName: Full=SNF1-related kinase 3.6; AltName: Full=SOS2-like protein kinase PKS18 gi|9758929|dbj|BAB09310.1| serine/threonine protein kinase [Arabidopsis thaliana] gi|14486384|gb|AAK61493.1| CBL-interacting protein kinase 20 [Arabidopsis thaliana] gi|62320368|dbj|BAD94760.1| CBL-interacting protein kinase 20 [Arabidopsis thaliana] gi|114213525|gb|ABI54345.1| At5g45820 [Arabidopsis thaliana] gi|332007920|gb|AED95303.1| CBL-interacting serine/threonine-protein kinase 20 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 655 bits (1690), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 313/447 (70%), Positives = 374/447 (83%), Gaps = 25/447 (5%)
Query: 1 MEKKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKRE 60
M+K +LM KYELGRLLGQGTFAKVYH RN+KTG+SVAIK++DK+K+ +VGLIDQIKRE
Sbjct: 1 MDKNGIVLMRKYELGRLLGQGTFAKVYHARNIKTGESVAIKVIDKQKVAKVGLIDQIKRE 60
Query: 61 ISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVD 120
ISVMRLVRHP++V L+EVMASKTKIYFAMEYV+GGELF+KV+KGKL+E +ARKYFQQL+
Sbjct: 61 ISVMRLVRHPHVVFLHEVMASKTKIYFAMEYVKGGELFDKVSKGKLKENIARKYFQQLIG 120
Query: 121 AVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAP 180
A+++CHSRGVYHRDLKPENLLLDENGDLKISDFGLSAL+ES +QDGLLHTTCGTPAYVAP
Sbjct: 121 AIDYCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALRESKQQDGLLHTTCGTPAYVAP 180
Query: 181 EVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVR 240
EVI K+GYDGAKAD+WSCGVVL+VLLAG LPF++ NL+E+Y+KIT+ EFKCPNWFPPEV+
Sbjct: 181 EVIGKKGYDGAKADVWSCGVVLYVLLAGFLPFHEQNLVEMYRKITKGEFKCPNWFPPEVK 240
Query: 241 KLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIETPESPRGQDRNKLISDIHAVFECESS 300
KLLSRILDPNP++R+ + K+MEN WF+KG+KKIETP+SP + LISD+HA F
Sbjct: 241 KLLSRILDPNPNSRIKIEKIMENSWFQKGFKKIETPKSPESHQIDSLISDVHAAF----- 295
Query: 301 SSRDTDPPTNSCRSPVRPSSFNAFDII-SLSKGFNLSGLFEGDANSKLEARFTTTKPASA 359
V+P S+NAFD+I SLS+GF+LSGLFE + S E++FTT K A
Sbjct: 296 --------------SVKPMSYNAFDLISSLSQGFDLSGLFEKEERS--ESKFTTKKDAKE 339
Query: 360 IVSKFEEIAVTESCKFN--KKDGTVKLQHNRQGRKGQLAVDAEIFEVTPAFHVVELKKAA 417
IVSKFEEIA T S +FN K D VK++ R+GRKG LA+D EIFEVT +FH+VE KK+
Sbjct: 340 IVSKFEEIA-TSSERFNLTKSDVGVKMEDKREGRKGHLAIDVEIFEVTNSFHMVEFKKSG 398
Query: 418 GDTMEYKDFCNQGLRPSLKDIVWTWQG 444
GDTMEYK FC++ LRPSLKDIVW WQG
Sbjct: 399 GDTMEYKQFCDRELRPSLKDIVWKWQG 425
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297791135|ref|XP_002863452.1| cbl-interacting protein kinase 20 [Arabidopsis lyrata subsp. lyrata] gi|297309287|gb|EFH39711.1| cbl-interacting protein kinase 20 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 654 bits (1686), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 310/446 (69%), Positives = 373/446 (83%), Gaps = 23/446 (5%)
Query: 1 MEKKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKRE 60
M+K +LM KYELGRLLGQGTFAKVYH RN+KTG+SVAIK++DK+K+ +VGLIDQIKRE
Sbjct: 1 MDKNGIVLMRKYELGRLLGQGTFAKVYHARNIKTGESVAIKVIDKQKVAKVGLIDQIKRE 60
Query: 61 ISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVD 120
ISVMRLVRHPN+V L+EVMASKTKIYFAMEYV GGELF+KV+KGKL+E++ARKYFQQL+
Sbjct: 61 ISVMRLVRHPNVVFLHEVMASKTKIYFAMEYVTGGELFDKVSKGKLKEDIARKYFQQLIG 120
Query: 121 AVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAP 180
A+++CHSRGVYHRDLKPENLLLDENGDLKISDFGLSAL+ES +QDGLLHTTCGTPAYVAP
Sbjct: 121 AIDYCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALRESKQQDGLLHTTCGTPAYVAP 180
Query: 181 EVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVR 240
EVI K+GYDGAKAD+WSCGVVL+VLLAG LPF++ NL+E+Y+KIT+ EFKCPNWFPPEV+
Sbjct: 181 EVIGKKGYDGAKADVWSCGVVLYVLLAGFLPFHEQNLVEMYRKITKGEFKCPNWFPPEVK 240
Query: 241 KLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIETPESPRGQDRNKLISDIHAVFECESS 300
KLLSRILDPNP++R+ + K+MEN WF+KG+KKIETP+SP + LISD+HA F
Sbjct: 241 KLLSRILDPNPNSRIKIDKIMENSWFQKGFKKIETPKSPDSHQIDSLISDVHAAF----- 295
Query: 301 SSRDTDPPTNSCRSPVRPSSFNAFDII-SLSKGFNLSGLFEGDANSKLEARFTTTKPASA 359
V+P S+NAFD+I SLS+GF+LSGLFE + S E++FTT K A
Sbjct: 296 --------------SVKPMSYNAFDLISSLSQGFDLSGLFEKEERS--ESKFTTKKEAKE 339
Query: 360 IVSKFEEIAV-TESCKFNKKDGTVKLQHNRQGRKGQLAVDAEIFEVTPAFHVVELKKAAG 418
IVSKFEEIA+ +E K + VK++ R+GRKGQLA+D EIFEVT +FH+VE KK+ G
Sbjct: 340 IVSKFEEIALSSERFNLTKSNVGVKMEDKREGRKGQLAIDVEIFEVTKSFHMVEFKKSGG 399
Query: 419 DTMEYKDFCNQGLRPSLKDIVWTWQG 444
DTMEYK FC++ L+PSLKDIVW WQG
Sbjct: 400 DTMEYKQFCDRELKPSLKDIVWKWQG 425
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|326522302|dbj|BAK07613.1| predicted protein [Hordeum vulgare subsp. vulgare] | Back alignment and taxonomy information |
|---|
Score = 642 bits (1657), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 305/443 (68%), Positives = 369/443 (83%), Gaps = 11/443 (2%)
Query: 1 MEKKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKRE 60
ME+K+ ILMN+YELGR+LGQGTFAKVYH R+L T QSVAIK++DKEK+ RVG+IDQIKRE
Sbjct: 1 MERKSTILMNRYELGRMLGQGTFAKVYHARSLATNQSVAIKVIDKEKVLRVGMIDQIKRE 60
Query: 61 ISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVD 120
IS+MRLVRHPNIVQL+EVMASK+KIYFAMEYVRGGELF +VAKG+L+E+ ARKYFQQL+
Sbjct: 61 ISIMRLVRHPNIVQLHEVMASKSKIYFAMEYVRGGELFARVAKGRLKEDAARKYFQQLIG 120
Query: 121 AVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAP 180
AV+FCHSR VYHRDLKPENLL+DE+G+LK+SDFGLSAL+E +QDGLLHTTCGTPAYVAP
Sbjct: 121 AVDFCHSRDVYHRDLKPENLLVDEHGNLKVSDFGLSALKECQKQDGLLHTTCGTPAYVAP 180
Query: 181 EVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVR 240
E+INK+GYDG KADIWSCGV+LFVLLAG LPF DSNLME+Y+KI++ + + P WF + R
Sbjct: 181 EIINKKGYDGEKADIWSCGVILFVLLAGYLPFQDSNLMEMYRKISKGDVRYPQWFSSDAR 240
Query: 241 KLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIETPESPRGQDRNKLISDIHAVFEC--- 297
KLL R+LDPNP+TR+TM KL+E+ WF+KGYK +PR +K ++D+ A F
Sbjct: 241 KLLCRLLDPNPNTRITMDKLIEHPWFKKGYKPAVMLGTPRA---SKDLNDVQAAFSTDHK 297
Query: 298 ESSSSRDTDPPTNSCRSPVRPSSFNAFDIISLSKGFNLSGLFEGDANSKLEARFTTTKPA 357
+ SR P SP++P+S NAFDIISLSKGF+LSGLFE D K +RF T KPA
Sbjct: 298 DGEGSRAEQP-----NSPLKPASLNAFDIISLSKGFDLSGLFEKDQEQKSNSRFMTQKPA 352
Query: 358 SAIVSKFEEIAVTESCKFNKKDGTVKLQHNRQGRKGQLAVDAEIFEVTPAFHVVELKKAA 417
SAIVSK E+IA TES K K+DG V LQ +++GRKGQLA+DAEIFEVTP+F+VVE+KK+A
Sbjct: 353 SAIVSKLEQIAETESFKVKKQDGLVTLQGSKEGRKGQLAIDAEIFEVTPSFYVVEVKKSA 412
Query: 418 GDTMEYKDFCNQGLRPSLKDIVW 440
GDT+EY+ FC +GLRPSLKDI W
Sbjct: 413 GDTLEYERFCKKGLRPSLKDICW 435
|
Source: Hordeum vulgare subsp. vulgare Species: Hordeum vulgare Genus: Hordeum Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357127243|ref|XP_003565293.1| PREDICTED: CBL-interacting protein kinase 5-like [Brachypodium distachyon] | Back alignment and taxonomy information |
|---|
Score = 636 bits (1641), Expect = e-180, Method: Compositional matrix adjust.
Identities = 297/447 (66%), Positives = 372/447 (83%), Gaps = 9/447 (2%)
Query: 1 MEKKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKRE 60
MEKKA ILMN+YELGR+LGQGTFAKVYH R+L + QSVAIK++DKEK+ RVG+I+QIKRE
Sbjct: 1 MEKKAAILMNRYELGRMLGQGTFAKVYHARHLASNQSVAIKVIDKEKVLRVGMIEQIKRE 60
Query: 61 ISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVD 120
IS+MRLVRHPN+V L+EVMASK+KIYFAMEYVRGGELF KVA+G+L+E+ ARKYFQQL+
Sbjct: 61 ISIMRLVRHPNVVHLHEVMASKSKIYFAMEYVRGGELFGKVARGRLKEDAARKYFQQLIG 120
Query: 121 AVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAP 180
AV+FCHSRGVYHRDLKPENLL+DE+G+LK+SDFGLSAL+E +QDGLLHTTCGTPAYVAP
Sbjct: 121 AVDFCHSRGVYHRDLKPENLLVDEHGNLKVSDFGLSALKECQKQDGLLHTTCGTPAYVAP 180
Query: 181 EVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVR 240
E+INK+GYDGAKADIWSCG++LFVLLAG LPF DSNL+E+Y+KI++ + + P+WF +VR
Sbjct: 181 EIINKKGYDGAKADIWSCGIILFVLLAGYLPFQDSNLVEMYRKISKGDVRYPHWFTSDVR 240
Query: 241 KLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIETPESPRGQDRNKLISDIHAVFECESS 300
KLL ++LDPNP++R+T+ KL+E+ WF+KGYK P G + ++D+ A F +
Sbjct: 241 KLLCKLLDPNPNSRITIEKLVEHPWFKKGYKPAVMLGQPHGSNS---LTDVQAAFGTDQK 297
Query: 301 SSRDTDPPTNSCRSPVRPSSFNAFDIISLSKGFNLSGLFEGDANSKLEARFTTTKPASAI 360
++ P SP++P S NAFDIISLSKGF+LSGLF+ D K +RF T KPASAI
Sbjct: 298 DNKAEQP-----ESPLKPVSLNAFDIISLSKGFDLSGLFD-DQEQKANSRFMTQKPASAI 351
Query: 361 VSKFEEIAVTESCKFNKKDGTVKLQHNRQGRKGQLAVDAEIFEVTPAFHVVELKKAAGDT 420
VSK E+IA TES K K+DG VKLQ +++GRKGQLA+DAEIFEVTP+F+VVE+KK+AGDT
Sbjct: 352 VSKLEQIAETESFKVKKQDGLVKLQGSKEGRKGQLAIDAEIFEVTPSFYVVEVKKSAGDT 411
Query: 421 MEYKDFCNQGLRPSLKDIVWTWQGNDE 447
+EY+ FC + LRPSL DI W Q +++
Sbjct: 412 LEYERFCKKDLRPSLNDICWNGQSDEK 438
|
Source: Brachypodium distachyon Species: Brachypodium distachyon Genus: Brachypodium Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|242051653|ref|XP_002454972.1| hypothetical protein SORBIDRAFT_03g002340 [Sorghum bicolor] gi|229609761|gb|ACQ83496.1| CBL-interacting protein kinase 20 [Sorghum bicolor] gi|241926947|gb|EES00092.1| hypothetical protein SORBIDRAFT_03g002340 [Sorghum bicolor] | Back alignment and taxonomy information |
|---|
Score = 636 bits (1641), Expect = e-180, Method: Compositional matrix adjust.
Identities = 300/445 (67%), Positives = 368/445 (82%), Gaps = 8/445 (1%)
Query: 1 MEKKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKRE 60
MEKK ILMN+YELGR+LGQGTFAKVYHGRNL + QSVAIK++DKEK+ RVG+IDQIKRE
Sbjct: 1 MEKKPTILMNRYELGRMLGQGTFAKVYHGRNLASSQSVAIKVIDKEKVLRVGMIDQIKRE 60
Query: 61 ISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVD 120
ISVMRLVRHPN+VQL+EVMASK+KIYFAMEYVRGGELF +VA+G+L+E+VAR+YF QL+
Sbjct: 61 ISVMRLVRHPNVVQLHEVMASKSKIYFAMEYVRGGELFARVARGRLKEDVARRYFHQLIG 120
Query: 121 AVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAP 180
AV+FCHSRGVYHRDLKPENLL+DE+G+LK+SDFGLSAL+E +QDGLLHTTCGTPAYVAP
Sbjct: 121 AVDFCHSRGVYHRDLKPENLLVDEHGNLKVSDFGLSALKECQKQDGLLHTTCGTPAYVAP 180
Query: 181 EVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVR 240
E+I+K+GYDGAKADIWSCGV+LFVLLAG LPF+DSNLME+Y++I+R + K P WF ++R
Sbjct: 181 EIISKKGYDGAKADIWSCGVILFVLLAGYLPFHDSNLMEMYRRISRGDVKYPQWFSSDLR 240
Query: 241 KLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIETPESPRGQDRNKLISDIHAVFE-CES 299
+ +S++LDPNP+TR+T+ KL+E+ WF+KGYK P G + + D+ F ++
Sbjct: 241 RFMSKLLDPNPNTRITIEKLVEHPWFKKGYKPAVMLAQPHGSNS---LKDVQVAFSTADN 297
Query: 300 SSSRDTDPPTNSCRSPVRPSSFNAFDIISLSKGFNLSGLFEGDANSKLE-ARFTTTKPAS 358
+ P S V+PSS NAFDIIS SKGF+LSGLF D K +RF T KPAS
Sbjct: 298 EGGSKVEQPAGSS---VKPSSLNAFDIISHSKGFDLSGLFAVDQEQKASNSRFMTQKPAS 354
Query: 359 AIVSKFEEIAVTESCKFNKKDGTVKLQHNRQGRKGQLAVDAEIFEVTPAFHVVELKKAAG 418
AIVSK E+IA TES K+DG VKLQ +++GRKGQLA+DAEIFEVTPAF+VVE+KK+AG
Sbjct: 355 AIVSKLEQIAETESFMVKKQDGLVKLQGSKEGRKGQLAIDAEIFEVTPAFYVVEVKKSAG 414
Query: 419 DTMEYKDFCNQGLRPSLKDIVWTWQ 443
DT+EY+ FCN+GLRPSL DI W+ Q
Sbjct: 415 DTLEYERFCNKGLRPSLSDICWSSQ 439
|
Source: Sorghum bicolor Species: Sorghum bicolor Genus: Sorghum Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 448 | ||||||
| TAIR|locus:2152380 | 439 | CIPK20 "CBL-interacting protei | 0.671 | 0.685 | 0.760 | 1.6e-171 | |
| TAIR|locus:2161273 | 479 | SIP1 "SOS3-interacting protein | 0.995 | 0.931 | 0.608 | 2.1e-148 | |
| TAIR|locus:2169444 | 456 | CIPK2 "CBL-interacting protein | 0.979 | 0.962 | 0.597 | 1.4e-144 | |
| TAIR|locus:2126749 | 441 | SIP3 "SOS3-interacting protein | 0.933 | 0.947 | 0.595 | 1.2e-136 | |
| TAIR|locus:2124072 | 489 | CIPK12 "CBL-interacting protei | 0.957 | 0.877 | 0.591 | 5.2e-136 | |
| TAIR|locus:2181047 | 421 | CIPK15 "CBL-interacting protei | 0.618 | 0.657 | 0.741 | 1.1e-135 | |
| TAIR|locus:2152370 | 483 | CIPK19 "CBL-interacting protei | 0.957 | 0.888 | 0.585 | 6.9e-134 | |
| TAIR|locus:2029974 | 520 | CIPK18 "CBL-interacting protei | 0.962 | 0.828 | 0.567 | 5.6e-132 | |
| UNIPROTKB|Q84XC0 | 516 | Q84XC0 "Calcineurin B-like-int | 0.598 | 0.519 | 0.676 | 3.7e-131 | |
| TAIR|locus:2179260 | 488 | CIPK25 "CBL-interacting protei | 0.964 | 0.885 | 0.559 | 6.6e-129 |
| TAIR|locus:2152380 CIPK20 "CBL-interacting protein kinase 20" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1271 (452.5 bits), Expect = 1.6e-171, Sum P(2) = 1.6e-171
Identities = 229/301 (76%), Positives = 273/301 (90%)
Query: 1 MEKKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKRE 60
M+K +LM KYELGRLLGQGTFAKVYH RN+KTG+SVAIK++DK+K+ +VGLIDQIKRE
Sbjct: 1 MDKNGIVLMRKYELGRLLGQGTFAKVYHARNIKTGESVAIKVIDKQKVAKVGLIDQIKRE 60
Query: 61 ISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVD 120
ISVMRLVRHP++V L+EVMASKTKIYFAMEYV+GGELF+KV+KGKL+E +ARKYFQQL+
Sbjct: 61 ISVMRLVRHPHVVFLHEVMASKTKIYFAMEYVKGGELFDKVSKGKLKENIARKYFQQLIG 120
Query: 121 AVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAP 180
A+++CHSRGVYHRDLKPENLLLDENGDLKISDFGLSAL+ES +QDGLLHTTCGTPAYVAP
Sbjct: 121 AIDYCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALRESKQQDGLLHTTCGTPAYVAP 180
Query: 181 EVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVR 240
EVI K+GYDGAKAD+WSCGVVL+VLLAG LPF++ NL+E+Y+KIT+ EFKCPNWFPPEV+
Sbjct: 181 EVIGKKGYDGAKADVWSCGVVLYVLLAGFLPFHEQNLVEMYRKITKGEFKCPNWFPPEVK 240
Query: 241 KLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIETPESPRGQDRNKLISDIHAVFECESS 300
KLLSRILDPNP++R+ + K+MEN WF+KG+KKIETP+SP + LISD+HA F +
Sbjct: 241 KLLSRILDPNPNSRIKIEKIMENSWFQKGFKKIETPKSPESHQIDSLISDVHAAFSVKPM 300
Query: 301 S 301
S
Sbjct: 301 S 301
|
|
| TAIR|locus:2161273 SIP1 "SOS3-interacting protein 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1449 (515.1 bits), Expect = 2.1e-148, P = 2.1e-148
Identities = 277/455 (60%), Positives = 355/455 (78%)
Query: 1 MEKKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKRE 60
ME K +L +KY++GRLLGQGTFAKVY+GR++ T QSVAIK++DKEK+ +VGLI+QIKRE
Sbjct: 1 MENKPSVLTDKYDVGRLLGQGTFAKVYYGRSILTNQSVAIKMIDKEKVMKVGLIEQIKRE 60
Query: 61 ISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVD 120
ISVMR+ RHPN+V+LYEVMA+KT+IYF MEY +GGELFNKVAKGKLR++VA KYF QL++
Sbjct: 61 ISVMRIARHPNVVELYEVMATKTRIYFVMEYCKGGELFNKVAKGKLRDDVAWKYFYQLIN 120
Query: 121 AVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAP 180
AV+FCHSR VYHRD+KPENLLLD+N +LK+SDFGLSAL + RQDGLLHTTCGTPAYVAP
Sbjct: 121 AVDFCHSREVYHRDIKPENLLLDDNENLKVSDFGLSALADCKRQDGLLHTTCGTPAYVAP 180
Query: 181 EVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVR 240
EVIN++GYDG KADIWSCGVVLFVLLAG LPF+DSNLME+Y+KI +A+FK P+WF PEVR
Sbjct: 181 EVINRKGYDGTKADIWSCGVVLFVLLAGYLPFHDSNLMEMYRKIGKADFKAPSWFAPEVR 240
Query: 241 KLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIETPESPRGQDRNKLISDIHAVFECESS 300
+LL ++LDPNP TR+T+A++ E+ WFRKG + R ++ N + + E +
Sbjct: 241 RLLCKMLDPNPETRITIARIRESSWFRKGLHMKQKKMEKRVKEINSVEAGTAGTNENGAG 300
Query: 301 SSRD-TDPPTNSCRSPVR-----PSSFNAFDIISLSKGFNLSGLFEGDANSKLEARFTTT 354
S + P N R P++ NAFD+I+LS GF+L+GLF GD N K E+RFT+
Sbjct: 301 PSENGAGPSENGDRVTEENHTDEPTNLNAFDLIALSAGFDLAGLF-GDDN-KRESRFTSQ 358
Query: 355 KPASAIVSKFEEIAVTESCKFNKKD-GTVKLQHNRQGRKGQLAVDAEIFEVTPAFHVVEL 413
KPAS I+SK EE+A K++ G KL+ ++GRKG L++DAEIF+VTP FH+VE+
Sbjct: 359 KPASVIISKLEEVAQRLKLSIRKREAGLFKLERLKEGRKGILSMDAEIFQVTPNFHLVEV 418
Query: 414 KKAAGDTMEYKDFCNQGLRPSLKDIVWTWQGNDEQ 448
KK+ GDT+EY+ + LRP+L DIVW WQG ++
Sbjct: 419 KKSNGDTLEYQKLVAEDLRPALSDIVWVWQGEKDE 453
|
|
| TAIR|locus:2169444 CIPK2 "CBL-interacting protein kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1413 (502.5 bits), Expect = 1.4e-144, P = 1.4e-144
Identities = 269/450 (59%), Positives = 345/450 (76%)
Query: 1 MEKKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKRE 60
ME K +L +YE+GRLLGQGTFAKVY GR+ T +SVAIK++DK+K+ RVGL QIKRE
Sbjct: 1 MENKPSVLTERYEVGRLLGQGTFAKVYFGRSNHTNESVAIKMIDKDKVMRVGLSQQIKRE 60
Query: 61 ISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVD 120
ISVMR+ +HPN+V+LYEVMA+K++IYF +EY +GGELFNKVAKGKL+E+VA KYF QL+
Sbjct: 61 ISVMRIAKHPNVVELYEVMATKSRIYFVIEYCKGGELFNKVAKGKLKEDVAWKYFYQLIS 120
Query: 121 AVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAP 180
AV+FCHSRGVYHRD+KPENLLLD+N +LK+SDFGLSAL + RQDGLLHTTCGTPAYVAP
Sbjct: 121 AVDFCHSRGVYHRDIKPENLLLDDNDNLKVSDFGLSALADCKRQDGLLHTTCGTPAYVAP 180
Query: 181 EVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVR 240
EVIN++GY+G KADIWSCGVVLFVLLAG LPF+D+NLME+Y+KI +A+FKCP+WF PEV+
Sbjct: 181 EVINRKGYEGTKADIWSCGVVLFVLLAGYLPFHDTNLMEMYRKIGKADFKCPSWFAPEVK 240
Query: 241 KLLSRILDPNPSTRVTMAKLMENYWFRKG-YKKIETPESPRGQDRNKLISDIHAVFECES 299
+LL ++LDPN TR+T+AK+ E+ WFRKG + K + E Q + + + A ++
Sbjct: 241 RLLCKMLDPNHETRITIAKIKESSWFRKGLHLKQKKMEKMEKQQVREATNPMEAGGSGQN 300
Query: 300 SSSRDTDPPTNSCRSPVRPSSFNAFDIISLSKGFNLSGLFEGDANSKLEARFTTTKPASA 359
+ + +PP R ++ NAFDII+LS GF L+GLF GD K E+RF + KPAS
Sbjct: 301 ENGENHEPP--------RLATLNAFDIIALSTGFGLAGLF-GDVYDKRESRFASQKPASE 351
Query: 360 IVSKFEEIAVTESCKFNKKD-GTVKLQHNRQGRKGQLAVDAEIFEVTPAFHVVELKKAAG 418
I+SK E+A K K+ G KL+ ++G+ G L +DAEIF+VTP FH+VE+KK G
Sbjct: 352 IISKLVEVAKCLKLKIRKQGAGLFKLERVKEGKNGILTMDAEIFQVTPTFHLVEVKKCNG 411
Query: 419 DTMEYKDFCNQGLRPSLKDIVWTWQGNDEQ 448
DTMEY+ + LRP+L DIVW WQG E+
Sbjct: 412 DTMEYQKLVEEDLRPALADIVWVWQGEKEK 441
|
|
| TAIR|locus:2126749 SIP3 "SOS3-interacting protein 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1338 (476.1 bits), Expect = 1.2e-136, P = 1.2e-136
Identities = 261/438 (59%), Positives = 337/438 (76%)
Query: 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMR 65
G+L +YELGRLLG GTFAKVYH RN++TG+SVA+K+V KEK+ +VG++DQIKREISVMR
Sbjct: 18 GLLHGRYELGRLLGHGTFAKVYHARNIQTGKSVAMKVVGKEKVVKVGMVDQIKREISVMR 77
Query: 66 LVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFC 125
+V+HPNIV+L+EVMASK+KIYFAME VRGGELF KVAKG+LRE+VAR YFQQL+ AV+FC
Sbjct: 78 MVKHPNIVELHEVMASKSKIYFAMELVRGGELFAKVAKGRLREDVARVYFQQLISAVDFC 137
Query: 126 HSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINK 185
HSRGVYHRDLKPENLLLDE G+LK++DFGLSA E +QDGLLHTTCGTPAYVAPEVI K
Sbjct: 138 HSRGVYHRDLKPENLLLDEEGNLKVTDFGLSAFTEHLKQDGLLHTTCGTPAYVAPEVILK 197
Query: 186 RGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSR 245
+GYDGAKAD+WSCGV+LFVLLAG LPF D NL+ +Y+KI R +FKCP W + R+L+++
Sbjct: 198 KGYDGAKADLWSCGVILFVLLAGYLPFQDDNLVNMYRKIYRGDFKCPGWLSSDARRLVTK 257
Query: 246 ILDPNPSTRVTMAKLMENYWFRKGYKKIETPESPRGQDRNKLISDIHAVFECESSSSRDT 305
+LDPNP+TR+T+ K+M++ WF+K ++ R RN+ ++ A +++ D
Sbjct: 258 LLDPNPNTRITIEKVMDSPWFKK--------QATRS--RNEPVA---ATI---TTTEEDV 301
Query: 306 DPPTNSCRSPVRPSSFNAFDIISLSKGFNLSGLFEGDANS-KLEARFTTTKPASAIVSKF 364
D + +S + NAF II+LS+GF+LS LFE K E RF T++PAS+++S
Sbjct: 302 DFLVH--KSKEETETLNAFHIIALSEGFDLSPLFEEKKKEEKREMRFATSRPASSVISSL 359
Query: 365 EEIA-VTESCKFNKKDGTVKLQHNRQGRKGQLAVDAEIFEVTPAFHVVELKKAAGDTMEY 423
EE A V K + V+++ + GRKG+LAV+AEIF V P+F VVE+KK GDT+EY
Sbjct: 360 EEAARVGNKFDVRKSESRVRIEGKQNGRKGKLAVEAEIFAVAPSFVVVEVKKDHGDTLEY 419
Query: 424 KDFCNQGLRPSLKDIVWT 441
+FC+ LRP+LKDI WT
Sbjct: 420 NNFCSTALRPALKDIFWT 437
|
|
| TAIR|locus:2124072 CIPK12 "CBL-interacting protein kinase 12" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1332 (473.9 bits), Expect = 5.2e-136, P = 5.2e-136
Identities = 259/438 (59%), Positives = 327/438 (74%)
Query: 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRL 66
+++ +YE+G+LLG GTFAKVY RN+KT +SVAIK++DKEK+ + GLI IKREIS++R
Sbjct: 21 LILGRYEMGKLLGHGTFAKVYLARNVKTNESVAIKVIDKEKVLKGGLIAHIKREISILRR 80
Query: 67 VRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCH 126
VRHPNIVQL+EVMA+K KIYF MEYVRGGELFNKVAKG+L+EEVARKYFQQL+ AV FCH
Sbjct: 81 VRHPNIVQLFEVMATKAKIYFVMEYVRGGELFNKVAKGRLKEEVARKYFQQLISAVTFCH 140
Query: 127 SRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKR 186
+RGVYHRDLKPENLLLDENG+LK+SDFGLSA+ + RQDGL HT CGTPAYVAPEV+ ++
Sbjct: 141 ARGVYHRDLKPENLLLDENGNLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLARK 200
Query: 187 GYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRI 246
GYD AK DIWSCGV+LFVL+AG LPF+D N+M +YKKI R EF+CP WF E+ +LLS++
Sbjct: 201 GYDAAKVDIWSCGVILFVLMAGYLPFHDRNVMAMYKKIYRGEFRCPRWFSTELTRLLSKL 260
Query: 247 LDPNPSTRVTMAKLMENYWFRKGYKKI----ETPESPRGQDRNKLISD-IHAVFECESSS 301
L+ NP R T ++MEN WF+KG+K I E + D ++L SD + + + +S
Sbjct: 261 LETNPEKRFTFPEIMENSWFKKGFKHIKFYVEDDKLCNVVDDDELESDSVESDRDSAASE 320
Query: 302 SR-DTDPPTNSCRSPVRPSSFNAFDIISLSKGFNLSGLFEGDANSKLEARFTTTKPASAI 360
S + P RP+S NAFDIIS S+GF+LSGLF+ D +RF + P S I
Sbjct: 321 SEIEYLEPRRRVGGLPRPASLNAFDIISFSQGFDLSGLFDDDGEG---SRFVSGAPVSKI 377
Query: 361 VSKFEEIAVTESCKFNKKDGTVKLQHNRQGRKGQLAVDAEIFEVTPAFHVVELKKAAGDT 420
+SK EEIA S KKD V L+ +RQG KG L + AEIFE+TP+ VVE+KK GD
Sbjct: 378 ISKLEEIAKVVSFTVRKKDCRVSLEGSRQGVKGPLTIAAEIFELTPSLVVVEVKKKGGDK 437
Query: 421 MEYKDFCNQGLRPSLKDI 438
EY+DFCN L+P L+++
Sbjct: 438 TEYEDFCNNELKPKLQNL 455
|
|
| TAIR|locus:2181047 CIPK15 "CBL-interacting protein kinase 15" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1102 (393.0 bits), Expect = 1.1e-135, Sum P(2) = 1.1e-135
Identities = 206/278 (74%), Positives = 244/278 (87%)
Query: 1 MEKKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKRE 60
MEKK +LM +YE+G+ LGQGTFAKVYH R+LKTG SVAIK++DKE+I +VG+ +QIKRE
Sbjct: 1 MEKKGSVLMLRYEVGKFLGQGTFAKVYHARHLKTGDSVAIKVIDKERILKVGMTEQIKRE 60
Query: 61 ISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVD 120
IS MRL+RHPNIV+L+EVMA+K+KIYF ME+V+GGELFNKV+ GKLRE+VARKYFQQLV
Sbjct: 61 ISAMRLLRHPNIVELHEVMATKSKIYFVMEHVKGGELFNKVSTGKLREDVARKYFQQLVR 120
Query: 121 AVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAP 180
AV+FCHSRGV HRDLKPENLLLDE+G+LKISDFGLSAL +S RQDGLLHTTCGTPAYVAP
Sbjct: 121 AVDFCHSRGVCHRDLKPENLLLDEHGNLKISDFGLSALSDSRRQDGLLHTTCGTPAYVAP 180
Query: 181 EVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVR 240
EVI++ GYDG KAD+WSCGV+LFVLLAG LPF DSNLMELYKKI +AE K PNW P +
Sbjct: 181 EVISRNGYDGFKADVWSCGVILFVLLAGYLPFRDSNLMELYKKIGKAEVKFPNWLAPGAK 240
Query: 241 KLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIETPES 278
+LL RILDPNP+TRV+ K+M++ WFRKG ++ E ES
Sbjct: 241 RLLKRILDPNPNTRVSTEKIMKSSWFRKGLQE-EVKES 277
|
|
| TAIR|locus:2152370 CIPK19 "CBL-interacting protein kinase 19" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1312 (466.9 bits), Expect = 6.9e-134, P = 6.9e-134
Identities = 258/441 (58%), Positives = 325/441 (73%)
Query: 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRL 66
+++ KYE+GRLLG GTFAKVY RN ++G+SVAIK++DKEK+ + GLI IKREIS++R
Sbjct: 23 LILGKYEMGRLLGHGTFAKVYLARNAQSGESVAIKVIDKEKVLKSGLIAHIKREISILRR 82
Query: 67 VRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCH 126
VRHPNIVQL+EVMA+K+KIYF MEYV+GGELFNKVAKG+L+EE+ARKYFQQL+ AV FCH
Sbjct: 83 VRHPNIVQLFEVMATKSKIYFVMEYVKGGELFNKVAKGRLKEEMARKYFQQLISAVSFCH 142
Query: 127 SRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKR 186
RGVYHRDLKPENLLLDENG+LK+SDFGLSA+ + RQDGL HT CGTPAYVAPEV+ ++
Sbjct: 143 FRGVYHRDLKPENLLLDENGNLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLARK 202
Query: 187 GYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRI 246
GYDGAK DIWSCGV+LFVL+AG LPF+D N+M +YKKI R +F+CP WFP E+ +LL R+
Sbjct: 203 GYDGAKVDIWSCGVILFVLMAGFLPFHDRNVMAMYKKIYRGDFRCPRWFPVEINRLLIRM 262
Query: 247 LDPNPSTRVTMAKLMENYWFRKGYKKIETPESPRGQDRNKLISD-IHAVFECESSSSRDT 305
L+ P R TM +ME WF+KG+K I+ Q N D I ++ SS +
Sbjct: 263 LETKPERRFTMPDIMETSWFKKGFKHIKFYVEDDHQLCNVADDDEIESIESVSGRSSTVS 322
Query: 306 DPPT----NSCR---SPVRPSSFNAFDIISLSKGFNLSGLFEGDANSKLEARFTTTKPAS 358
+P + R S RP+S NAFD+IS S GF+LSGLFE D +RF + P
Sbjct: 323 EPEDFESFDGRRRGGSMPRPASLNAFDLISFSPGFDLSGLFEDDGEG---SRFVSGAPVG 379
Query: 359 AIVSKFEEIAVTESCKFNKKDGTVKLQHNRQGR-KGQLAVDAEIFEVTPAFHVVELKKAA 417
I+SK EEIA S KKD V L+ +R+G KG L++ AEIFE+TPA VVE+KK
Sbjct: 380 QIISKLEEIARIVSFTVRKKDCKVSLEGSREGSMKGPLSIAAEIFELTPALVVVEVKKKG 439
Query: 418 GDTMEYKDFCNQGLRPSLKDI 438
GD MEY +FCN+ L+P L+++
Sbjct: 440 GDKMEYDEFCNKELKPKLQNL 460
|
|
| TAIR|locus:2029974 CIPK18 "CBL-interacting protein kinase 18" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1294 (460.6 bits), Expect = 5.6e-132, P = 5.6e-132
Identities = 248/437 (56%), Positives = 318/437 (72%)
Query: 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRL 66
ILM KYELG+LLG GTFAKVY +N+K+G VAIK++DKEKI + GL+ IKREIS++R
Sbjct: 69 ILMGKYELGKLLGHGTFAKVYLAQNIKSGDKVAIKVIDKEKIMKSGLVAHIKREISILRR 128
Query: 67 VRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCH 126
VRHP IV L+EVMA+K+KIYF MEYV GGELFN VAKG+L EE AR+YFQQL+ +V FCH
Sbjct: 129 VRHPYIVHLFEVMATKSKIYFVMEYVGGGELFNTVAKGRLPEETARRYFQQLISSVSFCH 188
Query: 127 SRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKR 186
RGVYHRDLKPENLLLD G+LK+SDFGLSA+ E RQDGL HT CGTPAY+APEV+ ++
Sbjct: 189 GRGVYHRDLKPENLLLDNKGNLKVSDFGLSAVAEQLRQDGLCHTFCGTPAYIAPEVLTRK 248
Query: 187 GYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRI 246
GYD AKAD+WSCGV+LFVL+AG++PFYD N+M +YKKI + EF+CP WF ++ +LL+R+
Sbjct: 249 GYDAAKADVWSCGVILFVLMAGHIPFYDKNIMVMYKKIYKGEFRCPRWFSSDLVRLLTRL 308
Query: 247 LDPNPSTRVTMAKLMENYWFRKGYKK----IETPESPRGQDRNKLISDIHAVFECESSSS 302
LD NP TR+T+ ++M+N WF+KG+K IE + R + + + S S
Sbjct: 309 LDTNPDTRITIPEIMKNRWFKKGFKHVKFYIEDDKLCREDEDEEEEASSSGRSSTVSESD 368
Query: 303 RDTDPPTNSCRSPVRPSSFNAFDIISLSKGFNLSGLFEGDANSKLEARFTTTKPASAIVS 362
+ D S RPSS NAFDIIS S GF+LSGLFE + RF + P S I+S
Sbjct: 369 AEFDVKRMGIGSMPRPSSLNAFDIISFSSGFDLSGLFEEEGGEG--TRFVSGAPVSKIIS 426
Query: 363 KFEEIAVTESCKFNKKDGTVKLQHNRQGRKGQLAVDAEIFEVTPAFHVVELKKAAGDTME 422
K EEIA S KK+ +++L+ R+G KG L + AEIFE+TP+ VVE+KK GD E
Sbjct: 427 KLEEIAKIVSFTVRKKEWSLRLEGCREGAKGPLTIAAEIFELTPSLVVVEVKKKGGDREE 486
Query: 423 YKDFCNQGLRPSLKDIV 439
Y++FCN+ LRP L+ ++
Sbjct: 487 YEEFCNKELRPELEKLI 503
|
|
| UNIPROTKB|Q84XC0 Q84XC0 "Calcineurin B-like-interacting protein kinase" [Pisum sativum (taxid:3888)] | Back alignment and assigned GO terms |
|---|
Score = 1029 (367.3 bits), Expect = 3.7e-131, Sum P(2) = 3.7e-131
Identities = 182/269 (67%), Positives = 235/269 (87%)
Query: 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRL 66
+L+ ++ELG+LLG GTFAKV+ +N+KTG++VAIKI+ K+KI + GL+ IKREIS++R
Sbjct: 21 LLLGRFELGKLLGHGTFAKVHLAKNIKTGEAVAIKIISKDKILKSGLVSHIKREISILRR 80
Query: 67 VRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCH 126
VRHPNIVQL+EVMA+KTKIYF MEYVRGGELFNKVAKG+L+EEVARKYFQQL+ AVEFCH
Sbjct: 81 VRHPNIVQLFEVMATKTKIYFVMEYVRGGELFNKVAKGRLKEEVARKYFQQLICAVEFCH 140
Query: 127 SRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKR 186
+RGV+HRD+KPENLLLDENG+LK+SDFGLSA+ + +QDGL HT CGTPAYVAPEV++++
Sbjct: 141 ARGVFHRDIKPENLLLDENGNLKVSDFGLSAVSDEIKQDGLFHTFCGTPAYVAPEVLSRK 200
Query: 187 GYDGAKADIWSCGVVLFVLLAGNLPFYD-SNLMELYKKITRAEFKCPNWFPPEVRKLLSR 245
GYDG K DIWSCGVVLFVL+AG LPF+D +N+M +YKKI + +F+CP WF PE+ LL+R
Sbjct: 201 GYDGGKVDIWSCGVVLFVLMAGYLPFHDPNNVMVMYKKIYKGDFRCPRWFSPELVNLLTR 260
Query: 246 ILDPNPSTRVTMAKLMENYWFRKGYKKIE 274
+LD P TR+++ ++MEN WF+ G+K+I+
Sbjct: 261 LLDTKPQTRISIPEIMENRWFKIGFKRIK 289
|
|
| TAIR|locus:2179260 CIPK25 "CBL-interacting protein kinase 25" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1265 (450.4 bits), Expect = 6.6e-129, P = 6.6e-129
Identities = 250/447 (55%), Positives = 334/447 (74%)
Query: 2 EKKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREI 61
+++ +L KYE+GRLLG+GTF KVY+G+ + TG+SVAIKI++K++++R G+++QIKREI
Sbjct: 33 QQQLRVLFAKYEMGRLLGKGTFGKVYYGKEITTGESVAIKIINKDQVKREGMMEQIKREI 92
Query: 62 SVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDA 121
S+MRLVRHPNIV+L EVMA+KTKI+F MEYV+GGELF+K+ KGKL+E+ ARKYFQQL+ A
Sbjct: 93 SIMRLVRHPNIVELKEVMATKTKIFFIMEYVKGGELFSKIVKGKLKEDSARKYFQQLISA 152
Query: 122 VEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPE 181
V+FCHSRGV HRDLKPENLL+DENGDLK+SDFGLSAL E QDGLLHT CGTPAYVAPE
Sbjct: 153 VDFCHSRGVSHRDLKPENLLVDENGDLKVSDFGLSALPEQILQDGLLHTQCGTPAYVAPE 212
Query: 182 VINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRK 241
V+ K+GYDGAK DIWSCG++L+VLLAG LPF D NLM++Y+KI ++EF+ P WF PE ++
Sbjct: 213 VLRKKGYDGAKGDIWSCGIILYVLLAGFLPFQDENLMKMYRKIFKSEFEYPPWFSPESKR 272
Query: 242 LLSRILDPNPSTRVTMAKLMENYWFRKGYKKIETPESPRGQDRNKLISDIHAVFECESSS 301
L+S++L +P+ R+++ +M WFRK SP ++L +I V E E+ +
Sbjct: 273 LISKLLVVDPNKRISIPAIMRTPWFRKNIN------SPIEFKIDEL--EIQNV-EDETPT 323
Query: 302 SRDTDPPTNSCRSPVRPSSFNAFDIIS-LSKGFNLSGLFEGDANSKLEARFTTTKPASAI 360
+ T T + +PV P FNAF+ IS +S GF+LS LFE + KL + FT+ AS I
Sbjct: 324 TTATTATTTT--TPVSPKFFNAFEFISSMSSGFDLSSLFE--SKRKLRSMFTSRWSASEI 379
Query: 361 VSKFEEIAVTESCKFNK-KDGTVKLQHNRQGRKGQLAVDAEIFEVTPAFHVVELKKAAGD 419
+ K E I + K + KD VKL +GRKGQ+AV AE+FEV P VVEL K+AGD
Sbjct: 380 MGKLEGIGKEMNMKVKRTKDFKVKLFGKTEGRKGQIAVTAEVFEVAPEVAVVELCKSAGD 439
Query: 420 TMEYKDFCNQGLRPSLKDIVWTWQGND 446
T+EY + +RP+L++IVW+W G++
Sbjct: 440 TLEYNRLYEEHVRPALEEIVWSWHGDN 466
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9FJ54 | CIPKK_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7002 | 0.9419 | 0.9612 | yes | no |
| Q9LWM4 | CIPK5_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.6930 | 0.9754 | 0.9479 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | CIPK11 | SubName- Full=CBL-interacting protein kinase 11; (451 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 448 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-106 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-96 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-79 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 6e-75 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-73 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-73 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-72 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 7e-69 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 9e-64 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-62 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-58 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-58 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-57 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-56 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-56 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 6e-55 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-51 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 8e-50 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-49 | |
| cd12195 | 116 | cd12195, CIPK_C, C-terminal regulatory domain of C | 9e-49 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-48 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-48 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-48 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-47 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-47 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-47 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-47 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-47 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 7e-47 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-46 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-46 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-46 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-46 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-46 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 6e-46 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 8e-46 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-45 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-45 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 9e-45 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-44 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-44 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-43 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 8e-43 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-42 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-42 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-42 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-42 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-42 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-42 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-42 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 9e-42 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-41 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-41 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-41 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-41 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-41 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-40 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-40 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-40 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-40 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-40 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-40 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-39 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-39 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-39 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-39 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 6e-39 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 6e-39 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-38 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-38 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-37 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-37 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-37 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-37 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-37 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-37 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-37 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-37 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-37 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-36 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-36 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-36 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-36 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-36 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-36 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 6e-36 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-35 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-35 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-35 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-35 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-35 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-35 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-35 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-35 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-35 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 7e-35 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-34 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-34 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-34 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-34 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 7e-34 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-33 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-33 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-33 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-33 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-33 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-33 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 6e-33 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 7e-33 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 8e-33 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 8e-33 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-32 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-32 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-32 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-32 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-32 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-31 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-31 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-31 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-31 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-31 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-31 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 6e-31 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 7e-31 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 8e-31 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-30 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-30 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-30 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-30 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-30 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 7e-30 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-29 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-29 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-29 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-29 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-29 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-29 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-29 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-29 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-29 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-29 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-29 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 5e-29 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-28 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-28 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-28 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-28 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-28 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-28 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-28 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 7e-28 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-27 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-27 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-27 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-27 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 7e-27 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-25 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-25 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-25 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-25 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-25 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-25 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 6e-25 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-25 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-25 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-24 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-24 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-24 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-24 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-23 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-23 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-23 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-23 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-23 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-23 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-23 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-23 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-22 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-22 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-22 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-22 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 6e-22 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 8e-22 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-21 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-21 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-21 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-21 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-21 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-21 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-21 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-21 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-21 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-21 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 6e-21 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 7e-21 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 7e-21 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 8e-21 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 8e-21 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 8e-21 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 9e-21 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-20 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-20 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-20 | |
| pfam03822 | 58 | pfam03822, NAF, NAF domain | 2e-20 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-20 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-20 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-20 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 5e-20 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-19 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-19 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-19 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-19 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-19 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-19 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-19 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-19 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 9e-19 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 9e-19 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-18 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-18 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-18 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-18 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-18 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 7e-18 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 9e-18 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-17 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-17 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-17 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-17 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-17 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-17 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-17 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 9e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-16 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-16 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-16 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-16 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 6e-16 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 8e-16 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-15 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-15 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-15 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 5e-15 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 9e-15 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-14 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-14 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-14 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-14 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-14 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-14 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-14 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-14 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 5e-14 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 9e-14 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 9e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-13 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-13 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-13 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-13 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-13 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-13 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-13 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-13 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-13 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-13 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 7e-13 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 8e-13 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-12 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 5e-12 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-12 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 6e-12 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 8e-12 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-11 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-11 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 4e-11 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-10 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-10 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-10 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-10 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-10 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 6e-10 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 8e-10 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-09 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-09 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-08 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-08 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-08 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 7e-08 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 1e-07 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-07 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 2e-07 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 2e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-07 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-06 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-06 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 7e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-05 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-05 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 3e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 4e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-04 | |
| cd12120 | 95 | cd12120, AMPKA_C_like, C-terminal regulatory domai | 3e-04 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-04 | |
| COG0478 | 304 | COG0478, COG0478, RIO-like serine/threonine protei | 3e-04 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 0.001 | |
| cd05144 | 198 | cd05144, RIO2_C, RIO kinase family; RIO2, C-termin | 0.001 | |
| COG0661 | 517 | COG0661, AarF, Predicted unusual protein kinase [G | 0.002 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 0.002 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 314 bits (807), Expect = e-106
Identities = 111/260 (42%), Positives = 170/260 (65%), Gaps = 11/260 (4%)
Query: 12 YELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPN 71
YE+ LG+G+F KVY R+ KTG+ VAIK++ K+KI+ ++I REI +++ ++HPN
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIK--KDRERILREIKILKKLKHPN 58
Query: 72 IVQLYEVMASKTKIYFAMEYVRGGELFNK-VAKGKLREEVARKYFQQLVDAVEFCHSRGV 130
IV+LY+V + K+Y MEY GG+LF+ +G+L E+ AR Y +Q++ A+E+ HS+G+
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118
Query: 131 YHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDG 190
HRDLKPEN+LLDE+G +K++DFGL+ + L T GTP Y+APEV+ +GY
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPG---EKLTTFVGTPEYMAPEVLLGKGYGK 175
Query: 191 AKADIWSCGVVLFVLLAGNLPFY-DSNLMELYKKITRAEFKCPNW---FPPEVRKLLSRI 246
DIWS GV+L+ LL G PF D L+EL+KKI + + P PE + L+ ++
Sbjct: 176 -AVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKL 234
Query: 247 LDPNPSTRVTMAKLMENYWF 266
L +P R+T + +++ +F
Sbjct: 235 LVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 289 bits (743), Expect = 2e-96
Identities = 100/263 (38%), Positives = 149/263 (56%), Gaps = 11/263 (4%)
Query: 12 YELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPN 71
YEL R LG G+F VY ++ TG+ VA+KI+ K + +REI ++R + HPN
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQ-TARREIRILRRLSHPN 59
Query: 72 IVQLYEVMASKTKIYFAMEYVRGGELFNK-VAKGKLREEVARKYFQQLVDAVEFCHSRGV 130
IV+L + K +Y MEY GG+LF+ G L E+ A+K Q++ +E+ HS G+
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119
Query: 131 YHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDG 190
HRDLKPEN+LLDENG +KI+DFGL+ + L T GTP Y+APEV+ G
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKS--SSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 191 AKADIWSCGVVLFVLLAGNLPFYDS---NLMELYKKITRAEFKCPNWF----PPEVRKLL 243
K D+WS GV+L+ LL G PF + ++L ++I + E + L+
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLI 237
Query: 244 SRILDPNPSTRVTMAKLMENYWF 266
+ L+ +PS R T +++++ WF
Sbjct: 238 KKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 245 bits (629), Expect = 2e-79
Identities = 96/238 (40%), Positives = 151/238 (63%), Gaps = 4/238 (1%)
Query: 18 LGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYE 77
LG+G+F KV R TG+ A+K++ K+KI + ++ E +++ + HP IV+L+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 78 VMASKTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLK 136
++ K+Y +EY GGELF+ ++K G+ EE AR Y ++V A+E+ HS G+ +RDLK
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120
Query: 137 PENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIW 196
PEN+LLD +G +K++DFGL+ E + + +T CGTP Y+APEV+ +GY A D W
Sbjct: 121 PENILLDADGHIKLTDFGLAK--ELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKA-VDWW 177
Query: 197 SCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILDPNPSTR 254
S GV+L+ +L G PFY + E+Y+KI + + P + PE R L+S +L +P+ R
Sbjct: 178 SLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 235 bits (603), Expect = 6e-75
Identities = 103/281 (36%), Positives = 166/281 (59%), Gaps = 18/281 (6%)
Query: 12 YELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPN 71
+E + LG G+F +V R+ +G+ A+KI+ K KI ++ ++ + E +++ +RHP
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPF 62
Query: 72 IVQLYEVMASKTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGV 130
+V LY + +Y MEYV GGELF+ + K G+ E VAR Y Q+V A+E+ HS +
Sbjct: 63 LVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDI 122
Query: 131 YHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDG 190
+RDLKPENLLLD +G +KI+DFG + R G +T CGTP Y+APE+I +GY
Sbjct: 123 VYRDLKPENLLLDSDGYIKITDFGF-----AKRVKGRTYTLCGTPEYLAPEIILSKGYGK 177
Query: 191 AKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILDPN 250
A D W+ G++++ +LAG PF+D N +++Y+KI + + P++F P+ + L+ +L +
Sbjct: 178 A-VDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQVD 236
Query: 251 PSTRVTMAK-----LMENYWFRK------GYKKIETPESPR 280
+ R+ K + + WF +KIE P P+
Sbjct: 237 LTKRLGNLKNGVNDIKNHPWFAGIDWIALLQRKIEAPFIPK 277
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 229 bits (587), Expect = 1e-73
Identities = 95/249 (38%), Positives = 143/249 (57%), Gaps = 38/249 (15%)
Query: 18 LGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYE 77
LG+G F VY R+ KTG+ VAIKI+ KE L++++ REI +++ + HPNIV+LY
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYG 58
Query: 78 VMASKTKIYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDL 135
V + +Y MEY GG L + + + GKL E+ + Q+++ +E+ HS G+ HRDL
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118
Query: 136 KPENLLLDE-NGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKAD 194
KPEN+LLD NG +K++DFGLS + T LL T GTPAY+APEV+ +GY K+D
Sbjct: 119 KPENILLDSDNGKVKLADFGLS--KLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSD 176
Query: 195 IWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILDPNPSTR 254
IWS GV+L+ L PE++ L+ ++L +P R
Sbjct: 177 IWSLGVILYEL-------------------------------PELKDLIRKMLQKDPEKR 205
Query: 255 VTMAKLMEN 263
+ +++E+
Sbjct: 206 PSAKEILEH 214
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 230 bits (588), Expect = 5e-73
Identities = 94/263 (35%), Positives = 148/263 (56%), Gaps = 18/263 (6%)
Query: 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVD----KEKIRRVGLIDQIKREISVMRL 66
KYE+ + +G+G+F KVY R G+ +K +D EK R E+ +++
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKERE-----DALNEVKILKK 55
Query: 67 VRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGK-----LREEVARKYFQQLVDA 121
+ HPNI++ YE K K+ MEY GG+L K+ K K EE +F QL A
Sbjct: 56 LNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLA 115
Query: 122 VEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPE 181
+++ HSR + HRD+KP+N+ L NG +K+ DFG+S + ST L T GTP Y++PE
Sbjct: 116 LKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD--LAKTVVGTPYYLSPE 173
Query: 182 VINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFK-CPNWFPPEVR 240
+ + Y+ K+DIWS G VL+ L PF NL+EL KI + ++ P+ + E+R
Sbjct: 174 LCQNKPYN-YKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELR 232
Query: 241 KLLSRILDPNPSTRVTMAKLMEN 263
L+S +L +P R ++A+++++
Sbjct: 233 NLVSSLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 228 bits (583), Expect = 5e-72
Identities = 87/274 (31%), Positives = 153/274 (55%), Gaps = 21/274 (7%)
Query: 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVM-RLVR 68
+ ++ G+++G+G+F+ V + +T + AIKI+DK ++ + + +K E V+ RL
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 69 HPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHS 127
HP I++LY + +YF +EY GEL + K G L E+ R Y +++ A+E+ HS
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHS 120
Query: 128 RGVYHRDLKPENLLLDENGDLKISDFGLS------ALQESTRQDGLLHTT---------- 171
+G+ HRDLKPEN+LLD++ +KI+DFG + + ES + D +
Sbjct: 121 KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFA 180
Query: 172 --CGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF 229
GT YV+PE++N G +D+W+ G +++ +L G PF SN ++KI + E+
Sbjct: 181 SFVGTAEYVSPELLN-EKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEY 239
Query: 230 KCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMEN 263
P FPP+ + L+ ++L +P R+ + + +
Sbjct: 240 SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDE 273
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 219 bits (560), Expect = 7e-69
Identities = 85/263 (32%), Positives = 139/263 (52%), Gaps = 10/263 (3%)
Query: 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHP 70
++ G LLG+G+F VY + TG+ +A+K V+ ++ ++REI ++ ++HP
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEE-ELEALEREIRILSSLQHP 59
Query: 71 NIVQLY--EVMASKTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHS 127
NIV+ Y E K + +EYV GG L + + K GKL E V RKY +Q+++ + + HS
Sbjct: 60 NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119
Query: 128 RGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRG 187
G+ HRD+K N+L+D +G +K++DFG + + GTP ++APEVI
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179
Query: 188 YDGAKADIWSCGVVLFVLLAGNLPFYD-SNLMELYKKITRAEFKCPN---WFPPEVRKLL 243
Y G ADIWS G + + G P+ + N M KI + + P E + L
Sbjct: 180 Y-GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSG-EPPEIPEHLSEEAKDFL 237
Query: 244 SRILDPNPSTRVTMAKLMENYWF 266
+ L +P R T +L+++ +
Sbjct: 238 RKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 206 bits (526), Expect = 9e-64
Identities = 87/246 (35%), Positives = 135/246 (54%), Gaps = 10/246 (4%)
Query: 18 LGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYE 77
+ +G + +V+ + TG AIK++ K + R +DQ+ E ++ + P +V+LY
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 78 VMASKTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLK 136
K +Y MEY+ GG+L + + G L E+VAR Y ++V A+E+ HS G+ HRDLK
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120
Query: 137 PENLLLDENGDLKISDFGLSALQESTRQDGLL------HTTCGTPAYVAPEVINKRGYDG 190
P+N+L+D NG LK++DFGLS + RQ L GTP Y+APEVI +G+
Sbjct: 121 PDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH-S 179
Query: 191 AKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWF--PPEVRKLLSRILD 248
D WS G +L+ L G PF+ E+++ I + + P E L+S++L
Sbjct: 180 KTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLV 239
Query: 249 PNPSTR 254
P+P R
Sbjct: 240 PDPEKR 245
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 202 bits (515), Expect = 2e-62
Identities = 87/257 (33%), Positives = 138/257 (53%), Gaps = 12/257 (4%)
Query: 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHP 70
+E+ +G+G F +VY R+ +TG+ VAIK++ E + ++I EI +++ +HP
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEK---KEKIINEIQILKKCKHP 57
Query: 71 NIVQLYEVMASKTKIYFAMEYVRGGELFN--KVAKGKLREEVARKYFQQLVDAVEFCHSR 128
NIV+ Y K +++ ME+ GG L + K L E ++L+ +E+ HS
Sbjct: 58 NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 129 GVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGY 188
G+ HRD+K N+LL +G++K+ DFGLSA T+ +T GTP ++APEVIN + Y
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKAR---NTMVGTPYWMAPEVINGKPY 174
Query: 189 DGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITR---AEFKCPNWFPPEVRKLLSR 245
D KADIWS G+ L G P+ + M+ KI + P + E + L +
Sbjct: 175 DY-KADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKK 233
Query: 246 ILDPNPSTRVTMAKLME 262
L NP R T +L++
Sbjct: 234 CLQKNPEKRPTAEQLLK 250
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 195 bits (496), Expect = 1e-58
Identities = 92/246 (37%), Positives = 145/246 (58%), Gaps = 9/246 (3%)
Query: 12 YELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPN 71
+E+G LG G+F +V ++ TG+ AIK + K +I ++ + + +E S++ + HP
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79
Query: 72 IVQLYEVMASKTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGV 130
IV + + ++YF +E+V GGELF + K G+ +VA+ Y +LV A E+ HS+ +
Sbjct: 80 IVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDI 139
Query: 131 YHRDLKPENLLLDENGDLKISDFGLSA-LQESTRQDGLLHTTCGTPAYVAPEVINKRGYD 189
+RDLKPENLLLD G +K++DFG + + + T T CGTP Y+APEVI +G+
Sbjct: 140 IYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT------FTLCGTPEYLAPEVIQSKGHG 193
Query: 190 GAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILDP 249
A D W+ GV+L+ +AG PF+D +Y+KI K PNWF R L+ +L
Sbjct: 194 KA-VDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGLLQT 252
Query: 250 NPSTRV 255
+ + R+
Sbjct: 253 DHTKRL 258
|
Length = 329 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 191 bits (487), Expect = 5e-58
Identities = 97/260 (37%), Positives = 138/260 (53%), Gaps = 16/260 (6%)
Query: 18 LGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYE 77
LG G F +V + ++ A+K V K I G + I E ++ HP IV+LY
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 78 VMASKTKIYFAMEYVRGGELFNKV-AKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLK 136
K IY MEY GGEL+ + +G E AR Y +V A E+ H+RG+ +RDLK
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120
Query: 137 PENLLLDENGDLKISDFGLS-ALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADI 195
PENLLLD NG +K+ DFG + L+ + T CGTP YVAPE+I +GYD + D
Sbjct: 121 PENLLLDSNGYVKLVDFGFAKKLKSGQKT----WTFCGTPEYVAPEIILNKGYDFS-VDY 175
Query: 196 WSCGVVLFVLLAGNLPFYDSNL--MELYKKITRAEFKC--PNWFPPEVRKLLSRILDPNP 251
WS G++L+ LL G PF + + ME+Y I + K PN+ + L+ ++L NP
Sbjct: 176 WSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNP 235
Query: 252 STRVTMAK-----LMENYWF 266
R+ K + ++ WF
Sbjct: 236 EERLGNLKGGIKDIKKHKWF 255
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 189 bits (482), Expect = 2e-57
Identities = 86/258 (33%), Positives = 139/258 (53%), Gaps = 6/258 (2%)
Query: 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHP 70
Y+LG L+G+G F VY G NL+TG VAIK + EKI+ + I +EI +++ ++HP
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKE-EALKSIMQEIDLLKNLKHP 59
Query: 71 NIVQLYEVMASKTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRG 129
NIV+ + + +Y +EY G L + K G E + Y Q++ + + H +G
Sbjct: 60 NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG 119
Query: 130 VYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYD 189
V HRD+K N+L ++G +K++DFG++ + + GTP ++APEVI G
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVA--TKLNDVSKDDASVVGTPYWMAPEVIEMSGAS 177
Query: 190 GAKADIWSCGVVLFVLLAGNLPFYDSNLME-LYKKITRAEFKCPNWFPPEVRKLLSRILD 248
+DIWS G + LL GN P+YD N M L++ + P PE++ L +
Sbjct: 178 -TASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQ 236
Query: 249 PNPSTRVTMAKLMENYWF 266
+P+ R T +L+++ W
Sbjct: 237 KDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 186 bits (474), Expect = 5e-56
Identities = 87/272 (31%), Positives = 141/272 (51%), Gaps = 29/272 (10%)
Query: 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVD------KEKIRRVGLIDQIKREISVM 64
YE+ +G+G+F V R G+ + K +D KEK Q+ E++++
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEK-------QQLVSEVNIL 53
Query: 65 RLVRHPNIVQLY--EVMASKTKIYFAMEYVRGGELFNKVAKGK-----LREEVARKYFQQ 117
R ++HPNIV+ Y + S +Y MEY GG+L + K K + EE + Q
Sbjct: 54 RELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQ 113
Query: 118 LVDAVEFCHSRG-----VYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTC 172
L+ A+ CH+R V HRDLKP N+ LD N ++K+ DFGL+ + T
Sbjct: 114 LLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSS--FAKTYV 171
Query: 173 GTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKC- 231
GTP Y++PE +N YD K+DIWS G +++ L A + PF N ++L KI +F+
Sbjct: 172 GTPYYMSPEQLNHMSYD-EKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRI 230
Query: 232 PNWFPPEVRKLLSRILDPNPSTRVTMAKLMEN 263
P + E+ +++ +L+ +P R + +L++
Sbjct: 231 PYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 189 bits (481), Expect = 6e-56
Identities = 97/359 (27%), Positives = 159/359 (44%), Gaps = 36/359 (10%)
Query: 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHP 70
Y + R LG+G+F +VY R+ K VA+K++ K+ + +++ REI ++ + HP
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 71 -NIVQLYEVMASKTKIYFAMEYVRGGELF----NKVAKGKLREEVARKYFQQLVDAVEFC 125
NIV+LY+ + +Y MEYV GG L KG L E A Q++ A+E+
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 126 HSRGVYHRDLKPENLLLDENGD-LKISDFGLSAL----QESTRQDGLLHTTCGTPAYVAP 180
HS+G+ HRD+KPEN+LLD +G +K+ DFGL+ L ++ L T+ GTP Y+AP
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 181 EVI--NKRGYDGAKADIWSCGVVLFVLLAGNLPFY----DSNLMELYKKITRAEFKC--- 231
EV+ Y + +DIWS G+ L+ LL G PF S + K I
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237
Query: 232 ------PNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIETPESPRG---- 281
P LL ++L +P R++ + + + K
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDS 297
Query: 282 ----QDRNKLISDIHAVFECESSSSRDTDPPTNSCRSPVRPSSFNAFDIISLSKGFNLS 336
+ + + + S D ++ + P+ ++ S S + +
Sbjct: 298 APLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGVSSSPHNSSSLLLSTA 356
|
Length = 384 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 183 bits (466), Expect = 6e-55
Identities = 93/269 (34%), Positives = 145/269 (53%), Gaps = 20/269 (7%)
Query: 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHP 70
+++ G +G GTF KVY NL TG+ +A+K + + I +I E+ V+ L++HP
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDP-KTIKEIADEMKVLELLKHP 59
Query: 71 NIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGK-LREEVARKYFQQLVDAVEFCHSRG 129
N+V+ Y V + K+Y MEY GG L + G+ L E V R Y QL++ + + HS G
Sbjct: 60 NLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG 119
Query: 130 VYHRDLKPENLLLDENGDLKISDFGLSA-LQESTRQDG-LLHTTCGTPAYVAPEVI---N 184
+ HRD+KP N+ LD NG +K+ DFG + L+ +T G + + GTPAY+APEVI
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK 179
Query: 185 KRGYDGAKADIWSCGVVLFVLLAGNLPF--YDSNLMELYKKITRAEFKCPNWFP------ 236
+G+ A ADIWS G V+ + G P+ D+ ++ P
Sbjct: 180 GKGHGRA-ADIWSLGCVVLEMATGKRPWSELDNEFQIMFH----VGAGHKPPIPDSLQLS 234
Query: 237 PEVRKLLSRILDPNPSTRVTMAKLMENYW 265
PE + L R L+ +P R T ++L+++ +
Sbjct: 235 PEGKDFLDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 175 bits (445), Expect = 2e-51
Identities = 83/264 (31%), Positives = 146/264 (55%), Gaps = 14/264 (5%)
Query: 12 YELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPN 71
E + +G GTF +V+ R+ + A+K++ ++ R+ + E V++ V HP
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62
Query: 72 IVQLYEVMASKTKIYFAMEYVRGGELFNKV-AKGKLREEVARKYFQQLVDAVEFCHSRGV 130
I++L+ + +Y MEYV GGELF+ + G+ Y ++V A+E+ HS+ +
Sbjct: 63 IIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEI 122
Query: 131 YHRDLKPENLLLDENGDLKISDFGLSA-LQESTRQDGLLHTTCGTPAYVAPEVINKRGYD 189
+RDLKPEN+LLD+ G +K++DFG + L++ T T CGTP Y+APEVI +G++
Sbjct: 123 VYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT------WTLCGTPEYLAPEVIQSKGHN 176
Query: 190 GAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILDP 249
A D W+ G++++ +L G PF+D N +Y+KI + + P + L+ ++L
Sbjct: 177 KA-VDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLVV 235
Query: 250 NPSTRVTMAK-----LMENYWFRK 268
+ + R+ K + + WF+
Sbjct: 236 DRTRRLGNMKNGADDVKNHRWFKS 259
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 8e-50
Identities = 95/247 (38%), Positives = 152/247 (61%), Gaps = 14/247 (5%)
Query: 16 RLLGQGTFAKVYHGRNLK---TGQSVAIKIVDKE--KIR-RVGLIDQIKREISVMRLVRH 69
++LGQG+F KV+ R + GQ A+K++ K K+R RV + K E ++ V H
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRV----RTKMERDILAEVNH 57
Query: 70 PNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKL-REEVARKYFQQLVDAVEFCHSR 128
P IV+L+ ++ K+Y ++++RGG+LF +++K + EE + Y +L A++ HS
Sbjct: 58 PFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL 117
Query: 129 GVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGY 188
G+ +RDLKPEN+LLDE G +K++DFGLS +ES + ++ CGT Y+APEV+N+RG+
Sbjct: 118 GIIYRDLKPENILLDEEGHIKLTDFGLS--KESIDHEKKAYSFCGTVEYMAPEVVNRRGH 175
Query: 189 DGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILD 248
+ AD WS GV++F +L G+LPF + E I +A+ P + PE + LL +
Sbjct: 176 TQS-ADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFK 234
Query: 249 PNPSTRV 255
NP+ R+
Sbjct: 235 RNPANRL 241
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 170 bits (431), Expect = 3e-49
Identities = 93/241 (38%), Positives = 139/241 (57%), Gaps = 4/241 (1%)
Query: 16 RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQL 75
+LLG+GTF KV R TG+ A+KI+ KE I + E V++ RHP + L
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 76 YEVMASKTKIYFAMEYVRGGELFNKVAKGKL-REEVARKYFQQLVDAVEFCHSRGVYHRD 134
+ ++ F MEY GGELF +++ ++ EE AR Y ++V A+E+ HSR V +RD
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120
Query: 135 LKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKAD 194
+K ENL+LD++G +KI+DFGL +E + T CGTP Y+APEV+ Y G D
Sbjct: 121 IKLENLMLDKDGHIKITDFGLC--KEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVD 177
Query: 195 IWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILDPNPSTR 254
W GVV++ ++ G LPFY+ + L++ I E + P PE + LL+ +L +P R
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237
Query: 255 V 255
+
Sbjct: 238 L 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|213380 cd12195, CIPK_C, C-terminal regulatory domain of Calcineurin B-Like (CBL)-interacting protein kinases | Back alignment and domain information |
|---|
Score = 161 bits (411), Expect = 9e-49
Identities = 64/116 (55%), Positives = 79/116 (68%), Gaps = 1/116 (0%)
Query: 322 NAFDIISLSKGFNLSGLFEGDANSKLEARFTTTKPASAIVSKFEEIAVTESCKFNKK-DG 380
NAFD+ISLS G +LSGLFE + K E RFT+ KPA I+ K EE A + KK +G
Sbjct: 1 NAFDLISLSSGLDLSGLFEEEDEVKRETRFTSRKPAEEIIEKLEEAAKKLGFRVRKKKEG 60
Query: 381 TVKLQHNRQGRKGQLAVDAEIFEVTPAFHVVELKKAAGDTMEYKDFCNQGLRPSLK 436
VKL+ + GRKG+LAV E+FEVTP+ VVE+KK+AGDT+EY F LRP LK
Sbjct: 61 GVKLEGQKGGRKGRLAVSVEVFEVTPSLVVVEVKKSAGDTLEYHKFWKDLLRPLLK 116
|
CIPKs are serine/threonine protein kinases (STKs), catalyzing the transfer of the gamma-phosphoryl group from ATP to S/T residues on protein substrates. They comprise a unique family in higher plants of proteins that interact with the calcineurin B-like (CBL) calcium sensors to form a signaling network that decode specific calcium signals triggered by a variety of environmental stimuli including salinity, drought, cold, light, and mechanical perturbation, among others. The specificity of the response relies on differences in expression and localization of both CBLs and CIPKs, as well as on the interaction specificity of CBL-CIPK combinations. There are 25, 30, and 43 CIPK genes identified in the Arabidopsis thaliana, Oryza sativa, and Zea mays genomes, respectively. The founding member of the CIPK family is Arabidopsis thaliana CIPK24, also called SOS2 (Salt Overlay Sensitive 2). CIPKs contain an N-terminal catalytic kinase domain and a C-terminal regulatory domain that contains the FISL (also called NAF for Asn-Ala-Phe) and PPI-binding motifs, which are involved in the interaction with CBLs and PP2C-type protein phosphatases, respectively. Studies using SOS2, SOS3, and ABI2 phosphatase show that the binding of CBL and PP2C-type protein phosphatase to CIPK is mutually exclusive. The binding of CBL to CIPK is inhibitory to kinase activity. Length = 116 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 1e-48
Identities = 92/298 (30%), Positives = 149/298 (50%), Gaps = 59/298 (19%)
Query: 12 YELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIK----REISVMRLV 67
YE LG+GT+ VY R+ KTG+ VA+K KIR + I REIS+++ +
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALK-----KIRLDNEEEGIPSTALREISLLKEL 55
Query: 68 RHPNIVQLYEVMASKTKIYFAMEYV----RGGELFNKVAKGKLREEVARKYFQQLVDAVE 123
+HPNIV+L +V+ ++ K+Y EY + + G L + + QL+ +
Sbjct: 56 KHPNIVKLLDVIHTERKLYLVFEYCDMDLKK---YLDKRPGPLSPNLIKSIMYQLLRGLA 112
Query: 124 FCHSRGVYHRDLKPENLLLDENGDLKISDFGLS-----ALQESTRQDGLLHTTCGTPAYV 178
+CHS + HRDLKP+N+L++ +G LK++DFGL+ L+ T T Y
Sbjct: 113 YCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYT-------HEVVTLWYR 165
Query: 179 APEVI-NKRGYDGAKADIWSCGVVLFVLLAGNLPFY-DSNLMELYK--KI----TRAEF- 229
APE++ + Y A DIWS G + ++ G F DS + +L+K +I T +
Sbjct: 166 APEILLGSKHYSTA-VDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWP 224
Query: 230 ---KCPNW---FP---------------PEVRKLLSRILDPNPSTRVTMAKLMENYWF 266
K P++ FP PE LLS++L NP+ R++ + +++ +F
Sbjct: 225 GVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 1e-48
Identities = 99/276 (35%), Positives = 149/276 (53%), Gaps = 15/276 (5%)
Query: 16 RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQL 75
+LLG+GTF KV R TG+ A+KI+ KE I + E V++ RHP + L
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 76 YEVMASKTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRD 134
+ ++ F MEY GGELF +++ E+ AR Y ++V A+ + HS V +RD
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRD 120
Query: 135 LKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKAD 194
LK ENL+LD++G +KI+DFGL +E + T CGTP Y+APEV+ Y G D
Sbjct: 121 LKLENLMLDKDGHIKITDFGLC--KEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVD 177
Query: 195 IWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILDPNPSTR 254
W GVV++ ++ G LPFY+ + +L++ I E + P PE + LL+ +L +P R
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237
Query: 255 V-----TMAKLMENYWFRK------GYKKIETPESP 279
+ ++ME+ +F KK+E P P
Sbjct: 238 LGGGPEDAKEIMEHRFFASINWQDVVQKKLEPPFKP 273
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 3e-48
Identities = 83/266 (31%), Positives = 135/266 (50%), Gaps = 18/266 (6%)
Query: 13 ELGRLLGQGTFAKVYHGRNLKTGQSVAIK---IVDKEKIRRVGLIDQIKREISVMRLVRH 69
E ++LGQG+ VY R+ TG+ A+K + E+ R+ Q+ RE+ +R
Sbjct: 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRK-----QLLRELKTLRSCES 58
Query: 70 PNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHS- 127
P +V+ Y + +I +EY+ GG L + + K GK+ E V +Q++ +++ H+
Sbjct: 59 PYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTK 118
Query: 128 RGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRG 187
R + HRD+KP NLL++ G++KI+DFG+S + E+T +T GT Y++PE I
Sbjct: 119 RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD--QCNTFVGTVTYMSPERIQGE- 175
Query: 188 YDGAKADIWSCGVVLFVLLAGNLPFYDSN---LMELYKKITR--AEFKCPNWFPPEVRKL 242
ADIWS G+ L G PF EL + I F PE R
Sbjct: 176 SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDF 235
Query: 243 LSRILDPNPSTRVTMAKLMENYWFRK 268
+S L +P R + A+L+++ + +K
Sbjct: 236 ISACLQKDPKKRPSAAELLQHPFIKK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 2e-47
Identities = 84/263 (31%), Positives = 140/263 (53%), Gaps = 7/263 (2%)
Query: 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIV--DKEKIRRVGLIDQIKREISVMRLV 67
+ G+LLGQG F +VY ++ TG+ +A+K V D + ++ ++ EI +++ +
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 68 RHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKV-AKGKLREEVARKYFQQLVDAVEFCH 126
+H IVQ Y + + MEY+ GG + +++ A G L E V RKY +Q+++ VE+ H
Sbjct: 62 QHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLH 121
Query: 127 SRGVYHRDLKPENLLLDENGDLKISDFGLSA-LQESTRQDGLLHTTCGTPAYVAPEVINK 185
S + HRD+K N+L D G++K+ DFG S LQ + + GTP +++PEVI+
Sbjct: 122 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISG 181
Query: 186 RGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITR--AEFKCPNWFPPEVRKLL 243
GY G KAD+WS G + +L P+ + M KI + P+ P+ R L
Sbjct: 182 EGY-GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFL 240
Query: 244 SRILDPNPSTRVTMAKLMENYWF 266
R N R + +L+ +++
Sbjct: 241 RRTFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 162 bits (413), Expect = 3e-47
Identities = 77/261 (29%), Positives = 139/261 (53%), Gaps = 10/261 (3%)
Query: 12 YELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPN 71
+EL R++G+G F KV + T + A+K ++K+K G + + E +++ + HP
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 72 IVQLYEVMASKTKIYFAMEYVRGGEL-FNKVAKGKLREEVARKYFQQLVDAVEFCHSRGV 130
+V L+ + +Y ++ + GG+L ++ K K EE + + ++V A+E+ HS+G+
Sbjct: 62 LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121
Query: 131 YHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDG 190
HRD+KP+N+LLDE G + I+DF ++ D L +T GTP Y+APEV+ ++GY
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIATK---VTPDTLTTSTSGTPGYMAPEVLCRQGY-S 177
Query: 191 AKADIWSCGVVLFVLLAGNLPFY--DSNLMELYK-KITRAEFKCPNWFPPEVRKLLSRIL 247
D WS GV + L G P+ + + + K A+ P + E ++++L
Sbjct: 178 VAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLL 237
Query: 248 DPNPSTR--VTMAKLMENYWF 266
+ +P R + L + +F
Sbjct: 238 ERDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 3e-47
Identities = 91/278 (32%), Positives = 146/278 (52%), Gaps = 16/278 (5%)
Query: 16 RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQ 74
++LG+G+F KV T + A+K++ K+ I + ++ E V+ L +HP + Q
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 75 LYEVMASKTKIYFAMEYVRGGEL-FNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHR 133
L+ +K +++F MEYV GG+L F+ G+ E AR Y ++V ++F H RG+ +R
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120
Query: 134 DLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKA 193
DLK +N+LLD G +KI+DFG+ +E T CGTP Y+APE+++ + Y G
Sbjct: 121 DLKLDNVLLDSEGHIKIADFGMC--KEGILGGVTTSTFCGTPDYIAPEILSYQPY-GPAV 177
Query: 194 DIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILDPNPST 253
D W+ GV+L+ +LAG PF + EL++ I E + P W E + +L L NP
Sbjct: 178 DWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEK 237
Query: 254 R----------VTMAKLMENY-WFRKGYKKIETPESPR 280
R + W + K+I+ P P+
Sbjct: 238 RLGCLPTGEQDIKGHPFFREIDWDKLERKEIKPPFKPK 275
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 5e-47
Identities = 83/257 (32%), Positives = 135/257 (52%), Gaps = 8/257 (3%)
Query: 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIV--DKEKIRRVGLIDQIKREISVMRLVR 68
++ G LLG G+F VY G NL G A+K V + + Q+++EI+++ ++
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60
Query: 69 HPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHS 127
HPNIVQ + +Y +E V GG L + K G E V R Y +Q++ +E+ H
Sbjct: 61 HPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHD 120
Query: 128 RGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRG 187
R HRD+K N+L+D NG +K++DFG++ ++ + G+P ++APEVI ++G
Sbjct: 121 RNTVHRDIKGANILVDTNGVVKLADFGMA--KQVVEFSFAK-SFKGSPYWMAPEVIAQQG 177
Query: 188 YDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF--KCPNWFPPEVRKLLSR 245
G ADIWS G + + G P+ + KI R++ P+ E + + +
Sbjct: 178 GYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILK 237
Query: 246 ILDPNPSTRVTMAKLME 262
L +PS R T A+L+E
Sbjct: 238 CLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 5e-47
Identities = 88/273 (32%), Positives = 140/273 (51%), Gaps = 22/273 (8%)
Query: 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRH 69
+ YEL ++G G A VY L + VAIK +D EK + +D++++E+ M H
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTS--VDELRKEVQAMSQCNH 58
Query: 70 PNIVQLYEVMASKTKIYFAMEYVRGGELFN----KVAKGKLREEVARKYFQQLVDAVEFC 125
PN+V+ Y +++ M Y+ GG L + +G L E + ++++ +E+
Sbjct: 59 PNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL 118
Query: 126 HSRGVYHRDLKPENLLLDENGDLKISDFGLSA--LQESTRQDGLLHTTCGTPAYVAPEVI 183
HS G HRD+K N+LL E+G +KI+DFG+SA R + T GTP ++APEV+
Sbjct: 119 HSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVM 178
Query: 184 N-KRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKI---------TRAEFKCPN 233
GYD KADIWS G+ L G P+ M++ T A++K
Sbjct: 179 EQVHGYD-FKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKK-- 235
Query: 234 WFPPEVRKLLSRILDPNPSTRVTMAKLMENYWF 266
+ RK++S L +PS R T +L+++ +F
Sbjct: 236 -YSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 7e-47
Identities = 77/261 (29%), Positives = 129/261 (49%), Gaps = 22/261 (8%)
Query: 12 YELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKR-----EISVMRL 66
+++ + LG+G++ VY + L Q A+K VD +G + Q +R EI ++
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVD------LGSMSQKEREDAVNEIRILAS 55
Query: 67 VRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGK-----LREEVARKYFQQLVDA 121
V HPNI+ E K+ MEY G+L ++K K + E+ + F QL+
Sbjct: 56 VNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG 115
Query: 122 VEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPE 181
++ H + + HRDLK N+LL N +KI D G+S + + + T GTP Y+APE
Sbjct: 116 LQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKK----NMAKTQIGTPHYMAPE 171
Query: 182 VINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF-KCPNWFPPEVR 240
V R Y K+DIWS G +L+ + PF ++ +L K+ R ++ P + +++
Sbjct: 172 VWKGRPYS-YKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQ 230
Query: 241 KLLSRILDPNPSTRVTMAKLM 261
+ +L P R K++
Sbjct: 231 NFIRSMLQVKPKLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 1e-46
Identities = 74/251 (29%), Positives = 134/251 (53%), Gaps = 12/251 (4%)
Query: 18 LGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYE 77
+G+G +VY + TG+ VAIK + K + + I EI +M+ +HPNIV Y+
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNK----ELIINEILIMKDCKHPNIVDYYD 82
Query: 78 VMASKTKIYFAMEYVRGGELFNKVA--KGKLREEVARKYFQQLVDAVEFCHSRGVYHRDL 135
+++ MEY+ GG L + + ++ E ++++ +E+ HS+ V HRD+
Sbjct: 83 SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDI 142
Query: 136 KPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADI 195
K +N+LL ++G +K++DFG +A + T++ ++ GTP ++APEVI ++ Y K DI
Sbjct: 143 KSDNILLSKDGSVKLADFGFAA--QLTKEKSKRNSVVGTPYWMAPEVIKRKDYG-PKVDI 199
Query: 196 WSCGVVLFVLLAGNLPFYDSNLMELYKKITRA---EFKCPNWFPPEVRKLLSRILDPNPS 252
WS G++ + G P+ + IT K P + PE + L++ L +P
Sbjct: 200 WSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPE 259
Query: 253 TRVTMAKLMEN 263
R + +L+++
Sbjct: 260 KRPSAEELLQH 270
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 1e-46
Identities = 89/245 (36%), Positives = 140/245 (57%), Gaps = 8/245 (3%)
Query: 16 RLLGQGTFAKVYHGRNLK---TGQSVAIKIVDKEKI-RRVGLIDQIKREISVMRLVRHPN 71
++LG+G + KV+ R + TG+ A+K++ K I R K E +++ V+HP
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 72 IVQLYEVMASKTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGV 130
IV L + K+Y +EY+ GGELF + + G E+ A Y ++ A+E H +G+
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGI 121
Query: 131 YHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDG 190
+RDLKPEN+LLD G +K++DFGL +ES + + HT CGT Y+APE++ + G+ G
Sbjct: 122 IYRDLKPENILLDAQGHVKLTDFGLC--KESIHEGTVTHTFCGTIEYMAPEILMRSGH-G 178
Query: 191 AKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILDPN 250
D WS G +++ +L G PF N + KI + + P + PE R LL ++L N
Sbjct: 179 KAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRN 238
Query: 251 PSTRV 255
PS+R+
Sbjct: 239 PSSRL 243
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 2e-46
Identities = 86/263 (32%), Positives = 137/263 (52%), Gaps = 11/263 (4%)
Query: 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRH 69
+ L +G+G+F +VY + +T Q VAIK++D E+ I+ I++EI + R
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE--IEDIQQEIQFLSQCRS 58
Query: 70 PNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRG 129
P I + Y +K++ MEY GG + + GKL E ++++ +E+ H G
Sbjct: 59 PYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEG 118
Query: 130 VYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYD 189
HRD+K N+LL E GD+K++DFG+S ST +T GTP ++APEVI + GYD
Sbjct: 119 KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK--RNTFVGTPFWMAPEVIKQSGYD 176
Query: 190 GAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCP----NWFPPEVRKLLSR 245
KADIWS G+ L G P D + M + I + P N F + +S
Sbjct: 177 E-KADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN--PPSLEGNKFSKPFKDFVSL 233
Query: 246 ILDPNPSTRVTMAKLMENYWFRK 268
L+ +P R + +L+++ + +K
Sbjct: 234 CLNKDPKERPSAKELLKHKFIKK 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 162 bits (411), Expect = 3e-46
Identities = 91/242 (37%), Positives = 141/242 (58%), Gaps = 5/242 (2%)
Query: 16 RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQL 75
+LLG+GTF KV + TG+ A+KI+ KE I + E V++ RHP + L
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 76 YEVMASKTKIYFAMEYVRGGELFNKVAKGKL-REEVARKYFQQLVDAVEFCHS-RGVYHR 133
+ ++ F MEY GGELF +++ ++ E+ AR Y ++V A+++ HS + V +R
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120
Query: 134 DLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKA 193
DLK ENL+LD++G +KI+DFGL +E + + T CGTP Y+APEV+ Y G
Sbjct: 121 DLKLENLMLDKDGHIKITDFGLC--KEGIKDGATMKTFCGTPEYLAPEVLEDNDY-GRAV 177
Query: 194 DIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILDPNPST 253
D W GVV++ ++ G LPFY+ + +L++ I E + P PE + LLS +L +P
Sbjct: 178 DWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQ 237
Query: 254 RV 255
R+
Sbjct: 238 RL 239
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 162 bits (413), Expect = 4e-46
Identities = 92/299 (30%), Positives = 146/299 (48%), Gaps = 49/299 (16%)
Query: 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRH 69
+ +E+ +++G+G F +V+ R+ TGQ A+K++ K + + I ++ E ++
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 70 PNIVQLYEVMASKTKIYFAMEYVRGGELFNK-VAKGKLREEVARKYFQQLVDAVEFCHSR 128
P IV+LY + +Y MEY+ GG+L N + K EE AR Y +LV A++ H
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL 120
Query: 129 GVYHRDLKPENLLLDENGDLKISDFGLSA--------------LQESTRQDGLL------ 168
G HRD+KP+N+L+D +G +K++DFGL +D +L
Sbjct: 121 GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDH 180
Query: 169 -------HTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELY 221
++T GTP Y+APEV+ Y + D WS GV+L+ +L G PFY L E Y
Sbjct: 181 KQRRVRANSTVGTPDYIAPEVLRGTPYGL-ECDWWSLGVILYEMLYGFPPFYSDTLQETY 239
Query: 222 KKITRAEFKCPNW-----FP------PEVRKLLSRILDPNPSTRVTMAK-LMENYWFRK 268
KI NW FP PE L+ R+L P R+ + + + +F+
Sbjct: 240 NKII-------NWKESLRFPPDPPVSPEAIDLICRLLCD-PEDRLGSFEEIKSHPFFKG 290
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 161 bits (408), Expect = 6e-46
Identities = 94/272 (34%), Positives = 143/272 (52%), Gaps = 13/272 (4%)
Query: 18 LGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYE 77
+G+G+F KV R T + A+K + K I + E +V+ V P IV L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 78 VMASKTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLK 136
S K+Y + ++ GGELF+ + + G+ AR Y +L+ A+E H V +RDLK
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120
Query: 137 PENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIW 196
PEN+LLD G + + DFGL L D +T CGTP Y+APE++ GY A D W
Sbjct: 121 PENILLDYQGHIALCDFGLCKLNMK--DDDKTNTFCGTPEYLAPELLLGHGYTKA-VDWW 177
Query: 197 SCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILDPNPSTR-- 254
+ GV+L+ +L G PFYD N+ E+Y+KI + + P+ F + + LL +L +P+ R
Sbjct: 178 TLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLG 237
Query: 255 VTMAKLMENY-------WFRKGYKKIETPESP 279
A+ ++N+ W + K I+ P P
Sbjct: 238 YNGAQEIKNHPFFSQLSWKKLLMKGIQPPFKP 269
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 159 bits (403), Expect = 8e-46
Identities = 82/242 (33%), Positives = 125/242 (51%), Gaps = 13/242 (5%)
Query: 20 QGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRH-PNIVQLYEV 78
+G F VY + TG AIK++ K + + +K E ++M + P + +LY
Sbjct: 6 KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65
Query: 79 MASKTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKP 137
SK +Y MEY+ GG+ + + G L E+ A++Y ++V VE H RG+ HRD+KP
Sbjct: 66 FQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKP 125
Query: 138 ENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWS 197
ENLL+D+ G LK++DFGLS ++ GTP Y+APE I G D +D WS
Sbjct: 126 ENLLIDQTGHLKLTDFGLSRNGLENKK------FVGTPDYLAPETILGVGDDKM-SDWWS 178
Query: 198 CGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCP----NWFPPEVRKLLSRILDPNPST 253
G V+F L G PF+ ++ I P + PE L++R+L +P+
Sbjct: 179 LGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAK 238
Query: 254 RV 255
R+
Sbjct: 239 RL 240
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 2e-45
Identities = 79/232 (34%), Positives = 119/232 (51%), Gaps = 17/232 (7%)
Query: 12 YELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPN 71
+++ LG+G++ VY + +TGQ VAIK+V E + +I +EIS+++ P
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE-----EDLQEIIKEISILKQCDSPY 59
Query: 72 IVQLYEVMASKTKIYFAMEYVRGGELFN--KVAKGKLREEVARKYFQQLVDAVEFCHSRG 129
IV+ Y T ++ MEY G + + K+ L EE Q + +E+ HS
Sbjct: 60 IVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK 119
Query: 130 VYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYD 189
HRD+K N+LL+E G K++DFG+S T +T GTP ++APEVI + GY+
Sbjct: 120 KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM--AKRNTVIGTPFWMAPEVIQEIGYN 177
Query: 190 GAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRK 241
KADIWS G+ + G P+ D + M RA F PN PP +
Sbjct: 178 -NKADIWSLGITAIEMAEGKPPYSDIHPM-------RAIFMIPNKPPPTLSD 221
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 159 bits (403), Expect = 4e-45
Identities = 89/241 (36%), Positives = 140/241 (58%), Gaps = 4/241 (1%)
Query: 16 RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQL 75
+LLG+GTF KV R +G+ A+KI+ KE I + E V++ RHP + L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 76 YEVMASKTKIYFAMEYVRGGELFNKVAKGKL-REEVARKYFQQLVDAVEFCHSRGVYHRD 134
+K ++ F MEYV GGELF +++ ++ E+ R Y ++V A+++ HS + +RD
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120
Query: 135 LKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKAD 194
LK ENL+LD++G +KI+DFGL +E + T CGTP Y+APEV+ Y G D
Sbjct: 121 LKLENLMLDKDGHIKITDFGLC--KEGITDAATMKTFCGTPEYLAPEVLEDNDY-GRAVD 177
Query: 195 IWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILDPNPSTR 254
W GVV++ ++ G LPFY+ + +L++ I + K P + + LLS +L +P+ R
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKR 237
Query: 255 V 255
+
Sbjct: 238 L 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 9e-45
Identities = 96/324 (29%), Positives = 148/324 (45%), Gaps = 19/324 (5%)
Query: 16 RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVM-RLVRHPNIVQ 74
+++G+G+F KV ++ G+ A+K++ K+ I + I E +V+ + V+HP +V
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 75 LYEVMASKTKIYFAMEYVRGGELFNKVAKGK-LREEVARKYFQQLVDAVEFCHSRGVYHR 133
L+ + K+YF ++YV GGELF + + + E AR Y ++ A+ + HS + +R
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120
Query: 134 DLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKA 193
DLKPEN+LLD G + ++DFGL +E T CGTP Y+APEV+ K+ YD
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLC--KEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRT-V 177
Query: 194 DIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILDPNPST 253
D W G VL+ +L G PFY + E+Y I + R LL +L + +
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTK 237
Query: 254 RVTMAKLMENY----------WFRKGYKKIETPESPRGQDRNKLISDIHAVFECES---S 300
R+ W KKI P +P L F E S
Sbjct: 238 RLGAKDDFLEIKNHVFFSSINWDDLVNKKITPPFNPNVSGPMDL-KHFDPEFTEEPVPNS 296
Query: 301 SSRDTDPPTNSCRSPVRPSSFNAF 324
+ D S +F F
Sbjct: 297 VGKSPDSVLVSASVKEADDAFLGF 320
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 2e-44
Identities = 92/269 (34%), Positives = 140/269 (52%), Gaps = 32/269 (11%)
Query: 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHP 70
YEL + +G GT+ VY R++ TG+ VAIK++ K+ + I++EIS+++ RHP
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVI---KLEPGDDFEIIQQEISMLKECRHP 60
Query: 71 NIVQLYEVMASKTKIYFAMEYVRGGELFN--KVAKGKLREE----VARKYFQQLVDAVEF 124
NIV + + K++ MEY GG L + +V +G L E V R+ + L +
Sbjct: 61 NIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGL----AY 116
Query: 125 CHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQEST---RQDGLLHTTCGTPAYVAPE 181
H G HRD+K N+LL E+GD+K++DFG+SA +T R+ + GTP ++APE
Sbjct: 117 LHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRK-----SFIGTPYWMAPE 171
Query: 182 VIN---KRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCP------ 232
V K GYDG K DIW+ G+ L P +D + M I+++ F P
Sbjct: 172 VAAVERKGGYDG-KCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKE 230
Query: 233 NWFPPEVRKLLSRILDPNPSTRVTMAKLM 261
W P + + L +P R T KL+
Sbjct: 231 KW-SPVFHDFIKKCLTKDPKKRPTATKLL 258
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 155 bits (395), Expect = 3e-44
Identities = 87/292 (29%), Positives = 145/292 (49%), Gaps = 43/292 (14%)
Query: 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRV--GLIDQIKREISVMRLVR 68
+Y++ +G+G V+ ++ +TG++VA+K K +RR+ G+ +Q REI ++ +
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALK---KVALRRLEGGIPNQALREIKALQACQ 57
Query: 69 HPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGK--LREEVARKYFQQLVDAVEFCH 126
HP +V+L +V + MEY+ +L + + L E + Y + L+ V + H
Sbjct: 58 HPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH 116
Query: 127 SRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVI-NK 185
+ G+ HRDLKP NLL+ +G LKI+DFGL+ L S + L T Y APE++
Sbjct: 117 ANGIMHRDLKPANLLISADGVLKIADFGLARLF-SEEEPRLYSHQVATRWYRAPELLYGA 175
Query: 186 RGYDGAKADIWSCGVVLFVLLAGNLPFY--DSNLMEL----------------------- 220
R YD D+W+ G + LL G+ P + ++++ +L
Sbjct: 176 RKYDPG-VDLWAVGCIFAELLNGS-PLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPD 233
Query: 221 YKKITRAEFKCPNW---FP---PEVRKLLSRILDPNPSTRVTMAKLMENYWF 266
Y KIT E K FP PE LL +L +PS R++ A+ + + +F
Sbjct: 234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 155 bits (392), Expect = 2e-43
Identities = 89/279 (31%), Positives = 146/279 (52%), Gaps = 17/279 (6%)
Query: 16 RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR-HPNIVQ 74
R+LG+G+F KV R ++G+ A+K++ K+ I + ++ E ++ L R HP + Q
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 75 LYEVMASKTKIYFAMEYVRGGELFNKVAKGK-LREEVARKYFQQLVDAVEFCHSRGVYHR 133
LY + +++F ME+V GG+L + K + E AR Y ++ A+ F H +G+ +R
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120
Query: 134 DLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKA 193
DLK +N+LLD G K++DFG+ +E T CGTP Y+APE++ + Y G
Sbjct: 121 DLKLDNVLLDHEGHCKLADFGMC--KEGIFNGKTTSTFCGTPDYIAPEILQEMLY-GPSV 177
Query: 194 DIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILDPNPST 253
D W+ GV+L+ +L G+ PF N +L++ I E P W + +L + NP+
Sbjct: 178 DWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTM 237
Query: 254 RV-------TMAKLMENY-----WFRKGYKKIETPESPR 280
R+ A L + W + ++IE P PR
Sbjct: 238 RLGSLTLGGEEAILRHPFFKELDWEKLNRRQIEPPFRPR 276
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 8e-43
Identities = 85/264 (32%), Positives = 142/264 (53%), Gaps = 20/264 (7%)
Query: 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRH 69
+E +L+ G + VY R+ +T Q A+K ++K+ + I Q+ E ++ +
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60
Query: 70 PNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSR 128
P +V ++ +K + MEYV GG+ + G L ++AR YF + V A+E+ H+
Sbjct: 61 PFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY 120
Query: 129 GVYHRDLKPENLLLDENGDLKISDFGLSA--------------LQESTRQDGLLHTTCGT 174
G+ HRDLKP+NLL+ G +K++DFGLS +++ TR+ L CGT
Sbjct: 121 GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE-FLDKQVCGT 179
Query: 175 PAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCP-- 232
P Y+APEVI ++GY G D W+ G++L+ L G +PF+ EL+ ++ + + P
Sbjct: 180 PEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEG 238
Query: 233 -NWFPPEVRKLLSRILDPNPSTRV 255
P + + L+SR+L NP R+
Sbjct: 239 DEALPADAQDLISRLLRQNPLERL 262
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 1e-42
Identities = 76/259 (29%), Positives = 127/259 (49%), Gaps = 14/259 (5%)
Query: 13 ELGRLLGQGTFAKVYHGR----NLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR 68
LG+ LG+G F +VY G+ K VA+K + ++ I++ RE +MR +
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASE--QQIEEFLREARIMRKLD 59
Query: 69 HPNIVQLYEVMASKTKIYFAMEYVRGGEL--FNKVAKGKLREEVARKYFQQLVDAVEFCH 126
HPN+V+L V + +Y MEY+ GG+L + + + KL + Q+ +E+
Sbjct: 60 HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE 119
Query: 127 SRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTP-AYVAPEVINK 185
S+ HRDL N L+ EN +KISDFGLS P ++APE + +
Sbjct: 120 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL--PIRWMAPESLKE 177
Query: 186 RGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAEF-KCPNWFPPEVRKLL 243
+ +K+D+WS GV+L+ + G P+ + E+ + + P PPE+ L+
Sbjct: 178 GKF-TSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPPELYDLM 236
Query: 244 SRILDPNPSTRVTMAKLME 262
+ +P R T ++L+E
Sbjct: 237 LQCWAEDPEDRPTFSELVE 255
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 1e-42
Identities = 92/283 (32%), Positives = 140/283 (49%), Gaps = 41/283 (14%)
Query: 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMR-LVR 68
+EL ++G+GT+ KVY R+ KTGQ VAIKI+D + ++IK E +++R
Sbjct: 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE----EEEIKEEYNILRKYSN 61
Query: 69 HPNIVQLYEVMASKT------KIYFAMEYVRGG---ELFNKV-AKGK-LREEVARKYFQQ 117
HPNI Y K +++ ME GG +L + KGK L+EE ++
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 118 LVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAY 177
+ + + H V HRD+K +N+LL +N ++K+ DFG+SA + G +T GTP +
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA--QLDSTLGRRNTFIGTPYW 179
Query: 178 VAPEVIN-----KRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCP 232
+APEVI YD A++D+WS G+ L G P D + M RA FK P
Sbjct: 180 MAPEVIACDEQPDASYD-ARSDVWSLGITAIELADGKPPLCDMHPM-------RALFKIP 231
Query: 233 NWFPPEVRK----------LLSRILDPNPSTRVTMAKLMENYW 265
PP ++ +S L N R M +L+E+ +
Sbjct: 232 RNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 2e-42
Identities = 88/299 (29%), Positives = 142/299 (47%), Gaps = 56/299 (18%)
Query: 12 YELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIR----RVGLIDQIKREISVMRLV 67
YE +G+GT+ +VY RN KTG+ VA+K KIR + G REI +++ +
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALK-----KIRMENEKEGFPITAIREIKLLQKL 55
Query: 68 RHPNIVQLYEVMASKTK--IYFAMEYVR---GGELFNKVAKGKLREEVARKYFQQLVDAV 122
RHPNIV+L E++ SK K IY EY+ G L + + K E + Y +QL++ +
Sbjct: 56 RHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSP--EVKFTESQIKCYMKQLLEGL 113
Query: 123 EFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEV 182
++ HS G+ HRD+K N+L++ +G LK++DFGL+ + T Y PE+
Sbjct: 114 QYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPEL 172
Query: 183 I-NKRGYDGAKADIWSCGVVLFVLLAG--------------------------------N 209
+ Y D+WS G +L L G
Sbjct: 173 LLGATRYGPE-VDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSK 231
Query: 210 LPFYDSNLM--ELYKKITRAEFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWF 266
LP+++ NL + YK+ R FK + P LL ++L +P R++ + +++ +F
Sbjct: 232 LPWFE-NLKPKKPYKRRLREFFK--HLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 3e-42
Identities = 91/289 (31%), Positives = 146/289 (50%), Gaps = 23/289 (7%)
Query: 12 YELGRLLGQGTFAKVYHGRNL---KTGQSVAIKIVDKEKI-RRVGLIDQIKREISVMRLV 67
+EL R+LG G + KV+ R + G+ A+K++ K I ++ + + E V+ V
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 68 RH-PNIVQLYEVMASKTKIYFAMEYVRGGELFNKV-AKGKLREEVARKYFQQLVDAVEFC 125
R P +V L+ + TK++ ++YV GGELF + + E R Y ++V A++
Sbjct: 62 RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHL 121
Query: 126 HSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINK 185
H G+ +RD+K EN+LLD G + ++DFGLS + ++ ++ CGT Y+APEVI
Sbjct: 122 HQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRG 180
Query: 186 --RGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKC----PNWFPPEV 239
G+D A D WS GV+ F LL G PF +I+R K P E
Sbjct: 181 GSGGHDKA-VDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEA 239
Query: 240 RKLLSRILDPNPSTRVTM--AKLMENYWFRKGY-------KKIETPESP 279
R + ++L+ +P R+ A ++N+ F +G K+I P P
Sbjct: 240 RDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDDLAAKRIPAPFKP 288
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 3e-42
Identities = 85/275 (30%), Positives = 136/275 (49%), Gaps = 41/275 (14%)
Query: 16 RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQL 75
+LLG+G +V+ R TG+ A+K++DK+++ + + ++ E ++ + HP + L
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 76 YEVMASKTKIYFAMEYVRGGELF---NKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYH 132
Y ++T + M+Y GGELF + L EEVAR Y +++ A+E+ H G+ +
Sbjct: 67 YASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVY 126
Query: 133 RDLKPENLLLDENGDLKISDFGLS-------------ALQESTRQDGLLHTT-------- 171
RDLKPEN+LL E+G + +SDF LS + S R +
Sbjct: 127 RDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPS 186
Query: 172 ------CGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKIT 225
GT Y+APEVI+ G+ A D W+ G++L+ +L G PF SN E + I
Sbjct: 187 FRSNSFVGTEEYIAPEVISGDGHGSA-VDWWTLGILLYEMLYGTTPFKGSNRDETFSNIL 245
Query: 226 RAEFKCPNWFPPEV------RKLLSRILDPNPSTR 254
+ E FP R L+ ++L +PS R
Sbjct: 246 KKEVT----FPGSPPVSSSARDLIRKLLVKDPSKR 276
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 151 bits (382), Expect = 4e-42
Identities = 85/268 (31%), Positives = 150/268 (55%), Gaps = 7/268 (2%)
Query: 16 RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQ 74
++LG+G+F KV T + AIK + K+ + ++ E V+ L HP +
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 75 LYEVMASKTKIYFAMEYVRGGEL-FNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHR 133
L+ +K ++F MEY+ GG+L F+ + G+ E AR Y +++ ++F H +G+ +R
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYR 120
Query: 134 DLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKA 193
DLK +N+LLD++G +KI+DFG+ +E+ +G T CGTP Y+APE++ + Y+
Sbjct: 121 DLKLDNVLLDKDGHIKIADFGMC--KENMNGEGKASTFCGTPDYIAPEILKGQKYN-ESV 177
Query: 194 DIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILDPNPST 253
D WS GV+L+ +L G PF+ + EL+ I P W E + LS++ + +P+
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTK 237
Query: 254 RVTMAKLMENYWFRKG--YKKIETPESP 279
R+ + + + F +G ++++E E P
Sbjct: 238 RLGVDGDIRQHPFFRGIDWERLEKREIP 265
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 5e-42
Identities = 82/262 (31%), Positives = 137/262 (52%), Gaps = 26/262 (9%)
Query: 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKR-----EISV 63
+ +++ + +G+G F+ VY L G+ VA+K K++ ++D R EI +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALK-----KVQIFEMMDAKARQDCLKEIDL 55
Query: 64 MRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGEL------FNKVAKGKLREEVAR-KYFQ 116
++ + HPN+++ ++ +E G+L F K + +L E KYF
Sbjct: 56 LKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKK--QKRLIPERTIWKYFV 113
Query: 117 QLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPA 176
QL A+E HS+ + HRD+KP N+ + G +K+ D GL S + H+ GTP
Sbjct: 114 QLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPY 171
Query: 177 YVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDS--NLMELYKKITRAEFK-CPN 233
Y++PE I++ GY+ K+DIWS G +L+ + A PFY NL L KKI + ++ P
Sbjct: 172 YMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPA 230
Query: 234 -WFPPEVRKLLSRILDPNPSTR 254
+ E+R L+SR ++P+P R
Sbjct: 231 DHYSEELRDLVSRCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 9e-42
Identities = 81/263 (30%), Positives = 137/263 (52%), Gaps = 20/263 (7%)
Query: 18 LGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYE 77
+GQG + +V+ + TG+ VA+K + K + ++ + + E ++ + +V+L
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 78 VMASKTKIYFAMEYVRGGE---LFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRD 134
+Y AMEYV GG+ L N G L E+ AR Y ++ +AV+ H G HRD
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLN--NLGVLSEDHARFYMAEMFEAVDALHELGYIHRD 126
Query: 135 LKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKAD 194
LKPEN L+D +G +K++DFGLS + ++ G+P Y+APEV+ +GYD D
Sbjct: 127 LKPENFLIDASGHIKLTDFGLSKGIVT-----YANSVVGSPDYMAPEVLRGKGYD-FTVD 180
Query: 195 IWSCGVVLFVLLAGNLPFYDSNLMELYKKIT--RAEFKCPNWFPP------EVRKLLSRI 246
WS G +L+ L G PF S E ++ + + + P + P E L++++
Sbjct: 181 YWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKL 240
Query: 247 LDPNPSTRVTMAKLMENYWFRKG 269
++ +PS R + ++N+ F K
Sbjct: 241 IN-DPSRRFGSLEDIKNHPFFKE 262
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 2e-41
Identities = 92/260 (35%), Positives = 138/260 (53%), Gaps = 18/260 (6%)
Query: 18 LGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYE 77
LG G F KVY ++ +TG A KI+ E L D + EI ++ +HPNIV LYE
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEE--LEDFMV-EIDILSECKHPNIVGLYE 69
Query: 78 VMASKTKIYFAMEYVRGGELFN---KVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRD 134
+ K++ +E+ GG L + ++ +G L E R +Q+++A+ F HS V HRD
Sbjct: 70 AYFYENKLWILIEFCDGGALDSIMLELERG-LTEPQIRYVCRQMLEALNFLHSHKVIHRD 128
Query: 135 LKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVIN-----KRGYD 189
LK N+LL +GD+K++DFG+SA +ST Q T GTP ++APEV+ YD
Sbjct: 129 LKAGNILLTLDGDVKLADFGVSAKNKSTLQK--RDTFIGTPYWMAPEVVACETFKDNPYD 186
Query: 190 GAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAE---FKCPNWFPPEVRKLLSRI 246
KADIWS G+ L L P ++ N M + KI ++E P+ + L
Sbjct: 187 -YKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSC 245
Query: 247 LDPNPSTRVTMAKLMENYWF 266
L +P R T A+L+++ +
Sbjct: 246 LVKDPDDRPTAAELLKHPFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 2e-41
Identities = 75/259 (28%), Positives = 122/259 (47%), Gaps = 13/259 (5%)
Query: 13 ELGRLLGQGTFAKVYHGR----NLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR 68
ELG+ LG+G F +VY G T VA+K + + ++ E S+M+ +
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEE--EREEFLEEASIMKKLS 59
Query: 69 HPNIVQLYEVMASKTKIYFAMEYVRGGEL--FNKVAKGKLREEVARKYFQQLVDAVEFCH 126
HPNIV+L V +Y EY+ GG+L F + KL + + Q+ +E+
Sbjct: 60 HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE 119
Query: 127 SRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTP-AYVAPEVINK 185
S+ HRDL N L+ EN +KISDFGLS P ++APE +
Sbjct: 120 SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYY-RKRGGGKLPIKWMAPESLKD 178
Query: 186 RGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAE-FKCPNWFPPEVRKLL 243
+ +K+D+WS GV+L+ + G P+ + E+ + + P P E+ +L+
Sbjct: 179 GKFT-SKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPENCPDELYELM 237
Query: 244 SRILDPNPSTRVTMAKLME 262
+ +P R T ++L+E
Sbjct: 238 LQCWAYDPEDRPTFSELVE 256
|
Length = 258 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 4e-41
Identities = 79/242 (32%), Positives = 130/242 (53%), Gaps = 5/242 (2%)
Query: 16 RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR-HPNIVQ 74
++LG+G+F KV T + AIK++ K+ I + +D E ++ L HP +
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 75 LYEVMASKTKIYFAMEYVRGGELFNKVAKG-KLREEVARKYFQQLVDAVEFCHSRGVYHR 133
L+ +K +++F MEYV GG+L ++ + K E +R Y ++ A+ F H GV +R
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120
Query: 134 DLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKA 193
DLK +N+LLD G K++DFG+ +E T CGTP Y+APE++ + Y G
Sbjct: 121 DLKLDNILLDAEGHCKLADFGMC--KEGILNGVTTTTFCGTPDYIAPEILQELEY-GPSV 177
Query: 194 DIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILDPNPST 253
D W+ GV+++ ++AG PF N +L++ I + P W E +L + NP+
Sbjct: 178 DWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNK 237
Query: 254 RV 255
R+
Sbjct: 238 RL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 4e-41
Identities = 81/222 (36%), Positives = 117/222 (52%), Gaps = 18/222 (8%)
Query: 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIK----IVDKEKIRRVGLIDQIKREISVMR 65
NKYE+ ++G+G + V RN TG+ VAIK D E +++ L RE+ V+R
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTAL-----REVKVLR 55
Query: 66 LVRHPNIVQLYEVMASKTKIYFAMEYVRGG--ELFNKVAKGKLREEVARKYFQQLVDAVE 123
+RH NIV L E K ++Y EYV EL G L + R Y QL+ A+
Sbjct: 56 QLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGG-LPPDAVRSYIWQLLQAIA 114
Query: 124 FCHSRGVYHRDLKPENLLLDENGDLKISDFGLS-ALQESTRQDGLLHTTCGTPAYVAPEV 182
+CHS + HRD+KPEN+L+ E+G LK+ DFG + AL+ L T Y APE+
Sbjct: 115 YCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASP--LTDYVATRWYRAPEL 172
Query: 183 INKRGYDGAKADIWSCGVVLFVLLAGNLPFY--DSNLMELYK 222
+ G D+W+ G ++ LL G P + DS++ +LY
Sbjct: 173 LVGDTNYGKPVDVWAIGCIMAELLDGE-PLFPGDSDIDQLYL 213
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 5e-41
Identities = 97/305 (31%), Positives = 145/305 (47%), Gaps = 67/305 (21%)
Query: 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIK-I-VDKEKIRRVGLIDQIKREISVMRLVR 68
+YE G+ LG+GT+A VY R+ +TG+ VAIK I + + K + G+ REI +++ ++
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 69 HPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGK---LREEVARKYFQQLVDAVEFC 125
HPNI+ L +V K+ I E++ +L KV K K L + Y + +E+
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMET-DL-EKVIKDKSIVLTPADIKSYMLMTLRGLEYL 118
Query: 126 HSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPA--------- 176
HS + HRDLKP NLL+ +G LK++DFGL+ + G+P
Sbjct: 119 HSNWILHRDLKPNNLLIASDGVLKLADFGLA-------------RSFGSPNRKMTHQVVT 165
Query: 177 --YVAPEVI-NKRGYDGAKADIWSCGVVLFVLLAGNLPFY--DSNLMELYKKITRAEFKC 231
Y APE++ R Y D+WS G + LL PF DS++ +L KI A
Sbjct: 166 RWYRAPELLFGARHYGVG-VDMWSVGCIFAELLLRV-PFLPGDSDIDQL-GKIFEA-LGT 221
Query: 232 P---NW--------------FPPEVRK------------LLSRILDPNPSTRVTMAKLME 262
P NW FPP K LL R+L NP+ R+T + +E
Sbjct: 222 PTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281
Query: 263 NYWFR 267
+ +F
Sbjct: 282 HPYFS 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 1e-40
Identities = 83/259 (32%), Positives = 140/259 (54%), Gaps = 16/259 (6%)
Query: 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQ---IKREISVMRLV 67
KYE R++G+G F V+ R + V IK + E++ + D+ + E V++L+
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK----DERLAAQNECQVLKLL 56
Query: 68 RHPNIVQLYEVMASKTKIYFAMEYVRGG---ELFNKVAKGKLREEVARKYFQQLVDAVEF 124
HPNI++ YE + MEY GG E K L E+ +F Q++ A+
Sbjct: 57 SHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHH 116
Query: 125 CHSRGVYHRDLKPENLLLDENGD-LKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVI 183
H++ + HRDLK +N+LLD++ +KI DFG+S + S + +T GTP Y++PE+
Sbjct: 117 VHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK---AYTVVGTPCYISPELC 173
Query: 184 NKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFK-CPNWFPPEVRKL 242
+ Y+ K+DIW+ G VL+ L + F +NL L KI F + + P++R+L
Sbjct: 174 EGKPYN-QKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQL 232
Query: 243 LSRILDPNPSTRVTMAKLM 261
+ +L+ +PS R ++++M
Sbjct: 233 ILSMLNLDPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 1e-40
Identities = 85/261 (32%), Positives = 139/261 (53%), Gaps = 17/261 (6%)
Query: 15 GRLLGQGTFAKVYHGRNLKTGQSVAIKIVD------KEKIRRVGLIDQIKREISVMRLVR 68
G L+G G+F VY G N +G+ +A+K V+ K R+ ++D + REI++++ ++
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64
Query: 69 HPNIVQLYEVMASKTKIYFAMEYVRGGE---LFNKVAKGKLREEVARKYFQQLVDAVEFC 125
H NIVQ + +EYV GG L N G E + R + +Q++ + +
Sbjct: 65 HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYL 122
Query: 126 HSRGVYHRDLKPENLLLDENGDLKISDFGLSALQE----STRQDGLLHTTCGTPAYVAPE 181
H+RG+ HRD+K N+L+D G +KISDFG+S E ST+ +G + G+ ++APE
Sbjct: 123 HNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE 182
Query: 182 VINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKI-TRAEFKCPNWFPPEVR 240
V+ + Y KADIWS G ++ +L G PF D ++ KI A + P+ E
Sbjct: 183 VVKQTSYT-RKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSEAI 241
Query: 241 KLLSRILDPNPSTRVTMAKLM 261
L + + + + R T A+L+
Sbjct: 242 DFLEKTFEIDHNKRPTAAELL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 1e-40
Identities = 87/289 (30%), Positives = 138/289 (47%), Gaps = 40/289 (13%)
Query: 12 YELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPN 71
Y+ +G+GT+ VY R+ TG+ VAIK + K + G+ REI +++ + HPN
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKI-KLRFESEGIPKTALREIKLLKELNHPN 59
Query: 72 IVQLYEVMASKTKIYFAMEYVRGG-ELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGV 130
I++L +V K +Y E++ K + L E + + Y QL+ + FCHS G+
Sbjct: 60 IIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGI 119
Query: 131 YHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTT-CGTPAYVAPEVI-NKRGY 188
HRDLKPENLL++ G LK++DFGL+ S +T T Y APE++ +GY
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLA---RSFGSPVRPYTHYVVTRWYRAPELLLGDKGY 176
Query: 189 DGAKADIWSCGVVLFVLLAGNLPFY--DSNLMELYK-----------------------K 223
DIWS G + LL+ P + S + +L+K K
Sbjct: 177 -STPVDIWSVGCIFAELLSRR-PLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK 234
Query: 224 ITRAEFKCPNW---FP---PEVRKLLSRILDPNPSTRVTMAKLMENYWF 266
+ + FP P+ LLS++L +P R+T + + + +F
Sbjct: 235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 1e-40
Identities = 82/266 (30%), Positives = 140/266 (52%), Gaps = 21/266 (7%)
Query: 15 GRLLGQGTFAKVYHGRNLKTGQSVAIK-------IVDKEKIRRVGLIDQIKREISVMRLV 67
G L+G+GT+ +VY N+ TG+ +A+K I + R+ ++ ++ EI ++ +
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 68 RHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCH 126
H NIVQ ++ + +EYV GG + + + G+ E++ R + +Q+++ + + H
Sbjct: 66 DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH 125
Query: 127 SRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVIN-- 184
S+G+ HRDLK +NLL+D +G KISDFG+S + + + G+ ++APEVI+
Sbjct: 126 SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSY 185
Query: 185 KRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLS 244
+GY AK DIWS G V+ + AG P+ D + K+ P PP+V LS
Sbjct: 186 SQGYS-AKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPP--IPPDVSMNLS 242
Query: 245 RI--------LDPNPSTRVTMAKLME 262
+ NP R T +L++
Sbjct: 243 PVALDFLNACFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 144 bits (367), Expect = 2e-40
Identities = 78/267 (29%), Positives = 125/267 (46%), Gaps = 29/267 (10%)
Query: 13 ELGRLLGQGTFAKVYHGR----NLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR 68
LG+ LG+G F +VY G VA+K + ++ + I++ RE +MR +
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQ--QIEEFLREARIMRKLD 59
Query: 69 HPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFC--- 125
HPNIV+L V + + MEY+ GG+L LR+ R L D + F
Sbjct: 60 HPNIVKLLGVCTEEEPLMIVMEYMPGGDL-----LDYLRK--NRPKELSLSDLLSFALQI 112
Query: 126 -------HSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTP-AY 177
S+ HRDL N L+ EN +KISDFGLS + P +
Sbjct: 113 ARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRW 170
Query: 178 VAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAEF-KCPNWF 235
+APE + + + +K+D+WS GV+L+ + G P+ + E+ + + + P
Sbjct: 171 MAPESLKEGKF-TSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNC 229
Query: 236 PPEVRKLLSRILDPNPSTRVTMAKLME 262
PPE+ KL+ + +P R T ++L+E
Sbjct: 230 PPELYKLMLQCWAEDPEDRPTFSELVE 256
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 2e-40
Identities = 81/256 (31%), Positives = 143/256 (55%), Gaps = 13/256 (5%)
Query: 18 LGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYE 77
+G+G+ V + TG+ VA+K +D K +R L+ E+ +MR +HPNIV++Y
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFN---EVVIMRDYQHPNIVEMYS 83
Query: 78 VMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKP 137
+++ ME++ GG L + V ++ EE ++ A+ F H++GV HRD+K
Sbjct: 84 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKS 143
Query: 138 ENLLLDENGDLKISDFGLSAL--QESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADI 195
+++LL +G +K+SDFG A +E R+ L+ GTP ++APEVI++ Y G + DI
Sbjct: 144 DSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV----GTPYWMAPEVISRLPY-GTEVDI 198
Query: 196 WSCGVVLFVLLAGNLPFYDSNLMELYKKITRAE---FKCPNWFPPEVRKLLSRILDPNPS 252
WS G+++ ++ G P+++ ++ K+I K + P +R L R+L +P+
Sbjct: 199 WSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPA 258
Query: 253 TRVTMAKLMENYWFRK 268
R T A+L+ + + K
Sbjct: 259 QRATAAELLNHPFLAK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 1e-39
Identities = 83/242 (34%), Positives = 134/242 (55%), Gaps = 5/242 (2%)
Query: 16 RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVM-RLVRHPNIVQ 74
+++G+G+F KV R+ + A+K++ K+ I + I E +V+ + V+HP +V
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 75 LYEVMASKTKIYFAMEYVRGGELFNKVAKGK-LREEVARKYFQQLVDAVEFCHSRGVYHR 133
L+ + K+YF ++Y+ GGELF + + + E AR Y ++ A+ + HS + +R
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120
Query: 134 DLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKA 193
DLKPEN+LLD G + ++DFGL +E+ +G T CGTP Y+APEV++K+ YD
Sbjct: 121 DLKPENILLDSQGHIVLTDFGLC--KENIEHNGTTSTFCGTPEYLAPEVLHKQPYD-RTV 177
Query: 194 DIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILDPNPST 253
D W G VL+ +L G PFY N E+Y I + R LL +L + +
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTK 237
Query: 254 RV 255
R+
Sbjct: 238 RL 239
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 2e-39
Identities = 98/321 (30%), Positives = 156/321 (48%), Gaps = 16/321 (4%)
Query: 16 RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVM-RLVRHPNIVQ 74
+++G+G+F KV + G A+K++ K+ I + + I E +V+ + ++HP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 75 LYEVMASKTKIYFAMEYVRGGELFNKVAKGK-LREEVARKYFQQLVDAVEFCHSRGVYHR 133
L+ + K+YF ++YV GGELF + + + E AR Y ++ A+ + HS + +R
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120
Query: 134 DLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKA 193
DLKPEN+LLD G + ++DFGL +E + T CGTP Y+APEV+ K YD
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLC--KEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRT-V 177
Query: 194 DIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILDPNPST 253
D W G VL+ +L G PFY ++ ++Y I + P LL +L +
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRR 237
Query: 254 RV-TMAKLME--NY-------WFRKGYKKIETPESPRGQDRNKLISDIHAVFECESSSSR 303
R+ A +E N+ W +K+I P +P L F E+ SS
Sbjct: 238 RLGAKADFLEIKNHVFFSPINWDDLYHKRITPPYNPNVAGPADL-RHFDPEFTQEAVSSS 296
Query: 304 DTDPPTNSCRSPVRPSSFNAF 324
P + S S+F F
Sbjct: 297 VGQTPDLTASSSSASSAFLGF 317
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 4e-39
Identities = 85/284 (29%), Positives = 150/284 (52%), Gaps = 31/284 (10%)
Query: 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIV-----DKEKIRRVGLIDQIKREIS 62
L + EL +G+G + VY G+++ TG+ VA+KI+ D + + I+RE++
Sbjct: 2 LYQRLEL---IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDD-------VSDIQREVA 51
Query: 63 VMRLVRH---PNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLV 119
++ +R PNI + Y +++ MEY GG + + G + E+ ++++
Sbjct: 52 LLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVL 111
Query: 120 DAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVA 179
A+++ H GV HRD+K N+L+ G++K+ DFG++AL T GTP ++A
Sbjct: 112 VALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS--SKRSTFVGTPYWMA 169
Query: 180 PEVINK-RGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCP----NW 234
PEVI + + YD KADIWS G+ ++ + GN P+ D + I ++ K P N
Sbjct: 170 PEVITEGKYYD-TKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS--KPPRLEDNG 226
Query: 235 FPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIETPES 278
+ +R+ ++ LD P R++ +L+++ W K + K TP S
Sbjct: 227 YSKLLREFVAACLDEEPKERLSAEELLKSKWI-KAHSK--TPVS 267
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 5e-39
Identities = 87/296 (29%), Positives = 142/296 (47%), Gaps = 66/296 (22%)
Query: 18 LGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIK--------REISVMRLVRH 69
+G+GT+ VY R+ TG+ VA+K KIR ++ REIS+++ + H
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALK-----KIR----LETEDEGVPSTAIREISLLKELNH 57
Query: 70 PNIVQLYEVMASKTKIYFAMEYVRGG--ELFNKVAKGKLREEVARKYFQQLVDAVEFCHS 127
PNIV+L +V+ S+ K+Y E++ + + L + + Y QL+ + +CHS
Sbjct: 58 PNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS 117
Query: 128 RGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGL-----LHTTCGTPAYVAPEV 182
V HRDLKP+NLL+D G LK++DFGL+ R G+ H T Y APE+
Sbjct: 118 HRVLHRDLKPQNLLIDREGALKLADFGLA------RAFGVPVRTYTHEVV-TLWYRAPEI 170
Query: 183 -INKRGYDGAKADIWSCGVVLFVLLAGNLPFY--DSNLMELYKKITRA------------ 227
+ R Y DIWS G + F + P + DS + +L+ +I R
Sbjct: 171 LLGSRQYSTP-VDIWSIGCI-FAEMVNRRPLFPGDSEIDQLF-RIFRTLGTPDEDVWPGV 227
Query: 228 ----EFKC--PNWFPPEVRK-----------LLSRILDPNPSTRVTMAKLMENYWF 266
++K P W ++ K LLS++L +P+ R++ +++ +F
Sbjct: 228 TSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 6e-39
Identities = 81/273 (29%), Positives = 128/273 (46%), Gaps = 50/273 (18%)
Query: 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRH 69
+ +E +++G+G F +V + TG A+K + K ++ + ++ E ++ +
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 70 PNIVQLYEVMASKTKIYFAMEYVRGGELFNK-VAKGKLREEVARKYFQQLVDAVEFCHSR 128
P +V+LY + +Y MEY+ GG++ + K EE R Y + + A++ H
Sbjct: 61 PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL 120
Query: 129 GVYHRDLKPENLLLDENGDLKISDFGLS-ALQESTRQD---------------------- 165
G HRD+KP+NLLLD G +K+SDFGL L++S R +
Sbjct: 121 GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMS 180
Query: 166 -------------GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPF 212
L ++T GTP Y+APEV + GY + D WS GV+++ +L G PF
Sbjct: 181 SKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGYPPF 239
Query: 213 YDSNLMELYKKITRAEFKCPNW-----FPPEVR 240
N E Y+KI NW FP EV
Sbjct: 240 CSDNPQETYRKII-------NWKETLQFPDEVP 265
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (361), Expect = 6e-39
Identities = 84/244 (34%), Positives = 135/244 (55%), Gaps = 9/244 (3%)
Query: 18 LGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQI--KREISVMRLVRH-PNIVQ 74
+G+GTF +VY R T + A+K++ K++I + +R I V L+ P IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 75 LYEVMASKTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHR 133
L + + +Y +Y+ GGELF + K G+ E+ A+ Y +LV A+E H + +R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 134 DLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEV-INKRGYDGAK 192
DLKPEN+LLD G + + DFGLS + + + +T CGT Y+APEV ++++GY
Sbjct: 121 DLKPENILLDATGHIALCDFGLS--KANLTDNKTTNTFCGTTEYLAPEVLLDEKGY-TKH 177
Query: 193 ADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCP-NWFPPEVRKLLSRILDPNP 251
D WS GV++F + G PFY + ++Y+ I + + P N E R+ + +L+ NP
Sbjct: 178 VDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNP 237
Query: 252 STRV 255
R+
Sbjct: 238 QHRL 241
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 1e-38
Identities = 86/274 (31%), Positives = 141/274 (51%), Gaps = 12/274 (4%)
Query: 16 RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQ 74
++LG+G+F KV+ T Q AIK + K+ + ++ E V+ L HP +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 75 LYEVMASKTKIYFAMEYVRGGEL-FNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHR 133
LY +K ++F MEY+ GG+L F+ + K A Y +++ ++F HS+G+ +R
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYR 120
Query: 134 DLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKA 193
DLK +N+LLD +G +KI+DFG+ +E+ D T CGTP Y+APE++ + Y
Sbjct: 121 DLKLDNILLDTDGHIKIADFGMC--KENMLGDAKTCTFCGTPDYIAPEILLGQKY-NTSV 177
Query: 194 DIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILDPNPST 253
D WS GV+L+ +L G PF+ + EL++ I P W E + +L ++ P
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPER 237
Query: 254 RVTMAK-------LMENYWFRKGYKKIETPESPR 280
R+ + E W ++IE P P+
Sbjct: 238 RLGVKGDIRQHPFFREIDWSALEEREIEPPFKPK 271
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 2e-38
Identities = 84/252 (33%), Positives = 140/252 (55%), Gaps = 16/252 (6%)
Query: 16 RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQ 74
R++G+G++AKV KT + A+K++ KE + ID ++ E V HP +V
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 75 LYEVMASKTKIYFAMEYVRGGEL-FNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHR 133
L+ ++++++F +E+V GG+L F+ + KL EE AR Y ++ A+ F H RG+ +R
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120
Query: 134 DLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYD-GAK 192
DLK +N+LLD G +K++D+G+ +E R T CGTP Y+APE++ RG D G
Sbjct: 121 DLKLDNVLLDAEGHIKLTDYGMC--KEGIRPGDTTSTFCGTPNYIAPEIL--RGEDYGFS 176
Query: 193 ADIWSCGVVLFVLLAGNLPF--------YDSNLME-LYKKITRAEFKCPNWFPPEVRKLL 243
D W+ GV++F ++AG PF D N + L++ I + + P + +L
Sbjct: 177 VDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVL 236
Query: 244 SRILDPNPSTRV 255
L+ +P R+
Sbjct: 237 KGFLNKDPKERL 248
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 1e-37
Identities = 81/241 (33%), Positives = 129/241 (53%), Gaps = 5/241 (2%)
Query: 17 LLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPN-IVQL 75
+LG+G+F KV T + AIKI+ K+ I + ++ E V+ L P + QL
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66
Query: 76 YEVMASKTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRD 134
+ + ++YF MEYV GG+L + + GK +E A Y ++ + F HS+G+ +RD
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRD 126
Query: 135 LKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKAD 194
LK +N++LD G +KI+DFG+ +E+ T CGTP Y+APE+I + Y G D
Sbjct: 127 LKLDNVMLDAEGHIKIADFGMC--KENIFGGKTTRTFCGTPDYIAPEIIAYQPY-GKSVD 183
Query: 195 IWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILDPNPSTR 254
W+ GV+L+ +LAG PF + EL++ I P E + +L +P+ R
Sbjct: 184 WWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKHPAKR 243
Query: 255 V 255
+
Sbjct: 244 L 244
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 1e-37
Identities = 88/279 (31%), Positives = 143/279 (51%), Gaps = 21/279 (7%)
Query: 16 RLLGQGTFAKVYHGRNLKTGQ--SVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIV 73
R LG G+F +V K VAIK +K KI + +D + E ++ + HP V
Sbjct: 36 RTLGTGSFGRVILAT-YKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCV 94
Query: 74 QLYEVMASKTKIYFAMEYVRGGELFNKVAKGK-LREEVARKYFQQLVDAVEFCHSRGVYH 132
LY ++ +Y +E+V GGE F + + K +V Y Q+V E+ S + +
Sbjct: 95 NLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVY 154
Query: 133 RDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAK 192
RDLKPENLLLD++G +K++DFG + + + TR +T CGTP Y+APE++ G+ G
Sbjct: 155 RDLKPENLLLDKDGFIKMTDFGFAKVVD-TRT----YTLCGTPEYIAPEILLNVGH-GKA 208
Query: 193 ADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILDPNPS 252
AD W+ G+ ++ +L G PFY + + +Y+KI P + + L+ ++L + +
Sbjct: 209 ADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLMKKLLSHDLT 268
Query: 253 TRVTMAK-----LMENYWFRK------GYKKIETPESPR 280
R K + E+ WF +K +E P P+
Sbjct: 269 KRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPK 307
|
Length = 340 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 1e-37
Identities = 75/256 (29%), Positives = 139/256 (54%), Gaps = 8/256 (3%)
Query: 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHP 70
KY + +G+G+F K ++ + G+ IK ++ K+ ++ ++E++V+ ++HP
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKER-EESRKEVAVLSNMKHP 59
Query: 71 NIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGK---LREEVARKYFQQLVDAVEFCHS 127
NIVQ E +Y M+Y GG+L+ K+ + E+ +F Q+ A++ H
Sbjct: 60 NIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD 119
Query: 128 RGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRG 187
R + HRD+K +N+ L ++G +K+ DFG++ + ST + L T GTP Y++PE+ R
Sbjct: 120 RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE--LARTCIGTPYYLSPEICENRP 177
Query: 188 YDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF-KCPNWFPPEVRKLLSRI 246
Y+ K+DIW+ G VL+ + F N+ L KI R + + + ++R L+S++
Sbjct: 178 YNN-KSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQL 236
Query: 247 LDPNPSTRVTMAKLME 262
NP R ++ ++E
Sbjct: 237 FKRNPRDRPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 2e-37
Identities = 90/299 (30%), Positives = 159/299 (53%), Gaps = 28/299 (9%)
Query: 12 YELGRLLGQGTFAKVYHGRNL---KTGQSVAIKIVDKEKI-RRVGLIDQIKREISVMRLV 67
+EL ++LG G + KV+ R + TG+ A+K++ K + ++ ++ + E +V+ V
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 68 RH-PNIVQLYEVMASKTKIYFAMEYVRGGELFNKV-AKGKLREEVARKYFQQLVDAVEFC 125
R P +V L+ ++ K++ ++YV GGE+F + + E+ R Y +++ A+E
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHL 121
Query: 126 HSRGVYHRDLKPENLLLDENGDLKISDFGLSA--LQESTRQDGLLHTTCGTPAYVAPEVI 183
H G+ +RD+K EN+LLD G + ++DFGLS L E + ++ CGT Y+APE+I
Sbjct: 122 HKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERT---YSFCGTIEYMAPEII 178
Query: 184 NKRGYDGAKADIWSCGVVLFVLLAGNLPFY----DSNLMELYKKITRAEFKCPNWFPPEV 239
+G G D WS G+++F LL G PF + E+ ++I + + P++ PE
Sbjct: 179 RGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEA 238
Query: 240 RKLLSRILDPNPSTRVTM----AKLMENYWFRKGY-------KKIETPESPRGQDRNKL 287
+ LL ++L +P R+ A ++ + F KG +K+ P P RN+L
Sbjct: 239 QDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKVNPPFRP--SIRNEL 295
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 2e-37
Identities = 81/260 (31%), Positives = 130/260 (50%), Gaps = 16/260 (6%)
Query: 12 YELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVD----KEKIRRVGLIDQIKREISVMRLV 67
Y R+LG+G F + R + V K V+ EK RR L EI ++ L+
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDAL-----NEIVILSLL 56
Query: 68 RHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGK---LREEVARKYFQQLVDAVEF 124
+HPNI+ Y + MEY GG L++K+ + K EE+ Y Q+V AV +
Sbjct: 57 QHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSY 116
Query: 125 CHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVIN 184
H G+ HRD+K N+ L + G +K+ DFG+S + S + + T GTP Y++PE+
Sbjct: 117 IHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGS--EYSMAETVVGTPYYMSPELCQ 174
Query: 185 KRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFK-CPNWFPPEVRKLL 243
Y+ K+DIW+ G VL+ LL F +N + L KI + + + + E+ L+
Sbjct: 175 GVKYN-FKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLV 233
Query: 244 SRILDPNPSTRVTMAKLMEN 263
+L +P R T ++++
Sbjct: 234 HSLLQQDPEKRPTADEVLDQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 3e-37
Identities = 94/298 (31%), Positives = 150/298 (50%), Gaps = 20/298 (6%)
Query: 16 RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVM-RLVRHPNIVQ 74
+++G+G+F KV + G+ A+K++ K+ + I E +V+ + V+HP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 75 LYEVMASKTKIYFAMEYVRGGELFNKVAKGK-LREEVARKYFQQLVDAVEFCHSRGVYHR 133
L+ + K+YF +++V GGELF + + + E AR Y ++ A+ + HS + +R
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120
Query: 134 DLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKA 193
DLKPEN+LLD G + ++DFGL +E Q T CGTP Y+APEVI K+ YD
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLC--KEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNT-V 177
Query: 194 DIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILDPNPST 253
D W G VL+ +L G PFY ++ E+Y I +L +L+ +
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQR 237
Query: 254 RVTMAK---LMENY-------WFRKGYKKIETPESPR--GQDRNKLISDIHAVFECES 299
R+ + ++ + W KKI P +P G D IS+ AVF E+
Sbjct: 238 RLGAKEDFLEIQEHPFFESLSWTDLEQKKIPPPFNPNVEGPDD---ISNFDAVFTEET 292
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 3e-37
Identities = 80/241 (33%), Positives = 132/241 (54%), Gaps = 26/241 (10%)
Query: 12 YELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKR--------EISV 63
+++ +++G+G F +V R+ + Q A+K++ K + IKR E +
Sbjct: 45 FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSK--------FEMIKRSDSAFFWEERDI 96
Query: 64 MRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVE 123
M IVQL+ +Y MEY+ GG+L N ++ + E+ AR Y ++V A++
Sbjct: 97 MAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALD 156
Query: 124 FCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLH--TTCGTPAYVAPE 181
HS G HRD+KP+N+LLD++G LK++DFG ++ +G++ T GTP Y++PE
Sbjct: 157 AIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA---NGMVRCDTAVGTPDYISPE 213
Query: 182 VINKRGYD---GAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPE 238
V+ +G D G + D WS GV L+ +L G+ PFY +L+ Y KI + K FP +
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM--DHKNSLTFPDD 271
Query: 239 V 239
+
Sbjct: 272 I 272
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 3e-37
Identities = 79/240 (32%), Positives = 118/240 (49%), Gaps = 6/240 (2%)
Query: 18 LGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQI---KREISVMRLVRHPNIVQ 74
LG+G F KV KTG+ AIK + K I ++ + KR RHP +V
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 75 LYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRD 134
L+ ++ + F MEY GG+L + E A Y +V +++ H + +RD
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRD 126
Query: 135 LKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKAD 194
LK +NLLLD G +KI+DFGL +E T CGTP ++APEV+ + Y A D
Sbjct: 127 LKLDNLLLDTEGFVKIADFGLC--KEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRA-VD 183
Query: 195 IWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILDPNPSTR 254
W GV+++ +L G PF + E++ I E + P + E ++ R+L NP R
Sbjct: 184 WWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLRRNPERR 243
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 4e-37
Identities = 77/266 (28%), Positives = 126/266 (47%), Gaps = 27/266 (10%)
Query: 18 LGQGTFAKVYHGRNLKTGQSVAIKIVD---KEKIRRVGLIDQIKREISVMRLVRHPNIVQ 74
LG G V + TG+ +A+K + E I++ QI RE+ ++ P IV
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQK-----QILRELDILHKCNSPYIVG 63
Query: 75 LYEVMASKTKIYFAMEYVRGGEL--FNKVAKGKLREEVARKYFQQLVDAVEFCHS-RGVY 131
Y + I MEY+ GG L K +G++ E + K ++ + + H +
Sbjct: 64 FYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKII 123
Query: 132 HRDLKPENLLLDENGDLKISDFGLSALQESTRQ--DGLLHTTCGTPAYVAPEVINKRGYD 189
HRD+KP N+L++ G +K+ DFG+S Q + L T GT +Y+APE I Y
Sbjct: 124 HRDVKPSNILVNSRGQIKLCDFGVS------GQLVNSLAKTFVGTSSYMAPERIQGNDY- 176
Query: 190 GAKADIWSCGVVLFVLLAGNLPFYDSN-----LMELYKKITRAEF-KCPN-WFPPEVRKL 242
K+DIWS G+ L L G P+ N + EL + I + P+ F P+ +
Sbjct: 177 SVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDF 236
Query: 243 LSRILDPNPSTRVTMAKLMENYWFRK 268
++ L +P R + +L+E+ + +K
Sbjct: 237 VNLCLIKDPRERPSYKELLEHPFIKK 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 1e-36
Identities = 84/251 (33%), Positives = 140/251 (55%), Gaps = 14/251 (5%)
Query: 16 RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVM-RLVRHPNIVQ 74
R++G+G++AKV R KT + A+K+V KE + ID ++ E V + HP +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 75 LYEVMASKTKIYFAMEYVRGGEL-FNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHR 133
L+ ++++++F +EYV GG+L F+ + KL EE AR Y ++ A+ + H RG+ +R
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 134 DLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKA 193
DLK +N+LLD G +K++D+G+ +E R T CGTP Y+APE++ Y G
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGMC--KEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSV 177
Query: 194 DIWSCGVVLFVLLAGNLPF--------YDSNLME-LYKKITRAEFKCPNWFPPEVRKLLS 244
D W+ GV++F ++AG PF D N + L++ I + + P + +L
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 237
Query: 245 RILDPNPSTRV 255
L+ +P R+
Sbjct: 238 SFLNKDPKERL 248
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 2e-36
Identities = 79/259 (30%), Positives = 141/259 (54%), Gaps = 13/259 (5%)
Query: 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHP 70
+YE+ + +G+G+F K+Y + + IK +D K+ V + K+E+ ++ ++HP
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMP-VKEKEASKKEVILLAKMKHP 59
Query: 71 NIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGK---LREEVARKYFQQLVDAVEFCHS 127
NIV + +++ MEY GG+L ++ + + E+ +F Q+ ++ H
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD 119
Query: 128 RGVYHRDLKPENLLLDENGDL-KISDFGLS-ALQESTRQDGLLHTTCGTPAYVAPEVINK 185
R + HRD+K +N+ L +NG + K+ DFG++ L +S L +T GTP Y++PE+
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME---LAYTCVGTPYYLSPEICQN 176
Query: 186 RGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFK--CPNWFPPEVRKLL 243
R Y+ K DIWS G VL+ L PF +NL +L KI + F PN F ++R L+
Sbjct: 177 RPYNN-KTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPN-FSRDLRSLI 234
Query: 244 SRILDPNPSTRVTMAKLME 262
S++ +P R ++ +++
Sbjct: 235 SQLFKVSPRDRPSITSILK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 135 bits (340), Expect = 3e-36
Identities = 85/260 (32%), Positives = 137/260 (52%), Gaps = 9/260 (3%)
Query: 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHP 70
KY +GQG VY ++ TGQ VAIK ++ ++ + LI EI VMR +HP
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELI---INEILVMRENKHP 76
Query: 71 NIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGV 130
NIV + +++ MEY+ GG L + V + + E ++ + A+EF HS V
Sbjct: 77 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQV 136
Query: 131 YHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDG 190
HRD+K +N+LL +G +K++DFG A + T + T GTP ++APEV+ ++ Y G
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAY-G 193
Query: 191 AKADIWSCGVVLFVLLAGNLPFYDSN-LMELYKKITRA--EFKCPNWFPPEVRKLLSRIL 247
K DIWS G++ ++ G P+ + N L LY T E + P R L+R L
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL 253
Query: 248 DPNPSTRVTMAKLMENYWFR 267
+ + R + +L+++ + +
Sbjct: 254 EMDVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 135 bits (340), Expect = 4e-36
Identities = 82/249 (32%), Positives = 137/249 (55%), Gaps = 12/249 (4%)
Query: 16 RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVM-RLVRHPNIVQ 74
R++G+G++AKV R K Q A+K+V KE + ID ++ E V + +P +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 75 LYEVMASKTKIYFAMEYVRGGEL-FNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHR 133
L+ + ++++ +EYV GG+L F+ + KL EE AR Y ++ A+ F H RG+ +R
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120
Query: 134 DLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKA 193
DLK +N+LLD +G +K++D+G+ +E T CGTP Y+APE++ Y G
Sbjct: 121 DLKLDNVLLDADGHIKLTDYGMC--KEGLGPGDTTSTFCGTPNYIAPEILRGEEY-GFSV 177
Query: 194 DIWSCGVVLFVLLAGNLPF------YDSNLME-LYKKITRAEFKCPNWFPPEVRKLLSRI 246
D W+ GV++F ++AG PF D N + L++ I + P + + +L
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGF 237
Query: 247 LDPNPSTRV 255
L+ +P R+
Sbjct: 238 LNKDPKERL 246
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 4e-36
Identities = 75/218 (34%), Positives = 126/218 (57%), Gaps = 8/218 (3%)
Query: 12 YELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPN 71
Y++ +++G+G F +V R+ + + A+K++ K ++ + E +M P
Sbjct: 45 YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104
Query: 72 IVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVY 131
+VQL+ +Y MEY+ GG+L N ++ + E+ A+ Y ++V A++ HS G+
Sbjct: 105 VVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLI 164
Query: 132 HRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLH--TTCGTPAYVAPEVINKR--- 186
HRD+KP+N+LLD++G LK++DFG + T G++ T GTP Y++PEV+ +
Sbjct: 165 HRDVKPDNMLLDKHGHLKLADFGTCMKMDET---GMVRCDTAVGTPDYISPEVLKSQGGD 221
Query: 187 GYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKI 224
GY G + D WS GV LF +L G+ PFY +L+ Y KI
Sbjct: 222 GYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKI 259
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 5e-36
Identities = 82/260 (31%), Positives = 133/260 (51%), Gaps = 21/260 (8%)
Query: 12 YELGRLLGQGTFAKVYHGRNLKTGQS-VAIKIVD-------KEKIRRVGLIDQIKREISV 63
Y + LG G F VY R GQ+ +A+K ++ K+K R I I E+++
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 64 MR-LVRHPNIVQLYEVMASKTKIYFAMEYVRG---GELFN--KVAKGKLREEVARKYFQQ 117
++ +RHPNIV+ Y+ ++Y M+ + G GE FN K K + EE F Q
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121
Query: 118 LVDAVEFCH-SRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPA 176
+V A+ + H + + HRDL P N++L E+ + I+DFGL A Q+ + L + GT
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL-AKQKQ--PESKLTSVVGTIL 178
Query: 177 YVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPN--W 234
Y PE++ Y G KAD+W+ G +L+ + PFY +N++ L KI A ++
Sbjct: 179 YSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGM 237
Query: 235 FPPEVRKLLSRILDPNPSTR 254
+ +V +++ L P+ R
Sbjct: 238 YSEDVTDVITSCLTPDAEAR 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 134 bits (337), Expect = 6e-36
Identities = 84/259 (32%), Positives = 137/259 (52%), Gaps = 22/259 (8%)
Query: 18 LGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYE 77
LG G F KVY +N +TG A K+++ + ++ EI ++ HP IV+L
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEE---LEDYMVEIEILATCNHPYIVKLLG 76
Query: 78 VMASKTKIYFAMEYVRGGE---LFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRD 134
K++ +E+ GG + ++ +G L E + +Q+++A+++ HS + HRD
Sbjct: 77 AFYWDGKLWIMIEFCPGGAVDAIMLELDRG-LTEPQIQVICRQMLEALQYLHSMKIIHRD 135
Query: 135 LKPENLLLDENGDLKISDFGLSALQEST--RQDGLLHTTCGTPAYVAPEVI-----NKRG 187
LK N+LL +GD+K++DFG+SA T R+D + GTP ++APEV+
Sbjct: 136 LKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI----GTPYWMAPEVVMCETMKDTP 191
Query: 188 YDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAE---FKCPNWFPPEVRKLLS 244
YD KADIWS G+ L + P ++ N M + KI ++E P+ + E R L
Sbjct: 192 YD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLK 250
Query: 245 RILDPNPSTRVTMAKLMEN 263
LD +P TR + A+L+E+
Sbjct: 251 TALDKHPETRPSAAQLLEH 269
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 1e-35
Identities = 69/197 (35%), Positives = 101/197 (51%), Gaps = 12/197 (6%)
Query: 12 YELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIK-REI-SVMRLVRH 69
Y++ + LG GTF VY RN +TG+ VAIK K K + + + RE+ S+ +L H
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIK---KMKKKFYSWEECMNLREVKSLRKLNEH 57
Query: 70 PNIVQLYEVMASKTKIYFAMEYVRGG--ELFNKVAKGKLREEVARKYFQQLVDAVEFCHS 127
PNIV+L EV ++YF EY+ G +L E V R Q++ + H
Sbjct: 58 PNIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK 117
Query: 128 RGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTT-CGTPAYVAPEVINKR 186
G +HRDLKPENLL+ +KI+DFGL+ S +T T Y APE++ +
Sbjct: 118 HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP----YTDYVSTRWYRAPEILLRS 173
Query: 187 GYDGAKADIWSCGVVLF 203
+ DIW+ G ++
Sbjct: 174 TSYSSPVDIWALGCIMA 190
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 1e-35
Identities = 77/265 (29%), Positives = 131/265 (49%), Gaps = 13/265 (4%)
Query: 15 GRLLGQGTFAKVYHGRNLKTGQSVAIKIVD---KEKIRRVGLIDQIKREISVMRLVRHPN 71
G+ LG G F+ Y R++KTG +A+K V + +++ +++EI +M + HP+
Sbjct: 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64
Query: 72 IVQLYEVMASKTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGV 130
I+++ + +E++ GG + + ++K G +E V Y +QL+ + + H +
Sbjct: 65 IIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQI 124
Query: 131 YHRDLKPENLLLDENG-DLKISDFGLSALQES--TRQDGLLHTTCGTPAYVAPEVINKRG 187
HRD+K NLL+D G L+I+DFG +A + T GT A++APEV+
Sbjct: 125 IHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQ 184
Query: 188 YDGAKADIWSCGVVLFVLLAGNLPFYD---SNLMELYKKITRAEF--KCPNWFPPEVRKL 242
Y G D+WS G V+ + P+ SN + L KI A P P +R +
Sbjct: 185 Y-GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDV 243
Query: 243 LSRILDPNPSTRVTMAKLMENYWFR 267
R L+ P R +L+++ FR
Sbjct: 244 TLRCLELQPEDRPPSRELLKHPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 2e-35
Identities = 77/242 (31%), Positives = 134/242 (55%), Gaps = 5/242 (2%)
Query: 16 RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQ 74
++LG+G+F KV G+ A+K + K+ + ++ E V+ L +P +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 75 LYEVMASKTKIYFAMEYVRGGEL-FNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHR 133
LY +K ++F ME++ GG+L F+ KG+ A Y ++V ++F HS+G+ +R
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120
Query: 134 DLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKA 193
DLK +N++LD +G +KI+DFG+ +E+ D T CGTP Y+APE++ Y +
Sbjct: 121 DLKLDNVMLDRDGHIKIADFGMC--KENVFGDNRASTFCGTPDYIAPEILQGLKYTFS-V 177
Query: 194 DIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILDPNPST 253
D WS GV+L+ +L G PF+ + EL++ I P W E + +L ++ + +P+
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTR 237
Query: 254 RV 255
R+
Sbjct: 238 RL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 2e-35
Identities = 76/218 (34%), Positives = 125/218 (57%), Gaps = 8/218 (3%)
Query: 12 YELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPN 71
YE+ +++G+G F +V R+ T + A+K++ K ++ + E +M P
Sbjct: 45 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104
Query: 72 IVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVY 131
+VQL+ +Y MEY+ GG+L N ++ + E+ AR Y ++V A++ HS G
Sbjct: 105 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFI 164
Query: 132 HRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLH--TTCGTPAYVAPEVINKR--- 186
HRD+KP+N+LLD++G LK++DFG ++G++ T GTP Y++PEV+ +
Sbjct: 165 HRDVKPDNMLLDKSGHLKLADFGTCM---KMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 221
Query: 187 GYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKI 224
GY G + D WS GV L+ +L G+ PFY +L+ Y KI
Sbjct: 222 GYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI 259
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 2e-35
Identities = 71/265 (26%), Positives = 118/265 (44%), Gaps = 28/265 (10%)
Query: 16 RLLGQGTFAKVYHGR---NLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNI 72
+ LG+G F +VY G+ VA+K + ++ +E VM+ + HPN+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEE--RKDFLKEARVMKKLGHPNV 58
Query: 73 VQLYEVMASKTKIYFAMEYVRGGEL----------FNKVAKGKLREEVARKYFQQLVDAV 122
V+L V + +Y +EY+ GG+L F K L + + Q+ +
Sbjct: 59 VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118
Query: 123 EFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYV---A 179
E+ S+ HRDL N L+ E+ +KISDFGLS D G + A
Sbjct: 119 EYLASKKFVHRDLAARNCLVGEDLVVKISDFGLS---RDVYDDDYYRKKTGGKLPIRWMA 175
Query: 180 PEVINKRGYDGAKADIWSCGVVL---FVLLAGNLPFYDSNLMELYKKITRAEF-KCPNWF 235
PE + + +K+D+WS GV+L F L G P+ + E+ + + + P +
Sbjct: 176 PESLKDGIFT-SKSDVWSFGVLLWEIFTL--GATPYPGLSNEEVLEYLRKGYRLPKPEYC 232
Query: 236 PPEVRKLLSRILDPNPSTRVTMAKL 260
P E+ +L+ +P R T ++L
Sbjct: 233 PDELYELMLSCWQLDPEDRPTFSEL 257
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 3e-35
Identities = 92/292 (31%), Positives = 147/292 (50%), Gaps = 57/292 (19%)
Query: 18 LGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIR----RVGLIDQIKREISVMRLVRHPNIV 73
+G+GT+ VY GRN KTGQ VA+K KIR G+ REIS+++ ++HPNIV
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMK-----KIRLESEEEGVPSTAIREISLLKELQHPNIV 62
Query: 74 QLYEVMASKTKIYFAMEYVRGG--ELFNKVAKGK-LREEVARKYFQQLVDAVEFCHSRGV 130
L +V+ ++++Y E++ + + + KG+ + E+ + Y Q++ + FCHSR V
Sbjct: 63 CLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRV 122
Query: 131 YHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGL-----LHTTCGTPAYVAPEVINK 185
HRDLKP+NLL+D G +K++DFGL+ R G+ H T Y APEV+
Sbjct: 123 LHRDLKPQNLLIDNKGVIKLADFGLA------RAFGIPVRVYTHEVV-TLWYRAPEVLLG 175
Query: 186 RGYDGAKADIWSCGVVLFVLLAGNLPFY--DSNLMELYKKITRA---------------- 227
DIWS G + F +A P + DS + +L+ +I R
Sbjct: 176 SPRYSTPVDIWSIGTI-FAEMATKKPLFHGDSEIDQLF-RIFRILGTPTEDVWPGVTSLP 233
Query: 228 EFKC--PNWFPPEVRK-----------LLSRILDPNPSTRVTMAKLMENYWF 266
++K P W +R LL ++L +P+ R++ K + + +F
Sbjct: 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 3e-35
Identities = 86/283 (30%), Positives = 146/283 (51%), Gaps = 18/283 (6%)
Query: 17 LLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQL 75
+LG+G+F KV T + AIKI+ K+ + + ++ E V+ L + P + QL
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66
Query: 76 YEVMASKTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRD 134
+ + ++YF MEYV GG+L ++ + G+ +E A Y ++ + F HS+G+ +RD
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRD 126
Query: 135 LKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTT-CGTPAYVAPEVINKRGYDGAKA 193
LK +N++LD G +KI+DFG+ + DG+ T CGTP Y+APE+I + Y G
Sbjct: 127 LKLDNVMLDSEGHIKIADFGMC---KENMWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSV 182
Query: 194 DIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILDPNPST 253
D W+ GV+L+ +LAG PF + EL++ I P E + ++ +P
Sbjct: 183 DWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGK 242
Query: 254 RVTMA-----KLMENYWFRK------GYKKIETPESPRGQDRN 285
R+ + E+ +FR K+++ P P+ R+
Sbjct: 243 RLGCGPEGERDIKEHAFFRYIDWEKLERKEVQPPYKPKACGRD 285
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 3e-35
Identities = 92/288 (31%), Positives = 140/288 (48%), Gaps = 50/288 (17%)
Query: 18 LGQGTFAKVYHGRNLKTGQSVAIKIV--DKEKIRRVGLIDQIKREISVMRLVRHPNIVQL 75
LG+GT+A VY GRN TG+ VA+K + D E+ G REIS+M+ ++H NIV+L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEE----GTPSTAIREISLMKELKHENIVRL 63
Query: 76 YEVMASKTKIYFAMEYVRGG---ELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYH 132
++V+ ++ K+ EY+ + +G L + + QL+ + FCH V H
Sbjct: 64 HDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLH 123
Query: 133 RDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCG----TPAYVAPEVI-NKRG 187
RDLKP+NLL+++ G+LK++DFGL+ R G+ T T Y AP+V+ R
Sbjct: 124 RDLKPQNLLINKRGELKLADFGLA------RAFGIPVNTFSNEVVTLWYRAPDVLLGSRT 177
Query: 188 YDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITR----------------AEFK- 230
Y DIWS G ++ ++ G F +N + KI R E+K
Sbjct: 178 YS-TSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP 236
Query: 231 ----CP-----NWFP---PEVRKLLSRILDPNPSTRVTMAKLMENYWF 266
P FP P LL R+L NP R++ +++ WF
Sbjct: 237 TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 5e-35
Identities = 87/326 (26%), Positives = 142/326 (43%), Gaps = 70/326 (21%)
Query: 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRV--GLID--QIKREISVMRL 66
+YEL + +G G + V + +TG+ VAIK KI V LID +I REI ++R
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIK-----KISNVFDDLIDAKRILREIKLLRH 55
Query: 67 VRHPNIVQLYEVMASKTK-----IYFAMEYVRGGELFNKV--AKGKLREEVARKYFQQLV 119
+RH NI+ L +++ + +Y E + +KV + L ++ + + Q++
Sbjct: 56 LRHENIIGLLDILRPPSPEDFNDVYIVTELMETD--LHKVIKSPQPLTDDHIQYFLYQIL 113
Query: 120 DAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLS-ALQESTRQDGLLHTTCGTPAYV 178
+++ HS V HRDLKP N+L++ N DLKI DFGL+ + + G L T YV
Sbjct: 114 RGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFL-----TE-YV 167
Query: 179 ------APEVI-NKRGYDGAKADIWSCGVVLFVLLAG-------------NLPF------ 212
APE++ + Y A DIWS G + LL NL
Sbjct: 168 VTRWYRAPELLLSSSRYTKA-IDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTP 226
Query: 213 ---------------YDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILDPNPSTRVTM 257
Y +L + K ++ P PE LL ++L +P R+T
Sbjct: 227 SEEDLKFITSEKARNYLKSLPK-KPKKPLSK-LFPG-ASPEAIDLLEKMLVFDPKKRITA 283
Query: 258 AKLMENYWFRKGYKKIETPESPRGQD 283
+ + + + + + + P + D
Sbjct: 284 DEALAHPYLAQLHDPEDEPVAKPPFD 309
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 7e-35
Identities = 86/269 (31%), Positives = 140/269 (52%), Gaps = 11/269 (4%)
Query: 17 LLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQL 75
+LG+G+F KV T + AIKI+ K+ + + ++ E V+ L + P + QL
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66
Query: 76 YEVMASKTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRD 134
+ + ++YF MEYV GG+L + + GK +E A Y ++ + F H RG+ +RD
Sbjct: 67 HSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRD 126
Query: 135 LKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKAD 194
LK +N++LD G +KI+DFG+ +E T CGTP Y+APE+I + Y G D
Sbjct: 127 LKLDNVMLDSEGHIKIADFGMC--KEHMVDGVTTRTFCGTPDYIAPEIIAYQPY-GKSVD 183
Query: 195 IWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILDPNPSTR 254
W+ GV+L+ +LAG PF + EL++ I P E + ++ +PS R
Sbjct: 184 WWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHPSKR 243
Query: 255 VTMAK-----LMENYWFRK-GYKKIETPE 277
+ + E+ +FR+ + K+E E
Sbjct: 244 LGCGPEGERDIREHAFFRRIDWDKLENRE 272
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 1e-34
Identities = 71/256 (27%), Positives = 123/256 (48%), Gaps = 8/256 (3%)
Query: 12 YELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPN 71
+E+ +G+G+F V+ + A+K +D K+ R + I E V+ +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAI-DEARVLAKLDSSY 60
Query: 72 IVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGK---LREEVARKYFQQLVDAVEFCHSR 128
I++ YE K K+ MEY G+L + + L E+ ++F Q++ + HS+
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 129 GVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGY 188
+ HRD+K NL LD ++KI D G++ L +T GTP Y++PE+ + Y
Sbjct: 121 KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD--NTNFANTIVGTPYYLSPELCEDKPY 178
Query: 189 DGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFK-CPNWFPPEVRKLLSRIL 247
+ K+D+W+ GVVL+ G PF +N L KI R F + ++ +L+ + L
Sbjct: 179 N-EKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCL 237
Query: 248 DPNPSTRVTMAKLMEN 263
+ R +L+ N
Sbjct: 238 TKDYRQRPDTFQLLRN 253
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 3e-34
Identities = 81/260 (31%), Positives = 135/260 (51%), Gaps = 22/260 (8%)
Query: 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKR-----EISV 63
+ + + + +G+G F++VY L G VA+K K++ L+D R EI +
Sbjct: 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALK-----KVQIFDLMDAKARADCIKEIDL 55
Query: 64 MRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGK-----LREEVARKYFQQL 118
++ + HPN+++ Y ++ +E G+L + K + E+ KYF QL
Sbjct: 56 LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQL 115
Query: 119 VDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYV 178
A+E HSR V HRD+KP N+ + G +K+ D GL S H+ GTP Y+
Sbjct: 116 CSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA--HSLVGTPYYM 173
Query: 179 APEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDS--NLMELYKKITRAEFK--CPNW 234
+PE I++ GY+ K+DIWS G +L+ + A PFY NL L KKI + ++ +
Sbjct: 174 SPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDH 232
Query: 235 FPPEVRKLLSRILDPNPSTR 254
+ E+R+L++ ++P+P R
Sbjct: 233 YSEELRQLVNMCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 3e-34
Identities = 84/263 (31%), Positives = 137/263 (52%), Gaps = 20/263 (7%)
Query: 18 LGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYE 77
+G+G+F +VY G + +T + VAIKI+D E+ I+ I++EI+V+ P I + Y
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDE--IEDIQQEITVLSQCDSPYITRYYG 69
Query: 78 VMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKP 137
TK++ MEY+ GG + + G L E ++++ +++ HS HRD+K
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKA 129
Query: 138 ENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWS 197
N+LL E GD+K++DFG++ T+ +T GTP ++APEVI + YD KADIWS
Sbjct: 130 ANVLLSEQGDVKLADFGVAGQLTDTQIK--RNTFVGTPFWMAPEVIKQSAYD-FKADIWS 186
Query: 198 CGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEV--------RKLLSRILDP 249
G+ L G P D + M R F P PP + ++ + L+
Sbjct: 187 LGITAIELAKGEPPNSDLHPM-------RVLFLIPKNSPPTLEGQYSKPFKEFVEACLNK 239
Query: 250 NPSTRVTMAKLMENYWFRKGYKK 272
+P R T +L+++ + + KK
Sbjct: 240 DPRFRPTAKELLKHKFITRYTKK 262
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 129 bits (324), Expect = 4e-34
Identities = 83/260 (31%), Positives = 139/260 (53%), Gaps = 9/260 (3%)
Query: 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHP 70
KY +GQG V+ ++ TGQ VAIK ++ +K + LI EI VM+ +++P
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELI---INEILVMKELKNP 76
Query: 71 NIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGV 130
NIV + +++ MEY+ GG L + V + + E ++ + A+EF H+ V
Sbjct: 77 NIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQV 136
Query: 131 YHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDG 190
HRD+K +N+LL +G +K++DFG A + T + T GTP ++APEV+ ++ Y G
Sbjct: 137 IHRDIKSDNVLLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAY-G 193
Query: 191 AKADIWSCGVVLFVLLAGNLPFYDSN-LMELYKKITRA--EFKCPNWFPPEVRKLLSRIL 247
K DIWS G++ ++ G P+ + N L LY T E + P P R L+R L
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCL 253
Query: 248 DPNPSTRVTMAKLMENYWFR 267
+ + R + +L+++ + +
Sbjct: 254 EMDVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 7e-34
Identities = 84/263 (31%), Positives = 138/263 (52%), Gaps = 20/263 (7%)
Query: 18 LGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYE 77
+G+G+F +V+ G + +T Q VAIKI+D E+ I+ I++EI+V+ P + + Y
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE--IEDIQQEITVLSQCDSPYVTKYYG 69
Query: 78 VMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKP 137
TK++ MEY+ GG + + G E ++++ +++ HS HRD+K
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKA 129
Query: 138 ENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWS 197
N+LL E GD+K++DFG++ T+ +T GTP ++APEVI + YD +KADIWS
Sbjct: 130 ANVLLSEQGDVKLADFGVAGQLTDTQIK--RNTFVGTPFWMAPEVIQQSAYD-SKADIWS 186
Query: 198 CGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEV--------RKLLSRILDP 249
G+ L G P D + M R F P PP + ++ + L+
Sbjct: 187 LGITAIELAKGEPPNSDMHPM-------RVLFLIPKNNPPTLTGEFSKPFKEFIDACLNK 239
Query: 250 NPSTRVTMAKLMENYWFRKGYKK 272
+PS R T +L+++ + K KK
Sbjct: 240 DPSFRPTAKELLKHKFIVKNAKK 262
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 1e-33
Identities = 74/249 (29%), Positives = 144/249 (57%), Gaps = 9/249 (3%)
Query: 18 LGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYE 77
+G+G+ V R +G+ VA+K++D K +R L+ E+ +MR +H N+V++Y+
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFN---EVVIMRDYQHQNVVEMYK 85
Query: 78 VMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKP 137
+++ ME+++GG L + V++ +L EE + ++ A+ + HS+GV HRD+K
Sbjct: 86 SYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKS 145
Query: 138 ENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWS 197
+++LL +G +K+SDFG A + ++ + GTP ++APEVI++ Y G + DIWS
Sbjct: 146 DSILLTLDGRVKLSDFGFCA--QISKDVPKRKSLVGTPYWMAPEVISRTPY-GTEVDIWS 202
Query: 198 CGVVLFVLLAGNLPFYDSNLMELYKKITRA---EFKCPNWFPPEVRKLLSRILDPNPSTR 254
G+++ ++ G P++ + ++ K++ + + K + P +R L R+L P R
Sbjct: 203 LGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQER 262
Query: 255 VTMAKLMEN 263
T +L+++
Sbjct: 263 ATAQELLDH 271
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 1e-33
Identities = 84/260 (32%), Positives = 137/260 (52%), Gaps = 9/260 (3%)
Query: 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHP 70
KY +GQG VY ++ TGQ VAI+ ++ ++ + LI EI VMR ++P
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI---INEILVMRENKNP 77
Query: 71 NIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGV 130
NIV + +++ MEY+ GG L + V + + E ++ + A+EF HS V
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQV 137
Query: 131 YHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDG 190
HRD+K +N+LL +G +K++DFG A + T + T GTP ++APEV+ ++ Y G
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAY-G 194
Query: 191 AKADIWSCGVVLFVLLAGNLPFYDSN-LMELYKKITRA--EFKCPNWFPPEVRKLLSRIL 247
K DIWS G++ ++ G P+ + N L LY T E + P R L+R L
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL 254
Query: 248 DPNPSTRVTMAKLMENYWFR 267
D + R + +L+++ + +
Sbjct: 255 DMDVEKRGSAKELLQHQFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 127 bits (319), Expect = 2e-33
Identities = 83/260 (31%), Positives = 137/260 (52%), Gaps = 9/260 (3%)
Query: 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHP 70
KY +GQG VY ++ TGQ VAIK ++ ++ + LI EI VMR ++P
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELI---INEILVMRENKNP 76
Query: 71 NIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGV 130
NIV + +++ MEY+ GG L + V + + E ++ + A++F HS V
Sbjct: 77 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQV 136
Query: 131 YHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDG 190
HRD+K +N+LL +G +K++DFG A + T + T GTP ++APEV+ ++ Y G
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAY-G 193
Query: 191 AKADIWSCGVVLFVLLAGNLPFYDSN-LMELYKKITRA--EFKCPNWFPPEVRKLLSRIL 247
K DIWS G++ ++ G P+ + N L LY T E + P R L+R L
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCL 253
Query: 248 DPNPSTRVTMAKLMENYWFR 267
+ + R + +L+++ + +
Sbjct: 254 EMDVDRRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 2e-33
Identities = 79/261 (30%), Positives = 133/261 (50%), Gaps = 24/261 (9%)
Query: 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR 68
+ +++ + +G+G F++VY L + VA+K V ++ +EI +++ +
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60
Query: 69 HPNIVQLYEVMASKTKIYFAMEYVRGGEL-----FNKVAKGKLREEVARKYFQQLVDAVE 123
HPN+++ + ++ +E G+L + K K + E KYF QL AVE
Sbjct: 61 HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120
Query: 124 FCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVI 183
HSR V HRD+KP N+ + G +K+ D GL S + H+ GTP Y++PE I
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPERI 178
Query: 184 NKRGYDGAKADIWSCGVVLFVLLAGNLPFYDS--NLMELYKKITRAEFKCPNWFPP---- 237
++ GY+ K+DIWS G +L+ + A PFY NL L +KI + + +PP
Sbjct: 179 HENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCD------YPPLPTE 231
Query: 238 ----EVRKLLSRILDPNPSTR 254
++R+L+S + P+P R
Sbjct: 232 HYSEKLRELVSMCIYPDPDQR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 2e-33
Identities = 70/240 (29%), Positives = 124/240 (51%), Gaps = 14/240 (5%)
Query: 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRH 69
+++ L+G+G F +V R TG A+K++ K + + + E ++ +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 70 PNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHS 127
P I QL K +Y MEY GG+L + + + + E++A+ Y +LV A+ H
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ 120
Query: 128 RGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTT--CGTPAYVAPEVI-- 183
G HRD+KPEN+L+D G +K++DFG +A + + ++++ GTP Y+APEV+
Sbjct: 121 MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTA---NKMVNSKLPVGTPDYIAPEVLTT 177
Query: 184 ---NKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVR 240
+ +G G + D WS GV+ + ++ G PF++ + Y I F+ FP + +
Sbjct: 178 MNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIM--NFQRFLKFPEDPK 235
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 125 bits (314), Expect = 5e-33
Identities = 78/217 (35%), Positives = 123/217 (56%), Gaps = 9/217 (4%)
Query: 15 GRLLGQGTFAKVYHGRNLKTGQSVAIKIV--DKEKIRRVGLIDQIKREISVMRLVRHPNI 72
G+LLGQG F +VY ++ TG+ +A K V D E + ++ EI +++ ++H I
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI 66
Query: 73 VQLYEVM---ASKTKIYFAMEYVRGGELFNKV-AKGKLREEVARKYFQQLVDAVEFCHSR 128
VQ Y + A KT F MEY+ GG + +++ A G L E V RKY +Q+++ + + HS
Sbjct: 67 VQYYGCLRDRAEKTLTIF-MEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN 125
Query: 129 GVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGL-LHTTCGTPAYVAPEVINKRG 187
+ HRD+K N+L D G++K+ DFG S ++ G + + GTP +++PEVI+ G
Sbjct: 126 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEG 185
Query: 188 YDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKI 224
Y G KAD+WS G + +L P+ + M KI
Sbjct: 186 Y-GRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKI 221
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 125 bits (314), Expect = 6e-33
Identities = 85/247 (34%), Positives = 132/247 (53%), Gaps = 15/247 (6%)
Query: 12 YELGRLLGQGTFAKVYHGRNLKTGQSVAIKIV--DKEKIRRVGLIDQIKREISVMRLVRH 69
+ LG+LLGQG F +VY + TG+ +A+K V D E ++ ++ EI +++ + H
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63
Query: 70 PNIVQLYEVM---ASKTKIYFAMEYVRGGELFNKV-AKGKLREEVARKYFQQLVDAVEFC 125
IVQ Y + +T F ME++ GG + +++ + G L E V RKY +Q+++ V +
Sbjct: 64 ERIVQYYGCLRDPMERTLSIF-MEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYL 122
Query: 126 HSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGL-LHTTCGTPAYVAPEVIN 184
HS + HRD+K N+L D G++K+ DFG S ++ G + + GTP +++PEVI+
Sbjct: 123 HSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVIS 182
Query: 185 KRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEV----R 240
GY G KADIWS G + +L P+ + M KI A PP V R
Sbjct: 183 GEGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKI--ATQPTNPVLPPHVSDHCR 239
Query: 241 KLLSRIL 247
L RI
Sbjct: 240 DFLKRIF 246
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 7e-33
Identities = 73/219 (33%), Positives = 122/219 (55%), Gaps = 7/219 (3%)
Query: 12 YELGRLLGQGTFAKVYHGRNLKTGQSVAIKIV--DKEKIRRVGLIDQIKREISVMRLVRH 69
+ LG+LLG+G F +VY + TG+ +A+K V D + ++ ++ EI +++ +RH
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63
Query: 70 PNIVQLYEVMASKT--KIYFAMEYVRGGELFNKV-AKGKLREEVARKYFQQLVDAVEFCH 126
IVQ Y + K+ +EY+ GG + +++ A G L E V R+Y +Q++ V + H
Sbjct: 64 DRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLH 123
Query: 127 SRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGL-LHTTCGTPAYVAPEVINK 185
S + HRD+K N+L D G++K+ DFG S ++ G + + GTP +++PEVI+
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISG 183
Query: 186 RGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKI 224
GY G KAD+WS + +L P+ + M KI
Sbjct: 184 EGY-GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKI 221
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 8e-33
Identities = 75/263 (28%), Positives = 127/263 (48%), Gaps = 16/263 (6%)
Query: 18 LGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYE 77
LG+G F +V + TG+ A K +DK+++++ E ++ V IV L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 78 VMASKTKIYFAMEYVRGGEL---FNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRD 134
+K + M + GG+L V + E A Y Q++ +E H R + +RD
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 135 LKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKAD 194
LKPEN+LLD++G+++ISD GL A++ + + GTP Y+APEV+ YD D
Sbjct: 121 LKPENVLLDDHGNVRISDLGL-AVELKGGKK--IKGRAGTPGYMAPEVLQGEVYD-FSVD 176
Query: 195 IWSCGVVLFVLLAGNLPFYDSNLM----ELYKKITRAEFKCPNWFPPEVRKLLSRILDPN 250
++ G L+ ++AG PF EL ++ + P+ F PE + L +L +
Sbjct: 177 WFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD 236
Query: 251 PSTRV-----TMAKLMENYWFRK 268
P R+ + ++ E+ F+
Sbjct: 237 PEKRLGCRGGSADEVREHPLFKD 259
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 8e-33
Identities = 79/277 (28%), Positives = 122/277 (44%), Gaps = 57/277 (20%)
Query: 16 RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQL 75
+ +G G F +V R + T A+K + K + +K E ++ + +V+L
Sbjct: 7 KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKL 66
Query: 76 YEVMASKTKIYFAMEYVRGGELFNK-VAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRD 134
Y K +YF M+Y+ GG++ + + G E++AR Y +L A+E H G HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRD 126
Query: 135 LKPENLLLDENGDLKISDFGLSA----------LQES--TRQDG---------------- 166
+KP+N+L+D +G +K++DFGL Q+ RQD
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLK 186
Query: 167 -------------LLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFY 213
L H+ GTP Y+APEV+ + GY D WS GV+L+ +L G PF
Sbjct: 187 PLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVGVILYEMLVGQPPFL 245
Query: 214 DSNLMELYKKITRAEFKCPNW-----FPPEVRKLLSR 245
E K+ NW P + + LSR
Sbjct: 246 ADTPAETQLKVI-------NWETTLHIPSQAK--LSR 273
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 1e-32
Identities = 84/289 (29%), Positives = 138/289 (47%), Gaps = 52/289 (17%)
Query: 18 LGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIR----RVGLIDQIKREISVMRLVRHPNIV 73
+G+GT+ VY RN TG+ VA+K KIR G+ REIS+++ + HPNIV
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKELNHPNIV 62
Query: 74 QLYEVMASKTKIYFAMEYVRGG--ELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVY 131
+L +V+ ++ K+Y E++ + + + + + Y QL+ + FCHS V
Sbjct: 63 KLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVL 122
Query: 132 HRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCG----TPAYVAPEVINKRG 187
HRDLKP+NLL++ G +K++DFGL+ R G+ T T Y APE++
Sbjct: 123 HRDLKPQNLLINTEGAIKLADFGLA------RAFGVPVRTYTHEVVTLWYRAPEILLGCK 176
Query: 188 YDGAKADIWSCGVVLFVLLAGNLPFY-DSNLMELYKKITRA----------------EFK 230
Y DIWS G + ++ F DS + +L+ +I R ++K
Sbjct: 177 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-RIFRTLGTPDEVVWPGVTSLPDYK 235
Query: 231 C--PNWFP-----------PEVRKLLSRILDPNPSTRVTMAKLMENYWF 266
P W + R LLS++L +P+ R++ + + +F
Sbjct: 236 PSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 2e-32
Identities = 76/256 (29%), Positives = 143/256 (55%), Gaps = 14/256 (5%)
Query: 12 YELGRLLGQGTFAKVYHGRNLK---TGQSVAIKIVDKEKI-RRVGLIDQIKREISVMRLV 67
+EL ++LG G + KV+ R + +G+ A+K++ K I ++ + + E V+ +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 68 RH-PNIVQLYEVMASKTKIYFAMEYVRGGELFNKVA-KGKLREEVARKYFQQLVDAVEFC 125
R P +V L+ + TK++ ++Y+ GGELF ++ + + +E+ + Y ++V A+E
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHL 121
Query: 126 HSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVI-- 183
H G+ +RD+K EN+LLD NG + ++DFGLS + + ++ CGT Y+AP+++
Sbjct: 122 HKLGIIYRDIKLENILLDSNGHVVLTDFGLSK-EFHEDEVERAYSFCGTIEYMAPDIVRG 180
Query: 184 NKRGYDGAKADIWSCGVVLFVLLAGNLPFY----DSNLMELYKKITRAEFKCPNWFPPEV 239
G+D A D WS GV+++ LL G PF ++ E+ ++I ++E P
Sbjct: 181 GDGGHDKA-VDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA 239
Query: 240 RKLLSRILDPNPSTRV 255
+ ++ R+L +P R+
Sbjct: 240 KDIIQRLLMKDPKKRL 255
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 3e-32
Identities = 80/263 (30%), Positives = 140/263 (53%), Gaps = 20/263 (7%)
Query: 18 LGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYE 77
+G+G+F +V+ G + +T + VAIKI+D E+ I+ I++EI+V+ P + + Y
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE--IEDIQQEITVLSQCDSPYVTKYYG 69
Query: 78 VMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKP 137
TK++ MEY+ GG + + G L E ++++ +++ HS HRD+K
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKA 129
Query: 138 ENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWS 197
N+LL E+G++K++DFG++ T+ +T GTP ++APEVI + YD +KADIWS
Sbjct: 130 ANVLLSEHGEVKLADFGVAGQLTDTQIK--RNTFVGTPFWMAPEVIKQSAYD-SKADIWS 186
Query: 198 CGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPE--------VRKLLSRILDP 249
G+ L G P + + M++ F P PP +++ + L+
Sbjct: 187 LGITAIELAKGEPPHSELHPMKVL-------FLIPKNNPPTLEGNYSKPLKEFVEACLNK 239
Query: 250 NPSTRVTMAKLMENYWFRKGYKK 272
PS R T +L+++ + + KK
Sbjct: 240 EPSFRPTAKELLKHKFIVRFAKK 262
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 4e-32
Identities = 67/208 (32%), Positives = 105/208 (50%), Gaps = 23/208 (11%)
Query: 12 YELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIR----RVGLIDQIKREISVMRLV 67
YE +G+G + VY R+L TG+ VA+K K+R G+ REI++++ +
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALK-----KVRVPLSEEGIPLSTLREIALLKQL 55
Query: 68 R---HPNIVQLYEV-----MASKTKIYFAMEYVRG--GELFNKVAKGKLREEVARKYFQQ 117
HPNIV+L +V + K+ E+V +K K L E + +Q
Sbjct: 56 ESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQ 115
Query: 118 LVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAY 177
L+ V+F HS + HRDLKP+N+L+ +G +KI+DFGL+ + + L + T Y
Sbjct: 116 LLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF---EMALTSVVVTLWY 172
Query: 178 VAPEVINKRGYDGAKADIWSCGVVLFVL 205
APEV+ + Y D+WS G + L
Sbjct: 173 RAPEVLLQSSY-ATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 5e-32
Identities = 76/255 (29%), Positives = 135/255 (52%), Gaps = 9/255 (3%)
Query: 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHP 70
+Y + R++G+G+F + +++ + Q A+K + K ++ ++E ++ ++HP
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHP 58
Query: 71 NIVQLYEVMASKTKIYFAMEYVRGGELFNKVA--KGKL-REEVARKYFQQLVDAVEFCHS 127
NIV E + +Y MEY GG+L K+ +GKL E+ ++F Q+ V+ H
Sbjct: 59 NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118
Query: 128 RGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRG 187
+ V HRD+K +N+ L +NG +K+ DFG + L T T GTP YV PE+
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLL--TSPGAYACTYVGTPYYVPPEIWENMP 176
Query: 188 YDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFK-CPNWFPPEVRKLLSRI 246
Y+ K+DIWS G +L+ L PF ++ L K+ + +K P+ + E+R L+ ++
Sbjct: 177 YNN-KSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQM 235
Query: 247 LDPNPSTRVTMAKLM 261
NP +R + ++
Sbjct: 236 FKRNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 79/268 (29%), Positives = 130/268 (48%), Gaps = 35/268 (13%)
Query: 13 ELGRLLGQGTFAKVYHGRNLKTGQSVAIKIV---DKEKIRRVGLIDQIKREISVMRLVRH 69
E +G G VY + TG+ A+K++ ++ +RR QI REI ++R V H
Sbjct: 77 ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRR-----QICREIEILRDVNH 131
Query: 70 PNIVQLYEVMASKTKIYFAMEYVRGGELFN-KVAKGKLREEVARKYFQQLVDAVEFCHSR 128
PN+V+ +++ +I +E++ GG L +A + +VAR Q++ + + H R
Sbjct: 132 PNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR----QILSGIAYLHRR 187
Query: 129 GVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVI----N 184
+ HRD+KP NLL++ ++KI+DFG+S + T +++ GT AY++PE I N
Sbjct: 188 HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP--CNSSVGTIAYMSPERINTDLN 245
Query: 185 KRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKC----------PNW 234
YDG DIWS GV + G PF + ++ A C P
Sbjct: 246 HGAYDGYAGDIWSLGVSILEFYLGRFPF------GVGRQGDWASLMCAICMSQPPEAPAT 299
Query: 235 FPPEVRKLLSRILDPNPSTRVTMAKLME 262
E R +S L P+ R + +L++
Sbjct: 300 ASREFRHFISCCLQREPAKRWSAMQLLQ 327
|
Length = 353 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 1e-31
Identities = 89/297 (29%), Positives = 139/297 (46%), Gaps = 53/297 (17%)
Query: 11 KYE-LGRLLGQGTFAKVYHGRNLKTGQSVAIK-IVDKEK---IRRVGLIDQIKREISVMR 65
KYE L ++ G+G++ V+ RN +TGQ VAIK V+ E I+++ L REI +++
Sbjct: 2 KYEKLSKI-GEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIAL-----REIRMLK 55
Query: 66 LVRHPNIVQLYEVMASKTKIYFAMEYVRGGEL--FNKVAKGKLREEVARKYFQQLVDAVE 123
++HPN+V L EV K K++ EY L K +G + E + +K Q + AV
Sbjct: 56 QLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRG-VPEHLIKKIIWQTLQAVN 114
Query: 124 FCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVI 183
FCH HRD+KPEN+L+ + G +K+ DFG + + T T Y APE++
Sbjct: 115 FCHKHNCIHRDVKPENILITKQGQIKLCDFGFARIL--TGPGDDYTDYVATRWYRAPELL 172
Query: 184 NKRGYDGAKADIWSCGVVLFVLLAGNLPFY--DSNLMELYKKITRA-------------- 227
G D+W+ G V LL G P + S++ +LY I +
Sbjct: 173 VGDTQYGPPVDVWAIGCVFAELLTG-QPLWPGKSDVDQLY-LIRKTLGDLIPRHQQIFST 230
Query: 228 ------------------EFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWF 266
E K PN P + L L +P+ R++ +L+E+ +F
Sbjct: 231 NQFFKGLSIPEPETREPLESKFPNISSPAL-SFLKGCLQMDPTERLSCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 1e-31
Identities = 78/247 (31%), Positives = 127/247 (51%), Gaps = 28/247 (11%)
Query: 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIV----DKEKIRRVGLIDQIKREISVMR 65
KYE L+G+G++ V ++ +TGQ VAIK D + ++++ + REI +++
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAM-----REIRMLK 55
Query: 66 LVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFN-KVAKGKLREEVARKYFQQLVDAVEF 124
+RH N+V L EV K ++Y E+V L + + L E RKY Q++ +EF
Sbjct: 56 QLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEF 115
Query: 125 CHSRGVYHRDLKPENLLLDENGDLKISDFG----LSALQESTRQDGLLHTTCGTPAYVAP 180
CHS + HRD+KPEN+L+ ++G +K+ DFG L+A E T Y AP
Sbjct: 116 CHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD------YVATRWYRAP 169
Query: 181 EVINKRGYDGAKADIWSCGVVLFVLLAGNLPFY--DSNLMELYKKITRAEFKCPNWFPPE 238
E++ G DIW+ G ++ +L G P + DS++ +LY I KC P
Sbjct: 170 ELLVGDTKYGRAVDIWAVGCLVTEMLTGE-PLFPGDSDIDQLYHII-----KCLGNLIPR 223
Query: 239 VRKLLSR 245
+++ +
Sbjct: 224 HQEIFQK 230
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 2e-31
Identities = 79/303 (26%), Positives = 137/303 (45%), Gaps = 81/303 (26%)
Query: 18 LGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIK--REISVMRLVR-HPNIVQ 74
+G+GTF++V ++ KTG+ AIK + K+ + ++Q+ REI +R + HPNI++
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKS---LEQVNNLREIQALRRLSPHPNILR 62
Query: 75 LYEVMASKT-------------KIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDA 121
L EV+ + +Y E ++G K L E+ + Y QL+ +
Sbjct: 63 LIEVLFDRKTGRLALVFELMDMNLY---ELIKG-------RKRPLPEKRVKSYMYQLLKS 112
Query: 122 VEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYV--- 178
++ H G++HRD+KPEN+L+ ++ LK++DFG S R P Y
Sbjct: 113 LDHMHRNGIFHRDIKPENILIKDD-ILKLADFG------SCR------GIYSKPPYTEYI 159
Query: 179 ------APEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSN---------------- 216
APE + GY G K DIW+ G V F +L+ F +N
Sbjct: 160 STRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPD 219
Query: 217 --LMELYKKITRAEFKCPNWFPPEVRKLL-----------SRILDPNPSTRVTMAKLMEN 263
+++ ++K + P+ +RKLL ++L +P R+T + + +
Sbjct: 220 AEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279
Query: 264 YWF 266
+F
Sbjct: 280 PYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 3e-31
Identities = 80/264 (30%), Positives = 133/264 (50%), Gaps = 21/264 (7%)
Query: 12 YELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPN 71
+EL + +G GT+ VY RN+ TG+ AIK++ E ++ Q EI +M+ +H N
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQ---EIIMMKDCKHSN 67
Query: 72 IVQLYEVMASKTKIYFAMEYVRGGELFNKV-AKGKLREEVARKYFQQLVDAVEFCHSRGV 130
IV + + K++ ME+ GG L + G L E ++ + + + HS+G
Sbjct: 68 IVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGK 127
Query: 131 YHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEV--INKRGY 188
HRD+K N+LL +NG +K++DFG+SA +T + GTP ++APEV + ++G
Sbjct: 128 MHRDIKGANILLTDNGHVKLADFGVSAQITATIAK--RKSFIGTPYWMAPEVAAVERKGG 185
Query: 189 DGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCP---------NWFPPEV 239
DIW+ G+ L P +D + M +T++ F+ P N F V
Sbjct: 186 YNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFV 245
Query: 240 RKLLSRILDPNPSTRVTMAKLMEN 263
+ L++ NP R T KL+++
Sbjct: 246 KMALTK----NPKKRPTAEKLLQH 265
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 4e-31
Identities = 81/258 (31%), Positives = 128/258 (49%), Gaps = 13/258 (5%)
Query: 12 YELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPN 71
YEL + +G GT+ VY RNL TG+ A+KI+ E LI Q EI +++ +H N
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQ---EIFMVKECKHCN 67
Query: 72 IVQLYEVMASKTKIYFAMEYVRGGELFNKV-AKGKLREEVARKYFQQLVDAVEFCHSRGV 130
IV + S+ K++ MEY GG L + G L E ++ + + + HS+G
Sbjct: 68 IVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGK 127
Query: 131 YHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEV--INKRGY 188
HRD+K N+LL +NGD+K++DFG++A +T + GTP ++APEV + K G
Sbjct: 128 MHRDIKGANILLTDNGDVKLADFGVAAKITATIAK--RKSFIGTPYWMAPEVAAVEKNGG 185
Query: 189 DGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNW-----FPPEVRKLL 243
DIW+ G+ L P +D + M ++++ F+ P + +
Sbjct: 186 YNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFV 245
Query: 244 SRILDPNPSTRVTMAKLM 261
L NP R T +L+
Sbjct: 246 KISLTKNPKKRPTAERLL 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 6e-31
Identities = 83/296 (28%), Positives = 138/296 (46%), Gaps = 52/296 (17%)
Query: 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIV----DKEKIRRVGLIDQIKREISVMRL 66
KYE +G+GT+ V+ +N +T + VA+K V D E + L REI +++
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL-----REICLLKE 55
Query: 67 VRHPNIVQLYEVMASKTKIYFAMEYV-RGGELFNKVAKGKLREEVARKYFQQLVDAVEFC 125
++H NIV+LY+V+ S K+ EY + + + G + E+ + + QL+ + FC
Sbjct: 56 LKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFC 115
Query: 126 HSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGL----LHTTCGTPAYVAPE 181
HS V HRDLKP+NLL+++NG+LK++DFGL+ R G+ T Y P+
Sbjct: 116 HSHNVLHRDLKPQNLLINKNGELKLADFGLA------RAFGIPVRCYSAEVVTLWYRPPD 169
Query: 182 VI-NKRGYDGAKADIWSCGVVLFVLLAGNLPFY-----DSNLMELYKKI-TRAEFKCPN- 233
V+ + Y D+WS G + L P + D L +++ + T E P
Sbjct: 170 VLFGAKLYS-TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGV 228
Query: 234 -------WFP----------------PEVRKLLSRILDPNPSTRVTMAKLMENYWF 266
+P R LL +L NP R++ + +++ +F
Sbjct: 229 SKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 7e-31
Identities = 81/244 (33%), Positives = 135/244 (55%), Gaps = 29/244 (11%)
Query: 12 YELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKR-EISVMR----- 65
+E+ +++G+G F +V + TGQ A+KI++K + +KR E + R
Sbjct: 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNK--------WEMLKRAETACFREERDV 54
Query: 66 LVRHPN--IVQLYEVMASKTKIYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDA 121
LV I L+ + +Y M+Y GG+L ++K +L E++AR Y ++V A
Sbjct: 55 LVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLA 114
Query: 122 VEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTT--CGTPAYVA 179
++ H G HRD+KP+N+LLD+NG ++++DFG S L+ DG + + GTP Y++
Sbjct: 115 IDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFG-SCLR--LLADGTVQSNVAVGTPDYIS 171
Query: 180 PEVI----NKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWF 235
PE++ + +G G + D WS GV ++ +L G PFY +L+E Y KI + + F
Sbjct: 172 PEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK-EHFQ-F 229
Query: 236 PPEV 239
PP+V
Sbjct: 230 PPDV 233
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 8e-31
Identities = 79/258 (30%), Positives = 133/258 (51%), Gaps = 20/258 (7%)
Query: 18 LGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYE 77
LG G F KVY +N +TG A K++D + ++ EI ++ HPNIV+L +
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEE---LEDYMVEIDILASCDHPNIVKLLD 69
Query: 78 VMASKTKIYFAMEYVRGGELFNKVAKGK--LREEVARKYFQQLVDAVEFCHSRGVYHRDL 135
+ ++ +E+ GG + + + + L E R +Q ++A+ + H + HRDL
Sbjct: 70 AFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDL 129
Query: 136 KPENLLLDENGDLKISDFGLSALQEST--RQDGLLHTTCGTPAYVAPEVI-----NKRGY 188
K N+L +GD+K++DFG+SA T R+D + GTP ++APEV+ R Y
Sbjct: 130 KAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI----GTPYWMAPEVVMCETSKDRPY 185
Query: 189 DGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAE---FKCPNWFPPEVRKLLSR 245
D KAD+WS G+ L + P ++ N M + KI ++E P+ + E + L +
Sbjct: 186 D-YKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKK 244
Query: 246 ILDPNPSTRVTMAKLMEN 263
L+ N R T +L+++
Sbjct: 245 CLEKNVDARWTTTQLLQH 262
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 1e-30
Identities = 81/265 (30%), Positives = 134/265 (50%), Gaps = 16/265 (6%)
Query: 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHP 70
KY + R+LG G V + + G+ A+K+VD E + ++ + E+ +
Sbjct: 33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSE-ADKNRAQAEVCCLLNCDFF 91
Query: 71 NIVQLYEVMASKTK--------IYFAMEYVRGGELFNKV-----AKGKLREEVARKYFQQ 117
+IV+ +E A K I ++Y G+L ++ RE A F Q
Sbjct: 92 SIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQ 151
Query: 118 LVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAY 177
++ AV HS+ + HRD+K N+LL NG +K+ DFG S + +T D + T CGTP Y
Sbjct: 152 VLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYY 211
Query: 178 VAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFK-CPNWFP 236
VAPE+ ++ Y KAD++S GV+L+ LL PF N+ E+ K + P
Sbjct: 212 VAPEIWRRKPYS-KKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPSIS 270
Query: 237 PEVRKLLSRILDPNPSTRVTMAKLM 261
PE++++++ +L +P R + +KL+
Sbjct: 271 PEMQEIVTALLSSDPKRRPSSSKLL 295
|
Length = 496 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-30
Identities = 74/257 (28%), Positives = 141/257 (54%), Gaps = 13/257 (5%)
Query: 18 LGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYE 77
+G+G+ V +G+ VA+K +D K +R L+ E+ +MR +H N+V++Y
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFN---EVVIMRDYQHENVVEMYN 84
Query: 78 VMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKP 137
+++ ME++ GG L + V ++ EE ++ A+ H++GV HRD+K
Sbjct: 85 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKS 144
Query: 138 ENLLLDENGDLKISDFGLSAL--QESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADI 195
+++LL +G +K+SDFG A +E R+ L+ GTP ++APE+I++ Y G + DI
Sbjct: 145 DSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV----GTPYWMAPELISRLPY-GPEVDI 199
Query: 196 WSCGVVLFVLLAGNLPFYDS---NLMELYKKITRAEFKCPNWFPPEVRKLLSRILDPNPS 252
WS G+++ ++ G P+++ M++ + + K + P ++ L R+L +P+
Sbjct: 200 WSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPA 259
Query: 253 TRVTMAKLMENYWFRKG 269
R T A+L+++ + K
Sbjct: 260 QRATAAELLKHPFLAKA 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 4e-30
Identities = 70/206 (33%), Positives = 112/206 (54%), Gaps = 10/206 (4%)
Query: 15 GRLLGQGTFAKVYHGRNLKTGQSVAIKIVD---KEKIRRVGLIDQIKREISVMRLVRHPN 71
G +LG+G + VY G GQ +A+K V+ + ++++ E+ +++ ++H N
Sbjct: 5 GEVLGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVN 63
Query: 72 IVQLYEVMASKTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGV 130
IVQ I ME+V GG + + + + G L E V KY +Q++D V + H+ V
Sbjct: 64 IVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCV 123
Query: 131 YHRDLKPENLLLDENGDLKISDFG----LSALQESTRQDGLLHTTCGTPAYVAPEVINKR 186
HRD+K N++L NG +K+ DFG L+ + +L + GTP ++APEVIN+
Sbjct: 124 VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES 183
Query: 187 GYDGAKADIWSCGVVLFVLLAGNLPF 212
GY G K+DIWS G +F + G P
Sbjct: 184 GY-GRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 4e-30
Identities = 75/262 (28%), Positives = 136/262 (51%), Gaps = 27/262 (10%)
Query: 18 LGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYE 77
+G+G+ V TG+ VA+K +D K +R L+ E+ +MR H N+V +Y
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFN---EVVIMRDYHHENVVDMYN 86
Query: 78 VMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKP 137
+++ ME++ GG L + V ++ EE ++ A+ + H++GV HRD+K
Sbjct: 87 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKS 146
Query: 138 ENLLLDENGDLKISDFGLSAL--QESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADI 195
+++LL +G +K+SDFG A +E ++ L+ GTP ++APEVI++ Y G + DI
Sbjct: 147 DSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV----GTPYWMAPEVISRLPY-GTEVDI 201
Query: 196 WSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEV----------RKLLSR 245
WS G+++ ++ G P+++ ++ ++I PP V R L
Sbjct: 202 WSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDN-------LPPRVKDSHKVSSVLRGFLDL 254
Query: 246 ILDPNPSTRVTMAKLMENYWFR 267
+L PS R T +L+++ + +
Sbjct: 255 MLVREPSQRATAQELLQHPFLK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 5e-30
Identities = 89/300 (29%), Positives = 143/300 (47%), Gaps = 53/300 (17%)
Query: 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR 68
M++YE +G+GT+ VY R+ T +++A+K + E+ G+ REIS+++ ++
Sbjct: 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQ 59
Query: 69 HPNIVQLYEVMASKTKIYFAMEYVR--------GGELFNKVAKGKLREEVARKYFQQLVD 120
H NIV+L +V+ S+ ++Y EY+ F K + + Y Q++
Sbjct: 60 HGNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAK------NPRLIKTYLYQILR 113
Query: 121 AVEFCHSRGVYHRDLKPENLLLDE-NGDLKISDFGLS-ALQESTRQDGLLHTTCGTPAYV 178
+ +CHS V HRDLKP+NLL+D LK++DFGL+ A R H T Y
Sbjct: 114 GIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT--FTHEVV-TLWYR 170
Query: 179 APEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFY--DSNLMELYKKITR---------- 226
APE++ + DIWS G + F + P + DS + EL+ KI R
Sbjct: 171 APEILLGSRHYSTPVDIWSVGCI-FAEMVNQKPLFPGDSEIDELF-KIFRILGTPNEETW 228
Query: 227 ------AEFKC--PNWFP-----------PEVRKLLSRILDPNPSTRVTMAKLMENYWFR 267
++K P W P P LLS++L +PS R+T +E+ +F+
Sbjct: 229 PGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFK 288
|
Length = 294 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 7e-30
Identities = 80/250 (32%), Positives = 130/250 (52%), Gaps = 31/250 (12%)
Query: 5 AGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVM 64
AGI +EL ++G GT+ +VY GR++KTGQ AIK++D + ++IK EI+++
Sbjct: 15 AGI----FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE----EEIKLEINML 66
Query: 65 R-LVRHPNIVQLYEVMASKT------KIYFAMEYVRGGELFNKVAKGK---LREEVARKY 114
+ H NI Y K+ +++ ME+ G + + V K L+E+
Sbjct: 67 KKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYI 126
Query: 115 FQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGT 174
++++ + H+ V HRD+K +N+LL EN ++K+ DFG+SA + R G +T GT
Sbjct: 127 CREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGT 184
Query: 175 PAYVAPEVI----NKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFK 230
P ++APEVI N ++DIWS G+ + G P D + M RA F
Sbjct: 185 PYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM-------RALFL 237
Query: 231 CPNWFPPEVR 240
P PP+++
Sbjct: 238 IPRNPPPKLK 247
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 1e-29
Identities = 74/232 (31%), Positives = 129/232 (55%), Gaps = 13/232 (5%)
Query: 12 YELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPN 71
+E+ +++G+G F +V + T + A+KI++K ++ + + E +V+
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW 62
Query: 72 IVQLYEVMASKTKIYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRG 129
I L+ + +Y M+Y GG+L ++K +L E++AR Y ++V A+ H
Sbjct: 63 ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH 122
Query: 130 VYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTT--CGTPAYVAPEVI---- 183
HRD+KP+N+LLD NG ++++DFG S L+ QDG + ++ GTP Y++PE++
Sbjct: 123 YVHRDIKPDNVLLDMNGHIRLADFG-SCLK--MNQDGTVQSSVAVGTPDYISPEILQAME 179
Query: 184 NKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAE--FKCPN 233
+ G G + D WS GV ++ +L G PFY +L+E Y KI E F+ P+
Sbjct: 180 DGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPS 231
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 2e-29
Identities = 69/231 (29%), Positives = 127/231 (54%), Gaps = 13/231 (5%)
Query: 12 YELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPN 71
+E+ +++G+G F +V + + A+KI++K ++ + + E V+ +
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 72 IVQLYEVMASKTKIYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRG 129
I L+ + +Y M+Y GG+L ++K +L E++AR Y ++V A++ H
Sbjct: 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122
Query: 130 VYHRDLKPENLLLDENGDLKISDFG--LSALQESTRQDGLLHTTCGTPAYVAPEVI---- 183
HRD+KP+N+L+D NG ++++DFG L +++ T Q + GTP Y++PE++
Sbjct: 123 YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV---AVGTPDYISPEILQAME 179
Query: 184 NKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKIT--RAEFKCP 232
+ +G G + D WS GV ++ +L G PFY +L+E Y KI + F+ P
Sbjct: 180 DGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFP 230
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-29
Identities = 80/248 (32%), Positives = 136/248 (54%), Gaps = 15/248 (6%)
Query: 17 LLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIR-----RVGLIDQIKREISVMRLVRHPN 71
++G+G F +VY R TG+ A+K +DK++I+ + L ++I +S++ P
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIM--LSLVSTGDCPF 58
Query: 72 IVQLYEVMASKTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGV 130
IV + + K+ F ++ + GG+L +++ G E+ R Y +++ +E H+R V
Sbjct: 59 IVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFV 118
Query: 131 YHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDG 190
+RDLKP N+LLDE+G ++ISD GL A S ++ H + GT Y+APEV+ K
Sbjct: 119 VYRDLKPANILLDEHGHVRISDLGL-ACDFSKKKP---HASVGTHGYMAPEVLQKGTAYD 174
Query: 191 AKADIWSCGVVLFVLLAGNLPFYD---SNLMELYKKITRAEFKCPNWFPPEVRKLLSRIL 247
+ AD +S G +LF LL G+ PF + E+ + + P+ F PE++ LL +L
Sbjct: 175 SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLL 234
Query: 248 DPNPSTRV 255
+ S R+
Sbjct: 235 QRDVSKRL 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-29
Identities = 82/259 (31%), Positives = 123/259 (47%), Gaps = 24/259 (9%)
Query: 16 RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKR----EISVMRLVRHPN 71
+G+G F VY G LK VA+K R L +KR E +++ HPN
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVKTC------RSTLPPDLKRKFLQEAEILKQYDHPN 53
Query: 72 IVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDA---VEFCHSR 128
IV+L V K IY ME V GG L + K K R V +K Q +DA +E+ S+
Sbjct: 54 IVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTV-KKLLQMSLDAAAGMEYLESK 112
Query: 129 GVYHRDLKPENLLLDENGDLKISDFGLSALQES---TRQDGLLHTTCGTPAYVAPEVINK 185
HRDL N L+ EN LKISDFG+S +E T DGL + APE +N
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPI---KWTAPEALNY 169
Query: 186 RGYDGAKADIWSCGVVLF-VLLAGNLPFYDSNLMELYKKITRA-EFKCPNWFPPEVRKLL 243
Y +++D+WS G++L+ G+ P+ + + ++I P P E+ +L+
Sbjct: 170 GRYT-SESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLM 228
Query: 244 SRILDPNPSTRVTMAKLME 262
+ +P R + +++
Sbjct: 229 LQCWAYDPENRPSFSEIYN 247
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 76/257 (29%), Positives = 119/257 (46%), Gaps = 47/257 (18%)
Query: 16 RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQL 75
+ LG G F +V R + T A+K + K+ + + +K E ++ + +V+L
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66
Query: 76 YEVMASKTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRD 134
Y K +YF M+Y+ GG++ + + + G E++AR Y +L AVE H G HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRD 126
Query: 135 LKPENLLLDENGDLKISDFGL---------SALQES---TRQDG---------------- 166
+KP+N+L+D +G +K++DFGL S +S RQD
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCG 186
Query: 167 -----------------LLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGN 209
L H+ GTP Y+APEV+ + GY D WS GV+L+ +L G
Sbjct: 187 DRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVGVILYEMLVGQ 245
Query: 210 LPFYDSNLMELYKKITR 226
PF +E K+
Sbjct: 246 PPFLAQTPLETQMKVIN 262
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 78/276 (28%), Positives = 124/276 (44%), Gaps = 59/276 (21%)
Query: 16 RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQL 75
+ LG G F +V + T A+K + K+ + + +K E ++ + +V+L
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66
Query: 76 YEVMASKTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRD 134
Y K +YF M+Y+ GG++ + + + E +AR Y +L A+E H G HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRD 126
Query: 135 LKPENLLLDENGDLKISDFGL--------------------------------------- 155
+KP+N+L+D +G +K++DFGL
Sbjct: 127 IKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCG 186
Query: 156 ----SALQESTRQDG--LLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGN 209
+ Q +T+Q L H+ GTP Y+APEV+ ++GY D WS GV+LF +L G
Sbjct: 187 DRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILFEMLVGQ 245
Query: 210 LPFYDSNLMELYKKITRAEFKCPNW-----FPPEVR 240
PF L T + K NW PP+V+
Sbjct: 246 PPF-------LAPTPTETQLKVINWENTLHIPPQVK 274
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 97/353 (27%), Positives = 151/353 (42%), Gaps = 77/353 (21%)
Query: 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRH 69
+ +++G+G F +V + TG+ A+K + K ++ + + +K E V+
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 70 PNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKL-REEVARKYFQQLVDAVEFCHSR 128
P +V LY +Y ME++ GG+L + K E+V R Y + V A+E H
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL 120
Query: 129 GVYHRDLKPENLLLDENGDLKISDFGLSA--------------LQESTRQDG-------- 166
G HRD+KP+N+L+D G +K+SDFGLS LQ + ++
Sbjct: 121 GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVA 180
Query: 167 -----------------------LLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLF 203
+ ++T GTP Y+APE+ ++GY G + D WS G ++F
Sbjct: 181 VDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLGAIMF 239
Query: 204 VLLAGNLPFYDSNLMELYKKITRAEFKCPNW-----FP------PEVRKLLSRILDPNPS 252
L G PF N E Y+KI NW FP E L+ R++ N
Sbjct: 240 ECLIGWPPFCSENSHETYRKII-------NWRETLYFPDDIHLSVEAEDLIRRLIT-NAE 291
Query: 253 TRVTMAKLMENYWFRKGYKKIETPESPRGQDRNKLISDIHAVFECESSSSRDT 305
R+ R G +I++ RG D + I I A F + S DT
Sbjct: 292 NRLG----------RGGAHEIKSHPFFRGVDWDT-IRQIRAPFIPQLKSITDT 333
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 3e-29
Identities = 82/247 (33%), Positives = 133/247 (53%), Gaps = 13/247 (5%)
Query: 17 LLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRH---PNIV 73
++G+G F +VY R TG+ A+K +DK++I+ E ++ LV P IV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 74 QLYEVMASKTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYH 132
+ + K+ F ++ + GG+L +++ G E R Y +++ +E H+R V +
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVY 120
Query: 133 RDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINK-RGYDGA 191
RDLKP N+LLDE+G ++ISD GL A S ++ H + GT Y+APEV+ K YD +
Sbjct: 121 RDLKPANILLDEHGHVRISDLGL-ACDFSKKKP---HASVGTHGYMAPEVLQKGVAYD-S 175
Query: 192 KADIWSCGVVLFVLLAGNLPF---YDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILD 248
AD +S G +LF LL G+ PF + E+ + + P+ F PE+R LL +L
Sbjct: 176 SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQ 235
Query: 249 PNPSTRV 255
+ + R+
Sbjct: 236 RDVNRRL 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 3e-29
Identities = 67/207 (32%), Positives = 105/207 (50%), Gaps = 18/207 (8%)
Query: 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRH 69
+KYE +GQGTF +V+ R+ KT Q VA+K V E + G REI +++L++H
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMEN-EKEGFPITALREIKILQLLKH 70
Query: 70 PNIVQLYEVMASKTK--------IYFAMEYVR---GGELFNKVAKGKLREEVARKYFQQL 118
N+V L E+ +K Y E+ G L NK K L E +K + L
Sbjct: 71 ENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSE--IKKVMKML 128
Query: 119 VDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLS-ALQESTRQDGLLHTT-CGTPA 176
++ + + H + HRD+K N+L+ ++G LK++DFGL+ A S +T T
Sbjct: 129 LNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLW 188
Query: 177 YVAPEV-INKRGYDGAKADIWSCGVVL 202
Y PE+ + +R Y G D+W G ++
Sbjct: 189 YRPPELLLGERDY-GPPIDMWGAGCIM 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 4e-29
Identities = 79/269 (29%), Positives = 128/269 (47%), Gaps = 47/269 (17%)
Query: 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRH 69
+ +E +++G+G F +V + TG A+KI+ K + + I+ E ++
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 70 PNIVQLYEVMASKTKIYFAMEYVRGGELFNKV-AKGKLREEVARKYFQQLVDAVEFCHSR 128
+V+++ K +Y ME++ GG++ + K L EE + Y + V A++ H
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL 120
Query: 129 GVYHRDLKPENLLLDENGDLKISDFGL-SALQESTRQD---------------------- 165
G HRD+KP+NLLLD G +K+SDFGL + L+++ R +
Sbjct: 121 GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKR 180
Query: 166 ----------GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDS 215
L ++T GTP Y+APEV + GY+ D WS GV+++ +L G PF
Sbjct: 181 KAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGVIMYEMLIGYPPFCSE 239
Query: 216 NLMELYKKITRAEFKCPNW-----FPPEV 239
E Y+K+ NW FPPEV
Sbjct: 240 TPQETYRKVM-------NWKETLVFPPEV 261
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 5e-29
Identities = 70/201 (34%), Positives = 111/201 (55%), Gaps = 10/201 (4%)
Query: 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRH 69
N+Y + +G G F V R+ TGQ+VAIK + K L + RE+ +++ +RH
Sbjct: 10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMK-PFSTPVLAKRTYRELKLLKHLRH 68
Query: 70 PNIVQLYEVMAS-KTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSR 128
NI+ L ++ S IYF E + G +L + L ++ + + Q++ +++ HS
Sbjct: 69 ENIISLSDIFISPLEDIYFVTE-LLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSA 127
Query: 129 GVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEV-INKRG 187
GV HRDLKP N+L++EN DLKI DFGL+ +Q+ + G + T Y APE+ + +
Sbjct: 128 GVVHRDLKPSNILINENCDLKICDFGLARIQDP-QMTGYVSTR----YYRAPEIMLTWQK 182
Query: 188 YDGAKADIWSCGVVLFVLLAG 208
YD + DIWS G + +L G
Sbjct: 183 YD-VEVDIWSAGCIFAEMLEG 202
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 5e-29
Identities = 80/267 (29%), Positives = 126/267 (47%), Gaps = 47/267 (17%)
Query: 12 YELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPN 71
+E +++G+G F +V + TG A+KI+ K + + I+ E ++
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 72 IVQLYEVMASKTKIYFAMEYVRGGELFNKV-AKGKLREEVARKYFQQLVDAVEFCHSRGV 130
+V+++ K +Y ME++ GG++ + K L EE + Y + V A++ H G
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF 122
Query: 131 YHRDLKPENLLLDENGDLKISDFGL-SALQESTRQD------------------------ 165
HRD+KP+NLLLD G +K+SDFGL + L+++ R +
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182
Query: 166 --------GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNL 217
L +T GTP Y+APEV + GY+ D WS GV+++ +L G PF
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGVIMYEMLIGYPPFCSETP 241
Query: 218 MELYKKITRAEFKCPNW-----FPPEV 239
E YKK+ NW FPPEV
Sbjct: 242 QETYKKVM-------NWKETLIFPPEV 261
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 1e-28
Identities = 80/303 (26%), Positives = 140/303 (46%), Gaps = 53/303 (17%)
Query: 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR 68
++K+++ +G+GT+ +VY R+ TG+ VA+K V + + I I REI ++R +
Sbjct: 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAI-REIKILRQLN 64
Query: 69 HPNIVQLYEVMASKTK----------IYFAMEYVRGGELFNKVAKG--KLREEVARKYFQ 116
H NIV L E++ K Y EY+ +L + G E+ + + +
Sbjct: 65 HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-DHDLMGLLESGLVHFSEDHIKSFMK 123
Query: 117 QLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTT-CGTP 175
QL++ + +CH + HRD+K N+LL+ G +K++DFGL+ L S ++ +T T
Sbjct: 124 QLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNS--EESRPYTNKVITL 181
Query: 176 AYVAPEVINKRGYDGAKADIWSCGVVL---FV---LLAGN-------------------- 209
Y PE++ G D+WSCG +L F + N
Sbjct: 182 WYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAV 241
Query: 210 ------LPFYDSNLME-LYKKITRAEFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262
LP++++ + Y++ R EF ++ P LL +L +PS R T + +
Sbjct: 242 WPDVIKLPYFNTMKPKKQYRRRLREEF---SFIPTPALDLLDHMLTLDPSKRCTAEEALN 298
Query: 263 NYW 265
+ W
Sbjct: 299 SPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-28
Identities = 76/264 (28%), Positives = 129/264 (48%), Gaps = 18/264 (6%)
Query: 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLID-----QIKREISVMR 65
+Y L + LG+G+F VY ++ K +K++ K VG ++ Q +E ++
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVL---KEIPVGELNPNETVQANQEAQLLS 57
Query: 66 LVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKV-----AKGKLREEVARKYFQQLVD 120
+ HP IV+ + + EY G +L K+ L E ++F QL+
Sbjct: 58 KLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL 117
Query: 121 AVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAP 180
V + H R + HRDLK +N+ L N LKI DFG+S L + L T GTP Y++P
Sbjct: 118 GVHYMHQRRILHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGSCD--LATTFTGTPYYMSP 174
Query: 181 EVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF-KCPNWFPPEV 239
E + +GYD +K+DIWS G +L+ + F N + + +I P + ++
Sbjct: 175 EALKHQGYD-SKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQL 233
Query: 240 RKLLSRILDPNPSTRVTMAKLMEN 263
++ +L+ +PS R + A+++ N
Sbjct: 234 NSIMQSMLNKDPSLRPSAAEILRN 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 2e-28
Identities = 84/297 (28%), Positives = 128/297 (43%), Gaps = 68/297 (22%)
Query: 20 QGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVM 79
+GT+ VY R+ KTG+ VA+K + EK + I + REI+++ ++HPNIV + EV+
Sbjct: 15 EGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSL-REINILLKLQHPNIVTVKEVV 73
Query: 80 ASKT--KIYFAMEYVRGGE-----LFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYH 132
KIY MEYV E L + + L+ EV + QL+ V H + H
Sbjct: 74 VGSNLDKIYMVMEYV---EHDLKSLMETMKQPFLQSEV-KCLMLQLLSGVAHLHDNWILH 129
Query: 133 RDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPA-----------YVAPE 181
RDLK NLLL+ G LKI DFGL+ R+ G+P Y APE
Sbjct: 130 RDLKTSNLLLNNRGILKICDFGLA------RE-------YGSPLKPYTQLVVTLWYRAPE 176
Query: 182 VINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA----------EF-K 230
++ D+WS G + LL F + ++ KI + F +
Sbjct: 177 LLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236
Query: 231 CPNW----------------FPPEVR-----KLLSRILDPNPSTRVTMAKLMENYWF 266
P FP LL+R+L +P+ R++ +++ +F
Sbjct: 237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-28
Identities = 80/259 (30%), Positives = 128/259 (49%), Gaps = 20/259 (7%)
Query: 17 LLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLY 76
+LG+GT+ VY R+L T +AIK + + R V + EI++ ++H NIVQ
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYV---QPLHEEIALHSYLKHRNIVQYL 71
Query: 77 EVMASKTKIYFAMEYVRGGELF----NKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYH 132
+ ME V GG L +K K E+ Y +Q+++ +++ H + H
Sbjct: 72 GSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVH 131
Query: 133 RDLKPENLLLDE-NGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINK--RGYD 189
RD+K +N+L++ +G +KISDFG S + + T GT Y+APEVI+K RGY
Sbjct: 132 RDIKGDNVLVNTYSGVVKISDFGTS--KRLAGINPCTETFTGTLQYMAPEVIDKGPRGY- 188
Query: 190 GAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF-----KCPNWFPPEVRKLLS 244
GA ADIWS G + + G PF + L E + + + P E + +
Sbjct: 189 GAPADIWSLGCTIVEMATGKPPFIE--LGEPQAAMFKVGMFKIHPEIPESLSAEAKNFIL 246
Query: 245 RILDPNPSTRVTMAKLMEN 263
R +P+P R + L+++
Sbjct: 247 RCFEPDPDKRASAHDLLQD 265
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 3e-28
Identities = 92/310 (29%), Positives = 150/310 (48%), Gaps = 29/310 (9%)
Query: 29 GRNLKTGQSVAIKIVD-KEKI--RRVGLIDQ-----IKREISVMRLVRHPNIVQLYEVMA 80
GRN T VA + D KEK+ + V L D+ + E+ + H IV+ ++
Sbjct: 76 GRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFK 135
Query: 81 SKTKIYFAMEYVRGGELFNKVAKGKLREEVARK------YFQQLVDAVEFCHSRGVYHRD 134
S K+ MEY GG+L NK K +L+E + + F Q+V A++ HSR + HRD
Sbjct: 136 SDDKLLLIMEYGSGGDL-NKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRD 194
Query: 135 LKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKAD 194
LK N+ L G +K+ DFG S + + + CGTP Y+APE+ ++ Y KAD
Sbjct: 195 LKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYS-KKAD 253
Query: 195 IWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFK-CPNWFPPEVRKLLSRILDPNPST 253
+WS GV+L+ LL + PF + E+ +++ ++ P ++ LL +L NP+
Sbjct: 254 MWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPAL 313
Query: 254 RVTMAKLMENYWFR---KGYKKI-ETPESPRGQDRNKLISDIHAVFECESSSSRDTDPPT 309
R T +L+ + + ++ I E+ DR +++ + S + PP
Sbjct: 314 RPTTQQLLHTEFLKYVANLFQDIVRHSETISPHDREEILRQL--------QESGERAPPP 365
Query: 310 NSCRSPVRPS 319
+S R V S
Sbjct: 366 SSIRYGVVTS 375
|
Length = 478 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 112 bits (280), Expect = 4e-28
Identities = 83/269 (30%), Positives = 133/269 (49%), Gaps = 24/269 (8%)
Query: 12 YELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMR-LVRHP 70
+EL L+G GT+ +VY GR++KTGQ AIK++D ++IK+EI++++ H
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE----EEIKQEINMLKKYSHHR 63
Query: 71 NIVQLYEVMASKT------KIYFAMEYVRGGELFNKVAKGK---LREEVARKYFQQLVDA 121
NI Y K +++ ME+ G + + + K L+EE ++++
Sbjct: 64 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 123
Query: 122 VEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPE 181
+ H V HRD+K +N+LL EN ++K+ DFG+SA + R G +T GTP ++APE
Sbjct: 124 LSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMAPE 181
Query: 182 VI----NKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITR---AEFKCPNW 234
VI N K+D+WS G+ + G P D + M I R K W
Sbjct: 182 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKW 241
Query: 235 FPPEVRKLLSRILDPNPSTRVTMAKLMEN 263
+ + + L N S R T +LM++
Sbjct: 242 -SKKFQSFIESCLVKNHSQRPTTEQLMKH 269
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 4e-28
Identities = 68/201 (33%), Positives = 102/201 (50%), Gaps = 11/201 (5%)
Query: 14 LGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIV 73
L R+ G+GT+ VY R+ +G+ VA+K V + R G+ REI+++ +RHPNIV
Sbjct: 12 LNRI-GEGTYGIVYRARDTTSGEIVALKKVRMDN-ERDGIPISSLREITLLLNLRHPNIV 69
Query: 74 QLYEVMASK--TKIYFAMEYVRG--GELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRG 129
+L EV+ K I+ MEY L + + E + QL+ +++ H
Sbjct: 70 ELKEVVVGKHLDSIFLVMEYCEQDLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLHENF 128
Query: 130 VYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVI-NKRGY 188
+ HRDLK NLLL + G LKI+DFGL+ + + T Y APE++ Y
Sbjct: 129 IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP--MTPKVVTLWYRAPELLLGCTTY 186
Query: 189 DGAKADIWSCGVVLFVLLAGN 209
A D+W+ G +L LLA
Sbjct: 187 TTA-IDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 7e-28
Identities = 74/265 (27%), Positives = 124/265 (46%), Gaps = 25/265 (9%)
Query: 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRL 66
I + +LG +G+G F V G GQ VA+K + + E SVM
Sbjct: 3 INSKELKLGATIGKGEFGDVMLG--DYRGQKVAVKCLKDD----STAAQAFLAEASVMTT 56
Query: 67 VRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQL------VD 120
+RHPN+VQL V+ +Y EY+ G L + + + R QQL +
Sbjct: 57 LRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYL---RSRGRAVITLAQQLGFALDVCE 113
Query: 121 AVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPA-YVA 179
+E+ + HRDL N+L+ E+ K+SDFGL+ + G L P + A
Sbjct: 114 GMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKL------PVKWTA 167
Query: 180 PEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EFKCPNWFPP 237
PE + ++ + K+D+WS G++L+ + + G +P+ L ++ + + + P PP
Sbjct: 168 PEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPP 226
Query: 238 EVRKLLSRILDPNPSTRVTMAKLME 262
EV K++ + +P+ R T +L E
Sbjct: 227 EVYKVMKDCWELDPAKRPTFKQLRE 251
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 3e-27
Identities = 72/253 (28%), Positives = 118/253 (46%), Gaps = 15/253 (5%)
Query: 16 RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQL 75
R +G G+F VY R+++T + VAIK + + I +E+ ++ +RHPN ++
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80
Query: 76 YEVMASKTKIYFAMEYVRGGEL-FNKVAKGKLRE-EVARKYFQQLVDAVEFCHSRGVYHR 133
+ + MEY G +V K L+E E+A L + + HS HR
Sbjct: 81 KGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGAL-QGLAYLHSHERIHR 139
Query: 134 DLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVI---NKRGYDG 190
D+K N+LL E G +K++DFG ++L ++ GTP ++APEVI ++ YDG
Sbjct: 140 DIKAGNILLTEPGTVKLADFGSASLVSPA------NSFVGTPYWMAPEVILAMDEGQYDG 193
Query: 191 AKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKC--PNWFPPEVRKLLSRILD 248
K D+WS G+ L P ++ N M I + + N + R + L
Sbjct: 194 -KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQ 252
Query: 249 PNPSTRVTMAKLM 261
P R + +L+
Sbjct: 253 KIPQDRPSSEELL 265
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 3e-27
Identities = 87/282 (30%), Positives = 130/282 (46%), Gaps = 31/282 (10%)
Query: 13 ELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNI 72
EL RL G+G V R TG A+K + + L QI RE+ + + + P I
Sbjct: 5 ELSRL-GEGAGGSVTKCRLKNTGMIFALKTITTDP--NPDLQKQILRELEINKSCKSPYI 61
Query: 73 VQLYE--VMASKTKIYFAMEYVRGGEL---FNKVAK--GKLREEVARKYFQQLVDAVEFC 125
V+ Y + S + I AMEY GG L + KV K G++ E+V K + ++ + +
Sbjct: 62 VKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYL 121
Query: 126 HSRGVYHRDLKPENLLLDENGDLKISDFGLSA-LQESTRQDGLLHTTCGTPAYVAPEVIN 184
HSR + HRD+KP N+LL G +K+ DFG+S L S L T GT Y+APE I
Sbjct: 122 HSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS-----LAGTFTGTSFYMAPERIQ 176
Query: 185 KRGYDGAKADIWSCGVVLFVLLAGNLPFYDSN-----LMELYKKITRAEF----KCP--- 232
+ Y +D+WS G+ L + PF +EL I P
Sbjct: 177 GKPYS-ITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNG 235
Query: 233 -NWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYKKI 273
W E + + + L+ +P+ R T ++E+ W + KK
Sbjct: 236 IKW-SEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKK 276
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 4e-27
Identities = 84/306 (27%), Positives = 131/306 (42%), Gaps = 61/306 (19%)
Query: 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKI----VDKEKIRRVGLIDQIKREISVMR 65
+ YE +G+GT+ KVY R+ TG+ VA+K +D+E I L REIS+++
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTAL-----REISLLQ 55
Query: 66 LVRH-PNIVQLYEVMASKTK-----IYFAMEYVRGG-----ELFNKVAKGKLREEVARKY 114
++ IV+L +V + K +Y EY+ + + L + + +
Sbjct: 56 MLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSF 115
Query: 115 FQQLVDAVEFCHSRGVYHRDLKPENLLLD-ENGDLKISDFGLS-----ALQESTRQDGLL 168
QL+ V CH GV HRDLKP+NLL+D + G LKI+D GL ++ T +
Sbjct: 116 MYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHE---- 171
Query: 169 HTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFY-DSNLMELYK----- 222
T Y APEV+ + DIWS G + + F DS L +L
Sbjct: 172 ---IVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLL 228
Query: 223 -----------KITRAEFKCPNWFP-----------PEVRKLLSRILDPNPSTRVTMAKL 260
R + P W P PE LL ++L +P+ R++
Sbjct: 229 GTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAA 288
Query: 261 MENYWF 266
+ + +F
Sbjct: 289 LTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 7e-27
Identities = 68/257 (26%), Positives = 122/257 (47%), Gaps = 14/257 (5%)
Query: 12 YELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPN 71
+ L R LG G F +V+ G K VAIKI+ + + + ++E+ ++ +RH +
Sbjct: 8 FTLERKLGSGYFGEVWEGL-WKNRVRVAIKILKSDDLLK---QQDFQKEVQALKRLRHKH 63
Query: 72 IVQLYEVMASKTKIYFAMEYVRGGEL--FNKVAKGK-LREEVARKYFQQLVDAVEFCHSR 128
++ L+ V + +Y E + G L F + +G+ L Q+ + + + +
Sbjct: 64 LISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ 123
Query: 129 GVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTP-AYVAPEVINKRG 187
HRDL N+L+ E+ K++DFGL+ L ++D L + P + APE +
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARL---IKEDVYLSSDKKIPYKWTAPEAASHGT 180
Query: 188 YDGAKADIWSCGVVLF-VLLAGNLPFYDSNLMELYKKITRA-EFKCPNWFPPEVRKLLSR 245
+ K+D+WS G++L+ + G +P+ N E+Y +IT CP P E+ K++
Sbjct: 181 FS-TKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIMLE 239
Query: 246 ILDPNPSTRVTMAKLME 262
P R + L E
Sbjct: 240 CWAAEPEDRPSFKALRE 256
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 7e-27
Identities = 79/272 (29%), Positives = 131/272 (48%), Gaps = 38/272 (13%)
Query: 18 LGQG---TFAKVYHGRNLKTGQSVAIKIV---DKEKIRRVGLIDQIKREISVMRLVRHPN 71
LG G + +KV H + TG +A K+V K +R+ QI RE+ +M R P
Sbjct: 13 LGAGNGGSVSKVKH---IPTGTVMAKKVVHIGAKSSVRK-----QILRELQIMHECRSPY 64
Query: 72 IVQLYEVMASKTKIYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSR- 128
IV Y ++ I ME++ G L +++ K G + E+ K +V+ + + ++
Sbjct: 65 IVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH 123
Query: 129 GVYHRDLKPENLLLDENGDLKISDFGLSA-LQESTRQDGLLHTTCGTPAYVAPEVINKRG 187
+ HRD+KP N+L++ G +K+ DFG+S L S T GT Y++PE I
Sbjct: 124 RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIAD-----TFVGTSTYMSPERIQGGK 178
Query: 188 YDGAKADIWSCGVVLFVLLAGNLPFYDSN-----------LMELYKKITRAEF-KCP-NW 234
Y K+D+WS G+ + L G PF SN +++L ++I + + P +
Sbjct: 179 YT-VKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSD 237
Query: 235 FPPEVRKLLSRILDPNPSTRVTMAKLMENYWF 266
FP ++R + L +P+ R T +L F
Sbjct: 238 FPEDLRDFVDACLLKDPTERPTPQQLCAMPPF 269
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 1e-25
Identities = 77/250 (30%), Positives = 124/250 (49%), Gaps = 34/250 (13%)
Query: 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQ-IKREISVMR-LV 67
+ +E+ +G+GT+ KV+ N K G A+KI+D + ID+ I+ E ++++ L
Sbjct: 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDP-----IHDIDEEIEAEYNILKALS 72
Query: 68 RHPNIVQLYEVMASKT-----KIYFAMEYVRGGELFNKVAKGKLR------EEVARKYFQ 116
HPN+V+ Y + K +++ +E GG + + KG L+ E +
Sbjct: 73 DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSV-TDLVKGFLKRGERMEEPIIAYILH 131
Query: 117 QLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPA 176
+ + ++ H HRD+K N+LL G +K+ DFG+SA STR +T+ GTP
Sbjct: 132 EALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPF 189
Query: 177 YVAPEVIN-----KRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKC 231
++APEVI YD A+ D+WS G+ L G+ P D + M RA FK
Sbjct: 190 WMAPEVIACEQQLDSTYD-ARCDVWSLGITAIELGDGDPPLADLHPM-------RALFKI 241
Query: 232 PNWFPPEVRK 241
P PP + +
Sbjct: 242 PRNPPPTLHQ 251
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 80/315 (25%), Positives = 141/315 (44%), Gaps = 60/315 (19%)
Query: 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRR--VGLID--QIKREISVMR 65
++Y+ +G G + +V + KTG+ VAIK K+ R I + RE+ +++
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIK-----KLSRPFQSAIHAKRTYRELRLLK 69
Query: 66 LVRHPNIVQLYEVMASKT------KIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLV 119
+ H N++ L +V + +Y + G +L N V KL ++ + Q++
Sbjct: 70 HMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQIL 128
Query: 120 DAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQ-DGLLHTTCGTPAYV 178
+++ HS G+ HRDLKP N+ ++E+ +LKI DFGL+ R D + T Y
Sbjct: 129 RGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA------RHTDDEMTGYVATRWYR 182
Query: 179 APEVI-NKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSN-------LMEL---------- 220
APE++ N Y+ DIWS G ++ LL G F S+ +M L
Sbjct: 183 APEIMLNWMHYNQT-VDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQ 241
Query: 221 -------------YKKITRAEFKCPNWFP---PEVRKLLSRILDPNPSTRVTMAKLMENY 264
++ + +FK F P LL ++L +P R+T A+ + +
Sbjct: 242 KISSESARNYIQSLPQMPKKDFK--EVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHP 299
Query: 265 WFRKGYKKIETPESP 279
+ + + + P +P
Sbjct: 300 YLAEYHDPEDEPVAP 314
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 68/196 (34%), Positives = 103/196 (52%), Gaps = 8/196 (4%)
Query: 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIK-IVDKEKIRRVGLIDQIKREISVMRLVR 68
NK+E+ ++G+G + V R+ +T + VAIK D E+ V + RE+ ++R ++
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVK--ETTLRELKMLRTLK 58
Query: 69 HPNIVQLYEVMASKTKIYFAMEYVRGG--ELFNKVAKGKLREEVARKYFQQLVDAVEFCH 126
NIV+L E + K+Y EYV EL ++ G E+V R Y QL+ A+ +CH
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKV-RSYIYQLIKAIHWCH 117
Query: 127 SRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKR 186
+ HRD+KPENLL+ N LK+ DFG A S + T Y +PE++
Sbjct: 118 KNDIVHRDIKPENLLISHNDVLKLCDFGF-ARNLSEGSNANYTEYVATRWYRSPELLLGA 176
Query: 187 GYDGAKADIWSCGVVL 202
Y G D+WS G +L
Sbjct: 177 PY-GKAVDMWSVGCIL 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 78/312 (25%), Positives = 135/312 (43%), Gaps = 50/312 (16%)
Query: 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRR----VGLIDQIKREISVMRL 66
+Y+ +G G + V + ++G+ VAIK KI L + RE+ ++R
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIK-----KIPHAFDVPTLAKRTLRELKILRH 60
Query: 67 VRHPNIVQLYEVMASKTK----IYFAMEYVRGGELFNKV-AKGKLREEVARKYFQQLVDA 121
+H NI+ + +++ +Y M+ + +L + + + L EE R + QL+
Sbjct: 61 FKHDNIIAIRDILRPPGADFKDVYVVMD-LMESDLHHIIHSDQPLTEEHIRYFLYQLLRG 119
Query: 122 VEFCHSRGVYHRDLKPENLLLDENGDLKISDFGL--SALQESTRQDGLLHTTCGTPAYVA 179
+++ HS V HRDLKP NLL++E+ +L+I DFG+ T + T Y A
Sbjct: 120 LKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRA 179
Query: 180 PEVI-NKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKI-------------- 224
PE++ + Y A D+WS G + +L F N + K I
Sbjct: 180 PELLLSLPEYTTA-IDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR 238
Query: 225 -----TRAEF-KCPN-----W---FP---PEVRKLLSRILDPNPSTRVTMAKLMENYWFR 267
R P W FP PE LLS++L +P R+T+ + +++ +
Sbjct: 239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLA 298
Query: 268 KGYKKIETPESP 279
+ + + P P
Sbjct: 299 QYHDPDDEPTCP 310
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 4e-25
Identities = 71/276 (25%), Positives = 122/276 (44%), Gaps = 30/276 (10%)
Query: 34 TGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAM-EYV 92
TG VAIK++ + + +RE ++ + HPNIV L + + + FA+ EYV
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61
Query: 93 RGGELFNKVA-KGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGD---L 148
G L +A G L + Q++DA+ H++G+ HRDLKP+N+++ + G
Sbjct: 62 PGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHA 121
Query: 149 KISDFGLSALQESTRQDGLLHTT-----CGTPAYVAPEVINKRGYD-GAKADIWSCGVVL 202
K+ DFG+ L R + T GTP Y APE + RG +D+++ G++
Sbjct: 122 KVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQL--RGEPVTPNSDLYAWGLIF 179
Query: 203 FVLLAGNLPFYDSNLME-LYKKITRAEFKCPNWFPPE-VRKLLSRILDPNPSTRVTMAKL 260
L G +++ E LY++++ + P W + ++L + L+ +P R A
Sbjct: 180 LECLTGQRVVQGASVAEILYQQLSPVDVSLPPWIAGHPLGQVLRKALNKDPRQRAASAPA 239
Query: 261 MEN---------------YWFRKGYKKIETPESPRG 281
+ G + I P G
Sbjct: 240 LAERFRALELCALVGILRMGEGAGREAIAAPLVASG 275
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 104 bits (263), Expect = 4e-25
Identities = 69/216 (31%), Positives = 112/216 (51%), Gaps = 32/216 (14%)
Query: 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIK---------REI 61
KYE+ + LG+G + V+ + +T + VA+K KI D + REI
Sbjct: 8 KYEILQKLGKGAYGIVWKAIDRRTKEVVALK-----KI-----FDAFRNATDAQRTFREI 57
Query: 62 SVMR-LVRHPNIVQLYEVMASK--TKIYFAMEYVRGGELFNKVAKGKLREEVARKY-FQQ 117
++ L HPNIV+L V+ ++ IY EY+ + V + + E+V ++Y Q
Sbjct: 58 MFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETD--LHAVIRANILEDVHKRYIMYQ 115
Query: 118 LVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLS---ALQESTRQDGLLHTTCGT 174
L+ A+++ HS V HRDLKP N+LL+ + +K++DFGL+ + E ++ +L T
Sbjct: 116 LLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVAT 175
Query: 175 PAYVAPEV-INKRGYDGAKA-DIWSCGVVLFVLLAG 208
Y APE+ + Y K D+WS G +L +L G
Sbjct: 176 RWYRAPEILLGSTRY--TKGVDMWSVGCILGEMLLG 209
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 6e-25
Identities = 87/316 (27%), Positives = 135/316 (42%), Gaps = 69/316 (21%)
Query: 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIK--IVDKEKIRRVGLIDQIKREISVMRL 66
+ YE+ LG+GTF +VY R +KTG+ VA+K ++ EK G REI +++
Sbjct: 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK---DGFPITALREIKILKK 63
Query: 67 VRHPNIVQLYEVMASKTK-----------IYFAMEYVRGGELFNKVAKGKLREEVARKYF 115
++HPN+V L ++ + + M++ G L N KL E + Y
Sbjct: 64 LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENP--SVKLTESQIKCYM 121
Query: 116 QQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGL------------SALQESTR 163
QL++ + + H + HRD+K N+L+D G LKI+DFGL TR
Sbjct: 122 LQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTR 181
Query: 164 QDGLLHTTC-GTPAYVAPE-VINKRGYDGAKADIWSCGVVLFVLLAGNLPFY----DSNL 217
+ +T T Y PE ++ +R Y A DIW G V + P D +
Sbjct: 182 K----YTNLVVTRWYRPPELLLGERRYTTA-VDIWGIGCVFAEMFTRR-PILQGKSDIDQ 235
Query: 218 MELYKKI--TRAEFKCPNW-------------------------FPPEVRKLLSRILDPN 250
+ L K+ T E P W PE LLS++L +
Sbjct: 236 LHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLD 295
Query: 251 PSTRVTMAKLMENYWF 266
P R+T + +E+ +F
Sbjct: 296 PYKRLTASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 6e-25
Identities = 72/269 (26%), Positives = 127/269 (47%), Gaps = 28/269 (10%)
Query: 18 LGQGTFAKVYHGRNLKTGQSVAIKIV----DKEKIRRVGLIDQIKREISVMRLVRHPNIV 73
LG+G + VY + TG ++A+K + D+ K QI E+ ++ P IV
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFN------QIIMELDILHKAVSPYIV 62
Query: 74 QLYEVMASKTKIYFAMEYVRGGEL----FNKVAKGKLREEVARKYFQQLVDAVEFCHSR- 128
Y + +Y MEY+ G L VA + E+V R+ +V ++F
Sbjct: 63 DFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH 122
Query: 129 GVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGY 188
+ HRD+KP N+L++ NG +K+ DFG+S ++ L T G +Y+APE I G
Sbjct: 123 NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS----LAKTNIGCQSYMAPERIKSGGP 178
Query: 189 DGA-----KADIWSCGVVLFVLLAGNLPF----YDSNLMELYKKITRAEFKCPNWFPPEV 239
+ ++D+WS G+ + + G P+ Y + +L + P+ + +
Sbjct: 179 NQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDA 238
Query: 240 RKLLSRILDPNPSTRVTMAKLMENYWFRK 268
+ +++ L+ P+ R T A+L+E+ W K
Sbjct: 239 QDFVAKCLNKIPNRRPTYAQLLEHPWLVK 267
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 7e-25
Identities = 75/247 (30%), Positives = 126/247 (51%), Gaps = 30/247 (12%)
Query: 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMR-LVR 68
+ +E+ +G+GT+ KVY N K G A+KI+D I V ++I+ E ++++ L
Sbjct: 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDP--ISDVD--EEIEAEYNILQSLPN 77
Query: 69 HPNIVQLYEVMASKTK-----IYFAMEYVRGGELFNKVAKG------KLREEVARKYFQQ 117
HPN+V+ Y + K ++ +E GG + ++ KG +L E +
Sbjct: 78 HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSV-TELVKGLLICGQRLDEAMISYILYG 136
Query: 118 LVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAY 177
+ ++ H+ + HRD+K N+LL G +K+ DFG+SA STR +T+ GTP +
Sbjct: 137 ALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFW 194
Query: 178 VAPEVIN-KRGYD---GAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPN 233
+APEVI ++ YD A+ D+WS G+ L G+ P +D + + + FK P
Sbjct: 195 MAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV-------KTLFKIPR 247
Query: 234 WFPPEVR 240
PP +
Sbjct: 248 NPPPTLL 254
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-24
Identities = 50/138 (36%), Positives = 81/138 (58%), Gaps = 1/138 (0%)
Query: 20 QGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVM 79
+G F KVY GR + A+K+V K + ++ Q++ E + L + P IV LY +
Sbjct: 14 RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL 73
Query: 80 ASKTKIYFAMEYVRGGELFNKVA-KGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPE 138
S +Y MEY+ GG++ + + G EE+A KY ++ A+++ H G+ HRDLKP+
Sbjct: 74 QSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPD 133
Query: 139 NLLLDENGDLKISDFGLS 156
N+L+ G +K++DFGLS
Sbjct: 134 NMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 83/279 (29%), Positives = 136/279 (48%), Gaps = 36/279 (12%)
Query: 17 LLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV--RH--PNI 72
+G GT +VY R KTG +A+K ++RR G ++ KR + + +V H P I
Sbjct: 22 EIGSGTCGQVYKMRFKKTGHVMAVK-----QMRRTGNKEENKRILMDLDVVLKSHDCPYI 76
Query: 73 VQLYEVMASKTKIYFAMEYVRGGELFNKVAK---GKLREEVARKYFQQLVDAVEFCHSR- 128
V+ Y + + ++ ME + +K+ K G + E++ K +V A+ + +
Sbjct: 77 VKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKH 134
Query: 129 GVYHRDLKPENLLLDENGDLKISDFGLSA-LQES---TRQDGLLHTTCGTPAYVAPEVIN 184
GV HRD+KP N+LLD +G++K+ DFG+S L +S TR G C AY+APE I+
Sbjct: 135 GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAG-----C--AAYMAPERID 187
Query: 185 ----KRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNL-MELYKKITRAEFKCPNW---FP 236
YD +AD+WS G+ L L G P+ + E+ KI + E F
Sbjct: 188 PPDPNPKYD-IRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFS 246
Query: 237 PEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIET 275
P+ + L + R +L+++ + R+ Y+ E
Sbjct: 247 PDFCSFVDLCLTKDHRKRPKYRELLQHPFIRR-YETAEV 284
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 78/291 (26%), Positives = 125/291 (42%), Gaps = 58/291 (19%)
Query: 16 RLLGQGTFAKVYHGRNLKTGQSVAIK---IVDKEKIRRVGLIDQIKREISVMRLVRHPNI 72
R LG G+ V+ + + VA+K + D + ++ REI ++R + H NI
Sbjct: 11 RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVK------HALREIKIIRRLDHDNI 64
Query: 73 VQLYEVMASKTK--------------IYFAMEYVRGGELFNKVAKGKLREEVARKYFQQL 118
V++YEV+ +Y EY+ +L N + +G L EE AR + QL
Sbjct: 65 VKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHARLFMYQL 123
Query: 119 VDAVEFCHSRGVYHRDLKPENLLLD-ENGDLKISDFGLSALQEST-RQDGLLHTTCGTPA 176
+ +++ HS V HRDLKP N+ ++ E+ LKI DFGL+ + + G L T
Sbjct: 124 LRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW 183
Query: 177 YVAPE-VINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKI------TRAE- 228
Y +P +++ Y A D+W+ G + +L G F ++ +E + I R E
Sbjct: 184 YRSPRLLLSPNNYTKA-IDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREED 242
Query: 229 -----------FKCPNWFP--------PEVRK----LLSRILDPNPSTRVT 256
+ P P V L +IL NP R+T
Sbjct: 243 RNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLT 293
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-24
Identities = 72/252 (28%), Positives = 125/252 (49%), Gaps = 17/252 (6%)
Query: 17 LLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLY 76
LLG+G F +V+ G LK VA+K ++ + + + + E +++ HPNIV+L
Sbjct: 2 LLGKGNFGEVFKG-TLKDKTPVAVKTCKEDLPQELKI--KFLSEARILKQYDHPNIVKLI 58
Query: 77 EVMASKTKIYFAMEYVRGGEL--FNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRD 134
V + IY ME V GG+ F + K +L+ + K+ + + S+ HRD
Sbjct: 59 GVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRD 118
Query: 135 LKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTP----AYVAPEVINKRGYDG 190
L N L+ EN LKISDFG+ S ++D ++++ G + APE +N Y
Sbjct: 119 LAARNCLVGENNVLKISDFGM-----SRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYS- 172
Query: 191 AKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EFKCPNWFPPEVRKLLSRILD 248
+++D+WS G++L+ + G P+ + +++ + CP P +V K++ R D
Sbjct: 173 SESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWD 232
Query: 249 PNPSTRVTMAKL 260
P R ++L
Sbjct: 233 YKPENRPKFSEL 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 64/205 (31%), Positives = 100/205 (48%), Gaps = 13/205 (6%)
Query: 12 YELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPN 71
Y+ +G+G + V + TG VAIK + + REI ++R +H N
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKI--SPFEHQTFCQRTLREIKILRRFKHEN 64
Query: 72 IVQLYEVMASKT-----KIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCH 126
I+ + +++ + +Y E + +L+ + L + + + Q++ +++ H
Sbjct: 65 IIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILRGLKYIH 123
Query: 127 SRGVYHRDLKPENLLLDENGDLKISDFGL--SALQESTRQDGLLHTTCGTPAYVAPEV-I 183
S V HRDLKP NLLL+ N DLKI DFGL A E G L T Y APE+ +
Sbjct: 124 SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHD-HTGFLTEYVATRWYRAPEIML 182
Query: 184 NKRGYDGAKADIWSCGVVLFVLLAG 208
N +GY A DIWS G +L +L+
Sbjct: 183 NSKGYTKA-IDIWSVGCILAEMLSN 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 1e-23
Identities = 74/257 (28%), Positives = 119/257 (46%), Gaps = 17/257 (6%)
Query: 14 LGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIV 73
+ LG G F V+ G+ + VAIK++ + + I++ K VM + HPN+V
Sbjct: 8 FLKELGSGQFGVVHLGK-WRGKIDVAIKMIREGAMSEDDFIEEAK----VMMKLSHPNLV 62
Query: 74 QLYEVMASKTKIYFAMEYVRGGELFN--KVAKGKLREEVARKYFQQLVDAVEFCHSRGVY 131
QLY V + I+ EY+ G L N + KGKL E + +A+E+ S G
Sbjct: 63 QLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFI 122
Query: 132 HRDLKPENLLLDENGDLKISDFGLSAL---QESTRQDGLLHTTCGTPAYVAPEVINKRGY 188
HRDL N L+ E+ +K+SDFGL+ + T G T + PEV + +
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQG----TKFPVKWAPPEVFDYSRF 178
Query: 189 DGAKADIWSCGVVLF-VLLAGNLPFYDSNLMELYKKITRA-EFKCPNWFPPEVRKLLSRI 246
+K+D+WS GV+++ V G +P+ + E+ + ++ P P EV ++
Sbjct: 179 S-SKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSC 237
Query: 247 LDPNPSTRVTMAKLMEN 263
P R KL+
Sbjct: 238 WHEKPEDRPAFKKLLSQ 254
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 2e-23
Identities = 75/275 (27%), Positives = 127/275 (46%), Gaps = 42/275 (15%)
Query: 18 LGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYE 77
LG+G++A VY G + GQ VA+K++ + G+ RE S+++ ++H NIV L++
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKT--EEGVPFTAIREASLLKGLKHANIVLLHD 70
Query: 78 VMASKTKIYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDL 135
++ +K + F EY+ +L + + G L R + QL+ + + H + + HRDL
Sbjct: 71 IIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDL 129
Query: 136 KPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADI 195
KP+NLL+ G+LK++DFGL+ + Q + T Y P+V+ + DI
Sbjct: 130 KPQNLLISYLGELKLADFGLARAKSIPSQT--YSSEVVTLWYRPPDVLLGATDYSSALDI 187
Query: 196 WSCGVVLFVLLAGNLPFYD-SNLMELYKKITRA----------------EFKCPNWF--- 235
W G + +L G F S++ E +KI +K P WF
Sbjct: 188 WGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYK-PEWFLPC 246
Query: 236 --------------PPEVRKLLSRILDPNPSTRVT 256
PP+ L S++L P R++
Sbjct: 247 KPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRIS 281
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 74/311 (23%), Positives = 125/311 (40%), Gaps = 65/311 (20%)
Query: 14 LGRLLGQGTFAKVYHGRNLKTGQSVAIKIV-----------DKEKIRRVGLIDQIKREIS 62
G LG+GT+ KV + TG+ VAIK V D++ + G+ RE+
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72
Query: 63 VMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARK--YFQQLVD 120
+M ++H NI+ L +V I M+ + KV K+R ++ Q+++
Sbjct: 73 IMNEIKHENIMGLVDVYVEGDFINLVMDIMASD--LKKVVDRKIRLTESQVKCILLQILN 130
Query: 121 AVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLS------------ALQESTRQDGLL 168
+ H HRDL P N+ ++ G KI+DFGL+ + E+ ++ +
Sbjct: 131 GLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEM 190
Query: 169 HTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKI---- 224
+ T Y APE++ D+WS G + LL G F N ++ +I
Sbjct: 191 TSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELL 250
Query: 225 -TRAEFKCPNWFPPEVRK----------------------------LLSRILDPNPSTRV 255
T E NW P+ +K LL +L NP R+
Sbjct: 251 GTPNE---DNW--PQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERI 305
Query: 256 TMAKLMENYWF 266
+ + +++ +F
Sbjct: 306 SAKEALKHEYF 316
|
Length = 335 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 2e-23
Identities = 70/276 (25%), Positives = 117/276 (42%), Gaps = 36/276 (13%)
Query: 16 RLLGQGTFAKVYHGR----NLKTGQSVAIKI--VDKEKIRRVGLIDQIKREISVMRLVRH 69
+ LG+G F KV R TG+ VA+K E+ R +REI ++R + H
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDF----EREIEILRTLDH 65
Query: 70 PNIVQLYEVM--ASKTKIYFAMEYVRGGELFNKVAKGKLREEVAR--KYFQQLVDAVEFC 125
NIV+ V + MEY+ G L + + + + + + R + Q+ +++
Sbjct: 66 ENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYL 125
Query: 126 HSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPA-YVAPEVIN 184
S+ HRDL N+L++ +KISDFGL+ + + + +P + APE +
Sbjct: 126 GSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLR 185
Query: 185 KRGYDGAKADIWSCGVVLFVLLAGNLPFYD------------------SNLMELYKKITR 226
+ + +D+WS GV L+ L P + L+EL K+ R
Sbjct: 186 TSKFS-SASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGER 244
Query: 227 AEFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262
P P EV L+ + P R + A L+
Sbjct: 245 --LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 4e-23
Identities = 72/245 (29%), Positives = 122/245 (49%), Gaps = 15/245 (6%)
Query: 18 LGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYE 77
+G+G F +V+ GR VA+K +E + L + +E +++ HPNIV+L
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSC-RETLPP-DLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 78 VMASKTKIYFAMEYVRGGEL--FNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDL 135
V K IY ME V+GG+ F + +L+ + + + +E+ S+ HRDL
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120
Query: 136 KPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTP----AYVAPEVINKRGYDGA 191
N L+ E LKISDFG+S +E DG+ +T G + APE +N Y +
Sbjct: 121 AARNCLVTEKNVLKISDFGMSREEE----DGVYASTGGMKQIPVKWTAPEALNYGRYS-S 175
Query: 192 KADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EFKCPNWFPPEVRKLLSRILDP 249
++D+WS G++L+ + G +P+ + + + + I + CP P V +L+ R +
Sbjct: 176 ESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEY 235
Query: 250 NPSTR 254
+P R
Sbjct: 236 DPGQR 240
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 5e-23
Identities = 72/256 (28%), Positives = 120/256 (46%), Gaps = 21/256 (8%)
Query: 16 RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQL 75
+ LG G F V+ G+ + VAIK +++ + I++ K VM + HP +VQL
Sbjct: 10 KELGSGQFGVVHLGK-WRAQIKVAIKAINEGAMSEEDFIEEAK----VMMKLSHPKLVQL 64
Query: 76 YEVMASKTKIYFAMEYVRGGELFN--KVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHR 133
Y V + +Y E++ G L N + +GKL +++ Q + + +E+ HR
Sbjct: 65 YGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHR 124
Query: 134 DLKPENLLLDENGDLKISDFGLSALQESTRQ--DGLLHTTCGTP---AYVAPEVINKRGY 188
DL N L+ G +K+SDFG+ TR D ++ G + PEV N Y
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGM------TRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKY 178
Query: 189 DGAKADIWSCGVVLF-VLLAGNLPFYDSNLMELYKKITRA-EFKCPNWFPPEVRKLLSRI 246
+K+D+WS GV+++ V G +PF + E+ + I+R P V +++
Sbjct: 179 S-SKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYSC 237
Query: 247 LDPNPSTRVTMAKLME 262
P R T A+L+
Sbjct: 238 WHEKPEGRPTFAELLR 253
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 6e-23
Identities = 94/321 (29%), Positives = 145/321 (45%), Gaps = 54/321 (16%)
Query: 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRV--GLID--QIKREISVMRL 66
+Y++ ++G+G++ V + TG+ VAIK KI V + D +I REI ++RL
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIK-----KINDVFEHVSDATRILREIKLLRL 55
Query: 67 VRHPNIVQLYEVMASKTKIYFAMEYV----RGGELFNKV-AKGKLREEVARKYFQQLVDA 121
+RHP+IV++ +M ++ F YV +L + A L E + + QL+ A
Sbjct: 56 LRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRA 115
Query: 122 VEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTT-CGTPAYVAP 180
+++ H+ V+HRDLKP+N+L + + LKI DFGL+ + + + T T Y AP
Sbjct: 116 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 175
Query: 181 EVINK--RGYDGAKADIWSCGVVLFVLLAGNLPFYDSN---------------------- 216
E+ Y A DIWS G + +L G F N
Sbjct: 176 ELCGSFFSKYTPA-IDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234
Query: 217 ---------LMELYKKITRA-EFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWF 266
L + KK K PN P +R LL R+L +P R T + + + +F
Sbjct: 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALR-LLERLLAFDPKDRPTAEEALADPYF 293
Query: 267 RKGYKKIETPESPRGQDRNKL 287
KG K+E P Q KL
Sbjct: 294 -KGLAKVE--REPSAQPITKL 311
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 1e-22
Identities = 66/259 (25%), Positives = 134/259 (51%), Gaps = 17/259 (6%)
Query: 12 YELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVD----KEKIRRVGLIDQIKREISVMRLV 67
Y R++G+G++ +V R+ G+ IK ++ + R+ ++E ++ +
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAA-----EQEAQLLSQL 56
Query: 68 RHPNIVQLYEVMASKT-KIYFAMEYVRGGELFNKVA--KGKL-REEVARKYFQQLVDAVE 123
+HPNIV E + +Y M + GG+L++K+ KGKL E ++F Q+ A++
Sbjct: 57 KHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQ 116
Query: 124 FCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVI 183
+ H + + HRDLK +N+ L +K+ D G++ + E+ Q + T GTP Y++PE+
Sbjct: 117 YLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN--QCDMASTLIGTPYYMSPELF 174
Query: 184 NKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF-KCPNWFPPEVRKL 242
+ + Y+ K+D+W+ G ++ + F ++ L +I + P + PE+ +L
Sbjct: 175 SNKPYN-YKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGEL 233
Query: 243 LSRILDPNPSTRVTMAKLM 261
++ +L P R ++ ++
Sbjct: 234 IATMLSKRPEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 2e-22
Identities = 54/141 (38%), Positives = 84/141 (59%), Gaps = 5/141 (3%)
Query: 18 LGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYE 77
LG+G++A VY GR+ TGQ VA+K + E G RE S+++ ++H NIV L++
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEH--EEGAPFTAIREASLLKDLKHANIVTLHD 70
Query: 78 VMASKTKIYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDL 135
++ +K + EY+ +L + G L R + QL+ + +CH R V HRDL
Sbjct: 71 IIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDL 129
Query: 136 KPENLLLDENGDLKISDFGLS 156
KP+NLL+ E G+LK++DFGL+
Sbjct: 130 KPQNLLISERGELKLADFGLA 150
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 2e-22
Identities = 73/259 (28%), Positives = 126/259 (48%), Gaps = 19/259 (7%)
Query: 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR 68
+ K LG ++G+G F V G TGQ VA+K + + + L E +VM +
Sbjct: 5 LQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDVTAQAFL-----EETAVMTKLH 57
Query: 69 HPNIVQLYEVMASKTKIYFAMEYVRGGELFNKV-AKGKLREEVAR--KYFQQLVDAVEFC 125
H N+V+L V+ +Y ME + G L N + +G+ V + ++ + + +E+
Sbjct: 58 HKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYL 116
Query: 126 HSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINK 185
S+ + HRDL N+L+ E+G K+SDFGL+ + + L + APE + K
Sbjct: 117 ESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK-----WTAPEAL-K 170
Query: 186 RGYDGAKADIWSCGVVLF-VLLAGNLPFYDSNLMELYKKITRA-EFKCPNWFPPEVRKLL 243
+K+D+WS GV+L+ V G P+ +L E+ + + + + P P +V L+
Sbjct: 171 HKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLM 230
Query: 244 SRILDPNPSTRVTMAKLME 262
+ + P R + KL E
Sbjct: 231 TSCWETEPKKRPSFHKLRE 249
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 3e-22
Identities = 76/282 (26%), Positives = 134/282 (47%), Gaps = 42/282 (14%)
Query: 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR 68
M +Y++ RL+G+G +VY + + VA+K + ++ L + RE + +
Sbjct: 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI 60
Query: 69 HPNIVQLYEVMASKTKIYFAMEYVRG---GELFNKV-AKGKLREEVARK--------YFQ 116
HP IV +Y + + +Y+ M Y+ G L V K L +E+A K F
Sbjct: 61 HPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFH 120
Query: 117 QLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQE---------STRQDGL 167
++ +E+ HS+GV HRDLKP+N+LL G++ I D+G + ++ + +
Sbjct: 121 KICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180
Query: 168 LHTT-------CGTPAYVAPEVINKRGYDGA-KADIWSCGVVLFVLLAGNLPFYDSNLME 219
+++ GTP Y+APE + G + DI++ GV+L+ +L + P+ +
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERL--LGVPASESTDIYALGVILYQMLTLSFPYRR----K 234
Query: 220 LYKKIT-RAEFKCPNWFPP--EVRKLLSRI----LDPNPSTR 254
+KI+ R P P E+ LS+I L +P+ R
Sbjct: 235 KGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAER 276
|
Length = 932 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 6e-22
Identities = 62/202 (30%), Positives = 101/202 (50%), Gaps = 15/202 (7%)
Query: 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR-- 68
+YE +G G + VY R+ +G VA+K V + + GL RE+++++ +
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSV-RVQTNEDGLPLSTVREVALLKRLEAF 59
Query: 69 -HPNIVQLYEVMAS-----KTKIYFAMEYVRGG--ELFNKVAKGKLREEVARKYFQQLVD 120
HPNIV+L +V A+ +TK+ E+V +KV L E + +Q +
Sbjct: 60 DHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLR 119
Query: 121 AVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAP 180
++F H+ + HRDLKPEN+L+ G +K++DFGL+ + L T Y AP
Sbjct: 120 GLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA---LTPVVVTLWYRAP 176
Query: 181 EVINKRGYDGAKADIWSCGVVL 202
EV+ + Y D+WS G +
Sbjct: 177 EVLLQSTY-ATPVDMWSVGCIF 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 95.2 bits (236), Expect = 8e-22
Identities = 73/271 (26%), Positives = 126/271 (46%), Gaps = 22/271 (8%)
Query: 16 RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQL 75
R +G G+F VY R+++T + VAIK + + I +E+ ++ ++HPN ++
Sbjct: 31 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90
Query: 76 YEVMASKTKIYFAMEYVRGG--ELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHR 133
+ + MEY G +L +V K L+E + + + HS + HR
Sbjct: 91 KGCYLREHTAWLVMEYCLGSASDLL-EVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHR 149
Query: 134 DLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVI---NKRGYDG 190
D+K N+LL E G +K++DFG +++ ++ GTP ++APEVI ++ YDG
Sbjct: 150 DIKAGNILLTEPGQVKLADFGSASIASPA------NSFVGTPYWMAPEVILAMDEGQYDG 203
Query: 191 AKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAE---FKCPNWFPPEVRKLLSRIL 247
K D+WS G+ L P ++ N M I + E + W R + L
Sbjct: 204 -KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEW-SDYFRNFVDSCL 261
Query: 248 DPNPSTRVTMAKLMENYWFRKGYKKIETPES 278
P R T +L+++ + + E PE+
Sbjct: 262 QKIPQDRPTSEELLKHMFVLR-----ERPET 287
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 2e-21
Identities = 73/261 (27%), Positives = 110/261 (42%), Gaps = 27/261 (10%)
Query: 18 LGQGTFAKVYHGR-----NLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNI 72
LG+G F KVY G + SVAIK + + + + ++E +M ++HPNI
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNI 70
Query: 73 VQLYEVMASKTKIYFAMEYVRGGELF---------NKVAKGKLREEVARKYFQ------- 116
V L V + EY+ G+L + V E V
Sbjct: 71 VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130
Query: 117 -QLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTP 175
Q+ +E+ S HRDL N L+ E +KISDFGLS S + +
Sbjct: 131 IQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPV 190
Query: 176 AYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKI-TRAEFKCPN 233
++ PE I G ++DIWS GVVL+ + + G P+Y + E+ + I +R CP
Sbjct: 191 RWMPPEAI-LYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLPCPE 249
Query: 234 WFPPEVRKLLSRILDPNPSTR 254
P V L+ + P+ R
Sbjct: 250 DCPARVYALMIECWNEIPARR 270
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 2e-21
Identities = 76/262 (29%), Positives = 120/262 (45%), Gaps = 32/262 (12%)
Query: 14 LGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIV 73
L R LG G F +V+ G T + VA+K + + + +E +M+ +RH +V
Sbjct: 10 LERKLGAGQFGEVWMGTWNGTTK-VAVKTLKPGTMSPEAFL----QEAQIMKKLRHDKLV 64
Query: 74 QLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARK-YFQQLVD-------AVEFC 125
QLY V + + IY EY+ G L + L+ +K QLVD + +
Sbjct: 65 QLYAVCSEEEPIYIVTEYMSKGSLLD-----FLKSGEGKKLRLPQLVDMAAQIAEGMAYL 119
Query: 126 HSRGVYHRDLKPENLLLDENGDLKISDFGLSALQE----STRQDGLLHTTCGTP-AYVAP 180
SR HRDL N+L+ EN KI+DFGL+ L E + R+ P + AP
Sbjct: 120 ESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKF------PIKWTAP 173
Query: 181 EVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EFKCPNWFPPE 238
E N + K+D+WS G++L ++ G +P+ E+ +++ R P P E
Sbjct: 174 EAANYGRFT-IKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEE 232
Query: 239 VRKLLSRILDPNPSTRVTMAKL 260
+ L+ + D +P R T L
Sbjct: 233 LYDLMLQCWDKDPEERPTFEYL 254
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 2e-21
Identities = 64/203 (31%), Positives = 107/203 (52%), Gaps = 16/203 (7%)
Query: 11 KYELGRLLGQGTFAKVYHGRNLKTG-QSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR- 68
+YE +G+G + KV+ R+LK G + VA+K V + + G+ RE++V+R +
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLET 60
Query: 69 --HPNIVQLYEVMA-----SKTKIYFAMEYVRGG--ELFNKVAKGKLREEVARKYFQQLV 119
HPN+V+L++V +TK+ E+V +KV + + E + QL+
Sbjct: 61 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 120
Query: 120 DAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVA 179
++F HS V HRDLKP+N+L+ +G +K++DFGL+ + L + T Y A
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWYRA 177
Query: 180 PEVINKRGYDGAKADIWSCGVVL 202
PEV+ + Y D+WS G +
Sbjct: 178 PEVLLQSSY-ATPVDLWSVGCIF 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 2e-21
Identities = 72/255 (28%), Positives = 129/255 (50%), Gaps = 17/255 (6%)
Query: 18 LGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYE 77
LG G + +VY G K +VA+K + ++ + +++ +E +VM+ ++HPN+VQL
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLG 69
Query: 78 VMASKTKIYFAMEYVRGGELFNKVAKGKLREE---VARKYF-QQLVDAVEFCHSRGVYHR 133
V + Y E++ G L + + + R+E V Y Q+ A+E+ + HR
Sbjct: 70 VCTREPPFYIITEFMTYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKKNFIHR 128
Query: 134 DLKPENLLLDENGDLKISDFGLSAL-QESTRQDGLLHTTCGTP-AYVAPEVINKRGYDGA 191
DL N L+ EN +K++DFGLS L T H P + APE + +
Sbjct: 129 DLAARNCLVGENHLVKVADFGLSRLMTGDTYT---AHAGAKFPIKWTAPESLAYNKFS-I 184
Query: 192 KADIWSCGVVLF-VLLAGNLPFYDSNLMELYKKITRA-EFKCPNWFPPEVRKLLSRILDP 249
K+D+W+ GV+L+ + G P+ +L ++Y+ + + + P PP+V +L+
Sbjct: 185 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMRACWQW 244
Query: 250 NPSTRVTMAKLMENY 264
NPS R + A++ + +
Sbjct: 245 NPSDRPSFAEIHQAF 259
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 3e-21
Identities = 72/245 (29%), Positives = 124/245 (50%), Gaps = 46/245 (18%)
Query: 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVD----KEKIRRVGLIDQIKREISVM 64
+N+YE+ + +G G F +V+ ++ +T + K + KE+ + Q+ E++VM
Sbjct: 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREK-----SQLVIEVNVM 66
Query: 65 RLVRHPNIVQLYEVMASKT--KIYFAMEYVRGGELFNKVAK-----GKLREEVARKYFQQ 117
R ++H NIV+ + +K K+Y ME+ G+L + K GK+ E +Q
Sbjct: 67 RELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQ 126
Query: 118 LVDAVEFCHS-------RGVYHRDLKPENLLLDE---------------NGD--LKISDF 153
L+ A+ +CH+ V HRDLKP+N+ L NG KI DF
Sbjct: 127 LLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDF 186
Query: 154 GLSALQESTRQDGLLHTTCGTPAYVAPEVI--NKRGYDGAKADIWSCGVVLFVLLAGNLP 211
GLS ++ + + H+ GTP Y +PE++ + YD K+D+W+ G +++ L +G P
Sbjct: 187 GLS---KNIGIESMAHSCVGTPYYWSPELLLHETKSYDD-KSDMWALGCIIYELCSGKTP 242
Query: 212 FYDSN 216
F+ +N
Sbjct: 243 FHKAN 247
|
Length = 1021 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 3e-21
Identities = 70/260 (26%), Positives = 117/260 (45%), Gaps = 15/260 (5%)
Query: 16 RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQL 75
R +G G+F VY R+++ + VAIK + + I +E+ ++ +RHPN +Q
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 76 YEVMASKTKIYFAMEYVRGG--ELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHR 133
+ + MEY G +L +V K L+E + + + HS + HR
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLL-EVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139
Query: 134 DLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVI---NKRGYDG 190
D+K N+LL E G +K+ DFG +++ + GTP ++APEVI ++ YDG
Sbjct: 140 DVKAGNILLSEPGLVKLGDFGSASIMAPA------NXFVGTPYWMAPEVILAMDEGQYDG 193
Query: 191 AKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKC--PNWFPPEVRKLLSRILD 248
K D+WS G+ L P ++ N M I + E + R + L
Sbjct: 194 -KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQ 252
Query: 249 PNPSTRVTMAKLMENYWFRK 268
P R T L+++ + +
Sbjct: 253 KIPQDRPTSEVLLKHRFVLR 272
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 4e-21
Identities = 68/246 (27%), Positives = 116/246 (47%), Gaps = 12/246 (4%)
Query: 18 LGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYE 77
LG+G F +V + TG+ A K +DK+++++ E ++ V P IV L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 78 VMASKTKIYFAMEYVRGGEL-FNKVAKGKLREEVAR--KYFQQLVDAVEFCHSRGVYHRD 134
SKT + M + GG+L ++ G+ E+ R Y Q+ + HS + +RD
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120
Query: 135 LKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKAD 194
+KPEN+LLD+ G+ ++SD GL+ + + GT Y+APE++ + Y D
Sbjct: 121 MKPENVLLDDQGNCRLSDLGLAV---ELKDGKTITQRAGTNGYMAPEILKEEPYS-YPVD 176
Query: 195 IWSCGVVLFVLLAGNLPFYDSNLM----ELYKKITRAEFKCPNW-FPPEVRKLLSRILDP 249
++ G ++ ++AG PF D EL ++ E K + F E + + L
Sbjct: 177 WFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAK 236
Query: 250 NPSTRV 255
P R+
Sbjct: 237 KPEDRL 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 5e-21
Identities = 71/252 (28%), Positives = 120/252 (47%), Gaps = 22/252 (8%)
Query: 18 LGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYE 77
LG+G F +V + TG+ A K ++K+++++ + E ++ V IV L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 78 VMASKTKIYFAMEYVRGGEL------FNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVY 131
+KT + M + GG+L ++ G E A Y Q++ +E H R +
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPG-FPEPRACFYTAQIISGLEHLHQRRII 119
Query: 132 HRDLKPENLLLDENGDLKISDFGLS----ALQESTRQDGLLHTTCGTPAYVAPEVINKRG 187
+RDLKPEN+LLD +G+++ISD GL+ Q T+ GTP ++APE++
Sbjct: 120 YRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTK------GYAGTPGFMAPELLQGEE 173
Query: 188 YDGAKADIWSCGVVLFVLLAGNLPFY----DSNLMELYKKITRAEFKCPNWFPPEVRKLL 243
YD + D ++ GV L+ ++A PF EL ++I P+ F P +
Sbjct: 174 YDFS-VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFC 232
Query: 244 SRILDPNPSTRV 255
+L +P R+
Sbjct: 233 EALLAKDPEKRL 244
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 5e-21
Identities = 80/264 (30%), Positives = 129/264 (48%), Gaps = 31/264 (11%)
Query: 18 LGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKR-----EISVMRLVRHPNI 72
LG+G + V R++ TG +A+K +IR + KR +IS MR V P
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVK-----RIRATVNSQEQKRLLMDLDIS-MRSVDCPYT 62
Query: 73 VQLYEVMASKTKIYFAMEYVRGG--ELFNKVAKGKLR--EEVARKYFQQLVDAVEFCHSR 128
V Y + + ++ ME + + + KV L E++ K +V A+E+ HS+
Sbjct: 63 VTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK 122
Query: 129 -GVYHRDLKPENLLLDENGDLKISDFGLSA-LQESTRQDGLLHTTCGTPAYVAPEVIN-- 184
V HRD+KP N+L++ NG +K+ DFG+S L +S + G Y+APE IN
Sbjct: 123 LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKT----IDAGCKPYMAPERINPE 178
Query: 185 --KRGYDGAKADIWSCGVVLFVLLAGNLPFYDS--NLMELYKKITRAEF-KCPN-WFPPE 238
++GYD K+D+WS G+ + L G P YDS + K++ + P F PE
Sbjct: 179 LNQKGYD-VKSDVWSLGITMIELATGRFP-YDSWKTPFQQLKQVVEEPSPQLPAEKFSPE 236
Query: 239 VRKLLSRILDPNPSTRVTMAKLME 262
+ +++ L N R +L++
Sbjct: 237 FQDFVNKCLKKNYKERPNYPELLQ 260
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 5e-21
Identities = 77/294 (26%), Positives = 135/294 (45%), Gaps = 38/294 (12%)
Query: 18 LGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYE 77
LG+GT+A V+ GR+ T VA+K + E G RE+S+++ ++H NIV L++
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLE--HEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 78 VMASKTKIYFAMEYV-RGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLK 136
++ + + EY+ + + + + + + Q++ + +CH R V HRDLK
Sbjct: 72 IVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLK 131
Query: 137 PENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIW 196
P+NLL++E G+LK++DFGL+ + + T Y P+V+ + D+W
Sbjct: 132 PQNLLINERGELKLADFGLARAKSVPTKT--YSNEVVTLWYRPPDVLLGSSEYSTQIDMW 189
Query: 197 SCGVVLFVLLAGNLPFYDSNLMELYKKITR----------------AEFKCPNWFP---- 236
G + F + +G F S + + I R EFK N FP
Sbjct: 190 GVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYN-FPKYKP 248
Query: 237 -----------PEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIET-PES 278
E +LL++ L R++ + M++ +FR +I + PES
Sbjct: 249 QPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGTRIHSLPES 302
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 6e-21
Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 33/220 (15%)
Query: 7 ILMNKYELGRLLGQGTFAKVYHG--RNLKTGQS---VAIKIV-DKEKIRRVGLIDQIKRE 60
+ K L R LGQG+F VY G + + G+ VAIK V + +R + E
Sbjct: 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRE---RIEFLNE 59
Query: 61 ISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKY------ 114
SVM+ ++V+L V+++ ME + G+L + + + E
Sbjct: 60 ASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQ 119
Query: 115 --FQ---QLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSAL---QESTRQDG 166
Q ++ D + + ++ HRDL N ++ E+ +KI DFG++ + R+ G
Sbjct: 120 KFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGG 179
Query: 167 --LLHTTCGTPA-YVAPEVINKRGYDGAKADIWSCGVVLF 203
LL P ++APE + K G K+D+WS GVVL+
Sbjct: 180 KGLL------PVRWMAPESL-KDGVFTTKSDVWSFGVVLW 212
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 7e-21
Identities = 65/213 (30%), Positives = 108/213 (50%), Gaps = 11/213 (5%)
Query: 18 LGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYE 77
LG+GT+A V+ GR+ T VA+K + E G RE+S+++ ++H NIV L++
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLE--HEEGAPCTAIREVSLLKNLKHANIVTLHD 70
Query: 78 VMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQ-QLVDAVEFCHSRGVYHRDLK 136
++ ++ + EY+ G L K F QL+ + +CH R + HRDLK
Sbjct: 71 IIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLK 130
Query: 137 PENLLLDENGDLKISDFGLS---ALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKA 193
P+NLL++E G+LK++DFGL+ ++ T + ++ T Y P+V+
Sbjct: 131 PQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-----TLWYRPPDVLLGSTEYSTPI 185
Query: 194 DIWSCGVVLFVLLAGNLPFYDSNLMELYKKITR 226
D+W G +L+ + G F S + E I R
Sbjct: 186 DMWGVGCILYEMATGRPMFPGSTVKEELHLIFR 218
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 7e-21
Identities = 64/207 (30%), Positives = 105/207 (50%), Gaps = 20/207 (9%)
Query: 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRV--GLIDQIK--REISVMRL 66
KY + +G+G + V +N +T + VAIK KI ID + REI ++R
Sbjct: 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIK-----KIANAFDNRIDAKRTLREIKLLRH 60
Query: 67 VRHPNIVQLYEVMASKTKIYFAMEYVRGGELFN----KVAKGK--LREEVARKYFQQLVD 120
+ H N++ + ++M + F Y+ EL + ++ + L ++ + + QL+
Sbjct: 61 LDHENVIAIKDIMPPPHREAFNDVYIV-YELMDTDLHQIIRSSQTLSDDHCQYFLYQLLR 119
Query: 121 AVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAP 180
+++ HS V HRDLKP NLLL+ N DLKI DFGL+ + ++ + + T Y AP
Sbjct: 120 GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA--RTTSEKGDFMTEYVVTRWYRAP 177
Query: 181 EVI-NKRGYDGAKADIWSCGVVLFVLL 206
E++ N Y D+WS G + LL
Sbjct: 178 ELLLNCSEY-TTAIDVWSVGCIFAELL 203
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 92.1 bits (228), Expect = 8e-21
Identities = 62/208 (29%), Positives = 107/208 (51%), Gaps = 13/208 (6%)
Query: 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRH 69
+ YE LG+G++A VY G++ G+ VA+K++ ++ G RE S+++ ++H
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQE--EEGTPFTAIREASLLKGLKH 62
Query: 70 PNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHS 127
NIV L++++ +K + EYV +L + K G L E + + QL+ + + H
Sbjct: 63 ANIVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ 121
Query: 128 RGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCG---TPAYVAPEVIN 184
R + HRDLKP+NLL+ + G+LK++DFGL+ + HT T Y P+V+
Sbjct: 122 RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-----HTYSNEVVTLWYRPPDVLL 176
Query: 185 KRGYDGAKADIWSCGVVLFVLLAGNLPF 212
D+W G + ++ G F
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 8e-21
Identities = 66/256 (25%), Positives = 116/256 (45%), Gaps = 14/256 (5%)
Query: 17 LLGQGTFAKVYHGRNLKTGQ---SVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIV 73
LG G+F V G +G VA+K + +K+ ++D +E ++M + H N++
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLI 59
Query: 74 QLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLRE---EVARKYFQQLVDAVEFCHSRGV 130
+LY V+ + + E G L +++ K L Y Q+ + + + S+
Sbjct: 60 RLYGVVLTH-PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRF 118
Query: 131 YHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTP-AYVAPEVINKRGYD 189
HRDL N+LL + +KI DFGL ++ P A+ APE + R +
Sbjct: 119 IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFS 178
Query: 190 GAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA--EFKCPNWFPPEVRKLLSRI 246
A +D+W GV L+ + G P+ + ++ KKI + + P P ++ ++ +
Sbjct: 179 HA-SDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQC 237
Query: 247 LDPNPSTRVTMAKLME 262
NP+ R T A L E
Sbjct: 238 WAHNPADRPTFAALRE 253
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 8e-21
Identities = 62/247 (25%), Positives = 112/247 (45%), Gaps = 11/247 (4%)
Query: 16 RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQL 75
R+LG+G F +V + TG+ A K ++K++I++ E ++ V +V L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 65
Query: 76 YEVMASKTKIYFAMEYVRGGEL---FNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYH 132
+K + + + GG+L + EE A Y ++ +E H + +
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVY 125
Query: 133 RDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAK 192
RDLKPEN+LLD+ G ++ISD GL+ + + GT Y+APEV+ Y
Sbjct: 126 RDLKPENILLDDYGHIRISDLGLAV---EIPEGETIRGRVGTVGYMAPEVVKNERY-TFS 181
Query: 193 ADIWSCGVVLFVLLAGNLPFYDS----NLMELYKKITRAEFKCPNWFPPEVRKLLSRILD 248
D W G +++ ++ G PF E+ +++ + + F R + ++L
Sbjct: 182 PDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLT 241
Query: 249 PNPSTRV 255
+P R+
Sbjct: 242 KDPGFRL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 9e-21
Identities = 67/257 (26%), Positives = 115/257 (44%), Gaps = 13/257 (5%)
Query: 18 LGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYE 77
+G G+F VY N T + VA+K + + I +E+ ++ ++HPN ++
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 78 VMASKTKIYFAMEYVRGGEL-FNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLK 136
+ + MEY G +V K L+E + + + HS + HRD+K
Sbjct: 89 CYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIK 148
Query: 137 PENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVI---NKRGYDGAKA 193
N+LL E G +K++DFG ++ ++ GTP ++APEVI ++ YDG K
Sbjct: 149 AGNILLTEPGQVKLADFGSASKSSPA------NSFVGTPYWMAPEVILAMDEGQYDG-KV 201
Query: 194 DIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKC--PNWFPPEVRKLLSRILDPNP 251
D+WS G+ L P ++ N M I + + N + R + L P
Sbjct: 202 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIP 261
Query: 252 STRVTMAKLMENYWFRK 268
R A+L+ + + R+
Sbjct: 262 QERPASAELLRHDFVRR 278
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 2e-20
Identities = 59/206 (28%), Positives = 108/206 (52%), Gaps = 11/206 (5%)
Query: 18 LGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYE 77
LG+GT+A VY GR+ T VA+K + E G RE+S+++ ++H NIV L++
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLE--HEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 78 VMASKTKIYFAMEYV-RGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLK 136
++ ++ + EY+ + + + + + + QL+ + +CH R V HRDLK
Sbjct: 72 IIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLK 131
Query: 137 PENLLLDENGDLKISDFGLS---ALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKA 193
P+NLL++E G+LK++DFGL+ ++ T + ++ T Y P+++ +
Sbjct: 132 PQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-----TLWYRPPDILLGSTDYSTQI 186
Query: 194 DIWSCGVVLFVLLAGNLPFYDSNLME 219
D+W G + + + G F S + E
Sbjct: 187 DMWGVGCIFYEMSTGRPLFPGSTVEE 212
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 2e-20
Identities = 66/248 (26%), Positives = 115/248 (46%), Gaps = 13/248 (5%)
Query: 16 RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQL 75
R+LG+G F +V + TG+ A K ++K++I++ E ++ V +V L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL 65
Query: 76 YEVMASKTKIYFAMEYVRGGEL----FNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVY 131
+K + + + GG+L +N G EE A Y +++ +E H
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG-FEEERALFYAAEILCGLEDLHRENTV 124
Query: 132 HRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGA 191
+RDLKPEN+LLD+ G ++ISD GL+ + + GT Y+APEV+N + Y
Sbjct: 125 YRDLKPENILLDDYGHIRISDLGLAV---KIPEGESIRGRVGTVGYMAPEVLNNQRY-TL 180
Query: 192 KADIWSCGVVLFVLLAGNLPFYDS----NLMELYKKITRAEFKCPNWFPPEVRKLLSRIL 247
D W G +++ ++ G PF E+ +++ E F E + + +L
Sbjct: 181 SPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLL 240
Query: 248 DPNPSTRV 255
+P R+
Sbjct: 241 TKDPKQRL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 2e-20
Identities = 74/260 (28%), Positives = 122/260 (46%), Gaps = 16/260 (6%)
Query: 13 ELGRLLGQGTFAKVYHG--RNLKTGQ-SVAIKIVDKEKIRRVGLIDQIKREISVMRLVRH 69
LGR +G+G F VY G + + + +VA+K V ++ +E +MR H
Sbjct: 9 TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVR--EKFLQEAYIMRQFDH 66
Query: 70 PNIVQLYEVMASKTKIYFAMEYVRGGEL--FNKVAKGKLREEVARKYFQQLVDAVEFCHS 127
P+IV+L V+ ++ ++ ME GEL + +V K L Y QL A+ + S
Sbjct: 67 PHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES 125
Query: 128 RGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGT-P-AYVAPEVINK 185
+ HRD+ N+L+ +K+ DFGLS E + + G P ++APE IN
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE---DESYYKASKGKLPIKWMAPESINF 182
Query: 186 RGYDGAKADIWSCGVVLF-VLLAGNLPFYDSNLMELYKKITRAE-FKCPNWFPPEVRKLL 243
R + A +D+W GV ++ +L+ G PF ++ +I E P PP + L+
Sbjct: 183 RRFTSA-SDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLM 241
Query: 244 SRILDPNPSTRVTMAKLMEN 263
++ +PS R +L
Sbjct: 242 TKCWAYDPSKRPRFTELKAQ 261
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|217748 pfam03822, NAF, NAF domain | Back alignment and domain information |
|---|
Score = 83.7 bits (208), Expect = 2e-20
Identities = 34/58 (58%), Positives = 39/58 (67%), Gaps = 1/58 (1%)
Query: 321 FNAFDIISLSKGFNLSGLFEGDANS-KLEARFTTTKPASAIVSKFEEIAVTESCKFNK 377
NAFD+ISLS G +LSGLFE + S K E RFT+ KPAS I+SK EEIA K K
Sbjct: 1 LNAFDLISLSSGLDLSGLFEEEKKSKKKETRFTSRKPASEIISKLEEIAKELGFKVKK 58
|
Length = 58 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 3e-20
Identities = 71/260 (27%), Positives = 131/260 (50%), Gaps = 19/260 (7%)
Query: 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR 68
M + +L + +G+G F V G G VA+K + + + L E SVM +R
Sbjct: 5 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLA-----EASVMTQLR 57
Query: 69 HPNIVQLYEVMAS-KTKIYFAMEYVRGGELFNKV-AKGK--LREEVARKYFQQLVDAVEF 124
H N+VQL V+ K +Y EY+ G L + + ++G+ L + K+ + +A+E+
Sbjct: 58 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 117
Query: 125 CHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVIN 184
+ HRDL N+L+ E+ K+SDFGL+ ST+ G L + APE +
Sbjct: 118 LEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK-----WTAPEALR 172
Query: 185 KRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EFKCPNWFPPEVRKL 242
++ + K+D+WS G++L+ + + G +P+ L ++ ++ + + P+ PP V +
Sbjct: 173 EKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDV 231
Query: 243 LSRILDPNPSTRVTMAKLME 262
+ + + +TR + +L E
Sbjct: 232 MKQCWHLDAATRPSFLQLRE 251
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 4e-20
Identities = 69/252 (27%), Positives = 117/252 (46%), Gaps = 21/252 (8%)
Query: 16 RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQL 75
R+LG+G F +V + TG+ A K ++K++I++ E ++ V +V L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL 65
Query: 76 YEVMASKTKIYFAMEYVRGGEL---FNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYH 132
+K + + + GG+L + + E A Y ++ +E H + +
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVY 125
Query: 133 RDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAK 192
RDLKPEN+LLD++G ++ISD GL+ + + GT Y+APEV+ Y +
Sbjct: 126 RDLKPENILLDDHGHIRISDLGLAV---HVPEGQTIKGRVGTVGYMAPEVVKNERYTFS- 181
Query: 193 ADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF---------KCPNWFPPEVRKLL 243
D W+ G +L+ ++AG PF + KKI R E + F P+ R L
Sbjct: 182 PDWWALGCLLYEMIAGQSPF-----QQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLC 236
Query: 244 SRILDPNPSTRV 255
+L +P R+
Sbjct: 237 KMLLCKDPKERL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 4e-20
Identities = 80/321 (24%), Positives = 132/321 (41%), Gaps = 70/321 (21%)
Query: 11 KYELGRLLGQGTFAKVYHGR--NLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR 68
KYE+ +G+GT+ +VY + N K G+ AIK +K + G+ REI+++R ++
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 69 HPNIVQLYEVMASKT--KIYFAMEYVRGGEL----FNKVAKGK-LREEVARKYFQQLVDA 121
H N+V L EV +Y +Y F++ AK + + + Q+++
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120
Query: 122 VEFCHSRGVYHRDLKPENLLL----DENGDLKISDFGL-----SALQESTRQDGLLHTTC 172
V + HS V HRDLKP N+L+ E G +KI D GL + L+ D ++ T
Sbjct: 121 VHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIW 180
Query: 173 GTPAYVAPEVI-NKRGYDGAKADIWSCGVVLFVLLA-------------GNLPFYDSNL- 217
Y APE++ R Y A DIW+ G + LL + PF L
Sbjct: 181 ----YRAPELLLGARHYTKA-IDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE 235
Query: 218 -------------------MELYKKITRAEFKCPNWFP-------------PEVRKLLSR 245
M Y + + + LL +
Sbjct: 236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRK 295
Query: 246 ILDPNPSTRVTMAKLMENYWF 266
+L+ +P+ R+T + +E+ +F
Sbjct: 296 LLEYDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 5e-20
Identities = 64/243 (26%), Positives = 118/243 (48%), Gaps = 29/243 (11%)
Query: 21 GTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMA 80
G KV + +T Q+ +K +R+ + + I + V PN+V L++ +
Sbjct: 4 GVIDKVLLVMDTRTQQTFILK-----GLRKSSEYSRERLTI-IPHCV--PNMVCLHKYIV 55
Query: 81 SKTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPEN 139
S+ ++ +++ GG+L++ ++K + EE +++ ++V A++ H G+ RDL P N
Sbjct: 56 SEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNN 115
Query: 140 LLLDENGDLKISDFG-LSALQESTRQDGLLHTTCGTPAYVAPEV--INKRGYDGAKADIW 196
+LLD+ G ++++ F S +++S + + Y APEV I++ + D W
Sbjct: 116 ILLDDRGHIQLTYFSRWSEVEDSCDGEAV------ENMYCAPEVGGISE---ETEACDWW 166
Query: 197 SCGVVLFVLLAGNLPFYDSNLMELYKK--ITRAEFKCPNWFPPEVRKLLSRILDPNPSTR 254
S G +LF LL G L+E + T P W E R LL ++L NP+ R
Sbjct: 167 SLGAILFELLTG------KTLVECHPSGINTHTTLNIPEWVSEEARSLLQQLLQFNPTER 220
Query: 255 VTM 257
+
Sbjct: 221 LGA 223
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 1e-19
Identities = 70/228 (30%), Positives = 114/228 (50%), Gaps = 22/228 (9%)
Query: 12 YELGRLLGQGTFAKVYHGRNLKT--GQSVAIK----IVDKEKIRRVGLIDQIKREISVMR 65
YEL + LGQG + V RN +T ++VAIK + K+ + + L RE+ ++R
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRAL-----RELKLLR 56
Query: 66 LVR-HPNIVQLYE---VMASK-TKIYFAMEYVRGGELFNKVAKGKLREEVARKYF-QQLV 119
R H NI LY+ V ++Y E + +L + G+ + + F Q++
Sbjct: 57 HFRGHKNITCLYDMDIVFPGNFNELYLYEELMEA-DLHQIIRSGQPLTDAHFQSFIYQIL 115
Query: 120 DAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLS-ALQESTRQ-DGLLHTTCGTPAY 177
+++ HS V HRDLKP NLL++ + +LKI DFGL+ E+ + G + T Y
Sbjct: 116 CGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWY 175
Query: 178 VAPEV-INKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKI 224
APE+ ++ + Y A D+WS G +L LL F + ++ +I
Sbjct: 176 RAPEIMLSFQSYTKA-IDVWSVGCILAELLGRKPVFKGKDYVDQLNQI 222
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 2e-19
Identities = 61/219 (27%), Positives = 110/219 (50%), Gaps = 11/219 (5%)
Query: 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHP 70
+Y+ +G G + V + + Q VA+K + + + + + RE+ +++ ++H
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSR-PFQSLIHARRTYRELRLLKHMKHE 74
Query: 71 NIVQLYEVMASKTKI-----YFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFC 125
N++ L +V T I + + + G +L N V KL +E + QL+ +++
Sbjct: 75 NVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYI 134
Query: 126 HSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINK 185
HS G+ HRDLKP N+ ++E+ +L+I DFGL A Q G + T Y APE++
Sbjct: 135 HSAGIIHRDLKPSNVAVNEDCELRILDFGL-ARQADDEMTGYV----ATRWYRAPEIMLN 189
Query: 186 RGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKI 224
+ DIWS G ++ LL G F ++ ++ K+I
Sbjct: 190 WMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRI 228
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 2e-19
Identities = 80/280 (28%), Positives = 130/280 (46%), Gaps = 40/280 (14%)
Query: 16 RLLGQGTFAKV----YHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPN 71
R LG+G F KV Y TG+ VA+K + E I +K+EI ++R + H N
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHEN 67
Query: 72 IVQLYEVMASK---TKIYFAMEYVRGGELFNKVA--KGKLREEVARKYFQQLVDAVEFCH 126
IV+ Y+ + ++ I ME++ G L + K K+ + KY Q+ +++
Sbjct: 68 IVK-YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG 126
Query: 127 SRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAY-VAPEVINK 185
SR HRDL N+L++ +KI DFGL+ E+ ++ + +P + APE + +
Sbjct: 127 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ 186
Query: 186 RGYDGAKADIWSCGVVLFVLLAGNLPFY---DSNLMELYKK----------ITR------ 226
+ A +D+WS GV L+ LL Y +S+ M L+ K +TR
Sbjct: 187 SKFYIA-SDVWSFGVTLYELLT-----YCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLE 240
Query: 227 --AEFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENY 264
P P EV +L+ + + PS R T L+E +
Sbjct: 241 EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGF 280
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 2e-19
Identities = 59/197 (29%), Positives = 95/197 (48%), Gaps = 14/197 (7%)
Query: 18 LGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYE 77
LG G VY +L T + +A+K++ + V L QI E+ ++ P I+ Y
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDIT--VELQKQIMSELEILYKCDSPYIIGFYG 66
Query: 78 VMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKP 137
+ +I E++ GG L K+ E V + +V + + S + HRD+KP
Sbjct: 67 AFFVENRISICTEFMDGGSL---DVYRKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKP 123
Query: 138 ENLLLDENGDLKISDFGLSALQESTRQ--DGLLHTTCGTPAYVAPEVINKRGYDGAKADI 195
N+L++ G +K+ DFG+S Q + + T GT AY+APE I+ Y G +D+
Sbjct: 124 SNMLVNTRGQVKLCDFGVS------TQLVNSIAKTYVGTNAYMAPERISGEQY-GIHSDV 176
Query: 196 WSCGVVLFVLLAGNLPF 212
WS G+ L G P+
Sbjct: 177 WSLGISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 3e-19
Identities = 81/279 (29%), Positives = 127/279 (45%), Gaps = 44/279 (15%)
Query: 16 RLLGQGTFAKV----YHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPN 71
R+LG+G F KV Y N TG+ VA+K + +E ++ K+EI++++ + H N
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQ--NTSGWKKEINILKTLYHEN 67
Query: 72 IVQLYEVMASK---TKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSR 128
IV+ Y+ S+ + MEYV G L + + K KL + QQ+ + + + HS+
Sbjct: 68 IVK-YKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQ 126
Query: 129 GVYHRDLKPENLLLDENGDLKISDFGLS-ALQES-----TRQDGLLHTTCGTPAY-VAPE 181
HRDL N+LLD + +KI DFGL+ A+ E R+DG +P + A E
Sbjct: 127 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG------DSPVFWYAVE 180
Query: 182 VINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDS------------------NLMELYKK 223
+ + + A +D+WS GV L+ LL L+EL ++
Sbjct: 181 CLKENKFSYA-SDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLER 239
Query: 224 ITRAEFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262
R CP P EV L+ + R T L+
Sbjct: 240 GMR--LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 3e-19
Identities = 60/222 (27%), Positives = 107/222 (48%), Gaps = 14/222 (6%)
Query: 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHP 70
+Y + +G G + V + +TG+ VAIK + + + + RE+++++ ++H
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEI-FAKRAYRELTLLKHMQHE 74
Query: 71 NIVQLYEVMASKT------KIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEF 124
N++ L +V S Y M Y++ K+ L E+ + Q++ +++
Sbjct: 75 NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKIMGHPLSEDKVQYLVYQMLCGLKY 132
Query: 125 CHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVIN 184
HS G+ HRDLKP NL ++E+ +LKI DFGL + D + T Y APEVI
Sbjct: 133 IHSAGIIHRDLKPGNLAVNEDCELKILDFGL-----ARHADAEMTGYVVTRWYRAPEVIL 187
Query: 185 KRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITR 226
+ DIWS G ++ +L G F + ++ +I +
Sbjct: 188 NWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK 229
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 3e-19
Identities = 70/271 (25%), Positives = 114/271 (42%), Gaps = 25/271 (9%)
Query: 14 LGRLLGQGTFAKVYHG--RNLKTGQS---VAIKIVDKEKIRRVGLIDQIKREISVMRLVR 68
L R LG+G F KV+ G +L+ VA+K + KE D +RE ++ +
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTL-KETASNDARKD-FEREAELLTNFQ 66
Query: 69 HPNIVQLYEVMASKTKIYFAMEYVRGGEL---------------FNKVAKGKLREEVARK 113
H NIV+ Y V EY+ G+L G+L +
Sbjct: 67 HENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQ 126
Query: 114 YFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCG 173
Q+ + + S+ HRDL N L+ + +KI DFG+S +T + T
Sbjct: 127 IAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTML 186
Query: 174 TPAYVAPEVINKRGYDGAKADIWSCGVVLF-VLLAGNLPFYDSNLMELYKKIT-RAEFKC 231
++ PE I R + ++D+WS GVVL+ + G P+Y + E+ + IT +
Sbjct: 187 PIRWMPPESIMYRKFT-TESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQR 245
Query: 232 PNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262
P P EV ++ +P R+ + + E
Sbjct: 246 PRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 4e-19
Identities = 58/214 (27%), Positives = 106/214 (49%), Gaps = 11/214 (5%)
Query: 18 LGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYE 77
+G G + V + KTG VA+K + + + + + RE+ +++ ++H N++ L +
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLD 83
Query: 78 VMASKTKI-----YFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYH 132
V + + + ++ G +L N V KL ++ + Q++ +++ HS + H
Sbjct: 84 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 143
Query: 133 RDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAK 192
RDLKP NL ++E+ +LKI DFGL + D + T Y APE++ +
Sbjct: 144 RDLKPSNLAVNEDCELKILDFGL-----ARHTDDEMTGYVATRWYRAPEIMLNWMHYNQT 198
Query: 193 ADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITR 226
DIWS G ++ LL G F ++ ++ K I R
Sbjct: 199 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 232
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 9e-19
Identities = 70/254 (27%), Positives = 118/254 (46%), Gaps = 23/254 (9%)
Query: 18 LGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLI--DQIKREISVMRLVRHPNIVQL 75
+G G F V+ G L+ + VAIK + R G + + E VM + HP +VQL
Sbjct: 12 IGSGQFGLVWLGYWLEK-RKVAIKTI------REGAMSEEDFIEEAQVMMKLSHPKLVQL 64
Query: 76 YEVMASKTKIYFAMEYVRGGEL--FNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHR 133
Y V ++ I E++ G L + + +GK +E + + + + S V HR
Sbjct: 65 YGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHR 124
Query: 134 DLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTP---AYVAPEVINKRGYDG 190
DL N L+ EN +K+SDFG++ D ++ GT + +PEV + Y
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFV----LDDQYTSSTGTKFPVKWSSPEVFSFSKYS- 179
Query: 191 AKADIWSCGVVLF-VLLAGNLPFYDSNLMELYKKITRAEFKC--PNWFPPEVRKLLSRIL 247
+K+D+WS GV+++ V G P+ + + E+ + I A F+ P V +L+
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETIN-AGFRLYKPRLASQSVYELMQHCW 238
Query: 248 DPNPSTRVTMAKLM 261
P R + + L+
Sbjct: 239 KERPEDRPSFSLLL 252
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 9e-19
Identities = 66/220 (30%), Positives = 105/220 (47%), Gaps = 26/220 (11%)
Query: 18 LGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYE 77
LG G F V +G+ + VAIK++ + + D+ E VM + H +VQLY
Sbjct: 12 LGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMKLSHEKLVQLYG 66
Query: 78 VMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVD-------AVEFCHSRGV 130
V + IY EY+ G L N LRE R QL++ + + S+
Sbjct: 67 VCTKQRPIYIVTEYMSNGCLLNY-----LREHGKRFQPSQLLEMCKDVCEGMAYLESKQF 121
Query: 131 YHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYV---APEVINKRG 187
HRDL N L+D+ G +K+SDFGLS D ++ G+ V PEV+
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDFGLSRYV----LDDEYTSSVGSKFPVRWSPPEVLLYSK 177
Query: 188 YDGAKADIWSCGVVLF-VLLAGNLPFYDSNLMELYKKITR 226
+ +K+D+W+ GV+++ V G +P+ N E +K+++
Sbjct: 178 FS-SKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQ 216
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 1e-18
Identities = 64/220 (29%), Positives = 103/220 (46%), Gaps = 19/220 (8%)
Query: 16 RLLGQGTFAKVYHGRNLKTGQ---SVAIKIVD---KEKIRRVGLIDQIKREISVMRLVRH 69
+++G G F +V GR G+ VAIK + +K R L E S+M H
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFL-----TEASIMGQFDH 64
Query: 70 PNIVQLYEVMASKTKIYFAMEYVRGGEL--FNKVAKGKLREEVARKYFQQLVDAVEFCHS 127
PNI++L V+ + EY+ G L F + GK + + +++
Sbjct: 65 PNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSE 124
Query: 128 RGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCG-TPA-YVAPEVINK 185
HRDL N+L++ N K+SDFGLS E + + T G P + APE I
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS--EATYTTKGGKIPIRWTAPEAIAY 182
Query: 186 RGYDGAKADIWSCGVVLF-VLLAGNLPFYDSNLMELYKKI 224
R + A +D+WS G+V++ V+ G P++D + ++ K +
Sbjct: 183 RKFTSA-SDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAV 221
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 1e-18
Identities = 68/261 (26%), Positives = 116/261 (44%), Gaps = 28/261 (10%)
Query: 13 ELGRLLGQGTFAKVYHGR-NLKTGQSVAIKIVDKEKIRRVGLID--QIKREISVMRLVRH 69
+L R LG G F +V+ G N T VA+K + + G +D E +M+ +RH
Sbjct: 9 QLLRKLGAGQFGEVWEGLWNNTT--PVAVKTL------KPGTMDPKDFLAEAQIMKKLRH 60
Query: 70 PNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVD-------AV 122
P ++QLY V + IY E ++ G L + G R QL+D +
Sbjct: 61 PKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRA----LKLPQLIDMAAQVASGM 116
Query: 123 EFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTP-AYVAPE 181
+ ++ HRDL N+L+ EN K++DFGL+ + + + P + APE
Sbjct: 117 AYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA--REGAKFPIKWTAPE 174
Query: 182 VINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EFKCPNWFPPEV 239
+ K+D+WS G++L ++ G +P+ E+ +++ + CP P E+
Sbjct: 175 AALYNRFS-IKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKEL 233
Query: 240 RKLLSRILDPNPSTRVTMAKL 260
++ +P R T L
Sbjct: 234 YDIMLDCWKEDPDDRPTFETL 254
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 1e-18
Identities = 77/307 (25%), Positives = 137/307 (44%), Gaps = 52/307 (16%)
Query: 18 LGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLID----QIKREISVMRLVRHPNIV 73
+G G + V + +TG VAIK K+ R + + RE+ +++ ++H N++
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIK-----KLYRPFQSELFAKRAYRELRLLKHMKHENVI 77
Query: 74 QLYEVMASKTKI------YFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHS 127
L +V + Y M ++ G +L + KL E+ + Q++ +++ H+
Sbjct: 78 GLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHA 136
Query: 128 RGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRG 187
G+ HRDLKP NL ++E+ +LKI DFGL A Q + G + T Y APEVI
Sbjct: 137 AGIIHRDLKPGNLAVNEDCELKILDFGL-ARQTDSEMTGYVVTRW----YRAPEVILNWM 191
Query: 188 YDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITR------AEF-------KCPNW 234
+ DIWS G ++ +L G F + ++ +I + EF N+
Sbjct: 192 HYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNY 251
Query: 235 FP--PEVRK----------------LLSRILDPNPSTRVTMAKLMENYWFRKGYKKIETP 276
P RK +L ++L + +R+T A+ + + +F + + +
Sbjct: 252 VKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDET 311
Query: 277 ESPRGQD 283
E+P D
Sbjct: 312 EAPPYDD 318
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 3e-18
Identities = 72/252 (28%), Positives = 119/252 (47%), Gaps = 19/252 (7%)
Query: 13 ELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNI 72
+L + LG G F +V+ G VAIK + + + + E ++M+ ++HP +
Sbjct: 9 KLVKKLGAGQFGEVWMGY-YNGHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRL 63
Query: 73 VQLYEVMASKTKIYFAMEYVRGGEL--FNKVAKG-KLREEVARKYFQQLVDAVEFCHSRG 129
V+LY V+ ++ IY EY+ G L F K +G KL Q+ + + F +
Sbjct: 64 VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN 122
Query: 130 VYHRDLKPENLLLDENGDLKISDFGLSAL---QESTRQDGLLHTTCGTPAYVAPEVINKR 186
HRDL+ N+L+ E KI+DFGL+ L E T ++G + APE IN
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPI----KWTAPEAIN-Y 177
Query: 187 GYDGAKADIWSCGVVLF-VLLAGNLPFYDSNLMELYKKITRA-EFKCPNWFPPEVRKLLS 244
G K+D+WS G++L ++ G +P+ E+ + + R P+ P E+ +L+
Sbjct: 178 GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMR 237
Query: 245 RILDPNPSTRVT 256
P R T
Sbjct: 238 LCWKEKPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 5e-18
Identities = 72/300 (24%), Positives = 124/300 (41%), Gaps = 59/300 (19%)
Query: 13 ELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVD---KEKIRRVGLIDQIKREISVMRLVRH 69
ELG G G KV H +G +A K++ K IR +QI RE+ V+
Sbjct: 8 ELGAGNG-GVVTKVLH---RPSGLIMARKLIHLEIKPAIR-----NQIIRELKVLHECNS 58
Query: 70 PNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHS 127
P IV Y S +I ME++ GG L ++V K G++ E + K ++ + +
Sbjct: 59 PYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPENILGKISIAVLRGLTYLRE 117
Query: 128 -RGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKR 186
+ HRD+KP N+L++ G++K+ DFG+S D + ++ GT +Y++PE +
Sbjct: 118 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG----QLIDSMANSFVGTRSYMSPERLQGT 173
Query: 187 GYDGAKADIWSCGVVLFVLLAGNLPF-------------YDSNLMELYKKITRAEFKCPN 233
Y ++DIWS G+ L + G P + E + P+
Sbjct: 174 HY-TVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPD 232
Query: 234 -------------------------WFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRK 268
F E + + + L NP R + +L ++ + ++
Sbjct: 233 SPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 7e-18
Identities = 56/181 (30%), Positives = 88/181 (48%), Gaps = 23/181 (12%)
Query: 60 EISVMRLVR-HPNIVQLYEVMASKTKIYFAMEYVRGGELFNKV-AKGKLREEVARKYFQQ 117
E V +L++ +PN ++LY + + M+Y++ G+LF+ + +GKL E +K +Q
Sbjct: 58 EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQ 117
Query: 118 LVDAVEFCHSRGVYHRDLKPENLLLDENGD-LKISDFGLSAL--QESTRQDGLLHTTCGT 174
LV+A+ H + H D+K EN+L D D + + D+GL + S D GT
Sbjct: 118 LVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSC-YD-------GT 169
Query: 175 PAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMEL---------YKKIT 225
Y +PE I YD D W+ GV+ + LL G PF + EL KK+
Sbjct: 170 LDYFSPEKIKGHNYD-VSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLP 228
Query: 226 R 226
Sbjct: 229 F 229
|
Length = 267 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 9e-18
Identities = 67/249 (26%), Positives = 117/249 (46%), Gaps = 15/249 (6%)
Query: 16 RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQL 75
R+LG+G F +V + TG+ A K ++K++I++ E ++ V +V L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL 65
Query: 76 YEVMASKTKIYFAMEYVRGGEL----FNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVY 131
+K + + + GG+L +N G E+ A Y +L +E +
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG-FDEQRAIFYAAELCCGLEDLQRERIV 124
Query: 132 HRDLKPENLLLDENGDLKISDFGLSA-LQESTRQDGLLHTTCGTPAYVAPEVINKRGYDG 190
+RDLKPEN+LLD+ G ++ISD GL+ + E G + GT Y+APEVIN Y
Sbjct: 125 YRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV----GTVGYMAPEVINNEKYTF 180
Query: 191 AKADIWSCGVVLFVLLAGNLPFYDSNLM----ELYKKITRAEFKCPNWFPPEVRKLLSRI 246
+ D W G +++ ++ G PF E+ +++ + + F + + + +
Sbjct: 181 S-PDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRML 239
Query: 247 LDPNPSTRV 255
L NP R+
Sbjct: 240 LTKNPKERL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 1e-17
Identities = 61/229 (26%), Positives = 106/229 (46%), Gaps = 15/229 (6%)
Query: 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQS----VAIKIVDKEKIRRVGLIDQIKREISVM 64
+ E ++LG G F VY G + G+ VAIK++ +E + +I E VM
Sbjct: 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKA--NKEILDEAYVM 63
Query: 65 RLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVA--KGKLREEVARKYFQQLVDAV 122
V HP++V+L + S + + + G L + V K + + + Q+ +
Sbjct: 64 ASVDHPHVVRLLGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGM 122
Query: 123 EFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCG-TP-AYVAP 180
+ + + HRDL N+L+ +KI+DFGL+ L + + H G P ++A
Sbjct: 123 SYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD--VDEKEYHAEGGKVPIKWMAL 180
Query: 181 EVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAE 228
E I R Y K+D+WS GV ++ L+ G P+ +E+ + + E
Sbjct: 181 ESILHRIYT-HKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGE 228
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 2e-17
Identities = 58/205 (28%), Positives = 103/205 (50%), Gaps = 9/205 (4%)
Query: 18 LGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYE 77
LG G V+ + +G +A K++ E + + +QI RE+ V+ P IV Y
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYG 70
Query: 78 VMASKTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSR-GVYHRDL 135
S +I ME++ GG L + K G++ E++ K ++ + + + + HRD+
Sbjct: 71 AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDV 130
Query: 136 KPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADI 195
KP N+L++ G++K+ DFG+S D + ++ GT +Y++PE + Y ++DI
Sbjct: 131 KPSNILVNSRGEIKLCDFGVSG----QLIDSMANSFVGTRSYMSPERLQGTHYS-VQSDI 185
Query: 196 WSCGVVLFVLLAGNLPFYDSNLMEL 220
WS G+ L + G P + EL
Sbjct: 186 WSMGLSLVEMAIGRYPIPPPDAKEL 210
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 2e-17
Identities = 80/255 (31%), Positives = 112/255 (43%), Gaps = 21/255 (8%)
Query: 18 LGQGTFAKVYHGRNL-KTGQS--VAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQ 74
LG G F V G L K+G+ VA+K + +E I + RE SVM + HP IV+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHI--AAGKKEFLREASVMAQLDHPCIVR 60
Query: 75 LYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEF----CHSRGV 130
L V + + ME G L K K R E+ ++L V S+
Sbjct: 61 LIGVCKGEP-LMLVMELAPLGPL-LKYLKK--RREIPVSDLKELAHQVAMGMAYLESKHF 116
Query: 131 YHRDLKPENLLLDENGDLKISDFGLS-ALQESTRQDGLLHTTCGT-P-AYVAPEVINKRG 187
HRDL N+LL KISDFG+S AL D TT G P + APE IN
Sbjct: 117 VHRDLAARNVLLVNRHQAKISDFGMSRAL--GAGSDYYRATTAGRWPLKWYAPECINYGK 174
Query: 188 YDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAE-FKCPNWFPPEVRKLLSR 245
+ +K+D+WS GV L+ + G P+ + E+ + E P P E+ ++
Sbjct: 175 FS-SKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLS 233
Query: 246 ILDPNPSTRVTMAKL 260
P R T ++L
Sbjct: 234 CWKYRPEDRPTFSEL 248
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 68/229 (29%), Positives = 108/229 (47%), Gaps = 23/229 (10%)
Query: 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRR----VGLIDQIKREISV 63
++ +Y+ + +G G V + TGQ+VAIK K+ R V + RE+ +
Sbjct: 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIK-----KLSRPFQNVTHAKRAYRELVL 68
Query: 64 MRLVRHPNIVQLYEVMASKTK------IYFAMEYVRGGELFNKVAKGKLREEVARKYFQQ 117
M+LV H NI+ L V + +Y ME + +V + L E Q
Sbjct: 69 MKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIQMDLDHERMSYLLYQ 126
Query: 118 LVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTT-CGTPA 176
++ ++ HS G+ HRDLKP N+++ + LKI DFGL+ T + T T
Sbjct: 127 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA----RTAGTSFMMTPYVVTRY 182
Query: 177 YVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKIT 225
Y APEVI GY DIWS G ++ ++ G + F ++ ++ + KI
Sbjct: 183 YRAPEVILGMGYK-ENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKII 230
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 3e-17
Identities = 75/268 (27%), Positives = 122/268 (45%), Gaps = 32/268 (11%)
Query: 13 ELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNI 72
+L + LG G F +V+ G VA+K + + ++ E +M+ +RH +
Sbjct: 9 QLIKKLGNGQFGEVWMG-TWNGNTKVAVKTLKPGTMSPESFLE----EAQIMKKLRHDKL 63
Query: 73 VQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVD-------AVEFC 125
VQLY V+ S+ IY EY+ G L + + G+ R A K LVD + +
Sbjct: 64 VQLYAVV-SEEPIYIVTEYMSKGSLLDFLKDGEGR---ALK-LPNLVDMAAQVAAGMAYI 118
Query: 126 HSRGVYHRDLKPENLLLDENGDLKISDFGLSALQE----STRQDGLLHTTCGTPAYVAPE 181
HRDL+ N+L+ + KI+DFGL+ L E + RQ + APE
Sbjct: 119 ERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIK-----WTAPE 173
Query: 182 VINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EFKCPNWFPPEV 239
G K+D+WS G++L L+ G +P+ N E+ +++ R CP P +
Sbjct: 174 AA-LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISL 232
Query: 240 RKLLSRILDPNPSTRVTMAKL---MENY 264
+L+ + +P R T L +E+Y
Sbjct: 233 HELMLQCWKKDPEERPTFEYLQSFLEDY 260
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 5e-17
Identities = 59/205 (28%), Positives = 102/205 (49%), Gaps = 9/205 (4%)
Query: 18 LGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYE 77
LG G V ++ +G +A K++ E + + +QI RE+ V+ P IV Y
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYG 70
Query: 78 VMASKTKIYFAMEYVRGGELFNKVAKGK-LREEVARKYFQQLVDAVEFCHSR-GVYHRDL 135
S +I ME++ GG L + + K + EE+ K ++ + + + + HRD+
Sbjct: 71 AFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDV 130
Query: 136 KPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADI 195
KP N+L++ G++K+ DFG+S D + ++ GT +Y++PE + Y ++DI
Sbjct: 131 KPSNILVNSRGEIKLCDFGVSG----QLIDSMANSFVGTRSYMSPERLQGTHYS-VQSDI 185
Query: 196 WSCGVVLFVLLAGNLPFYDSNLMEL 220
WS G+ L L G P + EL
Sbjct: 186 WSMGLSLVELAIGRYPIPPPDAKEL 210
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 5e-17
Identities = 76/280 (27%), Positives = 129/280 (46%), Gaps = 34/280 (12%)
Query: 11 KYELGRLLGQGTFAKVYHGR-----NLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMR 65
+ LG+ LG+G F +V N +VA+K++ K+ L D + E+ +M+
Sbjct: 13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKML-KDDATEKDLSDLVS-EMEMMK 70
Query: 66 LV-RHPNIVQLYEVMASKTKIYFAMEYVRGG-------------ELFNKVAKGKLREEVA 111
++ +H NI+ L V + +Y +EY G E + E +
Sbjct: 71 MIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLT 130
Query: 112 RK----YFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGL 167
+K + Q+ +EF S+ HRDL N+L+ E+ +KI+DFGL+ ++ D
Sbjct: 131 QKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLA--RDIHHIDYY 188
Query: 168 LHTTCG-TPA-YVAPEVINKRGYDGAKADIWSCGVVLF--VLLAGNLPFYDSNLMELYKK 223
TT G P ++APE + R Y ++D+WS GV+L+ L G+ P+ + EL+K
Sbjct: 189 RKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGS-PYPGIPVEELFKL 246
Query: 224 ITRAE-FKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262
+ + P E+ L+ PS R T +L+E
Sbjct: 247 LKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVE 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 9e-17
Identities = 72/239 (30%), Positives = 109/239 (45%), Gaps = 35/239 (14%)
Query: 16 RLLGQGTFAKVYHGRNLKTGQ---SVAIKIVD---KEKIRRVGLIDQIKREISVMRLVRH 69
+++G G F +V GR G+ VAIK + EK RR L E S+M H
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFL-----SEASIMGQFDH 64
Query: 70 PNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLV-------DAV 122
PNI+ L V+ + EY+ G L LR+ + QLV +
Sbjct: 65 PNIIHLEGVVTKSKPVMIVTEYMENGSL-----DAFLRKHDGQFTVIQLVGMLRGIASGM 119
Query: 123 EFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPA---YVA 179
++ G HRDL N+L++ N K+SDFGLS + E + +TT G + A
Sbjct: 120 KYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA--YTTRGGKIPIRWTA 177
Query: 180 PEVINKRGYDGAKADIWSCGVVLF-VLLAGNLPFYDSNLMELYKKITR-----AEFKCP 232
PE I R + A +D+WS G+V++ V+ G P+++ + ++ K I A CP
Sbjct: 178 PEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCP 235
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 1e-16
Identities = 67/218 (30%), Positives = 109/218 (50%), Gaps = 33/218 (15%)
Query: 13 ELGRLLGQGTFAKVYHGRNLKTGQSVAIK----IVDKEKIRRVGLIDQIKREI-SVMRLV 67
+LG +G+G F V + +G +A+K VD+++ +R + ++ VMR
Sbjct: 8 DLG-EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKR------LLMDLDVVMRSS 60
Query: 68 RHPNIVQLYEVMASKTKIYFAMEYVRGG-ELFNKVAKGKLR----EEVARKYFQQLVDAV 122
P IV+ Y + + + ME + + F K L+ EE+ K V A+
Sbjct: 61 DCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKAL 120
Query: 123 EFCHSR-GVYHRDLKPENLLLDENGDLKISDFGLSA-LQES---TRQDGLLHTTCGTPAY 177
+ + HRD+KP N+LLD NG++K+ DFG+S L +S TR G C P Y
Sbjct: 121 NYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAG-----C-RP-Y 173
Query: 178 VAPEVIN---KRGYDGAKADIWSCGVVLFVLLAGNLPF 212
+APE I+ + GYD ++D+WS G+ L+ + G P+
Sbjct: 174 MAPERIDPSARDGYD-VRSDVWSLGITLYEVATGKFPY 210
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 2e-16
Identities = 78/260 (30%), Positives = 117/260 (45%), Gaps = 24/260 (9%)
Query: 18 LGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYE 77
LGQG F +V+ G T + VAIK + + + +E VM+ +RH +VQLY
Sbjct: 14 LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFL----QEAQVMKKLRHEKLVQLYA 68
Query: 78 VMASKTKIYFAMEYVRGGEL--FNKVAKGK-LREEVARKYFQQLVDAVEFCHSRGVYHRD 134
V+ S+ IY EY+ G L F K GK LR Q+ + + HRD
Sbjct: 69 VV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 127
Query: 135 LKPENLLLDENGDLKISDFGLSALQE----STRQDGLLHTTCGTPAYVAPEVINKRGYDG 190
L+ N+L+ EN K++DFGL+ L E + RQ + APE G
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-----WTAPEAA-LYGRFT 181
Query: 191 AKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EFKCPNWFPPEVRKLLSRILD 248
K+D+WS G++L L G +P+ E+ ++ R CP P + L+ +
Sbjct: 182 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWR 241
Query: 249 PNPSTRVTMAKL---MENYW 265
P R T L +E+Y+
Sbjct: 242 KEPEERPTFEYLQAFLEDYF 261
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 3e-16
Identities = 73/261 (27%), Positives = 120/261 (45%), Gaps = 28/261 (10%)
Query: 18 LGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYE 77
LGQG F +V+ G T + VAIK + + + E +M+ +RH +V LY
Sbjct: 14 LGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEAFLQ----EAQIMKKLRHDKLVPLYA 68
Query: 78 VMASKTKIYFAMEYVRGGELFNKVAKG-----KLREEVARKYFQQLVDAVEFCHSRGVYH 132
V+ S+ IY E++ G L + + +G KL + V Q+ D + + H
Sbjct: 69 VV-SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMA--AQIADGMAYIERMNYIH 125
Query: 133 RDLKPENLLLDENGDLKISDFGLSALQE----STRQDGLLHTTCGTPAYVAPEVINKRGY 188
RDL+ N+L+ +N KI+DFGL+ L E + RQ + APE G
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIK-----WTAPEAA-LYGR 179
Query: 189 DGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EFKCPNWFPPEVRKLLSRI 246
K+D+WS G++L L+ G +P+ E+ +++ R CP P + +L+
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLC 239
Query: 247 LDPNPSTRVT---MAKLMENY 264
+P R T + +E+Y
Sbjct: 240 WKKDPDERPTFEYIQSFLEDY 260
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 4e-16
Identities = 58/261 (22%), Positives = 115/261 (44%), Gaps = 22/261 (8%)
Query: 12 YELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPN 71
+G+ V+ ++ T VA+K ++ + + L +++EI R ++HPN
Sbjct: 4 TLIGKCFEDLMI--VHLAKHKPTNTLVAVKKINLDSCSKEDLK-LLQQEIITSRQLQHPN 60
Query: 72 IVQLYEVMASKTKIYFAMEYVRGG---ELFNKVAKGKLREEVARKYFQQLVDAVEFCHSR 128
I+ +++Y + G +L L E + +++A+++ HS+
Sbjct: 61 ILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK 120
Query: 129 GVYHRDLKPENLLLDENGDLKISDF--GLSALQESTRQ----DGLLHTTCGTPAYVAPEV 182
G HR +K ++LL +G + +S +S ++ RQ D + P +++PEV
Sbjct: 121 GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLP-WLSPEV 179
Query: 183 I--NKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCP---NWFPP 237
+ N +GY+ K+DI+S G+ L G++PF D ++ + R C + +P
Sbjct: 180 LQQNLQGYN-EKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPL 238
Query: 238 ---EVRKLLSRILDPNPSTRV 255
+ + S PN V
Sbjct: 239 YEDSMSQSRSSNEHPNNRDSV 259
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 6e-16
Identities = 76/320 (23%), Positives = 135/320 (42%), Gaps = 55/320 (17%)
Query: 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV 67
++ +Y+ + +G G V + G +VA+K + + + + RE+ +++ V
Sbjct: 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSR-PFQNQTHAKRAYRELVLLKCV 77
Query: 68 RHPNIVQLYEVMASKTK------IYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDA 121
H NI+ L V + +Y ME + +V +L E Q++
Sbjct: 78 NHKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIHMELDHERMSYLLYQMLCG 135
Query: 122 VEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPE 181
++ HS G+ HRDLKP N+++ + LKI DFGL+ + + ++ T Y APE
Sbjct: 136 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTACTNFMMTPYVVTRYYRAPE 192
Query: 182 VINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITR------AEFKC---- 231
VI GY DIWS G ++ L+ G++ F ++ ++ + K+ AEF
Sbjct: 193 VILGMGYK-ENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP 251
Query: 232 ---------------------PNW-FPPE----------VRKLLSRILDPNPSTRVTMAK 259
P+W FP E R LLS++L +P R+++ +
Sbjct: 252 TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDE 311
Query: 260 LMENYWFRKGYKKIETPESP 279
+ + + Y E P
Sbjct: 312 ALRHPYITVWYDPAEAEAPP 331
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 8e-16
Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 23/213 (10%)
Query: 13 ELGRLLGQGTFAKVYHGRNLKTGQSVAIKIV-----DKEKIRRVGLIDQIKREISVMRLV 67
E R +G G F V+ + + G+ VA+K + + +RV RE+ ++
Sbjct: 3 EPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRV------FRELKMLCFF 56
Query: 68 RHPNIVQLYEVMASKTKIYFAMEYVRGGELFNK------VAKGKLREEVARKYFQQLVDA 121
+H N++ +++ F YV EL V+ L + + + Q++
Sbjct: 57 KHDNVLSALDILQPPHIDPFEEIYVVT-ELMQSDLHKIIVSPQPLSSDHVKVFLYQILRG 115
Query: 122 VEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTT--CGTPAYVA 179
+++ HS G+ HRD+KP NLL++ N LKI DFGL+ ++E D H T T Y A
Sbjct: 116 LKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEE---PDESKHMTQEVVTQYYRA 172
Query: 180 PEVINKRGYDGAKADIWSCGVVLFVLLAGNLPF 212
PE++ + + DIWS G + LL + F
Sbjct: 173 PEILMGSRHYTSAVDIWSVGCIFAELLGRRILF 205
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 69/263 (26%), Positives = 114/263 (43%), Gaps = 31/263 (11%)
Query: 18 LGQGTFAKVYHGR----NLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIV 73
LG+ F K+Y G + Q VAIK + + I + ++E S+M + HPNIV
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTL--KDINNPQQWGEFQQEASLMAELHHPNIV 70
Query: 74 QLYEVMASKTKIYFAMEYVRGGELFNKV--------------AKGKLREEVARKYFQ--- 116
L V+ + + EY+ G+L + G ++ + F
Sbjct: 71 CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130
Query: 117 -QLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTP 175
Q+ +E+ S H+DL N+L+ E +KISD GLS S + +
Sbjct: 131 IQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPI 190
Query: 176 AYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNL-PFY---DSNLMELYKKITRAEFKC 231
++ PE I + + +DIWS GVVL+ + + L P+Y + ++E+ +K R C
Sbjct: 191 RWMPPEAIMYGKFS-SDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK--RQLLPC 247
Query: 232 PNWFPPEVRKLLSRILDPNPSTR 254
PP + L++ PS R
Sbjct: 248 SEDCPPRMYSLMTECWQEGPSRR 270
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 1e-15
Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 20/211 (9%)
Query: 17 LLGQGTFAKVYHGRNLKTGQS---VAIKIVDKEKIRRVGLIDQIKR----EISVMRLVRH 69
++G G F +V GR G+ VAIK + + G ++ +R E S+M H
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTL------KSGYTEKQRRDFLSEASIMGQFDH 64
Query: 70 PNIVQLYEVMASKTKIYFAMEYVRGGEL--FNKVAKGKLREEVARKYFQQLVDAVEFCHS 127
PNI+ L V+ + E++ G L F + G+ + + +++
Sbjct: 65 PNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE 124
Query: 128 RGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPA---YVAPEVIN 184
HRDL N+L++ N K+SDFGLS E D ++ G + APE I
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIA 184
Query: 185 KRGYDGAKADIWSCGVVLF-VLLAGNLPFYD 214
R + A +D+WS G+V++ V+ G P++D
Sbjct: 185 YRKFTSA-SDVWSYGIVMWEVMSYGERPYWD 214
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 73/261 (27%), Positives = 119/261 (45%), Gaps = 18/261 (6%)
Query: 18 LGQGTFAKVYHG--RNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQL 75
LG G F V G + K+ ++VA+KI+ + L D++ RE +VM+ + +P IV++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRM 61
Query: 76 YEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAV----EFCHSRGVY 131
+ +++ + ME G L + K K V K +LV V ++
Sbjct: 62 IGICEAESWM-LVMELAELGPLNKFLQKNK---HVTEKNITELVHQVSMGMKYLEETNFV 117
Query: 132 HRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPA-YVAPEVINKRGYDG 190
HRDL N+LL KISDFGLS + T P + APE +N +
Sbjct: 118 HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS- 176
Query: 191 AKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAE-FKCPNWFPPEVRKLLSRILD 248
+K+D+WS GV+++ + G P+ E+ + I E +CP PPE+ L+
Sbjct: 177 SKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWT 236
Query: 249 PNPSTRVTMAKL---MENYWF 266
R A + + NY++
Sbjct: 237 YGVDERPGFAVVELRLRNYYY 257
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 5e-15
Identities = 74/282 (26%), Positives = 128/282 (45%), Gaps = 37/282 (13%)
Query: 12 YELGRLLGQGTFAKVYHGRNLK----TGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV 67
+ LGR+LG+G F V + LK + Q VA+K++ K I I++ RE + M+
Sbjct: 1 FTLGRMLGKGEFGSVREAQ-LKSEDGSFQKVAVKML-KADIFSSSDIEEFLREAACMKEF 58
Query: 68 RHPNIVQLYEV-MASKTKIYFA-----MEYVRGGELFNKVAKGKLREEVARKYFQQLVD- 120
HPN+++L V + S+ K + +++ G+L + ++ EE Q LV
Sbjct: 59 DHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRF 118
Query: 121 ------AVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQEST---RQDGLLHTT 171
+E+ S+ HRDL N +L+EN + ++DFGLS S RQ
Sbjct: 119 MIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQG------ 172
Query: 172 CGTP---AYVAPEVINKRGYDGAKADIWSCGVVLF-VLLAGNLPFYDSNLMELYKKITRA 227
C + ++A E + Y +D+W+ GV ++ ++ G P+ E+Y + +
Sbjct: 173 CASKLPVKWLALESLADNVYT-THSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG 231
Query: 228 E-FKCPNWFPPEVRKLLSRILDPNPSTRVTMAKL---MENYW 265
K P +V +L+ + P P R + L +E W
Sbjct: 232 NRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELIW 273
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 9e-15
Identities = 64/222 (28%), Positives = 108/222 (48%), Gaps = 26/222 (11%)
Query: 11 KYELGRLLGQGTFAKVYHGR--NLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR 68
+YE G +G+GT+ VY + + K + A+K +I G+ REI+++R ++
Sbjct: 3 EYE-GCKVGRGTYGHVYKAKRKDGKDEKEYALK-----QIEGTGISMSACREIALLRELK 56
Query: 69 HPNIVQLYEVMASKT--KIYFAMEYVRGGEL----FNKVAKG-----KLREEVARKYFQQ 117
HPN++ L +V S + K++ +Y F++ +K +L + + Q
Sbjct: 57 HPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQ 116
Query: 118 LVDAVEFCHSRGVYHRDLKPENLLL----DENGDLKISDFGLSALQESTRQD-GLLHTTC 172
++D + + H+ V HRDLKP N+L+ E G +KI+D G + L S + L
Sbjct: 117 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 173 GTPAYVAPE-VINKRGYDGAKADIWSCGVVLFVLLAGNLPFY 213
T Y APE ++ R Y A DIW+ G + LL F+
Sbjct: 177 VTFWYRAPELLLGARHYTKA-IDIWAIGCIFAELLTSEPIFH 217
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 64/236 (27%), Positives = 103/236 (43%), Gaps = 25/236 (10%)
Query: 59 REISVMRLVRHPNIVQLYEVMASKTK------IYFAMEYVRGGELFNKVAKGKLREEVAR 112
RE+ +M+ V H NI+ L V + +Y ME + +V + +L E
Sbjct: 72 RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMS 129
Query: 113 KYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTC 172
Q++ ++ HS G+ HRDLKP N+++ + LKI DFGL+ + ++
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYV 186
Query: 173 GTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKK-ITRAEFKC 231
T Y APEVI GY DIWS G ++ ++ G + F ++ ++ + K I + C
Sbjct: 187 VTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 245
Query: 232 PNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIETPESPRGQDRNKL 287
P + + L P T V Y F K + + P + NKL
Sbjct: 246 PEFM---------KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPAD---SEHNKL 289
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-14
Identities = 56/207 (27%), Positives = 102/207 (49%), Gaps = 17/207 (8%)
Query: 13 ELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNI 72
+L + LG G F +V+ G VA+K + + + E ++M+ ++H +
Sbjct: 9 KLVKKLGAGQFGEVWMGY-YNNSTKVAVKTLKPGTMS----VQAFLEEANLMKTLQHDKL 63
Query: 73 VQLYEVMASKTKIYFAMEYVRGGELFNKV---AKGKLREEVARKYFQQLVDAVEFCHSRG 129
V+LY V+ + IY EY+ G L + + GK+ + Q+ + + + +
Sbjct: 64 VRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN 123
Query: 130 VYHRDLKPENLLLDENGDLKISDFGLSAL---QESTRQDGLLHTTCGTPAYVAPEVINKR 186
HRDL+ N+L+ E+ KI+DFGL+ + E T ++G + APE IN
Sbjct: 124 YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPI----KWTAPEAIN-F 178
Query: 187 GYDGAKADIWSCGVVLF-VLLAGNLPF 212
G K+D+WS G++L+ ++ G +P+
Sbjct: 179 GSFTIKSDVWSFGILLYEIVTYGKIPY 205
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-14
Identities = 69/236 (29%), Positives = 110/236 (46%), Gaps = 15/236 (6%)
Query: 18 LGQGTFAKVYHG--RNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQL 75
LG G F V G + K VAIK++ E + V D++ RE +M + +P IV++
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVR--DEMMREAEIMHQLDNPYIVRM 60
Query: 76 YEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAV----EFCHSRGVY 131
V ++ + ME GG L NK GK ++E+ +L+ V ++ +
Sbjct: 61 IGVCEAEA-LMLVMEMASGGPL-NKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGKNFV 117
Query: 132 HRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTP-AYVAPEVINKRGYDG 190
HRDL N+LL KISDFGLS + + P + APE IN R +
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS- 176
Query: 191 AKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAE-FKCPNWFPPEVRKLLS 244
+++D+WS G+ ++ + G P+ E+ I + + CP PPE+ L+
Sbjct: 177 SRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMK 232
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-14
Identities = 65/229 (28%), Positives = 107/229 (46%), Gaps = 21/229 (9%)
Query: 16 RLLGQGTFAKVYHGRNLKTGQS---VAIKIVD---KEKIRRVGLIDQIKREISVMRLVRH 69
+++G G F +V+ G G+ VAIK + EK R+ L E S+M H
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFL-----SEASIMGQFSH 65
Query: 70 PNIVQLYEVMASKTKIYFAMEYVRGGEL--FNKVAKGKLREEVARKYFQQLVDAVEFCHS 127
NI++L V+ EY+ G L + + G+ + + +++
Sbjct: 66 HNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD 125
Query: 128 RGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPA---YVAPEVIN 184
HRDL N+L++ N + K+SDFGLS + E + +TT G + APE I
Sbjct: 126 MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEG--TYTTSGGKIPIRWTAPEAIA 183
Query: 185 KRGYDGAKADIWSCGVVLF-VLLAGNLPFYDSNLMELYKKITRAEFKCP 232
R + A +D+WS G+V++ V+ G P++D + E+ K I F+ P
Sbjct: 184 YRKFTSA-SDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDG-FRLP 230
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 2e-14
Identities = 73/260 (28%), Positives = 113/260 (43%), Gaps = 21/260 (8%)
Query: 14 LGRLLGQGTFAKVYHGR--NLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPN 71
L R LG+G F KV+ NL Q + V K RE ++ ++H +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68
Query: 72 IVQLYEVMASKTKIYFAMEYVRGGELFNK-----------VAKGKLREEVARKYF----Q 116
IV+ Y V + EY++ G+L NK +A+G E+ + Q
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHGDL-NKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 117 QLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPA 176
Q+ + + S+ HRDL N L+ EN +KI DFG+S ST + T
Sbjct: 128 QIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 187
Query: 177 YVAPEVINKRGYDGAKADIWSCGVVLF-VLLAGNLPFYDSNLMELYKKITRAE-FKCPNW 234
++ PE I R + ++D+WS GVVL+ + G P+Y + E+ + IT+ + P
Sbjct: 188 WMPPESIMYRKFT-TESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRT 246
Query: 235 FPPEVRKLLSRILDPNPSTR 254
P EV L+ P R
Sbjct: 247 CPKEVYDLMLGCWQREPHMR 266
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 3e-14
Identities = 74/331 (22%), Positives = 137/331 (41%), Gaps = 56/331 (16%)
Query: 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV 67
++ +Y+ + +G G V + ++VAIK + + + + RE+ +M+ V
Sbjct: 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCV 73
Query: 68 RHPNIVQLYEVMASKTK------IYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDA 121
H NI+ L V + +Y ME + +V + +L E Q++
Sbjct: 74 NHKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLCG 131
Query: 122 VEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPE 181
++ HS G+ HRDLKP N+++ + LKI DFGL+ + ++ T Y APE
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVVTRYYRAPE 188
Query: 182 VINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITR--------------- 226
VI GY DIWS G ++ ++ + F + ++ + K+
Sbjct: 189 VILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247
Query: 227 ------------AEFKCPNWFP---------------PEVRKLLSRILDPNPSTRVTMAK 259
A P FP + R LLS++L +P+ R+++ +
Sbjct: 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDE 307
Query: 260 LMENYWFRKGYKKIETPESPRGQDRNKLISD 290
+++ + Y E E+P Q +K + +
Sbjct: 308 ALQHPYINVWYDPAEV-EAPPPQIYDKQLDE 337
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 4e-14
Identities = 64/222 (28%), Positives = 107/222 (48%), Gaps = 26/222 (11%)
Query: 11 KYELGRLLGQGTFAKVYHGR--NLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR 68
+YE G +G+GT+ VY + + K + A+K +I G+ REI+++R ++
Sbjct: 3 EYE-GCKVGRGTYGHVYKAKRKDGKDDRDYALK-----QIEGTGISMSACREIALLRELK 56
Query: 69 HPNIVQLYEVMASKT--KIYFAMEYVRGGEL----FNKVAKG-----KLREEVARKYFQQ 117
HPN++ L +V S K++ +Y F++ +K +L + + Q
Sbjct: 57 HPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 116
Query: 118 LVDAVEFCHSRGVYHRDLKPENLLL----DENGDLKISDFGLSALQESTRQD-GLLHTTC 172
++D + + H+ V HRDLKP N+L+ E G +KI+D G + L S + L
Sbjct: 117 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 173 GTPAYVAPE-VINKRGYDGAKADIWSCGVVLFVLLAGNLPFY 213
T Y APE ++ R Y A DIW+ G + LL F+
Sbjct: 177 VTFWYRAPELLLGARHYTKA-IDIWAIGCIFAELLTSEPIFH 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 4e-14
Identities = 76/289 (26%), Positives = 132/289 (45%), Gaps = 46/289 (15%)
Query: 10 NKYELGRLLGQGTFAKVYHGRNL-------KTGQSVAIKIVDKEKIRRVGLIDQIKREIS 62
+K LG+ LG+G F +V L K +VA+K++ K+ L D + E+
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVS-EME 72
Query: 63 VMRLV-RHPNIVQLYEVMASKTKIYFAMEYVRGGEL-----------------FNKVAKG 104
+M+++ +H NI+ L +Y +EY G L +V
Sbjct: 73 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDE 132
Query: 105 KL--REEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQEST 162
++ ++ V+ Y Q+ +E+ S+ HRDL N+L+ EN +KI+DFGL+ ++
Sbjct: 133 QMTFKDLVSCTY--QVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA--RDVN 188
Query: 163 RQDGLLHTTCGT-PA-YVAPEVINKRGYDGAKADIWSCGVVLF-VLLAGNLPFYDSNLME 219
D TT G P ++APE + R Y ++D+WS GV+++ + G P+ + E
Sbjct: 189 NIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 247
Query: 220 LYKKITRAE-----FKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMEN 263
L+K + C N E+ ++ PS R T +L+E+
Sbjct: 248 LFKLLKEGHRMDKPANCTN----ELYMMMRDCWHAIPSHRPTFKQLVED 292
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 4e-14
Identities = 74/287 (25%), Positives = 123/287 (42%), Gaps = 45/287 (15%)
Query: 11 KYELGRLLGQGTFAKV-----YHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMR 65
LG+ LG+G F KV + + +VA+K++ KE L D + E ++++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKML-KENASSSELRDLLS-EFNLLK 58
Query: 66 LVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFN------KVAKGKLREEVARK------ 113
V HP++++LY + + +EY + G L + KV L + R
Sbjct: 59 QVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDN 118
Query: 114 -------------YFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQE 160
+ Q+ +++ + HRDL N+L+ E +KISDFGLS ++
Sbjct: 119 PDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLS--RD 176
Query: 161 STRQDGLLHTTCG-TPA-YVAPEVINKRGYDGAKADIWSCGVVLF--VLLAGNLPF---Y 213
+D + + G P ++A E + Y ++D+WS GV+L+ V L GN P+
Sbjct: 177 VYEEDSYVKRSKGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGN-PYPGIA 234
Query: 214 DSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKL 260
L L K R E P E+ L+ P R T A +
Sbjct: 235 PERLFNLLKTGYRMER--PENCSEEMYNLMLTCWKQEPDKRPTFADI 279
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 5e-14
Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 23/211 (10%)
Query: 11 KYELGRLLGQGTFAKVY----HGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRL 66
+Y + L G+ +V+ HG + V +K V K REI +++
Sbjct: 93 QYNILSSLTPGSEGEVFVCTKHGDEQRK--KVIVKAVTGGK--------TPGREIDILKT 142
Query: 67 VRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKV-AKGKLREEVARKYFQQLVDAVEFC 125
+ H I+ L K+ + M + +LF V G L E A ++L++A+ +
Sbjct: 143 ISHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQRRLLEALAYL 201
Query: 126 HSRGVYHRDLKPENLLLDENGDLKISDFGLSA-LQES--TRQDGLLHTTCGTPAYVAPEV 182
H RG+ HRD+K EN+ LDE + + DFG + L T Q + GT +PE+
Sbjct: 202 HGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQC---YGWSGTLETNSPEL 258
Query: 183 INKRGYDGAKADIWSCGVVLFVLLAGNLPFY 213
+ Y AK DIWS G+VLF + N+ +
Sbjct: 259 LALDPY-CAKTDIWSAGLVLFEMSVKNVTLF 288
|
Length = 392 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 9e-14
Identities = 71/270 (26%), Positives = 123/270 (45%), Gaps = 36/270 (13%)
Query: 17 LLGQGTFAKVYHGRNLKTG--QSVAIKIVDK---EKIRRVGLIDQIKREISVM-RLVRHP 70
++G+G F +V K G + AIK++ + E R E+ V+ +L HP
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHR-----DFAGELEVLCKLGHHP 63
Query: 71 NIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREE--------------VARKYFQ 116
NI+ L ++ +Y A+EY G L + + K ++ E +++ Q
Sbjct: 64 NIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQ 123
Query: 117 QLVDA---VEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCG 173
D +++ + HRDL N+L+ EN KI+DFGLS +E + T
Sbjct: 124 FASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKK----TMGR 179
Query: 174 TPA-YVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EFK 230
P ++A E +N Y K+D+WS GV+L+ +++ G P+ ELY+K+ + +
Sbjct: 180 LPVRWMAIESLNYSVYT-TKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRME 238
Query: 231 CPNWFPPEVRKLLSRILDPNPSTRVTMAKL 260
P EV +L+ + P R A++
Sbjct: 239 KPRNCDDEVYELMRQCWRDRPYERPPFAQI 268
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 9e-14
Identities = 75/267 (28%), Positives = 121/267 (45%), Gaps = 30/267 (11%)
Query: 17 LLGQGTFAKVYHGRNLKTG--QSVAIKIVDKEKIRRVGLIDQIKREISVM-RLVRHPNIV 73
++G+G F +V R K G AIK + KE + D E+ V+ +L HPNI+
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRD-FAGELEVLCKLGHHPNII 59
Query: 74 QLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREE---VARKY-------FQQLV---- 119
L + +Y A+EY G L + + K ++ E A QQL+
Sbjct: 60 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119
Query: 120 ---DAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPA 176
+++ + HRDL N+L+ EN KI+DFGLS QE + T P
Sbjct: 120 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK----TMGRLPV 175
Query: 177 -YVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EFKCPN 233
++A E +N Y +D+WS GV+L+ +++ G P+ ELY+K+ + + P
Sbjct: 176 RWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL 234
Query: 234 WFPPEVRKLLSRILDPNPSTRVTMAKL 260
EV L+ + P R + A++
Sbjct: 235 NCDDEVYDLMRQCWREKPYERPSFAQI 261
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 1e-13
Identities = 78/287 (27%), Positives = 128/287 (44%), Gaps = 52/287 (18%)
Query: 14 LGRLLGQGTFAKVYHGR-------NLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRL 66
LG+ LG+G F +V +VA+K++ K+ L D I E+ +M+L
Sbjct: 16 LGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKML-KDNATDKDLADLIS-EMELMKL 73
Query: 67 V-RHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEV-ARK----------- 113
+ +H NI+ L V + +Y +EY AKG LRE + AR+
Sbjct: 74 IGKHKNIINLLGVCTQEGPLYVIVEYA---------AKGNLREFLRARRPPGPDYTFDIT 124
Query: 114 -------YFQQLVDAV-------EFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQ 159
F+ LV E+ SR HRDL N+L+ E+ +KI+DFGL+ +
Sbjct: 125 KVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLA--R 182
Query: 160 ESTRQDGLLHTTCG-TPA-YVAPEVINKRGYDGAKADIWSCGVVLF-VLLAGNLPFYDSN 216
D T+ G P ++APE + R Y ++D+WS G++++ + G P+
Sbjct: 183 GVHDIDYYKKTSNGRLPVKWMAPEALFDRVYT-HQSDVWSFGILMWEIFTLGGSPYPGIP 241
Query: 217 LMELYKKITRA-EFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262
+ EL+K + P+ E+ L+ P+ R T +L+E
Sbjct: 242 VEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 19/201 (9%)
Query: 17 LLGQGTFAKV----YHGRNLKTGQSVAIKIVD---KEKIRRVGLIDQIKREISVMRLVRH 69
LG+G F V Y TG+ VA+K + E +R +REI +++ ++H
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLR------DFEREIEILKSLQH 64
Query: 70 PNIVQLYEVM--ASKTKIYFAMEYVRGGELFNKVAKGKLREEVAR--KYFQQLVDAVEFC 125
NIV+ V A + + MEY+ G L + + K + R + + Y Q+ +E+
Sbjct: 65 DNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYL 124
Query: 126 HSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAY-VAPEVIN 184
S+ HRDL N+L++ +KI DFGL+ + ++ + +P + APE +
Sbjct: 125 GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLT 184
Query: 185 KRGYDGAKADIWSCGVVLFVL 205
+ + A +D+WS GVVL+ L
Sbjct: 185 ESKFSVA-SDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 63/263 (23%), Positives = 115/263 (43%), Gaps = 24/263 (9%)
Query: 17 LLGQGTFAKVYHGRNLKTGQS-----VAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPN 71
LG+G F +V+ + + V +K + K K + + +RE+ + R + H N
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQS--EFRRELDMFRKLSHKN 69
Query: 72 IVQLYEVMASKTKIYFAMEYVRGGEL--FNKVAKGKLREEVARKYFQQLVDAVEFCHSRG 129
+V+L + Y +EY G+L F + K K + + A+ + G
Sbjct: 70 VVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALG 129
Query: 130 V--------YHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPA-YVAP 180
+ HRDL N L+ ++K+S LS ++ + P ++AP
Sbjct: 130 MDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLS--KDVYNSEYYKLRNALIPLRWLAP 187
Query: 181 EVINKRGYDGAKADIWSCGVVLF-VLLAGNLPFYDSNLMELYKKIT--RAEFKCPNWFPP 237
E + + + K+D+WS GV+++ V G LPFY + E+ ++ + E P P
Sbjct: 188 EAVQEDDFS-TKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPS 246
Query: 238 EVRKLLSRILDPNPSTRVTMAKL 260
+ KL++R NP R + ++L
Sbjct: 247 RLYKLMTRCWAVNPKDRPSFSEL 269
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 3e-13
Identities = 52/190 (27%), Positives = 92/190 (48%), Gaps = 12/190 (6%)
Query: 56 QIKREISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREE------ 109
Q++ EI + + H NI+++ E++ S+ Y + +L++ + +
Sbjct: 209 QLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLK 267
Query: 110 VARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLH 169
R +QL+ AVE+ H + + HRD+K EN+ L+ +G + + DFG + E R+ +
Sbjct: 268 QTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKERE-AFDY 326
Query: 170 TTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNL-PFYDS--NLMELYKKITR 226
GT A +PE++ GY DIWSCG++L +L+ + P D + KI
Sbjct: 327 GWVGTVATNSPEILAGDGY-CEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIID 385
Query: 227 AEFKCPNWFP 236
+ C FP
Sbjct: 386 SLSVCDEEFP 395
|
Length = 501 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 3e-13
Identities = 63/257 (24%), Positives = 119/257 (46%), Gaps = 17/257 (6%)
Query: 16 RLLGQGTFAKVYHGRNLKT-GQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQ 74
R++G+G F VYHG + + GQ + + +I + ++Q +E +M+ HPN++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 75 LYEVMASKTKI-YFAMEYVRGGELFNKVAKGKLREEVAR--KYFQQLVDAVEFCHSRGVY 131
L + + Y++ G+L N + V + Q+ +E+ S+
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFV 120
Query: 132 HRDLKPENLLLDENGDLKISDFGLS-----ALQESTRQDGLLHTTCGTPA-YVAPEVINK 185
HRDL N +LDE+ +K++DFGL+ S HT P ++A E +
Sbjct: 121 HRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN----HTGAKLPVKWMALESLQT 176
Query: 186 RGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EFKCPNWFPPEVRKLL 243
+ + K+D+WS GV+L+ L+ G P+ D + ++ + + P + P + +++
Sbjct: 177 QKFT-TKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVM 235
Query: 244 SRILDPNPSTRVTMAKL 260
P P R T ++L
Sbjct: 236 LSCWHPKPEMRPTFSEL 252
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 3e-13
Identities = 71/263 (26%), Positives = 112/263 (42%), Gaps = 31/263 (11%)
Query: 18 LGQGTFAKVYHGRNLKTG-----QSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNI 72
LG+ F KVY G T Q+VAIK + K+K L ++ K E + ++HPNI
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL-KDKAE-GPLREEFKHEAMMRSRLQHPNI 70
Query: 73 VQLYEVMASKTKIYFAMEYVRGGELF-----------------NKVAKGKLREEVARKYF 115
V L V+ + + Y +L +K K L
Sbjct: 71 VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130
Query: 116 QQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTP 175
Q+ +EF S V H+DL N+L+ + ++KISD GL + L+ +
Sbjct: 131 TQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPI 190
Query: 176 AYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFY----DSNLMELYKKITRAEFKC 231
+++PE I G +DIWS GVVL+ + + L Y + +++E+ + R C
Sbjct: 191 RWMSPEAI-MYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR--NRQVLPC 247
Query: 232 PNWFPPEVRKLLSRILDPNPSTR 254
P+ P V L+ + PS R
Sbjct: 248 PDDCPAWVYTLMLECWNEFPSRR 270
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 4e-13
Identities = 69/267 (25%), Positives = 115/267 (43%), Gaps = 23/267 (8%)
Query: 10 NKYELGRLLGQGTFAKVYHGRNLKTGQS-----VAIKIVDKEKIR---RVGLIDQIKREI 61
N G+ LG G F KV +S VA+K++ K R L+ ++K
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKML-KPTAHSSEREALMSELK--- 90
Query: 62 SVM-RLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGK---LREEVARKYFQQ 117
+M L H NIV L I EY G+L N + + + L E + Q
Sbjct: 91 -IMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQ 149
Query: 118 LVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPA- 176
+ + F S+ HRDL N+LL +KI DFGL A + ++ P
Sbjct: 150 VAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGL-ARDIMNDSNYVVKGNARLPVK 208
Query: 177 YVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAEFKC--PN 233
++APE I Y ++D+WS G++L+ + + G+ P+ + + K+ + ++ P
Sbjct: 209 WMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPE 267
Query: 234 WFPPEVRKLLSRILDPNPSTRVTMAKL 260
P E+ ++ D +P R T ++
Sbjct: 268 HAPAEIYDIMKTCWDADPLKRPTFKQI 294
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 4e-13
Identities = 71/279 (25%), Positives = 111/279 (39%), Gaps = 33/279 (11%)
Query: 10 NKYELGRLLGQGTFAKVYHGR--NLKTGQS---VAIKIVDKEKIRRVGLIDQIKREISVM 64
N E R +GQG F +V+ R L + VA+K++ +E + +RE ++M
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALM 62
Query: 65 RLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFN-----------KVAKGKLREEVARK 113
HPNIV+L V A + EY+ G+L ++
Sbjct: 63 AEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGL 122
Query: 114 YFQQLVDAVEFCHSRGV------------YHRDLKPENLLLDENGDLKISDFGLSALQES 161
L + C ++ V HRDL N L+ EN +KI+DFGLS S
Sbjct: 123 NPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 182
Query: 162 TRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMEL 220
++ PE I Y ++D+W+ GVVL+ + + G P+Y E+
Sbjct: 183 ADYYKASENDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGMQPYYGMAHEEV 241
Query: 221 YKKITRAE-FKCPNWFPPEVRKLLSRILDPNPSTRVTMA 258
+ CP+ P E+ L+ PS R + A
Sbjct: 242 IYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFA 280
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 4e-13
Identities = 78/275 (28%), Positives = 122/275 (44%), Gaps = 50/275 (18%)
Query: 16 RLLGQGTFAKVYHGRNLK-----TG-QSVAIKIVDKEKIRRVGLIDQIK----REISVMR 65
LG G F +VY G +G VA+K + K G DQ K +E +M
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRK------GATDQEKKEFLKEAHLMS 54
Query: 66 LVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKY--FQQLVDAVE 123
HPNIV+L V Y ME + GG+L + + + V R L + ++
Sbjct: 55 NFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDAR----VERFGPPLLTLKELLD 110
Query: 124 FCH--SRG-VY-------HRDLKPENLLLDENGD-----LKISDFGLSA-LQES----TR 163
C ++G VY HRDL N L+ E G +KI DFGL+ + +S
Sbjct: 111 ICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKE 170
Query: 164 QDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLF-VLLAGNLPFYDSNLMELYK 222
+GLL ++APE + G ++D+WS GV+++ +L G P+ N E+ +
Sbjct: 171 GEGLLPVR-----WMAPESL-LDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQ 224
Query: 223 KITR-AEFKCPNWFPPEVRKLLSRILDPNPSTRVT 256
+T + P P ++ +L++ +PS R T
Sbjct: 225 HVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPT 259
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 5e-13
Identities = 74/263 (28%), Positives = 115/263 (43%), Gaps = 33/263 (12%)
Query: 18 LGQGTFAKVYHGR--NLKTGQS---VAIKIVDK--EKIRRVGLIDQIKREISVMRLVRHP 70
LG+G F KV+ NL Q VA+K + + E R+ +RE ++ +++H
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQ-----DFQREAELLTVLQHQ 67
Query: 71 NIVQLYEVMASKTKIYFAMEYVRGGELFNK-----------------VAKGKLREEVARK 113
+IV+ Y V + EY+R G+L N+ VA G+L
Sbjct: 68 HIVRFYGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKILAGGEDVAPGQLTLGQMLA 126
Query: 114 YFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCG 173
Q+ + + S HRDL N L+ + +KI DFG+S ST + T
Sbjct: 127 IASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 186
Query: 174 TPAYVAPEVINKRGYDGAKADIWSCGVVLF-VLLAGNLPFYDSNLMELYKKITRA-EFKC 231
++ PE I R + ++DIWS GVVL+ + G P+Y + E + IT+ E +
Sbjct: 187 PIRWMPPESILYRKFT-TESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELER 245
Query: 232 PNWFPPEVRKLLSRILDPNPSTR 254
P PPEV ++ P R
Sbjct: 246 PRTCPPEVYAIMQGCWQREPQQR 268
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 7e-13
Identities = 65/217 (29%), Positives = 104/217 (47%), Gaps = 37/217 (17%)
Query: 12 YELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIK-REISVMRLVRHP 70
Y+LG ++G G+F VY + T + VAIK V ++ Q K RE+ +M+ + H
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP--------QYKNRELLIMKNLNHI 119
Query: 71 NIVQLYE------VMASKTKIYF--AMEYVRGGELFNKVAKGKLREE------VARKYFQ 116
NI+ L + ++ I+ ME++ + +K K R + + Y
Sbjct: 120 NIIFLKDYYYTECFKKNEKNIFLNVVMEFIP--QTVHKYMKHYARNNHALPLFLVKLYSY 177
Query: 117 QLVDAVEFCHSRGVYHRDLKPENLLLDENG-DLKISDFG----LSALQESTRQDGLLHTT 171
QL A+ + HS+ + HRDLKP+NLL+D N LK+ DFG L A Q S +
Sbjct: 178 QLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRS------VSYI 231
Query: 172 CGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAG 208
C + Y APE++ D+WS G ++ ++ G
Sbjct: 232 C-SRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 8e-13
Identities = 71/271 (26%), Positives = 118/271 (43%), Gaps = 28/271 (10%)
Query: 14 LGRLLGQGTFAKVYHGRNLK----TGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRH 69
LG++LG+G F V G L + VA+K + K I I++ E + M+ H
Sbjct: 3 LGKILGEGEFGSVMEG-QLSQDDGSQLKVAVKTM-KLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 70 PNIVQLYEV---MASKTKIYFAM---EYVRGGELFNKVAKGKLREEVARKYFQQLVD--- 120
PN+++L V +S KI M +++ G+L + + +L + Q L+
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120
Query: 121 ----AVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQEST---RQDGLLHTTCG 173
+E+ +R HRDL N +L E+ + ++DFGLS S RQ
Sbjct: 121 DIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQG---RIAKM 177
Query: 174 TPAYVAPEVINKRGYDGAKADIWSCGVVLF-VLLAGNLPFYDSNLMELYKKITRAE-FKC 231
++A E + R Y +K+D+W+ GV ++ + G P+ E+Y + K
Sbjct: 178 PVKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQ 236
Query: 232 PNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262
P E+ L+ +P R T KL E
Sbjct: 237 PEDCLDELYDLMYSCWRADPKDRPTFTKLRE 267
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 71/273 (26%), Positives = 121/273 (44%), Gaps = 26/273 (9%)
Query: 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVM-RLVR 68
N + ++G+G F +V R K G + I ++ E+ V+ +L
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66
Query: 69 HPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREE-----VARKYF-----QQL 118
HPNI+ L + +Y A+EY G L + + K ++ E +A QQL
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 119 VD-------AVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTT 171
+ +++ + HRDL N+L+ EN KI+DFGLS QE + T
Sbjct: 127 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK----TM 182
Query: 172 CGTPA-YVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-E 228
P ++A E +N Y +D+WS GV+L+ +++ G P+ ELY+K+ +
Sbjct: 183 GRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 241
Query: 229 FKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLM 261
+ P EV L+ + P R + A+++
Sbjct: 242 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 274
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 3e-12
Identities = 68/278 (24%), Positives = 110/278 (39%), Gaps = 41/278 (14%)
Query: 13 ELGRLLGQGTFAKVYHG-----RNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV 67
L R LG G F +VY G VA+K + E D + E +M
Sbjct: 9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTL-PESCSEQDESDFLM-EALIMSKF 66
Query: 68 RHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREE-----VARKYFQQLVDAV 122
H NIV+L V + + +E + GG+L + + + + R E + D
Sbjct: 67 NHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVA 126
Query: 123 EFCH---SRGVYHRDLKPENLLLDENGD---LKISDFGLSALQESTRQDGLLHTTCGTPA 176
+ C HRD+ N LL G KI+DFG++ ++ R + G A
Sbjct: 127 KGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMA--RDIYRAS---YYRKGGRA 181
Query: 177 -----YVAPEVINKRGYDG---AKADIWSCGVVLF-VLLAGNLPF---YDSNLMELYKKI 224
++ PE DG +K D+WS GV+L+ + G +P+ + +ME
Sbjct: 182 MLPIKWMPPEAF----LDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG 237
Query: 225 TRAEFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262
R + P P V ++++ P R A ++E
Sbjct: 238 GRLDP--PKGCPGPVYRIMTDCWQHTPEDRPNFATILE 273
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 5e-12
Identities = 41/151 (27%), Positives = 79/151 (52%), Gaps = 9/151 (5%)
Query: 60 EISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQ 117
E +++ V HP+++++ + + S + + +L+ + K L + A +Q
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQ 165
Query: 118 LVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQD-GLLHTTCGTPA 176
+++ + + H++ + HRD+K EN+ +++ + I D G + GL GT
Sbjct: 166 ILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGL----AGTVE 221
Query: 177 YVAPEVINKRGYDGAKADIWSCGVVLFVLLA 207
APEV+ + Y+ +KADIWS G+VLF +LA
Sbjct: 222 TNAPEVLARDKYN-SKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 6e-12
Identities = 66/265 (24%), Positives = 129/265 (48%), Gaps = 26/265 (9%)
Query: 13 ELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNI 72
+L + LG G F +V+ K + VA+K + + + E +VM+ ++H +
Sbjct: 9 KLEKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAFLA----EANVMKTLQHDKL 63
Query: 73 VQLYEVMASKTKIYFAMEYVRGGEL--FNKVAKGKLREEVAR--KYFQQLVDAVEFCHSR 128
V+L+ V+ +K IY E++ G L F K +G ++ + + + Q+ + + F R
Sbjct: 64 VKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGS-KQPLPKLIDFSAQIAEGMAFIEQR 121
Query: 129 GVYHRDLKPENLLLDENGDLKISDFGLSAL---QESTRQDGLLHTTCGTPAYVAPEVINK 185
HRDL+ N+L+ + KI+DFGL+ + E T ++G + APE IN
Sbjct: 122 NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPI----KWTAPEAINF 177
Query: 186 RGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAEFKCP--NWFPPEVRKL 242
+ K+D+WS G++L ++ G +P+ + E+ + + R ++ P P E+ +
Sbjct: 178 GSFT-IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-YRMPRPENCPEELYNI 235
Query: 243 LSRILDPNPSTRVT---MAKLMENY 264
+ R P R T + +++++
Sbjct: 236 MMRCWKNRPEERPTFEYIQSVLDDF 260
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 6e-12
Identities = 71/281 (25%), Positives = 126/281 (44%), Gaps = 38/281 (13%)
Query: 14 LGRLLGQGTFAKVYHGRNLKTGQS-------VAIKIVDKEKIRRVGLIDQIKREISVMRL 66
LG+ LG+G F +V + + VA+K++ + + L D I E+ +M++
Sbjct: 22 LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEK-DLSDLIS-EMEMMKM 79
Query: 67 V-RHPNIVQLYEVMASKTKIYFAMEYVRGGEL-------------------FNKVAKGKL 106
+ +H NI+ L +Y +EY G L +
Sbjct: 80 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSF 139
Query: 107 REEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDG 166
++ V+ Y Q+ +E+ S+ HRDL N+L+ E+ +KI+DFGL+ ++ D
Sbjct: 140 KDLVSCAY--QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA--RDIHHIDY 195
Query: 167 LLHTTCGT-PA-YVAPEVINKRGYDGAKADIWSCGVVLF-VLLAGNLPFYDSNLMELYKK 223
TT G P ++APE + R Y ++D+WS GV+L+ + G P+ + EL+K
Sbjct: 196 YKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 254
Query: 224 ITRA-EFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMEN 263
+ P+ E+ ++ PS R T +L+E+
Sbjct: 255 LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 6e-12
Identities = 57/228 (25%), Positives = 95/228 (41%), Gaps = 38/228 (16%)
Query: 60 EISVMRLVRHPNIVQL-----YEVMAS------KTKIYFAMEYVRGGELFNKVAKGKLRE 108
E ++R + HP+I+QL Y KT +Y + R + + +A +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAAKRNIAICDILA---IER 189
Query: 109 EVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLL 168
V R A+++ H + HRD+K EN+ ++ GD+ + DFG + +
Sbjct: 190 SVLR--------AIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK-Y 240
Query: 169 HTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLME-------LY 221
+ GT A APE++ + Y G DIWS G+VLF + + ++ + ++
Sbjct: 241 YGWAGTIATNAPELLARDPY-GPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQI 299
Query: 222 KKITRAEFKCPNWFPPEVRKLLSRIL-------DPNPSTRVTMAKLME 262
K I R PN FP + + L I P +R L E
Sbjct: 300 KLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYE 347
|
Length = 391 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 8e-12
Identities = 75/293 (25%), Positives = 131/293 (44%), Gaps = 52/293 (17%)
Query: 10 NKYELGRLLGQGTFAKVYHGRNLKTGQ-------SVAIKIVDKEKIRRVGLIDQIKREIS 62
+ LG+ LG+G F +V + + +VA+K++ + + L D + E+
Sbjct: 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDK-DLSDLVS-EME 69
Query: 63 VMRLV-RHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEV-ARK------- 113
+M+++ +H NI+ L +Y +EY +KG LRE + AR+
Sbjct: 70 MMKMIGKHKNIINLLGACTQDGPLYVLVEY---------ASKGNLREYLRARRPPGMDYS 120
Query: 114 -----------YFQQLVD-------AVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGL 155
F+ LV +E+ S+ HRDL N+L+ E+ +KI+DFGL
Sbjct: 121 FDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGL 180
Query: 156 SALQESTRQDGLLHTTCGT-PA-YVAPEVINKRGYDGAKADIWSCGVVLF-VLLAGNLPF 212
+ ++ D TT G P ++APE + R Y ++D+WS GV+L+ + G P+
Sbjct: 181 A--RDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPY 237
Query: 213 YDSNLMELYKKITRA-EFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENY 264
+ EL+K + P E+ ++ PS R T +L+E+
Sbjct: 238 PGIPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL 290
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 68/269 (25%), Positives = 115/269 (42%), Gaps = 24/269 (8%)
Query: 14 LGRLLGQGTFAKVYHGR--NLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPN 71
L R LG+G F KV+ NL + + V K + +RE ++ ++H +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 72 IVQLYEVMASKTKIYFAMEYVRGGELFNKV------------------AKGKLREEVARK 113
IV+ Y V + EY++ G+L NK AKG+L
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDL-NKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 114 YFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCG 173
Q+ + + S+ HRDL N L+ N +KI DFG+S ST + T
Sbjct: 128 IASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187
Query: 174 TPAYVAPEVINKRGYDGAKADIWSCGVVLF-VLLAGNLPFYDSNLMELYKKITRAE-FKC 231
++ PE I R + ++D+WS GV+L+ + G P++ + E+ + IT+ +
Sbjct: 188 PIRWMPPESIMYRKFT-TESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLER 246
Query: 232 PNWFPPEVRKLLSRILDPNPSTRVTMAKL 260
P P EV ++ P R+ + ++
Sbjct: 247 PRVCPKEVYDIMLGCWQREPQQRLNIKEI 275
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 58/214 (27%), Positives = 106/214 (49%), Gaps = 13/214 (6%)
Query: 8 LMNKYELGRL--LGQGTFAKVYHGRNLKTGQSV----AIKIVDKEKIRRVGLIDQIKREI 61
++ + EL R+ LG G F VY G + G++V AIKI+++ + + + E
Sbjct: 3 ILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV--EFMDEA 60
Query: 62 SVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGK--LREEVARKYFQQLV 119
+M + HP++V+L V S T I + + G L + V + K + ++ + Q+
Sbjct: 61 LIMASMDHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIA 119
Query: 120 DAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVA 179
+ + R + HRDL N+L+ +KI+DFGL+ L E ++ ++A
Sbjct: 120 KGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMA 179
Query: 180 PEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPF 212
E I+ R + ++D+WS GV ++ L+ G P+
Sbjct: 180 LECIHYRKFT-HQSDVWSYGVTIWELMTFGGKPY 212
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 4e-11
Identities = 55/215 (25%), Positives = 94/215 (43%), Gaps = 20/215 (9%)
Query: 13 ELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNI 72
E+GR G VY R+ TG V ++I D E L ++ E+ + RHPNI
Sbjct: 5 EIGR--GFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHL-KALQNEVVLSHFFRHPNI 61
Query: 73 VQLYEVMASKTKIYFA---MEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRG 129
+ + V + + ++ M Y L + E + + + + H G
Sbjct: 62 MTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG 121
Query: 130 VYHRDLKPENLLLDENGDLKISDFGLSALQESTRQ--------DGLLHTTCGTPAYVAPE 181
HR++K ++L+ +G + +S GLS L R D +T P +++PE
Sbjct: 122 YIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLP-WLSPE 178
Query: 182 VINK--RGYDGAKADIWSCGVVLFVLLAGNLPFYD 214
++ + GY+ K+DI+S G+ L G +PF D
Sbjct: 179 LLRQDLYGYN-VKSDIYSVGITACELATGRVPFQD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 30/88 (34%), Positives = 48/88 (54%), Gaps = 1/88 (1%)
Query: 116 QQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTP 175
+QL+ A+++ H G+ HRD+K EN+L++ D+ + DFG + + + GT
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTV 326
Query: 176 AYVAPEVINKRGYDGAKADIWSCGVVLF 203
APEV+ Y DIWS G+V+F
Sbjct: 327 DTNAPEVLAGDPYT-PSVDIWSAGLVIF 353
|
Length = 461 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 51/156 (32%), Positives = 77/156 (49%), Gaps = 10/156 (6%)
Query: 114 YFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCG 173
Y Q+ +EF SR HRDL N+LL EN +KI DFGL A D +
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGL-ARDIYKDPDYVRKGDAR 242
Query: 174 TP-AYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPF----YDSNLMELYKKITRA 227
P ++APE I R Y ++D+WS GV+L+ + + G P+ D K+ TR
Sbjct: 243 LPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR- 300
Query: 228 EFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMEN 263
+ P++ PE+ + + PS R T ++L+E+
Sbjct: 301 -MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 57/209 (27%), Positives = 98/209 (46%), Gaps = 18/209 (8%)
Query: 16 RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREI----SVMRLVRHPN 71
++LG G F VY G + G+ V I + KE R + +EI VM V +P+
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE--LREATSPKANKEILDEAYVMASVDNPH 70
Query: 72 IVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQ----QLVDAVEFCHS 127
+ +L + + T + + + G L + V + K + + +Y Q+ + +
Sbjct: 71 VCRLLGICLTST-VQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEE 127
Query: 128 RGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCG-TP-AYVAPEVINK 185
R + HRDL N+L+ +KI+DFGL+ L + ++ H G P ++A E I
Sbjct: 128 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKE--YHAEGGKVPIKWMALESILH 185
Query: 186 RGYDGAKADIWSCGVVLFVLLAGNLPFYD 214
R Y ++D+WS GV ++ L+ YD
Sbjct: 186 RIYT-HQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 48/155 (30%), Positives = 75/155 (48%), Gaps = 10/155 (6%)
Query: 114 YFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCG 173
Y Q+ +EF SR HRDL N+LL EN +KI DFGL A D + +
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGL-ARDIYKDPDYVRKGSAR 237
Query: 174 TP-AYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPF----YDSNLMELYKKITRA 227
P ++APE I + Y ++D+WS GV+L+ + + G P+ + + K TR
Sbjct: 238 LPLKWMAPESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTR- 295
Query: 228 EFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262
+ P PE+ +++ +P R T + L+E
Sbjct: 296 -MRAPENATPEIYRIMLACWQGDPKERPTFSALVE 329
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-10
Identities = 66/271 (24%), Positives = 120/271 (44%), Gaps = 27/271 (9%)
Query: 14 LGRLLGQGTFAKVYHGRNLKTGQS---VAIKIVDKEKIRRVGLIDQIKREISVMRLVRHP 70
LG+ LG+G F V G+ L S VA+K + R + D + E M+ HP
Sbjct: 3 LGKTLGEGEFGSVMEGQ-LNQDDSILKVAVKTMKIAICTRSEMEDFL-SEAVCMKEFDHP 60
Query: 71 NIVQLYEV--MASKTKIYFA----MEYVRGGELFNKVAKGKLRE-------EVARKYFQQ 117
N+++L V +++ Y + + +++ G+L + + +L + ++ K+
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120
Query: 118 LVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSAL---QESTRQDGLLHTTCGT 174
+ +E+ S+ HRDL N +L+EN ++ ++DFGLS + RQ +
Sbjct: 121 IASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPV-- 178
Query: 175 PAYVAPEVINKRGYDGAKADIWSCGVVLF-VLLAGNLPFYDSNLMELYKKITRA-EFKCP 232
++A E + R Y K+D+WS GV ++ + G P+ E+Y + + K P
Sbjct: 179 -KWIAIESLADRVYT-TKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQP 236
Query: 233 NWFPPEVRKLLSRILDPNPSTRVTMAKLMEN 263
+ L+S NP R + L
Sbjct: 237 PDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 5e-10
Identities = 59/224 (26%), Positives = 101/224 (45%), Gaps = 20/224 (8%)
Query: 14 LGRLLGQGTFAKVYHG--RNLKTG--QSVAIKIV-DKEKIRRVGLIDQIKREISVMRLVR 68
L LL +GTF ++++G + K G + V +K V D +V L+ Q E ++ +
Sbjct: 10 LSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQ---ESCLLYGLS 66
Query: 69 HPNIVQLYEVMASKT-KIYFAMEYVRGGELFNKVAKGKLREEVARKYF--QQLVD----- 120
H NI+ + V + Y+ G L + + +L E + QQLV
Sbjct: 67 HQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQI 126
Query: 121 --AVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYV 178
+ + H RGV H+D+ N ++DE +KI+D LS L ++
Sbjct: 127 ACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWM 186
Query: 179 APEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELY 221
A E + + Y A +D+WS GV+L+ L+ G P+ + + E+
Sbjct: 187 ALESLVNKEYSSA-SDVWSFGVLLWELMTLGQTPYVEIDPFEMA 229
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 5e-10
Identities = 50/155 (32%), Positives = 75/155 (48%), Gaps = 10/155 (6%)
Query: 114 YFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCG 173
Y Q+ +EF SR HRDL N+LL EN +KI DFGL A D +
Sbjct: 178 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGL-ARDIYKDPDYVRKGDAR 236
Query: 174 TP-AYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPF----YDSNLMELYKKITRA 227
P ++APE I + Y ++D+WS GV+L+ + + G P+ D K+ TR
Sbjct: 237 LPLKWMAPESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTR- 294
Query: 228 EFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262
+ P + PE+ ++ NP R T ++L+E
Sbjct: 295 -MRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVE 328
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 6e-10
Identities = 60/237 (25%), Positives = 97/237 (40%), Gaps = 30/237 (12%)
Query: 18 LGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIR-RVGLIDQIKREISVMRLVRHPNIVQLY 76
+G G F KV G G S A +V + + +E+ R + HPN++Q
Sbjct: 3 IGNGWFGKVLLGE-AHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 77 EVMASKTKIYFAMEYVRGGELFNKVAKGKLREE------VARKYFQQ-----LVDAVEFC 125
+E+ G+L K LR +A+K Q + + +
Sbjct: 62 GQCIESIPYLLVLEFCPLGDL-----KNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWL 116
Query: 126 HSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTC-GTP-AYVAPEVI 183
H H DL N L + +KI D+GL+ E +D + C P ++APE++
Sbjct: 117 HQADFIHSDLALRNCQLTADLSVKIGDYGLA--LEQYPEDYYITKDCHAVPLRWLAPELV 174
Query: 184 NKRGYD------GAKADIWSCGVVLFVLL-AGNLPFYD-SNLMELYKKITRAEFKCP 232
RG D K++IWS GV ++ L A + P+ D S+ L + + + K P
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLP 231
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 8e-10
Identities = 55/216 (25%), Positives = 97/216 (44%), Gaps = 18/216 (8%)
Query: 13 ELGRLLGQG--TFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHP 70
EL ++G+G V R TG+ V ++ ++ E ++ ++ E+ V +L HP
Sbjct: 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTN-EMVTFLQGELHVSKLFNHP 59
Query: 71 NIVQLYEVMASKTKIYFA---MEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHS 127
NIV + +++ M Y +L + E Q ++ A+++ H
Sbjct: 60 NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH 119
Query: 128 RGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAY-------VAP 180
G HR +K ++L+ +G + +S GL + L P Y ++P
Sbjct: 120 MGYVHRSVKASHILISVDGKVYLS--GLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSP 177
Query: 181 EVI--NKRGYDGAKADIWSCGVVLFVLLAGNLPFYD 214
EV+ N +GYD AK+DI+S G+ L G++PF D
Sbjct: 178 EVLQQNLQGYD-AKSDIYSVGITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 73/277 (26%), Positives = 120/277 (43%), Gaps = 35/277 (12%)
Query: 11 KYELGRLLGQGTFAKVYHG--RNLKTGQS---VAIKIVDKEKIRRVGLIDQIKREISVMR 65
K L R LGQG+F VY G R++ G++ VA+K V++ R + + E SVM+
Sbjct: 7 KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMK 64
Query: 66 LVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVA----------RKYF 115
++V+L V++ ME + G+L K LR E ++
Sbjct: 65 GFTCHHVVRLLGVVSKGQPTLVVMELMAHGDL--KSYLRSLRPEAENNPGRPPPTLQEMI 122
Query: 116 Q---QLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQ-----DGL 167
Q ++ D + + +++ HRDL N ++ + +KI DFG++ T GL
Sbjct: 123 QMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGL 182
Query: 168 LHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLF-VLLAGNLPFYD-SNLMELYKKIT 225
L ++APE + K G +D+WS GVVL+ + P+ SN L +
Sbjct: 183 LPVR-----WMAPESL-KDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMD 236
Query: 226 RAEFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262
P+ P V L+ NP R T +++
Sbjct: 237 GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVN 273
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 3e-09
Identities = 59/262 (22%), Positives = 105/262 (40%), Gaps = 41/262 (15%)
Query: 18 LGQGTFAKVYHGRNLKTGQ----------SVAIKIVDKEKIRRVGLIDQIKREISVMRLV 67
LGQGTF +Y G SV +K++ + + S+M +
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFF----ETASLMSQL 58
Query: 68 RHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYF--QQLVDAVEFC 125
H ++V+LY V I EYV+ G L + + K + K +QL A+ +
Sbjct: 59 SHKHLVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYL 117
Query: 126 HSRGVYHRDLKPENLLLDENG-------DLKISDFG--LSALQESTRQDGLLHTTCGTPA 176
+ + H ++ +N+L+ G +K+SD G ++ L R + +
Sbjct: 118 EDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERI--------P 169
Query: 177 YVAPEVI-NKRGYDGAKADIWSCGVVLF-VLLAGNLPF--YDSNLMELYKKITRAEFKCP 232
++APE I N + AD WS G L + G P S+ E + + + P
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQHRLPMP 228
Query: 233 NWFPPEVRKLLSRILDPNPSTR 254
+ E+ L+++ +P+ R
Sbjct: 229 DC--AELANLINQCWTYDPTKR 248
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 4e-09
Identities = 59/252 (23%), Positives = 108/252 (42%), Gaps = 19/252 (7%)
Query: 14 LGRLLGQGTFAKVYHG-RNLKTGQSVAIKIVDKEKIRRVGLIDQIKR----EISVMRLVR 68
+ R+LG G F ++ G L + + + + I R G D+ +R E +
Sbjct: 9 IERILGTGRFGELCRGCLKLPSKRELPVAI----HTLRAGCSDKQRRGFLAEALTLGQFD 64
Query: 69 HPNIVQLYEVMASKTKIYFAMEYVRGGEL--FNKVAKGKLREEVARKYFQQLVDAVEFCH 126
H NIV+L V+ + EY+ G L F + +G+L L +++
Sbjct: 65 HSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS 124
Query: 127 SRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCG-TPA-YVAPEVIN 184
G H+ L +L++ + KIS F LQE + + + T G +P + APE I
Sbjct: 125 EMGYVHKGLAAHKVLVNSDLVCKISGFR--RLQED-KSEAIYTTMSGKSPVLWAAPEAIQ 181
Query: 185 KRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EFKCPNWFPPEVRKL 242
+ A +D+WS G+V++ +++ G P++D + ++ K + P P + +L
Sbjct: 182 YHHFSSA-SDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQL 240
Query: 243 LSRILDPNPSTR 254
+ R
Sbjct: 241 MLDCWQKERGER 252
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 5e-09
Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 27/212 (12%)
Query: 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQI-KREISVM 64
IL + E ++ +G Y G+++K G +K ++ ++ I EI+ M
Sbjct: 687 DILSSLKE-ENVISRGKKGASYKGKSIKNGMQFVVKEIND--------VNSIPSSEIADM 737
Query: 65 RLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEF 124
++HPNIV+L + S+ Y EY+ G L ++V + L E RK + A+ F
Sbjct: 738 GKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNL-SEVLRN-LSWERRRKIAIGIAKALRF 795
Query: 125 CH---SRGVYHRDLKPENLLLD--ENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVA 179
H S V +L PE +++D + L++S GL + AYVA
Sbjct: 796 LHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTD---------TKCFISSAYVA 846
Query: 180 PEVINKRGYDGAKADIWSCGVVLFVLLAGNLP 211
PE + K+DI+ G++L LL G P
Sbjct: 847 PETRETKDIT-EKSDIYGFGLILIELLTGKSP 877
|
Length = 968 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-08
Identities = 68/263 (25%), Positives = 110/263 (41%), Gaps = 44/263 (16%)
Query: 18 LGQGTFAKVYHGRNLKTGQ-------SVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHP 70
LGQGTF K++ G + G V +K++DK + S+M + H
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDK---SHRNYSESFFEAASMMSQLSHK 59
Query: 71 NIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGK------LREEVARKYFQQLVDAVEF 124
++V Y V + EYV+ G L + K K + EVA+ QL A+ F
Sbjct: 60 HLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAK----QLAWALHF 115
Query: 125 CHSRGVYHRDLKPENLLLDENGD--------LKISDFGLSALQESTRQDGLLHTTCGTPA 176
+G+ H ++ +N+LL D +K+SD G+S ++ LL
Sbjct: 116 LEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP--KEILLERI----P 169
Query: 177 YVAPEVINKRGYDGAKADIWSCGVVLF-VLLAGNLPFYDSNLMELYKKI----TRAEFKC 231
+V PE I AD WS G L+ + G+ P + ++ KK+ R +
Sbjct: 170 WVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPL---SALDSQKKLQFYEDRHQLPA 226
Query: 232 PNWFPPEVRKLLSRILDPNPSTR 254
P W E+ L+++ +D P R
Sbjct: 227 PKW--TELANLINQCMDYEPDFR 247
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 42/176 (23%), Positives = 74/176 (42%), Gaps = 33/176 (18%)
Query: 10 NKYELGRLLGQGTFAKVY------------HGRNLKTGQS--VAIKIV--DKEKIRRVGL 53
+ L LG+G F +V+ G GQ VA+K++ D K R
Sbjct: 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTAR--- 61
Query: 54 IDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARK 113
+ +EI +M +++PNI++L V S + EY+ G+L +++ ++
Sbjct: 62 -NDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHA 120
Query: 114 -------------YFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLS 156
Q+ +++ S HRDL N L+ + +KI+DFG+S
Sbjct: 121 NNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMS 176
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 4e-08
Identities = 58/216 (26%), Positives = 96/216 (44%), Gaps = 33/216 (15%)
Query: 11 KYELGRLLGQGTFAKVYHGRNLKTG-------QSVAIKIVDKEKIRRVGLIDQIKREISV 63
K + R LGQG+F VY G + G VAIK V++ R + + E SV
Sbjct: 7 KITMSRELGQGSFGMVYEG--IAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASV 62
Query: 64 MRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREE--------VARKYF 115
M+ ++V+L V++ ME + G+L + + + E +K
Sbjct: 63 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMI 122
Query: 116 Q---QLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQ-----DGL 167
Q ++ D + + ++ HRDL N ++ E+ +KI DFG++ T GL
Sbjct: 123 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 182
Query: 168 LHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLF 203
L +++PE + K G +D+WS GVVL+
Sbjct: 183 LPVR-----WMSPESL-KDGVFTTYSDVWSFGVVLW 212
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 7e-08
Identities = 53/208 (25%), Positives = 95/208 (45%), Gaps = 14/208 (6%)
Query: 16 RLLGQGTFAKVYHGRNLKTGQS----VAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPN 71
++LG G F VY G + G++ VAIK++ + + +I E VM V P
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKAN--KEILDEAYVMAGVGSPY 70
Query: 72 IVQLYEVMASKTKIYFAMEYVRGGELFNKVA--KGKLREEVARKYFQQLVDAVEFCHSRG 129
+ +L + + T + + + G L + V K ++ + + Q+ + +
Sbjct: 71 VCRLLGICLTST-VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR 129
Query: 130 VYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCG-TP-AYVAPEVINKRG 187
+ HRDL N+L+ +KI+DFGL+ L + + H G P ++A E I R
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETE--YHADGGKVPIKWMALESILHRR 187
Query: 188 YDGAKADIWSCGVVLFVLLAGNLPFYDS 215
+ ++D+WS GV ++ L+ YD
Sbjct: 188 FT-HQSDVWSYGVTVWELMTFGAKPYDG 214
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 49/174 (28%), Positives = 77/174 (44%), Gaps = 35/174 (20%)
Query: 14 LGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDK-------------EKIRRV--------- 51
LG+ LG+G F VY + K V K E++RR
Sbjct: 136 LGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCADFV 195
Query: 52 -GLIDQI--KREISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKV---AKGK 105
G ++ + K+E + R+ L ++M SK Y Y L KV KG
Sbjct: 196 YGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPY-----LLGKVQDLPKGL 250
Query: 106 LRE-EVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDE-NGDLKISDFGLSA 157
RE ++ + +Q++ A++ HS G+ HRD+KP+N++ E +G KI D G +A
Sbjct: 251 ERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAA 304
|
Length = 566 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 51/222 (22%), Positives = 96/222 (43%), Gaps = 13/222 (5%)
Query: 15 GRLLGQGTFAKVYHGRNLKTGQS----VAIKIVDKEKIRRVGLIDQIKREISVMRLVRHP 70
+LLG G F V+ G + G S VAIK + R+ +I + M + H
Sbjct: 12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQT--FQEITDHMLAMGSLDHA 69
Query: 71 NIVQLYEVMASKTKIYFAMEYVRGGELFNKVA--KGKLREEVARKYFQQLVDAVEFCHSR 128
IV+L + + + G L + V + L + + Q+ + +
Sbjct: 70 YIVRLLGICPG-ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH 128
Query: 129 GVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTP-AYVAPEVINKRG 187
+ HR+L N+LL + ++I+DFG++ L + ++ TP ++A E I
Sbjct: 129 RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKK-YFYSEHKTPIKWMALESILFGR 187
Query: 188 YDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAE 228
Y ++D+WS GV ++ +++ G P+ E+ + + E
Sbjct: 188 YT-HQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGE 228
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 41/152 (26%), Positives = 71/152 (46%), Gaps = 10/152 (6%)
Query: 117 QLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPA 176
Q+ + F S+ HRDL N+LL KI DFGL A + ++ P
Sbjct: 222 QVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGL-ARDIRNDSNYVVKGNARLPV 280
Query: 177 -YVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPF----YDSNLMELYKKITRAEFK 230
++APE I Y ++D+WS G++L+ + + G+ P+ DS ++ K+ R
Sbjct: 281 KWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRML-- 337
Query: 231 CPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262
P P E+ ++ D +P R T ++++
Sbjct: 338 SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 68/242 (28%), Positives = 105/242 (43%), Gaps = 47/242 (19%)
Query: 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIV-DKEKIRRVGLIDQIKREISVMRLVRH 69
++++ LLG+GTF KV + K + A+KIV + K R K EI M VR
Sbjct: 130 RFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTR-----DAKIEIQFMEKVRQ 184
Query: 70 PNIVQLYEVMASKTKIYFAMEYVR--------GGELFNKVAK-GKL-REEVARKYFQQLV 119
+ + +M K + YF E G L + + K G +A+ FQ V
Sbjct: 185 ADPADRFPLM--KIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGV 242
Query: 120 DAVEFCHSR-GVYHRDLKPENLLLDENGD-----------------LKISDFGLSALQES 161
A+++ H+ + H DLKPEN+L+ E D ++I D G +
Sbjct: 243 -ALDYFHTELHLMHTDLKPENILM-ETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH 300
Query: 162 TRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDS--NLME 219
+R T Y +PEV+ G+ D+WS G +++ L G L YD+ NL
Sbjct: 301 SRT-----AIVSTRHYRSPEVVLGLGW-MYSTDMWSMGCIIYELYTGKL-LYDTHDNLEH 353
Query: 220 LY 221
L+
Sbjct: 354 LH 355
|
Length = 467 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 2e-07
Identities = 37/153 (24%), Positives = 61/153 (39%), Gaps = 23/153 (15%)
Query: 15 GRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQ 74
+L+ +G A++Y G L IK V K +I + ++ I R R I+
Sbjct: 1 MKLIKRGAEAEIYLGDFLG------IKAVIKWRIPKRYRHPELDERIRRERTRREARIMS 54
Query: 75 -----------LYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVE 123
+Y V I MEY+ G L + + + +++ V
Sbjct: 55 RARKAGVNVPAVYFVDPENFII--VMEYIEGEPLKDLINSN---GMEELELSREIGRLVG 109
Query: 124 FCHSRGVYHRDLKPENLLLDENGDLKISDFGLS 156
HS G+ H DL N++L G + + DFGL+
Sbjct: 110 KLHSAGIIHGDLTTSNMIL-SGGKIYLIDFGLA 141
|
Length = 211 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 3e-07
Identities = 56/246 (22%), Positives = 104/246 (42%), Gaps = 30/246 (12%)
Query: 35 GQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLY----EVMASKTKIYFAME 90
+ V I+ K LID + EI +R + NI+++Y +++ ++ +E
Sbjct: 43 NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE 102
Query: 91 YVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVY---------HRDLKPENLL 141
Y G L + L +E + +L A++ C +G+Y +++L + L
Sbjct: 103 YCTRGYL-----REVLDKEKDLSFKTKLDMAIDCC--KGLYNLYKYTNKPYKNLTSVSFL 155
Query: 142 LDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINK--RGYDGAKADIWSCG 199
+ EN LKI GL + S + Y + +++N Y K DI+S G
Sbjct: 156 VTENYKLKIICHGLEKILSSPPFKNV-----NFMVYFSYKMLNDIFSEYT-IKDDIYSLG 209
Query: 200 VVLFVLLAGNLPFYDSNLMELYKKITR--AEFKCPNWFPPEVRKLLSRILDPNPSTRVTM 257
VVL+ + G +PF + E+Y I K P P E++ ++ + R +
Sbjct: 210 VVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNI 269
Query: 258 AKLMEN 263
+++ N
Sbjct: 270 KEILYN 275
|
Length = 283 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 62/272 (22%), Positives = 110/272 (40%), Gaps = 40/272 (14%)
Query: 18 LGQGTFAKVYHGR--------NLKTGQSVAIKIVDKEKIRRVGLIDQIKREISV------ 63
LG+GT ++Y G + IK++ K ++D R+IS+
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILK-------VLDPSHRDISLAFFETA 55
Query: 64 --MRLVRHPNIVQLYEVMASKTKIYFAMEYVRGG--ELFNKVAKGKLREEVARKYFQQLV 119
MR V H +IV LY V + E+V G +LF L K +QL
Sbjct: 56 SMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLA 115
Query: 120 DAVEFCHSRGVYHRDLKPENLLLDENGD-------LKISDFGLSALQESTRQDGLLHTTC 172
A+ + + + H ++ +N+LL G +K+SD G+ + +RQ+ +
Sbjct: 116 SALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI-PITVLSRQECVERI-- 172
Query: 173 GTPAYVAPEVINKRGYDGAKADIWSCGVVLF-VLLAGNLPFYDSNLMELYKKITRAEFKC 231
++APE + AD WS G L+ + G +P D L E ++ +
Sbjct: 173 ---PWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE-KERFYEGQCML 228
Query: 232 PNWFPPEVRKLLSRILDPNPSTRVTMAKLMEN 263
E+ L++ ++ +P+ R +M +
Sbjct: 229 VTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 56/222 (25%), Positives = 94/222 (42%), Gaps = 41/222 (18%)
Query: 18 LGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIK--REISVMRLVRHPNIVQL 75
+G G F KV G + +G + A ++V KE + +Q+K E R ++H N++Q
Sbjct: 3 IGNGWFGKVILGE-VNSGYTPA-QVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 76 YEVMASKTKIYFAMEYVRGGELFNKVAKGKLREE-----------VARKYFQQLVDAVEF 124
T ME+ G+L KG LR ++ ++ +
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDL-----KGYLRSCRKAELMTPDPTTLQRMACEIALGLLH 115
Query: 125 CHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTP-------AY 177
H H DL N LL + +KI D+GLS + ++D + TP +
Sbjct: 116 LHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNK--YKEDYYV-----TPDQLWVPLRW 168
Query: 178 VAPEVI-----NKRGYDGAK-ADIWSCGVVLFVLLA-GNLPF 212
+APE++ N D K +++WS GV ++ L G+ P+
Sbjct: 169 IAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPY 210
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 4e-06
Identities = 28/110 (25%), Positives = 52/110 (47%), Gaps = 12/110 (10%)
Query: 59 REISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVA------- 111
+EI +M ++ PNI++L V + + EY+ G+L +++ + +E
Sbjct: 68 KEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTI 127
Query: 112 -----RKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLS 156
Q+ +++ S HRDL N L+ +N +KI+DFG+S
Sbjct: 128 SYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 7e-06
Identities = 39/148 (26%), Positives = 72/148 (48%), Gaps = 6/148 (4%)
Query: 117 QLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPA 176
Q+ ++F S+ HRD+ N+LL + KI DFGL A + ++ P
Sbjct: 220 QVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGL-ARDIMNDSNYVVKGNARLPV 278
Query: 177 -YVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLME--LYKKITRA-EFKCP 232
++APE I Y ++D+WS G++L+ + + Y L+ YK + R + P
Sbjct: 279 KWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRP 337
Query: 233 NWFPPEVRKLLSRILDPNPSTRVTMAKL 260
++ PPE+ ++ + P+ R T +++
Sbjct: 338 DFAPPEIYSIMKMCWNLEPTERPTFSQI 365
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 68/273 (24%), Positives = 111/273 (40%), Gaps = 48/273 (17%)
Query: 18 LGQGTFAKVYHGRNLKTG-----------QSVAIKIVDKEKIRRVGL--IDQIKREI--- 61
LGQGT +Y GR G + ++ + + RV L +D R+I
Sbjct: 3 LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALA 62
Query: 62 -----SVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYF- 115
S+M V H ++ ++ V ++ E+V G L + K K R VA K
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITV 122
Query: 116 -QQLVDAVEFCHSRGVYHRDLKPENLLLDENG-------DLKISDFGLS--ALQESTRQD 165
QQL A+ + + + H ++ +N+LL G +K+SD G+S AL R +
Sbjct: 123 AQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREERVE 182
Query: 166 GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLF-VLLAGNLPFYDSNLME---LY 221
+ ++APE + AD WS G L + G +P + E Y
Sbjct: 183 RI--------PWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFY 234
Query: 222 KKITRAEFKCPNWFPPEVRKLLSRILDPNPSTR 254
+K + + P E+ L+S+ L P+ R
Sbjct: 235 EK----KHRLPEPSCKELATLISQCLTYEPTQR 263
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 41/177 (23%), Positives = 74/177 (41%), Gaps = 42/177 (23%)
Query: 18 LGQGTFAKVYHGR--------------NLKTGQS--VAIKIV--DKEKIRRVGLIDQIKR 59
LG+G F +V+ N++ G+ VA+KI+ D K R + +
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFL----K 68
Query: 60 EISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQ--- 116
E+ ++ ++ PNI++L V + + EY+ G+L ++ L ++
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 117 -----------------QLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLS 156
Q+ +++ S HRDL N L+ EN +KI+DFG+S
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 35/114 (30%), Positives = 58/114 (50%), Gaps = 7/114 (6%)
Query: 117 QLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLH--TTCGT 174
Q+ + +EF S+ HRDL N+L+ E +KI DFGL+ ++ R + +T
Sbjct: 247 QVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLA--RDIMRDSNYISKGSTFLP 304
Query: 175 PAYVAPEVINKRGYDGAKADIWSCGVVLF-VLLAGNLPFYDSNLMEL-YKKITR 226
++APE I Y +D+WS G++L+ + G P+ + + E Y I R
Sbjct: 305 LKWMAPESIFNNLYT-TLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKR 357
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 3e-05
Identities = 33/133 (24%), Positives = 51/133 (38%), Gaps = 31/133 (23%)
Query: 132 HRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGA 191
HR K N+LL +G LK+ E +R D P ++APEVI +
Sbjct: 34 HRQAKSGNILLTWDGLLKLDGSVAFKTPEQSRPD---------PYFMAPEVI-QGQSYTE 83
Query: 192 KADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILDPNP 251
KADI+S G+ L+ L LP+ + E+ +L +L+ P
Sbjct: 84 KADIYSLGITLYEALDYELPYNE---------------------ERELSAILEILLNGMP 122
Query: 252 STRVTMAKLMENY 264
+ +E
Sbjct: 123 ADDPRDRSNLEGV 135
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 19/45 (42%), Positives = 29/45 (64%)
Query: 110 VARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFG 154
V + +Q++ + H G+ HRD+KPENLL+ +G +KI DFG
Sbjct: 310 VIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFG 354
|
Length = 507 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 5e-05
Identities = 41/152 (26%), Positives = 66/152 (43%), Gaps = 10/152 (6%)
Query: 117 QLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPA 176
Q+ +EF S+ HRDL N+LL + +KI DFGL+ +T
Sbjct: 245 QVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVK 304
Query: 177 YVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPF----YDSNLMELYKKITRA-EFK 230
++APE I Y +D+WS G++L+ + + G P+ DS Y KI
Sbjct: 305 WMAPESIFDNLYT-TLSDVWSYGILLWEIFSLGGTPYPGMIVDST---FYNKIKSGYRMA 360
Query: 231 CPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262
P+ EV ++ + + P R + L +
Sbjct: 361 KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 2e-04
Identities = 25/105 (23%), Positives = 46/105 (43%), Gaps = 11/105 (10%)
Query: 59 REISVMRLVR-HPNIV-QLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQ 116
RE+++++L+ V ++ S Y ME++ G L ++ EE +
Sbjct: 40 REVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL------DEVSEEEKEDIAE 93
Query: 117 QLVDAVEFCHSRGVY---HRDLKPENLLLDENGDLKISDFGLSAL 158
QL + + H + H DL P N+L+D+ L I D+ +
Sbjct: 94 QLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 3e-04
Identities = 20/52 (38%), Positives = 30/52 (57%), Gaps = 1/52 (1%)
Query: 173 GTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKI 224
GTP Y+APE++ + + A D W+ GV LF L G PF D ++++ I
Sbjct: 542 GTPDYLAPELLLGKPHGPA-VDWWALGVCLFEFLTGIPPFNDETPQQVFQNI 592
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|213376 cd12120, AMPKA_C_like, C-terminal regulatory domain of 5'-AMP-activated protein kinase (AMPK) alpha subunit and similar domains | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 3e-04
Identities = 13/86 (15%), Positives = 26/86 (30%), Gaps = 4/86 (4%)
Query: 346 KLEARFTTTKPASAIVSKFEEIAVTESCKF--NKKDGTVKLQH--NRQGRKGQLAVDAEI 401
K E + S I ++ + + + + + E+
Sbjct: 3 KWELEIHSRIDPSEIYEGIHKVLEGWGKNLVFRITNFIITGKLVNDHILFLRSTLFEIEV 62
Query: 402 FEVTPAFHVVELKKAAGDTMEYKDFC 427
+EV P +V+ KK G T +
Sbjct: 63 YEVGPGLFMVDFKKKTGSTKTFTKLA 88
|
This family is composed of AMPKs, microtubule-associated protein/microtubule affinity regulating kinases (MARKs), yeast Kcc4p-like proteins, plant calcineurin B-Like (CBL)-interacting protein kinases (CIPKs), and similar proteins. They are serine/threonine protein kinases (STKs) that catalyze the transfer of the gamma-phosphoryl group from ATP to S/T residues on protein substrates. AMPKs act as sensors for the energy status of the cell and are activated by cellular stresses that lead to ATP depletion such as hypoxia, heat shock, and glucose deprivation, among others. MARKs phosphorylate the tau protein and related microtubule-associated proteins (MAPs) on tubulin binding sites to induce detachment from microtubules, and are involved in the regulation of cell shape and polarity, cell cycle control, transport, and the cytoskeleton. Kcc4p and related proteins are septin-associated proteins that are involved in septin organization and in the yeast morphogenesis checkpoint coordinating the cell cycle with bud formation. CIPKs interact with the calcineurin B-like (CBL) calcium sensors to form a signaling network that decode specific calcium signals triggered by a variety of environmental stimuli including salinity, drought, cold, light, and mechanical perturbation, among others. All members of this family contain an N-terminal catalytic kinase domain and a C-terminal regulatory domain which is also called kinase associated domain 1 (KA1) in some cases. The C-terminal regulatory domain serves as a protein interaction domain in AMPKs and CIPKs. In MARKs and Kcc4p-like proteins, this domain binds phospholipids and may be involved in membrane localization. Length = 95 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 30/118 (25%), Positives = 50/118 (42%), Gaps = 15/118 (12%)
Query: 52 GLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVA 111
D +K E+ ++ + PNI +L V + MEY+ G+L N+ + + E
Sbjct: 62 AREDFLK-EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL-NQFLQKHVAETSG 119
Query: 112 RKYFQ-------------QLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLS 156
Q+ + + S HRDL N L+ +N +KI+DFG+S
Sbjct: 120 LACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|223554 COG0478, COG0478, RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 20/66 (30%), Positives = 35/66 (53%), Gaps = 4/66 (6%)
Query: 88 AMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGD 147
MEY+ G EL+ + +E+ K +++ A RG+ H DL N+L+ E+GD
Sbjct: 185 VMEYIEGVELYRLRLDVENPDEILDKILEEVRKAYR----RGIVHGDLSEFNILVTEDGD 240
Query: 148 LKISDF 153
+ + D+
Sbjct: 241 IVVIDW 246
|
Length = 304 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 39.9 bits (94), Expect = 0.001
Identities = 41/153 (26%), Positives = 63/153 (41%), Gaps = 30/153 (19%)
Query: 17 LLGQGTFAKVYHGRNLKTGQSVAIKI-VDK--------EKIRRVGLIDQIKREISVMRLV 67
L+ +G A +Y G L G IK V K E+IRR ++ + E ++
Sbjct: 1 LIAKGAEAIIYLGDFL--GLKAVIKERVPKSYRHPELDERIRR----ERTRNEARLLSRA 54
Query: 68 RHP--NIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLR--EEVARKYFQQLVDAVE 123
R N +Y+V I MEY+ G L + + +G E+ R V
Sbjct: 55 RKAGVNTPVVYDVDPDNKTI--VMEYIEGKPLKDVIEEGNDELLREIGR--------LVG 104
Query: 124 FCHSRGVYHRDLKPENLLLDENGDLKISDFGLS 156
H G+ H DL N+++ + L + DFGL
Sbjct: 105 KLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLG 136
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|240167 cd05144, RIO2_C, RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Score = 39.8 bits (94), Expect = 0.001
Identities = 21/66 (31%), Positives = 36/66 (54%), Gaps = 5/66 (7%)
Query: 88 AMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGD 147
MEY+ G EL +V + EEV + +++V A + G+ H DL N+L+D++
Sbjct: 109 VMEYIDGVEL-YRVRVLEDPEEVLDEILEEIVKAYK----HGIIHGDLSEFNILVDDDEK 163
Query: 148 LKISDF 153
+ I D+
Sbjct: 164 IYIIDW 169
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH domains may be involved in RNA recognition. RIO2 is essential for survival and is necessary for rRNA cleavage during 40S ribosomal subunit maturation. The biological substrates of RIO2 are still unknown. Length = 198 |
| >gnl|CDD|223733 COG0661, AarF, Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.002
Identities = 40/198 (20%), Positives = 80/198 (40%), Gaps = 72/198 (36%)
Query: 24 AKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-----RHP------NI 72
A+V+ LK+G+ VA+K+ +R G+ ++I+ ++ ++R + R P ++
Sbjct: 139 AQVHRAV-LKSGEEVAVKV------QRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDL 191
Query: 73 VQLYEV----------------MASKTKIYFA---------------------MEYVRGG 95
V++ + A + + F ME++ G
Sbjct: 192 VEVVDEFEKRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGI 251
Query: 96 ELFNKVAK---GKLREEVARK----YFQQ-LVDAVEFCHSRGVYHRDLKPENLLLDENGD 147
++ + A G R+E+A + +Q L D G +H D P N+L+ +G
Sbjct: 252 KISDIAALKSAGIDRKELAELLVRAFLRQLLRD--------GFFHADPHPGNILVRSDGR 303
Query: 148 LKISDFGLSA-LQESTRQ 164
+ + DFG+ L R+
Sbjct: 304 IVLLDFGIVGRLDPKFRR 321
|
Length = 517 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 38.8 bits (91), Expect = 0.002
Identities = 40/153 (26%), Positives = 63/153 (41%), Gaps = 26/153 (16%)
Query: 15 GRLLGQGTFAKVYHGRNLKTGQSVAIKI-VDK--------EKIRRVGLIDQIKREISVMR 65
L+ QG A +Y L G +K + K EK+RR ++ +RE ++
Sbjct: 1 MDLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRR----ERTRREARILA 54
Query: 66 LVRHP--NIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVE 123
R + +Y+V I MEY+ G ++ K L EE +++ V
Sbjct: 55 KAREAGVPVPIVYDVDPDNGLIV--MEYIEG-----ELLKDAL-EEARPDLLREVGRLVG 106
Query: 124 FCHSRGVYHRDLKPENLLLDENGDLKISDFGLS 156
H G+ H DL N++L G + DFGL
Sbjct: 107 KLHKAGIVHGDLTTSNIIL-SGGRIYFIDFGLG 138
|
Length = 204 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 448 | |||
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.96 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.93 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.92 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.92 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.91 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.91 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.9 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.9 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.9 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.89 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.86 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.84 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.82 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.82 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.81 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.81 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.8 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.79 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.77 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.76 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.71 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.7 | |
| PF03822 | 63 | NAF: NAF domain; InterPro: IPR004041 The NAF domai | 99.7 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.61 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.61 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.57 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.57 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.52 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.51 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.51 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.49 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.37 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.32 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.31 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.21 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.11 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.1 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.07 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.07 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.96 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.84 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.8 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.75 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.67 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.66 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.63 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.6 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.57 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.37 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.36 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.36 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.35 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.34 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.2 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 98.19 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.13 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.09 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.99 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.93 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.93 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.9 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.87 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.86 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.81 | |
| PF02149 | 47 | KA1: Kinase associated domain 1; InterPro: IPR0017 | 97.67 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.66 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.63 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.6 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.57 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.47 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.44 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.22 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.19 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.02 | |
| PLN02236 | 344 | choline kinase | 97.0 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.96 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.9 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.78 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.68 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.45 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.28 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.98 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.94 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.91 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.73 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.65 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.49 |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-64 Score=505.27 Aligned_cols=261 Identities=56% Similarity=1.021 Sum_probs=246.2
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccch--hHHHHHHHHHHHHHhCC-CCCcceEEEEEEeC
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRV--GLIDQIKREISVMRLVR-HPNIVQLYEVMASK 82 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~--~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~ 82 (448)
....++|++++.||+|+||+|++|.+..+|..||+|+++++..... ...+.+.+|+.++++++ ||||+++++++...
T Consensus 13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~ 92 (370)
T KOG0583|consen 13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP 92 (370)
T ss_pred ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence 3678899999999999999999999999999999998887644311 34577889999999999 99999999999999
Q ss_pred CEEEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCC-CCeEEeecccccccc
Q 037702 83 TKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDEN-GDLKISDFGLSALQE 160 (448)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~-g~lkl~DFGla~~~~ 160 (448)
+++|+|||||.||+|++++.. +++.|.+++.+|+||++||+|||++||+||||||||||++.+ +++||+|||++....
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 999999999999999999987 899999999999999999999999999999999999999999 999999999998764
Q ss_pred ccccCCCccccCCCCcccchhhhhccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCC-CHH
Q 037702 161 STRQDGLLHTTCGTPAYVAPEVINKRG-YDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWF-PPE 238 (448)
Q Consensus 161 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~-~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~-s~~ 238 (448)
..+..+++.||||.|+|||++.+.+ |++.++|||||||+||.|++|+.||.+.+...++.+|.++.+.+|.++ |++
T Consensus 173 --~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~~ 250 (370)
T KOG0583|consen 173 --GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLLSPE 250 (370)
T ss_pred --CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcCCHH
Confidence 4556789999999999999999988 999999999999999999999999999999999999999999999999 999
Q ss_pred HHHHHHhccCCCcCCCCCHHHHHhhhhccc
Q 037702 239 VRKLLSRILDPNPSTRVTMAKLMENYWFRK 268 (448)
Q Consensus 239 ~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 268 (448)
+++||++||.+||.+|+|+.+|+.||||+.
T Consensus 251 ~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 251 ARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred HHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 999999999999999999999999999998
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-63 Score=494.91 Aligned_cols=263 Identities=37% Similarity=0.726 Sum_probs=248.4
Q ss_pred CCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 037702 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAM 89 (448)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (448)
.+|+.++.||+|||+.||.+++..+|+.||+|++.+..+.+....+.+.+||++.+.|+|||||+++++|++.+++|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 36999999999999999999999999999999999998888888899999999999999999999999999999999999
Q ss_pred eecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCc
Q 037702 90 EYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLL 168 (448)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 168 (448)
|+|..++|..++++ +.++|.+++.|++||+.||.|||+++|+|||||..|+||+++.++||+|||||+..... +...
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~--~Erk 175 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD--GERK 175 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCc--cccc
Confidence 99999999999976 68999999999999999999999999999999999999999999999999999976532 2345
Q ss_pred cccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHHHHhccC
Q 037702 169 HTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILD 248 (448)
Q Consensus 169 ~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~ 248 (448)
.|.||||.|.||||+...++. ..+||||+||+||.||.|++||...+..+.|.+|...++.+|..+|.++++||.++|+
T Consensus 176 ~TlCGTPNYIAPEVl~k~gHs-fEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL~ 254 (592)
T KOG0575|consen 176 KTLCGTPNYIAPEVLNKSGHS-FEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKLLR 254 (592)
T ss_pred ceecCCCcccChhHhccCCCC-CchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHHHhc
Confidence 789999999999999988874 8999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcCCCCCHHHHHhhhhccccccccCC
Q 037702 249 PNPSTRVTMAKLMENYWFRKGYKKIET 275 (448)
Q Consensus 249 ~dP~~Rpt~~eil~hp~~~~~~~~~~~ 275 (448)
+||.+|||+++||.|+||+.++.+...
T Consensus 255 ~~P~~Rpsl~~vL~h~Ff~~g~~p~~l 281 (592)
T KOG0575|consen 255 PNPSERPSLDEVLDHPFFKSGFTPARL 281 (592)
T ss_pred CCcccCCCHHHHhcCHhhhCCCcCCCC
Confidence 999999999999999999888765433
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-63 Score=499.46 Aligned_cols=262 Identities=42% Similarity=0.795 Sum_probs=247.2
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIY 86 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 86 (448)
...|-|++++.||.|+-|.|.+|+|..||+.+|||+|.+...........+.+||.+|+.+.||||+++|++|+++.++|
T Consensus 9 ~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~ly 88 (786)
T KOG0588|consen 9 NTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLY 88 (786)
T ss_pred ccccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEE
Confidence 35789999999999999999999999999999999999875444445577899999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccC
Q 037702 87 FAMEYVRGGELFNKVA-KGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQD 165 (448)
Q Consensus 87 lV~E~~~gg~L~~~i~-~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~ 165 (448)
+|+||++||+||+++. +|+++|.++.++|+||+.|+.|||..+|+||||||||+|||..+++||+|||+|.+- ..+
T Consensus 89 lvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe---~~g 165 (786)
T KOG0588|consen 89 LVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLE---VPG 165 (786)
T ss_pred EEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecc---cCC
Confidence 9999999999999986 599999999999999999999999999999999999999999999999999999863 345
Q ss_pred CCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHHHHh
Q 037702 166 GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSR 245 (448)
Q Consensus 166 ~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 245 (448)
.++.|.||+|+|.|||++.+..|+|.++||||||||||.||+|++||++.|...++.++.++.|.+|..+|+++++||++
T Consensus 166 klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr~ 245 (786)
T KOG0588|consen 166 KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLRR 245 (786)
T ss_pred ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHHHH
Confidence 78899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCcCCCCCHHHHHhhhhcccccc
Q 037702 246 ILDPNPSTRVTMAKLMENYWFRKGYK 271 (448)
Q Consensus 246 ~L~~dP~~Rpt~~eil~hp~~~~~~~ 271 (448)
||+.||.+|+|.+||++|||+.....
T Consensus 246 ml~VDp~~RiT~~eI~kHP~l~g~~~ 271 (786)
T KOG0588|consen 246 MLDVDPSTRITTEEILKHPFLSGYTS 271 (786)
T ss_pred HhccCccccccHHHHhhCchhhcCCC
Confidence 99999999999999999999977543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-63 Score=476.97 Aligned_cols=259 Identities=37% Similarity=0.698 Sum_probs=232.3
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchh----HHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVG----LIDQIKREISVMRLVRHPNIVQLYEVMASK 82 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~----~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~ 82 (448)
...+.|.+.+.||+|+||.|.+|..+.||+.||||++++....... ....+.+|+++|++|+|||||+++++++..
T Consensus 169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ 248 (475)
T KOG0615|consen 169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP 248 (475)
T ss_pred hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence 3667899999999999999999999999999999999987664422 234477999999999999999999999999
Q ss_pred CEEEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCC---CCeEEeecccccc
Q 037702 83 TKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDEN---GDLKISDFGLSAL 158 (448)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~---g~lkl~DFGla~~ 158 (448)
+..||||||++||+|++++.. +.+.|+..+.+++||+.|+.|||++||+||||||+|||+..+ -.+||+|||+|++
T Consensus 249 ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~ 328 (475)
T KOG0615|consen 249 DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV 328 (475)
T ss_pred CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence 999999999999999999865 789999999999999999999999999999999999999876 6799999999997
Q ss_pred ccccccCCCccccCCCCcccchhhhhccCC--CCCcchHHHHHHHHHHHHhCCCCCCCCcHHH-HHHHHhhccCCCC--C
Q 037702 159 QESTRQDGLLHTTCGTPAYVAPEVINKRGY--DGAKADIWSCGVVLFVLLAGNLPFYDSNLME-LYKKITRAEFKCP--N 233 (448)
Q Consensus 159 ~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~--~~~~sDiwSlGvil~elltG~~Pf~~~~~~~-~~~~i~~~~~~~p--~ 233 (448)
.+ ....+.|.||||.|+|||++...++ ++.++|+|||||+||.+++|.+||.+..... +..+|.++.+.+- .
T Consensus 329 ~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~ 405 (475)
T KOG0615|consen 329 SG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQ 405 (475)
T ss_pred cc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChh
Confidence 64 4567789999999999999987664 3457899999999999999999998876555 8889999988653 3
Q ss_pred C--CCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccc
Q 037702 234 W--FPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRK 268 (448)
Q Consensus 234 ~--~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 268 (448)
| +|.++++||.+||..||++|||++|+|+||||+.
T Consensus 406 w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~ 442 (475)
T KOG0615|consen 406 WDRISEEALDLINWMLVVDPENRPSADEALNHPWFKD 442 (475)
T ss_pred hhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhc
Confidence 3 7899999999999999999999999999999975
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-60 Score=449.63 Aligned_cols=259 Identities=35% Similarity=0.723 Sum_probs=240.9
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIY 86 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 86 (448)
.-.++|++.++||+|+||+||.++.+.|++.||+|++.|..+-+....+....|..+|..++||.||+++..|++.+++|
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy 101 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY 101 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence 45789999999999999999999999999999999999998877777889999999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccC
Q 037702 87 FAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQD 165 (448)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~ 165 (448)
||+||+.||+|+..+++ |.++|+.++.|+..|+.||.|||++||+||||||||||||.+|+++|+|||||+.... ..
T Consensus 102 lVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~--~~ 179 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK--DG 179 (357)
T ss_pred EEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhccc--CC
Confidence 99999999999999985 8999999999999999999999999999999999999999999999999999985432 22
Q ss_pred CCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCC-CCCCCHHHHHHHH
Q 037702 166 GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKC-PNWFPPEVRKLLS 244 (448)
Q Consensus 166 ~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~-p~~~s~~~~~li~ 244 (448)
....+.|||+.|||||++.+.+|+ ..+|+|||||++|+|++|.+||.+.+...++++|.++.... |..++++++++|+
T Consensus 180 ~~t~tfcGT~eYmAPEil~~~gy~-~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll~ 258 (357)
T KOG0598|consen 180 DATRTFCGTPEYMAPEILLGKGYD-KAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLLK 258 (357)
T ss_pred CccccccCCccccChHHHhcCCCC-cccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHHH
Confidence 345678999999999999999997 77999999999999999999999999999999999999554 5559999999999
Q ss_pred hccCCCcCCCC----CHHHHHhhhhccc
Q 037702 245 RILDPNPSTRV----TMAKLMENYWFRK 268 (448)
Q Consensus 245 ~~L~~dP~~Rp----t~~eil~hp~~~~ 268 (448)
++|..||.+|. ++.+|.+||||..
T Consensus 259 ~LL~rdp~~RLg~~~d~~~ik~HpfF~~ 286 (357)
T KOG0598|consen 259 KLLKRDPRQRLGGPGDAEEIKRHPFFKG 286 (357)
T ss_pred HHhccCHHHhcCCCCChHHhhcCccccc
Confidence 99999999995 7999999999976
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-60 Score=435.90 Aligned_cols=256 Identities=38% Similarity=0.746 Sum_probs=243.3
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIY 86 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 86 (448)
...++|++.++||.|+||.|.+++++.+|..+|+|++++..+-+-..++...+|..+|+.+.||.++++++.+.+.+.+|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 56789999999999999999999999999999999999998877778899999999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccC
Q 037702 87 FAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQD 165 (448)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~ 165 (448)
|||||++||+|+.++++ +++++..++.|+.||+.||+|||+++|++|||||||||||.+|.+||+|||+|....
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~----- 195 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS----- 195 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEec-----
Confidence 99999999999999987 899999999999999999999999999999999999999999999999999997542
Q ss_pred CCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHHHHh
Q 037702 166 GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSR 245 (448)
Q Consensus 166 ~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 245 (448)
+...|.||||.|+|||++...+|. ..+|.|||||++|||++|++||.+.+...+|.+|..++..+|..+++++++||++
T Consensus 196 ~rT~TlCGTPeYLAPEii~sk~yn-kavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~~ 274 (355)
T KOG0616|consen 196 GRTWTLCGTPEYLAPEIIQSKGYN-KAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLKK 274 (355)
T ss_pred CcEEEecCCccccChHHhhcCCCC-cchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHHH
Confidence 335688999999999999999986 7899999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCcCCCC-----CHHHHHhhhhccc
Q 037702 246 ILDPNPSTRV-----TMAKLMENYWFRK 268 (448)
Q Consensus 246 ~L~~dP~~Rp-----t~~eil~hp~~~~ 268 (448)
+|+.|-.+|. ...+|..||||+.
T Consensus 275 LL~vD~t~R~gnlknG~~dIk~H~wF~~ 302 (355)
T KOG0616|consen 275 LLQVDLTKRFGNLKNGVEDIKNHPWFKG 302 (355)
T ss_pred HHhhhhHhhhcCcCCCccccccCccccc
Confidence 9999999993 6789999999974
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-59 Score=460.95 Aligned_cols=261 Identities=34% Similarity=0.687 Sum_probs=242.6
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEVMASKTKI 85 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~ 85 (448)
....+|.+++.||+|+|++|++|+++++++.||||++++..+-++..+..+.+|-.+|.+| .||+|++|+..|.+...+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 3467899999999999999999999999999999999999888777788899999999999 899999999999999999
Q ss_pred EEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccccc
Q 037702 86 YFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQ 164 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~ 164 (448)
|+|+||+++|+|.++|.+ |.|+|..++.|+.||+.||+|||++|||||||||||||||.+|++||+|||.|+.+.....
T Consensus 150 YFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~ 229 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQK 229 (604)
T ss_pred EEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhc
Confidence 999999999999999987 9999999999999999999999999999999999999999999999999999987653321
Q ss_pred C-------CC----ccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCC
Q 037702 165 D-------GL----LHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPN 233 (448)
Q Consensus 165 ~-------~~----~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~ 233 (448)
. .. ..+.+||..|++||+|... +.+..+|||+||||||.|++|.+||.+.|.--++++|...++.+|+
T Consensus 230 ~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~-~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~ 308 (604)
T KOG0592|consen 230 SQENPVDPNQASSRRSSFVGTAEYVSPELLNDS-PAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPE 308 (604)
T ss_pred cccCccCcccccCcccceeeeecccCHHHhcCC-CCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCC
Confidence 1 11 1457899999999999765 4568899999999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccc
Q 037702 234 WFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRK 268 (448)
Q Consensus 234 ~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 268 (448)
.+++.+++||+++|..||.+|+|+.+|.+||||..
T Consensus 309 ~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~ 343 (604)
T KOG0592|consen 309 GFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEG 343 (604)
T ss_pred CCCHHHHHHHHHHHccCccccccHHHHhhCccccc
Confidence 99999999999999999999999999999999976
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-57 Score=435.42 Aligned_cols=262 Identities=37% Similarity=0.697 Sum_probs=239.0
Q ss_pred ccccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 037702 4 KAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKT 83 (448)
Q Consensus 4 ~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~ 83 (448)
.+.-..++|.+.+.||+|+||.||+|+++.++..||||.+.+..... ...+.+..||.+|+.++|||||++++++..++
T Consensus 4 ~~~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~-k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~ 82 (429)
T KOG0595|consen 4 GSMRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNK-KLVELLLSEIKILKELKHPNIVRLLDCIEDDD 82 (429)
T ss_pred CcccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCH-HHHHHHHHHHHHHHhcCCcceeeEEEEEecCC
Confidence 34567889999999999999999999999999999999999887533 55688999999999999999999999999999
Q ss_pred EEEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCC------CCeEEeecccc
Q 037702 84 KIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDEN------GDLKISDFGLS 156 (448)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~------g~lkl~DFGla 156 (448)
.+|||||||+||+|.+++.. ++++|..++.++.||+.||++||+++||||||||+||||+.+ -.+||+|||+|
T Consensus 83 ~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 83 FIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred eEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 99999999999999999987 699999999999999999999999999999999999999875 35899999999
Q ss_pred ccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccC---CCCC
Q 037702 157 ALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF---KCPN 233 (448)
Q Consensus 157 ~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---~~p~ 233 (448)
+... ......+.||+|.|||||++....|+ +|+|+||+|+|||+|++|+.||+..+..+++..+.++.. ..|.
T Consensus 163 R~L~---~~~~a~tlcGSplYMAPEV~~~~~Yd-AKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~ 238 (429)
T KOG0595|consen 163 RFLQ---PGSMAETLCGSPLYMAPEVIMSQQYD-AKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPA 238 (429)
T ss_pred hhCC---chhHHHHhhCCccccCHHHHHhcccc-chhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhh
Confidence 9765 44567899999999999999888887 999999999999999999999999999999998887754 3455
Q ss_pred CCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccccc
Q 037702 234 WFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGY 270 (448)
Q Consensus 234 ~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 270 (448)
++++...+|+...|..||..|.+..+-+.|+++....
T Consensus 239 ~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 239 ELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred hccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 6888899999999999999999999999999986654
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-56 Score=427.22 Aligned_cols=257 Identities=33% Similarity=0.569 Sum_probs=232.3
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE-E
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTK-I 85 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~-~ 85 (448)
+..++.+.++.||+|+.|.||+++|+.|++.+|+|+|... .+....+++.+|+++++.++|||||.+|++|..+.. +
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~i 153 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEI 153 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceE
Confidence 4556788999999999999999999999999999999433 234567899999999999999999999999999984 9
Q ss_pred EEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCCEeecCCCCceEEcCCCCeEEeeccccccccccc
Q 037702 86 YFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHS-RGVYHRDLKPENLLLDENGDLKISDFGLSALQESTR 163 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~-~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~ 163 (448)
+|+||||+||+|.+.+.. |+++|.....++.++++||.|||+ ++|+||||||+|||++..|.+||||||.+......
T Consensus 154 sI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred EeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 999999999999999976 899999999999999999999995 99999999999999999999999999999865433
Q ss_pred cCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCC-----cHHHHHHHHhhccC-CCCCC-CC
Q 037702 164 QDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDS-----NLMELYKKITRAEF-KCPNW-FP 236 (448)
Q Consensus 164 ~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~-----~~~~~~~~i~~~~~-~~p~~-~s 236 (448)
...+.+||..|||||.+.+..|. .++||||||+.++|+++|+.||... +..+++..|..+.. ..|.. +|
T Consensus 233 ---~a~tfvGT~~YMsPERi~g~~Ys-~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS 308 (364)
T KOG0581|consen 233 ---IANTFVGTSAYMSPERISGESYS-VKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFS 308 (364)
T ss_pred ---hcccccccccccChhhhcCCcCC-cccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCC
Confidence 56789999999999999888775 8899999999999999999999874 66788888888654 56776 99
Q ss_pred HHHHHHHHhccCCCcCCCCCHHHHHhhhhccccc
Q 037702 237 PEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGY 270 (448)
Q Consensus 237 ~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 270 (448)
+++++||..||++||.+|||+.|+++|||+++..
T Consensus 309 ~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 309 PEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 9999999999999999999999999999998643
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-56 Score=441.89 Aligned_cols=262 Identities=33% Similarity=0.631 Sum_probs=237.6
Q ss_pred cccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 037702 5 AGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTK 84 (448)
Q Consensus 5 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 84 (448)
..+-.++|++++.||+||||.||+|+.+.||+.+|+|++.++.....+.++.++.|-.+|...++|+||++|..|.+.++
T Consensus 136 ~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~ 215 (550)
T KOG0605|consen 136 TRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEY 215 (550)
T ss_pred ccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCe
Confidence 34567899999999999999999999999999999999999988877888999999999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccc-
Q 037702 85 IYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQEST- 162 (448)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~- 162 (448)
+||||||++||++..++.+ +.|+|+.++.|+.+++.|++-+|+.|+|||||||+|+|||..|++||+|||||+-....
T Consensus 216 LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~ 295 (550)
T KOG0605|consen 216 LYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH 295 (550)
T ss_pred eEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhh
Confidence 9999999999999999865 89999999999999999999999999999999999999999999999999998632210
Q ss_pred -------------------ccCC-------------------------CccccCCCCcccchhhhhccCCCCCcchHHHH
Q 037702 163 -------------------RQDG-------------------------LLHTTCGTPAYVAPEVINKRGYDGAKADIWSC 198 (448)
Q Consensus 163 -------------------~~~~-------------------------~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSl 198 (448)
..+. .....+|||.||||||+.+.+|. ..+|+|||
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~-~~cDwWSL 374 (550)
T KOG0605|consen 296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYG-KECDWWSL 374 (550)
T ss_pred hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCC-ccccHHHH
Confidence 0000 11245899999999999999985 88999999
Q ss_pred HHHHHHHHhCCCCCCCCcHHHHHHHHhhcc--CCCCCC--CCHHHHHHHHhccCCCcCCCCC---HHHHHhhhhccc
Q 037702 199 GVVLFVLLAGNLPFYDSNLMELYKKITRAE--FKCPNW--FPPEVRKLLSRILDPNPSTRVT---MAKLMENYWFRK 268 (448)
Q Consensus 199 Gvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~--~s~~~~~li~~~L~~dP~~Rpt---~~eil~hp~~~~ 268 (448)
|||+||||.|++||...+..+.+++|.... +.+|.. ++++++|||.+||. ||.+|.. ++||.+||||+.
T Consensus 375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~ 450 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKG 450 (550)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCcccc
Confidence 999999999999999999999999998875 566654 78999999999999 9999984 999999999986
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-57 Score=433.04 Aligned_cols=263 Identities=41% Similarity=0.773 Sum_probs=249.4
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKI 85 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 85 (448)
..+..+|++.+.||+|+||+|.+|.....|..||||.|.++.+.++..+-.+.+||.||..|+||||+.+|++|++.+++
T Consensus 49 hnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKI 128 (668)
T KOG0611|consen 49 HNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKI 128 (668)
T ss_pred cchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceE
Confidence 34678999999999999999999999999999999999999999988888999999999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccccc
Q 037702 86 YFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQ 164 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~ 164 (448)
.|||||..+|+|++++.. +.++|.+++++|+||.+|+.|||.++++|||||.+|||||.|+++||+||||+.++. .
T Consensus 129 vivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~---~ 205 (668)
T KOG0611|consen 129 VIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYA---D 205 (668)
T ss_pred EEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhc---c
Confidence 999999999999999976 889999999999999999999999999999999999999999999999999998754 3
Q ss_pred CCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 037702 165 DGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLS 244 (448)
Q Consensus 165 ~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 244 (448)
..++.|.||+|.|.+||++++..|.|+.+|-|||||+||.|+.|.+||++.+...+.++|.++.+.-|. -|.++.-||+
T Consensus 206 ~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~-~PSdA~gLIR 284 (668)
T KOG0611|consen 206 KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE-TPSDASGLIR 284 (668)
T ss_pred ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC-CCchHHHHHH
Confidence 467889999999999999999999999999999999999999999999999999999999999998776 5778999999
Q ss_pred hccCCCcCCCCCHHHHHhhhhccccccc
Q 037702 245 RILDPNPSTRVTMAKLMENYWFRKGYKK 272 (448)
Q Consensus 245 ~~L~~dP~~Rpt~~eil~hp~~~~~~~~ 272 (448)
+||..||++|.|+++|..|=|+.=+|..
T Consensus 285 wmLmVNP~RRATieDiAsHWWvNwgy~~ 312 (668)
T KOG0611|consen 285 WMLMVNPERRATIEDIASHWWVNWGYNM 312 (668)
T ss_pred HHHhcCcccchhHHHHhhhheeeccccc
Confidence 9999999999999999999998777754
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-55 Score=396.80 Aligned_cols=259 Identities=37% Similarity=0.685 Sum_probs=244.7
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKI 85 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 85 (448)
....++|++++.||+|.||.||+|+.++++-.||+|++.++.+...+...++.||+++...|+||||+++|++|.+...+
T Consensus 18 ~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ri 97 (281)
T KOG0580|consen 18 TWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRI 97 (281)
T ss_pred ccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecccee
Confidence 45688999999999999999999999999999999999999888777889999999999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccc
Q 037702 86 YFAMEYVRGGELFNKVAK---GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQEST 162 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~ 162 (448)
|+++||+++|+|+..+.. .+++|..+..|+.|++.|+.|||.++|+||||||+|+|++..|.+||+|||.+....
T Consensus 98 yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-- 175 (281)
T KOG0580|consen 98 YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-- 175 (281)
T ss_pred EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence 999999999999999984 469999999999999999999999999999999999999999999999999997543
Q ss_pred ccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHH
Q 037702 163 RQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKL 242 (448)
Q Consensus 163 ~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 242 (448)
.....|.|||..|.|||...+.+++ ..+|+|++|++.||++.|.+||...+..+.|++|.+.++.+|..+|.+++||
T Consensus 176 --~~kR~tlcgt~dyl~pEmv~~~~hd-~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~dl 252 (281)
T KOG0580|consen 176 --SNKRKTLCGTLDYLPPEMVEGRGHD-KFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAADL 252 (281)
T ss_pred --CCCceeeecccccCCHhhcCCCCcc-chhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHHHH
Confidence 3345789999999999999999987 7799999999999999999999999999999999999999999999999999
Q ss_pred HHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 243 LSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 243 i~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
|.+||..+|.+|.+..|++.|||+...
T Consensus 253 I~~ll~~~p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 253 ISRLLVKNPIERLALTEVMDHPWIVAN 279 (281)
T ss_pred HHHHhccCccccccHHHHhhhHHHHhc
Confidence 999999999999999999999998753
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-54 Score=438.62 Aligned_cols=260 Identities=32% Similarity=0.615 Sum_probs=244.1
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR-HPNIVQLYEVMASKTK 84 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~ 84 (448)
.+-.++|.+.++||+|+||+|++|..+.+++.||||++.|..+...+.++..+.|.+|+.... ||.+++++..|.++++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 566889999999999999999999999999999999999998887788999999999999885 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccccc
Q 037702 85 IYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQ 164 (448)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~ 164 (448)
+|+||||+.||++..+...+.|+|..++.|+..++.||+|||++||||||||.+|||||.+|++||+|||+++.. ...
T Consensus 444 l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~--m~~ 521 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEG--MGQ 521 (694)
T ss_pred EEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEeccccccccc--CCC
Confidence 999999999999777777799999999999999999999999999999999999999999999999999999843 223
Q ss_pred CCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 037702 165 DGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLS 244 (448)
Q Consensus 165 ~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 244 (448)
.....|.||||.|||||++.+..|. ..+|+|||||+|||||.|..||.+.+.++++..|...+..+|.|+|.++.++++
T Consensus 522 g~~TsTfCGTpey~aPEil~e~~Yt-~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~~il~ 600 (694)
T KOG0694|consen 522 GDRTSTFCGTPEFLAPEVLTEQSYT-RAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAIAIMR 600 (694)
T ss_pred CCccccccCChhhcChhhhccCccc-chhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHHHHHH
Confidence 4456789999999999999998885 889999999999999999999999999999999999999999999999999999
Q ss_pred hccCCCcCCCCC-----HHHHHhhhhccc
Q 037702 245 RILDPNPSTRVT-----MAKLMENYWFRK 268 (448)
Q Consensus 245 ~~L~~dP~~Rpt-----~~eil~hp~~~~ 268 (448)
++|.+||++|.. +++|.+||||+.
T Consensus 601 ~ll~k~p~kRLG~~e~d~~~i~~hpFFr~ 629 (694)
T KOG0694|consen 601 RLLRKNPEKRLGSGERDAEDIKKHPFFRS 629 (694)
T ss_pred HHhccCcccccCCCCCCchhhhhCCcccc
Confidence 999999999985 588999999976
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-56 Score=402.92 Aligned_cols=260 Identities=35% Similarity=0.682 Sum_probs=235.3
Q ss_pred cccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 037702 5 AGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTK 84 (448)
Q Consensus 5 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 84 (448)
...+.+.|++.+.||+|.|+.||++.+..||+.+|+|+++...+... ..+.+.+|+.|-+.|+||||+++++.+.+...
T Consensus 6 ~~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~ 84 (355)
T KOG0033|consen 6 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESF 84 (355)
T ss_pred ccccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccce
Confidence 44567899999999999999999999999999999999998887765 45889999999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcC---CCCeEEeecccccccc
Q 037702 85 IYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDE---NGDLKISDFGLSALQE 160 (448)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~---~g~lkl~DFGla~~~~ 160 (448)
.|||+|+++|++|+.-|.. --++|..+-.+++||++||.|||.+||+|||+||+|+||-+ ..-+||+|||+|....
T Consensus 85 ~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 85 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred eEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 9999999999999766544 45899999999999999999999999999999999999954 3459999999998654
Q ss_pred ccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCC----CCC
Q 037702 161 STRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPN----WFP 236 (448)
Q Consensus 161 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s 236 (448)
.........|||.|||||++....| +.++|||++|||||-|+.|++||.+.+...+|..|..+.+.+|+ .++
T Consensus 165 ---~g~~~~G~~GtP~fmaPEvvrkdpy-~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is 240 (355)
T KOG0033|consen 165 ---DGEAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVT 240 (355)
T ss_pred ---CccccccccCCCcccCHHHhhcCCC-CCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCC
Confidence 3445567889999999999988777 48899999999999999999999999999999999999887664 388
Q ss_pred HHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 237 PEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 237 ~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
+++++|+++||..||.+|+|+.|.|+|||+++.
T Consensus 241 ~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 241 PEAKSLIRRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred HHHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence 999999999999999999999999999999764
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-54 Score=423.27 Aligned_cols=267 Identities=37% Similarity=0.669 Sum_probs=236.4
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccch-----------hHHHHHHHHHHHHHhCCCCCcce
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRV-----------GLIDQIKREISVMRLVRHPNIVQ 74 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~-----------~~~~~~~~Ei~~l~~l~hpnIv~ 74 (448)
...++.|++++.||+|.||+|.+|++..+++.||||++++...... .-.+++++||.+|++|.|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 4578899999999999999999999999999999999987654321 12478999999999999999999
Q ss_pred EEEEEEe--CCEEEEEEeecCCCchHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEe
Q 037702 75 LYEVMAS--KTKIYFAMEYVRGGELFNKVAKGK-LREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKIS 151 (448)
Q Consensus 75 l~~~~~~--~~~~~lV~E~~~gg~L~~~i~~~~-l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~ 151 (448)
|+++..+ .+++|||+|||..|.+...-.... +++.++++|+++++.||+|||.+||+||||||+|+||+++|++||+
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIs 252 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKIS 252 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEee
Confidence 9999976 468999999999999866554455 9999999999999999999999999999999999999999999999
Q ss_pred ecccccccccc---ccCCCccccCCCCcccchhhhhc---cCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHh
Q 037702 152 DFGLSALQEST---RQDGLLHTTCGTPAYVAPEVINK---RGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKIT 225 (448)
Q Consensus 152 DFGla~~~~~~---~~~~~~~~~~Gt~~Y~APEvl~~---~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~ 225 (448)
|||.+...... ..+..+...+|||.|+|||.+.. ..+.+.+.||||+||+||.|+.|++||.+....+++.+|.
T Consensus 253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIv 332 (576)
T KOG0585|consen 253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIV 332 (576)
T ss_pred ccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHh
Confidence 99999865332 12223445789999999999876 5577899999999999999999999999999999999999
Q ss_pred hccCCCCCC--CCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccccccc
Q 037702 226 RAEFKCPNW--FPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYKK 272 (448)
Q Consensus 226 ~~~~~~p~~--~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~ 272 (448)
...+.+|.. +.+++++||.+||.+||.+|+++.+|..|||.......
T Consensus 333 n~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~ 381 (576)
T KOG0585|consen 333 NDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDS 381 (576)
T ss_pred cCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCC
Confidence 999888876 78999999999999999999999999999999876543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-56 Score=407.90 Aligned_cols=247 Identities=34% Similarity=0.626 Sum_probs=222.9
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEE-EE-EeCCE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYE-VM-ASKTK 84 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~-~~-~~~~~ 84 (448)
....+|++.+.||+|+||.||++.+..+|..+|.|.+.-..... ...+.+..|+.+|++|+|||||++++ -+ +++..
T Consensus 16 ~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~-k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ev 94 (375)
T KOG0591|consen 16 KTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDA-KARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEV 94 (375)
T ss_pred ccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccH-HHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchh
Confidence 44567999999999999999999999999999999998554443 45678889999999999999999998 34 44455
Q ss_pred EEEEEeecCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH--CC--CEeecCCCCceEEcCCCCeEEeeccc
Q 037702 85 IYFAMEYVRGGELFNKVAK-----GKLREEVARKYFQQLVDAVEFCHS--RG--VYHRDLKPENLLLDENGDLKISDFGL 155 (448)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~aL~yLH~--~g--ivHrDLkp~NILl~~~g~lkl~DFGl 155 (448)
++||||||.+|+|.+.|+. ..++|..+|+++.||+.||..||+ .. |+||||||.||+|+.+|.+||+||||
T Consensus 95 lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL 174 (375)
T KOG0591|consen 95 LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGL 174 (375)
T ss_pred hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchh
Confidence 9999999999999999863 469999999999999999999999 45 99999999999999999999999999
Q ss_pred cccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCC-CC-C
Q 037702 156 SALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFK-CP-N 233 (448)
Q Consensus 156 a~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-~p-~ 233 (448)
++++.... ...++.+|||+||+||++...+|+ .+|||||+||++|||+.-..||.+.+..++.++|..++++ +| .
T Consensus 175 ~r~l~s~~--tfA~S~VGTPyYMSPE~i~~~~Y~-~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~ 251 (375)
T KOG0591|consen 175 GRFLSSKT--TFAHSLVGTPYYMSPERIHESGYN-FKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDE 251 (375)
T ss_pred HhHhcchh--HHHHhhcCCCcccCHHHHhcCCCC-cchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHH
Confidence 99876543 346788999999999999999997 9999999999999999999999999999999999999886 77 6
Q ss_pred CCCHHHHHHHHhccCCCcCCCCCH
Q 037702 234 WFPPEVRKLLSRILDPNPSTRVTM 257 (448)
Q Consensus 234 ~~s~~~~~li~~~L~~dP~~Rpt~ 257 (448)
.+|.++..||..|+.+||.+||+.
T Consensus 252 ~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 252 HYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred HhhhHHHHHHHHHccCCcccCCCc
Confidence 799999999999999999999997
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-53 Score=412.71 Aligned_cols=260 Identities=34% Similarity=0.620 Sum_probs=222.1
Q ss_pred cCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC--EEE
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKT--KIY 86 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~--~~~ 86 (448)
.-+|..++.||+|+||.||++.+..+|...|||.+....... .+.+.+|+.+|+.++|||||++++...... .++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~---~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT---SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh---HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence 346999999999999999999999999999999998763221 577999999999999999999999754444 699
Q ss_pred EEEeecCCCchHHHHhc-C-CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcC-CCCeEEeeccccccccc-c
Q 037702 87 FAMEYVRGGELFNKVAK-G-KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDE-NGDLKISDFGLSALQES-T 162 (448)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~-~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~-~g~lkl~DFGla~~~~~-~ 162 (448)
+.|||++||+|.+++.+ | +++|+.++.|.+|+++||.|||++||+||||||+|||++. +|.+||+|||++..... .
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 99999999999999987 4 7999999999999999999999999999999999999999 79999999999986553 1
Q ss_pred ccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCC-CcHHHHHHHHhhcc--CCCCCCCCHHH
Q 037702 163 RQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYD-SNLMELYKKITRAE--FKCPNWFPPEV 239 (448)
Q Consensus 163 ~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~~~--~~~p~~~s~~~ 239 (448)
..........|||.|||||++......+.++|||||||++.||+||+.||.. ....+....+.... +.+|.++|+++
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a 252 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEA 252 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHH
Confidence 1122234578999999999998632333589999999999999999999987 44444444444433 57889999999
Q ss_pred HHHHHhccCCCcCCCCCHHHHHhhhhcccccc
Q 037702 240 RKLLSRILDPNPSTRVTMAKLMENYWFRKGYK 271 (448)
Q Consensus 240 ~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~ 271 (448)
++||.+||..||++|||++++|+|||.+....
T Consensus 253 ~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 253 KDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred HHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 99999999999999999999999999976543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-54 Score=424.16 Aligned_cols=263 Identities=34% Similarity=0.656 Sum_probs=242.5
Q ss_pred cCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFA 88 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 88 (448)
+++|.+.+.||+|+||.||+|+.+.|.+.||||.++|..-.. .....+.+|+++++.++||||+.+++.|++..++|+|
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~-k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV 79 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNE-KELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV 79 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCch-HHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence 578999999999999999999999999999999999876443 4467899999999999999999999999999999999
Q ss_pred EeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCC
Q 037702 89 MEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGL 167 (448)
Q Consensus 89 ~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 167 (448)
+|||.| +|+.++.. +.++|+.++.++.|+++||.|||+++|.|||+||.|||++.+|.+|+||||+|+.... ....
T Consensus 80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~t~v 156 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST--NTSV 156 (808)
T ss_pred ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhccc--Ccee
Confidence 999988 99999986 8999999999999999999999999999999999999999999999999999986543 3345
Q ss_pred ccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHHHHhcc
Q 037702 168 LHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRIL 247 (448)
Q Consensus 168 ~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L 247 (448)
+....|||.|||||++.+..|+ ..+|+||||||||||++|++||...+..++.+.|.+....+|...|+.+.+|+..+|
T Consensus 157 ltsikGtPlYmAPElv~e~pyd-~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL 235 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEEQPYD-HTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGLL 235 (808)
T ss_pred eeeccCcccccCHHHHcCCCcc-chhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHHh
Confidence 5566899999999999988886 789999999999999999999999999999999999999999999999999999999
Q ss_pred CCCcCCCCCHHHHHhhhhccccccccCCC
Q 037702 248 DPNPSTRVTMAKLMENYWFRKGYKKIETP 276 (448)
Q Consensus 248 ~~dP~~Rpt~~eil~hp~~~~~~~~~~~~ 276 (448)
.+||.+|.|..+++.|||.+......+.+
T Consensus 236 ~kdP~~RltW~~Ll~HpF~k~~~~~~~~~ 264 (808)
T KOG0597|consen 236 IKDPAQRLTWTDLLGHPFWKGKINIAELP 264 (808)
T ss_pred hcChhhcccHHHHhcChHHhhhhhhhccc
Confidence 99999999999999999998766554443
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-54 Score=397.12 Aligned_cols=255 Identities=29% Similarity=0.492 Sum_probs=219.8
Q ss_pred cCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFA 88 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 88 (448)
+++|+....+|+|+||.||+|+++.||+.||||.+--+ ..+....+-..|||++|++++|||+|.++++|..+.++|+|
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Es-edd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV 79 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVES-EDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV 79 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccC-CccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence 57899999999999999999999999999999998533 23334455678999999999999999999999999999999
Q ss_pred EeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCC
Q 037702 89 MEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDG 166 (448)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 166 (448)
+|||+.. +.+-++. .+++++.++.|+.|++.|+.|||+++++||||||||||++.+|.+||||||+|+.... ...
T Consensus 80 FE~~dhT-vL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--pgd 156 (396)
T KOG0593|consen 80 FEYCDHT-VLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA--PGD 156 (396)
T ss_pred eeecchH-HHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC--Ccc
Confidence 9999874 4444443 5799999999999999999999999999999999999999999999999999997653 334
Q ss_pred CccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhcc------------------
Q 037702 167 LLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAE------------------ 228 (448)
Q Consensus 167 ~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~------------------ 228 (448)
.+..++.|.+|+|||.+.+...+|..+||||+||++.||++|.+.|++.+..+....|.+.-
T Consensus 157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~ 236 (396)
T KOG0593|consen 157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH 236 (396)
T ss_pred hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence 45667899999999999987777899999999999999999999999988776665554321
Q ss_pred -CCCC------------CCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcc
Q 037702 229 -FKCP------------NWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFR 267 (448)
Q Consensus 229 -~~~p------------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~ 267 (448)
..+| +.++.-+.+|++.||..||.+|++.++++.||+|.
T Consensus 237 Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd 288 (396)
T KOG0593|consen 237 GVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFD 288 (396)
T ss_pred eeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHH
Confidence 1111 12567889999999999999999999999999993
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-52 Score=414.95 Aligned_cols=258 Identities=36% Similarity=0.711 Sum_probs=235.4
Q ss_pred cccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 037702 5 AGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTK 84 (448)
Q Consensus 5 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 84 (448)
.....++|++.+.||+|+||.||+|++..+|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.+++.
T Consensus 13 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 92 (329)
T PTZ00263 13 SSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENR 92 (329)
T ss_pred CCCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCE
Confidence 34567899999999999999999999999999999999987655444456778999999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccc
Q 037702 85 IYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTR 163 (448)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~ 163 (448)
+|+||||++||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 93 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~-- 170 (329)
T PTZ00263 93 VYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD-- 170 (329)
T ss_pred EEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC--
Confidence 9999999999999999876 6799999999999999999999999999999999999999999999999999875422
Q ss_pred cCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 037702 164 QDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLL 243 (448)
Q Consensus 164 ~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 243 (448)
...+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+..+..+...+|.++++.+++||
T Consensus 171 ---~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li 246 (329)
T PTZ00263 171 ---RTFTLCGTPEYLAPEVIQSKGH-GKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLV 246 (329)
T ss_pred ---CcceecCChhhcCHHHHcCCCC-CCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHH
Confidence 1235689999999999987776 488999999999999999999999988888899999888999999999999999
Q ss_pred HhccCCCcCCCCC-----HHHHHhhhhccc
Q 037702 244 SRILDPNPSTRVT-----MAKLMENYWFRK 268 (448)
Q Consensus 244 ~~~L~~dP~~Rpt-----~~eil~hp~~~~ 268 (448)
.+||+.||.+||+ ++++++||||..
T Consensus 247 ~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 247 KGLLQTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred HHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 9999999999997 799999999976
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-53 Score=416.89 Aligned_cols=266 Identities=38% Similarity=0.730 Sum_probs=246.4
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKI 85 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 85 (448)
+.+.|=|.+-+.||+|.|+.|.+|++.-||+.||||+|++.+..... ..++.+|++.|+.++|||||++|++..+..++
T Consensus 14 gkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~s-t~hlfqEVRCMKLVQHpNiVRLYEViDTQTKl 92 (864)
T KOG4717|consen 14 GKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLS-TGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKL 92 (864)
T ss_pred cceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhh-hhHHHHHHHHHHHhcCcCeeeeeehhcccceE
Confidence 45778899999999999999999999999999999999998876543 36788999999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEc-CCCCeEEeecccccccccc
Q 037702 86 YFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLD-ENGDLKISDFGLSALQEST 162 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~-~~g~lkl~DFGla~~~~~~ 162 (448)
|||+|+-++|+|+++|-+ .++.|+.+++||.||+.|+.|||+..+|||||||||+.+. .-|-+||.|||++..+..
T Consensus 93 yLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P- 171 (864)
T KOG4717|consen 93 YLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP- 171 (864)
T ss_pred EEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCC-
Confidence 999999999999999976 4699999999999999999999999999999999998775 568999999999975543
Q ss_pred ccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHH
Q 037702 163 RQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKL 242 (448)
Q Consensus 163 ~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 242 (448)
...+.+.||+..|-|||++.+..|+.+++||||||||||-|++|++||+..|..+.+..|....+..|..+|.++++|
T Consensus 172 --G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdL 249 (864)
T KOG4717|consen 172 --GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDL 249 (864)
T ss_pred --cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHH
Confidence 345789999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHhccCCCcCCCCCHHHHHhhhhccccccccCC
Q 037702 243 LSRILDPNPSTRVTMAKLMENYWFRKGYKKIET 275 (448)
Q Consensus 243 i~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~ 275 (448)
|..||..||.+|.+.++|..++|++.+.....+
T Consensus 250 I~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~sT 282 (864)
T KOG4717|consen 250 IQSMLVRDPKKRASLEEIVSTSWLQAGDRGLST 282 (864)
T ss_pred HHHHHhcCchhhccHHHHhccccccCCCCCccc
Confidence 999999999999999999999999987655443
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-53 Score=416.43 Aligned_cols=262 Identities=31% Similarity=0.513 Sum_probs=228.3
Q ss_pred cccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCC
Q 037702 5 AGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR-HPNIVQLYEVMASKT 83 (448)
Q Consensus 5 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~ 83 (448)
...++++|.+.+.||.|+||.||+|+...+|+.||||.+.++-..- +..- =.||+..|++++ |||||++++++.+++
T Consensus 5 ~~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~-ee~~-nLREvksL~kln~hpniikL~Evi~d~~ 82 (538)
T KOG0661|consen 5 QVIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSW-EECM-NLREVKSLRKLNPHPNIIKLKEVIRDND 82 (538)
T ss_pred ehhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccH-HHHH-HHHHHHHHHhcCCCCcchhhHHHhhccC
Confidence 3467899999999999999999999999999999999997654332 2222 358999999998 999999999998887
Q ss_pred -EEEEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccc
Q 037702 84 -KIYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQE 160 (448)
Q Consensus 84 -~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~ 160 (448)
.+|+|||||+. +|+++++. ..|++..++.|+.||++||+|+|.+|++|||+||||||+..+..+||+|||||+...
T Consensus 83 ~~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 83 RILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred ceEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccc
Confidence 99999999965 99999976 469999999999999999999999999999999999999999999999999999765
Q ss_pred ccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhc-------------
Q 037702 161 STRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA------------- 227 (448)
Q Consensus 161 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~------------- 227 (448)
.. ..+..++.|.+|+|||+|...++++.+.||||+|||++|+.+-++.|.+.+..+...+|..-
T Consensus 162 Sk---pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~ 238 (538)
T KOG0661|consen 162 SK---PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY 238 (538)
T ss_pred cC---CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence 43 23456789999999999999999999999999999999999999999999887777666431
Q ss_pred ------cCCCCC-----------CCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccccccc
Q 037702 228 ------EFKCPN-----------WFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYKK 272 (448)
Q Consensus 228 ------~~~~p~-----------~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~ 272 (448)
.+.+|. ..++++.++|.+||.+||++|||++++++||||+.....
T Consensus 239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~ 300 (538)
T KOG0661|consen 239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRAS 300 (538)
T ss_pred HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccccc
Confidence 233332 267999999999999999999999999999999876543
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-51 Score=400.64 Aligned_cols=263 Identities=32% Similarity=0.544 Sum_probs=232.4
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKI 85 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 85 (448)
..-.+.|++...||.|..+.||+|++..+++.||||+++.++.... .+.+.+|+..|+.++||||++++..|..+..+
T Consensus 22 p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~L 99 (516)
T KOG0582|consen 22 PLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCSFVVDSEL 99 (516)
T ss_pred CCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEEEEeccee
Confidence 4567899999999999999999999999999999999999887653 68899999999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccc
Q 037702 86 YFAMEYVRGGELFNKVAK---GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQEST 162 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~ 162 (448)
|+||.||.+|++.+.+.. ..++|..+..+++++++||.|||++|.||||||+.||||+.+|.+||+|||.+......
T Consensus 100 WvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 100 WVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred EEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 999999999999999975 46999999999999999999999999999999999999999999999999998754433
Q ss_pred ccC-CCc-cccCCCCcccchhhhh--ccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCC-----
Q 037702 163 RQD-GLL-HTTCGTPAYVAPEVIN--KRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPN----- 233 (448)
Q Consensus 163 ~~~-~~~-~~~~Gt~~Y~APEvl~--~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~----- 233 (448)
... ... .+..|||+|||||++. ..||+ .|+|||||||+..||.+|..||.....+.+.-.-..+.++.+.
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYd-fKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~ 258 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYD-FKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLD 258 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCcc-chhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCC
Confidence 211 111 6779999999999964 35776 9999999999999999999999998888776665556554332
Q ss_pred -----CCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccccc
Q 037702 234 -----WFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYK 271 (448)
Q Consensus 234 -----~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~ 271 (448)
.++..++.+|..||+.||.+|||++++|+|+||++...
T Consensus 259 ~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~ 301 (516)
T KOG0582|consen 259 KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS 301 (516)
T ss_pred hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence 26788999999999999999999999999999987543
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-51 Score=413.04 Aligned_cols=259 Identities=39% Similarity=0.746 Sum_probs=236.4
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR-HPNIVQLYEVMASKTKI 85 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~ 85 (448)
-....|++++.||+|.||.||+|+++.||+.+|+|.+.+.........+.+.+|+.+|+.+. |||||.+++++++...+
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 35568999999999999999999999999999999999988766555678999999999998 99999999999999999
Q ss_pred EEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCC----CCeEEeeccccccccc
Q 037702 86 YFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDEN----GDLKISDFGLSALQES 161 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~----g~lkl~DFGla~~~~~ 161 (448)
|+|||+|.||+|++.+....++|..+..++.|++.|+.|||+.||+||||||||+|+... +.+|++|||+|.....
T Consensus 112 ~lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~ 191 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP 191 (382)
T ss_pred EEEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC
Confidence 999999999999999976459999999999999999999999999999999999999643 4799999999987644
Q ss_pred cccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCC--CC--CCH
Q 037702 162 TRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCP--NW--FPP 237 (448)
Q Consensus 162 ~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p--~~--~s~ 237 (448)
....++.||||.|+|||++...+|. ..+||||+|+++|.|++|.+||.+.+......+|..+++.++ .| +|.
T Consensus 192 ---~~~~~~~~Gtp~y~APEvl~~~~y~-~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~ 267 (382)
T KOG0032|consen 192 ---GERLHTIVGTPEYVAPEVLGGRPYG-DEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISE 267 (382)
T ss_pred ---CceEeeecCCccccCchhhcCCCCC-cccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCH
Confidence 4567889999999999999877775 889999999999999999999999999999999999877543 33 789
Q ss_pred HHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 238 EVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 238 ~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
.+++||++||..||.+|+|+.++|+|||++..
T Consensus 268 ~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 268 SAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred HHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 99999999999999999999999999998764
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-52 Score=404.02 Aligned_cols=253 Identities=31% Similarity=0.616 Sum_probs=230.4
Q ss_pred CCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 037702 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAM 89 (448)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (448)
++|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999999999999999998654443344567889999999999999999999999999999999
Q ss_pred eecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCc
Q 037702 90 EYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLL 168 (448)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 168 (448)
||+++|+|.+++.. +.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||++...... .
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-----~ 155 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-----T 155 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC-----c
Confidence 99999999999975 67999999999999999999999999999999999999999999999999998754321 2
Q ss_pred cccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHHHHhccC
Q 037702 169 HTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILD 248 (448)
Q Consensus 169 ~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~ 248 (448)
.+.+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+..+.+..+......+|..+++.+++||++||.
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~ 234 (291)
T cd05612 156 WTLCGTPEYLAPEVIQSKGHN-KAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLV 234 (291)
T ss_pred ccccCChhhcCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHcC
Confidence 346799999999999877764 8899999999999999999999999988999999988888999999999999999999
Q ss_pred CCcCCCCC-----HHHHHhhhhccc
Q 037702 249 PNPSTRVT-----MAKLMENYWFRK 268 (448)
Q Consensus 249 ~dP~~Rpt-----~~eil~hp~~~~ 268 (448)
.||.+||+ ++++++||||+.
T Consensus 235 ~dp~~R~~~~~~~~~~~l~h~~~~~ 259 (291)
T cd05612 235 VDRTRRLGNMKNGADDVKNHRWFKS 259 (291)
T ss_pred CCHHHccCCccCCHHHHhcCccccC
Confidence 99999995 999999999964
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-52 Score=409.29 Aligned_cols=259 Identities=33% Similarity=0.576 Sum_probs=228.2
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEE
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASK--TKI 85 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~ 85 (448)
..+.|+.++.||+|+||.||+|++..||+.||+|.+..+.... +...-+.|||.||++|+||||++|.+...+. ..+
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~-~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si 193 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKE-GFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI 193 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCC-cchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence 4567999999999999999999999999999999998776443 4556778999999999999999999998876 689
Q ss_pred EEEEeecCCCchHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccc
Q 037702 86 YFAMEYVRGGELFNKVAKG--KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTR 163 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~~--~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~ 163 (448)
|||+|||+. +|.-++... +|++.+++.|++||+.||+|||++||+|||||.+|||||.+|.+||+|||||+++....
T Consensus 194 YlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 194 YLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG 272 (560)
T ss_pred EEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence 999999987 888888774 79999999999999999999999999999999999999999999999999999876543
Q ss_pred cCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhc--c-----C---CCC-
Q 037702 164 QDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA--E-----F---KCP- 232 (448)
Q Consensus 164 ~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~-----~---~~p- 232 (448)
. ..+...+-|.+|+|||.|.+...++...|+||+||||.||++|++.|++.+..+...+|.+. . + .+|
T Consensus 273 ~-~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~ 351 (560)
T KOG0600|consen 273 S-APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPH 351 (560)
T ss_pred C-cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCc
Confidence 3 33566788999999999999888889999999999999999999999999988888877542 0 0 111
Q ss_pred ------------------CCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 233 ------------------NWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 233 ------------------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
..+++.+.+|+..+|..||.+|.|+.++|+++||...
T Consensus 352 ~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~ 406 (560)
T KOG0600|consen 352 ATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTE 406 (560)
T ss_pred ccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccC
Confidence 1267899999999999999999999999999999443
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-51 Score=407.21 Aligned_cols=251 Identities=37% Similarity=0.648 Sum_probs=225.7
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCC
Q 037702 16 RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGG 95 (448)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 95 (448)
+.||+|+||.||+|.+..+|+.||||++.+...........+.+|+.+++.++||||+++++++..++.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998765444444567789999999999999999999999999999999999999
Q ss_pred chHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCccccCCC
Q 037702 96 ELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGT 174 (448)
Q Consensus 96 ~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~Gt 174 (448)
+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+||
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~--~~~~~~~~~gt 158 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCccccc--CCCcccceecC
Confidence 99999876 6799999999999999999999999999999999999999999999999999874321 11223456899
Q ss_pred CcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHHHHhccCCCcCCC
Q 037702 175 PAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILDPNPSTR 254 (448)
Q Consensus 175 ~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R 254 (448)
+.|+|||++.+..+. .++|||||||++|+|++|..||...+.......+......+|..+++++.+||++||..||++|
T Consensus 159 ~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (323)
T cd05571 159 PEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237 (323)
T ss_pred ccccChhhhcCCCCC-ccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHc
Confidence 999999999877664 8899999999999999999999998888888888888888999999999999999999999999
Q ss_pred C-----CHHHHHhhhhcccc
Q 037702 255 V-----TMAKLMENYWFRKG 269 (448)
Q Consensus 255 p-----t~~eil~hp~~~~~ 269 (448)
| ++.++++||||...
T Consensus 238 ~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 238 LGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred CCCCCCCHHHHHcCCCcCCC
Confidence 9 89999999999763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-52 Score=414.45 Aligned_cols=255 Identities=32% Similarity=0.586 Sum_probs=230.1
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYF 87 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 87 (448)
...+|.....||+|+.|.||.|....+++.||||.++....... +-+.+|+.+|+..+|+|||++++.|...+.+|+
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~k---eLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWV 347 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKK---ELLLNEILVMRDLHHPNIVNFLDSYLVGDELWV 347 (550)
T ss_pred hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCch---hhhHHHHHHHHhccchHHHHHHHHhcccceeEE
Confidence 45689999999999999999999999999999999998766553 668899999999999999999999998899999
Q ss_pred EEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCC
Q 037702 88 AMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGL 167 (448)
Q Consensus 88 V~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 167 (448)
||||++||+|.+.+....++|.++..++++++.||+|||.+||+|||||.+|||++.+|.+||+|||+|+.+..... .
T Consensus 348 VMEym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--K 425 (550)
T KOG0578|consen 348 VMEYMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--K 425 (550)
T ss_pred EEeecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC--c
Confidence 99999999999999998999999999999999999999999999999999999999999999999999987654332 3
Q ss_pred ccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHh-hc--cCCCCCCCCHHHHHHHH
Q 037702 168 LHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKIT-RA--EFKCPNWFPPEVRKLLS 244 (448)
Q Consensus 168 ~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~-~~--~~~~p~~~s~~~~~li~ 244 (448)
..+.+|||+|||||++....| |.+.||||||++++||+-|++||...+.......|. ++ .++.|+.+|+.+++|+.
T Consensus 426 R~TmVGTPYWMAPEVvtrk~Y-G~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~ 504 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTRKPY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLD 504 (550)
T ss_pred cccccCCCCccchhhhhhccc-CccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHH
Confidence 467899999999999988887 599999999999999999999998766654444443 33 35678889999999999
Q ss_pred hccCCCcCCCCCHHHHHhhhhccc
Q 037702 245 RILDPNPSTRVTMAKLMENYWFRK 268 (448)
Q Consensus 245 ~~L~~dP~~Rpt~~eil~hp~~~~ 268 (448)
+||+.||.+|+++.|+|+||||+.
T Consensus 505 ~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 505 RCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred HHhhcchhcCCCHHHHhcChhhhh
Confidence 999999999999999999999953
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-51 Score=407.47 Aligned_cols=258 Identities=31% Similarity=0.600 Sum_probs=233.0
Q ss_pred cccccCCeEEEeeeeecCceEEEEEEECCCC-cEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 037702 5 AGILMNKYELGRLLGQGTFAKVYHGRNLKTG-QSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKT 83 (448)
Q Consensus 5 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g-~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~ 83 (448)
..+..++|++.+.||+|+||.||+|.+..++ ..||+|.+.+.........+.+.+|+.+++.++||||+++++++.+.+
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 104 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES 104 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence 4566789999999999999999999976655 689999998765544445677889999999999999999999999999
Q ss_pred EEEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccc
Q 037702 84 KIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQEST 162 (448)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~ 162 (448)
..|+||||++||+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~- 183 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT- 183 (340)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC-
Confidence 99999999999999999976 6799999999999999999999999999999999999999999999999999975432
Q ss_pred ccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHH
Q 037702 163 RQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKL 242 (448)
Q Consensus 163 ~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 242 (448)
...+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+..+..+...+|..+++.++++
T Consensus 184 ----~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l 258 (340)
T PTZ00426 184 ----RTYTLCGTPEYIAPEILLNVGH-GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHL 258 (340)
T ss_pred ----CcceecCChhhcCHHHHhCCCC-CccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHH
Confidence 1245689999999999987666 48899999999999999999999999888889999988888999999999999
Q ss_pred HHhccCCCcCCCC-----CHHHHHhhhhccc
Q 037702 243 LSRILDPNPSTRV-----TMAKLMENYWFRK 268 (448)
Q Consensus 243 i~~~L~~dP~~Rp-----t~~eil~hp~~~~ 268 (448)
|++||..||.+|+ +++++++||||..
T Consensus 259 i~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~ 289 (340)
T PTZ00426 259 MKKLLSHDLTKRYGNLKKGAQNVKEHPWFGN 289 (340)
T ss_pred HHHHcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 9999999999995 8999999999975
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-52 Score=383.52 Aligned_cols=258 Identities=36% Similarity=0.691 Sum_probs=230.7
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccc-----cchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEe
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKI-----RRVGLIDQIKREISVMRLV-RHPNIVQLYEVMAS 81 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~ 81 (448)
...+|+-.+.||+|..+.|.++.++.+|+.+|+|+++.-.. .-.+..+.-.+|+.+|+++ .||+|++++++|++
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 45678999999999999999999999999999999975322 1224566778899999998 79999999999999
Q ss_pred CCEEEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccc
Q 037702 82 KTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQE 160 (448)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~ 160 (448)
+..+++|+|.|+.|+|++++.. -.++|.+.+++++||++|+.|||.++|+||||||+|||+|+|.++||+|||+|+...
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLE 174 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccC
Confidence 9999999999999999999987 579999999999999999999999999999999999999999999999999998654
Q ss_pred ccccCCCccccCCCCcccchhhhhc------cCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCC--C
Q 037702 161 STRQDGLLHTTCGTPAYVAPEVINK------RGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKC--P 232 (448)
Q Consensus 161 ~~~~~~~~~~~~Gt~~Y~APEvl~~------~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~--p 232 (448)
. ...+...||||+|.|||.+.. .|| +...|+||||||||.|+.|.+||.....+-+.+.|..+.+++ |
T Consensus 175 ~---GekLrelCGTPgYLAPEtikC~m~e~~pGY-s~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~sp 250 (411)
T KOG0599|consen 175 P---GEKLRELCGTPGYLAPETIKCSMYENHPGY-SKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSP 250 (411)
T ss_pred C---chhHHHhcCCCcccChhheeeecccCCCCc-cchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCc
Confidence 3 334567899999999999853 344 478999999999999999999999999999999999997754 6
Q ss_pred CC--CCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 233 NW--FPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 233 ~~--~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
.| +|..+++||.+||+.||.+|+|++|+|+||||...
T Consensus 251 eWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~ 289 (411)
T KOG0599|consen 251 EWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQI 289 (411)
T ss_pred chhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence 66 78999999999999999999999999999999653
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-51 Score=373.26 Aligned_cols=255 Identities=30% Similarity=0.512 Sum_probs=224.9
Q ss_pred CCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 037702 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAM 89 (448)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (448)
.+|...+.||+|+||.||+|++..||+.||||.|......+ +......|||+.|+.++||||+.++++|...+.+.||+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd-Gi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD-GINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc-CccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 57999999999999999999999999999999998776554 33456779999999999999999999999999999999
Q ss_pred eecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCC
Q 037702 90 EYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGL 167 (448)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 167 (448)
||++. +|...|+. -.++...++.|+.|+++||+|||++.|+||||||.|+|++.+|.+||+|||+|+.+......
T Consensus 81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~-- 157 (318)
T KOG0659|consen 81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI-- 157 (318)
T ss_pred Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc--
Confidence 99976 99999976 46899999999999999999999999999999999999999999999999999987654432
Q ss_pred ccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhcc-----CCCCC---------
Q 037702 168 LHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAE-----FKCPN--------- 233 (448)
Q Consensus 168 ~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-----~~~p~--------- 233 (448)
....+-|.+|+|||.+.+...++...|+||.|||+.||+.|.+-|.+.+..+....|.+.- -.+|.
T Consensus 158 ~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~ 237 (318)
T KOG0659|consen 158 QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVK 237 (318)
T ss_pred cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHH
Confidence 2333789999999999988888899999999999999999999999998888777775531 01111
Q ss_pred --------------CCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccc
Q 037702 234 --------------WFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRK 268 (448)
Q Consensus 234 --------------~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 268 (448)
..++++.+|+.+||..||.+|+|+.|+++|+||+.
T Consensus 238 ~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~ 286 (318)
T KOG0659|consen 238 IQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS 286 (318)
T ss_pred HhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence 14688999999999999999999999999999986
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-50 Score=399.05 Aligned_cols=254 Identities=31% Similarity=0.551 Sum_probs=227.0
Q ss_pred eEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHH---HhCCCCCcceEEEEEEeCCEEEEE
Q 037702 12 YELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVM---RLVRHPNIVQLYEVMASKTKIYFA 88 (448)
Q Consensus 12 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l---~~l~hpnIv~l~~~~~~~~~~~lV 88 (448)
|++.+.||+|+||.||+|.+..+|+.||||++.+.........+.+.+|+.++ +.++||||+++++++.+...+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 78999999999999999999999999999999876544334456777777765 456799999999999999999999
Q ss_pred EeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCc
Q 037702 89 MEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLL 168 (448)
Q Consensus 89 ~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 168 (448)
|||++||+|...+..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .....
T Consensus 81 ~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~ 158 (324)
T cd05589 81 MEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG--FGDRT 158 (324)
T ss_pred EcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCC--CCCcc
Confidence 9999999999999888899999999999999999999999999999999999999999999999999864321 11223
Q ss_pred cccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHHHHhccC
Q 037702 169 HTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILD 248 (448)
Q Consensus 169 ~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~ 248 (448)
.+.+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+..+....+.......|..+++++.++|.+||.
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~ 237 (324)
T cd05589 159 STFCGTPEFLAPEVLTETSY-TRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLR 237 (324)
T ss_pred cccccCccccCHhHhcCCCC-CcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhh
Confidence 45789999999999987666 48899999999999999999999999888888888888888899999999999999999
Q ss_pred CCcCCCC-----CHHHHHhhhhccc
Q 037702 249 PNPSTRV-----TMAKLMENYWFRK 268 (448)
Q Consensus 249 ~dP~~Rp-----t~~eil~hp~~~~ 268 (448)
.||.+|| ++.++++||||+.
T Consensus 238 ~dP~~R~~~~~~~~~~l~~~~~f~~ 262 (324)
T cd05589 238 RNPERRLGSGEKDAEDVKKQPFFRD 262 (324)
T ss_pred cCHhHcCCCCCCCHHHHhhCCCcCC
Confidence 9999999 7999999999976
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-51 Score=413.37 Aligned_cols=263 Identities=41% Similarity=0.776 Sum_probs=247.4
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKI 85 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 85 (448)
....+.|.+.++||+|.|++|.+|++..||..||||+|++....... ...+.+|+++|+.++|||||+++.+.+....+
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~-~~k~~rev~imk~l~HPnIvkl~~v~~t~~~l 130 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSK-RQKLGREVDIMKSLNHPNIVKLFSVIETEATL 130 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHH-HHHHHHHHHHHHhcCCcceeeeeeeeeeccee
Confidence 34578999999999999999999999999999999999988765543 35589999999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccccc
Q 037702 86 YFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQ 164 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~ 164 (448)
|+||||+.+|++++++.+ |++.+..++.+|.|+.+|++|||+++|+|||||++||||+.+-++||+|||++.++. .
T Consensus 131 ylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~---~ 207 (596)
T KOG0586|consen 131 YLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD---Y 207 (596)
T ss_pred EEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec---c
Confidence 999999999999999987 889999999999999999999999999999999999999999999999999999865 3
Q ss_pred CCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 037702 165 DGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLS 244 (448)
Q Consensus 165 ~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 244 (448)
...+.+.||++.|.|||++.+..|+++++|+||+|++||.|++|.+||++.+...+..+...+.+.+|..++.++.++|+
T Consensus 208 ~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~lLr 287 (596)
T KOG0586|consen 208 GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDLLR 287 (596)
T ss_pred cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHHHH
Confidence 45678999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hccCCCcCCCCCHHHHHhhhhccccccc
Q 037702 245 RILDPNPSTRVTMAKLMENYWFRKGYKK 272 (448)
Q Consensus 245 ~~L~~dP~~Rpt~~eil~hp~~~~~~~~ 272 (448)
++|.++|.+|++.+++++|+|....+..
T Consensus 288 k~lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 288 KFLVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred HhhccCccccCCHHHhhhhcccchhhhh
Confidence 9999999999999999999999876655
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-50 Score=405.01 Aligned_cols=259 Identities=29% Similarity=0.520 Sum_probs=223.3
Q ss_pred CCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 037702 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAM 89 (448)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (448)
++|++.+.||+|+||.||+|.+..+|+.||||++.+...........+.+|+.++..++||||+++++.+.+...+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998765544455677889999999999999999999999999999999
Q ss_pred eecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccccc----
Q 037702 90 EYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQ---- 164 (448)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~---- 164 (448)
||++||+|.+++.+ +.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 99999999999965 6899999999999999999999999999999999999999999999999999875322100
Q ss_pred -----------------------------CCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 037702 165 -----------------------------DGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDS 215 (448)
Q Consensus 165 -----------------------------~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~ 215 (448)
.....+.+||+.|+|||++.+.+++ .++|||||||++|+|++|+.||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCC-CchhhhhhHHHHHHHHhCCCCCCCC
Confidence 0112346899999999999887775 7899999999999999999999998
Q ss_pred cHHHHHHHHhhc--cCCCCCC--CCHHHHHHHHhccCC--CcCCCCCHHHHHhhhhcccc
Q 037702 216 NLMELYKKITRA--EFKCPNW--FPPEVRKLLSRILDP--NPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 216 ~~~~~~~~i~~~--~~~~p~~--~s~~~~~li~~~L~~--dP~~Rpt~~eil~hp~~~~~ 269 (448)
+..+.+.++... ...+|+. +++++++||.+++.. ++..||++++|++||||+..
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~~~ 299 (363)
T cd05628 240 TPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEGV 299 (363)
T ss_pred CHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCCCC
Confidence 888888887753 3445543 689999999997752 33356899999999999763
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-50 Score=398.47 Aligned_cols=249 Identities=35% Similarity=0.622 Sum_probs=224.6
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCCch
Q 037702 18 LGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGEL 97 (448)
Q Consensus 18 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 97 (448)
||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999999999999999999866544444557788999999999999999999999999999999999999999
Q ss_pred HHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCccccCCCCc
Q 037702 98 FNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPA 176 (448)
Q Consensus 98 ~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~ 176 (448)
.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......+||+.
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~ 158 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD--DDKTNTFCGTPE 158 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccC--CCccccccCCcc
Confidence 999865 68999999999999999999999999999999999999999999999999998753221 122345689999
Q ss_pred ccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHHHHhccCCCcCCCC-
Q 037702 177 YVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILDPNPSTRV- 255 (448)
Q Consensus 177 Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rp- 255 (448)
|+|||++.+..+. .++|||||||++|+|++|..||.+.+..+.+..+......+|..+++++++||.+||..||.+||
T Consensus 159 y~aPE~~~~~~~~-~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~ 237 (312)
T cd05585 159 YLAPELLLGHGYT-KAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLG 237 (312)
T ss_pred cCCHHHHcCCCCC-CccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCC
Confidence 9999999877764 88999999999999999999999998889999998888889999999999999999999999997
Q ss_pred --CHHHHHhhhhcccc
Q 037702 256 --TMAKLMENYWFRKG 269 (448)
Q Consensus 256 --t~~eil~hp~~~~~ 269 (448)
++.+++.||||...
T Consensus 238 ~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 238 YNGAQEIKNHPFFSQL 253 (312)
T ss_pred CCCHHHHHcCCCcCCC
Confidence 58999999999763
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-50 Score=397.66 Aligned_cols=250 Identities=36% Similarity=0.654 Sum_probs=224.7
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCC
Q 037702 16 RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGG 95 (448)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 95 (448)
+.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+++.++||||+++++++..++.+|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998765444445577889999999999999999999999999999999999999
Q ss_pred chHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCccccCCC
Q 037702 96 ELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGT 174 (448)
Q Consensus 96 ~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~Gt 174 (448)
+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+||
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~~~~~gt 158 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGIT--DAATMKTFCGT 158 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCC--cccccccccCC
Confidence 99988865 6799999999999999999999999999999999999999999999999999874321 12223456899
Q ss_pred CcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHHHHhccCCCcCCC
Q 037702 175 PAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILDPNPSTR 254 (448)
Q Consensus 175 ~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R 254 (448)
+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+......+|..+++++.+||++||..||.+|
T Consensus 159 ~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (328)
T cd05593 159 PEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKR 237 (328)
T ss_pred cCccChhhhcCCCC-CccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCHHHc
Confidence 99999999977666 48899999999999999999999988888888888888888999999999999999999999999
Q ss_pred C-----CHHHHHhhhhccc
Q 037702 255 V-----TMAKLMENYWFRK 268 (448)
Q Consensus 255 p-----t~~eil~hp~~~~ 268 (448)
+ ++.++++||||..
T Consensus 238 ~~~~~~~~~~il~h~~~~~ 256 (328)
T cd05593 238 LGGGPDDAKEIMRHSFFTG 256 (328)
T ss_pred CCCCCCCHHHHhcCCCcCC
Confidence 7 8999999999965
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-51 Score=392.46 Aligned_cols=263 Identities=30% Similarity=0.506 Sum_probs=236.3
Q ss_pred cccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 037702 5 AGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTK 84 (448)
Q Consensus 5 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 84 (448)
+.+-.+.|++.+.||.|.-|.||+|+...++..+|+|+++++.........++..|-.||+.++||.++.||..++++..
T Consensus 72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~ 151 (459)
T KOG0610|consen 72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKY 151 (459)
T ss_pred CccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccce
Confidence 44556789999999999999999999999999999999999988776777888999999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccc
Q 037702 85 IYFAMEYVRGGELFNKVAK---GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQES 161 (448)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~ 161 (448)
.|+|||||+||+|..+.++ +.+++..++.|+..++-||+|||-.|||+||||||||||.++|++-|+||.|+.....
T Consensus 152 ~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 152 SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 9999999999999998875 4699999999999999999999999999999999999999999999999998742210
Q ss_pred c----------------------------c---c-C----------------------CCccccCCCCcccchhhhhccC
Q 037702 162 T----------------------------R---Q-D----------------------GLLHTTCGTPAYVAPEVINKRG 187 (448)
Q Consensus 162 ~----------------------------~---~-~----------------------~~~~~~~Gt~~Y~APEvl~~~~ 187 (448)
. . . . ......+||-.|+|||++.+.|
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 0 0 0 0 0112347999999999999999
Q ss_pred CCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCC--CCCHHHHHHHHhccCCCcCCCCC----HHHHH
Q 037702 188 YDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPN--WFPPEVRKLLSRILDPNPSTRVT----MAKLM 261 (448)
Q Consensus 188 ~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~~L~~dP~~Rpt----~~eil 261 (448)
.. .++|+|+|||.||||+.|..||.+.+..+.+.+|......+|. .++..++|||+++|.+||.+|.. ++||.
T Consensus 312 Hg-sAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK 390 (459)
T KOG0610|consen 312 HG-SAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIK 390 (459)
T ss_pred CC-chhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhh
Confidence 85 7799999999999999999999999999999999998888876 46899999999999999999998 99999
Q ss_pred hhhhccc
Q 037702 262 ENYWFRK 268 (448)
Q Consensus 262 ~hp~~~~ 268 (448)
+||||+.
T Consensus 391 ~HpFF~g 397 (459)
T KOG0610|consen 391 RHPFFEG 397 (459)
T ss_pred cCccccC
Confidence 9999976
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-50 Score=396.65 Aligned_cols=250 Identities=38% Similarity=0.676 Sum_probs=224.2
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCC
Q 037702 16 RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGG 95 (448)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 95 (448)
+.||+|+||.||+|++..+|..||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998765444444567788999999999999999999999999999999999999
Q ss_pred chHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCccccCCC
Q 037702 96 ELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGT 174 (448)
Q Consensus 96 ~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~Gt 174 (448)
+|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+||
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~gt 158 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccC--CCCccccccCC
Confidence 99988865 5799999999999999999999999999999999999999999999999999874221 11223456799
Q ss_pred CcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHHHHhccCCCcCCC
Q 037702 175 PAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILDPNPSTR 254 (448)
Q Consensus 175 ~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R 254 (448)
+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+....+..+......+|..+++++.+||.+||..||.+|
T Consensus 159 ~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (323)
T cd05595 159 PEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237 (323)
T ss_pred cCcCCcccccCCCC-CchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHHHh
Confidence 99999999977666 48899999999999999999999998888888888888888899999999999999999999999
Q ss_pred C-----CHHHHHhhhhccc
Q 037702 255 V-----TMAKLMENYWFRK 268 (448)
Q Consensus 255 p-----t~~eil~hp~~~~ 268 (448)
+ ++.++++||||..
T Consensus 238 ~~~~~~~~~~~l~h~~~~~ 256 (323)
T cd05595 238 LGGGPSDAKEVMEHRFFLS 256 (323)
T ss_pred CCCCCCCHHHHHcCCCcCC
Confidence 8 8999999999976
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-51 Score=385.75 Aligned_cols=262 Identities=36% Similarity=0.652 Sum_probs=243.0
Q ss_pred ccccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 037702 4 KAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKT 83 (448)
Q Consensus 4 ~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~ 83 (448)
+..+.+++|+..++||+|.||+|-+++.+.+|+.||||++.++-+-..+.+..-..|-++|+..+||.+..+...|..++
T Consensus 162 ~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~d 241 (516)
T KOG0690|consen 162 KNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQD 241 (516)
T ss_pred cceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCc
Confidence 34578999999999999999999999999999999999999987766666777888999999999999999999999999
Q ss_pred EEEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccc
Q 037702 84 KIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQEST 162 (448)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~ 162 (448)
.+|+||||+.||+|+-.+.+ ..++|+.++.|-..|++||.|||+++||+||||.+|+|||.+|++||+||||++.- .
T Consensus 242 rlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~--I 319 (516)
T KOG0690|consen 242 RLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEE--I 319 (516)
T ss_pred eEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhc--c
Confidence 99999999999999888865 67999999999999999999999999999999999999999999999999999742 2
Q ss_pred ccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHH
Q 037702 163 RQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKL 242 (448)
Q Consensus 163 ~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 242 (448)
.......+.||||.|.|||++....|. ..+|+|.+||++|||++|++||...+...++..|...+..+|..++++++.|
T Consensus 320 ~~g~t~kTFCGTPEYLAPEVleDnDYg-raVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktL 398 (516)
T KOG0690|consen 320 KYGDTTKTFCGTPEYLAPEVLEDNDYG-RAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTL 398 (516)
T ss_pred cccceeccccCChhhcCchhhcccccc-ceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHHH
Confidence 333456789999999999999988884 8899999999999999999999999999999999999999999999999999
Q ss_pred HHhccCCCcCCCC-----CHHHHHhhhhccc
Q 037702 243 LSRILDPNPSTRV-----TMAKLMENYWFRK 268 (448)
Q Consensus 243 i~~~L~~dP~~Rp-----t~~eil~hp~~~~ 268 (448)
+..+|.+||.+|. .+.||++|+||..
T Consensus 399 LsGLL~kdP~kRLGgGpdDakEi~~h~FF~~ 429 (516)
T KOG0690|consen 399 LSGLLKKDPKKRLGGGPDDAKEIMRHRFFAS 429 (516)
T ss_pred HHHHhhcChHhhcCCCchhHHHHHhhhhhcc
Confidence 9999999999997 5899999999965
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-49 Score=402.01 Aligned_cols=258 Identities=29% Similarity=0.533 Sum_probs=221.5
Q ss_pred CeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 037702 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAME 90 (448)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (448)
.|++++.||+|+||.||+|++..+++.||||++.+...........+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 69999999999999999999999999999999987665555556788999999999999999999999999999999999
Q ss_pred ecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccccc-----
Q 037702 91 YVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQ----- 164 (448)
Q Consensus 91 ~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~----- 164 (448)
|++||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++........
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~ 161 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQ 161 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccccc
Confidence 9999999999866 6799999999999999999999999999999999999999999999999999753311000
Q ss_pred ----------------------------------------CCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHH
Q 037702 165 ----------------------------------------DGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFV 204 (448)
Q Consensus 165 ----------------------------------------~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~e 204 (448)
.....+.+||+.|+|||++.+.++. .++|||||||++|+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlG~il~e 240 (381)
T cd05626 162 KGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILFE 240 (381)
T ss_pred ccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCC-CccceeehhhHHHH
Confidence 0011345799999999999877775 88999999999999
Q ss_pred HHhCCCCCCCCcHHHHHHHHhh--ccCCCCC--CCCHHHHHHHHhcc--CCCcCCCCCHHHHHhhhhcccc
Q 037702 205 LLAGNLPFYDSNLMELYKKITR--AEFKCPN--WFPPEVRKLLSRIL--DPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 205 lltG~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~~L--~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
|++|..||...+..+...++.. .....|. .+++++.+||.+|+ ..+|..|++++++++||||+..
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~ 311 (381)
T cd05626 241 MLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV 311 (381)
T ss_pred HHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence 9999999998877666666653 2344444 47899999999955 5566679999999999999763
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-49 Score=401.25 Aligned_cols=258 Identities=31% Similarity=0.592 Sum_probs=224.1
Q ss_pred CCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 037702 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAM 89 (448)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (448)
++|++.+.||+|+||.||+|++..+|+.||||++.+...........+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998765444445577889999999999999999999999999999999
Q ss_pred eecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccC---
Q 037702 90 EYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQD--- 165 (448)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~--- 165 (448)
||++||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.........
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 99999999999865 67999999999999999999999999999999999999999999999999998743221100
Q ss_pred ---------------------------------CCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCC
Q 037702 166 ---------------------------------GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPF 212 (448)
Q Consensus 166 ---------------------------------~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf 212 (448)
....+.+||+.|+|||++...++. .++|||||||++|+|++|..||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~G~~Pf 239 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYN-KECDWWSLGVIMYEMLVGYPPF 239 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCC-CeeeeecchhHHHHhhcCCCCC
Confidence 011245799999999999877774 8899999999999999999999
Q ss_pred CCCcHHHHHHHHhhcc--CCCCC--CCCHHHHHHHHhccCCCcCCCCC---HHHHHhhhhcccc
Q 037702 213 YDSNLMELYKKITRAE--FKCPN--WFPPEVRKLLSRILDPNPSTRVT---MAKLMENYWFRKG 269 (448)
Q Consensus 213 ~~~~~~~~~~~i~~~~--~~~p~--~~s~~~~~li~~~L~~dP~~Rpt---~~eil~hp~~~~~ 269 (448)
.+.+..+.+..+.... +..|. .+++++++||.+||. +|.+|++ ++++++||||+..
T Consensus 240 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~ 302 (364)
T cd05599 240 CSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV 302 (364)
T ss_pred CCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 9988877777776533 33444 368999999999997 9999998 9999999999753
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-49 Score=392.84 Aligned_cols=251 Identities=30% Similarity=0.589 Sum_probs=221.0
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeecCC
Q 037702 16 RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEVMASKTKIYFAMEYVRG 94 (448)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (448)
+.||+|+||.||+|++..+|+.||+|++.+.........+....|..++... +||||+++++++.+++.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4799999999999999999999999999875433223345667788888754 899999999999999999999999999
Q ss_pred CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCccccCC
Q 037702 95 GELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCG 173 (448)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~G 173 (448)
|+|..++.. +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ......+.+|
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF--GDNRASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeeccc--CCCceeccCC
Confidence 999998865 6799999999999999999999999999999999999999999999999999864211 1222345789
Q ss_pred CCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHHHHhccCCCcCC
Q 037702 174 TPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILDPNPST 253 (448)
Q Consensus 174 t~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~ 253 (448)
|+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+..++...+.......|.++++++++||.+||..||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 237 (316)
T cd05620 159 TPDYIAPEILQGLKYT-FSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTR 237 (316)
T ss_pred CcCccCHHHHcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence 9999999999877664 889999999999999999999999888888888888888889999999999999999999999
Q ss_pred CCCH-HHHHhhhhcccc
Q 037702 254 RVTM-AKLMENYWFRKG 269 (448)
Q Consensus 254 Rpt~-~eil~hp~~~~~ 269 (448)
||++ +++++||||...
T Consensus 238 R~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 238 RLGVVGNIRGHPFFKTI 254 (316)
T ss_pred cCCChHHHHcCCCcCCC
Confidence 9998 589999999763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=402.51 Aligned_cols=257 Identities=31% Similarity=0.564 Sum_probs=221.0
Q ss_pred CCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 037702 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAM 89 (448)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (448)
++|++.+.||+|+||.||+|.+..+|+.||||++.+.........+.+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999999999999999997655444445677889999999999999999999999999999999
Q ss_pred eecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccC---
Q 037702 90 EYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQD--- 165 (448)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~--- 165 (448)
||++||+|.+++.. +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 99999999999875 67999999999999999999999999999999999999999999999999998632110000
Q ss_pred ------------------------------------------CCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHH
Q 037702 166 ------------------------------------------GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLF 203 (448)
Q Consensus 166 ------------------------------------------~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ 203 (448)
......+||+.|+|||++.+..+. .++|||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ 239 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG-QECDWWSLGAIMF 239 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCC-CceeeEecchhhh
Confidence 001135799999999999877764 8899999999999
Q ss_pred HHHhCCCCCCCCcHHHHHHHHhhc--cCCCCC--CCCHHHHHHHHhccCCCcCCC---CCHHHHHhhhhccc
Q 037702 204 VLLAGNLPFYDSNLMELYKKITRA--EFKCPN--WFPPEVRKLLSRILDPNPSTR---VTMAKLMENYWFRK 268 (448)
Q Consensus 204 elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~~li~~~L~~dP~~R---pt~~eil~hp~~~~ 268 (448)
+|++|.+||.+.+..+.+..+... ...+|. .+++++++||.+||. +|.+| +++.+++.||||+.
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~ 310 (377)
T cd05629 240 ECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRG 310 (377)
T ss_pred hhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 999999999988877777777643 344454 378999999999997 67765 59999999999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-50 Score=397.15 Aligned_cols=253 Identities=29% Similarity=0.560 Sum_probs=224.9
Q ss_pred CCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 037702 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAM 89 (448)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (448)
++|++.+.||+|+||.||+|++..+|+.||||++.+...........+.+|+.+++.++||||+++++++...+..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 57999999999999999999999999999999998765444445577889999999999999999999999999999999
Q ss_pred eecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCc
Q 037702 90 EYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLL 168 (448)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 168 (448)
||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----~~ 155 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YA 155 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-----cc
Confidence 99999999999975 6799999999999999999999999999999999999999999999999999975432 23
Q ss_pred cccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhcc--CCCCC------CCCHHHH
Q 037702 169 HTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAE--FKCPN------WFPPEVR 240 (448)
Q Consensus 169 ~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~------~~s~~~~ 240 (448)
...+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+..+.+..+.... ...|. .+++++.
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~ 234 (333)
T cd05600 156 NSVVGSPDYMAPEVLRGKGYD-FTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAW 234 (333)
T ss_pred CCcccCccccChhHhcCCCCC-CccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHH
Confidence 456899999999999877664 88999999999999999999999988877777665432 22232 3589999
Q ss_pred HHHHhccCCCcCCCCCHHHHHhhhhccc
Q 037702 241 KLLSRILDPNPSTRVTMAKLMENYWFRK 268 (448)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~eil~hp~~~~ 268 (448)
+||.+||..+|.+||++.++++||||..
T Consensus 235 ~li~~~l~~~~~rr~s~~~ll~h~~~~~ 262 (333)
T cd05600 235 DLITKLINDPSRRFGSLEDIKNHPFFKE 262 (333)
T ss_pred HHHHHHhhChhhhcCCHHHHHhCcccCC
Confidence 9999999999999999999999999975
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-50 Score=395.15 Aligned_cols=250 Identities=32% Similarity=0.636 Sum_probs=223.6
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeecCC
Q 037702 16 RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEVMASKTKIYFAMEYVRG 94 (448)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (448)
+.||+|+||.||+|++..+++.||||++.+.........+.+.+|+.++..+ +||||+++++++...+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999999876544434456777888888876 799999999999999999999999999
Q ss_pred CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCccccCC
Q 037702 95 GELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCG 173 (448)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~G 173 (448)
|+|.+++.. +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~--~~~~~~~~~g 158 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF--NGKTTSTFCG 158 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc--CCCccccccc
Confidence 999998865 6799999999999999999999999999999999999999999999999999874321 1222345689
Q ss_pred CCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHHHHhccCCCcCC
Q 037702 174 TPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILDPNPST 253 (448)
Q Consensus 174 t~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~ 253 (448)
|+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+..+++..+.......|.++++++.+||++||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 237 (320)
T cd05590 159 TPDYIAPEILQEMLY-GPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTM 237 (320)
T ss_pred CccccCHHHHcCCCC-CCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHH
Confidence 999999999977666 4789999999999999999999999999899999998888899999999999999999999999
Q ss_pred CCCH------HHHHhhhhccc
Q 037702 254 RVTM------AKLMENYWFRK 268 (448)
Q Consensus 254 Rpt~------~eil~hp~~~~ 268 (448)
||++ +++++||||+.
T Consensus 238 R~~~~~~~~~~~~~~h~~f~~ 258 (320)
T cd05590 238 RLGSLTLGGEEAILRHPFFKE 258 (320)
T ss_pred CCCCCCCCCHHHHHcCCCcCC
Confidence 9998 99999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-49 Score=386.38 Aligned_cols=254 Identities=26% Similarity=0.427 Sum_probs=219.9
Q ss_pred CeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 037702 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAME 90 (448)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (448)
.|++.+.||+|+||.||+|.+..+|+.||+|.+.+...........+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 48899999999999999999999999999999987655443344567889999999999999999999999999999999
Q ss_pred ecCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCC
Q 037702 91 YVRGGELFNKVAK---GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGL 167 (448)
Q Consensus 91 ~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 167 (448)
|+++|+|.+.+.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~---~~ 157 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG---ET 157 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC---Ce
Confidence 9999999887743 36899999999999999999999999999999999999999999999999998754221 12
Q ss_pred ccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcH----HHHHHHHhhccCCCCCCCCHHHHHHH
Q 037702 168 LHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNL----MELYKKITRAEFKCPNWFPPEVRKLL 243 (448)
Q Consensus 168 ~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~----~~~~~~i~~~~~~~p~~~s~~~~~li 243 (448)
....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||...+. ......+......++..+++++.+||
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~-~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 236 (285)
T cd05631 158 VRGRVGTVGYMAPEVINNEKYT-FSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSIC 236 (285)
T ss_pred ecCCCCCCCccCHhhhcCCCCC-cccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHH
Confidence 2356799999999999877664 889999999999999999999987543 23333444455567778999999999
Q ss_pred HhccCCCcCCCCC-----HHHHHhhhhccc
Q 037702 244 SRILDPNPSTRVT-----MAKLMENYWFRK 268 (448)
Q Consensus 244 ~~~L~~dP~~Rpt-----~~eil~hp~~~~ 268 (448)
++||..||.+||+ ++++++||||..
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~ 266 (285)
T cd05631 237 RMLLTKNPKERLGCRGNGAAGVKQHPIFKN 266 (285)
T ss_pred HHHhhcCHHHhcCCCCCCHHHHhcCHhhcC
Confidence 9999999999997 899999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-49 Score=392.53 Aligned_cols=258 Identities=31% Similarity=0.585 Sum_probs=221.1
Q ss_pred CeEEEeeeeecCceEEEEEEEC---CCCcEEEEEEeeccccc-chhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 037702 11 KYELGRLLGQGTFAKVYHGRNL---KTGQSVAIKIVDKEKIR-RVGLIDQIKREISVMRLV-RHPNIVQLYEVMASKTKI 85 (448)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~-~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~ 85 (448)
+|++.+.||+|+||.||+|++. .+|+.||+|++.+.... .....+.+.+|+.+++.+ +||||+++++++..+..+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5999999999999999999864 47899999999765432 223456788999999999 599999999999999999
Q ss_pred EEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccccc
Q 037702 86 YFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQ 164 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~ 164 (448)
|+||||++||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++........
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~ 160 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK 160 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCC
Confidence 999999999999999865 6799999999999999999999999999999999999999999999999999875432211
Q ss_pred CCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCC----cHHHHHHHHhhccCCCCCCCCHHHH
Q 037702 165 DGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDS----NLMELYKKITRAEFKCPNWFPPEVR 240 (448)
Q Consensus 165 ~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~----~~~~~~~~i~~~~~~~p~~~s~~~~ 240 (448)
......+||+.|+|||++.+....+.++|||||||++|+|++|..||... ........+......+|..+++.+.
T Consensus 161 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (332)
T cd05614 161 -ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQ 239 (332)
T ss_pred -CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHH
Confidence 12234689999999999976554568899999999999999999999643 3345555666667778888999999
Q ss_pred HHHHhccCCCcCCCC-----CHHHHHhhhhcccc
Q 037702 241 KLLSRILDPNPSTRV-----TMAKLMENYWFRKG 269 (448)
Q Consensus 241 ~li~~~L~~dP~~Rp-----t~~eil~hp~~~~~ 269 (448)
++|.+||..||++|| +++++++||||+..
T Consensus 240 ~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 240 DLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred HHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 999999999999999 88999999999763
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-49 Score=393.42 Aligned_cols=255 Identities=32% Similarity=0.569 Sum_probs=227.6
Q ss_pred CeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCC-CcceEEEEEEeCCEEEEEE
Q 037702 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHP-NIVQLYEVMASKTKIYFAM 89 (448)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hp-nIv~l~~~~~~~~~~~lV~ 89 (448)
+|++.+.||+|+||.||+|++..+++.||||++.+.........+.+..|+.++..++|+ +|+++++++.+.+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 589999999999999999999999999999999876544444557788899999999765 5888999999999999999
Q ss_pred eecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCc
Q 037702 90 EYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLL 168 (448)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 168 (448)
||++||+|.+++.. +.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..... .....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~ 158 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF--GGKTT 158 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCC--CCCce
Confidence 99999999999865 6799999999999999999999999999999999999999999999999999864221 11223
Q ss_pred cccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHHHHhccC
Q 037702 169 HTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILD 248 (448)
Q Consensus 169 ~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~ 248 (448)
...+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+..+.+..+......+|..+++++.++|.+||.
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~ 237 (324)
T cd05587 159 RTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLT 237 (324)
T ss_pred eeecCCccccChhhhcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Confidence 456899999999999876664 8899999999999999999999999888899999888888899999999999999999
Q ss_pred CCcCCCCCH-----HHHHhhhhccc
Q 037702 249 PNPSTRVTM-----AKLMENYWFRK 268 (448)
Q Consensus 249 ~dP~~Rpt~-----~eil~hp~~~~ 268 (448)
.||.+|++. +++++||||..
T Consensus 238 ~~P~~R~~~~~~~~~~~~~hp~~~~ 262 (324)
T cd05587 238 KHPAKRLGCGPTGERDIREHAFFRR 262 (324)
T ss_pred cCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 999999986 89999999975
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-49 Score=401.44 Aligned_cols=261 Identities=30% Similarity=0.537 Sum_probs=228.6
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIY 86 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 86 (448)
...++|++.+.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.++..+|
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 45678999999999999999999999999999999998654443344466789999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCC
Q 037702 87 FAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDG 166 (448)
Q Consensus 87 lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 166 (448)
+||||++||+|.+++..+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++........ .
T Consensus 120 lv~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~-~ 198 (370)
T cd05596 120 MVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM-V 198 (370)
T ss_pred EEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc-c
Confidence 999999999999999888899999999999999999999999999999999999999999999999999875432211 1
Q ss_pred CccccCCCCcccchhhhhccC---CCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhcc--CCCCC--CCCHHH
Q 037702 167 LLHTTCGTPAYVAPEVINKRG---YDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAE--FKCPN--WFPPEV 239 (448)
Q Consensus 167 ~~~~~~Gt~~Y~APEvl~~~~---~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~--~~s~~~ 239 (448)
...+.+||+.|+|||++.... +.+.++|||||||++|+|++|+.||.+.+....+.++.... ..+|. .+|.++
T Consensus 199 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 278 (370)
T cd05596 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQA 278 (370)
T ss_pred cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHH
Confidence 224568999999999986532 34688999999999999999999999988888888886643 44555 479999
Q ss_pred HHHHHhccCCCcCC--CCCHHHHHhhhhccc
Q 037702 240 RKLLSRILDPNPST--RVTMAKLMENYWFRK 268 (448)
Q Consensus 240 ~~li~~~L~~dP~~--Rpt~~eil~hp~~~~ 268 (448)
++||.+||..+|.+ |+|++++++||||+.
T Consensus 279 ~~li~~~L~~~p~r~~R~s~~ell~h~~~~~ 309 (370)
T cd05596 279 KDLICAFLTDREVRLGRNGVDEIKSHPFFKN 309 (370)
T ss_pred HHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence 99999999999988 999999999999976
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-49 Score=394.11 Aligned_cols=250 Identities=31% Similarity=0.587 Sum_probs=224.2
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeecCC
Q 037702 16 RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEVMASKTKIYFAMEYVRG 94 (448)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (448)
+.||+|+||.||+|++..+|+.||||++.+.........+.+..|+.++..+ +||||+++++++.++..+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999999999999999999876544444456677899998866 899999999999999999999999999
Q ss_pred CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCccccCC
Q 037702 95 GELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCG 173 (448)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~G 173 (448)
|+|...+.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~g 158 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGIL--NGVTTTTFCG 158 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceeccc--CCcccccccc
Confidence 999998865 6799999999999999999999999999999999999999999999999999874322 1222345689
Q ss_pred CCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHHHHhccCCCcCC
Q 037702 174 TPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILDPNPST 253 (448)
Q Consensus 174 t~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~ 253 (448)
|+.|+|||++.+..++ .++|||||||++|+|++|+.||...+..+.+..+.......|.++++++.++|.+||..||++
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp~~ 237 (321)
T cd05591 159 TPDYIAPEILQELEYG-PSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNK 237 (321)
T ss_pred CccccCHHHHcCCCCC-CccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHH
Confidence 9999999999876664 889999999999999999999999999999999999888899999999999999999999999
Q ss_pred CC-------CHHHHHhhhhccc
Q 037702 254 RV-------TMAKLMENYWFRK 268 (448)
Q Consensus 254 Rp-------t~~eil~hp~~~~ 268 (448)
|| +++++++||||..
T Consensus 238 R~~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 238 RLGCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred cCCCCCCCCCHHHHhcCCccCC
Confidence 99 9999999999965
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-49 Score=392.45 Aligned_cols=250 Identities=32% Similarity=0.601 Sum_probs=219.7
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHH-HHHhCCCCCcceEEEEEEeCCEEEEEEeecCC
Q 037702 16 RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREIS-VMRLVRHPNIVQLYEVMASKTKIYFAMEYVRG 94 (448)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~-~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (448)
+.||+|+||+||+|++..+|+.||||++.+...........+.+|.. +++.++||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999999999999999998765433333344555554 56889999999999999999999999999999
Q ss_pred CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCccccCC
Q 037702 95 GELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCG 173 (448)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~G 173 (448)
|+|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE--HSKTTSTFCG 158 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCccccc--CCCccccccC
Confidence 999998875 6799999999999999999999999999999999999999999999999999864321 1222345689
Q ss_pred CCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHHHHhccCCCcCC
Q 037702 174 TPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILDPNPST 253 (448)
Q Consensus 174 t~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~ 253 (448)
|+.|+|||++.+..++ .++|||||||++|+|++|..||...+..+++..+.......++.+++++.++|.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (323)
T cd05575 159 TPEYLAPEVLRKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTK 237 (323)
T ss_pred ChhhcChhhhcCCCCC-ccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHh
Confidence 9999999999877664 789999999999999999999999988889988888888888889999999999999999999
Q ss_pred CCCH----HHHHhhhhccc
Q 037702 254 RVTM----AKLMENYWFRK 268 (448)
Q Consensus 254 Rpt~----~eil~hp~~~~ 268 (448)
||++ .++++||||..
T Consensus 238 R~~~~~~~~~il~~~~~~~ 256 (323)
T cd05575 238 RLGAKDDFLEIKNHVFFSS 256 (323)
T ss_pred CCCCCCCHHHHHcCCCcCC
Confidence 9987 69999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-49 Score=401.12 Aligned_cols=263 Identities=30% Similarity=0.558 Sum_probs=227.8
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKI 85 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 85 (448)
....++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.++..+
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 34568999999999999999999999999999999999865444334456688999999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccC
Q 037702 86 YFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQD 165 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~ 165 (448)
|+||||++||+|.+++....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|....... .
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~-~ 197 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG-M 197 (370)
T ss_pred EEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCC-c
Confidence 999999999999999988889999999999999999999999999999999999999999999999999997643221 1
Q ss_pred CCccccCCCCcccchhhhhccC---CCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhcc--CCCCC--CCCHH
Q 037702 166 GLLHTTCGTPAYVAPEVINKRG---YDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAE--FKCPN--WFPPE 238 (448)
Q Consensus 166 ~~~~~~~Gt~~Y~APEvl~~~~---~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~--~~s~~ 238 (448)
....+.+||+.|+|||++...+ +.+.++|||||||++|+|++|+.||...+....+.++.... +.+|. .+++.
T Consensus 198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~ 277 (370)
T cd05621 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKH 277 (370)
T ss_pred eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHH
Confidence 1224668999999999997543 34688999999999999999999999988888888876543 44555 46899
Q ss_pred HHHHHHhccCCCcCC--CCCHHHHHhhhhcccc
Q 037702 239 VRKLLSRILDPNPST--RVTMAKLMENYWFRKG 269 (448)
Q Consensus 239 ~~~li~~~L~~dP~~--Rpt~~eil~hp~~~~~ 269 (448)
++++|.+||..+|.+ |+|++++++||||+..
T Consensus 278 ~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 278 AKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred HHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 999999999865544 8999999999999763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-49 Score=393.69 Aligned_cols=257 Identities=29% Similarity=0.538 Sum_probs=223.3
Q ss_pred CCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 037702 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAM 89 (448)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (448)
++|++.+.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47999999999999999999999999999999998765544445677889999999999999999999999999999999
Q ss_pred eecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCC
Q 037702 90 EYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGL 167 (448)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 167 (448)
||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++........ ..
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~-~~ 159 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM-VN 159 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc-ee
Confidence 99999999999976 5799999999999999999999999999999999999999999999999999975432211 12
Q ss_pred ccccCCCCcccchhhhhc-----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhcc--CCCC--CCCCHH
Q 037702 168 LHTTCGTPAYVAPEVINK-----RGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAE--FKCP--NWFPPE 238 (448)
Q Consensus 168 ~~~~~Gt~~Y~APEvl~~-----~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p--~~~s~~ 238 (448)
....+||+.|+|||++.. ....+.++|||||||++|+|++|..||...+....+.++.... ..+| ..++++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (330)
T cd05601 160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSD 239 (330)
T ss_pred eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHH
Confidence 234579999999999863 2333578999999999999999999999888777777765432 2333 357899
Q ss_pred HHHHHHhccCCCcCCCCCHHHHHhhhhccc
Q 037702 239 VRKLLSRILDPNPSTRVTMAKLMENYWFRK 268 (448)
Q Consensus 239 ~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 268 (448)
+.+||.+||. ||.+|||++++++||||..
T Consensus 240 ~~~li~~ll~-~p~~R~t~~~l~~h~~~~~ 268 (330)
T cd05601 240 FLDLIQSLLC-GQKERLGYEGLCCHPFFSK 268 (330)
T ss_pred HHHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence 9999999998 9999999999999999976
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-50 Score=381.41 Aligned_cols=264 Identities=27% Similarity=0.439 Sum_probs=224.5
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe-----
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMAS----- 81 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~----- 81 (448)
.+..+|...+.||+|+||.|+.|.++.||+.||||.+... +...-..++..||+.+|+.++|+||+.+++++..
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~-F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~ 97 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP-FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK 97 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhh-hhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence 3456777789999999999999999999999999998632 4444556888999999999999999999999865
Q ss_pred CCEEEEEEeecCCCchHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccc
Q 037702 82 KTKIYFAMEYVRGGELFNKVAKGK-LREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQE 160 (448)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~~~-l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~ 160 (448)
-..+|+|+|+| +.+|.+.++.++ ++++.++.++.||+.||.|+||.||+||||||.|+|++.+..+||+|||+|+...
T Consensus 98 f~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~ 176 (359)
T KOG0660|consen 98 FNDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLD 176 (359)
T ss_pred cceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeecc
Confidence 45799999999 559999999877 9999999999999999999999999999999999999999999999999999765
Q ss_pred ccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhc-------------
Q 037702 161 STRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA------------- 227 (448)
Q Consensus 161 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~------------- 227 (448)
.......++..+.|.+|.|||++.....++...||||+|||+.||++|++-|.+.+..+....|..-
T Consensus 177 ~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~ 256 (359)
T KOG0660|consen 177 KFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIR 256 (359)
T ss_pred ccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhc
Confidence 4434555667789999999999876665568899999999999999999999987755544443221
Q ss_pred ----------cCCCC--------CCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccccccc
Q 037702 228 ----------EFKCP--------NWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYKK 272 (448)
Q Consensus 228 ----------~~~~p--------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~ 272 (448)
....| +..++.+.+|+.+||..||.+|+|++|+|+|||+.....+
T Consensus 257 s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp 319 (359)
T KOG0660|consen 257 SEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDP 319 (359)
T ss_pred cHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCC
Confidence 11111 2467999999999999999999999999999999765543
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-50 Score=395.59 Aligned_cols=250 Identities=37% Similarity=0.666 Sum_probs=224.2
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCC
Q 037702 16 RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGG 95 (448)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 95 (448)
+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++..++.+|+||||++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998765544444567788999999999999999999999999999999999999
Q ss_pred chHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCccccCC
Q 037702 96 ELFNKVAK-GKLREEVARKYFQQLVDAVEFCHS-RGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCG 173 (448)
Q Consensus 96 ~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~-~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~G 173 (448)
+|..++.. +.+++..++.++.||+.||+|||+ +||+||||||+|||++.+|.+||+|||++..... ......+.+|
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~g 158 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKTFCG 158 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCC--CCcccccccC
Confidence 99998865 679999999999999999999998 7999999999999999999999999999874321 1122345679
Q ss_pred CCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHHHHhccCCCcCC
Q 037702 174 TPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILDPNPST 253 (448)
Q Consensus 174 t~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~ 253 (448)
|+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+......+|..+++++.+||.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~ 237 (325)
T cd05594 159 TPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQ 237 (325)
T ss_pred CcccCCHHHHccCCC-CCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCHHH
Confidence 999999999977666 4889999999999999999999999888888888888888889999999999999999999999
Q ss_pred CC-----CHHHHHhhhhccc
Q 037702 254 RV-----TMAKLMENYWFRK 268 (448)
Q Consensus 254 Rp-----t~~eil~hp~~~~ 268 (448)
|+ ++.++++||||..
T Consensus 238 R~~~~~~~~~~il~h~~~~~ 257 (325)
T cd05594 238 RLGGGPDDAKEIMQHKFFAG 257 (325)
T ss_pred hCCCCCCCHHHHhcCCCcCC
Confidence 97 9999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-49 Score=391.73 Aligned_cols=250 Identities=31% Similarity=0.575 Sum_probs=218.8
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeecCC
Q 037702 16 RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEVMASKTKIYFAMEYVRG 94 (448)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (448)
+.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.+ +||||+++++++.+...+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4799999999999999999999999999876555545567788999999988 799999999999999999999999999
Q ss_pred CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCccccCC
Q 037702 95 GELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCG 173 (448)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~G 173 (448)
|+|.+++.. +++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ......+.+|
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~g 158 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR--PGDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCcccccccc--CCCccccccC
Confidence 999988865 6899999999999999999999999999999999999999999999999999864211 1222345689
Q ss_pred CCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCC---------cHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 037702 174 TPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDS---------NLMELYKKITRAEFKCPNWFPPEVRKLLS 244 (448)
Q Consensus 174 t~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~---------~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 244 (448)
|+.|+|||++.+..++ .++|+|||||++|+|++|+.||... .....+..+.......|..+++++.++|+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~ 237 (329)
T cd05588 159 TPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLK 237 (329)
T ss_pred CccccCHHHHcCCCCC-CccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999877664 8899999999999999999999631 12235566677778889999999999999
Q ss_pred hccCCCcCCCCC------HHHHHhhhhccc
Q 037702 245 RILDPNPSTRVT------MAKLMENYWFRK 268 (448)
Q Consensus 245 ~~L~~dP~~Rpt------~~eil~hp~~~~ 268 (448)
+||..||.+|++ ++++++||||..
T Consensus 238 ~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 238 GFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred HHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 999999999987 799999999965
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-49 Score=401.30 Aligned_cols=257 Identities=31% Similarity=0.587 Sum_probs=221.8
Q ss_pred CCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 037702 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAM 89 (448)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (448)
.+|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 36999999999999999999999999999999998765544455678899999999999999999999999999999999
Q ss_pred eecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccc-----
Q 037702 90 EYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTR----- 163 (448)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~----- 163 (448)
||++||+|.+++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~ 160 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence 99999999999865 679999999999999999999999999999999999999999999999999975321100
Q ss_pred ----------------------------------------cCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHH
Q 037702 164 ----------------------------------------QDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLF 203 (448)
Q Consensus 164 ----------------------------------------~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ 203 (448)
......+.+||+.|+|||++.+.+|+ .++|||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlGvil~ 239 (382)
T cd05625 161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILY 239 (382)
T ss_pred ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCC-CeeeEEechHHHH
Confidence 00011245799999999999887775 8899999999999
Q ss_pred HHHhCCCCCCCCcHHHHHHHHhhc--cCCCC--CCCCHHHHHHHHhccCCCcCCCCC---HHHHHhhhhccc
Q 037702 204 VLLAGNLPFYDSNLMELYKKITRA--EFKCP--NWFPPEVRKLLSRILDPNPSTRVT---MAKLMENYWFRK 268 (448)
Q Consensus 204 elltG~~Pf~~~~~~~~~~~i~~~--~~~~p--~~~s~~~~~li~~~L~~dP~~Rpt---~~eil~hp~~~~ 268 (448)
+|++|++||...+..+...++... ....| ..+++++.++|.+|+ .||.+|++ ++++++||||+.
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~ 310 (382)
T cd05625 240 EMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKT 310 (382)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCC
Confidence 999999999988877766666543 23344 357999999999976 59999997 999999999976
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-49 Score=398.96 Aligned_cols=257 Identities=30% Similarity=0.547 Sum_probs=220.5
Q ss_pred CCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 037702 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAM 89 (448)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (448)
++|++.+.||+|+||.||+|++..+|+.||||++.+...........+.+|+.+++.++||||+++++.+.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999997655444344577889999999999999999999999999999999
Q ss_pred eecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccccc----
Q 037702 90 EYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQ---- 164 (448)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~---- 164 (448)
||++||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|........
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 99999999999976 6789999999999999999999999999999999999999999999999999753211000
Q ss_pred -------------------------------------CCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh
Q 037702 165 -------------------------------------DGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA 207 (448)
Q Consensus 165 -------------------------------------~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt 207 (448)
.....+.+||+.|+|||++.+..+. .++|||||||++|+|++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyell~ 239 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLV 239 (376)
T ss_pred ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCC-cceeeeeccceeeehhh
Confidence 0011235799999999999877774 88999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHhhc--cCCCC--CCCCHHHHHHHHhccCCCcCCCC---CHHHHHhhhhccc
Q 037702 208 GNLPFYDSNLMELYKKITRA--EFKCP--NWFPPEVRKLLSRILDPNPSTRV---TMAKLMENYWFRK 268 (448)
Q Consensus 208 G~~Pf~~~~~~~~~~~i~~~--~~~~p--~~~s~~~~~li~~~L~~dP~~Rp---t~~eil~hp~~~~ 268 (448)
|+.||.+.+..+....+... ....| ..+++++.++|.+|+ .+|.+|+ |+.++++||||+.
T Consensus 240 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~ 306 (376)
T cd05598 240 GQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKG 306 (376)
T ss_pred CCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCC
Confidence 99999988877766665543 22333 357899999999976 5999999 9999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-49 Score=396.00 Aligned_cols=257 Identities=34% Similarity=0.656 Sum_probs=226.8
Q ss_pred CCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 037702 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAM 89 (448)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (448)
++|++.+.||+|+||.||+|++..+|+.||||++.+...........+.+|+.++..++||||+++++++.+++.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999999999999999998765544445677889999999999999999999999999999999
Q ss_pred eecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccc-----
Q 037702 90 EYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTR----- 163 (448)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~----- 163 (448)
||++|++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 99999999999976 689999999999999999999999999999999999999999999999999997544322
Q ss_pred ----------------------cCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHH
Q 037702 164 ----------------------QDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELY 221 (448)
Q Consensus 164 ----------------------~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~ 221 (448)
.........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+....+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 239 (350)
T cd05573 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPY-GLECDWWSLGVILYEMLYGFPPFYSDTLQETY 239 (350)
T ss_pred ccccccccccccccccccccccccccccccccCccccCHHHHcCCCC-CCceeeEecchhhhhhccCCCCCCCCCHHHHH
Confidence 0112235679999999999987766 48899999999999999999999998887777
Q ss_pred HHHhh--ccCCCCCC--CCHHHHHHHHhccCCCcCCCCC-HHHHHhhhhccc
Q 037702 222 KKITR--AEFKCPNW--FPPEVRKLLSRILDPNPSTRVT-MAKLMENYWFRK 268 (448)
Q Consensus 222 ~~i~~--~~~~~p~~--~s~~~~~li~~~L~~dP~~Rpt-~~eil~hp~~~~ 268 (448)
.++.. .....|.. +++++.+||.+||. ||.+||+ ++++++||||+.
T Consensus 240 ~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~ 290 (350)
T cd05573 240 NKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKG 290 (350)
T ss_pred HHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCC
Confidence 77766 44445544 59999999999997 9999999 999999999976
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-49 Score=387.90 Aligned_cols=250 Identities=32% Similarity=0.639 Sum_probs=220.0
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHh-CCCCCcceEEEEEEeCCEEEEEEeecCC
Q 037702 16 RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRL-VRHPNIVQLYEVMASKTKIYFAMEYVRG 94 (448)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~-l~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (448)
+.||+|+||.||+|.+..+++.||||++.+.........+....|..++.. .+||||+++++++..+..+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999999999999999987654333344556667777765 4899999999999999999999999999
Q ss_pred CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCccccCC
Q 037702 95 GELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCG 173 (448)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~G 173 (448)
|+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......+|
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~--~~~~~~~~g 158 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG--EGKASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCC--CCccccccC
Confidence 999999865 68999999999999999999999999999999999999999999999999998743221 123345689
Q ss_pred CCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHHHHhccCCCcCC
Q 037702 174 TPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILDPNPST 253 (448)
Q Consensus 174 t~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~ 253 (448)
|+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+++..+.......|.+++.++.+||.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P~~ 237 (316)
T cd05592 159 TPDYIAPEILKGQKY-NESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTK 237 (316)
T ss_pred CccccCHHHHcCCCC-CCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence 999999999987666 4889999999999999999999999988888888888878889999999999999999999999
Q ss_pred CCCH-HHHHhhhhccc
Q 037702 254 RVTM-AKLMENYWFRK 268 (448)
Q Consensus 254 Rpt~-~eil~hp~~~~ 268 (448)
||++ .++++||||..
T Consensus 238 R~~~~~~l~~h~~~~~ 253 (316)
T cd05592 238 RLGVDGDIRQHPFFRG 253 (316)
T ss_pred cCCChHHHHcCcccCC
Confidence 9986 48889999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-49 Score=389.96 Aligned_cols=251 Identities=35% Similarity=0.661 Sum_probs=222.0
Q ss_pred eeeeecCceEEEEEEEC---CCCcEEEEEEeeccccc-chhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 037702 16 RLLGQGTFAKVYHGRNL---KTGQSVAIKIVDKEKIR-RVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAMEY 91 (448)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 91 (448)
+.||+|+||.||+|++. .+++.||+|++.+.... .......+.+|+.+++.++||||+++++++..++.+|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 67999999999999864 47889999999765432 223345678899999999999999999999999999999999
Q ss_pred cCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCccc
Q 037702 92 VRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHT 170 (448)
Q Consensus 92 ~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~ 170 (448)
++||+|.+++.. +.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..... .......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~ 159 (323)
T cd05584 82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH--EGTVTHT 159 (323)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeeccc--CCCcccc
Confidence 999999999965 6789999999999999999999999999999999999999999999999999874321 1222345
Q ss_pred cCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHHHHhccCCC
Q 037702 171 TCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILDPN 250 (448)
Q Consensus 171 ~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~d 250 (448)
.+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+.......+..+....|+.+++++.+||.+||..|
T Consensus 160 ~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 238 (323)
T cd05584 160 FCGTIEYMAPEILMRSGH-GKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRN 238 (323)
T ss_pred cCCCccccChhhccCCCC-CCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHcccC
Confidence 689999999999987666 4889999999999999999999999888888888888888899999999999999999999
Q ss_pred cCCCC-----CHHHHHhhhhcccc
Q 037702 251 PSTRV-----TMAKLMENYWFRKG 269 (448)
Q Consensus 251 P~~Rp-----t~~eil~hp~~~~~ 269 (448)
|.+|| +++++++||||...
T Consensus 239 p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 239 PSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred HhHcCCCCCCCHHHHhcCCCcCCC
Confidence 99999 89999999999763
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-49 Score=390.28 Aligned_cols=250 Identities=32% Similarity=0.578 Sum_probs=219.0
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHH-HHHhCCCCCcceEEEEEEeCCEEEEEEeecCC
Q 037702 16 RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREIS-VMRLVRHPNIVQLYEVMASKTKIYFAMEYVRG 94 (448)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~-~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (448)
+.||+|+||+||+|++..+|+.||+|++.+...........+.+|.. +++.++||||+++++++...+..|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999999999999999998764433333345555654 56789999999999999999999999999999
Q ss_pred CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCccccCC
Q 037702 95 GELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCG 173 (448)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~G 173 (448)
|+|..++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..... ........+|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~~~~~g 158 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA--QSDTTTTFCG 158 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCC--CCCCcccccC
Confidence 999988865 6799999999999999999999999999999999999999999999999999874321 1122345689
Q ss_pred CCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHHHHhccCCCcCC
Q 037702 174 TPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILDPNPST 253 (448)
Q Consensus 174 t~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~ 253 (448)
|+.|+|||++.+..++ .++|||||||++|+|++|..||...+..+++..+.......++..+..+.++|.+||..||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p~~ 237 (325)
T cd05604 159 TPEYLAPEVIRKQPYD-NTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQR 237 (325)
T ss_pred ChhhCCHHHHcCCCCC-CcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccCHHh
Confidence 9999999999877765 789999999999999999999999988888888888887777889999999999999999999
Q ss_pred CCCH----HHHHhhhhccc
Q 037702 254 RVTM----AKLMENYWFRK 268 (448)
Q Consensus 254 Rpt~----~eil~hp~~~~ 268 (448)
||++ .++++||||..
T Consensus 238 R~~~~~~~~~i~~h~~f~~ 256 (325)
T cd05604 238 RLGAKEDFLEIQEHPFFES 256 (325)
T ss_pred cCCCCCCHHHHhcCCCcCC
Confidence 9976 59999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-49 Score=382.63 Aligned_cols=254 Identities=28% Similarity=0.456 Sum_probs=213.3
Q ss_pred CCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 037702 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAM 89 (448)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (448)
++|++.+.||+|+||.||+|++..+++.||+|++....... ...+.+.+|+.+++.++||||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENE-EVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccc-cchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 47999999999999999999999999999999997653322 33467889999999999999999999999999999999
Q ss_pred eecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCc
Q 037702 90 EYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLL 168 (448)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 168 (448)
||++++.+..+... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~ 158 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS-NANY 158 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc-cccc
Confidence 99999877665543 579999999999999999999999999999999999999999999999999998653221 1122
Q ss_pred cccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhcc-------------------C
Q 037702 169 HTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAE-------------------F 229 (448)
Q Consensus 169 ~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-------------------~ 229 (448)
....||+.|+|||++.+..+ +.++|||||||++|+|++|++||.+.+..+....+.... .
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~-~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 159 TEYVATRWYRSPELLLGAPY-GKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred cccccccccCCcHHHcCCCC-CCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 34579999999999987776 488999999999999999999998766544333222110 0
Q ss_pred CC-------------CCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhc
Q 037702 230 KC-------------PNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWF 266 (448)
Q Consensus 230 ~~-------------p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 266 (448)
.. ...+|+++.+||.+||+.||.+|||++++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 01 11267889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-49 Score=389.98 Aligned_cols=255 Identities=31% Similarity=0.562 Sum_probs=227.5
Q ss_pred CeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEE
Q 037702 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEVMASKTKIYFAM 89 (448)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~ 89 (448)
+|++.+.||+|+||.||+|++..+++.||||++.+.........+....|..++..+ .||+|+++++++.+.+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 589999999999999999999999999999999876544444456677788888877 5899999999999999999999
Q ss_pred eecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCc
Q 037702 90 EYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLL 168 (448)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 168 (448)
||+++|+|.+.+.. +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... .....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~--~~~~~ 158 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW--DGVTT 158 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCC--CCCcc
Confidence 99999999999865 6799999999999999999999999999999999999999999999999999874321 12223
Q ss_pred cccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHHHHhccC
Q 037702 169 HTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILD 248 (448)
Q Consensus 169 ~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~ 248 (448)
...+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+...++..+......+|..+++++.+++.+||+
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~l~ 237 (323)
T cd05616 159 KTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMT 237 (323)
T ss_pred ccCCCChhhcCHHHhcCCCCC-CccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHcc
Confidence 456899999999999877765 8899999999999999999999999988999999888888999999999999999999
Q ss_pred CCcCCCCC-----HHHHHhhhhccc
Q 037702 249 PNPSTRVT-----MAKLMENYWFRK 268 (448)
Q Consensus 249 ~dP~~Rpt-----~~eil~hp~~~~ 268 (448)
.||.+|++ ..++++||||+.
T Consensus 238 ~~p~~R~~~~~~~~~~i~~h~~~~~ 262 (323)
T cd05616 238 KHPGKRLGCGPEGERDIKEHAFFRY 262 (323)
T ss_pred cCHHhcCCCCCCCHHHHhcCCCcCC
Confidence 99999998 489999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-49 Score=382.56 Aligned_cols=253 Identities=27% Similarity=0.473 Sum_probs=213.3
Q ss_pred cCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFA 88 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 88 (448)
+++|++.+.||.|+||.||+|.+..++..||+|++...... .....+.+|+.+++.++||||+++++++.+....|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC--CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 57899999999999999999999999999999999754322 2235677899999999999999999999999999999
Q ss_pred EeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCC
Q 037702 89 MEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDG 166 (448)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 166 (448)
|||+++ +|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~--~~ 158 (288)
T cd07871 82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVP--TK 158 (288)
T ss_pred EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCC--Cc
Confidence 999975 89888864 35799999999999999999999999999999999999999999999999998754322 12
Q ss_pred CccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhcc------------------
Q 037702 167 LLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAE------------------ 228 (448)
Q Consensus 167 ~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~------------------ 228 (448)
......||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR 238 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence 23456789999999998765444688999999999999999999998877655544432210
Q ss_pred -CCCC-----------CCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhc
Q 037702 229 -FKCP-----------NWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWF 266 (448)
Q Consensus 229 -~~~p-----------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 266 (448)
..+| +.+++++.+||.+||..||.+|||++|+++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 0111 2367899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-49 Score=387.79 Aligned_cols=251 Identities=34% Similarity=0.633 Sum_probs=224.4
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeecCC
Q 037702 16 RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEVMASKTKIYFAMEYVRG 94 (448)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (448)
+.||+|+||.||+|.+..+++.||||++.+...........+.+|+.+++.+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999876544444456778899999888 799999999999999999999999999
Q ss_pred CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCccccCC
Q 037702 95 GELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCG 173 (448)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~G 173 (448)
|+|..++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL--GGVTTSTFCG 158 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCc--CCCcccceec
Confidence 999998876 5899999999999999999999999999999999999999999999999999864221 1122345679
Q ss_pred CCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHHHHhccCCCcCC
Q 037702 174 TPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILDPNPST 253 (448)
Q Consensus 174 t~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~ 253 (448)
|+.|+|||++.+..++ .++|||||||++|+|++|+.||...+....+..+.......|..+++++.+||++||..||.+
T Consensus 159 ~~~y~aPE~~~~~~~~-~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 237 (318)
T cd05570 159 TPDYIAPEILSYQPYG-PAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEK 237 (318)
T ss_pred CccccCHHHhcCCCCC-cchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCHHH
Confidence 9999999999877665 789999999999999999999999888888888888888888899999999999999999999
Q ss_pred CCCH-----HHHHhhhhcccc
Q 037702 254 RVTM-----AKLMENYWFRKG 269 (448)
Q Consensus 254 Rpt~-----~eil~hp~~~~~ 269 (448)
|||+ .++++||||+..
T Consensus 238 R~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 238 RLGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred cCCCCCCCHHHHhcCCCcCCC
Confidence 9999 999999999763
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-51 Score=396.95 Aligned_cols=256 Identities=33% Similarity=0.566 Sum_probs=230.4
Q ss_pred cCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFA 88 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 88 (448)
...|...+.||+|+||.||+|.+..+++.||||+++.+...+ .++.+.+|+.+|..++++||.++|+.+..+..++++
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~d--eIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii 89 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAED--EIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII 89 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcch--hhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence 446888899999999999999999999999999999886654 468899999999999999999999999999999999
Q ss_pred EeecCCCchHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCC
Q 037702 89 MEYVRGGELFNKVAKGKL-REEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGL 167 (448)
Q Consensus 89 ~E~~~gg~L~~~i~~~~l-~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 167 (448)
||||.||++.+.++.+.+ +|..+..++++++.||.|||+++.+|||||+.|||+..+|.+||+|||.+........ .
T Consensus 90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~--r 167 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK--R 167 (467)
T ss_pred HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhh--c
Confidence 999999999999998765 9999999999999999999999999999999999999999999999999986654332 2
Q ss_pred ccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCC-CCCCCCHHHHHHHHhc
Q 037702 168 LHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFK-CPNWFPPEVRKLLSRI 246 (448)
Q Consensus 168 ~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~li~~~ 246 (448)
..+.+|||.||||||+...+|+ .++||||||++.|||++|.+||.+...+.....|.+..++ ....+|+.+++|+..|
T Consensus 168 r~tfvGTPfwMAPEVI~~~~Y~-~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~C 246 (467)
T KOG0201|consen 168 RKTFVGTPFWMAPEVIKQSGYD-TKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEAC 246 (467)
T ss_pred cccccccccccchhhhcccccc-chhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHH
Confidence 3789999999999999988887 8899999999999999999999988876665556554433 3346899999999999
Q ss_pred cCCCcCCCCCHHHHHhhhhcccc
Q 037702 247 LDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 247 L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
|+.||+.||+|.++|+|+|++..
T Consensus 247 L~k~P~~RpsA~~LLKh~FIk~a 269 (467)
T KOG0201|consen 247 LDKNPEFRPSAKELLKHKFIKRA 269 (467)
T ss_pred hhcCcccCcCHHHHhhhHHHHhc
Confidence 99999999999999999999873
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-49 Score=390.78 Aligned_cols=250 Identities=33% Similarity=0.578 Sum_probs=216.9
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcE-EEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-E
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQS-VAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKT-K 84 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~-vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~-~ 84 (448)
+......+.+.||+|+||+||+|.+ .|.. ||||++......... .+.+.+|+.+|.+++|||||++++++.+.. .
T Consensus 38 i~~~~l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~ 114 (362)
T KOG0192|consen 38 IDPDELPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGS 114 (362)
T ss_pred cChHHhhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 3445667778899999999999998 5666 999999876655444 678999999999999999999999999888 7
Q ss_pred EEEEEeecCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC-CEeecCCCCceEEcCCC-CeEEeeccccccc
Q 037702 85 IYFAMEYVRGGELFNKVAK---GKLREEVARKYFQQLVDAVEFCHSRG-VYHRDLKPENLLLDENG-DLKISDFGLSALQ 159 (448)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~yLH~~g-ivHrDLkp~NILl~~~g-~lkl~DFGla~~~ 159 (448)
..+||||+++|+|++++.. +.++...+..++.||+.||.|||+++ ||||||||+|||++.++ ++||+|||+++..
T Consensus 115 ~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~ 194 (362)
T KOG0192|consen 115 LCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREK 194 (362)
T ss_pred eEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceee
Confidence 9999999999999999954 68999999999999999999999999 99999999999999998 9999999999865
Q ss_pred cccccCCCccccCCCCcccchhhhh--ccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhc--cCCCCCCC
Q 037702 160 ESTRQDGLLHTTCGTPAYVAPEVIN--KRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA--EFKCPNWF 235 (448)
Q Consensus 160 ~~~~~~~~~~~~~Gt~~Y~APEvl~--~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~ 235 (448)
.... .......||+.|||||++. ...|+ .|+|||||||+||||+||+.||.+....+....+... ...+|..+
T Consensus 195 ~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~-~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~ 271 (362)
T KOG0192|consen 195 VISK--TSMTSVAGTYRWMAPEVLRGEKSPYT-EKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKEC 271 (362)
T ss_pred cccc--ccccCCCCCccccChhhhcCCCCcCC-ccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccC
Confidence 4332 2223368999999999998 44564 9999999999999999999999998876665555432 34567779
Q ss_pred CHHHHHHHHhccCCCcCCCCCHHHHHh
Q 037702 236 PPEVRKLLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 236 s~~~~~li~~~L~~dP~~Rpt~~eil~ 262 (448)
++.+..|+.+||..||.+||++.+|+.
T Consensus 272 ~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 272 PPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred CHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 999999999999999999999999976
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=383.40 Aligned_cols=256 Identities=27% Similarity=0.468 Sum_probs=210.3
Q ss_pred cCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFA 88 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 88 (448)
.++|++.+.||+|+||.||+|.+..+|+.||||++....... ....+.+|+.+++.++||||+++++++.+....|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG--TPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc--cchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 478999999999999999999999999999999997543222 224567899999999999999999999999999999
Q ss_pred EeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCC
Q 037702 89 MEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDG 166 (448)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 166 (448)
|||+. ++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~~ 158 (303)
T cd07869 82 FEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP--SH 158 (303)
T ss_pred EECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCC--Cc
Confidence 99996 578777754 56999999999999999999999999999999999999999999999999998743222 12
Q ss_pred CccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcH-HHHHHHHhhc--c---------------
Q 037702 167 LLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNL-MELYKKITRA--E--------------- 228 (448)
Q Consensus 167 ~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~~--~--------------- 228 (448)
.....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+... .+....+... .
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHF 238 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccc
Confidence 234567899999999987655456889999999999999999999987532 2222222110 0
Q ss_pred ----C--CCCC---------CCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 229 ----F--KCPN---------WFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 229 ----~--~~p~---------~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
+ ..|. .+++++.+||.+||+.||.+|||+.++++||||++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 239 KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred ccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 0 0010 135789999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-49 Score=396.04 Aligned_cols=257 Identities=29% Similarity=0.555 Sum_probs=223.4
Q ss_pred CCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 037702 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAM 89 (448)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (448)
++|++.+.||+|+||.||+|.+..+|+.||||++.+...........+.+|+.++..++||||+++++.+.+++.+|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998655444455677889999999999999999999999999999999
Q ss_pred eecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccccc----
Q 037702 90 EYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQ---- 164 (448)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~---- 164 (448)
||++||+|.+++.+ +.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 99999999999865 6799999999999999999999999999999999999999999999999999874322110
Q ss_pred -----------------------------CCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 037702 165 -----------------------------DGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDS 215 (448)
Q Consensus 165 -----------------------------~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~ 215 (448)
.....+.+||+.|+|||++.+.+++ .++|||||||++|+|++|+.||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyel~tG~~Pf~~~ 239 (360)
T cd05627 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE 239 (360)
T ss_pred cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCC-CcceeccccceeeecccCCCCCCCC
Confidence 0112245899999999999887775 7899999999999999999999998
Q ss_pred cHHHHHHHHhhc--cCCCCCC--CCHHHHHHHHhccCCCcCCCC---CHHHHHhhhhccc
Q 037702 216 NLMELYKKITRA--EFKCPNW--FPPEVRKLLSRILDPNPSTRV---TMAKLMENYWFRK 268 (448)
Q Consensus 216 ~~~~~~~~i~~~--~~~~p~~--~s~~~~~li~~~L~~dP~~Rp---t~~eil~hp~~~~ 268 (448)
+....+.++... ...+|+. +++++++||.+++. ||.+|+ +++++++||||+.
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~ 298 (360)
T cd05627 240 TPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEG 298 (360)
T ss_pred CHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCC
Confidence 888888777653 3344543 78999999999874 999998 4899999999976
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-48 Score=386.07 Aligned_cols=250 Identities=32% Similarity=0.586 Sum_probs=219.1
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHH-HHHhCCCCCcceEEEEEEeCCEEEEEEeecCC
Q 037702 16 RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREIS-VMRLVRHPNIVQLYEVMASKTKIYFAMEYVRG 94 (448)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~-~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (448)
+.||+|+||.||+|++..+|+.||+|++.+...........+.+|+. +++.++||||+++++++.+.+..|+||||++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999998765433333345555554 67889999999999999999999999999999
Q ss_pred CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCccccCC
Q 037702 95 GELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCG 173 (448)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~G 173 (448)
|+|...+.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..... ........+|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE--PEETTSTFCG 158 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCC--CCCccccccC
Confidence 999988865 6799999999999999999999999999999999999999999999999999874321 1222345689
Q ss_pred CCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHHHHhccCCCcCC
Q 037702 174 TPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILDPNPST 253 (448)
Q Consensus 174 t~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~ 253 (448)
|+.|+|||++.+..++ .++|||||||++|+|++|..||...+....+..+......+|...+.++.++|.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (321)
T cd05603 159 TPEYLAPEVLRKEPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRR 237 (321)
T ss_pred CcccCCHHHhcCCCCC-CcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHhh
Confidence 9999999999876665 789999999999999999999999988888888888888888889999999999999999999
Q ss_pred CCCH----HHHHhhhhccc
Q 037702 254 RVTM----AKLMENYWFRK 268 (448)
Q Consensus 254 Rpt~----~eil~hp~~~~ 268 (448)
||++ .++++|+||..
T Consensus 238 R~~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 238 RLGAKADFLEIKNHVFFSP 256 (321)
T ss_pred cCCCCCCHHHHhCCCCcCC
Confidence 9875 59999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=394.57 Aligned_cols=263 Identities=31% Similarity=0.559 Sum_probs=226.8
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKI 85 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 85 (448)
....++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.++..+
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 118 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 34568999999999999999999999999999999999765444334456678999999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccC
Q 037702 86 YFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQD 165 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~ 165 (448)
|+||||++||+|.+++....+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++....... .
T Consensus 119 ~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~-~ 197 (371)
T cd05622 119 YMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-M 197 (371)
T ss_pred EEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCC-c
Confidence 999999999999999988889999999999999999999999999999999999999999999999999997543221 1
Q ss_pred CCccccCCCCcccchhhhhccC---CCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhcc--CCCCC--CCCHH
Q 037702 166 GLLHTTCGTPAYVAPEVINKRG---YDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAE--FKCPN--WFPPE 238 (448)
Q Consensus 166 ~~~~~~~Gt~~Y~APEvl~~~~---~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~--~~s~~ 238 (448)
....+.+||+.|+|||++...+ +.+.++|||||||++|+|++|..||...+....+.++.... ..+|. .+++.
T Consensus 198 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 277 (371)
T cd05622 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKE 277 (371)
T ss_pred ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHH
Confidence 1224568999999999997543 34688999999999999999999999998888888886543 33443 58999
Q ss_pred HHHHHHhccCCCcCC--CCCHHHHHhhhhcccc
Q 037702 239 VRKLLSRILDPNPST--RVTMAKLMENYWFRKG 269 (448)
Q Consensus 239 ~~~li~~~L~~dP~~--Rpt~~eil~hp~~~~~ 269 (448)
++++|.+||..++.+ |++++++++||||++.
T Consensus 278 ~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 278 AKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred HHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 999999999854443 7899999999999763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-48 Score=385.89 Aligned_cols=255 Identities=32% Similarity=0.567 Sum_probs=226.6
Q ss_pred CeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEE
Q 037702 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR-HPNIVQLYEVMASKTKIYFAM 89 (448)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lV~ 89 (448)
+|++.+.||+|+||.||+|++..+|+.||+|++.+.........+.+..|+.++..+. ||+|+++++++.+.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4889999999999999999999999999999998765444444566778999998886 567888999999999999999
Q ss_pred eecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCc
Q 037702 90 EYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLL 168 (448)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 168 (448)
||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ....
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~--~~~~ 158 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD--GVTT 158 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCC--Cccc
Confidence 99999999999876 68999999999999999999999999999999999999999999999999998743221 1223
Q ss_pred cccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHHHHhccC
Q 037702 169 HTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILD 248 (448)
Q Consensus 169 ~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~ 248 (448)
...+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+.......+.......|..+++++.+++.+||.
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~ 237 (323)
T cd05615 159 RTFCGTPDYIAPEIIAYQPYG-KSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMT 237 (323)
T ss_pred cCccCCccccCHHHHcCCCCC-CccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcc
Confidence 456799999999999876664 8899999999999999999999999888888999888888999999999999999999
Q ss_pred CCcCCCCC-----HHHHHhhhhccc
Q 037702 249 PNPSTRVT-----MAKLMENYWFRK 268 (448)
Q Consensus 249 ~dP~~Rpt-----~~eil~hp~~~~ 268 (448)
.||.+|++ .+++++||||+.
T Consensus 238 ~~p~~R~~~~~~~~~~i~~h~~f~~ 262 (323)
T cd05615 238 KHPSKRLGCGPEGERDIREHAFFRR 262 (323)
T ss_pred cCHhhCCCCCCCCHHHHhcCcccCC
Confidence 99999997 579999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-48 Score=385.73 Aligned_cols=251 Identities=32% Similarity=0.596 Sum_probs=220.6
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHh-CCCCCcceEEEEEEeCCEEEEEEeecCC
Q 037702 16 RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRL-VRHPNIVQLYEVMASKTKIYFAMEYVRG 94 (448)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~-l~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (448)
+.||+|+||.||+|++..+++.||||++.+..............|..++.. ++||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999999999999999987643322334556678888876 4999999999999999999999999999
Q ss_pred CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCccccCC
Q 037702 95 GELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCG 173 (448)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~G 173 (448)
|+|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENML--GDAKTCTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCC--CCCceeeecC
Confidence 999999976 6799999999999999999999999999999999999999999999999999874221 1122345679
Q ss_pred CCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHHHHhccCCCcCC
Q 037702 174 TPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILDPNPST 253 (448)
Q Consensus 174 t~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~ 253 (448)
|+.|+|||++.+..++ .++||||+||++|+|++|..||...+..+.+..+.......|.+++.+++++|.+||..||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~ 237 (316)
T cd05619 159 TPDYIAPEILLGQKYN-TSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPER 237 (316)
T ss_pred CccccCHHHHcCCCCC-chhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccCHhh
Confidence 9999999999876664 889999999999999999999999888888888887777888899999999999999999999
Q ss_pred CCCHH-HHHhhhhcccc
Q 037702 254 RVTMA-KLMENYWFRKG 269 (448)
Q Consensus 254 Rpt~~-eil~hp~~~~~ 269 (448)
||++. ++++||||...
T Consensus 238 R~~~~~~l~~h~~~~~~ 254 (316)
T cd05619 238 RLGVKGDIRQHPFFREI 254 (316)
T ss_pred cCCChHHHHcCcccCCC
Confidence 99996 89999999763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-48 Score=387.54 Aligned_cols=250 Identities=32% Similarity=0.590 Sum_probs=217.9
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeecCC
Q 037702 16 RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEVMASKTKIYFAMEYVRG 94 (448)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (448)
+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999876555545567788999998776 899999999999999999999999999
Q ss_pred CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCccccCC
Q 037702 95 GELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCG 173 (448)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~G 173 (448)
|+|..++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... .......+|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~--~~~~~~~~g 158 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCC--CCccccccC
Confidence 999988865 67999999999999999999999999999999999999999999999999998743211 122345689
Q ss_pred CCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCC---------CcHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 037702 174 TPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYD---------SNLMELYKKITRAEFKCPNWFPPEVRKLLS 244 (448)
Q Consensus 174 t~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~---------~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 244 (448)
|+.|+|||++.+..++ .++|||||||++|+|++|+.||.. .........+.......|..++..+.+||.
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~ 237 (329)
T cd05618 159 TPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 237 (329)
T ss_pred CccccCHHHHcCCCCC-CccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 9999999999877664 789999999999999999999952 122335556667777889999999999999
Q ss_pred hccCCCcCCCCC------HHHHHhhhhccc
Q 037702 245 RILDPNPSTRVT------MAKLMENYWFRK 268 (448)
Q Consensus 245 ~~L~~dP~~Rpt------~~eil~hp~~~~ 268 (448)
+||..||.+||+ ++++++||||+.
T Consensus 238 ~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~ 267 (329)
T cd05618 238 SFLNKDPKERLGCHPQTGFADIQGHPFFRN 267 (329)
T ss_pred HHhcCCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 999999999998 589999999965
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=386.18 Aligned_cols=249 Identities=36% Similarity=0.661 Sum_probs=221.1
Q ss_pred eeeeecCceEEEEEEEC---CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeec
Q 037702 16 RLLGQGTFAKVYHGRNL---KTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAMEYV 92 (448)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 92 (448)
+.||+|+||.||++++. .+|+.||+|++.+..... .....+.+|+.+++.++||||+++++++.++..+|+||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKV-RDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 67999999999999863 578999999998654332 22355778999999999999999999999999999999999
Q ss_pred CCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCcccc
Q 037702 93 RGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTT 171 (448)
Q Consensus 93 ~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~ 171 (448)
++|+|.+++.+ ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......
T Consensus 81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~--~~~~~~~ 158 (318)
T cd05582 81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH--EKKAYSF 158 (318)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCC--CCceecc
Confidence 99999999965 57999999999999999999999999999999999999999999999999998754322 1223456
Q ss_pred CCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHHHHhccCCCc
Q 037702 172 CGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILDPNP 251 (448)
Q Consensus 172 ~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP 251 (448)
+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+..+....+.......|..+++++.+||++||+.||
T Consensus 159 ~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~P 237 (318)
T cd05582 159 CGTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNP 237 (318)
T ss_pred cCChhhcCHHHHcCCCC-CCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCH
Confidence 89999999999987666 48899999999999999999999998888888888888888899999999999999999999
Q ss_pred CCCCC-----HHHHHhhhhccc
Q 037702 252 STRVT-----MAKLMENYWFRK 268 (448)
Q Consensus 252 ~~Rpt-----~~eil~hp~~~~ 268 (448)
.+||+ +++++.||||..
T Consensus 238 ~~R~~a~~~~~~~~~~~~~~~~ 259 (318)
T cd05582 238 ANRLGAGPDGVEEIKRHPFFST 259 (318)
T ss_pred hHcCCCCCCCHHHHhCCCCcCC
Confidence 99999 788999999975
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-48 Score=387.26 Aligned_cols=249 Identities=33% Similarity=0.583 Sum_probs=217.5
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC---CCCCcceEEEEEEeCCEEEEEEeecCC
Q 037702 18 LGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV---RHPNIVQLYEVMASKTKIYFAMEYVRG 94 (448)
Q Consensus 18 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l---~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (448)
||+|+||.||+|++..+|+.||||++.+..............|..++..+ +||||+++++++.+.+.+|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999999999999999999865544333344556677777665 699999999999999999999999999
Q ss_pred CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCccccCC
Q 037702 95 GELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCG 173 (448)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~G 173 (448)
|+|..++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ......+.+|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~--~~~~~~~~~g 158 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLT--DNKTTNTFCG 158 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCC--CCCCccCccC
Confidence 999988865 6799999999999999999999999999999999999999999999999999874322 1223346789
Q ss_pred CCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCC-CCCHHHHHHHHhccCCCcC
Q 037702 174 TPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPN-WFPPEVRKLLSRILDPNPS 252 (448)
Q Consensus 174 t~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~-~~s~~~~~li~~~L~~dP~ 252 (448)
|+.|+|||++.+....+.++|||||||++|+|++|..||...+..+.+..+..+...+|. .+++++.+||++||.+||.
T Consensus 159 t~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~ 238 (330)
T cd05586 159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQ 238 (330)
T ss_pred CccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHH
Confidence 999999999876544468899999999999999999999999888888888887777775 4799999999999999999
Q ss_pred CCC----CHHHHHhhhhccc
Q 037702 253 TRV----TMAKLMENYWFRK 268 (448)
Q Consensus 253 ~Rp----t~~eil~hp~~~~ 268 (448)
+|| ++.++++||||..
T Consensus 239 ~R~~~~~~~~~ll~h~~~~~ 258 (330)
T cd05586 239 HRLGAHRDAVELKEHPFFAD 258 (330)
T ss_pred HCCCCCCCHHHHhcCccccC
Confidence 998 7999999999975
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-48 Score=382.20 Aligned_cols=250 Identities=33% Similarity=0.604 Sum_probs=217.9
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHH-HHHHhCCCCCcceEEEEEEeCCEEEEEEeecCC
Q 037702 16 RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREI-SVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRG 94 (448)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei-~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (448)
+.||+|+||.||+|++..+++.||+|++.+...........+.+|. .+++.++||||+++++++...+.+|+||||++|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 4799999999999999999999999999865443322233444444 457889999999999999999999999999999
Q ss_pred CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCccccCC
Q 037702 95 GELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCG 173 (448)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~G 173 (448)
|+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~--~~~~~~~~~g 158 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE--HNGTTSTFCG 158 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCccccc--CCCCcccccC
Confidence 999999876 6799999999999999999999999999999999999999999999999999874321 1223345689
Q ss_pred CCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHHHHhccCCCcCC
Q 037702 174 TPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILDPNPST 253 (448)
Q Consensus 174 t~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~ 253 (448)
|+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..+.+..+.......++.+++.+.++|.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (325)
T cd05602 159 TPEYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTK 237 (325)
T ss_pred CccccCHHHHcCCCCC-CccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccCHHH
Confidence 9999999999876664 789999999999999999999999888888888888777888889999999999999999999
Q ss_pred CCCHH----HHHhhhhccc
Q 037702 254 RVTMA----KLMENYWFRK 268 (448)
Q Consensus 254 Rpt~~----eil~hp~~~~ 268 (448)
|+++. ++++|+||..
T Consensus 238 R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 238 RLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred CCCCCCCHHHHhcCcccCC
Confidence 99876 8999999965
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-48 Score=382.03 Aligned_cols=251 Identities=32% Similarity=0.583 Sum_probs=218.9
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeecCC
Q 037702 16 RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEVMASKTKIYFAMEYVRG 94 (448)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (448)
+.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.++..+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999877655545567788999999888 699999999999999999999999999
Q ss_pred CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCccccCC
Q 037702 95 GELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCG 173 (448)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~G 173 (448)
|+|..++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ......+.+|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG--PGDTTSTFCG 158 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccC--CCCceecccC
Confidence 999988865 6899999999999999999999999999999999999999999999999999874221 1122345789
Q ss_pred CCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCC-------cHHHHHHHHhhccCCCCCCCCHHHHHHHHhc
Q 037702 174 TPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDS-------NLMELYKKITRAEFKCPNWFPPEVRKLLSRI 246 (448)
Q Consensus 174 t~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~-------~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 246 (448)
|+.|+|||++.+..+ +.++|||||||++|+|++|..||... .....+..+.......|..++..+.++|.+|
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~ 237 (327)
T cd05617 159 TPNYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGF 237 (327)
T ss_pred CcccCCHHHHCCCCC-CchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHH
Confidence 999999999987766 48899999999999999999999531 2234556666667788888999999999999
Q ss_pred cCCCcCCCCC------HHHHHhhhhcccc
Q 037702 247 LDPNPSTRVT------MAKLMENYWFRKG 269 (448)
Q Consensus 247 L~~dP~~Rpt------~~eil~hp~~~~~ 269 (448)
|..||.+|++ ++++++||||...
T Consensus 238 L~~dP~~R~~~~~~~~~~~i~~h~~f~~~ 266 (327)
T cd05617 238 LNKDPKERLGCQPQTGFSDIKSHTFFRSI 266 (327)
T ss_pred hccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence 9999999998 5799999999763
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=381.69 Aligned_cols=256 Identities=29% Similarity=0.482 Sum_probs=207.9
Q ss_pred CeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----CEE
Q 037702 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASK-----TKI 85 (448)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~-----~~~ 85 (448)
+|++.+.||+|+||.||+|++..+|..||||.+...... ......+.+|+.+++.++||||+++++++... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEH-VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhcc-chhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 699999999999999999999999999999998753222 22335688999999999999999999987543 358
Q ss_pred EEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccccc
Q 037702 86 YFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQ 164 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~ 164 (448)
|+||||+. ++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 158 (338)
T cd07859 80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 158 (338)
T ss_pred EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence 99999995 689888865 5799999999999999999999999999999999999999999999999999975432221
Q ss_pred -CCCccccCCCCcccchhhhhcc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhh----------------
Q 037702 165 -DGLLHTTCGTPAYVAPEVINKR-GYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITR---------------- 226 (448)
Q Consensus 165 -~~~~~~~~Gt~~Y~APEvl~~~-~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~---------------- 226 (448)
.......+||+.|+|||++.+. ...+.++|||||||++|+|++|++||.+.+.......+..
T Consensus 159 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 238 (338)
T cd07859 159 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNE 238 (338)
T ss_pred ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence 1222346799999999998652 2335889999999999999999999987654332221110
Q ss_pred ----------ccCCC-----CCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccc
Q 037702 227 ----------AEFKC-----PNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRK 268 (448)
Q Consensus 227 ----------~~~~~-----p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 268 (448)
..... .+.+++++.++|.+||+.||++|||++++++||||+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~ 295 (338)
T cd07859 239 KARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKG 295 (338)
T ss_pred hHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhh
Confidence 00000 1236788999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-49 Score=367.99 Aligned_cols=256 Identities=32% Similarity=0.632 Sum_probs=222.9
Q ss_pred cccccccCCeEEEe-eeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEE
Q 037702 3 KKAGILMNKYELGR-LLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEVMA 80 (448)
Q Consensus 3 ~~~~~~~~~y~~~~-~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~ 80 (448)
.+..-+.++|.+-. +||-|-.|+|-.|.++.||+.+|+|++... ...++|+++.-+. .|||||.++++|+
T Consensus 54 ~k~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVye 125 (400)
T KOG0604|consen 54 FKEYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYE 125 (400)
T ss_pred hhcccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhh
Confidence 34445778888875 589999999999999999999999988533 5567899987766 6999999999986
Q ss_pred e----CCEEEEEEeecCCCchHHHHhc-C--CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCC---CCeEE
Q 037702 81 S----KTKIYFAMEYVRGGELFNKVAK-G--KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDEN---GDLKI 150 (448)
Q Consensus 81 ~----~~~~~lV~E~~~gg~L~~~i~~-~--~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~---g~lkl 150 (448)
+ ...+.+|||.++||+|++.|.. | .++|.++..+.+||..|+.|||+.+|+||||||||+|...+ ..+||
T Consensus 126 Ns~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKL 205 (400)
T KOG0604|consen 126 NSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKL 205 (400)
T ss_pred hhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEe
Confidence 4 4678899999999999999976 3 49999999999999999999999999999999999999754 46999
Q ss_pred eeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcH----HHHHHHHhh
Q 037702 151 SDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNL----MELYKKITR 226 (448)
Q Consensus 151 ~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~----~~~~~~i~~ 226 (448)
+|||+|+... ....+.+.|-||+|+|||++....|+ ..+|+||+|||+|.||+|++||+.... ..+..+|..
T Consensus 206 tDfGFAK~t~---~~~~L~TPc~TPyYvaPevlg~eKyd-kscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~ 281 (400)
T KOG0604|consen 206 TDFGFAKETQ---EPGDLMTPCFTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRT 281 (400)
T ss_pred cccccccccC---CCccccCCcccccccCHHHhCchhcC-CCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhc
Confidence 9999998543 24567899999999999999887876 789999999999999999999987542 467788888
Q ss_pred ccCCCCC--C--CCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccccc
Q 037702 227 AEFKCPN--W--FPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGY 270 (448)
Q Consensus 227 ~~~~~p~--~--~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 270 (448)
+.+.+|. | +|.+++++|+.+|..+|.+|.|+.+++.|||+....
T Consensus 282 gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~ 329 (400)
T KOG0604|consen 282 GQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE 329 (400)
T ss_pred cCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence 8887764 4 789999999999999999999999999999997654
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-47 Score=379.50 Aligned_cols=258 Identities=29% Similarity=0.557 Sum_probs=219.6
Q ss_pred CCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 037702 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAM 89 (448)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (448)
++|++.+.||+|+||.||+|++..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.++..+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 57999999999999999999999999999999998654444444567889999999999999999999999999999999
Q ss_pred eecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCC
Q 037702 90 EYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGL 167 (448)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 167 (448)
||++||+|.+++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ ..
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~ 159 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT-VQ 159 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC-cc
Confidence 99999999999965 5799999999999999999999999999999999999999999999999999865432211 11
Q ss_pred ccccCCCCcccchhhhhc----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhcc--CCCC---CCCCHH
Q 037702 168 LHTTCGTPAYVAPEVINK----RGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAE--FKCP---NWFPPE 238 (448)
Q Consensus 168 ~~~~~Gt~~Y~APEvl~~----~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p---~~~s~~ 238 (448)
....+||+.|+|||++.. .+..+.++|||||||++|+|++|+.||.+.+..+.+..+.... +..| ..+|++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 239 (331)
T cd05597 160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEE 239 (331)
T ss_pred ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHH
Confidence 223579999999999863 2344678999999999999999999999888877777775432 2333 347899
Q ss_pred HHHHHHhccCCCcC--CCCCHHHHHhhhhccc
Q 037702 239 VRKLLSRILDPNPS--TRVTMAKLMENYWFRK 268 (448)
Q Consensus 239 ~~~li~~~L~~dP~--~Rpt~~eil~hp~~~~ 268 (448)
+++||++||..+++ .|+++.++++||||..
T Consensus 240 ~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~ 271 (331)
T cd05597 240 AKDLIRRLICSPETRLGRNGLQDFKDHPFFEG 271 (331)
T ss_pred HHHHHHHHccCcccccCCCCHHHHhcCCCCCC
Confidence 99999998865444 3889999999999965
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-48 Score=374.24 Aligned_cols=248 Identities=29% Similarity=0.471 Sum_probs=213.7
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCCch
Q 037702 18 LGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGEL 97 (448)
Q Consensus 18 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 97 (448)
||+|+||+||+|.+..+|+.||+|.+.+.........+.+..|+.+++.++||||+++++++..+..+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999999999999999999876544434446678899999999999999999999999999999999999999
Q ss_pred HHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCccccC
Q 037702 98 FNKVAK-----GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTC 172 (448)
Q Consensus 98 ~~~i~~-----~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~ 172 (448)
...+.. ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++....... .......
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~ 158 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--SKTKGYA 158 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCC--ccccccC
Confidence 887732 468999999999999999999999999999999999999999999999999987543221 1223457
Q ss_pred CCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcH----HHHHHHHhhccCCCCCCCCHHHHHHHHhccC
Q 037702 173 GTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNL----MELYKKITRAEFKCPNWFPPEVRKLLSRILD 248 (448)
Q Consensus 173 Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~----~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~ 248 (448)
||+.|+|||++.+..++ .++|||||||++|+|++|+.||..... ......+.......|..+++++.+++.+||+
T Consensus 159 g~~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 237 (280)
T cd05608 159 GTPGFMAPELLQGEEYD-FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLA 237 (280)
T ss_pred CCcCccCHHHhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhc
Confidence 99999999999877665 789999999999999999999976432 2334444455556777899999999999999
Q ss_pred CCcCCCC-----CHHHHHhhhhccc
Q 037702 249 PNPSTRV-----TMAKLMENYWFRK 268 (448)
Q Consensus 249 ~dP~~Rp-----t~~eil~hp~~~~ 268 (448)
.||.+|| +++++++||||+.
T Consensus 238 ~~P~~R~~~~~~~~~~~l~h~~~~~ 262 (280)
T cd05608 238 KDPEKRLGFRDGNCDGLRTHPLFRD 262 (280)
T ss_pred CCHHHhcCCCCCCHHHHhcChhhhc
Confidence 9999999 8899999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=367.40 Aligned_cols=258 Identities=29% Similarity=0.431 Sum_probs=221.9
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEE
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMAS--KTKI 85 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~~~~ 85 (448)
..+.|+.++.|++|+||.||+|+++.|++.||+|.+..+.... +.--...|||.+|..++|||||.+.++... -+.+
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~-GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i 152 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKE-GFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI 152 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccC-CCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence 3567999999999999999999999999999999998766332 333345689999999999999999998754 4679
Q ss_pred EEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccc
Q 037702 86 YFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTR 163 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~ 163 (448)
|||||||+. +|..++.. .+|.+.+++.+..|+++|++|||.+.|+||||||+|+|++..|.+||+|||+|+.++...
T Consensus 153 y~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 153 YIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL 231 (419)
T ss_pred eeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence 999999987 89888876 479999999999999999999999999999999999999999999999999999776542
Q ss_pred cCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhcc---------------
Q 037702 164 QDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAE--------------- 228 (448)
Q Consensus 164 ~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--------------- 228 (448)
. .+...+-|.+|+|||.+.+...++...|+||+|||+.||+++++-|.+.+..+...+|...-
T Consensus 232 k--~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp 309 (419)
T KOG0663|consen 232 K--PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP 309 (419)
T ss_pred c--cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccc
Confidence 2 23456789999999999988777899999999999999999999999998887777775420
Q ss_pred ----CCCCC------------C-CCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 229 ----FKCPN------------W-FPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 229 ----~~~p~------------~-~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
..++. . ++....+|++.+|..||.+|.|+++.|+|.||...
T Consensus 310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~ 367 (419)
T KOG0663|consen 310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET 367 (419)
T ss_pred hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence 11111 1 45888999999999999999999999999999764
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=373.27 Aligned_cols=254 Identities=25% Similarity=0.427 Sum_probs=219.3
Q ss_pred CeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 037702 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAME 90 (448)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (448)
.|++.+.||+|+||.||++.+..+++.||+|++.............+.+|+.+++.++||||+++++.+.+++.+|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 48999999999999999999999999999999986654443444567789999999999999999999999999999999
Q ss_pred ecCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCC
Q 037702 91 YVRGGELFNKVAK---GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGL 167 (448)
Q Consensus 91 ~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 167 (448)
|+++|+|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||++++++.++|+|||++...... ..
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~---~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG---ET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC---Cc
Confidence 9999999888753 46999999999999999999999999999999999999999999999999998754321 12
Q ss_pred ccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHH----HHHHHhhccCCCCCCCCHHHHHHH
Q 037702 168 LHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLME----LYKKITRAEFKCPNWFPPEVRKLL 243 (448)
Q Consensus 168 ~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~----~~~~i~~~~~~~p~~~s~~~~~li 243 (448)
....+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+... ....+......+|..+++.+.+||
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~-~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKNERY-TFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSIC 236 (285)
T ss_pred cccccCCCCccCcHHhcCCCC-CccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHH
Confidence 234579999999999977665 478999999999999999999998765433 223344444556677899999999
Q ss_pred HhccCCCcCCCC-----CHHHHHhhhhccc
Q 037702 244 SRILDPNPSTRV-----TMAKLMENYWFRK 268 (448)
Q Consensus 244 ~~~L~~dP~~Rp-----t~~eil~hp~~~~ 268 (448)
.+||..||.+|| +++++++||||..
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 237 RQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred HHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 999999999999 8999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-47 Score=378.54 Aligned_cols=256 Identities=26% Similarity=0.457 Sum_probs=217.6
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIY 86 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 86 (448)
+..++|++.+.||+|+||.||+|++..+|..+|+|++..+. .....+.+.+|+.+++.++||||+++++++..++.+|
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 35689999999999999999999999999999999997642 2234567899999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC-CCEeecCCCCceEEcCCCCeEEeecccccccccccc
Q 037702 87 FAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSR-GVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQ 164 (448)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~-givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~ 164 (448)
+||||++||+|.+++.. +.+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--- 156 (331)
T cd06649 80 ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--- 156 (331)
T ss_pred EEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccc---
Confidence 99999999999999976 5799999999999999999999986 699999999999999999999999999875432
Q ss_pred CCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHh-------------------
Q 037702 165 DGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKIT------------------- 225 (448)
Q Consensus 165 ~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~------------------- 225 (448)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+..++...+.
T Consensus 157 -~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (331)
T cd06649 157 -SMANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPR 234 (331)
T ss_pred -cccccCCCCcCcCCHhHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccc
Confidence 12245679999999999987666 488999999999999999999997665544322211
Q ss_pred ---------------------------hcc-CCC-CCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 226 ---------------------------RAE-FKC-PNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 226 ---------------------------~~~-~~~-p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
... ... ...+++++++||.+||..||++|||+.++++||||+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 000 011 11367899999999999999999999999999999763
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-48 Score=388.22 Aligned_cols=259 Identities=30% Similarity=0.514 Sum_probs=237.9
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE-EE
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTK-IY 86 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~-~~ 86 (448)
.+++|+.++.+|+|+||.+++++++.++..|++|.|......... .+...+|+.+++++.|||||.+.+.|..++. .+
T Consensus 2 ~m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~-r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~ 80 (426)
T KOG0589|consen 2 EMDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE-RRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLC 80 (426)
T ss_pred ccchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh-hHHHHHHHHHHHhccCCCeeeeccchhcCCceEE
Confidence 367899999999999999999999999999999999988766543 3578899999999999999999999998888 99
Q ss_pred EEEeecCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccc
Q 037702 87 FAMEYVRGGELFNKVAK---GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTR 163 (448)
Q Consensus 87 lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~ 163 (448)
|||+||+||+|.+.|.+ .-++|+.+..||.|++.|+.|||++.|.|||||+.|||++.++.+||+|||+|+.....
T Consensus 81 Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~- 159 (426)
T KOG0589|consen 81 IVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE- 159 (426)
T ss_pred EEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCc-
Confidence 99999999999999975 24899999999999999999999999999999999999999999999999999976543
Q ss_pred cCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhcc-CCCCCCCCHHHHHH
Q 037702 164 QDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAE-FKCPNWFPPEVRKL 242 (448)
Q Consensus 164 ~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~l 242 (448)
.....+..|||.||.||++.+..|. .|+|||||||++|||++-+++|...+...+..+|.++. .+.|..++.+++.+
T Consensus 160 -~~~a~tvvGTp~YmcPEil~d~pYn-~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~l 237 (426)
T KOG0589|consen 160 -DSLASTVVGTPYYMCPEILSDIPYN-EKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSL 237 (426)
T ss_pred -hhhhheecCCCcccCHHHhCCCCCC-ccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHH
Confidence 2466788999999999999999886 99999999999999999999999999999999999887 57888999999999
Q ss_pred HHhccCCCcCCCCCHHHHHhhhhccccc
Q 037702 243 LSRILDPNPSTRVTMAKLMENYWFRKGY 270 (448)
Q Consensus 243 i~~~L~~dP~~Rpt~~eil~hp~~~~~~ 270 (448)
|+.||..+|..||++.++|.+|......
T Consensus 238 v~~~l~~~P~~RPsa~~LL~~P~l~~~~ 265 (426)
T KOG0589|consen 238 VKSMLRKNPEHRPSALELLRRPHLLRYL 265 (426)
T ss_pred HHHHhhcCCccCCCHHHHhhChhhhhHH
Confidence 9999999999999999999999876433
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-47 Score=398.93 Aligned_cols=261 Identities=31% Similarity=0.506 Sum_probs=228.0
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC---
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKT--- 83 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~--- 83 (448)
...++|++.+.||+|+||.||+|++..+|+.||||++....... .....+.+|+.++..++|+||+++++.+....
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSE-ADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCH-HHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 45689999999999999999999999999999999998765433 34567889999999999999999998775432
Q ss_pred -----EEEEEEeecCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeec
Q 037702 84 -----KIYFAMEYVRGGELFNKVAK-----GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDF 153 (448)
Q Consensus 84 -----~~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DF 153 (448)
.+++||||+++|+|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DF 187 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDF 187 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEec
Confidence 47899999999999998853 36899999999999999999999999999999999999999999999999
Q ss_pred cccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccC-CCC
Q 037702 154 GLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF-KCP 232 (448)
Q Consensus 154 Gla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p 232 (448)
|+++............+.+||+.|+|||++.+..++ .++|||||||++|+|++|+.||...+..+.+.++..+.. ..|
T Consensus 188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s-~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 266 (496)
T PTZ00283 188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS-KKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLP 266 (496)
T ss_pred ccCeeccccccccccccccCCcceeCHHHhCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCC
Confidence 999865443333344567899999999999876664 889999999999999999999999888888777766554 467
Q ss_pred CCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 233 NWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 233 ~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
+.+++++.+++.+||..||.+||++.++++|||++..
T Consensus 267 ~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~ 303 (496)
T PTZ00283 267 PSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF 303 (496)
T ss_pred CCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence 7899999999999999999999999999999998764
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-47 Score=393.66 Aligned_cols=251 Identities=25% Similarity=0.406 Sum_probs=206.5
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASK----- 82 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~----- 82 (448)
..++|++++.||+|+||.||+|.+..+++.||||.+.... ....+|+.+|+.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~ 136 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKN 136 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence 4568999999999999999999999999999999886432 2235799999999999999999876432
Q ss_pred ---CEEEEEEeecCCCchHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCC-CeEEeec
Q 037702 83 ---TKIYFAMEYVRGGELFNKVA-----KGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENG-DLKISDF 153 (448)
Q Consensus 83 ---~~~~lV~E~~~gg~L~~~i~-----~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g-~lkl~DF 153 (448)
..+++||||+++ +|.+++. ...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+||
T Consensus 137 ~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 137 EKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred CCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecc
Confidence 257799999976 6666553 25699999999999999999999999999999999999999765 6999999
Q ss_pred cccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhc------
Q 037702 154 GLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA------ 227 (448)
Q Consensus 154 Gla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~------ 227 (448)
|+|...... ......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+...++...
T Consensus 216 Gla~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 216 GSAKNLLAG---QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE 292 (440)
T ss_pred ccchhccCC---CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 999854322 12235678999999999876544568999999999999999999999987665544443221
Q ss_pred -----------cC------------CCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 228 -----------EF------------KCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 228 -----------~~------------~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
.. .+|...|+++.+||.+||..||.+|||+.|+++||||..-
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence 01 1244568899999999999999999999999999999753
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-47 Score=395.52 Aligned_cols=258 Identities=28% Similarity=0.452 Sum_probs=224.9
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCC-CcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKT-GQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIY 86 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~-g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 86 (448)
....|.+.+.||+|+||.||+|.+..+ +..||+|.+.... ......+.+|+.+++.++||||+++++++..++.+|
T Consensus 65 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~ 141 (478)
T PTZ00267 65 REHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND---ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLL 141 (478)
T ss_pred cceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEE
Confidence 345699999999999999999998877 7889999875442 233456788999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccc
Q 037702 87 FAMEYVRGGELFNKVAK-----GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQES 161 (448)
Q Consensus 87 lV~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~ 161 (448)
|||||++||+|.+++.. ..+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 221 (478)
T PTZ00267 142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD 221 (478)
T ss_pred EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence 99999999999887742 4689999999999999999999999999999999999999999999999999986543
Q ss_pred cccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccC-CCCCCCCHHHH
Q 037702 162 TRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF-KCPNWFPPEVR 240 (448)
Q Consensus 162 ~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~ 240 (448)
........+.+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+..++...+..+.. +.|..+++++.
T Consensus 222 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 300 (478)
T PTZ00267 222 SVSLDVASSFCGTPYYLAPELWERKRY-SKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMK 300 (478)
T ss_pred ccccccccccCCCccccCHhHhCCCCC-CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHH
Confidence 322233456689999999999987666 4889999999999999999999998888888877766654 45667899999
Q ss_pred HHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 241 KLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
++|.+||..||++||++++++.|+|++..
T Consensus 301 ~li~~~L~~dP~~Rps~~~~l~~~~~~~~ 329 (478)
T PTZ00267 301 ALLDPLLSKNPALRPTTQQLLHTEFLKYV 329 (478)
T ss_pred HHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence 99999999999999999999999998653
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-47 Score=376.20 Aligned_cols=258 Identities=28% Similarity=0.516 Sum_probs=220.4
Q ss_pred CCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 037702 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAM 89 (448)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (448)
++|++.+.||+|+||.||++++..+++.||+|++.+...........+.+|+.++..++||||+++++++.+++..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57999999999999999999999999999999998654433344566888999999999999999999999999999999
Q ss_pred eecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCC
Q 037702 90 EYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGL 167 (448)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 167 (448)
||++||+|.+++.. +.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++........ ..
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-~~ 159 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT-VQ 159 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc-ee
Confidence 99999999999975 5799999999999999999999999999999999999999999999999999875432211 11
Q ss_pred ccccCCCCcccchhhhhcc----CCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhcc--CCCCC---CCCHH
Q 037702 168 LHTTCGTPAYVAPEVINKR----GYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAE--FKCPN---WFPPE 238 (448)
Q Consensus 168 ~~~~~Gt~~Y~APEvl~~~----~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~---~~s~~ 238 (448)
....+||+.|+|||++.+. +..+.++|||||||+||+|++|+.||...+..+.+.++.... +++|. .++++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~ 239 (331)
T cd05624 160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEE 239 (331)
T ss_pred eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHH
Confidence 2345799999999998652 233578999999999999999999999888888777776543 33443 36899
Q ss_pred HHHHHHhccCCCcCC--CCCHHHHHhhhhccc
Q 037702 239 VRKLLSRILDPNPST--RVTMAKLMENYWFRK 268 (448)
Q Consensus 239 ~~~li~~~L~~dP~~--Rpt~~eil~hp~~~~ 268 (448)
++++|.+||..++.+ |++++++++||||+.
T Consensus 240 ~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 240 AKDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred HHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 999999999876654 579999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-47 Score=384.86 Aligned_cols=252 Identities=22% Similarity=0.355 Sum_probs=207.6
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKI 85 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 85 (448)
++..++|++.+.||+|+||.||+|.+..+++.||+|.... ..+.+|+.+++.++||||+++++++..+...
T Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 158 (391)
T PHA03212 88 GIEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFT 158 (391)
T ss_pred ccccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCee
Confidence 4556789999999999999999999999999999996532 3456899999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccccc
Q 037702 86 YFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQ 164 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~ 164 (448)
++|||++. ++|..++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.......
T Consensus 159 ~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~- 236 (391)
T PHA03212 159 CLILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN- 236 (391)
T ss_pred EEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc-
Confidence 99999995 688888765 679999999999999999999999999999999999999999999999999997533221
Q ss_pred CCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCc-------HHHHHHHHh------------
Q 037702 165 DGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSN-------LMELYKKIT------------ 225 (448)
Q Consensus 165 ~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~-------~~~~~~~i~------------ 225 (448)
.......+||+.|+|||++.+..| +.++|||||||++|+|++|..||.... .......+.
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~ 315 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPY-GPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI 315 (391)
T ss_pred ccccccccCccCCCChhhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence 122345689999999999987666 588999999999999999998875321 111111110
Q ss_pred --------------hccC----CCCC-----CCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 226 --------------RAEF----KCPN-----WFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 226 --------------~~~~----~~p~-----~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
.... ..|. .++.++.+||.+||+.||.+|||++|+|+||||+..
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 382 (391)
T PHA03212 316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI 382 (391)
T ss_pred chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence 1000 1111 246789999999999999999999999999999764
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=366.28 Aligned_cols=257 Identities=30% Similarity=0.513 Sum_probs=220.4
Q ss_pred cCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC-cceEEEEEEeCC----
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPN-IVQLYEVMASKT---- 83 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpn-Iv~l~~~~~~~~---- 83 (448)
+..|+..+.||+|+||+||+|+++.+|+.||+|.+..+... ++.-....+|+.+++.++|+| |+++++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 45688888999999999999999999999999999876432 234456789999999999999 999999998877
Q ss_pred --EEEEEEeecCCCchHHHHhc-C----CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccc
Q 037702 84 --KIYFAMEYVRGGELFNKVAK-G----KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLS 156 (448)
Q Consensus 84 --~~~lV~E~~~gg~L~~~i~~-~----~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla 156 (448)
.+|+|+||++- +|..++.. + .++...++.++.||+.||+|||++||+||||||+|||++++|.+||+|||+|
T Consensus 89 ~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 89 IGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred cceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence 89999999965 89888875 2 4788899999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhc---------
Q 037702 157 ALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA--------- 227 (448)
Q Consensus 157 ~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--------- 227 (448)
+...... ..+.+.++|.+|.|||++.+...++...||||+|||++||++++.-|.+.+..+....|.+.
T Consensus 168 ra~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 168 RAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred HHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 8544222 23556789999999999999877778999999999999999999999998887777666432
Q ss_pred ---------cCCCCCC------------CCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 228 ---------EFKCPNW------------FPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 228 ---------~~~~p~~------------~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
...+|.| .+++..+++.+||+.+|.+|.|+..+|.||||...
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 1122222 23588999999999999999999999999999764
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-47 Score=368.19 Aligned_cols=251 Identities=30% Similarity=0.483 Sum_probs=207.5
Q ss_pred CCeEEEeeeeecCceEEEEEEECC-CCcEEEEEEeecccccchhHHHHHHHHHHHHHhC---CCCCcceEEEEEE-----
Q 037702 10 NKYELGRLLGQGTFAKVYHGRNLK-TGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV---RHPNIVQLYEVMA----- 80 (448)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~-~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l---~hpnIv~l~~~~~----- 80 (448)
++|++.+.||+|+||.||+|++.. +|..||+|.+....... .....+.+|+.+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 479999999999999999999865 46889999987654322 2234556788877766 6999999999885
Q ss_pred eCCEEEEEEeecCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccc
Q 037702 81 SKTKIYFAMEYVRGGELFNKVAK---GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSA 157 (448)
Q Consensus 81 ~~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~ 157 (448)
....+++||||+. ++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 3457899999996 588888864 358999999999999999999999999999999999999999999999999997
Q ss_pred cccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccC--------
Q 037702 158 LQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF-------- 229 (448)
Q Consensus 158 ~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-------- 229 (448)
..... .......||+.|+|||++.+..+. .++|||||||++|+|++|.+||.+.+..+.+.++.....
T Consensus 159 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 159 IYSFQ---MALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred eccCC---cccccccccccccChHHHhCCCCC-CccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 54322 223456799999999999776664 789999999999999999999998877666665543210
Q ss_pred -------------------CCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhc
Q 037702 230 -------------------KCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWF 266 (448)
Q Consensus 230 -------------------~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 266 (448)
...+.+++.+++||.+||+.||++|||+.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 0112467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=370.81 Aligned_cols=258 Identities=27% Similarity=0.469 Sum_probs=215.2
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYF 87 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 87 (448)
.+++|++.+.||+|+||.||+|.+..+++.||+|.+....... ....+.+|+.+++.++||||+++++++..++..|+
T Consensus 4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 81 (309)
T cd07872 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTL 81 (309)
T ss_pred CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC--cchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEE
Confidence 4678999999999999999999999999999999997554322 23456789999999999999999999999999999
Q ss_pred EEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccC
Q 037702 88 AMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQD 165 (448)
Q Consensus 88 V~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~ 165 (448)
||||+++ +|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 158 (309)
T cd07872 82 VFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT-- 158 (309)
T ss_pred EEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCc--
Confidence 9999976 88887754 358999999999999999999999999999999999999999999999999987533221
Q ss_pred CCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhc------------------
Q 037702 166 GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA------------------ 227 (448)
Q Consensus 166 ~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~------------------ 227 (448)
.......||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+.+.
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence 12234578999999999876555568899999999999999999999887665444333211
Q ss_pred -cCCCC-----------CCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccccc
Q 037702 228 -EFKCP-----------NWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGY 270 (448)
Q Consensus 228 -~~~~p-----------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 270 (448)
....| +.+++++++||.+||..||.+|||++|+++||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 01111 23688999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-47 Score=377.24 Aligned_cols=258 Identities=27% Similarity=0.520 Sum_probs=220.2
Q ss_pred CCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 037702 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAM 89 (448)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (448)
++|++.+.||+|+||.||++++..+++.||+|++.+...........+.+|+.++..++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999997654433344566889999999999999999999999999999999
Q ss_pred eecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCC
Q 037702 90 EYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGL 167 (448)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 167 (448)
||+++|+|.+++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~-~~~ 159 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-TVQ 159 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCC-cce
Confidence 99999999999975 579999999999999999999999999999999999999999999999999986432211 112
Q ss_pred ccccCCCCcccchhhhhc----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhcc--CCCCC---CCCHH
Q 037702 168 LHTTCGTPAYVAPEVINK----RGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAE--FKCPN---WFPPE 238 (448)
Q Consensus 168 ~~~~~Gt~~Y~APEvl~~----~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~---~~s~~ 238 (448)
....+||+.|+|||++.. .+..+.++|||||||++|+|++|+.||...+..+.+.++.... ..+|. .++++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~ 239 (332)
T cd05623 160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSED 239 (332)
T ss_pred ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHH
Confidence 234579999999999863 2334688999999999999999999999988888888776543 23333 47899
Q ss_pred HHHHHHhccCCCcCC--CCCHHHHHhhhhccc
Q 037702 239 VRKLLSRILDPNPST--RVTMAKLMENYWFRK 268 (448)
Q Consensus 239 ~~~li~~~L~~dP~~--Rpt~~eil~hp~~~~ 268 (448)
+++||++||..+|.+ |++++++++||||..
T Consensus 240 ~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~ 271 (332)
T cd05623 240 AKDLIRRLICSREHRLGQNGIEDFKQHPFFTG 271 (332)
T ss_pred HHHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence 999999999654444 789999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=379.10 Aligned_cols=258 Identities=26% Similarity=0.457 Sum_probs=211.2
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC---
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKT--- 83 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~--- 83 (448)
.+.++|++.+.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.++||||+++++++....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE 96 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcc
Confidence 467899999999999999999999999999999999975532 2233466789999999999999999999986543
Q ss_pred ---EEEEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccc
Q 037702 84 ---KIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQE 160 (448)
Q Consensus 84 ---~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~ 160 (448)
.+|+||||+++ +|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~ 174 (359)
T cd07876 97 EFQDVYLVMELMDA-NLCQVIH-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC 174 (359)
T ss_pred ccceeEEEEeCCCc-CHHHHHh-ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence 57999999976 5666654 358999999999999999999999999999999999999999999999999987532
Q ss_pred ccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhh--------------
Q 037702 161 STRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITR-------------- 226 (448)
Q Consensus 161 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~-------------- 226 (448)
. ........||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+..+.+..+..
T Consensus 175 ~---~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (359)
T cd07876 175 T---NFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ 250 (359)
T ss_pred c---CccCCCCcccCCCCCchhccCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHH
Confidence 2 2223456799999999999877775 789999999999999999999987654433222111
Q ss_pred --------ccCC---------CC-----------CCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccccc
Q 037702 227 --------AEFK---------CP-----------NWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYK 271 (448)
Q Consensus 227 --------~~~~---------~p-----------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~ 271 (448)
.... +| ...++++++||.+||..||++|||+.|+++||||+..+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~ 323 (359)
T cd07876 251 PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYD 323 (359)
T ss_pred HHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcC
Confidence 0000 11 123578999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=366.28 Aligned_cols=253 Identities=38% Similarity=0.754 Sum_probs=229.4
Q ss_pred CCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 037702 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAM 89 (448)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (448)
++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.++++++||||+++++++.....+|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998765544455677899999999999999999999999999999999
Q ss_pred eecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCc
Q 037702 90 EYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLL 168 (448)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 168 (448)
||+++++|.+++.. +.+++..+..++.||+.||.|||++|++||||+|.|||++.++.+||+|||++...... .
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-----~ 155 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----T 155 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-----C
Confidence 99999999999976 67999999999999999999999999999999999999999999999999998764332 2
Q ss_pred cccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHHHHhccC
Q 037702 169 HTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILD 248 (448)
Q Consensus 169 ~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~ 248 (448)
...+|++.|+|||.+.+..+ +.++||||||+++|+|++|..||...+.......+..+....|..+++.++++|.+||.
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 234 (290)
T cd05580 156 YTLCGTPEYLAPEIILSKGY-GKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQ 234 (290)
T ss_pred CCCCCCccccChhhhcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHHcc
Confidence 35579999999999876654 47899999999999999999999888877788888888888888899999999999999
Q ss_pred CCcCCCC-----CHHHHHhhhhccc
Q 037702 249 PNPSTRV-----TMAKLMENYWFRK 268 (448)
Q Consensus 249 ~dP~~Rp-----t~~eil~hp~~~~ 268 (448)
.||.+|+ +++++++||||+.
T Consensus 235 ~~p~~R~~~~~~~~~~l~~~~~~~~ 259 (290)
T cd05580 235 VDLTKRLGNLKNGVNDIKNHPWFAG 259 (290)
T ss_pred CCHHHccCcccCCHHHHHcCccccc
Confidence 9999999 9999999999964
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-47 Score=361.11 Aligned_cols=252 Identities=40% Similarity=0.711 Sum_probs=213.7
Q ss_pred eEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 037702 12 YELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAMEY 91 (448)
Q Consensus 12 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 91 (448)
|++++.||+|+||.||+|++..+++.||+|++......... .....+|+.+++.++||||+++++++......++||||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc-cchhhhhhhccccccccccccccccccccccccccccc
Confidence 89999999999999999999999999999999887554322 23345699999999999999999999999999999999
Q ss_pred cCCCchHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCccc
Q 037702 92 VRGGELFNKVA-KGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHT 170 (448)
Q Consensus 92 ~~gg~L~~~i~-~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~ 170 (448)
+++++|.+++. .+.+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++... .........
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~--~~~~~~~~~ 157 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKL--SENNENFNP 157 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEES--TSTTSEBSS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccccccc
Confidence 99999999997 588999999999999999999999999999999999999999999999999998753 112233345
Q ss_pred cCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCc---HHHHHHHHhhccCCCC----CCCCHHHHHHH
Q 037702 171 TCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSN---LMELYKKITRAEFKCP----NWFPPEVRKLL 243 (448)
Q Consensus 171 ~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~---~~~~~~~i~~~~~~~p----~~~s~~~~~li 243 (448)
.+||+.|+|||++......+.++||||||+++|+|++|..||...+ ......+........+ ...++.+.++|
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 237 (260)
T PF00069_consen 158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLI 237 (260)
T ss_dssp SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHH
Confidence 6799999999998734455689999999999999999999999873 3333333332222111 11248999999
Q ss_pred HhccCCCcCCCCCHHHHHhhhhc
Q 037702 244 SRILDPNPSTRVTMAKLMENYWF 266 (448)
Q Consensus 244 ~~~L~~dP~~Rpt~~eil~hp~~ 266 (448)
.+||+.||++|||+.++++||||
T Consensus 238 ~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 238 KKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHccCChhHCcCHHHHhcCCCC
Confidence 99999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-47 Score=378.91 Aligned_cols=255 Identities=29% Similarity=0.477 Sum_probs=213.4
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYF 87 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 87 (448)
..++|++.+.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+++.++|+||+++++++...+.+|+
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 149 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQV 149 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEE
Confidence 4678999999999999999999999999999999996543 22345678899999999999999999999999999999
Q ss_pred EEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCC
Q 037702 88 AMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGL 167 (448)
Q Consensus 88 V~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 167 (448)
||||+++|+|.+. ...++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 150 v~e~~~~~~L~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~ 224 (353)
T PLN00034 150 LLEFMDGGSLEGT---HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM--DP 224 (353)
T ss_pred EEecCCCCccccc---ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc--cc
Confidence 9999999998653 346788889999999999999999999999999999999999999999999998653221 12
Q ss_pred ccccCCCCcccchhhhhc----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHH---HHHHHHh-hccCCCCCCCCHHH
Q 037702 168 LHTTCGTPAYVAPEVINK----RGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLM---ELYKKIT-RAEFKCPNWFPPEV 239 (448)
Q Consensus 168 ~~~~~Gt~~Y~APEvl~~----~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~---~~~~~i~-~~~~~~p~~~s~~~ 239 (448)
.....||+.|+|||++.. ..+.+.++|||||||++|+|++|+.||...... .....+. ......+..+++++
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 304 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREF 304 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHH
Confidence 235679999999998743 234567899999999999999999999743322 2222222 22334566789999
Q ss_pred HHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 240 RKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 240 ~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
++||.+||..||++|||+.|+++||||...
T Consensus 305 ~~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 305 RHFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred HHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 999999999999999999999999999764
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-47 Score=378.43 Aligned_cols=257 Identities=25% Similarity=0.421 Sum_probs=214.5
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC----
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASK---- 82 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~---- 82 (448)
.+.++|++.+.||+|+||.||+|.+..+++.||||++.+..... .....+.+|+.+++.++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSL-IHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhh-HHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 45689999999999999999999999999999999987643221 2345677899999999999999999987543
Q ss_pred --CEEEEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccc
Q 037702 83 --TKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQE 160 (448)
Q Consensus 83 --~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~ 160 (448)
...|++||++ +++|.+++..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 169 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD 169 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecC
Confidence 4579999998 7799998888889999999999999999999999999999999999999999999999999997543
Q ss_pred ccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhcc------------
Q 037702 161 STRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAE------------ 228 (448)
Q Consensus 161 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~------------ 228 (448)
. .....+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 170 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07878 170 D-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKIS 244 (343)
T ss_pred C-----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 2 22356799999999999765555689999999999999999999998776554444332210
Q ss_pred -----------CCCC--------CCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccccc
Q 037702 229 -----------FKCP--------NWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGY 270 (448)
Q Consensus 229 -----------~~~p--------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 270 (448)
...| ...++.+.+||.+||..||.+|||+.++++||||....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~ 305 (343)
T cd07878 245 SEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH 305 (343)
T ss_pred hhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccC
Confidence 0001 13567789999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=358.42 Aligned_cols=256 Identities=31% Similarity=0.583 Sum_probs=220.1
Q ss_pred CCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccc--hhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 037702 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRR--VGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYF 87 (448)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 87 (448)
++|++.+.||+|++|.||.|.+..+++.||+|.+....... ......+.+|+.+++.++||||+++++++..+..+|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57999999999999999999999999999999987543221 1234678899999999999999999999999999999
Q ss_pred EEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccC-
Q 037702 88 AMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQD- 165 (448)
Q Consensus 88 V~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~- 165 (448)
||||++|++|.+.+.. +.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.........
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~ 161 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence 9999999999999875 67899999999999999999999999999999999999999999999999998754322111
Q ss_pred CCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhc--cCCCCCCCCHHHHHHH
Q 037702 166 GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA--EFKCPNWFPPEVRKLL 243 (448)
Q Consensus 166 ~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li 243 (448)
.......|++.|+|||++.+..+ +.++|||||||++|+|++|+.||...+.......+... ....|..++..+.++|
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 240 (263)
T cd06625 162 TGMKSVTGTPYWMSPEVISGEGY-GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFL 240 (263)
T ss_pred ccccCCCcCccccCcceeccCCC-CchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHH
Confidence 11134568899999999987665 58899999999999999999999887665555444333 3456777899999999
Q ss_pred HhccCCCcCCCCCHHHHHhhhhc
Q 037702 244 SRILDPNPSTRVTMAKLMENYWF 266 (448)
Q Consensus 244 ~~~L~~dP~~Rpt~~eil~hp~~ 266 (448)
.+||..||.+|||+.++++||||
T Consensus 241 ~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 241 RRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHhhcCcccCCCHHHHhhCCCC
Confidence 99999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-46 Score=371.92 Aligned_cols=257 Identities=27% Similarity=0.475 Sum_probs=216.1
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIY 86 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 86 (448)
+..++|++.+.||+|+||.||+|.+..+|..+|+|.+.... .......+.+|+++++.++||||+++++++.+++.+|
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEE
Confidence 45689999999999999999999999999999999987642 2234467889999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC-CCEeecCCCCceEEcCCCCeEEeecccccccccccc
Q 037702 87 FAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSR-GVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQ 164 (448)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~-givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~ 164 (448)
+||||++||+|.+++.. +.+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-- 157 (333)
T cd06650 80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (333)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence 99999999999999876 6789999999999999999999985 7999999999999999999999999998754221
Q ss_pred CCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH---------------------
Q 037702 165 DGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKK--------------------- 223 (448)
Q Consensus 165 ~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~--------------------- 223 (448)
.....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......++...
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (333)
T cd06650 158 --MANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPP 234 (333)
T ss_pred --ccccCCCCccccCHHHhcCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCc
Confidence 2234579999999999977655 4889999999999999999999976544332211
Q ss_pred -----------------------Hhhcc-CCCC-CCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccccc
Q 037702 224 -----------------------ITRAE-FKCP-NWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGY 270 (448)
Q Consensus 224 -----------------------i~~~~-~~~p-~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 270 (448)
+.... ...+ ..++.++++||.+||+.||++|||++|++.||||+...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 235 GRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred cchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence 11110 1111 13678999999999999999999999999999997643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-46 Score=375.11 Aligned_cols=258 Identities=25% Similarity=0.446 Sum_probs=211.9
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC----
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASK---- 82 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~---- 82 (448)
...++|++.+.||+|+||.||+|.+..+++.||||.+...... ......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 92 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLE 92 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccC-hHHHHHHHHHHHHHHHhCCCchhceeeeeecccccc
Confidence 4678999999999999999999999999999999998754322 23346778899999999999999999988643
Q ss_pred --CEEEEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccc
Q 037702 83 --TKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQE 160 (448)
Q Consensus 83 --~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~ 160 (448)
...|+||||+++ +|.+.+.. .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 93 ~~~~~~lv~e~~~~-~l~~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~ 170 (355)
T cd07874 93 EFQDVYLVMELMDA-NLCQVIQM-ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_pred ccceeEEEhhhhcc-cHHHHHhh-cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence 357999999976 66666643 58999999999999999999999999999999999999999999999999997543
Q ss_pred ccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhc-------------
Q 037702 161 STRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA------------- 227 (448)
Q Consensus 161 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~------------- 227 (448)
. ........||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+..+.+..+...
T Consensus 171 ~---~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (355)
T cd07874 171 T---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_pred C---ccccCCccccCCccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhc
Confidence 2 1223456799999999999877765 7899999999999999999999887654443322110
Q ss_pred ---------c-----CC---------------CCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccccc
Q 037702 228 ---------E-----FK---------------CPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYK 271 (448)
Q Consensus 228 ---------~-----~~---------------~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~ 271 (448)
. .. .+...+.++++||.+||..||.+|||+.|+++||||...+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~ 319 (355)
T cd07874 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYD 319 (355)
T ss_pred HHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccC
Confidence 0 00 11123567899999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=379.35 Aligned_cols=256 Identities=25% Similarity=0.450 Sum_probs=213.7
Q ss_pred CeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----EE
Q 037702 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKT-----KI 85 (448)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~-----~~ 85 (448)
+|++.+.||+|+||.||+|.+..+|+.||||.+.... .+......+.+|+.+++.++||||+++++++.... .+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 4889999999999999999999999999999986432 22233467889999999999999999999998776 89
Q ss_pred EEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccccc
Q 037702 86 YFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQ 164 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~ 164 (448)
|+||||+. ++|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~- 157 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE- 157 (372)
T ss_pred EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCc-
Confidence 99999996 578777755 679999999999999999999999999999999999999999999999999997543221
Q ss_pred CCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhh------------------
Q 037702 165 DGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITR------------------ 226 (448)
Q Consensus 165 ~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~------------------ 226 (448)
........||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+..
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 237 (372)
T cd07853 158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGAR 237 (372)
T ss_pred cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHH
Confidence 12223456899999999997765556889999999999999999999988776554444321
Q ss_pred -----ccC---------CCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 227 -----AEF---------KCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 227 -----~~~---------~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
... ......++++.+||.+||..||.+|||+.++++||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 238 AHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 011 1223457899999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-46 Score=375.75 Aligned_cols=257 Identities=26% Similarity=0.435 Sum_probs=212.3
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC----
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASK---- 82 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~---- 82 (448)
.+.++|++.+.||+|+||.||+|.+..+++.||||++...... ......+.+|+.+++.++||||+++++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~ 99 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 99 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccC-chhHHHHHHHHHHHHhcCCCCccccceeeccccccc
Confidence 3578999999999999999999999999999999999754322 23346678999999999999999999987543
Q ss_pred --CEEEEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccc
Q 037702 83 --TKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQE 160 (448)
Q Consensus 83 --~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~ 160 (448)
..+|+||||+++ +|.+.+.. .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 100 ~~~~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 177 (364)
T cd07875 100 EFQDVYIVMELMDA-NLCQVIQM-ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177 (364)
T ss_pred ccCeEEEEEeCCCC-CHHHHHHh-cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence 468999999975 67776653 58899999999999999999999999999999999999999999999999997543
Q ss_pred ccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccC-----------
Q 037702 161 STRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF----------- 229 (448)
Q Consensus 161 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~----------- 229 (448)
. ........||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+..+.+.++.....
T Consensus 178 ~---~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (364)
T cd07875 178 T---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 253 (364)
T ss_pred C---CCcccCCcccCCcCCHHHHhCCCCC-chhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhh
Confidence 2 1223456799999999999877765 789999999999999999999988776655554432100
Q ss_pred -----------C---------C-----------CCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccccc
Q 037702 230 -----------K---------C-----------PNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGY 270 (448)
Q Consensus 230 -----------~---------~-----------p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 270 (448)
. + ....+.++++||.+||..||.+|||+.++++||||...+
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~ 325 (364)
T cd07875 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 325 (364)
T ss_pred HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccccc
Confidence 0 0 011246789999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-46 Score=363.20 Aligned_cols=254 Identities=26% Similarity=0.447 Sum_probs=215.9
Q ss_pred CeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 037702 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAME 90 (448)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (448)
.|++.+.||+|+||.||+|.+..+++.||+|.+.+...........+.+|+.+++.++|+||+++++.+.+.+.+|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 48899999999999999999999999999999987655444444667789999999999999999999999999999999
Q ss_pred ecCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCC
Q 037702 91 YVRGGELFNKVAK---GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGL 167 (448)
Q Consensus 91 ~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 167 (448)
|++|++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++...... ..
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~---~~ 157 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG---QT 157 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC---cc
Confidence 9999999988853 35899999999999999999999999999999999999999999999999998754321 11
Q ss_pred ccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHH---HHHHHH-hhccCCCCCCCCHHHHHHH
Q 037702 168 LHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLM---ELYKKI-TRAEFKCPNWFPPEVRKLL 243 (448)
Q Consensus 168 ~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~---~~~~~i-~~~~~~~p~~~s~~~~~li 243 (448)
.....||+.|+|||++.+..+ +.++||||+||++|+|++|+.||...... ...... .......+..+++++.+|+
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERY-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLC 236 (285)
T ss_pred ccCCCCCccccChHHHcCCCC-CCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHH
Confidence 234579999999999987666 48899999999999999999999864321 111111 2222345667899999999
Q ss_pred HhccCCCcCCCCC-----HHHHHhhhhccc
Q 037702 244 SRILDPNPSTRVT-----MAKLMENYWFRK 268 (448)
Q Consensus 244 ~~~L~~dP~~Rpt-----~~eil~hp~~~~ 268 (448)
.+||+.||.+||| ++++++||||..
T Consensus 237 ~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 237 KMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred HHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 9999999999999 999999999964
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-48 Score=411.03 Aligned_cols=260 Identities=30% Similarity=0.541 Sum_probs=233.8
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIY 86 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 86 (448)
.-.++|+++++||+|+||.|.+++++.|++.||+|++++-..........|..|-.+|..-+.+-|++++..|.++.++|
T Consensus 72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LY 151 (1317)
T KOG0612|consen 72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLY 151 (1317)
T ss_pred CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceE
Confidence 34678999999999999999999999999999999999865554455578999999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccC
Q 037702 87 FAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQD 165 (448)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~ 165 (448)
+||||++||+|..++.+ ++++|+.++.|+..|..||+-||+.|+|||||||+|||||..|++||+|||.+......+ .
T Consensus 152 lVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG-~ 230 (1317)
T KOG0612|consen 152 LVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADG-T 230 (1317)
T ss_pred EEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCC-c
Confidence 99999999999999987 679999999999999999999999999999999999999999999999999987554322 2
Q ss_pred CCccccCCCCcccchhhhhc----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhc--cCCCC--CCCCH
Q 037702 166 GLLHTTCGTPAYVAPEVINK----RGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA--EFKCP--NWFPP 237 (448)
Q Consensus 166 ~~~~~~~Gt~~Y~APEvl~~----~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p--~~~s~ 237 (448)
-...+.+|||.|++||++.. .+.+|..+|+||+||++|||+.|..||+..+..+.|.+|..- .+.+| ..+|+
T Consensus 231 V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSe 310 (1317)
T KOG0612|consen 231 VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSE 310 (1317)
T ss_pred EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCH
Confidence 23456789999999999953 356689999999999999999999999999999999999765 67888 55899
Q ss_pred HHHHHHHhccCCCcCCCCC---HHHHHhhhhccc
Q 037702 238 EVRKLLSRILDPNPSTRVT---MAKLMENYWFRK 268 (448)
Q Consensus 238 ~~~~li~~~L~~dP~~Rpt---~~eil~hp~~~~ 268 (448)
++++||.+++.. |+.|.. ++++..||||..
T Consensus 311 eakdLI~~ll~~-~e~RLgrngiedik~HpFF~g 343 (1317)
T KOG0612|consen 311 EAKDLIEALLCD-REVRLGRNGIEDIKNHPFFEG 343 (1317)
T ss_pred HHHHHHHHHhcC-hhhhcccccHHHHHhCccccC
Confidence 999999999975 889998 999999999976
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=357.11 Aligned_cols=262 Identities=30% Similarity=0.587 Sum_probs=224.9
Q ss_pred ccCCeEEE-eeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 037702 8 LMNKYELG-RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEVMASKTKI 85 (448)
Q Consensus 8 ~~~~y~~~-~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~ 85 (448)
..+-|++. +.||+|+|+.|--|++..||..||||+|++..- ....++.||++++..+ .|+||++++++|++++.+
T Consensus 75 F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~g---HsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~F 151 (463)
T KOG0607|consen 75 FEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPG---HSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRF 151 (463)
T ss_pred HHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCc---hHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceE
Confidence 34445554 568999999999999999999999999998732 3357889999999999 699999999999999999
Q ss_pred EEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCC---eEEeeccccccccc
Q 037702 86 YFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGD---LKISDFGLSALQES 161 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~---lkl~DFGla~~~~~ 161 (448)
|||||.+.||.|...|.+ ..|+|.++.++.++|+.||+|||.+||+||||||+|||...... +|||||.|..-...
T Consensus 152 YLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~ 231 (463)
T KOG0607|consen 152 YLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKL 231 (463)
T ss_pred EEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccccccc
Confidence 999999999999999976 46999999999999999999999999999999999999976654 89999999764322
Q ss_pred c-----ccCCCccccCCCCcccchhhhh----ccCCCCCcchHHHHHHHHHHHHhCCCCCCCC---------------cH
Q 037702 162 T-----RQDGLLHTTCGTPAYVAPEVIN----KRGYDGAKADIWSCGVVLFVLLAGNLPFYDS---------------NL 217 (448)
Q Consensus 162 ~-----~~~~~~~~~~Gt~~Y~APEvl~----~~~~~~~~sDiwSlGvil~elltG~~Pf~~~---------------~~ 217 (448)
. .....+.+.||+..|||||+.. ...++..++|.||||||||.||+|++||.+. -.
T Consensus 232 ~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ 311 (463)
T KOG0607|consen 232 NNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQ 311 (463)
T ss_pred CCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHH
Confidence 1 2234456889999999999974 2334458899999999999999999999752 14
Q ss_pred HHHHHHHhhccCCCCCC----CCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccccccc
Q 037702 218 MELYKKITRAEFKCPNW----FPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYKK 272 (448)
Q Consensus 218 ~~~~~~i~~~~~~~p~~----~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~ 272 (448)
..++..|..+.+.+|.. +|.+++++|+.+|..|+.+|.++.++++|||++.-...
T Consensus 312 ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 312 NKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE 370 (463)
T ss_pred HHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence 56888999999999963 89999999999999999999999999999999875544
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-46 Score=362.23 Aligned_cols=250 Identities=29% Similarity=0.473 Sum_probs=206.0
Q ss_pred CeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC---CCCCcceEEEEEEe-----C
Q 037702 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV---RHPNIVQLYEVMAS-----K 82 (448)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l---~hpnIv~l~~~~~~-----~ 82 (448)
+|++.+.||+|+||.||+|.+..+|+.||+|.+....... .....+.+|+.+++.+ +||||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 6999999999999999999999999999999987643222 2223456777777765 79999999998764 3
Q ss_pred CEEEEEEeecCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccc
Q 037702 83 TKIYFAMEYVRGGELFNKVAK---GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQ 159 (448)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~ 159 (448)
..+++||||+.+ +|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 568999999975 88888765 35899999999999999999999999999999999999999999999999999765
Q ss_pred cccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhcc-----------
Q 037702 160 ESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAE----------- 228 (448)
Q Consensus 160 ~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~----------- 228 (448)
... .......||+.|+|||++.+..+ +.++|||||||++|+|++|.+||...+..+...++....
T Consensus 159 ~~~---~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 159 SCQ---MALTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred cCc---ccCCCccccccccCchHhhCCCC-CCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 322 12234578999999999977665 488999999999999999999998876655554443210
Q ss_pred C----------------CCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhc
Q 037702 229 F----------------KCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWF 266 (448)
Q Consensus 229 ~----------------~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 266 (448)
. .+.+.++..+.++|.+||+.||.+|||+.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0 0112367889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-47 Score=362.31 Aligned_cols=251 Identities=33% Similarity=0.532 Sum_probs=212.5
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC---C-
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASK---T- 83 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~---~- 83 (448)
..=.|+-.+++|.|+||.||.|....+++.||||.+-.+.-. -.+|+.+|+.++|||||++..+|... +
T Consensus 22 ~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~-------knrEl~im~~l~HpNIV~L~~~f~~~~~~d~ 94 (364)
T KOG0658|consen 22 VEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY-------KNRELQIMRKLDHPNIVRLLYFFSSSTESDE 94 (364)
T ss_pred eEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc-------CcHHHHHHHhcCCcCeeeEEEEEEecCCCch
Confidence 344699999999999999999999999999999988655322 23799999999999999999887542 2
Q ss_pred -EEEEEEeecCCCchHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCC-CCeEEeecccc
Q 037702 84 -KIYFAMEYVRGGELFNKVA-----KGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDEN-GDLKISDFGLS 156 (448)
Q Consensus 84 -~~~lV~E~~~gg~L~~~i~-----~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~-g~lkl~DFGla 156 (448)
...+||||++. +|.+.++ +.+++.-.++-|..||++||.|||+.||+||||||.|||+|.+ |.+||||||.|
T Consensus 95 ~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSA 173 (364)
T KOG0658|consen 95 VYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSA 173 (364)
T ss_pred hHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcc
Confidence 34599999976 9999887 3579999999999999999999999999999999999999976 99999999999
Q ss_pred ccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhc---------
Q 037702 157 ALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA--------- 227 (448)
Q Consensus 157 ~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--------- 227 (448)
+........ .+...|..|+|||.+.+...++.+.||||+||++.||+.|++-|.+.+..+....|.+.
T Consensus 174 K~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I 250 (364)
T KOG0658|consen 174 KVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDI 250 (364)
T ss_pred eeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 976543332 45667999999999988877789999999999999999999999998877666555331
Q ss_pred --------cCCCC------------CCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 228 --------EFKCP------------NWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 228 --------~~~~p------------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
+..+| ...++++.+|+.++|..+|.+|.++.|++.||||..-
T Consensus 251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdel 312 (364)
T KOG0658|consen 251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDEL 312 (364)
T ss_pred hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHh
Confidence 11122 2367999999999999999999999999999999653
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-46 Score=361.26 Aligned_cols=247 Identities=28% Similarity=0.445 Sum_probs=208.3
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCCch
Q 037702 18 LGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGEL 97 (448)
Q Consensus 18 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 97 (448)
||+|+||.||++++..+|+.||+|.+.............+..|+.+++.++||||+++++++.++..+|+||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999999999999999999765544333345566799999999999999999999999999999999999999
Q ss_pred HHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCccccCCC
Q 037702 98 FNKVAK---GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGT 174 (448)
Q Consensus 98 ~~~i~~---~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~Gt 174 (448)
.+++.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||++...... .......||
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~---~~~~~~~~~ 157 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG---KTITQRAGT 157 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC---ceeeccCCC
Confidence 888754 25889999999999999999999999999999999999999999999999998754322 122345799
Q ss_pred CcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcH----HHHHHHHhhccCCCC-CCCCHHHHHHHHhccCC
Q 037702 175 PAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNL----MELYKKITRAEFKCP-NWFPPEVRKLLSRILDP 249 (448)
Q Consensus 175 ~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~----~~~~~~i~~~~~~~p-~~~s~~~~~li~~~L~~ 249 (448)
+.|+|||++.+..+ +.++|||||||++|+|++|..||..... .++...+.......+ ..+++++++||.+||+.
T Consensus 158 ~~y~aPE~~~~~~~-~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 236 (277)
T cd05607 158 NGYMAPEILKEEPY-SYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAK 236 (277)
T ss_pred CCccCHHHHccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhcc
Confidence 99999999987765 4889999999999999999999976432 334444444343332 35899999999999999
Q ss_pred CcCCCCCH----HHHHhhhhccc
Q 037702 250 NPSTRVTM----AKLMENYWFRK 268 (448)
Q Consensus 250 dP~~Rpt~----~eil~hp~~~~ 268 (448)
||.+||++ ++++.||||+.
T Consensus 237 ~P~~R~~~~~~~~~~~~h~~f~~ 259 (277)
T cd05607 237 KPEDRLGSREKNDDPRKHEFFKT 259 (277)
T ss_pred CHhhCCCCccchhhhhcChhhcC
Confidence 99999999 67889999964
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-46 Score=372.43 Aligned_cols=253 Identities=26% Similarity=0.435 Sum_probs=205.9
Q ss_pred cccCCeEEEeeeeecCceEEEEEEEC-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNL-----KTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEVMA 80 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~ 80 (448)
+..++|++.+.||+|+||.||+|.+. .++..||+|++..... ......+.+|+.+++.+ +||||+++++++.
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGAT--ASEHKALMSELKILIHIGNHLNVVNLLGACT 81 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccc--hHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence 45679999999999999999999752 3457899999864422 23346788999999999 8999999999887
Q ss_pred eC-CEEEEEEeecCCCchHHHHhcC-------------------------------------------------------
Q 037702 81 SK-TKIYFAMEYVRGGELFNKVAKG------------------------------------------------------- 104 (448)
Q Consensus 81 ~~-~~~~lV~E~~~gg~L~~~i~~~------------------------------------------------------- 104 (448)
.. ..+|+||||+++|+|.+++...
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 54 4689999999999999988641
Q ss_pred --------CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCccccCCCCc
Q 037702 105 --------KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPA 176 (448)
Q Consensus 105 --------~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~ 176 (448)
.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.............+..+++.
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 367788899999999999999999999999999999999999999999999975432211111223456788
Q ss_pred ccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHH-HHHHHhhc-cCCCCCCCCHHHHHHHHhccCCCcCC
Q 037702 177 YVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLME-LYKKITRA-EFKCPNWFPPEVRKLLSRILDPNPST 253 (448)
Q Consensus 177 Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~-~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~ 253 (448)
|+|||++.+..++ .++|||||||+||+|++ |..||.+....+ ....+..+ ....|..+++++.++|.+||..||.+
T Consensus 242 y~aPE~~~~~~~~-~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~ 320 (338)
T cd05102 242 WMAPESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKE 320 (338)
T ss_pred ccCcHHhhcCCCC-cccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhh
Confidence 9999999776664 88999999999999997 999998765433 33333333 23456678999999999999999999
Q ss_pred CCCHHHHHh
Q 037702 254 RVTMAKLME 262 (448)
Q Consensus 254 Rpt~~eil~ 262 (448)
|||+.++++
T Consensus 321 RPs~~el~~ 329 (338)
T cd05102 321 RPTFSALVE 329 (338)
T ss_pred CcCHHHHHH
Confidence 999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-46 Score=362.77 Aligned_cols=257 Identities=27% Similarity=0.479 Sum_probs=215.1
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYF 87 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 87 (448)
..++|++.+.||+|+||.||+|.+..+++.||+|.+...... .....+.+|+.+++.++||||+++++++......|+
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 81 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL 81 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc--CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEE
Confidence 467899999999999999999999999999999998754322 223456789999999999999999999999999999
Q ss_pred EEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccC
Q 037702 88 AMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQD 165 (448)
Q Consensus 88 V~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~ 165 (448)
||||++ ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 82 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-- 158 (301)
T cd07873 82 VFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-- 158 (301)
T ss_pred EEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC--
Confidence 999997 488888764 468999999999999999999999999999999999999999999999999987533211
Q ss_pred CCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhc------------------
Q 037702 166 GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA------------------ 227 (448)
Q Consensus 166 ~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~------------------ 227 (448)
.......+++.|+|||++.+....+.++|||||||++|+|++|++||...+..+....+...
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (301)
T cd07873 159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 238 (301)
T ss_pred CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence 12234567999999999876555568899999999999999999999887765444332211
Q ss_pred -cCCCC-----------CCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 228 -EFKCP-----------NWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 228 -~~~~p-----------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
....| +.+++++++||.+||..||.+|||++++++||||+.-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~ 292 (301)
T cd07873 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL 292 (301)
T ss_pred cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 01111 2468899999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=359.73 Aligned_cols=255 Identities=25% Similarity=0.424 Sum_probs=219.7
Q ss_pred CeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 037702 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAME 90 (448)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (448)
.|+..+.||+|+||+||+|.+..+|+.||+|.+.+...........+.+|+.+++.++|+||+.+++.+..++..|+|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 48889999999999999999999999999999987655444444567889999999999999999999999999999999
Q ss_pred ecCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCC
Q 037702 91 YVRGGELFNKVAK---GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGL 167 (448)
Q Consensus 91 ~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 167 (448)
|+++++|.+.+.. .++++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++...... ..
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~---~~ 157 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG---ES 157 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC---Cc
Confidence 9999999888753 36999999999999999999999999999999999999999999999999998654321 12
Q ss_pred ccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHH----HHHHhhccCCCCCCCCHHHHHHH
Q 037702 168 LHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMEL----YKKITRAEFKCPNWFPPEVRKLL 243 (448)
Q Consensus 168 ~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~----~~~i~~~~~~~p~~~s~~~~~li 243 (448)
.....|++.|+|||++.+..+ +.++|+|||||++|+|++|..||...+.... ...+......++..+++++.+|+
T Consensus 158 ~~~~~g~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05632 158 IRGRVGTVGYMAPEVLNNQRY-TLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSIC 236 (285)
T ss_pred ccCCCCCcCccChHHhcCCCC-CcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHH
Confidence 234579999999999977666 4889999999999999999999987654332 33334444556677899999999
Q ss_pred HhccCCCcCCCCC-----HHHHHhhhhcccc
Q 037702 244 SRILDPNPSTRVT-----MAKLMENYWFRKG 269 (448)
Q Consensus 244 ~~~L~~dP~~Rpt-----~~eil~hp~~~~~ 269 (448)
.+||+.||.+||+ +.+++.|+||+..
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 237 KMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred HHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 9999999999999 8999999999763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-46 Score=386.11 Aligned_cols=254 Identities=23% Similarity=0.364 Sum_probs=203.8
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCC------CCcceEEEEEEe
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRH------PNIVQLYEVMAS 81 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~h------pnIv~l~~~~~~ 81 (448)
..++|++.+.||+|+||.||+|.+..+++.||||++.... ........|+.+++.++| ++++++++++..
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 3578999999999999999999999999999999996432 122445667888777755 458889998876
Q ss_pred C-CEEEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCCEeecCCCCceEEcCCC------------
Q 037702 82 K-TKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHS-RGVYHRDLKPENLLLDENG------------ 146 (448)
Q Consensus 82 ~-~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~-~givHrDLkp~NILl~~~g------------ 146 (448)
. ..+|+|||++ |++|.+++.+ +.+++..++.++.||+.||+|||+ .||+||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~ 281 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALP 281 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccC
Confidence 4 5789999988 6788888765 689999999999999999999998 5999999999999998766
Q ss_pred ----CeEEeeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHH
Q 037702 147 ----DLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYK 222 (448)
Q Consensus 147 ----~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~ 222 (448)
.+||+|||++.... ......+||+.|+|||++.+..|. .++|||||||++|||++|++||.+.+..+...
T Consensus 282 ~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~-~~~DiwSlGvil~elltG~~pf~~~~~~~~~~ 355 (467)
T PTZ00284 282 PDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWM-YSTDMWSMGCIIYELYTGKLLYDTHDNLEHLH 355 (467)
T ss_pred CCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 49999999875322 122456899999999999887775 88999999999999999999998776554433
Q ss_pred HHhhccCCCC----------------------------C--------------CCCHHHHHHHHhccCCCcCCCCCHHHH
Q 037702 223 KITRAEFKCP----------------------------N--------------WFPPEVRKLLSRILDPNPSTRVTMAKL 260 (448)
Q Consensus 223 ~i~~~~~~~p----------------------------~--------------~~s~~~~~li~~~L~~dP~~Rpt~~ei 260 (448)
.+.......| . ..++.+.+||.+||..||.+|||++|+
T Consensus 356 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~ 435 (467)
T PTZ00284 356 LMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQM 435 (467)
T ss_pred HHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHH
Confidence 3322110000 0 013567899999999999999999999
Q ss_pred Hhhhhccccccc
Q 037702 261 MENYWFRKGYKK 272 (448)
Q Consensus 261 l~hp~~~~~~~~ 272 (448)
|+||||.+.+..
T Consensus 436 L~Hp~~~~~~~~ 447 (467)
T PTZ00284 436 TTHPYVLKYYPE 447 (467)
T ss_pred hcCccccccCCc
Confidence 999999876543
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-48 Score=386.05 Aligned_cols=256 Identities=31% Similarity=0.505 Sum_probs=228.4
Q ss_pred cCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFA 88 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 88 (448)
-+-|+|+..||.|+||+||+|.++.++-..|.|+|... ..+.++.+.-||.||..++||+||++++.|...+++||.
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk---seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwil 107 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK---SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWIL 107 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc---chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEE
Confidence 34688999999999999999999999999999999754 345567888999999999999999999999999999999
Q ss_pred EeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCC
Q 037702 89 MEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDG 166 (448)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 166 (448)
.|||.||-+...+-. +.++++++..+++|++.||.|||+++|||||||..|||++-+|.++|+|||.+....... .
T Consensus 108 iEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~--q 185 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR--Q 185 (1187)
T ss_pred EeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHH--h
Confidence 999999999888765 579999999999999999999999999999999999999999999999999987533222 2
Q ss_pred CccccCCCCcccchhhhh-----ccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCC---CCCCCCHH
Q 037702 167 LLHTTCGTPAYVAPEVIN-----KRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFK---CPNWFPPE 238 (448)
Q Consensus 167 ~~~~~~Gt~~Y~APEvl~-----~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---~p~~~s~~ 238 (448)
...+..|||+|||||+.. ...|+ .++||||||++|.+|..+.+|....+.+.+..+|.+.+++ -|..++..
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYD-ykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~ 264 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRS 264 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCch-hhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhH
Confidence 235788999999999974 34565 8899999999999999999999999999999999887754 46778999
Q ss_pred HHHHHHhccCCCcCCCCCHHHHHhhhhccccc
Q 037702 239 VRKLLSRILDPNPSTRVTMAKLMENYWFRKGY 270 (448)
Q Consensus 239 ~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 270 (448)
+.||+.+||.+||..||+++++++||||++..
T Consensus 265 F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~ 296 (1187)
T KOG0579|consen 265 FSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAP 296 (1187)
T ss_pred HHHHHHHHHhcCCccCCCHHHHhhCcccccCC
Confidence 99999999999999999999999999998543
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-47 Score=381.48 Aligned_cols=255 Identities=30% Similarity=0.540 Sum_probs=220.9
Q ss_pred eeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCCc
Q 037702 17 LLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGE 96 (448)
Q Consensus 17 ~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 96 (448)
+||+|+||+||.|++..|....|||.|.... ....+-+..||.+.+.|+|.|||++++.+.+++.+-|.||-++||+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 5999999999999999999999999996543 2345778999999999999999999999999999999999999999
Q ss_pred hHHHHhc--CCC--CHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEc-CCCCeEEeeccccccccccccCCCcccc
Q 037702 97 LFNKVAK--GKL--REEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLD-ENGDLKISDFGLSALQESTRQDGLLHTT 171 (448)
Q Consensus 97 L~~~i~~--~~l--~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~-~~g~lkl~DFGla~~~~~~~~~~~~~~~ 171 (448)
|.++++. |++ +|..+..|.+||++||.|||++.|||||||-+|+|++ -.|.+||+|||.++.... -.....|.
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TETF 736 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTETF 736 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhcc--CCcccccc
Confidence 9999986 888 8889999999999999999999999999999999996 579999999999986533 33456788
Q ss_pred CCCCcccchhhhhc--cCCCCCcchHHHHHHHHHHHHhCCCCCCCCc--HHHHHH-HHhhccCCCCCCCCHHHHHHHHhc
Q 037702 172 CGTPAYVAPEVINK--RGYDGAKADIWSCGVVLFVLLAGNLPFYDSN--LMELYK-KITRAEFKCPNWFPPEVRKLLSRI 246 (448)
Q Consensus 172 ~Gt~~Y~APEvl~~--~~~~~~~sDiwSlGvil~elltG~~Pf~~~~--~~~~~~-~i~~~~~~~p~~~s~~~~~li~~~ 246 (448)
.||..|||||++.. .|| |.++|||||||++.||.||++||.... ...+++ ...+..+++|..+|.+++.||.+|
T Consensus 737 TGTLQYMAPEvIDqG~RGY-G~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~Filrc 815 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGY-GKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRC 815 (1226)
T ss_pred ccchhhhChHhhccCCcCC-CchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHH
Confidence 89999999999964 345 688999999999999999999997533 233333 234556788889999999999999
Q ss_pred cCCCcCCCCCHHHHHhhhhccccccccCCCC
Q 037702 247 LDPNPSTRVTMAKLMENYWFRKGYKKIETPE 277 (448)
Q Consensus 247 L~~dP~~Rpt~~eil~hp~~~~~~~~~~~~~ 277 (448)
+.+||..||++.++|.+||++.+.++.....
T Consensus 816 Fepd~~~R~sA~~LL~DpFlq~~~kk~r~~l 846 (1226)
T KOG4279|consen 816 FEPDPCDRPSAKDLLQDPFLQHNNKKPRPKL 846 (1226)
T ss_pred cCCCcccCccHHHhccCcccccCCCCCCCCC
Confidence 9999999999999999999998855544433
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=350.37 Aligned_cols=252 Identities=25% Similarity=0.521 Sum_probs=218.5
Q ss_pred CeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe-CCEEEEEE
Q 037702 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMAS-KTKIYFAM 89 (448)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~-~~~~~lV~ 89 (448)
+|++.+.||+|++|.||.+.+..+++.||+|.+....... ...+.+.+|+.+++.++|||++++++.+.. ...+|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASR-RERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCH-HHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 5999999999999999999999999999999997654432 334668899999999999999999998764 45789999
Q ss_pred eecCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCC
Q 037702 90 EYVRGGELFNKVAK---GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDG 166 (448)
Q Consensus 90 E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 166 (448)
||+++++|.+++.. ..+++.+++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++....... .
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~--~ 157 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC--D 157 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC--C
Confidence 99999999999864 358999999999999999999999999999999999999999999999999997653322 2
Q ss_pred CccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccC-CCCCCCCHHHHHHHHh
Q 037702 167 LLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF-KCPNWFPPEVRKLLSR 245 (448)
Q Consensus 167 ~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~ 245 (448)
......|++.|+|||++.+..++ .++|||||||++|+|++|..||...+.......+..+.. ..+..+++++.++|.+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (257)
T cd08223 158 MASTLIGTPYYMSPELFSNKPYN-YKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIAT 236 (257)
T ss_pred ccccccCCcCccChhHhcCCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHH
Confidence 33456789999999999776654 789999999999999999999988777666666655544 4566789999999999
Q ss_pred ccCCCcCCCCCHHHHHhhhhc
Q 037702 246 ILDPNPSTRVTMAKLMENYWF 266 (448)
Q Consensus 246 ~L~~dP~~Rpt~~eil~hp~~ 266 (448)
||++||.+|||+.++++||||
T Consensus 237 ~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 237 MLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HhccCcccCCCHHHHhcCCCC
Confidence 999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-47 Score=368.60 Aligned_cols=259 Identities=29% Similarity=0.483 Sum_probs=232.1
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKI 85 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 85 (448)
.+..+.|+..++||+|+||.||-++-+.||+.||+|.++++.++..........|-.+|.+++.+.||.+-..|++++.+
T Consensus 181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~L 260 (591)
T KOG0986|consen 181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDAL 260 (591)
T ss_pred hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCce
Confidence 45678899999999999999999999999999999999999887766667788999999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHhc-C--CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccc
Q 037702 86 YFAMEYVRGGELFNKVAK-G--KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQEST 162 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~--~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~ 162 (448)
++||..|+||+|.-.|.. | .++|..++.|+.+|+.||++||+.+||+|||||+|||||+.|+++|+|+|||..+...
T Consensus 261 ClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 261 CLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 999999999999776654 4 7999999999999999999999999999999999999999999999999999865432
Q ss_pred ccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCc----HHHHHHHHhhccCCCCCCCCHH
Q 037702 163 RQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSN----LMELYKKITRAEFKCPNWFPPE 238 (448)
Q Consensus 163 ~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~----~~~~~~~i~~~~~~~p~~~s~~ 238 (448)
. .....+||.+|||||++.+..|+ ...|+|||||+||+|+.|..||.... ..++-+.+......+|..+|++
T Consensus 341 ~---~~~~rvGT~GYMAPEvl~ne~Y~-~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~e 416 (591)
T KOG0986|consen 341 K---PIRGRVGTVGYMAPEVLQNEVYD-FSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEE 416 (591)
T ss_pred C---ccccccCcccccCHHHHcCCccc-CCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHH
Confidence 2 23445999999999999888875 88999999999999999999997643 3455666777777888999999
Q ss_pred HHHHHHhccCCCcCCCC-----CHHHHHhhhhccc
Q 037702 239 VRKLLSRILDPNPSTRV-----TMAKLMENYWFRK 268 (448)
Q Consensus 239 ~~~li~~~L~~dP~~Rp-----t~~eil~hp~~~~ 268 (448)
++++.+.+|.+||.+|. .++++.+||||+.
T Consensus 417 akslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~ 451 (591)
T KOG0986|consen 417 AKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKD 451 (591)
T ss_pred HHHHHHHHHccCHHHhccCCCcCcchhhhCccccc
Confidence 99999999999999997 5779999999986
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=358.24 Aligned_cols=256 Identities=31% Similarity=0.535 Sum_probs=220.8
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIY 86 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 86 (448)
-...+|++.+.||+|+||.||+|.+..++..||+|.+....... .+.+.+|+.+++.++||||+++++.+......|
T Consensus 17 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~---~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~ 93 (296)
T cd06654 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELW 93 (296)
T ss_pred CcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch---HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEE
Confidence 45679999999999999999999999999999999997654332 366889999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCC
Q 037702 87 FAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDG 166 (448)
Q Consensus 87 lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 166 (448)
+||||++|++|.+++..+.+++.++..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 94 lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~--~ 171 (296)
T cd06654 94 VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--S 171 (296)
T ss_pred EeecccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccc--c
Confidence 99999999999999988889999999999999999999999999999999999999999999999999987543221 1
Q ss_pred CccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhc---cCCCCCCCCHHHHHHH
Q 037702 167 LLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA---EFKCPNWFPPEVRKLL 243 (448)
Q Consensus 167 ~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~li 243 (448)
......|++.|+|||.+.+..+ +.++|||||||++|+|++|+.||...+.......+... ....|..+++.+.++|
T Consensus 172 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 250 (296)
T cd06654 172 KRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFL 250 (296)
T ss_pred ccCcccCCccccCHHHHcCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHH
Confidence 1234579999999999876655 48899999999999999999999877654433333222 2234556889999999
Q ss_pred HhccCCCcCCCCCHHHHHhhhhccc
Q 037702 244 SRILDPNPSTRVTMAKLMENYWFRK 268 (448)
Q Consensus 244 ~~~L~~dP~~Rpt~~eil~hp~~~~ 268 (448)
.+||..||.+|||+.++++||||..
T Consensus 251 ~~~l~~~p~~Rpt~~eil~~~~~~~ 275 (296)
T cd06654 251 NRCLDMDVEKRGSAKELLQHQFLKI 275 (296)
T ss_pred HHHCcCCcccCcCHHHHhhChhhhc
Confidence 9999999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=351.98 Aligned_cols=255 Identities=31% Similarity=0.582 Sum_probs=218.8
Q ss_pred CeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccc------hhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 037702 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRR------VGLIDQIKREISVMRLVRHPNIVQLYEVMASKTK 84 (448)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~------~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 84 (448)
+|.++..||+|+||.||+|.+..+++.+|+|.+....... ....+.+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 5889999999999999999998899999999987543321 2334678899999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccc
Q 037702 85 IYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTR 163 (448)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~ 163 (448)
.++||||+++++|.+++.. +.+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 9999999999999999976 678999999999999999999999999999999999999999999999999987654221
Q ss_pred c----CCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhc-cCCCCCCCCHH
Q 037702 164 Q----DGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA-EFKCPNWFPPE 238 (448)
Q Consensus 164 ~----~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~ 238 (448)
. ........|++.|+|||.+.+..+ +.++|+|||||++|+|++|+.||...+.......+... ....|..++..
T Consensus 161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd06628 161 LSTKTNGARPSLQGSVFWMAPEVVKQTSY-TRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSE 239 (267)
T ss_pred ccCCccccccccCCCcCccChhHhccCCC-CchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCHH
Confidence 1 111123468999999999977665 47899999999999999999999887665554444433 33566678999
Q ss_pred HHHHHHhccCCCcCCCCCHHHHHhhhhc
Q 037702 239 VRKLLSRILDPNPSTRVTMAKLMENYWF 266 (448)
Q Consensus 239 ~~~li~~~L~~dP~~Rpt~~eil~hp~~ 266 (448)
+.++|.+||++||.+||++.++++||||
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 240 AIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 9999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=355.34 Aligned_cols=252 Identities=31% Similarity=0.511 Sum_probs=209.1
Q ss_pred CeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 037702 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAME 90 (448)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (448)
+|++.+.||+|+||.||+|.+..+|+.||||.+...... ......+.+|+.+++.++||||+++++++.++..+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE-EGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc-CCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 589999999999999999999999999999998754322 2334677889999999999999999999999999999999
Q ss_pred ecCCCchHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCC
Q 037702 91 YVRGGELFNKVAK----GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDG 166 (448)
Q Consensus 91 ~~~gg~L~~~i~~----~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 166 (448)
|++ ++|.+++.. +.+++..++.++.||+.||.|||++|++||||||+|||++.+|.+||+|||++...... ..
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~~ 156 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP--VR 156 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCC--cc
Confidence 997 588888753 46899999999999999999999999999999999999999999999999998754322 12
Q ss_pred CccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhc------------------c
Q 037702 167 LLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA------------------E 228 (448)
Q Consensus 167 ~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~------------------~ 228 (448)
......|++.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+... .
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK 236 (285)
T ss_pred cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHH
Confidence 2234467899999999866554458899999999999999999999876543322221110 0
Q ss_pred -----------CCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhc
Q 037702 229 -----------FKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWF 266 (448)
Q Consensus 229 -----------~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 266 (448)
......+++++.++|.+||..||.+|||+.++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 237 NTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 00122378999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-46 Score=371.41 Aligned_cols=245 Identities=29% Similarity=0.501 Sum_probs=212.6
Q ss_pred CeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 037702 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAME 90 (448)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (448)
.+.+.+.||+|-||.|+.|.+.. ...||+|.+....... +.+.+|+++|+.|+|+|||++++++..+..+|||||
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~~----~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE 281 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMSP----EAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTE 281 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccCh----hHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEE
Confidence 34567889999999999999832 2489999997654332 567799999999999999999999999889999999
Q ss_pred ecCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCC
Q 037702 91 YVRGGELFNKVAK---GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGL 167 (448)
Q Consensus 91 ~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 167 (448)
|++.|+|.++++. +.+...+...++.||++|++||+++++|||||.+.||||++++.+||+|||||+..... ....
T Consensus 282 ~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~-~Y~~ 360 (468)
T KOG0197|consen 282 YMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDD-EYTA 360 (468)
T ss_pred ecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCC-ceee
Confidence 9999999999986 46999999999999999999999999999999999999999999999999999943221 1111
Q ss_pred ccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhc-cCCCCCCCCHHHHHHHHh
Q 037702 168 LHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EFKCPNWFPPEVRKLLSR 245 (448)
Q Consensus 168 ~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~ 245 (448)
....--...|.|||.+....+. .+||||||||+||||+| |+.||.+.+..++...+.++ .++.|..+|+++.+++..
T Consensus 361 ~~~~kfPIkWtAPEa~~~~~FS-~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~~ 439 (468)
T KOG0197|consen 361 SEGGKFPIKWTAPEALNYGKFS-SKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELMKS 439 (468)
T ss_pred cCCCCCCceecCHHHHhhCCcc-cccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHHHH
Confidence 1122235579999999887775 89999999999999998 99999999999999999887 468999999999999999
Q ss_pred ccCCCcCCCCCHHHHHh
Q 037702 246 ILDPNPSTRVTMAKLME 262 (448)
Q Consensus 246 ~L~~dP~~Rpt~~eil~ 262 (448)
||..+|++|||++.+..
T Consensus 440 CW~~~P~~RPtF~~L~~ 456 (468)
T KOG0197|consen 440 CWHEDPEDRPTFETLRE 456 (468)
T ss_pred HhhCCcccCCCHHHHHH
Confidence 99999999999997653
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-45 Score=359.56 Aligned_cols=258 Identities=33% Similarity=0.578 Sum_probs=225.2
Q ss_pred CCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 037702 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAM 89 (448)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (448)
.+|++.+.||+|+||.||+|.+..+++.||+|.+.+...........+.+|+.+++.++||||+++++.+......|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47999999999999999999999999999999998776554345577899999999999999999999999999999999
Q ss_pred eecCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccC-
Q 037702 90 EYVRGGELFNKVAK---GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQD- 165 (448)
Q Consensus 90 E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~- 165 (448)
||+.|++|.+++.. ..+++..++.++.|++.||+|||++|++||||||+||+++.++.++|+|||++.........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 99999999999865 46899999999999999999999999999999999999999999999999998754321110
Q ss_pred --------------------------CCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHH
Q 037702 166 --------------------------GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLME 219 (448)
Q Consensus 166 --------------------------~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~ 219 (448)
.......||..|+|||++.+..+ +.++||||||+++|+|++|..||...+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 239 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCC-CchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence 01123468999999999977665 578999999999999999999999888777
Q ss_pred HHHHHhhccCCCCCC--CCHHHHHHHHhccCCCcCCCCC----HHHHHhhhhccc
Q 037702 220 LYKKITRAEFKCPNW--FPPEVRKLLSRILDPNPSTRVT----MAKLMENYWFRK 268 (448)
Q Consensus 220 ~~~~i~~~~~~~p~~--~s~~~~~li~~~L~~dP~~Rpt----~~eil~hp~~~~ 268 (448)
.+..+......+|.. +++.+.++|.+||..||++||| +++++.||||+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~ 294 (316)
T cd05574 240 TFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRG 294 (316)
T ss_pred HHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhc
Confidence 777776666555554 6899999999999999999999 999999999975
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-45 Score=349.12 Aligned_cols=255 Identities=32% Similarity=0.561 Sum_probs=219.7
Q ss_pred CCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 037702 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAM 89 (448)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (448)
++|++++.||.|+||.||+|.+..++..+|+|++....... ....+.+|+.+++.++||||+++++.+......|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 47999999999999999999998899999999997654332 4577899999999999999999999999999999999
Q ss_pred eecCCCchHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccC
Q 037702 90 EYVRGGELFNKVAK----GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQD 165 (448)
Q Consensus 90 E~~~gg~L~~~i~~----~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~ 165 (448)
|+++|++|.+++.. +.+++..++.++.||+.||.|||++|++||||+|+||++++++.++|+|||++.........
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 99999999999965 35899999999999999999999999999999999999999999999999999765443222
Q ss_pred --CCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCC-CC-----CCCCH
Q 037702 166 --GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFK-CP-----NWFPP 237 (448)
Q Consensus 166 --~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-~p-----~~~s~ 237 (448)
......+|++.|+|||++......+.++|+|||||++|+|++|+.||...+....+.++...... .+ ..+++
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSK 238 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccH
Confidence 12344579999999999876634568899999999999999999999887766655555443321 11 24678
Q ss_pred HHHHHHHhccCCCcCCCCCHHHHHhhhhc
Q 037702 238 EVRKLLSRILDPNPSTRVTMAKLMENYWF 266 (448)
Q Consensus 238 ~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 266 (448)
.+.+++.+||..||.+|||++++++||||
T Consensus 239 ~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 239 SFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 99999999999999999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-45 Score=356.31 Aligned_cols=256 Identities=30% Similarity=0.547 Sum_probs=221.8
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYF 87 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 87 (448)
...+|++.+.||.|+||.||+|.+..+|+.||+|.+...... ..+.+.+|+.+++.++||||+++++.+.....+|+
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 93 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP---KKELIINEILVMKELKNPNIVNFLDSFLVGDELFV 93 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc---hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEE
Confidence 456799999999999999999999999999999999765332 24678899999999999999999999999999999
Q ss_pred EEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCC
Q 037702 88 AMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGL 167 (448)
Q Consensus 88 V~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 167 (448)
|+||+++++|..++..+.+++.++..++.|++.||.|||++|++||||||+||+++.++.+||+|||++....... ..
T Consensus 94 v~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~--~~ 171 (296)
T cd06655 94 VMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ--SK 171 (296)
T ss_pred EEEecCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccccc--cc
Confidence 9999999999999988889999999999999999999999999999999999999999999999999987543221 11
Q ss_pred ccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhc---cCCCCCCCCHHHHHHHH
Q 037702 168 LHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA---EFKCPNWFPPEVRKLLS 244 (448)
Q Consensus 168 ~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~li~ 244 (448)
....+|++.|+|||.+.+..+ +.++|||||||++|+|++|+.||...+.......+... ....|..+++.+.++|.
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 250 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLN 250 (296)
T ss_pred CCCcCCCccccCcchhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHH
Confidence 234578999999999876665 47899999999999999999999887765544444332 23345668899999999
Q ss_pred hccCCCcCCCCCHHHHHhhhhcccc
Q 037702 245 RILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 245 ~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
+||..||.+|||+.+++.||||+..
T Consensus 251 ~~l~~dp~~Rpt~~~il~~~~~~~~ 275 (296)
T cd06655 251 RCLEMDVEKRGSAKELLQHPFLKLA 275 (296)
T ss_pred HHhhcChhhCCCHHHHhhChHhhhc
Confidence 9999999999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-45 Score=346.14 Aligned_cols=252 Identities=28% Similarity=0.494 Sum_probs=221.4
Q ss_pred CeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 037702 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAME 90 (448)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (448)
+|++.+.||+|+||.||+|.+..+|+.|++|.+....... .....+.+|+.+++.++||||+++++++.+....|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNR-REREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCH-HHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 5899999999999999999999999999999997654433 345678899999999999999999999999999999999
Q ss_pred ecCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCC
Q 037702 91 YVRGGELFNKVAK---GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGL 167 (448)
Q Consensus 91 ~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 167 (448)
|++|++|.+++.. ..+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++....... ..
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~--~~ 157 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT--NF 157 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc--ch
Confidence 9999999999865 468999999999999999999999999999999999999999999999999987543321 12
Q ss_pred ccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCC-CCCCCCHHHHHHHHhc
Q 037702 168 LHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFK-CPNWFPPEVRKLLSRI 246 (448)
Q Consensus 168 ~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~li~~~ 246 (448)
....+|++.|+|||++.+..++ .++|+|||||++|+|++|+.||...+......++...... .+..++.++.++|.+|
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd08529 158 ANTIVGTPYYLSPELCEDKPYN-EKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQC 236 (256)
T ss_pred hhccccCccccCHHHhcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHH
Confidence 2345789999999999876654 7899999999999999999999988877777777665543 4446889999999999
Q ss_pred cCCCcCCCCCHHHHHhhhhc
Q 037702 247 LDPNPSTRVTMAKLMENYWF 266 (448)
Q Consensus 247 L~~dP~~Rpt~~eil~hp~~ 266 (448)
|+.+|++||++.++++|||+
T Consensus 237 l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 237 LTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred ccCCcccCcCHHHHhhCCCC
Confidence 99999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=373.86 Aligned_cols=253 Identities=25% Similarity=0.422 Sum_probs=207.5
Q ss_pred cccCCeEEEeeeeecCceEEEEEEEC--CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNL--KTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTK 84 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~--~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 84 (448)
+...+|++.+.||+|+||.||+|... .++..||+|.+... ....+|+.+++.++||||+++++++.....
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~ 160 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKST 160 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCCE
Confidence 45668999999999999999999764 35678999988643 234589999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccc
Q 037702 85 IYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTR 163 (448)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~ 163 (448)
.|+|||++. ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 161 ~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 161 VCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred EEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 999999996 588888864 679999999999999999999999999999999999999999999999999997554332
Q ss_pred cCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcH---HHHHHHHhhc-------------
Q 037702 164 QDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNL---MELYKKITRA------------- 227 (448)
Q Consensus 164 ~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~---~~~~~~i~~~------------- 227 (448)
.........||+.|+|||++....|. .++|||||||++|+|++|+.||.+... ...+..+.+.
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPYC-AKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred ccccccccccccCccCHhHhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 22223356799999999999877665 789999999999999999999976432 1111111110
Q ss_pred ----------------cCCCCC-----CCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 228 ----------------EFKCPN-----WFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 228 ----------------~~~~p~-----~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
.+..|. .++.++.++|.+||..||.+|||+.+++.||||++.
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE 381 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence 011111 246788999999999999999999999999999763
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-46 Score=377.62 Aligned_cols=252 Identities=30% Similarity=0.483 Sum_probs=215.6
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-C-----CCcceEEEEEE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR-H-----PNIVQLYEVMA 80 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-h-----pnIv~l~~~~~ 80 (448)
.+..+|++.+.||+|+||+|-+|.+..|++.||||++..+. ....+...|+.+|..|+ | -|+|+++++|.
T Consensus 183 ~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~ 258 (586)
T KOG0667|consen 183 HIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFY 258 (586)
T ss_pred eeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccc
Confidence 44559999999999999999999999999999999997654 44577788999999997 3 48999999999
Q ss_pred eCCEEEEEEeecCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCC--CeEEeeccc
Q 037702 81 SKTKIYFAMEYVRGGELFNKVAK---GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENG--DLKISDFGL 155 (448)
Q Consensus 81 ~~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g--~lkl~DFGl 155 (448)
..++.|||+|+.. -+|+++++. .+++...++.+++||+.||.+||+.||||+|||||||||...+ .+||+|||.
T Consensus 259 fr~HlciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGS 337 (586)
T KOG0667|consen 259 FRNHLCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGS 337 (586)
T ss_pred cccceeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccc
Confidence 9999999999995 499999986 4689999999999999999999999999999999999997654 699999999
Q ss_pred cccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhcc-------
Q 037702 156 SALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAE------- 228 (448)
Q Consensus 156 a~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~------- 228 (448)
|+.... . ..+.+-+..|+|||++.+..|+ .+.||||||||++||++|.+.|.+.+..+.+..|....
T Consensus 338 Sc~~~q----~-vytYiQSRfYRAPEVILGlpY~-~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~m 411 (586)
T KOG0667|consen 338 SCFESQ----R-VYTYIQSRFYRAPEVILGLPYD-TAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKM 411 (586)
T ss_pred ccccCC----c-ceeeeeccccccchhhccCCCC-CccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHH
Confidence 986432 2 2378889999999999999997 77999999999999999999999988777666553210
Q ss_pred ---------------------------------------------CCCCCC-----------CCHHHHHHHHhccCCCcC
Q 037702 229 ---------------------------------------------FKCPNW-----------FPPEVRKLLSRILDPNPS 252 (448)
Q Consensus 229 ---------------------------------------------~~~p~~-----------~s~~~~~li~~~L~~dP~ 252 (448)
...|+. -...+.+||++||.+||.
T Consensus 412 L~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~ 491 (586)
T KOG0667|consen 412 LDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPA 491 (586)
T ss_pred HHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCch
Confidence 001100 114578999999999999
Q ss_pred CCCCHHHHHhhhhcccc
Q 037702 253 TRVTMAKLMENYWFRKG 269 (448)
Q Consensus 253 ~Rpt~~eil~hp~~~~~ 269 (448)
+|+|+.++|+||||+..
T Consensus 492 ~R~tp~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 492 ERITPAQALNHPFLTGT 508 (586)
T ss_pred hcCCHHHHhcCcccccc
Confidence 99999999999999853
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-45 Score=357.49 Aligned_cols=258 Identities=33% Similarity=0.643 Sum_probs=222.5
Q ss_pred CCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 037702 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAM 89 (448)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (448)
++|++.+.||+|+||.||+|.+..+++.||+|.+...........+.+.+|+.+++.++||||+++++.+..++.+|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999998765433344567889999999999999999999999999999999
Q ss_pred eecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccc-----
Q 037702 90 EYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTR----- 163 (448)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~----- 163 (448)
||++|++|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 99999999999976 679999999999999999999999999999999999999999999999999986321110
Q ss_pred --------cCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCC--
Q 037702 164 --------QDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPN-- 233 (448)
Q Consensus 164 --------~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~-- 233 (448)
.........|++.|+|||.+....+ +.++|+|||||++|+|++|..||.+.+..+....+.......|.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (305)
T cd05609 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGD 239 (305)
T ss_pred ccccccchhhccccCCccCccccCchhccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCcc
Confidence 0011123468899999999877665 58899999999999999999999988877777777666544333
Q ss_pred -CCCHHHHHHHHhccCCCcCCCCC---HHHHHhhhhccc
Q 037702 234 -WFPPEVRKLLSRILDPNPSTRVT---MAKLMENYWFRK 268 (448)
Q Consensus 234 -~~s~~~~~li~~~L~~dP~~Rpt---~~eil~hp~~~~ 268 (448)
.+++++.++|.+||..||.+||+ +.++++||||..
T Consensus 240 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~ 278 (305)
T cd05609 240 EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG 278 (305)
T ss_pred ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence 47899999999999999999998 799999999965
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-45 Score=357.98 Aligned_cols=253 Identities=27% Similarity=0.469 Sum_probs=213.7
Q ss_pred CCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 037702 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAM 89 (448)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (448)
++|++.+.||+|+||.||+|.+..+|..+|+|.+.... ......++.+|+++++.++||||+++++++.+++.+|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 47999999999999999999999999999999986542 2234567889999999999999999999999999999999
Q ss_pred eecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCC
Q 037702 90 EYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHS-RGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGL 167 (448)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~-~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 167 (448)
||++|++|.+++.. +.+++..+..++.|++.||.|||+ .|++||||||+|||++.++.+||+|||++..... ..
T Consensus 79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~ 154 (308)
T cd06615 79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SM 154 (308)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccc----cc
Confidence 99999999999976 679999999999999999999998 5999999999999999999999999999864322 12
Q ss_pred ccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhc--------------------
Q 037702 168 LHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA-------------------- 227 (448)
Q Consensus 168 ~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-------------------- 227 (448)
..+.+|++.|+|||++.+..+ +.++|+|||||++|+|++|..||...+.......+...
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHY-TVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS 233 (308)
T ss_pred cccCCCCcCccChhHhcCCCC-CccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence 345689999999999876555 48899999999999999999999765543333222111
Q ss_pred -----------------cCCCC-CCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 228 -----------------EFKCP-NWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 228 -----------------~~~~p-~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
....| ..+++++++||.+||..||++|||+.++++||||...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred cchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 00111 1267889999999999999999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=351.95 Aligned_cols=252 Identities=30% Similarity=0.575 Sum_probs=223.1
Q ss_pred CeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 037702 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAME 90 (448)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (448)
+|++.+.||.|+||.||+|.+..+++.||+|++.+.........+.+.+|+.++++++||||+++++.+.++...|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 59999999999999999999999999999999987665554556789999999999999999999999999999999999
Q ss_pred ecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCcc
Q 037702 91 YVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLH 169 (448)
Q Consensus 91 ~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~ 169 (448)
|+.|++|.+++.. +.+++..+..++.||++||.|||++|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~---~~~ 157 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTT 157 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc---ccc
Confidence 9999999999976 489999999999999999999999999999999999999999999999999987543321 234
Q ss_pred ccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCc---HHHHHHHHhhccCCCCCCCCHHHHHHHHhc
Q 037702 170 TTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSN---LMELYKKITRAEFKCPNWFPPEVRKLLSRI 246 (448)
Q Consensus 170 ~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~---~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 246 (448)
...|+..|+|||++....+ +.++|+||||+++|+|++|..||...+ ...............|..++.++.++|.+|
T Consensus 158 ~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (258)
T cd05578 158 STSGTPGYMAPEVLCRQGY-SVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKL 236 (258)
T ss_pred ccCCChhhcCHHHHcccCC-CCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHHH
Confidence 5678999999999977665 588999999999999999999998766 334443333355667788899999999999
Q ss_pred cCCCcCCCCCH--HHHHhhhhc
Q 037702 247 LDPNPSTRVTM--AKLMENYWF 266 (448)
Q Consensus 247 L~~dP~~Rpt~--~eil~hp~~ 266 (448)
|..||.+||++ .|+++||||
T Consensus 237 l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 237 LERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred ccCChhHcCCccHHHHhcCCCC
Confidence 99999999999 999999997
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=361.50 Aligned_cols=246 Identities=27% Similarity=0.452 Sum_probs=194.0
Q ss_pred EeeeeecCceEEEEEEEC--CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEEEEEEe
Q 037702 15 GRLLGQGTFAKVYHGRNL--KTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMAS--KTKIYFAME 90 (448)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~--~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~~~~~lV~E 90 (448)
++.||+|+||.||+|++. .+++.||+|.+..... ...+.+|+.+++.++||||+++++++.. ...+|++||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 568999999999999975 4678999999865432 2456789999999999999999999854 467899999
Q ss_pred ecCCCchHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEE----cCCCCeEEeecccc
Q 037702 91 YVRGGELFNKVAK----------GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLL----DENGDLKISDFGLS 156 (448)
Q Consensus 91 ~~~gg~L~~~i~~----------~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl----~~~g~lkl~DFGla 156 (448)
|+.+ +|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 81 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred ccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 9965 78777642 248999999999999999999999999999999999999 45678999999999
Q ss_pred cccccccc-CCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcH---------HHHHHHHhh
Q 037702 157 ALQESTRQ-DGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNL---------MELYKKITR 226 (448)
Q Consensus 157 ~~~~~~~~-~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~---------~~~~~~i~~ 226 (448)
........ .......+||+.|+|||++.+....+.++||||+||++|+|++|.+||...+. ......+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 239 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence 86543221 12234567999999999997765556889999999999999999999964321 111111110
Q ss_pred c----------------------------cCCC----------CCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhc
Q 037702 227 A----------------------------EFKC----------PNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWF 266 (448)
Q Consensus 227 ~----------------------------~~~~----------p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 266 (448)
. .... ....+.++.+||.+||+.||.+|||++|+++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred hcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0 0000 01134678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=350.97 Aligned_cols=254 Identities=29% Similarity=0.474 Sum_probs=212.1
Q ss_pred CCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 037702 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAM 89 (448)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (448)
++|++.+.||+|+||.||+|.+..+|+.||+|++....... ...+.+.+|+.+++.++||||+++++++......|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDP-VIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCc-cccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 57999999999999999999999999999999986543221 22355788999999999999999999999999999999
Q ss_pred eecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCc
Q 037702 90 EYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLL 168 (448)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 168 (448)
||++++.|..++.. +.+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++........ ..
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~~ 157 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD--DY 157 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc--cc
Confidence 99999988887765 5799999999999999999999999999999999999999999999999999986533221 12
Q ss_pred cccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhc-------------------cC
Q 037702 169 HTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA-------------------EF 229 (448)
Q Consensus 169 ~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-------------------~~ 229 (448)
....++..|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+... ..
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07847 158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL 237 (286)
T ss_pred cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc
Confidence 34468899999999876555568899999999999999999999876654333222110 00
Q ss_pred CCC------------CCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhc
Q 037702 230 KCP------------NWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWF 266 (448)
Q Consensus 230 ~~p------------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 266 (448)
..| +.++..+.+||.+||++||++|||+.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 001 2357889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=356.51 Aligned_cols=252 Identities=30% Similarity=0.525 Sum_probs=208.5
Q ss_pred CeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 037702 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAME 90 (448)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (448)
+|++.+.||+|+||.||+|.+..+|+.||+|.+...... ......+.+|+.+++.++||||+++++++.+....|+|+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccc-ccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 699999999999999999999999999999999765332 2233567789999999999999999999999999999999
Q ss_pred ecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCc
Q 037702 91 YVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLL 168 (448)
Q Consensus 91 ~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 168 (448)
|+++ +|.+++.. +.+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++....... ...
T Consensus 80 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~ 156 (284)
T cd07839 80 YCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV--RCY 156 (284)
T ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC--CCc
Confidence 9975 78777653 679999999999999999999999999999999999999999999999999987543221 122
Q ss_pred cccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCC-CCCcHHHHHHHHhhcc-------------------
Q 037702 169 HTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPF-YDSNLMELYKKITRAE------------------- 228 (448)
Q Consensus 169 ~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf-~~~~~~~~~~~i~~~~------------------- 228 (448)
....+++.|+|||++.+....+.++|||||||++|+|++|..|| .+.+..+.+..+.+.-
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07839 157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKP 236 (284)
T ss_pred CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccc
Confidence 34568899999999876555568899999999999999998885 4444444333332110
Q ss_pred C----------CCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhc
Q 037702 229 F----------KCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWF 266 (448)
Q Consensus 229 ~----------~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 266 (448)
+ ...+.+++++++||.+||..||.+|||++++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 0 0112367899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=355.31 Aligned_cols=256 Identities=34% Similarity=0.515 Sum_probs=220.8
Q ss_pred cCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFA 88 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 88 (448)
.++|++.+.||.|+||.||+|.+..++..||+|.+.... ....+.+.+|+.+++.++||||+++++++..+...|+|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES---EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC---HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence 467999999999999999999998899999999986542 23346788999999999999999999999999999999
Q ss_pred EeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCC
Q 037702 89 MEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDG 166 (448)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 166 (448)
|||+++++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-- 158 (280)
T cd06611 81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-- 158 (280)
T ss_pred eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccccc--
Confidence 999999999999875 4699999999999999999999999999999999999999999999999999875432211
Q ss_pred CccccCCCCcccchhhhhcc----CCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccC---CCCCCCCHHH
Q 037702 167 LLHTTCGTPAYVAPEVINKR----GYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF---KCPNWFPPEV 239 (448)
Q Consensus 167 ~~~~~~Gt~~Y~APEvl~~~----~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~ 239 (448)
......||+.|+|||++... ...+.++|+|||||++|+|++|+.||...+......++..... ..|..++.++
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSF 238 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHH
Confidence 22345789999999998532 2224689999999999999999999988877666666665432 3456789999
Q ss_pred HHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 240 RKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 240 ~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
.++|.+||..||.+||+++++++||||.+.
T Consensus 239 ~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 239 NDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred HHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 999999999999999999999999999754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=351.03 Aligned_cols=253 Identities=31% Similarity=0.516 Sum_probs=212.0
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYF 87 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 87 (448)
..++|++.+.||+|+||.||+|.+..+|+.||+|++..... .....+.+|+.+++.++||||+++++++..+..+|+
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~i 83 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG---DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWI 83 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc---chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEE
Confidence 45689999999999999999999999999999999975432 223567899999999999999999999999999999
Q ss_pred EEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCC
Q 037702 88 AMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDG 166 (448)
Q Consensus 88 V~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 166 (448)
||||+++++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++....... .
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--~ 161 (267)
T cd06646 84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI--A 161 (267)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccc--c
Confidence 9999999999998864 679999999999999999999999999999999999999999999999999997543221 1
Q ss_pred CccccCCCCcccchhhhhc--cCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCC-----CCCCHHH
Q 037702 167 LLHTTCGTPAYVAPEVINK--RGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCP-----NWFPPEV 239 (448)
Q Consensus 167 ~~~~~~Gt~~Y~APEvl~~--~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p-----~~~s~~~ 239 (448)
......|++.|+|||++.. ....+.++|+|||||++|+|++|..||...+.......+....+..+ ..++..+
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTF 241 (267)
T ss_pred ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHH
Confidence 1234578999999999853 22234789999999999999999999976554433333333322222 2367899
Q ss_pred HHHHHhccCCCcCCCCCHHHHHhhhh
Q 037702 240 RKLLSRILDPNPSTRVTMAKLMENYW 265 (448)
Q Consensus 240 ~~li~~~L~~dP~~Rpt~~eil~hp~ 265 (448)
.+||++||..||.+|||++++++|+|
T Consensus 242 ~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 242 HNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 99999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-45 Score=354.26 Aligned_cols=245 Identities=22% Similarity=0.314 Sum_probs=211.2
Q ss_pred CeEEE--eeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe----CCE
Q 037702 11 KYELG--RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMAS----KTK 84 (448)
Q Consensus 11 ~y~~~--~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~----~~~ 84 (448)
+++.. ..||+|++|.||+|.+ +|+.||||.+.+.........+.+.+|+.+|++++||||+++++++.+ ...
T Consensus 19 ~i~~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~ 96 (283)
T PHA02988 19 DIDKYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPR 96 (283)
T ss_pred HcCCCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCc
Confidence 34444 6789999999999998 799999999987655444456788899999999999999999999876 457
Q ss_pred EEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCCEeecCCCCceEEcCCCCeEEeecccccccccc
Q 037702 85 IYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHS-RGVYHRDLKPENLLLDENGDLKISDFGLSALQEST 162 (448)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~-~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~ 162 (448)
+++||||++||+|.+++.. +.+++.....++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++......
T Consensus 97 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~ 176 (283)
T PHA02988 97 LSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP 176 (283)
T ss_pred eEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc
Confidence 8999999999999999976 578999999999999999999998 49999999999999999999999999998754321
Q ss_pred ccCCCccccCCCCcccchhhhhc--cCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhc--cCCCCCCCCHH
Q 037702 163 RQDGLLHTTCGTPAYVAPEVINK--RGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA--EFKCPNWFPPE 238 (448)
Q Consensus 163 ~~~~~~~~~~Gt~~Y~APEvl~~--~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~ 238 (448)
.....||+.|+|||++.+ ..+ +.++|||||||++|+|++|..||.+.+..+++..+... .+..|..++++
T Consensus 177 -----~~~~~~~~~y~aPE~~~~~~~~~-~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 250 (283)
T PHA02988 177 -----PFKNVNFMVYFSYKMLNDIFSEY-TIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLE 250 (283)
T ss_pred -----cccccCcccccCHHHhhhccccc-cchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHH
Confidence 124578999999999975 344 58999999999999999999999998888888777544 44556578999
Q ss_pred HHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 239 VRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 239 ~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
+++||.+||+.||++|||++++++.
T Consensus 251 l~~li~~cl~~dp~~Rps~~ell~~ 275 (283)
T PHA02988 251 IKCIVEACTSHDSIKRPNIKEILYN 275 (283)
T ss_pred HHHHHHHHhcCCcccCcCHHHHHHH
Confidence 9999999999999999999999863
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=362.85 Aligned_cols=254 Identities=20% Similarity=0.390 Sum_probs=206.8
Q ss_pred EEeeeeec--CceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 037702 14 LGRLLGQG--TFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAMEY 91 (448)
Q Consensus 14 ~~~~LG~G--~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 91 (448)
+.++||+| +|++||++.+..+|+.||+|.+..+.... ...+.+.+|+.+++.++||||+++++++..++..|+||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTN-EMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccH-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 56789999 78999999999999999999997654332 3456788999999999999999999999999999999999
Q ss_pred cCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccccc----
Q 037702 92 VRGGELFNKVAK---GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQ---- 164 (448)
Q Consensus 92 ~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~---- 164 (448)
+++|+|.+++.. ..+++..++.++.|++.||+|||++||+||||||+|||++.++.++++||+.+........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~ 160 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV 160 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence 999999999864 4589999999999999999999999999999999999999999999999986543211111
Q ss_pred -CCCccccCCCCcccchhhhhcc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCC------------
Q 037702 165 -DGLLHTTCGTPAYVAPEVINKR-GYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFK------------ 230 (448)
Q Consensus 165 -~~~~~~~~Gt~~Y~APEvl~~~-~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~------------ 230 (448)
........++..|+|||++.+. ...+.++|||||||++|+|++|+.||..............+..+
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (327)
T cd08227 161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEE 240 (327)
T ss_pred cccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhh
Confidence 0111234678889999998753 22358899999999999999999999875544333222211110
Q ss_pred ----------------------------------CCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccc
Q 037702 231 ----------------------------------CPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRK 268 (448)
Q Consensus 231 ----------------------------------~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 268 (448)
....+++++.+||.+||+.||++|||++++++||||+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 241 LTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred cccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence 01124678999999999999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-45 Score=351.14 Aligned_cols=255 Identities=33% Similarity=0.567 Sum_probs=222.8
Q ss_pred CCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 037702 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAM 89 (448)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (448)
++|++.+.||.|+||.||+|.+..+|+.||+|.+..... ......+.+|+.+++.++||||+++++++.++..+|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA--EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc--chHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 479999999999999999999999999999999976532 233466889999999999999999999999999999999
Q ss_pred eecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCcc
Q 037702 90 EYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLH 169 (448)
Q Consensus 90 E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~ 169 (448)
||+++++|.+++..+++++..++.++.|++.||.|||++|++||||+|+||+++.++.++|+|||++....... ....
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~~ 156 (274)
T cd06609 79 EYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--SKRN 156 (274)
T ss_pred EeeCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc--cccc
Confidence 99999999999988889999999999999999999999999999999999999999999999999998654332 1223
Q ss_pred ccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccC-CCCCC-CCHHHHHHHHhcc
Q 037702 170 TTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF-KCPNW-FPPEVRKLLSRIL 247 (448)
Q Consensus 170 ~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~-~s~~~~~li~~~L 247 (448)
...|++.|+|||.+.+..+ +.++|||||||++|+|++|..||...+.......+..... ..+.. +++++.+++.+||
T Consensus 157 ~~~~~~~y~~PE~~~~~~~-~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l 235 (274)
T cd06609 157 TFVGTPFWMAPEVIKQSGY-DEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCL 235 (274)
T ss_pred cccCCccccChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHh
Confidence 4578999999999987665 4889999999999999999999988776665555554433 33444 7899999999999
Q ss_pred CCCcCCCCCHHHHHhhhhcccc
Q 037702 248 DPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 248 ~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
..||++|||++++++||||++.
T Consensus 236 ~~~p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 236 NKDPKERPSAKELLKHKFIKKA 257 (274)
T ss_pred hCChhhCcCHHHHhhChhhcCC
Confidence 9999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-45 Score=393.89 Aligned_cols=265 Identities=27% Similarity=0.460 Sum_probs=219.0
Q ss_pred cccccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe-
Q 037702 3 KKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMAS- 81 (448)
Q Consensus 3 ~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~- 81 (448)
..+....++|++.+.||+|+||.||+|.+..++..||+|++....... .....+.+|+.+++.++||||++++++|..
T Consensus 6 ~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e-~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de 84 (1021)
T PTZ00266 6 DDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKE-REKSQLVIEVNVMRELKHKNIVRYIDRFLNK 84 (1021)
T ss_pred cCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCH-HHHHHHHHHHHHHHHcCCCCcCeEEEEEEec
Confidence 346678899999999999999999999999999999999997654433 345678899999999999999999998854
Q ss_pred -CCEEEEEEeecCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC-------CCEeecCCCCceEEcC----
Q 037702 82 -KTKIYFAMEYVRGGELFNKVAK-----GKLREEVARKYFQQLVDAVEFCHSR-------GVYHRDLKPENLLLDE---- 144 (448)
Q Consensus 82 -~~~~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~aL~yLH~~-------givHrDLkp~NILl~~---- 144 (448)
...+||||||+++|+|.+++.. +.+++..++.++.||+.||.|||+. +|+||||||+||||+.
T Consensus 85 ~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~ 164 (1021)
T PTZ00266 85 ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH 164 (1021)
T ss_pred CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence 4679999999999999998864 5799999999999999999999995 4999999999999964
Q ss_pred -------------CCCeEEeeccccccccccccCCCccccCCCCcccchhhhhcc-CCCCCcchHHHHHHHHHHHHhCCC
Q 037702 145 -------------NGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKR-GYDGAKADIWSCGVVLFVLLAGNL 210 (448)
Q Consensus 145 -------------~g~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~-~~~~~~sDiwSlGvil~elltG~~ 210 (448)
.+.+||+|||++...... ......+||+.|+|||++.+. ...+.++||||||||||+|++|..
T Consensus 165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~---s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~ 241 (1021)
T PTZ00266 165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIE---SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT 241 (1021)
T ss_pred cccccccccccCCCCceEEccCCcccccccc---ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCC
Confidence 235899999999754322 223456799999999998643 234588999999999999999999
Q ss_pred CCCCCcHH-HHHHHHhhccCCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccccc
Q 037702 211 PFYDSNLM-ELYKKITRAEFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYK 271 (448)
Q Consensus 211 Pf~~~~~~-~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~ 271 (448)
||...+.. .+...+...........++++.+||.+||..+|.+||++.++|.|||++....
T Consensus 242 PF~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~ 303 (1021)
T PTZ00266 242 PFHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGP 303 (1021)
T ss_pred CCCcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCC
Confidence 99865544 33333333322222457899999999999999999999999999999976543
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-45 Score=376.06 Aligned_cols=250 Identities=23% Similarity=0.361 Sum_probs=205.6
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYF 87 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 87 (448)
...+|.+.+.||+|+||.||+|.+..+++.||||.... ..+.+|+.+|++++||||+++++++......++
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~l 237 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCL 237 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence 35589999999999999999999999999999996421 234589999999999999999999999999999
Q ss_pred EEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccC
Q 037702 88 AMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQD 165 (448)
Q Consensus 88 V~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~ 165 (448)
|||++. ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 238 v~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 238 VLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred EEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 999995 688888864 46999999999999999999999999999999999999999999999999999865433222
Q ss_pred CCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCC--------cHHHHHHHHhhccC--------
Q 037702 166 GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDS--------NLMELYKKITRAEF-------- 229 (448)
Q Consensus 166 ~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~--------~~~~~~~~i~~~~~-------- 229 (448)
......+||+.|+|||++.+..++ .++|||||||+||||++|..|+... ...++.+.+.....
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~-~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYT-PSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCC-chHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 223346799999999999877764 8899999999999999987665321 12223332222111
Q ss_pred ---------------------CCCC-----CCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccc
Q 037702 230 ---------------------KCPN-----WFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRK 268 (448)
Q Consensus 230 ---------------------~~p~-----~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 268 (448)
..+. .+++++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 0111 24568999999999999999999999999999964
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-45 Score=356.88 Aligned_cols=257 Identities=30% Similarity=0.531 Sum_probs=220.2
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIY 86 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 86 (448)
-..++|++.+.||+|+||.||+|.+..+|+.||+|.+....... .+.+.+|+.+++.++||||+++++++......|
T Consensus 16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~ 92 (297)
T cd06656 16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELW 92 (297)
T ss_pred ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEE
Confidence 34589999999999999999999999999999999997654332 366789999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCC
Q 037702 87 FAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDG 166 (448)
Q Consensus 87 lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 166 (448)
+||||+++++|.+++.+..+++..+..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++....... .
T Consensus 93 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~--~ 170 (297)
T cd06656 93 VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--S 170 (297)
T ss_pred EeecccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc--c
Confidence 99999999999999988889999999999999999999999999999999999999999999999999987543221 1
Q ss_pred CccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhc---cCCCCCCCCHHHHHHH
Q 037702 167 LLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA---EFKCPNWFPPEVRKLL 243 (448)
Q Consensus 167 ~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~li 243 (448)
......|++.|+|||.+.+..+ +.++|+|||||++|+|++|..||...+.......+... ....|..+++.+.+|+
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 249 (297)
T cd06656 171 KRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFL 249 (297)
T ss_pred CcCcccCCccccCHHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHH
Confidence 2234578999999999977665 48899999999999999999999876543332222221 1234556789999999
Q ss_pred HhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 244 SRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 244 ~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
.+||..||.+||+++++++||||+..
T Consensus 250 ~~~l~~~p~~Rps~~~il~~~~~~~~ 275 (297)
T cd06656 250 NRCLEMDVDRRGSAKELLQHPFLKLA 275 (297)
T ss_pred HHHccCChhhCcCHHHHhcCchhccc
Confidence 99999999999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=347.93 Aligned_cols=254 Identities=29% Similarity=0.523 Sum_probs=215.5
Q ss_pred CeEEEeeeeecCceEEEEEEECCCCcEEEEEEeeccccc---chhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 037702 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIR---RVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYF 87 (448)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~---~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 87 (448)
+|++++.||+|+||.||+|.+ .+|+.+|+|.+...... .......+.+|+.+++.++|+||+++++++.+....|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 589999999999999999986 58899999998754321 12334678999999999999999999999999999999
Q ss_pred EEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccc---
Q 037702 88 AMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTR--- 163 (448)
Q Consensus 88 V~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~--- 163 (448)
||||++|++|.+++.+ +.+++..+..++.|++.||+|||+.||+|+||+|+||+++.++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 9999999999999976 679999999999999999999999999999999999999999999999999987542211
Q ss_pred -cCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhc---cCCCCCCCCHHH
Q 037702 164 -QDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA---EFKCPNWFPPEV 239 (448)
Q Consensus 164 -~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~ 239 (448)
.........|++.|+|||++.+..+. .++|+|||||++|+|++|..||...+.......+... ....|..++.++
T Consensus 160 ~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd06631 160 THSNMLKSMHGTPYWMAPEVINESGYG-RKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAA 238 (265)
T ss_pred cccccccccCCCccccChhhhcCCCCc-chhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHH
Confidence 11222345789999999999776664 8899999999999999999999876654444333332 224566688999
Q ss_pred HHHHHhccCCCcCCCCCHHHHHhhhhc
Q 037702 240 RKLLSRILDPNPSTRVTMAKLMENYWF 266 (448)
Q Consensus 240 ~~li~~~L~~dP~~Rpt~~eil~hp~~ 266 (448)
.++|.+||.+||.+||++.++++||||
T Consensus 239 ~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 239 IDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=351.45 Aligned_cols=253 Identities=30% Similarity=0.504 Sum_probs=212.5
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYF 87 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 87 (448)
..++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++.+...+..|+
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~l 83 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG---EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWI 83 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Confidence 45689999999999999999999999999999999875532 223567889999999999999999999999999999
Q ss_pred EEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCC
Q 037702 88 AMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDG 166 (448)
Q Consensus 88 V~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 166 (448)
||||+++++|.+++.. +.+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++....... .
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--~ 161 (267)
T cd06645 84 CMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI--A 161 (267)
T ss_pred EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc--c
Confidence 9999999999999865 689999999999999999999999999999999999999999999999999987543211 1
Q ss_pred CccccCCCCcccchhhhhc--cCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCC-----CCCCHHH
Q 037702 167 LLHTTCGTPAYVAPEVINK--RGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCP-----NWFPPEV 239 (448)
Q Consensus 167 ~~~~~~Gt~~Y~APEvl~~--~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p-----~~~s~~~ 239 (448)
......|++.|+|||++.. .+..+.++|+|||||++|+|++|..||...................+ ..++..+
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (267)
T cd06645 162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSF 241 (267)
T ss_pred ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHH
Confidence 1234579999999999742 22235789999999999999999999976554433333333332222 2367889
Q ss_pred HHHHHhccCCCcCCCCCHHHHHhhhh
Q 037702 240 RKLLSRILDPNPSTRVTMAKLMENYW 265 (448)
Q Consensus 240 ~~li~~~L~~dP~~Rpt~~eil~hp~ 265 (448)
.++|.+||..||++|||++++++|||
T Consensus 242 ~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 242 HHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHHHHccCCchhCcCHHHHhcCCC
Confidence 99999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=351.47 Aligned_cols=254 Identities=30% Similarity=0.508 Sum_probs=215.2
Q ss_pred CeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 037702 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAME 90 (448)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (448)
+|++.+.||+|+||.||+|.+..+|..||+|++....... .....+.+|+.+++.++||||+++++++......|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEG-GIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccc-hhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 6999999999999999999999999999999997654332 334678899999999999999999999999999999999
Q ss_pred ecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCc
Q 037702 91 YVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLL 168 (448)
Q Consensus 91 ~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 168 (448)
|+ +++|.+++.. +.+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++........ ...
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~ 157 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RLY 157 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-Ccc
Confidence 99 9999999864 5699999999999999999999999999999999999999999999999999886543221 223
Q ss_pred cccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhcc-------------------C
Q 037702 169 HTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAE-------------------F 229 (448)
Q Consensus 169 ~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-------------------~ 229 (448)
....|+..|+|||++.+....+.++|||||||++|+|++|.+||...+....+..+...- .
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI 237 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence 446799999999998765555688999999999999999998887766555444332210 0
Q ss_pred C-----------CCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcc
Q 037702 230 K-----------CPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFR 267 (448)
Q Consensus 230 ~-----------~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~ 267 (448)
. ..+..+..+.+||.+||..||.+|||++++++||||.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 0 0123568899999999999999999999999999983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=348.25 Aligned_cols=256 Identities=30% Similarity=0.528 Sum_probs=214.8
Q ss_pred CeEEEeeeeecCceEEEEEEECCCCcEEEEEEeeccccc-------chhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 037702 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIR-------RVGLIDQIKREISVMRLVRHPNIVQLYEVMASKT 83 (448)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~-------~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~ 83 (448)
+|.+.+.||.|+||.||+|.+..+|+.||+|.+...... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 689999999999999999999989999999998643211 1123457889999999999999999999999999
Q ss_pred EEEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccc
Q 037702 84 KIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQEST 162 (448)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~ 162 (448)
.+++||||+++++|.+++.. +.+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 99999999999999999976 78999999999999999999999999999999999999999999999999998754332
Q ss_pred ccCCCccccCCCCcccchhhhhccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhc--cCCCCC----CC
Q 037702 163 RQDGLLHTTCGTPAYVAPEVINKRG-YDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA--EFKCPN----WF 235 (448)
Q Consensus 163 ~~~~~~~~~~Gt~~Y~APEvl~~~~-~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~----~~ 235 (448)
..........|+..|+|||++.... ..+.++|+||||+++|+|++|..||...+.......+... ....+. .+
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (272)
T cd06629 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL 241 (272)
T ss_pred ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccC
Confidence 2222233457899999999987654 2358899999999999999999999766554444333222 222332 35
Q ss_pred CHHHHHHHHhccCCCcCCCCCHHHHHhhhhc
Q 037702 236 PPEVRKLLSRILDPNPSTRVTMAKLMENYWF 266 (448)
Q Consensus 236 s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 266 (448)
+.++.++|.+||.+||.+|||++++++|||+
T Consensus 242 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 242 SPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred CHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 8899999999999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-45 Score=347.57 Aligned_cols=247 Identities=38% Similarity=0.685 Sum_probs=219.3
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCCch
Q 037702 18 LGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGEL 97 (448)
Q Consensus 18 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 97 (448)
||.|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++.+.++...|++|||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 69999999999999999999999999876655445567899999999999999999999999999999999999999999
Q ss_pred HHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCccccCCCCc
Q 037702 98 FNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPA 176 (448)
Q Consensus 98 ~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~ 176 (448)
.+++.+ ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....... .....+|++.
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~ 157 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPE 157 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccccCCcC
Confidence 999976 568999999999999999999999999999999999999999999999999998654322 2234578999
Q ss_pred ccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCc--HHHHHHHHh--hccCCCCCCCCHHHHHHHHhccCCCcC
Q 037702 177 YVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSN--LMELYKKIT--RAEFKCPNWFPPEVRKLLSRILDPNPS 252 (448)
Q Consensus 177 Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~--~~~~~~~i~--~~~~~~p~~~s~~~~~li~~~L~~dP~ 252 (448)
|+|||.+....++ .++|+||||+++|+|++|..||.... ....+.++. ......|...++++.++|.+||..||.
T Consensus 158 ~~~PE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 236 (262)
T cd05572 158 YVAPEIILNKGYD-FSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPE 236 (262)
T ss_pred ccChhHhcCCCCC-ChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChh
Confidence 9999998776664 78999999999999999999998766 666677666 445667777899999999999999999
Q ss_pred CCCC-----HHHHHhhhhccc
Q 037702 253 TRVT-----MAKLMENYWFRK 268 (448)
Q Consensus 253 ~Rpt-----~~eil~hp~~~~ 268 (448)
+||+ ++|+++||||+.
T Consensus 237 ~R~~~~~~~~~~l~~~~~~~~ 257 (262)
T cd05572 237 ERLGNLKGGIKDIKKHKWFNG 257 (262)
T ss_pred hCcCCcccCHHHHhcChhhhC
Confidence 9999 999999999974
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=350.67 Aligned_cols=250 Identities=26% Similarity=0.469 Sum_probs=210.8
Q ss_pred CCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 037702 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAM 89 (448)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (448)
++|++.+.||+|+||.||+|.+..+++.||+|.+..... ......+.+|+.++++++||||+++++.+...+..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT--VELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCC--hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 468999999999999999999999999999999976532 233467889999999999999999999999999999999
Q ss_pred eecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCcc
Q 037702 90 EYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLH 169 (448)
Q Consensus 90 E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~ 169 (448)
||+++++|..+ +.+++..+..++.|++.||.|||++||+|+||||+|||++.++.++|+|||++...... ...
T Consensus 79 e~~~~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~----~~~ 151 (279)
T cd06619 79 EFMDGGSLDVY---RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAK 151 (279)
T ss_pred ecCCCCChHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc----ccc
Confidence 99999998654 45889999999999999999999999999999999999999999999999999754322 234
Q ss_pred ccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcH-------HHHHHHHhhccC-CC-CCCCCHHHH
Q 037702 170 TTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNL-------MELYKKITRAEF-KC-PNWFPPEVR 240 (448)
Q Consensus 170 ~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~-------~~~~~~i~~~~~-~~-p~~~s~~~~ 240 (448)
..+||+.|+|||++.+..+ +.++|+|||||++|+|++|..||..... ......+..... .. ....++++.
T Consensus 152 ~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (279)
T cd06619 152 TYVGTNAYMAPERISGEQY-GIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFV 230 (279)
T ss_pred CCCCChhhcCceeecCCCC-CCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHH
Confidence 5689999999999987666 4889999999999999999999965321 122222222221 11 234788999
Q ss_pred HHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 241 KLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
++|.+||..||.+||+++++++||||+..
T Consensus 231 ~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 231 HFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred HHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 99999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=342.40 Aligned_cols=252 Identities=30% Similarity=0.541 Sum_probs=222.1
Q ss_pred CeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 037702 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAME 90 (448)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (448)
+|++.+.||.|+||.||.+++..+++.+++|.+....... .....+.+|+.++++++|+||+++++++.+...++++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE-KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch-hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 6999999999999999999999999999999997665433 334678899999999999999999999999999999999
Q ss_pred ecCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCC
Q 037702 91 YVRGGELFNKVAK---GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGL 167 (448)
Q Consensus 91 ~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 167 (448)
|+++++|.+++.. ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++........ .
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--~ 157 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--M 157 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc--c
Confidence 9999999999965 3589999999999999999999999999999999999999999999999999876533221 2
Q ss_pred ccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCC-CCCCCCHHHHHHHHhc
Q 037702 168 LHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFK-CPNWFPPEVRKLLSRI 246 (448)
Q Consensus 168 ~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~li~~~ 246 (448)
.....|++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...+..+....+..+.+. .+..++.++.++|.+|
T Consensus 158 ~~~~~~~~~y~ape~~~~~~~-~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd08221 158 AETVVGTPYYMSPELCQGVKY-NFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSL 236 (256)
T ss_pred ccccCCCccccCHhhcCCCCC-CCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHH
Confidence 345679999999999876655 47899999999999999999999988887777777665543 3456889999999999
Q ss_pred cCCCcCCCCCHHHHHhhhhc
Q 037702 247 LDPNPSTRVTMAKLMENYWF 266 (448)
Q Consensus 247 L~~dP~~Rpt~~eil~hp~~ 266 (448)
|..||.+||++.++++|||+
T Consensus 237 l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 237 LQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred cccCcccCCCHHHHhhCcCC
Confidence 99999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=359.62 Aligned_cols=262 Identities=33% Similarity=0.578 Sum_probs=237.4
Q ss_pred ccccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 037702 4 KAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEVMASK 82 (448)
Q Consensus 4 ~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~ 82 (448)
+.-+...+|..+.+||+|+||+|-+|..+.|.+.||||++.++-+-..+.++.-..|-++|... +-|.+++++.+|.+-
T Consensus 343 ~d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTm 422 (683)
T KOG0696|consen 343 RDRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTM 422 (683)
T ss_pred ccceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhh
Confidence 3346677899999999999999999999999999999999988765555556666788888877 567899999999999
Q ss_pred CEEEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccc
Q 037702 83 TKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQES 161 (448)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~ 161 (448)
+.+|+||||+.||+|.-.|+. |++.|..|..|+..|+-||-|||++||++||||.+|||||.+|++||+|||++...
T Consensus 423 DRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn-- 500 (683)
T KOG0696|consen 423 DRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN-- 500 (683)
T ss_pred hheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccc--
Confidence 999999999999999888877 99999999999999999999999999999999999999999999999999999742
Q ss_pred cccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHH
Q 037702 162 TRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRK 241 (448)
Q Consensus 162 ~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ 241 (448)
........|.||||.|+|||++....| +..+|+||+||+||||++|.+||++.+..++++.|......+|..+|.++.+
T Consensus 501 i~~~~TTkTFCGTPdYiAPEIi~YqPY-gksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~ 579 (683)
T KOG0696|consen 501 IFDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVA 579 (683)
T ss_pred ccCCcceeeecCCCcccccceEEeccc-ccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHHH
Confidence 223344568899999999999988887 5889999999999999999999999999999999999999999999999999
Q ss_pred HHHhccCCCcCCCCCH-----HHHHhhhhccc
Q 037702 242 LLSRILDPNPSTRVTM-----AKLMENYWFRK 268 (448)
Q Consensus 242 li~~~L~~dP~~Rpt~-----~eil~hp~~~~ 268 (448)
+++.+|.+.|.+|... .+|-.||||+.
T Consensus 580 ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~ 611 (683)
T KOG0696|consen 580 ICKGLLTKHPGKRLGCGPEGERDIREHPFFRR 611 (683)
T ss_pred HHHHHhhcCCccccCCCCccccchhhCcchhh
Confidence 9999999999999753 68999999976
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=351.48 Aligned_cols=254 Identities=28% Similarity=0.420 Sum_probs=216.9
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCC-----cEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTG-----QSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMAS 81 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g-----~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~ 81 (448)
+..++|++.+.||+|+||.||+|.+...+ ..||+|.+.... .......+.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~ 79 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK 79 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcC
Confidence 34678999999999999999999976555 679999986443 22345678899999999999999999999999
Q ss_pred CCEEEEEEeecCCCchHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcC
Q 037702 82 KTKIYFAMEYVRGGELFNKVAK-----------------GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDE 144 (448)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~ 144 (448)
....|++|||+++|+|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~ 159 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGE 159 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcC
Confidence 9999999999999999999864 34788899999999999999999999999999999999999
Q ss_pred CCCeEEeeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHH
Q 037702 145 NGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKK 223 (448)
Q Consensus 145 ~g~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~ 223 (448)
++.++|+|||++................+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.+..+....
T Consensus 160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05048 160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKF-TTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM 238 (283)
T ss_pred CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcC-chhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 99999999999875432222222334567899999999876666 488999999999999998 9999998888888777
Q ss_pred HhhccC-CCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 224 ITRAEF-KCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 224 i~~~~~-~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
+..... ..|..+|+++.+|+.+||+.||.+||++.+|+++
T Consensus 239 i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 239 IRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 765543 4567789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=350.70 Aligned_cols=254 Identities=30% Similarity=0.492 Sum_probs=216.6
Q ss_pred CeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 037702 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAME 90 (448)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (448)
-|++.+.||+|+||.||+|.+..++..+++|.+.... ....+.+.+|+.+++.++||||+++++++..+...|+|||
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e 82 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 82 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEE
Confidence 3788999999999999999999999999999986543 2334678889999999999999999999999999999999
Q ss_pred ecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCc
Q 037702 91 YVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLL 168 (448)
Q Consensus 91 ~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 168 (448)
|+++++|...+.. +++++..+..++.|++.||.|||+.|++||||||+|||++.++.+||+|||++....... ...
T Consensus 83 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~~ 160 (282)
T cd06643 83 FCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRR 160 (282)
T ss_pred ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccc--ccc
Confidence 9999999888754 579999999999999999999999999999999999999999999999999987543211 122
Q ss_pred cccCCCCcccchhhhhc----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhcc---CCCCCCCCHHHHH
Q 037702 169 HTTCGTPAYVAPEVINK----RGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAE---FKCPNWFPPEVRK 241 (448)
Q Consensus 169 ~~~~Gt~~Y~APEvl~~----~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~ 241 (448)
....||+.|+|||++.. ....+.++|||||||++|+|++|.+||...+..+....+.... ...|..++.++.+
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKD 240 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHH
Confidence 34578999999999842 1222468999999999999999999998877666655554432 2345568899999
Q ss_pred HHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 242 LLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
||.+||..||.+||+++++++||||+..
T Consensus 241 li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 241 FLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred HHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 9999999999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-45 Score=368.61 Aligned_cols=253 Identities=23% Similarity=0.421 Sum_probs=208.7
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCC-----cEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTG-----QSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEVMA 80 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g-----~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~ 80 (448)
...++|++++.||+|+||.||+|++..+| ..||+|.+...... ...+.+.+|+.+++.+ +||||+++++++.
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~il~~l~~h~nIv~~~~~~~ 112 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT--DEREALMSELKILSHLGQHKNIVNLLGACT 112 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH--HHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence 44668999999999999999999875444 57999999755322 2346788999999999 8999999999999
Q ss_pred eCCEEEEEEeecCCCchHHHHhc---------------------------------------------------------
Q 037702 81 SKTKIYFAMEYVRGGELFNKVAK--------------------------------------------------------- 103 (448)
Q Consensus 81 ~~~~~~lV~E~~~gg~L~~~i~~--------------------------------------------------------- 103 (448)
.....|+||||+++|+|.+++..
T Consensus 113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (374)
T cd05106 113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS 192 (374)
T ss_pred CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence 99999999999999999998743
Q ss_pred --------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCcc
Q 037702 104 --------------GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLH 169 (448)
Q Consensus 104 --------------~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~ 169 (448)
.++++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.............
T Consensus 193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 136788899999999999999999999999999999999999999999999987543222111112
Q ss_pred ccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhc--cCCCCCCCCHHHHHHHHhc
Q 037702 170 TTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA--EFKCPNWFPPEVRKLLSRI 246 (448)
Q Consensus 170 ~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~ 246 (448)
+..+++.|+|||++.+..+ +.++|||||||++|+|++ |+.||........+...... ....|..+++++.++|.+|
T Consensus 273 ~~~~~~~y~aPE~~~~~~~-~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 351 (374)
T cd05106 273 NARLPVKWMAPESIFDCVY-TVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMC 351 (374)
T ss_pred CCCCccceeCHHHhcCCCC-CccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHH
Confidence 2345678999999976665 488999999999999997 99999876554433333333 3456677899999999999
Q ss_pred cCCCcCCCCCHHHHHh
Q 037702 247 LDPNPSTRVTMAKLME 262 (448)
Q Consensus 247 L~~dP~~Rpt~~eil~ 262 (448)
|+.||.+|||+.++++
T Consensus 352 l~~dp~~RPs~~~l~~ 367 (374)
T cd05106 352 WNLEPTERPTFSQISQ 367 (374)
T ss_pred cCCChhhCcCHHHHHH
Confidence 9999999999999986
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=343.48 Aligned_cols=252 Identities=30% Similarity=0.593 Sum_probs=220.9
Q ss_pred CeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 037702 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAME 90 (448)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (448)
+|++.+.||+|+||.||.+.+..+|+.||+|.+....... .....+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSP-KEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCCh-HHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 6999999999999999999999999999999997654332 234678899999999999999999999999999999999
Q ss_pred ecCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCC
Q 037702 91 YVRGGELFNKVAK---GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGL 167 (448)
Q Consensus 91 ~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 167 (448)
|+++++|.+.+.. ..+++..+..++.|++.||.|||++|++|+||+|+|||++.++.++|+|||++........ .
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~ 157 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE--L 157 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh--h
Confidence 9999999999864 2589999999999999999999999999999999999999999999999999975433221 1
Q ss_pred ccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccC-CCCCCCCHHHHHHHHhc
Q 037702 168 LHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF-KCPNWFPPEVRKLLSRI 246 (448)
Q Consensus 168 ~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~ 246 (448)
.....|++.|+|||++.+..+ +.++|+|||||++|+|++|..||...+..+....+..+.. ..|..++.++.++|.+|
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 236 (256)
T cd08218 158 ARTCIGTPYYLSPEICENRPY-NNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQL 236 (256)
T ss_pred hhhccCCccccCHHHhCCCCC-CCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHH
Confidence 223468999999999876655 4789999999999999999999988887777777666554 35667899999999999
Q ss_pred cCCCcCCCCCHHHHHhhhhc
Q 037702 247 LDPNPSTRVTMAKLMENYWF 266 (448)
Q Consensus 247 L~~dP~~Rpt~~eil~hp~~ 266 (448)
|+.+|.+||++.++++||||
T Consensus 237 l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 237 FKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred hhCChhhCcCHHHHhhCcCC
Confidence 99999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-45 Score=352.58 Aligned_cols=254 Identities=30% Similarity=0.475 Sum_probs=214.2
Q ss_pred CCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 037702 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAM 89 (448)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (448)
++|++.+.||+|+||.||+|.+..+|+.||+|.+.+..... ...+.+.+|+.+++.++||||+++++++..+...|+||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 57999999999999999999999899999999987644332 34467889999999999999999999999999999999
Q ss_pred eecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCc
Q 037702 90 EYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLL 168 (448)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 168 (448)
||++++.|..+... +.+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++....... ...
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~--~~~ 157 (286)
T cd07846 80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--EVY 157 (286)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc--ccc
Confidence 99999999887765 469999999999999999999999999999999999999999999999999987543322 222
Q ss_pred cccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhcc-------------------C
Q 037702 169 HTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAE-------------------F 229 (448)
Q Consensus 169 ~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-------------------~ 229 (448)
....|+..|+|||++.+....+.++|||||||++|+|++|++||......+....+.... .
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence 345689999999998765555688999999999999999999998765544333322110 0
Q ss_pred ------------CCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhc
Q 037702 230 ------------KCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWF 266 (448)
Q Consensus 230 ------------~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 266 (448)
..++.++..+.+|+.+||..||.+||++.++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0123468889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=351.88 Aligned_cols=259 Identities=30% Similarity=0.455 Sum_probs=216.8
Q ss_pred CeEEEeeeeecCceEEEEEEECCCCcEEEEEEeeccccc--chhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 037702 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIR--RVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFA 88 (448)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~--~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 88 (448)
+|++.+.||+|+||.||+|.+..+|+.||||.+...... .......+..|+.+++.++||||+++++++.+...+|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 589999999999999999999999999999999766443 122345677899999999999999999999999999999
Q ss_pred EeecCCCchHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCC
Q 037702 89 MEYVRGGELFNKVAKG--KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDG 166 (448)
Q Consensus 89 ~E~~~gg~L~~~i~~~--~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 166 (448)
|||+ +|+|.+++... .+++..+..++.||++||.|||++|++||||||+|||++.++.++|+|||++....... .
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--~ 157 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN--R 157 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC--c
Confidence 9999 88999999763 59999999999999999999999999999999999999999999999999997654321 1
Q ss_pred CccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccC-----------------
Q 037702 167 LLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF----------------- 229 (448)
Q Consensus 167 ~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~----------------- 229 (448)
......+++.|+|||.+.+....+.++|+|||||++|+|++|.+||.+.+..+.+.++...-.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence 223345788999999986555556889999999999999999888887766555544432100
Q ss_pred ------C-----CCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccccccc
Q 037702 230 ------K-----CPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYKK 272 (448)
Q Consensus 230 ------~-----~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~ 272 (448)
. .....+.++.++|.+||.+||++|||+.+++.||||++....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~ 291 (298)
T cd07841 238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAP 291 (298)
T ss_pred cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCC
Confidence 0 012346889999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=350.54 Aligned_cols=248 Identities=31% Similarity=0.514 Sum_probs=204.2
Q ss_pred eeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHH---hCCCCCcceEEEEEEeCCEEEEEEeecC
Q 037702 17 LLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMR---LVRHPNIVQLYEVMASKTKIYFAMEYVR 93 (448)
Q Consensus 17 ~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~---~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 93 (448)
.||+|+||.||+|.+..+|+.+|+|.+.+.............+|..+++ ..+||||+.+++++..++..|+||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999999999999999998765433222233444544444 3479999999999999999999999999
Q ss_pred CCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCccccC
Q 037702 94 GGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTC 172 (448)
Q Consensus 94 gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~ 172 (448)
||+|.+++.. +.+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||++...... ......
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~----~~~~~~ 156 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASV 156 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc----CccCcC
Confidence 9999998865 67999999999999999999999999999999999999999999999999998644321 123457
Q ss_pred CCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCc---HHHHHHHHhhccCCCCCCCCHHHHHHHHhccCC
Q 037702 173 GTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSN---LMELYKKITRAEFKCPNWFPPEVRKLLSRILDP 249 (448)
Q Consensus 173 Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~---~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~ 249 (448)
||+.|+|||++......+.++||||+||++|+|++|..||.... ...............|..+++++.++|.+||..
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 236 (279)
T cd05633 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQR 236 (279)
T ss_pred CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcC
Confidence 99999999998643334588999999999999999999997532 222222223334556777899999999999999
Q ss_pred CcCCCC-----CHHHHHhhhhccc
Q 037702 250 NPSTRV-----TMAKLMENYWFRK 268 (448)
Q Consensus 250 dP~~Rp-----t~~eil~hp~~~~ 268 (448)
||.+|| |+.++++||||+.
T Consensus 237 ~p~~R~~~~~~~~~~~~~h~~~~~ 260 (279)
T cd05633 237 DVSKRLGCLGRGAQEVKEHVFFKG 260 (279)
T ss_pred CHHHhcCCCCCCHHHHHhCccccC
Confidence 999999 6999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=348.10 Aligned_cols=253 Identities=31% Similarity=0.498 Sum_probs=211.5
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEe-----
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEVMAS----- 81 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~----- 81 (448)
..+.|++.+.||+|+||.||+|.+..+++.||+|.+..... ....+.+|+.+++.+ +||||+++++++..
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 79 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence 45789999999999999999999999999999999975432 235678899999998 79999999999865
Q ss_pred -CCEEEEEEeecCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccc
Q 037702 82 -KTKIYFAMEYVRGGELFNKVAK---GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSA 157 (448)
Q Consensus 82 -~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~ 157 (448)
...+|+||||+++++|.+++.. ..+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++.
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 80 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred CCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCce
Confidence 3568999999999999999875 358999999999999999999999999999999999999999999999999987
Q ss_pred cccccccCCCccccCCCCcccchhhhhcc----CCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccC--CC
Q 037702 158 LQESTRQDGLLHTTCGTPAYVAPEVINKR----GYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF--KC 231 (448)
Q Consensus 158 ~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~----~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--~~ 231 (448)
...... ....+..|++.|+|||++... ...+.++|||||||++|+|++|..||...........+..... ..
T Consensus 160 ~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 237 (272)
T cd06637 160 QLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLK 237 (272)
T ss_pred eccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCC
Confidence 543221 223456799999999998532 1234789999999999999999999987655544443333222 12
Q ss_pred CCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhc
Q 037702 232 PNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWF 266 (448)
Q Consensus 232 p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 266 (448)
+..++.++.+||.+||..||.+|||+.++++||||
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 238 SKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 33578999999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=352.14 Aligned_cols=257 Identities=31% Similarity=0.477 Sum_probs=218.1
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIY 86 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 86 (448)
...++|++.+.||.|+||.||+|.+..++..+|+|.+.... ....+.+.+|+.+++.++||||+++++.+..+..+|
T Consensus 9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (292)
T cd06644 9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLW 85 (292)
T ss_pred CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEE
Confidence 34567999999999999999999999999999999987542 234567888999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccccc
Q 037702 87 FAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQ 164 (448)
Q Consensus 87 lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~ 164 (448)
+||||++|++|..++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 86 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~- 164 (292)
T cd06644 86 IMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL- 164 (292)
T ss_pred EEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccc-
Confidence 99999999999888753 568999999999999999999999999999999999999999999999999986432211
Q ss_pred CCCccccCCCCcccchhhhhcc----CCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccC---CCCCCCCH
Q 037702 165 DGLLHTTCGTPAYVAPEVINKR----GYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF---KCPNWFPP 237 (448)
Q Consensus 165 ~~~~~~~~Gt~~Y~APEvl~~~----~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~ 237 (448)
.......|++.|+|||++... ...+.++|+|||||++|+|++|..||...+....+.++..... ..+..++.
T Consensus 165 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (292)
T cd06644 165 -QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSM 243 (292)
T ss_pred -cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCH
Confidence 112345689999999998532 1224689999999999999999999988776665555544322 33556789
Q ss_pred HHHHHHHhccCCCcCCCCCHHHHHhhhhccc
Q 037702 238 EVRKLLSRILDPNPSTRVTMAKLMENYWFRK 268 (448)
Q Consensus 238 ~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 268 (448)
++.++|.+||..||++||+++++++||||..
T Consensus 244 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 274 (292)
T cd06644 244 EFRDFLKTALDKHPETRPSAAQLLEHPFVSS 274 (292)
T ss_pred HHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 9999999999999999999999999999965
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-48 Score=356.18 Aligned_cols=253 Identities=28% Similarity=0.488 Sum_probs=223.3
Q ss_pred CCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 037702 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAM 89 (448)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (448)
+-|.++..||+|+||.||+|.++.+|+.+|||.+..+ ..++.+.+||.+|++++.|++|++|+.|..+..+|+||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVM 107 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVM 107 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeeh
Confidence 3477889999999999999999999999999998765 33577889999999999999999999999999999999
Q ss_pred eecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCC
Q 037702 90 EYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGL 167 (448)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 167 (448)
|||..|++.+.++. ..++|.++..+++..+.||+|||...-+|||||..||||+.+|..||+|||.|......- ..
T Consensus 108 EYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM--AK 185 (502)
T KOG0574|consen 108 EYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM--AK 185 (502)
T ss_pred hhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhH--Hh
Confidence 99999999999864 579999999999999999999999999999999999999999999999999997543321 22
Q ss_pred ccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhc---cCCCCCCCCHHHHHHHH
Q 037702 168 LHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA---EFKCPNWFPPEVRKLLS 244 (448)
Q Consensus 168 ~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~li~ 244 (448)
..+..|||.|||||++..-||+ .++||||||++..||..|++||.+-..+...--|... .+..|...|.++.+|++
T Consensus 186 RNTVIGTPFWMAPEVI~EIGY~-~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~ 264 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEEIGYD-TKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIR 264 (502)
T ss_pred hCccccCcccccHHHHHHhccc-hhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHH
Confidence 3578999999999999999998 7899999999999999999999887765543333222 34456668899999999
Q ss_pred hccCCCcCCCCCHHHHHhhhhccccc
Q 037702 245 RILDPNPSTRVTMAKLMENYWFRKGY 270 (448)
Q Consensus 245 ~~L~~dP~~Rpt~~eil~hp~~~~~~ 270 (448)
.||.++|++|-|+.++++|||+++..
T Consensus 265 ~CLiK~PE~R~TA~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 265 SCLIKKPEERKTALRLCEHTFIKNAP 290 (502)
T ss_pred HHhcCCHHHHHHHHHHhhhhhhcCCC
Confidence 99999999999999999999998753
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=351.83 Aligned_cols=255 Identities=28% Similarity=0.510 Sum_probs=216.8
Q ss_pred CCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 037702 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAM 89 (448)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (448)
++|++.+.||+|+||.||+|.+..+|..||+|.+.... .......+.+|+.++++++||||+++++.+...+.+|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 47999999999999999999999999999999986542 2233467889999999999999999999999999999999
Q ss_pred eecCCCchHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH-CCCEeecCCCCceEEcCCCCeEEeecccccccccccc
Q 037702 90 EYVRGGELFNKVAKG----KLREEVARKYFQQLVDAVEFCHS-RGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQ 164 (448)
Q Consensus 90 E~~~gg~L~~~i~~~----~l~e~~~~~~~~qll~aL~yLH~-~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~ 164 (448)
||++|++|..++..+ .+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||++.....
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--- 155 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA--- 155 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccC---
Confidence 999999999888764 79999999999999999999997 5999999999999999999999999999875422
Q ss_pred CCCccccCCCCcccchhhhhccCC-----CCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH---Hhhc-cCCCCCCC
Q 037702 165 DGLLHTTCGTPAYVAPEVINKRGY-----DGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKK---ITRA-EFKCPNWF 235 (448)
Q Consensus 165 ~~~~~~~~Gt~~Y~APEvl~~~~~-----~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~---i~~~-~~~~p~~~ 235 (448)
....+..|++.|+|||++.+... .+.++|+|||||++|+|++|..||........+.. +... ....|..+
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd06622 156 -SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGY 234 (286)
T ss_pred -CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCccc
Confidence 22345678999999999854332 25789999999999999999999976655444333 2222 23456668
Q ss_pred CHHHHHHHHhccCCCcCCCCCHHHHHhhhhccccc
Q 037702 236 PPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGY 270 (448)
Q Consensus 236 s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 270 (448)
++++.+||.+||..||.+||++++++.||||....
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 235 SDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 99999999999999999999999999999997643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=352.96 Aligned_cols=253 Identities=19% Similarity=0.290 Sum_probs=205.6
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECC----------------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCC
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLK----------------TGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHP 70 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~----------------~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hp 70 (448)
+..++|++.+.||+|+||.||+|.+.. ++..||+|++..... ......+.+|+.+++.++||
T Consensus 2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~ 79 (304)
T cd05096 2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDAN--KNARNDFLKEVKILSRLKDP 79 (304)
T ss_pred CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCC--HHHHHHHHHHHHHHhhcCCC
Confidence 346799999999999999999998532 345799999875432 23346788999999999999
Q ss_pred CcceEEEEEEeCCEEEEEEeecCCCchHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCC
Q 037702 71 NIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKG--------------------KLREEVARKYFQQLVDAVEFCHSRGV 130 (448)
Q Consensus 71 nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~--------------------~l~e~~~~~~~~qll~aL~yLH~~gi 130 (448)
||+++++++.+.+..|+||||+++|+|.+++... .+++..+..++.||+.||.|||++||
T Consensus 80 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i 159 (304)
T cd05096 80 NIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF 159 (304)
T ss_pred CeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCc
Confidence 9999999999999999999999999999988542 25677889999999999999999999
Q ss_pred EeecCCCCceEEcCCCCeEEeeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh--C
Q 037702 131 YHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA--G 208 (448)
Q Consensus 131 vHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt--G 208 (448)
+||||||+|||++.++.+||+|||++................+++.|+|||++....+ +.++|||||||++|+|++ +
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~~ 238 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKF-TTASDVWAFGVTLWEILMLCK 238 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCC-CchhhhHHHHHHHHHHHHccC
Confidence 9999999999999999999999999975432221112233456889999999876655 588999999999999986 6
Q ss_pred CCCCCCCcHHHHHHHHhh--------ccCCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHh
Q 037702 209 NLPFYDSNLMELYKKITR--------AEFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 209 ~~Pf~~~~~~~~~~~i~~--------~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 262 (448)
..||...+..+....+.. .....|+.+++.+.+||.+||..||.+|||+.+|.+
T Consensus 239 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 239 EQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred CCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 788887665554443321 112345668899999999999999999999999954
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=345.27 Aligned_cols=256 Identities=29% Similarity=0.531 Sum_probs=214.2
Q ss_pred CCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeeccccc--chhHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEE
Q 037702 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIR--RVGLIDQIKREISVMRLVRHPNIVQLYEVMAS--KTKI 85 (448)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~--~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~~~~ 85 (448)
.+|++.+.||+|+||.||+|.+..+|..||+|.+...... .......+.+|+.+++.++||||+++++++.. ...+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3799999999999999999999999999999998754322 22334678899999999999999999998865 4678
Q ss_pred EEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccc-
Q 037702 86 YFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTR- 163 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~- 163 (448)
+++|||+++++|.+++.. +.+++...+.++.|++.||+|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 999999999999999876 578999999999999999999999999999999999999999999999999987543211
Q ss_pred cCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhc--cCCCCCCCCHHHHH
Q 037702 164 QDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA--EFKCPNWFPPEVRK 241 (448)
Q Consensus 164 ~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~ 241 (448)
.........|+..|+|||.+.+..+ +.++||||+||++|+|++|+.||...........+... ....|..+++.+++
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (266)
T cd06651 162 SGTGIRSVTGTPYWMSPEVISGEGY-GRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARD 240 (266)
T ss_pred cCCccccCCccccccCHHHhCCCCC-CchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHH
Confidence 1111233568999999999977655 47899999999999999999999876655444433322 34456678899999
Q ss_pred HHHhccCCCcCCCCCHHHHHhhhhcc
Q 037702 242 LLSRILDPNPSTRVTMAKLMENYWFR 267 (448)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~hp~~~ 267 (448)
+| +||..||++||+++++++||||+
T Consensus 241 li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 241 FL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HH-HHhcCChhhCcCHHHHhcCcccc
Confidence 99 67778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=347.21 Aligned_cols=256 Identities=28% Similarity=0.533 Sum_probs=215.1
Q ss_pred CeEEEeeeeecCceEEEEEEECCCCcEEEEEEeeccccc---chhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 037702 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIR---RVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYF 87 (448)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~---~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 87 (448)
+|+.++.||+|+||.||+|.+..+|+.||+|++...... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 588999999999999999999999999999999754321 12245788999999999999999999999999999999
Q ss_pred EEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCC-CeEEeecccccccccccc-
Q 037702 88 AMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENG-DLKISDFGLSALQESTRQ- 164 (448)
Q Consensus 88 V~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g-~lkl~DFGla~~~~~~~~- 164 (448)
||||++|++|.+++.. +++++..+..++.||+.||.|||++|++||||+|+||+++.++ .+||+|||++........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence 9999999999999875 6799999999999999999999999999999999999998876 599999999876543211
Q ss_pred -CCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHh-----hccCCCCCCCCHH
Q 037702 165 -DGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKIT-----RAEFKCPNWFPPE 238 (448)
Q Consensus 165 -~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~-----~~~~~~p~~~s~~ 238 (448)
........||..|+|||++.+..+ +.++|+||+||++|+|++|..||...+.......+. ......|..++++
T Consensus 161 ~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (268)
T cd06630 161 AGEFQGQLLGTIAFMAPEVLRGEQY-GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPG 239 (268)
T ss_pred CCccccccccccceeCHhHhccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHH
Confidence 111223468999999999877665 488999999999999999999997554332222221 1233456678899
Q ss_pred HHHHHHhccCCCcCCCCCHHHHHhhhhcc
Q 037702 239 VRKLLSRILDPNPSTRVTMAKLMENYWFR 267 (448)
Q Consensus 239 ~~~li~~~L~~dP~~Rpt~~eil~hp~~~ 267 (448)
+.+++.+||..||.+||++.++++||||+
T Consensus 240 ~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 240 LRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 99999999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=343.41 Aligned_cols=256 Identities=31% Similarity=0.543 Sum_probs=214.1
Q ss_pred CCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccc--cchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEE
Q 037702 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKI--RRVGLIDQIKREISVMRLVRHPNIVQLYEVMAS--KTKI 85 (448)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~--~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~~~~ 85 (448)
.+|++.+.||+|+||.||.|.+..+|..||||.+..... ......+.+.+|+.+++.++||||+++++++.+ ...+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 579999999999999999999999999999999864322 122345678899999999999999999998866 3578
Q ss_pred EEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccccc
Q 037702 86 YFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQ 164 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~ 164 (448)
|++|||++|++|.+++.. +.+++..+..++.|++.||.|||++|++|+||||+|||++.++.++|+|||++........
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 899999999999999876 5789999999999999999999999999999999999999999999999999875432211
Q ss_pred -CCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhc--cCCCCCCCCHHHHH
Q 037702 165 -DGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA--EFKCPNWFPPEVRK 241 (448)
Q Consensus 165 -~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~ 241 (448)
........|+..|+|||++.+..+ +.++|||||||++|+|++|+.||...+.......+... ....|..++..+.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISGEGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRD 240 (265)
T ss_pred cccccccCCCCccccChhhhcCCCC-CcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHH
Confidence 112234568999999999977665 48899999999999999999999876554444443322 23356667889999
Q ss_pred HHHhccCCCcCCCCCHHHHHhhhhcc
Q 037702 242 LLSRILDPNPSTRVTMAKLMENYWFR 267 (448)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~hp~~~ 267 (448)
+|.+||. +|.+||+++++++|||+.
T Consensus 241 ~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 241 FLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 9999995 899999999999999973
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=349.27 Aligned_cols=256 Identities=33% Similarity=0.684 Sum_probs=227.7
Q ss_pred CCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEE
Q 037702 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR-HPNIVQLYEVMASKTKIYFA 88 (448)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lV 88 (448)
++|++.+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.++ ||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999999999999999998765554445577889999999998 99999999999999999999
Q ss_pred EeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccC--
Q 037702 89 MEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQD-- 165 (448)
Q Consensus 89 ~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~-- 165 (448)
|||+++++|.+++.+ +.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~ 160 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence 999999999999977 58999999999999999999999999999999999999999999999999998755432211
Q ss_pred ----------------CCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccC
Q 037702 166 ----------------GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF 229 (448)
Q Consensus 166 ----------------~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~ 229 (448)
.......|+..|+|||++....+ +.++|+||||++++++++|..||...+....+..+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 239 (280)
T cd05581 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA-GKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEY 239 (280)
T ss_pred CCCCCccccccccccccccccccCCccccCHHHhCCCCC-ChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCC
Confidence 12234468899999999876554 5789999999999999999999998887777777777778
Q ss_pred CCCCCCCHHHHHHHHhccCCCcCCCCCH----HHHHhhhhc
Q 037702 230 KCPNWFPPEVRKLLSRILDPNPSTRVTM----AKLMENYWF 266 (448)
Q Consensus 230 ~~p~~~s~~~~~li~~~L~~dP~~Rpt~----~eil~hp~~ 266 (448)
..|..+++.+.+||.+||+.||.+|||+ +++++||||
T Consensus 240 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 240 SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 8888899999999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-44 Score=340.67 Aligned_cols=251 Identities=33% Similarity=0.558 Sum_probs=219.5
Q ss_pred CeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 037702 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAME 90 (448)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (448)
+|++.+.||+|+||.||+|.+..+++.+|+|.+....... .....+.+|+.+++.++||||+++++.+...+..++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccccc-HHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 6999999999999999999999999999999998765443 335778999999999999999999999999999999999
Q ss_pred ecCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCC-CeEEeeccccccccccccCC
Q 037702 91 YVRGGELFNKVAK---GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENG-DLKISDFGLSALQESTRQDG 166 (448)
Q Consensus 91 ~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g-~lkl~DFGla~~~~~~~~~~ 166 (448)
|+++++|.+++.. ..+++..+..++.|++.||.|||++|++||||+|+||+++.++ .+||+|||++.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~--- 156 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS--- 156 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc---
Confidence 9999999999975 2489999999999999999999999999999999999998655 58999999998653322
Q ss_pred CccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccC-CCCCCCCHHHHHHHHh
Q 037702 167 LLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF-KCPNWFPPEVRKLLSR 245 (448)
Q Consensus 167 ~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~ 245 (448)
......|++.|+|||.+.+..+ +.++||||||+++|+|++|..||...+.......+..... ..+..+++++.+++.+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 235 (256)
T cd08220 157 KAYTVVGTPCYISPELCEGKPY-NQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILS 235 (256)
T ss_pred cccccccCCcccCchhccCCCC-CcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHH
Confidence 1234568999999999976555 4789999999999999999999988877777666655443 4666789999999999
Q ss_pred ccCCCcCCCCCHHHHHhhhhc
Q 037702 246 ILDPNPSTRVTMAKLMENYWF 266 (448)
Q Consensus 246 ~L~~dP~~Rpt~~eil~hp~~ 266 (448)
||.+||.+|||+.++++||||
T Consensus 236 ~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 236 MLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HccCChhhCCCHHHHhhCCCC
Confidence 999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=346.79 Aligned_cols=256 Identities=29% Similarity=0.593 Sum_probs=218.7
Q ss_pred CeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEEEE
Q 037702 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR---HPNIVQLYEVMASKTKIYF 87 (448)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~---hpnIv~l~~~~~~~~~~~l 87 (448)
.|++.+.||+|+||.||+|.+..+|+.||+|.+...... .....+.+|+.+++.++ |||++++++++..+...|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPD--DDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCc--hhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 588899999999999999999999999999998754322 23467889999999996 9999999999999999999
Q ss_pred EEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCC
Q 037702 88 AMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGL 167 (448)
Q Consensus 88 V~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 167 (448)
||||++|++|.+++..+.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++....... ..
T Consensus 80 v~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~ 157 (277)
T cd06917 80 IMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS--SK 157 (277)
T ss_pred EEecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc--cc
Confidence 9999999999999988889999999999999999999999999999999999999999999999999987654322 12
Q ss_pred ccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccC-CCCC-CCCHHHHHHHHh
Q 037702 168 LHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF-KCPN-WFPPEVRKLLSR 245 (448)
Q Consensus 168 ~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~-~~s~~~~~li~~ 245 (448)
.....|++.|+|||.+......+.++|+|||||++|+|++|..||...+.......+..... .++. .++.++.+++.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 237 (277)
T cd06917 158 RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAA 237 (277)
T ss_pred cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHHH
Confidence 23457999999999986544446889999999999999999999987766554444333322 2233 278899999999
Q ss_pred ccCCCcCCCCCHHHHHhhhhccccc
Q 037702 246 ILDPNPSTRVTMAKLMENYWFRKGY 270 (448)
Q Consensus 246 ~L~~dP~~Rpt~~eil~hp~~~~~~ 270 (448)
||..||++||++.+++.|+||+...
T Consensus 238 ~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 238 CLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred HcCCCcccCcCHHHHhhChHhhccc
Confidence 9999999999999999999997654
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=365.35 Aligned_cols=254 Identities=25% Similarity=0.399 Sum_probs=207.9
Q ss_pred cccCCeEEEeeeeecCceEEEEEEE-----CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRN-----LKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEVMA 80 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~-----~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~ 80 (448)
+..++|++++.||+|+||.||+|.+ ..++..||||++...... ...+.+.+|+.+++.+ +||||+++++++.
T Consensus 32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~ 109 (375)
T cd05104 32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHL--TEREALMSELKVLSYLGNHINIVNLLGACT 109 (375)
T ss_pred cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCc--HHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence 3456899999999999999999974 346778999998644322 2346788999999999 8999999999999
Q ss_pred eCCEEEEEEeecCCCchHHHHhcC--------------------------------------------------------
Q 037702 81 SKTKIYFAMEYVRGGELFNKVAKG-------------------------------------------------------- 104 (448)
Q Consensus 81 ~~~~~~lV~E~~~gg~L~~~i~~~-------------------------------------------------------- 104 (448)
..+..|+||||++||+|.+++...
T Consensus 110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 189 (375)
T cd05104 110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV 189 (375)
T ss_pred cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence 999999999999999999888531
Q ss_pred --------------------CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccccc
Q 037702 105 --------------------KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQ 164 (448)
Q Consensus 105 --------------------~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~ 164 (448)
.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence 367888999999999999999999999999999999999999999999999975433221
Q ss_pred CCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHH-HHHHHhhc-cCCCCCCCCHHHHH
Q 037702 165 DGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLME-LYKKITRA-EFKCPNWFPPEVRK 241 (448)
Q Consensus 165 ~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~-~~~~i~~~-~~~~p~~~s~~~~~ 241 (448)
.....+..++..|+|||++.+..+ +.++|||||||++|+|++ |..||....... ..+.+..+ ....|...+.++.+
T Consensus 270 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 348 (375)
T cd05104 270 YVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYD 348 (375)
T ss_pred ccccCCCCCCcceeChhHhcCCCC-CCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHH
Confidence 111122345678999999977666 488999999999999998 899998765443 33333333 23345667899999
Q ss_pred HHHhccCCCcCCCCCHHHHHhh
Q 037702 242 LLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~h 263 (448)
||.+||++||++|||+.++++.
T Consensus 349 li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 349 IMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HHHHHccCChhHCcCHHHHHHH
Confidence 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=348.18 Aligned_cols=248 Identities=32% Similarity=0.520 Sum_probs=207.8
Q ss_pred eeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHH---HHHHHhCCCCCcceEEEEEEeCCEEEEEEeecC
Q 037702 17 LLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKRE---ISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVR 93 (448)
Q Consensus 17 ~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~E---i~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 93 (448)
.||+|+||.||+|.+..+|+.||+|.+.+..............| +..++...||||+++++++.+.+..|+||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 48999999999999999999999999987654322222223333 344555689999999999999999999999999
Q ss_pred CCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCccccC
Q 037702 94 GGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTC 172 (448)
Q Consensus 94 gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~ 172 (448)
||+|..++.. +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++...... ...+.+
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~----~~~~~~ 156 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASV 156 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc----CCcCcC
Confidence 9999988865 67999999999999999999999999999999999999999999999999998754322 223567
Q ss_pred CCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCC---cHHHHHHHHhhccCCCCCCCCHHHHHHHHhccCC
Q 037702 173 GTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDS---NLMELYKKITRAEFKCPNWFPPEVRKLLSRILDP 249 (448)
Q Consensus 173 Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~---~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~ 249 (448)
|++.|+|||++.+....+.++||||+||++|+|++|+.||.+. ........+.......|..+|+++.++|.+||..
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~ 236 (278)
T cd05606 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQR 236 (278)
T ss_pred CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhc
Confidence 9999999999865433458899999999999999999999876 3344444454455667777899999999999999
Q ss_pred CcCCCC-----CHHHHHhhhhccc
Q 037702 250 NPSTRV-----TMAKLMENYWFRK 268 (448)
Q Consensus 250 dP~~Rp-----t~~eil~hp~~~~ 268 (448)
||.+|| ++.++++||||+.
T Consensus 237 ~p~~R~~~~~~~~~~ll~~~~~~~ 260 (278)
T cd05606 237 DVNRRLGCLGRGAQEVKEHPFFRS 260 (278)
T ss_pred CHHhccCCCCCCHHHHHhCccccC
Confidence 999999 9999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-44 Score=340.64 Aligned_cols=253 Identities=33% Similarity=0.556 Sum_probs=217.6
Q ss_pred CeEEEeeeeecCceEEEEEEECCCCcEEEEEEeeccccc--chhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 037702 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIR--RVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFA 88 (448)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~--~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 88 (448)
+|+..+.||+|+||.||+|.+..+++.|++|.+...... .....+.+.+|+.+++.++||||+++++++.+...+|++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 588899999999999999999889999999998754321 223456789999999999999999999999999999999
Q ss_pred EeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCC
Q 037702 89 MEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGL 167 (448)
Q Consensus 89 ~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 167 (448)
|||+++++|.+++.+ +.+++..+..++.||+.||.|||++|++|+||+|+||+++.++.+||+|||++....... .
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---~ 157 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---F 157 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc---c
Confidence 999999999999976 568999999999999999999999999999999999999999999999999987643322 2
Q ss_pred ccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhh--ccCCCCCCCCHHHHHHHHh
Q 037702 168 LHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITR--AEFKCPNWFPPEVRKLLSR 245 (448)
Q Consensus 168 ~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~li~~ 245 (448)
.....|++.|+|||.+......+.++|+|||||++|+|++|..||..........++.. .....|..+++++.+++.+
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 237 (258)
T cd06632 158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILK 237 (258)
T ss_pred ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHH
Confidence 24567899999999987655245889999999999999999999987665444444433 2234566789999999999
Q ss_pred ccCCCcCCCCCHHHHHhhhhc
Q 037702 246 ILDPNPSTRVTMAKLMENYWF 266 (448)
Q Consensus 246 ~L~~dP~~Rpt~~eil~hp~~ 266 (448)
||..||.+||++.+++.|||+
T Consensus 238 ~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 238 CLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HhhcCcccCcCHHHHhcCCCC
Confidence 999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-44 Score=351.45 Aligned_cols=259 Identities=30% Similarity=0.469 Sum_probs=214.7
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEE
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASK--TKI 85 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~ 85 (448)
..++|++.+.||+|+||.||+|.+..+|+.||+|.+....... .....+.+|+.+++.++||||+++++++... +.+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 5678999999999999999999999999999999987554322 2223456899999999999999999998754 578
Q ss_pred EEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccc
Q 037702 86 YFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTR 163 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~ 163 (448)
|+||||+.+ +|.+++.. ..+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 84 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 84 FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred EEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 999999975 78887764 569999999999999999999999999999999999999999999999999997654321
Q ss_pred cCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhc----------------
Q 037702 164 QDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA---------------- 227 (448)
Q Consensus 164 ~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---------------- 227 (448)
.......+++.|+|||++.+....+.++|||||||++|+|++|++||...+..+.+..+...
T Consensus 163 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07845 163 --KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP 240 (309)
T ss_pred --CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccc
Confidence 11223456889999999876554568899999999999999999999988776666554331
Q ss_pred ---cCCCC-----------CCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccccc
Q 037702 228 ---EFKCP-----------NWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGY 270 (448)
Q Consensus 228 ---~~~~p-----------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 270 (448)
.+..+ .++++++.+||.+||.+||++|||+.++++||||+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~ 297 (309)
T cd07845 241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKP 297 (309)
T ss_pred ccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCC
Confidence 11111 23588999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=341.24 Aligned_cols=251 Identities=33% Similarity=0.575 Sum_probs=216.4
Q ss_pred cCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFA 88 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 88 (448)
.++|++.+.||.|+||.||+|.+..+++.+|+|++...... ..+.+.+|+.+++.++||||+++++++.+...+|++
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~ 78 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD---DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIV 78 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh---hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEE
Confidence 46899999999999999999999999999999999765332 357889999999999999999999999999999999
Q ss_pred EeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCC
Q 037702 89 MEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDG 166 (448)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 166 (448)
|||+++++|.+++.. +.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++....... .
T Consensus 79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~ 156 (262)
T cd06613 79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--A 156 (262)
T ss_pred EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhh--h
Confidence 999999999998865 579999999999999999999999999999999999999999999999999987644321 1
Q ss_pred CccccCCCCcccchhhhhcc---CCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCC-----CCCCCCHH
Q 037702 167 LLHTTCGTPAYVAPEVINKR---GYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFK-----CPNWFPPE 238 (448)
Q Consensus 167 ~~~~~~Gt~~Y~APEvl~~~---~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-----~p~~~s~~ 238 (448)
......|+..|+|||.+... .++ .++|+|||||++|+|++|..||.+.+.......+....+. .+..++.+
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~-~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYD-GKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPV 235 (262)
T ss_pred ccccccCCccccCchhhcccccCCcC-chhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHH
Confidence 22345789999999998665 454 7899999999999999999999887655554444444222 22345788
Q ss_pred HHHHHHhccCCCcCCCCCHHHHHhhhh
Q 037702 239 VRKLLSRILDPNPSTRVTMAKLMENYW 265 (448)
Q Consensus 239 ~~~li~~~L~~dP~~Rpt~~eil~hp~ 265 (448)
+.++|++||..||..|||+.+++.|+|
T Consensus 236 ~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 236 FHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=343.93 Aligned_cols=251 Identities=20% Similarity=0.320 Sum_probs=211.9
Q ss_pred ccCCeEEEeeeeecCceEEEEEEEC---CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNL---KTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTK 84 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 84 (448)
-..+|++.+.||+|+||.||+|.+. ..+..||+|.+..... ......+.+|+.+++.++||||+++++++..++.
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 80 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS--DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT 80 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence 3467999999999999999999865 3567899999875432 2334678899999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccc
Q 037702 85 IYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQEST 162 (448)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~ 162 (448)
.|+||||+++|+|.+++.. +.+++..++.++.||+.||+|||++|++||||||+|||++.++.++++|||.+......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 9999999999999999865 47899999999999999999999999999999999999999999999999987643221
Q ss_pred ccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhc-cCCCCCCCCHHHH
Q 037702 163 RQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EFKCPNWFPPEVR 240 (448)
Q Consensus 163 ~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 240 (448)
.. .......+++.|+|||++.+..+ +.++|||||||++|++++ |..||.+.+..+....+..+ ..+.|..++..+.
T Consensus 161 ~~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (266)
T cd05064 161 AI-YTTMSGKSPVLWAAPEAIQYHHF-SSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLH 238 (266)
T ss_pred ch-hcccCCCCceeecCHHHHhhCCc-cchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHH
Confidence 11 11112345678999999977666 488999999999999775 99999988877777766554 3356677899999
Q ss_pred HHHHhccCCCcCCCCCHHHHHh
Q 037702 241 KLLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~eil~ 262 (448)
+++.+||..||.+||++++|++
T Consensus 239 ~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 239 QLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHHHcCCCchhCCCHHHHHH
Confidence 9999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=356.46 Aligned_cols=260 Identities=27% Similarity=0.456 Sum_probs=212.3
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASK----- 82 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~----- 82 (448)
+.++|++.+.||+|+||.||+|.+..+|+.||||.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 80 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESF 80 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeeccccccc
Confidence 4579999999999999999999999999999999986422 223346678899999999999999999987544
Q ss_pred CEEEEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccc
Q 037702 83 TKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQEST 162 (448)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~ 162 (448)
..+|+||||+.+ +|.+.+..+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~lv~e~~~~-~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 81 NDVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred ceEEEEehhccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 358999999965 8888888888999999999999999999999999999999999999999999999999998754332
Q ss_pred cc-CCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhh---------------
Q 037702 163 RQ-DGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITR--------------- 226 (448)
Q Consensus 163 ~~-~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~--------------- 226 (448)
.. .......+||+.|+|||++.+....+.++||||+||++|+|++|+.||.+.+.......+..
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIIS 239 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhc
Confidence 21 12223457899999999876544446889999999999999999999987654332221110
Q ss_pred c-----------cCC-----CCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccccc
Q 037702 227 A-----------EFK-----CPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGY 270 (448)
Q Consensus 227 ~-----------~~~-----~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 270 (448)
. ... ..+..++++.++|.+||+.||.+|||+.++++||||....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred hhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 0 000 1123578899999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-44 Score=339.86 Aligned_cols=248 Identities=29% Similarity=0.574 Sum_probs=216.5
Q ss_pred CeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 037702 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAME 90 (448)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (448)
+|++.+.||+|+||.||++.+..+++.+|+|.+...... ...+.+.+|+.+++.++||||+++++.+.+++.+|+|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS--SAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcch--HHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 589999999999999999999999999999998754322 335678899999999999999999999999999999999
Q ss_pred ecCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCC
Q 037702 91 YVRGGELFNKVAK---GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGL 167 (448)
Q Consensus 91 ~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 167 (448)
|+++++|.+++.. ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++....... ..
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~--~~ 156 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG--AY 156 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccc--cc
Confidence 9999999998864 358999999999999999999999999999999999999999999999999987543221 12
Q ss_pred ccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccC-CCCCCCCHHHHHHHHhc
Q 037702 168 LHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF-KCPNWFPPEVRKLLSRI 246 (448)
Q Consensus 168 ~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~ 246 (448)
.....|++.|+|||++.+..+ +.++|+||||+++|+|++|..||...+.......+..+.. ..|..++..+.++|.+|
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 235 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPY-NNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQM 235 (255)
T ss_pred cccccCCccccCHHHHccCCc-CchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHH
Confidence 234568999999999977665 4889999999999999999999998887777766665544 35667889999999999
Q ss_pred cCCCcCCCCCHHHHHhh
Q 037702 247 LDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 247 L~~dP~~Rpt~~eil~h 263 (448)
|..||.+|||+.+++.-
T Consensus 236 l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 236 FKRNPRSRPSATTILSR 252 (255)
T ss_pred HhCCcccCCCHHHHhhc
Confidence 99999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=347.23 Aligned_cols=247 Identities=30% Similarity=0.501 Sum_probs=212.1
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCCch
Q 037702 18 LGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGEL 97 (448)
Q Consensus 18 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 97 (448)
||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999999999999999999876544434445667899999999999999999999999999999999999999
Q ss_pred HHHHhc-C--CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCccccCCC
Q 037702 98 FNKVAK-G--KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGT 174 (448)
Q Consensus 98 ~~~i~~-~--~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~Gt 174 (448)
.+++.. + .+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++..... ........|+
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~~ 157 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAGT 157 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc---CCccccccCC
Confidence 998865 3 699999999999999999999999999999999999999999999999999875432 1222345688
Q ss_pred CcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcH----HHHHHHHhhccCCCCCCCCHHHHHHHHhccCCC
Q 037702 175 PAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNL----MELYKKITRAEFKCPNWFPPEVRKLLSRILDPN 250 (448)
Q Consensus 175 ~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~----~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~d 250 (448)
..|+|||++.+..+ +.++|||||||++|+|++|+.||..... ..+...+.......|..+++.+.++|.+||+.|
T Consensus 158 ~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 236 (277)
T cd05577 158 PGYMAPEVLQGEVY-DFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD 236 (277)
T ss_pred CCcCCHHHhcCCCC-CchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCC
Confidence 99999999876665 4789999999999999999999976543 333333444455566778999999999999999
Q ss_pred cCCCC-----CHHHHHhhhhccc
Q 037702 251 PSTRV-----TMAKLMENYWFRK 268 (448)
Q Consensus 251 P~~Rp-----t~~eil~hp~~~~ 268 (448)
|.+|| ++.++++||||..
T Consensus 237 p~~R~~~~~~~~~~ll~h~~~~~ 259 (277)
T cd05577 237 PEKRLGCRGGSADEVREHPLFKD 259 (277)
T ss_pred hhHccCCCcccHHHHHhChhhhc
Confidence 99999 8899999999964
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=346.65 Aligned_cols=256 Identities=30% Similarity=0.530 Sum_probs=220.5
Q ss_pred cCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFA 88 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 88 (448)
.+.|+..+.||.|+||.||.|.+..++..||+|++...... .....+.+|+.+++.++||||+++++++.++...|+|
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWII 80 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 35688899999999999999999999999999998755322 3357788999999999999999999999999999999
Q ss_pred EeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCc
Q 037702 89 MEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLL 168 (448)
Q Consensus 89 ~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 168 (448)
|||++|++|.+++..+++++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 81 ~e~~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~ 158 (277)
T cd06640 81 MEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KR 158 (277)
T ss_pred EecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc--cc
Confidence 9999999999999888999999999999999999999999999999999999999999999999999875433221 12
Q ss_pred cccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhcc-CCCCCCCCHHHHHHHHhcc
Q 037702 169 HTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAE-FKCPNWFPPEVRKLLSRIL 247 (448)
Q Consensus 169 ~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L 247 (448)
....++..|+|||++.+..+ +.++|+|||||++|+|++|..||...+.......+.... ...+..++..+.++|.+||
T Consensus 159 ~~~~~~~~y~apE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 237 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAY-DSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACL 237 (277)
T ss_pred ccccCcccccCHhHhccCCC-ccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHc
Confidence 23468899999999876655 488999999999999999999998776655554443332 2334457889999999999
Q ss_pred CCCcCCCCCHHHHHhhhhcccc
Q 037702 248 DPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 248 ~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
..||.+||++.++++|+||...
T Consensus 238 ~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 238 NKDPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred ccCcccCcCHHHHHhChHhhhc
Confidence 9999999999999999999653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=352.40 Aligned_cols=257 Identities=26% Similarity=0.477 Sum_probs=219.8
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYF 87 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 87 (448)
..+.|.....||+|+||.||++.+..++..||||.+..... ...+.+.+|+.+++.++||||+++++.+...+..|+
T Consensus 20 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~l 96 (292)
T cd06658 20 PREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQ---QRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWV 96 (292)
T ss_pred hHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchH---HHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEE
Confidence 34567777889999999999999999999999999865432 334678899999999999999999999999999999
Q ss_pred EEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCC
Q 037702 88 AMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGL 167 (448)
Q Consensus 88 V~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 167 (448)
||||+++++|.+++..+.+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++....... ..
T Consensus 97 v~e~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--~~ 174 (292)
T cd06658 97 VMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--PK 174 (292)
T ss_pred EEeCCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc--cc
Confidence 9999999999999988889999999999999999999999999999999999999999999999999987543221 12
Q ss_pred ccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhcc---CCCCCCCCHHHHHHHH
Q 037702 168 LHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAE---FKCPNWFPPEVRKLLS 244 (448)
Q Consensus 168 ~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~li~ 244 (448)
.....|++.|+|||.+.+..++ .++||||||+++|+|++|+.||...+.......+.... ...+..++..+.++|.
T Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 253 (292)
T cd06658 175 RKSLVGTPYWMAPEVISRLPYG-TEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLD 253 (292)
T ss_pred CceeecCccccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHH
Confidence 2345789999999998776664 78999999999999999999998877665555444321 1222347889999999
Q ss_pred hccCCCcCCCCCHHHHHhhhhccccc
Q 037702 245 RILDPNPSTRVTMAKLMENYWFRKGY 270 (448)
Q Consensus 245 ~~L~~dP~~Rpt~~eil~hp~~~~~~ 270 (448)
+||..||.+|||++++++||||....
T Consensus 254 ~~l~~~P~~Rpt~~~il~~~~~~~~~ 279 (292)
T cd06658 254 LMLVREPSQRATAQELLQHPFLKLAG 279 (292)
T ss_pred HHccCChhHCcCHHHHhhChhhhccC
Confidence 99999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=344.21 Aligned_cols=253 Identities=34% Similarity=0.541 Sum_probs=213.1
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC---
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEVMASKT--- 83 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~--- 83 (448)
..++|++.+.||+|+||.||+|.+..+++.+++|++..... ..+.+.+|+.+++++ +||||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG 79 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence 45899999999999999999999998999999999875532 236788999999999 7999999999986644
Q ss_pred ---EEEEEEeecCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccc
Q 037702 84 ---KIYFAMEYVRGGELFNKVAK-----GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGL 155 (448)
Q Consensus 84 ---~~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGl 155 (448)
.+|+||||+++++|.+++.. +.+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||+
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence 58999999999999988753 4799999999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCccccCCCCcccchhhhhccC----CCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccC--
Q 037702 156 SALQESTRQDGLLHTTCGTPAYVAPEVINKRG----YDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF-- 229 (448)
Q Consensus 156 a~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~----~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-- 229 (448)
+....... .......|++.|+|||++.... ..+.++|||||||++|+|++|..||...+.......+.....
T Consensus 160 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 237 (275)
T cd06608 160 SAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPT 237 (275)
T ss_pred ceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCC
Confidence 87543221 2223457899999999985422 234789999999999999999999987665555555544422
Q ss_pred -CCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhc
Q 037702 230 -KCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWF 266 (448)
Q Consensus 230 -~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 266 (448)
..+..++.++.+||.+||..||++|||+.++++|||+
T Consensus 238 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 238 LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 2233467899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=347.26 Aligned_cols=255 Identities=32% Similarity=0.518 Sum_probs=215.1
Q ss_pred CCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 037702 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAM 89 (448)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (448)
++|++.+.||+|+||.||+|.+..+++.||+|.+...... ....+.+.+|+.+++.++||||+++++++..++..|+||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD-EDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhccc-ccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 5799999999999999999999999999999998754332 234577899999999999999999999999999999999
Q ss_pred eecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCc
Q 037702 90 EYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLL 168 (448)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 168 (448)
||++++.+..+... ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.+||+|||++........ ...
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-~~~ 158 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-SPL 158 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-ccc
Confidence 99999777766655 5699999999999999999999999999999999999999999999999999886543322 123
Q ss_pred cccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhc---------------------
Q 037702 169 HTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA--------------------- 227 (448)
Q Consensus 169 ~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--------------------- 227 (448)
....|+..|+|||++......+.++||||||+++|+|++|.+||...+..+....+...
T Consensus 159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07833 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV 238 (288)
T ss_pred cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccc
Confidence 34578999999999977634468999999999999999999999876554433322110
Q ss_pred c-----------CCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhc
Q 037702 228 E-----------FKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWF 266 (448)
Q Consensus 228 ~-----------~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 266 (448)
. ..+|..+++++.+||.+||..||++|||++++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 0 01233458999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=345.79 Aligned_cols=255 Identities=28% Similarity=0.489 Sum_probs=213.4
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC---
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEVMASK--- 82 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~--- 82 (448)
...++|++.+.||+|+||.||+|.+..+++.+|+|++.... .....+.+|+.+++.+ +||||+++++++...
T Consensus 19 ~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~ 94 (291)
T cd06639 19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKL 94 (291)
T ss_pred CCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecccc
Confidence 35688999999999999999999999999999999986542 1235677899999998 899999999998653
Q ss_pred --CEEEEEEeecCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccc
Q 037702 83 --TKIYFAMEYVRGGELFNKVAK-----GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGL 155 (448)
Q Consensus 83 --~~~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGl 155 (448)
...|+||||++|++|.+++.. ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||+
T Consensus 95 ~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~ 174 (291)
T cd06639 95 VGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGV 174 (291)
T ss_pred CCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeeccc
Confidence 368999999999999988752 4689999999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCccccCCCCcccchhhhhccC----CCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhcc---
Q 037702 156 SALQESTRQDGLLHTTCGTPAYVAPEVINKRG----YDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAE--- 228 (448)
Q Consensus 156 a~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~----~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--- 228 (448)
+........ ......|++.|+|||++.... ..+.++|||||||++|+|++|+.||...+.......+.+..
T Consensus 175 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 252 (291)
T cd06639 175 SAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPT 252 (291)
T ss_pred chhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCC
Confidence 875432221 123457899999999985432 13578999999999999999999998776655554554432
Q ss_pred CCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcc
Q 037702 229 FKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFR 267 (448)
Q Consensus 229 ~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~ 267 (448)
...+..++..+.++|.+||+.||++||++.++++||||+
T Consensus 253 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 253 LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 223455778899999999999999999999999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=341.29 Aligned_cols=250 Identities=32% Similarity=0.546 Sum_probs=216.3
Q ss_pred cCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFA 88 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 88 (448)
.++|++.+.||+|+||.||+|.+..++..+|+|.+..... .+.+.+|+.+++.++||||+++++.+.+....|++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~ 76 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIV 76 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEE
Confidence 3689999999999999999999998899999999865422 47889999999999999999999999999999999
Q ss_pred EeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCC
Q 037702 89 MEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDG 166 (448)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 166 (448)
+||+++++|.+++.. ..+++..++.++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++........
T Consensus 77 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-- 154 (256)
T cd06612 77 MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-- 154 (256)
T ss_pred EecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--
Confidence 999999999999864 5689999999999999999999999999999999999999999999999999886543221
Q ss_pred CccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhc---cCCCCCCCCHHHHHHH
Q 037702 167 LLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA---EFKCPNWFPPEVRKLL 243 (448)
Q Consensus 167 ~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~li 243 (448)
......|+..|+|||++.+..++ .++|||||||++|+|++|+.||...+.......+... ....+..++.++.++|
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 233 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGYN-NKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFV 233 (256)
T ss_pred ccccccCCccccCHHHHhcCCCC-chhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHH
Confidence 22345589999999999877664 8899999999999999999999876654443333222 2234455788999999
Q ss_pred HhccCCCcCCCCCHHHHHhhhhc
Q 037702 244 SRILDPNPSTRVTMAKLMENYWF 266 (448)
Q Consensus 244 ~~~L~~dP~~Rpt~~eil~hp~~ 266 (448)
.+||+.||++|||+.++++||||
T Consensus 234 ~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 234 KKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHHhcChhhCcCHHHHhcCCCC
Confidence 99999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-44 Score=346.70 Aligned_cols=254 Identities=30% Similarity=0.510 Sum_probs=207.3
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYF 87 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 87 (448)
..++|++.+.||+|++|.||+|.+..+++.||||.+....... ....+.+|+.+++.++||||+++++++.+++..|+
T Consensus 3 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (291)
T cd07844 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG--APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTL 80 (291)
T ss_pred CccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC--CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEE
Confidence 3578999999999999999999999899999999987543221 12346689999999999999999999999999999
Q ss_pred EEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccC
Q 037702 88 AMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQD 165 (448)
Q Consensus 88 V~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~ 165 (448)
||||+.+ +|.+++.. +.+++..++.++.|+++||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 v~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-- 157 (291)
T cd07844 81 VFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS-- 157 (291)
T ss_pred EEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCC--
Confidence 9999985 89988865 468999999999999999999999999999999999999999999999999987432211
Q ss_pred CCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCc-HHHHHHHHhhc-----------------
Q 037702 166 GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSN-LMELYKKITRA----------------- 227 (448)
Q Consensus 166 ~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~-~~~~~~~i~~~----------------- 227 (448)
.......+++.|+|||++.+....+.++||||+||++|+|++|+.||.+.. ..+....+...
T Consensus 158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07844 158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE 237 (291)
T ss_pred ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence 112234578999999998764444588999999999999999999997655 22222221110
Q ss_pred --c--CCC---------CCCCC--HHHHHHHHhccCCCcCCCCCHHHHHhhhhc
Q 037702 228 --E--FKC---------PNWFP--PEVRKLLSRILDPNPSTRVTMAKLMENYWF 266 (448)
Q Consensus 228 --~--~~~---------p~~~s--~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 266 (448)
. ... ...++ .++.++|.+||.+||.+|||+.++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0 000 01234 788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=361.67 Aligned_cols=246 Identities=24% Similarity=0.385 Sum_probs=199.6
Q ss_pred cCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFA 88 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 88 (448)
..+|++.+.||+|+||.||+|.+..++..||+|+..+. ....|+.+++.++||||+++++++......|+|
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 45799999999999999999999999999999985433 224689999999999999999999999999999
Q ss_pred EeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCC
Q 037702 89 MEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDG 166 (448)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 166 (448)
||++. ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 136 ~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---~ 211 (357)
T PHA03209 136 LPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA---P 211 (357)
T ss_pred EEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC---c
Confidence 99995 588888754 57999999999999999999999999999999999999999999999999998743221 1
Q ss_pred CccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCC-CCCCcH----------HHHHHHHhhcc---CCCC
Q 037702 167 LLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLP-FYDSNL----------MELYKKITRAE---FKCP 232 (448)
Q Consensus 167 ~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~P-f~~~~~----------~~~~~~i~~~~---~~~p 232 (448)
......||+.|+|||++.+..+. .++|||||||++|+|+++..| |..... ..+...+.... ..+|
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 290 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKYN-SKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP 290 (357)
T ss_pred ccccccccccccCCeecCCCCCC-chhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcC
Confidence 22345799999999999877664 889999999999999985544 433211 11111111000 0011
Q ss_pred ------------------------------CCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccc
Q 037702 233 ------------------------------NWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRK 268 (448)
Q Consensus 233 ------------------------------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 268 (448)
..++.++.+||.+||+.||.+|||+.|+++||||++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred CCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 124667888999999999999999999999999975
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=343.18 Aligned_cols=250 Identities=35% Similarity=0.658 Sum_probs=220.5
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCCch
Q 037702 18 LGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGEL 97 (448)
Q Consensus 18 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 97 (448)
||.|+||.||+|++..+|+.+|+|++...........+.+.+|+.++++++||||+++++.+..+...|++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999989999999999776554445567889999999999999999999999999999999999999999
Q ss_pred HHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccccc------CCCccc
Q 037702 98 FNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQ------DGLLHT 170 (448)
Q Consensus 98 ~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~------~~~~~~ 170 (448)
.+++.+ +.+++..+..++.||+.||+|||++|++||||+|+||+++.++.++|+|||++........ ......
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 160 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence 999976 6899999999999999999999999999999999999999999999999999875432211 112234
Q ss_pred cCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCC--CHHHHHHHHhccC
Q 037702 171 TCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWF--PPEVRKLLSRILD 248 (448)
Q Consensus 171 ~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~--s~~~~~li~~~L~ 248 (448)
..+++.|+|||.+....+ +.++|+||||+++|+|++|..||......+.+..+.......|... ++.+.+++.+||+
T Consensus 161 ~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 239 (265)
T cd05579 161 IVGTPDYIAPEVILGQGH-SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLV 239 (265)
T ss_pred cccCccccCHHHhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhc
Confidence 568899999999876664 5889999999999999999999998888888888777666666665 8999999999999
Q ss_pred CCcCCCCCH---HHHHhhhhccc
Q 037702 249 PNPSTRVTM---AKLMENYWFRK 268 (448)
Q Consensus 249 ~dP~~Rpt~---~eil~hp~~~~ 268 (448)
.+|.+|||+ .++++||||++
T Consensus 240 ~~p~~Rpt~~~~~~~l~~~~~~~ 262 (265)
T cd05579 240 PDPEKRLGAKSIEEIKNHPFFKG 262 (265)
T ss_pred CCHhhcCCCccHHHHhcCccccC
Confidence 999999999 99999999964
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-44 Score=349.36 Aligned_cols=259 Identities=25% Similarity=0.420 Sum_probs=208.5
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC--
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKT-- 83 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~-- 83 (448)
....++|++.+.||+|+||.||+|.+..+|+.||||.+....... .....+.+|+.+++.++||||+++++++....
T Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (310)
T cd07865 8 CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKATP 86 (310)
T ss_pred cchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC-CchhHHHHHHHHHHhCCCCCccceEEEEeccccc
Confidence 345778999999999999999999999999999999987543222 22345668999999999999999999986543
Q ss_pred ------EEEEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccc
Q 037702 84 ------KIYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGL 155 (448)
Q Consensus 84 ------~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGl 155 (448)
..|+||||+.+ +|.+.+.. ..+++.+++.++.||+.||.|||++|++|+||||+||+++.++.+||+|||+
T Consensus 87 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 87 YNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred ccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCC
Confidence 46999999965 78777765 3799999999999999999999999999999999999999999999999999
Q ss_pred cccccccccC--CCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhcc-----
Q 037702 156 SALQESTRQD--GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAE----- 228 (448)
Q Consensus 156 a~~~~~~~~~--~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~----- 228 (448)
+......... .......++..|+|||++.+....+.++||||||+++|+|++|..||...+.......+....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 9765432221 112344688999999998665444678999999999999999999998766543333222110
Q ss_pred --------------CCCC-------------CCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhc
Q 037702 229 --------------FKCP-------------NWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWF 266 (448)
Q Consensus 229 --------------~~~p-------------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 266 (448)
...| ...++.+.+||.+||..||.+|||++++++||||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 0011 1135778899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-44 Score=356.87 Aligned_cols=259 Identities=28% Similarity=0.464 Sum_probs=213.3
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC----
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASK---- 82 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~---- 82 (448)
.+.++|++.+.||+|+||.||+|.+..+|+.||||.+.+... +......+.+|+.++++++||||+++++++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLE 91 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcc
Confidence 357899999999999999999999999999999999865432 223345677899999999999999999988643
Q ss_pred --CEEEEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccc
Q 037702 83 --TKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQE 160 (448)
Q Consensus 83 --~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~ 160 (448)
...|+||||+.+ +|.+.+... +++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 92 ~~~~~~lv~e~~~~-~l~~~~~~~-l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 92 EFQDVYLVMELMDA-NLCQVIQMD-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred ccCcEEEEEeccCC-CHHHHHhhc-CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 357999999965 888877654 9999999999999999999999999999999999999999999999999997543
Q ss_pred ccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhcc------------
Q 037702 161 STRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAE------------ 228 (448)
Q Consensus 161 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~------------ 228 (448)
.. .......||+.|+|||++.+..+. .++|||||||++|+|++|+.||...+....+.++....
T Consensus 170 ~~---~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T cd07850 170 TS---FMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ 245 (353)
T ss_pred CC---CCCCCCcccccccCHHHHhCCCCC-CchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 22 223345789999999999887775 88999999999999999999998776544444332100
Q ss_pred ----------C--------------CC-------CCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccccccc
Q 037702 229 ----------F--------------KC-------PNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYKK 272 (448)
Q Consensus 229 ----------~--------------~~-------p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~ 272 (448)
. .+ +...++.++++|.+||+.||.+|||+.+++.||||+..+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~ 320 (353)
T cd07850 246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDP 320 (353)
T ss_pred hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCC
Confidence 0 00 11235678999999999999999999999999999876643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=347.35 Aligned_cols=252 Identities=29% Similarity=0.511 Sum_probs=210.1
Q ss_pred CeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 037702 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAME 90 (448)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (448)
+|++.+.||.|+||.||+|++..+|+.||||.+..+.... .....+.+|++++++++||||+++++++.+....|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccccc-ccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 5899999999999999999999999999999987553222 233578899999999999999999999999999999999
Q ss_pred ecCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCC
Q 037702 91 YVRGGELFNKVAK---GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGL 167 (448)
Q Consensus 91 ~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 167 (448)
|+. ++|.+++.. +.+++..++.++.|++.||+|||++|++||||+|+||+++.++.+||+|||++....... ..
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~--~~ 156 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RT 156 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc--cc
Confidence 996 588888754 568999999999999999999999999999999999999999999999999987543221 12
Q ss_pred ccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhc------------------cC
Q 037702 168 LHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA------------------EF 229 (448)
Q Consensus 168 ~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~------------------~~ 229 (448)
.....+++.|+|||++.+....+.++|||||||++|+|++|+.||...+..+...++... ..
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07860 157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKP 236 (284)
T ss_pred cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHh
Confidence 234467899999998876555568899999999999999999999876654333222211 00
Q ss_pred CC-----------CCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhc
Q 037702 230 KC-----------PNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWF 266 (448)
Q Consensus 230 ~~-----------p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 266 (448)
.+ .+.++++++++|.+||+.||.+|||++++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 237 SFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred hcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 11 12367899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=338.04 Aligned_cols=255 Identities=34% Similarity=0.617 Sum_probs=216.1
Q ss_pred CeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 037702 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAME 90 (448)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (448)
+|.+.+.||+|+||.||+|.+..++..||+|.+...... ....+.+.+|+.+++.++||||+++++.+...+.+++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 699999999999999999999889999999999766543 3456889999999999999999999999999999999999
Q ss_pred ecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCC-C-
Q 037702 91 YVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDG-L- 167 (448)
Q Consensus 91 ~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~-~- 167 (448)
|+++++|.+++.. +.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++.......... .
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 159 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE 159 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence 9999999999977 458999999999999999999999999999999999999999999999999988654322211 1
Q ss_pred ccccCCCCcccchhhhhccC--CCCCcchHHHHHHHHHHHHhCCCCCCCCc-HHHHHHHHhh-ccCCCCCCC--CHHHHH
Q 037702 168 LHTTCGTPAYVAPEVINKRG--YDGAKADIWSCGVVLFVLLAGNLPFYDSN-LMELYKKITR-AEFKCPNWF--PPEVRK 241 (448)
Q Consensus 168 ~~~~~Gt~~Y~APEvl~~~~--~~~~~sDiwSlGvil~elltG~~Pf~~~~-~~~~~~~i~~-~~~~~p~~~--s~~~~~ 241 (448)
.....|++.|+|||++.... ..+.++||||||+++|+|++|+.||.... .......+.. .....|.+. ++.+.+
T Consensus 160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (264)
T cd06626 160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKD 239 (264)
T ss_pred ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHH
Confidence 22457899999999987654 13578999999999999999999997653 2222222222 233455554 899999
Q ss_pred HHHhccCCCcCCCCCHHHHHhhhhc
Q 037702 242 LLSRILDPNPSTRVTMAKLMENYWF 266 (448)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~hp~~ 266 (448)
+|.+||+.||.+|||+++++.|||+
T Consensus 240 li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 240 FLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHccCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=344.62 Aligned_cols=254 Identities=28% Similarity=0.502 Sum_probs=210.7
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEE-----
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEVMA----- 80 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~----- 80 (448)
...++|++.+.||+|+||.||+|.+..+++.+|+|++.... .....+.+|+.+++.+ +||||+++++++.
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 90 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK 90 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence 46789999999999999999999999999999999886432 1235677899999999 7999999999873
Q ss_pred eCCEEEEEEeecCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccc
Q 037702 81 SKTKIYFAMEYVRGGELFNKVAK-----GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGL 155 (448)
Q Consensus 81 ~~~~~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGl 155 (448)
.+...|+||||++|++|.+++.. +.+++..++.++.|++.||.|||+++++||||||+||+++.++.+||+|||+
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~ 170 (286)
T cd06638 91 NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGV 170 (286)
T ss_pred CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCc
Confidence 45679999999999999987642 4689999999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCccccCCCCcccchhhhhcc----CCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhc---c
Q 037702 156 SALQESTRQDGLLHTTCGTPAYVAPEVINKR----GYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA---E 228 (448)
Q Consensus 156 a~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~----~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---~ 228 (448)
+....... .......|++.|+|||++... ...+.++|||||||++|+|++|+.||...+.......+... .
T Consensus 171 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (286)
T cd06638 171 SAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPT 248 (286)
T ss_pred eeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCc
Confidence 87543221 122345799999999998532 12347899999999999999999999877654444333322 1
Q ss_pred CCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhc
Q 037702 229 FKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWF 266 (448)
Q Consensus 229 ~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 266 (448)
...|..++..+.++|.+||+.||++|||+.++++|+||
T Consensus 249 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 249 LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 22345578899999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=342.65 Aligned_cols=255 Identities=29% Similarity=0.524 Sum_probs=220.5
Q ss_pred CeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 037702 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAME 90 (448)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (448)
=|++.+.||+|+||.||+|.+..++..||||.+...... .....+.+|+.+++.++||||+++++++..+...|+|||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccch--HHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 477889999999999999999889999999998654332 334678899999999999999999999999999999999
Q ss_pred ecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCccc
Q 037702 91 YVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHT 170 (448)
Q Consensus 91 ~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~ 170 (448)
|+++++|.+++..+.+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 83 ~~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~--~~~~~ 160 (277)
T cd06641 83 YLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IKRNT 160 (277)
T ss_pred eCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccch--hhhcc
Confidence 9999999999988889999999999999999999999999999999999999999999999999987543221 11234
Q ss_pred cCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccC-CCCCCCCHHHHHHHHhccCC
Q 037702 171 TCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF-KCPNWFPPEVRKLLSRILDP 249 (448)
Q Consensus 171 ~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L~~ 249 (448)
..|+..|+|||.+..... +.++|+|||||++|+|++|..||...+.......+..... ..+..++.++.++|.+||..
T Consensus 161 ~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 239 (277)
T cd06641 161 FVGTPFWMAPEVIKQSAY-DSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNK 239 (277)
T ss_pred ccCCccccChhhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHccC
Confidence 568999999999876555 4789999999999999999999987766655555544332 35566889999999999999
Q ss_pred CcCCCCCHHHHHhhhhccccc
Q 037702 250 NPSTRVTMAKLMENYWFRKGY 270 (448)
Q Consensus 250 dP~~Rpt~~eil~hp~~~~~~ 270 (448)
||.+||++.++++||||.+..
T Consensus 240 ~p~~Rp~~~~~l~~~~~~~~~ 260 (277)
T cd06641 240 EPSFRPTAKELLKHKFIVRFA 260 (277)
T ss_pred ChhhCcCHHHHHhCHHHhhhh
Confidence 999999999999999998743
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=353.78 Aligned_cols=257 Identities=26% Similarity=0.418 Sum_probs=215.8
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC---
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKT--- 83 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~--- 83 (448)
.+.++|++.+.||+|+||.||+|.+..+|..||||.+.+.. ........+.+|+.+++.++||||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 36789999999999999999999999999999999986542 22233456889999999999999999999987653
Q ss_pred ---EEEEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccc
Q 037702 84 ---KIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQE 160 (448)
Q Consensus 84 ---~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~ 160 (448)
.+++||||+ |++|.+++..+.+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++....
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~ 169 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD 169 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence 468999999 7799998888889999999999999999999999999999999999999999999999999987543
Q ss_pred ccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccC-----------
Q 037702 161 STRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF----------- 229 (448)
Q Consensus 161 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~----------- 229 (448)
.. .....+++.|+|||++.+....+.++|+|||||++|+|++|..||.+.+....+.++.....
T Consensus 170 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07880 170 SE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQ 244 (343)
T ss_pred cC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhc
Confidence 21 23346799999999987644456889999999999999999999987765544443322111
Q ss_pred --------------------CCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccccc
Q 037702 230 --------------------KCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGY 270 (448)
Q Consensus 230 --------------------~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 270 (448)
...+.+++++.++|.+||..||.+|||+.+++.||||+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 245 SEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred chhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 11235788899999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=348.41 Aligned_cols=254 Identities=30% Similarity=0.534 Sum_probs=217.7
Q ss_pred CCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 037702 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAM 89 (448)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (448)
+.|+..+.||+|+||.||+|.+..++..||+|.+...... ...+.+.+|+.+++.++||||+++++++..+...|+||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM 81 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccch--HHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence 4577788999999999999999999999999998754322 33467889999999999999999999999999999999
Q ss_pred eecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCcc
Q 037702 90 EYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLH 169 (448)
Q Consensus 90 E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~ 169 (448)
||+++++|.+++..+.+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~~~ 159 (277)
T cd06642 82 EYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKRN 159 (277)
T ss_pred EccCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcc--hhhh
Confidence 99999999999988889999999999999999999999999999999999999999999999999987543221 1122
Q ss_pred ccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhcc-CCCCCCCCHHHHHHHHhccC
Q 037702 170 TTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAE-FKCPNWFPPEVRKLLSRILD 248 (448)
Q Consensus 170 ~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~ 248 (448)
...|+..|+|||++.+..+ +.++|+|||||++|+|++|..||...........+.... ...+..++.++.++|.+||.
T Consensus 160 ~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 238 (277)
T cd06642 160 TFVGTPFWMAPEVIKQSAY-DFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLN 238 (277)
T ss_pred cccCcccccCHHHhCcCCC-chhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHcc
Confidence 3468999999999977665 478999999999999999999998765554444443332 23344578899999999999
Q ss_pred CCcCCCCCHHHHHhhhhccc
Q 037702 249 PNPSTRVTMAKLMENYWFRK 268 (448)
Q Consensus 249 ~dP~~Rpt~~eil~hp~~~~ 268 (448)
.+|.+||++.++++||||..
T Consensus 239 ~~p~~Rp~~~~il~~~~~~~ 258 (277)
T cd06642 239 KDPRFRPTAKELLKHKFITR 258 (277)
T ss_pred CCcccCcCHHHHHHhHHHHH
Confidence 99999999999999999975
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=337.74 Aligned_cols=252 Identities=32% Similarity=0.602 Sum_probs=219.3
Q ss_pred CeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE--eCCEEEEE
Q 037702 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMA--SKTKIYFA 88 (448)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~--~~~~~~lV 88 (448)
+|++.+.||.|+||.||+|.+..+|..||+|.+....... ...+.+.+|+.+++.++||||+++++++. .+...|++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTE-KEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCH-HHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 5999999999999999999999999999999997654432 33467889999999999999999999775 35678999
Q ss_pred EeecCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH-----HCCCEeecCCCCceEEcCCCCeEEeecccccc
Q 037702 89 MEYVRGGELFNKVAK-----GKLREEVARKYFQQLVDAVEFCH-----SRGVYHRDLKPENLLLDENGDLKISDFGLSAL 158 (448)
Q Consensus 89 ~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~aL~yLH-----~~givHrDLkp~NILl~~~g~lkl~DFGla~~ 158 (448)
|||+++++|.+++.. +++++..++.++.||+.||.||| +.+++|+||||+||+++.++.+||+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 999999999998853 47899999999999999999999 89999999999999999999999999999986
Q ss_pred ccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccC-CCCCCCCH
Q 037702 159 QESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF-KCPNWFPP 237 (448)
Q Consensus 159 ~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~ 237 (448)
...... ......|++.|+|||++....+ +.++|+||||+++|+|++|..||...+.......+..... ..|..++.
T Consensus 160 ~~~~~~--~~~~~~~~~~~~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (265)
T cd08217 160 LGHDSS--FAKTYVGTPYYMSPEQLNHMSY-DEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSS 236 (265)
T ss_pred ccCCcc--cccccccCCCccChhhhcCCCC-CchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCH
Confidence 543221 1234578999999999977665 4789999999999999999999998887777777766654 45667889
Q ss_pred HHHHHHHhccCCCcCCCCCHHHHHhhhhc
Q 037702 238 EVRKLLSRILDPNPSTRVTMAKLMENYWF 266 (448)
Q Consensus 238 ~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 266 (448)
++.+++.+||..+|.+||++.+|++|||+
T Consensus 237 ~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 237 ELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 99999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=342.76 Aligned_cols=248 Identities=31% Similarity=0.504 Sum_probs=205.9
Q ss_pred eEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeC--CEEEEE
Q 037702 12 YELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR-HPNIVQLYEVMASK--TKIYFA 88 (448)
Q Consensus 12 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~--~~~~lV 88 (448)
|++.+.||+|+||.||+|.+..++..||+|.+.+..... .. ....+|+.+++++. ||||+++++++.+. +.+++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL-EQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc-hh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 788999999999999999999999999999986543221 22 23457888898885 99999999999887 889999
Q ss_pred EeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCC
Q 037702 89 MEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDG 166 (448)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 166 (448)
|||+++ +|.+.+.. +.+++..++.++.|++.||.|||++|++||||+|+||+++. +.+||+|||++.......
T Consensus 79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~--- 153 (282)
T cd07831 79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP--- 153 (282)
T ss_pred EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCC---
Confidence 999975 78877764 46899999999999999999999999999999999999999 999999999997543221
Q ss_pred CccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhc------------------c
Q 037702 167 LLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA------------------E 228 (448)
Q Consensus 167 ~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~------------------~ 228 (448)
......+++.|+|||++...++.+.++|||||||++|+|++|..||.+.+..+....+... .
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07831 154 PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN 233 (282)
T ss_pred CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence 1223468999999998766566678999999999999999999999887765554443321 1
Q ss_pred CCCC-----------CCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhc
Q 037702 229 FKCP-----------NWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWF 266 (448)
Q Consensus 229 ~~~p-----------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 266 (448)
+.+| +.++.++.++|.+||.+||.+|||++++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 1111 2467899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-44 Score=344.75 Aligned_cols=252 Identities=30% Similarity=0.504 Sum_probs=210.3
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEE------
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEVMA------ 80 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~------ 80 (448)
..+.|++.+.||.|+||.||+|.+..+++.+|+|++.... .....+..|+.+++++ +||||+++++++.
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 89 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG 89 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence 4579999999999999999999999999999999987543 2235678899999988 7999999999985
Q ss_pred eCCEEEEEEeecCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccc
Q 037702 81 SKTKIYFAMEYVRGGELFNKVAK---GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSA 157 (448)
Q Consensus 81 ~~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~ 157 (448)
....+|++|||+++|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.
T Consensus 90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~ 169 (282)
T cd06636 90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 169 (282)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchh
Confidence 35678999999999999999864 458899999999999999999999999999999999999999999999999987
Q ss_pred cccccccCCCccccCCCCcccchhhhhc-----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccC-C-
Q 037702 158 LQESTRQDGLLHTTCGTPAYVAPEVINK-----RGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF-K- 230 (448)
Q Consensus 158 ~~~~~~~~~~~~~~~Gt~~Y~APEvl~~-----~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~- 230 (448)
...... .......|++.|+|||++.. ..+ +.++|+|||||++|+|++|..||...........+..... .
T Consensus 170 ~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~-~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 246 (282)
T cd06636 170 QLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATY-DYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKL 246 (282)
T ss_pred hhhccc--cCCCcccccccccCHhhcCcccCcCcCC-CcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCC
Confidence 543221 12245679999999999852 234 4689999999999999999999977655444333333221 1
Q ss_pred CCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhc
Q 037702 231 CPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWF 266 (448)
Q Consensus 231 ~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 266 (448)
.+..++.++.+||.+||..||.+|||+.+|++||||
T Consensus 247 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 247 KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred cccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 223478999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=338.86 Aligned_cols=252 Identities=29% Similarity=0.574 Sum_probs=213.3
Q ss_pred cCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFA 88 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 88 (448)
.++|++.+.||+|+||.||+|++..+|+.||||.+.............+.+|+.+++.++||||+++++++...+..|+|
T Consensus 1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence 36899999999999999999999999999999998765444445556788999999999999999999999999999999
Q ss_pred EeecCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccc
Q 037702 89 MEYVRGGELFNKVAK-----GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTR 163 (448)
Q Consensus 89 ~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~ 163 (448)
|||+++|+|.+++.. ..+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~ 160 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence 999999999988742 348999999999999999999999999999999999999999999999999987653321
Q ss_pred cCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCc--HHHHHHHHhhccCC-C-CCCCCHHH
Q 037702 164 QDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSN--LMELYKKITRAEFK-C-PNWFPPEV 239 (448)
Q Consensus 164 ~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~--~~~~~~~i~~~~~~-~-p~~~s~~~ 239 (448)
.......|++.|+|||.+.+..++ .++|+||||+++|+|++|..||.... .......+....++ . +..++..+
T Consensus 161 --~~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd08228 161 --TAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKL 237 (267)
T ss_pred --HHHhcCCCCccccChhhhccCCCC-chhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHH
Confidence 122345789999999999776664 78999999999999999999996543 23444444433322 2 23577899
Q ss_pred HHHHHhccCCCcCCCCCHHHHHhh
Q 037702 240 RKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 240 ~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
.++|.+||..+|++||+++++++.
T Consensus 238 ~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 238 RELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHHHHHCCCCcccCcCHHHHHHH
Confidence 999999999999999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-44 Score=351.03 Aligned_cols=246 Identities=27% Similarity=0.454 Sum_probs=192.6
Q ss_pred EeeeeecCceEEEEEEECC--CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE--eCCEEEEEEe
Q 037702 15 GRLLGQGTFAKVYHGRNLK--TGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMA--SKTKIYFAME 90 (448)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~--~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~--~~~~~~lV~E 90 (448)
+..||+|+||.||+|.+.. ++..||+|.+..... ...+.+|+.+++.++||||+++++++. .+..+|+|||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence 5689999999999999654 668899999865432 245678999999999999999999885 4567899999
Q ss_pred ecCCCchHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEE----cCCCCeEEeecccc
Q 037702 91 YVRGGELFNKVAK----------GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLL----DENGDLKISDFGLS 156 (448)
Q Consensus 91 ~~~gg~L~~~i~~----------~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl----~~~g~lkl~DFGla 156 (448)
|+.+ +|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 81 YAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred eeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 9875 77776642 248899999999999999999999999999999999999 56678999999999
Q ss_pred cccccccc-CCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHH---------HHHHHHhh
Q 037702 157 ALQESTRQ-DGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLM---------ELYKKITR 226 (448)
Q Consensus 157 ~~~~~~~~-~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~---------~~~~~i~~ 226 (448)
........ ........||+.|+|||++.+....+.++|||||||++|+|++|.+||...... .....+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS 239 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence 86543221 112234578999999999976555568899999999999999999999643211 00000000
Q ss_pred ----------------------------ccC----------CCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhc
Q 037702 227 ----------------------------AEF----------KCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWF 266 (448)
Q Consensus 227 ----------------------------~~~----------~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 266 (448)
... ......+..+.+||.+||..||.+|||++|+++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 000 0011134678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-44 Score=355.60 Aligned_cols=263 Identities=26% Similarity=0.421 Sum_probs=219.8
Q ss_pred CccccccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 037702 1 MEKKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMA 80 (448)
Q Consensus 1 m~~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~ 80 (448)
|.+....+.++|++.+.||+|+||.||+|++..+++.||||++...... ......+.+|+.+++.++||||+++++++.
T Consensus 6 ~~~~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 84 (343)
T cd07851 6 LNKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS-AIHAKRTYRELRLLKHMDHENVIGLLDVFT 84 (343)
T ss_pred hccceecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccch-hhHHHHHHHHHHHHHhccCCCHHHHHHHhh
Confidence 3444556788999999999999999999999999999999998654222 233466788999999999999999998876
Q ss_pred eCCE------EEEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecc
Q 037702 81 SKTK------IYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFG 154 (448)
Q Consensus 81 ~~~~------~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFG 154 (448)
..+. .|+|+||+ +++|.+++..+++++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||
T Consensus 85 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 85 PASSLEDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred ccccccccccEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccc
Confidence 5544 89999999 6699999988889999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccC-----
Q 037702 155 LSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF----- 229 (448)
Q Consensus 155 la~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~----- 229 (448)
++...... .....+|+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+.+..+.....
T Consensus 164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 238 (343)
T cd07851 164 LARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEE 238 (343)
T ss_pred cccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Confidence 98754321 23457899999999986644556889999999999999999999988776655554432110
Q ss_pred --------------------------CCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccccc
Q 037702 230 --------------------------KCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGY 270 (448)
Q Consensus 230 --------------------------~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 270 (448)
.....+++++.+||.+||.+||.+|||+.++++||||.+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~ 305 (343)
T cd07851 239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYH 305 (343)
T ss_pred HHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccC
Confidence 00123588999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=353.91 Aligned_cols=258 Identities=28% Similarity=0.437 Sum_probs=211.9
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASK----- 82 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~----- 82 (448)
+.++|++.+.||.|+||.||+|.+..+|+.||+|.+..... ...+.+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLT 79 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccc
Confidence 45899999999999999999999999999999999876543 3346788999999999999999999876543
Q ss_pred ---------CEEEEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcC-CCCeEEee
Q 037702 83 ---------TKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDE-NGDLKISD 152 (448)
Q Consensus 83 ---------~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~-~g~lkl~D 152 (448)
...|+||||++ ++|.+++..+.+++..++.++.||++||.|||++||+||||||+||+++. ++.+||+|
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 80 EDVGSLTELNSVYIVQEYME-TDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred cccccccccceEEEEeeccc-ccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence 35899999997 58999888888999999999999999999999999999999999999984 55789999
Q ss_pred cccccccccccc-CCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhcc---
Q 037702 153 FGLSALQESTRQ-DGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAE--- 228 (448)
Q Consensus 153 FGla~~~~~~~~-~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--- 228 (448)
||++........ ........|+..|+|||++......+.++|||||||++|+|++|+.||...+..+....+....
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999875432211 1112234689999999987654445688999999999999999999998776554444332210
Q ss_pred ----------------------C-----CCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 229 ----------------------F-----KCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 229 ----------------------~-----~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
. .+.+.++.++.+||.+||..||.+|||+.+++.||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred ChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 0 0123467899999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-44 Score=341.93 Aligned_cols=252 Identities=29% Similarity=0.518 Sum_probs=216.4
Q ss_pred CCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 037702 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAM 89 (448)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (448)
++|++.+.||+|+||.||+|.+..+++.+|+|.+...... .....+.+|+.+++.++||||+++++.+......|+++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE--AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh--HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 4789999999999999999999999999999999765432 34467889999999999999999999999999999999
Q ss_pred eecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH-CCCEeecCCCCceEEcCCCCeEEeeccccccccccccCC
Q 037702 90 EYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHS-RGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDG 166 (448)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~-~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 166 (448)
||+++++|.+++.. ..+++..+..++.|++.||.|||+ .|++||||||+||+++.++.++|+|||++........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 156 (265)
T cd06605 79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-- 156 (265)
T ss_pred EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh--
Confidence 99999999999975 578999999999999999999999 9999999999999999999999999999875532221
Q ss_pred CccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCC-----cHHHHHHHHhhcc-CCCCCC-CCHHH
Q 037702 167 LLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDS-----NLMELYKKITRAE-FKCPNW-FPPEV 239 (448)
Q Consensus 167 ~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~-----~~~~~~~~i~~~~-~~~p~~-~s~~~ 239 (448)
....|+..|+|||.+.+..+ +.++||||||+++|+|++|..||... ...+....+.... ...+.. +++++
T Consensus 157 --~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (265)
T cd06605 157 --KTFVGTSSYMAPERIQGNDY-SVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDF 233 (265)
T ss_pred --hcccCChhccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHH
Confidence 22678999999999977665 48899999999999999999999754 2333444443332 233443 78999
Q ss_pred HHHHHhccCCCcCCCCCHHHHHhhhhccc
Q 037702 240 RKLLSRILDPNPSTRVTMAKLMENYWFRK 268 (448)
Q Consensus 240 ~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 268 (448)
.++|.+||..||.+|||+.+++.||||+.
T Consensus 234 ~~li~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 234 QDFVNLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred HHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence 99999999999999999999999999965
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=344.31 Aligned_cols=251 Identities=27% Similarity=0.403 Sum_probs=213.2
Q ss_pred ccCCeEEEeeeeecCceEEEEEEEC-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNL-----KTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASK 82 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~ 82 (448)
-.++|.+.+.||+|+||.||++.+. .++..+|+|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEG 79 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 3568999999999999999999852 345679999886542 23356788999999999999999999999999
Q ss_pred CEEEEEEeecCCCchHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCe
Q 037702 83 TKIYFAMEYVRGGELFNKVAKG--------------KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDL 148 (448)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~~--------------~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~l 148 (448)
..+|+||||+++++|.+++... .+++..+..++.|++.||+|||++|++||||||+|||++.++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence 9999999999999999998642 38999999999999999999999999999999999999999999
Q ss_pred EEeeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhc
Q 037702 149 KISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA 227 (448)
Q Consensus 149 kl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~ 227 (448)
||+|||++................+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...+..+....+..+
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~ 238 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG 238 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 9999999875432221112233456789999999976655 478999999999999998 99999988877777777766
Q ss_pred cC-CCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHh
Q 037702 228 EF-KCPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 228 ~~-~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 262 (448)
.. ..+..+++++.+|+.+||++||.+|||+.++++
T Consensus 239 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 239 RVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 53 445668899999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=343.80 Aligned_cols=254 Identities=30% Similarity=0.452 Sum_probs=208.2
Q ss_pred CCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCE----
Q 037702 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR-HPNIVQLYEVMASKTK---- 84 (448)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~---- 84 (448)
++|++.+.||+|+||.||+|.+..+|+.||+|.+...... ......+.+|+.+++.+. ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDE-EGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccc-cCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 5799999999999999999999999999999998665322 223456788999999995 6999999999877665
Q ss_pred -EEEEEeecCCCchHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcC-CCCeEEeecccc
Q 037702 85 -IYFAMEYVRGGELFNKVAK------GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDE-NGDLKISDFGLS 156 (448)
Q Consensus 85 -~~lV~E~~~gg~L~~~i~~------~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~-~g~lkl~DFGla 156 (448)
.|+||||+++ +|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 8999999986 78887753 24799999999999999999999999999999999999998 889999999998
Q ss_pred ccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhcc-----C--
Q 037702 157 ALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAE-----F-- 229 (448)
Q Consensus 157 ~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-----~-- 229 (448)
....... .......+++.|+|||++.+....+.++||||||+++|+|++|..||.+.+......++.... .
T Consensus 159 ~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 159 RAFSIPV--KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred eecCCCc--cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 7543221 112234678999999998654444688999999999999999999998876655444332210 0
Q ss_pred ----------CC-----------CCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcc
Q 037702 230 ----------KC-----------PNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFR 267 (448)
Q Consensus 230 ----------~~-----------p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~ 267 (448)
.. .+.+++++.+||.+||.+||.+||++.+++.||||+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 00 123788999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-44 Score=346.88 Aligned_cols=254 Identities=31% Similarity=0.457 Sum_probs=213.2
Q ss_pred cCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEEE
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASK--TKIY 86 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~~ 86 (448)
.++|++.+.||+|+||.||+|.+..+++.+|+|.+....... .....+.+|+.+++.++||||+++++++... ...|
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKE-GFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccc-cchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 467999999999999999999999999999999997654332 3334567899999999999999999998877 8999
Q ss_pred EEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccccc
Q 037702 87 FAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQ 164 (448)
Q Consensus 87 lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~ 164 (448)
+||||+++ +|.+++.. ..+++..++.++.|++.||+|||++|++||||||+|||++.++.+||+|||++.......
T Consensus 83 lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~- 160 (293)
T cd07843 83 MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL- 160 (293)
T ss_pred EEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc-
Confidence 99999975 89888865 358999999999999999999999999999999999999999999999999988654321
Q ss_pred CCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhcc----------------
Q 037702 165 DGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAE---------------- 228 (448)
Q Consensus 165 ~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~---------------- 228 (448)
.......+++.|+|||++.+....+.++|+||||+++|+|++|..||...+..+...++...-
T Consensus 161 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (293)
T cd07843 161 -KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPG 239 (293)
T ss_pred -cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccch
Confidence 122345688999999998765555688999999999999999999998877665554432210
Q ss_pred ---------------CCCCCC-CCHHHHHHHHhccCCCcCCCCCHHHHHhhhhc
Q 037702 229 ---------------FKCPNW-FPPEVRKLLSRILDPNPSTRVTMAKLMENYWF 266 (448)
Q Consensus 229 ---------------~~~p~~-~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 266 (448)
..+|.. +++.+.++|.+||+.||++|||+.|+++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred hcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 112222 58889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=346.95 Aligned_cols=258 Identities=31% Similarity=0.522 Sum_probs=219.5
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIY 86 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 86 (448)
...++|++.+.||+|+||.||++.+..++..||+|.+..... ...+.+.+|+.+++.++||||+++++++...+..|
T Consensus 16 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~ 92 (293)
T cd06647 16 DPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKHPNIVNYLDSYLVGDELW 92 (293)
T ss_pred CchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc---hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEE
Confidence 346899999999999999999999988999999999865432 22467889999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCC
Q 037702 87 FAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDG 166 (448)
Q Consensus 87 lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 166 (448)
+|+||+++++|.+++.+..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++....... .
T Consensus 93 lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~--~ 170 (293)
T cd06647 93 VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--S 170 (293)
T ss_pred EEEecCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccc--c
Confidence 99999999999999988889999999999999999999999999999999999999999999999999987543222 1
Q ss_pred CccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhc---cCCCCCCCCHHHHHHH
Q 037702 167 LLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA---EFKCPNWFPPEVRKLL 243 (448)
Q Consensus 167 ~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~li 243 (448)
......|++.|+|||.+....+ +.++|+|||||++|+|++|+.||...+.......+... .+..+..++..++++|
T Consensus 171 ~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 249 (293)
T cd06647 171 KRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFL 249 (293)
T ss_pred ccccccCChhhcCchhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHH
Confidence 2234568999999999877655 47899999999999999999999876654433322221 1223344678999999
Q ss_pred HhccCCCcCCCCCHHHHHhhhhccccc
Q 037702 244 SRILDPNPSTRVTMAKLMENYWFRKGY 270 (448)
Q Consensus 244 ~~~L~~dP~~Rpt~~eil~hp~~~~~~ 270 (448)
++||..+|.+||++.+++.|+||+...
T Consensus 250 ~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 250 NRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred HHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=342.09 Aligned_cols=253 Identities=26% Similarity=0.407 Sum_probs=212.5
Q ss_pred ccCCeEEEeeeeecCceEEEEEEEC----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNL----KTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKT 83 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~----~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~ 83 (448)
...+|++.+.||+|+||.||+|.+. .++..||+|.+..... ......+.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 80 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINN--PQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ 80 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCC--HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence 4578999999999999999999853 4567899999864322 233467889999999999999999999999999
Q ss_pred EEEEEEeecCCCchHHHHhc------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCC
Q 037702 84 KIYFAMEYVRGGELFNKVAK------------------GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDEN 145 (448)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~------------------~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~ 145 (448)
..|+||||+++++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+|||++.+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence 99999999999999998842 237888899999999999999999999999999999999999
Q ss_pred CCeEEeeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHH
Q 037702 146 GDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKI 224 (448)
Q Consensus 146 g~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i 224 (448)
+.+||+|||++................++..|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~ 239 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKF-SSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV 239 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999975433222222234456788999999876655 588999999999999998 99999887766666555
Q ss_pred hhcc-CCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 225 TRAE-FKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 225 ~~~~-~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
.... ...|..+++.+.+++.+||+.||.+||++.+|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 240 RKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 5443 45677789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=336.62 Aligned_cols=252 Identities=29% Similarity=0.586 Sum_probs=217.0
Q ss_pred CeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 037702 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAME 90 (448)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (448)
+|++.+.||+|+||.||+|.+..+|..+|+|.+....... ...+.+.+|+.+++.++||||+++++.+......|+|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 6999999999999999999999999999999997654332 234678899999999999999999999999999999999
Q ss_pred ecCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCC-eEEeeccccccccccccCC
Q 037702 91 YVRGGELFNKVAK---GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGD-LKISDFGLSALQESTRQDG 166 (448)
Q Consensus 91 ~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~-lkl~DFGla~~~~~~~~~~ 166 (448)
|+++++|.+++.. ..+++..+..++.|++.||.|||++|++|+||||+||+++.++. +||+|||++....... .
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~--~ 157 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM--E 157 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc--c
Confidence 9999999999865 24799999999999999999999999999999999999998865 6999999987653321 1
Q ss_pred CccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccC-CCCCCCCHHHHHHHHh
Q 037702 167 LLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF-KCPNWFPPEVRKLLSR 245 (448)
Q Consensus 167 ~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~ 245 (448)
......|++.|+|||++....+ +.++|+||||+++|+|++|..||...+..+....+..... ..++.++.++.++|.+
T Consensus 158 ~~~~~~~~~~~~ape~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 236 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQNRPY-NNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQ 236 (257)
T ss_pred cccccCCCccccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHH
Confidence 2233468999999999876655 4789999999999999999999988776666655554433 3445678999999999
Q ss_pred ccCCCcCCCCCHHHHHhhhhc
Q 037702 246 ILDPNPSTRVTMAKLMENYWF 266 (448)
Q Consensus 246 ~L~~dP~~Rpt~~eil~hp~~ 266 (448)
||..+|++|||+.++++||||
T Consensus 237 ~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 237 LFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HhccChhhCcCHHHHhhCCCC
Confidence 999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=341.27 Aligned_cols=254 Identities=22% Similarity=0.317 Sum_probs=211.6
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLK-----TGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMAS 81 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~ 81 (448)
+..++|++.+.||+|+||.||+|.+.. ++..||||.+..... ......+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~ 80 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS--MRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 80 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 467899999999999999999998642 456799999864322 1234568899999999999999999999999
Q ss_pred CCEEEEEEeecCCCchHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEE
Q 037702 82 KTKIYFAMEYVRGGELFNKVAKG-----------KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKI 150 (448)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~~-----------~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl 150 (448)
+...++||||+++|+|.+++... .++...+..++.|++.||.|||++|++||||||+|||++.++.++|
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEE
Confidence 99999999999999999998641 2467788999999999999999999999999999999999999999
Q ss_pred eeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhccC
Q 037702 151 SDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAEF 229 (448)
Q Consensus 151 ~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~ 229 (448)
+|||++................+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+.....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~ 239 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGL 239 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCc-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc
Confidence 99999875432221111123456788999999976655 588999999999999999 7999988887777666655443
Q ss_pred -CCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 230 -KCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 230 -~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
..|..+++.+.+++.+||..||++|||+.+++++
T Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 240 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 4566788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=343.23 Aligned_cols=252 Identities=26% Similarity=0.402 Sum_probs=214.2
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLK-----TGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASK 82 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~ 82 (448)
..++|.+.+.||+|+||.||+|.+.. ++..||||.+..... .+..+.+.+|+++++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 80 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS--NDARKDFEREAELLTNFQHENIVKFYGVCTEG 80 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC--HHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence 35679999999999999999998743 467899999865432 22347889999999999999999999999999
Q ss_pred CEEEEEEeecCCCchHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCC
Q 037702 83 TKIYFAMEYVRGGELFNKVAK---------------GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGD 147 (448)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~---------------~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~ 147 (448)
...|+||||+++++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence 999999999999999999864 23788899999999999999999999999999999999999999
Q ss_pred eEEeeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhh
Q 037702 148 LKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITR 226 (448)
Q Consensus 148 lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~ 226 (448)
+||+|||++................+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~ 239 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQ 239 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCc-chhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 99999999875322211112234456789999999977666 478999999999999998 9999988887777777776
Q ss_pred ccCC-CCCCCCHHHHHHHHhccCCCcCCCCCHHHHHh
Q 037702 227 AEFK-CPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 227 ~~~~-~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 262 (448)
+... .|..++..+.+++.+||..||.+||++.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 240 GRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 5543 45568899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=338.36 Aligned_cols=246 Identities=33% Similarity=0.585 Sum_probs=208.9
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHH-HHhCCCCCcceEEEEEEeCCEEEEEEeecCC
Q 037702 16 RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISV-MRLVRHPNIVQLYEVMASKTKIYFAMEYVRG 94 (448)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~-l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (448)
+.||+|+||.||+|.+..+|+.||+|++.+...........+..|..+ ....+||||+++++++..++.+|+||||++|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 579999999999999999999999999976543322223344455544 4455899999999999999999999999999
Q ss_pred CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCccccCC
Q 037702 95 GELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCG 173 (448)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~G 173 (448)
++|.+++.. +.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++..... .....|
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~~~~~ 155 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKKFVG 155 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc------cccCCC
Confidence 999999976 6799999999999999999999999999999999999999999999999999875322 234568
Q ss_pred CCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCC----CCCCCHHHHHHHHhccCC
Q 037702 174 TPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKC----PNWFPPEVRKLLSRILDP 249 (448)
Q Consensus 174 t~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~----p~~~s~~~~~li~~~L~~ 249 (448)
++.|+|||.+.+..+ +.++||||||+++|+|++|..||...+....+..+......+ +..+++++.++|.+||..
T Consensus 156 ~~~y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 234 (260)
T cd05611 156 TPDYLAPETILGVGD-DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCM 234 (260)
T ss_pred CcCccChhhhcCCCC-cchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccC
Confidence 999999999877664 588999999999999999999999888877777766554433 235789999999999999
Q ss_pred CcCCCC---CHHHHHhhhhccc
Q 037702 250 NPSTRV---TMAKLMENYWFRK 268 (448)
Q Consensus 250 dP~~Rp---t~~eil~hp~~~~ 268 (448)
||++|| +++|++.||||++
T Consensus 235 ~p~~R~~~~~~~~~l~~~~~~~ 256 (260)
T cd05611 235 DPAKRLGANGYQEIKSHPFFKS 256 (260)
T ss_pred CHHHccCCCcHHHHHcChHhhc
Confidence 999999 5589999999965
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=364.89 Aligned_cols=252 Identities=27% Similarity=0.446 Sum_probs=219.9
Q ss_pred CeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 037702 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAME 90 (448)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (448)
.|.-.+.||.|+||.||.|++..+.+.||||.++.+.-...+-.+.+.+|+..|+.++|||++.+.++|..+...|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 35567889999999999999999999999999988776666667889999999999999999999999999999999999
Q ss_pred ecCCCchHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCc
Q 037702 91 YVRGGELFNKVA--KGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLL 168 (448)
Q Consensus 91 ~~~gg~L~~~i~--~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 168 (448)
||-| +-.|++. +.++.|.++..+..+.+.||+|||+.+.||||||..||||++.|.+||+|||.|..... .
T Consensus 107 YClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P------A 179 (948)
T KOG0577|consen 107 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP------A 179 (948)
T ss_pred HHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc------h
Confidence 9965 5566654 35799999999999999999999999999999999999999999999999999986543 3
Q ss_pred cccCCCCcccchhhhh--ccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCC-CC-CCCCHHHHHHHH
Q 037702 169 HTTCGTPAYVAPEVIN--KRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFK-CP-NWFPPEVRKLLS 244 (448)
Q Consensus 169 ~~~~Gt~~Y~APEvl~--~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-~p-~~~s~~~~~li~ 244 (448)
.+.+|||+||||||+. ..|.+.-++|||||||++.||...++|+...|.+..+..|...+.+ .+ +.+|..+.+|+.
T Consensus 180 nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd 259 (948)
T KOG0577|consen 180 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVD 259 (948)
T ss_pred hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHH
Confidence 5679999999999985 3344447799999999999999999999999888666666555432 32 236899999999
Q ss_pred hccCCCcCCCCCHHHHHhhhhcccc
Q 037702 245 RILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 245 ~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
.||++-|.+|||.+++|.|+|+...
T Consensus 260 ~CLqKipqeRptse~ll~H~fv~R~ 284 (948)
T KOG0577|consen 260 SCLQKIPQERPTSEELLKHRFVLRE 284 (948)
T ss_pred HHHhhCcccCCcHHHHhhcchhccC
Confidence 9999999999999999999998654
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=341.70 Aligned_cols=251 Identities=32% Similarity=0.532 Sum_probs=211.3
Q ss_pred CeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 037702 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAME 90 (448)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (448)
+|++.+.||.|++|.||+|.+..+|+.||||.+...... ...+.+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE--GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc--cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 599999999999999999999999999999999765322 223567789999999999999999999999999999999
Q ss_pred ecCCCchHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCC
Q 037702 91 YVRGGELFNKVAK----GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDG 166 (448)
Q Consensus 91 ~~~gg~L~~~i~~----~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 166 (448)
|+++ +|.+++.. ..+++..+..++.|++.||+|||+.|++||||||+||++++++.++|+|||++........
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 155 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-- 155 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc--
Confidence 9985 88888764 3589999999999999999999999999999999999999999999999999975432211
Q ss_pred CccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhcc------------------
Q 037702 167 LLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAE------------------ 228 (448)
Q Consensus 167 ~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~------------------ 228 (448)
......+|+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+...++....
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence 12345678999999998665555688999999999999999999998877665554433210
Q ss_pred CC-----------CCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhc
Q 037702 229 FK-----------CPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWF 266 (448)
Q Consensus 229 ~~-----------~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 266 (448)
.. ..+.+++.+.++|.+||+.||.+||+++++++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 00 112457889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=341.99 Aligned_cols=253 Identities=30% Similarity=0.534 Sum_probs=218.6
Q ss_pred CeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 037702 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAME 90 (448)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (448)
.|...+.||+|++|.||+|.+..+++.+|+|.+..... ...+.+.+|+.+++.++||||+++++++...+..|+++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch---hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 56667899999999999999999999999999864432 224568899999999999999999999999999999999
Q ss_pred ecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCccc
Q 037702 91 YVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHT 170 (448)
Q Consensus 91 ~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~ 170 (448)
|++|++|.+++..+++++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++....... .....
T Consensus 97 ~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~--~~~~~ 174 (285)
T cd06648 97 FLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV--PRRKS 174 (285)
T ss_pred ccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC--ccccc
Confidence 9999999999988889999999999999999999999999999999999999999999999999887543221 12234
Q ss_pred cCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCC---CCCCCCHHHHHHHHhcc
Q 037702 171 TCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFK---CPNWFPPEVRKLLSRIL 247 (448)
Q Consensus 171 ~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---~p~~~s~~~~~li~~~L 247 (448)
..|++.|+|||.+.+..+ +.++||||+||++|+|++|+.||...+.......+...... .+..++..+.++|.+||
T Consensus 175 ~~~~~~y~aPE~~~~~~~-~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 253 (285)
T cd06648 175 LVGTPYWMAPEVISRLPY-GTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRML 253 (285)
T ss_pred ccCCccccCHHHhcCCCC-CCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHc
Confidence 569999999999877665 48899999999999999999999887776666666554322 23337889999999999
Q ss_pred CCCcCCCCCHHHHHhhhhcccc
Q 037702 248 DPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 248 ~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
..||++|||+.++++||||.+.
T Consensus 254 ~~~p~~Rpt~~~il~~~~~~~~ 275 (285)
T cd06648 254 VRDPAQRATAAELLNHPFLAKA 275 (285)
T ss_pred ccChhhCcCHHHHccCcccccC
Confidence 9999999999999999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=347.68 Aligned_cols=255 Identities=29% Similarity=0.543 Sum_probs=218.2
Q ss_pred CCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 037702 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAM 89 (448)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (448)
.-|+....||+|+||.||+|.+..+++.||+|.+...... ..+.+.+|+.+++.++||||+++++.+..+...|+||
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~ 97 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ---RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLM 97 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc---hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEE
Confidence 3455677899999999999999989999999999754322 2366889999999999999999999999999999999
Q ss_pred eecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCcc
Q 037702 90 EYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLH 169 (448)
Q Consensus 90 E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~ 169 (448)
||+++++|..++....+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++....... ....
T Consensus 98 e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~ 175 (297)
T cd06659 98 EFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRK 175 (297)
T ss_pred ecCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc--cccc
Confidence 99999999998887889999999999999999999999999999999999999999999999999987543221 1123
Q ss_pred ccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhcc---CCCCCCCCHHHHHHHHhc
Q 037702 170 TTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAE---FKCPNWFPPEVRKLLSRI 246 (448)
Q Consensus 170 ~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~li~~~ 246 (448)
..+|++.|+|||++.+..+ +.++|||||||++|+|++|+.||...+..+....+.... ...+..+++.+.++|.+|
T Consensus 176 ~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~ 254 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPY-GTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERM 254 (297)
T ss_pred ceecCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHH
Confidence 4679999999999977665 488999999999999999999998777666555554332 223345788999999999
Q ss_pred cCCCcCCCCCHHHHHhhhhccccc
Q 037702 247 LDPNPSTRVTMAKLMENYWFRKGY 270 (448)
Q Consensus 247 L~~dP~~Rpt~~eil~hp~~~~~~ 270 (448)
|..||.+||+++++++||||.+..
T Consensus 255 l~~~P~~Rps~~~ll~~~~~~~~~ 278 (297)
T cd06659 255 LTREPQERATAQELLDHPFLLQTG 278 (297)
T ss_pred hcCCcccCcCHHHHhhChhhccCC
Confidence 999999999999999999997643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=332.71 Aligned_cols=252 Identities=36% Similarity=0.652 Sum_probs=222.0
Q ss_pred CeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 037702 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAME 90 (448)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (448)
+|++.+.||+|+||.||++.+..++..||+|.+...... ......+.+|+++++.++|||++++++.+......++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 699999999999999999999989999999999765433 2345678899999999999999999999999999999999
Q ss_pred ecCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccC
Q 037702 91 YVRGGELFNKVAK-----GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQD 165 (448)
Q Consensus 91 ~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~ 165 (448)
|+++++|.+.+.. +.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 157 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-- 157 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc--
Confidence 9999999998864 569999999999999999999999999999999999999999999999999998654332
Q ss_pred CCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccC-CCCCCCCHHHHHHHH
Q 037702 166 GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF-KCPNWFPPEVRKLLS 244 (448)
Q Consensus 166 ~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~ 244 (448)
......+|++.|+|||.+....+ +.++|+||+|+++|+|++|..||...+.......+..... ..|..++.++.+++.
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQNKPY-NYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVS 236 (258)
T ss_pred ceecceeeeecccChhHhccCCC-CccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence 23345679999999999877665 4789999999999999999999988877777666655433 456678899999999
Q ss_pred hccCCCcCCCCCHHHHHhhhhc
Q 037702 245 RILDPNPSTRVTMAKLMENYWF 266 (448)
Q Consensus 245 ~~L~~dP~~Rpt~~eil~hp~~ 266 (448)
+||..||.+|||+.++++||||
T Consensus 237 ~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 237 SLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHcCCChhhCcCHHHHhcCCCC
Confidence 9999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=345.60 Aligned_cols=258 Identities=24% Similarity=0.412 Sum_probs=214.9
Q ss_pred cccccccCCeEEEeeeeecCceEEEEEEECC-------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcce
Q 037702 3 KKAGILMNKYELGRLLGQGTFAKVYHGRNLK-------TGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQ 74 (448)
Q Consensus 3 ~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~-------~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~ 74 (448)
++..+..++|.+++.||+|+||.||+|++.. ++..+|+|.+..... ......+.+|+.+++.+ +||||++
T Consensus 11 ~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~~h~~i~~ 88 (307)
T cd05098 11 PRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNIIN 88 (307)
T ss_pred CcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCC--hHHHHHHHHHHHHHHHhcCCCCEee
Confidence 3445677899999999999999999998643 235699999875421 23346688899999999 7999999
Q ss_pred EEEEEEeCCEEEEEEeecCCCchHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCC
Q 037702 75 LYEVMASKTKIYFAMEYVRGGELFNKVAKG-----------------KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKP 137 (448)
Q Consensus 75 l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-----------------~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp 137 (448)
+++++......|+||||+++|+|.+++... .+++..+..++.|++.||+|||++|++||||||
T Consensus 89 ~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp 168 (307)
T cd05098 89 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAA 168 (307)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccH
Confidence 999999999999999999999999999642 378889999999999999999999999999999
Q ss_pred CceEEcCCCCeEEeeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCc
Q 037702 138 ENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSN 216 (448)
Q Consensus 138 ~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~ 216 (448)
+|||++.++.+||+|||++................+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...+
T Consensus 169 ~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~~~g~~p~~~~~ 247 (307)
T cd05098 169 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVP 247 (307)
T ss_pred HheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCC-CcHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence 999999999999999999875432211111112234578999999977655 488999999999999998 899998888
Q ss_pred HHHHHHHHhhcc-CCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 217 LMELYKKITRAE-FKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 217 ~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
..+....+.... ...|..++.++.+||.+||..+|.+|||+.+++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 248 VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 777777665554 35667789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=336.19 Aligned_cols=251 Identities=26% Similarity=0.463 Sum_probs=215.3
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIY 86 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 86 (448)
+...+|++.+.||+|+||.||+|.+..+++.||+|.+.... .....+.+|+.+++.++||||+++++++...+.++
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 78 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcE
Confidence 44567999999999999999999999999999999986542 22466889999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccc
Q 037702 87 FAMEYVRGGELFNKVAK---GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTR 163 (448)
Q Consensus 87 lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~ 163 (448)
++|||+++++|.+++.. ..+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||++.......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 99999999999999864 358999999999999999999999999999999999999999999999999987643321
Q ss_pred cCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhc-cCCCCCCCCHHHHH
Q 037702 164 QDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EFKCPNWFPPEVRK 241 (448)
Q Consensus 164 ~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 241 (448)
.. ......+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.+..+.+..+... ....|..+++++.+
T Consensus 159 ~~-~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (263)
T cd05052 159 YT-AHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYE 236 (263)
T ss_pred ee-ccCCCCCccccCCHHHhccCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHH
Confidence 11 1112234678999999876665 478999999999999998 99999988877777776554 44567778999999
Q ss_pred HHHhccCCCcCCCCCHHHHHhh
Q 037702 242 LLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~h 263 (448)
+|.+||..||++|||+.++++.
T Consensus 237 li~~cl~~~p~~Rp~~~~l~~~ 258 (263)
T cd05052 237 LMRACWQWNPSDRPSFAEIHQA 258 (263)
T ss_pred HHHHHccCCcccCCCHHHHHHH
Confidence 9999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=347.86 Aligned_cols=253 Identities=22% Similarity=0.370 Sum_probs=210.9
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcE----EEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQS----VAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASK 82 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~----vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~ 82 (448)
+...+|++.+.||+|+||.||+|.+..+|+. ||+|++.... .....+.+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~ 81 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 81 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC
Confidence 3456899999999999999999998776664 8999986432 223346788999999999999999999998764
Q ss_pred CEEEEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccc
Q 037702 83 TKIYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQE 160 (448)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~ 160 (448)
..++++||+++|+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 82 -~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 82 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred -CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccccc
Confidence 57899999999999999976 368999999999999999999999999999999999999999999999999998654
Q ss_pred ccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhc-cCCCCCCCCHH
Q 037702 161 STRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EFKCPNWFPPE 238 (448)
Q Consensus 161 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~ 238 (448)
............++..|+|||++.+..++ .++|||||||++|+|++ |..||.+....+....+... ..+.|..++.+
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID 239 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHH
Confidence 32221112233456789999999776664 88999999999999997 99999887766655444333 33556778999
Q ss_pred HHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 239 VRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 239 ~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
+.+++.+||..||.+||++.+++.+
T Consensus 240 ~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 240 VYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=336.54 Aligned_cols=252 Identities=23% Similarity=0.380 Sum_probs=213.5
Q ss_pred cCCeEEEeeeeecCceEEEEEEECCC---CcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNLKT---GQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKI 85 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 85 (448)
.++|++.+.||+|+||.||+|.+..+ ...||||.+..... ......+.+|+.+++.++||||+++++.+......
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSS--DKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCC--hHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 46899999999999999999998654 45799998865432 23346688899999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccc
Q 037702 86 YFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTR 163 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~ 163 (448)
|+||||+++++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 999999999999999865 579999999999999999999999999999999999999999999999999998664222
Q ss_pred cCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhc-cCCCCCCCCHHHHH
Q 037702 164 QDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EFKCPNWFPPEVRK 241 (448)
Q Consensus 164 ~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 241 (448)
.........+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||...........+... ..+.+..+++.+.+
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAYRKF-TSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQ 239 (266)
T ss_pred cceeccCCCCCccccChhhhccCCC-ccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 1111122345678999999877665 478999999999999998 99999887777777666554 33456678999999
Q ss_pred HHHhccCCCcCCCCCHHHHHhh
Q 037702 242 LLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~h 263 (448)
++.+||+.||++||++.+++++
T Consensus 240 li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 240 LMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHHcCCCcccCcCHHHHHHH
Confidence 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=341.82 Aligned_cols=256 Identities=30% Similarity=0.513 Sum_probs=210.9
Q ss_pred cCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFA 88 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 88 (448)
+++|++.+.||+|++|.||+|.+..+|+.||+|.+....... ...+.+.+|+.+++.++||||+++++++.+....|+|
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDE-GVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV 79 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccc-cchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence 468999999999999999999999999999999986653322 3346678899999999999999999999999999999
Q ss_pred EeecCCCchHHHHhc-C--CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcC-CCCeEEeecccccccccccc
Q 037702 89 MEYVRGGELFNKVAK-G--KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDE-NGDLKISDFGLSALQESTRQ 164 (448)
Q Consensus 89 ~E~~~gg~L~~~i~~-~--~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~-~g~lkl~DFGla~~~~~~~~ 164 (448)
|||++ ++|.+.+.. . .+++..++.++.||+.||+|||++|++||||+|+||+++. ++.+||+|||++.......
T Consensus 80 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~- 157 (294)
T PLN00009 80 FEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV- 157 (294)
T ss_pred Eeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc-
Confidence 99996 478777754 2 3688899999999999999999999999999999999985 4579999999997543221
Q ss_pred CCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhcc----------------
Q 037702 165 DGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAE---------------- 228 (448)
Q Consensus 165 ~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~---------------- 228 (448)
.......|++.|+|||++.+....+.++|||||||++|+|++|..||......+...++....
T Consensus 158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (294)
T PLN00009 158 -RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236 (294)
T ss_pred -cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence 112344678999999998765545688999999999999999999998766555444432110
Q ss_pred ----C-C--------CCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccc
Q 037702 229 ----F-K--------CPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRK 268 (448)
Q Consensus 229 ----~-~--------~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 268 (448)
. . ..+.+++++.+++.+||+.||.+||++.++++||||+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~ 289 (294)
T PLN00009 237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKD 289 (294)
T ss_pred hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhH
Confidence 0 0 12346889999999999999999999999999999975
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=341.12 Aligned_cols=253 Identities=30% Similarity=0.484 Sum_probs=204.8
Q ss_pred cCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFA 88 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 88 (448)
.++|.+.+.||+|+||.||+|.+..+|+.||+|.+...... .....+.+|+.+++.++|+||+++++++..+...|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE--GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC--CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence 36899999999999999999999999999999998755322 2224567899999999999999999999999999999
Q ss_pred EeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCC
Q 037702 89 MEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDG 166 (448)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 166 (448)
|||+. ++|.+.+.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-- 158 (291)
T cd07870 82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ-- 158 (291)
T ss_pred Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC--
Confidence 99996 577666643 5688999999999999999999999999999999999999999999999999875432211
Q ss_pred CccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHH-HHHHHHhhc------------------
Q 037702 167 LLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLM-ELYKKITRA------------------ 227 (448)
Q Consensus 167 ~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~------------------ 227 (448)
......+++.|+|||++.+....+.++|||||||++|+|++|..||...+.. +...++...
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07870 159 TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNY 238 (291)
T ss_pred CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccc
Confidence 1234568999999999865443457899999999999999999999765432 221111100
Q ss_pred --c-C--CCCC---------CCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhc
Q 037702 228 --E-F--KCPN---------WFPPEVRKLLSRILDPNPSTRVTMAKLMENYWF 266 (448)
Q Consensus 228 --~-~--~~p~---------~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 266 (448)
. . ..+. ..++++.+++.+||..||.+|||+.+++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 239 KPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred cchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 0 0 0000 125689999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=347.25 Aligned_cols=255 Identities=27% Similarity=0.446 Sum_probs=206.6
Q ss_pred CeEEEeeeeecCceEEEEEEECC--CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEEE
Q 037702 11 KYELGRLLGQGTFAKVYHGRNLK--TGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASK--TKIY 86 (448)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~--~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~~ 86 (448)
+|++.+.||+|+||.||+|.+.. ++..||+|.+...........+.+.+|+.+++.++||||+++++++.+. ..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 59999999999999999999988 8999999999875433334446778899999999999999999999888 8899
Q ss_pred EEEeecCCCchHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcC----CCCeEEeecccc
Q 037702 87 FAMEYVRGGELFNKVAK------GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDE----NGDLKISDFGLS 156 (448)
Q Consensus 87 lV~E~~~gg~L~~~i~~------~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~----~g~lkl~DFGla 156 (448)
+||||+++ +|.+.+.. +.+++..++.++.|++.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999975 66665532 26899999999999999999999999999999999999999 899999999999
Q ss_pred cccccccc-CCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHH---------HHHHHh-
Q 037702 157 ALQESTRQ-DGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLME---------LYKKIT- 225 (448)
Q Consensus 157 ~~~~~~~~-~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~---------~~~~i~- 225 (448)
........ .......++|+.|+|||++.+....+.++|||||||++|+|++|++||.+.+... ....+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence 86543322 1122345789999999998765544688999999999999999999997543221 000000
Q ss_pred -------------------------hccCCCC-----------CCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhc
Q 037702 226 -------------------------RAEFKCP-----------NWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWF 266 (448)
Q Consensus 226 -------------------------~~~~~~p-----------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 266 (448)
.....++ ...+.++.++|.+||.+||++|||+.++++||||
T Consensus 240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 0001111 1456789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=345.44 Aligned_cols=252 Identities=26% Similarity=0.436 Sum_probs=209.9
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcE--EEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQS--VAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEVMASKT 83 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~--vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~ 83 (448)
+..++|++.+.||+|+||.||+|.+..+|.. +|+|.+... ........+.+|+.++.++ +||||+++++++...+
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~ 81 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 81 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC
Confidence 4567899999999999999999999888865 466665432 2223456788999999999 8999999999999999
Q ss_pred EEEEEEeecCCCchHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCC
Q 037702 84 KIYFAMEYVRGGELFNKVAKG-----------------KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENG 146 (448)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~~-----------------~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g 146 (448)
.+|+||||+++++|.+++... .+++..++.++.||+.||+|||++|++||||||+|||++.++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 161 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC
Confidence 999999999999999998642 478999999999999999999999999999999999999999
Q ss_pred CeEEeeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHh
Q 037702 147 DLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKIT 225 (448)
Q Consensus 147 ~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~ 225 (448)
.+||+|||++........ .....++..|+|||++....+ +.++|||||||++|+|++ |..||...+..+.+..+.
T Consensus 162 ~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 237 (303)
T cd05088 162 VAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 237 (303)
T ss_pred cEEeCccccCcccchhhh---cccCCCcccccCHHHHhccCC-cccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHh
Confidence 999999999863221111 112234678999999876655 588999999999999998 999998887777776665
Q ss_pred hc-cCCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhh
Q 037702 226 RA-EFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENY 264 (448)
Q Consensus 226 ~~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 264 (448)
.. ....|..+++++.+||.+||+.||++||++++++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l 277 (303)
T cd05088 238 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 277 (303)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 44 2334556789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=341.75 Aligned_cols=258 Identities=23% Similarity=0.320 Sum_probs=212.6
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLK-----TGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMAS 81 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~ 81 (448)
+..++|++.+.||+|+||.||+|.++. .+..||+|.+...... .....+.+|+.+++.++||||+++++++.+
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL--RERIEFLNEASVMKGFTCHHVVRLLGVVSK 80 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCH--HHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 456799999999999999999997642 3458999988644321 223457789999999999999999999999
Q ss_pred CCEEEEEEeecCCCchHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEE
Q 037702 82 KTKIYFAMEYVRGGELFNKVAK-----------GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKI 150 (448)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~-----------~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl 150 (448)
....|+||||+++|+|.+++.. ..++...+..++.|++.||.|||++||+||||||+|||++.++.++|
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999999964 12456788999999999999999999999999999999999999999
Q ss_pred eeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhcc-
Q 037702 151 SDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAE- 228 (448)
Q Consensus 151 ~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~- 228 (448)
+|||+++...............++..|+|||.+.+..+ +.++|+|||||++|+|++ |..||.+.+..+....+....
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~ 239 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY 239 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCC-ChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 99999875432221111123346778999999876655 488999999999999998 799998887777776665543
Q ss_pred CCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHh------hhhcc
Q 037702 229 FKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLME------NYWFR 267 (448)
Q Consensus 229 ~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~------hp~~~ 267 (448)
...|..+++.+.+++.+||+.||.+|||+.++++ ||||.
T Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~ 284 (288)
T cd05061 240 LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP 284 (288)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCC
Confidence 3456677899999999999999999999999987 66664
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-45 Score=358.56 Aligned_cols=248 Identities=32% Similarity=0.664 Sum_probs=220.5
Q ss_pred EeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCC
Q 037702 15 GRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRG 94 (448)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (448)
.++||.|-||+||-|+++++|+.||||+|++..+...+ ..+++.|+.||+.+.||+||.+--.|++.+++++|||.+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCch-HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence 36899999999999999999999999999998876543 38899999999999999999999999999999999999977
Q ss_pred CchHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCC---CeEEeeccccccccccccCCCcc
Q 037702 95 GELFNKVA--KGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENG---DLKISDFGLSALQESTRQDGLLH 169 (448)
Q Consensus 95 g~L~~~i~--~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g---~lkl~DFGla~~~~~~~~~~~~~ 169 (448)
.-|.-.+. +|+++|...+.++.||+.||.|||.+||+|.|||||||||.... ++||||||+|++++.. ....
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk---sFRr 724 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK---SFRR 724 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchh---hhhh
Confidence 54544443 48999999999999999999999999999999999999997654 6999999999987543 3456
Q ss_pred ccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCC--C--CCHHHHHHHHh
Q 037702 170 TTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPN--W--FPPEVRKLLSR 245 (448)
Q Consensus 170 ~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~--~--~s~~~~~li~~ 245 (448)
+.+|||.|.|||++.++||+ ..-|+||.|||+|.-+.|..||... +++-.+|.+..+-+|+ | +++++.+||..
T Consensus 725 sVVGTPAYLaPEVLrnkGyN-rSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQNAaFMyPp~PW~eis~~AidlIn~ 801 (888)
T KOG4236|consen 725 SVVGTPAYLAPEVLRNKGYN-RSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQNAAFMYPPNPWSEISPEAIDLINN 801 (888)
T ss_pred hhcCCccccCHHHHhhcccc-ccccceeeeEEEEEEecccccCCCc--cchhHHhhccccccCCCchhhcCHHHHHHHHH
Confidence 78999999999999999997 7799999999999999999999764 3566677888777664 3 89999999999
Q ss_pred ccCCCcCCCCCHHHHHhhhhcccc
Q 037702 246 ILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 246 ~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
+|+..-.+|.|+++.+.|||++..
T Consensus 802 LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 802 LLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred HHHHHHHHhcchHhhccchhhhcc
Confidence 999999999999999999999864
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=351.51 Aligned_cols=262 Identities=26% Similarity=0.419 Sum_probs=213.6
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE----eCC
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMA----SKT 83 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~----~~~ 83 (448)
+.++|++.+.||+|+||.||+|.+..+|+.||+|.+...... ......+.+|+.+++.++||||+++++++. ...
T Consensus 3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 81 (334)
T cd07855 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDV-PTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFK 81 (334)
T ss_pred hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccccc-ccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCc
Confidence 347899999999999999999999999999999999764322 233567788999999999999999998875 345
Q ss_pred EEEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccc
Q 037702 84 KIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQEST 162 (448)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~ 162 (448)
.+|+||||+. ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 82 DVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred eEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 7899999996 589888865 56999999999999999999999999999999999999999999999999998754332
Q ss_pred cc--CCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhc-------------
Q 037702 163 RQ--DGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA------------- 227 (448)
Q Consensus 163 ~~--~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~------------- 227 (448)
.. .......+|+..|+|||++......+.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~ 240 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIG 240 (334)
T ss_pred CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhc
Confidence 21 112234579999999999866444568899999999999999999999876544332221110
Q ss_pred -----------c--CCC-----CCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccccc
Q 037702 228 -----------E--FKC-----PNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYK 271 (448)
Q Consensus 228 -----------~--~~~-----p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~ 271 (448)
. ... .+..++++.++|.+||+.||.+|||+++++.||||.....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~ 302 (334)
T cd07855 241 SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHD 302 (334)
T ss_pred hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccC
Confidence 0 001 1336889999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=338.46 Aligned_cols=253 Identities=25% Similarity=0.341 Sum_probs=214.4
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCC-----CcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKT-----GQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMAS 81 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~-----g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~ 81 (448)
+..++|++.+.||+|+||.||+|.+... +..||+|.+...... .....+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASM--RERIEFLNEASVMKEFNCHHVVRLLGVVST 80 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCH--HHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence 4567999999999999999999998644 378999998644321 234567899999999999999999999999
Q ss_pred CCEEEEEEeecCCCchHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEE
Q 037702 82 KTKIYFAMEYVRGGELFNKVAK-----------GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKI 150 (448)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~-----------~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl 150 (448)
....|+||||+++|+|.+++.. +.+++..+..++.|++.||.|||++|++||||||+|||++.++.+||
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEE
Confidence 9999999999999999999853 23678899999999999999999999999999999999999999999
Q ss_pred eeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhcc-
Q 037702 151 SDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAE- 228 (448)
Q Consensus 151 ~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~- 228 (448)
+|||+++...............+|..|+|||.+....+ +.++|||||||++|+|++ |..||.+.+.....+.+....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~ 239 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGH 239 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCC-CcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCC
Confidence 99999875443322222334567889999999876555 588999999999999998 999998887777766666443
Q ss_pred CCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHh
Q 037702 229 FKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 229 ~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 262 (448)
...|..++.++.++|.+||..+|++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 240 LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 4567778999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-43 Score=331.01 Aligned_cols=254 Identities=32% Similarity=0.577 Sum_probs=219.4
Q ss_pred CeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEEEEE
Q 037702 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASK--TKIYFA 88 (448)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~~lV 88 (448)
+|++.+.||+|++|.||+|.+..++..|++|++...... ....+.+.+|+.++++++||||+++++.+... ..+++|
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 589999999999999999999989999999999766433 23457889999999999999999999999988 899999
Q ss_pred EeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCC
Q 037702 89 MEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGL 167 (448)
Q Consensus 89 ~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 167 (448)
|||+++++|.+++.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+...........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG 159 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence 999999999999976 4899999999999999999999999999999999999999999999999999986554332112
Q ss_pred ccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCc-HHHHHHHHhh--ccCCCCCCCCHHHHHHHH
Q 037702 168 LHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSN-LMELYKKITR--AEFKCPNWFPPEVRKLLS 244 (448)
Q Consensus 168 ~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~-~~~~~~~i~~--~~~~~p~~~s~~~~~li~ 244 (448)
.....++..|+|||.+....+ +.++||||||+++|+|++|..||...+ .......+.. .....|..++..+.++|.
T Consensus 160 ~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~ 238 (260)
T cd06606 160 TGSVRGTPYWMAPEVIRGEEY-GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLR 238 (260)
T ss_pred ccCCCCCccccCHhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHH
Confidence 345678999999999876654 588999999999999999999998765 3333333332 334566778999999999
Q ss_pred hccCCCcCCCCCHHHHHhhhhc
Q 037702 245 RILDPNPSTRVTMAKLMENYWF 266 (448)
Q Consensus 245 ~~L~~dP~~Rpt~~eil~hp~~ 266 (448)
+||..||.+||++.+++.||||
T Consensus 239 ~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 239 KCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HhCcCChhhCCCHHHHhhCCCC
Confidence 9999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=334.91 Aligned_cols=244 Identities=27% Similarity=0.488 Sum_probs=203.8
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCC
Q 037702 16 RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGG 95 (448)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 95 (448)
+.||+|+||.||+|.+..+|+.||+|.+.... ..+....+.+|+.+++.++||||+++++++......|+||||++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 46999999999999999999999999876432 2234567889999999999999999999999999999999999999
Q ss_pred chHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCccccCC
Q 037702 96 ELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCG 173 (448)
Q Consensus 96 ~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~G 173 (448)
+|.+++.. ..+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||++................+
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 158 (252)
T cd05084 79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI 158 (252)
T ss_pred cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCC
Confidence 99999865 3589999999999999999999999999999999999999999999999999875332111110111123
Q ss_pred CCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhc-cCCCCCCCCHHHHHHHHhccCCCc
Q 037702 174 TPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EFKCPNWFPPEVRKLLSRILDPNP 251 (448)
Q Consensus 174 t~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP 251 (448)
+..|+|||.+.+..+ +.++|||||||++|+|++ |..||...+.......+... ....|..++..+.+|+.+||..||
T Consensus 159 ~~~y~aPE~~~~~~~-~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 237 (252)
T cd05084 159 PVKWTAPEALNYGRY-SSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDP 237 (252)
T ss_pred ceeecCchhhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCCh
Confidence 457999999876665 478999999999999997 99999876665555554433 345667789999999999999999
Q ss_pred CCCCCHHHHHh
Q 037702 252 STRVTMAKLME 262 (448)
Q Consensus 252 ~~Rpt~~eil~ 262 (448)
++|||+.++++
T Consensus 238 ~~Rps~~~~~~ 248 (252)
T cd05084 238 GQRPSFSTVHQ 248 (252)
T ss_pred hhCcCHHHHHH
Confidence 99999999985
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=334.13 Aligned_cols=254 Identities=33% Similarity=0.577 Sum_probs=219.9
Q ss_pred CCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 037702 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAM 89 (448)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (448)
++|++.+.||+|++|.||+|.+..+|+.||+|++...... .....+.+|+..+..++||||+++++++......|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 4699999999999999999999999999999999765432 33577889999999999999999999999999999999
Q ss_pred eecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCC
Q 037702 90 EYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHS-RGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGL 167 (448)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~-~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 167 (448)
||+++++|.+++.. +.+++..+..++.|++.|++|||+ +|++||||+|+||+++.++.++|+|||++........ .
T Consensus 79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~--~ 156 (264)
T cd06623 79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD--Q 156 (264)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC--c
Confidence 99999999999976 789999999999999999999999 9999999999999999999999999999876533221 1
Q ss_pred ccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCC---cHHHHHHHHhhcc-CCCCCC-CCHHHHHH
Q 037702 168 LHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDS---NLMELYKKITRAE-FKCPNW-FPPEVRKL 242 (448)
Q Consensus 168 ~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~---~~~~~~~~i~~~~-~~~p~~-~s~~~~~l 242 (448)
.....|+..|+|||.+....+ +.++|+||||+++|+|++|..||... ...+....+.... ...+.. ++..+.++
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 235 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESY-SYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDF 235 (264)
T ss_pred ccceeecccccCHhhhCCCCC-CchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHH
Confidence 124568999999999876644 58899999999999999999999776 4445555554332 334555 78999999
Q ss_pred HHhccCCCcCCCCCHHHHHhhhhccc
Q 037702 243 LSRILDPNPSTRVTMAKLMENYWFRK 268 (448)
Q Consensus 243 i~~~L~~dP~~Rpt~~eil~hp~~~~ 268 (448)
|.+||.++|++|||+.++++|||++.
T Consensus 236 i~~~l~~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 236 ISACLQKDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred HHHHccCChhhCCCHHHHHhCHHHHh
Confidence 99999999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=337.25 Aligned_cols=250 Identities=25% Similarity=0.396 Sum_probs=208.9
Q ss_pred eEEEeeeeecCceEEEEEEECCC---CcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE----
Q 037702 12 YELGRLLGQGTFAKVYHGRNLKT---GQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTK---- 84 (448)
Q Consensus 12 y~~~~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~---- 84 (448)
|++++.||+|+||.||.|.+..+ +..||+|.+..+.... ...+.+.+|+..++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTY-SEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCH-HHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 67899999999999999987653 4789999987653332 345678999999999999999999998865544
Q ss_pred --EEEEEeecCCCchHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccc
Q 037702 85 --IYFAMEYVRGGELFNKVAK-------GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGL 155 (448)
Q Consensus 85 --~~lV~E~~~gg~L~~~i~~-------~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGl 155 (448)
.+++|||+++|+|..++.. ..+++..+..++.|++.||.|||++|++||||||+||++++++.+||+|||+
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence 7999999999999888742 2589999999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhc-cCCCCC
Q 037702 156 SALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EFKCPN 233 (448)
Q Consensus 156 a~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~ 233 (448)
+................++..|+|||.+....+ +.++|||||||++|+|++ |..||.+.+..+.+..+..+ ....|.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY-TSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPE 238 (273)
T ss_pred eeeccccccccccccccCCccccCHhhcccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence 875433221111222345778999999876555 488999999999999999 99999888777777666654 345677
Q ss_pred CCCHHHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 234 WFPPEVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 234 ~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
.+++++.+++.+||+.||.+|||+.+++++
T Consensus 239 ~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 239 DCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=342.52 Aligned_cols=255 Identities=29% Similarity=0.483 Sum_probs=216.0
Q ss_pred cCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFA 88 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 88 (448)
.++|++.+.||+|+||.||+|.+..+|+.||+|++.... .......+.+|+.+++.++||||+++++.+.....+|+|
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence 468999999999999999999999999999999987542 223457789999999999999999999999999999999
Q ss_pred EeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCCEeecCCCCceEEcCCCCeEEeeccccccccccccCC
Q 037702 89 MEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHS-RGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDG 166 (448)
Q Consensus 89 ~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~-~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 166 (448)
|||+++++|.+++.. +.+++..+..++.|++.||.|||+ .|++||||||+||+++.++.++|+|||++......
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~---- 157 (284)
T cd06620 82 MEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS---- 157 (284)
T ss_pred EecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh----
Confidence 999999999999876 679999999999999999999997 69999999999999999999999999998643221
Q ss_pred CccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHH-----------HHHHHHhhcc-CCCCCC
Q 037702 167 LLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLM-----------ELYKKITRAE-FKCPNW 234 (448)
Q Consensus 167 ~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~-----------~~~~~i~~~~-~~~p~~ 234 (448)
.....+|+..|+|||++.+..+ +.++|+|||||++|+|++|..||...+.. +....+.... ...+..
T Consensus 158 ~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd06620 158 IADTFVGTSTYMSPERIQGGKY-TVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSS 236 (284)
T ss_pred ccCccccCcccCCHHHHccCCC-CccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCch
Confidence 1234579999999999876655 47899999999999999999999865431 2333333222 223333
Q ss_pred -CCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccccc
Q 037702 235 -FPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGY 270 (448)
Q Consensus 235 -~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 270 (448)
++.++.+||.+||..||.+|||+.++++|+||.+..
T Consensus 237 ~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~ 273 (284)
T cd06620 237 DFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL 273 (284)
T ss_pred hcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 778999999999999999999999999999997643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=339.14 Aligned_cols=254 Identities=22% Similarity=0.335 Sum_probs=212.0
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLK-----TGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMAS 81 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~ 81 (448)
+..++|.+.+.||+|+||.||+|.+.. ++..||+|.+..... ......+.+|+.+++.++||||+++++++.+
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCS--EQDESDFLMEALIMSKFNHQNIVRLIGVSFE 80 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 345789999999999999999999977 778899998864422 2233568889999999999999999999999
Q ss_pred CCEEEEEEeecCCCchHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCC---CeEE
Q 037702 82 KTKIYFAMEYVRGGELFNKVAKG--------KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENG---DLKI 150 (448)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~~--------~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g---~lkl 150 (448)
....|+||||++|++|.+++... .+++..+..++.||+.||+|||++|++||||||+|||++.++ .+||
T Consensus 81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEe
Confidence 99999999999999999998652 488999999999999999999999999999999999998765 5999
Q ss_pred eeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhc-c
Q 037702 151 SDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-E 228 (448)
Q Consensus 151 ~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~ 228 (448)
+|||++................+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+... .
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~ 239 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIF-TSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGR 239 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCc-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc
Confidence 99999975422111111112334578999999976665 488999999999999997 99999987777666655443 3
Q ss_pred CCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 229 FKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 229 ~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
...|..++..+.+++.+||..||++|||+.++++|
T Consensus 240 ~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 240 LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 45567789999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=344.00 Aligned_cols=257 Identities=26% Similarity=0.429 Sum_probs=216.5
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIY 86 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 86 (448)
....+|++.+.||+|+||.||+|.+..+|+.||+|.+.............+.+|+.+++.++||||+++++++.+....|
T Consensus 12 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~ 91 (307)
T cd06607 12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAW 91 (307)
T ss_pred CcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEE
Confidence 45567999999999999999999999999999999997654444444567889999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccccc
Q 037702 87 FAMEYVRGGELFNKVA--KGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQ 164 (448)
Q Consensus 87 lV~E~~~gg~L~~~i~--~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~ 164 (448)
+||||+.| +|.+.+. .+.+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++......
T Consensus 92 lv~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-- 168 (307)
T cd06607 92 LVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-- 168 (307)
T ss_pred EEHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC--
Confidence 99999975 6766664 357999999999999999999999999999999999999999999999999998754221
Q ss_pred CCCccccCCCCcccchhhhhc--cCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccC-CC-CCCCCHHHH
Q 037702 165 DGLLHTTCGTPAYVAPEVINK--RGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF-KC-PNWFPPEVR 240 (448)
Q Consensus 165 ~~~~~~~~Gt~~Y~APEvl~~--~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~-p~~~s~~~~ 240 (448)
....|++.|+|||++.. .+..+.++||||||+++|+|++|..||...+.......+..... .. +..++.++.
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (307)
T cd06607 169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFR 244 (307)
T ss_pred ----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHH
Confidence 24568899999998742 23345789999999999999999999988776655444443322 22 234678999
Q ss_pred HHHHhccCCCcCCCCCHHHHHhhhhccccc
Q 037702 241 KLLSRILDPNPSTRVTMAKLMENYWFRKGY 270 (448)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 270 (448)
++|.+||..||.+||++.+++.||||....
T Consensus 245 ~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 245 NFVDSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred HHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence 999999999999999999999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=333.14 Aligned_cols=245 Identities=27% Similarity=0.472 Sum_probs=214.0
Q ss_pred eeeeecCceEEEEEEECCC---CcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeec
Q 037702 16 RLLGQGTFAKVYHGRNLKT---GQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAMEYV 92 (448)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 92 (448)
+.||+|+||.||+|.+... +..||+|.+....... ..+.+.+|+.+++.++||||+++++++.....+++||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 4699999999999999866 8999999997654332 4578899999999999999999999999999999999999
Q ss_pred CCCchHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccc
Q 037702 93 RGGELFNKVAK----------GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQEST 162 (448)
Q Consensus 93 ~gg~L~~~i~~----------~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~ 162 (448)
++++|.+++.. ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||.+......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 99999999975 56899999999999999999999999999999999999999999999999999865443
Q ss_pred ccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhc-cCCCCCCCCHHHH
Q 037702 163 RQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EFKCPNWFPPEVR 240 (448)
Q Consensus 163 ~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 240 (448)
..........+++.|+|||.+....+ +.++|||||||++|+|++ |..||......+....+... ....|..+|+++.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (262)
T cd00192 159 DYYRKKTGGKLPIRWMAPESLKDGIF-TSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELY 237 (262)
T ss_pred cccccccCCCcCccccCHHHhccCCc-chhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHH
Confidence 22222344568899999999877655 588999999999999999 69999998887777777654 3456778899999
Q ss_pred HHHHhccCCCcCCCCCHHHHHhh
Q 037702 241 KLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~eil~h 263 (448)
+++.+||..||.+|||+.+++++
T Consensus 238 ~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 238 ELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred HHHHHHccCCcccCcCHHHHHHh
Confidence 99999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=330.54 Aligned_cols=252 Identities=34% Similarity=0.646 Sum_probs=220.6
Q ss_pred CeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 037702 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAME 90 (448)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (448)
+|++.+.||+|++|.||+|.+..+++.||+|.+....... ...+.+.+|+++++.++|||++++++++.+....|++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKE-EALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCH-HHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 6899999999999999999999999999999998765432 345789999999999999999999999999999999999
Q ss_pred ecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCcc
Q 037702 91 YVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLH 169 (448)
Q Consensus 91 ~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~ 169 (448)
|+++++|.+++.. +.+++..++.++.|++.||.|||++|++||||+|+||+++.++.++|+|||++........ ...
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~ 157 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK--DDA 157 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc--ccc
Confidence 9999999999876 6899999999999999999999999999999999999999999999999999986543322 123
Q ss_pred ccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHh-hccCCCCCCCCHHHHHHHHhccC
Q 037702 170 TTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKIT-RAEFKCPNWFPPEVRKLLSRILD 248 (448)
Q Consensus 170 ~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~-~~~~~~p~~~s~~~~~li~~~L~ 248 (448)
...|+..|+|||.+....+ +.++||||||+++|+|++|..||...+......++. ......|..+++.+.++|.+||.
T Consensus 158 ~~~~~~~y~~pe~~~~~~~-~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 236 (254)
T cd06627 158 SVVGTPYWMAPEVIEMSGA-STASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQ 236 (254)
T ss_pred ccccchhhcCHhhhcCCCC-CcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHh
Confidence 4578999999999876664 588999999999999999999998766544443333 33445667789999999999999
Q ss_pred CCcCCCCCHHHHHhhhhc
Q 037702 249 PNPSTRVTMAKLMENYWF 266 (448)
Q Consensus 249 ~dP~~Rpt~~eil~hp~~ 266 (448)
.||++|||+.+++.||||
T Consensus 237 ~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 237 KDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred CChhhCcCHHHHhcCCCC
Confidence 999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=337.31 Aligned_cols=250 Identities=24% Similarity=0.371 Sum_probs=207.4
Q ss_pred eEEEeeeeecCceEEEEEEECCCCc--EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC------C
Q 037702 12 YELGRLLGQGTFAKVYHGRNLKTGQ--SVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASK------T 83 (448)
Q Consensus 12 y~~~~~LG~G~fg~Vy~a~~~~~g~--~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~------~ 83 (448)
|.+++.||+|+||.||+|.+..++. .+|+|.+...... ....+.+.+|+.+++.++||||+++++++... .
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICT-RSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 4578999999999999999877775 6899988754322 23457788999999999999999999986432 3
Q ss_pred EEEEEEeecCCCchHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccc
Q 037702 84 KIYFAMEYVRGGELFNKVAK-------GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLS 156 (448)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-------~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla 156 (448)
..+++|||+++|+|.+++.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 57899999999999888732 24789999999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhccC-CCCCC
Q 037702 157 ALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAEF-KCPNW 234 (448)
Q Consensus 157 ~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~ 234 (448)
................+++.|+|||.+....+ +.++|||||||++|+|++ |..||......+.+..+..+.. ..+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVY-TTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPD 238 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCc-ChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 86533221111123356788999999977665 488999999999999999 8999988777777777766543 45667
Q ss_pred CCHHHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 235 FPPEVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 235 ~s~~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
++..+.++|.+||+.||.+|||+.+++++
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 239 CLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 88999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=339.18 Aligned_cols=254 Identities=26% Similarity=0.462 Sum_probs=205.2
Q ss_pred CCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHH-HHhCCCCCcceEEEEEEeCCEEEEE
Q 037702 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISV-MRLVRHPNIVQLYEVMASKTKIYFA 88 (448)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~-l~~l~hpnIv~l~~~~~~~~~~~lV 88 (448)
++|++.+.||+|+||.||+|++..+|+.||||.+....... . ...+..|+.+ ++.++||||+++++++..+..+|++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ-E-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH-H-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 47999999999999999999999999999999997653322 2 2344456554 6778999999999999999999999
Q ss_pred EeecCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CCEeecCCCCceEEcCCCCeEEeecccccccccc
Q 037702 89 MEYVRGGELFNKVAK-----GKLREEVARKYFQQLVDAVEFCHSR-GVYHRDLKPENLLLDENGDLKISDFGLSALQEST 162 (448)
Q Consensus 89 ~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~aL~yLH~~-givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~ 162 (448)
|||++ |+|.+++.. ..+++..++.++.|++.||+|||++ +++||||||+|||++.++.+||+|||++......
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99997 577666643 3689999999999999999999998 9999999999999999999999999998754321
Q ss_pred ccCCCccccCCCCcccchhhhhcc---CCCCCcchHHHHHHHHHHHHhCCCCCCCC-cHHHHHHHHhh-ccCCCC-CCCC
Q 037702 163 RQDGLLHTTCGTPAYVAPEVINKR---GYDGAKADIWSCGVVLFVLLAGNLPFYDS-NLMELYKKITR-AEFKCP-NWFP 236 (448)
Q Consensus 163 ~~~~~~~~~~Gt~~Y~APEvl~~~---~~~~~~sDiwSlGvil~elltG~~Pf~~~-~~~~~~~~i~~-~~~~~p-~~~s 236 (448)
.......|+..|+|||++.+. ...+.++|+|||||++|+|++|+.||... +..+....+.. .....| ..+|
T Consensus 158 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd06617 158 ---VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFS 234 (283)
T ss_pred ---cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccC
Confidence 111235689999999988542 12257899999999999999999999753 22222223222 223333 3478
Q ss_pred HHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 237 PEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 237 ~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
.++.++|.+||..+|.+||++.++++||||++.
T Consensus 235 ~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 267 (283)
T cd06617 235 PEFQDFVNKCLKKNYKERPNYPELLQHPFFELH 267 (283)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence 999999999999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=341.20 Aligned_cols=251 Identities=30% Similarity=0.503 Sum_probs=209.9
Q ss_pred eEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 037702 12 YELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAMEY 91 (448)
Q Consensus 12 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 91 (448)
|++.+.||.|++|.||+|.+..+|..||+|++..+.... .....+.+|+.+++.++||||+++++++.+.+..|++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDE-GVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccc-cchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 678899999999999999999999999999997654332 3335677899999999999999999999999999999999
Q ss_pred cCCCchHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCc
Q 037702 92 VRGGELFNKVAKG---KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLL 168 (448)
Q Consensus 92 ~~gg~L~~~i~~~---~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 168 (448)
++ ++|.+++... .+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++....... ...
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~ 156 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV--RTY 156 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc--ccc
Confidence 95 6899988653 58999999999999999999999999999999999999999999999999987543221 112
Q ss_pred cccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhcc--------------------
Q 037702 169 HTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAE-------------------- 228 (448)
Q Consensus 169 ~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-------------------- 228 (448)
....+++.|+|||++.+....+.++|+||||+++|+|++|++||...+......++....
T Consensus 157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07835 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT 236 (283)
T ss_pred CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence 334678999999988665444588999999999999999999998776544333322210
Q ss_pred ---------CCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhc
Q 037702 229 ---------FKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWF 266 (448)
Q Consensus 229 ---------~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 266 (448)
....+.+++++.++|.+||++||.+|||++++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 237 FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred cccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 01123467899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=349.75 Aligned_cols=258 Identities=27% Similarity=0.423 Sum_probs=212.0
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASK----- 82 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~----- 82 (448)
+..+|.+.+.||+|+||.||+|.+..+|+.||||.+....... .....+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNR-IDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAF 81 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccccc-chhHHHHHHHHHHHhcCCCCccchHHheeccccccc
Confidence 4578999999999999999999999999999999987543222 2235677899999999999999999987644
Q ss_pred CEEEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccc
Q 037702 83 TKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQES 161 (448)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~ 161 (448)
..+|+||||+. ++|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 82 NDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred CcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 35899999996 688888865 6799999999999999999999999999999999999999999999999999975432
Q ss_pred cccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhc--------------
Q 037702 162 TRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA-------------- 227 (448)
Q Consensus 162 ~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-------------- 227 (448)
.. .......|+..|+|||++......+.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 161 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07858 161 KG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN 238 (337)
T ss_pred Cc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCc
Confidence 21 22345578999999999875444568899999999999999999999876543322222110
Q ss_pred --------------cC---CCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 228 --------------EF---KCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 228 --------------~~---~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
.. ...+.+++++.++|.+||+.||.+|||++++++||||...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 239 EKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 00 0123578999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=342.22 Aligned_cols=253 Identities=26% Similarity=0.389 Sum_probs=214.5
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCC-----CcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKT-----GQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASK 82 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~-----g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~ 82 (448)
-..+|++.+.||+|+||.||+|.+..+ +..||||++.... .....+.+.+|+.++..++||||+++++++.+.
T Consensus 3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~ 80 (283)
T cd05091 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE 80 (283)
T ss_pred CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence 456789999999999999999987543 5789999987543 223456788999999999999999999999999
Q ss_pred CEEEEEEeecCCCchHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCC
Q 037702 83 TKIYFAMEYVRGGELFNKVAK-----------------GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDEN 145 (448)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~ 145 (448)
...++++||+.+++|.+++.. +.+++..+..++.|++.||+|||++||+||||||+|||++.+
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK 160 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence 999999999999999998842 247888899999999999999999999999999999999999
Q ss_pred CCeEEeeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHH
Q 037702 146 GDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKI 224 (448)
Q Consensus 146 g~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i 224 (448)
+.+||+|||++................+++.|+|||++....+ +.++|||||||++|+|++ |..||.+....+....+
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i 239 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKF-SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI 239 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999875433222222234456789999999876655 478999999999999998 88999888887888777
Q ss_pred hhccC-CCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 225 TRAEF-KCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 225 ~~~~~-~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
..... ..|..++..+.+|+.+||+.||.+||++++|+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 240 RNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 66654 4577799999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=333.95 Aligned_cols=246 Identities=27% Similarity=0.463 Sum_probs=209.8
Q ss_pred CCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 037702 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAM 89 (448)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (448)
++|++.+.||+|+||.||+|.+. ++..+|+|.+...... .+.+.+|+.+++.++||||+++++++......|+||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 78 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMS----EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVT 78 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCcc----HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEE
Confidence 56999999999999999999874 4568999988654322 256788999999999999999999999999999999
Q ss_pred eecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCC
Q 037702 90 EYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGL 167 (448)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 167 (448)
||+++|+|.+++.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++........ ..
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~~ 157 (256)
T cd05114 79 EFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TS 157 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCce-ec
Confidence 99999999999864 5689999999999999999999999999999999999999999999999999875422111 11
Q ss_pred ccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhcc-CCCCCCCCHHHHHHHHh
Q 037702 168 LHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAE-FKCPNWFPPEVRKLLSR 245 (448)
Q Consensus 168 ~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~ 245 (448)
.....++..|+|||++....+. .++|+||||+++|+|++ |+.||...+..+....+..+. ...|...+.++.+++.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~-~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYS-SKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYS 236 (256)
T ss_pred cCCCCCchhhCChhhcccCccc-hhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH
Confidence 1122356789999999766664 78999999999999999 999999888777777776653 33466678999999999
Q ss_pred ccCCCcCCCCCHHHHHh
Q 037702 246 ILDPNPSTRVTMAKLME 262 (448)
Q Consensus 246 ~L~~dP~~Rpt~~eil~ 262 (448)
||..||.+||+++++++
T Consensus 237 c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 237 CWHEKPEGRPTFAELLR 253 (256)
T ss_pred HccCCcccCcCHHHHHH
Confidence 99999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=333.49 Aligned_cols=255 Identities=30% Similarity=0.536 Sum_probs=215.4
Q ss_pred CCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccc--cchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEE
Q 037702 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKI--RRVGLIDQIKREISVMRLVRHPNIVQLYEVMASK--TKI 85 (448)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~--~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~ 85 (448)
.+|++.+.||+|+||.||+|.+..+|+.||+|.+..... ........+.+|+.+++.++||||+++++.+.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 479999999999999999999999999999999864321 1223456889999999999999999999998664 568
Q ss_pred EEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccccc
Q 037702 86 YFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQ 164 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~ 164 (448)
+++|||+++++|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++........
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 999999999999999876 6789999999999999999999999999999999999999999999999999975432211
Q ss_pred -CCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhc--cCCCCCCCCHHHHH
Q 037702 165 -DGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA--EFKCPNWFPPEVRK 241 (448)
Q Consensus 165 -~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~ 241 (448)
........|+..|+|||.+.+..+ +.++|+|||||++|+|++|+.||.+........++... ....|..+++.+.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 240 (264)
T cd06653 162 SGTGIKSVTGTPYWMSPEVISGEGY-GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRD 240 (264)
T ss_pred cCccccccCCcccccCHhhhcCCCC-CccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHH
Confidence 111234568999999999977665 47899999999999999999999887665555444432 23467788999999
Q ss_pred HHHhccCCCcCCCCCHHHHHhhhhc
Q 037702 242 LLSRILDPNPSTRVTMAKLMENYWF 266 (448)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~hp~~ 266 (448)
+|.+||. +|.+||++.+++.|||.
T Consensus 241 ~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 241 FLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHhc-CcccCccHHHHhcCCCC
Confidence 9999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-43 Score=348.76 Aligned_cols=258 Identities=26% Similarity=0.406 Sum_probs=213.0
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC----
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASK---- 82 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~---- 82 (448)
...++|++.+.||+|+||.||+|.+..+|+.||+|++.+.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (345)
T cd07877 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 92 (345)
T ss_pred hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchh-hHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccc
Confidence 3568999999999999999999999999999999998754322 22346678899999999999999999988643
Q ss_pred --CEEEEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccc
Q 037702 83 --TKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQE 160 (448)
Q Consensus 83 --~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~ 160 (448)
...|++++++ |++|.+++..+.+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++....
T Consensus 93 ~~~~~~lv~~~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~ 171 (345)
T cd07877 93 EFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 171 (345)
T ss_pred ccccEEEEehhc-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccc
Confidence 3478899887 7799988887889999999999999999999999999999999999999999999999999987532
Q ss_pred ccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccC-----------
Q 037702 161 STRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF----------- 229 (448)
Q Consensus 161 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~----------- 229 (448)
. ......||+.|+|||++.+....+.++|||||||++|+|++|+.||...+.......+.....
T Consensus 172 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (345)
T cd07877 172 D-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 246 (345)
T ss_pred c-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcc
Confidence 2 123457899999999986644446889999999999999999999987665444333222100
Q ss_pred ------------CC--------CCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccccc
Q 037702 230 ------------KC--------PNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYK 271 (448)
Q Consensus 230 ------------~~--------p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~ 271 (448)
.. ....++++.++|.+||..||.+||++.+++.||||++...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~ 308 (345)
T cd07877 247 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 308 (345)
T ss_pred cHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCC
Confidence 00 1125788999999999999999999999999999987443
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=335.57 Aligned_cols=251 Identities=29% Similarity=0.496 Sum_probs=208.5
Q ss_pred CeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 037702 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAME 90 (448)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (448)
.......||+|+||.||+|.+..++..||+|.+..... ...+.+.+|+.+++.++||||+++++++..++..|+|||
T Consensus 9 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 85 (268)
T cd06624 9 ENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS---RYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFME 85 (268)
T ss_pred cCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCH---HHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEe
Confidence 34445689999999999999999999999999875532 234678899999999999999999999999999999999
Q ss_pred ecCCCchHHHHhc--CCC--CHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcC-CCCeEEeeccccccccccccC
Q 037702 91 YVRGGELFNKVAK--GKL--REEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDE-NGDLKISDFGLSALQESTRQD 165 (448)
Q Consensus 91 ~~~gg~L~~~i~~--~~l--~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~-~g~lkl~DFGla~~~~~~~~~ 165 (448)
|+++++|.+++.. +.+ ++..+..++.||+.||.|||++||+||||||+||+++. ++.++|+|||++.......
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~-- 163 (268)
T cd06624 86 QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN-- 163 (268)
T ss_pred cCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCC--
Confidence 9999999999875 455 88889999999999999999999999999999999986 6799999999987543221
Q ss_pred CCccccCCCCcccchhhhhccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCcHH--HHHHH-HhhccCCCCCCCCHHHHH
Q 037702 166 GLLHTTCGTPAYVAPEVINKRG-YDGAKADIWSCGVVLFVLLAGNLPFYDSNLM--ELYKK-ITRAEFKCPNWFPPEVRK 241 (448)
Q Consensus 166 ~~~~~~~Gt~~Y~APEvl~~~~-~~~~~sDiwSlGvil~elltG~~Pf~~~~~~--~~~~~-i~~~~~~~p~~~s~~~~~ 241 (448)
.......|++.|+|||++.... ..+.++|+||+|+++|+|++|..||...... ..+.. ........|..+++++.+
T Consensus 164 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (268)
T cd06624 164 PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKN 243 (268)
T ss_pred CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHH
Confidence 1223346899999999986532 2357899999999999999999999754322 22221 223334567778999999
Q ss_pred HHHhccCCCcCCCCCHHHHHhhhhc
Q 037702 242 LLSRILDPNPSTRVTMAKLMENYWF 266 (448)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~hp~~ 266 (448)
|+.+||+.+|.+|||+.+++.||||
T Consensus 244 li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 244 FILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHHHHcCCCchhCCCHHHHHhCCCC
Confidence 9999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=338.38 Aligned_cols=246 Identities=27% Similarity=0.460 Sum_probs=204.7
Q ss_pred ccCCeEEEeee--eecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE
Q 037702 8 LMNKYELGRLL--GQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEVMASKTK 84 (448)
Q Consensus 8 ~~~~y~~~~~L--G~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~ 84 (448)
..++|++.+.+ |+|+||.||++.+..+|..+|+|++....... .|+.....+ +||||+++++.+...+.
T Consensus 12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~ 83 (267)
T PHA03390 12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKG 83 (267)
T ss_pred HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCe
Confidence 34678887777 99999999999999999999999987654321 122222222 79999999999999999
Q ss_pred EEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCC-CeEEeecccccccccc
Q 037702 85 IYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENG-DLKISDFGLSALQEST 162 (448)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g-~lkl~DFGla~~~~~~ 162 (448)
.|+||||+++++|.+++.. +.+++..++.++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++......
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 163 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP 163 (267)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC
Confidence 9999999999999999976 4899999999999999999999999999999999999999998 9999999998754321
Q ss_pred ccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHH----HHHHhhccCCCCCCCCHH
Q 037702 163 RQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMEL----YKKITRAEFKCPNWFPPE 238 (448)
Q Consensus 163 ~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~----~~~i~~~~~~~p~~~s~~ 238 (448)
....|++.|+|||++.+..+. .++|||||||++|+|++|..||........ +..........++.+++.
T Consensus 164 ------~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T PHA03390 164 ------SCYDGTLDYFSPEKIKGHNYD-VSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKN 236 (267)
T ss_pred ------ccCCCCCcccChhhhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHH
Confidence 234689999999999877764 789999999999999999999975533221 111223334556678999
Q ss_pred HHHHHHhccCCCcCCCCC-HHHHHhhhhccc
Q 037702 239 VRKLLSRILDPNPSTRVT-MAKLMENYWFRK 268 (448)
Q Consensus 239 ~~~li~~~L~~dP~~Rpt-~~eil~hp~~~~ 268 (448)
+.+||.+||++||.+||+ ++++++||||++
T Consensus 237 ~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 237 ANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred HHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 999999999999999996 699999999963
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=336.43 Aligned_cols=251 Identities=30% Similarity=0.602 Sum_probs=212.9
Q ss_pred cCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFA 88 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 88 (448)
.++|++.+.||+|+||.||+|.+..+|..+|||.+.............+.+|+.+++.++||||+++++++..++..+++
T Consensus 1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08229 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 80 (267)
T ss_pred CchhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence 36799999999999999999999999999999998765544444556788999999999999999999999999999999
Q ss_pred EeecCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccc
Q 037702 89 MEYVRGGELFNKVAK-----GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTR 163 (448)
Q Consensus 89 ~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~ 163 (448)
|||++|++|.+++.. ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence 999999999998852 458999999999999999999999999999999999999999999999999987653322
Q ss_pred cCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcH--HHHHHHHhhccCC-C-CCCCCHHH
Q 037702 164 QDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNL--MELYKKITRAEFK-C-PNWFPPEV 239 (448)
Q Consensus 164 ~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~--~~~~~~i~~~~~~-~-p~~~s~~~ 239 (448)
......+|++.|+|||.+.+..+. .++|+||||+++|+|++|..||..... ......+...... . +..+++.+
T Consensus 161 --~~~~~~~~~~~~~ape~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd08229 161 --TAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL 237 (267)
T ss_pred --cccccccCCcCccCHHHhcCCCcc-chhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHH
Confidence 222345799999999999776664 789999999999999999999975443 3444444433322 2 23578999
Q ss_pred HHHHHhccCCCcCCCCCHHHHHh
Q 037702 240 RKLLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 240 ~~li~~~L~~dP~~Rpt~~eil~ 262 (448)
.++|.+||..||.+|||+.+|++
T Consensus 238 ~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 238 RQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHHHhcCCCcccCCCHHHHHH
Confidence 99999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=360.74 Aligned_cols=260 Identities=32% Similarity=0.560 Sum_probs=239.3
Q ss_pred cccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 037702 5 AGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTK 84 (448)
Q Consensus 5 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 84 (448)
..+...+.+++.+||-|+||.|-++........+|+|++.+..+-+....+.+..|-++|..++.|.||++|..|.+..+
T Consensus 415 a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~ky 494 (732)
T KOG0614|consen 415 AQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKY 494 (732)
T ss_pred cccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchh
Confidence 34567788999999999999999998755555699999998888777777899999999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccc
Q 037702 85 IYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTR 163 (448)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~ 163 (448)
+||.||-|-||+|...++. |.|++..++.|+.-+++|++|||++|||+|||||||+|||.+|-+||.|||+|+.....
T Consensus 495 vYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g- 573 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG- 573 (732)
T ss_pred hhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccC-
Confidence 9999999999999999976 88999999999999999999999999999999999999999999999999999976543
Q ss_pred cCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhc--cCCCCCCCCHHHHH
Q 037702 164 QDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA--EFKCPNWFPPEVRK 241 (448)
Q Consensus 164 ~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~ 241 (448)
....|.||||.|+|||++.++|++ ..+|.||||+++|||++|.+||.+.+.+..|+.|.++ .+.+|..++..+.+
T Consensus 574 --~KTwTFcGTpEYVAPEIILnKGHD-~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~ 650 (732)
T KOG0614|consen 574 --RKTWTFCGTPEYVAPEIILNKGHD-RAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATD 650 (732)
T ss_pred --CceeeecCCcccccchhhhccCcc-hhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHH
Confidence 345689999999999999999998 7899999999999999999999999999999999987 46789999999999
Q ss_pred HHHhccCCCcCCCCC-----HHHHHhhhhccc
Q 037702 242 LLSRILDPNPSTRVT-----MAKLMENYWFRK 268 (448)
Q Consensus 242 li~~~L~~dP~~Rpt-----~~eil~hp~~~~ 268 (448)
||+++...+|.+|.. +.+|.+|.||..
T Consensus 651 Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~g 682 (732)
T KOG0614|consen 651 LIKKLCRDNPTERLGYQKGGINDIKKHRWFEG 682 (732)
T ss_pred HHHHHHhcCcHhhhccccCChHHHHhhhhhhc
Confidence 999999999999986 899999999965
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=368.20 Aligned_cols=250 Identities=29% Similarity=0.527 Sum_probs=209.4
Q ss_pred cCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEE-EEe---C-
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR-HPNIVQLYEV-MAS---K- 82 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~-~~~---~- 82 (448)
..++++.+.|.+|||+.||+|++...|..||+|.+-.. ++...+.+++||++|+.|+ |||||.+++. ... +
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 34788999999999999999999988899999998654 4566788999999999996 9999999993 221 1
Q ss_pred --CEEEEEEeecCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--CEeecCCCCceEEcCCCCeEEeeccc
Q 037702 83 --TKIYFAMEYVRGGELFNKVAK---GKLREEVARKYFQQLVDAVEFCHSRG--VYHRDLKPENLLLDENGDLKISDFGL 155 (448)
Q Consensus 83 --~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~yLH~~g--ivHrDLkp~NILl~~~g~lkl~DFGl 155 (448)
-.++|.||||.||.|-+++.. .+|+|.++++||.|+++||.+||..+ |||||||-|||||+.+|+.||||||.
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccc
Confidence 246799999999999999974 57999999999999999999999998 99999999999999999999999999
Q ss_pred cccccccc-c-CCC-----ccccCCCCcccchhhhh---ccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHh
Q 037702 156 SALQESTR-Q-DGL-----LHTTCGTPAYVAPEVIN---KRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKIT 225 (448)
Q Consensus 156 a~~~~~~~-~-~~~-----~~~~~Gt~~Y~APEvl~---~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~ 225 (448)
|+-.-... . ... .-....|+-|+|||++. +.+. +.|+|||+|||+||-|+....||.+... ..|.
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI-~eKsDIWALGclLYkLCy~t~PFe~sg~----laIl 267 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPI-GEKSDIWALGCLLYKLCYFTTPFEESGK----LAIL 267 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCC-cchhHHHHHHHHHHHHHHhCCCcCcCcc----eeEE
Confidence 87322111 0 000 01234799999999985 3344 5899999999999999999999987643 3467
Q ss_pred hccCCCCC--CCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhc
Q 037702 226 RAEFKCPN--WFPPEVRKLLSRILDPNPSTRVTMAKLMENYWF 266 (448)
Q Consensus 226 ~~~~~~p~--~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 266 (448)
.+.|.+|+ .++..+++||+.||++||.+||++-+++.+-+-
T Consensus 268 ng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~ 310 (738)
T KOG1989|consen 268 NGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE 310 (738)
T ss_pred eccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence 78888886 588999999999999999999999999887543
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=331.66 Aligned_cols=250 Identities=30% Similarity=0.606 Sum_probs=213.2
Q ss_pred CCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 037702 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAM 89 (448)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (448)
++|++.+.||+|+||.||+|.+..+|+.||+|.+......+....+.+.+|+.+++.++|+||+++++++......++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 68999999999999999999999999999999987654444444577899999999999999999999999999999999
Q ss_pred eecCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccccc
Q 037702 90 EYVRGGELFNKVAK-----GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQ 164 (448)
Q Consensus 90 E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~ 164 (448)
||+++++|.+++.. ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~- 160 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT- 160 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCC-
Confidence 99999999998853 358999999999999999999999999999999999999999999999999987543221
Q ss_pred CCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCc--HHHHHHHHhhccC-CCCC-CCCHHHH
Q 037702 165 DGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSN--LMELYKKITRAEF-KCPN-WFPPEVR 240 (448)
Q Consensus 165 ~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~--~~~~~~~i~~~~~-~~p~-~~s~~~~ 240 (448)
.......|++.|+|||.+.+..+. .++|+|||||++|+|++|+.||.... ..+....+..+.. +.|. .++..+.
T Consensus 161 -~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd08224 161 -TAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELR 238 (267)
T ss_pred -cccceecCCccccCHHHhccCCCC-chhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHH
Confidence 122345789999999999877664 78999999999999999999996543 3344444444333 2343 6788999
Q ss_pred HHHHhccCCCcCCCCCHHHHHh
Q 037702 241 KLLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~eil~ 262 (448)
++|.+||..+|.+|||+.+|++
T Consensus 239 ~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 239 DLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHHcCCCcccCCCHHHHHH
Confidence 9999999999999999999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-43 Score=376.40 Aligned_cols=254 Identities=25% Similarity=0.448 Sum_probs=207.8
Q ss_pred cCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFA 88 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 88 (448)
+++|++.+.||+|+||.||+|.+..+|+.||||++..+........+.+.+|+.+++.++||||+++++++.+++..|+|
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 47999999999999999999999999999999999765444444556788999999999999999999999999999999
Q ss_pred EeecCCCchHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccc
Q 037702 89 MEYVRGGELFNKVAK------------GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLS 156 (448)
Q Consensus 89 ~E~~~gg~L~~~i~~------------~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla 156 (448)
|||++||+|.+++.. .+++...+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence 999999999998853 12455678899999999999999999999999999999999999999999999
Q ss_pred cccccccc----------------CCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHH
Q 037702 157 ALQESTRQ----------------DGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMEL 220 (448)
Q Consensus 157 ~~~~~~~~----------------~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~ 220 (448)
........ .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||........
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~-S~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPA-SESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCC-CcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 76521110 001123479999999999977666 4889999999999999999999987554433
Q ss_pred HHHHhh-ccC--CCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 221 YKKITR-AEF--KCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 221 ~~~i~~-~~~--~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
...... ... .....+|+.+.+++.+||..||++||+..+.+.+
T Consensus 240 ~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 240 SYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred hhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 222111 111 1123478999999999999999999887666554
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=331.80 Aligned_cols=246 Identities=39% Similarity=0.739 Sum_probs=221.5
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCCch
Q 037702 18 LGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGEL 97 (448)
Q Consensus 18 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 97 (448)
||+|+||.||.+.+..+++.+|+|++.+...........+.+|+.+++.++||||+++++.+..+..+|+||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999999889999999999887665555667889999999999999999999999999999999999999999
Q ss_pred HHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCccccCCCCc
Q 037702 98 FNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPA 176 (448)
Q Consensus 98 ~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~ 176 (448)
.+++.. +.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....... .......|+..
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~ 158 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFCGTPE 158 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCcCCcc
Confidence 999976 478999999999999999999999999999999999999999999999999987643321 12345578999
Q ss_pred ccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHHHHhccCCCcCCCCC
Q 037702 177 YVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILDPNPSTRVT 256 (448)
Q Consensus 177 Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt 256 (448)
|+|||.+.+... +.++|+||||+++|+|++|..||...+.......+....+.+|..++..+.++|.+||..||++||+
T Consensus 159 ~~~Pe~~~~~~~-~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~ 237 (250)
T cd05123 159 YLAPEVLLGKGY-GKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLG 237 (250)
T ss_pred ccChHHhCCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhhCCC
Confidence 999999876554 4789999999999999999999988877777888877778888889999999999999999999999
Q ss_pred H---HHHHhhhhc
Q 037702 257 M---AKLMENYWF 266 (448)
Q Consensus 257 ~---~eil~hp~~ 266 (448)
+ +++++||||
T Consensus 238 ~~~~~~l~~~~~f 250 (250)
T cd05123 238 SGGAEEIKAHPFF 250 (250)
T ss_pred cccHHHHHhCCCC
Confidence 9 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-43 Score=340.22 Aligned_cols=251 Identities=25% Similarity=0.413 Sum_probs=212.1
Q ss_pred ccCCeEEEeeeeecCceEEEEEEEC-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNL-----KTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASK 82 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~ 82 (448)
..++|.+.+.||+|+||.||+|++. .++..+++|.+..... ...+.+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL---AARKDFQREAELLTNLQHEHIVKFYGVCGDG 79 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH---HHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence 4568999999999999999999854 3456789998864432 2235688999999999999999999999999
Q ss_pred CEEEEEEeecCCCchHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCC
Q 037702 83 TKIYFAMEYVRGGELFNKVAK-----------------GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDEN 145 (448)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~ 145 (448)
...++||||+++++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN 159 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence 999999999999999999864 237899999999999999999999999999999999999999
Q ss_pred CCeEEeeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHH
Q 037702 146 GDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKI 224 (448)
Q Consensus 146 g~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i 224 (448)
+.++|+|||++................|++.|+|||++.+..+ +.++|||||||++|+|++ |..||...+..+....+
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~ 238 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI 238 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9999999999975433221122234557889999999877665 478999999999999998 99999888777777766
Q ss_pred hhccC-CCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHh
Q 037702 225 TRAEF-KCPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 225 ~~~~~-~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 262 (448)
..+.. ..+..+|..+.+++.+||..||++|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 239 TQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred hCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 65544 345567899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=350.56 Aligned_cols=255 Identities=26% Similarity=0.437 Sum_probs=206.8
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLK-----TGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEVM 79 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~ 79 (448)
.+..++|++.+.||+|+||.||+|.+.. +++.||+|++...... ...+.+.+|+.+++++ +||||+++++++
T Consensus 3 ~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~E~~~~~~l~~h~niv~~~~~~ 80 (337)
T cd05054 3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATA--SEYKALMTELKILIHIGHHLNVVNLLGAC 80 (337)
T ss_pred ccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCH--HHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence 4456799999999999999999997543 4578999998654322 2346678899999999 899999999987
Q ss_pred Ee-CCEEEEEEeecCCCchHHHHhc-------------------------------------------------------
Q 037702 80 AS-KTKIYFAMEYVRGGELFNKVAK------------------------------------------------------- 103 (448)
Q Consensus 80 ~~-~~~~~lV~E~~~gg~L~~~i~~------------------------------------------------------- 103 (448)
.. ...++++|||+++++|.+++..
T Consensus 81 ~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 81 TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred ecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 64 4678999999999999988843
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCccccCCCCc
Q 037702 104 -------GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPA 176 (448)
Q Consensus 104 -------~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~ 176 (448)
.++++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.............+..++..
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence 1578899999999999999999999999999999999999999999999999986432221111223456778
Q ss_pred ccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHH-HHhhc-cCCCCCCCCHHHHHHHHhccCCCcCC
Q 037702 177 YVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYK-KITRA-EFKCPNWFPPEVRKLLSRILDPNPST 253 (448)
Q Consensus 177 Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~-~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~ 253 (448)
|+|||++.+..+. .++|||||||++|+|++ |..||.+....+.+. .+... ....|...++++.+++.+||+.+|++
T Consensus 241 y~aPE~~~~~~~~-~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~ 319 (337)
T cd05054 241 WMAPESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPED 319 (337)
T ss_pred ccCcHHhcCCCCC-ccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhh
Confidence 9999999877765 78999999999999998 999998755433332 33222 23456668899999999999999999
Q ss_pred CCCHHHHHhh
Q 037702 254 RVTMAKLMEN 263 (448)
Q Consensus 254 Rpt~~eil~h 263 (448)
||++.++++|
T Consensus 320 RPs~~ell~~ 329 (337)
T cd05054 320 RPTFSELVEI 329 (337)
T ss_pred CcCHHHHHHH
Confidence 9999999985
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=356.37 Aligned_cols=254 Identities=27% Similarity=0.404 Sum_probs=208.3
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCC-----CcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKT-----GQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR-HPNIVQLYEVM 79 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~-----g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~ 79 (448)
....++|++++.||+|+||.||+|.+... +..||||++..... ....+.+.+|+.+++.+. ||||+++++++
T Consensus 33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~ 110 (400)
T cd05105 33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR--SSEKQALMSELKIMTHLGPHLNIVNLLGAC 110 (400)
T ss_pred eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence 45577899999999999999999987433 34799999865422 233467889999999996 99999999999
Q ss_pred EeCCEEEEEEeecCCCchHHHHhc--------------------------------------------------------
Q 037702 80 ASKTKIYFAMEYVRGGELFNKVAK-------------------------------------------------------- 103 (448)
Q Consensus 80 ~~~~~~~lV~E~~~gg~L~~~i~~-------------------------------------------------------- 103 (448)
.+...+|||||||++|+|.+++..
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 999999999999999999988743
Q ss_pred -----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEE
Q 037702 104 -----------------------------------------GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLL 142 (448)
Q Consensus 104 -----------------------------------------~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl 142 (448)
..+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill 270 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEE
Confidence 136778889999999999999999999999999999999
Q ss_pred cCCCCeEEeeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHH-H
Q 037702 143 DENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLME-L 220 (448)
Q Consensus 143 ~~~g~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~-~ 220 (448)
+.++.+||+|||++................+++.|+|||++.+..+ +.++|||||||++|+|++ |..||....... .
T Consensus 271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~ 349 (400)
T cd05105 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLY-TTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF 349 (400)
T ss_pred eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCcccchhHHH
Confidence 9999999999999975433222222233457889999999977665 488999999999999997 999998755433 3
Q ss_pred HHHHhhc-cCCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHh
Q 037702 221 YKKITRA-EFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 221 ~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 262 (448)
+..+..+ ....|..++.++.+++.+||..||++|||+.++.+
T Consensus 350 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 350 YNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 3333333 23456678999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=336.72 Aligned_cols=254 Identities=30% Similarity=0.483 Sum_probs=210.6
Q ss_pred CCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEEEE
Q 037702 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMAS--KTKIYF 87 (448)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~~~~~l 87 (448)
++|+..+.||.|++|.||+|.+..+++.+|+|.+...... .....+.+|+++++.++||||+++++++.. ...+|+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP--DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch--HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 5799999999999999999999999999999999755322 345678899999999999999999998854 447899
Q ss_pred EEeecCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccc
Q 037702 88 AMEYVRGGELFNKVAK-----GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQEST 162 (448)
Q Consensus 88 V~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~ 162 (448)
||||++|++|.+++.. +.+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 9999999999887642 46899999999999999999999999999999999999999999999999998754322
Q ss_pred ccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCC-----cHHHHHHHHhhccC-CCC----
Q 037702 163 RQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDS-----NLMELYKKITRAEF-KCP---- 232 (448)
Q Consensus 163 ~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~-----~~~~~~~~i~~~~~-~~p---- 232 (448)
. .....++..|+|||.+.+..++ .++|||||||++|+|++|..||... ...+....+..... ..+
T Consensus 159 ~----~~~~~~~~~y~~pE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd06621 159 L----AGTFTGTSFYMAPERIQGKPYS-ITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPG 233 (287)
T ss_pred c----cccccCCccccCHHHhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCC
Confidence 1 1244688999999998776664 7899999999999999999999765 22333333333111 111
Q ss_pred --CCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccccc
Q 037702 233 --NWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGY 270 (448)
Q Consensus 233 --~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 270 (448)
..+++.+.++|.+||..||.+|||+.|+++||||++..
T Consensus 234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 273 (287)
T cd06621 234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM 273 (287)
T ss_pred CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence 12467899999999999999999999999999996644
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=341.58 Aligned_cols=259 Identities=28% Similarity=0.527 Sum_probs=213.2
Q ss_pred cccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-
Q 037702 5 AGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKT- 83 (448)
Q Consensus 5 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~- 83 (448)
+....++|++.+.||+|+||.||+|.+..+|+.||+|.+....... .....+.+|+.+++.++||||+++++++.+..
T Consensus 2 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~ 80 (302)
T cd07864 2 GKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKE-GFPITAIREIKILRQLNHRNIVNLKEIVTDKQD 80 (302)
T ss_pred chhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccccc-CchHHHHHHHHHHHhCCCCCeeeeeheecCcch
Confidence 4567889999999999999999999999999999999997653322 23356778999999999999999999987654
Q ss_pred ---------EEEEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEee
Q 037702 84 ---------KIYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISD 152 (448)
Q Consensus 84 ---------~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~D 152 (448)
.+|+||||+++ +|...+.. ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|
T Consensus 81 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 81 ALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred hhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCc
Confidence 79999999986 67676664 4699999999999999999999999999999999999999999999999
Q ss_pred ccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccC---
Q 037702 153 FGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF--- 229 (448)
Q Consensus 153 FGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--- 229 (448)
||++........ .......+++.|+|||++.+....+.++|||||||++|+|++|++||...+..+....+.....
T Consensus 160 fg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 238 (302)
T cd07864 160 FGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC 238 (302)
T ss_pred ccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 999986543221 1122345688999999986554446889999999999999999999987766554444332100
Q ss_pred ---------------------------CCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhc
Q 037702 230 ---------------------------KCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWF 266 (448)
Q Consensus 230 ---------------------------~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 266 (448)
.....+|+.+.++|.+||..||.+|||+++++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 239 PAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred hhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 0012368899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=339.00 Aligned_cols=255 Identities=25% Similarity=0.449 Sum_probs=214.8
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCC-----cEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTG-----QSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEVM 79 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g-----~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~ 79 (448)
.+-.++|++.+.||+|+||.||+|.+...+ ..+|+|.+..... ......+.+|+.+++++ +||||+++++++
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 85 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLLGVC 85 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC--HHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 455679999999999999999999986443 6899999875432 22345688999999999 899999999999
Q ss_pred EeCCEEEEEEeecCCCchHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEE
Q 037702 80 ASKTKIYFAMEYVRGGELFNKVAK-----------------GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLL 142 (448)
Q Consensus 80 ~~~~~~~lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl 142 (448)
..+..+|++|||+++|+|..++.. +.+++..+..++.|++.||+|||++||+||||||+|||+
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~ 165 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV 165 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE
Confidence 999999999999999999999853 358899999999999999999999999999999999999
Q ss_pred cCCCCeEEeeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHH
Q 037702 143 DENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELY 221 (448)
Q Consensus 143 ~~~g~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~ 221 (448)
+.++.+||+|||++................++..|+|||++.+..+ +.++|||||||++|+|++ |..||...+..+.+
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 244 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 244 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCc-CcccceeehhhHHHHHhcCCCCCCCCCCHHHHH
Confidence 9999999999999986543221111122345678999999876665 488999999999999997 99999988887777
Q ss_pred HHHhhcc-CCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 222 KKITRAE-FKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 222 ~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
..+.... ...|..++.++.+|+.+||..||++|||+.+++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 245 KLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 7665543 34566788999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-43 Score=333.23 Aligned_cols=247 Identities=28% Similarity=0.479 Sum_probs=208.8
Q ss_pred CCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 037702 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAM 89 (448)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (448)
.+|++.+.||+|+||.||+|.+. ++..+|+|++...... .+.+.+|+.+++.++||||+++++++......|+||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT 78 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence 46899999999999999999875 5678999998654332 246778999999999999999999999999999999
Q ss_pred eecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCC
Q 037702 90 EYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGL 167 (448)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 167 (448)
||++|++|.+++.. +.+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++........ ..
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-~~ 157 (256)
T cd05059 79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-TS 157 (256)
T ss_pred ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccc-cc
Confidence 99999999999864 4689999999999999999999999999999999999999999999999999875432111 01
Q ss_pred ccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhc-cCCCCCCCCHHHHHHHHh
Q 037702 168 LHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EFKCPNWFPPEVRKLLSR 245 (448)
Q Consensus 168 ~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~ 245 (448)
.....++..|+|||.+.+..+. .++|||||||++|+|++ |..||...+..+....+... ....|..+|+++.+++.+
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFS-SKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYS 236 (256)
T ss_pred cCCCCCCccccCHHHhccCCCC-chhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHH
Confidence 1112234579999998776664 78999999999999998 89999887777766666554 345566789999999999
Q ss_pred ccCCCcCCCCCHHHHHhh
Q 037702 246 ILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 246 ~L~~dP~~Rpt~~eil~h 263 (448)
||..+|++|||+.++++.
T Consensus 237 cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 237 CWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HhcCChhhCcCHHHHHHH
Confidence 999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=361.70 Aligned_cols=244 Identities=34% Similarity=0.568 Sum_probs=216.4
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEE
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEVMASKTKIY 86 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~ 86 (448)
..+.|++...+|.|+|+.|..+.+..+++..++|++.+... +..+|+.++.+. +||||+++++++.+....|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~ 392 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY 392 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccccc-------ccccccchhhhhcCCCcceeecceecCCceee
Confidence 46789999999999999999999999999999999987732 223577555544 8999999999999999999
Q ss_pred EEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEE-cCCCCeEEeeccccccccccccC
Q 037702 87 FAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLL-DENGDLKISDFGLSALQESTRQD 165 (448)
Q Consensus 87 lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl-~~~g~lkl~DFGla~~~~~~~~~ 165 (448)
+|||++.|+.|.+.+...+....++..|+.||+.|+.|||++||+||||||+|||+ +..|+++|+|||.+......
T Consensus 393 ~v~e~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--- 469 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--- 469 (612)
T ss_pred eeehhccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh---
Confidence 99999999999999988666668888999999999999999999999999999999 68999999999999864332
Q ss_pred CCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcH-HHHHHHHhhccCCCCCCCCHHHHHHHH
Q 037702 166 GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNL-MELYKKITRAEFKCPNWFPPEVRKLLS 244 (448)
Q Consensus 166 ~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~~~~~~p~~~s~~~~~li~ 244 (448)
..+.|-|..|.|||++...+|+ ..+||||||++||+||+|+.||..... .++..++..+.+. .++|.++++||+
T Consensus 470 --~~tp~~t~~y~APEvl~~~~yt-~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s--~~vS~~AKdLl~ 544 (612)
T KOG0603|consen 470 --CDTPALTLQYVAPEVLAIQEYT-EACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS--ECVSDEAKDLLQ 544 (612)
T ss_pred --hcccchhhcccChhhhccCCCC-cchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc--cccCHHHHHHHH
Confidence 4577889999999999988886 889999999999999999999976544 4777777766555 889999999999
Q ss_pred hccCCCcCCCCCHHHHHhhhhc
Q 037702 245 RILDPNPSTRVTMAKLMENYWF 266 (448)
Q Consensus 245 ~~L~~dP~~Rpt~~eil~hp~~ 266 (448)
+||+.||.+|+++.++..||||
T Consensus 545 ~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 545 QLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HhccCChhhCcChhhhccCcch
Confidence 9999999999999999999999
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=393.55 Aligned_cols=260 Identities=33% Similarity=0.589 Sum_probs=224.1
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYF 87 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 87 (448)
+.-+|.-+..||.|.||.||-|.+..||+..|+|.+...... ......+.+|..++..++|||+|++|++-.+.+..||
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence 345788999999999999999999999999999999766544 4556788999999999999999999999999999999
Q ss_pred EEeecCCCchHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccc--c
Q 037702 88 AMEYVRGGELFNKVAKGK-LREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTR--Q 164 (448)
Q Consensus 88 V~E~~~gg~L~~~i~~~~-l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~--~ 164 (448)
.||||+||+|.+.++.|+ .+|...+.|..|++.|+.|||+.|||||||||+||||+.+|-+|++|||.|....... -
T Consensus 1312 FMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~ 1391 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTM 1391 (1509)
T ss_pred HHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcC
Confidence 999999999999999865 5666678889999999999999999999999999999999999999999998654432 2
Q ss_pred CCCccccCCCCcccchhhhhccCC--CCCcchHHHHHHHHHHHHhCCCCCCCCcH-HHHHHHHhhc-cCCCCCCCCHHHH
Q 037702 165 DGLLHTTCGTPAYVAPEVINKRGY--DGAKADIWSCGVVLFVLLAGNLPFYDSNL-MELYKKITRA-EFKCPNWFPPEVR 240 (448)
Q Consensus 165 ~~~~~~~~Gt~~Y~APEvl~~~~~--~~~~sDiwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~~-~~~~p~~~s~~~~ 240 (448)
.+.+....|||.|||||++.+..- .+-++|||||||++.||+||+.||...+. -++..++..+ .+++|..+|++.+
T Consensus 1392 ~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~ 1471 (1509)
T KOG4645|consen 1392 PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGR 1471 (1509)
T ss_pred CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHH
Confidence 244567789999999999965331 24569999999999999999999975433 3444445444 5678999999999
Q ss_pred HHHHhccCCCcCCCCCHHHHHhhhhccc
Q 037702 241 KLLSRILDPNPSTRVTMAKLMENYWFRK 268 (448)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~eil~hp~~~~ 268 (448)
+||.+||..||++|.++.||++|.|-+.
T Consensus 1472 dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1472 DFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred HHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence 9999999999999999999999988643
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=338.98 Aligned_cols=252 Identities=21% Similarity=0.292 Sum_probs=210.6
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCC----------------cEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTG----------------QSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPN 71 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g----------------~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpn 71 (448)
..++|++.+.||+|+||.||+|.+..++ ..||+|.+...... ...+.+.+|+.+++.++|||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~ 80 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD--NAREDFLKEVKILSRLSDPN 80 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH--HHHHHHHHHHHHHHhcCCCC
Confidence 4578999999999999999999876544 45899998755322 34577889999999999999
Q ss_pred cceEEEEEEeCCEEEEEEeecCCCchHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCc
Q 037702 72 IVQLYEVMASKTKIYFAMEYVRGGELFNKVAKG------------KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPEN 139 (448)
Q Consensus 72 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~------------~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~N 139 (448)
|+++++++..+...+++|||+++++|.+++... .+++..++.++.|++.||+|||++|++||||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 999999999999999999999999999998652 58999999999999999999999999999999999
Q ss_pred eEEcCCCCeEEeeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh--CCCCCCCCcH
Q 037702 140 LLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA--GNLPFYDSNL 217 (448)
Q Consensus 140 ILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt--G~~Pf~~~~~ 217 (448)
|+++.++.++|+|||++................+++.|+|||++....+ +.++|||||||++|+|++ |..||...+.
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKF-TTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCC-CccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 9999999999999999875433222222234557889999999876555 588999999999999998 7889987766
Q ss_pred HHHHHHHhhc--------cCCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHh
Q 037702 218 MELYKKITRA--------EFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 218 ~~~~~~i~~~--------~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 262 (448)
.+.+..+... ....|..+|.++.+++.+||+.||.+|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 240 QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred HHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 6665554322 12345567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=348.34 Aligned_cols=262 Identities=27% Similarity=0.423 Sum_probs=215.0
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEe--C
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEVMAS--K 82 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~--~ 82 (448)
..+.++|++.+.||+|+||.||+|.+..+|+.+|+|.+.+.... ......+.+|+.+++.+ +||||+++++++.. .
T Consensus 3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~ 81 (337)
T cd07852 3 KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRN-ATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND 81 (337)
T ss_pred chhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCc-chhhhhhhHHHHHHHHhcCCCCccceeeeeccCCC
Confidence 35678999999999999999999999989999999998653222 22335677899999999 99999999998864 3
Q ss_pred CEEEEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccc
Q 037702 83 TKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQEST 162 (448)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~ 162 (448)
...|+||||+. ++|.+++..+.+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 82 KDIYLVFEYME-TDLHAVIRANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred ceEEEEecccc-cCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 46899999997 49999998778899999999999999999999999999999999999999999999999999865432
Q ss_pred ccC---CCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhcc-----------
Q 037702 163 RQD---GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAE----------- 228 (448)
Q Consensus 163 ~~~---~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~----------- 228 (448)
... .......||+.|+|||++.+....+.++|||||||++|+|++|+.||.+....+...++....
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240 (337)
T ss_pred cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHH
Confidence 211 223345689999999988665555688999999999999999999998765444333321110
Q ss_pred ----------------C----CCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 229 ----------------F----KCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 229 ----------------~----~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
. ...+.++.++.++|.+||+.||.+|||+.++++|||++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 0 0112368899999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=354.16 Aligned_cols=258 Identities=26% Similarity=0.424 Sum_probs=210.9
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEVMASKTKI 85 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~ 85 (448)
+-...|++.+.||+||.++||++... +...||+|.+.... .+...+.-+..||.+|..| .|.+||+++++-..++.+
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL 435 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence 44567999999999999999999864 34566776665443 3346678899999999999 589999999999999999
Q ss_pred EEEEeecCCCchHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccc
Q 037702 86 YFAMEYVRGGELFNKVAKG--KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTR 163 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~~--~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~ 163 (448)
||||||-+ -+|..++.++ -++.-.++.|++|++.|+.++|+.||||.||||.|+|+ -.|.+||+|||+|.......
T Consensus 436 YmvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 436 YMVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPDT 513 (677)
T ss_pred EEEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcccCccc
Confidence 99999864 4999999874 34445899999999999999999999999999999998 67899999999998776655
Q ss_pred cCCCccccCCCCcccchhhhhccCCC----------CCcchHHHHHHHHHHHHhCCCCCCCCc-HHHHHHHHhhc--cCC
Q 037702 164 QDGLLHTTCGTPAYVAPEVINKRGYD----------GAKADIWSCGVVLFVLLAGNLPFYDSN-LMELYKKITRA--EFK 230 (448)
Q Consensus 164 ~~~~~~~~~Gt~~Y~APEvl~~~~~~----------~~~sDiwSlGvil~elltG~~Pf~~~~-~~~~~~~i~~~--~~~ 230 (448)
..-...+.+||+.|||||.+....+. +.++||||||||||+|+.|++||..-. ...-+..|... +..
T Consensus 514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Ie 593 (677)
T KOG0596|consen 514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIE 593 (677)
T ss_pred cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcccc
Confidence 55556778999999999999654443 578999999999999999999996532 33333344333 235
Q ss_pred CCCCCCHH-HHHHHHhccCCCcCCCCCHHHHHhhhhccc
Q 037702 231 CPNWFPPE-VRKLLSRILDPNPSTRVTMAKLMENYWFRK 268 (448)
Q Consensus 231 ~p~~~s~~-~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 268 (448)
+|..-+.. +.++++.||..||++|||+.++|+|||++-
T Consensus 594 fp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 594 FPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred ccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 55543433 999999999999999999999999999864
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=341.07 Aligned_cols=254 Identities=28% Similarity=0.504 Sum_probs=215.8
Q ss_pred eEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 037702 12 YELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAMEY 91 (448)
Q Consensus 12 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 91 (448)
|+....||+|+||.||++.+..+|+.||||.+.... ......+.+|+.+++.++||||+++++.+..++..|+||||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 98 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEec
Confidence 344467999999999999999999999999985432 22346788999999999999999999999999999999999
Q ss_pred cCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCcccc
Q 037702 92 VRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTT 171 (448)
Q Consensus 92 ~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~ 171 (448)
+++++|.+++..+++++..++.++.|++.||+|||++|++||||+|+||+++.++.++|+|||++....... ......
T Consensus 99 ~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~~ 176 (292)
T cd06657 99 LEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSL 176 (292)
T ss_pred CCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccc--cccccc
Confidence 999999999888889999999999999999999999999999999999999999999999999986543221 112345
Q ss_pred CCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhc---cCCCCCCCCHHHHHHHHhccC
Q 037702 172 CGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA---EFKCPNWFPPEVRKLLSRILD 248 (448)
Q Consensus 172 ~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~li~~~L~ 248 (448)
.|++.|+|||.+....+ +.++|+||+|+++|+|++|..||...+.......+... .......+++.+.+++.+||.
T Consensus 177 ~~~~~y~~pE~~~~~~~-~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 255 (292)
T cd06657 177 VGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLV 255 (292)
T ss_pred ccCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHh
Confidence 68999999999876555 47899999999999999999999877665554444322 222334578999999999999
Q ss_pred CCcCCCCCHHHHHhhhhcccccc
Q 037702 249 PNPSTRVTMAKLMENYWFRKGYK 271 (448)
Q Consensus 249 ~dP~~Rpt~~eil~hp~~~~~~~ 271 (448)
.||.+||++.++++||||.+...
T Consensus 256 ~~P~~R~~~~~ll~~~~~~~~~~ 278 (292)
T cd06657 256 RDPAQRATAAELLKHPFLAKAGP 278 (292)
T ss_pred CCcccCcCHHHHhcChHHhccCC
Confidence 99999999999999999988663
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-44 Score=357.44 Aligned_cols=260 Identities=28% Similarity=0.535 Sum_probs=224.9
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIY 86 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 86 (448)
.-..-|..++.||-|+||+|.+++...|...||+|.+.+..+.....+..++.|-.||..-+.+-||+||..|.+++.+|
T Consensus 626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLY 705 (1034)
T KOG0608|consen 626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLY 705 (1034)
T ss_pred ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceE
Confidence 34456888999999999999999999999999999999988877777888999999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccC
Q 037702 87 FAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQD 165 (448)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~ 165 (448)
+||||++||++..++-+ |-|+|+.++.|+..|..|+++.|..|+|||||||+|||||.+|++||.||||++-+..+...
T Consensus 706 FVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 706 FVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred EEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccc
Confidence 99999999999888755 88999999999999999999999999999999999999999999999999999744322110
Q ss_pred ------------C----------------------------CccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHH
Q 037702 166 ------------G----------------------------LLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVL 205 (448)
Q Consensus 166 ------------~----------------------------~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~el 205 (448)
. ..+..+||+.|+|||++...||. ..+|+||.|||||||
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~-q~cdwws~gvil~em 864 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYT-QLCDWWSVGVILYEM 864 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcc-ccchhhHhhHHHHHH
Confidence 0 11344799999999999999997 779999999999999
Q ss_pred HhCCCCCCCCcHHHHHHHHhhcc----CCCCCCCCHHHHHHHHhccCCCcCCCC---CHHHHHhhhhccc
Q 037702 206 LAGNLPFYDSNLMELYKKITRAE----FKCPNWFPPEVRKLLSRILDPNPSTRV---TMAKLMENYWFRK 268 (448)
Q Consensus 206 ltG~~Pf~~~~~~~~~~~i~~~~----~~~p~~~s~~~~~li~~~L~~dP~~Rp---t~~eil~hp~~~~ 268 (448)
+.|++||.+....+...++.+.+ +..-..+|+++.++|.++.. +++.|. .++++..||||+.
T Consensus 865 ~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkg 933 (1034)
T KOG0608|consen 865 LVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKG 933 (1034)
T ss_pred hhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccc
Confidence 99999999887776666655432 23334689999999998764 477887 4678999999975
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=345.85 Aligned_cols=264 Identities=25% Similarity=0.363 Sum_probs=215.2
Q ss_pred ccCCeEE-EeeeeecCceEEEEEEECCCCcEEEEEEeecccccchh-----------HHHHHHHHHHHHHhCCCCCcceE
Q 037702 8 LMNKYEL-GRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVG-----------LIDQIKREISVMRLVRHPNIVQL 75 (448)
Q Consensus 8 ~~~~y~~-~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~-----------~~~~~~~Ei~~l~~l~hpnIv~l 75 (448)
+.++|.. .+.||.|+||.||+|.+..+|+.||||++......... ....+.+|+.+++.++||||+++
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 85 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL 85 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence 4578874 57799999999999999999999999998654322100 11246789999999999999999
Q ss_pred EEEEEeCCEEEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecc
Q 037702 76 YEVMASKTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFG 154 (448)
Q Consensus 76 ~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFG 154 (448)
++++..++..|+||||+. |+|.+++.. ..+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||
T Consensus 86 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg 164 (335)
T PTZ00024 86 VDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFG 164 (335)
T ss_pred eEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCcc
Confidence 999999999999999997 589888865 679999999999999999999999999999999999999999999999999
Q ss_pred ccccccccc------------cCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHH
Q 037702 155 LSALQESTR------------QDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYK 222 (448)
Q Consensus 155 la~~~~~~~------------~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~ 222 (448)
++....... .........+++.|+|||.+.+....+.++|||||||++|+|++|.+||...+..+.+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~ 244 (335)
T PTZ00024 165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG 244 (335)
T ss_pred ceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 987544110 01112234578899999998765555688999999999999999999998877665554
Q ss_pred HHhhcc-------C---------------------CCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccccccc
Q 037702 223 KITRAE-------F---------------------KCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYKK 272 (448)
Q Consensus 223 ~i~~~~-------~---------------------~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~ 272 (448)
.+.... + ......+.++.++|.+||+.||.+|||+++++.||||+.....
T Consensus 245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~~ 322 (335)
T PTZ00024 245 RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLP 322 (335)
T ss_pred HHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCCC
Confidence 443210 0 0012357889999999999999999999999999999865433
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=334.28 Aligned_cols=248 Identities=25% Similarity=0.466 Sum_probs=213.9
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYF 87 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 87 (448)
...+|++.+.||.|+||.||+|.+.. +..+|+|++...... ....+.+|+.+++.++||||+++++++......|+
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLL---KQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYI 79 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchh---hHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEE
Confidence 34679999999999999999999877 899999998765432 24678899999999999999999999999999999
Q ss_pred EEeecCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccccc
Q 037702 88 AMEYVRGGELFNKVAK---GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQ 164 (448)
Q Consensus 88 V~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~ 164 (448)
||||+++++|.+++.. ..+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~- 158 (261)
T cd05148 80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV- 158 (261)
T ss_pred EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcc-
Confidence 9999999999999975 358999999999999999999999999999999999999999999999999997543211
Q ss_pred CCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhc-cCCCCCCCCHHHHHH
Q 037702 165 DGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EFKCPNWFPPEVRKL 242 (448)
Q Consensus 165 ~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~l 242 (448)
.......++..|+|||++....+ +.++||||||+++|+|++ |..||...+..+.+..+... ..+.|..+++.+.++
T Consensus 159 -~~~~~~~~~~~~~~PE~~~~~~~-~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (261)
T cd05148 159 -YLSSDKKIPYKWTAPEAASHGTF-STKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKI 236 (261)
T ss_pred -ccccCCCCceEecCHHHHccCCC-CchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHH
Confidence 11123446778999999876655 478999999999999998 89999888877777766654 345567789999999
Q ss_pred HHhccCCCcCCCCCHHHHHh
Q 037702 243 LSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 243 i~~~L~~dP~~Rpt~~eil~ 262 (448)
|.+||..||.+|||+.++++
T Consensus 237 i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 237 MLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHHcCCCchhCcCHHHHHH
Confidence 99999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=339.96 Aligned_cols=255 Identities=24% Similarity=0.377 Sum_probs=211.6
Q ss_pred cccccCCeEEEeeeeecCceEEEEEEE-----CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEE
Q 037702 5 AGILMNKYELGRLLGQGTFAKVYHGRN-----LKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEV 78 (448)
Q Consensus 5 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~-----~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~ 78 (448)
.....++|++.+.||+|+||.||+|.+ ..++..||+|.+..... ....+.+.+|+.+++++ +||||++++++
T Consensus 30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 107 (302)
T cd05055 30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH--SSEREALMSELKIMSHLGNHENIVNLLGA 107 (302)
T ss_pred ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC--hHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence 456677999999999999999999975 33566899999865432 23346788999999999 79999999999
Q ss_pred EEeCCEEEEEEeecCCCchHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccc
Q 037702 79 MASKTKIYFAMEYVRGGELFNKVAKG---KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGL 155 (448)
Q Consensus 79 ~~~~~~~~lV~E~~~gg~L~~~i~~~---~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGl 155 (448)
+...+..|+||||+++|+|.+++... .+++.++..++.|++.||.|||++||+|+||||+|||++.++.++|+|||+
T Consensus 108 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 108 CTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred EecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcc
Confidence 99999999999999999999998652 389999999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhcc--CCCC
Q 037702 156 SALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAE--FKCP 232 (448)
Q Consensus 156 a~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~--~~~p 232 (448)
+................+++.|+|||++....+ +.++||||+||++|+|++ |..||...+..+.+.+..... ...|
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 266 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQP 266 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhhccCCC-CcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCC
Confidence 875433221111123346788999999877665 478999999999999998 999998876655444443332 2345
Q ss_pred CCCCHHHHHHHHhccCCCcCCCCCHHHHHh
Q 037702 233 NWFPPEVRKLLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 233 ~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 262 (448)
...++++.+++.+||.++|++|||+.++++
T Consensus 267 ~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 267 EHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 668899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=331.23 Aligned_cols=248 Identities=25% Similarity=0.406 Sum_probs=209.4
Q ss_pred cCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFA 88 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 88 (448)
.++|++.+.||+|+||.||.|.+. .+..+|+|.+...... .+.+.+|+.+++.++||||+++++++......|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV 77 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCccc----HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence 467999999999999999999874 3456999998654322 25688999999999999999999999999999999
Q ss_pred EeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCC
Q 037702 89 MEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDG 166 (448)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 166 (448)
|||+++|+|.+++.. ..+++..++.++.|++.||+|||++|++|+||||+|||++.++.+||+|||++........ .
T Consensus 78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~ 156 (256)
T cd05113 78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-T 156 (256)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCce-e
Confidence 999999999999875 3689999999999999999999999999999999999999999999999999875432111 1
Q ss_pred CccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhccC-CCCCCCCHHHHHHHH
Q 037702 167 LLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAEF-KCPNWFPPEVRKLLS 244 (448)
Q Consensus 167 ~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~ 244 (448)
......++..|+|||++.+..+. .++|||||||++|+|++ |..||...+..+....+..... ..+...++.+.+++.
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~-~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 235 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFS-SKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMY 235 (256)
T ss_pred ecCCCccChhhCCHHHHhcCccc-chhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence 11122356789999999766654 78999999999999998 9999988777777776665533 345567899999999
Q ss_pred hccCCCcCCCCCHHHHHhh
Q 037702 245 RILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 245 ~~L~~dP~~Rpt~~eil~h 263 (448)
+||..||.+|||+.+++++
T Consensus 236 ~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 236 SCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHcCCCcccCCCHHHHHHh
Confidence 9999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=338.31 Aligned_cols=248 Identities=26% Similarity=0.429 Sum_probs=208.2
Q ss_pred CCeEEEeeeeecCceEEEEEEECCCCc--EEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEE
Q 037702 10 NKYELGRLLGQGTFAKVYHGRNLKTGQ--SVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEVMASKTKIY 86 (448)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~--~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~ 86 (448)
++|++.+.||+|+||.||+|.+..+|. .+++|.+... ......+.+.+|+.++.++ +||||+++++++.....+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 689999999999999999999877775 4688877532 1223346788999999999 7999999999999999999
Q ss_pred EEEeecCCCchHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeE
Q 037702 87 FAMEYVRGGELFNKVAKG-----------------KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLK 149 (448)
Q Consensus 87 lV~E~~~gg~L~~~i~~~-----------------~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lk 149 (448)
+||||+++++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 999999999999998642 478899999999999999999999999999999999999999999
Q ss_pred EeeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhcc
Q 037702 150 ISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAE 228 (448)
Q Consensus 150 l~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~ 228 (448)
|+|||++........ ......+..|+|||++....+ +.++|||||||++|+|++ |..||...+..+...++....
T Consensus 160 l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~ 235 (297)
T cd05089 160 IADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVY-TTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 235 (297)
T ss_pred ECCcCCCccccceec---cCCCCcCccccCchhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence 999999863221111 111233557999999876665 488999999999999997 999999888877777766542
Q ss_pred -CCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 229 -FKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 229 -~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
...|..+++++.+||.+||..||.+|||++++++.
T Consensus 236 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 236 RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 34566789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=331.70 Aligned_cols=249 Identities=24% Similarity=0.433 Sum_probs=210.6
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIY 86 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 86 (448)
+-.++|++.+.||+|+||.||+|.+. ++..||+|.+..... ..+.+.+|+.+++.++||||+++++++......|
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY 77 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch----hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 45678999999999999999999864 567899998865432 2467889999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccc
Q 037702 87 FAMEYVRGGELFNKVAK---GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTR 163 (448)
Q Consensus 87 lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~ 163 (448)
++|||+++++|.+++.. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 99999999999999864 468899999999999999999999999999999999999999999999999998643221
Q ss_pred cCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhc-cCCCCCCCCHHHHH
Q 037702 164 QDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EFKCPNWFPPEVRK 241 (448)
Q Consensus 164 ~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 241 (448)
. .......++..|+|||.+....+ +.++|||||||++|+|++ |..||......+....+... ..+.+..++.++.+
T Consensus 158 ~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (261)
T cd05072 158 Y-TAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYD 235 (261)
T ss_pred e-eccCCCccceecCCHHHhccCCC-ChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 1 11122346778999999876555 478999999999999998 99999887777766666544 23344567899999
Q ss_pred HHHhccCCCcCCCCCHHHHHh
Q 037702 242 LLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~ 262 (448)
++.+||..||++||+++++++
T Consensus 236 li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 236 IMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHHHccCCcccCcCHHHHHH
Confidence 999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=334.04 Aligned_cols=252 Identities=21% Similarity=0.361 Sum_probs=210.0
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCc----EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQ----SVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKT 83 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~----~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~ 83 (448)
...+|++.+.||+|+||.||+|.+..+|. .||+|++..... ......+.+|+.+++.++||||+++++++.. .
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~ 81 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS--PKANKEILDEAYVMAGVGSPYVCRLLGICLT-S 81 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCC--HHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-C
Confidence 45689999999999999999999887776 489999865432 2334678899999999999999999999875 4
Q ss_pred EEEEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccc
Q 037702 84 KIYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQES 161 (448)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~ 161 (448)
..+++|||+++|+|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 57899999999999999965 4689999999999999999999999999999999999999999999999999986543
Q ss_pred cccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhcc-CCCCCCCCHHH
Q 037702 162 TRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAE-FKCPNWFPPEV 239 (448)
Q Consensus 162 ~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~ 239 (448)
...........+++.|+|||.+.+..++ .++|||||||++|||++ |..||...........+.... ...+..++.++
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFT-HQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDV 240 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHH
Confidence 2211111223456789999999776664 78999999999999998 999998776666665555443 34566789999
Q ss_pred HHHHHhccCCCcCCCCCHHHHHhh
Q 037702 240 RKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 240 ~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
.+++.+||..||++||++.++++.
T Consensus 241 ~~li~~~l~~dp~~Rp~~~~l~~~ 264 (279)
T cd05109 241 YMIMVKCWMIDSECRPRFRELVDE 264 (279)
T ss_pred HHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=340.87 Aligned_cols=257 Identities=28% Similarity=0.478 Sum_probs=208.3
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASK----- 82 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~----- 82 (448)
..++|++.+.||+|+||.||+|.+..+++.+|||.+......+ .....+.+|+.+++.++||||+++++++...
T Consensus 6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 84 (311)
T cd07866 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD-GFPITALREIKILKKLKHPNVVPLIDMAVERPDKSK 84 (311)
T ss_pred ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC-CcchhHHHHHHHHHhcCCCCccchhhheeccccccc
Confidence 4789999999999999999999999999999999987654332 1224567899999999999999999887433
Q ss_pred ---CEEEEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccc
Q 037702 83 ---TKIYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSA 157 (448)
Q Consensus 83 ---~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~ 157 (448)
..+|+||||+.+ +|...+.. ..+++..+..++.||++||+|||++||+||||||+|||++.++.++|+|||++.
T Consensus 85 ~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 85 RKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred ccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccch
Confidence 357999999975 67666653 479999999999999999999999999999999999999999999999999997
Q ss_pred cccccccC---------CCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhcc
Q 037702 158 LQESTRQD---------GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAE 228 (448)
Q Consensus 158 ~~~~~~~~---------~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~ 228 (448)
........ .......|++.|+|||.+.+....+.++|||||||++|+|++|++||.+.+.......+....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~ 243 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC 243 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 54322111 111234578899999998665445688999999999999999999998877766555443211
Q ss_pred C-----------------------CCC-------CCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhc
Q 037702 229 F-----------------------KCP-------NWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWF 266 (448)
Q Consensus 229 ~-----------------------~~p-------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 266 (448)
. ..+ ..+++.+.++|.+||..||.+|||+.+++.||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred CCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 0 001 1244678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=338.89 Aligned_cols=256 Identities=25% Similarity=0.425 Sum_probs=214.8
Q ss_pred cccccCCeEEEeeeeecCceEEEEEEEC-------CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEE
Q 037702 5 AGILMNKYELGRLLGQGTFAKVYHGRNL-------KTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLY 76 (448)
Q Consensus 5 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~-------~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~ 76 (448)
..+..++|++.+.||+|+||.||+|++. .++..||+|.+..... ......+.+|+.+++.+ +||||++++
T Consensus 10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~ 87 (304)
T cd05101 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLL 87 (304)
T ss_pred ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccc--hHHHHHHHHHHHHHHhhccCCCchhee
Confidence 4567789999999999999999999753 2345799998865422 23346788999999999 899999999
Q ss_pred EEEEeCCEEEEEEeecCCCchHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCc
Q 037702 77 EVMASKTKIYFAMEYVRGGELFNKVAKG-----------------KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPEN 139 (448)
Q Consensus 77 ~~~~~~~~~~lV~E~~~gg~L~~~i~~~-----------------~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~N 139 (448)
+++......|+||||+++|+|.+++... .++...+..++.||+.||.|||++|++||||||+|
T Consensus 88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N 167 (304)
T cd05101 88 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARN 167 (304)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccce
Confidence 9999999999999999999999998642 36778889999999999999999999999999999
Q ss_pred eEEcCCCCeEEeeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHH
Q 037702 140 LLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLM 218 (448)
Q Consensus 140 ILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~ 218 (448)
||++.++.+||+|||++................+++.|+|||++.+..++ .++||||||+++|+|++ |..||...+..
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~ 246 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVE 246 (304)
T ss_pred EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCC-chhhHHHHHHHHHHHHcCCCCCcccCCHH
Confidence 99999999999999999755432222222334567889999999776664 78999999999999998 88999988888
Q ss_pred HHHHHHhhcc-CCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 219 ELYKKITRAE-FKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 219 ~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
++...+.... ...|..++.++.+||.+||.++|.+|||+.++++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 247 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 8877776543 34566788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=336.53 Aligned_cols=258 Identities=29% Similarity=0.552 Sum_probs=216.5
Q ss_pred CeEEEeeeeecCceEEEEEEEC---CCCcEEEEEEeeccccc-chhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 037702 11 KYELGRLLGQGTFAKVYHGRNL---KTGQSVAIKIVDKEKIR-RVGLIDQIKREISVMRLV-RHPNIVQLYEVMASKTKI 85 (448)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~-~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~ 85 (448)
+|++.+.||.|+||.||.|.+. .+|..||+|++...... .....+.+.+|+.+++.+ +||||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 5899999999999999999875 47899999999754332 223346678899999999 699999999999999999
Q ss_pred EEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccccc
Q 037702 86 YFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQ 164 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~ 164 (448)
|+||||+++++|.+++.. +.+++..+..++.|++.||.|||++|++||||+|+|||++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~- 159 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE- 159 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccccc-
Confidence 999999999999999865 678999999999999999999999999999999999999999999999999987543221
Q ss_pred CCCccccCCCCcccchhhhhcc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCc----HHHHHHHHhhccCCCCCCCCHHH
Q 037702 165 DGLLHTTCGTPAYVAPEVINKR-GYDGAKADIWSCGVVLFVLLAGNLPFYDSN----LMELYKKITRAEFKCPNWFPPEV 239 (448)
Q Consensus 165 ~~~~~~~~Gt~~Y~APEvl~~~-~~~~~~sDiwSlGvil~elltG~~Pf~~~~----~~~~~~~i~~~~~~~p~~~s~~~ 239 (448)
.......+|+..|+|||.+... ...+.++||||||+++|+|++|..||...+ ..++...+.......|..+++.+
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (290)
T cd05613 160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA 239 (290)
T ss_pred ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCHHH
Confidence 1222346799999999998643 233578999999999999999999996432 23444445455566777789999
Q ss_pred HHHHHhccCCCcCCCC-----CHHHHHhhhhcccc
Q 037702 240 RKLLSRILDPNPSTRV-----TMAKLMENYWFRKG 269 (448)
Q Consensus 240 ~~li~~~L~~dP~~Rp-----t~~eil~hp~~~~~ 269 (448)
.+++.+||..||++|| ++++++.||||+..
T Consensus 240 ~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 274 (290)
T cd05613 240 KDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI 274 (290)
T ss_pred HHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccC
Confidence 9999999999999997 89999999999763
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=339.78 Aligned_cols=255 Identities=25% Similarity=0.420 Sum_probs=212.5
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECC-------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLK-------TGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYE 77 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~-------~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~ 77 (448)
....++|.+.+.||+|+||.||+|.+.. ....+|+|.+..... ......+.+|+.+++.+ +||||+++++
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT--DKDLADLISEMELMKLIGKHKNIINLLG 85 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC--hHHHHHHHHHHHHHHhccCCCCeeeEEE
Confidence 4566899999999999999999998632 345799999865422 23346788999999999 6999999999
Q ss_pred EEEeCCEEEEEEeecCCCchHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCce
Q 037702 78 VMASKTKIYFAMEYVRGGELFNKVAK-----------------GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENL 140 (448)
Q Consensus 78 ~~~~~~~~~lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NI 140 (448)
++.....+|+||||+++|+|.+++.. ..+++..+..++.||+.||.|||++|++||||||+||
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 165 (314)
T cd05099 86 VCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNV 165 (314)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeE
Confidence 99999999999999999999999854 2378889999999999999999999999999999999
Q ss_pred EEcCCCCeEEeeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHH
Q 037702 141 LLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLME 219 (448)
Q Consensus 141 Ll~~~g~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~ 219 (448)
|++.++.+||+|||++................+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...+..+
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~~g~~p~~~~~~~~ 244 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVY-THQSDVWSFGILMWEIFTLGGSPYPGIPVEE 244 (314)
T ss_pred EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCc-CccchhhHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999999975432221111222335578999999976655 488999999999999999 899999888777
Q ss_pred HHHHHhhcc-CCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 220 LYKKITRAE-FKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 220 ~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
.+..+.... ...|..++.++.++|.+||..||++|||+.++++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 289 (314)
T cd05099 245 LFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEA 289 (314)
T ss_pred HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 777766543 34566788999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=336.31 Aligned_cols=251 Identities=26% Similarity=0.403 Sum_probs=211.1
Q ss_pred ccCCeEEEeeeeecCceEEEEEEEC-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNL-----KTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASK 82 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~ 82 (448)
...+|++.+.||+|+||.||++... .++..+|+|.+.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHIVRFYGVCTEG 79 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---HHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence 4568999999999999999999742 356789999876432 23356789999999999999999999999999
Q ss_pred CEEEEEEeecCCCchHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCC
Q 037702 83 TKIYFAMEYVRGGELFNKVAKG----------------KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENG 146 (448)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~~----------------~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g 146 (448)
...+++|||+++++|.+++... .+++..+..++.||+.||+|||++|++||||||+|||+++++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL 159 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence 9999999999999999998652 378899999999999999999999999999999999999999
Q ss_pred CeEEeeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHh
Q 037702 147 DLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKIT 225 (448)
Q Consensus 147 ~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~ 225 (448)
.+||+|||++................+++.|+|||.+.+..++ .++|||||||++|+|++ |.+||......+....+.
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 238 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT-TESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT 238 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcC-chhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence 9999999998754322111112234467889999998776664 88999999999999998 999998877766666665
Q ss_pred hc-cCCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHh
Q 037702 226 RA-EFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 226 ~~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 262 (448)
.. ....|..+++.+.++|.+||+.||.+||+++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 239 QGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred cCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 44 34556778999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=329.71 Aligned_cols=249 Identities=25% Similarity=0.434 Sum_probs=210.5
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIY 86 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 86 (448)
+..++|++.+.||+|+||.||+|.+. +++.||+|.+...... .+.+.+|+.+++.++||||+++++++......|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMD----PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY 77 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCccc----HHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence 34578999999999999999999964 5578999998654322 356888999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccc
Q 037702 87 FAMEYVRGGELFNKVAKG---KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTR 163 (448)
Q Consensus 87 lV~E~~~gg~L~~~i~~~---~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~ 163 (448)
+||||+++++|.+++... .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 999999999999999752 58999999999999999999999999999999999999999999999999998654221
Q ss_pred cCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhc-cCCCCCCCCHHHHH
Q 037702 164 QDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EFKCPNWFPPEVRK 241 (448)
Q Consensus 164 ~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 241 (448)
.. ......++..|+|||++.+..+ +.++||||||+++|+|++ |+.||.+.+.......+... ....+..++..+.+
T Consensus 158 ~~-~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (261)
T cd05068 158 YE-AREGAKFPIKWTAPEAALYNRF-SIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYD 235 (261)
T ss_pred cc-ccCCCcCceeccCccccccCCC-CchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence 11 1111223457999999876655 478999999999999999 99999988777777766544 23456668899999
Q ss_pred HHHhccCCCcCCCCCHHHHHh
Q 037702 242 LLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~ 262 (448)
++.+||..||.+||++.++++
T Consensus 236 li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 236 IMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHHHhhcCcccCCCHHHHHH
Confidence 999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=335.00 Aligned_cols=252 Identities=32% Similarity=0.536 Sum_probs=211.3
Q ss_pred eEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEEEEEE
Q 037702 12 YELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASK--TKIYFAM 89 (448)
Q Consensus 12 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~~lV~ 89 (448)
|++.+.||+|+||.||+|.+..+|+.+|+|.+.... ........+.+|+.+++.++|||++++++++... ...|+||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 789999999999999999999999999999998664 2223346678899999999999999999999888 8999999
Q ss_pred eecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCC
Q 037702 90 EYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGL 167 (448)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 167 (448)
||+++ +|.+++.. ..+++..++.++.||+.||+|||++|++|+||+|+||+++.++.+||+|||++........ ..
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-~~ 157 (287)
T cd07840 80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-AD 157 (287)
T ss_pred ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-cc
Confidence 99975 88888865 3799999999999999999999999999999999999999999999999999986543321 12
Q ss_pred ccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccC------------------
Q 037702 168 LHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF------------------ 229 (448)
Q Consensus 168 ~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~------------------ 229 (448)
.....++..|+|||.+.+....+.++||||||+++|+|++|+.||...+.......+.....
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN 237 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence 23456788999999876554456889999999999999999999988776555544432100
Q ss_pred -----C--------CCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhc
Q 037702 230 -----K--------CPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWF 266 (448)
Q Consensus 230 -----~--------~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 266 (448)
. +...+++.+.++|.+||..||.+||+++++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 0 011138899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=330.96 Aligned_cols=248 Identities=28% Similarity=0.441 Sum_probs=208.5
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIY 86 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 86 (448)
+..++|++.+.||+|+||.||+|.+..+ ..||+|.+...... .+.+.+|+.+++.++||||+++++++. ....|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~ 76 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIY 76 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccC----HHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcE
Confidence 4567899999999999999999988655 46999999754332 256789999999999999999999875 45689
Q ss_pred EEEeecCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccc
Q 037702 87 FAMEYVRGGELFNKVAK---GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTR 163 (448)
Q Consensus 87 lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~ 163 (448)
+||||+++|+|.+++.. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 99999999999999975 358899999999999999999999999999999999999999999999999997553222
Q ss_pred cCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhc-cCCCCCCCCHHHHH
Q 037702 164 QDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EFKCPNWFPPEVRK 241 (448)
Q Consensus 164 ~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 241 (448)
. .......++..|+|||++.+..+ +.++|||||||++|+|++ |..||.+.........+... ....+..++..+.+
T Consensus 157 ~-~~~~~~~~~~~y~~PE~~~~~~~-~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 234 (262)
T cd05071 157 Y-TARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 234 (262)
T ss_pred c-ccccCCcccceecCHhHhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHH
Confidence 1 11223456778999999876666 488999999999999999 89999887776666666543 23455668899999
Q ss_pred HHHhccCCCcCCCCCHHHHHh
Q 037702 242 LLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~ 262 (448)
+|.+||.+||.+||+++++++
T Consensus 235 li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 235 LMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHHHHccCCcccCCCHHHHHH
Confidence 999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=329.96 Aligned_cols=243 Identities=27% Similarity=0.398 Sum_probs=204.4
Q ss_pred eeeecCceEEEEEEE--CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCC
Q 037702 17 LLGQGTFAKVYHGRN--LKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRG 94 (448)
Q Consensus 17 ~LG~G~fg~Vy~a~~--~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (448)
.||+|+||.||+|.+ ..++..+|+|++..... +....+.+.+|+.+++.++||||+++++++. ....++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNN-DPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCC-cHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 589999999999965 45788999999865432 2345577899999999999999999999875 4567899999999
Q ss_pred CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCC-CccccC
Q 037702 95 GELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDG-LLHTTC 172 (448)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~-~~~~~~ 172 (448)
|+|.+++.. +.+++..+..++.|++.||+|||++||+||||||.|||++.++.+||+|||++.......... ......
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 159 (257)
T cd05116 80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGK 159 (257)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCC
Confidence 999999965 579999999999999999999999999999999999999999999999999997543322110 112234
Q ss_pred CCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhcc-CCCCCCCCHHHHHHHHhccCCC
Q 037702 173 GTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAE-FKCPNWFPPEVRKLLSRILDPN 250 (448)
Q Consensus 173 Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~d 250 (448)
+++.|+|||.+....+ +.++|+|||||++|+|++ |..||...+..+....+..+. ...|..+++++.++|.+||+.|
T Consensus 160 ~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~ 238 (257)
T cd05116 160 WPVKWYAPECMNYYKF-SSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYG 238 (257)
T ss_pred CCccccCHhHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccC
Confidence 5689999999866554 478999999999999998 999999887777777776543 4567789999999999999999
Q ss_pred cCCCCCHHHHHh
Q 037702 251 PSTRVTMAKLME 262 (448)
Q Consensus 251 P~~Rpt~~eil~ 262 (448)
|.+||++++|.+
T Consensus 239 p~~Rp~~~~i~~ 250 (257)
T cd05116 239 VDERPGFAVVEL 250 (257)
T ss_pred chhCcCHHHHHH
Confidence 999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=335.86 Aligned_cols=249 Identities=23% Similarity=0.390 Sum_probs=208.7
Q ss_pred CeEEEeeeeecCceEEEEEEECC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 037702 11 KYELGRLLGQGTFAKVYHGRNLK-----TGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKI 85 (448)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 85 (448)
+|++.+.||+|+||.||+|.+.. ....+|+|.+...... .....+.+|+.+++.++||||+++++.+...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASS--SELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCH--HHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 58899999999999999998753 2356899988654322 2346788999999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHhc-------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCce
Q 037702 86 YFAMEYVRGGELFNKVAK-------------------------GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENL 140 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-------------------------~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NI 140 (448)
|++|||+.+|+|.+++.. ..+++..++.++.|++.||.|||++|++||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 999999999999998753 2477889999999999999999999999999999999
Q ss_pred EEcCCCCeEEeeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHH
Q 037702 141 LLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLME 219 (448)
Q Consensus 141 Ll~~~g~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~ 219 (448)
|++.++.+||+|||++...............+++..|+|||++.+..+ +.++||||||+++|+|++ |..||.+.....
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIY-TTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCc-chHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 999999999999999875432222111233456788999999876655 488999999999999998 999998887777
Q ss_pred HHHHHhhc-cCCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHh
Q 037702 220 LYKKITRA-EFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 220 ~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 262 (448)
+...+... ....|..++.++.+++.+||+.||.+||+++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 238 LFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 76665543 33456678999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=328.03 Aligned_cols=250 Identities=29% Similarity=0.512 Sum_probs=219.7
Q ss_pred CeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 037702 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAME 90 (448)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (448)
+|++.+.||+|+||.||++.+..+|+.+|+|.+....... .....+.+|+.+++.++||||+++++++.+....|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ-KEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccH-HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 5999999999999999999999999999999997654332 334667789999999999999999999999999999999
Q ss_pred ecCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccC
Q 037702 91 YVRGGELFNKVAK-----GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQD 165 (448)
Q Consensus 91 ~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~ 165 (448)
|+++++|.+++.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--- 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--- 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC---
Confidence 9999999998865 46899999999999999999999999999999999999999999999999999765432
Q ss_pred CCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccC-CCCCCCCHHHHHHHH
Q 037702 166 GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF-KCPNWFPPEVRKLLS 244 (448)
Q Consensus 166 ~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~ 244 (448)
......|++.|+|||.+.+..+. .++|+||||+++|+|++|+.||...+.......+....+ ..+..++.++++++.
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~~~~~-~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 234 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKGRPYS-YKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIR 234 (256)
T ss_pred -CcccccCCccccCHHHHCCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHH
Confidence 23346789999999999776654 789999999999999999999998887776666655554 345568899999999
Q ss_pred hccCCCcCCCCCHHHHHhhhhc
Q 037702 245 RILDPNPSTRVTMAKLMENYWF 266 (448)
Q Consensus 245 ~~L~~dP~~Rpt~~eil~hp~~ 266 (448)
+||..+|++|||+.++++||++
T Consensus 235 ~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 235 SMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHcCCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=333.41 Aligned_cols=252 Identities=21% Similarity=0.343 Sum_probs=207.7
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcE----EEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQS----VAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKT 83 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~----vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~ 83 (448)
..++|++.+.||+|+||.||+|.+..+|.. +++|.+.... .......+..|+..++.++||||+++++++. ..
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~ 81 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GA 81 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc--chHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CC
Confidence 457899999999999999999999887774 6777764321 1223456778888999999999999999875 45
Q ss_pred EEEEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccc
Q 037702 84 KIYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQES 161 (448)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~ 161 (448)
..++++||+++|+|.+++.. +.+++..+..++.||+.||+|||++|++||||||+|||++.++.+||+|||++.....
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 67899999999999999964 5789999999999999999999999999999999999999999999999999975432
Q ss_pred cccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhcc-CCCCCCCCHHH
Q 037702 162 TRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAE-FKCPNWFPPEV 239 (448)
Q Consensus 162 ~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~ 239 (448)
...........|+..|+|||++.+..+ +.++|||||||++|+|++ |..||.+.........+..+. ...|..++.++
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRY-THQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDV 240 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCc-CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHH
Confidence 222222234557789999999976665 488999999999999998 999998877665555554443 34455678899
Q ss_pred HHHHHhccCCCcCCCCCHHHHHhh
Q 037702 240 RKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 240 ~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
.+++.+||..||.+|||+.++++.
T Consensus 241 ~~li~~c~~~~p~~Rps~~el~~~ 264 (279)
T cd05111 241 YMVMVKCWMIDENVRPTFKELANE 264 (279)
T ss_pred HHHHHHHcCCCcccCcCHHHHHHH
Confidence 999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=329.99 Aligned_cols=248 Identities=26% Similarity=0.442 Sum_probs=209.2
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIY 86 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 86 (448)
+..++|++.+.||+|+||.||+|.+. ++..+|+|.+...... .+.+.+|+.+++.++||||+++++++. ....|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~ 76 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIY 76 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcE
Confidence 45678999999999999999999864 6677999998765432 256889999999999999999999875 45689
Q ss_pred EEEeecCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccc
Q 037702 87 FAMEYVRGGELFNKVAK---GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTR 163 (448)
Q Consensus 87 lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~ 163 (448)
++|||+++++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 99999999999999864 358999999999999999999999999999999999999999999999999997543221
Q ss_pred cCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhc-cCCCCCCCCHHHHH
Q 037702 164 QDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EFKCPNWFPPEVRK 241 (448)
Q Consensus 164 ~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 241 (448)
. .......++..|+|||.+....+ +.++|+||||+++|+|++ |.+||.+.+..+....+... ..+.|...+..+.+
T Consensus 157 ~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (260)
T cd05070 157 Y-TARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHE 234 (260)
T ss_pred c-ccccCCCCCccccChHHHhcCCC-cchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence 1 11112335678999999876555 478999999999999999 99999888777777766544 34566778999999
Q ss_pred HHHhccCCCcCCCCCHHHHHh
Q 037702 242 LLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~ 262 (448)
|+.+||.+||.+|||++++.+
T Consensus 235 li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 235 LMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHHHHcccCcccCcCHHHHHH
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=365.32 Aligned_cols=261 Identities=25% Similarity=0.363 Sum_probs=197.3
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCC-CcEEEEEEee--------------cccccchhHHHHHHHHHHHHHhCCCC
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKT-GQSVAIKIVD--------------KEKIRRVGLIDQIKREISVMRLVRHP 70 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~-g~~vAiK~i~--------------~~~~~~~~~~~~~~~Ei~~l~~l~hp 70 (448)
....++|++.+.||+|+||+||+|..+.. +...+.|.+. +...........+.+|+.+|+.++||
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence 34568999999999999999999876543 2333333211 11111122346688999999999999
Q ss_pred CcceEEEEEEeCCEEEEEEeecCCCchHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcC
Q 037702 71 NIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKG------KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDE 144 (448)
Q Consensus 71 nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~------~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~ 144 (448)
||+++++++...+..|+|+|++. ++|++++..+ ......++.++.||+.||+|||++||+||||||+|||++.
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~ 302 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNC 302 (501)
T ss_pred CcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC
Confidence 99999999999999999999995 5777776542 2346678899999999999999999999999999999999
Q ss_pred CCCeEEeeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCC-CCCC--cHHHHH
Q 037702 145 NGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLP-FYDS--NLMELY 221 (448)
Q Consensus 145 ~g~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~P-f~~~--~~~~~~ 221 (448)
++.+||+|||++........ ......+||+.|+|||++.+.++. .++|||||||++|+|++|..| |... +....+
T Consensus 303 ~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYC-EITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 99999999999976543221 122346899999999999887775 889999999999999998754 4322 111111
Q ss_pred HHHhh----------------------ccC-----CCC-----CCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 222 KKITR----------------------AEF-----KCP-----NWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 222 ~~i~~----------------------~~~-----~~p-----~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
.++.. ..+ ..+ ..++.++.++|.+||..||.+|||+.|+|+||||...
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence 11111 000 000 1245678889999999999999999999999999764
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=323.61 Aligned_cols=248 Identities=34% Similarity=0.602 Sum_probs=213.5
Q ss_pred CeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 037702 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAME 90 (448)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (448)
+|++.+.||+|++|.||++.+..+|+.+++|++..... .....+.+|+.+++.++||||+++++++......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 58999999999999999999988999999999976543 234778899999999999999999999999999999999
Q ss_pred ecCCCchHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCc
Q 037702 91 YVRGGELFNKVAKG--KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLL 168 (448)
Q Consensus 91 ~~~gg~L~~~i~~~--~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 168 (448)
|++|++|.+++... .+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++........ .
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~ 154 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---R 154 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---c
Confidence 99999999998764 799999999999999999999999999999999999999999999999999876543221 2
Q ss_pred cccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhcc-CCC--CCCCCHHHHHHHHh
Q 037702 169 HTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAE-FKC--PNWFPPEVRKLLSR 245 (448)
Q Consensus 169 ~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~~--p~~~s~~~~~li~~ 245 (448)
....|+..|+|||.+....+ +.++|+||||+++|+|++|..||...+.......+.... ... +..++..+.++|.+
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 233 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPY-DYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKK 233 (253)
T ss_pred cceecCCcccCHHHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHH
Confidence 45678999999999876554 588999999999999999999998775444333333222 122 22348999999999
Q ss_pred ccCCCcCCCCCHHHHHhhhh
Q 037702 246 ILDPNPSTRVTMAKLMENYW 265 (448)
Q Consensus 246 ~L~~dP~~Rpt~~eil~hp~ 265 (448)
||+.||.+|||+.++++|||
T Consensus 234 ~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 234 CLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HccCChhhCCCHHHHhcCCC
Confidence 99999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=357.89 Aligned_cols=254 Identities=25% Similarity=0.544 Sum_probs=219.3
Q ss_pred cCCe-EEEeeeeecCceEEEEEEECCCCcEEEEEEeecccc-cchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE--
Q 037702 9 MNKY-ELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKI-RRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTK-- 84 (448)
Q Consensus 9 ~~~y-~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~-- 84 (448)
.++| +....||+|+|-+||+|.|..+|..||.-.+....+ +..+..++++.|+.+|+.|+||||+++|..|.+..+
T Consensus 38 ~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~ 117 (632)
T KOG0584|consen 38 TGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKT 117 (632)
T ss_pred CCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCce
Confidence 4455 345669999999999999999999999876654443 344557899999999999999999999999987655
Q ss_pred EEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC--CCEeecCCCCceEEcCC-CCeEEeecccccccc
Q 037702 85 IYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSR--GVYHRDLKPENLLLDEN-GDLKISDFGLSALQE 160 (448)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~--givHrDLkp~NILl~~~-g~lkl~DFGla~~~~ 160 (448)
+-+|+|++..|+|+.|.++ ++++...++.|++||+.||.|||++ .|+|||||.+||+|+.+ |.+||+|+|||++..
T Consensus 118 in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 118 INFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred eeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 8899999999999999987 7899999999999999999999998 49999999999999864 899999999999765
Q ss_pred ccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCC-CcHHHHHHHHhhccCC--CCCCCCH
Q 037702 161 STRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYD-SNLMELYKKITRAEFK--CPNWFPP 237 (448)
Q Consensus 161 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~s~ 237 (448)
.. ......|||.|||||+.. ..|+ ..+||||||++|.||+|+..||.. .+..++|+++..+..+ +...-.|
T Consensus 198 ~s----~aksvIGTPEFMAPEmYE-E~Yn-E~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dP 271 (632)
T KOG0584|consen 198 KS----HAKSVIGTPEFMAPEMYE-ENYN-ELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDP 271 (632)
T ss_pred cc----ccceeccCccccChHHHh-hhcc-hhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCH
Confidence 43 234578999999999986 5676 889999999999999999999965 6788999999887532 2222358
Q ss_pred HHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 238 EVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 238 ~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
++++||.+||.. .+.|+|+.|+|.||||...
T Consensus 272 evr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 272 EVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred HHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 999999999999 9999999999999999875
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=333.78 Aligned_cols=247 Identities=30% Similarity=0.548 Sum_probs=204.0
Q ss_pred EEEeeeeecCceEEEEEEEC----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 037702 13 ELGRLLGQGTFAKVYHGRNL----KTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFA 88 (448)
Q Consensus 13 ~~~~~LG~G~fg~Vy~a~~~----~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 88 (448)
.+.+.||.|+||.||+|.+. ..+..|+||.+... ......+.+.+|++.++.++||||+++++++...+..++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccccccccccccccccccccccc
Confidence 57889999999999999987 34678999999542 2223467889999999999999999999999988889999
Q ss_pred EeecCCCchHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccC
Q 037702 89 MEYVRGGELFNKVAKG---KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQD 165 (448)
Q Consensus 89 ~E~~~gg~L~~~i~~~---~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~ 165 (448)
|||+++|+|.+++... .+++.....++.||+.||.|||+++++|+||+|.|||++.++.+||+|||++.........
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999764 7999999999999999999999999999999999999999999999999999865222111
Q ss_pred CCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhcc-CCCCCCCCHHHHHHH
Q 037702 166 GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAE-FKCPNWFPPEVRKLL 243 (448)
Q Consensus 166 ~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li 243 (448)
.......+...|+|||.+....+ +.++||||||+++|||++ |+.||.+.+..+...++.... ...|..++..+.++|
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~-~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEY-TKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLI 238 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEE-SHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHH
T ss_pred ccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHH
Confidence 22233457789999999977665 589999999999999999 789999888888777775544 355667899999999
Q ss_pred HhccCCCcCCCCCHHHHHh
Q 037702 244 SRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 244 ~~~L~~dP~~Rpt~~eil~ 262 (448)
.+||..||.+|||+.+|++
T Consensus 239 ~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 239 QQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHT-SSGGGS--HHHHHH
T ss_pred HHHcCCChhhCcCHHHHHh
Confidence 9999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=335.09 Aligned_cols=252 Identities=28% Similarity=0.411 Sum_probs=212.5
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLK-----TGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASK 82 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~ 82 (448)
..++|++.+.||+|+||.||+|.+.. ++..||+|.+..... ......+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC--HHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 45789999999999999999998743 678999999865432 23346788999999999999999999999999
Q ss_pred CEEEEEEeecCCCchHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCc
Q 037702 83 TKIYFAMEYVRGGELFNKVAKG-----------------------KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPEN 139 (448)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~~-----------------------~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~N 139 (448)
...|+||||+++|+|.+++..+ .+++..+..++.||+.||+|||++|++||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 9999999999999999998632 36788899999999999999999999999999999
Q ss_pred eEEcCCCCeEEeeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHH
Q 037702 140 LLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLM 218 (448)
Q Consensus 140 ILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~ 218 (448)
||++.++.++|+|||++................+++.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+..
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCC-chhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999998754322111112233456789999998776664 88999999999999997 88999888877
Q ss_pred HHHHHHhhccC-CCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHh
Q 037702 219 ELYKKITRAEF-KCPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 219 ~~~~~i~~~~~-~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 262 (448)
+....+..+.. ..|..++.++.+||.+||+.||.+|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 240 EVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 77777765544 456778999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=343.96 Aligned_cols=258 Identities=28% Similarity=0.440 Sum_probs=217.0
Q ss_pred CeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----EE
Q 037702 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKT-----KI 85 (448)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~-----~~ 85 (448)
+|++.+.||+|+||.||+|++..+|+.||||.+..... .....+.+.+|+.+++.++||||+++++++.... .+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD-DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc-cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 69999999999999999999998999999999876432 2234467889999999999999999999987765 79
Q ss_pred EEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccccc
Q 037702 86 YFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQ 164 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~ 164 (448)
|++|||+.+ +|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++........
T Consensus 80 ~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~ 158 (330)
T cd07834 80 YIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158 (330)
T ss_pred EEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence 999999974 89888876 5799999999999999999999999999999999999999999999999999986543321
Q ss_pred -CCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCC-------------
Q 037702 165 -DGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFK------------- 230 (448)
Q Consensus 165 -~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~------------- 230 (448)
........+|+.|+|||++.+....+.++|+||||+++|+|++|..||.+.+..+.+..+......
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 238 (330)
T cd07834 159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEK 238 (330)
T ss_pred ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccc
Confidence 012334568999999999977634568899999999999999999999988776665554432100
Q ss_pred ------------------CCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccccc
Q 037702 231 ------------------CPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGY 270 (448)
Q Consensus 231 ------------------~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 270 (448)
..+.+++++.++|.+||+.||.+|||+++++.||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 239 ARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred hhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 1123678899999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=334.14 Aligned_cols=254 Identities=30% Similarity=0.569 Sum_probs=219.5
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYF 87 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 87 (448)
..+.|++.+.||+|+||.||+|.+..++..||+|++..... ..+.+.+|+.+++.++||||+++++.+......|+
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence 55679999999999999999999988999999999975532 34678899999999999999999999999999999
Q ss_pred EEeecCCCchHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccC
Q 037702 88 AMEYVRGGELFNKVAKG--KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQD 165 (448)
Q Consensus 88 V~E~~~gg~L~~~i~~~--~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~ 165 (448)
++||++|++|.+++... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 93 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 171 (286)
T cd06614 93 VMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS- 171 (286)
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-
Confidence 99999999999999874 799999999999999999999999999999999999999999999999999875432211
Q ss_pred CCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccC---CCCCCCCHHHHHH
Q 037702 166 GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF---KCPNWFPPEVRKL 242 (448)
Q Consensus 166 ~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~l 242 (448)
......|++.|+|||++.+..+ +.++|+|||||++|+|++|..||...+.......+..... ..+..++.++.++
T Consensus 172 -~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 249 (286)
T cd06614 172 -KRNSVVGTPYWMAPEVIKRKDY-GPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDF 249 (286)
T ss_pred -hhccccCCcccCCHhHhcCCCC-CCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHH
Confidence 2234468899999999877665 4889999999999999999999988776555554443322 2223378999999
Q ss_pred HHhccCCCcCCCCCHHHHHhhhhccc
Q 037702 243 LSRILDPNPSTRVTMAKLMENYWFRK 268 (448)
Q Consensus 243 i~~~L~~dP~~Rpt~~eil~hp~~~~ 268 (448)
|.+||+.+|.+|||+.++++|+||++
T Consensus 250 i~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 250 LNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred HHHHhccChhhCcCHHHHhhChHhhc
Confidence 99999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=331.71 Aligned_cols=260 Identities=33% Similarity=0.597 Sum_probs=234.8
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEVMASKTK 84 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~ 84 (448)
++-.++|++.++||+|+|++|-+++.++|.+.||+|++.++-+.+.+.++.++.|-.+...- +||.+|.++.+|.+++.
T Consensus 246 ~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesr 325 (593)
T KOG0695|consen 246 GLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESR 325 (593)
T ss_pred ccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccce
Confidence 46678999999999999999999999999999999999999888877888899998888766 79999999999999999
Q ss_pred EEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccc
Q 037702 85 IYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTR 163 (448)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~ 163 (448)
+++|.||++||+|.-.+.+ ++++|+.++.|...|+.||.|||++||++||||..|+|+|..|++||.|+|+++.. ..
T Consensus 326 lffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~--l~ 403 (593)
T KOG0695|consen 326 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG--LG 403 (593)
T ss_pred EEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcC--CC
Confidence 9999999999999666654 78999999999999999999999999999999999999999999999999999742 34
Q ss_pred cCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCC-------Cc-HHHHHHHHhhccCCCCCCC
Q 037702 164 QDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYD-------SN-LMELYKKITRAEFKCPNWF 235 (448)
Q Consensus 164 ~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~-------~~-~~~~~~~i~~~~~~~p~~~ 235 (448)
......|.||||.|.|||++.+..| +...|+|+|||+++||++|+.||+- .| ..-+++-|...+..+|..+
T Consensus 404 ~gd~tstfcgtpnyiapeilrgeey-gfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprsl 482 (593)
T KOG0695|consen 404 PGDTTSTFCGTPNYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSL 482 (593)
T ss_pred CCcccccccCCCcccchhhhccccc-CceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccccccee
Confidence 4456678999999999999998877 5999999999999999999999962 22 2356677888899999999
Q ss_pred CHHHHHHHHhccCCCcCCCC------CHHHHHhhhhccc
Q 037702 236 PPEVRKLLSRILDPNPSTRV------TMAKLMENYWFRK 268 (448)
Q Consensus 236 s~~~~~li~~~L~~dP~~Rp------t~~eil~hp~~~~ 268 (448)
|-.+..+++..|.+||.+|. ..+++..|+||+.
T Consensus 483 svkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~ 521 (593)
T KOG0695|consen 483 SVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRS 521 (593)
T ss_pred ehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhh
Confidence 99999999999999999996 4789999999974
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=343.65 Aligned_cols=254 Identities=19% Similarity=0.369 Sum_probs=203.7
Q ss_pred eeeeec--CceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecC
Q 037702 16 RLLGQG--TFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVR 93 (448)
Q Consensus 16 ~~LG~G--~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 93 (448)
..||+| +||.||+|.+..+|+.||+|++....... ...+.+.+|+.+++.++||||+++++++..++..|+||||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTE-EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 356666 99999999999999999999987654333 345788999999999999999999999999999999999999
Q ss_pred CCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccC-----
Q 037702 94 GGELFNKVAK---GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQD----- 165 (448)
Q Consensus 94 gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~----- 165 (448)
+++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++++||+.+.........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence 9999998875 35899999999999999999999999999999999999999999999999865432211110
Q ss_pred CCccccCCCCcccchhhhhccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccC---------------
Q 037702 166 GLLHTTCGTPAYVAPEVINKRG-YDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF--------------- 229 (448)
Q Consensus 166 ~~~~~~~Gt~~Y~APEvl~~~~-~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--------------- 229 (448)
.......++..|+|||++.+.. ..+.++|||||||++|+|++|..||.................
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (328)
T cd08226 163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESR 242 (328)
T ss_pred cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhh
Confidence 0011224567899999986532 235889999999999999999999987654433322221110
Q ss_pred --------------------------------CCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccccc
Q 037702 230 --------------------------------KCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGY 270 (448)
Q Consensus 230 --------------------------------~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 270 (448)
..+..+++.+.+||++||..||++|||++++++||||....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~ 315 (328)
T cd08226 243 MKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK 315 (328)
T ss_pred hccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence 01122567899999999999999999999999999997654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-44 Score=353.39 Aligned_cols=239 Identities=26% Similarity=0.469 Sum_probs=208.4
Q ss_pred cCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFA 88 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 88 (448)
++...-++-||.|+.|.||+|+. .++.||||.+.. .-..+|+-|+.|+||||+.+.++|.....++||
T Consensus 123 Fe~IsELeWlGSGaQGAVF~Grl--~netVAVKKV~e----------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIi 190 (904)
T KOG4721|consen 123 FEEISELEWLGSGAQGAVFLGRL--HNETVAVKKVRE----------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCII 190 (904)
T ss_pred HHHhhhhhhhccCcccceeeeec--cCceehhHHHhh----------hhhhhHHHHHhccCcceeeEeeeecCCceeEEe
Confidence 33334456799999999999986 678999998742 223579999999999999999999999999999
Q ss_pred EeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCC
Q 037702 89 MEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGL 167 (448)
Q Consensus 89 ~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 167 (448)
||||..|.|+..++. +.+.......|.++|+.|+.|||.+.|||||||.-||||..+..+||+|||.++..... ..
T Consensus 191 MEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---ST 267 (904)
T KOG4721|consen 191 MEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK---ST 267 (904)
T ss_pred eeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh---hh
Confidence 999999999999987 46899999999999999999999999999999999999999999999999999865433 22
Q ss_pred ccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhc--cCCCCCCCCHHHHHHHHh
Q 037702 168 LHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA--EFKCPNWFPPEVRKLLSR 245 (448)
Q Consensus 168 ~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~ 245 (448)
....+||..|||||++.+.... .|+|||||||+|||||||..||.+.+...+.-.+-.. .++.|..+|..++=||++
T Consensus 268 kMSFaGTVaWMAPEvIrnePcs-EKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kq 346 (904)
T KOG4721|consen 268 KMSFAGTVAWMAPEVIRNEPCS-EKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQ 346 (904)
T ss_pred hhhhhhhHhhhCHHHhhcCCcc-cccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHH
Confidence 3467999999999999887764 9999999999999999999999887766655444333 456788899999999999
Q ss_pred ccCCCcCCCCCHHHHHhh
Q 037702 246 ILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 246 ~L~~dP~~Rpt~~eil~h 263 (448)
||...|..||++.+|+.|
T Consensus 347 cw~sKpRNRPSFrqil~H 364 (904)
T KOG4721|consen 347 CWNSKPRNRPSFRQILLH 364 (904)
T ss_pred HHhcCCCCCccHHHHHHH
Confidence 999999999999999988
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=370.37 Aligned_cols=149 Identities=34% Similarity=0.673 Sum_probs=139.7
Q ss_pred cCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFA 88 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 88 (448)
+++|++.+.||+|+||.||+|.+..+++.||||++.+...........+.+|+.+++.++||||+++++++.....+|||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 67899999999999999999999999999999999876655555667889999999999999999999999999999999
Q ss_pred EeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccc
Q 037702 89 MEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSA 157 (448)
Q Consensus 89 ~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~ 157 (448)
|||+.|++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999975 678999999999999999999999999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=332.59 Aligned_cols=251 Identities=28% Similarity=0.398 Sum_probs=202.4
Q ss_pred cCCe-EEEeeeeecCceEEEEEE----ECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe--
Q 037702 9 MNKY-ELGRLLGQGTFAKVYHGR----NLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMAS-- 81 (448)
Q Consensus 9 ~~~y-~~~~~LG~G~fg~Vy~a~----~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~-- 81 (448)
.++| ++.+.||+|+||+||++. ...++..||+|.+...... .....+.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 79 (283)
T cd05080 2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQ--QNTSGWKKEINILKTLYHENIVKYKGCCSEQG 79 (283)
T ss_pred ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 4566 999999999999998865 3357889999998754321 234667899999999999999999998765
Q ss_pred CCEEEEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccc
Q 037702 82 KTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQES 161 (448)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~ 161 (448)
...+|+||||+++++|.+++..+.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 80 ~~~~~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 80 GKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred CceEEEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 34689999999999999999888899999999999999999999999999999999999999999999999999876543
Q ss_pred cccC-CCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcH--HHHH-------------HHHh
Q 037702 162 TRQD-GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNL--MELY-------------KKIT 225 (448)
Q Consensus 162 ~~~~-~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~--~~~~-------------~~i~ 225 (448)
.... .......++..|+|||++....+ +.++|||||||++|+|++|..||..... .+.. ..+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKF-SYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCC-CcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence 2211 11123356778999999876655 4889999999999999999999865321 1110 0111
Q ss_pred h-ccCCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHh
Q 037702 226 R-AEFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 226 ~-~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 262 (448)
. ...+.|..++.++.+++.+||.+||++|||++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1 122346668899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=329.91 Aligned_cols=252 Identities=23% Similarity=0.413 Sum_probs=211.5
Q ss_pred cCCeEEEeeeeecCceEEEEEEECCCCc---EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQ---SVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKI 85 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~---~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 85 (448)
.++|++.+.||+|+||.||+|.+..+++ .||||.+.... .......+..|+.+++.++||||+++++++.++...
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 4679999999999999999999887665 59999986542 223457789999999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccc
Q 037702 86 YFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTR 163 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~ 163 (448)
++||||+++++|.+++.. +.+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 999999999999999865 568999999999999999999999999999999999999999999999999987543322
Q ss_pred cCCCccccC---CCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhc-cCCCCCCCCHH
Q 037702 164 QDGLLHTTC---GTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EFKCPNWFPPE 238 (448)
Q Consensus 164 ~~~~~~~~~---Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~ 238 (448)
......... ++..|+|||.+....++ .++|||||||++|+|++ |..||...+..+....+... ..+.+..++..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 239 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTA 239 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCccc-chhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHH
Confidence 211111112 24579999999776664 78999999999999886 99999887777766666443 23445668899
Q ss_pred HHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 239 VRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 239 ~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
+.+++.+||..||.+||++++++..
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~i~~~ 264 (269)
T cd05065 240 LHQLMLDCWQKDRNARPKFGQIVST 264 (269)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=336.65 Aligned_cols=253 Identities=25% Similarity=0.420 Sum_probs=213.6
Q ss_pred CCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 037702 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAM 89 (448)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (448)
+.|...+.||+|+||.||+|.+..+|..||+|.+.............+.+|+.+++.++|||++++++++.+....|+||
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 100 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVM 100 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEE
Confidence 44777888999999999999999999999999998765544445567889999999999999999999999999999999
Q ss_pred eecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCC
Q 037702 90 EYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGL 167 (448)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 167 (448)
||+.| +|.+.+.. +.+++..+..++.||+.||.|||++|++||||+|+||+++.++.+||+|||++.... .
T Consensus 101 e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~------~ 173 (313)
T cd06633 101 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS------P 173 (313)
T ss_pred ecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC------C
Confidence 99964 77777653 568999999999999999999999999999999999999999999999999986421 1
Q ss_pred ccccCCCCcccchhhhhc--cCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCC--CCCCCCHHHHHHH
Q 037702 168 LHTTCGTPAYVAPEVINK--RGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFK--CPNWFPPEVRKLL 243 (448)
Q Consensus 168 ~~~~~Gt~~Y~APEvl~~--~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~--~p~~~s~~~~~li 243 (448)
.....|+..|+|||++.. .+..+.++|||||||++|+|++|..||...+.......+.....+ ....++..+++|+
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 253 (313)
T cd06633 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFV 253 (313)
T ss_pred CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHH
Confidence 234578999999999842 233457899999999999999999999887765555555443322 1234678899999
Q ss_pred HhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 244 SRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 244 ~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
.+||+.+|.+||++.+++.||||+..
T Consensus 254 ~~~l~~~P~~Rp~~~~~l~~~~~~~~ 279 (313)
T cd06633 254 DYCLQKIPQERPASAELLRHDFVRRD 279 (313)
T ss_pred HHHccCChhhCcCHHHHhcCcccCCC
Confidence 99999999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=337.36 Aligned_cols=254 Identities=26% Similarity=0.449 Sum_probs=216.5
Q ss_pred CCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 037702 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAM 89 (448)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (448)
..|+..+.||+|+||.||+|++..+|..||+|.+.............+.+|+.+++.++|||++++++++.++...|+||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 45889999999999999999999999999999998664444455577889999999999999999999999999999999
Q ss_pred eecCCCchHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCC
Q 037702 90 EYVRGGELFNKVA--KGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGL 167 (448)
Q Consensus 90 E~~~gg~L~~~i~--~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 167 (448)
||+.| +|.+.+. .+++++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++.....
T Consensus 105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~------ 177 (317)
T cd06635 105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP------ 177 (317)
T ss_pred eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC------
Confidence 99975 7777664 35789999999999999999999999999999999999999999999999999865322
Q ss_pred ccccCCCCcccchhhhhc--cCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCC--CCCCCCHHHHHHH
Q 037702 168 LHTTCGTPAYVAPEVINK--RGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFK--CPNWFPPEVRKLL 243 (448)
Q Consensus 168 ~~~~~Gt~~Y~APEvl~~--~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~--~p~~~s~~~~~li 243 (448)
.....|++.|+|||++.. .+..+.++|||||||++|+|++|..||...+.......+...... .+..+++.++++|
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 257 (317)
T cd06635 178 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFV 257 (317)
T ss_pred cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHH
Confidence 234578999999999742 233457899999999999999999999887766666665554432 2234788999999
Q ss_pred HhccCCCcCCCCCHHHHHhhhhccccc
Q 037702 244 SRILDPNPSTRVTMAKLMENYWFRKGY 270 (448)
Q Consensus 244 ~~~L~~dP~~Rpt~~eil~hp~~~~~~ 270 (448)
.+||+.+|.+||++.++++|+|+....
T Consensus 258 ~~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 258 DSCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred HHHccCCcccCcCHHHHHhChhhhccC
Confidence 999999999999999999999996643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=329.74 Aligned_cols=251 Identities=24% Similarity=0.424 Sum_probs=210.3
Q ss_pred cCCeEEEeeeeecCceEEEEEEECCCCc---EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQ---SVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKI 85 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~---~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 85 (448)
.++|++.+.||+|+||.||+|.+..++. .+|+|.+..... ....+.+.+|+.+++.++||||+++++++..++..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 4689999999999999999999865544 799999865432 23346788999999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccc
Q 037702 86 YFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTR 163 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~ 163 (448)
|+||||+++++|.+++.. +.+++.++..++.|++.||.|||++|++||||||+|||++.++.++|+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 999999999999999875 468999999999999999999999999999999999999999999999999998654322
Q ss_pred cCCC-ccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhc-cCCCCCCCCHHHH
Q 037702 164 QDGL-LHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EFKCPNWFPPEVR 240 (448)
Q Consensus 164 ~~~~-~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 240 (448)
.... .....++..|+|||.+.+..+ +.++|+|||||++|++++ |..||.+.+..+....+... ..+.+..+++.+.
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALH 239 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCcc-CchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHH
Confidence 1111 111223568999999976665 588999999999999886 99999887776666666544 2344556789999
Q ss_pred HHHHhccCCCcCCCCCHHHHHh
Q 037702 241 KLLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~eil~ 262 (448)
+++.+||+.+|.+||++.++++
T Consensus 240 ~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 240 QLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHHHHcccCchhCCCHHHHHH
Confidence 9999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=341.32 Aligned_cols=257 Identities=24% Similarity=0.413 Sum_probs=213.7
Q ss_pred cccccCCeEEEeeeeecCceEEEEEEECCC-------CcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEE
Q 037702 5 AGILMNKYELGRLLGQGTFAKVYHGRNLKT-------GQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLY 76 (448)
Q Consensus 5 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~-------g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~ 76 (448)
..+...+|++++.||+|+||.||+|.+... +..||+|.+.... .....+.+.+|+.+++++ +||||++++
T Consensus 7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 84 (334)
T cd05100 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLL 84 (334)
T ss_pred cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeee
Confidence 445667899999999999999999986432 2368999886432 123356788999999999 899999999
Q ss_pred EEEEeCCEEEEEEeecCCCchHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCc
Q 037702 77 EVMASKTKIYFAMEYVRGGELFNKVAKG-----------------KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPEN 139 (448)
Q Consensus 77 ~~~~~~~~~~lV~E~~~gg~L~~~i~~~-----------------~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~N 139 (448)
+++.....+|++|||+++|+|.+++... .++...+..++.|++.||.|||++|++||||||+|
T Consensus 85 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N 164 (334)
T cd05100 85 GACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARN 164 (334)
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccce
Confidence 9999999999999999999999998641 36778889999999999999999999999999999
Q ss_pred eEEcCCCCeEEeeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHH
Q 037702 140 LLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLM 218 (448)
Q Consensus 140 ILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~ 218 (448)
||++.++.+||+|||+++...............++..|+|||++.+..+. .++|||||||++|+|++ |..||.+.+..
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~ 243 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIPVE 243 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcC-chhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 99999999999999998754332211112223446789999999776664 78999999999999998 89999988888
Q ss_pred HHHHHHhhcc-CCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhh
Q 037702 219 ELYKKITRAE-FKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENY 264 (448)
Q Consensus 219 ~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 264 (448)
+....+.... ...|..++.++.++|.+||+.+|.+|||+.+++++-
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l 290 (334)
T cd05100 244 ELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL 290 (334)
T ss_pred HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 8777776543 345667889999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=345.03 Aligned_cols=254 Identities=26% Similarity=0.431 Sum_probs=205.1
Q ss_pred cccCCeEEEeeeeecCceEEEEEEE-----CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRN-----LKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEVMA 80 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~-----~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~ 80 (448)
...++|++.+.||+|+||.||+|.+ ..+++.||||++...... .....+.+|+.++..+ +||||+++++++.
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNLLGACT 81 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCCh--HHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence 4467999999999999999999985 346789999999754322 2346788999999999 6899999999876
Q ss_pred e-CCEEEEEEeecCCCchHHHHhcC-------------------------------------------------------
Q 037702 81 S-KTKIYFAMEYVRGGELFNKVAKG------------------------------------------------------- 104 (448)
Q Consensus 81 ~-~~~~~lV~E~~~gg~L~~~i~~~------------------------------------------------------- 104 (448)
. +..+++||||+++|+|.+++...
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 5 45689999999999999988531
Q ss_pred -------------CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCcccc
Q 037702 105 -------------KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTT 171 (448)
Q Consensus 105 -------------~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~ 171 (448)
.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.............+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 2577788899999999999999999999999999999999999999999998754322111111233
Q ss_pred CCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHH-HHHHHHhhc-cCCCCCCCCHHHHHHHHhccC
Q 037702 172 CGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLM-ELYKKITRA-EFKCPNWFPPEVRKLLSRILD 248 (448)
Q Consensus 172 ~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~-~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~ 248 (448)
.+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...... .....+..+ ....|.+.++++.+++.+||+
T Consensus 242 ~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~ 320 (343)
T cd05103 242 RLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 320 (343)
T ss_pred CCCcceECcHHhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcc
Confidence 46678999999877666 488999999999999997 99999775433 233333332 345567788999999999999
Q ss_pred CCcCCCCCHHHHHhh
Q 037702 249 PNPSTRVTMAKLMEN 263 (448)
Q Consensus 249 ~dP~~Rpt~~eil~h 263 (448)
.||.+|||+.+|++|
T Consensus 321 ~~p~~Rps~~eil~~ 335 (343)
T cd05103 321 GEPSQRPTFSELVEH 335 (343)
T ss_pred CChhhCcCHHHHHHH
Confidence 999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=339.36 Aligned_cols=256 Identities=30% Similarity=0.484 Sum_probs=211.7
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe-CCEEE
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMAS-KTKIY 86 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~-~~~~~ 86 (448)
..++|++.+.||+|+||.||+|.+..+|+.||||.+.+.... ......+.+|+.+++.++||||+++++++.. ....|
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFST-PVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccc-cchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 567899999999999999999999999999999998654322 2334678899999999999999999999865 56789
Q ss_pred EEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCC
Q 037702 87 FAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDG 166 (448)
Q Consensus 87 lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 166 (448)
++|||+ +++|..++..+.+++..+..++.||++||.|||++||+||||+|.|||++.++.++|+|||++.....
T Consensus 87 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~----- 160 (328)
T cd07856 87 FVTELL-GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP----- 160 (328)
T ss_pred EEeehh-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC-----
Confidence 999998 56899888888899999999999999999999999999999999999999999999999999874322
Q ss_pred CccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhh--------------------
Q 037702 167 LLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITR-------------------- 226 (448)
Q Consensus 167 ~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~-------------------- 226 (448)
......+++.|+|||++.+....+.++|||||||++|+|++|+.||...+....+..+..
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd07856 161 QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLR 240 (328)
T ss_pred CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHH
Confidence 123456789999999876534446889999999999999999999987654322211110
Q ss_pred ------ccCCC-----CCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccccc
Q 037702 227 ------AEFKC-----PNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGY 270 (448)
Q Consensus 227 ------~~~~~-----p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 270 (448)
..... .+.+++++.++|.+||+.||.+|||+++++.||||...-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~ 295 (328)
T cd07856 241 FVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYH 295 (328)
T ss_pred HHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccccc
Confidence 00011 124678999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=354.32 Aligned_cols=253 Identities=25% Similarity=0.434 Sum_probs=220.1
Q ss_pred cccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 037702 5 AGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTK 84 (448)
Q Consensus 5 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 84 (448)
..+..+...++..||+|.||+||+|++- ..||||+++....... ..+.+++|+.+++.-+|.||+-+.|++.....
T Consensus 387 WeIp~~ev~l~~rIGsGsFGtV~Rg~wh---GdVAVK~Lnv~~pt~~-qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 387 WEIPPEEVLLGERIGSGSFGTVYRGRWH---GDVAVKLLNVDDPTPE-QLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccCHHHhhccceeccccccceeecccc---cceEEEEEecCCCCHH-HHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 4567788899999999999999999984 4699999998877664 67999999999999999999999999988877
Q ss_pred EEEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccc
Q 037702 85 IYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQEST 162 (448)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~ 162 (448)
.||+.+|+|.+|+.++.- -+|.....+.|++|++.|+.|||.++|||||||..||||.+++.|||+||||+......
T Consensus 463 -AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w 541 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRW 541 (678)
T ss_pred -eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeee
Confidence 999999999999999864 57999999999999999999999999999999999999999999999999999876555
Q ss_pred ccCCCccccCCCCcccchhhhhccC--CCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCC-----CCCCC
Q 037702 163 RQDGLLHTTCGTPAYVAPEVINKRG--YDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFK-----CPNWF 235 (448)
Q Consensus 163 ~~~~~~~~~~Gt~~Y~APEvl~~~~--~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-----~p~~~ 235 (448)
.....+...-|...|||||++.... .++..+|||||||++|||+||.+||...+.+++.-.+-++... ....+
T Consensus 542 ~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~ 621 (678)
T KOG0193|consen 542 SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNC 621 (678)
T ss_pred ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccC
Confidence 5555566778999999999996432 2358899999999999999999999977777776666555322 22346
Q ss_pred CHHHHHHHHhccCCCcCCCCCHHHHHh
Q 037702 236 PPEVRKLLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 236 s~~~~~li~~~L~~dP~~Rpt~~eil~ 262 (448)
+.++++|+..||..++++||.+.+||.
T Consensus 622 pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 622 PKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred HHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 679999999999999999999999987
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=336.60 Aligned_cols=253 Identities=23% Similarity=0.387 Sum_probs=205.8
Q ss_pred CCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEE
Q 037702 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR-HPNIVQLYEVMASKTKIYFA 88 (448)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lV 88 (448)
++|+..+.||+|+||.||++.+..+|+.||+|.+...... .....+.+|+.++.++. ||||+++++++..+...+++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~ 81 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC 81 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence 4677888999999999999999999999999998765433 33467889999999996 99999999999999999999
Q ss_pred EeecCCCchHH---HHh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CCEeecCCCCceEEcCCCCeEEeeccccccccc
Q 037702 89 MEYVRGGELFN---KVA---KGKLREEVARKYFQQLVDAVEFCHSR-GVYHRDLKPENLLLDENGDLKISDFGLSALQES 161 (448)
Q Consensus 89 ~E~~~gg~L~~---~i~---~~~l~e~~~~~~~~qll~aL~yLH~~-givHrDLkp~NILl~~~g~lkl~DFGla~~~~~ 161 (448)
|||+.+ +|.+ .+. .+.+++..+..++.|++.||+|||+. |++||||||+|||++.++.+||+|||++.....
T Consensus 82 ~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 82 MELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred EecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 999865 4433 332 25799999999999999999999985 999999999999999999999999999875432
Q ss_pred cccCCCccccCCCCcccchhhhhcc--CCCCCcchHHHHHHHHHHHHhCCCCCCCCcH-HHHHHHHhhccC-CC----CC
Q 037702 162 TRQDGLLHTTCGTPAYVAPEVINKR--GYDGAKADIWSCGVVLFVLLAGNLPFYDSNL-MELYKKITRAEF-KC----PN 233 (448)
Q Consensus 162 ~~~~~~~~~~~Gt~~Y~APEvl~~~--~~~~~~sDiwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~~~~-~~----p~ 233 (448)
. .......|++.|+|||++... ...+.++|||||||++|+|++|+.||...+. .+....+..... .. +.
T Consensus 161 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd06616 161 S---IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEER 237 (288)
T ss_pred C---CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCC
Confidence 1 112344689999999999765 2345789999999999999999999976542 122222222221 11 22
Q ss_pred CCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccc
Q 037702 234 WFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRK 268 (448)
Q Consensus 234 ~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 268 (448)
.++.++.+||.+||.+||.+|||++++++||||+.
T Consensus 238 ~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 272 (288)
T cd06616 238 EFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272 (288)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence 37899999999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=327.01 Aligned_cols=248 Identities=27% Similarity=0.448 Sum_probs=207.2
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIY 86 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 86 (448)
+..++|++.+.||+|+||.||+|.+..+ ..+|+|.+..... ..+.+.+|+.+++.++||||+++++++. ....|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05069 3 IPRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIY 76 (260)
T ss_pred CChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcE
Confidence 4567899999999999999999987554 4699998865432 2356788999999999999999999885 45689
Q ss_pred EEEeecCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccc
Q 037702 87 FAMEYVRGGELFNKVAK---GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTR 163 (448)
Q Consensus 87 lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~ 163 (448)
+||||+++++|.+++.. ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 99999999999999965 247899999999999999999999999999999999999999999999999997543221
Q ss_pred cCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhc-cCCCCCCCCHHHHH
Q 037702 164 QDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EFKCPNWFPPEVRK 241 (448)
Q Consensus 164 ~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 241 (448)
. .......++..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+....+....+... ....|..++..+.+
T Consensus 157 ~-~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (260)
T cd05069 157 Y-TARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHE 234 (260)
T ss_pred c-cccCCCccchhhCCHHHhccCCc-ChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHH
Confidence 1 11122346778999999876555 588999999999999999 99999888777766666544 23456678899999
Q ss_pred HHHhccCCCcCCCCCHHHHHh
Q 037702 242 LLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~ 262 (448)
++++||.+||.+||+++++++
T Consensus 235 li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 235 LMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHHHHccCCcccCcCHHHHHH
Confidence 999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=335.48 Aligned_cols=252 Identities=21% Similarity=0.293 Sum_probs=205.5
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCC--------------cEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcc
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTG--------------QSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIV 73 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g--------------~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv 73 (448)
..++|++.+.||+|+||.||+|.+..++ ..||+|.+..... ....+.+.+|+++++.++||||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~ei~~l~~l~h~~i~ 80 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT--KTARNDFLKEIKIMSRLKNPNII 80 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC--HHHHHHHHHHHHHHHhCCCCCcC
Confidence 3568999999999999999999875432 3589999875422 23456788999999999999999
Q ss_pred eEEEEEEeCCEEEEEEeecCCCchHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCce
Q 037702 74 QLYEVMASKTKIYFAMEYVRGGELFNKVAKG-------------KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENL 140 (448)
Q Consensus 74 ~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-------------~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NI 140 (448)
++++++......|+||||+++++|.+++... .+++..+..++.|++.||+|||++|++||||||+||
T Consensus 81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni 160 (295)
T cd05097 81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC 160 (295)
T ss_pred eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence 9999999999999999999999999988542 367888999999999999999999999999999999
Q ss_pred EEcCCCCeEEeeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh--CCCCCCCCcHH
Q 037702 141 LLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA--GNLPFYDSNLM 218 (448)
Q Consensus 141 Ll~~~g~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt--G~~Pf~~~~~~ 218 (448)
|++.++.+||+|||++................+++.|+|||++....+ +.++|||||||++|+|++ |..||...+..
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~ 239 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKF-TTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCc-CchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence 999999999999999875432221111223345778999999876665 588999999999999988 67888876655
Q ss_pred HHHHHHhh--------ccCCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHh
Q 037702 219 ELYKKITR--------AEFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 219 ~~~~~i~~--------~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 262 (448)
+....+.. .....++.+++.+.+||.+||..||.+|||+++|++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 240 QVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 55443321 112335567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=329.72 Aligned_cols=252 Identities=25% Similarity=0.408 Sum_probs=213.6
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCc----EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQ----SVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASK 82 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~----~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~ 82 (448)
+..++|++.+.||+|+||.||+|.+..+|+ .+|+|.+..... ......+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 80 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS- 80 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-
Confidence 345789999999999999999999877765 589998865533 2334678899999999999999999999887
Q ss_pred CEEEEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccc
Q 037702 83 TKIYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQE 160 (448)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~ 160 (448)
...++||||+++|+|.+++.. +.+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++....
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence 789999999999999999875 469999999999999999999999999999999999999999999999999998654
Q ss_pred ccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhcc-CCCCCCCCHH
Q 037702 161 STRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAE-FKCPNWFPPE 238 (448)
Q Consensus 161 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~ 238 (448)
............++..|+|||.+....+. .++|+|||||++|++++ |..||.+.+..++...+.... ...|...+.+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYT-HKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTID 239 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcC-chhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHH
Confidence 32221111222346789999998766554 78999999999999998 999999888777777766543 4566778899
Q ss_pred HHHHHHhccCCCcCCCCCHHHHHh
Q 037702 239 VRKLLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 239 ~~~li~~~L~~dP~~Rpt~~eil~ 262 (448)
+.+++.+||..||..||++.++++
T Consensus 240 ~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 240 VYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred HHHHHHHHcCCChhhCCCHHHHHH
Confidence 999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=341.91 Aligned_cols=254 Identities=27% Similarity=0.449 Sum_probs=209.2
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASK----- 82 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~----- 82 (448)
+.++|.+.+.||+|+||.||+|.+..+|+.||||.+.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 91 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQS-EIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDE 91 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcccc-ccchhHHHHHHHHHHhcCCCCccchhheecccccCCC
Confidence 457999999999999999999999999999999998754322 23345678999999999999999999998654
Q ss_pred -CEEEEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccc
Q 037702 83 -TKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQES 161 (448)
Q Consensus 83 -~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~ 161 (448)
..+|+||||+.+ +|.... ...+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++.....
T Consensus 92 ~~~~~lv~e~~~~-~l~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~ 169 (342)
T cd07879 92 FQDFYLVMPYMQT-DLQKIM-GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA 169 (342)
T ss_pred CceEEEEeccccc-CHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence 356999999964 676654 34699999999999999999999999999999999999999999999999999875322
Q ss_pred cccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhcc-------------
Q 037702 162 TRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAE------------- 228 (448)
Q Consensus 162 ~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~------------- 228 (448)
......||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+....+..+....
T Consensus 170 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (342)
T cd07879 170 -----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED 244 (342)
T ss_pred -----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 12345688999999998764445688999999999999999999999877555444332210
Q ss_pred ----------CCC--------CCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 229 ----------FKC--------PNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 229 ----------~~~--------p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
..+ .+..++++.+||.+||+.||.+||++++++.||||+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 245 KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred cchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 000 12367889999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=350.17 Aligned_cols=255 Identities=25% Similarity=0.388 Sum_probs=209.5
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEEC-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNL-----KTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR-HPNIVQLYEVM 79 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~ 79 (448)
.+..++|.+++.||+|+||.||+|++. .+++.||+|++...... ...+.+.+|+.+|.++. ||||+++++++
T Consensus 33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l~~H~niv~~~~~~ 110 (401)
T cd05107 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS--SEKQALMSELKIMSHLGPHLNIVNLLGAC 110 (401)
T ss_pred eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCCh--hHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence 455678999999999999999999864 34568999999754322 23456889999999997 99999999999
Q ss_pred EeCCEEEEEEeecCCCchHHHHhcC-------------------------------------------------------
Q 037702 80 ASKTKIYFAMEYVRGGELFNKVAKG------------------------------------------------------- 104 (448)
Q Consensus 80 ~~~~~~~lV~E~~~gg~L~~~i~~~------------------------------------------------------- 104 (448)
.....+|+||||+++|+|.+++...
T Consensus 111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 9999999999999999999988542
Q ss_pred --------------------------------------------CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCce
Q 037702 105 --------------------------------------------KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENL 140 (448)
Q Consensus 105 --------------------------------------------~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NI 140 (448)
.+++..++.++.||+.||.|||++|++||||||+||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~Ni 270 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNV 270 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceE
Confidence 245667888999999999999999999999999999
Q ss_pred EEcCCCCeEEeeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHH
Q 037702 141 LLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLME 219 (448)
Q Consensus 141 Ll~~~g~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~ 219 (448)
|++.++.+||+|||++.............+..|++.|+|||.+.+..+ +.++|||||||++|+|++ |..||......+
T Consensus 271 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGvil~e~l~~g~~P~~~~~~~~ 349 (401)
T cd05107 271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLY-TTLSDVWSFGILLWEIFTLGGTPYPELPMNE 349 (401)
T ss_pred EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCC-CcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence 999999999999999975432221111223467889999999976655 588999999999999998 899998765544
Q ss_pred HHHH-Hhhc-cCCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 220 LYKK-ITRA-EFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 220 ~~~~-i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
.... +..+ ....|..++.++.+|+.+||..+|.+||++++|++.
T Consensus 350 ~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 350 QFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 4333 3333 245667789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=325.82 Aligned_cols=243 Identities=28% Similarity=0.514 Sum_probs=207.6
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEE-EeCCEE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVM-ASKTKI 85 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~-~~~~~~ 85 (448)
+-..+|++.+.||+|+||.||++.. .|..||+|.+.... ..+.+.+|+.+++.++|||++++++++ ..+...
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 75 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCce
Confidence 3467899999999999999999986 58899999985432 235688999999999999999999975 456789
Q ss_pred EEEEeecCCCchHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccc
Q 037702 86 YFAMEYVRGGELFNKVAKG---KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQEST 162 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~~---~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~ 162 (448)
|+||||+++++|.+++... .+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc
Confidence 9999999999999998752 3789999999999999999999999999999999999999999999999998743221
Q ss_pred ccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhc-cCCCCCCCCHHHH
Q 037702 163 RQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EFKCPNWFPPEVR 240 (448)
Q Consensus 163 ~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 240 (448)
..+..++..|+|||++....+. .++|||||||++|+|++ |+.||...+..+....+... ....+..+++.+.
T Consensus 156 -----~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (256)
T cd05082 156 -----QDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVY 229 (256)
T ss_pred -----CCCCccceeecCHHHHccCCCC-chhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence 1234456789999998776664 78999999999999997 99999988877776666554 2345667899999
Q ss_pred HHHHhccCCCcCCCCCHHHHHh
Q 037702 241 KLLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~eil~ 262 (448)
++|.+||..||++|||+.++++
T Consensus 230 ~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 230 DVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHHHHhcCChhhCcCHHHHHH
Confidence 9999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=333.94 Aligned_cols=252 Identities=20% Similarity=0.315 Sum_probs=204.9
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECC----------------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLK----------------TGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPN 71 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~----------------~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpn 71 (448)
..++|++.+.||+|+||.||++.+.. ++..+|+|++.... .......+.+|+.+++.++|||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~ 80 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPN 80 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCC
Confidence 34689999999999999999986532 34468999986542 2234567889999999999999
Q ss_pred cceEEEEEEeCCEEEEEEeecCCCchHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCc
Q 037702 72 IVQLYEVMASKTKIYFAMEYVRGGELFNKVAKG------------KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPEN 139 (448)
Q Consensus 72 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~------------~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~N 139 (448)
|+++++++......|+||||+++|+|.+++... .+++..+..++.|++.||+|||++|++||||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N 160 (296)
T cd05095 81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN 160 (296)
T ss_pred cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence 999999999999999999999999999998652 25677899999999999999999999999999999
Q ss_pred eEEcCCCCeEEeeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh--CCCCCCCCcH
Q 037702 140 LLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA--GNLPFYDSNL 217 (448)
Q Consensus 140 ILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt--G~~Pf~~~~~ 217 (448)
||++.++.++|+|||++................+++.|+|||+.....+ +.++|||||||++|+|++ |..||...+.
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~DiwSlG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKF-TTASDVWAFGVTLWEILTLCKEQPYSQLSD 239 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCc-cchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence 9999999999999999875432221111223345678999998876555 588999999999999998 7899987665
Q ss_pred HHHHHHHhh--------ccCCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHh
Q 037702 218 MELYKKITR--------AEFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 218 ~~~~~~i~~--------~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 262 (448)
.+....... ...+.|..+++.+.+|+.+||..||.+||++.+|++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 240 EQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 554433211 123445668899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=326.77 Aligned_cols=248 Identities=27% Similarity=0.452 Sum_probs=209.2
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIY 86 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 86 (448)
+..++|++.+.||+|+||.||+|.+ .+++.||+|.+...... .+.+.+|+.+++.++||||+++++++. .+..|
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY 76 (260)
T ss_pred cchHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCCc----HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence 5678899999999999999999985 46788999998755432 357889999999999999999999874 45689
Q ss_pred EEEeecCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccc
Q 037702 87 FAMEYVRGGELFNKVAK---GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTR 163 (448)
Q Consensus 87 lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~ 163 (448)
++|||+++++|.+++.. ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 99999999999999864 368999999999999999999999999999999999999999999999999987543211
Q ss_pred cCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhc-cCCCCCCCCHHHHH
Q 037702 164 QDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EFKCPNWFPPEVRK 241 (448)
Q Consensus 164 ~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 241 (448)
. .......++..|+|||++....+ +.++||||||+++|+|++ |++||.+.+..+....+... ....+...+.++.+
T Consensus 157 ~-~~~~~~~~~~~y~~pe~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (260)
T cd05067 157 Y-TAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYE 234 (260)
T ss_pred c-ccccCCcccccccCHHHhccCCc-CcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 1 11122346778999999876655 488999999999999999 99999888777766665544 23456668899999
Q ss_pred HHHhccCCCcCCCCCHHHHHh
Q 037702 242 LLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~ 262 (448)
+|.+||..||++|||++++++
T Consensus 235 li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 235 LMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHHHccCChhhCCCHHHHHH
Confidence 999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=321.05 Aligned_cols=254 Identities=27% Similarity=0.439 Sum_probs=208.1
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe-----
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMAS----- 81 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~----- 81 (448)
+-..||++.+.||+|||+.||++++..++..||+|.+..+.. +..+...+||+..++++|||+++++++...
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~---~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~ 94 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQ---EDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG 94 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccch---HHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence 345699999999999999999999999999999999987653 345788999999999999999999876533
Q ss_pred CCEEEEEEeecCCCchHHHHhc----C-CCCHHHHHHHHHHHHHHHHHHHHCC--CEeecCCCCceEEcCCCCeEEeecc
Q 037702 82 KTKIYFAMEYVRGGELFNKVAK----G-KLREEVARKYFQQLVDAVEFCHSRG--VYHRDLKPENLLLDENGDLKISDFG 154 (448)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~----~-~l~e~~~~~~~~qll~aL~yLH~~g--ivHrDLkp~NILl~~~g~lkl~DFG 154 (448)
....||+++|...|+|.+.++. | -++|.++..|+.++++||++||+.. ++||||||.|||+.+++.++|.|||
T Consensus 95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~G 174 (302)
T KOG2345|consen 95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLG 174 (302)
T ss_pred ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEecc
Confidence 3459999999999999998864 3 5999999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccCC-------CccccCCCCcccchhhhhccCCC--CCcchHHHHHHHHHHHHhCCCCCCCCcH--HHHHHH
Q 037702 155 LSALQESTRQDG-------LLHTTCGTPAYVAPEVINKRGYD--GAKADIWSCGVVLFVLLAGNLPFYDSNL--MELYKK 223 (448)
Q Consensus 155 la~~~~~~~~~~-------~~~~~~Gt~~Y~APEvl~~~~~~--~~~sDiwSlGvil~elltG~~Pf~~~~~--~~~~~~ 223 (448)
.++.....-... .......|..|+|||.+.-+.+. +.++|||||||+||+|+.|.-||+..-. ..+.-.
T Consensus 175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLA 254 (302)
T KOG2345|consen 175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALA 254 (302)
T ss_pred CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEe
Confidence 987543221110 01123468999999998654432 5789999999999999999999953211 111223
Q ss_pred HhhccCCCCC--CCCHHHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 224 ITRAEFKCPN--WFPPEVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 224 i~~~~~~~p~--~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
+..+++.+|. .+|..+.++|+.||++||.+||++.+++.+
T Consensus 255 v~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 255 VQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred eeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 4445666664 389999999999999999999999999875
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=325.09 Aligned_cols=243 Identities=28% Similarity=0.399 Sum_probs=203.9
Q ss_pred eeeeecCceEEEEEEECCCC---cEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeec
Q 037702 16 RLLGQGTFAKVYHGRNLKTG---QSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAMEYV 92 (448)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g---~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 92 (448)
+.||+|+||.||+|.+..++ ..+|+|.+...... ...+.+.+|+.+++.++||||+++++++. .+..++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 46999999999999876654 78999998766543 33467889999999999999999999876 45689999999
Q ss_pred CCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCC-Cccc
Q 037702 93 RGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDG-LLHT 170 (448)
Q Consensus 93 ~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~-~~~~ 170 (448)
++|+|.+++.. +.+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++.......... ....
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~ 157 (257)
T cd05060 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA 157 (257)
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence 99999999976 459999999999999999999999999999999999999999999999999997553322111 0111
Q ss_pred cCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhcc-CCCCCCCCHHHHHHHHhccC
Q 037702 171 TCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAE-FKCPNWFPPEVRKLLSRILD 248 (448)
Q Consensus 171 ~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~ 248 (448)
..++..|+|||.+....+ +.++|||||||++|+|++ |.+||...+..+....+.... ...|..+++.++++|.+||.
T Consensus 158 ~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 236 (257)
T cd05060 158 GRWPLKWYAPECINYGKF-SSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWK 236 (257)
T ss_pred ccccccccCHHHhcCCCC-CccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhc
Confidence 223567999999876665 478999999999999998 999998877777666665543 35677789999999999999
Q ss_pred CCcCCCCCHHHHHh
Q 037702 249 PNPSTRVTMAKLME 262 (448)
Q Consensus 249 ~dP~~Rpt~~eil~ 262 (448)
.||++||++.++++
T Consensus 237 ~~p~~Rp~~~~l~~ 250 (257)
T cd05060 237 YRPEDRPTFSELES 250 (257)
T ss_pred CChhhCcCHHHHHH
Confidence 99999999999986
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=304.26 Aligned_cols=256 Identities=30% Similarity=0.512 Sum_probs=218.7
Q ss_pred CCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 037702 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAM 89 (448)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (448)
.+|.-.+.||+|+||+||+|++..+++.||+|.+..+.-. ++.-....+||.+++.++|.|||+++++..++.++-+|+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrldddd-egvpssalreicllkelkhknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCC-CCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence 4677788999999999999999999999999999766432 344566789999999999999999999999999999999
Q ss_pred eecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCC
Q 037702 90 EYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGL 167 (448)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 167 (448)
|||.. +|..+... |.++.+.++.++.|++.||.|||++++.||||||.|+|++.||.+|++|||+++.++..-. -
T Consensus 81 e~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvr--c 157 (292)
T KOG0662|consen 81 EFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR--C 157 (292)
T ss_pred HHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceE--e
Confidence 99965 78777765 7899999999999999999999999999999999999999999999999999986654321 2
Q ss_pred ccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhcc-----CCCC---------
Q 037702 168 LHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAE-----FKCP--------- 232 (448)
Q Consensus 168 ~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-----~~~p--------- 232 (448)
....+-|.+|.+|.++.+...++...|+||.|||+.|+.. |++.|++.+..+...+|.+.- -.+|
T Consensus 158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk 237 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK 237 (292)
T ss_pred eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence 2345679999999999888777788999999999999985 888899998888887775421 0111
Q ss_pred ---------------CCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 233 ---------------NWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 233 ---------------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
+.++..-++|+.++|.-+|.+|+++++.++||||...
T Consensus 238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 1123456899999999999999999999999999753
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=326.36 Aligned_cols=254 Identities=24% Similarity=0.394 Sum_probs=211.9
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCc---EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQ---SVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKT 83 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~---~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~ 83 (448)
+..++|+..+.||+|+||.||+|.+..++. .+|+|.+..... ....+.+..|+.+++.++||||+++++++...+
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT--EKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK 79 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC--HHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCC
Confidence 345689999999999999999999876665 799998865422 223467889999999999999999999999999
Q ss_pred EEEEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccc
Q 037702 84 KIYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQES 161 (448)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~ 161 (448)
..|+||||+++++|.+++.. +.+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 80 PAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 99999999999999999864 5789999999999999999999999999999999999999999999999999875533
Q ss_pred cccCCCc-cccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhc-cCCCCCCCCHH
Q 037702 162 TRQDGLL-HTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EFKCPNWFPPE 238 (448)
Q Consensus 162 ~~~~~~~-~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~ 238 (448)
....... .....++.|+|||++....+ +.++|||||||++|+|++ |..||...+..+....+... ..+.+..++.+
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 238 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKF-TSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSA 238 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCc-ChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHH
Confidence 2211111 11223567999999977666 488999999999999997 99999887777777766544 22344557899
Q ss_pred HHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 239 VRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 239 ~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
+.+++.+||..||++||++.++++.
T Consensus 239 ~~~li~~c~~~~p~~Rp~~~~i~~~ 263 (268)
T cd05063 239 VYQLMLQCWQQDRARRPRFVDIVNL 263 (268)
T ss_pred HHHHHHHHcCCCcccCcCHHHHHHH
Confidence 9999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=324.41 Aligned_cols=245 Identities=27% Similarity=0.513 Sum_probs=211.4
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIY 86 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 86 (448)
+-.++|++.+.||.|+||.||+|.. .|+.||+|.+..... ..+++.+|+.+++.++||||+++++++.+....|
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 76 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLY 76 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeE
Confidence 3467899999999999999999987 589999999975532 3467889999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccc
Q 037702 87 FAMEYVRGGELFNKVAKG---KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTR 163 (448)
Q Consensus 87 lV~E~~~gg~L~~~i~~~---~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~ 163 (448)
+||||+++++|.+++... .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 999999999999999752 58999999999999999999999999999999999999999999999999997542211
Q ss_pred cCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhc-cCCCCCCCCHHHHH
Q 037702 164 QDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EFKCPNWFPPEVRK 241 (448)
Q Consensus 164 ~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 241 (448)
....++..|+|||.+....+ +.++||||||+++|+|++ |..||...+..++...+... ....|..+++.+.+
T Consensus 157 -----~~~~~~~~~~ape~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (256)
T cd05039 157 -----DSGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYK 230 (256)
T ss_pred -----ccCCCcccccCchhhcCCcC-CcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHH
Confidence 12345678999999876555 478999999999999997 99999888777776665544 33456678999999
Q ss_pred HHHhccCCCcCCCCCHHHHHhh
Q 037702 242 LLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~h 263 (448)
+|.+||..||.+|||+.++++.
T Consensus 231 li~~~l~~~p~~Rp~~~~l~~~ 252 (256)
T cd05039 231 VMKDCWELDPAKRPTFKQLREQ 252 (256)
T ss_pred HHHHHhccChhhCcCHHHHHHH
Confidence 9999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=324.48 Aligned_cols=249 Identities=29% Similarity=0.460 Sum_probs=212.2
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIY 86 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 86 (448)
+..++|++.+.||+|+||.||+|.+. ++..||||.+...... .+.+.+|+.+++.++||||+++++++......+
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMS----PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY 77 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccC----HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence 45789999999999999999999975 5578999998754432 356889999999999999999999999989999
Q ss_pred EEEeecCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccc
Q 037702 87 FAMEYVRGGELFNKVAK---GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTR 163 (448)
Q Consensus 87 lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~ 163 (448)
+||||+++++|.+++.. ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++.......
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 99999999999999965 368999999999999999999999999999999999999999999999999987543211
Q ss_pred cCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhc-cCCCCCCCCHHHHH
Q 037702 164 QDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EFKCPNWFPPEVRK 241 (448)
Q Consensus 164 ~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 241 (448)
. .......++..|+|||.+.+..+ +.++|+|||||++|+|++ |+.||.+.+.......+... ....|...+.++.+
T Consensus 158 ~-~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (261)
T cd05034 158 Y-TAREGAKFPIKWTAPEAANYGRF-TIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYD 235 (261)
T ss_pred h-hhhhccCCCccccCHHHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 1 11112235678999999876555 588999999999999998 99999887777777776554 33556667899999
Q ss_pred HHHhccCCCcCCCCCHHHHHh
Q 037702 242 LLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~ 262 (448)
++.+||..||.+||+++++++
T Consensus 236 ~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 236 LMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHHHHcccCcccCCCHHHHHH
Confidence 999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=331.66 Aligned_cols=257 Identities=31% Similarity=0.558 Sum_probs=214.7
Q ss_pred CeEEEeeeeecCceEEEEEEEC---CCCcEEEEEEeeccccc-chhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 037702 11 KYELGRLLGQGTFAKVYHGRNL---KTGQSVAIKIVDKEKIR-RVGLIDQIKREISVMRLV-RHPNIVQLYEVMASKTKI 85 (448)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~-~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~ 85 (448)
+|++.+.||+|+||.||+|.+. .+++.||||++.+.... .....+.+.+|+.++..+ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4899999999999999999864 46789999998754332 223346678999999999 699999999999999999
Q ss_pred EEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccccc
Q 037702 86 YFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQ 164 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~ 164 (448)
|+||||+++|+|.+++.. +.+++..++.++.|++.||.|||+.|++||||||.||+++.++.++|+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 159 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE- 159 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccccc-
Confidence 999999999999999875 579999999999999999999999999999999999999999999999999987543321
Q ss_pred CCCccccCCCCcccchhhhhccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCc----HHHHHHHHhhccCCCCCCCCHHH
Q 037702 165 DGLLHTTCGTPAYVAPEVINKRG-YDGAKADIWSCGVVLFVLLAGNLPFYDSN----LMELYKKITRAEFKCPNWFPPEV 239 (448)
Q Consensus 165 ~~~~~~~~Gt~~Y~APEvl~~~~-~~~~~sDiwSlGvil~elltG~~Pf~~~~----~~~~~~~i~~~~~~~p~~~s~~~ 239 (448)
.......+|++.|+|||.+.+.. ..+.++|+||||+++|+|++|..||...+ ..+....+.......|..+++++
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 239 (288)
T cd05583 160 EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEA 239 (288)
T ss_pred ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCHHH
Confidence 11223456899999999986543 23578999999999999999999996432 23444455555667778899999
Q ss_pred HHHHHhccCCCcCCCCC---HHHHHhhhhccc
Q 037702 240 RKLLSRILDPNPSTRVT---MAKLMENYWFRK 268 (448)
Q Consensus 240 ~~li~~~L~~dP~~Rpt---~~eil~hp~~~~ 268 (448)
.++|.+||+.||++||| +.++++||||+.
T Consensus 240 ~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~ 271 (288)
T cd05583 240 RDFIQKLLEKDPKKRLGANGADEIKNHPFFQG 271 (288)
T ss_pred HHHHHHHhcCCHhhccCcchHHHHhcCccccc
Confidence 99999999999999998 567899999965
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=331.97 Aligned_cols=251 Identities=32% Similarity=0.534 Sum_probs=211.7
Q ss_pred eEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 037702 12 YELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAMEY 91 (448)
Q Consensus 12 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 91 (448)
|++.+.||+|++|.||+|.+..+|+.+|+|.+....... .....+.+|+.+++.++||||+++++++..+..+|+||||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESE-GIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccc-hhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 678899999999999999999999999999987654332 3446788999999999999999999999999999999999
Q ss_pred cCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCcc
Q 037702 92 VRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLH 169 (448)
Q Consensus 92 ~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~ 169 (448)
+++ +|.+.+.. +.+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||.+....... ....
T Consensus 80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~~~ 156 (283)
T cd05118 80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RPYT 156 (283)
T ss_pred cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--cccc
Confidence 976 88887765 479999999999999999999999999999999999999999999999999987654322 1223
Q ss_pred ccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhcc-------------------CC
Q 037702 170 TTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAE-------------------FK 230 (448)
Q Consensus 170 ~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-------------------~~ 230 (448)
...++..|+|||.+.+....+.++|+||||+++|+|++|+.||...+..+...++.... ..
T Consensus 157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05118 157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFS 236 (283)
T ss_pred CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhh
Confidence 34688999999998766345688999999999999999999998877665554443210 00
Q ss_pred -----------CCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhc
Q 037702 231 -----------CPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWF 266 (448)
Q Consensus 231 -----------~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 266 (448)
..+.++.++.++|.+||.+||.+||++.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 237 FPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 012367889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=324.69 Aligned_cols=242 Identities=27% Similarity=0.411 Sum_probs=201.7
Q ss_pred eeeecCceEEEEEEEC--CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCC
Q 037702 17 LLGQGTFAKVYHGRNL--KTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRG 94 (448)
Q Consensus 17 ~LG~G~fg~Vy~a~~~--~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (448)
.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.+++.++||||+++++++. ....++||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCC
Confidence 3899999999999875 345679999986542 2234467889999999999999999999885 4578999999999
Q ss_pred CchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCC-Ccccc
Q 037702 95 GELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDG-LLHTT 171 (448)
Q Consensus 95 g~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~-~~~~~ 171 (448)
++|.+++.. +.+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++.......... .....
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence 999999863 579999999999999999999999999999999999999999999999999997543221111 11112
Q ss_pred CCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhc-cCCCCCCCCHHHHHHHHhccCC
Q 037702 172 CGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EFKCPNWFPPEVRKLLSRILDP 249 (448)
Q Consensus 172 ~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~ 249 (448)
.+++.|+|||++....+ +.++|||||||++|+|++ |..||.+....+....+..+ ...+|...++++.++|.+||..
T Consensus 159 ~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~ 237 (257)
T cd05115 159 KWPLKWYAPECINFRKF-SSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIY 237 (257)
T ss_pred CCCcccCCHHHHccCCC-CchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCC
Confidence 34678999999876665 478999999999999996 99999988777776666554 3467778899999999999999
Q ss_pred CcCCCCCHHHHHh
Q 037702 250 NPSTRVTMAKLME 262 (448)
Q Consensus 250 dP~~Rpt~~eil~ 262 (448)
||++||++.+|++
T Consensus 238 ~~~~Rp~~~~i~~ 250 (257)
T cd05115 238 KWEDRPNFAKVEE 250 (257)
T ss_pred ChhhCcCHHHHHH
Confidence 9999999999976
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=334.55 Aligned_cols=255 Identities=25% Similarity=0.417 Sum_probs=214.1
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYF 87 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 87 (448)
....|...+.||+|+||.||+|++..+++.+|+|.+.............+.+|+.+++.++|||++++++++......|+
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 92 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence 34468888999999999999999999999999999976544333445678899999999999999999999999999999
Q ss_pred EEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccC
Q 037702 88 AMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQD 165 (448)
Q Consensus 88 V~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~ 165 (448)
||||+. |+|.+.+.. ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++.....
T Consensus 93 v~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~---- 167 (308)
T cd06634 93 VMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---- 167 (308)
T ss_pred EEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC----
Confidence 999997 577776643 5689999999999999999999999999999999999999999999999999875432
Q ss_pred CCccccCCCCcccchhhhhc--cCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCC--CCCCCCHHHHH
Q 037702 166 GLLHTTCGTPAYVAPEVINK--RGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFK--CPNWFPPEVRK 241 (448)
Q Consensus 166 ~~~~~~~Gt~~Y~APEvl~~--~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~--~p~~~s~~~~~ 241 (448)
.....|++.|+|||++.. .+..+.++|||||||++|+|++|..||...+.......+...... .+..++..+.+
T Consensus 168 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (308)
T cd06634 168 --ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRN 245 (308)
T ss_pred --cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHH
Confidence 124568999999999752 233357899999999999999999999877655554444443332 23357889999
Q ss_pred HHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 242 LLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
||++||..+|.+||+++++++|||+...
T Consensus 246 li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 246 FVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred HHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 9999999999999999999999999763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=323.73 Aligned_cols=243 Identities=26% Similarity=0.490 Sum_probs=206.3
Q ss_pred eeeeecCceEEEEEEECC-CCc--EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeec
Q 037702 16 RLLGQGTFAKVYHGRNLK-TGQ--SVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAMEYV 92 (448)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~-~g~--~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 92 (448)
+.||+|++|.||+|.+.. .+. .||||.+...... ...+.+.+|+.++++++||||+++++++.. ...++||||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 468999999999999865 333 6999999876543 456788999999999999999999999988 8899999999
Q ss_pred CCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccC-CCc
Q 037702 93 RGGELFNKVAK---GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQD-GLL 168 (448)
Q Consensus 93 ~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~-~~~ 168 (448)
++++|.+.+.. +.+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++......... ...
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 157 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME 157 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence 99999999976 35899999999999999999999999999999999999999999999999999865432211 111
Q ss_pred cccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhc--cCCCCCCCCHHHHHHHHh
Q 037702 169 HTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA--EFKCPNWFPPEVRKLLSR 245 (448)
Q Consensus 169 ~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~ 245 (448)
....++..|+|||.+....+. .++|||||||++|+|++ |..||...+..+....+... ....|..+|..+.+++.+
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (257)
T cd05040 158 EHLKVPFAWCAPESLRTRTFS-HASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQ 236 (257)
T ss_pred cCCCCCceecCHHHhcccCcC-chhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHH
Confidence 234578899999998776664 78999999999999998 99999887777776666542 234455678999999999
Q ss_pred ccCCCcCCCCCHHHHHh
Q 037702 246 ILDPNPSTRVTMAKLME 262 (448)
Q Consensus 246 ~L~~dP~~Rpt~~eil~ 262 (448)
||..+|++|||+.++++
T Consensus 237 ~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 237 CWAHNPADRPTFAALRE 253 (257)
T ss_pred HCCCCcccCCCHHHHHH
Confidence 99999999999999986
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=336.64 Aligned_cols=257 Identities=27% Similarity=0.424 Sum_probs=206.1
Q ss_pred CeEEEeeeeecCceEEEEEEECCC--CcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEe----CC
Q 037702 11 KYELGRLLGQGTFAKVYHGRNLKT--GQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEVMAS----KT 83 (448)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~--g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~----~~ 83 (448)
+|++.+.||+|+||.||+|.+..+ +..||+|.+.... ........+.+|+.+++.+ +||||+++++.... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 599999999999999999999888 8999999986432 2222346678899999999 59999999987533 24
Q ss_pred EEEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccc
Q 037702 84 KIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQEST 162 (448)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~ 162 (448)
.+|++|||+. ++|.+.+.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence 6889999986 589888865 67999999999999999999999999999999999999999999999999999754322
Q ss_pred cc--CCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhc-------------
Q 037702 163 RQ--DGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA------------- 227 (448)
Q Consensus 163 ~~--~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~------------- 227 (448)
.. ........||+.|+|||++.+....+.++|||||||++|+|++|.+||...+.......+...
T Consensus 159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (332)
T cd07857 159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238 (332)
T ss_pred cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence 11 112234579999999998765433458899999999999999999999876544333222110
Q ss_pred ------------c---CC---CCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 228 ------------E---FK---CPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 228 ------------~---~~---~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
. .. ..+..+..+.+|+.+||+.||.+|||+.+++.|||+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~ 298 (332)
T cd07857 239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW 298 (332)
T ss_pred hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence 0 00 112257899999999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=327.39 Aligned_cols=253 Identities=22% Similarity=0.350 Sum_probs=210.6
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECC----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe-
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLK----TGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMAS- 81 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~----~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~- 81 (448)
+-.++|++.+.||+|+||.||+|.+.. ++..|++|.+.... .....+.+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 80 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA--SEIQVTLLLQESCLLYGLSHQNILPILHVCIED 80 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 345789999999999999999999876 35789999876432 23345778899999999999999999998765
Q ss_pred CCEEEEEEeecCCCchHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEee
Q 037702 82 KTKIYFAMEYVRGGELFNKVAK---------GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISD 152 (448)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~---------~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~D 152 (448)
+...++++||+++++|.+++.. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence 5778999999999999999864 3488999999999999999999999999999999999999999999999
Q ss_pred ccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhcc-CC
Q 037702 153 FGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAE-FK 230 (448)
Q Consensus 153 FGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~ 230 (448)
||+++...............++..|+|||++.+..+ +.++|||||||++|++++ |++||...+..+....+..+. +.
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 239 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEY-SSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLA 239 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCC-CchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCC
Confidence 999975432211111123346778999999977665 488999999999999998 999999887777766655442 24
Q ss_pred CCCCCCHHHHHHHHhccCCCcCCCCCHHHHHh
Q 037702 231 CPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 231 ~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 262 (448)
.+..+++++.+++.+||..||++|||+.++++
T Consensus 240 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 240 QPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 45567899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=330.14 Aligned_cols=251 Identities=31% Similarity=0.545 Sum_probs=211.4
Q ss_pred eEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 037702 12 YELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAMEY 91 (448)
Q Consensus 12 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 91 (448)
|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+....|+||||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE-EEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccc-cccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 6788999999999999999999999999999986542 223346678899999999999999999999999999999999
Q ss_pred cCCCchHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCcc
Q 037702 92 VRGGELFNKVAKG--KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLH 169 (448)
Q Consensus 92 ~~gg~L~~~i~~~--~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~ 169 (448)
+++ +|.+++... .+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++........ ...
T Consensus 80 ~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~~ 156 (282)
T cd07829 80 CDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--TYT 156 (282)
T ss_pred cCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--ccC
Confidence 984 899999764 799999999999999999999999999999999999999999999999999876533221 223
Q ss_pred ccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhc------------------cCCC
Q 037702 170 TTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA------------------EFKC 231 (448)
Q Consensus 170 ~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~------------------~~~~ 231 (448)
...++..|+|||.+......+.++|||||||++|+|++|..||...+....+.++... ...+
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07829 157 HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTF 236 (282)
T ss_pred ccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccc
Confidence 3456888999999876645568899999999999999999999887665554443221 0001
Q ss_pred C-----------CCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhc
Q 037702 232 P-----------NWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWF 266 (448)
Q Consensus 232 p-----------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 266 (448)
+ +.++..+.++|++||..||++||++++++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 237 PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 1 1247889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=326.15 Aligned_cols=242 Identities=27% Similarity=0.443 Sum_probs=201.5
Q ss_pred eeeeecCceEEEEEEECCCCcE--EEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeec
Q 037702 16 RLLGQGTFAKVYHGRNLKTGQS--VAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEVMASKTKIYFAMEYV 92 (448)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~--vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E~~ 92 (448)
+.||+|+||.||+|.+..+|.. +|+|.+.... .....+.+.+|+.++.++ +||||+++++++......|+||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 4689999999999999888764 6888776332 223346788999999999 8999999999999999999999999
Q ss_pred CCCchHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccc
Q 037702 93 RGGELFNKVAKG-----------------KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGL 155 (448)
Q Consensus 93 ~gg~L~~~i~~~-----------------~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGl 155 (448)
++|+|.+++... .+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 999999998642 378899999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhcc-CCCCC
Q 037702 156 SALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAE-FKCPN 233 (448)
Q Consensus 156 a~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~ 233 (448)
+........ ......++.|+|||++....+ +.++|||||||++|+|++ |..||.+.+..+.+..+.... ...+.
T Consensus 159 ~~~~~~~~~---~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 234 (270)
T cd05047 159 SRGQEVYVK---KTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL 234 (270)
T ss_pred ccccchhhh---ccCCCCccccCChHHHccCCC-CchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCC
Confidence 863221111 112234667999999876655 488999999999999997 999998887777777665542 34556
Q ss_pred CCCHHHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 234 WFPPEVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 234 ~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
.++.++.+++.+||..||.+|||+++++..
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 264 (270)
T cd05047 235 NCDDEVYDLMRQCWREKPYERPSFAQILVS 264 (270)
T ss_pred cCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=321.67 Aligned_cols=248 Identities=26% Similarity=0.434 Sum_probs=210.4
Q ss_pred cCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFA 88 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 88 (448)
..+|++.+.||+|+||.||+|.+. ++..+|+|.+...... ...+.+|+.+++.++||||+++++++......|+|
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV 77 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEE
Confidence 357999999999999999999875 4778999998654332 25678899999999999999999999999999999
Q ss_pred EeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCC
Q 037702 89 MEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDG 166 (448)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 166 (448)
|||+++++|.+++.. +.++++.++.++.|++.|+.|||++|++||||||+||+++.++.++|+|||++........ .
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~ 156 (256)
T cd05112 78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-T 156 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcc-c
Confidence 999999999999864 5689999999999999999999999999999999999999999999999999875432111 1
Q ss_pred CccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhcc-CCCCCCCCHHHHHHHH
Q 037702 167 LLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAE-FKCPNWFPPEVRKLLS 244 (448)
Q Consensus 167 ~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~ 244 (448)
......++..|+|||.+.+..+ +.++||||||+++|+|++ |..||...........+..+. ...|...+..+.+|+.
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKY-SSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQ 235 (256)
T ss_pred ccCCCccchhhcCHhHhccCCc-ChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHH
Confidence 1122335678999999876655 478999999999999998 999999888777777766543 3345667899999999
Q ss_pred hccCCCcCCCCCHHHHHhh
Q 037702 245 RILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 245 ~~L~~dP~~Rpt~~eil~h 263 (448)
+||..+|++|||+.+++++
T Consensus 236 ~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 236 HCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HHcccChhhCCCHHHHHHh
Confidence 9999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=321.77 Aligned_cols=244 Identities=27% Similarity=0.449 Sum_probs=206.1
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCC
Q 037702 16 RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGG 95 (448)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 95 (448)
+.||+|+||.||+|.+.. ++.||+|.+...... .....+.+|+.+++.++||||+++++++.+....|+||||++|+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 469999999999999877 999999998765433 34467889999999999999999999999999999999999999
Q ss_pred chHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCccccCC
Q 037702 96 ELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCG 173 (448)
Q Consensus 96 ~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~G 173 (448)
+|.+++.. ..+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++................+
T Consensus 78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 99999865 4689999999999999999999999999999999999999999999999999875432111111122334
Q ss_pred CCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhc-cCCCCCCCCHHHHHHHHhccCCCc
Q 037702 174 TPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EFKCPNWFPPEVRKLLSRILDPNP 251 (448)
Q Consensus 174 t~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP 251 (448)
+..|+|||.+.+..+ +.++|+|||||++|+|++ |..||...........+... ....|..++.++.+++.+||..+|
T Consensus 158 ~~~y~~PE~~~~~~~-~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 236 (251)
T cd05041 158 PIKWTAPEALNYGRY-TSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDP 236 (251)
T ss_pred eeccCChHhhccCCC-CcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccCh
Confidence 667999999876555 588999999999999998 89999887766666665543 344566789999999999999999
Q ss_pred CCCCCHHHHHhh
Q 037702 252 STRVTMAKLMEN 263 (448)
Q Consensus 252 ~~Rpt~~eil~h 263 (448)
.+|||+.++++.
T Consensus 237 ~~Rp~~~ell~~ 248 (251)
T cd05041 237 ENRPSFSEIYNE 248 (251)
T ss_pred hhCcCHHHHHHH
Confidence 999999999873
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=326.48 Aligned_cols=252 Identities=29% Similarity=0.519 Sum_probs=212.1
Q ss_pred CeEEEeeeeecCceEEEEEEECCCCcEEEEEEeeccccc--chhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 037702 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIR--RVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFA 88 (448)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~--~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 88 (448)
+|.+.+.||+|+||.||++.+..++..+++|++...... ......++.+|+.+++.++||||+++++.+.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 699999999999999999999888777777776543221 112234577899999999999999999999999999999
Q ss_pred EeecCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccc
Q 037702 89 MEYVRGGELFNKVAK-----GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTR 163 (448)
Q Consensus 89 ~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~ 163 (448)
|||+++++|.+.+.. +.+++..++.++.|++.||.|||++|++|+||+|+||+++. +.++|+|||++......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~- 158 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS- 158 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCC-
Confidence 999999999988752 46899999999999999999999999999999999999975 67999999998754322
Q ss_pred cCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccC-CCCCCCCHHHHHH
Q 037702 164 QDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF-KCPNWFPPEVRKL 242 (448)
Q Consensus 164 ~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~l 242 (448)
........|++.|+|||.+.+..++ .++|+||||+++|+|++|..||...+.......+..... ..|..++.++.++
T Consensus 159 -~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (260)
T cd08222 159 -CDLATTFTGTPYYMSPEALKHQGYD-SKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSI 236 (260)
T ss_pred -cccccCCCCCcCccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHH
Confidence 1222345689999999998766664 789999999999999999999987776666666654433 4456688999999
Q ss_pred HHhccCCCcCCCCCHHHHHhhhhc
Q 037702 243 LSRILDPNPSTRVTMAKLMENYWF 266 (448)
Q Consensus 243 i~~~L~~dP~~Rpt~~eil~hp~~ 266 (448)
|.+||..||.+||++.++++||||
T Consensus 237 i~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 237 MQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHhcCChhhCcCHHHHhhCCCC
Confidence 999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=335.35 Aligned_cols=247 Identities=20% Similarity=0.396 Sum_probs=197.6
Q ss_pred CceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCCchHHHH
Q 037702 22 TFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKV 101 (448)
Q Consensus 22 ~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i 101 (448)
++|.||.+++..+|+.||||++....... ...+.+.+|+.+++.++||||+++++++......|++|||+++|+|.+++
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l 90 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSK-EDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL 90 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccch-hHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHH
Confidence 44556666666699999999998653332 34578999999999999999999999999999999999999999999998
Q ss_pred hc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccccc-----CCCccccCC
Q 037702 102 AK---GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQ-----DGLLHTTCG 173 (448)
Q Consensus 102 ~~---~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~-----~~~~~~~~G 173 (448)
.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||.+........ ........+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (314)
T cd08216 91 KTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK 170 (314)
T ss_pred HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccc
Confidence 75 4689999999999999999999999999999999999999999999999998864322111 111233457
Q ss_pred CCcccchhhhhcc--CCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHH-HHHhhc-----------------------
Q 037702 174 TPAYVAPEVINKR--GYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELY-KKITRA----------------------- 227 (448)
Q Consensus 174 t~~Y~APEvl~~~--~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~-~~i~~~----------------------- 227 (448)
+..|+|||++... ++ +.++|+||+||++|+|++|..||......... .++...
T Consensus 171 ~~~y~aPE~~~~~~~~~-~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (314)
T cd08216 171 NLPWLSPEVLQQNLQGY-NEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSS 249 (314)
T ss_pred cccccCHHHhcCCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCccccc
Confidence 8899999998653 34 47899999999999999999999875543322 222110
Q ss_pred ----------cCCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccccc
Q 037702 228 ----------EFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGY 270 (448)
Q Consensus 228 ----------~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 270 (448)
....+..++.++.+|+.+||..||++|||++++++||||+...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 250 NEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred ccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 0001112356789999999999999999999999999997543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=328.80 Aligned_cols=238 Identities=24% Similarity=0.366 Sum_probs=198.0
Q ss_pred eeeeecCceEEEEEEECCCCc-------EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 037702 16 RLLGQGTFAKVYHGRNLKTGQ-------SVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFA 88 (448)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~-------~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 88 (448)
+.||+|+||.||+|.+..++. .+|+|.+.... ....+.+.+|+.+++.++||||+++++++..+...++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 469999999999999866554 38888876442 23346788899999999999999999999999999999
Q ss_pred EeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCC--------eEEeecccccc
Q 037702 89 MEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGD--------LKISDFGLSAL 158 (448)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~--------lkl~DFGla~~ 158 (448)
|||+++|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++. ++++|||++..
T Consensus 78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 999999999999975 35899999999999999999999999999999999999987765 69999998864
Q ss_pred ccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhC-CCCCCCCcHHHHHHHHhhccCCCCCCCCH
Q 037702 159 QESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAG-NLPFYDSNLMELYKKITRAEFKCPNWFPP 237 (448)
Q Consensus 159 ~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG-~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~ 237 (448)
... .....|++.|+|||++.+....+.++|||||||++|+|++| ..||...+..... .........|...+.
T Consensus 158 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 230 (258)
T cd05078 158 VLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL-QFYEDRHQLPAPKWT 230 (258)
T ss_pred cCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH-HHHHccccCCCCCcH
Confidence 321 12456889999999997655456889999999999999998 5666655444332 233445566777789
Q ss_pred HHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 238 EVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 238 ~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
++.++|.+||+.||++|||++++++.
T Consensus 231 ~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 231 ELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred HHHHHHHHHhccChhhCCCHHHHHHh
Confidence 99999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=320.64 Aligned_cols=247 Identities=31% Similarity=0.499 Sum_probs=210.9
Q ss_pred eEEEeeeeecCceEEEEEEECCCC----cEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 037702 12 YELGRLLGQGTFAKVYHGRNLKTG----QSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYF 87 (448)
Q Consensus 12 y~~~~~LG~G~fg~Vy~a~~~~~g----~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 87 (448)
+++.+.||.|+||.||+|.+..++ ..||+|.+...... .....+..|+.+++.++||||+++++++.+.+..|+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADE--QQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCCh--HHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 357889999999999999998766 89999999655322 245788899999999999999999999999999999
Q ss_pred EEeecCCCchHHHHhcC--C-CCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccccc
Q 037702 88 AMEYVRGGELFNKVAKG--K-LREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQ 164 (448)
Q Consensus 88 V~E~~~gg~L~~~i~~~--~-l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~ 164 (448)
+|||+++++|.+++... . +++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++........
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 99999999999999753 2 99999999999999999999999999999999999999999999999999976543211
Q ss_pred CCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhccC-CCCCCCCHHHHHH
Q 037702 165 DGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAEF-KCPNWFPPEVRKL 242 (448)
Q Consensus 165 ~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~l 242 (448)
... ....+++.|+|||.+....+ +.++|+|||||++|+|++ |..||...+.......+..... ..+..++.++.++
T Consensus 159 ~~~-~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (258)
T smart00219 159 YKK-KGGKLPIRWMAPESLKDGKF-TSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKL 236 (258)
T ss_pred ccc-ccCCCcccccChHHhccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHH
Confidence 111 11237789999999865444 588999999999999998 8999988887777777665543 4566789999999
Q ss_pred HHhccCCCcCCCCCHHHHHh
Q 037702 243 LSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 243 i~~~L~~dP~~Rpt~~eil~ 262 (448)
+.+||..||.+|||+.++++
T Consensus 237 i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 237 MLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHCcCChhhCcCHHHHHh
Confidence 99999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=326.90 Aligned_cols=249 Identities=31% Similarity=0.476 Sum_probs=206.2
Q ss_pred eEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC---CCCCcceEEEEEEeCCE----
Q 037702 12 YELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV---RHPNIVQLYEVMASKTK---- 84 (448)
Q Consensus 12 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l---~hpnIv~l~~~~~~~~~---- 84 (448)
|++.+.||+|+||.||+|++..+++.||+|.+...... ......+.+|+.+++.+ +||||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSE-EGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEecccccc-chhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 78999999999999999999888999999999754332 22334566788877766 59999999999988776
Q ss_pred -EEEEEeecCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccc
Q 037702 85 -IYFAMEYVRGGELFNKVAK---GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQE 160 (448)
Q Consensus 85 -~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~ 160 (448)
++++|||+.+ +|.+++.. ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++....
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 9999999975 78888765 258999999999999999999999999999999999999999999999999987653
Q ss_pred ccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhcc-----CCC----
Q 037702 161 STRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAE-----FKC---- 231 (448)
Q Consensus 161 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-----~~~---- 231 (448)
.. .......+++.|+|||++.+..+ +.++|+||+||++|+|++|.+||.+.+..+...++.... ..+
T Consensus 159 ~~---~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 159 FE---MALTSVVVTLWYRAPEVLLQSSY-ATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred CC---cccccccccccccChHHhccCCC-CCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence 22 12233458899999999977665 488999999999999999999999887766665553310 000
Q ss_pred ------------------CCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhc
Q 037702 232 ------------------PNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWF 266 (448)
Q Consensus 232 ------------------p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 266 (448)
.+.+++.+.++|.+||+.||.+||++.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 01245788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=325.54 Aligned_cols=251 Identities=24% Similarity=0.404 Sum_probs=211.8
Q ss_pred cCCeEEEeeeeecCceEEEEEEECC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNLK-----TGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKT 83 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~ 83 (448)
..+|++.+.||+|+||.||+|++.. +.+.||+|.+..... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 81 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD--ENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE 81 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccc--hHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence 4689999999999999999999754 346799998865432 224567899999999999999999999999999
Q ss_pred EEEEEEeecCCCchHHHHhc-C---------CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeec
Q 037702 84 KIYFAMEYVRGGELFNKVAK-G---------KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDF 153 (448)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-~---------~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DF 153 (448)
..|+||||+++|+|.+++.. + .+++..+..++.||+.||+|||++||+||||||+|||++.++.++++||
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence 99999999999999999865 3 4899999999999999999999999999999999999999999999999
Q ss_pred cccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhccC--C
Q 037702 154 GLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAEF--K 230 (448)
Q Consensus 154 Gla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~--~ 230 (448)
|++....... ........+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||.+.........+..... .
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 239 (275)
T cd05046 162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDF-STKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELP 239 (275)
T ss_pred ccccccCccc-ccccCCceeEEeecChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCC
Confidence 9986432211 112233456788999999876655 478999999999999998 8899988777777776665443 3
Q ss_pred CCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 231 CPNWFPPEVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 231 ~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
.+..++..+.+++.+||..||.+|||+.++++.
T Consensus 240 ~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 240 VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 455688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=329.24 Aligned_cols=261 Identities=28% Similarity=0.465 Sum_probs=210.6
Q ss_pred cccccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEe
Q 037702 3 KKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEVMAS 81 (448)
Q Consensus 3 ~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~ 81 (448)
+...+..++|++.+.||+|+||.||+|.+..+|+.||||.+.+.... .....+.+|+.++... .||||+++++++.+
T Consensus 8 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 85 (296)
T cd06618 8 QKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVKCYGYFIT 85 (296)
T ss_pred eeccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh--HHHHHHHHHHHHHHhccCCCchHhhheeeec
Confidence 44556778999999999999999999999988999999999765322 2234556677766666 59999999999999
Q ss_pred CCEEEEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH-CCCEeecCCCCceEEcCCCCeEEeecccccc
Q 037702 82 KTKIYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHS-RGVYHRDLKPENLLLDENGDLKISDFGLSAL 158 (448)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~-~givHrDLkp~NILl~~~g~lkl~DFGla~~ 158 (448)
....|++|||+.+ .|.+.+.. +.+++..+..++.|++.||+|||+ .||+||||+|+||+++.++.+||+|||++..
T Consensus 86 ~~~~~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~ 164 (296)
T cd06618 86 DSDVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGR 164 (296)
T ss_pred CCeEEEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchh
Confidence 9999999999854 67666654 579999999999999999999997 5999999999999999999999999999875
Q ss_pred ccccccCCCccccCCCCcccchhhhhccC---CCCCcchHHHHHHHHHHHHhCCCCCCCCcH-HHHHHHHhhccC-CCC-
Q 037702 159 QESTRQDGLLHTTCGTPAYVAPEVINKRG---YDGAKADIWSCGVVLFVLLAGNLPFYDSNL-MELYKKITRAEF-KCP- 232 (448)
Q Consensus 159 ~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~---~~~~~sDiwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~~~~-~~p- 232 (448)
..... ......|++.|+|||.+.... ..+.++||||||+++|+|++|+.||..... .+.+..+..... ..+
T Consensus 165 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 241 (296)
T cd06618 165 LVDSK---AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPP 241 (296)
T ss_pred ccCCC---cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCC
Confidence 43221 112345889999999986542 234789999999999999999999976432 234444433322 222
Q ss_pred -CCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 233 -NWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 233 -~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
..++.++.+||.+||..||.+||++++++.||||+..
T Consensus 242 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 279 (296)
T cd06618 242 NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY 279 (296)
T ss_pred CCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence 2368899999999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=346.30 Aligned_cols=252 Identities=28% Similarity=0.471 Sum_probs=216.3
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCc---E-EEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQ---S-VAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASK 82 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~---~-vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~ 82 (448)
+..++-.+.+.||+|+||+||+|..+..+. . ||||....+..........+.+|+++|+.++|||||++||+....
T Consensus 154 l~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~ 233 (474)
T KOG0194|consen 154 LSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLE 233 (474)
T ss_pred EeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCC
Confidence 344566677999999999999998765432 3 899998764444456678899999999999999999999999999
Q ss_pred CEEEEEEeecCCCchHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccc
Q 037702 83 TKIYFAMEYVRGGELFNKVAKG--KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQE 160 (448)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~~--~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~ 160 (448)
..+|+|||+|+||+|.+++++. .++..+...++.+.+.||+|||+++++||||-.+|+|++.++.+||+|||+++...
T Consensus 234 ~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~ 313 (474)
T KOG0194|consen 234 EPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGS 313 (474)
T ss_pred CccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCc
Confidence 9999999999999999999873 49999999999999999999999999999999999999999999999999987543
Q ss_pred ccccCCCcccc-CCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhccC--CCCCCCC
Q 037702 161 STRQDGLLHTT-CGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAEF--KCPNWFP 236 (448)
Q Consensus 161 ~~~~~~~~~~~-~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~--~~p~~~s 236 (448)
. ....... --...|+|||.+...-| +.++||||+||++||+++ |..||.+....++..+|....+ +.|...|
T Consensus 314 ~---~~~~~~~~klPirWLAPEtl~~~~~-s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p 389 (474)
T KOG0194|consen 314 Q---YVMKKFLKKLPIRWLAPETLNTGIF-SFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTP 389 (474)
T ss_pred c---eeeccccccCcceecChhhhccCcc-ccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCH
Confidence 1 1111111 24578999999987655 589999999999999998 8999999999999999966554 5666788
Q ss_pred HHHHHHHHhccCCCcCCCCCHHHHHh
Q 037702 237 PEVRKLLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 237 ~~~~~li~~~L~~dP~~Rpt~~eil~ 262 (448)
.++..++.+|+..||++|||+.++.+
T Consensus 390 ~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 390 KELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHHHHHHHHhccCChhhccCHHHHHH
Confidence 99999999999999999999999986
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=318.05 Aligned_cols=243 Identities=28% Similarity=0.500 Sum_probs=203.7
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCC
Q 037702 16 RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGG 95 (448)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 95 (448)
+.||+|+||.||+|.. .++..+|+|.+..... ......+.+|+.+++.++||||+++++++......++||||++++
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLP--QELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 4689999999999985 4788999999865432 223356889999999999999999999999999999999999999
Q ss_pred chHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCccccCC
Q 037702 96 ELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCG 173 (448)
Q Consensus 96 ~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~G 173 (448)
+|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++........ .......+
T Consensus 78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~ 156 (250)
T cd05085 78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGLKQI 156 (250)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccccc-ccCCCCCC
Confidence 99999864 4689999999999999999999999999999999999999999999999999864322111 11112345
Q ss_pred CCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhc-cCCCCCCCCHHHHHHHHhccCCCc
Q 037702 174 TPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EFKCPNWFPPEVRKLLSRILDPNP 251 (448)
Q Consensus 174 t~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP 251 (448)
++.|+|||++....+ +.++||||||+++|++++ |..||...+.......+... ....|..++..+.+++.+||..||
T Consensus 157 ~~~y~aPE~~~~~~~-~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 235 (250)
T cd05085 157 PIKWTAPEALNYGRY-SSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKP 235 (250)
T ss_pred cccccCHHHhccCCC-CchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCc
Confidence 678999999876555 478999999999999998 99999888776666666544 235567789999999999999999
Q ss_pred CCCCCHHHHHhh
Q 037702 252 STRVTMAKLMEN 263 (448)
Q Consensus 252 ~~Rpt~~eil~h 263 (448)
.+||++.++++.
T Consensus 236 ~~Rp~~~~l~~~ 247 (250)
T cd05085 236 ENRPKFSELQKE 247 (250)
T ss_pred ccCCCHHHHHHH
Confidence 999999999863
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=369.67 Aligned_cols=255 Identities=31% Similarity=0.554 Sum_probs=210.4
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASK----- 82 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~----- 82 (448)
...+|+..+.||+||||.||+++++-+|..||||.|.... .......+.+|+..+.+|+|||||++|..|.+.
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 3567889999999999999999999999999999998765 334557899999999999999999997322100
Q ss_pred --------------------------------------------------------------------------------
Q 037702 83 -------------------------------------------------------------------------------- 82 (448)
Q Consensus 83 -------------------------------------------------------------------------------- 82 (448)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred ----------------------------------CEEEEEEeecCCCchHHHHhcCCCC--HHHHHHHHHHHHHHHHHHH
Q 037702 83 ----------------------------------TKIYFAMEYVRGGELFNKVAKGKLR--EEVARKYFQQLVDAVEFCH 126 (448)
Q Consensus 83 ----------------------------------~~~~lV~E~~~gg~L~~~i~~~~l~--e~~~~~~~~qll~aL~yLH 126 (448)
..+||-||||+...|.+++..+.+. .+.+|++|+||++||.|+|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence 1378999999999999999887664 8899999999999999999
Q ss_pred HCCCEeecCCCCceEEcCCCCeEEeecccccccc----c------------cccCCCccccCCCCcccchhhhhccC--C
Q 037702 127 SRGVYHRDLKPENLLLDENGDLKISDFGLSALQE----S------------TRQDGLLHTTCGTPAYVAPEVINKRG--Y 188 (448)
Q Consensus 127 ~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~----~------------~~~~~~~~~~~Gt~~Y~APEvl~~~~--~ 188 (448)
++|||||||||.||+||+++++||+|||+|+... . ...++.....+||..|+|||++.+.. .
T Consensus 715 ~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~ 794 (1351)
T KOG1035|consen 715 DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK 794 (1351)
T ss_pred hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence 9999999999999999999999999999998621 0 01122345568999999999998766 3
Q ss_pred CCCcchHHHHHHHHHHHHhCCCCCCCC-cHHHHHHHHhhccCCCCCCCC----HHHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 189 DGAKADIWSCGVVLFVLLAGNLPFYDS-NLMELYKKITRAEFKCPNWFP----PEVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 189 ~~~~sDiwSlGvil~elltG~~Pf~~~-~~~~~~~~i~~~~~~~p~~~s----~~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
+..|+|+|||||||+||+ .||... ........+.++.++.|..+. +.-..+|++||+.||.+||||.|+|++
T Consensus 795 Yn~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 795 YNSKIDMYSLGIVLFEML---YPFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNS 871 (1351)
T ss_pred ccchhhhHHHHHHHHHHh---ccCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhc
Confidence 459999999999999999 467543 334556666666776664332 566789999999999999999999999
Q ss_pred hhcc
Q 037702 264 YWFR 267 (448)
Q Consensus 264 p~~~ 267 (448)
.||.
T Consensus 872 ~llp 875 (1351)
T KOG1035|consen 872 ELLP 875 (1351)
T ss_pred cCCC
Confidence 9986
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=322.95 Aligned_cols=252 Identities=27% Similarity=0.433 Sum_probs=209.4
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCC---CcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKT---GQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKT 83 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~ 83 (448)
+...+|.+.+.||+|+||.||+|.+..+ ...||||.+..... ....+.+.+|+.+++.++||||+++++++.+ .
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~ 79 (270)
T cd05056 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS--PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-N 79 (270)
T ss_pred echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-C
Confidence 3456799999999999999999987554 34689998865432 2344678899999999999999999998875 4
Q ss_pred EEEEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccc
Q 037702 84 KIYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQES 161 (448)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~ 161 (448)
..|+||||+++|+|.+++.. ..+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++.....
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 57899999999999999975 3589999999999999999999999999999999999999999999999999875433
Q ss_pred cccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhcc-CCCCCCCCHHH
Q 037702 162 TRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAE-FKCPNWFPPEV 239 (448)
Q Consensus 162 ~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~ 239 (448)
.... ......+++.|+|||.+....+ +.++|||||||++|+|++ |..||...+..+....+.... ...|..+|+.+
T Consensus 160 ~~~~-~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (270)
T cd05056 160 ESYY-KASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL 237 (270)
T ss_pred ccce-ecCCCCccccccChhhhccCCC-CchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHH
Confidence 2111 1112334578999999876665 488999999999999986 999998887766666665543 45677789999
Q ss_pred HHHHHhccCCCcCCCCCHHHHHhh
Q 037702 240 RKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 240 ~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
.++|.+||..+|.+|||+.+++..
T Consensus 238 ~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 238 YSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=320.72 Aligned_cols=249 Identities=24% Similarity=0.414 Sum_probs=208.5
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKI 85 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 85 (448)
.+..++|++.+.||+|+||.||+|.+. .+..+|+|.+.... ...+.+.+|+.+++.++|+||+++++++.. ...
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~ 75 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPI 75 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh----hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCe
Confidence 457789999999999999999999854 56679999886442 224678899999999999999999999887 778
Q ss_pred EEEEeecCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccc
Q 037702 86 YFAMEYVRGGELFNKVAK---GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQEST 162 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~ 162 (448)
|++|||+++++|.+++.+ ..+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 76 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred EEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 999999999999999965 35788899999999999999999999999999999999999999999999998754322
Q ss_pred ccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhcc-CCCCCCCCHHHH
Q 037702 163 RQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAE-FKCPNWFPPEVR 240 (448)
Q Consensus 163 ~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~ 240 (448)
.. .......++..|+|||++....+ +.++|+|||||++|++++ |..||...+..+....+.... ...+...+.++.
T Consensus 156 ~~-~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (260)
T cd05073 156 EY-TAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELY 233 (260)
T ss_pred Cc-ccccCCcccccccCHhHhccCCc-CccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHH
Confidence 11 11122345678999999976554 578999999999999998 999999877776666655442 244566889999
Q ss_pred HHHHhccCCCcCCCCCHHHHHh
Q 037702 241 KLLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~eil~ 262 (448)
+++.+||++||++||++.++++
T Consensus 234 ~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 234 NIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHHHHHcccCcccCcCHHHHHH
Confidence 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=327.86 Aligned_cols=249 Identities=32% Similarity=0.499 Sum_probs=206.7
Q ss_pred eEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEe
Q 037702 12 YELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR-HPNIVQLYEVMASKTKIYFAME 90 (448)
Q Consensus 12 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lV~E 90 (448)
|++.+.||+|+||.||+|.+..+++.||||.+....... ......+|+..++.++ ||||+++++++..++..|+|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW--EECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccch--hHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 788999999999999999998899999999986543221 1233457999999999 9999999999999999999999
Q ss_pred ecCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCC
Q 037702 91 YVRGGELFNKVAK---GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGL 167 (448)
Q Consensus 91 ~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 167 (448)
|+ +|+|.+.+.. ..+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++....... .
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~---~ 154 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP---P 154 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC---C
Confidence 99 7899888865 268999999999999999999999999999999999999999999999999997543321 2
Q ss_pred ccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhc-------------------c
Q 037702 168 LHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA-------------------E 228 (448)
Q Consensus 168 ~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-------------------~ 228 (448)
.....|+..|+|||++......+.++|+||||+++|+|++|++||...+..+.+.++... .
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 234568999999998865444468899999999999999999999877655544433211 0
Q ss_pred CCC-----------CCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhc
Q 037702 229 FKC-----------PNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWF 266 (448)
Q Consensus 229 ~~~-----------p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 266 (448)
... .+..++++.++|++||..||.+|||+.|++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 000 11236889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=323.22 Aligned_cols=244 Identities=21% Similarity=0.312 Sum_probs=192.7
Q ss_pred eeeeecCceEEEEEEECC--CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecC
Q 037702 16 RLLGQGTFAKVYHGRNLK--TGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVR 93 (448)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~--~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 93 (448)
+.||+|+||.||+|.... ....+|+|.+.... .......+.+|+.+++.++||||+++++.+......|+||||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 368999999999996432 34578888775432 22334567889999999999999999999999999999999999
Q ss_pred CCchHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCC
Q 037702 94 GGELFNKVAKG------KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGL 167 (448)
Q Consensus 94 gg~L~~~i~~~------~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 167 (448)
+|+|.+++... ..++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 99999998652 246788899999999999999999999999999999999999999999999864322111111
Q ss_pred ccccCCCCcccchhhhhcc------CCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhc-cCC-----CCCC
Q 037702 168 LHTTCGTPAYVAPEVINKR------GYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EFK-----CPNW 234 (448)
Q Consensus 168 ~~~~~Gt~~Y~APEvl~~~------~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~-----~p~~ 234 (448)
.....+++.|+|||++... ...+.++|||||||++|+|++ |..||......+....+... ... .+..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLK 238 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccccc
Confidence 1234567789999998542 223578999999999999999 88999877665555444332 222 2335
Q ss_pred CCHHHHHHHHhccCCCcCCCCCHHHHHh
Q 037702 235 FPPEVRKLLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 235 ~s~~~~~li~~~L~~dP~~Rpt~~eil~ 262 (448)
+++.+.+++..|+ .||++|||++++++
T Consensus 239 ~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 239 YSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred CCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 7888999999998 59999999999986
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=323.14 Aligned_cols=238 Identities=24% Similarity=0.334 Sum_probs=194.5
Q ss_pred eeeeecCceEEEEEEECC------------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 037702 16 RLLGQGTFAKVYHGRNLK------------TGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKT 83 (448)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~------------~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~ 83 (448)
+.||+|+||.||+|.... ....+|+|++.... ......+.+|+.+++.++||||+++++++..+.
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 468999999999998532 22358999876542 233456788999999999999999999999999
Q ss_pred EEEEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCC-------eEEeecc
Q 037702 84 KIYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGD-------LKISDFG 154 (448)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~-------lkl~DFG 154 (448)
..++||||+++|+|..++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++. ++++|||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 99999999999999888864 56999999999999999999999999999999999999987664 8999999
Q ss_pred ccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHH-hCCCCCCCCcHHHHHHHHhhccCCCCC
Q 037702 155 LSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLL-AGNLPFYDSNLMELYKKITRAEFKCPN 233 (448)
Q Consensus 155 la~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ell-tG~~Pf~~~~~~~~~~~i~~~~~~~p~ 233 (448)
++..... .....|+..|+|||++......+.++|||||||++|+|+ .|..||......+.. ...........
T Consensus 158 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~~~~~~ 230 (262)
T cd05077 158 IPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQCMLVT 230 (262)
T ss_pred CCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcCccCCC
Confidence 9864321 123468899999999865454568899999999999998 589998876554432 22333333334
Q ss_pred CCCHHHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 234 WFPPEVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 234 ~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
..++++.+||.+||+.||.+||++.+|+++
T Consensus 231 ~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 231 PSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred CChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 456889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=326.54 Aligned_cols=237 Identities=24% Similarity=0.330 Sum_probs=194.3
Q ss_pred eeeecCceEEEEEEECCC------------------------CcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc
Q 037702 17 LLGQGTFAKVYHGRNLKT------------------------GQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNI 72 (448)
Q Consensus 17 ~LG~G~fg~Vy~a~~~~~------------------------g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnI 72 (448)
.||+|+||.||+|....+ ...||+|++.... ......+.+|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence 599999999999975322 2358899886542 2334567889999999999999
Q ss_pred ceEEEEEEeCCEEEEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCC----
Q 037702 73 VQLYEVMASKTKIYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENG---- 146 (448)
Q Consensus 73 v~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g---- 146 (448)
+++++++.+....|+||||+++|+|..++.. +.+++..+..++.||+.||+|||++||+||||||+|||++..+
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999998864 5789999999999999999999999999999999999998654
Q ss_pred ---CeEEeeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHH-hCCCCCCCCcHHHHHH
Q 037702 147 ---DLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLL-AGNLPFYDSNLMELYK 222 (448)
Q Consensus 147 ---~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ell-tG~~Pf~~~~~~~~~~ 222 (448)
.+|++|||++..... .....+++.|+|||.+.+....+.++|||||||++|+|+ +|..||......+...
T Consensus 159 ~~~~~kl~d~g~~~~~~~------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 232 (274)
T cd05076 159 TSPFIKLSDPGVSFTALS------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232 (274)
T ss_pred ccceeeecCCcccccccc------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 389999998753221 123457889999998866444468899999999999985 7999998765544332
Q ss_pred HHhhccCCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 223 KITRAEFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 223 ~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
........|...++++.++|.+||+.+|.+|||+.+++++
T Consensus 233 -~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 233 -FYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred -HHHhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 2333445556567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=328.83 Aligned_cols=252 Identities=23% Similarity=0.385 Sum_probs=207.7
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCc----EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQ----SVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKT 83 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~----~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~ 83 (448)
..++|+..+.||+|+||.||+|.+..+|. .||+|.+..... ......+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~- 81 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG--PKANVEFMDEALIMASMDHPHLVRLLGVCLSP- 81 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-
Confidence 45689999999999999999999988876 468888764432 22234678999999999999999999998654
Q ss_pred EEEEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccc
Q 037702 84 KIYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQES 161 (448)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~ 161 (448)
..++++||+++|+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccC
Confidence 46799999999999999875 3689999999999999999999999999999999999999999999999999986543
Q ss_pred cccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhcc-CCCCCCCCHHH
Q 037702 162 TRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAE-FKCPNWFPPEV 239 (448)
Q Consensus 162 ~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~ 239 (448)
...........++..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.........+.... +..+...+..+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKF-THQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDV 240 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCC-ChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHH
Confidence 222112223456789999999876665 488999999999999997 999998776555544444332 34456678999
Q ss_pred HHHHHhccCCCcCCCCCHHHHHhh
Q 037702 240 RKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 240 ~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
.+++.+||..||++||+++++++.
T Consensus 241 ~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 241 YMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=323.26 Aligned_cols=244 Identities=26% Similarity=0.414 Sum_probs=203.3
Q ss_pred eeeeecCceEEEEEEECCCC------cEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 037702 16 RLLGQGTFAKVYHGRNLKTG------QSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAM 89 (448)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g------~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (448)
+.||+|+||.||+|.+...+ ..+|||.+.+.... .....+.+|+.+++.++||||+++++++......|+||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATD--QEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccch--hhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 46899999999999976543 68999988654221 23467888999999999999999999999999999999
Q ss_pred eecCCCchHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCC-----CeEEeecccc
Q 037702 90 EYVRGGELFNKVAK--------GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENG-----DLKISDFGLS 156 (448)
Q Consensus 90 E~~~gg~L~~~i~~--------~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g-----~lkl~DFGla 156 (448)
||+++++|.+++.. ..+++..+..++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 99999999999853 2378899999999999999999999999999999999999888 8999999998
Q ss_pred ccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhc-cCCCCCC
Q 037702 157 ALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EFKCPNW 234 (448)
Q Consensus 157 ~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~ 234 (448)
................++..|+|||++.+..+ +.++|||||||++|+|++ |..||...+..+....+... .+..+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKF-TTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPEN 237 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCc-ccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCccc
Confidence 75432221111223456789999999976655 588999999999999998 99999887776666665543 3456677
Q ss_pred CCHHHHHHHHhccCCCcCCCCCHHHHHh
Q 037702 235 FPPEVRKLLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 235 ~s~~~~~li~~~L~~dP~~Rpt~~eil~ 262 (448)
+|+.+.++|.+||.++|.+||++.++++
T Consensus 238 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 238 CPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred chHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 8999999999999999999999999976
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=321.53 Aligned_cols=228 Identities=27% Similarity=0.445 Sum_probs=193.0
Q ss_pred cCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCCchHHH
Q 037702 21 GTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNK 100 (448)
Q Consensus 21 G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~ 100 (448)
|.||.||+|++..+|+.||+|.+.+.. ...+|...+....||||+++++++.+....|+||||++||+|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 899999999999999999999997653 122445555566799999999999999999999999999999999
Q ss_pred Hhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCccccCCCCcccc
Q 037702 101 VAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVA 179 (448)
Q Consensus 101 i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~A 179 (448)
+.+ +.+++..+..++.|+++||+|||++||+||||||+||+++.++.++++|||++...... .....++..|+|
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y~a 150 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMYCA 150 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCccccC
Confidence 865 57999999999999999999999999999999999999999999999999987644321 223456788999
Q ss_pred hhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHHHHhccCCCcCCCCCH--
Q 037702 180 PEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILDPNPSTRVTM-- 257 (448)
Q Consensus 180 PEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~-- 257 (448)
||.+....+ +.++|+||+||++|+|++|+.||...... . -.......|.++++.++++|.+||+.||++||++
T Consensus 151 PE~~~~~~~-~~~~DvwslG~il~el~~g~~~~~~~~~~-~---~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 151 PEVGGISEE-TEACDWWSLGAILFELLTGKTLVECHPSG-I---NTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGV 225 (237)
T ss_pred CcccCCCCC-CchhhHHHHHHHHHHHHHCcchhhcCchh-c---ccccccCCcccCCHHHHHHHHHHccCCHHHhcCCCc
Confidence 999876665 47899999999999999999987643211 0 0112345778899999999999999999999985
Q ss_pred ---HHHHhhhhc
Q 037702 258 ---AKLMENYWF 266 (448)
Q Consensus 258 ---~eil~hp~~ 266 (448)
+++++||||
T Consensus 226 ~~~~~~~~h~~~ 237 (237)
T cd05576 226 AGVEDIKSHPFF 237 (237)
T ss_pred cchHHHHcCCCC
Confidence 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=321.86 Aligned_cols=244 Identities=19% Similarity=0.245 Sum_probs=193.5
Q ss_pred eeeeecCceEEEEEEEC--CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecC
Q 037702 16 RLLGQGTFAKVYHGRNL--KTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVR 93 (448)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~--~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 93 (448)
+.||+|+||.||+|... .++..+|+|.+...... .....+.+|+.+++.++||||+++++++.+....|+||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASV--QEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 46899999999999864 35568999988654322 223568889999999999999999999999999999999999
Q ss_pred CCchHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCC
Q 037702 94 GGELFNKVAKG------KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGL 167 (448)
Q Consensus 94 gg~L~~~i~~~------~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 167 (448)
+|+|.+++... ..++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 99999998641 356778889999999999999999999999999999999999999999999874322211111
Q ss_pred ccccCCCCcccchhhhhccC------CCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhh-ccCCC--C---CC
Q 037702 168 LHTTCGTPAYVAPEVINKRG------YDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITR-AEFKC--P---NW 234 (448)
Q Consensus 168 ~~~~~Gt~~Y~APEvl~~~~------~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~-~~~~~--p---~~ 234 (448)
.....|++.|+|||++.+.. ..+.++|||||||++|+|++ |..||......+....... ..... | ..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLP 238 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCC
Confidence 22346788999999986422 12578999999999999996 9999987665554433222 22222 1 23
Q ss_pred CCHHHHHHHHhccCCCcCCCCCHHHHHh
Q 037702 235 FPPEVRKLLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 235 ~s~~~~~li~~~L~~dP~~Rpt~~eil~ 262 (448)
.++.+.+++.+|+ .+|++|||+++|+.
T Consensus 239 ~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 239 LSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred CChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 6788999999999 68999999999985
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=356.37 Aligned_cols=252 Identities=28% Similarity=0.433 Sum_probs=218.2
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLK-----TGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMAS 81 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~ 81 (448)
+...+-++.+.||+|+||+||+|+... +...||||.+.... +.....+|+||+.++..++|||||+++|+|..
T Consensus 483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~ 560 (774)
T KOG1026|consen 483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLGVCRE 560 (774)
T ss_pred echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence 345567788999999999999998633 33579999987553 33456889999999999999999999999999
Q ss_pred CCEEEEEEeecCCCchHHHHhcC-----------C----CCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCC
Q 037702 82 KTKIYFAMEYVRGGELFNKVAKG-----------K----LREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENG 146 (448)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~~-----------~----l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g 146 (448)
++.+|||+|||..|||.++++.. . ++..+...++.||+.|++||-++.+|||||...|+||.++-
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENL 640 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccce
Confidence 99999999999999999998531 1 77889999999999999999999999999999999999999
Q ss_pred CeEEeeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHh
Q 037702 147 DLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKIT 225 (448)
Q Consensus 147 ~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~ 225 (448)
.|||+||||++-.-...-........-..+|||||.+....|. .+|||||+||+|||+++ |..||.+....++...|.
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFT-teSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~ 719 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFT-TESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIR 719 (774)
T ss_pred EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCccc-chhhhhhhhhhhhhhhccccCcccccchHHHHHHHH
Confidence 9999999999854333222222233446789999999887775 88999999999999998 999999999999999998
Q ss_pred hcc-CCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHH
Q 037702 226 RAE-FKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLM 261 (448)
Q Consensus 226 ~~~-~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil 261 (448)
.++ +++|..+|.++.+|+..||+.+|.+||++.||-
T Consensus 720 ~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 720 AGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred cCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 876 489999999999999999999999999999984
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=318.09 Aligned_cols=241 Identities=28% Similarity=0.513 Sum_probs=204.5
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYF 87 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 87 (448)
..++|++.+.||+|+||.||++.. +++.||+|.+.... ..+.+.+|+.+++.++||||+++++++..+ ..|+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~ 75 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI 75 (254)
T ss_pred cHHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence 357899999999999999999874 78899999986432 235678999999999999999999998654 4799
Q ss_pred EEeecCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccccc
Q 037702 88 AMEYVRGGELFNKVAK---GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQ 164 (448)
Q Consensus 88 V~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~ 164 (448)
||||+++++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-- 153 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-- 153 (254)
T ss_pred EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc--
Confidence 9999999999999965 25899999999999999999999999999999999999999999999999998753221
Q ss_pred CCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhcc-CCCCCCCCHHHHHH
Q 037702 165 DGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAE-FKCPNWFPPEVRKL 242 (448)
Q Consensus 165 ~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~l 242 (448)
......+..|+|||.+.+..+ +.++|+|||||++|+|++ |..||...+..+....+..+. ...+..+++.+.++
T Consensus 154 ---~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 229 (254)
T cd05083 154 ---VDNSKLPVKWTAPEALKHKKF-SSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVL 229 (254)
T ss_pred ---CCCCCCCceecCHHHhccCCc-CchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHH
Confidence 122334678999999876555 488999999999999997 999998887777666665442 23455688999999
Q ss_pred HHhccCCCcCCCCCHHHHHh
Q 037702 243 LSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 243 i~~~L~~dP~~Rpt~~eil~ 262 (448)
+.+||..+|.+||++++++.
T Consensus 230 i~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 230 MTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=318.51 Aligned_cols=245 Identities=24% Similarity=0.416 Sum_probs=198.9
Q ss_pred eeeeecCceEEEEEEECC---CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE-eCCEEEEEEee
Q 037702 16 RLLGQGTFAKVYHGRNLK---TGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMA-SKTKIYFAMEY 91 (448)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~---~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~-~~~~~~lV~E~ 91 (448)
+.||+|+||.||+|.+.. ++..||||.+.... .....+.+.+|+.+++.++||||+++++++. .+...++||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC--CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 468999999999998754 34579999875422 2234567889999999999999999999765 45668999999
Q ss_pred cCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccccc--CCC
Q 037702 92 VRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQ--DGL 167 (448)
Q Consensus 92 ~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~--~~~ 167 (448)
+.+|+|.+++.. ..+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++........ ...
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 158 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN 158 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecc
Confidence 999999999875 3567888899999999999999999999999999999999999999999999874322110 011
Q ss_pred ccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhcc-CCCCCCCCHHHHHHHHh
Q 037702 168 LHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAE-FKCPNWFPPEVRKLLSR 245 (448)
Q Consensus 168 ~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~ 245 (448)
.....+++.|+|||.+....+ +.++|||||||++|+|++ |.+||...+..+....+..+. ...|..+++.+.+++.+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 237 (262)
T cd05058 159 HTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLS 237 (262)
T ss_pred cccCcCCccccChhHhccCcc-chHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHH
Confidence 123346778999999877665 478999999999999999 577787777666666665543 34456678999999999
Q ss_pred ccCCCcCCCCCHHHHHhh
Q 037702 246 ILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 246 ~L~~dP~~Rpt~~eil~h 263 (448)
||..+|++||++.++++.
T Consensus 238 cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 238 CWHPKPEMRPTFSELVSR 255 (262)
T ss_pred HcCCChhhCCCHHHHHHH
Confidence 999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=323.38 Aligned_cols=250 Identities=28% Similarity=0.418 Sum_probs=201.3
Q ss_pred CeEEEeeeeecCceEEEEEEE----CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CE
Q 037702 11 KYELGRLLGQGTFAKVYHGRN----LKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASK--TK 84 (448)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~----~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~ 84 (448)
-|++.+.||+|+||.||+|.. ..++..||+|.+.... .......+.+|+.+++.++||||+++++++... ..
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 468999999999999999974 4578899999986543 223346789999999999999999999998775 67
Q ss_pred EEEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccc
Q 037702 85 IYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQEST 162 (448)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~ 162 (448)
.++||||++|++|.+++.+ ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++......
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 162 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccC
Confidence 8999999999999999865 35899999999999999999999999999999999999999999999999999865432
Q ss_pred ccC-CCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCc---------------HHHHHHHHhh
Q 037702 163 RQD-GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSN---------------LMELYKKITR 226 (448)
Q Consensus 163 ~~~-~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~---------------~~~~~~~i~~ 226 (448)
... .......|+..|+|||++.+..+ +.++|||||||++|+|+++..|+.... .......+..
T Consensus 163 ~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05079 163 KEYYTVKDDLDSPVFWYAPECLIQSKF-YIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEE 241 (284)
T ss_pred ccceeecCCCCCCccccCHHHhccCCC-CccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHc
Confidence 211 11224557788999999876655 478999999999999999877653211 0111111111
Q ss_pred -ccCCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 227 -AEFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 227 -~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
...+.+..++..+.+||.+||+.||.+|||+.+++++
T Consensus 242 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 242 GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred CccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 1233455688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=314.73 Aligned_cols=253 Identities=29% Similarity=0.497 Sum_probs=209.7
Q ss_pred cCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEE
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEVMASKTKIYF 87 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~l 87 (448)
.++.+.+..||.|+.|.|++++.+.+|...|||.+.+.... +...++...+.++... ++|+||+.+++|..+..+++
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nk--ee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~I 168 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFI 168 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCH--HHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHH
Confidence 34556678899999999999999999999999999876433 3346677777777665 48999999999999999999
Q ss_pred EEeecCCCchHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH-CCCEeecCCCCceEEcCCCCeEEeecccccccccccc
Q 037702 88 AMEYVRGGELFNKVA--KGKLREEVARKYFQQLVDAVEFCHS-RGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQ 164 (448)
Q Consensus 88 V~E~~~gg~L~~~i~--~~~l~e~~~~~~~~qll~aL~yLH~-~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~ 164 (448)
.||.|.. -+..++. +++++|..+-++...+++||.||.. +||+|||+||+|||+|+.|++||||||++...-...
T Consensus 169 cMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk- 246 (391)
T KOG0983|consen 169 CMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK- 246 (391)
T ss_pred HHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeeccc-
Confidence 9999843 3333333 3789999999999999999999986 599999999999999999999999999997543322
Q ss_pred CCCccccCCCCcccchhhhhc---cCCCCCcchHHHHHHHHHHHHhCCCCCCCCcH-HHHHHHHhhccCCC-CC--CCCH
Q 037702 165 DGLLHTTCGTPAYVAPEVINK---RGYDGAKADIWSCGVVLFVLLAGNLPFYDSNL-MELYKKITRAEFKC-PN--WFPP 237 (448)
Q Consensus 165 ~~~~~~~~Gt~~Y~APEvl~~---~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~~~~~~-p~--~~s~ 237 (448)
......|-+.|||||-+.- ..|+ ..+||||||++|+||.||..||.+.+. -++..++...+.+. |. .+|+
T Consensus 247 --AhtrsAGC~~YMaPERidp~~~~kYD-iRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp 323 (391)
T KOG0983|consen 247 --AHTRSAGCAAYMAPERIDPPDKPKYD-IRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSP 323 (391)
T ss_pred --ccccccCCccccCccccCCCCCCccc-hhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCH
Confidence 1234579999999999853 3455 789999999999999999999998554 47777787766543 22 3899
Q ss_pred HHHHHHHhccCCCcCCCCCHHHHHhhhhccc
Q 037702 238 EVRKLLSRILDPNPSTRVTMAKLMENYWFRK 268 (448)
Q Consensus 238 ~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 268 (448)
++.+|+..||.+|+.+||...++|+|||+..
T Consensus 324 ~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ 354 (391)
T KOG0983|consen 324 DFQSFVKDCLTKDHRKRPKYNKLLEHPFIKR 354 (391)
T ss_pred HHHHHHHHHhhcCcccCcchHHHhcCcceee
Confidence 9999999999999999999999999999865
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=320.55 Aligned_cols=250 Identities=24% Similarity=0.417 Sum_probs=206.3
Q ss_pred eEEEeeeeecCceEEEEEEECC---CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----
Q 037702 12 YELGRLLGQGTFAKVYHGRNLK---TGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKT----- 83 (448)
Q Consensus 12 y~~~~~LG~G~fg~Vy~a~~~~---~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~----- 83 (448)
|++.++||+|+||.||+|.+.. ++..||||++..+... ....+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFS-SSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCC-hHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 6788999999999999998643 5789999999655333 234577889999999999999999999876432
Q ss_pred -EEEEEEeecCCCchHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccc
Q 037702 84 -KIYFAMEYVRGGELFNKVAK-------GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGL 155 (448)
Q Consensus 84 -~~~lV~E~~~gg~L~~~i~~-------~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGl 155 (448)
..++++||+.+|+|.+++.. ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence 34789999999999887642 2478899999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhc-cCCCCC
Q 037702 156 SALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EFKCPN 233 (448)
Q Consensus 156 a~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~ 233 (448)
+................+++.|++||.+....++ .++|||||||++|+|++ |.+||.+.+..+.+..+... ....+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYT-THSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPP 238 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhcCccc-hhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCC
Confidence 8854322111112233466789999998776664 78999999999999999 99999888777777766554 345566
Q ss_pred CCCHHHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 234 WFPPEVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 234 ~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
.+++.+.+++.+||..+|++|||+.++++.
T Consensus 239 ~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 239 DCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=320.94 Aligned_cols=251 Identities=25% Similarity=0.414 Sum_probs=200.0
Q ss_pred cCCeEEEeeeeecCceEEEEEE----ECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe--C
Q 037702 9 MNKYELGRLLGQGTFAKVYHGR----NLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMAS--K 82 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~----~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~ 82 (448)
..+|++.+.||+|+||.||.|. +..++..||+|.+.... ....+.+.+|+.+++.++||||+++++++.. .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 79 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 79 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence 3579999999999999999997 34578899999986543 2334678899999999999999999998643 4
Q ss_pred CEEEEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccc
Q 037702 83 TKIYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQE 160 (448)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~ 160 (448)
..+++||||+++|+|.+++.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 568999999999999999865 468999999999999999999999999999999999999999999999999998653
Q ss_pred ccccCC-CccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHH----------------HHHHH
Q 037702 161 STRQDG-LLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLM----------------ELYKK 223 (448)
Q Consensus 161 ~~~~~~-~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~----------------~~~~~ 223 (448)
...... ......++..|+|||++.+..+ +.++|||||||++|+|++|..|+...... .+...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL 238 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCc-ChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence 322111 1111234556999999976655 48899999999999999988776433211 01111
Q ss_pred Hhh-ccCCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 224 ITR-AEFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 224 i~~-~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
+.. ..++.+..++.++.+||.+||..+|++|||+.++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 279 (284)
T cd05081 239 LKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQ 279 (284)
T ss_pred HhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 111 1223455688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=316.50 Aligned_cols=249 Identities=29% Similarity=0.584 Sum_probs=209.6
Q ss_pred CeEEEeeeeecCceEEEEEEECC-CCcEEEEEEeecccc-------cchhHHHHHHHHHHHHHh-CCCCCcceEEEEEEe
Q 037702 11 KYELGRLLGQGTFAKVYHGRNLK-TGQSVAIKIVDKEKI-------RRVGLIDQIKREISVMRL-VRHPNIVQLYEVMAS 81 (448)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~-~g~~vAiK~i~~~~~-------~~~~~~~~~~~Ei~~l~~-l~hpnIv~l~~~~~~ 81 (448)
.|++.+.||+|+||.||+|.+.. +++.+|+|.+..... ........+.+|+.++.. ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48899999999999999999987 688999999864321 122334567788888865 799999999999999
Q ss_pred CCEEEEEEeecCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCCEeecCCCCceEEcCCCCeEEeeccc
Q 037702 82 KTKIYFAMEYVRGGELFNKVAK-----GKLREEVARKYFQQLVDAVEFCHS-RGVYHRDLKPENLLLDENGDLKISDFGL 155 (448)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~aL~yLH~-~givHrDLkp~NILl~~~g~lkl~DFGl 155 (448)
++..+++|||++|++|.+++.. ..+++..++.++.|++.||.|||+ .|++||||+|+|||++.++.++|+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999888732 468999999999999999999996 7899999999999999999999999999
Q ss_pred cccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCC-CC-C
Q 037702 156 SALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFK-CP-N 233 (448)
Q Consensus 156 a~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-~p-~ 233 (448)
+....... ......|+..|+|||.+.+..+ +.++|+||||+++|+|++|+.||...+.......+...... .+ .
T Consensus 161 ~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
T cd08528 161 AKQKQPES---KLTSVVGTILYSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEG 236 (269)
T ss_pred eeeccccc---ccccccCcccCcChhhhcCCCC-chHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcc
Confidence 97643322 2345678999999999976555 58899999999999999999999887776666666555433 22 2
Q ss_pred CCCHHHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 234 WFPPEVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 234 ~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
.+++++.++|.+||..||++||++.|+.++
T Consensus 237 ~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 237 MYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred cCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 578999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=315.66 Aligned_cols=235 Identities=23% Similarity=0.315 Sum_probs=193.0
Q ss_pred eeeeecCceEEEEEEECCCC----------cEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 037702 16 RLLGQGTFAKVYHGRNLKTG----------QSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKI 85 (448)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g----------~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 85 (448)
+.||+|+||.||+|.+..++ ..+++|++...... ...+.+|+.+++.++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD----SLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh----HHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 46899999999999998776 35788876544211 4678899999999999999999999887 778
Q ss_pred EEEEeecCCCchHHHHhc-C-CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCC-------CeEEeecccc
Q 037702 86 YFAMEYVRGGELFNKVAK-G-KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENG-------DLKISDFGLS 156 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~-~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g-------~lkl~DFGla 156 (448)
++||||+++|+|.+++.. + .+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 999999999999999975 3 689999999999999999999999999999999999999888 7999999998
Q ss_pred ccccccccCCCccccCCCCcccchhhhhcc-CCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhccCCCCCC
Q 037702 157 ALQESTRQDGLLHTTCGTPAYVAPEVINKR-GYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAEFKCPNW 234 (448)
Q Consensus 157 ~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~-~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~ 234 (448)
..... .....++..|+|||++... ...+.++|||||||++|+|++ |..||...+..+...... .....|..
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~ 228 (259)
T cd05037 156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQHRLPMP 228 (259)
T ss_pred ccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cCCCCCCC
Confidence 75432 1234578899999998765 244688999999999999999 688887765433332222 22222332
Q ss_pred CCHHHHHHHHhccCCCcCCCCCHHHHHh
Q 037702 235 FPPEVRKLLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 235 ~s~~~~~li~~~L~~dP~~Rpt~~eil~ 262 (448)
....+.++|.+||..||.+|||+.++++
T Consensus 229 ~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 229 DCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred CchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 3489999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=320.64 Aligned_cols=261 Identities=28% Similarity=0.460 Sum_probs=211.3
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCc----EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe-C
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQ----SVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMAS-K 82 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~----~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~-~ 82 (448)
....|++...||+|+||.||+|....++. .+|||.+.-++-. .+......||+.+++.++||||+.+..++.+ +
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~-tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDG-TGISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCC-CCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 34579999999999999999997665543 6899998755322 1333567799999999999999999999877 8
Q ss_pred CEEEEEEeecCCCchHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCC----CCeEEee
Q 037702 83 TKIYFAMEYVRGGELFNKVAK------GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDEN----GDLKISD 152 (448)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~------~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~----g~lkl~D 152 (448)
..+++++||++. +|...|.. ..++...++.++.||++|+.|||++-|+||||||.|||+..+ |.+||+|
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeec
Confidence 899999999987 88888753 358999999999999999999999999999999999999988 8999999
Q ss_pred ccccccccccccCC-CccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcH---------HHHHH
Q 037702 153 FGLSALQESTRQDG-LLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNL---------MELYK 222 (448)
Q Consensus 153 FGla~~~~~~~~~~-~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~---------~~~~~ 222 (448)
||+++++...-..- .....+-|.+|+|||.+.+...++.+.||||.|||+.||++-++-|.+... .+...
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 99999876543322 334567899999999999988888999999999999999999888865321 12222
Q ss_pred HHhhc-------cC----CCCCC--------------------------CCHHHHHHHHhccCCCcCCCCCHHHHHhhhh
Q 037702 223 KITRA-------EF----KCPNW--------------------------FPPEVRKLLSRILDPNPSTRVTMAKLMENYW 265 (448)
Q Consensus 223 ~i~~~-------~~----~~p~~--------------------------~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 265 (448)
+|.+- .+ ..|.+ -++.+.+|+.++|..||.+|+|+++.|+|+|
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y 339 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY 339 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence 33211 00 11111 2566899999999999999999999999999
Q ss_pred ccccc
Q 037702 266 FRKGY 270 (448)
Q Consensus 266 ~~~~~ 270 (448)
|+...
T Consensus 340 F~~d~ 344 (438)
T KOG0666|consen 340 FTEDP 344 (438)
T ss_pred cccCC
Confidence 98763
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=319.71 Aligned_cols=254 Identities=17% Similarity=0.224 Sum_probs=193.0
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCC---CcEEEEEEeecccccc--hhH------HHHHHHHHHHHHhCCCCCcce
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKT---GQSVAIKIVDKEKIRR--VGL------IDQIKREISVMRLVRHPNIVQ 74 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~--~~~------~~~~~~Ei~~l~~l~hpnIv~ 74 (448)
.+..++|++.+.||+|+||.||+|.+..+ +..+|+|+........ +.. ......+...+..++|+||++
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 87 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK 87 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence 35567999999999999999999998877 6678888654332110 000 011223344556678999999
Q ss_pred EEEEEEeCC----EEEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeE
Q 037702 75 LYEVMASKT----KIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLK 149 (448)
Q Consensus 75 l~~~~~~~~----~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lk 149 (448)
+++++.... ..+++||++.. ++.+.+.. ...++..++.++.|++.||+|||++||+||||||+|||++.++.++
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~ 166 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGY 166 (294)
T ss_pred EEEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEE
Confidence 999765543 45788888744 56666654 3578899999999999999999999999999999999999999999
Q ss_pred Eeecccccccccccc-----CCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcH-H-----
Q 037702 150 ISDFGLSALQESTRQ-----DGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNL-M----- 218 (448)
Q Consensus 150 l~DFGla~~~~~~~~-----~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~-~----- 218 (448)
|+|||+|+....... ........||+.|+|||++.+..+ +.++|||||||++|+|++|.+||.+.+. .
T Consensus 167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~-~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~ 245 (294)
T PHA02882 167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACV-TRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA 245 (294)
T ss_pred EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCC-CcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence 999999976532211 111233479999999999987766 5899999999999999999999987632 1
Q ss_pred ---HHHHHHhhccCCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHh
Q 037702 219 ---ELYKKITRAEFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 219 ---~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 262 (448)
+....+....... +..++.+.+++..|+..+|++||+++++++
T Consensus 246 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 246 AKCDFIKRLHEGKIKI-KNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred hHHHHHHHhhhhhhcc-CCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 2233344443333 346899999999999999999999999986
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=329.59 Aligned_cols=248 Identities=31% Similarity=0.488 Sum_probs=197.2
Q ss_pred cCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-EEEE
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKT-KIYF 87 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~-~~~l 87 (448)
.++|.-.+.||+|+||.||+|.- .+|..||||.+....... ...+.+|+.++.+++|||+|+++|+|.+.+ ..+|
T Consensus 74 T~~Fs~~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~L 149 (361)
T KOG1187|consen 74 TNNFSESNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLL 149 (361)
T ss_pred HhCCchhcceecCCCeEEEEEEE-CCCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEE
Confidence 46788889999999999999985 455899999887654331 245999999999999999999999999998 5999
Q ss_pred EEeecCCCchHHHHhc--C-CCCHHHHHHHHHHHHHHHHHHHHCC---CEeecCCCCceEEcCCCCeEEeeccccccccc
Q 037702 88 AMEYVRGGELFNKVAK--G-KLREEVARKYFQQLVDAVEFCHSRG---VYHRDLKPENLLLDENGDLKISDFGLSALQES 161 (448)
Q Consensus 88 V~E~~~gg~L~~~i~~--~-~l~e~~~~~~~~qll~aL~yLH~~g---ivHrDLkp~NILl~~~g~lkl~DFGla~~~~~ 161 (448)
|+||+++|+|.+.+.. + .+++....+|+.++|.||+|||+.. |+||||||+|||||++.+.||+|||+|.....
T Consensus 150 VYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~ 229 (361)
T KOG1187|consen 150 VYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPE 229 (361)
T ss_pred EEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCc
Confidence 9999999999999965 3 7899999999999999999999854 99999999999999999999999999975433
Q ss_pred cccCCCcccc-CCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCc------HHHHHH-HHhhcc-----
Q 037702 162 TRQDGLLHTT-CGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSN------LMELYK-KITRAE----- 228 (448)
Q Consensus 162 ~~~~~~~~~~-~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~------~~~~~~-~i~~~~----- 228 (448)
. .....+. .||.+|+|||.+.. +..+.++|||||||+|.||++|+.|.+... ..+... .+..+.
T Consensus 230 ~--~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eii 306 (361)
T KOG1187|consen 230 G--DTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIV 306 (361)
T ss_pred c--ccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhhee
Confidence 1 1222233 89999999999865 455689999999999999999998877432 122111 111111
Q ss_pred -CCCC-CCCC--HH---HHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 229 -FKCP-NWFP--PE---VRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 229 -~~~p-~~~s--~~---~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
.... ...+ .+ +..+..+|++.+|..||++.++++.
T Consensus 307 D~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~ 348 (361)
T KOG1187|consen 307 DPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKE 348 (361)
T ss_pred CCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHH
Confidence 1111 1223 23 4567789999999999999998653
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=318.42 Aligned_cols=251 Identities=25% Similarity=0.390 Sum_probs=204.3
Q ss_pred cCCeEEEeeeeecCceEEEEEEEC----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe--C
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNL----KTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMAS--K 82 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~----~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~ 82 (448)
...|++.+.||+|+||.||+|.+. .+++.||||.+...... ...+.+.+|+.+++.++||||+++++++.. .
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~ 80 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG 80 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence 357889999999999999999864 34889999999765432 345778999999999999999999999877 6
Q ss_pred CEEEEEEeecCCCchHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccc
Q 037702 83 TKIYFAMEYVRGGELFNKVAKG--KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQE 160 (448)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~~--~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~ 160 (448)
...++||||+++++|.+++... .+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++....
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 6899999999999999999764 49999999999999999999999999999999999999999999999999998654
Q ss_pred ccccC-CCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHH---------------HHHHH
Q 037702 161 STRQD-GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLME---------------LYKKI 224 (448)
Q Consensus 161 ~~~~~-~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~---------------~~~~i 224 (448)
..... .......++..|+|||.+....+ +.++|||||||++|+|++|..||....... ....+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKF-SSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL 239 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCC-CcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence 22111 11112345667999999876655 478999999999999999999986542211 11122
Q ss_pred hhc-cCCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHh
Q 037702 225 TRA-EFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 225 ~~~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 262 (448)
... ....+..++.++.+++.+||..||.+|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 240 KEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 211 23445567899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=314.86 Aligned_cols=244 Identities=17% Similarity=0.278 Sum_probs=192.9
Q ss_pred eeeeecCceEEEEEEECCC--CcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecC
Q 037702 16 RLLGQGTFAKVYHGRNLKT--GQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVR 93 (448)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~--g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 93 (448)
+.||+|+||.||+|....+ ...+++|.+..... ....+.+.+|+.+++.++||||+++++.+......|+||||++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS--SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE 78 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC--hHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence 3699999999999975433 23566777654432 2234678899999999999999999999999999999999999
Q ss_pred CCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCc
Q 037702 94 GGELFNKVAK-----GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLL 168 (448)
Q Consensus 94 gg~L~~~i~~-----~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 168 (448)
+|+|.+++.. ..+++..++.++.||+.||+|||++|++||||||+|||++.++.++|+|||++............
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 9999999864 23567788899999999999999999999999999999999999999999998632211111112
Q ss_pred cccCCCCcccchhhhhccC------CCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhcc------CCCCCCC
Q 037702 169 HTTCGTPAYVAPEVINKRG------YDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAE------FKCPNWF 235 (448)
Q Consensus 169 ~~~~Gt~~Y~APEvl~~~~------~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~------~~~p~~~ 235 (448)
...+|++.|+|||++.... ..+.++|||||||++|+|++ |..||...+..+.+..+.... ...+..+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPY 238 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCC
Confidence 3457899999999985321 12468999999999999996 678998777666666554332 1223447
Q ss_pred CHHHHHHHHhccCCCcCCCCCHHHHHh
Q 037702 236 PPEVRKLLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 236 s~~~~~li~~~L~~dP~~Rpt~~eil~ 262 (448)
++.+.+++..|| .+|.+||+++++++
T Consensus 239 ~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 239 SERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred cHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 889999999999 67999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=354.75 Aligned_cols=249 Identities=25% Similarity=0.450 Sum_probs=212.8
Q ss_pred cCCeEEEeeeeecCceEEEEEEECCC-Cc----EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNLKT-GQ----SVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKT 83 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~-g~----~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~ 83 (448)
-..-++.+.||+|+||.||.|..... |. .||||.+.+. .+.+....+.+|..+|+.++|||||++++++.+..
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 45678899999999999999987653 32 3888887644 44566788999999999999999999999999999
Q ss_pred EEEEEEeecCCCchHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccc
Q 037702 84 KIYFAMEYVRGGELFNKVAKG--------KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGL 155 (448)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~~--------~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGl 155 (448)
..+|++|||+||+|..+|++. .++......++.|+++|+.||+++++|||||...|+||+....+||+|||+
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccch
Confidence 999999999999999999763 388899999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCcccc--CCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHH-HhhccCCC
Q 037702 156 SALQESTRQDGLLHTT--CGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKK-ITRAEFKC 231 (448)
Q Consensus 156 a~~~~~~~~~~~~~~~--~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~-i~~~~~~~ 231 (448)
|+-+-.. +...... .-...|||||.+....+ +.|+|||||||+|||+++ |..||.+.+..++... ...+.+..
T Consensus 849 ArDiy~~--~yyr~~~~a~lPvkWm~PEsl~d~iF-tskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~ 925 (1025)
T KOG1095|consen 849 ARDIYDK--DYYRKHGEAMLPVKWMPPESLKDGIF-TSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDP 925 (1025)
T ss_pred hHhhhhc--hheeccCccccceecCCHHHHhhccc-ccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCC
Confidence 9832211 1111111 22357999999987555 589999999999999998 9999999888887774 44557788
Q ss_pred CCCCCHHHHHHHHhccCCCcCCCCCHHHHHh
Q 037702 232 PNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 232 p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 262 (448)
|..+|..+.+++.+||..+|++||++..|++
T Consensus 926 P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 926 PSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred CCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 9999999999999999999999999999997
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=338.91 Aligned_cols=242 Identities=33% Similarity=0.552 Sum_probs=198.0
Q ss_pred cCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKT----- 83 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~----- 83 (448)
.+-|...+.||+||||.||+++++.||+.||||.+++.... ...+...+|+++|++++|||||+++++-++..
T Consensus 12 ~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~--r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~ 89 (732)
T KOG4250|consen 12 NYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSL--RPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVT 89 (732)
T ss_pred CcceeehhhhcCCccceeeeecccccccchhHHhhhhhccc--chHHHHHHHHHHHHHcCchhhhhhcccCCccccCccc
Confidence 46788999999999999999999999999999999876533 33577889999999999999999999866544
Q ss_pred -EEEEEEeecCCCchHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcC--CC--CeEEeecc
Q 037702 84 -KIYFAMEYVRGGELFNKVAK----GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDE--NG--DLKISDFG 154 (448)
Q Consensus 84 -~~~lV~E~~~gg~L~~~i~~----~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~--~g--~lkl~DFG 154 (448)
...+|||||.||+|+..+++ .+++|.+.+.++..+..||.|||++||+||||||.||++.. +| .-||+|||
T Consensus 90 ~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 90 RLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred ccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 46799999999999999975 47999999999999999999999999999999999999853 34 37999999
Q ss_pred ccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCC-----cHHHHHHHHhhc--
Q 037702 155 LSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDS-----NLMELYKKITRA-- 227 (448)
Q Consensus 155 la~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~-----~~~~~~~~i~~~-- 227 (448)
.|+..+. +....+..||+.|.+||+....++++..+|.|||||++|+.+||..||... +..-++..+.+.
T Consensus 170 ~Arel~d---~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~ 246 (732)
T KOG4250|consen 170 AARELDD---NSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPS 246 (732)
T ss_pred ccccCCC---CCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCC
Confidence 9986543 335677899999999999986667789999999999999999999999532 122233322211
Q ss_pred ------------------cCCCCCCCCHH----HHHHHHhccCCCcCCCC
Q 037702 228 ------------------EFKCPNWFPPE----VRKLLSRILDPNPSTRV 255 (448)
Q Consensus 228 ------------------~~~~p~~~s~~----~~~li~~~L~~dP~~Rp 255 (448)
.++.|..+++. +...+..+|..||.+|.
T Consensus 247 ~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 247 GVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred ceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 23344445544 34567788899999998
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=338.98 Aligned_cols=255 Identities=31% Similarity=0.545 Sum_probs=224.0
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEe-----
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEVMAS----- 81 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~----- 81 (448)
..+.|++.+++|.|.+|+||+++++.+|+..|+|+.+...-. .+.+..|.++++.+ .|||++.+++++.-
T Consensus 17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~----deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~ 92 (953)
T KOG0587|consen 17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE----EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGN 92 (953)
T ss_pred CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc----cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence 457899999999999999999999999999999998765422 35677889999887 69999999999853
Q ss_pred CCEEEEEEeecCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccc
Q 037702 82 KTKIYFAMEYVRGGELFNKVAK---GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSAL 158 (448)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~ 158 (448)
++.+|||||||.||+..|+++. +++.|+.+..+++.++.|+.+||.+.++|||||-.|||++.+|.+||+|||.++.
T Consensus 93 ~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQ 172 (953)
T KOG0587|consen 93 GDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 172 (953)
T ss_pred CCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeee
Confidence 5789999999999999999975 5799999999999999999999999999999999999999999999999999987
Q ss_pred ccccccCCCccccCCCCcccchhhhhcc-----CCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccC---C
Q 037702 159 QESTRQDGLLHTTCGTPAYVAPEVINKR-----GYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF---K 230 (448)
Q Consensus 159 ~~~~~~~~~~~~~~Gt~~Y~APEvl~~~-----~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---~ 230 (448)
...+. +...|..|||.|||||++... .|+ ..+|+||||++..||..|.+|+.+...+..+-+|.+... .
T Consensus 173 ldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd-~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLk 249 (953)
T KOG0587|consen 173 LDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYD-YRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLK 249 (953)
T ss_pred eeccc--ccccCcCCCcccccceeeecccCCCCCcc-cccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCcccc
Confidence 65443 334688999999999999643 343 679999999999999999999999998877777766543 2
Q ss_pred CCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 231 CPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 231 ~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
.|...+.++.+||..||.+|-.+||+..++++|||++.+
T Consensus 250 rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~ 288 (953)
T KOG0587|consen 250 RPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ 288 (953)
T ss_pred chhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence 356678999999999999999999999999999999843
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=309.51 Aligned_cols=264 Identities=24% Similarity=0.420 Sum_probs=215.2
Q ss_pred cccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe---
Q 037702 5 AGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMAS--- 81 (448)
Q Consensus 5 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--- 81 (448)
.-...+.|+-...+|+|.||+||+|+...+|+.||+|++-.+... ++.-....+|+.+|..++|+|++.++++|..
T Consensus 12 ~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneK-eGfpitalreikiL~~lkHenv~nliEic~tk~T 90 (376)
T KOG0669|consen 12 FCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKAT 90 (376)
T ss_pred ceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccc-cCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccC
Confidence 345677899999999999999999999999999999877544322 2344556789999999999999999988743
Q ss_pred -----CCEEEEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecc
Q 037702 82 -----KTKIYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFG 154 (448)
Q Consensus 82 -----~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFG 154 (448)
...+|+|+.+|+. +|+-++.. -+++..++.++++++++||.|+|++.|+|||+||+|+||+.+|.+||+|||
T Consensus 91 p~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 91 PTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred CcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccc
Confidence 3458999999976 88888865 479999999999999999999999999999999999999999999999999
Q ss_pred cccccccccc--CCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhh--ccC-
Q 037702 155 LSALQESTRQ--DGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITR--AEF- 229 (448)
Q Consensus 155 la~~~~~~~~--~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~--~~~- 229 (448)
+++.+..... .......+-|.+|.+||.+.+...++.+.|||..|||+.||.+|.+-|.+.........|.. +.+
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t 249 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT 249 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence 9975543321 12234556799999999999888788999999999999999999998887665444433321 110
Q ss_pred -------------------CCCC-------------CCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccccc
Q 037702 230 -------------------KCPN-------------WFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGY 270 (448)
Q Consensus 230 -------------------~~p~-------------~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 270 (448)
+.|. .-.+++.+|+.++|..||.+|+++++++.|.||.+..
T Consensus 250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp 322 (376)
T KOG0669|consen 250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDP 322 (376)
T ss_pred cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCC
Confidence 0111 1246889999999999999999999999999997653
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=319.53 Aligned_cols=253 Identities=29% Similarity=0.485 Sum_probs=207.6
Q ss_pred cccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCC--C----CcceEEEE
Q 037702 5 AGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRH--P----NIVQLYEV 78 (448)
Q Consensus 5 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~h--p----nIv~l~~~ 78 (448)
+..+.++|.+..+||+|+||+|-.+.+..++..||||++..- . ...+..+-|+++|+++.+ | -++++.++
T Consensus 84 gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V--~--kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~w 159 (415)
T KOG0671|consen 84 GDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV--D--KYREAALIEIEVLQKINESDPNGKFRCVQMRDW 159 (415)
T ss_pred ccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH--H--HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehh
Confidence 346789999999999999999999999999999999998532 1 234667789999999942 3 37888899
Q ss_pred EEeCCEEEEEEeecCCCchHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcC-----------
Q 037702 79 MASKTKIYFAMEYVRGGELFNKVAKG---KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDE----------- 144 (448)
Q Consensus 79 ~~~~~~~~lV~E~~~gg~L~~~i~~~---~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~----------- 144 (448)
|+-.++++||+|.+ |.++++++..+ +++.+.++.+.+||+++++|||+.+++|-||||||||+-+
T Consensus 160 FdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~ 238 (415)
T KOG0671|consen 160 FDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKK 238 (415)
T ss_pred hhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCC
Confidence 99999999999998 66999999873 6999999999999999999999999999999999999842
Q ss_pred ---------CCCeEEeeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 037702 145 ---------NGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDS 215 (448)
Q Consensus 145 ---------~g~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~ 215 (448)
+-.++|+|||.|+.... ...+.+.|..|.|||++.+-|+. .++||||+||||+|+.+|...|+..
T Consensus 239 ~~~~~r~~ks~~I~vIDFGsAtf~~e-----~hs~iVsTRHYRAPEViLgLGwS-~pCDvWSiGCIL~ElytG~~LFqtH 312 (415)
T KOG0671|consen 239 KVCFIRPLKSTAIKVIDFGSATFDHE-----HHSTIVSTRHYRAPEVILGLGWS-QPCDVWSIGCILVELYTGETLFQTH 312 (415)
T ss_pred ccceeccCCCcceEEEecCCcceecc-----CcceeeeccccCCchheeccCcC-CccCceeeeeEEEEeeccceecccC
Confidence 33589999999985322 12566789999999999999996 8899999999999999999999865
Q ss_pred cHHH---HHHHHhh------------------ccCCCCCCC-------------------------CHHHHHHHHhccCC
Q 037702 216 NLME---LYKKITR------------------AEFKCPNWF-------------------------PPEVRKLLSRILDP 249 (448)
Q Consensus 216 ~~~~---~~~~i~~------------------~~~~~p~~~-------------------------s~~~~~li~~~L~~ 249 (448)
+..+ +.+.|.. +.+.+|... -.++-+||++||..
T Consensus 313 en~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~f 392 (415)
T KOG0671|consen 313 ENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEF 392 (415)
T ss_pred CcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHcc
Confidence 4332 4444322 111111110 13578999999999
Q ss_pred CcCCCCCHHHHHhhhhccc
Q 037702 250 NPSTRVTMAKLMENYWFRK 268 (448)
Q Consensus 250 dP~~Rpt~~eil~hp~~~~ 268 (448)
||.+|+|+.|+|.||||..
T Consensus 393 DP~~RiTl~EAL~HpFF~~ 411 (415)
T KOG0671|consen 393 DPARRITLREALSHPFFAR 411 (415)
T ss_pred CccccccHHHHhcCHHhhc
Confidence 9999999999999999975
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=339.55 Aligned_cols=256 Identities=19% Similarity=0.310 Sum_probs=180.9
Q ss_pred cccccCCeEEEeeeeecCceEEEEEEECCC----CcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEE--
Q 037702 5 AGILMNKYELGRLLGQGTFAKVYHGRNLKT----GQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEV-- 78 (448)
Q Consensus 5 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~----g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~-- 78 (448)
.....++|++.+.||+|+||.||+|.+..+ +..||+|.+...... +....| .++...+.++..+...
T Consensus 127 ~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-----e~~~~e--~l~~~~~~~~~~~~~~~~ 199 (566)
T PLN03225 127 PSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-----EIWMNE--RVRRACPNSCADFVYGFL 199 (566)
T ss_pred CCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-----HHHHHH--HHHhhchhhHHHHHHhhh
Confidence 345678999999999999999999999988 999999987643211 111111 1222222333222211
Q ss_pred ----EEeCCEEEEEEeecCCCchHHHHhcCCC---------------------CHHHHHHHHHHHHHHHHHHHHCCCEee
Q 037702 79 ----MASKTKIYFAMEYVRGGELFNKVAKGKL---------------------REEVARKYFQQLVDAVEFCHSRGVYHR 133 (448)
Q Consensus 79 ----~~~~~~~~lV~E~~~gg~L~~~i~~~~l---------------------~e~~~~~~~~qll~aL~yLH~~givHr 133 (448)
......+++||||+.+++|.+++....+ .+..+..++.||+.||.|||++||+||
T Consensus 200 ~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHR 279 (566)
T PLN03225 200 EPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHR 279 (566)
T ss_pred cccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeC
Confidence 2456789999999999999998865322 134467899999999999999999999
Q ss_pred cCCCCceEEcC-CCCeEEeeccccccccccccCCCccccCCCCcccchhhhhccCCC---------------------CC
Q 037702 134 DLKPENLLLDE-NGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYD---------------------GA 191 (448)
Q Consensus 134 DLkp~NILl~~-~g~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~---------------------~~ 191 (448)
||||+|||++. ++.+||+|||+|+...... .......+||+.|+|||++....+. ..
T Consensus 280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~ 358 (566)
T PLN03225 280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPD 358 (566)
T ss_pred cCCHHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCC
Confidence 99999999986 5899999999997543221 2233456899999999976432221 23
Q ss_pred cchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCC---------------------CCCCCCHHHHHHHHhccCCC
Q 037702 192 KADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFK---------------------CPNWFPPEVRKLLSRILDPN 250 (448)
Q Consensus 192 ~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------------~p~~~s~~~~~li~~~L~~d 250 (448)
++|||||||+||||+++..|+... .......+...... .....+....+||.+||+.|
T Consensus 359 k~DVwSlGviL~el~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d 437 (566)
T PLN03225 359 RFDIYSAGLIFLQMAFPNLRSDSN-LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFK 437 (566)
T ss_pred CcccHHHHHHHHHHHhCcCCCchH-HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCC
Confidence 569999999999999987765432 11222222111110 01112234568999999999
Q ss_pred cCCCCCHHHHHhhhhcccc
Q 037702 251 PSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 251 P~~Rpt~~eil~hp~~~~~ 269 (448)
|.+|||+.++|+||||+..
T Consensus 438 P~kR~ta~e~L~Hpff~~~ 456 (566)
T PLN03225 438 GRQRISAKAALAHPYFDRE 456 (566)
T ss_pred cccCCCHHHHhCCcCcCCC
Confidence 9999999999999999764
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=293.37 Aligned_cols=239 Identities=45% Similarity=0.828 Sum_probs=207.4
Q ss_pred CceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCCchHHHH
Q 037702 22 TFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKV 101 (448)
Q Consensus 22 ~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i 101 (448)
+||.||+|.+..+|+.+|+|++........ .+.+.+|+..+++++|+||+++++.+......+++|||+++++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 689999999988999999999976644321 478889999999999999999999999999999999999999999999
Q ss_pred hcC-CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCccccCCCCcccch
Q 037702 102 AKG-KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAP 180 (448)
Q Consensus 102 ~~~-~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~AP 180 (448)
... .+++..+..++.+++.++.|||+.|++|+||+|.||+++.++.++|+|||++....... ......|+..|+||
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~p 155 (244)
T smart00220 79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYMAP 155 (244)
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCCCH
Confidence 764 48999999999999999999999999999999999999999999999999998654322 23456789999999
Q ss_pred hhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCC-CcHHHHHHHHhhccCCCCCC---CCHHHHHHHHhccCCCcCCCCC
Q 037702 181 EVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYD-SNLMELYKKITRAEFKCPNW---FPPEVRKLLSRILDPNPSTRVT 256 (448)
Q Consensus 181 Evl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~p~~---~s~~~~~li~~~L~~dP~~Rpt 256 (448)
|.+....++ .++||||||+++|+|++|..||.. .+.......+.......+.. ++.++.+++.+||..||++||+
T Consensus 156 E~~~~~~~~-~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~ 234 (244)
T smart00220 156 EVLLGKGYG-KAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLT 234 (244)
T ss_pred HHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccC
Confidence 999766664 699999999999999999999987 55555665555554443322 8899999999999999999999
Q ss_pred HHHHHhhhhc
Q 037702 257 MAKLMENYWF 266 (448)
Q Consensus 257 ~~eil~hp~~ 266 (448)
+.++++||||
T Consensus 235 ~~~~~~~~~~ 244 (244)
T smart00220 235 AEEALQHPFF 244 (244)
T ss_pred HHHHhhCCCC
Confidence 9999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=318.39 Aligned_cols=245 Identities=28% Similarity=0.504 Sum_probs=207.3
Q ss_pred CeEEEeeeeecCceEEEEEEECCC--Cc--EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 037702 11 KYELGRLLGQGTFAKVYHGRNLKT--GQ--SVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIY 86 (448)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~--g~--~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 86 (448)
.-.+.+.||.|-||.||.|....- |+ .||||....+... +..+.+..|..+|+.++||||++++|++.+. .+|
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~--d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~W 466 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTP--DDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMW 466 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCCh--hhHHHHHHHHHHHHhCCCcchhheeeeeecc-cee
Confidence 344567899999999999987432 33 5899988765433 2358899999999999999999999999764 589
Q ss_pred EEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccccc
Q 037702 87 FAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQ 164 (448)
Q Consensus 87 lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~ 164 (448)
||||+++-|+|+.+++. ..++......|+.||..||.|||+..+|||||...|||+.....+||+||||++-.....
T Consensus 467 ivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~- 545 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA- 545 (974)
T ss_pred EEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccc-
Confidence 99999999999999976 468889999999999999999999999999999999999999999999999998654322
Q ss_pred CCCccccCC--CCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhc-cCCCCCCCCHHHH
Q 037702 165 DGLLHTTCG--TPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EFKCPNWFPPEVR 240 (448)
Q Consensus 165 ~~~~~~~~G--t~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 240 (448)
.++...| ..-|||||.++-..+. .++|||-|||++||++. |..||.+-...++.-.+.++ .+++|+.+|+.+.
T Consensus 546 --yYkaS~~kLPIKWmaPESINfRrFT-tASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LY 622 (974)
T KOG4257|consen 546 --YYKASRGKLPIKWMAPESINFRRFT-TASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALY 622 (974)
T ss_pred --hhhccccccceeecCccccchhccc-chhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHH
Confidence 2222233 4569999999877765 77999999999999886 99999997777776666665 4689999999999
Q ss_pred HHHHhccCCCcCCCCCHHHHHh
Q 037702 241 KLLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~eil~ 262 (448)
.|+.+||+.||.+||++.+|..
T Consensus 623 slmskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 623 SLMSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred HHHHHHhccCcccCCcHHHHHH
Confidence 9999999999999999988754
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=297.92 Aligned_cols=259 Identities=27% Similarity=0.455 Sum_probs=215.7
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC----
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASK---- 82 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~---- 82 (448)
....||.-.+.+|.|+- .|..|.|..++++||+|.+... ...........+|..++..++|+||++++.++.-.
T Consensus 14 tv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~ 91 (369)
T KOG0665|consen 14 TVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLE 91 (369)
T ss_pred eeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHH
Confidence 45568999999999999 8889999999999999998776 33334457788999999999999999999998643
Q ss_pred --CEEEEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccc
Q 037702 83 --TKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQE 160 (448)
Q Consensus 83 --~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~ 160 (448)
...|+|||++.. +|.+.+. ..++-..+..++.|++.|++|||+.||+||||||+||++..++.+||.|||+|...+
T Consensus 92 ~~~e~y~v~e~m~~-nl~~vi~-~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~ 169 (369)
T KOG0665|consen 92 EFQEVYLVMELMDA-NLCQVIL-MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTED 169 (369)
T ss_pred HHHhHHHHHHhhhh-HHHHHHH-HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccC
Confidence 358999999965 8887776 457888999999999999999999999999999999999999999999999997432
Q ss_pred ccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhcc------------
Q 037702 161 STRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAE------------ 228 (448)
Q Consensus 161 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~------------ 228 (448)
.+......+.|..|.|||++.+.+|. +.+||||+|||+.||++|...|.+.+..+.+.++...-
T Consensus 170 ---~~~~mtpyVvtRyyrapevil~~~~k-e~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~ 245 (369)
T KOG0665|consen 170 ---TDFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQ 245 (369)
T ss_pred ---cccccCchhheeeccCchheeccCCc-ccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhh
Confidence 22345667899999999999999965 88999999999999999999999887666666553210
Q ss_pred ---------------CC----CCCC-----------CCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccccccc
Q 037702 229 ---------------FK----CPNW-----------FPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYKKI 273 (448)
Q Consensus 229 ---------------~~----~p~~-----------~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~ 273 (448)
+. +|.+ -+..+++++.+||..||++|.+++++|+|||++-.+...
T Consensus 246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~~~ 320 (369)
T KOG0665|consen 246 PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYDPD 320 (369)
T ss_pred HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeecccc
Confidence 01 1111 135689999999999999999999999999998554433
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=320.28 Aligned_cols=258 Identities=26% Similarity=0.462 Sum_probs=221.6
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECC-CCc--EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLK-TGQ--SVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKT 83 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~-~g~--~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~ 83 (448)
+-.++..+.+.||+|.||.|++|.|.. +|+ .||||.+....... ....|.+|+.+|-+|+|||+++||++..+ .
T Consensus 107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-q 183 (1039)
T KOG0199|consen 107 IPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-Q 183 (1039)
T ss_pred ccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-c
Confidence 344567788999999999999999876 344 58999997665442 56889999999999999999999999987 6
Q ss_pred EEEEEEeecCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccc
Q 037702 84 KIYFAMEYVRGGELFNKVAK---GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQE 160 (448)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~ 160 (448)
.+.||||+++.|+|.+.+++ +.|.......|+.||+.|+.||.++++|||||...||||-....+||+||||.+-+.
T Consensus 184 p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg 263 (1039)
T KOG0199|consen 184 PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALG 263 (1039)
T ss_pred hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccC
Confidence 78899999999999999976 468889999999999999999999999999999999999999999999999998765
Q ss_pred ccccCCC-ccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhcc-CCCCCCCCH
Q 037702 161 STRQDGL-LHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAE-FKCPNWFPP 237 (448)
Q Consensus 161 ~~~~~~~-~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~ 237 (448)
....... .....-...|+|||.+....+. .++|||++||++|||++ |+.||.+.+..+++++|..++ +..|+.+|.
T Consensus 264 ~ned~Yvm~p~rkvPfAWCaPEsLrh~kFS-haSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~cse 342 (1039)
T KOG0199|consen 264 ENEDMYVMAPQRKVPFAWCAPESLRHRKFS-HASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSE 342 (1039)
T ss_pred CCCcceEecCCCcCcccccCHhHhcccccc-ccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChH
Confidence 5433221 1122345679999999887775 78999999999999998 899999999999999987654 578999999
Q ss_pred HHHHHHHhccCCCcCCCCCHHHHHhhhhccc
Q 037702 238 EVRKLLSRILDPNPSTRVTMAKLMENYWFRK 268 (448)
Q Consensus 238 ~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 268 (448)
++.+++.+||..+|.+|||+..|.+.-+...
T Consensus 343 dIY~imk~cWah~paDRptFsair~~~~l~e 373 (1039)
T KOG0199|consen 343 DIYQIMKNCWAHNPADRPTFSAIREDLVLAE 373 (1039)
T ss_pred HHHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence 9999999999999999999999986655433
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=316.39 Aligned_cols=262 Identities=19% Similarity=0.304 Sum_probs=190.2
Q ss_pred cccCCeEEEeeeeecCceEEEEEEEC----------------CCCcEEEEEEeecccccch-----------hHHHHHHH
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNL----------------KTGQSVAIKIVDKEKIRRV-----------GLIDQIKR 59 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~----------------~~g~~vAiK~i~~~~~~~~-----------~~~~~~~~ 59 (448)
...++|++.+.||+|+||.||+|.+. ..+..||||.+........ ...+....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 45779999999999999999999753 2356799999864321100 01122335
Q ss_pred HHHHHHhCCCCCc-----ceEEEEEEe--------CCEEEEEEeecCCCchHHHHhc--C--------------------
Q 037702 60 EISVMRLVRHPNI-----VQLYEVMAS--------KTKIYFAMEYVRGGELFNKVAK--G-------------------- 104 (448)
Q Consensus 60 Ei~~l~~l~hpnI-----v~l~~~~~~--------~~~~~lV~E~~~gg~L~~~i~~--~-------------------- 104 (448)
|+.++.+++|.++ +++++++.. ....|+||||+++++|.+++.. +
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 7777777776654 566666643 3568999999999999888753 1
Q ss_pred ---CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCccccCCCCcccchh
Q 037702 105 ---KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPE 181 (448)
Q Consensus 105 ---~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE 181 (448)
.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++........ .......+|+.|+|||
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSPPE 380 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeChh
Confidence 234567889999999999999999999999999999999999999999999865332111 1111234589999999
Q ss_pred hhhccC--------------------CC-CCcchHHHHHHHHHHHHhCCC-CCCCCc-----------HHHHHHHHhhcc
Q 037702 182 VINKRG--------------------YD-GAKADIWSCGVVLFVLLAGNL-PFYDSN-----------LMELYKKITRAE 228 (448)
Q Consensus 182 vl~~~~--------------------~~-~~~sDiwSlGvil~elltG~~-Pf~~~~-----------~~~~~~~i~~~~ 228 (448)
++.... |. ..+.||||+||++|+|++|.+ ||.+.. ....++.+....
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~ 460 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK 460 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence 985322 11 124799999999999999986 775421 112222233333
Q ss_pred CCCC--CCCCHHHHHHHHhccCCCc---CCCCCHHHHHhhhhcccc
Q 037702 229 FKCP--NWFPPEVRKLLSRILDPNP---STRVTMAKLMENYWFRKG 269 (448)
Q Consensus 229 ~~~p--~~~s~~~~~li~~~L~~dP---~~Rpt~~eil~hp~~~~~ 269 (448)
+.++ ...++.+++|+.+||..+| .+|+|++|+|+||||...
T Consensus 461 ~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~~ 506 (507)
T PLN03224 461 YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLPE 506 (507)
T ss_pred CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCCC
Confidence 3333 3478999999999999766 789999999999999653
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=308.08 Aligned_cols=263 Identities=29% Similarity=0.472 Sum_probs=216.0
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccc----hhHHHHHHHHHHHHHhCCCCCcceEEEEEE-
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRR----VGLIDQIKREISVMRLVRHPNIVQLYEVMA- 80 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~----~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~- 80 (448)
..+.++|-++.+||+|+|++||+|.+......||||+-...+.++ +.......+|..|.+.|+||.||++|+++.
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL 538 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence 356789999999999999999999999999999999976554432 234566789999999999999999999986
Q ss_pred eCCEEEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC--CCEeecCCCCceEEc---CCCCeEEeecc
Q 037702 81 SKTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSR--GVYHRDLKPENLLLD---ENGDLKISDFG 154 (448)
Q Consensus 81 ~~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~--givHrDLkp~NILl~---~~g~lkl~DFG 154 (448)
+.+.+|-|+|||+|.+|.-++.. .-++|.+++.++.||+.||.||... .|||-||||.||||- .-|.+||.|||
T Consensus 539 DtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 539 DTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred ccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 55678899999999999888876 4589999999999999999999976 599999999999994 34789999999
Q ss_pred ccccccccccC-----CCccccCCCCcccchhhhhc---cCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHH-HHH--HH
Q 037702 155 LSALQESTRQD-----GLLHTTCGTPAYVAPEVINK---RGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLM-ELY--KK 223 (448)
Q Consensus 155 la~~~~~~~~~-----~~~~~~~Gt~~Y~APEvl~~---~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~-~~~--~~ 223 (448)
|+...+....+ .+.....||.+|++||.+.- ...-+.++||||.|||+|..+.|+.||...... +++ ..
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNT 698 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENT 698 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhc
Confidence 99987643322 23345679999999998742 223367899999999999999999999764322 222 22
Q ss_pred Hhh-ccCCCC--CCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccc
Q 037702 224 ITR-AEFKCP--NWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRK 268 (448)
Q Consensus 224 i~~-~~~~~p--~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 268 (448)
|.+ .+..+| +.+++++++||++||+.--+.|....++..||+|..
T Consensus 699 IlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 699 ILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred hhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 332 234444 568999999999999999999999999999999864
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=292.60 Aligned_cols=252 Identities=25% Similarity=0.441 Sum_probs=204.2
Q ss_pred CeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHH-HHhCCCCCcceEEEEEEeCCEEEEEE
Q 037702 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISV-MRLVRHPNIVQLYEVMASKTKIYFAM 89 (448)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~-l~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (448)
+.+-...||.|+||.|++-.++.+|+..|||.|...... ....++..|... ++.-+.||||++|+.+..++..||.|
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~--keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCM 142 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIE--KEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICM 142 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccch--HHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeH
Confidence 344456799999999999999999999999999876553 234667777766 45558999999999999999999999
Q ss_pred eecCCCchHH---HH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCCEeecCCCCceEEcCCCCeEEeecccccccccc
Q 037702 90 EYVRGGELFN---KV---AKGKLREEVARKYFQQLVDAVEFCHS-RGVYHRDLKPENLLLDENGDLKISDFGLSALQEST 162 (448)
Q Consensus 90 E~~~gg~L~~---~i---~~~~l~e~~~~~~~~qll~aL~yLH~-~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~ 162 (448)
|+|+- +|.. ++ .+..++|...-.+.--.+.||.||.. ..|+|||+||+|||||..|.+||||||++......
T Consensus 143 ELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S 221 (361)
T KOG1006|consen 143 ELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS 221 (361)
T ss_pred HHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHH
Confidence 99954 4422 22 23679999999999999999999975 58999999999999999999999999998744321
Q ss_pred ccCCCccccCCCCcccchhhhhc--cCCCCCcchHHHHHHHHHHHHhCCCCCCCC-cHHHHHHHHhhccCCC---CC---
Q 037702 163 RQDGLLHTTCGTPAYVAPEVINK--RGYDGAKADIWSCGVVLFVLLAGNLPFYDS-NLMELYKKITRAEFKC---PN--- 233 (448)
Q Consensus 163 ~~~~~~~~~~Gt~~Y~APEvl~~--~~~~~~~sDiwSlGvil~elltG~~Pf~~~-~~~~~~~~i~~~~~~~---p~--- 233 (448)
- ......|-.+|||||-+.. .||+ .+|||||||++|||+.||..||..- +..+....+..+.++. +.
T Consensus 222 i---AkT~daGCrpYmAPERi~p~~~gyD-iRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~ 297 (361)
T KOG1006|consen 222 I---AKTVDAGCRPYMAPERIDPSDKGYD-IRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECV 297 (361)
T ss_pred H---HhhhccCCccccChhccCCccCCcc-hhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCccccc
Confidence 1 1123468899999999853 4566 8899999999999999999999764 3445555566665542 22
Q ss_pred CCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 234 WFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 234 ~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
.++..+..+|..||.+|-+.||...+++++||++..
T Consensus 298 ~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y 333 (361)
T KOG1006|consen 298 HYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY 333 (361)
T ss_pred ccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence 278999999999999999999999999999998754
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=282.37 Aligned_cols=251 Identities=25% Similarity=0.510 Sum_probs=204.1
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeC--CE
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR-HPNIVQLYEVMASK--TK 84 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~--~~ 84 (448)
..++|++.+.+|+|.+++||.|.+..+++.++||++..- . ...++||+.+|+.|. ||||++++++..+. ..
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV--k----kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV--K----KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH--H----HHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 457899999999999999999999999999999998532 2 367999999999996 99999999998654 45
Q ss_pred EEEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCC-CCeEEeeccccccccccc
Q 037702 85 IYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDEN-GDLKISDFGLSALQESTR 163 (448)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~-g~lkl~DFGla~~~~~~~ 163 (448)
..+++||+++.+...+.. .++.-.++.|+.||+.||+||||+||+|||+||.|+++|.. ..++|+|+|||.+.....
T Consensus 110 paLiFE~v~n~Dfk~ly~--tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~ 187 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLYP--TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
T ss_pred chhHhhhhccccHHHHhh--hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCc
Confidence 679999999877655543 37888999999999999999999999999999999999965 569999999998764332
Q ss_pred cCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCC-CcHHHHHHHHh-------------hccC
Q 037702 164 QDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYD-SNLMELYKKIT-------------RAEF 229 (448)
Q Consensus 164 ~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~-~~~~~~~~~i~-------------~~~~ 229 (448)
.....+.+..|--||.+-.-..+...-|+|||||+|..|+..+.||.. .+..+..-+|. +-..
T Consensus 188 ---eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i 264 (338)
T KOG0668|consen 188 ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQI 264 (338)
T ss_pred ---eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHcc
Confidence 234567888999999997766556889999999999999999999853 22222222221 1111
Q ss_pred CCC-------------C-----------CCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 230 KCP-------------N-----------WFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 230 ~~p-------------~-----------~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
..+ + ..++++.+|+.++|..|-.+|+|+.|++.||||..-
T Consensus 265 ~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~ 328 (338)
T KOG0668|consen 265 DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV 328 (338)
T ss_pred CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence 111 1 146999999999999999999999999999999653
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=307.41 Aligned_cols=251 Identities=21% Similarity=0.329 Sum_probs=207.8
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYF 87 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 87 (448)
.-.+..+++.||+|-||+|.+|.- ..+..||+|.+...... .....+.+||++|.+|+||||++++++|..++.+++
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~--~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicm 612 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDATK--NARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCM 612 (807)
T ss_pred chhheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccch--hHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHH
Confidence 345678899999999999999984 44689999999766443 335789999999999999999999999999999999
Q ss_pred EEeecCCCchHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccccc
Q 037702 88 AMEYVRGGELFNKVAKGKL---REEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQ 164 (448)
Q Consensus 88 V~E~~~gg~L~~~i~~~~l---~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~ 164 (448)
++||++.|+|.+++.+... .......++.||++|++||.+.++|||||.+.|+|+|.++++||+|||+++-.-....
T Consensus 613 I~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 613 ITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred HHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCc
Confidence 9999999999999987532 3455677999999999999999999999999999999999999999999984332221
Q ss_pred CCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHH--hCCCCCCCCcHHHHHHHHhh---c-----cCCCCCC
Q 037702 165 DGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLL--AGNLPFYDSNLMELYKKITR---A-----EFKCPNW 234 (448)
Q Consensus 165 ~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ell--tG~~Pf~~~~~~~~~~~i~~---~-----~~~~p~~ 234 (448)
....-..+-...|||||.+....+. .++|+|++|++|||++ +...||.+...++....... . -+..|.-
T Consensus 693 y~vqgr~vlpiRwmawEsillgkFt-taSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~ 771 (807)
T KOG1094|consen 693 YRVQGRAVLPIRWMAWESILLGKFT-TASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPA 771 (807)
T ss_pred eeeecceeeeeeehhHHHHHhcccc-chhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCc
Confidence 1111123446789999998776664 7899999999999976 58899988777666554322 1 2356778
Q ss_pred CCHHHHHHHHhccCCCcCCCCCHHHHHh
Q 037702 235 FPPEVRKLLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 235 ~s~~~~~li~~~L~~dP~~Rpt~~eil~ 262 (448)
++..+.+++-+||..|-++||+++++-.
T Consensus 772 cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 772 CPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred CcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 9999999999999999999999999855
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=308.05 Aligned_cols=246 Identities=26% Similarity=0.474 Sum_probs=211.7
Q ss_pred CeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 037702 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAME 90 (448)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (448)
+......||-|-||.||.|.|++-.-.||||.+..+.. .++.+..|..+|+.++|||+|+++++|..+..+|||+|
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM----eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTE 343 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITE 343 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcch----hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEe
Confidence 34566789999999999999999888999999864432 35788999999999999999999999999999999999
Q ss_pred ecCCCchHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCC
Q 037702 91 YVRGGELFNKVAKG---KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGL 167 (448)
Q Consensus 91 ~~~gg~L~~~i~~~---~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 167 (448)
||..|+|.+++++. .++.-....++.||.+|++||..+++|||||...|.|+.++..+|++||||+++.....-..
T Consensus 344 fM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTA- 422 (1157)
T KOG4278|consen 344 FMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTA- 422 (1157)
T ss_pred cccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCceec-
Confidence 99999999999862 46677778899999999999999999999999999999999999999999999764321100
Q ss_pred ccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhc-cCCCCCCCCHHHHHHHHh
Q 037702 168 LHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EFKCPNWFPPEVRKLLSR 245 (448)
Q Consensus 168 ~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~ 245 (448)
.....-..-|.|||.+....+ +.|+|||+|||+|||+.| |-.||.+.+..++|..+.++ .+.-|+.+++.+.+|++.
T Consensus 423 HAGAKFPIKWTAPEsLAyNtF-SiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVYeLMra 501 (1157)
T KOG4278|consen 423 HAGAKFPIKWTAPESLAYNTF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYELMRA 501 (1157)
T ss_pred ccCccCcccccCccccccccc-ccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHHHHHHHH
Confidence 001112457999999976665 489999999999999998 89999999999999887765 457799999999999999
Q ss_pred ccCCCcCCCCCHHHHHh
Q 037702 246 ILDPNPSTRVTMAKLME 262 (448)
Q Consensus 246 ~L~~dP~~Rpt~~eil~ 262 (448)
||+++|..||+++||-+
T Consensus 502 CW~WsPsDRPsFaeiHq 518 (1157)
T KOG4278|consen 502 CWNWSPSDRPSFAEIHQ 518 (1157)
T ss_pred HhcCCcccCccHHHHHH
Confidence 99999999999999843
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=319.00 Aligned_cols=253 Identities=25% Similarity=0.432 Sum_probs=219.6
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCc---EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQ---SVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKT 83 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~---~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~ 83 (448)
+-...-.|-++||.|.||+||.|+-+..|+ .||||.+.... .+.....|..|+.||-+++||||++|-++.....
T Consensus 626 Id~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~ 703 (996)
T KOG0196|consen 626 IDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSK 703 (996)
T ss_pred cChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCc
Confidence 334556788999999999999999877664 59999986543 2344577999999999999999999999999999
Q ss_pred EEEEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccc
Q 037702 84 KIYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQES 161 (448)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~ 161 (448)
.+.||+|||++|+|..+++. |+|+..+...+++.|+.|+.||-+.|+|||||...|||++.+-.+|++||||+++...
T Consensus 704 PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 704 PVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred eeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeeccc
Confidence 99999999999999999976 7899999999999999999999999999999999999999999999999999997754
Q ss_pred cccCCCccccCC--CCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhc-cCCCCCCCCH
Q 037702 162 TRQDGLLHTTCG--TPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EFKCPNWFPP 237 (448)
Q Consensus 162 ~~~~~~~~~~~G--t~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~ 237 (448)
.. +....+.-| ...|.|||.+....+. ..|||||+||+|||.++ |+.||.+.+..++.+.|..+ .++.|-.+|.
T Consensus 784 d~-~~~ytt~GGKIPiRWTAPEAIa~RKFT-sASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~ 861 (996)
T KOG0196|consen 784 DP-EAAYTTLGGKIPIRWTAPEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPA 861 (996)
T ss_pred CC-CccccccCCccceeecChhHhhhcccC-chhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcH
Confidence 43 222333333 3679999999887775 77999999999999886 99999999988988888766 3466678999
Q ss_pred HHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 238 EVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 238 ~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
.+.+|+..||++|-..||.+++|+.+
T Consensus 862 aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 862 ALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred HHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 99999999999999999999999874
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=310.21 Aligned_cols=254 Identities=27% Similarity=0.482 Sum_probs=212.7
Q ss_pred cccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCC------CCcceEEEE
Q 037702 5 AGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRH------PNIVQLYEV 78 (448)
Q Consensus 5 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~h------pnIv~l~~~ 78 (448)
+.++.++|.+....|+|-|+.|..|.+...|..||||+|....+ +...=.+|+.+|+.|+. -|+++++..
T Consensus 427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~----M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~ 502 (752)
T KOG0670|consen 427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV----MHKTGLKELEILKKLNDADPEDKFHCLRLFRH 502 (752)
T ss_pred hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH----HhhhhhHHHHHHHHhhccCchhhhHHHHHHHH
Confidence 56788999999999999999999999999999999999976543 23445689999999953 489999999
Q ss_pred EEeCCEEEEEEeecCCCchHHHHhc-C---CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCC-CeEEeec
Q 037702 79 MASKTKIYFAMEYVRGGELFNKVAK-G---KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENG-DLKISDF 153 (448)
Q Consensus 79 ~~~~~~~~lV~E~~~gg~L~~~i~~-~---~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g-~lkl~DF 153 (448)
|...+++|||+|-+. .+|.+.+.+ | +|....++.|++||+-||..|...||+|.||||.|||++++. .+|||||
T Consensus 503 F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDf 581 (752)
T KOG0670|consen 503 FKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDF 581 (752)
T ss_pred hhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccC
Confidence 999999999999884 489999976 4 488899999999999999999999999999999999999765 5899999
Q ss_pred cccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCC
Q 037702 154 GLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPN 233 (448)
Q Consensus 154 Gla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~ 233 (448)
|.|....... ...+.-+..|.|||++.+..|+ ...|+||.||+||||.||+.-|++....++++.......++|.
T Consensus 582 GSA~~~~ene----itPYLVSRFYRaPEIiLG~~yd-~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~ 656 (752)
T KOG0670|consen 582 GSASFASENE----ITPYLVSRFYRAPEIILGLPYD-YPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPN 656 (752)
T ss_pred cccccccccc----ccHHHHHHhccCcceeecCccc-CCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcH
Confidence 9997654322 2334566789999999999997 7799999999999999999999998766665543222222211
Q ss_pred C-----------------------------------------------------CC-------HHHHHHHHhccCCCcCC
Q 037702 234 W-----------------------------------------------------FP-------PEVRKLLSRILDPNPST 253 (448)
Q Consensus 234 ~-----------------------------------------------------~s-------~~~~~li~~~L~~dP~~ 253 (448)
. ++ ..+++|+.+||..||.+
T Consensus 657 KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~K 736 (752)
T KOG0670|consen 657 KMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEK 736 (752)
T ss_pred HHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhh
Confidence 0 11 45889999999999999
Q ss_pred CCCHHHHHhhhhccc
Q 037702 254 RVTMAKLMENYWFRK 268 (448)
Q Consensus 254 Rpt~~eil~hp~~~~ 268 (448)
|.|..++|+||||+.
T Consensus 737 Rit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 737 RITVNQALKHPFITE 751 (752)
T ss_pred cCCHHHHhcCCcccC
Confidence 999999999999964
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=339.28 Aligned_cols=237 Identities=24% Similarity=0.362 Sum_probs=187.8
Q ss_pred CCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 037702 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAM 89 (448)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (448)
..|...+.||+|+||.||+|++..+|..||||.+...... ..+|+..+++++||||+++++++.+....|+||
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~ 762 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH 762 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence 4566678899999999999999899999999998643211 124688999999999999999999999999999
Q ss_pred eecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCC
Q 037702 90 EYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCH---SRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDG 166 (448)
Q Consensus 90 E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH---~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 166 (448)
||+++|+|.+++.. +++..+..++.|++.||+||| +.+|+||||||+||+++.++..++. ||.+.....
T Consensus 763 Ey~~~g~L~~~l~~--l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~----- 834 (968)
T PLN00113 763 EYIEGKNLSEVLRN--LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT----- 834 (968)
T ss_pred eCCCCCcHHHHHhc--CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc-----
Confidence 99999999999964 889999999999999999999 6799999999999999999888875 665543211
Q ss_pred CccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCc-----HHHHHHHHhhc-------cCCC---
Q 037702 167 LLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSN-----LMELYKKITRA-------EFKC--- 231 (448)
Q Consensus 167 ~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~-----~~~~~~~i~~~-------~~~~--- 231 (448)
..+..||+.|+|||++.+..|. .++|||||||++|||++|+.||.... ..+..+..... +...
T Consensus 835 -~~~~~~t~~y~aPE~~~~~~~~-~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (968)
T PLN00113 835 -DTKCFISSAYVAPETRETKDIT-EKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGD 912 (968)
T ss_pred -CCCccccccccCcccccCCCCC-cccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCC
Confidence 1234689999999999876664 88999999999999999999985421 11111111000 0001
Q ss_pred ---CCCCCHHHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 232 ---PNWFPPEVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 232 ---p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
+.....++.+++.+||+.||.+|||++++++.
T Consensus 913 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 913 VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 00112356789999999999999999999874
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=312.42 Aligned_cols=257 Identities=32% Similarity=0.538 Sum_probs=226.2
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIY 86 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 86 (448)
...++|++...+|.|+||.||+|+++.+++..|+|++..+.-.+ ..-+..||-+++.++||||+.+++.+...+..+
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd---~~~iqqei~~~~dc~h~nivay~gsylr~dklw 88 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD---FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLW 88 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc---ccccccceeeeecCCCcChHHHHhhhhhhcCcE
Confidence 35678999999999999999999999999999999998775443 355778999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccC
Q 037702 87 FAMEYVRGGELFNKVA-KGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQD 165 (448)
Q Consensus 87 lV~E~~~gg~L~~~i~-~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~ 165 (448)
+.||||.||+|.+... .|.++|.++....+..+.|+.|||+.|-+|||||-.|||++..|.+|++|||.+..+...-
T Consensus 89 icMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati-- 166 (829)
T KOG0576|consen 89 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI-- 166 (829)
T ss_pred EEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhh--
Confidence 9999999999998765 4899999999999999999999999999999999999999999999999999987654322
Q ss_pred CCccccCCCCcccchhhhh---ccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCC-----CCCH
Q 037702 166 GLLHTTCGTPAYVAPEVIN---KRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPN-----WFPP 237 (448)
Q Consensus 166 ~~~~~~~Gt~~Y~APEvl~---~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~-----~~s~ 237 (448)
.......|||+|||||+.. ..+|. ..+|||++|+...|+---.+|..+...+.......+..++.|. ..++
T Consensus 167 ~KrksfiGtpywmapEvaaverkggyn-qlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~ 245 (829)
T KOG0576|consen 167 AKRKSFIGTPYWMAPEVAAVERKGGYN-QLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSE 245 (829)
T ss_pred hhhhcccCCccccchhHHHHHhccccc-ccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchH
Confidence 2234678999999999863 44564 8899999999999999889998888888777777777766553 3678
Q ss_pred HHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 238 EVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 238 ~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
-+.+|++.+|.+||++|||++.+|.|||....
T Consensus 246 ~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 246 FFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred HHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 99999999999999999999999999998654
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=301.74 Aligned_cols=203 Identities=30% Similarity=0.558 Sum_probs=182.0
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhH-----HHHHHHHHHHHHhCC---CCCcceEEEEE
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGL-----IDQIKREISVMRLVR---HPNIVQLYEVM 79 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~-----~~~~~~Ei~~l~~l~---hpnIv~l~~~~ 79 (448)
...+|...+.||.|+||+|++|.++.+...|+||.|.|+++.-... .-.+-.||+||..++ |+||++++++|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 3457999999999999999999999999999999999887643222 234668999999997 99999999999
Q ss_pred EeCCEEEEEEeec-CCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccc
Q 037702 80 ASKTKIYFAMEYV-RGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSA 157 (448)
Q Consensus 80 ~~~~~~~lV~E~~-~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~ 157 (448)
++++.+||+||-- +|.+||++|+. .+++|.++..+|+|++.|+++||++||+|||||-||+.++.+|.+||+|||.|.
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa 718 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAA 718 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchh
Confidence 9999999999965 56699999986 579999999999999999999999999999999999999999999999999987
Q ss_pred cccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 037702 158 LQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYD 214 (448)
Q Consensus 158 ~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~ 214 (448)
.. ..+...+..||..|.|||++.+..|-|.+-|||+||++||.++...-||+.
T Consensus 719 ~~----ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 719 YT----KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hh----cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 53 334567889999999999999999999999999999999999998888864
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=311.71 Aligned_cols=243 Identities=28% Similarity=0.477 Sum_probs=195.0
Q ss_pred EeeeeecCceE-EEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeec
Q 037702 15 GRLLGQGTFAK-VYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEVMASKTKIYFAMEYV 92 (448)
Q Consensus 15 ~~~LG~G~fg~-Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E~~ 92 (448)
-+.+|.|+.|+ ||+|.. .|+.||||.+-.+ ..+.+.+||..|+.- +|||||++|+.-.+....||..|.|
T Consensus 514 ~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVY--EGREVAVKRLLEE------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred HHHcccCCCCcEEEEEee--CCceehHHHHhhH------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 45689999986 899987 7889999987543 335678999999988 6999999999999999999999999
Q ss_pred CCCchHHHHhcC-C---C-CHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcC---CC--CeEEeecccccccccc
Q 037702 93 RGGELFNKVAKG-K---L-REEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDE---NG--DLKISDFGLSALQEST 162 (448)
Q Consensus 93 ~gg~L~~~i~~~-~---l-~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~---~g--~lkl~DFGla~~~~~~ 162 (448)
.. +|.++++.. . . .....+..+.|+++||++||+.+||||||||.||||+. ++ .++|+|||+++.....
T Consensus 586 ~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~ 664 (903)
T KOG1027|consen 586 AC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG 664 (903)
T ss_pred hh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence 65 999999762 1 1 11445888999999999999999999999999999986 34 6899999999876544
Q ss_pred ccC-CCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhC-CCCCCCCcHHHHHHHHhhccCCCCCC---CCH
Q 037702 163 RQD-GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAG-NLPFYDSNLMELYKKITRAEFKCPNW---FPP 237 (448)
Q Consensus 163 ~~~-~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG-~~Pf~~~~~~~~~~~i~~~~~~~p~~---~s~ 237 (448)
... ....+..||-+|+|||++...... .++|||||||++|+.++| ..||.+.-.. ...|..+.+..-.. -..
T Consensus 665 ~sS~~r~s~~sGt~GW~APE~L~~~~~~-~avDiFslGCvfyYvltgG~HpFGd~~~R--~~NIl~~~~~L~~L~~~~d~ 741 (903)
T KOG1027|consen 665 KSSFSRLSGGSGTSGWQAPEQLREDRKT-QAVDIFSLGCVFYYVLTGGSHPFGDSLER--QANILTGNYTLVHLEPLPDC 741 (903)
T ss_pred cchhhcccCCCCcccccCHHHHhccccC-cccchhhcCceEEEEecCCccCCCchHHh--hhhhhcCccceeeeccCchH
Confidence 332 234566799999999999776554 679999999999998885 9999765432 23455554432211 112
Q ss_pred HHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 238 EVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 238 ~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
++.+||.+||+++|..||++.++|.||+|=..
T Consensus 742 eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ 773 (903)
T KOG1027|consen 742 EAKDLISRMLNPDPQLRPSATDVLNHPLFWDS 773 (903)
T ss_pred HHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence 89999999999999999999999999999543
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=280.04 Aligned_cols=256 Identities=24% Similarity=0.450 Sum_probs=208.4
Q ss_pred CCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----E
Q 037702 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKT-----K 84 (448)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~-----~ 84 (448)
.+.+-.+.||-|+||.||.+.+..+|+.||+|.+..- +.+-...+.+.+|+.+|..++|.|++..+++..-.. .
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv-fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqE 131 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV-FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQE 131 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCccchhHhhcchH-HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHH
Confidence 3456678999999999999999999999999988532 222233467889999999999999999998875432 4
Q ss_pred EEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccc
Q 037702 85 IYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTR 163 (448)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~ 163 (448)
+|+++|++.. +|...|.. ..++.+.++-+++||+.||.|||+.||.||||||.|+|++.|..+||||||+++..+..
T Consensus 132 iYV~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d- 209 (449)
T KOG0664|consen 132 LYVLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQR- 209 (449)
T ss_pred HHHHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchh-
Confidence 7888998854 78777765 67999999999999999999999999999999999999999999999999999975433
Q ss_pred cCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhh-----------------
Q 037702 164 QDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITR----------------- 226 (448)
Q Consensus 164 ~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~----------------- 226 (448)
....+...+-|-+|.|||++.+...++...||||.|||+.||+..+..|...+..+....|..
T Consensus 210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGA 289 (449)
T KOG0664|consen 210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGA 289 (449)
T ss_pred hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhh
Confidence 223344556789999999999888778889999999999999999999988776555444321
Q ss_pred ------ccCCCCC-----------CCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccc
Q 037702 227 ------AEFKCPN-----------WFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRK 268 (448)
Q Consensus 227 ------~~~~~p~-----------~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 268 (448)
+..+-|. .-..+...++.++|.+||++|++.++.+.|++...
T Consensus 290 k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e 348 (449)
T KOG0664|consen 290 KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEE 348 (449)
T ss_pred HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccc
Confidence 1122221 12356788999999999999999999999998754
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=306.74 Aligned_cols=252 Identities=26% Similarity=0.474 Sum_probs=210.5
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECC---C----CcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLK---T----GQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEV 78 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~---~----g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~ 78 (448)
+..++..+.+.||+|+||.|++|.-.. . ...||||.+...... ...+.+..|+.+|+.+ .||||+.+.++
T Consensus 293 ~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 293 IPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred echhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 344455778899999999999997321 1 346999988655433 4458899999999999 69999999999
Q ss_pred EEeCCEEEEEEeecCCCchHHHHhcCC-----------------CCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceE
Q 037702 79 MASKTKIYFAMEYVRGGELFNKVAKGK-----------------LREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLL 141 (448)
Q Consensus 79 ~~~~~~~~lV~E~~~gg~L~~~i~~~~-----------------l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NIL 141 (448)
+..+..+++|+||+..|+|.++++..+ ++......++.||+.|++||++.+++||||-..|||
T Consensus 371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVL 450 (609)
T KOG0200|consen 371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVL 450 (609)
T ss_pred eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEE
Confidence 999999999999999999999998766 889999999999999999999999999999999999
Q ss_pred EcCCCCeEEeeccccccccccccCCCccccCCCC--cccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCc-H
Q 037702 142 LDENGDLKISDFGLSALQESTRQDGLLHTTCGTP--AYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSN-L 217 (448)
Q Consensus 142 l~~~g~lkl~DFGla~~~~~~~~~~~~~~~~Gt~--~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~-~ 217 (448)
+..+..+||+|||+|+........ ......|+. .|||||.+....| +.++||||+||+|||+++ |..||.+.. .
T Consensus 451 i~~~~~~kIaDFGlar~~~~~~~y-~~~~~~~~LP~kWmApEsl~~~~f-t~kSDVWSfGI~L~EifsLG~~PYp~~~~~ 528 (609)
T KOG0200|consen 451 ITKNKVIKIADFGLARDHYNKDYY-RTKSSAGTLPVKWMAPESLFDRVF-TSKSDVWSFGILLWEIFTLGGTPYPGIPPT 528 (609)
T ss_pred ecCCCEEEEccccceeccCCCCce-EecCCCCccceeecCHHHhccCcc-cccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence 999999999999999843322111 112223333 4999999988555 589999999999999998 999999855 5
Q ss_pred HHHHHHHhhcc-CCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHh
Q 037702 218 MELYKKITRAE-FKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 218 ~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 262 (448)
.+++..+..+. ...|..+++++.++++.||+.+|++||++.++.+
T Consensus 529 ~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 529 EELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 66777676664 4789999999999999999999999999999986
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=299.61 Aligned_cols=247 Identities=23% Similarity=0.375 Sum_probs=213.2
Q ss_pred eEEEeeeeecCceEEEEEEECCCCc----EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 037702 12 YELGRLLGQGTFAKVYHGRNLKTGQ----SVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYF 87 (448)
Q Consensus 12 y~~~~~LG~G~fg~Vy~a~~~~~g~----~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 87 (448)
.+..++||.|+||+||+|.+...|+ +||||++...... .....+.+|+-+|..++|||++++++++.... +-|
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~--~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql 774 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSP--KASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL 774 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCc--hhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence 3456789999999999999987776 5799988765433 23467889999999999999999999998766 889
Q ss_pred EEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccC
Q 037702 88 AMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQD 165 (448)
Q Consensus 88 V~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~ 165 (448)
|++|+++|.|.++++. +.+.......|..||++|+.|||.++++||||-..|||+.+-.++||.|||+|.........
T Consensus 775 vtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred HHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence 9999999999999975 67889999999999999999999999999999999999999999999999999987654443
Q ss_pred CCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhc-cCCCCCCCCHHHHHHH
Q 037702 166 GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EFKCPNWFPPEVRKLL 243 (448)
Q Consensus 166 ~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li 243 (448)
.......-.+.|||=|.+....|. .++||||+||++||++| |..|+.+....++-+.+..+ .++.|+.++-++..++
T Consensus 855 y~~~~gK~pikwmale~i~~~~~t-hqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~m 933 (1177)
T KOG1025|consen 855 YSAPGGKVPIKWMALESIRIRKYT-HQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVM 933 (1177)
T ss_pred ccccccccCcHHHHHHHhhccCCC-chhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHHH
Confidence 333333346779999999877775 88999999999999998 99999999888887777665 4688999999999999
Q ss_pred HhccCCCcCCCCCHHHHHh
Q 037702 244 SRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 244 ~~~L~~dP~~Rpt~~eil~ 262 (448)
.+||..|+..||+++++..
T Consensus 934 vkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 934 VKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHHhccCcccCccHHHHHH
Confidence 9999999999999998764
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=277.89 Aligned_cols=247 Identities=28% Similarity=0.523 Sum_probs=193.8
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHH--hCCCCCcceEEEEEEe----
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMR--LVRHPNIVQLYEVMAS---- 81 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~--~l~hpnIv~l~~~~~~---- 81 (448)
+...-.+.+.||+|.||+||+|.+ .|+.||||++.... .....||.++.+ .|+|+||+.+++.-..
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srd------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs 280 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRD------ERSWFRETEIYQTVMLRHENILGFIAADNKDNGS 280 (513)
T ss_pred hhheeEEEEEecCccccceeeccc--cCCceEEEEecccc------hhhhhhHHHHHHHHHhccchhhhhhhccccCCCc
Confidence 556788999999999999999999 79999999996432 144556776665 5699999999987532
Q ss_pred CCEEEEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CCEeecCCCCceEEcCCCCeEEeec
Q 037702 82 KTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSR--------GVYHRDLKPENLLLDENGDLKISDF 153 (448)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~--------givHrDLkp~NILl~~~g~lkl~DF 153 (448)
-+.+|||++|-+.|+|+|++.+..++.+...+++..+++||++||-. .|+|||||..|||+..+|.+.|+|+
T Consensus 281 ~TQLwLvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL 360 (513)
T KOG2052|consen 281 WTQLWLVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 360 (513)
T ss_pred eEEEEEeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence 35799999999999999999999999999999999999999999953 4999999999999999999999999
Q ss_pred ccccccccccc--CCCccccCCCCcccchhhhhccC----CCC-CcchHHHHHHHHHHHHhC----------CCCCCC--
Q 037702 154 GLSALQESTRQ--DGLLHTTCGTPAYVAPEVINKRG----YDG-AKADIWSCGVVLFVLLAG----------NLPFYD-- 214 (448)
Q Consensus 154 Gla~~~~~~~~--~~~~~~~~Gt~~Y~APEvl~~~~----~~~-~~sDiwSlGvil~elltG----------~~Pf~~-- 214 (448)
|||........ +-.....+||..|||||++...- +.+ ..+||||||.++||++.. .+||.+
T Consensus 361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V 440 (513)
T KOG2052|consen 361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV 440 (513)
T ss_pred eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence 99976544321 22345679999999999996421 111 358999999999998752 678864
Q ss_pred ---CcHHHHHHHH--hhccCCCCC-CCC----HHHHHHHHhccCCCcCCCCCHHHHHh
Q 037702 215 ---SNLMELYKKI--TRAEFKCPN-WFP----PEVRKLLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 215 ---~~~~~~~~~i--~~~~~~~p~-~~s----~~~~~li~~~L~~dP~~Rpt~~eil~ 262 (448)
++.+++.+-+ .+-.+..|+ |-+ ..+..+++.||..||.-|.|+-.|.+
T Consensus 441 p~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 441 PSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred CCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 3444444322 222334444 333 34567899999999999999877754
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=284.83 Aligned_cols=246 Identities=24% Similarity=0.371 Sum_probs=197.7
Q ss_pred cCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHH--hCCCCCcceEEEEEEeCC---
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMR--LVRHPNIVQLYEVMASKT--- 83 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~--~l~hpnIv~l~~~~~~~~--- 83 (448)
....++.+++|+|.||.||+|+- +++.||||++.... .+.+..|-+|.+ .++|+||++++++-...+
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~------kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~ 280 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQE------KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADR 280 (534)
T ss_pred CCchhhHHHhhcCccceeehhhc--cCceeEEEecCHHH------HHHHHhHHHHHhccCccchhHHHhhchhccCCccc
Confidence 34567788999999999999986 67999999996442 355666666665 458999999999866554
Q ss_pred -EEEEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---------CCEeecCCCCceEEcCCCCeEEeec
Q 037702 84 -KIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSR---------GVYHRDLKPENLLLDENGDLKISDF 153 (448)
Q Consensus 84 -~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~---------givHrDLkp~NILl~~~g~lkl~DF 153 (448)
.++||+||.+.|+|.+++..+.+++....+++..+++||+|||+- .|+|||||..||||.+++...|+||
T Consensus 281 ~eywLVt~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 281 MEYWLVTEFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred cceeEEeeeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 799999999999999999999999999999999999999999963 6999999999999999999999999
Q ss_pred cccccccccccCCCccccCCCCcccchhhhhccCCC-----CCcchHHHHHHHHHHHHhCC------------CCCC---
Q 037702 154 GLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYD-----GAKADIWSCGVVLFVLLAGN------------LPFY--- 213 (448)
Q Consensus 154 Gla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~-----~~~sDiwSlGvil~elltG~------------~Pf~--- 213 (448)
|||..+......+-....+||.+|||||++.+.-.- -.+.||||+|.+||||++.. +||.
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 999987766666666778999999999999653221 13589999999999998742 2333
Q ss_pred --CCcHHHHHHHHhhc--cCCCCCC-----CCHHHHHHHHhccCCCcCCCCCHHHHHh
Q 037702 214 --DSNLMELYKKITRA--EFKCPNW-----FPPEVRKLLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 214 --~~~~~~~~~~i~~~--~~~~p~~-----~s~~~~~li~~~L~~dP~~Rpt~~eil~ 262 (448)
.+...++...+.+. ++.+|.. -...+++.+..||+.||+.|.|+.=+.+
T Consensus 441 G~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~e 498 (534)
T KOG3653|consen 441 GNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEE 498 (534)
T ss_pred cCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHH
Confidence 23445555554433 3444432 2366889999999999999999876654
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=278.31 Aligned_cols=132 Identities=26% Similarity=0.485 Sum_probs=115.3
Q ss_pred cccc-CCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-----C---CCcceEE
Q 037702 6 GILM-NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR-----H---PNIVQLY 76 (448)
Q Consensus 6 ~~~~-~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-----h---pnIv~l~ 76 (448)
.++. +||.+.+.||.|-|++||+|.|..+...||+|++.... ...+....||.+|++++ | .+||+|+
T Consensus 73 D~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq----hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~Ll 148 (590)
T KOG1290|consen 73 DVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ----HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLL 148 (590)
T ss_pred ccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh----HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeee
Confidence 3444 89999999999999999999999999999999986543 34467789999999983 3 3799999
Q ss_pred EEEEe----CCEEEEEEeecCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH-CCCEeecCCCCceEE
Q 037702 77 EVMAS----KTKIYFAMEYVRGGELFNKVAK---GKLREEVARKYFQQLVDAVEFCHS-RGVYHRDLKPENLLL 142 (448)
Q Consensus 77 ~~~~~----~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~yLH~-~givHrDLkp~NILl 142 (448)
+.|.. +.+++||+|+. |.+|..+|.. ..++...++.|++|++.||+|||. .||||-||||+|||+
T Consensus 149 D~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 149 DHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred ccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence 99864 56899999999 6688888875 579999999999999999999996 599999999999998
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=250.26 Aligned_cols=212 Identities=45% Similarity=0.841 Sum_probs=186.6
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCCch
Q 037702 18 LGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGEL 97 (448)
Q Consensus 18 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 97 (448)
||+|++|.||++.+..+|+.+++|++....... ..+.+.+|+..++.++|++|+++++++......+++||+++|++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999998889999999997664321 346788999999999999999999999999999999999999999
Q ss_pred HHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcC-CCCeEEeeccccccccccccCCCccccCCC
Q 037702 98 FNKVAKG--KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDE-NGDLKISDFGLSALQESTRQDGLLHTTCGT 174 (448)
Q Consensus 98 ~~~i~~~--~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~-~g~lkl~DFGla~~~~~~~~~~~~~~~~Gt 174 (448)
.+++... .+++..++.++.+++.++.|||+.|++|+||+|.||+++. ++.++|+|||.+........ ......+.
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~ 156 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGT 156 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccCC
Confidence 9999774 7999999999999999999999999999999999999999 89999999999975433221 12345688
Q ss_pred CcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHHHHhccCCCcCCC
Q 037702 175 PAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILDPNPSTR 254 (448)
Q Consensus 175 ~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R 254 (448)
..|++||.+......+.++|+|++|+++++| ..+.+++.+|+..||.+|
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------~~~~~~l~~~l~~~p~~R 205 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------PELKDLIRKMLQKDPEKR 205 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------HHHHHHHHHHhhCCcccC
Confidence 8999999987652445889999999999999 678999999999999999
Q ss_pred CCHHHHHhhh
Q 037702 255 VTMAKLMENY 264 (448)
Q Consensus 255 pt~~eil~hp 264 (448)
|+++++++++
T Consensus 206 ~~~~~l~~~~ 215 (215)
T cd00180 206 PSAKEILEHL 215 (215)
T ss_pred cCHHHHhhCC
Confidence 9999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-32 Score=252.04 Aligned_cols=218 Identities=43% Similarity=0.723 Sum_probs=186.3
Q ss_pred eEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 037702 12 YELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAMEY 91 (448)
Q Consensus 12 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 91 (448)
|++.+.||.|++|.||++.+..+++.+|+|.+...... ...+.+.+|+..++.++|+|++++++.+......++++|+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 67899999999999999999888999999999866443 2457888999999999999999999999999999999999
Q ss_pred cCCCchHHHHhcC-C-CCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCcc
Q 037702 92 VRGGELFNKVAKG-K-LREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLH 169 (448)
Q Consensus 92 ~~gg~L~~~i~~~-~-l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~ 169 (448)
+++++|.+++... . +++..+..++.|++.++.|||++|++|+||+|.||+++.++.++|+|||++........ ....
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~~~ 157 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-ALLK 157 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-cccc
Confidence 9999999999763 4 89999999999999999999999999999999999999999999999999886543321 1224
Q ss_pred ccCCCCcccchhhh-hccCCCCCcchHHHHHHHHHHHHhCCCCCCC--CcHHHHHHHHhhccCCCCC
Q 037702 170 TTCGTPAYVAPEVI-NKRGYDGAKADIWSCGVVLFVLLAGNLPFYD--SNLMELYKKITRAEFKCPN 233 (448)
Q Consensus 170 ~~~Gt~~Y~APEvl-~~~~~~~~~sDiwSlGvil~elltG~~Pf~~--~~~~~~~~~i~~~~~~~p~ 233 (448)
...++..|++||.+ ....+. .++|+||||+++++|++|+.||.. .+...+.+.+..+.....+
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~-~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 223 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYG-EAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPLLWE 223 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCC-chhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCccccc
Confidence 45788999999998 444444 689999999999999999999987 4444777777776644433
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=249.23 Aligned_cols=212 Identities=27% Similarity=0.487 Sum_probs=171.7
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEE
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEVMASKTKIY 86 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~ 86 (448)
..+...-+..||+|++|.|-+-++..+|...|+|.+...-. + ....++.+|+++..+. .+|.+|.+|+.+.....+|
T Consensus 44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-~-q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvw 121 (282)
T KOG0984|consen 44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-S-QEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVW 121 (282)
T ss_pred chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC-h-HHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEE
Confidence 34455567789999999999999999999999999965432 2 3346777888886554 8999999999999999999
Q ss_pred EEEeecCCCchHHHH----hc-CCCCHHHHHHHHHHHHHHHHHHHHC-CCEeecCCCCceEEcCCCCeEEeecccccccc
Q 037702 87 FAMEYVRGGELFNKV----AK-GKLREEVARKYFQQLVDAVEFCHSR-GVYHRDLKPENLLLDENGDLKISDFGLSALQE 160 (448)
Q Consensus 87 lV~E~~~gg~L~~~i----~~-~~l~e~~~~~~~~qll~aL~yLH~~-givHrDLkp~NILl~~~g~lkl~DFGla~~~~ 160 (448)
+.||.|.- +|..+. .. +.++|..+-+++..++.||.|||++ .++|||+||+|||++.+|++|+||||++-...
T Consensus 122 IcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~ 200 (282)
T KOG0984|consen 122 ICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLV 200 (282)
T ss_pred EeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeeh
Confidence 99999954 664443 33 5799999999999999999999986 89999999999999999999999999987543
Q ss_pred ccccCCCccc-cCCCCcccchhhhh----ccCCCCCcchHHHHHHHHHHHHhCCCCCCC-CcHHHHHHHHhhc
Q 037702 161 STRQDGLLHT-TCGTPAYVAPEVIN----KRGYDGAKADIWSCGVVLFVLLAGNLPFYD-SNLMELYKKITRA 227 (448)
Q Consensus 161 ~~~~~~~~~~-~~Gt~~Y~APEvl~----~~~~~~~~sDiwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~~ 227 (448)
. ....+ ..|-..|||||.+. ..+|+ .++||||||++++||.+++.||.. ...-+.++++...
T Consensus 201 d----SiAkt~daGCkpYmaPEri~~e~n~~gY~-vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 201 D----SIAKTMDAGCKPYMAPERINPELNQKGYS-VKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE 268 (282)
T ss_pred h----hhHHHHhcCCCccCChhhcCcccCcccce-eehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence 2 22233 56888999999985 34665 899999999999999999999964 3444555555544
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=260.32 Aligned_cols=256 Identities=27% Similarity=0.461 Sum_probs=203.8
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEE-EEeCCE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEV-MASKTK 84 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~-~~~~~~ 84 (448)
.+.+.|.+.+.||+|-||++-+|+|+.+...+++|.+.+... ....+.+|...--.| .|.||+.-|++ |++.+.
T Consensus 21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t----t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~ 96 (378)
T KOG1345|consen 21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT----TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDA 96 (378)
T ss_pred chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh----hHHHHHHHhccceeeccchhhhHHHHHHhhcCce
Confidence 356789999999999999999999999999999999987653 346788888776666 58899998886 677788
Q ss_pred EEEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCC--CCeEEeecccccccccc
Q 037702 85 IYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDEN--GDLKISDFGLSALQEST 162 (448)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~--g~lkl~DFGla~~~~~~ 162 (448)
+.++|||++-|+|..-+...++-|....+++.|+++|++|+|++++||||||.+||||-.. -.+||||||+.+..+..
T Consensus 97 YvF~qE~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t 176 (378)
T KOG1345|consen 97 YVFVQEFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT 176 (378)
T ss_pred EEEeeccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCce
Confidence 8899999999999999988889999999999999999999999999999999999999543 37999999998744322
Q ss_pred ccCCCccccCCCCcccchhhhhccC----CCCCcchHHHHHHHHHHHHhCCCCCCCCcHH----HHHHHHhhc-cCCCCC
Q 037702 163 RQDGLLHTTCGTPAYVAPEVINKRG----YDGAKADIWSCGVVLFVLLAGNLPFYDSNLM----ELYKKITRA-EFKCPN 233 (448)
Q Consensus 163 ~~~~~~~~~~Gt~~Y~APEvl~~~~----~~~~~sDiwSlGvil~elltG~~Pf~~~~~~----~~~~~i~~~-~~~~p~ 233 (448)
.+...-+..|.|||++.... ...+.+|+|.||+++|.+++|++||+....+ -.+.++..+ ....|.
T Consensus 177 -----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~ 251 (378)
T KOG1345|consen 177 -----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPK 251 (378)
T ss_pred -----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCch
Confidence 12233467899999875321 1135689999999999999999999854322 122233332 234443
Q ss_pred ---CCCHHHHHHHHhccCCCcCCC---CCHHHHHhhhhcccccc
Q 037702 234 ---WFPPEVRKLLSRILDPNPSTR---VTMAKLMENYWFRKGYK 271 (448)
Q Consensus 234 ---~~s~~~~~li~~~L~~dP~~R---pt~~eil~hp~~~~~~~ 271 (448)
.+|+.+..+.++-|.++|++| .++..-...-|......
T Consensus 252 ~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~i~ 295 (378)
T KOG1345|consen 252 KFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKLIK 295 (378)
T ss_pred hhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhhhc
Confidence 378999999999999999999 66677777778765443
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=272.65 Aligned_cols=255 Identities=26% Similarity=0.504 Sum_probs=203.4
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECC---CCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLK---TGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEVMASK 82 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~---~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~ 82 (448)
.+.+.|.+.+.||+|+|+.||+|.+.. .++.||+|.+..-. ....+..|+++|..+ .+.||+++.+++..+
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-----~p~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-----SPSRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-----CchHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 466789999999999999999999877 78899999986542 236688999999999 689999999999999
Q ss_pred CEEEEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcC-CCCeEEeeccccccccc
Q 037702 83 TKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDE-NGDLKISDFGLSALQES 161 (448)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~-~g~lkl~DFGla~~~~~ 161 (448)
+...+||||++..+-.++... ++-.+++.|++.++.||.++|.+|||||||||.|+|.+. .+.-.|+|||||...+.
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~--l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~ 185 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRS--LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDG 185 (418)
T ss_pred CeeEEEecccCccCHHHHHhc--CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHh
Confidence 999999999999888777765 678899999999999999999999999999999999974 56789999999872110
Q ss_pred cc------c-------------------------CCC-----------ccccCCCCcccchhhhhccCCCCCcchHHHHH
Q 037702 162 TR------Q-------------------------DGL-----------LHTTCGTPAYVAPEVINKRGYDGAKADIWSCG 199 (448)
Q Consensus 162 ~~------~-------------------------~~~-----------~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlG 199 (448)
.. . .+. .....||++|.|||++...+-.+.++||||.|
T Consensus 186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~G 265 (418)
T KOG1167|consen 186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAG 265 (418)
T ss_pred hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecc
Confidence 00 0 000 01236999999999998887778899999999
Q ss_pred HHHHHHHhCCCCCCCCcH-----HHH---------HH------H--Hhh-cc-------------------CC-------
Q 037702 200 VVLFVLLAGNLPFYDSNL-----MEL---------YK------K--ITR-AE-------------------FK------- 230 (448)
Q Consensus 200 vil~elltG~~Pf~~~~~-----~~~---------~~------~--i~~-~~-------------------~~------- 230 (448)
||+.-++++..||..... .++ .+ + +.. .. .+
T Consensus 266 VI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~ 345 (418)
T KOG1167|consen 266 VILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTE 345 (418)
T ss_pred ceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccccee
Confidence 999999999999854211 010 00 0 000 00 00
Q ss_pred ---CCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccc
Q 037702 231 ---CPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRK 268 (448)
Q Consensus 231 ---~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 268 (448)
....++..+.+|+.+||..||.+|+|+++.|+||||..
T Consensus 346 ~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 346 REIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred eccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 00124568999999999999999999999999999973
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-33 Score=293.57 Aligned_cols=261 Identities=30% Similarity=0.505 Sum_probs=211.1
Q ss_pred cCCe-EEEeeeeecCceEEEEEEECCCCcEEEEEEeecc---cccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 037702 9 MNKY-ELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKE---KIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTK 84 (448)
Q Consensus 9 ~~~y-~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~---~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 84 (448)
..+| .....+|.|++|.|+.+......+.++.|..... ..........+..|..+-..+.|||++.....+.+...
T Consensus 316 ~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~ 395 (601)
T KOG0590|consen 316 SEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG 395 (601)
T ss_pred ccccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc
Confidence 4455 5677899999999999888777777777765421 11112222337778888889999999887777666666
Q ss_pred EEEEEeecCCCchHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccc
Q 037702 85 IYFAMEYVRGGELFNKVAKG-KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTR 163 (448)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~~-~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~ 163 (448)
.+-+||||++ +|+.++... .+...++..+++||+.||+|||+.||.|||+||+|++++.+|.+||+|||.+..+....
T Consensus 396 ~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 396 ILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred chhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 6666999999 999999874 89999999999999999999999999999999999999999999999999999876665
Q ss_pred cC--CCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHH--H-------HHhhccCCCC
Q 037702 164 QD--GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELY--K-------KITRAEFKCP 232 (448)
Q Consensus 164 ~~--~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~--~-------~i~~~~~~~p 232 (448)
.. ......+|+.+|+|||++.+..|+....||||+|++++.|.+|+.||.-....+.. . ++..+....-
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLL 554 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHH
Confidence 54 55667899999999999999999999999999999999999999999754433221 1 1111112222
Q ss_pred CCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccccc
Q 037702 233 NWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGY 270 (448)
Q Consensus 233 ~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 270 (448)
..++...+.+|.+||++||.+|.|+++|++++||+...
T Consensus 555 ~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 555 SLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE 592 (601)
T ss_pred HhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence 34778899999999999999999999999999998643
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-32 Score=298.62 Aligned_cols=200 Identities=18% Similarity=0.224 Sum_probs=147.1
Q ss_pred hCCC-CCcceEEEEE-------EeCCEEEEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecC
Q 037702 66 LVRH-PNIVQLYEVM-------ASKTKIYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDL 135 (448)
Q Consensus 66 ~l~h-pnIv~l~~~~-------~~~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDL 135 (448)
.++| +||+++++.+ .....++++||++ +++|++++.. +.+++.+++.++.||+.||+|||++||+||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 3455 5777777776 2334678889987 5699999965 46999999999999999999999999999999
Q ss_pred CCCceEEcCC-------------------CCeEEeecccccccccccc--------------CCCccccCCCCcccchhh
Q 037702 136 KPENLLLDEN-------------------GDLKISDFGLSALQESTRQ--------------DGLLHTTCGTPAYVAPEV 182 (448)
Q Consensus 136 kp~NILl~~~-------------------g~lkl~DFGla~~~~~~~~--------------~~~~~~~~Gt~~Y~APEv 182 (448)
||+||||+.. +.+|++|||+++....... .......+||+.|||||+
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 9999999654 4556666666643211000 000112468999999999
Q ss_pred hhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCC-CCCCCCHHHHHHHHhccCCCcCCCCCHHHHH
Q 037702 183 INKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFK-CPNWFPPEVRKLLSRILDPNPSTRVTMAKLM 261 (448)
Q Consensus 183 l~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil 261 (448)
+.+..| +.++|||||||+||||++|..|+.... .....+.....+ .+....+...+++.+||.+||.+||++.+++
T Consensus 187 ~~~~~~-~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil 263 (793)
T PLN00181 187 DNGSSS-NCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELL 263 (793)
T ss_pred hccCCC-CchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHh
Confidence 988777 589999999999999999998876432 122222111111 1111246678999999999999999999999
Q ss_pred hhhhcccc
Q 037702 262 ENYWFRKG 269 (448)
Q Consensus 262 ~hp~~~~~ 269 (448)
+||||...
T Consensus 264 ~h~~~~~~ 271 (793)
T PLN00181 264 QSEFINEP 271 (793)
T ss_pred hchhhhhh
Confidence 99999764
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=241.05 Aligned_cols=253 Identities=21% Similarity=0.317 Sum_probs=207.8
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCC-----cEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE-
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTG-----QSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMA- 80 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g-----~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~- 80 (448)
+...|+++..++-+|+||.||.|.+++.. +.|-+|.+... .++-.+..+..|...+..+.|||++.+.+++.
T Consensus 281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie 358 (563)
T KOG1024|consen 281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE 358 (563)
T ss_pred hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence 45568889999999999999999876543 23555655322 12234577888999999999999999999874
Q ss_pred eCCEEEEEEeecCCCchHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEe
Q 037702 81 SKTKIYFAMEYVRGGELFNKVAK---------GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKIS 151 (448)
Q Consensus 81 ~~~~~~lV~E~~~gg~L~~~i~~---------~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~ 151 (448)
+.+..+..+.+..-|+|..++.. ..++..+...++.|++.|++|||++||+|.||...|.+||+.-++||+
T Consensus 359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVklt 438 (563)
T KOG1024|consen 359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLT 438 (563)
T ss_pred ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEec
Confidence 55678889999999999888862 236677888999999999999999999999999999999999999999
Q ss_pred eccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhcc-C
Q 037702 152 DFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAE-F 229 (448)
Q Consensus 152 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~ 229 (448)
|=.+++-.-...-.-+-........||+||.+.+..|. ..+|+||||++||||+| |+.|+-+-++.+++..+..+. .
T Consensus 439 DsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~ys-sasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRl 517 (563)
T KOG1024|consen 439 DSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYS-SASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRL 517 (563)
T ss_pred cchhccccCcccccccCCCCCCcccccCHHHHhhhhhc-chhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcccee
Confidence 99998843322222222233456789999999888776 77999999999999998 999999999999998887764 4
Q ss_pred CCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHh
Q 037702 230 KCPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 230 ~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 262 (448)
.-|..+|.++-.++.-||..+|++||+++|+..
T Consensus 518 aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 518 AQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 678889999999999999999999999999864
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=228.20 Aligned_cols=158 Identities=22% Similarity=0.266 Sum_probs=128.4
Q ss_pred CchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCccccC
Q 037702 95 GELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTC 172 (448)
Q Consensus 95 g~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~ 172 (448)
|+|.+++.. +.+++..++.++.|++.||.|||+++ ||+|||++.++.+|+ ||++...... ...
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-------~~~ 65 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE-------QSR 65 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc-------cCC
Confidence 689999974 45999999999999999999999999 999999999999999 9998764321 236
Q ss_pred CCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcH-HHHHHHHhhccCC-------CCCCCCH--HHHHH
Q 037702 173 GTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNL-MELYKKITRAEFK-------CPNWFPP--EVRKL 242 (448)
Q Consensus 173 Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~~~~~-------~p~~~s~--~~~~l 242 (448)
||+.|||||++.+..|+ .++|||||||++|+|++|+.||..... ......+...... .+..++. ++.++
T Consensus 66 g~~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (176)
T smart00750 66 VDPYFMAPEVIQGQSYT-EKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADF 144 (176)
T ss_pred CcccccChHHhcCCCCc-chhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHH
Confidence 89999999999887775 889999999999999999999976543 2333333222111 1122333 69999
Q ss_pred HHhccCCCcCCCCCHHHHHhhhhccc
Q 037702 243 LSRILDPNPSTRVTMAKLMENYWFRK 268 (448)
Q Consensus 243 i~~~L~~dP~~Rpt~~eil~hp~~~~ 268 (448)
|.+||..||.+||++.++++|+|+..
T Consensus 145 i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 145 MRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHHHhcccccccCHHHHHHHHHHHH
Confidence 99999999999999999999999753
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-28 Score=233.33 Aligned_cols=255 Identities=34% Similarity=0.590 Sum_probs=212.9
Q ss_pred eEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCC-CcceEEEEEEeCCEEEEEEe
Q 037702 12 YELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHP-NIVQLYEVMASKTKIYFAME 90 (448)
Q Consensus 12 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hp-nIv~l~~~~~~~~~~~lV~E 90 (448)
|.+.+.||.|+||.||.+.+. ..+++|.+.............+.+|+.+++.+.|+ +|+++++++......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 889999999999999999986 88999999877655433567899999999999988 79999999988888999999
Q ss_pred ecCCCchHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCC-CeEEeeccccccccccccC
Q 037702 91 YVRGGELFNKVAKG----KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENG-DLKISDFGLSALQESTRQD 165 (448)
Q Consensus 91 ~~~gg~L~~~i~~~----~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g-~lkl~DFGla~~~~~~~~~ 165 (448)
++.++++.+.+... .+++..+..++.|++.++.|+|+.|++|||+||+||+++..+ .++++|||++.........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 99999999877764 699999999999999999999999999999999999999999 7999999999754332221
Q ss_pred C----CccccCCCCcccchhhhhcc--CCCCCcchHHHHHHHHHHHHhCCCCCCCCcH----HHHHHHHhhccCC-CCCC
Q 037702 166 G----LLHTTCGTPAYVAPEVINKR--GYDGAKADIWSCGVVLFVLLAGNLPFYDSNL----MELYKKITRAEFK-CPNW 234 (448)
Q Consensus 166 ~----~~~~~~Gt~~Y~APEvl~~~--~~~~~~sDiwSlGvil~elltG~~Pf~~~~~----~~~~~~i~~~~~~-~p~~ 234 (448)
. .....+||+.|+|||.+... .+.....|+||+|++++++++|..||..... ......+...... ....
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence 1 34677899999999999774 4556889999999999999999999887663 4555555544433 2222
Q ss_pred CC--------HHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 235 FP--------PEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 235 ~s--------~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
.. ..+.+++.+++..+|..|.+..+...++|....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 22 478999999999999999999999988766543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-30 Score=260.47 Aligned_cols=239 Identities=33% Similarity=0.599 Sum_probs=208.4
Q ss_pred eeeecCceEEEEEEE---CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEeec
Q 037702 17 LLGQGTFAKVYHGRN---LKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR-HPNIVQLYEVMASKTKIYFAMEYV 92 (448)
Q Consensus 17 ~LG~G~fg~Vy~a~~---~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lV~E~~ 92 (448)
++|+|+||.|++++. ...|..+|+|+..+......... .-..|..++..++ ||.+++++..+..+.+.|+++++.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 479999999998753 33577899999887655433222 4556788888886 999999999999999999999999
Q ss_pred CCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCcccc
Q 037702 93 RGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTT 171 (448)
Q Consensus 93 ~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~ 171 (448)
.||+|+..+.. ..+.+.....+...++-+++++|+.||+|||+|++||+++.+|++++.|||+++..-... ..
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~------~~ 153 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK------IA 153 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhh------hc
Confidence 99999998876 568888899999999999999999999999999999999999999999999998653322 22
Q ss_pred CCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHHHHhccCCCc
Q 037702 172 CGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILDPNP 251 (448)
Q Consensus 172 ~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP 251 (448)
|||..|||||+++ ++. ..+|.||+|+++++|++|..||.. ++...|.+..+..|..++..+++++.+++..+|
T Consensus 154 cgt~eymApEI~~--gh~-~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p 226 (612)
T KOG0603|consen 154 CGTYEYRAPEIIN--GHL-SAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRELSAEARSLFRQLFKRNP 226 (612)
T ss_pred ccchhhhhhHhhh--ccC-CcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCH
Confidence 9999999999997 454 679999999999999999999988 788889999999999999999999999999999
Q ss_pred CCCCC-----HHHHHhhhhcccc
Q 037702 252 STRVT-----MAKLMENYWFRKG 269 (448)
Q Consensus 252 ~~Rpt-----~~eil~hp~~~~~ 269 (448)
.+|.- +.++++|++|+.-
T Consensus 227 ~nrLg~~~~~~~eik~h~f~~~i 249 (612)
T KOG0603|consen 227 ENRLGAGPDGVDEIKQHEFFQSI 249 (612)
T ss_pred HHHhccCcchhHHHhccchheee
Confidence 99985 4799999999763
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-28 Score=242.25 Aligned_cols=170 Identities=21% Similarity=0.247 Sum_probs=135.0
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECC-CCcEEEEEEeecccc--cchhHHHHHHHHHHHHHhCCCCCcce-EEEEEEe
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLK-TGQSVAIKIVDKEKI--RRVGLIDQIKREISVMRLVRHPNIVQ-LYEVMAS 81 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~-~g~~vAiK~i~~~~~--~~~~~~~~~~~Ei~~l~~l~hpnIv~-l~~~~~~ 81 (448)
..+.++|++.+.||+|+||+||+|.+.. +|..||||++..... ......+.+.+|+.+|+.++|+||+. +++.
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 4678899999999999999999999876 677889998763311 12234567899999999999999985 4432
Q ss_pred CCEEEEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecC-CCCceEEcCCCCeEEeecccccccc
Q 037702 82 KTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDL-KPENLLLDENGDLKISDFGLSALQE 160 (448)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDL-kp~NILl~~~g~lkl~DFGla~~~~ 160 (448)
...|+||||++|++|... .. .. ...++.|+++||.|||++||+|||| ||+|||++.++.+||+|||+|+...
T Consensus 91 -~~~~LVmE~~~G~~L~~~-~~--~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~ 163 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHLA-RP--HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR 163 (365)
T ss_pred -CCcEEEEEccCCCCHHHh-Cc--cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence 457999999999999732 21 11 1568899999999999999999999 9999999999999999999998654
Q ss_pred ccccCCC------ccccCCCCcccchhhhhc
Q 037702 161 STRQDGL------LHTTCGTPAYVAPEVINK 185 (448)
Q Consensus 161 ~~~~~~~------~~~~~Gt~~Y~APEvl~~ 185 (448)
....... ..+.+|++.|+|||.+..
T Consensus 164 ~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 164 RRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred cCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 3321111 245678999999999853
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-26 Score=227.34 Aligned_cols=248 Identities=25% Similarity=0.351 Sum_probs=195.0
Q ss_pred CeEEEeeeeecCceEEEEEEECCCC-cEEEEEEeecccccchhHHHHHHHHHHHHHhCCC----CCcceEEEEE-EeCCE
Q 037702 11 KYELGRLLGQGTFAKVYHGRNLKTG-QSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRH----PNIVQLYEVM-ASKTK 84 (448)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~g-~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~h----pnIv~l~~~~-~~~~~ 84 (448)
+|.+.+.||+|+||.||.+.+..++ ..+|+|+......... ..+..|+.++..+.. +++..+++.. ..+..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 8999999999999999999998775 6789998765432221 257789999998873 6899999998 57888
Q ss_pred EEEEEeecCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCC-----CCeEEeecccc
Q 037702 85 IYFAMEYVRGGELFNKVAK---GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDEN-----GDLKISDFGLS 156 (448)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~-----g~lkl~DFGla 156 (448)
.|+||+.+ |.+|.++... ++++...+..++.|++.+|++||+.|++||||||+|+++... ..+.|.|||+|
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999998 7799887743 579999999999999999999999999999999999999865 36999999999
Q ss_pred ccccccccCC-------C-ccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHH---HHHHHHh
Q 037702 157 ALQESTRQDG-------L-LHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLM---ELYKKIT 225 (448)
Q Consensus 157 ~~~~~~~~~~-------~-~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~---~~~~~i~ 225 (448)
+........+ . .....||..|+++.++.+... +.+.|+||++.++.+|+.|.+||...... ..+.+..
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~-~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQ-GRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCcc-CCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 8332111111 1 123459999999999987766 58999999999999999999999765532 2222222
Q ss_pred hccCC--CCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 226 RAEFK--CPNWFPPEVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 226 ~~~~~--~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
..... .....+.++.++...+-..+...+|....+...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 254 RKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 22221 233456788888888888999999999888764
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-26 Score=207.81 Aligned_cols=248 Identities=25% Similarity=0.369 Sum_probs=202.2
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCC-CCcceEEEEEEeCCE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRH-PNIVQLYEVMASKTK 84 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~h-pnIv~l~~~~~~~~~ 84 (448)
-+..++|.+++.||.|+||.+|+|.+..+|+.||||+-... ... .++..|..+.+.|++ .+|..+..+..+...
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~-a~h----pqL~yEskvY~iL~~g~GiP~i~~y~~e~~y 85 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK-AKH----PQLLYESKVYRILQGGVGIPHIRHYGTEKDY 85 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc-CCC----cchhHHHHHHHHhccCCCCchhhhhcccccc
Confidence 46789999999999999999999999999999999976433 332 457789999999965 678888888888889
Q ss_pred EEEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCC---CCeEEeeccccccc
Q 037702 85 IYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDEN---GDLKISDFGLSALQ 159 (448)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~---g~lkl~DFGla~~~ 159 (448)
-.+|||+. |-+|.+++.- +.++...+.-++-|++.-++|+|.++++||||||+|.|..-+ ..+.|+|||||+..
T Consensus 86 nvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 86 NVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred ceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhh
Confidence 99999998 6688887753 679999999999999999999999999999999999998643 46899999999865
Q ss_pred cccccCC-----CccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCc---HHHHHHHHhhccCCC
Q 037702 160 ESTRQDG-----LLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSN---LMELYKKITRAEFKC 231 (448)
Q Consensus 160 ~~~~~~~-----~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~---~~~~~~~i~~~~~~~ 231 (448)
....... .-....||..|.+--.+.+... +...|+-|+|.+|.++.-|.+||++.. ..+-+.+|.+...+.
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eq-SRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~ 243 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQ-SRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMST 243 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhh-hhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCC
Confidence 5433221 1234579999999777665544 477899999999999999999999854 456677787777665
Q ss_pred C-----CCCCHHHHHHHHhccCCCcCCCCCHHHH
Q 037702 232 P-----NWFPPEVRKLLSRILDPNPSTRVTMAKL 260 (448)
Q Consensus 232 p-----~~~s~~~~~li~~~L~~dP~~Rpt~~ei 260 (448)
| ..+|.++.-.+..|-..--++-|...-+
T Consensus 244 ~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~yl 277 (341)
T KOG1163|consen 244 PIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYL 277 (341)
T ss_pred CHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHH
Confidence 5 3588999999999887777777776544
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-26 Score=245.41 Aligned_cols=220 Identities=32% Similarity=0.639 Sum_probs=179.3
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYF 87 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 87 (448)
.-.+|+.++++..|+||.||+.+|+.+.+++|+ .++++..- .|- ++.....|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~li--------lRn--ilt~a~npfvv-------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNLI--------LRN--ILTFAGNPFVV-------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhh-cccccchh--------hhc--cccccCCccee--------------
Confidence 456899999999999999999999999999999 45554321 111 44444555555
Q ss_pred EEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccc---
Q 037702 88 AMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTR--- 163 (448)
Q Consensus 88 V~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~--- 163 (448)
|+-...++. |.++.+. +.+++|||+-||+|||+||+|+||+.=|++|+.|||++.......
T Consensus 136 -------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 -------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred -------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 444455544 5666555 779999999999999999999999999999999999987432211
Q ss_pred ----------cCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCC
Q 037702 164 ----------QDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPN 233 (448)
Q Consensus 164 ----------~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~ 233 (448)
........||||.|.||||+...|| |..+|+|++|+|+|+++-|+.||.+...++++..+......+|+
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgy-gkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE 279 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 279 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhhhcc-CCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccc
Confidence 1112245699999999999999998 58899999999999999999999999999999999988887776
Q ss_pred C---CCHHHHHHHHhccCCCcCCCC---CHHHHHhhhhccc
Q 037702 234 W---FPPEVRKLLSRILDPNPSTRV---TMAKLMENYWFRK 268 (448)
Q Consensus 234 ~---~s~~~~~li~~~L~~dP~~Rp---t~~eil~hp~~~~ 268 (448)
. ++++++++|.++|+.+|..|. .+-++.+|+||+.
T Consensus 280 ~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~ 320 (1205)
T KOG0606|consen 280 EDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQL 320 (1205)
T ss_pred cCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceee
Confidence 4 679999999999999999995 6778999999976
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-25 Score=209.54 Aligned_cols=247 Identities=22% Similarity=0.384 Sum_probs=203.1
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEVMASKTKI 85 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~ 85 (448)
+..-.|++++.||+|+||..+.|.+.-++++||||.-.... ..-++..|....+.| ..++|...|.+-.++.+-
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~N 99 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYN 99 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEeccccC-----CcchHHHHHHHHHHHcCCCCCCceeeeccccchh
Confidence 55668999999999999999999999999999999755432 236788999999988 579999999999999999
Q ss_pred EEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCC-----CeEEeecccccc
Q 037702 86 YFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENG-----DLKISDFGLSAL 158 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g-----~lkl~DFGla~~ 158 (448)
.||||+. |-+|.|++.- ++|+...+..++.|++.-++|+|++.+|+|||||+|+||...+ .+.++|||+|+.
T Consensus 100 iLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 100 ILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 9999998 6688888764 5799999999999999999999999999999999999997544 489999999987
Q ss_pred ccccccC-----CCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCC---CcHHHHHHHHhhccCC
Q 037702 159 QESTRQD-----GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYD---SNLMELYKKITRAEFK 230 (448)
Q Consensus 159 ~~~~~~~-----~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~---~~~~~~~~~i~~~~~~ 230 (448)
....... .......||..||+-.-+.+.... ...|+-|||-+++++|-|.+||.+ .+..+-|.+|-.....
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQS-RRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~ 257 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRS 257 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhh-hhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccccc
Confidence 6544322 223455799999998777776664 789999999999999999999987 4556778888665544
Q ss_pred CC-----CCCCHHHHHHHHhccCCCcCCCCCHHHH
Q 037702 231 CP-----NWFPPEVRKLLSRILDPNPSTRVTMAKL 260 (448)
Q Consensus 231 ~p-----~~~s~~~~~li~~~L~~dP~~Rpt~~ei 260 (448)
.| ..+|.++...++..-..+-.+-|..+-+
T Consensus 258 T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdyl 292 (449)
T KOG1165|consen 258 TPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYL 292 (449)
T ss_pred CCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHH
Confidence 43 3478888888877777777777876543
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.4e-25 Score=205.54 Aligned_cols=175 Identities=18% Similarity=0.218 Sum_probs=137.6
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHH------HHHHHHHHHhCCCCCcceEEEEEE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQ------IKREISVMRLVRHPNIVQLYEVMA 80 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~------~~~Ei~~l~~l~hpnIv~l~~~~~ 80 (448)
++.++|++.++||.|+||.||++.. ++..+|||++..+.......... +.+|+..+.++.||+|..+..++.
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 5789999999999999999999765 57789999997665444433333 679999999999999999998865
Q ss_pred eC--------CEEEEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEee
Q 037702 81 SK--------TKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISD 152 (448)
Q Consensus 81 ~~--------~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~D 152 (448)
.. ...+|||||++|.+|.+.. .+++ ....+++.+|..||+.|++|||+||+||+++.+| ++|+|
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~---~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liD 177 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMP---EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIID 177 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhh---hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEE
Confidence 43 3578999999999998773 2333 2456999999999999999999999999999988 99999
Q ss_pred ccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHH
Q 037702 153 FGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLL 206 (448)
Q Consensus 153 FGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ell 206 (448)
||.+........ ...+.....|+ .++|+||||+++..+.
T Consensus 178 fg~~~~~~e~~a--------------~d~~vler~y~-~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 178 LSGKRCTAQRKA--------------KDRIDLERHYG-IKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCCcccccchhh--------------HHHHHHHhHhc-ccccccceeEeehHHH
Confidence 998764321110 01133455566 7899999999987554
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=199.66 Aligned_cols=141 Identities=21% Similarity=0.294 Sum_probs=112.8
Q ss_pred EeeeeecCceEEEEEEECCCCcEEEEEEeecccccchh-----------------------HHHHHHHHHHHHHhCCCCC
Q 037702 15 GRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVG-----------------------LIDQIKREISVMRLVRHPN 71 (448)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~-----------------------~~~~~~~Ei~~l~~l~hpn 71 (448)
...||+|+||.||+|.+. +|+.||||++......... ......+|+.++..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 467999999999999986 8999999999765321111 0123456999999998888
Q ss_pred cceEEEEEEeCCEEEEEEeecCCCchHHH-HhcCCCCHHHHHHHHHHHHHHHHHH-HHCCCEeecCCCCceEEcCCCCeE
Q 037702 72 IVQLYEVMASKTKIYFAMEYVRGGELFNK-VAKGKLREEVARKYFQQLVDAVEFC-HSRGVYHRDLKPENLLLDENGDLK 149 (448)
Q Consensus 72 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~-i~~~~l~e~~~~~~~~qll~aL~yL-H~~givHrDLkp~NILl~~~g~lk 149 (448)
+.....+... . .+|||||++|+++... +..+++++..+..++.|++.+|.|| |+.||+||||||+|||++ ++.++
T Consensus 81 v~~p~~~~~~-~-~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 81 IPCPEPILLK-S-HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCCcEEEec-C-CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence 7544433222 2 3899999999887655 4557899999999999999999999 799999999999999998 58899
Q ss_pred Eeeccccccc
Q 037702 150 ISDFGLSALQ 159 (448)
Q Consensus 150 l~DFGla~~~ 159 (448)
|+|||+|...
T Consensus 158 LiDFG~a~~~ 167 (190)
T cd05147 158 IIDVSQSVEH 167 (190)
T ss_pred EEEccccccC
Confidence 9999998743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.91 E-value=6e-24 Score=203.71 Aligned_cols=233 Identities=25% Similarity=0.388 Sum_probs=153.3
Q ss_pred CeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCC----------CCcceEEEEEE
Q 037702 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRH----------PNIVQLYEVMA 80 (448)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~h----------pnIv~l~~~~~ 80 (448)
.+..++.||.|+++.||.+.+..||+.+|+|+............+++++|.-....+.+ -.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 46778999999999999999999999999999876553334456778877765555432 12333233221
Q ss_pred ---------eC---C-----EEEEEEeecCCCchHHHHhc----CCC---CHHHH-HHHHHHHHHHHHHHHHCCCEeecC
Q 037702 81 ---------SK---T-----KIYFAMEYVRGGELFNKVAK----GKL---REEVA-RKYFQQLVDAVEFCHSRGVYHRDL 135 (448)
Q Consensus 81 ---------~~---~-----~~~lV~E~~~gg~L~~~i~~----~~l---~e~~~-~~~~~qll~aL~yLH~~givHrDL 135 (448)
.. + +.+++|+-+ .++|.+.+.. ... ....+ ..+..|++..+++||+.|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 11 1 236778877 4588777642 222 12223 344589999999999999999999
Q ss_pred CCCceEEcCCCCeEEeeccccccccccccCCCccccCCCCcccchhhhhccC-------CCCCcchHHHHHHHHHHHHhC
Q 037702 136 KPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRG-------YDGAKADIWSCGVVLFVLLAG 208 (448)
Q Consensus 136 kp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~-------~~~~~sDiwSlGvil~elltG 208 (448)
+|+|+|++.+|.++|+||+.....+.... ....+..|.+||...... ..+.+.|.|+||+++|.|.||
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~-----~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRYR-----CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEEE-----GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCceee-----ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 99999999999999999987764332211 133457899999875431 124678999999999999999
Q ss_pred CCCCCCCcHHHHHHHHhhccC-CCCCCCCHHHHHHHHhccCCCcCCC
Q 037702 209 NLPFYDSNLMELYKKITRAEF-KCPNWFPPEVRKLLSRILDPNPSTR 254 (448)
Q Consensus 209 ~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L~~dP~~R 254 (448)
..||........... .+ .|. .+|..++.||+.+|++||.+|
T Consensus 247 ~lPf~~~~~~~~~~~----~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADPEW----DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGSTSGG----GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCccccccc----cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999986543221110 23 344 789999999999999999988
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.7e-24 Score=193.73 Aligned_cols=141 Identities=21% Similarity=0.292 Sum_probs=115.1
Q ss_pred EeeeeecCceEEEEEEECCCCcEEEEEEeecccccch-----------------------hHHHHHHHHHHHHHhCCCCC
Q 037702 15 GRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRV-----------------------GLIDQIKREISVMRLVRHPN 71 (448)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~-----------------------~~~~~~~~Ei~~l~~l~hpn 71 (448)
.+.||+|+||.||+|.+. +|+.||||++........ .....+.+|...+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 578999999999999987 899999999986532100 00233568999999999999
Q ss_pred cceEEEEEEeCCEEEEEEeecCCCchHH-HHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCEeecCCCCceEEcCCCCeE
Q 037702 72 IVQLYEVMASKTKIYFAMEYVRGGELFN-KVAKGKLREEVARKYFQQLVDAVEFCHS-RGVYHRDLKPENLLLDENGDLK 149 (448)
Q Consensus 72 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~-~i~~~~l~e~~~~~~~~qll~aL~yLH~-~givHrDLkp~NILl~~~g~lk 149 (448)
|.....+.... .||||||++|+++.. .+..+++++..+..++.|++.++.+||+ +||+||||||+|||++ ++.++
T Consensus 81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~ 157 (190)
T cd05145 81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPY 157 (190)
T ss_pred CCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEE
Confidence 86555444333 489999999886543 4566788999999999999999999999 9999999999999998 89999
Q ss_pred Eeeccccccc
Q 037702 150 ISDFGLSALQ 159 (448)
Q Consensus 150 l~DFGla~~~ 159 (448)
|+|||+|...
T Consensus 158 liDFG~a~~~ 167 (190)
T cd05145 158 IIDVSQAVEL 167 (190)
T ss_pred EEEcccceec
Confidence 9999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.2e-24 Score=204.67 Aligned_cols=253 Identities=27% Similarity=0.466 Sum_probs=178.6
Q ss_pred cccccCCeEEEeeeeecCceEEEEEEECCCCc-----------------------------------EEEEEEeeccccc
Q 037702 5 AGILMNKYELGRLLGQGTFAKVYHGRNLKTGQ-----------------------------------SVAIKIVDKEKIR 49 (448)
Q Consensus 5 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~-----------------------------------~vAiK~i~~~~~~ 49 (448)
++..+++|++++.||+|..+.||.|.-..+|. +.|||.+-.-...
T Consensus 152 skFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~ 231 (598)
T KOG4158|consen 152 SKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHD 231 (598)
T ss_pred cccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccC
Confidence 35678899999999999999999986433211 2355554221111
Q ss_pred --chhHHHHHHHHHH------H--------HHh--------CCCCCcceEEEEEEe------------------------
Q 037702 50 --RVGLIDQIKREIS------V--------MRL--------VRHPNIVQLYEVMAS------------------------ 81 (448)
Q Consensus 50 --~~~~~~~~~~Ei~------~--------l~~--------l~hpnIv~l~~~~~~------------------------ 81 (448)
+....+.+.+|.. . .+. -+|||||+++.+|.+
T Consensus 232 s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g 311 (598)
T KOG4158|consen 232 SGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSG 311 (598)
T ss_pred CchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccc
Confidence 1122333333321 0 111 259999999876543
Q ss_pred ---CCEEEEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEc--CCC--CeEEeecc
Q 037702 82 ---KTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLD--ENG--DLKISDFG 154 (448)
Q Consensus 82 ---~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~--~~g--~lkl~DFG 154 (448)
+..+|+||...+. +|+.++-....+....+-++.|+++|+.|||.+||.|||+|.+|||+. .++ .+.|+|||
T Consensus 312 ~g~~~tlylvMkrY~~-tLr~yl~~~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFG 390 (598)
T KOG4158|consen 312 AGEPKTLYLVMKRYRQ-TLREYLWTRHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFG 390 (598)
T ss_pred cCCCceEEEehhcchh-hHHHHHhcCCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccc
Confidence 2468999998865 999999887788889999999999999999999999999999999984 333 48999999
Q ss_pred ccccccccc--c--CCCccccCCCCcccchhhhhccC-----CCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH-H
Q 037702 155 LSALQESTR--Q--DGLLHTTCGTPAYVAPEVINKRG-----YDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKK-I 224 (448)
Q Consensus 155 la~~~~~~~--~--~~~~~~~~Gt~~Y~APEvl~~~~-----~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~-i 224 (448)
.+---.... - .......-|...-||||+..... .+-.++|.|++|.+.||+++..-||+....+.+-.. .
T Consensus 391 CcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Y 470 (598)
T KOG4158|consen 391 CCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTY 470 (598)
T ss_pred eeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhh
Confidence 875322100 0 01112335788899999985422 122579999999999999999999988543322111 1
Q ss_pred hhc-cCCCCCCCCHHHHHHHHhccCCCcCCCCCHH
Q 037702 225 TRA-EFKCPNWFPPEVRKLLSRILDPNPSTRVTMA 258 (448)
Q Consensus 225 ~~~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~ 258 (448)
... -...|..+++.+++++..+|++||++|++..
T Consensus 471 qe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 471 QESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred hhhhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence 122 3457788999999999999999999999853
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.7e-23 Score=189.01 Aligned_cols=193 Identities=19% Similarity=0.264 Sum_probs=144.8
Q ss_pred eEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhH-HHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEE
Q 037702 12 YELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGL-IDQIKREISVMRLVR-HPNIVQLYEVMASKTKIYFAM 89 (448)
Q Consensus 12 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~-~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lV~ 89 (448)
..+...|++|+||+||++.. .+..++.+.+.......... ...+.+|+++|++|. |++|++++++ ...|++|
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 34678999999999998865 67888888776554322111 225789999999995 5889999886 3469999
Q ss_pred eecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecC-CCCceEEcCCCCeEEeeccccccccccccC---
Q 037702 90 EYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDL-KPENLLLDENGDLKISDFGLSALQESTRQD--- 165 (448)
Q Consensus 90 E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDL-kp~NILl~~~g~lkl~DFGla~~~~~~~~~--- 165 (448)
||+.|.+|...+..+ ...++.|++.+|.+||++||+|||| ||+|||++.+|.++|+|||+|.........
T Consensus 78 eyI~G~~L~~~~~~~------~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~ 151 (218)
T PRK12274 78 SYLAGAAMYQRPPRG------DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRL 151 (218)
T ss_pred eeecCccHHhhhhhh------hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHH
Confidence 999999997654322 2357889999999999999999999 799999999999999999999854322110
Q ss_pred -C-------CccccCCCCcccchhhhhccCCC-CCcchHHHHHHHHHHHHhCCCCCCCCc
Q 037702 166 -G-------LLHTTCGTPAYVAPEVINKRGYD-GAKADIWSCGVVLFVLLAGNLPFYDSN 216 (448)
Q Consensus 166 -~-------~~~~~~Gt~~Y~APEvl~~~~~~-~~~sDiwSlGvil~elltG~~Pf~~~~ 216 (448)
. .......++.|++|+...--.-. -...+.++.|+-+|.++|+.+|+.+++
T Consensus 152 L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 152 LAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0 01122368899999865332111 245789999999999999999876543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-25 Score=237.77 Aligned_cols=259 Identities=31% Similarity=0.555 Sum_probs=219.6
Q ss_pred cCCeEEEeeeeecCceEEEEEEECC-CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEE
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNLK-TGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR-HPNIVQLYEVMASKTKIY 86 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~-~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~ 86 (448)
...|.+.+.||+|+|+.|-.+.+.. +...+|.|.+.... ........+..|..+-+.+. |+|++.+++...+....+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 5679999999999999999988744 34467888776554 33344567778999988887 999999999999999999
Q ss_pred EEEeecCCCchHHHH-hcC--CCCHHHHHHHHHHHHHHHHHHH-HCCCEeecCCCCceEEcCCC-CeEEeeccccccccc
Q 037702 87 FAMEYVRGGELFNKV-AKG--KLREEVARKYFQQLVDAVEFCH-SRGVYHRDLKPENLLLDENG-DLKISDFGLSALQES 161 (448)
Q Consensus 87 lV~E~~~gg~L~~~i-~~~--~l~e~~~~~~~~qll~aL~yLH-~~givHrDLkp~NILl~~~g-~lkl~DFGla~~~~~ 161 (448)
++++|..|+++++.+ ... ..+...+..++.|+..++.|+| ..++.||||||+|.+++.++ .++++|||+|+....
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999999999999999 553 6888999999999999999999 99999999999999999999 999999999998776
Q ss_pred -cccCCCccccCC-CCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHH-HHHHHhhc--c--CCCCCC
Q 037702 162 -TRQDGLLHTTCG-TPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLME-LYKKITRA--E--FKCPNW 234 (448)
Q Consensus 162 -~~~~~~~~~~~G-t~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~-~~~~i~~~--~--~~~p~~ 234 (448)
..........|| ++.|+|||...+..|.+...|+||+|+++..+++|..||....... .+...... . ......
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNS 257 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcccc
Confidence 555666777899 9999999999888899999999999999999999999997655432 11222221 1 223344
Q ss_pred CCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccc
Q 037702 235 FPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRK 268 (448)
Q Consensus 235 ~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 268 (448)
++....+++.++|..+|..|.+.+++..+||+..
T Consensus 258 ~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 258 ISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred CChhhhhcccccccCCchhccccccccccccccc
Confidence 7899999999999999999999999999999987
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.9e-24 Score=228.18 Aligned_cols=239 Identities=25% Similarity=0.354 Sum_probs=183.7
Q ss_pred CeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccc-cchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 037702 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKI-RRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAM 89 (448)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (448)
.|...+.||.+.|=+|.+|++. .| .|+||++-+... -.-....+..+|++ ...++|||++.+..+.+.+...|||-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-eG-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-EG-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-Cc-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 7889999999999999999974 33 499999976542 11122344445666 67779999999999988888899999
Q ss_pred eecCCCchHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccc--ccC-
Q 037702 90 EYVRGGELFNKVAKGK-LREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQEST--RQD- 165 (448)
Q Consensus 90 E~~~gg~L~~~i~~~~-l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~--~~~- 165 (448)
+|+.. +|+|++..++ +...+.+.|+.||+.||.-||..||+|+|||.|||||+.-+-+.|+||..-+..--. +..
T Consensus 101 qyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPad 179 (1431)
T KOG1240|consen 101 QYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPAD 179 (1431)
T ss_pred HHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCccc
Confidence 99976 9999998765 677788889999999999999999999999999999999999999999765421111 111
Q ss_pred --CCccccCCCCcccchhhhhccC-C---------CCCcchHHHHHHHHHHHHh-CCCCCCCC-----------cHHHHH
Q 037702 166 --GLLHTTCGTPAYVAPEVINKRG-Y---------DGAKADIWSCGVVLFVLLA-GNLPFYDS-----------NLMELY 221 (448)
Q Consensus 166 --~~~~~~~Gt~~Y~APEvl~~~~-~---------~~~~sDiwSlGvil~ellt-G~~Pf~~~-----------~~~~~~ 221 (448)
....|...-..|.|||-+...+ + -+++-||||+||+++||++ |++||.-. +.....
T Consensus 180 f~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~L 259 (1431)
T KOG1240|consen 180 FTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQLL 259 (1431)
T ss_pred ceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHHH
Confidence 1223444456799999875422 1 2456899999999999998 78888421 112222
Q ss_pred HHHhhccCCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 222 KKITRAEFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 222 ~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
.+| -+..++.+|..|++.||++|.++++.|+.
T Consensus 260 e~I----------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 260 EKI----------EDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HhC----------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 222 13578999999999999999999999986
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.3e-24 Score=194.77 Aligned_cols=246 Identities=22% Similarity=0.389 Sum_probs=200.9
Q ss_pred ccccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 037702 4 KAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKT 83 (448)
Q Consensus 4 ~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~ 83 (448)
..|+-++...+...|.+...|+.|+|++ .|..++.|++....... .....+..|.-.|+.+.||||+.+++.|.+..
T Consensus 184 ~~gid~~~lnl~tkl~e~hsgelwrgrw--qgndivakil~vr~~t~-risrdfneefp~lrifshpnilpvlgacnspp 260 (448)
T KOG0195|consen 184 YTGIDVSSLNLITKLAESHSGELWRGRW--QGNDIVAKILNVREVTA-RISRDFNEEFPALRIFSHPNILPVLGACNSPP 260 (448)
T ss_pred ccCcchhhhhhhhhhccCCCcccccccc--cCcchhhhhhhhhhcch-hhcchhhhhCcceeeecCCchhhhhhhccCCC
Confidence 3466777788888999999999999999 56678888887654432 23366888999999999999999999999999
Q ss_pred EEEEEEeecCCCchHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--CEeecCCCCceEEcCCCCeEEe--ecccc
Q 037702 84 KIYFAMEYVRGGELFNKVAKG---KLREEVARKYFQQLVDAVEFCHSRG--VYHRDLKPENLLLDENGDLKIS--DFGLS 156 (448)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~~---~l~e~~~~~~~~qll~aL~yLH~~g--ivHrDLkp~NILl~~~g~lkl~--DFGla 156 (448)
++.++..|++-|+|++.+..+ -.+..++.+++.+++.|++|||+.. |----|....+++|++-+.+|+ |--++
T Consensus 261 nlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfs 340 (448)
T KOG0195|consen 261 NLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFS 340 (448)
T ss_pred CceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceee
Confidence 999999999999999999774 3678899999999999999999974 3344688899999998876664 32222
Q ss_pred ccccccccCCCccccCCCCcccchhhhhccCCC--CCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhc--cCCCC
Q 037702 157 ALQESTRQDGLLHTTCGTPAYVAPEVINKRGYD--GAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA--EFKCP 232 (448)
Q Consensus 157 ~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~--~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p 232 (448)
- +. ....-.|.||+||.+.....+ -..+|+|||.++||||.|...||.+-+.++.--+|.-. ...+|
T Consensus 341 f--qe-------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ip 411 (448)
T KOG0195|consen 341 F--QE-------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIP 411 (448)
T ss_pred e--ec-------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCC
Confidence 1 00 122347899999999766544 34699999999999999999999998888776666544 45689
Q ss_pred CCCCHHHHHHHHhccCCCcCCCCCHHHHH
Q 037702 233 NWFPPEVRKLLSRILDPNPSTRVTMAKLM 261 (448)
Q Consensus 233 ~~~s~~~~~li~~~L~~dP~~Rpt~~eil 261 (448)
+.+++....|++-|+..||.+||.+..|+
T Consensus 412 pgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 412 PGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred CCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 99999999999999999999999988765
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=187.45 Aligned_cols=135 Identities=19% Similarity=0.244 Sum_probs=110.1
Q ss_pred EEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-----CCCCcceEEEEEEeCC---EE
Q 037702 14 LGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-----RHPNIVQLYEVMASKT---KI 85 (448)
Q Consensus 14 ~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-----~hpnIv~l~~~~~~~~---~~ 85 (448)
-.+.||+|+||.||. +..++.. +||++...... ..+.+.+|+.+++.+ +||||++++++++++. .+
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~---~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDG---GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCe-EEEEEeccccc---hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 356899999999995 7777666 69998765322 246789999999999 6799999999998874 43
Q ss_pred E-EEEee--cCCCchHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHHCCCEeecCCCCceEEcC----CCCeEEeecccc
Q 037702 86 Y-FAMEY--VRGGELFNKVAKGKLREEVARKYFQQLVDAV-EFCHSRGVYHRDLKPENLLLDE----NGDLKISDFGLS 156 (448)
Q Consensus 86 ~-lV~E~--~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL-~yLH~~givHrDLkp~NILl~~----~g~lkl~DFGla 156 (448)
+ +|||| +.+|+|.+++..+.+++. ..++.|++.++ +|||+++|+||||||+|||++. ++.++|+||+.+
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQCRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 4 78999 558999999988777777 35677888777 9999999999999999999974 347999995433
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.1e-21 Score=183.83 Aligned_cols=143 Identities=19% Similarity=0.250 Sum_probs=114.9
Q ss_pred CeEEEeeeeecCceEEEEEE-ECCCCcEEEEEEeecccccc---------------------hhHHHHHHHHHHHHHhCC
Q 037702 11 KYELGRLLGQGTFAKVYHGR-NLKTGQSVAIKIVDKEKIRR---------------------VGLIDQIKREISVMRLVR 68 (448)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~-~~~~g~~vAiK~i~~~~~~~---------------------~~~~~~~~~Ei~~l~~l~ 68 (448)
-|++.+.||+|+||.||+|. +..+|+.||||++....... ......+.+|+.+++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48899999999999999998 67799999999997543210 001234678999999997
Q ss_pred CCC--cceEEEEEEeCCEEEEEEeecCCCchHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCC-CEeecCCCCceEEcC
Q 037702 69 HPN--IVQLYEVMASKTKIYFAMEYVRGGELFNKV-AKGKLREEVARKYFQQLVDAVEFCHSRG-VYHRDLKPENLLLDE 144 (448)
Q Consensus 69 hpn--Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~i-~~~~l~e~~~~~~~~qll~aL~yLH~~g-ivHrDLkp~NILl~~ 144 (448)
+.+ +.++++. . ..++||||++|++|.... ....+.+..+..++.|++.++.+||++| |+||||||+||+++
T Consensus 109 ~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 109 EAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred hcCCCCCeeeEe---c-CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 633 3444442 2 358999999998887665 3456677778899999999999999999 99999999999999
Q ss_pred CCCeEEeecccccc
Q 037702 145 NGDLKISDFGLSAL 158 (448)
Q Consensus 145 ~g~lkl~DFGla~~ 158 (448)
++.++|+|||.|..
T Consensus 184 ~~~i~LiDFg~a~~ 197 (237)
T smart00090 184 DGKVVIIDVSQSVE 197 (237)
T ss_pred CCCEEEEEChhhhc
Confidence 88999999999874
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.5e-20 Score=169.55 Aligned_cols=137 Identities=23% Similarity=0.381 Sum_probs=116.5
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEeecccccchh-----HHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 037702 16 RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVG-----LIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAME 90 (448)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~-----~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (448)
+.||+|++|.||+|.+ +|..+++|+.......... ....+.+|+.++..+.|++|.....++...+..+++||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5799999999999987 7888999987544322211 12457889999999999999888777777788899999
Q ss_pred ecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccc
Q 037702 91 YVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSAL 158 (448)
Q Consensus 91 ~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~ 158 (448)
|++|++|.+.+..... ....++.+++.+|.++|+.|++|||++|.|||++ ++.++|+|||++..
T Consensus 80 ~~~G~~L~~~~~~~~~---~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNGM---EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhccH---HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999999865422 7889999999999999999999999999999999 88999999999874
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.4e-19 Score=166.68 Aligned_cols=133 Identities=22% Similarity=0.332 Sum_probs=109.4
Q ss_pred eeeecCceEEEEEEECCCCcEEEEEEeecccccch-----hHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 037702 17 LLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRV-----GLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAMEY 91 (448)
Q Consensus 17 ~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~-----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 91 (448)
.||+|+||.||+|.. +|..+++|.......... .....+.+|+.+++.+.|+++....-++......++||||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 489999999999985 678999998654332211 1235678999999999988766555555566678999999
Q ss_pred cCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccc
Q 037702 92 VRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSAL 158 (448)
Q Consensus 92 ~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~ 158 (448)
++|++|.+.+..+.. .++.|++.+|.+||+.|++|||++|.||+++ ++.++++|||++..
T Consensus 79 ~~g~~l~~~~~~~~~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGND------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcHH------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999988765321 7899999999999999999999999999999 89999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.9e-21 Score=191.54 Aligned_cols=248 Identities=23% Similarity=0.342 Sum_probs=168.8
Q ss_pred cCCeEEEeeeeecCceEEEEEEECCC---CcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEE-------E
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNLKT---GQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYE-------V 78 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~-------~ 78 (448)
...+.+.+..+..+++.++..+-..+ .+.+.-+..+.+.. .......+++..+....|.+..-+.+ .
T Consensus 243 ~~s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~---~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~ 319 (516)
T KOG1033|consen 243 SGSSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSL---CACKYTFRQLGVLVDSSHSNRSILEDLRPSLFES 319 (516)
T ss_pred cccccccccccccccCCchhhhhcccchhhhhccchhhhccch---hhhhhhhhhhhheeccccCCcccccCCCCchhhh
Confidence 34556666677777777765543322 23333333322221 22344456666666555544444333 1
Q ss_pred EE-----eCCEEEEEEeecCCCchHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeE
Q 037702 79 MA-----SKTKIYFAMEYVRGGELFNKVAKG----KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLK 149 (448)
Q Consensus 79 ~~-----~~~~~~lV~E~~~gg~L~~~i~~~----~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lk 149 (448)
+. ....+||.|++|...+|.+++... ..+......++.|++.|++| +|.+|||+||.||+...+..+|
T Consensus 320 ~~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~k 396 (516)
T KOG1033|consen 320 SKRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLK 396 (516)
T ss_pred ccccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhh
Confidence 11 123588999999999999999753 36677889999999999999 9999999999999999999999
Q ss_pred Eeeccccccccccc----cCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHH
Q 037702 150 ISDFGLSALQESTR----QDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKI 224 (448)
Q Consensus 150 l~DFGla~~~~~~~----~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i 224 (448)
|.|||+.+...... .........||..||+||.+.+..|. .++||||||+||+|++. -..+|.. ...+..+
T Consensus 397 IgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~-~kvdIyaLGlil~EL~~~f~T~~er---~~t~~d~ 472 (516)
T KOG1033|consen 397 IGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYS-EKVDIYALGLILAELLIQFSTQFER---IATLTDI 472 (516)
T ss_pred hhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhh-hhcchhhHHHHHHHHHHHhccHHHH---HHhhhhh
Confidence 99999987543322 11123456899999999999988875 99999999999999997 3333322 1222233
Q ss_pred hhccCCCCCCC-CHHHHHHHHhccCCCcCCCCCHHHHHhhhhc
Q 037702 225 TRAEFKCPNWF-PPEVRKLLSRILDPNPSTRVTMAKLMENYWF 266 (448)
Q Consensus 225 ~~~~~~~p~~~-s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 266 (448)
..+.++.--+. -|+-.+|+.++|.+.|.+||++.+.--|+|.
T Consensus 473 r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 473 RDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred hcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 33333211111 2456799999999999999988777777664
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.4e-20 Score=197.28 Aligned_cols=235 Identities=21% Similarity=0.338 Sum_probs=176.1
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC---CCCcceEEEEEEeCC
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR---HPNIVQLYEVMASKT 83 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~---hpnIv~l~~~~~~~~ 83 (448)
+-..+|.|.+.||+|+||+||.|.+.. |+.||+|+=.......--...+ ++.+|+ -+.|+.+...+.-.+
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q------~~~RLk~~~~~~~~~~~~a~~~~~ 767 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQ------VMERLKPQMLPSIMHISSAHVFQN 767 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHH------HHHhhchhhhcchHHHHHHHccCC
Confidence 446689999999999999999999876 9999999876655544333333 333443 245666666666777
Q ss_pred EEEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcC-------CCCeEEeeccc
Q 037702 84 KIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDE-------NGDLKISDFGL 155 (448)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~-------~g~lkl~DFGl 155 (448)
.-++|+||.+-|+|.+++.. +.+++..+..+..|++..|+.||..||||+||||+|.||.. +--++|+|||-
T Consensus 768 ~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~ 847 (974)
T KOG1166|consen 768 ASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGR 847 (974)
T ss_pred cceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEeccc
Confidence 78999999999999999986 56999999999999999999999999999999999999952 33599999999
Q ss_pred cccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccC-C----
Q 037702 156 SALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF-K---- 230 (448)
Q Consensus 156 a~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~---- 230 (448)
|.-..-..........++|-.+-.+|+..+..+. .++|.|.+..+++.||.|+.- + ...+.. .
T Consensus 848 siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWt-Yq~DyfGlAa~~h~mLFG~y~-------q----~~~g~~~~~~~~ 915 (974)
T KOG1166|consen 848 SIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWT-YQIDYFGLAATVHVMLFGKYM-------E----VKNGSSWMVKTN 915 (974)
T ss_pred ceeeeEcCCCcEEeeeeccccchhHHHhcCCCCc-hhhhhHHHHHHHHHHHHHHHH-------H----hcCCcceecccc
Confidence 8633322222345567899999999999999886 889999999999999998631 1 222211 1
Q ss_pred CCCCCCH-HHHHHHHhccCCCcCCCCCHHHH
Q 037702 231 CPNWFPP-EVRKLLSRILDPNPSTRVTMAKL 260 (448)
Q Consensus 231 ~p~~~s~-~~~~li~~~L~~dP~~Rpt~~ei 260 (448)
++..+-. -..+|+..+|.+|-..=|...+|
T Consensus 916 ~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~l 946 (974)
T KOG1166|consen 916 FPRYWKRDMWNKFFDLLLNPDCDTLPNLQEL 946 (974)
T ss_pred chhhhhHHHHHHHHHHHhCcCcccchhHHHH
Confidence 2222222 23468888888555555555554
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.4e-19 Score=166.76 Aligned_cols=138 Identities=20% Similarity=0.299 Sum_probs=109.9
Q ss_pred eEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccch-------------------hHHHHHHHHHHHHHhCCCCC-
Q 037702 12 YELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRV-------------------GLIDQIKREISVMRLVRHPN- 71 (448)
Q Consensus 12 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~-------------------~~~~~~~~Ei~~l~~l~hpn- 71 (448)
|.+.+.||+|+||.||+|.+ .+|+.||||++......-. .......+|+.++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEc-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 88999999999999999987 4899999999865431000 01123678999999998874
Q ss_pred -cceEEEEEEeCCEEEEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEE
Q 037702 72 -IVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKI 150 (448)
Q Consensus 72 -Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl 150 (448)
++..++ ....++||||++|++|...... .....++.+++.++.++|+.||+||||||+||+++.++.++|
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-----~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~l 166 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL-----EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYI 166 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc-----ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEE
Confidence 444443 2345899999999998765431 346678899999999999999999999999999999999999
Q ss_pred eeccccccc
Q 037702 151 SDFGLSALQ 159 (448)
Q Consensus 151 ~DFGla~~~ 159 (448)
+|||++...
T Consensus 167 iDfg~~~~~ 175 (198)
T cd05144 167 IDWPQMVST 175 (198)
T ss_pred EECCccccC
Confidence 999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.4e-19 Score=181.31 Aligned_cols=199 Identities=24% Similarity=0.410 Sum_probs=157.3
Q ss_pred HHhCCCCCcceEEEEEEeCCEEEEEEeecCCCchHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCC-EeecCCCCce
Q 037702 64 MRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKG--KLREEVARKYFQQLVDAVEFCHSRGV-YHRDLKPENL 140 (448)
Q Consensus 64 l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~--~l~e~~~~~~~~qll~aL~yLH~~gi-vHrDLkp~NI 140 (448)
|+.+.|.|+.++++.+.+....+.|.+||.-|+|.+.+... +++.-....+.++|+.||.|||+..| +|+.+++.|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 45689999999999999999999999999999999999874 46666778889999999999998876 9999999999
Q ss_pred EEcCCCCeEEeeccccccccccccCCCccccCCCCcccchhhhhccCC------CCCcchHHHHHHHHHHHHhCCCCCCC
Q 037702 141 LLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGY------DGAKADIWSCGVVLFVLLAGNLPFYD 214 (448)
Q Consensus 141 Ll~~~g~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~------~~~~sDiwSlGvil~elltG~~Pf~~ 214 (448)
++|....+||+|||+..+..........+...-...|.|||.+..... .+.++||||+|++++|+++...||..
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 999999999999999886643111111222234557999999976422 24669999999999999999999976
Q ss_pred Cc----HHHHHHHHhh-ccCCC-CC-----CCCHHHHHHHHhccCCCcCCCCCHHHHHh
Q 037702 215 SN----LMELYKKITR-AEFKC-PN-----WFPPEVRKLLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 215 ~~----~~~~~~~i~~-~~~~~-p~-----~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 262 (448)
.+ ..++..++.+ +...+ |. .+++++..++++||..+|.+||+++++-.
T Consensus 161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 32 2345555555 22222 21 24457899999999999999999999854
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.2e-19 Score=186.00 Aligned_cols=139 Identities=21% Similarity=0.316 Sum_probs=113.8
Q ss_pred CCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeeccccc-----chhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 037702 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIR-----RVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTK 84 (448)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~-----~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 84 (448)
..|...+.||+|+||.||+|.+. +..+++|+....... .....+.+.+|+.+++.++|++|+....++.....
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred cccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 34566889999999999999873 445555544322211 11123568899999999999999988877777778
Q ss_pred EEEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccc
Q 037702 85 IYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSAL 158 (448)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~ 158 (448)
.++||||++|++|.+++. ....++.|++.+|.|||+.|++||||||+|||+ .++.++|+|||++..
T Consensus 411 ~~lv~E~~~g~~L~~~l~-------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE-------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CEEEEEecCCCcHHHHHH-------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 899999999999998875 457789999999999999999999999999999 688999999999875
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.6e-18 Score=157.96 Aligned_cols=138 Identities=20% Similarity=0.321 Sum_probs=101.4
Q ss_pred EeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHH---------------------HHHHHHHHHHhCCCCC--
Q 037702 15 GRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLID---------------------QIKREISVMRLVRHPN-- 71 (448)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~---------------------~~~~Ei~~l~~l~hpn-- 71 (448)
++.||+|+||.||+|.+. +|+.||||++............ ....|...+..+.+.+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 578999999999999976 8999999998764322111111 1145666676665443
Q ss_pred cceEEEEEEeCCEEEEEEeecCCCchHH-HHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCEeecCCCCceEEcCCCCeE
Q 037702 72 IVQLYEVMASKTKIYFAMEYVRGGELFN-KVAKGKLREEVARKYFQQLVDAVEFCHS-RGVYHRDLKPENLLLDENGDLK 149 (448)
Q Consensus 72 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~-~i~~~~l~e~~~~~~~~qll~aL~yLH~-~givHrDLkp~NILl~~~g~lk 149 (448)
+.+.++. ...++||||++|+.+.. .+...... ..++.++.+++.++.++|+ +||+||||||+||+++ ++.++
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~ 154 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVY 154 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEE
Confidence 4455543 23589999999964422 22221111 6788999999999999999 9999999999999999 99999
Q ss_pred Eeeccccccc
Q 037702 150 ISDFGLSALQ 159 (448)
Q Consensus 150 l~DFGla~~~ 159 (448)
|+|||.+...
T Consensus 155 liDfg~a~~~ 164 (187)
T cd05119 155 IIDVPQAVEI 164 (187)
T ss_pred EEECcccccc
Confidence 9999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.76 E-value=9.8e-18 Score=159.03 Aligned_cols=137 Identities=19% Similarity=0.303 Sum_probs=106.5
Q ss_pred eeee-ecCceEEEEEEECCCCcEEEEEEeecccc-----c-----chhHHHHHHHHHHHHHhCCCCCc--ceEEEEEEeC
Q 037702 16 RLLG-QGTFAKVYHGRNLKTGQSVAIKIVDKEKI-----R-----RVGLIDQIKREISVMRLVRHPNI--VQLYEVMASK 82 (448)
Q Consensus 16 ~~LG-~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-----~-----~~~~~~~~~~Ei~~l~~l~hpnI--v~l~~~~~~~ 82 (448)
..|| .|+.|.||.+.. .+..++||.+..... . .......+.+|+.++..+.|++| ++.+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4566 677777777765 478899998864321 1 11223567899999999998885 6777764332
Q ss_pred -CE---EEEEEeecCC-CchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccc
Q 037702 83 -TK---IYFAMEYVRG-GELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSA 157 (448)
Q Consensus 83 -~~---~~lV~E~~~g-g~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~ 157 (448)
.. .++|||+++| .+|.+++..+.+++.. +.||+.+|.+||++||+||||||+|||++.++.++|+|||.+.
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~ 190 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEAPLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGE 190 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcCCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCcc
Confidence 22 3599999997 6899888877777654 5789999999999999999999999999999999999999886
Q ss_pred c
Q 037702 158 L 158 (448)
Q Consensus 158 ~ 158 (448)
.
T Consensus 191 ~ 191 (239)
T PRK01723 191 L 191 (239)
T ss_pred c
Confidence 4
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.6e-18 Score=181.32 Aligned_cols=263 Identities=25% Similarity=0.424 Sum_probs=209.8
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIY 86 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 86 (448)
...+.+.+.+.+-+|+++.++.+.-..+|...++|+..+...-.....+.+.++-.++-...+|-++....-+......+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 35677888999999999999999887888777777664432222112233334444444445566666555566678899
Q ss_pred EEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccc---
Q 037702 87 FAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQEST--- 162 (448)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~--- 162 (448)
++++|+.|++|...+.. +..+++.++.++..+..+++|||+..+.|||++|.|+|...+|+.+++|||+.......
T Consensus 881 L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~ 960 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPT 960 (1205)
T ss_pred hhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCc
Confidence 99999999999999987 66888899999999999999999999999999999999999999999999843211100
Q ss_pred -------------------c-------cCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCc
Q 037702 163 -------------------R-------QDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSN 216 (448)
Q Consensus 163 -------------------~-------~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~ 216 (448)
. .....+...||+.|.|||.+.+... +..+|+|+.|+++++.++|.+||....
T Consensus 961 ~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~h-gs~ad~~~~g~~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen 961 TDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRH-GSAADWWSSGVCLFEVLTGIPPFNAET 1039 (1205)
T ss_pred CCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccC-CCcchhhhhhhhhhhhhcCCCCCCCcc
Confidence 0 0011234579999999999987766 477999999999999999999999999
Q ss_pred HHHHHHHHhhccCCCCCC---CCHHHHHHHHhccCCCcCCCCCHH---HHHhhhhccccc
Q 037702 217 LMELYKKITRAEFKCPNW---FPPEVRKLLSRILDPNPSTRVTMA---KLMENYWFRKGY 270 (448)
Q Consensus 217 ~~~~~~~i~~~~~~~p~~---~s~~~~~li~~~L~~dP~~Rpt~~---eil~hp~~~~~~ 270 (448)
....+..|.+...++|.. .+.++++++.++|..+|.+|..+. ++..|+||+...
T Consensus 1040 pq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~ 1099 (1205)
T KOG0606|consen 1040 PQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVD 1099 (1205)
T ss_pred hhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCC
Confidence 999999999988877654 789999999999999999999887 999999998743
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.3e-16 Score=138.37 Aligned_cols=132 Identities=23% Similarity=0.316 Sum_probs=113.3
Q ss_pred EEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCC--CCcceEEEEEEeCCEEEEEEee
Q 037702 14 LGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRH--PNIVQLYEVMASKTKIYFAMEY 91 (448)
Q Consensus 14 ~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~h--pnIv~l~~~~~~~~~~~lV~E~ 91 (448)
+.+.||+|.++.||++.+ .+..+++|....... ...+.+|+.+++.+.| +++++++......+..|++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~--~~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGT--KDEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEe--cCCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 457899999999999997 347899999865432 3568899999999977 5899999988888899999999
Q ss_pred cCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCEeecCCCCceEEcCCCCeEEeecccccc
Q 037702 92 VRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSR---GVYHRDLKPENLLLDENGDLKISDFGLSAL 158 (448)
Q Consensus 92 ~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~---givHrDLkp~NILl~~~g~lkl~DFGla~~ 158 (448)
++|+.+... +......++.+++.++.++|.. +++|+|++|+||+++..+.++++|||++..
T Consensus 75 ~~g~~~~~~------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 999877654 5566778899999999999985 799999999999999999999999998863
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PF03822 NAF: NAF domain; InterPro: IPR004041 The NAF domain is a 24 amino acid domain that is found in a plant-specific subgroup of serine-threonine protein kinases (CIPKs), that interact with calcineurin B-like calcium sensor proteins (CBLs) | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.5e-17 Score=120.92 Aligned_cols=60 Identities=57% Similarity=0.840 Sum_probs=48.2
Q ss_pred CCCCCchhhcccCCCCCCCCCCccccc--CcccceEEeCCCHHHHHHHHHHHhhhcCcEEEe
Q 037702 318 PSSFNAFDIISLSKGFNLSGLFEGDAN--SKLEARFTTTKPASAIVSKFEEIAVTESCKFNK 377 (448)
Q Consensus 318 ~~~~~~~~~~~~s~~~~~~~~~~~~~~--~~~~~rf~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (448)
|..+||||+||+|+|+|||+||+.... .++++||+|+.|+++|++|||++|+.+||+|+|
T Consensus 2 p~~lNAFdiIS~S~G~DLSgLFe~~~~~~~~~~~RF~S~~~~~~Ii~klEe~a~~~~~~V~K 63 (63)
T PF03822_consen 2 PKSLNAFDIISLSSGFDLSGLFEEKDKSSVKRETRFTSKEPASEIIEKLEEIAKKLGFRVKK 63 (63)
T ss_dssp -EE--HHHHHCTSTTTSCGGGGGCG-S-SS---EEEEESS-HHHHHHHHHHHHHHTTEEEEE
T ss_pred CccccHHHHHHhccCCChHHhcCccccccccccceEecCCCHHHHHHHHHHHHHhcCceeeC
Confidence 678999999999999999999984333 468999999999999999999999999999986
|
Whereas the N-terminal part of CIPKs comprises a conserved catalytic domain typical of Ser-Thr kinases, the much less conserved C-terminal domain appears to be unique to this subgroup of kinases. The only exception is the NAF domain that forms an 'island of conservation' in this otherwise variable region. The NAF domain has been named after the prominent conserved amino acids Asn-Ala-Phe. It represents a minimum protein interaction module that is both necessary and sufficient to mediate the interaction with the CBL calcium sensor proteins []. The secondary structure of the NAF domain is currently not known, but secondary structure computation of the C-terminal region of Arabidopsis thaliana CBL-interacting protein kinase 1 revealed a long helical structure [].; GO: 0007165 signal transduction; PDB: 2ZFD_B 2EHB_D. |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.61 E-value=5.6e-15 Score=151.94 Aligned_cols=141 Identities=21% Similarity=0.328 Sum_probs=97.3
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEeecccccch---------------------------h----HHH------HHH
Q 037702 16 RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRV---------------------------G----LID------QIK 58 (448)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~---------------------------~----~~~------~~~ 58 (448)
+.||.|++|.||+|+. .+|+.||||+......... . ... .+.
T Consensus 123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 6799999999999985 5899999999854321000 0 001 234
Q ss_pred HHHHHHHhCC----CCCcceEEEEE-EeCCEEEEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHH-HHHHHHHCCC
Q 037702 59 REISVMRLVR----HPNIVQLYEVM-ASKTKIYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVD-AVEFCHSRGV 130 (448)
Q Consensus 59 ~Ei~~l~~l~----hpnIv~l~~~~-~~~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~-aL~yLH~~gi 130 (448)
+|...+.++. |.+-+.+-.++ ...+..+|||||++|++|.+.... ...+ ...++.+++. .+..+|..|+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCc
Confidence 4555555542 22222222222 234457999999999999887643 2222 2345556655 4688999999
Q ss_pred EeecCCCCceEEcCCCCeEEeecccccccc
Q 037702 131 YHRDLKPENLLLDENGDLKISDFGLSALQE 160 (448)
Q Consensus 131 vHrDLkp~NILl~~~g~lkl~DFGla~~~~ 160 (448)
+|+|+||.||+++.+|.++++|||++....
T Consensus 279 ~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 279 FHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred eeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.61 E-value=5.1e-16 Score=161.81 Aligned_cols=146 Identities=18% Similarity=0.344 Sum_probs=102.1
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccc---------------------------h----hHHHH
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRR---------------------------V----GLIDQ 56 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~---------------------------~----~~~~~ 56 (448)
+...|+. +.||.|++|+||+|+.+.+|+.||||+..+..... . +..+.
T Consensus 118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~ 196 (537)
T PRK04750 118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT 196 (537)
T ss_pred HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence 4566887 89999999999999998889999999997542100 0 11223
Q ss_pred HHHHHHH------HHhC----CCCCcceEEEEEE-eCCEEEEEEeecCCCchHHH--Hhc-C----CCCHHHHHHHHHHH
Q 037702 57 IKREISV------MRLV----RHPNIVQLYEVMA-SKTKIYFAMEYVRGGELFNK--VAK-G----KLREEVARKYFQQL 118 (448)
Q Consensus 57 ~~~Ei~~------l~~l----~hpnIv~l~~~~~-~~~~~~lV~E~~~gg~L~~~--i~~-~----~l~e~~~~~~~~ql 118 (448)
+.+|++. +.++ .+.+.+.+-.++. -.+..+|||||++|+.+.+. +.. | .+.+..+..++.|+
T Consensus 197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi 276 (537)
T PRK04750 197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV 276 (537)
T ss_pred HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence 3344433 3333 2333344334432 24567899999999999764 333 3 25556666677776
Q ss_pred HHHHHHHHHCCCEeecCCCCceEEcCCC----CeEEeeccccccccc
Q 037702 119 VDAVEFCHSRGVYHRDLKPENLLLDENG----DLKISDFGLSALQES 161 (448)
Q Consensus 119 l~aL~yLH~~givHrDLkp~NILl~~~g----~lkl~DFGla~~~~~ 161 (448)
+ ..|++|+|+||.||+++.+| .++++|||++.....
T Consensus 277 f-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 F-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred H-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 5 59999999999999999988 999999999875543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.7e-15 Score=154.54 Aligned_cols=256 Identities=18% Similarity=0.242 Sum_probs=192.0
Q ss_pred ccCCeEEEeeeee--cCceEEEEEEE--CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 037702 8 LMNKYELGRLLGQ--GTFAKVYHGRN--LKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEVMASK 82 (448)
Q Consensus 8 ~~~~y~~~~~LG~--G~fg~Vy~a~~--~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~ 82 (448)
....+.+...+|. |.+|.||.+.. ..++..+|+|.-... .........-.+|+...+.+ .|+|.++.+..++..
T Consensus 112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p-~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~ 190 (524)
T KOG0601|consen 112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIP-FSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS 190 (524)
T ss_pred hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCC-CCCccccccccchhhcccccCccccccccCcccccC
Confidence 4456778889999 99999999998 889999999973221 11111112234667666666 599999999999999
Q ss_pred CEEEEEEeecCCCchHHHHhc-CC-CCHHHHHHHHHHHHH----HHHHHHHCCCEeecCCCCceEEcCC-CCeEEeeccc
Q 037702 83 TKIYFAMEYVRGGELFNKVAK-GK-LREEVARKYFQQLVD----AVEFCHSRGVYHRDLKPENLLLDEN-GDLKISDFGL 155 (448)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~-~~-l~e~~~~~~~~qll~----aL~yLH~~givHrDLkp~NILl~~~-g~lkl~DFGl 155 (448)
+..|+-+|+|. .+|..+... .. +++..++..+.+... ||.++|+.+++|-|+||.||++..+ ...+++|||+
T Consensus 191 ~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 191 GILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred Ccceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcce
Confidence 99999999995 688887765 44 899999999999999 9999999999999999999999999 8899999999
Q ss_pred cccccccccCCC---ccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhcc--CC
Q 037702 156 SALQESTRQDGL---LHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAE--FK 230 (448)
Q Consensus 156 a~~~~~~~~~~~---~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~ 230 (448)
...+....-... .....|..-|++||.+++ ..+..+|+||+|.+..+-.+|..++..... ..+..+.... ..
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~-~~W~~~r~~~ip~e 346 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKN-SSWSQLRQGYIPLE 346 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCC-CCccccccccCchh
Confidence 876554332111 122367889999999854 446789999999999988887655432200 0011111111 11
Q ss_pred CCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccc
Q 037702 231 CPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRK 268 (448)
Q Consensus 231 ~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 268 (448)
+-...+.++...+..+++.+|..|++.+.++.|+++..
T Consensus 347 ~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 347 FCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred hhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 11234566777999999999999999999999998864
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.57 E-value=4.4e-14 Score=145.66 Aligned_cols=170 Identities=19% Similarity=0.347 Sum_probs=132.1
Q ss_pred EEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCCchHHHHhcCCCC
Q 037702 28 HGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLR 107 (448)
Q Consensus 28 ~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~l~ 107 (448)
.|..+.++.+|.|..+..+.- +..+.+++-++-|+.++||||+++++.++..+.+|+|+|.+.. |..++.+ +.
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P--l~~~lk~--l~ 102 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP--LETVLKE--LG 102 (690)
T ss_pred ccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc--HHHHHHH--hH
Confidence 466678999999999876643 3456788899999999999999999999999999999999854 4455544 33
Q ss_pred HHHHHHHHHHHHHHHHHHH-HCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCccccCCCCcccchhhhhcc
Q 037702 108 EEVARKYFQQLVDAVEFCH-SRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKR 186 (448)
Q Consensus 108 e~~~~~~~~qll~aL~yLH-~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~ 186 (448)
...+..-+.||+.||.||| ..+++|++|.-..|+++..|..||++|.++........ ..+...---.|..|+.+...
T Consensus 103 ~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 103 KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCcc
Confidence 6677778999999999997 67899999999999999999999999998864332221 11111122246777765433
Q ss_pred CCCCCcchHHHHHHHHHHHHhCC
Q 037702 187 GYDGAKADIWSCGVVLFVLLAGN 209 (448)
Q Consensus 187 ~~~~~~sDiwSlGvil~elltG~ 209 (448)
. -..|.|-|||++++++.|.
T Consensus 181 ~---~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 181 E---WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred c---cchhhhhHHHHHHHHhCcc
Confidence 3 3479999999999999993
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.9e-15 Score=143.28 Aligned_cols=202 Identities=18% Similarity=0.285 Sum_probs=143.0
Q ss_pred HHHHhCCCCCcceEEEEEEeC-----CEEEEEEeecCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC--C
Q 037702 62 SVMRLVRHPNIVQLYEVMASK-----TKIYFAMEYVRGGELFNKVAK-----GKLREEVARKYFQQLVDAVEFCHSR--G 129 (448)
Q Consensus 62 ~~l~~l~hpnIv~l~~~~~~~-----~~~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~aL~yLH~~--g 129 (448)
.-+-.+.|.|||+++.++.+. ....+++||++.|+|..++++ ..+......+|+-||++||.|||+. -
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp 198 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence 445556799999999998654 458899999999999999975 2478888899999999999999987 4
Q ss_pred CEeecCCCCceEEcCCCCeEEeecccccccccccc--CCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh
Q 037702 130 VYHRDLKPENLLLDENGDLKISDFGLSALQESTRQ--DGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA 207 (448)
Q Consensus 130 ivHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~--~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt 207 (448)
|+|+++...-|++..+|-+|+.--........... ........|-++|.|||.=..... ..++|||++|+...+|..
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~-~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNT-TGASDIYKFGMCALEMAI 277 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCccccc-ccchhhhhhhHHHHHHHH
Confidence 99999999999999999999863222211111111 111122347789999996433333 356999999999999998
Q ss_pred CCCC-CCCCcHHHHHHHHhhccCCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcc
Q 037702 208 GNLP-FYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFR 267 (448)
Q Consensus 208 G~~P-f~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~ 267 (448)
|..- -...+.......+.+.-+... ...-+++|.+||...|..||++.+++.||.+-
T Consensus 278 lEiq~tnseS~~~~ee~ia~~i~~le---n~lqr~~i~kcl~~eP~~rp~ar~llfHpllf 335 (458)
T KOG1266|consen 278 LEIQSTNSESKVEVEENIANVIIGLE---NGLQRGSITKCLEGEPNGRPDARLLLFHPLLF 335 (458)
T ss_pred heeccCCCcceeehhhhhhhheeecc---CccccCcCcccccCCCCCCcchhhhhcCceee
Confidence 7654 222222222222222211111 12236789999999999999999999999753
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.51 E-value=2.5e-13 Score=124.09 Aligned_cols=140 Identities=16% Similarity=0.233 Sum_probs=104.5
Q ss_pred EeeeeecCceEEEEEEECC------CCcEEEEEEeecccc--c-----------------chhHHHH----HHHHHHHHH
Q 037702 15 GRLLGQGTFAKVYHGRNLK------TGQSVAIKIVDKEKI--R-----------------RVGLIDQ----IKREISVMR 65 (448)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~------~g~~vAiK~i~~~~~--~-----------------~~~~~~~----~~~Ei~~l~ 65 (448)
...||.|.-+.||.|.... .+..+|||++..... + ....... .++|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3568999999999998643 357999999853211 0 0111223 348999999
Q ss_pred hCCC--CCcceEEEEEEeCCEEEEEEeecCCCchH-HHHhcCCCCHHHHHHHHHHHHHHHHHH-HHCCCEeecCCCCceE
Q 037702 66 LVRH--PNIVQLYEVMASKTKIYFAMEYVRGGELF-NKVAKGKLREEVARKYFQQLVDAVEFC-HSRGVYHRDLKPENLL 141 (448)
Q Consensus 66 ~l~h--pnIv~l~~~~~~~~~~~lV~E~~~gg~L~-~~i~~~~l~e~~~~~~~~qll~aL~yL-H~~givHrDLkp~NIL 141 (448)
++.. -++.+++.+ ..-+|||||+.++.+. ..+....+++..+..++.|++.+|..| |+.|++|+||+|.|||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL 157 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML 157 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 9854 456667764 4568999999876553 234444566777788899999999999 8999999999999999
Q ss_pred EcCCCCeEEeeccccccc
Q 037702 142 LDENGDLKISDFGLSALQ 159 (448)
Q Consensus 142 l~~~g~lkl~DFGla~~~ 159 (448)
++ ++.+.|+|||.|...
T Consensus 158 ~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 158 WH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred EE-CCcEEEEECCCceeC
Confidence 96 578999999988643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.51 E-value=8.1e-14 Score=124.53 Aligned_cols=127 Identities=21% Similarity=0.302 Sum_probs=97.4
Q ss_pred EeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcc-eEEEEEEeCCEEEEEEeecC
Q 037702 15 GRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIV-QLYEVMASKTKIYFAMEYVR 93 (448)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv-~l~~~~~~~~~~~lV~E~~~ 93 (448)
.+.|+.|.++.||++.. .|..|++|+....... ...+.+|+.+++.+.+.+++ +++.... +..++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~~----~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTEL----LINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCccc----ccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence 46789999999999986 4789999987654211 13456899999998665544 4554433 33589999999
Q ss_pred CCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCC-----EeecCCCCceEEcCCCCeEEeeccccc
Q 037702 94 GGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGV-----YHRDLKPENLLLDENGDLKISDFGLSA 157 (448)
Q Consensus 94 gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~gi-----vHrDLkp~NILl~~~g~lkl~DFGla~ 157 (448)
|.++... .......+.+++.+|..||+.++ +|+|++|.||+++ ++.++++|||.+.
T Consensus 75 G~~l~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 75 GSELLTE-------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred CCccccc-------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 9887643 11123467899999999999985 9999999999999 6789999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.6e-14 Score=147.60 Aligned_cols=252 Identities=18% Similarity=0.171 Sum_probs=191.6
Q ss_pred cccccCCeEEEeeeeecCceEEEEEEEC-CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 037702 5 AGILMNKYELGRLLGQGTFAKVYHGRNL-KTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEVMASK 82 (448)
Q Consensus 5 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~-~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~ 82 (448)
.....++|.++..||.|.|+.|+..... .++..|++|.+........+.+ .-..|+.+...+ .|.++++++..|...
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di-~sl~ev~l~~~l~~~~~~~g~~~~W~~~ 338 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDI-FSLGEVILEAILGSHLPSVGKNSSWSQL 338 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhh-cchhhhhHhhHhhcccccCCCCCCcccc
Confidence 3456788999999999999999988755 5788899998865544333222 233566666666 699999999999999
Q ss_pred CEEEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCC-CCeEEeecccccccc
Q 037702 83 TKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDEN-GDLKISDFGLSALQE 160 (448)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~-g~lkl~DFGla~~~~ 160 (448)
...|+-.|||+++++...+.- ..+.+...+....|++.++.++|+..++|+|+||+||++..+ +..+++|||.++...
T Consensus 339 r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~ 418 (524)
T KOG0601|consen 339 RQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA 418 (524)
T ss_pred ccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccc
Confidence 999999999999988666532 458889999999999999999999999999999999999886 789999999986321
Q ss_pred ccccCCCccccCCCCccc-chhhhhccCCCCCcchHHHHHHHHHHHHhCCCC-CCCCcHHHHHHHHhhccCCCCCCCCHH
Q 037702 161 STRQDGLLHTTCGTPAYV-APEVINKRGYDGAKADIWSCGVVLFVLLAGNLP-FYDSNLMELYKKITRAEFKCPNWFPPE 238 (448)
Q Consensus 161 ~~~~~~~~~~~~Gt~~Y~-APEvl~~~~~~~~~sDiwSlGvil~elltG~~P-f~~~~~~~~~~~i~~~~~~~p~~~s~~ 238 (448)
.. .....++-.+. .+|++........++|++|||..+++.++|..- ... .....|..+..+..+..+.+
T Consensus 419 ~~-----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~----~~~~~i~~~~~p~~~~~~~~ 489 (524)
T KOG0601|consen 419 FS-----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG----VQSLTIRSGDTPNLPGLKLQ 489 (524)
T ss_pred ee-----cccccccccccccchhhccccccccccccccccccccccccCcccCccc----ccceeeecccccCCCchHHh
Confidence 11 11122334445 356665554556899999999999999988642 222 22334455555555556688
Q ss_pred HHHHHHhccCCCcCCCCCHHHHHhhhhc
Q 037702 239 VRKLLSRILDPNPSTRVTMAKLMENYWF 266 (448)
Q Consensus 239 ~~~li~~~L~~dP~~Rpt~~eil~hp~~ 266 (448)
+..+.+.++.+++..||.+.++..|.-|
T Consensus 490 ~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 490 LQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred hhhhhhhhcCCccccchhhhhhcccchh
Confidence 9999999999999999999998877644
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.37 E-value=7.3e-12 Score=111.19 Aligned_cols=134 Identities=22% Similarity=0.321 Sum_probs=102.8
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEeecccccchhH-----HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 037702 16 RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGL-----IDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAME 90 (448)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~-----~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (448)
..+++|+-+.+|.+.+ -|..+++|.=-++.....+. .+.-.+|..++..+.--+|.-..=+..+.....|+||
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 4578999999999976 45567777654444443333 3456789999998876666555555556667789999
Q ss_pred ecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccc
Q 037702 91 YVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSAL 158 (448)
Q Consensus 91 ~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~ 158 (448)
|++|-.|.+.+... ...++..+-.-+.-||..||+|+||.++||++..++ +.++||||+.+
T Consensus 80 ~I~G~~lkd~l~~~------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999999888765 245666777788889999999999999999996654 99999999874
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.32 E-value=2.8e-11 Score=107.05 Aligned_cols=144 Identities=22% Similarity=0.299 Sum_probs=110.1
Q ss_pred EEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhH-----HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 037702 14 LGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGL-----IDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFA 88 (448)
Q Consensus 14 ~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~-----~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 88 (448)
....+-+|+-+.|+++.+ .|+.+.||.-..+....+.. ..+.++|+++|.++.--+|.-..=++.+...-.|+
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 567889999999999987 78999998755444333322 35578899999988765665555556666667789
Q ss_pred EeecCC-CchHHHHhc--CCCCHHH-HHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCC---eEEeeccccccc
Q 037702 89 MEYVRG-GELFNKVAK--GKLREEV-ARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGD---LKISDFGLSALQ 159 (448)
Q Consensus 89 ~E~~~g-g~L~~~i~~--~~l~e~~-~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~---lkl~DFGla~~~ 159 (448)
|||++| .++.+++.. ..-.++. ...++++|-+.+.-||.++|+|+||..+||+|..+|. +.++|||++...
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 999987 477777754 2223333 3788999999999999999999999999999977663 589999998753
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.3e-11 Score=114.86 Aligned_cols=140 Identities=21% Similarity=0.310 Sum_probs=109.9
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCC--CcceEEEEEEeCC---EEEEEEe
Q 037702 16 RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHP--NIVQLYEVMASKT---KIYFAME 90 (448)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hp--nIv~l~~~~~~~~---~~~lV~E 90 (448)
+.||.|.++.||++... +|+.+++|........ .....+.+|..+++.+.+. ++.+++.+..... ..++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 67899999999999863 3689999997654321 1235678999999999764 4577777766543 6789999
Q ss_pred ecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------------
Q 037702 91 YVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHS------------------------------------------- 127 (448)
Q Consensus 91 ~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~------------------------------------------- 127 (448)
|++|.++.+.+..+.+++.....++.+++.+|..||+
T Consensus 81 ~i~G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 81 RVDGRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred EeCCEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 9999988776543567788888888888888888884
Q ss_pred -------------CCCEeecCCCCceEEcC--CCCeEEeecccccc
Q 037702 128 -------------RGVYHRDLKPENLLLDE--NGDLKISDFGLSAL 158 (448)
Q Consensus 128 -------------~givHrDLkp~NILl~~--~g~lkl~DFGla~~ 158 (448)
..++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23699999999999998 56689999998763
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.21 E-value=5.4e-10 Score=112.59 Aligned_cols=211 Identities=17% Similarity=0.272 Sum_probs=158.0
Q ss_pred ceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe----CCEEEEEEeecCC-Cch
Q 037702 23 FAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMAS----KTKIYFAMEYVRG-GEL 97 (448)
Q Consensus 23 fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~----~~~~~lV~E~~~g-g~L 97 (448)
-.+.|+|....+|..|++|.++-.+.... .....-+++++++.|+|||++.+++.. +..+++|++|.++ ++|
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQST---NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCc---ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 46789999999999999999954433322 223345788999999999999999873 4568999999986 477
Q ss_pred HHHHh----------------cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccc
Q 037702 98 FNKVA----------------KGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQES 161 (448)
Q Consensus 98 ~~~i~----------------~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~ 161 (448)
.++.- ..+.+|..+|.|+.||..||.++|+.|+.-+-|.|.+||++.+-+++|+..|+..+...
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 66541 12478899999999999999999999999999999999999999999998888765433
Q ss_pred cccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCC-CCCCcHHHH-HHHHhhccCCCCCCCCHHH
Q 037702 162 TRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLP-FYDSNLMEL-YKKITRAEFKCPNWFPPEV 239 (448)
Q Consensus 162 ~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~P-f~~~~~~~~-~~~i~~~~~~~p~~~s~~~ 239 (448)
.. . |-+.. ..+-|.=.||.++..|.||..- +........ ...| -..+|.++
T Consensus 446 d~--------------~--~~le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I-------~~~yS~D~ 498 (655)
T KOG3741|consen 446 DP--------------T--EPLES----QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI-------TTTYSTDL 498 (655)
T ss_pred CC--------------C--cchhH----HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh-------hhhhhHHH
Confidence 21 0 11211 1457899999999999999643 222222221 1222 13478899
Q ss_pred HHHHHhccCCCcCCCCCHHHHHhhh
Q 037702 240 RKLLSRILDPNPSTRVTMAKLMENY 264 (448)
Q Consensus 240 ~~li~~~L~~dP~~Rpt~~eil~hp 264 (448)
+++|..+...++++ -++.+++.+-
T Consensus 499 rn~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 499 RNVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred HHHHHHHHhcCccc-ccHHHHHHHH
Confidence 99999999999987 7888988763
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.11 E-value=5.8e-10 Score=101.50 Aligned_cols=127 Identities=24% Similarity=0.413 Sum_probs=85.6
Q ss_pred EEEEEEECCCCcEEEEEEeecccc-----------------------cchhHHHHHHHHHHHHHhCCCC--CcceEEEEE
Q 037702 25 KVYHGRNLKTGQSVAIKIVDKEKI-----------------------RRVGLIDQIKREISVMRLVRHP--NIVQLYEVM 79 (448)
Q Consensus 25 ~Vy~a~~~~~g~~vAiK~i~~~~~-----------------------~~~~~~~~~~~Ei~~l~~l~hp--nIv~l~~~~ 79 (448)
.||.|.. .+|..+|||+...... .........++|...|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 4899986 5688999999854210 0011135678999999999766 466776543
Q ss_pred EeCCEEEEEEeecC--CCchHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHHCCCEeecCCCCceEEcCCCCeEEeecccc
Q 037702 80 ASKTKIYFAMEYVR--GGELFNKVAKGKLREEVARKYFQQLVDAVEF-CHSRGVYHRDLKPENLLLDENGDLKISDFGLS 156 (448)
Q Consensus 80 ~~~~~~~lV~E~~~--gg~L~~~i~~~~l~e~~~~~~~~qll~aL~y-LH~~givHrDLkp~NILl~~~g~lkl~DFGla 156 (448)
.-+|||||++ |..+.. +....++.+....++.+++..+.. +|..||+|+||.+.|||++.+ .+.++|||.+
T Consensus 80 ----~~~ivME~I~~~G~~~~~-l~~~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~qa 153 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPR-LKDVDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQA 153 (188)
T ss_dssp ----TTEEEEE--EETTEEGGC-HHHCGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTTE
T ss_pred ----CCEEEEEecCCCccchhh-HHhccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCcc
Confidence 2369999998 555544 433333356677788888886666 579999999999999999877 9999999987
Q ss_pred cc
Q 037702 157 AL 158 (448)
Q Consensus 157 ~~ 158 (448)
..
T Consensus 154 v~ 155 (188)
T PF01163_consen 154 VD 155 (188)
T ss_dssp EE
T ss_pred ee
Confidence 64
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.10 E-value=2e-09 Score=103.58 Aligned_cols=134 Identities=14% Similarity=0.094 Sum_probs=96.1
Q ss_pred CceEEEEEEECCCCcEEEEEEeecccccc---h-----hHHHHHHHHHHHHHhCCCCCc--ceEEEEEEe-----CCEEE
Q 037702 22 TFAKVYHGRNLKTGQSVAIKIVDKEKIRR---V-----GLIDQIKREISVMRLVRHPNI--VQLYEVMAS-----KTKIY 86 (448)
Q Consensus 22 ~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~---~-----~~~~~~~~Ei~~l~~l~hpnI--v~l~~~~~~-----~~~~~ 86 (448)
....|++... .|+.|.||......... . .-...+.+|...+.+|..-+| +.+..+.+. ...-+
T Consensus 34 ~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~ 111 (268)
T PRK15123 34 EGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSF 111 (268)
T ss_pred CCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeE
Confidence 3334556544 67889999774332110 0 001147789999888854333 333444433 23578
Q ss_pred EEEeecCCC-chHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcC-------CCCeEEeeccc
Q 037702 87 FAMEYVRGG-ELFNKVAK---GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDE-------NGDLKISDFGL 155 (448)
Q Consensus 87 lV~E~~~gg-~L~~~i~~---~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~-------~g~lkl~DFGl 155 (448)
||||++++- +|.+++.. ...++.....++.+++..+.-||+.||+|+|+++.|||++. ++.+.|+||+.
T Consensus 112 LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r 191 (268)
T PRK15123 112 IITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHR 191 (268)
T ss_pred EEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCc
Confidence 999999886 78888753 45677788899999999999999999999999999999985 46799999998
Q ss_pred cc
Q 037702 156 SA 157 (448)
Q Consensus 156 a~ 157 (448)
+.
T Consensus 192 ~~ 193 (268)
T PRK15123 192 AQ 193 (268)
T ss_pred cc
Confidence 75
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.07 E-value=3.4e-09 Score=104.48 Aligned_cols=234 Identities=20% Similarity=0.240 Sum_probs=153.4
Q ss_pred EEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEE------EEe-CCE
Q 037702 13 ELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEV------MAS-KTK 84 (448)
Q Consensus 13 ~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~------~~~-~~~ 84 (448)
..++.||+|+.+.+|..-. -.-.+-|++.+...... . +.+..|... .||-+-.=+.+ -.+ ...
T Consensus 14 ~~gr~LgqGgea~ly~l~e---~~d~VAKIYh~Pppa~~-----a-qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~ 84 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGE---VRDQVAKIYHAPPPAAQ-----A-QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKV 84 (637)
T ss_pred CCCccccCCccceeeecch---hhchhheeecCCCchHH-----H-HHHHHhccCCCCcchhhhhcccHHHhhCCCccce
Confidence 4578899999999996532 12245588876643321 1 122333333 56644331111 112 233
Q ss_pred EEEEEeecCCCch-HHHHhc----C---CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccc
Q 037702 85 IYFAMEYVRGGEL-FNKVAK----G---KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLS 156 (448)
Q Consensus 85 ~~lV~E~~~gg~L-~~~i~~----~---~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla 156 (448)
+-+.|..++|..- ..+... . -+.++.+.+..+.|+.+.+.||..|.+-+|+.++|+|+.+++.+.|.|-..-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence 7899999988633 222221 1 2677889999999999999999999999999999999999999999985543
Q ss_pred ccccccccCCCccccCCCCcccchhhhh-----ccCCCCCcchHHHHHHHHHHHHhC-CCCCCCCcH-----HHHHHHHh
Q 037702 157 ALQESTRQDGLLHTTCGTPAYVAPEVIN-----KRGYDGAKADIWSCGVVLFVLLAG-NLPFYDSNL-----MELYKKIT 225 (448)
Q Consensus 157 ~~~~~~~~~~~~~~~~Gt~~Y~APEvl~-----~~~~~~~~sDiwSlGvil~elltG-~~Pf~~~~~-----~~~~~~i~ 225 (448)
.+. ..+...-..+|.+.|.+||.-. +.+- +...|.|.||+++++++.| +.||.+-.. ...-..|.
T Consensus 165 qi~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r-~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia 240 (637)
T COG4248 165 QIN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFER-TANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIA 240 (637)
T ss_pred eec---cCCceEecccCccccCCHHHhccccccccCC-CccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhh
Confidence 322 2233445678999999999754 2222 3668999999999999875 999975211 01111222
Q ss_pred hcc----------C-CCC---C--CCCHHHHHHHHhccCC--CcCCCCCHHH
Q 037702 226 RAE----------F-KCP---N--WFPPEVRKLLSRILDP--NPSTRVTMAK 259 (448)
Q Consensus 226 ~~~----------~-~~p---~--~~s~~~~~li~~~L~~--dP~~Rpt~~e 259 (448)
.+. + +.| + -+++++..|..+|+.. +|.-|||++.
T Consensus 241 ~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 241 HGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred cceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 221 1 111 1 2679999999999954 4678999865
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.07 E-value=5.3e-11 Score=123.61 Aligned_cols=154 Identities=21% Similarity=0.379 Sum_probs=114.1
Q ss_pred HHHHHHHHHHHHC-CCEeecCCCCceEEcCCCCeEEeeccccccccccccC-------CCccccCCCCcccchhhhhccC
Q 037702 116 QQLVDAVEFCHSR-GVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQD-------GLLHTTCGTPAYVAPEVINKRG 187 (448)
Q Consensus 116 ~qll~aL~yLH~~-givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~-------~~~~~~~Gt~~Y~APEvl~~~~ 187 (448)
.+.+.|+.|+|.. ++||++|.|++|.++.+|.+||+.|+++......... .......-...|.|||.+.. .
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~ 184 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-T 184 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-c
Confidence 3445999999965 8999999999999999999999999988644331111 11111124567999999977 4
Q ss_pred CCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHH----hhccCCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHh
Q 037702 188 YDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKI----TRAEFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 188 ~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i----~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 262 (448)
..+.++|+||+||++|.+.. |+.-+...+....+... ....+.....+|+++++=+.++|..++.-||++..++.
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhc
Confidence 55688999999999999984 55545444332222211 11223455678999999999999999999999999999
Q ss_pred hhhccccc
Q 037702 263 NYWFRKGY 270 (448)
Q Consensus 263 hp~~~~~~ 270 (448)
.|||....
T Consensus 265 ~~ff~D~~ 272 (700)
T KOG2137|consen 265 IPFFSDPG 272 (700)
T ss_pred ccccCCch
Confidence 99998754
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.96 E-value=4e-09 Score=99.20 Aligned_cols=137 Identities=23% Similarity=0.378 Sum_probs=104.1
Q ss_pred eEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccc--cc-----------------hhHHHHHHHHHHHHHhCCCC--
Q 037702 12 YELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKI--RR-----------------VGLIDQIKREISVMRLVRHP-- 70 (448)
Q Consensus 12 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~--~~-----------------~~~~~~~~~Ei~~l~~l~hp-- 70 (448)
+.++..||.|.-|.||.|.+. .|.++|||.-..... .+ .-.....++|..+|.+|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 457899999999999999964 799999997532110 00 00134578999999999655
Q ss_pred CcceEEEEEEeCCEEEEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEE
Q 037702 71 NIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKI 150 (448)
Q Consensus 71 nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl 150 (448)
.|.+.+++ +.-.+||||++|-.|... +++.+.+..++..|+.-+.-+-..|++|+|+.+-||+++++|.+.+
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~v 243 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRL----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVV 243 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeecc----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEE
Confidence 66666653 456799999999777543 2345556667777777777777999999999999999999999999
Q ss_pred eeccccc
Q 037702 151 SDFGLSA 157 (448)
Q Consensus 151 ~DFGla~ 157 (448)
+||--+.
T Consensus 244 IDwPQ~v 250 (304)
T COG0478 244 IDWPQAV 250 (304)
T ss_pred EeCcccc
Confidence 9997654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.84 E-value=3.9e-08 Score=91.18 Aligned_cols=125 Identities=20% Similarity=0.290 Sum_probs=92.1
Q ss_pred CCcEEEEEEeecccccc----hhHHHHHHHHHHHHHhCCCCC--cceEEEEEEeC----CEEEEEEeecCCC-chHHHHh
Q 037702 34 TGQSVAIKIVDKEKIRR----VGLIDQIKREISVMRLVRHPN--IVQLYEVMASK----TKIYFAMEYVRGG-ELFNKVA 102 (448)
Q Consensus 34 ~g~~vAiK~i~~~~~~~----~~~~~~~~~Ei~~l~~l~hpn--Iv~l~~~~~~~----~~~~lV~E~~~gg-~L~~~i~ 102 (448)
.++.+-+|........+ .-......+|...+..|..-+ +.+.+++.+.. ..-++|+|+++|. +|.+++.
T Consensus 31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~ 110 (206)
T PF06293_consen 31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ 110 (206)
T ss_pred cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence 45566666543221111 112346778888888875433 34555555442 2458999999985 7888887
Q ss_pred c-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCC---CeEEeecccccc
Q 037702 103 K-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENG---DLKISDFGLSAL 158 (448)
Q Consensus 103 ~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g---~lkl~DFGla~~ 158 (448)
. ..++......++.+++..+.-||++||+|+|++|.|||++.++ .+.++||+-+..
T Consensus 111 ~~~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 111 QWEQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred hhcccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 6 3477778899999999999999999999999999999999887 899999997764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.80 E-value=8.2e-08 Score=88.25 Aligned_cols=137 Identities=15% Similarity=0.133 Sum_probs=100.4
Q ss_pred eecCceEEEEEEECCCCcEEEEEEeecccc---cchhHHHHHHHHHHHHHhCCCCC--cceEEEEEEe--C--CEEEEEE
Q 037702 19 GQGTFAKVYHGRNLKTGQSVAIKIVDKEKI---RRVGLIDQIKREISVMRLVRHPN--IVQLYEVMAS--K--TKIYFAM 89 (448)
Q Consensus 19 G~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~---~~~~~~~~~~~Ei~~l~~l~hpn--Iv~l~~~~~~--~--~~~~lV~ 89 (448)
|+||-+.|+.... .|+.+-+|.-..... ....-...+.+|+..+..|..-+ +.++...-.. . -.-+||+
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 6789999998765 455788887642211 10223467889999999885433 4444422111 1 2357999
Q ss_pred eecCC-CchHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCC--eEEeeccccc
Q 037702 90 EYVRG-GELFNKVAKG---KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGD--LKISDFGLSA 157 (448)
Q Consensus 90 E~~~g-g~L~~~i~~~---~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~--lkl~DFGla~ 157 (448)
|-++| -+|.+++..+ +.++.....++.+++.++.-||+.|+.|+|+.+.|||++.+|. ++++||.-++
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 98765 4888888664 4577888899999999999999999999999999999987777 9999998665
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.4e-07 Score=87.15 Aligned_cols=141 Identities=23% Similarity=0.307 Sum_probs=95.1
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHH------HHHHHHHHHHHhCCC---CCcceEEE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLI------DQIKREISVMRLVRH---PNIVQLYE 77 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~------~~~~~Ei~~l~~l~h---pnIv~l~~ 77 (448)
++.++|.+.+++-......|.+..- +|+.+++|.........+... ....+.+..+.++.. .....++-
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 5678999999999888888887765 789999998754432211111 112344444444432 23333333
Q ss_pred EEE-----eCCEEEEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEee
Q 037702 78 VMA-----SKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISD 152 (448)
Q Consensus 78 ~~~-----~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~D 152 (448)
+.+ -....+|+|||++|.+|.+... +++ .+...+.+++.-||+.|++|+|.+|.|++++. +.++++|
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~---i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~-~~i~iID 177 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED---IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSN-NGIRIID 177 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh---cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEEC-CcEEEEE
Confidence 322 2234568999999988866532 333 24466778899999999999999999999985 4599999
Q ss_pred ccccc
Q 037702 153 FGLSA 157 (448)
Q Consensus 153 FGla~ 157 (448)
|+...
T Consensus 178 ~~~k~ 182 (229)
T PF06176_consen 178 TQGKR 182 (229)
T ss_pred Ccccc
Confidence 98654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.67 E-value=1.4e-07 Score=98.28 Aligned_cols=137 Identities=21% Similarity=0.384 Sum_probs=92.1
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEeecccccc---------------------------hh----HHHH------HH
Q 037702 16 RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRR---------------------------VG----LIDQ------IK 58 (448)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~---------------------------~~----~~~~------~~ 58 (448)
+.|+.++-|+||+|+- .+|+.||||+....-... .+ ..+. +.
T Consensus 131 ~PiAsASIaQVH~A~L-~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVL-KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEe-cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 5789999999999996 569999999975421000 00 0111 34
Q ss_pred HHHHHHHhC-----CCCCcceEEEEEEeCCEEEEEEeecCCCchHHH--HhcCCCCHHH-----HHHHHHHHHHHHHHHH
Q 037702 59 REISVMRLV-----RHPNIVQLYEVMASKTKIYFAMEYVRGGELFNK--VAKGKLREEV-----ARKYFQQLVDAVEFCH 126 (448)
Q Consensus 59 ~Ei~~l~~l-----~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~--i~~~~l~e~~-----~~~~~~qll~aL~yLH 126 (448)
+|...+.++ +.|+|.-..=+++-.+.-.|+|||++|-.+.+. ++..+++... +..++.|++
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~------- 282 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLL------- 282 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHH-------
Confidence 455555444 234433333334445667899999999988777 4444455333 333444433
Q ss_pred HCCCEeecCCCCceEEcCCCCeEEeecccccccc
Q 037702 127 SRGVYHRDLKPENLLLDENGDLKISDFGLSALQE 160 (448)
Q Consensus 127 ~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~ 160 (448)
..|++|.|.+|.||+++.+|.+.+.|||+.....
T Consensus 283 ~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 283 RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred hcCccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 3899999999999999999999999999987544
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.66 E-value=3.7e-07 Score=85.87 Aligned_cols=133 Identities=17% Similarity=0.182 Sum_probs=85.3
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC--cceEEEEEEeCCEEEEEEeecC
Q 037702 16 RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPN--IVQLYEVMASKTKIYFAMEYVR 93 (448)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpn--Iv~l~~~~~~~~~~~lV~E~~~ 93 (448)
..||+|..+.||+. .|..+++|...... ....+.+|.++++.+..-+ +.+.+.+.+..+...+|||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 56899999999973 35578889875422 1245789999999986444 4777888888888899999999
Q ss_pred CCc-hHHH--------------H-------hc---CCCCHHH-HHHHHHHH----------HH-HHHHHHH----CCCEe
Q 037702 94 GGE-LFNK--------------V-------AK---GKLREEV-ARKYFQQL----------VD-AVEFCHS----RGVYH 132 (448)
Q Consensus 94 gg~-L~~~--------------i-------~~---~~l~e~~-~~~~~~ql----------l~-aL~yLH~----~givH 132 (448)
|.+ +... + .. ...+... ...+..++ .. ...+|.+ ..++|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 963 1111 1 00 0011000 01111111 11 1122221 24789
Q ss_pred ecCCCCceEEcCCCCeEEeecccccc
Q 037702 133 RDLKPENLLLDENGDLKISDFGLSAL 158 (448)
Q Consensus 133 rDLkp~NILl~~~g~lkl~DFGla~~ 158 (448)
+|+.|.||++++++ +.|+||+.+..
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhcCc
Confidence 99999999999888 99999998753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.63 E-value=4.6e-07 Score=84.55 Aligned_cols=136 Identities=21% Similarity=0.311 Sum_probs=83.2
Q ss_pred EeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC--cceEEEEE---EeCCEEEEEE
Q 037702 15 GRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPN--IVQLYEVM---ASKTKIYFAM 89 (448)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpn--Iv~l~~~~---~~~~~~~lV~ 89 (448)
++.|+.|..+.||+..... ..+++|..... .....+.+|..+++.+...+ +.+++... ......+++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 4689999999999998743 59999997544 23467778999988885433 45666644 2344679999
Q ss_pred eecCCCchHH----------------HHhc---C--C---CCHHH---------HHH------------HHHHHHH-HHH
Q 037702 90 EYVRGGELFN----------------KVAK---G--K---LREEV---------ARK------------YFQQLVD-AVE 123 (448)
Q Consensus 90 E~~~gg~L~~----------------~i~~---~--~---l~e~~---------~~~------------~~~qll~-aL~ 123 (448)
++++|..+.. .+.. - . +.... ... ....+.. .++
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999987766 1111 0 0 01000 000 0111222 334
Q ss_pred HHHH-------CCCEeecCCCCceEEc-CCCCeEEeeccccc
Q 037702 124 FCHS-------RGVYHRDLKPENLLLD-ENGDLKISDFGLSA 157 (448)
Q Consensus 124 yLH~-------~givHrDLkp~NILl~-~~g~lkl~DFGla~ 157 (448)
.+++ ..++|+|+.|.|||++ .++.+-|+||+.+.
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 4432 3599999999999999 66667899999765
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.60 E-value=7.9e-07 Score=83.08 Aligned_cols=137 Identities=18% Similarity=0.238 Sum_probs=98.1
Q ss_pred eeeecCceEEEEEEECCCCcEEEEEEeecccccchh---------------------HHHHHHHHHHHHHhCC--CCCcc
Q 037702 17 LLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVG---------------------LIDQIKREISVMRLVR--HPNIV 73 (448)
Q Consensus 17 ~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~---------------------~~~~~~~Ei~~l~~l~--hpnIv 73 (448)
.|..|.-+.||+|.. .++..+|+|++......-.. ......+|..-|+++. +=.+.
T Consensus 55 ~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 55 CISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 556777788999984 57899999998654321111 1234567888888874 33445
Q ss_pred eEEEEEEeCCEEEEEEeecCCCc-hHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCEeecCCCCceEEcCCCCeEEe
Q 037702 74 QLYEVMASKTKIYFAMEYVRGGE-LFNKVAKGKLREEVARKYFQQLVDAVEFCHS-RGVYHRDLKPENLLLDENGDLKIS 151 (448)
Q Consensus 74 ~l~~~~~~~~~~~lV~E~~~gg~-L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~-~givHrDLkp~NILl~~~g~lkl~ 151 (448)
+.+.+.. -.|||||+.... -.-.+..-++..+++..+..++++.+.-|-. .|+||+||..-|||+. +|.+.++
T Consensus 134 ~Pi~~~~----nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~iI 208 (268)
T COG1718 134 EPIAFRN----NVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYII 208 (268)
T ss_pred CceeecC----CeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEEE
Confidence 5555443 469999996541 1222333344555789999999999999877 9999999999999998 8999999
Q ss_pred eccccccc
Q 037702 152 DFGLSALQ 159 (448)
Q Consensus 152 DFGla~~~ 159 (448)
|||-|...
T Consensus 209 D~~QaV~~ 216 (268)
T COG1718 209 DVSQAVTI 216 (268)
T ss_pred ECcccccc
Confidence 99987643
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.57 E-value=8.4e-09 Score=106.44 Aligned_cols=240 Identities=21% Similarity=0.186 Sum_probs=166.4
Q ss_pred CeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC-cceEEEEEEeCCEEEEEE
Q 037702 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPN-IVQLYEVMASKTKIYFAM 89 (448)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpn-Iv~l~~~~~~~~~~~lV~ 89 (448)
.|....-+++|+++++++.+...+...+ .+.+... ....-++++|.+++||| .+..++-++.++..+++|
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~ 313 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPM 313 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccchhh
Confidence 4556667899999999999876665544 6655433 23446899999999999 777777788888999999
Q ss_pred eecCCC-chHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCC
Q 037702 90 EYVRGG-ELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDG 166 (448)
Q Consensus 90 E~~~gg-~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 166 (448)
+++.++ +....... -.+.+-+.....+.-+.+++|+|+.-=+||| ||+..+ +..+..||+.........
T Consensus 314 ~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--- 385 (829)
T KOG0576|consen 314 RICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--- 385 (829)
T ss_pred hhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc---
Confidence 999887 22221111 1233444555666778899999999888999 777654 789999999876543322
Q ss_pred CccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCC------CCCCHHHH
Q 037702 167 LLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCP------NWFPPEVR 240 (448)
Q Consensus 167 ~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p------~~~s~~~~ 240 (448)
...+..+|+.++|||+.....++ ...|.|++|.--.+|.-|.+|-.... .....+..+ ...| .|-+..-.
T Consensus 386 ~~~t~~~~~~~~~pev~~~~~~~-~~p~~~~~~~~~~~~ap~~pPr~~P~--~~~~~~g~~-p~s~~L~~~~aw~~~~~~ 461 (829)
T KOG0576|consen 386 KPRTAIGTPEPLAPEVIQENTID-GCPDSGSLAVSAIQMAPGLPPRSSPP--AVLPMIGNG-PNSPMLTDKSAWSPVFHR 461 (829)
T ss_pred ccccCCCCCCCCCchhhcccccc-cCCCccCCCcchhhcCCCCCCCCCCc--cccCCCCCC-CCccccchhhhcCccccc
Confidence 23567899999999999888787 67999999988778887877743311 000000000 0001 11122223
Q ss_pred HHHHhccCCCcCCCCCHHHHHhhhhcccccc
Q 037702 241 KLLSRILDPNPSTRVTMAKLMENYWFRKGYK 271 (448)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~ 271 (448)
++...|+..-|..|+.....+.|-+|..-..
T Consensus 462 ~~~~~~~~g~P~~pkv~mgacfsKvfngCpl 492 (829)
T KOG0576|consen 462 DFPAPCLNGLPPTPKVHMGACFSKVFNGCPL 492 (829)
T ss_pred CCcccccCCCCCCCcchhhHHHHHHhccCcc
Confidence 5778899999999999999999888865433
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.37 E-value=2.9e-06 Score=93.41 Aligned_cols=202 Identities=19% Similarity=0.217 Sum_probs=143.8
Q ss_pred HHHHHHHHHHhCCCCCcceEEEEEEeCCEE----EEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 037702 56 QIKREISVMRLVRHPNIVQLYEVMASKTKI----YFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGV 130 (448)
Q Consensus 56 ~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~----~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~gi 130 (448)
...-|+..+....|+|++.++.+-...... .+..++|++.++...+.. +..+.+.++.+..++++|+.|+|+...
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l 307 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSL 307 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhcc
Confidence 344566777888999999999987554333 345678999999998876 889999999999999999999999977
Q ss_pred EeecCCCC---ceEEcCCCCeEEe--eccccccccccccCCCccccCCCCcccchhhhhccCCC-CCcchHHHHHHHHHH
Q 037702 131 YHRDLKPE---NLLLDENGDLKIS--DFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYD-GAKADIWSCGVVLFV 204 (448)
Q Consensus 131 vHrDLkp~---NILl~~~g~lkl~--DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~-~~~sDiwSlGvil~e 204 (448)
.|.-+... +-..+..+...++ ||+.+......... ....-+..+.|||......+. +...|+|++|..+..
T Consensus 308 ~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~ 384 (1351)
T KOG1035|consen 308 EHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQ 384 (1351)
T ss_pred ceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHHHHHHHhh
Confidence 77666655 4445566677776 88887755433222 233345678888887655443 223699999999999
Q ss_pred HHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 205 LLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 205 lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
+..|..+-.-. ....... +........++..+|+..++++|+++.+++.|+|.+..
T Consensus 385 ~~~~~~i~~~~---~~~~~~l------~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 385 LSQGEDISEKS---AVPVSLL------DVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFP 440 (1351)
T ss_pred hhhcCcccccc---cchhhhh------ccccchhhhhhhhhhcchhhhhccchhhhhhchhcccc
Confidence 98875442111 0000000 11112267889999999999999999999999998643
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.36 E-value=1e-05 Score=74.26 Aligned_cols=134 Identities=21% Similarity=0.351 Sum_probs=100.0
Q ss_pred EeeeeecCceEEEEEEECCCCcEEEEEEeecccc-------------cchhHHHHHHHHHHHHHhCC------CCCcceE
Q 037702 15 GRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKI-------------RRVGLIDQIKREISVMRLVR------HPNIVQL 75 (448)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-------------~~~~~~~~~~~Ei~~l~~l~------hpnIv~l 75 (448)
...||+|+.=.||.- ......+||++..... .......+..+|+.....+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 356899999999963 3456678999977651 01112356677887777766 7899999
Q ss_pred EEEEEeCCEEEEEEeecCC------CchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCC---
Q 037702 76 YEVMASKTKIYFAMEYVRG------GELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENG--- 146 (448)
Q Consensus 76 ~~~~~~~~~~~lV~E~~~g------g~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g--- 146 (448)
+|+.+++.-.-+|+|.+.+ -+|.+++..+.+++ .+...+-+-.+||-+.+|+.+|++|.||++..++
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~----~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~ 158 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGGLTE----ELRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE 158 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCCccH----HHHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence 9999999999999998753 26888888877777 3444556667788999999999999999996433
Q ss_pred -CeEEee-ccc
Q 037702 147 -DLKISD-FGL 155 (448)
Q Consensus 147 -~lkl~D-FGl 155 (448)
.+.|+| ||-
T Consensus 159 ~~lvlIDG~G~ 169 (199)
T PF10707_consen 159 FRLVLIDGLGE 169 (199)
T ss_pred eEEEEEeCCCC
Confidence 467776 443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.36 E-value=2.4e-06 Score=88.98 Aligned_cols=140 Identities=19% Similarity=0.309 Sum_probs=89.4
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEeecccccch-----------------------------hHHHHHH------HH
Q 037702 16 RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRV-----------------------------GLIDQIK------RE 60 (448)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~-----------------------------~~~~~~~------~E 60 (448)
+.||.-+.|+||+|+-+ +|+.||||+-... +... +..+.+. +|
T Consensus 167 ~piaaASlaQVhrA~L~-~G~~VaVKVQ~P~-l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E 244 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLK-NGEDVAVKVQHPG-LEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE 244 (538)
T ss_pred chhhhcchhheEEEEec-CCCEEEEEecCcC-hHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence 57899999999999964 5999999985432 1100 1112222 23
Q ss_pred HHHH----HhCCCCC------cceEEEEEEeCCEEEEEEeecCCCchHH--HHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Q 037702 61 ISVM----RLVRHPN------IVQLYEVMASKTKIYFAMEYVRGGELFN--KVAKGKLREEVARKYFQQLVDAVEFCHSR 128 (448)
Q Consensus 61 i~~l----~~l~hpn------Iv~l~~~~~~~~~~~lV~E~~~gg~L~~--~i~~~~l~e~~~~~~~~qll~aL~yLH~~ 128 (448)
.+-. +.+.|-+ |.++|.- -.+...|+||||+|..+.+ .|.+.+++...+...+.+...-+ +=..
T Consensus 245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~q--If~~ 320 (538)
T KOG1235|consen 245 AKNAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQ--IFKT 320 (538)
T ss_pred HHhHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHH--HHhc
Confidence 2222 2233444 3444332 3356789999999987744 45666677665544433332221 2246
Q ss_pred CCEeecCCCCceEEcC----CCCeEEeeccccccccc
Q 037702 129 GVYHRDLKPENLLLDE----NGDLKISDFGLSALQES 161 (448)
Q Consensus 129 givHrDLkp~NILl~~----~g~lkl~DFGla~~~~~ 161 (448)
|++|.|-+|.||++.. ++.+.+-|||+......
T Consensus 321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 8999999999999984 66899999999875543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.35 E-value=4.2e-06 Score=79.42 Aligned_cols=133 Identities=14% Similarity=0.134 Sum_probs=83.7
Q ss_pred eeeecCc-eEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEeecCC
Q 037702 17 LLGQGTF-AKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR-HPNIVQLYEVMASKTKIYFAMEYVRG 94 (448)
Q Consensus 17 ~LG~G~f-g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (448)
.|-.|.+ +.||+... .+..+.+|+..... ...+.+|+.+++.+. +--+.+++.+....+..++|||+++|
T Consensus 5 ~~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 76 (244)
T cd05150 5 RVTEGQSGATVYRLDG--KNPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG 76 (244)
T ss_pred ecCCCCCcCeEEEEcC--CCCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence 4445555 78999865 34688889875432 234668999988884 34466778877776778999999999
Q ss_pred CchHHHH----------------hc-CCCCH-----H-HHHHHHHH-----------------------HHHHHHHHH--
Q 037702 95 GELFNKV----------------AK-GKLRE-----E-VARKYFQQ-----------------------LVDAVEFCH-- 126 (448)
Q Consensus 95 g~L~~~i----------------~~-~~l~e-----~-~~~~~~~q-----------------------ll~aL~yLH-- 126 (448)
.+|.... .. ..++. . .....+.+ +...++.|-
T Consensus 77 ~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 156 (244)
T cd05150 77 VPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEAT 156 (244)
T ss_pred ccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhh
Confidence 7664321 00 11110 0 00000000 111122221
Q ss_pred -----HCCCEeecCCCCceEEcCCCCeEEeeccccc
Q 037702 127 -----SRGVYHRDLKPENLLLDENGDLKISDFGLSA 157 (448)
Q Consensus 127 -----~~givHrDLkp~NILl~~~g~lkl~DFGla~ 157 (448)
...++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 157 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 157 RPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 2348999999999999998778899999775
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.34 E-value=6.3e-06 Score=91.92 Aligned_cols=144 Identities=18% Similarity=0.373 Sum_probs=92.2
Q ss_pred EEeeeeecCceEEEEEEECCCC--cEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCc--ceEEEEEEeC---CEE
Q 037702 14 LGRLLGQGTFAKVYHGRNLKTG--QSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR-HPNI--VQLYEVMASK---TKI 85 (448)
Q Consensus 14 ~~~~LG~G~fg~Vy~a~~~~~g--~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnI--v~l~~~~~~~---~~~ 85 (448)
-.+.|+.|.++.+|+......+ ..+++|+........ ....+.+|+.+|+.+. |+++ .+++.++.+. ...
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~--~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~ 119 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ--SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA 119 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc--cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence 3677899999999998764332 467888765432211 1246789999999995 6665 7788877664 467
Q ss_pred EEEEeecCCCchHH--------------------HHhc-CCCC----------------HHHHHHHHHH-----------
Q 037702 86 YFAMEYVRGGELFN--------------------KVAK-GKLR----------------EEVARKYFQQ----------- 117 (448)
Q Consensus 86 ~lV~E~~~gg~L~~--------------------~i~~-~~l~----------------e~~~~~~~~q----------- 117 (448)
|+||||++|..+.+ .+.. +.++ ..++..|..|
T Consensus 120 flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~ 199 (822)
T PLN02876 120 FYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPP 199 (822)
T ss_pred eEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCC
Confidence 89999999864321 1110 0111 1123222222
Q ss_pred ----HHHHHHHHHH-----------CCCEeecCCCCceEEcCC-CC-eEEeeccccccc
Q 037702 118 ----LVDAVEFCHS-----------RGVYHRDLKPENLLLDEN-GD-LKISDFGLSALQ 159 (448)
Q Consensus 118 ----ll~aL~yLH~-----------~givHrDLkp~NILl~~~-g~-lkl~DFGla~~~ 159 (448)
+...+++|.. ..++|+|++|.|||++.+ +. .-|.||++++.-
T Consensus 200 ~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 200 RNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred CChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 2234566632 249999999999999853 33 579999988753
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.20 E-value=1.1e-05 Score=71.57 Aligned_cols=128 Identities=23% Similarity=0.370 Sum_probs=93.0
Q ss_pred EEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcce-EEEEEEeCCEEEEEEeec
Q 037702 14 LGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQ-LYEVMASKTKIYFAMEYV 92 (448)
Q Consensus 14 ~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~-l~~~~~~~~~~~lV~E~~ 92 (448)
..+.||+|.+|.||++.+ .|..+|+|+-..+.. ...+..|.++|..+.--++.. ++.+-. .++.|||+
T Consensus 26 v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds~-----r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i 94 (201)
T COG2112 26 VEKELAKGTTSVVYLGEW--RGGEVALKVRRRDSP-----RRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYI 94 (201)
T ss_pred hhhhhhcccccEEEEeec--cCceEEEEEecCCcc-----hhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhh
Confidence 456799999999999998 677999998655432 367889999999998777654 444332 23459999
Q ss_pred CCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCC-CCceEEcCCCCeEEeecccccc
Q 037702 93 RGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLK-PENLLLDENGDLKISDFGLSAL 158 (448)
Q Consensus 93 ~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLk-p~NILl~~~g~lkl~DFGla~~ 158 (448)
.|-+|......+ + ++-+..++++---|-..||-|..|. |...+|-.++.+.|+||.-|++
T Consensus 95 ~G~~L~~~~~~~--~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 95 DGRPLGKLEIGG--D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred cCcchhhhhhcc--c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 998886655432 1 3334456666555778899999986 5555555666999999998874
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=98.19 E-value=1.1e-07 Score=106.12 Aligned_cols=209 Identities=18% Similarity=0.128 Sum_probs=146.0
Q ss_pred HHHHHHHHHHHhCCCCCcceEEEEEE--eCCEEEEEEeecCCCchHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH
Q 037702 55 DQIKREISVMRLVRHPNIVQLYEVMA--SKTKIYFAMEYVRGGELFNKVAKG-----KLREEVARKYFQQLVDAVEFCHS 127 (448)
Q Consensus 55 ~~~~~Ei~~l~~l~hpnIv~l~~~~~--~~~~~~lV~E~~~gg~L~~~i~~~-----~l~e~~~~~~~~qll~aL~yLH~ 127 (448)
+....|...++...|+++...+.-.. +....|.+++|+.+|.+++.|-+| .+.+.-+...-++.+.+..-+|+
T Consensus 1274 emll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1274 EMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred HhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhh
Confidence 44555666677789999887766553 344578999999999999999764 24444455555555778888886
Q ss_pred CC-----CEeecCCCCceEEcCCCCeEEeeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHH
Q 037702 128 RG-----VYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVL 202 (448)
Q Consensus 128 ~g-----ivHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil 202 (448)
+. .+|++||+-|.+|..+.++|++++|+.+..... ........+++.|++|++.+.-.+. .++|+|+.|+-+
T Consensus 1354 ~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~--~sf~Gl~l~sp~~v~qli~N~ik~t-~rsdilr~s~~l 1430 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV--LSFFGLELCSPIYVLQLIKNEIKFT-KRSDILRRSLSL 1430 (2724)
T ss_pred cccCCccchhhhhhhhccceecCCcccccccccccccCch--HhhhhhhhCCHHHHHHHHHHHHhhh-hHHHHHHHHHHH
Confidence 52 799999999999999999999999999832211 1223456789999999999887775 559999999999
Q ss_pred HHHHhCCCCCCCCcHHHHHHHHhhcc-CCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhc
Q 037702 203 FVLLAGNLPFYDSNLMELYKKITRAE-FKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWF 266 (448)
Q Consensus 203 ~elltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 266 (448)
|+...|..||.......+...+.... +..+...|.++......+|-..-..||.-..++.-+.|
T Consensus 1431 y~rs~~n~~fi~flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~ 1495 (2724)
T KOG1826|consen 1431 YLRSDGNAYFIFFLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHF 1495 (2724)
T ss_pred HHHhcccHHHHHHHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhcccccc
Confidence 99999988875433333322333322 23444445555555555555556677777777666555
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.13 E-value=4e-05 Score=70.10 Aligned_cols=128 Identities=20% Similarity=0.293 Sum_probs=91.4
Q ss_pred CCeEEEeeeeecCc-eEEEEEEECCCCcEEEEEEeec---cc-------ccch--------hHHHHHHHHHHHHHhCC--
Q 037702 10 NKYELGRLLGQGTF-AKVYHGRNLKTGQSVAIKIVDK---EK-------IRRV--------GLIDQIKREISVMRLVR-- 68 (448)
Q Consensus 10 ~~y~~~~~LG~G~f-g~Vy~a~~~~~g~~vAiK~i~~---~~-------~~~~--------~~~~~~~~Ei~~l~~l~-- 68 (448)
.+++..+.||.|+- |.||+++- +|+.||+|+... .. .... ...+-+..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 68999999999999 99999987 788999999321 11 1100 12234677877776664
Q ss_pred -CCCc--ceEEEEEEeC------------------CEEEEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH
Q 037702 69 -HPNI--VQLYEVMASK------------------TKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHS 127 (448)
Q Consensus 69 -hpnI--v~l~~~~~~~------------------~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~ 127 (448)
+.++ ++.+++..-. ....||.||++... .+. ..-+.+|.+-+..+|.
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------~~~----~~~~~~~~~dl~~~~k 182 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------PLQ----IRDIPQMLRDLKILHK 182 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------ccc----hhHHHHHHHHHHHHHH
Confidence 5566 8999986321 12458888886643 122 3345677888889999
Q ss_pred CCCEeecCCCCceEEcCCCCeEEeecccc
Q 037702 128 RGVYHRDLKPENLLLDENGDLKISDFGLS 156 (448)
Q Consensus 128 ~givHrDLkp~NILl~~~g~lkl~DFGla 156 (448)
.||+-+|+++.|.. .=||+|||.+
T Consensus 183 ~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 183 LGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred CCeeeccCcccccc-----CCEEEecccC
Confidence 99999999999986 4588999864
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.09 E-value=1.7e-05 Score=74.90 Aligned_cols=72 Identities=7% Similarity=0.133 Sum_probs=46.0
Q ss_pred eeeeecCce-EEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCC---CcceEEEEEEeC---CEEEEE
Q 037702 16 RLLGQGTFA-KVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHP---NIVQLYEVMASK---TKIYFA 88 (448)
Q Consensus 16 ~~LG~G~fg-~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hp---nIv~l~~~~~~~---~~~~lV 88 (448)
+.++.|+.. .||+. +..+++|...... ....+.+|..+++.+... -+.++++..... ...+++
T Consensus 3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~~~-----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l 72 (235)
T cd05155 3 EPVDSGGTDNATFRL-----GDDMSVRLPSAAG-----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV 72 (235)
T ss_pred eeccCCCcccceEEc-----CCceEEEcCCccc-----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence 567766666 58875 2357788654321 235788999999888532 344555543332 245899
Q ss_pred EeecCCCch
Q 037702 89 MEYVRGGEL 97 (448)
Q Consensus 89 ~E~~~gg~L 97 (448)
|++++|.++
T Consensus 73 ~~~i~G~~l 81 (235)
T cd05155 73 YRWLEGETA 81 (235)
T ss_pred EEeecCCCC
Confidence 999999766
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.99 E-value=0.00016 Score=73.43 Aligned_cols=80 Identities=16% Similarity=0.199 Sum_probs=54.9
Q ss_pred EeeeeecCceEEEEEEECCCCcEEEEEEeecccc--cc--hhHHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEEEE
Q 037702 15 GRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKI--RR--VGLIDQIKREISVMRLVR---HPNIVQLYEVMASKTKIYF 87 (448)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~--~~--~~~~~~~~~Ei~~l~~l~---hpnIv~l~~~~~~~~~~~l 87 (448)
.+.||.|.+..||++.....++.++||.-..... .. .-..++...|...|+.+. ..++++++.+. .+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEE
Confidence 4679999999999999854336899998542110 00 112456777888888762 34677787773 355789
Q ss_pred EEeecCCCc
Q 037702 88 AMEYVRGGE 96 (448)
Q Consensus 88 V~E~~~gg~ 96 (448)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998743
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.93 E-value=0.00013 Score=68.66 Aligned_cols=75 Identities=17% Similarity=0.294 Sum_probs=48.9
Q ss_pred EeeeeecCceEEEEEEECC-CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEEEEeec
Q 037702 15 GRLLGQGTFAKVYHGRNLK-TGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNI-VQLYEVMASKTKIYFAMEYV 92 (448)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~-~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnI-v~l~~~~~~~~~~~lV~E~~ 92 (448)
.+.|..|-...+|++.... .++.|++|+....... .-...+|+.+++.+...++ .+++.... + .++|||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~----~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL----IIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc----eecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEee
Confidence 4668888889999987532 3578999977543211 1223478989988854343 44444332 2 3799999
Q ss_pred CCCch
Q 037702 93 RGGEL 97 (448)
Q Consensus 93 ~gg~L 97 (448)
+|.++
T Consensus 75 ~G~~l 79 (235)
T cd05157 75 PGRTL 79 (235)
T ss_pred CCCcC
Confidence 98765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.93 E-value=5.6e-05 Score=73.87 Aligned_cols=135 Identities=16% Similarity=0.178 Sum_probs=84.2
Q ss_pred EeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC--cceEEE------EEEeCCEEE
Q 037702 15 GRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPN--IVQLYE------VMASKTKIY 86 (448)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpn--Iv~l~~------~~~~~~~~~ 86 (448)
.+.|..|....+|+... ++..+++|+.... . .+.+..|+.++..+.+.+ +.+++. +....+..+
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~---~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~ 90 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKV---S---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA 90 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCCC---C---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence 56678888889999864 4457999987541 1 245677888888885433 444443 123345678
Q ss_pred EEEeecCCCchHH-----------HH---hc--CCCCH--------HHHH------------HHHHHHHHHHHHHHH---
Q 037702 87 FAMEYVRGGELFN-----------KV---AK--GKLRE--------EVAR------------KYFQQLVDAVEFCHS--- 127 (448)
Q Consensus 87 lV~E~~~gg~L~~-----------~i---~~--~~l~e--------~~~~------------~~~~qll~aL~yLH~--- 127 (448)
+|++|++|..+.. .+ .. ..+.. .... .....+..++.++.+
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 9999999876421 00 00 00100 0000 011123344455543
Q ss_pred ----CCCEeecCCCCceEEcCCCCeEEeeccccc
Q 037702 128 ----RGVYHRDLKPENLLLDENGDLKISDFGLSA 157 (448)
Q Consensus 128 ----~givHrDLkp~NILl~~~g~lkl~DFGla~ 157 (448)
.+++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred hcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 479999999999999987777899999765
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.90 E-value=0.00023 Score=69.86 Aligned_cols=78 Identities=10% Similarity=0.119 Sum_probs=56.1
Q ss_pred EEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCC---CCcceEEEEEEe---CCEEE
Q 037702 13 ELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRH---PNIVQLYEVMAS---KTKIY 86 (448)
Q Consensus 13 ~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~h---pnIv~l~~~~~~---~~~~~ 86 (448)
.-.+.||.|..+.||.... ++..+.+|.. +... ....+..|...|+.+.- -.+.++++++.. .+..+
T Consensus 17 ~~~~~i~~G~~~~vy~~~~--~~~~~~~k~~-~~~~----~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~ 89 (297)
T PRK10593 17 SRVECISEQPYAALWALYD--SQGNPMPLMA-RSFS----TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDV 89 (297)
T ss_pred heeeecCCccceeEEEEEc--CCCCEEEEEe-cccc----cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeE
Confidence 3456799999999999864 3335777774 3211 12567899999998853 367888887754 36689
Q ss_pred EEEeecCCCch
Q 037702 87 FAMEYVRGGEL 97 (448)
Q Consensus 87 lV~E~~~gg~L 97 (448)
||||+++|+++
T Consensus 90 LVmE~i~G~~~ 100 (297)
T PRK10593 90 LLLERLRGVSV 100 (297)
T ss_pred EEEeccCCEec
Confidence 99999998754
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.87 E-value=7.1e-05 Score=71.63 Aligned_cols=132 Identities=17% Similarity=0.196 Sum_probs=78.7
Q ss_pred eeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEEEEeecCCC
Q 037702 17 LLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNI-VQLYEVMASKTKIYFAMEYVRGG 95 (448)
Q Consensus 17 ~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnI-v~l~~~~~~~~~~~lV~E~~~gg 95 (448)
.+..|-.+.+|+.. .+|+.+++|........ ..-...+|..+++.+...++ .+++.... -++||||++|.
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~---~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~ 73 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKA---LGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGE 73 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCccccc---ccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCc
Confidence 45668888999887 36778999976433211 10124678899988864433 34444332 36899999986
Q ss_pred chHH--------------HHhc-CC-------CC-HHHHHHHHHHHH---------HHHHHHHH--------CCCEeecC
Q 037702 96 ELFN--------------KVAK-GK-------LR-EEVARKYFQQLV---------DAVEFCHS--------RGVYHRDL 135 (448)
Q Consensus 96 ~L~~--------------~i~~-~~-------l~-e~~~~~~~~qll---------~aL~yLH~--------~givHrDL 135 (448)
.+.. .+.+ .. ++ ...+..+..++. ..+..+-. ..++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 6531 1111 11 11 122233332221 11222222 25899999
Q ss_pred CCCceEEcCCCCeEEeecccccc
Q 037702 136 KPENLLLDENGDLKISDFGLSAL 158 (448)
Q Consensus 136 kp~NILl~~~g~lkl~DFGla~~ 158 (448)
.|.||+++.++ +.|+||..|..
T Consensus 154 ~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 154 HAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CcCcEEEeCCC-CEEEeccccCc
Confidence 99999999877 78999998764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.86 E-value=6.5e-05 Score=68.55 Aligned_cols=98 Identities=21% Similarity=0.310 Sum_probs=80.9
Q ss_pred HHHHHHHHhCCC-CCcceEEEEEEeCCEEEEEEeecCCCchHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHH---CC
Q 037702 58 KREISVMRLVRH-PNIVQLYEVMASKTKIYFAMEYVRGGELFNK----VAKGKLREEVARKYFQQLVDAVEFCHS---RG 129 (448)
Q Consensus 58 ~~Ei~~l~~l~h-pnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~----i~~~~l~e~~~~~~~~qll~aL~yLH~---~g 129 (448)
..|.-+|+.+.+ +++++++|.|.. ++|.||...+++... ..-...++....+++.++++.+.+++. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 358889999976 699999999843 678999987766421 122357899999999999999999997 45
Q ss_pred CEeecCCCCceEEcCCCCeEEeeccccccc
Q 037702 130 VYHRDLKPENLLLDENGDLKISDFGLSALQ 159 (448)
Q Consensus 130 ivHrDLkp~NILl~~~g~lkl~DFGla~~~ 159 (448)
+.-.|++|+|+-++++|++|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 888999999999999999999999887644
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00016 Score=71.22 Aligned_cols=136 Identities=15% Similarity=0.195 Sum_probs=82.0
Q ss_pred EeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC--cceEEEE------EEeCCEEE
Q 037702 15 GRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPN--IVQLYEV------MASKTKIY 86 (448)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpn--Iv~l~~~------~~~~~~~~ 86 (448)
.+.++.|....+|++.. ++..+++|+..... . .+.+..|+.++..|...+ +.+++.. ....+..+
T Consensus 27 i~~~~~G~~n~~y~v~t--~~~~~vLK~~~~~~--~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~ 99 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTT--DVGRYILTLYEKRV--K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPA 99 (307)
T ss_pred ccccCCccccceEEEEe--CCCcEEEEEecCCC--C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEE
Confidence 56677888889999864 34468889875421 1 234556777777774322 3444331 12245678
Q ss_pred EEEeecCCCchH-----------HH---Hhc--CCCCH-------HHHH----------------HHHHHHHHHHHHHHH
Q 037702 87 FAMEYVRGGELF-----------NK---VAK--GKLRE-------EVAR----------------KYFQQLVDAVEFCHS 127 (448)
Q Consensus 87 lV~E~~~gg~L~-----------~~---i~~--~~l~e-------~~~~----------------~~~~qll~aL~yLH~ 127 (448)
+++||++|.++. .. +.. ..++. ...+ .....+...++++..
T Consensus 100 ~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~ 179 (307)
T TIGR00938 100 CLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDK 179 (307)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHh
Confidence 999999986431 00 110 01100 0000 011123345555543
Q ss_pred -------CCCEeecCCCCceEEcCCCCeEEeeccccc
Q 037702 128 -------RGVYHRDLKPENLLLDENGDLKISDFGLSA 157 (448)
Q Consensus 128 -------~givHrDLkp~NILl~~~g~lkl~DFGla~ 157 (448)
.+++|+|+++.||+++.++.+.|+||+.+.
T Consensus 180 ~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 180 FWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 689999999999999998877899999764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF02149 KA1: Kinase associated domain 1; InterPro: IPR001772 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=97.67 E-value=7.5e-05 Score=51.58 Aligned_cols=42 Identities=24% Similarity=0.541 Sum_probs=35.2
Q ss_pred ccEEEEEEEEEEc-CceEEEEEEecCCCchhHHHHhhcCccccc
Q 037702 393 GQLAVDAEIFEVT-PAFHVVELKKAAGDTMEYKDFCNQGLRPSL 435 (448)
Q Consensus 393 ~~l~~~~~v~~~~-~~~~~ve~~~~~Gd~~e~~~~~~~~~~~~l 435 (448)
..+.|.+||+.+. ++++.|+|||.+||...|+++|.+ |-..|
T Consensus 3 ~~v~fEieV~kl~~~~l~Gv~~kRi~Gd~~~yk~lc~~-il~~l 45 (47)
T PF02149_consen 3 EVVKFEIEVCKLPRLGLYGVDFKRISGDSWQYKDLCSK-ILNEL 45 (47)
T ss_dssp C-EEEEEEEEEECCCTCEEEEEEEEES-HHHHHHHHHH-HHHHT
T ss_pred cceEEEEEEEEecCCCeeEEEEEEeeCCHHHHHHHHHH-HHHHc
Confidence 3578999999997 899999999999999999999998 44433
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. Members of the KIN2/PAR-1/MARK kinase subfamily are conserved from yeast to human and share the same domain organisation: an N-terminal kinase domain (IPR000719 from INTERPRO) and a C-terminal kinase associated domain 1 (KA1). Some members of the KIN1/PAR-1/MARK family also contain an UBA domain (IPR000449 from INTERPRO). Members of this kinase subfamily are involved in various biological processes such as cell polarity, cell cycle control, intracellular signalling, microtubule stability and protein stability []. The function of the KA1 domain is not yet known. Some proteins known to contain a KA1 domain are listed below: Mammalian MAP/microtubule affinity-regulating kinases (MARK 1,2,3). They regulate polarity in neuronal cell models and appear to function redundantly in phosphorylating MT-associated proteins and in regulating MT stability []. Mammalian maternal embryonic leucine zipper kinase (MELK). It phosphorylates ZNF622 and may contribute to its redirection to the nucleus. It may be involved in the inhibition of spliceosome assembly during mitosis. Caenorhabditis elegans and drosophila PAR-1 protein. It is required for establishing polarity in embryos where it is asymmetrically distributed []. Fungal Kin1 and Kin2 protein kinases involved in regulation of exocytosis. They localise to the cytoplasmic face of the plasma membrane []. Plant KIN10 and KIN11 proteins, catalytic subunits of the putative trimeric SNF1-related protein kinase (SnRK) complex. This entry represents the KA1 domain.; GO: 0004674 protein serine/threonine kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3OSE_A 1V5S_A 1UL7_A. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00067 Score=67.07 Aligned_cols=135 Identities=14% Similarity=0.182 Sum_probs=75.4
Q ss_pred EeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC--cceEEE------EEEeCCEEE
Q 037702 15 GRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPN--IVQLYE------VMASKTKIY 86 (448)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpn--Iv~l~~------~~~~~~~~~ 86 (448)
.+.|+.|....+|+... ++..+++|++.. .. .+.+..|+.+++.|...+ +.+++. +....+..+
T Consensus 27 ~~~l~~G~~n~~y~v~t--~~g~~vLK~~~~--~~----~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~ 98 (319)
T PRK05231 27 LKGIAEGIENSNFFLTT--TQGEYVLTLFER--LT----AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPA 98 (319)
T ss_pred cchhccccccceEEEEe--CCCcEEEEEecc--CC----hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEE
Confidence 34566777789999875 334789998751 11 133445666666653222 333332 123356789
Q ss_pred EEEeecCCCchH-----------HHHhc-----CCCC----------H-HH-HH-----------HHHHH-HHHHHHHHH
Q 037702 87 FAMEYVRGGELF-----------NKVAK-----GKLR----------E-EV-AR-----------KYFQQ-LVDAVEFCH 126 (448)
Q Consensus 87 lV~E~~~gg~L~-----------~~i~~-----~~l~----------e-~~-~~-----------~~~~q-ll~aL~yLH 126 (448)
+++||++|..+. ..+.+ ..++ . .. .. ..+.+ +...++.+.
T Consensus 99 ~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 178 (319)
T PRK05231 99 AIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLA 178 (319)
T ss_pred EEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhh
Confidence 999999987431 11110 0110 0 00 00 01111 111222222
Q ss_pred -------HCCCEeecCCCCceEEcCCCCeEEeeccccc
Q 037702 127 -------SRGVYHRDLKPENLLLDENGDLKISDFGLSA 157 (448)
Q Consensus 127 -------~~givHrDLkp~NILl~~~g~lkl~DFGla~ 157 (448)
..|++|+|++|.|||++.+...-|+||+.+.
T Consensus 179 ~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 179 SAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 2389999999999999866556899999875
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00047 Score=67.79 Aligned_cols=141 Identities=20% Similarity=0.308 Sum_probs=92.1
Q ss_pred eEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCC--CCcceEEEEEEeCC--EEEE
Q 037702 12 YELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRH--PNIVQLYEVMASKT--KIYF 87 (448)
Q Consensus 12 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~h--pnIv~l~~~~~~~~--~~~l 87 (448)
..+.+..-.|....+|.... +++.+++. ... ............+|..+++.+.- --+...+++|.++. ..|.
T Consensus 27 ~~~v~~~~~G~sn~t~~~~~--~~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~ 102 (321)
T COG3173 27 LLIVEEISGGWSNDTFRLGD--TGQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFY 102 (321)
T ss_pred CceeeeccCCcccceEEEec--CCceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceE
Confidence 34455554455555666655 38888888 332 12222345677889999988753 23445566676665 7799
Q ss_pred EEeecCCCchHHHHhcCCCCHHHHHHHHH-HHHHHHHHHHH---------------------------------------
Q 037702 88 AMEYVRGGELFNKVAKGKLREEVARKYFQ-QLVDAVEFCHS--------------------------------------- 127 (448)
Q Consensus 88 V~E~~~gg~L~~~i~~~~l~e~~~~~~~~-qll~aL~yLH~--------------------------------------- 127 (448)
||+|++|..+.+........ ..++. .+++.|.-||+
T Consensus 103 v~~~veGe~~~~~~~~~~~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p 178 (321)
T COG3173 103 VMEWVEGEVVWSALPPESLG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIP 178 (321)
T ss_pred EEEEecceeccCcCCcccch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCc
Confidence 99999996443332221111 22223 56666666664
Q ss_pred -------------------CCCEeecCCCCceEEcCCCCeEEeecccccccc
Q 037702 128 -------------------RGVYHRDLKPENLLLDENGDLKISDFGLSALQE 160 (448)
Q Consensus 128 -------------------~givHrDLkp~NILl~~~g~lkl~DFGla~~~~ 160 (448)
..++|+|+++.||+++.++-+-|.||+++.+.+
T Consensus 179 ~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 179 LADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred hHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 248999999999999999999999999987643
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.60 E-value=4.3e-05 Score=74.08 Aligned_cols=136 Identities=15% Similarity=0.272 Sum_probs=97.3
Q ss_pred eEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccc-----cc---------h-hH----HHHHHHHHHHHHhCCCC--
Q 037702 12 YELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKI-----RR---------V-GL----IDQIKREISVMRLVRHP-- 70 (448)
Q Consensus 12 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-----~~---------~-~~----~~~~~~Ei~~l~~l~hp-- 70 (448)
|.+++.||-|.-+.||.+-+ ..|.+.++|.-..... +. . .+ .-...+|...|+.|...
T Consensus 94 ~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 56899999999999999986 5689999996432111 00 0 00 12346788999888532
Q ss_pred CcceEEEEEEeCCEEEEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEE
Q 037702 71 NIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKI 150 (448)
Q Consensus 71 nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl 150 (448)
-+.+.++ .+..++|||++.|-.|...-.- ..+..+...++.-+.-|-.+|+||+|..--||++++++.+++
T Consensus 173 pVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v-----~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~v 243 (465)
T KOG2268|consen 173 PVPKPID----HNRHCVVMELVDGYPLRQVRHV-----EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIVV 243 (465)
T ss_pred CCCCccc----ccceeeHHHhhcccceeeeeec-----CChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEEE
Confidence 2344443 3456899999999877654311 123445666777778888999999999999999999999999
Q ss_pred eeccccc
Q 037702 151 SDFGLSA 157 (448)
Q Consensus 151 ~DFGla~ 157 (448)
+||--..
T Consensus 244 IDFPQmv 250 (465)
T KOG2268|consen 244 IDFPQMV 250 (465)
T ss_pred eechHhh
Confidence 9997543
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00073 Score=66.25 Aligned_cols=75 Identities=17% Similarity=0.237 Sum_probs=48.8
Q ss_pred EeeeeecCceEEEEEEECC------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEE
Q 037702 15 GRLLGQGTFAKVYHGRNLK------TGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNI-VQLYEVMASKTKIYF 87 (448)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~------~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnI-v~l~~~~~~~~~~~l 87 (448)
.+.|..|-...+|++.... +++.+++|+...... ......+|..+++.+...++ .+++..+.. .+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~ 74 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE----LLIDRERELVVFARLSERNLGPKLYGIFPN----GR 74 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc----ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cc
Confidence 3566777778899887532 257899999754321 12345688888888854333 355555532 35
Q ss_pred EEeecCCCch
Q 037702 88 AMEYVRGGEL 97 (448)
Q Consensus 88 V~E~~~gg~L 97 (448)
|+||++|..+
T Consensus 75 v~e~i~G~~l 84 (302)
T cd05156 75 IEEFIPSRTL 84 (302)
T ss_pred hhheeCCCcC
Confidence 8999988765
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.0014 Score=64.89 Aligned_cols=142 Identities=23% Similarity=0.302 Sum_probs=100.1
Q ss_pred EEeeeeecCceEEEEEEECCCCcEEEEEEeecccc--cc--------------------hhH-HHHHHHHHHHHHhCCCC
Q 037702 14 LGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKI--RR--------------------VGL-IDQIKREISVMRLVRHP 70 (448)
Q Consensus 14 ~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~--~~--------------------~~~-~~~~~~Ei~~l~~l~hp 70 (448)
+-..|..|.-+.||.|. ..+|..+|||++..+-. .+ ..+ .-....|++-|+++..-
T Consensus 148 inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 44567789999999997 46889999999854321 00 011 22456788888888765
Q ss_pred CcceEEEEEEeCCEEEEEEeecCCCc-hHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHCCCEeecCCCCceEEcCCCCe
Q 037702 71 NIVQLYEVMASKTKIYFAMEYVRGGE-LFNKVAKGKLREEVARKYFQQLVDAVEFC-HSRGVYHRDLKPENLLLDENGDL 148 (448)
Q Consensus 71 nIv~l~~~~~~~~~~~lV~E~~~gg~-L~~~i~~~~l~e~~~~~~~~qll~aL~yL-H~~givHrDLkp~NILl~~~g~l 148 (448)
+|.-.--+.. ....|||+|+.... -.-.+..-.++...+..+-.|++.-+.-| |..++||.||.--|+|+ .+|.+
T Consensus 227 GIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG~l 303 (520)
T KOG2270|consen 227 GIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDGKL 303 (520)
T ss_pred CCCCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECCEE
Confidence 5432211111 12368999996422 23344455788889999999999999887 56799999999999998 67899
Q ss_pred EEeeccccccc
Q 037702 149 KISDFGLSALQ 159 (448)
Q Consensus 149 kl~DFGla~~~ 159 (448)
.++|-+-+...
T Consensus 304 yiIDVSQSVE~ 314 (520)
T KOG2270|consen 304 YIIDVSQSVEH 314 (520)
T ss_pred EEEEccccccC
Confidence 99999876543
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.0018 Score=65.79 Aligned_cols=87 Identities=16% Similarity=0.109 Sum_probs=56.8
Q ss_pred EEeeeeecCceEEEEEEECCCCcEEEEEEeecccc-cch---hHHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEEE
Q 037702 14 LGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKI-RRV---GLIDQIKREISVMRLVR---HPNIVQLYEVMASKTKIY 86 (448)
Q Consensus 14 ~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~---~~~~~~~~Ei~~l~~l~---hpnIv~l~~~~~~~~~~~ 86 (448)
..+.||.|....||+..+ .+..++||.-..... ... ...++...|...|+.+. ..++.+++.++.+ .-+
T Consensus 36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCE
Confidence 467889999999999886 356799997652211 000 12344556677777664 3478888888873 457
Q ss_pred EEEeecCCC--chHHHHhcC
Q 037702 87 FAMEYVRGG--ELFNKVAKG 104 (448)
Q Consensus 87 lV~E~~~gg--~L~~~i~~~ 104 (448)
++||+++++ .+.+.+..|
T Consensus 112 lvME~L~~~~~ilr~~Ll~G 131 (418)
T PLN02756 112 IGMRYLEPPHIILRKGLIAG 131 (418)
T ss_pred EEEeecCCcceehhhhhccC
Confidence 889999872 454444333
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.003 Score=63.04 Aligned_cols=86 Identities=14% Similarity=0.127 Sum_probs=52.7
Q ss_pred eeeecCceEEEEEEECCCCcEEEEEEeecccc--c-c-hhHHHHHHHHHHHHHhCC--CC-CcceEEEEEEeCCEEEEEE
Q 037702 17 LLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKI--R-R-VGLIDQIKREISVMRLVR--HP-NIVQLYEVMASKTKIYFAM 89 (448)
Q Consensus 17 ~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~--~-~-~~~~~~~~~Ei~~l~~l~--hp-nIv~l~~~~~~~~~~~lV~ 89 (448)
.+|.|....||++.+...++.|+||.-...-- . + .-..++..-|...|+... .| .+.++|.+ +.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 47999999999999754446899997532110 0 0 122455667888887763 34 45555543 344456999
Q ss_pred eecCCC-chHHHHhcC
Q 037702 90 EYVRGG-ELFNKVAKG 104 (448)
Q Consensus 90 E~~~gg-~L~~~i~~~ 104 (448)
|+++.. .|...+-.|
T Consensus 80 EdL~~~~ilR~~Li~g 95 (370)
T TIGR01767 80 EDLSHHKIARKGLIEG 95 (370)
T ss_pred hhCccchHHHHHHHcC
Confidence 998653 344444444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.0014 Score=67.37 Aligned_cols=164 Identities=22% Similarity=0.263 Sum_probs=104.8
Q ss_pred HHHHHHHHHHHhCCCCCcceEEEEEEe-CCEEEEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEee
Q 037702 55 DQIKREISVMRLVRHPNIVQLYEVMAS-KTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHR 133 (448)
Q Consensus 55 ~~~~~Ei~~l~~l~hpnIv~l~~~~~~-~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHr 133 (448)
.++.-...+++.+.|+|.-.++++... .....+|||++ +.+|.+....+.+...... +||
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~l~~~s~~------------------~~~ 87 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGNLKDESLL------------------AHG 87 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcccchhhhc------------------ccc
Confidence 455667889999999999999988754 34578999999 5589988877642221111 222
Q ss_pred cCCCCceEEcCCCCeEEeeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCC
Q 037702 134 DLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFY 213 (448)
Q Consensus 134 DLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~ 213 (448)
=+ +-|+ ++.+| -++. . | |- ..++|+||||+|.++.++.-|..-|.
T Consensus 88 ~~-~~~~-------~~~td-~~~t-----~-------------~--~~------~~~pKsdVwsl~~i~~el~L~~~l~~ 132 (725)
T KOG1093|consen 88 VL-HLNI-------IYITD-HFLT-----K-------------Y--PS------PIGPKSDVWSLGFIILELYLGISLEA 132 (725)
T ss_pred cc-eehh-------hhccc-cccc-----c-------------C--CC------CCCcchhhhhHHHHHHHHHHhhHHHH
Confidence 11 1122 22233 0000 0 0 10 11248999999999999999877665
Q ss_pred CCcHHHHHHHHhhccCCC------------CCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccccccc
Q 037702 214 DSNLMELYKKITRAEFKC------------PNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYKK 272 (448)
Q Consensus 214 ~~~~~~~~~~i~~~~~~~------------p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~ 272 (448)
.....+....+.+-...- --.++....++..+|+...|..||...++++++-|...+..
T Consensus 133 ~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev~~~ 203 (725)
T KOG1093|consen 133 ELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEVYKD 203 (725)
T ss_pred HHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHHHhh
Confidence 544444433333221110 01145667889999999999999999999999999877543
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.02 E-value=0.0057 Score=60.04 Aligned_cols=29 Identities=31% Similarity=0.626 Sum_probs=25.7
Q ss_pred CCCEeecCCCCceEEcCCCCeEEeeccccc
Q 037702 128 RGVYHRDLKPENLLLDENGDLKISDFGLSA 157 (448)
Q Consensus 128 ~givHrDLkp~NILl~~~g~lkl~DFGla~ 157 (448)
.+++|+|+++.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 57899999999999987 678999999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.0071 Score=60.62 Aligned_cols=135 Identities=16% Similarity=0.225 Sum_probs=81.0
Q ss_pred EeeeeecCceEEEEEEECC----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcc-eEEEEEEeCCEEEEEE
Q 037702 15 GRLLGQGTFAKVYHGRNLK----TGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIV-QLYEVMASKTKIYFAM 89 (448)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~----~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv-~l~~~~~~~~~~~lV~ 89 (448)
...|-.|-...+|++.... +++.|++|+...... ..++ ..+|..+++.+..-++- ++++.+... .|.
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~---~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~ 112 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE---LFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVE 112 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC---eeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEE
Confidence 4455558888999987432 346899998765421 2222 25789999888654443 555655332 579
Q ss_pred eecCCCchHH----------HH----h---cCC------C-CHHHHHHHHHHHH-----------------HHHHHH---
Q 037702 90 EYVRGGELFN----------KV----A---KGK------L-REEVARKYFQQLV-----------------DAVEFC--- 125 (448)
Q Consensus 90 E~~~gg~L~~----------~i----~---~~~------l-~e~~~~~~~~qll-----------------~aL~yL--- 125 (448)
||++|.+|.. .+ . ... . ..+.+..++.++. ..+..|
T Consensus 113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~ 192 (344)
T PLN02236 113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE 192 (344)
T ss_pred EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence 9998766531 11 1 101 1 1223334432221 112222
Q ss_pred -H----HCCCEeecCCCCceEEcC-CCCeEEeeccccc
Q 037702 126 -H----SRGVYHRDLKPENLLLDE-NGDLKISDFGLSA 157 (448)
Q Consensus 126 -H----~~givHrDLkp~NILl~~-~g~lkl~DFGla~ 157 (448)
. ...++|+|+++.|||+++ ++.+.++||..|.
T Consensus 193 ~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 193 LSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred hcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 1 235899999999999986 4789999998875
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.0047 Score=59.93 Aligned_cols=30 Identities=27% Similarity=0.506 Sum_probs=25.4
Q ss_pred CCEeecCCCCceEEcCCCC-eEEeecccccc
Q 037702 129 GVYHRDLKPENLLLDENGD-LKISDFGLSAL 158 (448)
Q Consensus 129 givHrDLkp~NILl~~~g~-lkl~DFGla~~ 158 (448)
.++|+|++|.|||++.++. .-|.||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997565 46999998764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.014 Score=57.54 Aligned_cols=30 Identities=20% Similarity=0.259 Sum_probs=27.7
Q ss_pred CCEeecCCCCceEEcCCCCeEEeecccccc
Q 037702 129 GVYHRDLKPENLLLDENGDLKISDFGLSAL 158 (448)
Q Consensus 129 givHrDLkp~NILl~~~g~lkl~DFGla~~ 158 (448)
+++|+|+.+.|+|++.++.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 799999999999999999999999998763
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.007 Score=61.24 Aligned_cols=88 Identities=17% Similarity=0.181 Sum_probs=55.7
Q ss_pred EeeeeecCceEEEEEEECCCCcEEEEEEeecccccc---hhHHHHHHHHHHHHHhCC--CC-CcceEEEEEEeCCEEEEE
Q 037702 15 GRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRR---VGLIDQIKREISVMRLVR--HP-NIVQLYEVMASKTKIYFA 88 (448)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~---~~~~~~~~~Ei~~l~~l~--hp-nIv~l~~~~~~~~~~~lV 88 (448)
.+.||.|.-..||++.+...++.|+||.-...--.. .-..++..-|..+|+... .| .+.++|.+ +.+...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 678899999999999984446789999653211100 122466777888888763 34 45556554 34455689
Q ss_pred EeecCCC-chHHHHhcC
Q 037702 89 MEYVRGG-ELFNKVAKG 104 (448)
Q Consensus 89 ~E~~~gg-~L~~~i~~~ 104 (448)
||+++.. .|+..+-.|
T Consensus 112 MEdL~~~~ilR~~Li~G 128 (409)
T PRK12396 112 MEDLSDHTILRTALINH 128 (409)
T ss_pred HHhCcccHHHHHHHHcC
Confidence 9988643 344444443
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.68 E-value=0.011 Score=58.86 Aligned_cols=138 Identities=16% Similarity=0.258 Sum_probs=80.2
Q ss_pred CeEEEeeeeecCceEEEEEEECCC---CcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEE
Q 037702 11 KYELGRLLGQGTFAKVYHGRNLKT---GQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNI-VQLYEVMASKTKIY 86 (448)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnI-v~l~~~~~~~~~~~ 86 (448)
..++ +.|..|-...+|+...... +..|++|+...... .. -.-.+|..+++.+..-++ .++++++. +.
T Consensus 16 ~i~i-~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~---~~-IdR~~E~~il~~l~~~gl~P~~l~~~~-~G--- 86 (330)
T PLN02421 16 DFSV-ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD---YV-IDRERELQAIKYLSAAGFGAKLLGVFG-NG--- 86 (330)
T ss_pred ceEE-EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC---eE-echHHHHHHHHHHHhcCCCCceeEEeC-Cc---
Confidence 3443 4454577788998865332 34899998754321 11 123478899988866555 35565553 22
Q ss_pred EEEeecCCCchHH----------HH----h---cCCC-------CHHHHHHHHHHHH----------------------H
Q 037702 87 FAMEYVRGGELFN----------KV----A---KGKL-------REEVARKYFQQLV----------------------D 120 (448)
Q Consensus 87 lV~E~~~gg~L~~----------~i----~---~~~l-------~e~~~~~~~~qll----------------------~ 120 (448)
+|.+|++|..|.. .+ + ..++ ....+..|+.++- .
T Consensus 87 ~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 166 (330)
T PLN02421 87 MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRD 166 (330)
T ss_pred EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHH
Confidence 5889998765411 11 1 1111 1223333433321 1
Q ss_pred HHHHHH----HCC----CEeecCCCCceEEcC-CCCeEEeeccccc
Q 037702 121 AVEFCH----SRG----VYHRDLKPENLLLDE-NGDLKISDFGLSA 157 (448)
Q Consensus 121 aL~yLH----~~g----ivHrDLkp~NILl~~-~g~lkl~DFGla~ 157 (448)
-+..+. +.+ ++|+|+.|.|||+++ ++.++++||..|.
T Consensus 167 ~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 167 EIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred HHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 122221 122 799999999999975 5789999999875
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.45 E-value=0.0074 Score=55.88 Aligned_cols=30 Identities=33% Similarity=0.730 Sum_probs=21.7
Q ss_pred CCEeecCCCCceEE-cCCCCeEEeecccccc
Q 037702 129 GVYHRDLKPENLLL-DENGDLKISDFGLSAL 158 (448)
Q Consensus 129 givHrDLkp~NILl-~~~g~lkl~DFGla~~ 158 (448)
-++|+|+.|.|||+ +.++.++++||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 58999999999999 8899999999998763
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.28 E-value=0.053 Score=52.87 Aligned_cols=75 Identities=12% Similarity=0.182 Sum_probs=48.1
Q ss_pred EEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEEEEEE
Q 037702 13 ELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR---HPNIVQLYEVMASKTKIYFAM 89 (448)
Q Consensus 13 ~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~---hpnIv~l~~~~~~~~~~~lV~ 89 (448)
+-.+.++.|....+|+.. .+++.+.||+-.... ...+..|..-|+.|. .-.+.+++.+....+.-||||
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~------~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLll 91 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESG------RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLL 91 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGG------CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEE
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecChhh------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEE
Confidence 445678889999999987 578899999876221 245667888888873 445778888888777779999
Q ss_pred eecCCC
Q 037702 90 EYVRGG 95 (448)
Q Consensus 90 E~~~gg 95 (448)
||++.+
T Consensus 92 e~l~~~ 97 (288)
T PF03881_consen 92 EFLEMG 97 (288)
T ss_dssp E-----
T ss_pred EeecCC
Confidence 999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.98 E-value=0.073 Score=52.89 Aligned_cols=129 Identities=19% Similarity=0.252 Sum_probs=78.8
Q ss_pred CceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc------ceEE----EEEEeCCEEEEEEee
Q 037702 22 TFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNI------VQLY----EVMASKTKIYFAMEY 91 (448)
Q Consensus 22 ~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnI------v~l~----~~~~~~~~~~lV~E~ 91 (448)
.-..+|+... ++..+++|+.... .. ..++..|+..|..|.-.+| ..+= .......+.+-+.+|
T Consensus 37 ~eN~~f~~~~--~~g~~iLki~~~~-~~----~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~ 109 (331)
T COG2334 37 EENSNFRVQT--EDGRYILKIYRPG-WT----RAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEY 109 (331)
T ss_pred ccCceEEEEe--cCCCeEEEEecCC-CC----HHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEe
Confidence 4567888875 3344499998765 22 2567778888888742221 2111 122222478899999
Q ss_pred cCCCchHH------------H---Hhc--CCC-----------CHH----H---------HHHHHHHHHHHHHHHHH---
Q 037702 92 VRGGELFN------------K---VAK--GKL-----------REE----V---------ARKYFQQLVDAVEFCHS--- 127 (448)
Q Consensus 92 ~~gg~L~~------------~---i~~--~~l-----------~e~----~---------~~~~~~qll~aL~yLH~--- 127 (448)
++|..+.. . +.. ..+ .+. . ......++...++.+.+
T Consensus 110 l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~ 189 (331)
T COG2334 110 LPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLP 189 (331)
T ss_pred cCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhch
Confidence 99987762 0 100 011 111 0 01133345555555554
Q ss_pred -----CC--CEeecCCCCceEEcCCCC-eEEeeccccc
Q 037702 128 -----RG--VYHRDLKPENLLLDENGD-LKISDFGLSA 157 (448)
Q Consensus 128 -----~g--ivHrDLkp~NILl~~~g~-lkl~DFGla~ 157 (448)
.+ +||+|+.|.||+++.+.. ..+.|||-+.
T Consensus 190 ~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 190 AHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 24 999999999999999886 8999999764
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.94 E-value=0.061 Score=54.64 Aligned_cols=76 Identities=16% Similarity=0.263 Sum_probs=45.6
Q ss_pred EEeeeeecCceEEEEEEECCC-CcE-----EEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEE
Q 037702 14 LGRLLGQGTFAKVYHGRNLKT-GQS-----VAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNI-VQLYEVMASKTKIY 86 (448)
Q Consensus 14 ~~~~LG~G~fg~Vy~a~~~~~-g~~-----vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnI-v~l~~~~~~~~~~~ 86 (448)
..+.|..|-...+|++..... +.. |.+++..... +..-.-.+|+.+++.+...++ .++++.+.. +
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~----~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g 125 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYN----SLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----F 125 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCC----ceEeccHHHHHHHHHHHhCCCCCeEEEecCC----E
Confidence 344565688889999875332 222 4444332111 111123578999999976555 455665542 5
Q ss_pred EEEeecCCCch
Q 037702 87 FAMEYVRGGEL 97 (448)
Q Consensus 87 lV~E~~~gg~L 97 (448)
++.||++|.+|
T Consensus 126 ~l~efIeGr~l 136 (383)
T PTZ00384 126 TIQEWVEGNTM 136 (383)
T ss_pred EEEEEeccccC
Confidence 99999998765
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.91 E-value=0.026 Score=56.08 Aligned_cols=85 Identities=22% Similarity=0.362 Sum_probs=61.1
Q ss_pred CCCcceEEEEE-EeCCEEEEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCEeecCCCCceEEcCCC
Q 037702 69 HPNIVQLYEVM-ASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSR-GVYHRDLKPENLLLDENG 146 (448)
Q Consensus 69 hpnIv~l~~~~-~~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~-givHrDLkp~NILl~~~g 146 (448)
-++..+.+-+- .+....|++|++- |+.+. .+.. -..+++..++.+.+..++-+..+ ..-|||+.-.||||+ +|
T Consensus 284 ~~~~e~~~vv~~de~~y~yl~~kdh-gt~is-~ik~--~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~G 358 (488)
T COG5072 284 SVFLETLKVVSLDETLYLYLHFKDH-GTPIS-IIKA--DRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EG 358 (488)
T ss_pred chhhhcceEEecCCceEEEEEEecC-Cceee-eeec--ccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cC
Confidence 34444444443 3344567788875 43432 2221 34677888999998888887765 789999999999999 99
Q ss_pred CeEEeecccccc
Q 037702 147 DLKISDFGLSAL 158 (448)
Q Consensus 147 ~lkl~DFGla~~ 158 (448)
++.|+||-++++
T Consensus 359 nvtLIDfklsRl 370 (488)
T COG5072 359 NVTLIDFKLSRL 370 (488)
T ss_pred ceEEEEeeeeec
Confidence 999999999984
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.73 E-value=0.039 Score=55.60 Aligned_cols=62 Identities=24% Similarity=0.258 Sum_probs=47.6
Q ss_pred EEEEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHCCCEeecCCCCceEEcCC
Q 037702 84 KIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFC-HSRGVYHRDLKPENLLLDEN 145 (448)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yL-H~~givHrDLkp~NILl~~~ 145 (448)
...|+-+|..|.++..++.....+|....+++.-...|+--+ --.+++|.|++|.||++-.+
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKWKSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN 381 (565)
T ss_pred cceeeeeccccccHHhhhhcccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence 356777889999999988876677777777776666666544 45689999999999999644
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.65 E-value=0.23 Score=56.87 Aligned_cols=31 Identities=29% Similarity=0.484 Sum_probs=26.4
Q ss_pred CCCEeecCCCCceEEcCCC--CeE-Eeecccccc
Q 037702 128 RGVYHRDLKPENLLLDENG--DLK-ISDFGLSAL 158 (448)
Q Consensus 128 ~givHrDLkp~NILl~~~g--~lk-l~DFGla~~ 158 (448)
.++||+|+.+.|||++.++ .+. |+|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4799999999999999876 555 999998753
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.49 E-value=0.29 Score=48.65 Aligned_cols=72 Identities=15% Similarity=0.117 Sum_probs=44.3
Q ss_pred ecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC--cceEE---E--EEEeCCEEEEEEeec
Q 037702 20 QGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPN--IVQLY---E--VMASKTKIYFAMEYV 92 (448)
Q Consensus 20 ~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpn--Iv~l~---~--~~~~~~~~~lV~E~~ 92 (448)
.+.-..||+... .+|..+++|+...... ....+..|+..+..|.... ++... + +...++..+.+++++
T Consensus 35 ~s~eN~vy~v~~-~~~~~~vlKv~r~~~~----~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~ 109 (325)
T PRK11768 35 NSYENRVYQFGD-EDGRRVVAKFYRPERW----SDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRR 109 (325)
T ss_pred ccccceEEEEec-CCCCEEEEEEcCcccC----CHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeee
Confidence 345567898864 4577899998754321 2356777888887773222 22211 1 123356788899999
Q ss_pred CCCc
Q 037702 93 RGGE 96 (448)
Q Consensus 93 ~gg~ 96 (448)
+|..
T Consensus 110 ~G~~ 113 (325)
T PRK11768 110 GGRA 113 (325)
T ss_pred CCCC
Confidence 8764
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 448 | ||||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-66 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-65 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-64 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-62 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-62 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-62 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-62 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-60 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 8e-60 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-59 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-59 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-59 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-59 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-59 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-59 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-59 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-58 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 7e-56 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-56 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-51 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-51 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-51 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-51 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-51 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 7e-51 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 7e-51 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 8e-51 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 9e-51 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-50 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-50 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-50 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-50 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-50 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-50 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-50 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-50 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-50 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-50 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-50 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-50 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-50 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-50 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-50 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-50 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-50 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 6e-50 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 6e-50 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 6e-50 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 7e-50 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 8e-50 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 9e-50 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-49 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-49 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 6e-49 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 6e-49 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-48 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-47 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-47 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-47 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-46 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-46 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-46 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-45 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-45 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-45 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-45 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-45 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-45 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-44 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-44 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-44 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-44 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-44 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-44 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-44 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-44 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-44 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-44 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-44 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-44 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-44 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-44 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 6e-44 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 6e-44 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-44 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-44 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-44 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 8e-44 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-43 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-43 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-43 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-43 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-43 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-43 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-43 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-43 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-43 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-43 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-43 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 9e-43 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-42 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-42 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-42 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-42 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-42 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-42 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-42 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-42 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-42 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 8e-42 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 9e-42 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-41 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-41 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-41 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-41 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-41 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-41 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-41 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-41 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-41 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-41 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-41 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-41 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-41 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-41 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 7e-41 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 8e-41 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 8e-41 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 8e-41 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 8e-41 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 8e-41 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 9e-41 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 9e-41 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 9e-41 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-40 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-40 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-40 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-40 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-40 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-40 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-40 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-40 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-40 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-40 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-40 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-40 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-40 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-40 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-40 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-40 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-40 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-40 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-40 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-40 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-40 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-40 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-40 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-40 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-40 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-40 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-40 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-40 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-40 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-40 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-40 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-40 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-40 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-40 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-40 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-40 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-40 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-40 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-40 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-40 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-40 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-40 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-40 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 6e-40 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 6e-40 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-40 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 6e-40 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-40 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-40 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 7e-40 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 7e-40 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 7e-40 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 7e-40 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 7e-40 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 7e-40 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 7e-40 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 7e-40 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 8e-40 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-40 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 8e-40 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-39 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-39 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-39 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-39 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-39 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-39 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-39 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-39 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-39 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-39 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-39 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-39 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-39 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 7e-39 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 7e-39 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 8e-39 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-38 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-38 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-38 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-38 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-38 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 6e-38 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-38 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 8e-38 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-37 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-37 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 6e-37 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-36 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-36 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-35 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-35 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-35 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-35 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-35 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-35 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-35 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-35 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-35 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-35 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-35 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-35 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-35 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-35 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-35 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-35 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-35 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-35 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-35 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-35 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-35 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-35 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-35 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-35 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-35 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 5e-35 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-35 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-35 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-35 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-35 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 7e-35 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-34 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-34 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-34 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-34 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-34 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-34 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-34 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-34 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 7e-34 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 9e-34 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 9e-34 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-33 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-33 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-33 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-33 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 6e-33 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 7e-33 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 7e-33 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-32 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-32 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-31 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-31 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-31 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-31 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-31 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-31 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-31 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-31 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-31 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 4e-31 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 4e-31 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 4e-31 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 7e-31 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 9e-31 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-30 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-30 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-30 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-30 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-30 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-30 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-30 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-30 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-30 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 7e-30 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-29 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-29 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-29 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-29 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-29 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-29 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-29 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-29 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 6e-29 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 6e-29 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-28 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-28 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-28 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-28 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-28 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-28 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-28 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-28 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-28 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-28 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-28 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-28 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-28 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-28 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-28 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-28 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-28 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-28 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-28 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-28 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-28 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-28 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-28 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-28 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-28 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-28 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-28 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-28 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-28 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-28 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 5e-28 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 5e-28 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 5e-28 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 7e-28 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-28 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-27 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-27 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-27 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-27 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-27 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-27 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-27 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-27 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-27 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-27 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-27 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-27 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-27 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-27 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-27 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-27 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-27 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-27 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-27 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-27 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 7e-27 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 9e-27 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-26 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-26 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-26 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-26 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-26 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-26 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-26 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-26 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-26 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-26 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-26 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-26 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 8e-26 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 9e-26 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-25 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-25 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-25 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-25 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-25 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-25 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-25 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-25 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-25 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-25 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-25 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-25 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-25 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-25 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-25 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-25 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-25 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-25 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-25 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-25 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-25 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-25 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-25 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-25 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-25 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-25 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-25 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-25 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-25 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-25 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-25 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-25 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-25 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-25 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 6e-25 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-25 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 9e-25 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-24 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-24 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-24 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-24 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 7e-24 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 7e-24 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-23 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-23 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-23 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-23 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-23 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-23 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-22 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 8e-22 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 8e-22 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-21 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-21 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-21 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-21 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-21 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-21 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-21 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 5e-21 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-21 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-21 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-21 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 7e-21 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-21 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 8e-21 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 9e-21 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-20 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-20 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-20 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-20 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-20 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-20 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-20 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-20 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-20 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-20 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-20 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-20 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-20 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-20 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-20 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-20 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-20 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-20 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-20 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-20 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-20 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-20 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-20 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-20 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-20 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-20 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-20 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-20 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-20 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-20 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-20 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-20 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-20 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-20 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-20 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-20 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 6e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-20 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 6e-20 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-20 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-20 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 8e-20 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 9e-20 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 9e-20 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 9e-20 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-19 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-19 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-19 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-19 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-19 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-19 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-19 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-19 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-19 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-19 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-19 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-19 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-19 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-19 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-19 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-19 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-19 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 4e-19 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-19 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-19 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-19 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 6e-19 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 7e-19 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-19 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 8e-19 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-19 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 9e-19 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-19 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 9e-19 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 9e-19 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-18 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-18 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-18 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-18 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-18 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-18 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-18 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-18 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-18 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-18 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-18 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-18 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-18 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-18 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-18 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-18 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-18 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-18 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-18 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-18 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-18 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-18 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-18 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-18 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-18 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-18 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-18 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-18 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-18 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-18 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-18 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-18 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-18 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-18 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-18 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-18 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-18 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-18 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-18 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-18 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-18 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-18 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-18 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-18 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-18 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-18 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-18 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-18 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-18 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-18 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-18 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-18 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-18 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-18 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-18 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-18 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-18 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-18 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-18 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-18 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-18 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-18 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-18 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-18 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-18 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-18 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-18 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-18 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 6e-18 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 6e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-18 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-18 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 6e-18 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-18 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 6e-18 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 7e-18 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 7e-18 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-18 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-18 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-18 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 9e-18 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-17 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-17 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-17 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-17 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-17 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-17 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-17 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-17 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-17 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-17 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-17 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-17 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-17 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-17 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-17 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-17 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-17 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-17 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-17 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-17 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-17 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-17 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-17 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-17 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 6e-17 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-17 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-17 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-17 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 7e-17 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 8e-17 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 8e-17 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-17 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 8e-17 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 9e-17 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 9e-17 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 9e-17 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 9e-17 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 9e-17 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 9e-17 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 9e-17 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 9e-17 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-16 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-16 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-16 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-16 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-16 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-16 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-16 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-16 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-16 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-16 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-16 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-16 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-16 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-16 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-16 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-16 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-16 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-16 | ||
| 2ehb_D | 143 | The Structure Of The C-Terminal Domain Of The Prote | 3e-16 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-16 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-16 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-16 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-16 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-16 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-16 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 4e-16 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-16 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-16 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 5e-16 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-16 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-16 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 5e-16 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-16 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-16 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-16 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 6e-16 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-16 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 6e-16 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 6e-16 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-16 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-16 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 6e-16 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 7e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 7e-16 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 8e-16 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-16 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 8e-16 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 9e-16 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 9e-16 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-15 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-15 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-15 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-15 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-15 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-15 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-15 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-15 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-15 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-15 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-15 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-15 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-15 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-15 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-15 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-15 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-15 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-15 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-15 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-15 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-15 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-15 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-15 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-15 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-15 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-15 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-15 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-15 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-15 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-15 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-15 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-15 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-15 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-15 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-15 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-15 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-15 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-15 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 6e-15 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 6e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 7e-15 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 8e-15 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 9e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-14 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-14 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-14 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-14 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-14 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-14 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-14 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-14 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-14 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-14 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-14 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-14 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-14 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 1e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-14 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-14 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-14 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-14 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-14 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-14 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-14 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-14 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-14 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-14 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-14 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-14 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-14 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-14 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-14 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-14 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-14 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-14 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-14 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-14 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-14 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-14 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-14 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-14 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-14 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-14 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-14 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-14 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-14 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-14 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-14 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-14 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-14 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-14 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-14 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-14 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-14 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-14 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-14 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 7e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 7e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 7e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 7e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 7e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 8e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 8e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 8e-14 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 8e-14 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 8e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 8e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 8e-14 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 8e-14 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 9e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 9e-14 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 9e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 9e-14 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-13 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-13 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-13 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-13 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-13 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-13 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 1e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-13 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-13 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-13 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-13 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-13 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 6e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 7e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 7e-13 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 8e-13 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-12 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-12 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 2e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-12 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-12 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-12 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-12 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 3e-12 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-12 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-12 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-12 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 4e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-12 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 5e-12 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 5e-12 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-12 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 6e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-12 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-12 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 6e-12 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 6e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 6e-12 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 6e-12 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 6e-12 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 6e-12 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 6e-12 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 7e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 7e-12 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 7e-12 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 7e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 7e-12 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 8e-12 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 8e-12 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 8e-12 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 8e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 9e-12 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 9e-12 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 9e-12 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-11 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-11 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-11 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-11 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-11 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-11 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-11 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-11 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-11 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-11 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 6e-11 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 6e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-10 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-10 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-10 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-10 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 2e-10 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-10 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 2e-10 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-10 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 2e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-10 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-10 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-10 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-10 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 4e-10 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 4e-10 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 4e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-10 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-10 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-10 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 5e-10 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 5e-10 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 5e-10 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 5e-10 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 5e-10 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-10 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-10 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 5e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-10 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 6e-10 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 6e-10 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 6e-10 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 6e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 6e-10 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 6e-10 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 7e-10 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 7e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-10 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 8e-10 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 8e-10 |
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2EHB|D Chain D, The Structure Of The C-Terminal Domain Of The Protein Kinase Atsos2 Bound To The Calcium Sensor Atsos3 Length = 143 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 509 bits (1313), Expect = e-179
Identities = 132/471 (28%), Positives = 224/471 (47%), Gaps = 52/471 (11%)
Query: 2 EKKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREI 61
+ + + Y LG LG GTF KV G++ TG VA+KI++++KIR + ++ +I+REI
Sbjct: 8 KHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREI 67
Query: 62 SVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNK-VAKGKLREEVARKYFQQLVD 120
++L RHP+I++LY+V+++ + I+ MEYV GGELF+ G+L E+ +R+ FQQ++
Sbjct: 68 QNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS 127
Query: 121 AVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAP 180
V++CH V HRDLKPEN+LLD + + KI+DFGLS + L T+CG+P Y AP
Sbjct: 128 GVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM---SDGEFLRTSCGSPNYAAP 184
Query: 181 EVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVR 240
EVI+ R Y G + DIWS GV+L+ LL G LPF D ++ L+KKI F P + P V
Sbjct: 185 EVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVI 244
Query: 241 KLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIETPESPR------------------GQ 282
LL +L +P R T+ + E+ WF++ K PE P
Sbjct: 245 SLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKFEC 304
Query: 283 DRNKLISDIHA--------------------------VFECESSSSRDTDPPTNSCRSPV 316
+++S ++ + S D + P
Sbjct: 305 SEEEVLSCLYNRNHQDPLAVAYHLIIDNRRIMNEAKDFYLATSPPDSFLDDHHLTRPHPE 364
Query: 317 RPSSFNA---FDIISLSKGFNLSGLFEGDANSKLEARFTTTKPASAIVSKFEEIAVTESC 373
R A +L + +G +K + + I+++
Sbjct: 365 RVPFLVAETPRARHTLDELNPQKSKHQGVRKAKWHLGIRSQSRPNDIMAEVCRAIKQLDY 424
Query: 374 KFNKKDG-TVKLQHNRQGRKGQLAVDAEIFEVTPAFHVVELKKAAGDTMEY 423
++ + ++++ + ++++V ++++ + + +E
Sbjct: 425 EWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEILEV 475
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 488 bits (1258), Expect = e-174
Identities = 120/277 (43%), Positives = 173/277 (62%), Gaps = 4/277 (1%)
Query: 2 EKKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREI 61
+ + + Y LG LG GTF KV G + TG VA+KI++++KIR + ++ +IKREI
Sbjct: 3 KHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREI 62
Query: 62 SVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNK-VAKGKLREEVARKYFQQLVD 120
++L RHP+I++LY+V+++ T + MEYV GGELF+ G++ E AR+ FQQ++
Sbjct: 63 QNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS 122
Query: 121 AVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAP 180
AV++CH V HRDLKPEN+LLD + + KI+DFGLS + L T+CG+P Y AP
Sbjct: 123 AVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM---SDGEFLRTSCGSPNYAAP 179
Query: 181 EVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVR 240
EVI+ R Y G + DIWSCGV+L+ LL G LPF D ++ L+KKI F P + V
Sbjct: 180 EVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVA 239
Query: 241 KLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIETPE 277
LL +L +P R T+ + E+ WF++ PE
Sbjct: 240 TLLMHMLQVDPLKRATIKDIREHEWFKQDLPSYLFPE 276
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 486 bits (1253), Expect = e-173
Identities = 103/302 (34%), Positives = 168/302 (55%), Gaps = 16/302 (5%)
Query: 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLID-QIKREISVMRL 66
L+ KY +G LLG+G++ KV + +T A+KI+ K+K+RR+ + +K+EI ++R
Sbjct: 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRR 62
Query: 67 VRHPNIVQLYEVM--ASKTKIYFAMEYVRGG--ELFNKVAKGKLREEVARKYFQQLVDAV 122
+RH N++QL +V+ K K+Y MEY G E+ + V + + A YF QL+D +
Sbjct: 63 LRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGL 122
Query: 123 EFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEV 182
E+ HS+G+ H+D+KP NLLL G LKIS G++ D T+ G+PA+ PE+
Sbjct: 123 EYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEI 182
Query: 183 IN-KRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRK 241
N + G K DIWS GV L+ + G PF N+ +L++ I + + P P +
Sbjct: 183 ANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLSD 242
Query: 242 LLSRILDPNPSTRVTMAKLMENYWFRKGYKKIE----TPESPRGQDRNKLIS------DI 291
LL +L+ P+ R ++ ++ ++ WFRK + E P SP +DR + ++ D+
Sbjct: 243 LLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPDTKDRWRSMTVVPYLEDL 302
Query: 292 HA 293
H
Sbjct: 303 HG 304
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 480 bits (1239), Expect = e-171
Identities = 97/273 (35%), Positives = 152/273 (55%), Gaps = 6/273 (2%)
Query: 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV 67
+ ++L + LG+G + +V N T ++VA+KIVD ++ V + IK+EI + +++
Sbjct: 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKML 62
Query: 68 RHPNIVQLYEVMASKTKIYFAMEYVRGGELFNK-VAKGKLREEVARKYFQQLVDAVEFCH 126
H N+V+ Y Y +EY GGELF++ + E A+++F QL+ V + H
Sbjct: 63 NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 127 SRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKR 186
G+ HRD+KPENLLLDE +LKISDFGL+ + ++ LL+ CGT YVAPE++ +R
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 187 GYDGAKADIWSCGVVLFVLLAGNLPFYD-SNLMELYKKITRAEFKCPNW--FPPEVRKLL 243
+ D+WSCG+VL +LAG LP+ S+ + Y + W LL
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242
Query: 244 SRILDPNPSTRVTMAKLMENYWFRKGYKKIETP 276
+IL NPS R+T+ + ++ W+ K KK
Sbjct: 243 HKILVENPSARITIPDIKKDRWYNKPLKKGAKR 275
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 481 bits (1241), Expect = e-171
Identities = 104/312 (33%), Positives = 166/312 (53%), Gaps = 10/312 (3%)
Query: 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV 67
+ ++L + LG+G + +V N T ++VA+KIVD ++ V + IK+EI + +++
Sbjct: 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKML 62
Query: 68 RHPNIVQLYEVMASKTKIYFAMEYVRGGELFNK-VAKGKLREEVARKYFQQLVDAVEFCH 126
H N+V+ Y Y +EY GGELF++ + E A+++F QL+ V + H
Sbjct: 63 NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 127 SRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKR 186
G+ HRD+KPENLLLDE +LKISDFGL+ + ++ LL+ CGT YVAPE++ +R
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 187 GYDGAKADIWSCGVVLFVLLAGNLPFYD-SNLMELYKKITRAEFKCPNW--FPPEVRKLL 243
+ D+WSCG+VL +LAG LP+ S+ + Y + W LL
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242
Query: 244 SRILDPNPSTRVTMAKLMENYWFRKGYKKIETPESPRGQDRNKLISDIHAVFECESSSSR 303
+IL NPS R+T+ + ++ W+ K KK +S+ + F S+
Sbjct: 243 HKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGG----VSESPSGFSKHIQSNL 298
Query: 304 DTDPPTNSCRSP 315
D P ++ R+P
Sbjct: 299 DFSPVNSASRTP 310
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 475 bits (1225), Expect = e-168
Identities = 114/363 (31%), Positives = 179/363 (49%), Gaps = 28/363 (7%)
Query: 1 MEKKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKRE 60
++ ++Y+ + +G G F R+ T + VA+K +++ + + ++RE
Sbjct: 11 LDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA----IDENVQRE 66
Query: 61 ISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNK-VAKGKLREEVARKYFQQLV 119
I R +RHPNIV+ EV+ + T + MEY GGEL+ + G+ E+ AR +FQQL+
Sbjct: 67 IINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLL 126
Query: 120 DAVEFCHSRGVYHRDLKPENLLLDEN--GDLKISDFGLSALQESTRQDGLLHTTCGTPAY 177
V +CHS + HRDLK EN LLD + LKI DFG S +T GTPAY
Sbjct: 127 SGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS---VLHSQPKSTVGTPAY 183
Query: 178 VAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKK----ITRAEFKCPN 233
+APEV+ ++ YDG AD+WSCGV L+V+L G PF D Y+K I ++ P+
Sbjct: 184 IAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPD 243
Query: 234 --WFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIETPESPRGQDRNKLISDI 291
PE L+SRI +P+TR+++ ++ + WF K ES G + +
Sbjct: 244 DIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPM 303
Query: 292 HAVFECESSSSRDTDPPTNSCRSPVRPSSFNAFDIISLSKGFNLSGLFEGDANSKLEARF 351
++ S T P VR + F ++ +L + D +S+ E
Sbjct: 304 QSLDTIMQIISEATIP-------AVRNRCLDDF----MTDNLDLDDDMD-DFDSESEIDI 351
Query: 352 TTT 354
++
Sbjct: 352 DSS 354
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 472 bits (1216), Expect = e-167
Identities = 112/322 (34%), Positives = 186/322 (57%), Gaps = 9/322 (2%)
Query: 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHP 70
Y + LG+G+F KV + KT Q VA+K + ++ +++ + +++REIS ++L+RHP
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69
Query: 71 NIVQLYEVMASKTKIYFAMEYVRGGELFNK-VAKGKLREEVARKYFQQLVDAVEFCHSRG 129
+I++LY+V+ + T I +EY GGELF+ V K ++ E+ R++FQQ++ A+E+CH
Sbjct: 70 HIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK 128
Query: 130 VYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYD 189
+ HRDLKPENLLLD+N ++KI+DFGLS + L T+CG+P Y APEVIN + Y
Sbjct: 129 IVHRDLKPENLLLDDNLNVKIADFGLSNIM---TDGNFLKTSCGSPNYAAPEVINGKLYA 185
Query: 190 GAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILDP 249
G + D+WSCG+VL+V+L G LPF D + L+KK+ + P++ P + L+ R++
Sbjct: 186 GPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMIVA 245
Query: 250 NPSTRVTMAKLMENYWFRKGYKKIETPESPRGQDRNKLISDIHAVFECESSSSRDTDPPT 309
+P R+T+ ++ + WF P D V + + D
Sbjct: 246 DPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYA----DSRIVSKLGEAMGFSEDYIV 301
Query: 310 NSCRSPVRPSSFNAFDIISLSK 331
+ RS A++++ ++
Sbjct: 302 EALRSDENNEVKEAYNLLHENQ 323
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 461 bits (1189), Expect = e-163
Identities = 88/296 (29%), Positives = 156/296 (52%), Gaps = 31/296 (10%)
Query: 2 EKKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRV---------- 51
+ +N+Y L +G+G++ V N A+K++ K+K+ R
Sbjct: 5 SSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPR 64
Query: 52 -------------GLIDQIKREISVMRLVRHPNIVQLYEVM--ASKTKIYFAMEYVRGGE 96
G I+Q+ +EI++++ + HPN+V+L EV+ ++ +Y E V G
Sbjct: 65 GTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGP 124
Query: 97 LFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLS 156
+ L E+ AR YFQ L+ +E+ H + + HRD+KP NLL+ E+G +KI+DFG+S
Sbjct: 125 VMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVS 184
Query: 157 ALQESTRQDGLLHTTCGTPAYVAPEVIN--KRGYDGAKADIWSCGVVLFVLLAGNLPFYD 214
+ D LL T GTPA++APE ++ ++ + G D+W+ GV L+ + G PF D
Sbjct: 185 NEFK--GSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242
Query: 215 SNLMELYKKITRAEFKCPNW--FPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRK 268
+M L+ KI + P+ +++ L++R+LD NP +R+ + ++ + W +
Sbjct: 243 ERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 458 bits (1181), Expect = e-162
Identities = 91/283 (32%), Positives = 159/283 (56%), Gaps = 6/283 (2%)
Query: 3 KKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREIS 62
K ++ +++GR LG+G F VY R + +A+K++ K ++ + G+ Q++REI
Sbjct: 7 PKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIE 66
Query: 63 VMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDA 121
+ +RHPNI+++Y + +IY +E+ GEL+ ++ K G+ E+ + + ++L DA
Sbjct: 67 IQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADA 126
Query: 122 VEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPE 181
+ +CH R V HRD+KPENLL+ G+LKI+DFG S S R T CGT Y+ PE
Sbjct: 127 LHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR----RRTMCGTLDYLPPE 182
Query: 182 VINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRK 241
+I + +D K D+W GV+ + L G PF + E +++I + K P + +
Sbjct: 183 MIEGKTHD-EKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKD 241
Query: 242 LLSRILDPNPSTRVTMAKLMENYWFRKGYKKIETPESPRGQDR 284
L+S++L +P R+ + +ME+ W + +++ P Q +
Sbjct: 242 LISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPVYQSTQSK 284
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 457 bits (1179), Expect = e-162
Identities = 87/269 (32%), Positives = 139/269 (51%), Gaps = 4/269 (1%)
Query: 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHP 70
+Y GR LG+G FAK + + T + A KIV K + + +++ EIS+ R + H
Sbjct: 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 75
Query: 71 NIVQLYEVMASKTKIYFAMEYVRGGELFNK-VAKGKLREEVARKYFQQLVDAVEFCHSRG 129
++V + ++ +E R L + L E AR Y +Q+V ++ H
Sbjct: 76 HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR 135
Query: 130 VYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYD 189
V HRDLK NL L+E+ ++KI DFGL+ E CGTP Y+APEV++K+G+
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE--YDGERKKVLCGTPNYIAPEVLSKKGHS 193
Query: 190 GAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILDP 249
+ D+WS G +++ LL G PF S L E Y +I + E+ P P L+ ++L
Sbjct: 194 F-EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQT 252
Query: 250 NPSTRVTMAKLMENYWFRKGYKKIETPES 278
+P+ R T+ +L+ + +F GY P +
Sbjct: 253 DPTARPTINELLNDEFFTSGYIPARLPIT 281
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 455 bits (1172), Expect = e-161
Identities = 80/279 (28%), Positives = 153/279 (54%), Gaps = 5/279 (1%)
Query: 1 MEKKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKRE 60
+ G + +++G LLG+G+FA VY ++ TG VAIK++DK+ + + G++ +++ E
Sbjct: 2 LATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNE 61
Query: 61 ISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFN--KVAKGKLREEVARKYFQQL 118
+ + ++HP+I++LY +Y +E GE+ K E AR + Q+
Sbjct: 62 VKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQI 121
Query: 119 VDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYV 178
+ + + HS G+ HRDL NLLL N ++KI+DFGL+ + +T CGTP Y+
Sbjct: 122 ITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM--PHEKHYTLCGTPNYI 179
Query: 179 APEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPE 238
+PE+ + + G ++D+WS G + + LL G PF + K+ A+++ P++ E
Sbjct: 180 SPEIATRSAH-GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIE 238
Query: 239 VRKLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIETPE 277
+ L+ ++L NP+ R++++ ++++ + + E
Sbjct: 239 AKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSSTKSKDE 277
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 456 bits (1175), Expect = e-161
Identities = 87/269 (32%), Positives = 139/269 (51%), Gaps = 4/269 (1%)
Query: 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHP 70
+Y GR LG+G FAK + + T + A KIV K + + +++ EIS+ R + H
Sbjct: 42 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 101
Query: 71 NIVQLYEVMASKTKIYFAMEYVRGGELFNK-VAKGKLREEVARKYFQQLVDAVEFCHSRG 129
++V + ++ +E R L + L E AR Y +Q+V ++ H
Sbjct: 102 HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR 161
Query: 130 VYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYD 189
V HRDLK NL L+E+ ++KI DFGL+ E CGTP Y+APEV++K+G+
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY--DGERKKVLCGTPNYIAPEVLSKKGHS 219
Query: 190 GAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILDP 249
+ D+WS G +++ LL G PF S L E Y +I + E+ P P L+ ++L
Sbjct: 220 F-EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQT 278
Query: 250 NPSTRVTMAKLMENYWFRKGYKKIETPES 278
+P+ R T+ +L+ + +F GY P +
Sbjct: 279 DPTARPTINELLNDEFFTSGYIPARLPIT 307
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 442 bits (1140), Expect = e-156
Identities = 100/276 (36%), Positives = 157/276 (56%), Gaps = 6/276 (2%)
Query: 3 KKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREIS 62
KK + +E+GR LG+G F VY R ++ +A+K++ K ++ + G+ Q++RE+
Sbjct: 2 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 63 VMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDA 121
+ +RHPNI++LY T++Y +EY G ++ ++ K K E+ Y +L +A
Sbjct: 62 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121
Query: 122 VEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPE 181
+ +CHS+ V HRD+KPENLLL G+LKI+DFG S S+R CGT Y+ PE
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTDLCGTLDYLPPE 177
Query: 182 VINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRK 241
+I R +D K D+WS GV+ + L G PF + E YK+I+R EF P++ R
Sbjct: 178 MIEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 236
Query: 242 LLSRILDPNPSTRVTMAKLMENYWFRKGYKKIETPE 277
L+SR+L NPS R + +++E+ W K +
Sbjct: 237 LISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQ 272
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 427 bits (1100), Expect = e-149
Identities = 113/290 (38%), Positives = 176/290 (60%), Gaps = 8/290 (2%)
Query: 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHP 70
Y L + +G+G FAKV R++ TG+ VAIKI+DK ++ L ++ RE+ +M+++ HP
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSL-QKLFREVRIMKILNHP 74
Query: 71 NIVQLYEVMASKTKIYFAMEYVRGGELFNK-VAKGKLREEVARKYFQQLVDAVEFCHSRG 129
NIV+L+EV+ ++ +Y MEY GGE+F+ VA G+++E+ AR F+Q+V AV++CH +
Sbjct: 75 NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR 134
Query: 130 VYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYD 189
+ HRDLK ENLLLD + ++KI+DFG S G L CG P Y APE+ + YD
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEF---TVGGKLDAFCGAPPYAAPELFQGKKYD 191
Query: 190 GAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILDP 249
G + D+WS GV+L+ L++G+LPF NL EL +++ R +++ P + + LL R L
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFLVL 251
Query: 250 NPSTRVTMAKLMENYWFRKGYKKIETPESPRGQDRNKLISDIHAVFECES 299
NP R T+ ++M++ W G+ E E + ISD +
Sbjct: 252 NPIKRGTLEQIMKDRWINAGH---EEDELKPFVEPELDISDQKRIDIMVG 298
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 423 bits (1089), Expect = e-148
Identities = 83/284 (29%), Positives = 139/284 (48%), Gaps = 20/284 (7%)
Query: 3 KKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQ---IKR 59
K +Y LG LLG+G F V+ G L VAIK++ + ++ +
Sbjct: 24 KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL 83
Query: 60 EISVMRLVR----HPNIVQLYEVMASKTKIYFAMEY-VRGGELFNK-VAKGKLREEVARK 113
E++++ V HP +++L + ++ +E + +LF+ KG L E +R
Sbjct: 84 EVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRC 143
Query: 114 YFQQLVDAVEFCHSRGVYHRDLKPENLLLD-ENGDLKISDFGLSALQESTRQDGLLHTTC 172
+F Q+V A++ CHSRGV HRD+K EN+L+D G K+ DFG AL D
Sbjct: 144 FFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL----HDEPYTDFD 199
Query: 173 GTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCP 232
GT Y PE I++ Y A +WS G++L+ ++ G++PF ++I AE P
Sbjct: 200 GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER------DQEILEAELHFP 253
Query: 233 NWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIETP 276
P+ L+ R L P PS+R ++ +++ + W + + +
Sbjct: 254 AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLN 297
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 424 bits (1091), Expect = e-148
Identities = 85/313 (27%), Positives = 145/313 (46%), Gaps = 17/313 (5%)
Query: 1 MEKKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLID----- 55
+ G KY LG G F V+ + + + V +K + KEK+ I+
Sbjct: 15 LAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLG 74
Query: 56 QIKREISVMRLVRHPNIVQLYEVMASKTKIYFAME-YVRGGELFNK-VAKGKLREEVARK 113
++ EI+++ V H NI+++ ++ ++ ME + G +LF +L E +A
Sbjct: 75 KVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASY 134
Query: 114 YFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCG 173
F+QLV AV + + + HRD+K EN+++ E+ +K+ DFG +A E + L +T CG
Sbjct: 135 IFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE---RGKLFYTFCG 191
Query: 174 TPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPN 233
T Y APEV+ Y G + ++WS GV L+ L+ PF + ++ A P
Sbjct: 192 TIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE------LEETVEAAIHPPY 245
Query: 234 WFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIETPESPRGQDRNKLISDIHA 293
E+ L+S +L P P R T+ KL+ + W + + NK S + +
Sbjct: 246 LVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEV-FRVNKPESGVLS 304
Query: 294 VFECESSSSRDTD 306
E + +D
Sbjct: 305 AASLEMGNRSLSD 317
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 415 bits (1068), Expect = e-145
Identities = 87/285 (30%), Positives = 142/285 (49%), Gaps = 18/285 (6%)
Query: 3 KKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLID---QIKR 59
K+ L ++Y++G LLG G F VY G + VAIK V+K++I G + ++
Sbjct: 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 95
Query: 60 EISVMRLVRH--PNIVQLYEVMASKTKIYFAMEYVRG-GELFNK-VAKGKLREEVARKYF 115
E+ +++ V +++L + +E +LF+ +G L+EE+AR +F
Sbjct: 96 EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 155
Query: 116 QQLVDAVEFCHSRGVYHRDLKPENLLLDEN-GDLKISDFGLSALQESTRQDGLLHTTCGT 174
Q+++AV CH+ GV HRD+K EN+L+D N G+LK+ DFG AL +D + GT
Sbjct: 156 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGT 211
Query: 175 PAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNW 234
Y PE I Y G A +WS G++L+ ++ G++PF ++I R +
Sbjct: 212 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQR 265
Query: 235 FPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIETPESP 279
E + L+ L PS R T ++ + W + ET E
Sbjct: 266 VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIH 310
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 399 bits (1028), Expect = e-138
Identities = 74/332 (22%), Positives = 138/332 (41%), Gaps = 52/332 (15%)
Query: 2 EKKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRR----------- 50
K+ +N Y + R L QG F K+ K + A+K +K + +
Sbjct: 23 VKEKDKYINDYRIIRTLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDK 80
Query: 51 ---VGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFN-------- 99
D K E+ ++ +++ + ++ + ++Y EY+ +
Sbjct: 81 ISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVL 140
Query: 100 -KVAKGKLREEVARKYFQQLVDAVEFCHS-RGVYHRDLKPENLLLDENGDLKISDFGLSA 157
K + +V + + ++++ + H+ + + HRD+KP N+L+D+NG +K+SDFG S
Sbjct: 141 DKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESE 200
Query: 158 LQESTRQDGLLHTTCGTPAYVAPEVI-NKRGYDGAKADIWSCGVVLFVLLAGNLPFYD-S 215
D + + GT ++ PE N+ Y+GAK DIWS G+ L+V+ +PF
Sbjct: 201 YMV----DKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256
Query: 216 NLMELYKKITRAEFKCP-------------------NWFPPEVRKLLSRILDPNPSTRVT 256
+L+EL+ I + P N+ E L L NP+ R+T
Sbjct: 257 SLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERIT 316
Query: 257 MAKLMENYWFRK-GYKKIETPESPRGQDRNKL 287
+++ W + + + R KL
Sbjct: 317 SEDALKHEWLADTNIEDLREFSKELYKKRKKL 348
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 340 bits (875), Expect = e-116
Identities = 68/294 (23%), Positives = 132/294 (44%), Gaps = 37/294 (12%)
Query: 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRH 69
+ +E +LGQG F +V RN + AIK + + + I E+ ++ + H
Sbjct: 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKL----STILSEVMLLASLNH 61
Query: 70 PNIVQLYEV-------------MASKTKIYFAMEYVRGGELFNKVAKGK--LREEVARKY 114
+V+ Y + K+ ++ MEY G L++ + + + +
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 115 FQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQEST------------ 162
F+Q+++A+ + HS+G+ HRDLKP N+ +DE+ ++KI DFGL+ +
Sbjct: 122 FRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 163 RQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYK 222
L + GT YVA EV++ G+ K D++S G++ F ++ + + K
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--FSTGMERVNILK 239
Query: 223 KITRAEFKCPNWFP----PEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYKK 272
K+ + P F +K++ ++D +P+ R L+ + W ++
Sbjct: 240 KLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQD 293
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 314 bits (806), Expect = e-105
Identities = 95/324 (29%), Positives = 158/324 (48%), Gaps = 22/324 (6%)
Query: 1 MEKKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKI-----RRVGLID 55
M L ++Y + + LG G +V KT + VAIKI+ K K R
Sbjct: 1 MSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPAL 60
Query: 56 QIKREISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNK-VAKGKLREEVARKY 114
++ EI +++ + HP I+++ ++ Y +E + GGELF+K V +L+E + Y
Sbjct: 61 NVETEIEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLY 119
Query: 115 FQQLVDAVEFCHSRGVYHRDLKPENLLL---DENGDLKISDFGLSALQESTRQDGLLHTT 171
F Q++ AV++ H G+ HRDLKPEN+LL +E+ +KI+DFG S + + L+ T
Sbjct: 120 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETSLMRTL 176
Query: 172 CGTPAYVAPEVIN---KRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNL-MELYKKITRA 227
CGTP Y+APEV+ GY D WS GV+LF+ L+G PF + + L +IT
Sbjct: 177 CGTPTYLAPEVLVSVGTAGY-NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 235
Query: 228 --EFKCPNWFP--PEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIETPESPRGQD 283
F W + L+ ++L +P R T + + + W + K + + ++
Sbjct: 236 KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEEN 295
Query: 284 RNKLISDIHAVFECESSSSRDTDP 307
+ + + A R+ +
Sbjct: 296 ESTALPQVLAQPSTSRKRPREGEA 319
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 307 bits (789), Expect = e-102
Identities = 66/297 (22%), Positives = 133/297 (44%), Gaps = 20/297 (6%)
Query: 3 KKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREIS 62
+ + Y + + +G G +KV+ N + Q AIK V+ E+ +D + EI+
Sbjct: 21 QSMSVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQT-LDSYRNEIA 78
Query: 63 VMRLVRHPN--IVQLYEVMASKTKIYFAMEYVRGGELFNK-VAKGKLREEVARKYFQQLV 119
+ ++ + I++LY+ + IY ME +L + K + + Y++ ++
Sbjct: 79 YLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNML 137
Query: 120 DAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVA 179
+AV H G+ H DLKP N L+ +G LK+ DFG++ + + + GT Y+
Sbjct: 138 EAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 196
Query: 180 PEVINKRGYD----------GAKADIWSCGVVLFVLLAGNLPFYD--SNLMELYKKITR- 226
PE I K+D+WS G +L+ + G PF + + +L+ I
Sbjct: 197 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 256
Query: 227 AEFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIETPESPRGQD 283
E + P+ +++ +L L +P R+++ +L+ + + + + ++
Sbjct: 257 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEE 313
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 306 bits (785), Expect = e-102
Identities = 67/314 (21%), Positives = 112/314 (35%), Gaps = 51/314 (16%)
Query: 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMR 65
+ + L +LGQG A V+ GR+ KTG AIK+ + R +D RE V++
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLK 62
Query: 66 LVRHPNIVQLYEVMASKTK--IYFAMEYVRGGELFNKVAK----GKLREEVARKYFQQLV 119
+ H NIV+L+ + T ME+ G L+ + + L E + +V
Sbjct: 63 KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 122
Query: 120 DAVEFCHSRGVYHRDLKPENLLL----DENGDLKISDFGLSALQESTRQDGLLHTTCGTP 175
+ G+ HR++KP N++ D K++DFG + E D + GT
Sbjct: 123 GGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE---DDEQFVSLYGTE 179
Query: 176 AYVAPEVINKRGYD-------GAKADIWSCGVVLFVLLAGNLPFYDS----NLMELYKKI 224
Y+ P++ + GA D+WS GV + G+LPF E+ KI
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239
Query: 225 TRAEF-------------------------KCPNWFPPEVRKLLSRILDPNPSTRVTMAK 259
+ + +L+ IL+ + +
Sbjct: 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQ 299
Query: 260 LMENYWFRKGYKKI 273
Sbjct: 300 FFAETSDILHRGNS 313
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 303 bits (779), Expect = e-101
Identities = 90/268 (33%), Positives = 146/268 (54%), Gaps = 13/268 (4%)
Query: 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRH 69
+ Y++ LG+G F+ V + TG A KI++ +K+ +++RE + R ++H
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD-FQKLEREARICRKLQH 64
Query: 70 PNIVQLYEVMASKTKIYFAMEYVRGGELFNK-VAKGKLREEVARKYFQQLVDAVEFCHSR 128
PNIV+L++ + ++ Y + V GGELF VA+ E A QQ+++++ +CHS
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124
Query: 129 GVYHRDLKPENLLL---DENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINK 185
G+ HR+LKPENLLL + +K++DFGL+ H GTP Y++PEV+ K
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE---VNDSEAWHGFAGTPGYLSPEVLKK 181
Query: 186 RGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA--EFKCPNWFP--PEVRK 241
Y DIW+CGV+L++LL G PF+D + LY +I ++ P W PE +
Sbjct: 182 DPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS 240
Query: 242 LLSRILDPNPSTRVTMAKLMENYWFRKG 269
L+ +L NP R+T + ++ W
Sbjct: 241 LIDSMLTVNPKKRITADQALKVPWICNR 268
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 303 bits (778), Expect = e-101
Identities = 93/269 (34%), Positives = 152/269 (56%), Gaps = 20/269 (7%)
Query: 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHP 70
+ +LG G F++V+ + TG+ A+K + K R ++ EI+V++ ++H
Sbjct: 10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR---DSSLENEIAVLKKIKHE 66
Query: 71 NIVQLYEVMASKTKIYFAMEYVRGGELFNK-VAKGKLREEVARKYFQQLVDAVEFCHSRG 129
NIV L ++ S T Y M+ V GGELF++ + +G E+ A QQ++ AV++ H G
Sbjct: 67 NIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG 126
Query: 130 VYHRDLKPENLLL---DENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKR 186
+ HRDLKPENLL +EN + I+DFGLS +++ +G++ T CGTP YVAPEV+ ++
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ----NGIMSTACGTPGYVAPEVLAQK 182
Query: 187 GYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA--EFKCPNWFPPEV----R 240
Y D WS GV+ ++LL G PFY+ +L++KI EF+ P W ++ +
Sbjct: 183 PY-SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFW--DDISESAK 239
Query: 241 KLLSRILDPNPSTRVTMAKLMENYWFRKG 269
+ +L+ +P+ R T K + + W
Sbjct: 240 DFICHLLEKDPNERYTCEKALSHPWIDGN 268
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 301 bits (773), Expect = e-101
Identities = 95/282 (33%), Positives = 141/282 (50%), Gaps = 16/282 (5%)
Query: 3 KKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREIS 62
G + Y L +G+G++ +V T A K + K + +D+ K+EI
Sbjct: 2 STKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIE 58
Query: 63 VMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNK-VAKGKLREEVARKYFQQLVDA 121
+M+ + HPNI++LYE T IY ME GGELF + V K RE A + + ++ A
Sbjct: 59 IMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSA 118
Query: 122 VEFCHSRGVYHRDLKPENLLL---DENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYV 178
V +CH V HRDLKPEN L + LK+ DFGL+A + ++ T GTP YV
Sbjct: 119 VAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR---FKPGKMMRTKVGTPYYV 175
Query: 179 APEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA--EFKCPNWFP 236
+P+V+ + Y G + D WS GV+++VLL G PF E+ KI F +W
Sbjct: 176 SPQVL-EGLY-GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLN 233
Query: 237 --PEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIETP 276
P+ L+ R+L +P R+T + +E+ WF K
Sbjct: 234 VSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSSPRN 275
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 305 bits (783), Expect = e-100
Identities = 70/352 (19%), Positives = 121/352 (34%), Gaps = 51/352 (14%)
Query: 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMR 65
+ + L +LGQG A V+ GR+ KTG AIK+ + R +D RE V++
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLK 62
Query: 66 LVRHPNIVQLYEVMASKTK--IYFAMEYVRGGELFNKVAK----GKLREEVARKYFQQLV 119
+ H NIV+L+ + T ME+ G L+ + + L E + +V
Sbjct: 63 KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 122
Query: 120 DAVEFCHSRGVYHRDLKPENLLL----DENGDLKISDFGLSALQESTRQDGLLHTTCGTP 175
+ G+ HR++KP N++ D K++DFG + E D + GT
Sbjct: 123 GGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE---DDEQFVSLYGTE 179
Query: 176 AYVAPEVINKRGYD-------GAKADIWSCGVVLFVLLAGNLPFYD----SNLMELYKKI 224
Y+ P++ + GA D+WS GV + G+LPF E+ KI
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239
Query: 225 TRAEF-------------------------KCPNWFPPEVRKLLSRILDPNPSTRVTMAK 259
+ + +L+ IL+ + +
Sbjct: 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQ 299
Query: 260 LMENYWFRKGYKKIETPESPRGQDRNKLISDIHAVFECESSSSRDTDPPTNS 311
I + I + + T +++
Sbjct: 300 FFAETSDILHRMVIHVFSLQQMTAHKIYIHSYNTATIFHELVYKQTKIISSN 351
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 304 bits (780), Expect = e-100
Identities = 93/294 (31%), Positives = 152/294 (51%), Gaps = 13/294 (4%)
Query: 1 MEKKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKRE 60
M + + Y++ LG+G F+ V + TG A KI++ +K+ +++RE
Sbjct: 20 MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD-FQKLERE 78
Query: 61 ISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNK-VAKGKLREEVARKYFQQLV 119
+ R ++HPNIV+L++ + ++ Y + V GGELF VA+ E A QQ++
Sbjct: 79 ARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL 138
Query: 120 DAVEFCHSRGVYHRDLKPENLLL---DENGDLKISDFGLSALQESTRQDGLLHTTCGTPA 176
+++ +CHS G+ HR+LKPENLLL + +K++DFGL+ + H GTP
Sbjct: 139 ESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPG 195
Query: 177 YVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA--EFKCPNW 234
Y++PEV+ K Y DIW+CGV+L++LL G PF+D + LY +I ++ P W
Sbjct: 196 YLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEW 254
Query: 235 FP--PEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIETPESPRGQDRNK 286
PE + L+ +L NP R+T + ++ W + D K
Sbjct: 255 DTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCLK 308
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 305 bits (784), Expect = e-100
Identities = 91/298 (30%), Positives = 149/298 (50%), Gaps = 22/298 (7%)
Query: 2 EKKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKI-----RRVGLIDQ 56
L ++Y + + LG G +V KT + VAI+I+ K K R
Sbjct: 127 SVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALN 186
Query: 57 IKREISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNK-VAKGKLREEVARKYF 115
++ EI +++ + HP I+++ ++ Y +E + GGELF+K V +L+E + YF
Sbjct: 187 VETEIEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYF 245
Query: 116 QQLVDAVEFCHSRGVYHRDLKPENLLL---DENGDLKISDFGLSALQESTRQDGLLHTTC 172
Q++ AV++ H G+ HRDLKPEN+LL +E+ +KI+DFG S + + L+ T C
Sbjct: 246 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETSLMRTLC 302
Query: 173 GTPAYVAPEVI---NKRGYDGAKADIWSCGVVLFVLLAGNLPFYD-SNLMELYKKITRA- 227
GTP Y+APEV+ GY D WS GV+LF+ L+G PF + + L +IT
Sbjct: 303 GTPTYLAPEVLVSVGTAGY-NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK 361
Query: 228 -EFKCPNWFP--PEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIETPESPRGQ 282
F W + L+ ++L +P R T + + + W + K + + +
Sbjct: 362 YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEE 419
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 300 bits (770), Expect = e-100
Identities = 86/284 (30%), Positives = 141/284 (49%), Gaps = 22/284 (7%)
Query: 3 KKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLID------Q 56
YE +LG+G + V + T + A+KI+D +
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 57 IKREISVMR-LVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNK-VAKGKLREEVARKY 114
+E+ ++R + HPNI+QL + + T + + ++ GELF+ K L E+ RK
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI 129
Query: 115 FQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGT 174
+ L++ + H + HRDLKPEN+LLD++ ++K++DFG S L CGT
Sbjct: 130 MRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ---LDPGEKLREVCGT 186
Query: 175 PAYVAPEVI------NKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA- 227
P+Y+APE+I N GY G + D+WS GV+++ LLAG+ PF+ M + + I
Sbjct: 187 PSYLAPEIIECSMNDNHPGY-GKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN 245
Query: 228 -EFKCPNWFP--PEVRKLLSRILDPNPSTRVTMAKLMENYWFRK 268
+F P W V+ L+SR L P R T + + + +F++
Sbjct: 246 YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 289
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 302 bits (774), Expect = e-100
Identities = 89/283 (31%), Positives = 148/283 (52%), Gaps = 21/283 (7%)
Query: 3 KKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRV-----GLIDQI 57
A KY+ ++G+G + V + TG A+KI++ R + +
Sbjct: 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREAT 146
Query: 58 KREISVMR-LVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNK-VAKGKLREEVARKYF 115
+RE ++R + HP+I+ L + S + ++ + +R GELF+ K L E+ R
Sbjct: 147 RRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIM 206
Query: 116 QQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTP 175
+ L++AV F H+ + HRDLKPEN+LLD+N +++SDFG S L CGTP
Sbjct: 207 RSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCH---LEPGEKLRELCGTP 263
Query: 176 AYVAPEVI------NKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA-- 227
Y+APE++ GY G + D+W+CGV+LF LLAG+ PF+ + + + I
Sbjct: 264 GYLAPEILKCSMDETHPGY-GKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQY 322
Query: 228 EFKCPNWFP--PEVRKLLSRILDPNPSTRVTMAKLMENYWFRK 268
+F P W V+ L+SR+L +P R+T + +++ +F +
Sbjct: 323 QFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 298 bits (766), Expect = 1e-99
Identities = 90/277 (32%), Positives = 145/277 (52%), Gaps = 18/277 (6%)
Query: 4 KAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISV 63
G + + + R LG G F V+ +G IK ++K++ + ++QI+ EI V
Sbjct: 16 FQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ--VPMEQIEAEIEV 73
Query: 64 MRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKV-----AKGKLREEVARKYFQQL 118
++ + HPNI++++EV +Y ME GGEL ++ L E + +Q+
Sbjct: 74 LKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQM 133
Query: 119 VDAVEFCHSRGVYHRDLKPENLLL---DENGDLKISDFGLSALQESTRQDGLLHTTCGTP 175
++A+ + HS+ V H+DLKPEN+L + +KI DFGL+ L +S GT
Sbjct: 134 MNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH---STNAAGTA 190
Query: 176 AYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFK-CPNW 234
Y+APEV KR K DIWS GVV++ LL G LPF ++L E+ +K T E
Sbjct: 191 LYMAPEVF-KRDV-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVEC 248
Query: 235 FP--PEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269
P P+ LL ++L +P R + A+++ + WF++
Sbjct: 249 RPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQA 285
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 299 bits (768), Expect = 4e-99
Identities = 69/327 (21%), Positives = 136/327 (41%), Gaps = 20/327 (6%)
Query: 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRH 69
Y + + +G G +KV+ N + Q AIK V+ E+ +D + EI+ + ++
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQ-TLDSYRNEIAYLNKLQQ 66
Query: 70 PN--IVQLYEVMASKTKIYFAMEYVRGGELFNK-VAKGKLREEVARKYFQQLVDAVEFCH 126
+ I++LY+ + IY ME +L + K + + Y++ +++AV H
Sbjct: 67 HSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 125
Query: 127 SRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKR 186
G+ H DLKP N L+ +G LK+ DFG++ + + + GT Y+ PE I
Sbjct: 126 QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184
Query: 187 GYD----------GAKADIWSCGVVLFVLLAGNLPFYD-SNLMELYKKITRA--EFKCPN 233
K+D+WS G +L+ + G PF N + I E + P+
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 244
Query: 234 WFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIETPESPRGQDRNKLISDIHA 293
+++ +L L +P R+++ +L+ + + + + ++ ++ +
Sbjct: 245 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVG 304
Query: 294 VFECESSSSRDTDPPTNSCRSPVRPSS 320
+ S + SS
Sbjct: 305 LNSPNSILKAAKTLYEHYSGGESHNSS 331
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 301 bits (774), Expect = 1e-98
Identities = 99/284 (34%), Positives = 155/284 (54%), Gaps = 12/284 (4%)
Query: 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHP 70
+Y+L LG+G F+ V + GQ A I++ +K+ +++RE + RL++HP
Sbjct: 12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARD-HQKLEREARICRLLKHP 70
Query: 71 NIVQLYEVMASKTKIYFAMEYVRGGELFNK-VAKGKLREEVARKYFQQLVDAVEFCHSRG 129
NIV+L++ ++ + Y + V GGELF VA+ E A QQ+++AV CH G
Sbjct: 71 NIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG 130
Query: 130 VYHRDLKPENLLL---DENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKR 186
V HR+LKPENLLL + +K++DFGL+ E +Q GTP Y++PEV+ K
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ--AWFGFAGTPGYLSPEVLRKD 188
Query: 187 GYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA--EFKCPNWFP--PEVRKL 242
Y G D+W+CGV+L++LL G PF+D + LY++I +F P W PE + L
Sbjct: 189 PY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDL 247
Query: 243 LSRILDPNPSTRVTMAKLMENYWFRKGYKKIETPESPRGQDRNK 286
++++L NPS R+T A+ +++ W D K
Sbjct: 248 INKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLK 291
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 298 bits (765), Expect = 4e-98
Identities = 68/334 (20%), Positives = 137/334 (41%), Gaps = 20/334 (5%)
Query: 3 KKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREIS 62
+ + Y + + +G G +KV+ N + Q AIK V+ E+ +D + EI+
Sbjct: 49 ECISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQ-TLDSYRNEIA 106
Query: 63 VMRLVRHPN--IVQLYEVMASKTKIYFAMEYVRGGELFNK-VAKGKLREEVARKYFQQLV 119
+ ++ + I++LY+ + IY ME +L + K + + Y++ ++
Sbjct: 107 YLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNML 165
Query: 120 DAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVA 179
+AV H G+ H DLKP N L+ +G LK+ DFG++ + + + G Y+
Sbjct: 166 EAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMP 224
Query: 180 PEVINKRGYD----------GAKADIWSCGVVLFVLLAGNLPFYD-SNLMELYKKITRA- 227
PE I K+D+WS G +L+ + G PF N + I
Sbjct: 225 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 284
Query: 228 -EFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIETPESPRGQDRNK 286
E + P+ +++ +L L +P R+++ +L+ + + + + ++
Sbjct: 285 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKY 344
Query: 287 LISDIHAVFECESSSSRDTDPPTNSCRSPVRPSS 320
++ + + S + SS
Sbjct: 345 VLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSS 378
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 307 bits (788), Expect = 4e-98
Identities = 71/301 (23%), Positives = 118/301 (39%), Gaps = 43/301 (14%)
Query: 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHP 70
+E+ LG G F V + TG+ VAIK +E + ++ EI +M+ + HP
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPK--NRERWCLEIQIMKKLNHP 72
Query: 71 NIVQLYEVMASKTKI------YFAMEYVRGGELFNKVAK----GKLREEVARKYFQQLVD 120
N+V EV K+ AMEY GG+L + + L+E R +
Sbjct: 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 121 AVEFCHSRGVYHRDLKPENLLLDENGD---LKISDFGLSALQESTRQDGLLHTTCGTPAY 177
A+ + H + HRDLKPEN++L KI D G + + Q L GT Y
Sbjct: 133 ALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD---QGELCTEFVGTLQY 189
Query: 178 VAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFY-DSNLMELYKKITRAEFKCPNWFP 236
+APE++ ++ Y D WS G + F + G PF + ++ + K+ + +
Sbjct: 190 LAPELLEQKKYT-VTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD 248
Query: 237 -----------------------PEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYKKI 273
++ + L +L + R T + F+ +
Sbjct: 249 DLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSIL 308
Query: 274 E 274
Sbjct: 309 S 309
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 296 bits (759), Expect = 8e-98
Identities = 95/324 (29%), Positives = 149/324 (45%), Gaps = 52/324 (16%)
Query: 3 KKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQ--IKRE 60
L KY L +GQG++ V +T AIKI++K KIR++ D IK E
Sbjct: 19 GSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTE 78
Query: 61 ISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAK----------------- 103
+ +M+ + HPNI +LYEV + I ME GG L +K+
Sbjct: 79 VRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQ 138
Query: 104 ------------------------GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPEN 139
RE++ +Q+ A+ + H++G+ HRD+KPEN
Sbjct: 139 ICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPEN 198
Query: 140 LLL--DENGDLKISDFGLSAL--QESTRQDGLLHTTCGTPAYVAPEVINKRGYD-GAKAD 194
L +++ ++K+ DFGLS + + + + T GTP +VAPEV+N G K D
Sbjct: 199 FLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258
Query: 195 IWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAE--FKCPNW--FPPEVRKLLSRILDPN 250
WS GV+L +LL G +PF N + ++ + F+ PN+ P R LLS +L+ N
Sbjct: 259 AWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRN 318
Query: 251 PSTRVTMAKLMENYWFRKGYKKIE 274
R + +++ W + KI
Sbjct: 319 VDERFDAMRALQHPWISQFSDKIY 342
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 294 bits (754), Expect = 9e-98
Identities = 85/271 (31%), Positives = 152/271 (56%), Gaps = 14/271 (5%)
Query: 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRH 69
+Y + +LG+G+F +V ++ T Q A+K+++K + I RE+ +++ + H
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD-TSTILREVELLKKLDH 80
Query: 70 PNIVQLYEVMASKTKIYFAMEYVRGGELFNK-VAKGKLREEVARKYFQQLVDAVEFCHSR 128
PNI++L+E++ + Y E GGELF++ + + + E A + +Q+ + + H
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 129 GVYHRDLKPENLLL---DENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINK 185
+ HRDLKPEN+LL +++ D+KI DFGLS +Q+ + GT Y+APEV+ +
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC---FQQNTKMKDRIGTAYYIAPEVL-R 196
Query: 186 RGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA--EFKCPNWFP--PEVRK 241
Y K D+WS GV+L++LL+G PFY N ++ K++ F P W + +
Sbjct: 197 GTY-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD 255
Query: 242 LLSRILDPNPSTRVTMAKLMENYWFRKGYKK 272
L+ ++L +PS R+T + +E+ W +K +
Sbjct: 256 LIRKMLTFHPSLRITATQCLEHPWIQKYSSE 286
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 298 bits (765), Expect = 8e-97
Identities = 87/291 (29%), Positives = 166/291 (57%), Gaps = 13/291 (4%)
Query: 1 MEKKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKRE 60
++ I ++Y+ R+LG+G+F +V ++ TGQ A+K++ K ++++ + + RE
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 61 ISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNK-VAKGKLREEVARKYFQQLV 119
+ +++ + HPNI++LYE K Y E GGELF++ +++ + E A + +Q++
Sbjct: 77 VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVL 136
Query: 120 DAVEFCHSRGVYHRDLKPENLLL---DENGDLKISDFGLSALQESTRQDGLLHTTCGTPA 176
+ + H + HRDLKPENLLL ++ +++I DFGLS E++++ + GT
Sbjct: 137 SGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK---MKDKIGTAY 193
Query: 177 YVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAE--FKCPNW 234
Y+APEV++ Y K D+WS GV+L++LL+G PF +N ++ KK+ + + F+ P W
Sbjct: 194 YIAPEVLHGT-Y-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQW 251
Query: 235 --FPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIETPESPRGQD 283
+ L+ ++L PS R++ +++ W + K+ + + P +
Sbjct: 252 KKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDN 302
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 293 bits (751), Expect = 2e-96
Identities = 96/341 (28%), Positives = 166/341 (48%), Gaps = 25/341 (7%)
Query: 1 MEKKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQ--IK 58
M + + YEL ++G+G F+ V N +TGQ A+KIVD K + +K
Sbjct: 15 MADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLK 74
Query: 59 REISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNK-VAKGKLR----EEVARK 113
RE S+ +++HP+IV+L E +S +Y E++ G +L + V + E VA
Sbjct: 75 REASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASH 134
Query: 114 YFQQLVDAVEFCHSRGVYHRDLKPENLLL---DENGDLKISDFGLSALQESTRQDGLLHT 170
Y +Q+++A+ +CH + HRD+KP +LL + + +K+ FG++ + +
Sbjct: 135 YMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI--QLGESGLVAGG 192
Query: 171 TCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA--E 228
GTP ++APEV+ + Y G D+W CGV+LF+LL+G LPFY + L++ I + +
Sbjct: 193 RVGTPHFMAPEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTKE-RLFEGIIKGKYK 250
Query: 229 FKCPNWFP--PEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIETPESPRGQD--- 283
W + L+ R+L +P+ R+T+ + + + W ++ + P +
Sbjct: 251 MNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLR 310
Query: 284 ----RNKLISDIHAVFECESSSSRDTDPPTNSCRSPVRPSS 320
R KL + A +S DPP P+S
Sbjct: 311 KFNARRKLKGAVLAAVSSHKFNSFYGDPPEELPDFSEDPTS 351
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 289 bits (743), Expect = 4e-96
Identities = 91/282 (32%), Positives = 152/282 (53%), Gaps = 20/282 (7%)
Query: 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKI---RRVGLIDQIKREISVMRL 66
+ YE+G LG G FA V R TG+ A K + K ++ RR ++I+RE++++R
Sbjct: 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 67 VRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNK-VAKGKLREEVARKYFQQLVDAVEFC 125
+RHPNI+ L+++ +KT + +E V GGELF+ K L E+ A ++ +Q++D V +
Sbjct: 65 IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYL 124
Query: 126 HSRGVYHRDLKPENLLL----DENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPE 181
HS+ + H DLKPEN++L N +K+ DFG++ E GTP +VAPE
Sbjct: 125 HSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE---AGNEFKNIFGTPEFVAPE 181
Query: 182 VINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA--EFKCPNWFPPEV 239
++N G +AD+WS GV+ ++LL+G PF E I+ +F +
Sbjct: 182 IVNYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYF--SNT 238
Query: 240 ----RKLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIETPE 277
+ + R+L +P R+T+A+ +E+ W + ++ E
Sbjct: 239 SELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNVRGE 280
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 294 bits (754), Expect = 3e-95
Identities = 86/276 (31%), Positives = 153/276 (55%), Gaps = 14/276 (5%)
Query: 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV 67
+Y + +LG+G+F +V ++ T Q A+K+++K + I RE+ +++ +
Sbjct: 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD-TSTILREVELLKKL 78
Query: 68 RHPNIVQLYEVMASKTKIYFAMEYVRGGELFNK-VAKGKLREEVARKYFQQLVDAVEFCH 126
HPNI++L+E++ + Y E GGELF++ + + + E A + +Q+ + + H
Sbjct: 79 DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMH 138
Query: 127 SRGVYHRDLKPENLLL---DENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVI 183
+ HRDLKPEN+LL +++ D+KI DFGLS +Q+ + GT Y+APEV+
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC---FQQNTKMKDRIGTAYYIAPEVL 195
Query: 184 NKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAE--FKCPNW--FPPEV 239
Y K D+WS GV+L++LL+G PFY N ++ K++ + F P W +
Sbjct: 196 RGT-Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDA 253
Query: 240 RKLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIET 275
+ L+ ++L +PS R+T + +E+ W +K + T
Sbjct: 254 KDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPT 289
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 294 bits (754), Expect = 6e-95
Identities = 87/295 (29%), Positives = 147/295 (49%), Gaps = 23/295 (7%)
Query: 3 KKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLI-------- 54
KK G + Y R LG G + +V + AIK++ K + +
Sbjct: 29 KKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEK 88
Query: 55 --DQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNK-VAKGKLREEVA 111
++I EIS+++ + HPNI++L++V K Y E+ GGELF + + + K E A
Sbjct: 89 FHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDA 148
Query: 112 RKYFQQLVDAVEFCHSRGVYHRDLKPENLLL---DENGDLKISDFGLSALQESTRQDGLL 168
+Q++ + + H + HRD+KPEN+LL + ++KI DFGLS+ + L
Sbjct: 149 ANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK---L 205
Query: 169 HTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAE 228
GT Y+APEV+ K+ Y K D+WSCGV++++LL G PF N ++ KK+ + +
Sbjct: 206 RDRLGTAYYIAPEVL-KKKY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGK 263
Query: 229 --FKCPNW--FPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIETPESP 279
F +W E ++L+ +L + + R T + + + W +K I +
Sbjct: 264 YYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQK 318
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 287 bits (736), Expect = 2e-94
Identities = 86/310 (27%), Positives = 147/310 (47%), Gaps = 28/310 (9%)
Query: 1 MEKKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKRE 60
+ + + + YE+ +G G+++ + T A+KI+DK K E
Sbjct: 13 LHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------PTEE 65
Query: 61 ISVM-RLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNK-VAKGKLREEVARKYFQQL 118
I ++ R +HPNI+ L +V +Y E ++GGEL +K + + E A +
Sbjct: 66 IEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTI 125
Query: 119 VDAVEFCHSRGVYHRDLKPENLLLDENGD----LKISDFGLSALQESTRQDGLLHTTCGT 174
VE+ H++GV HRDLKP N+L + ++I DFG + + ++GLL T C T
Sbjct: 126 TKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA--ENGLLMTPCYT 183
Query: 175 PAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFY---DSNLMELYKKITRA--EF 229
+VAPEV+ ++GYD A DIWS GV+L+ +L G PF D E+ +I
Sbjct: 184 ANFVAPEVLERQGYD-AACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSL 242
Query: 230 KCPNWFPPEV----RKLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIETPESPRGQDRN 285
W V + L+S++L +P R+T A ++ + W + + + + +
Sbjct: 243 SGGYW--NSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQ-DAPH 299
Query: 286 KLISDIHAVF 295
+ + A +
Sbjct: 300 LVKGAMAATY 309
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 286 bits (733), Expect = 4e-94
Identities = 86/298 (28%), Positives = 142/298 (47%), Gaps = 20/298 (6%)
Query: 4 KAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKI---RRVGLIDQIKRE 60
K + + Y++G LG G FA V R TG A K + K + RR ++I+RE
Sbjct: 6 KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIERE 65
Query: 61 ISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNK-VAKGKLREEVARKYFQQLV 119
+S++R V H N++ L++V ++T + +E V GGELF+ K L EE A + +Q++
Sbjct: 66 VSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL 125
Query: 120 DAVEFCHSRGVYHRDLKPENLLL----DENGDLKISDFGLSALQESTRQDGLLHTTCGTP 175
D V + H++ + H DLKPEN++L +K+ DFGL+ E GTP
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE---DGVEFKNIFGTP 182
Query: 176 AYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA--EFKCPN 233
+VAPE++N G +AD+WS GV+ ++LL+G PF E IT +F
Sbjct: 183 EFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEF 241
Query: 234 WFPPEV----RKLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIETPESPRGQDRNKL 287
+ + + ++L R+T+ + + + W + +
Sbjct: 242 F--SHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLENF 297
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 285 bits (731), Expect = 9e-94
Identities = 88/298 (29%), Positives = 147/298 (49%), Gaps = 20/298 (6%)
Query: 4 KAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKI---RRVGLIDQIKRE 60
+ + + Y+ G LG G FA V R TG A K + K + RR + I+RE
Sbjct: 5 RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 64
Query: 61 ISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNK-VAKGKLREEVARKYFQQLV 119
+S+++ ++HPN++ L+EV +KT + +E V GGELF+ K L EE A ++ +Q++
Sbjct: 65 VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL 124
Query: 120 DAVEFCHSRGVYHRDLKPENLLL----DENGDLKISDFGLSALQESTRQDGLLHTTCGTP 175
+ V + HS + H DLKPEN++L +KI DFGL+ + GTP
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---FGNEFKNIFGTP 181
Query: 176 AYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA--EFKCPN 233
+VAPE++N G +AD+WS GV+ ++LL+G PF E ++ EF+
Sbjct: 182 EFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 234 WFPPEV----RKLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIETPESPRGQDRNKL 287
+ + + R+L +P R+T+ +++ W + + + K
Sbjct: 241 F--SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASAVNMEKF 296
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 285 bits (731), Expect = 2e-93
Identities = 91/322 (28%), Positives = 149/322 (46%), Gaps = 29/322 (9%)
Query: 4 KAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKI---RRVGLIDQIKRE 60
K + + Y++G LG G FA V R TG A K + K + RR ++I+RE
Sbjct: 6 KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIERE 65
Query: 61 ISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNK-VAKGKLREEVARKYFQQLV 119
+S++R V HPNI+ L++V ++T + +E V GGELF+ K L EE A + +Q++
Sbjct: 66 VSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL 125
Query: 120 DAVEFCHSRGVYHRDLKPENLLL----DENGDLKISDFGLSALQESTRQDGLLHTTCGTP 175
D V + H++ + H DLKPEN++L +K+ DFGL+ E GTP
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE---DGVEFKNIFGTP 182
Query: 176 AYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA--EFKCPN 233
+VAPE++N G +AD+WS GV+ ++LL+G PF E IT +F
Sbjct: 183 EFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEF 241
Query: 234 WFPPEV----RKLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIETPESPRGQD------ 283
+ + + + ++L R+T+ + + + W + +
Sbjct: 242 F--SQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNLENFKK 299
Query: 284 ---RNKLISDIHAVFECESSSS 302
R + V C +
Sbjct: 300 QYVRRRWKLSFSIVSLCNHLTR 321
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 289 bits (741), Expect = 3e-93
Identities = 94/286 (32%), Positives = 155/286 (54%), Gaps = 14/286 (4%)
Query: 1 MEKKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKRE 60
+ K G L Y+ + LG G + +V R+ T AIKI+ K + ++ E
Sbjct: 28 ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS-NSKLLEE 86
Query: 61 ISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNK-VAKGKLREEVARKYFQQLV 119
++V++L+ HPNI++LY+ K Y ME +GGELF++ + + K E A +Q++
Sbjct: 87 VAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVL 146
Query: 120 DAVEFCHSRGVYHRDLKPENLLL---DENGDLKISDFGLSALQESTRQDGLLHTTCGTPA 176
V + H + HRDLKPENLLL +++ +KI DFGLSA+ E+ ++ + GT
Sbjct: 147 SGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK---MKERLGTAY 203
Query: 177 YVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAE--FKCPNW 234
Y+APEV+ K+ Y K D+WS GV+LF+LLAG PF E+ +K+ + + F P W
Sbjct: 204 YIAPEVLRKK-Y-DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEW 261
Query: 235 --FPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIETPES 278
+ L+ ++L + R++ + +E+ W ++ K E+
Sbjct: 262 KNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIE 307
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 284 bits (728), Expect = 5e-93
Identities = 92/277 (33%), Positives = 147/277 (53%), Gaps = 22/277 (7%)
Query: 3 KKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREIS 62
L + +E+ LG+G + VY + T + A+K++ K ++ EI
Sbjct: 46 SNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIG 100
Query: 63 VMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNK-VAKGKLREEVARKYFQQLVDA 121
V+ + HPNI++L E+ + T+I +E V GGELF++ V KG E A +Q+++A
Sbjct: 101 VLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEA 160
Query: 122 VEFCHSRGVYHRDLKPENLLL---DENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYV 178
V + H G+ HRDLKPENLL + LKI+DFGLS + E L+ T CGTP Y
Sbjct: 161 VAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE---HQVLMKTVCGTPGYC 217
Query: 179 APEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYD-SNLMELYKKITRA--EFKCPNWF 235
APE++ Y G + D+WS G++ ++LL G PFYD ++++I F P W
Sbjct: 218 APEILRGCAY-GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWW- 275
Query: 236 PPEV----RKLLSRILDPNPSTRVTMAKLMENYWFRK 268
EV + L+ +++ +P R+T + +++ W
Sbjct: 276 -DEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTG 311
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 283 bits (726), Expect = 2e-92
Identities = 52/302 (17%), Positives = 101/302 (33%), Gaps = 54/302 (17%)
Query: 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR-- 68
G +LGQ + +TG+S + + + I Q+K E+ +RL+R
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 69 -----------------------HPNIVQLYEVMASKT--KIYFAME------YVRGGEL 97
++++ +F G L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 98 FNKVAKGKLREEVARKY-FQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLS 156
+ + K AR Q++ + H G+ H L+P +++LD+ G + ++ F
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 253
Query: 157 ALQESTRQDGLLHTTCGTPAYVAPEVINKRG----------YDGAKADIWSCGVVLFVLL 206
+DG + + + PE+ +R D W+ G+V++ +
Sbjct: 254 ------VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307
Query: 207 AGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWF 266
+LP + + I F+ P VR LL L R+ + ME +
Sbjct: 308 CADLPITKDAALGGSEWI----FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEY 363
Query: 267 RK 268
+
Sbjct: 364 EQ 365
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 280 bits (719), Expect = 4e-92
Identities = 97/292 (33%), Positives = 150/292 (51%), Gaps = 28/292 (9%)
Query: 4 KAGILMNKYELG---RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKRE 60
K Y+L + LG+G+F+ + K+ Q+ A+KI+ K ++E
Sbjct: 2 KDSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANT------QKE 55
Query: 61 ISVMRLVR-HPNIVQLYEVMASKTKIYFAMEYVRGGELFNK-VAKGKLREEVARKYFQQL 118
I+ ++L HPNIV+L+EV + + ME + GGELF + K E A ++L
Sbjct: 56 ITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKL 115
Query: 119 VDAVEFCHSRGVYHRDLKPENLLL---DENGDLKISDFGLSALQESTRQDGLLHTTCGTP 175
V AV H GV HRDLKPENLL ++N ++KI DFG + L+ + L T C T
Sbjct: 116 VSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP--DNQPLKTPCFTL 173
Query: 176 AYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSN-------LMELYKKITRA- 227
Y APE++N+ GYD D+WS GV+L+ +L+G +PF + +E+ KKI +
Sbjct: 174 HYAAPELLNQNGYD-ESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD 232
Query: 228 -EFKCPNWFP--PEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIETP 276
F+ W E + L+ +L +P+ R+ M+ L N W + G + P
Sbjct: 233 FSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNP 284
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 278 bits (713), Expect = 4e-91
Identities = 67/288 (23%), Positives = 129/288 (44%), Gaps = 20/288 (6%)
Query: 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRH 69
KY + LG+G F V+ + ++ K V + + +K+EIS++ + RH
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ----VLVKKEISILNIARH 60
Query: 70 PNIVQLYEVMASKTKIYFAMEYVRGGELFNK-VAKG-KLREEVARKYFQQLVDAVEFCHS 127
NI+ L+E S ++ E++ G ++F + +L E Y Q+ +A++F HS
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 128 RGVYHRDLKPENLLL--DENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINK 185
+ H D++PEN++ + +KI +FG + + P Y APEV
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK---PGDNFRLLFTAPEYYAPEVHQH 177
Query: 186 RGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA--EFKCPNWFPPEV---- 239
D+WS G +++VLL+G PF ++ + I A F + E+
Sbjct: 178 DVV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF--KEISIEA 234
Query: 240 RKLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIETPESPRGQDRNKL 287
+ R+L +R+T ++ +++ W ++ +++ T + R
Sbjct: 235 MDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYY 282
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 278 bits (713), Expect = 7e-91
Identities = 83/316 (26%), Positives = 155/316 (49%), Gaps = 14/316 (4%)
Query: 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR 68
M KY + +G+G+F K ++ + G+ IK ++ ++ ++ +RE++V+ ++
Sbjct: 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS-KEREESRREVAVLANMK 81
Query: 69 HPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGK---LREEVARKYFQQLVDAVEFC 125
HPNIVQ E +Y M+Y GG+LF ++ K +E+ +F Q+ A++
Sbjct: 82 HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV 141
Query: 126 HSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINK 185
H R + HRD+K +N+ L ++G +++ DFG++ + ST + L GTP Y++PE+
Sbjct: 142 HDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE--LARACIGTPYYLSPEICEN 199
Query: 186 RGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKC-PNWFPPEVRKLLS 244
+ Y+ K+DIW+ G VL+ L F ++ L KI F + ++R L+S
Sbjct: 200 KPYN-NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVS 258
Query: 245 RILDPNPSTRVTMAKLMENYWFRKGYKKIETPESPRGQDRNKLISDIHAVFECESSSSRD 304
++ NP R ++ ++E + K +K +P+ + K S + S
Sbjct: 259 QLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFS------KFGSQPIPA 312
Query: 305 TDPPTNSCRSPVRPSS 320
P + V P+
Sbjct: 313 KRPASGQNSISVMPAQ 328
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 271 bits (695), Expect = 2e-88
Identities = 77/281 (27%), Positives = 130/281 (46%), Gaps = 21/281 (7%)
Query: 3 KKAGILMNKYEL-GRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREI 61
+ N Y L + LG+G FA V + TGQ A K + K + + +I EI
Sbjct: 21 QSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDC-RAEILHEI 79
Query: 62 SVMRLVRH-PNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAK---GKLREEVARKYFQQ 117
+V+ L + P ++ L+EV + ++I +EY GGE+F+ + E + +Q
Sbjct: 80 AVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQ 139
Query: 118 LVDAVEFCHSRGVYHRDLKPENLLL---DENGDLKISDFGLSALQESTRQDGLLHTTCGT 174
+++ V + H + H DLKP+N+LL GD+KI DFG+S L GT
Sbjct: 140 ILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG---HACELREIMGT 196
Query: 175 PAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA--EFKCP 232
P Y+APE++N D+W+ G++ ++LL PF + E Y I++ ++
Sbjct: 197 PEYLAPEILNYDPI-TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEE 255
Query: 233 NWFPPEV----RKLLSRILDPNPSTRVTMAKLMENYWFRKG 269
+ V + +L NP R T + + W ++
Sbjct: 256 TF--SSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQW 294
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 273 bits (700), Expect = 2e-88
Identities = 74/286 (25%), Positives = 137/286 (47%), Gaps = 15/286 (5%)
Query: 2 EKKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREI 61
E K G + + Y++ LG G F V+ TG+ K ++ +K EI
Sbjct: 43 EVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD---KYTVKNEI 99
Query: 62 SVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNK-VAKG-KLREEVARKYFQQLV 119
S+M + HP ++ L++ K ++ +E++ GGELF++ A+ K+ E Y +Q
Sbjct: 100 SIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQAC 159
Query: 120 DAVEFCHSRGVYHRDLKPENLLL--DENGDLKISDFGLSALQESTRQDGLLHTTCGTPAY 177
+ ++ H + H D+KPEN++ + +KI DFGL+ D ++ T T +
Sbjct: 160 EGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN---PDEIVKVTTATAEF 216
Query: 178 VAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA--EFKCPNWF 235
APE++++ G D+W+ GV+ +VLL+G PF + +E + + R EF +
Sbjct: 217 AAPEIVDREPV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFS 275
Query: 236 P--PEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIETPESP 279
PE + + +L P R+T+ +E+ W + + + +
Sbjct: 276 SVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPS 321
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 270 bits (692), Expect = 4e-88
Identities = 83/306 (27%), Positives = 145/306 (47%), Gaps = 48/306 (15%)
Query: 11 KYELGR-LLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR- 68
Y+L +LG+G A+V NL T Q A+KI++K+ ++ RE+ ++ +
Sbjct: 13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIR---SRVFREVEMLYQCQG 69
Query: 69 HPNIVQLYEVMASKTKIYFAMEYVRGGELFNK-VAKGKLREEVARKYFQQLVDAVEFCHS 127
H N+++L E + + Y E +RGG + + + E A Q + A++F H+
Sbjct: 70 HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHN 129
Query: 128 RGVYHRDLKPENLLL---DENGDLKISDFGLSALQE-----STRQDGLLHTTCGTPAYVA 179
+G+ HRDLKPEN+L ++ +KI DF L + + S L T CG+ Y+A
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 180 PEVINK-----RGYDGAKADIWSCGVVLFVLLAGNLPFYDSNL---------------ME 219
PEV+ YD + D+WS GV+L++LL+G PF
Sbjct: 190 PEVVEAFSEEASIYD-KRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNM 248
Query: 220 LYKKITRA--EFKCPNWFPPEV----RKLLSRILDPNPSTRVTMAKLMENYWFRKGYKKI 273
L++ I EF +W + + L+S++L + R++ A+++++ W +
Sbjct: 249 LFESIQEGKYEFPDKDW--AHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQG----- 301
Query: 274 ETPESP 279
PE+
Sbjct: 302 CAPENT 307
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 270 bits (693), Expect = 6e-88
Identities = 85/295 (28%), Positives = 144/295 (48%), Gaps = 33/295 (11%)
Query: 2 EKKAGILMNKYELGR-LLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKRE 60
E K + + Y+L + +LG G KV + +TGQ A+K++ + ++E
Sbjct: 20 EPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--------KARQE 71
Query: 61 ISVM-RLVRHPNIVQLYEV----MASKTKIYFAMEYVRGGELFNK-VAKGKLR--EEVAR 112
+ + P+IV + +V K + ME + GGELF++ +G E A
Sbjct: 72 VDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAA 131
Query: 113 KYFQQLVDAVEFCHSRGVYHRDLKPENLLL---DENGDLKISDFGLSALQESTRQDGLLH 169
+ + + A++F HS + HRD+KPENLL +++ LK++DFG + L
Sbjct: 132 EIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT----QNALQ 187
Query: 170 TTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSN----LMELYKKIT 225
T C TP YVAPEV+ YD D+WS GV++++LL G PFY + + ++I
Sbjct: 188 TPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIR 246
Query: 226 RA--EFKCPNWFP--PEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIETP 276
F P W + ++L+ +L +P+ R+T+ + M + W + +TP
Sbjct: 247 LGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTP 301
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 271 bits (695), Expect = 2e-87
Identities = 90/293 (30%), Positives = 147/293 (50%), Gaps = 31/293 (10%)
Query: 3 KKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREIS 62
KK I+ + ++LG G KV N +T + A+K++ + +RE+
Sbjct: 55 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVE 106
Query: 63 VM-RLVRHPNIVQLYEV----MASKTKIYFAMEYVRGGELFNK-VAKGKLR--EEVARKY 114
+ R + P+IV++ +V A + + ME + GGELF++ +G E A +
Sbjct: 107 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 166
Query: 115 FQQLVDAVEFCHSRGVYHRDLKPENLLL---DENGDLKISDFGLSALQESTRQDGLLHTT 171
+ + +A+++ HS + HRD+KPENLL N LK++DFG + T L T
Sbjct: 167 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE---TTSHNSLTTP 223
Query: 172 CGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLM----ELYKKITRA 227
C TP YVAPEV+ YD D+WS GV++++LL G PFY ++ + + +I
Sbjct: 224 CYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG 282
Query: 228 --EFKCPNWFP--PEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIETP 276
EF P W EV+ L+ +L P+ R+T+ + M + W + K +TP
Sbjct: 283 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 335
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 276 bits (708), Expect = 2e-87
Identities = 92/407 (22%), Positives = 166/407 (40%), Gaps = 39/407 (9%)
Query: 2 EKKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREI 61
E K +++ Y++ LG G F V+ TG + A K V + +++EI
Sbjct: 149 EIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT---PHESDKETVRKEI 205
Query: 62 SVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVA--KGKLREEVARKYFQQLV 119
M ++RHP +V L++ ++ E++ GGELF KVA K+ E+ A +Y +Q+
Sbjct: 206 QTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVC 265
Query: 120 DAVEFCHSRGVYHRDLKPENLLL--DENGDLKISDFGLSALQESTRQDGLLHTTCGTPAY 177
+ H H DLKPEN++ + +LK+ DFGL+A + + T GT +
Sbjct: 266 KGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD---PKQSVKVTTGTAEF 322
Query: 178 VAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA--EFKCPNWF 235
APEV + G D+WS GV+ ++LL+G PF N E + + +
Sbjct: 323 AAPEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF- 380
Query: 236 PPEV----RKLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIETPESP-------RGQDR 284
+ + + ++L +P+TR+T+ + +E+ W G + P R +
Sbjct: 381 -SGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIK 439
Query: 285 NKLISDIHAV-----FECESSSSRDTDPPTNSCRSPVRPSSFNAFDIISLSKGFNLSGLF 339
K + + SS + + + S I+ +
Sbjct: 440 TKYDAWPEPLPPLGRISNYSSLRKHRPQEYSIRDAFWDRSEAQPRFIVKPYGTE----VG 495
Query: 340 EGDANSKLEARFTTTKPASAIVSKFEEIAVTESCKFNKK--DGTVKL 384
EG ++ R + ++ + +S K+ K+ L
Sbjct: 496 EGQ-SANFYCRV-IASSPPVVTWHKDDRELKQSVKYMKRYNGNDYGL 540
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 268 bits (687), Expect = 2e-87
Identities = 83/264 (31%), Positives = 146/264 (55%), Gaps = 8/264 (3%)
Query: 12 YELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPN 71
++ G++LG+G+F+ V R L T + AIKI++K I + + + RE VM + HP
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 72 IVQLYEVMASKTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGV 130
V+LY K+YF + Y + GEL + K G E R Y ++V A+E+ H +G+
Sbjct: 92 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 131 YHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDG 190
HRDLKPEN+LL+E+ ++I+DFG + + + ++ GT YV+PE++ ++
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACK 211
Query: 191 AKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILDPN 250
+ +D+W+ G +++ L+AG PF N +++KI + E+ P F P+ R L+ ++L +
Sbjct: 212 S-SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 270
Query: 251 PSTRVT------MAKLMENYWFRK 268
+ R+ L + +F
Sbjct: 271 ATKRLGCEEMEGYGPLKAHPFFES 294
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 268 bits (686), Expect = 2e-86
Identities = 82/277 (29%), Positives = 137/277 (49%), Gaps = 17/277 (6%)
Query: 2 EKKAGILMNKYELGRL--LGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKR 59
K G + + Y + + LG G F +V+ TG +A KI+ ++ +++K
Sbjct: 79 TAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD---KEEVKN 135
Query: 60 EISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNK-VAKG-KLREEVARKYFQQ 117
EISVM + H N++QLY+ SK I MEYV GGELF++ + + L E + +Q
Sbjct: 136 EISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQ 195
Query: 118 LVDAVEFCHSRGVYHRDLKPENLLL--DENGDLKISDFGLSALQESTRQDGLLHTTCGTP 175
+ + + H + H DLKPEN+L + +KI DFGL+ + L GTP
Sbjct: 196 ICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYK---PREKLKVNFGTP 252
Query: 176 AYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA--EFKCPN 233
++APEV+N D+WS GV+ ++LL+G PF N E I + +
Sbjct: 253 EFLAPEVVNYDFV-SFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEE 311
Query: 234 WFP--PEVRKLLSRILDPNPSTRVTMAKLMENYWFRK 268
+ E ++ +S++L S R++ ++ +++ W
Sbjct: 312 FQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSD 348
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 264 bits (676), Expect = 4e-86
Identities = 82/273 (30%), Positives = 140/273 (51%), Gaps = 17/273 (6%)
Query: 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR 68
YE+ +G G++ + R G+ + K +D + + E++++R ++
Sbjct: 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLRELK 63
Query: 69 HPNIVQLYE--VMASKTKIYFAMEYVRGGELFNKVAKGK-----LREEVARKYFQQLVDA 121
HPNIV+ Y+ + + T +Y MEY GG+L + + KG L EE + QL A
Sbjct: 64 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123
Query: 122 VEFCHSRG-----VYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPA 176
++ CH R V HRDLKP N+ LD ++K+ DFGL+ + T GTP
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS--FAKTFVGTPY 181
Query: 177 YVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKC-PNWF 235
Y++PE +N+ Y+ K+DIWS G +L+ L A PF + EL KI +F+ P +
Sbjct: 182 YMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY 240
Query: 236 PPEVRKLLSRILDPNPSTRVTMAKLMENYWFRK 268
E+ ++++R+L+ R ++ +++EN +
Sbjct: 241 SDELNEIITRMLNLKDYHRPSVEEILENPLILE 273
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 263 bits (673), Expect = 5e-85
Identities = 77/301 (25%), Positives = 132/301 (43%), Gaps = 36/301 (11%)
Query: 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMR- 65
+ + + R+L +G FA VY +++ +G+ A+K + + + I +E+ M+
Sbjct: 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEK---NRAIIQEVCFMKK 81
Query: 66 LVRHPNIVQLY-------EVMASKTKIYFAMEYVRGGELF----NKVAKGKLREEVARKY 114
L HPNIVQ E + + + + G+L ++G L + K
Sbjct: 82 LSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKI 141
Query: 115 FQQLVDAVEFCHSRG--VYHRDLKPENLLLDENGDLKISDFGLSALQE-------STRQD 165
F Q AV+ H + + HRDLK ENLLL G +K+ DFG + S ++
Sbjct: 142 FYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRR 201
Query: 166 GLLH---TTCGTPAYVAPEVIN--KRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMEL 220
L+ T TP Y PE+I+ G K DIW+ G +L++L PF D +
Sbjct: 202 ALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL-- 259
Query: 221 YKKITRAEFKCPNW--FPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIETPES 278
+I ++ P L+ +L NP R+++A+++ + + P+S
Sbjct: 260 --RIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNV-NPKS 316
Query: 279 P 279
P
Sbjct: 317 P 317
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 254 bits (652), Expect = 4e-82
Identities = 60/280 (21%), Positives = 111/280 (39%), Gaps = 24/280 (8%)
Query: 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHP 70
Y + LG+G F+ V L G A+K + + + ++ +RE + RL HP
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQD---REEAQREADMHRLFNHP 86
Query: 71 NIVQLYEV----MASKTKIYFAMEYVRGGELFN-----KVAKGKLREEVARKYFQQLVDA 121
NI++L +K + + + + + G L+N K L E+ +
Sbjct: 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 122 VEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQEST-------RQDGLLHTTCGT 174
+E H++G HRDLKP N+LL + G + D G T
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 175 PAYVAPEVINKRGYD--GAKADIWSCGVVLFVLLAGNLPFYDSNL-MELYKKITRAEFKC 231
+Y APE+ + + + + D+WS G VL+ ++ G P+ + + +
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSI 266
Query: 232 PNW--FPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269
P + +LL+ ++ +P R + L+ +
Sbjct: 267 PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 254 bits (651), Expect = 4e-82
Identities = 78/281 (27%), Positives = 133/281 (47%), Gaps = 12/281 (4%)
Query: 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR 68
+ + + + +G+G F++VY L G VA+K V + +EI +++ +
Sbjct: 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 90
Query: 69 HPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGK-----LREEVARKYFQQLVDAVE 123
HPN+++ Y ++ +E G+L + K + E KYF QL A+E
Sbjct: 91 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150
Query: 124 FCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVI 183
HSR V HRD+KP N+ + G +K+ D GL S H+ GTP Y++PE I
Sbjct: 151 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--TTAAHSLVGTPYYMSPERI 208
Query: 184 NKRGYDGAKADIWSCGVVLFVLLAGNLPFY--DSNLMELYKKITRAEFKC--PNWFPPEV 239
++ GY+ K+DIWS G +L+ + A PFY NL L KKI + ++ + + E+
Sbjct: 209 HENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL 267
Query: 240 RKLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIETPESPR 280
R+L++ ++P+P R + + +
Sbjct: 268 RQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLEHHHH 308
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 251 bits (644), Expect = 3e-81
Identities = 61/279 (21%), Positives = 124/279 (44%), Gaps = 34/279 (12%)
Query: 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR 68
++ L+G G F +V+ ++ G++ IK V ++ +RE+ + +
Sbjct: 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLD 62
Query: 69 HPNIVQLYE----------------VMASKTKIYFAMEYVRGGELFNKVAKGK---LREE 109
H NIV + ++ ME+ G L + K + L +
Sbjct: 63 HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122
Query: 110 VARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLH 169
+A + F+Q+ V++ HS+ + +RDLKP N+ L + +KI DFGL ++ DG
Sbjct: 123 LALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKN---DGKRT 179
Query: 170 TTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF 229
+ GT Y++PE I+ + Y + D+++ G++L LL ++++ + + +
Sbjct: 180 RSKGTLRYMSPEQISSQDYG-KEVDLYALGLILAELLHVCDTAFETS--KFFTDLRDGII 236
Query: 230 KCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRK 268
+ F + + LL ++L P R ++++ K
Sbjct: 237 --SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 255 bits (652), Expect = 1e-80
Identities = 60/280 (21%), Positives = 111/280 (39%), Gaps = 25/280 (8%)
Query: 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMR-LVRH 69
+ +LG G + + R + + VA+K + E RE+ ++R H
Sbjct: 25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF------SFADREVQLLRESDEH 77
Query: 70 PNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLR--EEVARKYFQQLVDAVEFCHS 127
PN+++ + + Y A+E L V + QQ + HS
Sbjct: 78 PNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS 136
Query: 128 RGVYHRDLKPENLLLDENGD-----LKISDFGLSA-LQESTRQDGLLHTTCGTPAYVAPE 181
+ HRDLKP N+L+ ISDFGL L GT ++APE
Sbjct: 137 LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196
Query: 182 VIN---KRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAEFKCPNWFP- 236
+++ K DI+S G V + +++ G+ PF S + + C +
Sbjct: 197 MLSEDCKENPT-YTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKH 255
Query: 237 --PEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIE 274
R+L+ +++ +P R + ++++ +F K+++
Sbjct: 256 EDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQ 295
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 249 bits (637), Expect = 5e-80
Identities = 63/269 (23%), Positives = 108/269 (40%), Gaps = 11/269 (4%)
Query: 3 KKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREIS 62
+ ++ LG G++ +V+ R+ + G+ A+K ++ S
Sbjct: 50 RPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGS 109
Query: 63 VMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVD 120
++ +HP V+L + +Y E G L L E Y + +
Sbjct: 110 HEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLL 168
Query: 121 AVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAP 180
A+ HS+G+ H D+KP N+ L G K+ DFGL + G G P Y+AP
Sbjct: 169 ALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA---GAGEVQEGDPRYMAP 225
Query: 181 EVINKRGYDGAKADIWSCGVVLFVLLAGN-LPFYDSNLMELYKKITRAEFKCPNWFPPEV 239
E++ Y AD++S G+ + + LP +L + EF E+
Sbjct: 226 ELLQG-SYG-TAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEF--TAGLSSEL 281
Query: 240 RKLLSRILDPNPSTRVTMAKLMENYWFRK 268
R +L +L+P+P R T L+ R+
Sbjct: 282 RSVLVMMLEPDPKLRATAEALLALPVLRQ 310
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 248 bits (637), Expect = 1e-79
Identities = 98/285 (34%), Positives = 171/285 (60%), Gaps = 20/285 (7%)
Query: 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR 68
+ +++ R LG G+F +V+ R+ G+ A+K++ KE + R+ ++ E ++ +V
Sbjct: 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 64
Query: 69 HPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHS 127
HP I++++ +I+ M+Y+ GGELF+ + K + VA+ Y ++ A+E+ HS
Sbjct: 65 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 124
Query: 128 RGVYHRDLKPENLLLDENGDLKISDFGLS-ALQESTRQDGLLHTTCGTPAYVAPEVINKR 186
+ + +RDLKPEN+LLD+NG +KI+DFG + + + T +T CGTP Y+APEV++ +
Sbjct: 125 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT------YTLCGTPDYIAPEVVSTK 178
Query: 187 GYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRI 246
Y+ + D WS G++++ +LAG PFYDSN M+ Y+KI AE + P +F +V+ LLSR+
Sbjct: 179 PYNKS-IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRL 237
Query: 247 LDPNPSTRVTMAK-----LMENYWFRK------GYKKIETPESPR 280
+ + S R+ + + + WF++ + IETP P
Sbjct: 238 ITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPP 282
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 247 bits (634), Expect = 6e-79
Identities = 82/254 (32%), Positives = 148/254 (58%), Gaps = 7/254 (2%)
Query: 2 EKKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREI 61
+ +++++ + LG G+F +V ++ ++G A+KI+DK+K+ ++ I+ E
Sbjct: 33 PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 62 SVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVD 120
+++ V P +V+L + +Y MEYV GGE+F+ + + G+ E AR Y Q+V
Sbjct: 93 RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 121 AVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAP 180
E+ HS + +RDLKPENLL+D+ G ++++DFG + R G T CGTP +AP
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF-----AKRVKGRTWTLCGTPEALAP 207
Query: 181 EVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVR 240
E+I +GY+ A D W+ GV+++ + AG PF+ +++Y+KI + + P+ F +++
Sbjct: 208 EIILSKGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 241 KLLSRILDPNPSTR 254
LL +L + + R
Sbjct: 267 DLLRNLLQVDLTKR 280
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 248 bits (633), Expect = 1e-78
Identities = 44/315 (13%), Positives = 92/315 (29%), Gaps = 49/315 (15%)
Query: 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHP 70
K +L L G + V+ R+++ + A+K+ ++++ +
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 71 NIVQLYEVM--------------------------ASKTKIYFAMEYVRG-----GELFN 99
+ + + + M +
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 100 KV--AKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSA 157
V +G QL+ S+G+ H P+NL + +G L + D
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALW 242
Query: 158 LQESTRQDGLLHTTCGTPAYVAPEVINKRGYD-GAKADIWSCGVVLFVLLAGNLPFYDSN 216
+ + Y E +N + W G+ ++ + LPF
Sbjct: 243 -----KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297
Query: 217 --LMELYKKITRAE-------FKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFR 267
+ +K+ + F P V+ L+ R L+ + R+ + ME F
Sbjct: 298 PGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFL 357
Query: 268 KGYKKIETPESPRGQ 282
+ +I + GQ
Sbjct: 358 QLQNEISSSL-STGQ 371
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 244 bits (625), Expect = 2e-78
Identities = 72/301 (23%), Positives = 119/301 (39%), Gaps = 34/301 (11%)
Query: 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR 68
+ +E + LG+G F V+ +N + AIK + +++ RE+ + +
Sbjct: 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELA--REKVMREVKALAKLE 61
Query: 69 HPNIVQLYEV------------MASKTKIYFAMEYVRGGELFNKVAKGK----LREEVAR 112
HP IV+ + + K +Y M+ R L + + V
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 113 KYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQ-------- 164
F Q+ +AVEF HS+G+ HRDLKP N+ + +K+ DFGL + +
Sbjct: 122 HIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 165 --DGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFY-DSNLMELY 221
GT Y++PE I+ Y K DI+S G++LF LL PF +
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYS-HKVDIFSLGLILFELLY---PFSTQMERVRTL 237
Query: 222 KKITRAEF-KCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIETPESPR 280
+ +F P ++ +L P+P R ++EN F +T R
Sbjct: 238 TDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQR 297
Query: 281 G 281
Sbjct: 298 S 298
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 247 bits (633), Expect = 8e-78
Identities = 77/302 (25%), Positives = 123/302 (40%), Gaps = 46/302 (15%)
Query: 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMR-LVR 68
N ++LG G+ V + G+ VA+K + + D EI ++
Sbjct: 15 NLVVSEKILGYGSSGTVVF-QGSFQGRPVAVKRMLIDFC------DIALMEIKLLTESDD 67
Query: 69 HPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAK--------GKLREEVARKYFQQLVD 120
HPN+++ Y + +Y A+E L + V +E +Q+
Sbjct: 68 HPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 121 AVEFCHSRGVYHRDLKPENLLLD-------------ENGDLKISDFGLSALQESTRQ--D 165
V HS + HRDLKP+N+L+ EN + ISDFGL +S +
Sbjct: 127 GVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 166 GLLHTTCGTPAYVAPEVIN-------KRGYDGAKADIWSCGVVLFVLL-AGNLPFYDSNL 217
L+ GT + APE++ KR DI+S G V + +L G PF D
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRL-TRSIDIFSMGCVFYYILSKGKHPFGDKYS 245
Query: 218 ME---LYKKITRAEFKCPNWFP--PEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYKK 272
E + + E KC + E L+S+++D +P R T K++ + F KK
Sbjct: 246 RESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPKSKK 305
Query: 273 IE 274
+E
Sbjct: 306 LE 307
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 241 bits (617), Expect = 5e-77
Identities = 80/295 (27%), Positives = 134/295 (45%), Gaps = 56/295 (18%)
Query: 3 KKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREIS 62
KK I+ + ++LG G KV N +T + A+K++ +RE+
Sbjct: 11 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK--------ARREVE 62
Query: 63 VM-RLVRHPNIVQLYEV----MASKTKIYFAMEYVRGGELFNK-VAKGKLR--EEVARKY 114
+ R + P+IV++ +V A + + ME + GGELF++ +G E A +
Sbjct: 63 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 122
Query: 115 FQQLVDAVEFCHSRGVYHRDLKPENLLL---DENGDLKISDFGLSALQESTRQDGLLHTT 171
+ + +A+++ HS + HRD+KPENLL N LK++DFG
Sbjct: 123 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF---------------- 166
Query: 172 CGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLM----ELYKKITRA 227
A E YD D+WS GV++++LL G PFY ++ + + +I
Sbjct: 167 -------AKETT-GEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG 217
Query: 228 --EFKCPNWFPPEV----RKLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIETP 276
EF P W EV + L+ +L P+ R+T+ + M + W + K +TP
Sbjct: 218 QYEFPNPEW--SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 270
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 244 bits (623), Expect = 1e-76
Identities = 49/311 (15%), Positives = 103/311 (33%), Gaps = 43/311 (13%)
Query: 12 YELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRL----- 66
G +LGQ + +TG+S + + + I Q+K E+ +RL
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 67 -----------------VRHPNIVQLYEVMASKTKIYFAMEYV-----------RGGELF 98
V+ P ++ V + ++ + G L
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 99 NKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSA 157
+ + L + Q++ + H G+ H L+P +++LD+ G + ++ F
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEH-L 258
Query: 158 LQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAK----ADIWSCGVVLFVLLAGNLPFY 213
+++ + P A ++ + D W+ G+ ++ + +LP
Sbjct: 259 VRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNT 318
Query: 214 DSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYKKI 273
D + + I F+ P VR LL L R+ + ME + + ++
Sbjct: 319 DDAALGGSEWI----FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTEL 374
Query: 274 ETPESPRGQDR 284
D
Sbjct: 375 SAALPLYQTDG 385
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 236 bits (605), Expect = 7e-75
Identities = 85/251 (33%), Positives = 138/251 (54%), Gaps = 8/251 (3%)
Query: 9 MNKYELGRLLGQGTFAKVY---HGRNLKTGQSVAIKIVDKEKI-RRVGLIDQIKREISVM 64
+EL R+LG+G + KV+ TG+ A+K++ K I R K E +++
Sbjct: 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNIL 75
Query: 65 RLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVE 123
V+HP IV L + K+Y +EY+ GGELF ++ + G E+ A Y ++ A+
Sbjct: 76 EEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALG 135
Query: 124 FCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVI 183
H +G+ +RDLKPEN++L+ G +K++DFGL +ES + HT CGT Y+APE++
Sbjct: 136 HLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLC--KESIHDGTVTHTFCGTIEYMAPEIL 193
Query: 184 NKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLL 243
+ G++ A D WS G +++ +L G PF N + KI + + P + E R LL
Sbjct: 194 MRSGHNRA-VDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLL 252
Query: 244 SRILDPNPSTR 254
++L N ++R
Sbjct: 253 KKLLKRNAASR 263
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 237 bits (606), Expect = 9e-75
Identities = 41/293 (13%), Positives = 97/293 (33%), Gaps = 36/293 (12%)
Query: 10 NKYELGRLLGQGTFAKVYHGR-----NLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVM 64
+ LLG+G FA+VY + K Q +K+ + + +
Sbjct: 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWE---FYIGTQLMERL 121
Query: 65 RLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGK------LREEVARKYFQQL 118
+ ++ Y + E G L N + K + + + + ++
Sbjct: 122 KPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRM 181
Query: 119 VDAVEFCHSRGVYHRDLKPENLLL-----------DENGDLKISDFGLSALQESTRQDGL 167
+ +E H + H D+KP+N +L D + L + D G S + + +
Sbjct: 182 LYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTI 241
Query: 168 LHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFY-DSNLMELYKKITR 226
C T + E+++ + ++ + D + ++ +L G + + + R
Sbjct: 242 FTAKCETSGFQCVEMLSNKPWN-YQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFR 300
Query: 227 AEFKCPNWFPPEVRKLLSRILDPNPSTRVT----MAKLMENYWFRKGYKKIET 275
W + +L+ + + + ++ + + KI
Sbjct: 301 RLPHLDMW-----NEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRA 348
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 2e-72
Identities = 91/250 (36%), Positives = 148/250 (59%), Gaps = 8/250 (3%)
Query: 9 MNKYELGRLLGQGTFAKVY---HGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMR 65
+++EL ++LGQG+F KV+ Q A+K++ K ++ + K E ++
Sbjct: 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVR-TKMERDILV 81
Query: 66 LVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEF 124
V HP IV+L+ ++ K+Y ++++RGG+LF +++K EE + Y +L A++
Sbjct: 82 EVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDH 141
Query: 125 CHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVIN 184
HS G+ +RDLKPEN+LLDE G +K++DFGLS +ES + ++ CGT Y+APEV+N
Sbjct: 142 LHSLGIIYRDLKPENILLDEEGHIKLTDFGLS--KESIDHEKKAYSFCGTVEYMAPEVVN 199
Query: 185 KRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLS 244
+RG+ + AD WS GV++F +L G LPF + E I +A+ P + PE + LL
Sbjct: 200 RRGHTQS-ADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLR 258
Query: 245 RILDPNPSTR 254
+ NP+ R
Sbjct: 259 MLFKRNPANR 268
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 3e-72
Identities = 96/337 (28%), Positives = 157/337 (46%), Gaps = 22/337 (6%)
Query: 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVM-RLV 67
+ + +++G+G+F KV R+ A+K++ K+ I + I E +V+ + V
Sbjct: 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV 96
Query: 68 RHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCH 126
+HP +V L+ + K+YF ++Y+ GGELF + + E AR Y ++ A+ + H
Sbjct: 97 KHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLH 156
Query: 127 SRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKR 186
S + +RDLKPEN+LLD G + ++DFGL +E+ + T CGTP Y+APEV++K+
Sbjct: 157 SLNIVYRDLKPENILLDSQGHIVLTDFGLC--KENIEHNSTTSTFCGTPEYLAPEVLHKQ 214
Query: 187 GYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRI 246
YD D W G VL+ +L G PFY N E+Y I + R LL +
Sbjct: 215 PYDRT-VDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGL 273
Query: 247 LDPNPSTRV----TMAKLMENYWFRK------GYKKIETPESPRGQDRNKLISDIHAVFE 296
L + + R+ ++ + +F KKI P +P N + F
Sbjct: 274 LQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLINKKITPPFNPNVSGPND-LRHFDPEFT 332
Query: 297 CESSSSRDTDPPTNSCRSPVRPSSFNAFDIISLSKGF 333
E + P + + + AF GF
Sbjct: 333 EEPVPNAIGKAPDSVLVTASVKEAAEAF------LGF 363
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 9e-72
Identities = 95/247 (38%), Positives = 140/247 (56%), Gaps = 4/247 (1%)
Query: 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR 68
MN ++ +LLG+GTF KV R TG+ A+KI+ KE I + E V++ R
Sbjct: 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 69 HPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHS 127
HP + L + ++ F MEY GGELF +++ EE AR Y ++V A+E+ HS
Sbjct: 64 HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 128 RGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRG 187
R V +RD+K ENL+LD++G +KI+DFGL +E + T CGTP Y+APEV+
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLC--KEGISDGATMKTFCGTPEYLAPEVLEDND 181
Query: 188 YDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRIL 247
Y A D W GVV++ ++ G LPFY+ + L++ I E + P PE + LL+ +L
Sbjct: 182 YGRA-VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLL 240
Query: 248 DPNPSTR 254
+P R
Sbjct: 241 KKDPKQR 247
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 1e-70
Identities = 74/291 (25%), Positives = 146/291 (50%), Gaps = 18/291 (6%)
Query: 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR 68
+ +E+ R +G+G+F KV + T + A+K ++K+K + + +E+ +M+ +
Sbjct: 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE 73
Query: 69 HPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHS 127
HP +V L+ + ++ ++ + GG+L + + +EE + + +LV A+++ +
Sbjct: 74 HPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQN 133
Query: 128 RGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKR- 186
+ + HRD+KP+N+LLDE+G + I+DF ++A ++ + T GT Y+APE+ + R
Sbjct: 134 QRIIHRDMKPDNILLDEHGHVHITDFNIAA---MLPRETQITTMAGTKPYMAPEMFSSRK 190
Query: 187 --GYDGAKADIWSCGVVLFVLLAGNLPFY---DSNLMELYKKITRAEFKCPNWFPPEVRK 241
GY A D WS GV + LL G P++ ++ E+ P+ + E+
Sbjct: 191 GAGYSFA-VDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVS 249
Query: 242 LLSRILDPNPSTRV-TMAKLMENYWFRK------GYKKIETPESPRGQDRN 285
LL ++L+PNP R ++ + + K++ P N
Sbjct: 250 LLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAVFQKRLIPGFIPNKGRLN 300
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 224 bits (574), Expect = 5e-70
Identities = 80/248 (32%), Positives = 135/248 (54%), Gaps = 5/248 (2%)
Query: 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV- 67
+ + L ++LG+G+F KV+ KT Q AIK + K+ + ++ E V+ L
Sbjct: 16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 75
Query: 68 RHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCH 126
HP + ++ +K ++F MEY+ GG+L + K A Y +++ ++F H
Sbjct: 76 EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 135
Query: 127 SRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKR 186
S+G+ +RDLK +N+LLD++G +KI+DFG+ +E+ D +T CGTP Y+APE++ +
Sbjct: 136 SKGIVYRDLKLDNILLDKDGHIKIADFGMC--KENMLGDAKTNTFCGTPDYIAPEILLGQ 193
Query: 187 GYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRI 246
Y+ + D WS GV+L+ +L G PF+ + EL+ I P W E + LL ++
Sbjct: 194 KYNHS-VDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKL 252
Query: 247 LDPNPSTR 254
P R
Sbjct: 253 FVREPEKR 260
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 224 bits (574), Expect = 5e-70
Identities = 81/256 (31%), Positives = 138/256 (53%), Gaps = 5/256 (1%)
Query: 1 MEKKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKRE 60
+ + ++ +E R+LG+G+F KV R +TG A+K++ K+ I + ++ E
Sbjct: 14 VNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTE 73
Query: 61 ISVMRLV-RHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQL 118
++ L HP + QL+ + +++F ME+V GG+L + K + E AR Y ++
Sbjct: 74 KRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEI 133
Query: 119 VDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYV 178
+ A+ F H +G+ +RDLK +N+LLD G K++DFG+ +E T CGTP Y+
Sbjct: 134 ISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMC--KEGICNGVTTATFCGTPDYI 191
Query: 179 APEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPE 238
APE++ + Y A D W+ GV+L+ +L G+ PF N +L++ I E P W +
Sbjct: 192 APEILQEMLYGPA-VDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHED 250
Query: 239 VRKLLSRILDPNPSTR 254
+L + NP+ R
Sbjct: 251 ATGILKSFMTKNPTMR 266
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 7e-70
Identities = 94/248 (37%), Positives = 143/248 (57%), Gaps = 5/248 (2%)
Query: 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR 68
MN++E +LLG+GTF KV + TG+ A+KI+ KE I + E V++ R
Sbjct: 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR 206
Query: 69 HPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHS 127
HP + L + ++ F MEY GGELF +++ E+ AR Y ++V A+++ HS
Sbjct: 207 HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHS 266
Query: 128 -RGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKR 186
+ V +RDLK ENL+LD++G +KI+DFGL +E + + T CGTP Y+APEV+
Sbjct: 267 EKNVVYRDLKLENLMLDKDGHIKITDFGLC--KEGIKDGATMKTFCGTPEYLAPEVLEDN 324
Query: 187 GYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRI 246
Y A D W GVV++ ++ G LPFY+ + +L++ I E + P PE + LLS +
Sbjct: 325 DYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGL 383
Query: 247 LDPNPSTR 254
L +P R
Sbjct: 384 LKKDPKQR 391
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 1e-69
Identities = 75/248 (30%), Positives = 129/248 (52%), Gaps = 5/248 (2%)
Query: 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV- 67
+ + +LG+G+F KV T + A+KI+ K+ + + ++ E V+ L
Sbjct: 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG 78
Query: 68 RHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCH 126
+ P + QL+ + ++YF MEYV GG+L + + G+ +E A Y ++ + F
Sbjct: 79 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ 138
Query: 127 SRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKR 186
S+G+ +RDLK +N++LD G +KI+DFG+ +E+ T CGTP Y+APE+I +
Sbjct: 139 SKGIIYRDLKLDNVMLDSEGHIKIADFGMC--KENIWDGVTTKTFCGTPDYIAPEIIAYQ 196
Query: 187 GYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRI 246
Y + D W+ GV+L+ +LAG PF + EL++ I P E + +
Sbjct: 197 PYGKS-VDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGL 255
Query: 247 LDPNPSTR 254
+ +P R
Sbjct: 256 MTKHPGKR 263
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 4e-69
Identities = 78/259 (30%), Positives = 140/259 (54%), Gaps = 16/259 (6%)
Query: 9 MNKYELGRLLGQGTFAKVY---HGRNLKTGQSVAIKIVDKEKI-RRVGLIDQIKREISVM 64
+ +EL ++LG G + KV+ TG+ A+K++ K I ++ + + E V+
Sbjct: 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 112
Query: 65 RLVRH-PNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAV 122
+R P +V L+ ++TK++ ++Y+ GGELF +++ + E + Y ++V A+
Sbjct: 113 EHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLAL 172
Query: 123 EFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLL-HTTCGTPAYVAPE 181
E H G+ +RD+K EN+LLD NG + ++DFGLS +E + + CGT Y+AP+
Sbjct: 173 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS--KEFVADETERAYDFCGTIEYMAPD 230
Query: 182 VI--NKRGYDGAKADIWSCGVVLFVLLAGNLPFY----DSNLMELYKKITRAEFKCPNWF 235
++ G+D A D WS GV+++ LL G PF ++ E+ ++I ++E P
Sbjct: 231 IVRGGDSGHDKA-VDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM 289
Query: 236 PPEVRKLLSRILDPNPSTR 254
+ L+ R+L +P R
Sbjct: 290 SALAKDLIQRLLMKDPKKR 308
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 223 bits (569), Expect = 2e-68
Identities = 80/250 (32%), Positives = 133/250 (53%), Gaps = 9/250 (3%)
Query: 12 YELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPN 71
YE+ +++G+G F +V R+ T + A+K++ K ++ + E +M P
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 130
Query: 72 IVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVY 131
+VQL+ +Y MEY+ GG+L N ++ + E+ AR Y ++V A++ HS G
Sbjct: 131 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFI 190
Query: 132 HRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYD-- 189
HRD+KP+N+LLD++G LK++DFG ++ + T GTP Y++PEV+ +G D
Sbjct: 191 HRDVKPDNMLLDKSGHLKLADFGT-CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGY 249
Query: 190 -GAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKI--TRAEFKCPN--WFPPEVRKLLS 244
G + D WS GV L+ +L G+ PFY +L+ Y KI + P+ E + L+
Sbjct: 250 YGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLIC 309
Query: 245 RILDPNPSTR 254
L + R
Sbjct: 310 AFLT-DREVR 318
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 219 bits (559), Expect = 7e-68
Identities = 81/262 (30%), Positives = 140/262 (53%), Gaps = 14/262 (5%)
Query: 4 KAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISV 63
+ + ++L R++G+G++AKV R KT + A+K+V KE + ID ++ E V
Sbjct: 3 MDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHV 62
Query: 64 MRLV-RHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDA 121
HP +V L+ ++++++F +EYV GG+L + + KL EE AR Y ++ A
Sbjct: 63 FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA 122
Query: 122 VEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPE 181
+ + H RG+ +RDLK +N+LLD G +K++D+G+ +E R T CGTP Y+APE
Sbjct: 123 LNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC--KEGLRPGDTTSTFCGTPNYIAPE 180
Query: 182 VINKRGYDGAKADIWSCGVVLFVLLAGNLPF---------YDSNLMELYKKITRAEFKCP 232
++ Y + D W+ GV++F ++AG PF + L++ I + + P
Sbjct: 181 ILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP 239
Query: 233 NWFPPEVRKLLSRILDPNPSTR 254
+ +L L+ +P R
Sbjct: 240 RSLSVKAASVLKSFLNKDPKER 261
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 2e-67
Identities = 80/264 (30%), Positives = 142/264 (53%), Gaps = 14/264 (5%)
Query: 2 EKKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREI 61
+ + + + ++L R++G+G++AKV R KT + A+++V KE + ID ++ E
Sbjct: 44 KASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEK 103
Query: 62 SVMRLV-RHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLV 119
V HP +V L+ ++++++F +EYV GG+L + + KL EE AR Y ++
Sbjct: 104 HVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEIS 163
Query: 120 DAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVA 179
A+ + H RG+ +RDLK +N+LLD G +K++D+G+ +E R T CGTP Y+A
Sbjct: 164 LALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC--KEGLRPGDTTSTFCGTPNYIA 221
Query: 180 PEVINKRGYDGAKADIWSCGVVLFVLLAGNLPF---------YDSNLMELYKKITRAEFK 230
PE++ Y + D W+ GV++F ++AG PF + L++ I + +
Sbjct: 222 PEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR 280
Query: 231 CPNWFPPEVRKLLSRILDPNPSTR 254
P + +L L+ +P R
Sbjct: 281 IPRSLSVKAASVLKSFLNKDPKER 304
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 3e-66
Identities = 71/252 (28%), Positives = 125/252 (49%), Gaps = 14/252 (5%)
Query: 12 YELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPN 71
+E+ +++G+G F +V + + A+KI++K ++ + + E V+
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135
Query: 72 IVQLYEVMASKTKIYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRG 129
I L+ +Y M+Y GG+L ++K +L EE+AR Y ++V A++ H
Sbjct: 136 ITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH 195
Query: 130 VYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVIN----- 184
HRD+KP+N+L+D NG ++++DFG L+ GTP Y++PE++
Sbjct: 196 YVHRDIKPDNILMDMNGHIRLADFGSC-LKLMEDGTVQSSVAVGTPDYISPEILQAMEGG 254
Query: 185 KRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKI--TRAEFKCPNW---FPPEV 239
K Y G + D WS GV ++ +L G PFY +L+E Y KI + F+ P
Sbjct: 255 KGRY-GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENA 313
Query: 240 RKLLSRILDPNP 251
+ L+ R++
Sbjct: 314 KDLIRRLICSRE 325
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 212 bits (543), Expect = 3e-66
Identities = 52/289 (17%), Positives = 97/289 (33%), Gaps = 36/289 (12%)
Query: 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRH 69
++ +G G F V+ G AIK K V + ++ + L +H
Sbjct: 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQH 70
Query: 70 PNIVQLYEVMASKTKIYFAMEYVRGGELF-----NKVAKGKLREEVARKYFQQLVDAVEF 124
++V+ + A + EY GG L N +E + Q+ + +
Sbjct: 71 SHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 130
Query: 125 CHSRGVYHRDLKPENLLLDENGDL-------------------KISDFGLSALQESTRQD 165
HS + H D+KP N+ + KI D G S
Sbjct: 131 IHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP--- 187
Query: 166 GLLHTTCGTPAYVAPEVIN-KRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKI 224
G ++A EV+ + KADI++ + + + + +I
Sbjct: 188 ---QVEEGDSRFLANEVLQENYTHLP-KADIFALALTVVCAAGAEPLPRNGDQW---HEI 240
Query: 225 TRAEF-KCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYKK 272
+ + P E +LL ++ P+P R + L+++ +K
Sbjct: 241 RQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASRK 289
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 5e-66
Identities = 75/256 (29%), Positives = 131/256 (51%), Gaps = 5/256 (1%)
Query: 1 MEKKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKRE 60
+ + + + +LG+G+F KV T + A+KI+ K+ + + ++ E
Sbjct: 332 NGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVE 391
Query: 61 ISVMRLV-RHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQL 118
V+ L + P + QL+ + ++YF MEYV GG+L + + G+ +E A Y ++
Sbjct: 392 KRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEI 451
Query: 119 VDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYV 178
+ F S+G+ +RDLK +N++LD G +KI+DFG+ +E+ T CGTP Y+
Sbjct: 452 AIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC--KENIWDGVTTKTFCGTPDYI 509
Query: 179 APEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPE 238
APE+I + Y + D W+ GV+L+ +LAG PF + EL++ I P E
Sbjct: 510 APEIIAYQPYGKS-VDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKE 568
Query: 239 VRKLLSRILDPNPSTR 254
+ ++ +P R
Sbjct: 569 AVAICKGLMTKHPGKR 584
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 6e-66
Identities = 83/286 (29%), Positives = 136/286 (47%), Gaps = 21/286 (7%)
Query: 2 EKKAGILMNKYEL-----GRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQ 56
+ ++ +L YE +LG+GT+ VY GR+L +AIK + + R
Sbjct: 9 DCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRY---SQP 65
Query: 57 IKREISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELF----NKVAKGKLREEVAR 112
+ EI++ + ++H NIVQ + I ME V GG L +K K E+
Sbjct: 66 LHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIG 125
Query: 113 KYFQQLVDAVEFCHSRGVYHRDLKPENLLLD-ENGDLKISDFGLSALQESTRQDGLLHTT 171
Y +Q+++ +++ H + HRD+K +N+L++ +G LKISDFG S + T
Sbjct: 126 FYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSK--RLAGINPCTETF 183
Query: 172 CGTPAYVAPEVINK--RGYDGAKADIWSCGVVLFVLLAGNLPFYD-SNLMELYKKITRAE 228
GT Y+APE+I+K RGY G ADIWS G + + G PFY+ K+ +
Sbjct: 184 TGTLQYMAPEIIDKGPRGY-GKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFK 242
Query: 229 F--KCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYKK 272
+ P E + + + +P+P R L+ + + + KK
Sbjct: 243 VHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKK 288
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 219 bits (559), Expect = 1e-65
Identities = 69/255 (27%), Positives = 120/255 (47%), Gaps = 12/255 (4%)
Query: 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR 68
+ + R+LG+G F +V+ + TG+ A K ++K+++++ E ++ V
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH 243
Query: 69 HPNIVQLYEVMASKTKIYFAMEYVRGGELF-----NKVAKGKLREEVARKYFQQLVDAVE 123
IV L +KT + M + GG++ +E A Y Q+V +E
Sbjct: 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 124 FCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVI 183
H R + +RDLKPEN+LLD++G+++ISD GL+ E GTP ++APE++
Sbjct: 304 HLHQRNIIYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKTKGYAGTPGFMAPELL 361
Query: 184 NKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLM----ELYKKITRAEFKCPNWFPPEV 239
YD + D ++ GV L+ ++A PF EL +++ P+ F P
Sbjct: 362 LGEEYDFS-VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPAS 420
Query: 240 RKLLSRILDPNPSTR 254
+ +L +P R
Sbjct: 421 KDFCEALLQKDPEKR 435
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 1e-65
Identities = 65/265 (24%), Positives = 110/265 (41%), Gaps = 17/265 (6%)
Query: 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR 68
++ +G+G+F +V+ ++ +TG A+K V L E+ +
Sbjct: 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR--------LEVFRVEELVACAGLS 108
Query: 69 HPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHS 127
P IV LY + + ME + GG L + + G L E+ A Y Q ++ +E+ H+
Sbjct: 109 SPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHT 168
Query: 128 RGVYHRDLKPENLLLDENG-DLKISDFGLSA---LQESTRQDGLLHTTCGTPAYVAPEVI 183
R + H D+K +N+LL +G + DFG + + GT ++APEV+
Sbjct: 169 RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV 228
Query: 184 NKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAE---FKCPNWFPPEVR 240
+ D AK DIWS ++ +L G P+ L KI + P P
Sbjct: 229 MGKPCD-AKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTA 287
Query: 241 KLLSRILDPNPSTRVTMAKLMENYW 265
+ + L P R + +L
Sbjct: 288 QAIQEGLRKEPVHRASAMELRRKVG 312
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 2e-65
Identities = 77/256 (30%), Positives = 128/256 (50%), Gaps = 15/256 (5%)
Query: 12 YELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPN 71
+E+ +++G+G F++V + +TGQ A+KI++K + + G + + E V+
Sbjct: 63 FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRW 122
Query: 72 IVQLYEVMASKTKIYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRG 129
I QL+ + +Y MEY GG+L ++K ++ E+AR Y ++V A++ H G
Sbjct: 123 ITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG 182
Query: 130 VYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYD 189
HRD+KP+N+LLD G ++++DFG L+ GTP Y++PE++ G
Sbjct: 183 YVHRDIKPDNILLDRCGHIRLADFGSC-LKLRADGTVRSLVAVGTPDYLSPEILQAVGGG 241
Query: 190 ------GAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKI--TRAEFKCPN---WFPPE 238
G + D W+ GV + + G PFY + E Y KI + P P E
Sbjct: 242 PGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEE 301
Query: 239 VRKLLSRILDPNPSTR 254
R + R+L P TR
Sbjct: 302 ARDFIQRLLC-PPETR 316
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 5e-64
Identities = 67/253 (26%), Positives = 119/253 (47%), Gaps = 11/253 (4%)
Query: 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR 68
N + R+LG+G F +V + TG+ A K ++K++I++ E ++ V
Sbjct: 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN 242
Query: 69 HPNIVQLYEVMASKTKIYFAMEYVRGGELF---NKVAKGKLREEVARKYFQQLVDAVEFC 125
+V L +K + + + GG+L + + E A Y ++ +E
Sbjct: 243 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDL 302
Query: 126 HSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINK 185
H + +RDLKPEN+LLD++G ++ISD GL+ + + GT Y+APEV+
Sbjct: 303 HRERIVYRDLKPENILLDDHGHIRISDLGLA---VHVPEGQTIKGRVGTVGYMAPEVVKN 359
Query: 186 RGYDGAKADIWSCGVVLFVLLAGNLPFYDSN----LMELYKKITRAEFKCPNWFPPEVRK 241
Y + D W+ G +L+ ++AG PF E+ + + + F P+ R
Sbjct: 360 ERYTFS-PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARS 418
Query: 242 LLSRILDPNPSTR 254
L S++L +P+ R
Sbjct: 419 LCSQLLCKDPAER 431
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 1e-62
Identities = 96/328 (29%), Positives = 158/328 (48%), Gaps = 26/328 (7%)
Query: 1 MEKKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKRE 60
+E + MN + + R++G+G F +VY R TG+ A+K +DK++I+ E
Sbjct: 180 VELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE 239
Query: 61 ISVMRLV---RHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQ 116
++ LV P IV + + K+ F ++ + GG+L +++ G E R Y
Sbjct: 240 RIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA 299
Query: 117 QLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPA 176
+++ +E H+R V +RDLKP N+LLDE+G ++ISD GL+ H + GT
Sbjct: 300 EIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHASVGTHG 355
Query: 177 YVAPEVINKR-GYDGAKADIWSCGVVLFVLLAGNLPFYDSNLM---ELYKKITRAEFKCP 232
Y+APEV+ K YD + AD +S G +LF LL G+ PF E+ + + P
Sbjct: 356 YMAPEVLQKGVAYDSS-ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP 414
Query: 233 NWFPPEVRKLLSRILDPNPSTRV-----TMAKLMENYWFRK------GYKKIETPESP-R 280
+ F PE+R LL +L + + R+ ++ E+ +FR +K P P R
Sbjct: 415 DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPR 474
Query: 281 GQDRNKLISDIHAVFECESSSSRDTDPP 308
G+ DI + F+ E +
Sbjct: 475 GEVNAADAFDIGS-FDEEDTKGIKLLDS 501
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 3e-60
Identities = 63/268 (23%), Positives = 131/268 (48%), Gaps = 18/268 (6%)
Query: 12 YELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPN 71
+ +G+G+F VY G + +T VA + K+ + + K E +++ ++HPN
Sbjct: 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPN 86
Query: 72 IVQLY----EVMASKTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCH 126
IV+ Y + K I E + G L + + ++ +V R + +Q++ ++F H
Sbjct: 87 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 146
Query: 127 SRG--VYHRDLKPENLLLD-ENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVI 183
+R + HRDLK +N+ + G +KI D GL+ L+ ++ GTP ++APE+
Sbjct: 147 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA----KAVIGTPEFMAPEMY 202
Query: 184 NKRGYDGAKADIWSCGVVLFVLLAGNLPFYD-SNLMELYKKITRAE--FKCPNWFPPEVR 240
+ YD D+++ G+ + + P+ + N ++Y+++T PEV+
Sbjct: 203 -EEKYD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK 260
Query: 241 KLLSRILDPNPSTRVTMAKLMENYWFRK 268
+++ + N R ++ L+ + +F++
Sbjct: 261 EIIEGCIRQNKDERYSIKDLLNHAFFQE 288
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 4e-60
Identities = 70/331 (21%), Positives = 122/331 (36%), Gaps = 75/331 (22%)
Query: 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVD-------KEKIRR-VGLIDQIK-- 58
+ +E + +G+G F V+ +N + AIK + +EK+ R V + +++
Sbjct: 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHP 64
Query: 59 ---------------------------------------------REISVMRLVRHPNIV 73
+I M N V
Sbjct: 65 GIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTV 124
Query: 74 QLYEVMASKTKIYFAMEYVRGGELFNKVAKGK----LREEVARKYFQQLVDAVEFCHSRG 129
+ + K +Y M+ R L + + + V F Q+ +AVEF HS+G
Sbjct: 125 GQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG 184
Query: 130 VYHRDLKPENLLLDENGDLKISDFGLSALQESTRQD----------GLLHTTCGTPAYVA 179
+ HRDLKP N+ + +K+ DFGL + ++ GT Y++
Sbjct: 185 LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244
Query: 180 PEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFY-DSNLMELYKKITRAEF-KCPNWFPP 237
PE I+ Y K DI+S G++LF LL F + + + +F P
Sbjct: 245 PEQIHGNNYS-HKVDIFSLGLILFELLY---SFSTQMERVRIITDVRNLKFPLLFTQKYP 300
Query: 238 EVRKLLSRILDPNPSTRVTMAKLMENYWFRK 268
+ ++ +L P+P+ R ++EN F
Sbjct: 301 QEHMMVQDMLSPSPTERPEATDIIENAIFEN 331
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 2e-58
Identities = 81/271 (29%), Positives = 139/271 (51%), Gaps = 20/271 (7%)
Query: 12 YELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPN 71
+ +G+G+F +V+ G + +T + VAIKI+D E+ I+ I++EI+V+ P
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPY 81
Query: 72 IVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVY 131
+ + Y TK++ MEY+ GG + + G L E ++++ +++ HS
Sbjct: 82 VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKI 141
Query: 132 HRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGA 191
HRD+K N+LL E+G++K++DFG++ T+ +T GTP ++APEVI + YD +
Sbjct: 142 HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPEVIKQSAYD-S 198
Query: 192 KADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRI----- 246
KADIWS G+ L G P + + M + F P PP + S+
Sbjct: 199 KADIWSLGITAIELARGEPPHSELHPM-------KVLFLIPKNNPPTLEGNYSKPLKEFV 251
Query: 247 ---LDPNPSTRVTMAKLMENYWFRKGYKKIE 274
L+ PS R T +L+++ + + KK
Sbjct: 252 EACLNKEPSFRPTAKELLKHKFILRNAKKTS 282
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 2e-58
Identities = 68/265 (25%), Positives = 124/265 (46%), Gaps = 16/265 (6%)
Query: 7 ILMNKYELGRLLGQGTFAKVYHGR-NLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMR 65
I + +G G+F V+ + G VA+KI+ ++ +++ RE+++M+
Sbjct: 34 IPWCDLNIKEKIGAGSFGTVHRAEWH---GSDVAVKILMEQDFHA-ERVNEFLREVAIMK 89
Query: 66 LVRHPNIVQLYEVMASKTKIYFAMEYVRGGELF----NKVAKGKLREEVARKYFQQLVDA 121
+RHPNIV + + EY+ G L+ A+ +L E +
Sbjct: 90 RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKG 149
Query: 122 VEFCHSRG--VYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVA 179
+ + H+R + HR+LK NLL+D+ +K+ DFGLS L+ ST + GTP ++A
Sbjct: 150 MNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS--KSAAGTPEWMA 207
Query: 180 PEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFK--CPNWFPP 237
PEV+ + K+D++S GV+L+ L P+ + N ++ + + P P
Sbjct: 208 PEVLRDEPSN-EKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNP 266
Query: 238 EVRKLLSRILDPNPSTRVTMAKLME 262
+V ++ P R + A +M+
Sbjct: 267 QVAAIIEGCWTNEPWKRPSFATIMD 291
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 190 bits (486), Expect = 8e-58
Identities = 60/266 (22%), Positives = 125/266 (46%), Gaps = 15/266 (5%)
Query: 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRL 66
I + +G+ +G G+F VY G K VA+K+++ + K E+ V+R
Sbjct: 21 IPDGQITVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTP-QQLQAFKNEVGVLRK 76
Query: 67 VRHPNIVQLYEVMASKTKIYFAMEYVRGGELFN--KVAKGKLREEVARKYFQQLVDAVEF 124
RH NI+ + ++ ++ G L++ ++ K + +Q +++
Sbjct: 77 TRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDY 135
Query: 125 CHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVIN 184
H++ + HRDLK N+ L E+ +KI DFGL+ + G+ ++APEVI
Sbjct: 136 LHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195
Query: 185 KRGYD--GAKADIWSCGVVLFVLLAGNLPFYD-SNLMELYKKITR-----AEFKCPNWFP 236
+ + ++D+++ G+VL+ L+ G LP+ + +N ++ + + R K + P
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCP 255
Query: 237 PEVRKLLSRILDPNPSTRVTMAKLME 262
+++L++ L R + +++
Sbjct: 256 KRMKRLMAECLKKKRDERPSFPRILA 281
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 6e-56
Identities = 71/262 (27%), Positives = 144/262 (54%), Gaps = 9/262 (3%)
Query: 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHP 70
+ +G+G+ V R +G+ VA+K++D K +R + + E+ +MR +H
Sbjct: 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR---RELLFNEVVIMRDYQHF 102
Query: 71 NIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGV 130
N+V++Y+ +++ ME+++GG L + V++ +L EE + ++ A+ + H++GV
Sbjct: 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGV 162
Query: 131 YHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDG 190
HRD+K +++LL +G +K+SDFG A + GTP ++APEVI++ Y
Sbjct: 163 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR--KSLVGTPYWMAPEVISRSLYA- 219
Query: 191 AKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA---EFKCPNWFPPEVRKLLSRIL 247
+ DIWS G+++ ++ G P++ + ++ K++ + + K + P +R L R+L
Sbjct: 220 TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERML 279
Query: 248 DPNPSTRVTMAKLMENYWFRKG 269
+P R T +L+++ + +
Sbjct: 280 VRDPQERATAQELLDHPFLLQT 301
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 7e-56
Identities = 70/272 (25%), Positives = 122/272 (44%), Gaps = 22/272 (8%)
Query: 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRL 66
I + E+G L+G+G F +VYHGR VAI+++D E+ + KRE+ R
Sbjct: 30 IPFEQLEIGELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNE-DQLKAFKREVMAYRQ 85
Query: 67 VRHPNIVQLYEVMASKTKIYFAMEYVRGGELFN--KVAKGKLREEVARKYFQQLVDAVEF 124
RH N+V S + +G L++ + AK L R+ Q++V + +
Sbjct: 86 TRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGY 145
Query: 125 CHSRGVYHRDLKPENLLLDENGDLKISDFGLS---ALQESTRQDGLLHTTCGTPAYVAPE 181
H++G+ H+DLK +N+ D NG + I+DFGL + ++ R++ L G ++APE
Sbjct: 146 LHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPE 204
Query: 182 VINKRGYDGA--------KADIWSCGVVLFVLLAGNLPFYDSNLMELYKKI---TRAEFK 230
+I + D +D+++ G + + L A PF + ++ +
Sbjct: 205 IIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNL- 263
Query: 231 CPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262
E+ +L R T KLM+
Sbjct: 264 SQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 2e-55
Identities = 77/262 (29%), Positives = 132/262 (50%), Gaps = 9/262 (3%)
Query: 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHP 70
KY +GQG VY ++ TGQ VAI+ ++ ++ + + I EI VMR ++P
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNP 77
Query: 71 NIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGV 130
NIV + +++ MEY+ GG L + V + + E ++ + A+EF HS V
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQV 137
Query: 131 YHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDG 190
HRD+K +N+LL +G +K++DFG A + T GTP ++APEV+ ++ Y
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGP 195
Query: 191 AKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA---EFKCPNWFPPEVRKLLSRIL 247
K DIWS G++ ++ G P+ + N + I E + P R L+R L
Sbjct: 196 -KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL 254
Query: 248 DPNPSTRVTMAKLMENYWFRKG 269
+ + R + +L+++ + +
Sbjct: 255 EMDVEKRGSAKELLQHQFLKIA 276
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 4e-55
Identities = 71/267 (26%), Positives = 113/267 (42%), Gaps = 26/267 (9%)
Query: 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRL 66
I + E+ ++G+G F V + + VAIK ++ E R E+ +
Sbjct: 5 IDYKEIEVEEVVGRGAFGVVCKAK--WRAKDVAIKQIESESER-----KAFIVELRQLSR 57
Query: 67 VRHPNIVQLYEVMASKTKIYFAMEYVRGGELF----NKVAKGKLREEVARKYFQQLVDAV 122
V HPNIV+LY A + MEY GG L+ A + Q V
Sbjct: 58 VNHPNIVKLYG--ACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGV 115
Query: 123 EFCHSR---GVYHRDLKPENLLLDENGD-LKISDFGLSALQESTRQDGLLHTTCGTPAYV 178
+ HS + HRDLKP NLLL G LKI DFG + ++ + G+ A++
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-----MTNNKGSAAWM 170
Query: 179 APEVINKRGYDGAKADIWSCGVVLFVLLAGNLPF--YDSNLMELYKKITRAE-FKCPNWF 235
APEV Y K D++S G++L+ ++ PF + +
Sbjct: 171 APEVFEGSNYS-EKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNL 229
Query: 236 PPEVRKLLSRILDPNPSTRVTMAKLME 262
P + L++R +PS R +M ++++
Sbjct: 230 PKPIESLMTRCWSKDPSQRPSMEEIVK 256
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 5e-55
Identities = 69/270 (25%), Positives = 128/270 (47%), Gaps = 21/270 (7%)
Query: 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVG-LIDQIKREISVMR 65
I + L ++G G F KVY + G VA+K + + I+ +++E +
Sbjct: 4 IDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFA 61
Query: 66 LVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFC 125
+++HPNI+ L V + + ME+ RGG L ++ ++ ++ + Q+ + +
Sbjct: 62 MLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYL 121
Query: 126 HSRGVY---HRDLKPENLLLDE--------NGDLKISDFGLSALQESTRQDGLLHTTCGT 174
H + HRDLK N+L+ + N LKI+DFGL+ T + + G
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM----SAAGA 177
Query: 175 PAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF--KCP 232
A++APEVI + +D+WS GV+L+ LL G +PF + + + + + P
Sbjct: 178 YAWMAPEVIRASMFS-KGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIP 236
Query: 233 NWFPPEVRKLLSRILDPNPSTRVTMAKLME 262
+ P KL+ +P+P +R + +++
Sbjct: 237 STCPEPFAKLMEDCWNPDPHSRPSFTNILD 266
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 6e-55
Identities = 55/272 (20%), Positives = 108/272 (39%), Gaps = 23/272 (8%)
Query: 3 KKAGILMNKYELGRLLGQGTFAKVYHGR-NLKTGQSVAIKIVDKEKIRRVGLIDQIKREI 61
K +GI + L + +++ GR G + +K++ E
Sbjct: 3 KHSGIDFKQLNFLTKLNENHSGELWKGRWQ---GNDIVVKVLKVRDWST-RKSRDFNEEC 58
Query: 62 SVMRLVRHPNIVQLYEVMASKTKIYFA--MEYVRGGELFN---KVAKGKLREEVARKYFQ 116
+R+ HPN++ + S + ++ G L+N + + + A K+
Sbjct: 59 PRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFAL 118
Query: 117 QLVDAVEFCHSRG--VYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGT 174
+ + F H+ + L ++++DE+ +IS + +S
Sbjct: 119 DMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP-------GRMYA 171
Query: 175 PAYVAPEVINKRGYDGA--KADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF--K 230
PA+VAPE + K+ D AD+WS V+L+ L+ +PF D + ME+ K+
Sbjct: 172 PAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPT 231
Query: 231 CPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262
P P V KL+ ++ +P+ R ++
Sbjct: 232 IPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 1e-54
Identities = 83/325 (25%), Positives = 135/325 (41%), Gaps = 75/325 (23%)
Query: 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIK----REISV 63
+M KYE +G+G++ V+ RN TGQ VAIK K IK REI +
Sbjct: 1 MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK-----KFLESEDDPVIKKIALREIRM 55
Query: 64 MRLVRHPNIVQLYEVMASKTKIYFAMEYVRG---GELFNKVAKGKLREEVARKYFQQLVD 120
++ ++HPN+V L EV K +++ EY EL + + E + + Q +
Sbjct: 56 LKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHEL--DRYQRGVPEHLVKSITWQTLQ 113
Query: 121 AVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPA---- 176
AV FCH HRD+KPEN+L+ ++ +K+ DFG + R P+
Sbjct: 114 AVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFA------R-------LLTGPSDYYD 160
Query: 177 -------YVAPEVI-NKRGYDGAKADIWSCGVVLFVLLAGNLPFY--DSNLMELYKKITR 226
Y +PE++ Y G D+W+ G V LL+G P + S++ +LY I +
Sbjct: 161 DEVATRWYRSPELLVGDTQY-GPPVDVWAIGCVFAELLSGV-PLWPGKSDVDQLY-LIRK 217
Query: 227 A-------------------EFKCPNWFPPEVRK------------LLSRILDPNPSTRV 255
K P+ E + LL L +P+ R+
Sbjct: 218 TLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERL 277
Query: 256 TMAKLMENYWFRKGYKKIETPESPR 280
T +L+ + +F + + +
Sbjct: 278 TCEQLLHHPYFENIREIEDLAKEHD 302
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 3e-54
Identities = 82/268 (30%), Positives = 134/268 (50%), Gaps = 16/268 (5%)
Query: 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHP 70
+E+ LG G F KVY +N +TG A K+++ + ++ EI ++ HP
Sbjct: 20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE---LEDYIVEIEILATCDHP 76
Query: 71 NIVQLYEVMASKTKIYFAMEYVRGGELFN--KVAKGKLREEVARKYFQQLVDAVEFCHSR 128
IV+L K++ +E+ GG + L E + +Q+++A+ F HS+
Sbjct: 77 YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 136
Query: 129 GVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVI----- 183
+ HRDLK N+L+ GD++++DFG+SA T Q + GTP ++APEV+
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK--RDSFIGTPYWMAPEVVMCETM 194
Query: 184 NKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAE---FKCPNWFPPEVR 240
YD KADIWS G+ L + P ++ N M + KI +++ P+ + E R
Sbjct: 195 KDTPYDY-KADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFR 253
Query: 241 KLLSRILDPNPSTRVTMAKLMENYWFRK 268
L LD NP TR + A+L+E+ +
Sbjct: 254 DFLKIALDKNPETRPSAAQLLEHPFVSS 281
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 4e-54
Identities = 64/275 (23%), Positives = 120/275 (43%), Gaps = 27/275 (9%)
Query: 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIV----DKEKIRRVGLIDQIKREIS 62
+ N+ E + +G+G F V+ GR +K VAIK + + + + + +RE+
Sbjct: 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 63 VMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFN--KVAKGKLREEVARKYFQQLVD 120
+M + HPNIV+LY ME+V G+L++ ++ V + +
Sbjct: 76 IMSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIAL 133
Query: 121 AVEFCHSRG--VYHRDLKPENLLLDENGD-----LKISDFGLSALQESTRQDGLLHTTCG 173
+E+ ++ + HRDL+ N+ L + K++DFGLS + + G
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS-----VSGLLG 188
Query: 174 TPAYVAPEVINKRG--YDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFK- 230
++APE I Y KAD +S ++L+ +L G PF + + ++ E
Sbjct: 189 NFQWMAPETIGAEEESYT-EKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL 247
Query: 231 ---CPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262
P PP +R ++ +P R + +++
Sbjct: 248 RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 7e-54
Identities = 83/282 (29%), Positives = 137/282 (48%), Gaps = 26/282 (9%)
Query: 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRH 69
+ YEL ++G G A V + VAIK ++ EK + +D++ +EI M H
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS--MDELLKEIQAMSQCHH 72
Query: 70 PNIVQLYEVMASKTKIYFAMEYVRGGELFN---------KVAKGKLREEVARKYFQQLVD 120
PNIV Y K +++ M+ + GG + + + G L E +++++
Sbjct: 73 PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132
Query: 121 AVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLL---HTTCGTPAY 177
+E+ H G HRD+K N+LL E+G ++I+DFG+SA + T GTP +
Sbjct: 133 GLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCW 192
Query: 178 VAPEVINK-RGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLME-LYKKITRA-------- 227
+APEV+ + RGYD KADIWS G+ L G P++ M+ L +
Sbjct: 193 MAPEVMEQVRGYD-FKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGV 251
Query: 228 -EFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRK 268
+ + + RK++S L +P R T A+L+ + +F+K
Sbjct: 252 QDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 293
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 2e-53
Identities = 82/301 (27%), Positives = 133/301 (44%), Gaps = 55/301 (18%)
Query: 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIK----REISVM 64
M KYE L+G+G++ V RN TG+ VAIK K +K REI ++
Sbjct: 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIK-----KFLESDDDKMVKKIAMREIKLL 78
Query: 65 RLVRHPNIVQLYEVMASKTKIYFAMEYVRG---GELFNKVAKGKLREEVARKYFQQLVDA 121
+ +RH N+V L EV K + Y E+V +L ++ L +V +KY Q+++
Sbjct: 79 KQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDL--ELFPNGLDYQVVQKYLFQIING 136
Query: 122 VEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLS-ALQESTRQDGLLHTTCGTPAYVAP 180
+ FCHS + HRD+KPEN+L+ ++G +K+ DFG + L T Y AP
Sbjct: 137 IGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV--YDDEVA-TRWYRAP 193
Query: 181 EVI-NKRGYDGAKADIWSCGVVLFVLLAGNLPFY--DSNLMELYKKITRA---------- 227
E++ Y A D+W+ G ++ + G P + DS++ +LY I
Sbjct: 194 ELLVGDVKYGKA-VDVWAIGCLVTEMFMGE-PLFPGDSDIDQLY-HIMMCLGNLIPRHQE 250
Query: 228 ---------EFKCPNWFPPEVRK------------LLSRILDPNPSTRVTMAKLMENYWF 266
+ P E + L + L +P R A+L+ + +F
Sbjct: 251 LFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFF 310
Query: 267 R 267
+
Sbjct: 311 Q 311
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 3e-53
Identities = 79/282 (28%), Positives = 132/282 (46%), Gaps = 21/282 (7%)
Query: 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISV-MR 65
+N E +G GT +V+ R KTG +A+K + + + +I ++ V ++
Sbjct: 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEE--NKRILMDLDVVLK 79
Query: 66 LVRHPNIVQLYEVMASKTKIYFAMEYVRGG-ELFNKVAKGKLREEVARKYFQQLVDAVEF 124
P IVQ + + T ++ AME + E K +G + E + K +V A+ +
Sbjct: 80 SHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYY 139
Query: 125 CHS-RGVYHRDLKPENLLLDENGDLKISDFGLSA-LQESTRQDGLLHTTCGTPAYVAPEV 182
GV HRD+KP N+LLDE G +K+ DFG+S L + +D + G AY+APE
Sbjct: 140 LKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKD----RSAGCAAYMAPER 195
Query: 183 I-----NKRGYDGAKADIWSCGVVLFVLLAGNLPFYD-SNLMELYKKITRAE---FKCPN 233
I K YD +AD+WS G+ L L G P+ + E+ K+ + E
Sbjct: 196 IDPPDPTKPDYD-IRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHM 254
Query: 234 WFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIET 275
F + + + L + R KL+E+ + ++ Y+ +E
Sbjct: 255 GFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR-YETLEV 295
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 7e-53
Identities = 68/271 (25%), Positives = 118/271 (43%), Gaps = 29/271 (10%)
Query: 13 ELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDK--EKIRRVGLIDQIKREISVMRLVRHP 70
G +LG+G F + + +TG+ + +K + + E+ +R +E+ VMR + HP
Sbjct: 13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQR-----TFLKEVKVMRCLEHP 67
Query: 71 NIVQLYEVMASKTKIYFAMEYVRGGELFN--KVAKGKLREEVARKYFQQLVDAVEFCHSR 128
N+++ V+ ++ F EY++GG L K + + + + + + HS
Sbjct: 68 NVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM 127
Query: 129 GVYHRDLKPENLLLDENGDLKISDFGLSALQEST------------RQDGLLHTTCGTPA 176
+ HRDL N L+ EN ++ ++DFGL+ L +T G P
Sbjct: 128 NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPY 187
Query: 177 YVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYD-----SNLMELYKKITRAEFKC 231
++APE+IN R YD K D++S G+VL ++ D + + C
Sbjct: 188 WMAPEMINGRSYD-EKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRY--C 244
Query: 232 PNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262
P PP + R D +P R + KL
Sbjct: 245 PPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 2e-52
Identities = 74/257 (28%), Positives = 124/257 (48%), Gaps = 13/257 (5%)
Query: 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHP 70
+++ LG+G++ VY + +TGQ VAIK V E + +I +EIS+M+ P
Sbjct: 30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-----LQEIIKEISIMQQCDSP 84
Query: 71 NIVQLYEVMASKTKIYFAMEYVRGGELFN--KVAKGKLREEVARKYFQQLVDAVEFCHSR 128
++V+ Y T ++ MEY G + + ++ L E+ Q + +E+ H
Sbjct: 85 HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM 144
Query: 129 GVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGY 188
HRD+K N+LL+ G K++DFG++ T +T GTP ++APEVI + GY
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKR--NTVIGTPFWMAPEVIQEIGY 202
Query: 189 DGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA---EFKCPNWFPPEVRKLLSR 245
+ ADIWS G+ + G P+ D + M I F+ P + + +
Sbjct: 203 NC-VADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQ 261
Query: 246 ILDPNPSTRVTMAKLME 262
L +P R T +L++
Sbjct: 262 CLVKSPEQRATATQLLQ 278
|
| >2ehb_D CBL-interacting serine/threonine-protein kinase 2; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} Length = 143 | Back alignment and structure |
|---|
Score = 169 bits (428), Expect = 3e-51
Identities = 45/132 (34%), Positives = 77/132 (58%), Gaps = 2/132 (1%)
Query: 318 PSSFNAFDIISLSKGFNLSGLFEGDAN-SKLEARFTTTKPASAIVSKFEEIAVTESCKFN 376
P NAF++I+LS+G NLS LF+ + K + RF + + S I++ E +A + K +
Sbjct: 4 PLMMNAFEMITLSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANSMGFKSH 63
Query: 377 KKDGTVKLQHNRQGRKGQLAVDAEIFEVTPAFHVVELKKAAGDTMEYKDFCNQGLRPSLK 436
++ +L+ + GQLAV EI+EV P+ +V+++KAAG+T+EY F + L L+
Sbjct: 64 TRNFKTRLEGLSSIKAGQLAVVIEIYEVAPSLFMVDVRKAAGETLEYHKFYKK-LCSKLE 122
Query: 437 DIVWTWQGNDEQ 448
+I+W +
Sbjct: 123 NIIWRATEGIPK 134
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 3e-51
Identities = 69/259 (26%), Positives = 115/259 (44%), Gaps = 15/259 (5%)
Query: 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHP 70
+ R +G G+F VY R+++ + VAIK + + I +E+ ++ +RHP
Sbjct: 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 114
Query: 71 NIVQLYEVMASKTKIYFAMEYVRGGEL-FNKVAKGKLREEVARKYFQQLVDAVEFCHSRG 129
N +Q + + MEY G +V K L+E + + + HS
Sbjct: 115 NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN 174
Query: 130 VYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVI---NKR 186
+ HRD+K N+LL E G +K+ DFG ++ + ++ GTP ++APEVI ++
Sbjct: 175 MIHRDVKAGNILLSEPGLVKLGDFGSAS-IMAPA-----NSFVGTPYWMAPEVILAMDEG 228
Query: 187 GYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA---EFKCPNWFPPEVRKLL 243
YDG K D+WS G+ L P ++ N M I + + +W R +
Sbjct: 229 QYDG-KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW-SEYFRNFV 286
Query: 244 SRILDPNPSTRVTMAKLME 262
L P R T L++
Sbjct: 287 DSCLQKIPQDRPTSEVLLK 305
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 9e-51
Identities = 79/314 (25%), Positives = 137/314 (43%), Gaps = 82/314 (26%)
Query: 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIK--------RE 60
M KYE +G+GT+ V+ +N +T + VA+K ++R +D RE
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALK-----RVR----LDDDDEGVPSSALRE 51
Query: 61 ISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGEL----FNKVAKGKLREEVARKYFQ 116
I +++ ++H NIV+L++V+ S K+ E+ + + G L E+ + +
Sbjct: 52 ICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC---DQDLKKYFDSCNGDLDPEIVKSFLF 108
Query: 117 QLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPA 176
QL+ + FCHSR V HRDLKP+NLL++ NG+LK+++FGL+ R G P
Sbjct: 109 QLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLA------R-------AFGIPV 155
Query: 177 -----------YVAPEVI-NKRGYDGAKADIWSCGVVLFVLLAGNLPFY--DSNLMELYK 222
Y P+V+ + Y + D+WS G + L P + + +L
Sbjct: 156 RCYSAEVVTLWYRPPDVLFGAKLYSTS-IDMWSAGCIFAELANAGRPLFPGNDVDDQLK- 213
Query: 223 KITRA----------------EFKC-PNWFPPEVRK------------LLSRILDPNPST 253
+I R ++K P + LL +L NP
Sbjct: 214 RIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQ 273
Query: 254 RVTMAKLMENYWFR 267
R++ + +++ +F
Sbjct: 274 RISAEEALQHPYFS 287
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 2e-50
Identities = 55/293 (18%), Positives = 110/293 (37%), Gaps = 21/293 (7%)
Query: 10 NKYELGRLLGQG--TFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV 67
YEL ++G+G V R TG+ V ++ ++ E ++ ++ E+ V +L
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN-EMVTFLQGELHVSKLF 83
Query: 68 RHPNIVQLYEVMASKTKIYFAMEYVRGG---ELFNKVAKGKLREEVARKYFQQLVDAVEF 124
HPNIV + +++ ++ G +L + E Q ++ A+++
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDY 143
Query: 125 CHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQ-----DGLLHTTCGTPAYVA 179
H G HR +K ++L+ +G + +S + S Q + +++
Sbjct: 144 IHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLS 203
Query: 180 PEVI--NKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPP 237
PEV+ N +GYD AK+DI+S G+ L G++PF D + + N P
Sbjct: 204 PEVLQQNLQGYD-AKSDIYSVGITACELANGHVPFKDMPAT-------QMLLEKLNGTVP 255
Query: 238 EVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIETPESPRGQDRNKLISD 290
+ + + + + ++ S
Sbjct: 256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSP 308
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 2e-50
Identities = 83/283 (29%), Positives = 132/283 (46%), Gaps = 38/283 (13%)
Query: 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMR-LVR 68
+EL L+G GT+ +VY GR++KTGQ AIK++D ++IK+EI++++
Sbjct: 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSH 79
Query: 69 HPNIVQLYE------VMASKTKIYFAMEYVRGG---ELFNKVAKGKLREEVARKYFQQLV 119
H NI Y +++ ME+ G +L L+EE ++++
Sbjct: 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 139
Query: 120 DAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVA 179
+ H V HRD+K +N+LL EN ++K+ DFG+SA + T +T GTP ++A
Sbjct: 140 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR--RNTFIGTPYWMA 197
Query: 180 PEVI-----NKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNW 234
PEVI YD K+D+WS G+ + G P D + M RA F P
Sbjct: 198 PEVIACDENPDATYDF-KSDLWSLGITAIEMAEGAPPLCDMHPM-------RALFLIPRN 249
Query: 235 FPP---------EVRKLLSRILDPNPSTRVTMAKLMENYWFRK 268
P + + + L N S R +LM++ + R
Sbjct: 250 PAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRD 292
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 3e-50
Identities = 83/313 (26%), Positives = 129/313 (41%), Gaps = 79/313 (25%)
Query: 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIK--------RE 60
+YE LG+G FA VY R+ T Q VAIK KI+ +G + K RE
Sbjct: 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIK-----KIK-LGHRSEAKDGINRTALRE 62
Query: 61 ISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGEL----FNKVAKGKLREEVARKYFQ 116
I +++ + HPNI+ L + K+ I +++ E K L + Y
Sbjct: 63 IKLLQELSHPNIIGLLDAFGHKSNISLVFDFM---ETDLEVIIKDNSLVLTPSHIKAYML 119
Query: 117 QLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPA 176
+ +E+ H + HRDLKP NLLLDENG LK++DFGL+ + G+P
Sbjct: 120 MTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLA-------------KSFGSPN 166
Query: 177 -----------YVAPEVI-NKRGYDGAKADIWSCGVVLFVLLAGNLPFY--DSNLMELYK 222
Y APE++ R Y D+W+ G +L LL PF DS+L +L
Sbjct: 167 RAYTHQVVTRWYRAPELLFGARMYGVG-VDMWAVGCILAELLLRV-PFLPGDSDLDQLT- 223
Query: 223 KITRA----------------EFKC-PNWFPPEVRK-----------LLSRILDPNPSTR 254
+I ++ ++ + L+ + NP R
Sbjct: 224 RIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCAR 283
Query: 255 VTMAKLMENYWFR 267
+T + ++ +F
Sbjct: 284 ITATQALKMKYFS 296
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 6e-50
Identities = 83/340 (24%), Positives = 140/340 (41%), Gaps = 89/340 (26%)
Query: 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQ--------IKRE 60
++++ LG GT+A VY G N TG VA+K +++ +D I RE
Sbjct: 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALK-----EVK----LDSEEGTPSTAI-RE 53
Query: 61 ISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRG------GELFNKVAKGKLREEVARKY 114
IS+M+ ++H NIV+LY+V+ ++ K+ E++ L + + +
Sbjct: 54 ISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYF 113
Query: 115 FQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGT 174
QL+ + FCH + HRDLKP+NLL+++ G LK+ DFGL+ R G
Sbjct: 114 QWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLA------R-------AFGI 160
Query: 175 PA-----------YVAPEVI-NKRGYDGAKADIWSCGVVLFVLLAGNLPFY--DSNLMEL 220
P Y AP+V+ R Y + DIWSCG +L ++ G P + ++ +L
Sbjct: 161 PVNTFSSEVVTLWYRAPDVLMGSRTYSTS-IDIWSCGCILAEMITGK-PLFPGTNDEEQL 218
Query: 221 YKKITRA----------------EFKC--PNWFPPEVRK----------------LLSRI 246
I ++ P ++R+ L +
Sbjct: 219 K-LIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGL 277
Query: 247 LDPNPSTRVTMAKLMENYWFRKGYKKIETPESP-RGQDRN 285
L NP R++ + + + WF + Y S +
Sbjct: 278 LQLNPDMRLSAKQALHHPWFAEYYHHASMGGSRSHHHHHH 317
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 6e-50
Identities = 67/292 (22%), Positives = 125/292 (42%), Gaps = 26/292 (8%)
Query: 2 EKKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREI 61
E+ + +G+G + V + +GQ +A+K + + Q+ ++
Sbjct: 14 EQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKE--QKQLLMDL 71
Query: 62 SV-MRLVRHPNIVQLYEVMASKTKIYFAMEYVRGG-----ELFNKVAKGKLREEVARKYF 115
V MR P IVQ Y + + + ME + + V + EE+ K
Sbjct: 72 DVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKIT 131
Query: 116 QQLVDAVEFCHS-RGVYHRDLKPENLLLDENGDLKISDFGLSA-LQESTRQDGLLHTTCG 173
V A+ + HRD+KP N+LLD +G++K+ DFG+S L +S + G
Sbjct: 132 LATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK----TRDAG 187
Query: 174 TPAYVAPEVI----NKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLM-ELYKKITRAE 228
Y+APE I +++GYD ++D+WS G+ L+ L G P+ N + + ++ + +
Sbjct: 188 CRPYMAPERIDPSASRQGYD-VRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGD 246
Query: 229 -----FKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIET 275
F P ++ L + S R +L+++ + Y++
Sbjct: 247 PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM-YEERAV 297
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 1e-49
Identities = 84/314 (26%), Positives = 143/314 (45%), Gaps = 84/314 (26%)
Query: 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIK--------RE 60
M KY +G+GT+ VY +N G++ A+K KIR +++ RE
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALK-----KIR----LEKEDEGIPSTTIRE 50
Query: 61 ISVMRLVRHPNIVQLYEVMASKTKIYFAMEYV----RGGELFNKVAKGKLREEVARKYFQ 116
IS+++ ++H NIV+LY+V+ +K ++ E++ + V +G L A+ +
Sbjct: 51 ISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKK---LLDVCEGGLESVTAKSFLL 107
Query: 117 QLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPA 176
QL++ + +CH R V HRDLKP+NLL++ G+LKI+DFGL+ R G P
Sbjct: 108 QLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLA------R-------AFGIPV 154
Query: 177 -----------YVAPEVI-NKRGYDGAKADIWSCGVVLFVLLAGNLPFY--DSNLMELYK 222
Y AP+V+ + Y DIWS G + ++ G P + S +L
Sbjct: 155 RKYTHEIVTLWYRAPDVLMGSKKYSTT-IDIWSVGCIFAEMVNGT-PLFPGVSEADQLM- 211
Query: 223 KITRA----------------EFKC--PNWFPPEVRK-----------LLSRILDPNPST 253
+I R ++ + P LLS++L +P+
Sbjct: 212 RIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQ 271
Query: 254 RVTMAKLMENYWFR 267
R+T + +E+ +F+
Sbjct: 272 RITAKQALEHAYFK 285
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 1e-49
Identities = 79/315 (25%), Positives = 132/315 (41%), Gaps = 85/315 (26%)
Query: 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIK--------RE 60
M KY+ +G+GT+ VY ++ G+ VA+K +IR +D RE
Sbjct: 20 MEKYQKLEKVGEGTYGVVYKAKD-SQGRIVALK-----RIR----LDAEDEGIPSTAIRE 69
Query: 61 ISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGEL----FNKVAKGKLREEVARKYFQ 116
IS+++ + HPNIV L +V+ S+ + E++ E K L++ + Y
Sbjct: 70 ISLLKELHHPNIVSLIDVIHSERCLTLVFEFM---EKDLKKVLDENKTGLQDSQIKIYLY 126
Query: 117 QLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPA 176
QL+ V CH + HRDLKP+NLL++ +G LK++DFGL+ R G P
Sbjct: 127 QLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLA------R-------AFGIPV 173
Query: 177 -----------YVAPEVI-NKRGYDGAKADIWSCGVVLFVLLAGNLPFY--DSNLMELYK 222
Y AP+V+ + Y + DIWS G + ++ G P + ++ +L
Sbjct: 174 RSYTHEVVTLWYRAPDVLMGSKKYSTS-VDIWSIGCIFAEMITGK-PLFPGVTDDDQLP- 230
Query: 223 KITRA-------------------EFKCPNWFPPEVRK-----------LLSRILDPNPS 252
KI + + LLS +L +P+
Sbjct: 231 KIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPN 290
Query: 253 TRVTMAKLMENYWFR 267
R++ M + +F+
Sbjct: 291 KRISARDAMNHPYFK 305
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 3e-49
Identities = 68/264 (25%), Positives = 119/264 (45%), Gaps = 13/264 (4%)
Query: 1 MEKKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKRE 60
+K + + +E LG G V+ + +G +A K++ E + +QI RE
Sbjct: 24 KQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI--RNQIIRE 81
Query: 61 ISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQL 118
+ V+ P IV Y S +I ME++ GG L ++V K G++ E++ K +
Sbjct: 82 LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAV 140
Query: 119 VDAVEFCHSRG-VYHRDLKPENLLLDENGDLKISDFGLSA-LQESTRQDGLLHTTCGTPA 176
+ + + + + HRD+KP N+L++ G++K+ DFG+S L +S ++ GT +
Sbjct: 141 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA-----NSFVGTRS 195
Query: 177 YVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFP 236
Y++PE + Y ++DIWS G+ L + G P + EL P
Sbjct: 196 YMSPERLQGTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 254
Query: 237 PEVRKLLSRILDPNPSTRVTMAKL 260
P R + +R MA
Sbjct: 255 PRPRTPGRPLNKFGMDSRPPMAIF 278
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 6e-49
Identities = 71/257 (27%), Positives = 119/257 (46%), Gaps = 14/257 (5%)
Query: 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREI-SVMR 65
I+ +Y++ LG G + VY + VAIK + + + + +RE+ + +
Sbjct: 8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQ 67
Query: 66 LVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVA-KGKLREEVARKYFQQLVDAVEF 124
L H NIV + +V Y MEY+ G L + G L + A + Q++D ++
Sbjct: 68 LS-HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKH 126
Query: 125 CHSRGVYHRDLKPENLLLDENGDLKISDFGLS-ALQESTR-QDGLLHTTCGTPAYVAPEV 182
H + HRD+KP+N+L+D N LKI DFG++ AL E++ Q GT Y +PE
Sbjct: 127 AHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTN---HVLGTVQYFSPEQ 183
Query: 183 INKRGYDGAKADIWSCGVVLFVLLAGNLPFY-DSNLMELYKKITRAEFKCPNWF----PP 237
K DI+S G+VL+ +L G PF ++ + K I + P
Sbjct: 184 A-KGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQ 242
Query: 238 EVRKLLSRILDPNPSTR 254
+ ++ R + + + R
Sbjct: 243 SLSNVILRATEKDKANR 259
|
| >2zfd_B Putative uncharacterized protein T20L15_90; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} Length = 123 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 1e-48
Identities = 41/126 (32%), Positives = 61/126 (48%), Gaps = 5/126 (3%)
Query: 316 VRPSSFNAFDIISLSKGFNLSGLFEGDANSKLEARFTTTKPASAIVSKFEEIAVTESCKF 375
+ NAFDIIS S GFNLSGLF RF + A +V + EEI E+
Sbjct: 1 MGARRMNAFDIISGSPGFNLSGLFGDARKYDRVERFVSAWTAERVVERLEEIVSAENLTV 60
Query: 376 NKKD-GTVKLQHNRQGRKGQLAVDAEIFEVTPAFHVVELKKAAGDTMEYKDFCNQGLRPS 434
KK+ +K++ G+KG A+ EI ++T ++E++K +D LRP
Sbjct: 61 AKKETWGMKIE----GQKGNFAMVVEINQLTDELVMIEVRKRQRAAASGRDLWTDTLRPF 116
Query: 435 LKDIVW 440
++V
Sbjct: 117 FVELVH 122
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 6e-48
Identities = 71/283 (25%), Positives = 127/283 (44%), Gaps = 22/283 (7%)
Query: 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISV-MR 65
+ + E LG+G + V R++ +GQ +A+K + + ++ ++ + MR
Sbjct: 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQE--QKRLLMDLDISMR 61
Query: 66 LVRHPNIVQLYEVMASKTKIYFAMEYVRGG--ELFNKVAK--GKLREEVARKYFQQLVDA 121
V P V Y + + ++ ME + + + +V + E++ K +V A
Sbjct: 62 TVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKA 121
Query: 122 VEFCHS-RGVYHRDLKPENLLLDENGDLKISDFGLSA-LQESTRQDGLLHTTCGTPAYVA 179
+E HS V HRD+KP N+L++ G +K+ DFG+S L + +D G Y+A
Sbjct: 122 LEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKD----IDAGCKPYMA 177
Query: 180 PEVI----NKRGYDGAKADIWSCGVVLFVLLAGNLPFYD-SNLMELYKKITRAE--FKCP 232
PE I N++GY K+DIWS G+ + L P+ + K++
Sbjct: 178 PERINPELNQKGYS-VKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPA 236
Query: 233 NWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIET 275
+ F E S+ L N R T +LM++ +F ++ T
Sbjct: 237 DKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL-HESKGT 278
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 8e-48
Identities = 68/314 (21%), Positives = 129/314 (41%), Gaps = 83/314 (26%)
Query: 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIK-------REI 61
M Y LG+GT+A VY G++ T VA+K +IR ++ + RE+
Sbjct: 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALK-----EIR----LEHEEGAPCTAIREV 51
Query: 62 SVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGEL----FNKVAKGKLREEVARKYFQQ 117
S+++ ++H NIV L++++ ++ + EY+ + + + + + Q
Sbjct: 52 SLLKDLKHANIVTLHDIIHTEKSLTLVFEYL---DKDLKQYLDDCGNIINMHNVKLFLFQ 108
Query: 118 LVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPA- 176
L+ + +CH + V HRDLKP+NLL++E G+LK++DFGL+ R P
Sbjct: 109 LLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLA------R-------AKSIPTK 155
Query: 177 ----------YVAPEVI-NKRGYDGAKADIWSCGVVLFVLLAGNLPFY--DSNLMELYKK 223
Y P+++ Y D+W G + + + G P + + +L+
Sbjct: 156 TYDNEVVTLWYRPPDILLGSTDYSTQ-IDMWGVGCIFYEMATGR-PLFPGSTVEEQLH-F 212
Query: 224 ITRA-------------------EFKCPNWFPPEVRK-----------LLSRILDPNPST 253
I R + P + + LL+++L
Sbjct: 213 IFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRN 272
Query: 254 RVTMAKLMENYWFR 267
R++ M++ +F
Sbjct: 273 RISAEDAMKHPFFL 286
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 2e-47
Identities = 75/312 (24%), Positives = 124/312 (39%), Gaps = 69/312 (22%)
Query: 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIV--DKEKIRRVGLIDQIKREISVMR- 65
++YE +G G + VY R+ +G VA+K V GL RE++++R
Sbjct: 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRR 67
Query: 66 --LVRHPNIVQLYEVMASK-----TKIYFAMEYVRG--GELFNKVAKGKLREEVARKYFQ 116
HPN+V+L +V A+ K+ E+V +K L E + +
Sbjct: 68 LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMR 127
Query: 117 QLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPA 176
Q + ++F H+ + HRDLKPEN+L+ G +K++DFGL+ R
Sbjct: 128 QFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA------R-------IYSYQM 174
Query: 177 ----------YVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFY--DSNLMELYK-- 222
Y APEV+ + Y D+WS G + + P + +S +L K
Sbjct: 175 ALTPVVVTLWYRAPEVLLQSTYATP-VDMWSVGCIFAEMFRRK-PLFCGNSEADQLGKIF 232
Query: 223 ---------------KITRAEFKCPNWFPPEVRK-----------LLSRILDPNPSTRVT 256
+ R F P P V+ LL +L NP R++
Sbjct: 233 DLIGLPPEDDWPRDVSLPRGAF--PPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRIS 290
Query: 257 MAKLMENYWFRK 268
+ +++ + K
Sbjct: 291 AFRALQHSYLHK 302
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 3e-47
Identities = 80/318 (25%), Positives = 138/318 (43%), Gaps = 86/318 (27%)
Query: 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIK--------RE 60
+++Y LG+GT+ +VY + T ++VAIK +IR ++ + RE
Sbjct: 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIK-----RIR----LEHEEEGVPGTAIRE 83
Query: 61 ISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRG--GELFNKVAKGKLREEVARKYFQQL 118
+S+++ ++H NI++L V+ +++ EY + +K + V + + QL
Sbjct: 84 VSLLKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDK--NPDVSMRVIKSFLYQL 141
Query: 119 VDAVEFCHSRGVYHRDLKPENLLLD-----ENGDLKISDFGLSALQESTRQDGLLHTTCG 173
++ V FCHSR HRDLKP+NLLL E LKI DFGL+ R G
Sbjct: 142 INGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA------R-------AFG 188
Query: 174 TPA-----------YVAPEVI-NKRGYDGAKADIWSCGVVLFVLLAGNLPFY--DSNLME 219
P Y PE++ R Y + DIWS + +L P + DS + +
Sbjct: 189 IPIRQFTHEIITLWYRPPEILLGSRHYSTS-VDIWSIACIWAEMLMKT-PLFPGDSEIDQ 246
Query: 220 LYKKITRA----------------EFKC--PNWFPPEVRK------------LLSRILDP 249
L+ KI ++K P + +++ LL+ +L+
Sbjct: 247 LF-KIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEM 305
Query: 250 NPSTRVTMAKLMENYWFR 267
+P R++ +E+ +F
Sbjct: 306 DPVKRISAKNALEHPYFS 323
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 161 bits (411), Expect = 3e-46
Identities = 79/337 (23%), Positives = 139/337 (41%), Gaps = 85/337 (25%)
Query: 9 MNKYELGRLLGQGTFAKVYHGRNLK-TGQSVAIKIVDKEKIRRVGLIDQIK--------R 59
+YE +G+G + KV+ R+LK G+ VA+K ++R + + R
Sbjct: 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALK-----RVR----VQTGEEGMPLSTIR 60
Query: 60 EISVMR---LVRHPNIVQLYEV-----MASKTKIYFAMEYVRG--GELFNKVAKGKLREE 109
E++V+R HPN+V+L++V +TK+ E+V +KV + + E
Sbjct: 61 EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTE 120
Query: 110 VARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLH 169
+ QL+ ++F HS V HRDLKP+N+L+ +G +K++DFGL+ R
Sbjct: 121 TIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA------R------ 168
Query: 170 TTCGTPA----------YVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFY--DSNL 217
Y APEV+ + Y D+WS G + + P + S++
Sbjct: 169 -IYSFQMALTSVVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRK-PLFRGSSDV 225
Query: 218 MELYK-----------------KITRAEFKCPNWFPPEVRK-----------LLSRILDP 249
+L K + R F + + K LL + L
Sbjct: 226 DQLGKILDVIGLPGEEDWPRDVALPRQAF--HSKSAQPIEKFVTDIDELGKDLLLKCLTF 283
Query: 250 NPSTRVTMAKLMENYWFRKGYKKIETPESPRGQDRNK 286
NP+ R++ + + +F+ + E +S +N
Sbjct: 284 NPAKRISAYSALSHPYFQDLERCKENLDSHLPPSQNT 320
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 5e-46
Identities = 73/260 (28%), Positives = 127/260 (48%), Gaps = 15/260 (5%)
Query: 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKRE-ISVMR 65
L ++YELG +LG G ++V+ R+L+ + VA+K++ + R + +RE +
Sbjct: 9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 68
Query: 66 LVRHPNIVQLY---EVMASKTKIYF-AMEYVRGGELFNKVAK-GKLREEVARKYFQQLVD 120
L HP IV +Y E + + MEYV G L + V G + + A +
Sbjct: 69 LN-HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ 127
Query: 121 AVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLS-ALQESTRQDGLLHTTCGTPAYVA 179
A+ F H G+ HRD+KP N+++ +K+ DFG++ A+ +S GT Y++
Sbjct: 128 ALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187
Query: 180 PEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFY-DSNLMELYKKITRAEFKCPN----W 234
PE + A++D++S G VL+ +L G PF DS + Y+ + R + P+
Sbjct: 188 PEQA-RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV-REDPIPPSARHEG 245
Query: 235 FPPEVRKLLSRILDPNPSTR 254
++ ++ + L NP R
Sbjct: 246 LSADLDAVVLKALAKNPENR 265
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 2e-45
Identities = 68/265 (25%), Positives = 105/265 (39%), Gaps = 32/265 (12%)
Query: 7 ILMNKYELGRLLGQGTFAKVYHGRNLK-TGQSVAIKIV----DKEKIRRVGLIDQIKREI 61
I+ +YE+ + G +Y + G+ V +K + D E E
Sbjct: 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMA------MAER 130
Query: 62 SVMRLVRHPNIVQLYEV-----MASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQ 116
+ V HP+IVQ++ Y MEYV G L + KL A Y
Sbjct: 131 QFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSL-KRSKGQKLPVAEAIAYLL 189
Query: 117 QLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPA 176
+++ A+ + HS G+ + DLKPEN++L E LK+ D G + S GTP
Sbjct: 190 EILPALSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRINSF------GYLYGTPG 242
Query: 177 YVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFP 236
+ APE++ R DI++ G L L + L + +
Sbjct: 243 FQAPEIV--RTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLK------TY 294
Query: 237 PEVRKLLSRILDPNPSTRVTMAKLM 261
+LL R +DP+P R T A+ M
Sbjct: 295 DSYGRLLRRAIDPDPRQRFTTAEEM 319
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 6e-45
Identities = 74/311 (23%), Positives = 134/311 (43%), Gaps = 62/311 (19%)
Query: 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIV----DKEKIRRVGLIDQIKREISVM 64
++KYE +GQGTF +V+ R+ KTGQ VA+K V +KE L REI ++
Sbjct: 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITAL-----REIKIL 70
Query: 65 RLVRHPNIVQLYEVMASK--------TKIYFAMEYVR---GGELFNKVAKGKLREEVARK 113
+L++H N+V L E+ +K IY ++ G L N K ++
Sbjct: 71 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKR 128
Query: 114 YFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLS-ALQESTRQDGLLHTTC 172
Q L++ + + H + HRD+K N+L+ +G LK++DFGL+ A + +T
Sbjct: 129 VMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 188
Query: 173 -GTPAYVAPEVI-NKRGYDGAKADIWSCGVVLFVLLAGNLPFY--DSNLMELYKKITRA- 227
T Y PE++ +R Y G D+W G ++ + + P ++ +L I++
Sbjct: 189 VVTLWYRPPELLLGERDY-GPPIDLWGAGCIMAEMWTRS-PIMQGNTEQHQLA-LISQLC 245
Query: 228 ------------------EFKCPNWFPPEVRK-------------LLSRILDPNPSTRVT 256
+ + +V+ L+ ++L +P+ R+
Sbjct: 246 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID 305
Query: 257 MAKLMENYWFR 267
+ + +F
Sbjct: 306 SDDALNHDFFW 316
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 4e-44
Identities = 67/258 (25%), Positives = 117/258 (45%), Gaps = 14/258 (5%)
Query: 5 AGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKRE-ISV 63
G Y L RL+G+G VY + + VA+K++ + +++RE +
Sbjct: 29 EGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTA 88
Query: 64 MRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAV 122
RL + P++V +++ ++Y M + G +L + + G L A +Q+ A+
Sbjct: 89 GRL-QEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSAL 147
Query: 123 EFCHSRGVYHRDLKPENLLLDENGDLKISDFGL-SALQESTR-QDGLLHTTCGTPAYVAP 180
+ H+ G HRD+KPEN+L+ + + DFG+ SA + Q G T GT Y+AP
Sbjct: 148 DAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLG---NTVGTLYYMAP 204
Query: 181 EVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWF----P 236
E + +ADI++ VL+ L G+ P+ L + I P+ P
Sbjct: 205 ERF-SESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHI-NQAIPRPSTVRPGIP 262
Query: 237 PEVRKLLSRILDPNPSTR 254
+++R + NP R
Sbjct: 263 VAFDAVIARGMAKNPEDR 280
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 5e-44
Identities = 63/292 (21%), Positives = 116/292 (39%), Gaps = 49/292 (16%)
Query: 13 ELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNI 72
L +G+G + +V+ G + G++VA+KI + + E+ ++RH NI
Sbjct: 11 TLLECVGKGRYGEVWRGS-WQ-GENVAVKIFSSRDEKS----WFRETELYNTVMLRHENI 64
Query: 73 VQLY----EVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSR 128
+ S T+++ Y G L++ + L + + + H
Sbjct: 65 LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIE 124
Query: 129 --------GVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLL--HTTCGTPAYV 178
+ HRDLK +N+L+ +NG I+D GL+ + + + + GT Y+
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 179 APEVINKRGYDGA-----KADIWSCGVVLFVLLAGN----------LPFYDSN-----LM 218
APEV+++ + DIW+ G+VL+ + PFYD
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE 244
Query: 219 ELYKKI----TRAEFKCPNWF----PPEVRKLLSRILDPNPSTRVTMAKLME 262
++ K + R WF + KL+ NPS R+T ++ +
Sbjct: 245 DMRKVVCVDQQRPNIP-NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 3e-43
Identities = 93/370 (25%), Positives = 156/370 (42%), Gaps = 75/370 (20%)
Query: 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHP 70
Y +++G G+F VY + +G+ VAIK V ++K + RE+ +MR + H
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLDHC 107
Query: 71 NIVQLYEVMASKT------KIYFAMEYV-----RGGELFNKVAKGKLREEVARKYFQQLV 119
NIV+L S + ++YV R +++ AK L + Y QL
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR-AKQTLPVIYVKLYMYQLF 166
Query: 120 DAVEFCHSRGVYHRDLKPENLLLDEN-GDLKISDFGLSALQESTRQDGLLHTTCGTPAYV 178
++ + HS G+ HRD+KP+NLLLD + LK+ DFG + ++ R + + C + Y
Sbjct: 167 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA--KQLVRGEPNVSYIC-SRYYR 223
Query: 179 APEVI-NKRGYDGAKADIWSCGVVLFVLLAGNLPFY--DSNLMELYKKI----------- 224
APE+I Y + D+WS G VL LL G P + DS + +L + I
Sbjct: 224 APELIFGATDYTSS-IDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQI 281
Query: 225 -----TRAEFKCPNW------------FPPEVRKLLSRILDPNPSTRVTMAKLMENYWFR 267
EFK P PPE L SR+L+ P+ R+T + + +F
Sbjct: 282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF- 340
Query: 268 KGYKKIETPESPRGQDR-----------------NKLISDIHAVFECESSSSRDTDPPTN 310
+ + P G+D ++ HA + +S+ + ++
Sbjct: 341 DELRDPNV-KLPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQAAASTPTNATAASD 399
Query: 311 SCRSPVRPSS 320
+ ++
Sbjct: 400 ANTGDRGQTN 409
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 3e-43
Identities = 88/323 (27%), Positives = 146/323 (45%), Gaps = 61/323 (18%)
Query: 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR 68
Y +++G G+F V+ + +++ + VAIK V ++K R RE+ +MR+V+
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDK-RFKN------RELQIMRIVK 90
Query: 69 HPNIVQLYEVMAS------KTKIYFAMEYV-----RGGELFNKVAKGKLREEVARKYFQQ 117
HPN+V L S + + +EYV R + K K + + + Y Q
Sbjct: 91 HPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAK-LKQTMPMLLIKLYMYQ 149
Query: 118 LVDAVEFCHSRGVYHRDLKPENLLLDEN-GDLKISDFGLSALQESTRQDGLLHTTCGTPA 176
L+ ++ + HS G+ HRD+KP+NLLLD G LK+ DFG + + + + C +
Sbjct: 150 LLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP--NVSYIC-SRY 206
Query: 177 YVAPEVI-NKRGYDGAKADIWSCGVVLFVLLAGNLPFY--DSNLMELYKKITR------- 226
Y APE+I Y DIWS G V+ L+ G P + +S + +L +I +
Sbjct: 207 YRAPELIFGATNYT-TNIDIWSTGCVMAELMQGQ-PLFPGESGIDQLV-EIIKVLGTPSR 263
Query: 227 ----------AEFKCPNW------------FPPEVRKLLSRILDPNPSTRVTMAKLMENY 264
E K P PP+ L+SR+L+ PS R+T + + +
Sbjct: 264 EQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHP 323
Query: 265 WFRKGYKKIETPESPRGQDRNKL 287
+F + E P G++ L
Sbjct: 324 FF-DELRTGEA-RMPNGRELPPL 344
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 8e-43
Identities = 60/225 (26%), Positives = 114/225 (50%), Gaps = 20/225 (8%)
Query: 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMR-LV 67
+ Y+L R LG+G +++V+ N+ + V +KI+ K ++ IKREI ++ L
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK------IKREIKILENLR 88
Query: 68 RHPNIVQLYEVM--ASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFC 125
PNI+ L +++ E+V + K L + R Y +++ A+++C
Sbjct: 89 GGPNIITLADIVKDPVSRTPALVFEHVNNTDF--KQLYQTLTDYDIRFYMYEILKALDYC 146
Query: 126 HSRGVYHRDLKPENLLLD-ENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVI- 183
HS G+ HRD+KP N+++D E+ L++ D+GL+ E + + + PE++
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA---EFYHPGQEYNVRVASRYFKGPELLV 203
Query: 184 NKRGYDGAKADIWSCGVVLFVLLAGNLPFY--DSNLMELYKKITR 226
+ + YD + D+WS G +L ++ PF+ N +L +I +
Sbjct: 204 DYQMYDYS-LDMWSLGCMLASMIFRKEPFFHGHDNYDQL-VRIAK 246
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-41
Identities = 42/263 (15%), Positives = 84/263 (31%), Gaps = 38/263 (14%)
Query: 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRL 66
I +Y L G + + + + VA+ VD + + ++ + +
Sbjct: 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSR 87
Query: 67 VRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCH 126
+ P + ++ +V+ ++ E++RGG L +VA A + Q L A + H
Sbjct: 88 IDKPGVARVLDVVHTRAGGLVVAEWIRGGSL-QEVADTSPSPVGAIRAMQSLAAAADAAH 146
Query: 127 SRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKR 186
GV P + + +GD+ + PA +
Sbjct: 147 RAGVALSIDHPSRVRVSIDGDVVL----------------------AYPATMPDA----- 179
Query: 187 GYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPN-------WFPPEV 239
+ DI G L+ LL P ++ + R P P ++
Sbjct: 180 ---NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQI 236
Query: 240 RKLLSRILDPNPSTRVTMAKLME 262
+ +R + + R L
Sbjct: 237 SAVAARSVQGDGGIRSASTLLNL 259
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-40
Identities = 61/297 (20%), Positives = 123/297 (41%), Gaps = 47/297 (15%)
Query: 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRL 66
+ + ++ + +G+G + +V+ G+ + G+ VA+K+ + + EI L
Sbjct: 34 TIAKQIQMVKQIGKGRYGEVWMGK-WR-GEKVAVKVFFTTEEAS----WFRETEIYQTVL 87
Query: 67 VRHPNIVQLY----EVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAV 122
+RH NI+ + S T++Y +Y G L++ + L + K V +
Sbjct: 88 MRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGL 147
Query: 123 EFCHSR--------GVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQ--DGLLHTTC 172
H+ + HRDLK +N+L+ +NG I+D GL+ S D +T
Sbjct: 148 CHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV 207
Query: 173 GTPAYVAPEVINKRGYDGA-----KADIWSCGVVLFVLLAGNLPFYDSNLMEL-YKKITR 226
GT Y+ PEV+++ AD++S G++L+ + + +L Y +
Sbjct: 208 GTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP 267
Query: 227 AEFKC-----------------PNW----FPPEVRKLLSRILDPNPSTRVTMAKLME 262
++ W ++ KL++ NP++R+T ++ +
Sbjct: 268 SDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-39
Identities = 58/295 (19%), Positives = 112/295 (37%), Gaps = 49/295 (16%)
Query: 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRH 69
+L + +G F V+ + + VA+KI + + Q + E+ + ++H
Sbjct: 24 MPLQLLEVKARGRFGCVWKAQ--LLNEYVAVKIFPIQDKQSW----QNEYEVYSLPGMKH 77
Query: 70 PNIVQLY----EVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFC 125
NI+Q + ++ + G L + + + + + + +
Sbjct: 78 ENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYL 137
Query: 126 HSRGVY----------HRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTP 175
H HRD+K +N+LL N I+DFGL+ E+ + G H GT
Sbjct: 138 HEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTR 197
Query: 176 AYVAPEV----INKRGYDGAKADIWSCGVVLFVLLAG-----------NLPFYDS----- 215
Y+APEV IN + + D+++ G+VL+ L + LPF +
Sbjct: 198 RYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP 257
Query: 216 NLMELYK----KITRAEFKCPNWFPPEVRKLLSRIL----DPNPSTRVTMAKLME 262
+L ++ + K R + W +L + D + R++ + E
Sbjct: 258 SLEDMQEVVVHKKKRPVLR-DYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-39
Identities = 63/291 (21%), Positives = 118/291 (40%), Gaps = 47/291 (16%)
Query: 13 ELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNI 72
L +G+G F +V+ G+ + G+ VA+KI + R + EI ++RH NI
Sbjct: 45 VLQESIGKGRFGEVWRGK-WR-GEEVAVKIFSSREERS----WFREAEIYQTVMLRHENI 98
Query: 73 VQLY----EVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSR 128
+ + + T+++ +Y G LF+ + + + E K + H
Sbjct: 99 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHME 158
Query: 129 --------GVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQ--DGLLHTTCGTPAYV 178
+ HRDLK +N+L+ +NG I+D GL+ +S D + GT Y+
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 179 APEVINKRGYDGA-----KADIWSCGVVLFVLLAG----------NLPFY-----DSNLM 218
APEV++ +ADI++ G+V + + LP+Y D ++
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 278
Query: 219 ELYKKITRA-------EFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262
E+ K + + K++ N + R+T ++ +
Sbjct: 279 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-38
Identities = 72/328 (21%), Positives = 126/328 (38%), Gaps = 79/328 (24%)
Query: 10 NKYE-LGRLLGQGTFAKVYHGRNL--KTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRL 66
+ +E G +G+GT+ VY + K + A+K +I G+ REI+++R
Sbjct: 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALK-----QIEGTGISMSACREIALLRE 74
Query: 67 VRHPNIVQLYEVMASKT--KIYFAMEYV---------RGGELFNKVAKGKLREEVARKYF 115
++HPN++ L +V S K++ +Y +L + +
Sbjct: 75 LKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLL 134
Query: 116 QQLVDAVEFCHSRGVYHRDLKPENLLL----DENGDLKISDFGLS-ALQESTRQDGLLHT 170
Q++D + + H+ V HRDLKP N+L+ E G +KI+D G + + L
Sbjct: 135 YQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP--LADL 192
Query: 171 TCG--TPAYVAPEVI-NKRGYDGAKADIWSCGVVLFVLLAG------------------- 208
T Y APE++ R Y A DIW+ G + LL
Sbjct: 193 DPVVVTFWYRAPELLLGARHYTKA-IDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH 251
Query: 209 ----------------------NLPFYDSNLMELYKKITRAEFKCPNWFPPEVRK----- 241
+P + S LM+ +++ T + K
Sbjct: 252 DQLDRIFNVMGFPADKDWEDIKKMPEH-STLMKDFRRNTYTNCSLIKYMEKHKVKPDSKA 310
Query: 242 --LLSRILDPNPSTRVTMAKLMENYWFR 267
LL ++L +P R+T + M++ +F
Sbjct: 311 FHLLQKLLTMDPIKRITSEQAMQDPYFL 338
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 138 bits (348), Expect = 3e-37
Identities = 52/296 (17%), Positives = 107/296 (36%), Gaps = 46/296 (15%)
Query: 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRL 66
+ ++ +L L+G+G + VY G L + VA+K+ + E ++ R+
Sbjct: 10 LDLDNLKLLELIGRGRYGAVYKGS-LD-ERPVAVKVFSFANRQ------NFINEKNIYRV 61
Query: 67 --VRHPNIVQLY-----EVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLV 119
+ H NI + + + MEY G L ++ + + +
Sbjct: 62 PLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVT 121
Query: 120 DAVEFCHS---------RGVYHRDLKPENLLLDENGDLKISDFGLSALQESTR------Q 164
+ + H+ + HRDL N+L+ +G ISDFGLS R +
Sbjct: 122 RGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEE 181
Query: 165 DGLLHTTCGTPAYVAPEVINKR------GYDGAKADIWSCGVVLFVLLAGNLPFYDSNLM 218
D + GT Y+APEV+ + D+++ G++ + + + +
Sbjct: 182 DNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241
Query: 219 ELYKKITRAEFKCPNWFPPEVRKL---------LSRILDPNPSTRVTMAKLMENYW 265
Y ++ + +++ L N ++ + +E+ W
Sbjct: 242 PEY-QMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCW 296
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 5e-37
Identities = 77/302 (25%), Positives = 126/302 (41%), Gaps = 69/302 (22%)
Query: 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRL-- 66
M+++++ R+ GQGTF V G+ TG SVAIK V ++ R RE+ +M+
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR-------NRELQIMQDLA 74
Query: 67 -VRHPNIVQLYEVMASKTK-------IYFAMEYVRGGELFNKVAK--GKLREEVARKYFQ 116
+ HPNIVQL + + + MEYV + ++ + + + +
Sbjct: 75 VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV--PDTLHRCCRNYYRRQVAPPPILIK 132
Query: 117 ----QLVDAVEFCH--SRGVYHRDLKPENLLLD-ENGDLKISDFGLSALQESTRQDGLLH 169
QL+ ++ H S V HRD+KP N+L++ +G LK+ DFG + + +
Sbjct: 133 VFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP--NVA 190
Query: 170 TTCGTPAYVAPEVI-NKRGYDGAKADIWSCGVVLFVLLAGNLPFY--DSNLMELYKKITR 226
C + Y APE+I + Y A DIWS G + ++ G P + D++ +L +I R
Sbjct: 191 YIC-SRYYRAPELIFGNQHYTTA-VDIWSVGCIFAEMMLGE-PIFRGDNSAGQL-HEIVR 246
Query: 227 -----------------AEFKCPNW---------------FPPEVRKLLSRILDPNPSTR 254
+ N E LLS +L P R
Sbjct: 247 VLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEER 306
Query: 255 VT 256
+
Sbjct: 307 MK 308
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-36
Identities = 76/362 (20%), Positives = 136/362 (37%), Gaps = 86/362 (23%)
Query: 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR 68
KY LG+ LG G+F V ++++G+ A+K V ++ RE+ +M+++
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-------KNRELDIMKVLD 58
Query: 69 HPNIVQLYEVMASKTK--------------------------------------IYFAME 90
H NI++L + + + ME
Sbjct: 59 HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIME 118
Query: 91 YV-----RGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLD-E 144
YV + + F + + + + Y QL AV F HS G+ HRD+KP+NLL++ +
Sbjct: 119 YVPDTLHKVLKSFIR-SGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSK 177
Query: 145 NGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVI-NKRGYDGAKADIWSCGVVLF 203
+ LK+ DFG + ++ + + C + Y APE++ Y + D+WS G V
Sbjct: 178 DNTLKLCDFGSA--KKLIPSEPSVAYIC-SRFYRAPELMLGATEYTPS-IDLWSIGCVFG 233
Query: 204 VLLAGNLPF----YDSNLMELYKKI-------------TRAEFKCPNW--------F--- 235
L+ G F L+ + + + E + P
Sbjct: 234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEG 293
Query: 236 -PPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIETPESPRGQDRNKLISDIHAV 294
P LL +IL P R+ + M + +F E+ + + +I +
Sbjct: 294 TPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIPQL 353
Query: 295 FE 296
F
Sbjct: 354 FN 355
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-36
Identities = 74/295 (25%), Positives = 125/295 (42%), Gaps = 67/295 (22%)
Query: 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRV--GLID--QIKREISVMR 65
Y +G G + V + ++G+ VAIK K+ R I + RE+ +++
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIK-----KLSRPFQSEIFAKRAYRELLLLK 78
Query: 66 LVRHPNIVQLYEVMASKTK------IYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLV 119
++H N++ L +V + Y M ++ +L K+ K EE + Q++
Sbjct: 79 HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDL-QKIMGLKFSEEKIQYLVYQML 136
Query: 120 DAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYV- 178
+++ HS GV HRDLKP NL ++E+ +LKI DFGL+ ++ YV
Sbjct: 137 KGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG-----------YVV 185
Query: 179 -----APEVI-NKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITR------ 226
APEVI + Y+ DIWS G ++ +L G F + ++ +I +
Sbjct: 186 TRWYRAPEVILSWMHYNQT-VDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG 244
Query: 227 AEF--------------KCPNW--------FP---PEVRKLLSRILDPNPSTRVT 256
EF P FP P+ LL ++L+ + R+T
Sbjct: 245 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLT 299
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-36
Identities = 69/258 (26%), Positives = 117/258 (45%), Gaps = 15/258 (5%)
Query: 13 ELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNI 72
LG +G+G F +V+ GR VA+K + L + +E +++ HPNI
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPD--LKAKFLQEARILKQYSHPNI 174
Query: 73 VQLYEVMASKTKIYFAMEYVRGGELFN--KVAKGKLREEVARKYFQQLVDAVEFCHSRGV 130
V+L V K IY ME V+GG+ + +LR + + +E+ S+
Sbjct: 175 VRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCC 234
Query: 131 YHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAY----VAPEVINKR 186
HRDL N L+ E LKISDFG+S + DG+ + G APE +N
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEA----DGVYAASGGLRQVPVKWTAPEALNYG 290
Query: 187 GYDGAKADIWSCGVVLF-VLLAGNLPFYDSNLMELYKKITRAE-FKCPNWFPPEVRKLLS 244
Y +++D+WS G++L+ G P+ + + + + + + CP P V +L+
Sbjct: 291 RYS-SESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLME 349
Query: 245 RILDPNPSTRVTMAKLME 262
+ P R + + + +
Sbjct: 350 QCWAYEPGQRPSFSTIYQ 367
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 138 bits (348), Expect = 3e-36
Identities = 59/229 (25%), Positives = 104/229 (45%), Gaps = 45/229 (19%)
Query: 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRV--GLID--QIKREISV 63
+ ++YE+ L+G G++ V + + VAIK KI RV LID +I REI++
Sbjct: 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIK-----KILRVFEDLIDCKRILREIAI 105
Query: 64 MRLVRHPNIVQLYEVMASKT-----KIYFAMEYVRGGELFNKV--AKGKLREEVARKYFQ 116
+ + H ++V++ +++ K ++Y +E + K+ L E +
Sbjct: 106 LNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDF-KKLFRTPVYLTELHIKTLLY 163
Query: 117 QLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLS-ALQESTRQDGLLHTTCGTP 175
L+ V++ HS G+ HRDLKP N L++++ +K+ DFGL+ + + L +
Sbjct: 164 NLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRED 223
Query: 176 A------------------YV------APEVI-NKRGYDGAKADIWSCG 199
+V APE+I + Y A D+WS G
Sbjct: 224 DMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEA-IDVWSIG 271
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 5e-36
Identities = 61/228 (26%), Positives = 106/228 (46%), Gaps = 21/228 (9%)
Query: 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRV--GLID--QIKREISV 63
++ +Y+ + +G G V + ++VAIK K+ R + RE+ +
Sbjct: 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIK-----KLSRPFQNQTHAKRAYRELVL 77
Query: 64 MRLVRHPNIVQLYEVMASKTK------IYFAMEYVRGGELFNKVAKGKLREEVARKYFQQ 117
M+ V H NI+ L V + +Y ME + L +V + +L E Q
Sbjct: 78 MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANL-CQVIQMELDHERMSYLLYQ 135
Query: 118 LVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAY 177
++ ++ HS G+ HRDLKP N+++ + LKI DFGL+ + ++ T Y
Sbjct: 136 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVVTRYY 192
Query: 178 VAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKIT 225
APEVI GY DIWS G ++ ++ G + F ++ ++ + K+
Sbjct: 193 RAPEVILGMGYKEN-VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI 239
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 60/225 (26%), Positives = 102/225 (45%), Gaps = 21/225 (9%)
Query: 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRV--GLID--QIKREISVMRL 66
+Y+ + +G G V + ++VAIK K+ R + RE+ +M+
Sbjct: 63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK-----KLSRPFQNQTHAKRAYRELVLMKC 117
Query: 67 VRHPNIVQLYEVMASKTK------IYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVD 120
V H NI+ L V + +Y ME + L +V + +L E Q++
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANL-CQVIQMELDHERMSYLLYQMLC 175
Query: 121 AVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAP 180
++ HS G+ HRDLKP N+++ + LKI DFGL+ + ++ T Y AP
Sbjct: 176 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVVTRYYRAP 232
Query: 181 EVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKIT 225
EVI GY DIWS G ++ ++ + F + ++ + K+
Sbjct: 233 EVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 276
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-34
Identities = 62/218 (28%), Positives = 102/218 (46%), Gaps = 28/218 (12%)
Query: 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIR---RVGLIDQIKREISVMRL 66
+ ++L LLG+G + V + TG+ VAIK KI + + REI +++
Sbjct: 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIK-----KIEPFDKPLFALRTLREIKILKH 65
Query: 67 VRHPNIVQLYEVMASKTK-----IYFAMEYVRGGELFNKVAKGKLREEVARKYFQ-QLVD 120
+H NI+ ++ + + +Y E + +L ++V ++ + +YF Q +
Sbjct: 66 FKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDL-HRVISTQMLSDDHIQYFIYQTLR 123
Query: 121 AVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLS---ALQESTRQDGLLHTTCGTPAY 177
AV+ H V HRDLKP NLL++ N DLK+ DFGL+ + + + +
Sbjct: 124 AVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE-F 182
Query: 178 V------APEVI-NKRGYDGAKADIWSCGVVLFVLLAG 208
V APEV+ Y A D+WSCG +L L
Sbjct: 183 VATRWYRAPEVMLTSAKYSRA-MDVWSCGCILAELFLR 219
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-34
Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 19/210 (9%)
Query: 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIR---RVGLIDQIKREISVMRL 66
+Y +G+G + V + VAIK KI + REI ++
Sbjct: 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK-----KISPFEHQTYCQRTLREIKILLR 81
Query: 67 VRHPNIVQLYEVMASKTK-----IYFAMEYVRGGELFNKVAKGKLREEVARKYFQ-QLVD 120
RH NI+ + +++ + T +Y + + +L K+ K + YF Q++
Sbjct: 82 FRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDL-YKLLKTQHLSNDHICYFLYQILR 139
Query: 121 AVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLS-ALQESTRQDGLLHTTCGTPAYVA 179
+++ HS V HRDLKP NLLL+ DLKI DFGL+ G L T Y A
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 180 PEVI-NKRGYDGAKADIWSCGVVLFVLLAG 208
PE++ N +GY + DIWS G +L +L+
Sbjct: 200 PEIMLNSKGYTKS-IDIWSVGCILAEMLSN 228
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-34
Identities = 78/290 (26%), Positives = 123/290 (42%), Gaps = 56/290 (19%)
Query: 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRV--GLID--QIKREISVMR 65
Y + +G G + V + +TG VAIK K+ R + + RE+ +++
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIK-----KLYRPFQSELFAKRAYRELRLLK 79
Query: 66 LVRHPNIVQLYEVMASKTK------IYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLV 119
+RH N++ L +V Y M ++ G +L + KL E+ + Q++
Sbjct: 80 HMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQML 138
Query: 120 DAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTT-CGTPAYV 178
+ + H+ G+ HRDLKP NL ++E+ +LKI DFGL+ RQ T T Y
Sbjct: 139 KGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA------RQADSEMTGYVVTRWYR 192
Query: 179 APEVI-NKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITR------AEF-- 229
APEVI N Y DIWS G ++ ++ G F S+ ++ K+I + AEF
Sbjct: 193 APEVILNWMRYTQT-VDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 251
Query: 230 ------------KCPNW--------FP---PEVRKLLSRILDPNPSTRVT 256
P P LL ++L + RVT
Sbjct: 252 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVT 301
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 5e-34
Identities = 60/230 (26%), Positives = 102/230 (44%), Gaps = 38/230 (16%)
Query: 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRV--GLID--QIKREISVMR 65
+ Y + L+G+G++ VY + T ++VAIK K+ R+ LID +I REI+++
Sbjct: 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIK-----KVNRMFEDLIDCKRILREITILN 80
Query: 66 LVRHPNIVQLYEVMASKTK-----IYFAMEYVRGGELFNKVAKGKLREEVARKYFQ-QLV 119
++ I++LY+++ +Y +E +L E K L+
Sbjct: 81 RLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLL 139
Query: 120 DAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPA--- 176
F H G+ HRDLKP N LL+++ +K+ DFGL+ S + +++
Sbjct: 140 LGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGP 199
Query: 177 -----------YV------APEVI-NKRGYDGAKADIWSCGVVLFVLLAG 208
+V APE+I + Y + DIWS G + LL
Sbjct: 200 HNKNLKKQLTSHVVTRWYRAPELILLQENYTKS-IDIWSTGCIFAELLNM 248
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 5e-34
Identities = 72/291 (24%), Positives = 123/291 (42%), Gaps = 58/291 (19%)
Query: 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRV--GLID--QIKREISVMR 65
+Y+ +G G + V + KTG VA+K K+ R +I + RE+ +++
Sbjct: 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK-----KLSRPFQSIIHAKRTYRELRLLK 83
Query: 66 LVRHPNIVQLYEVMASKTK------IYFAMEYVRGGELFNKVAKGKLREEVARKYFQ-QL 118
++H N++ L +V +Y + G +L N + K + + ++ Q+
Sbjct: 84 HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQI 141
Query: 119 VDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQ-DGLLHTTCGTPAY 177
+ +++ HS + HRDLKP NL ++E+ +LKI DFGL+ R + T Y
Sbjct: 142 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA------RHTADEMTGYVATRWY 195
Query: 178 VAPEVI-NKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITR------AEF- 229
APE++ N Y+ DIWS G ++ LL G F ++ ++ K I R AE
Sbjct: 196 RAPEIMLNWMHYNQT-VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 254
Query: 230 -------------KCPNW--------FP---PEVRKLLSRILDPNPSTRVT 256
F P LL ++L + R+T
Sbjct: 255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 305
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 8e-34
Identities = 78/344 (22%), Positives = 131/344 (38%), Gaps = 83/344 (24%)
Query: 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRV--GLID--QIKREISVMR- 65
KYEL + LG+G + V+ + +TG+ VA+K KI D + REI ++
Sbjct: 10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVK-----KIFDAFQNSTDAQRTFREIMILTE 64
Query: 66 LVRHPNIVQLYEVMASKTK--IYFAMEYVRGGELFNKVAKGKLREEVARKYFQ-QLVDAV 122
L H NIV L V+ + +Y +Y+ +L + V + + E V ++Y QL+ +
Sbjct: 65 LSGHENIVNLLNVLRADNDRDVYLVFDYM-ETDL-HAVIRANILEPVHKQYVVYQLIKVI 122
Query: 123 EFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPA------ 176
++ HS G+ HRD+KP N+LL+ +K++DFGLS + R+
Sbjct: 123 KYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDD 182
Query: 177 -------YV------APEVI-NKRGYDGAKADIWSCGVVLFVLLAG-------------- 208
YV APE++ Y D+WS G +L +L G
Sbjct: 183 DQPILTDYVATRWYRAPEILLGSTKYTKG-IDMWSLGCILGEILCGKPIFPGSSTMNQLE 241
Query: 209 ---------------------------NLPFYD-SNLMELYKKITRAEFKCPNWFP---- 236
+L T+ + P
Sbjct: 242 RIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADC 301
Query: 237 -PEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIETPESP 279
E LL ++L NP+ R++ +++ + + E P
Sbjct: 302 NEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCD 345
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-33
Identities = 72/301 (23%), Positives = 119/301 (39%), Gaps = 66/301 (21%)
Query: 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLID--QIKREISVMRLV 67
++Y + LG G V+ + + VAIK KI REI ++R +
Sbjct: 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIK-----KIVLTDPQSVKHALREIKIIRRL 65
Query: 68 RHPNIVQLYEVMASKTK--------------IYFAMEYVRGGELFNKVAKGKLREEVARK 113
H NIV+++E++ +Y EY+ +L N + +G L EE AR
Sbjct: 66 DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLLEEHARL 124
Query: 114 YFQQLVDAVEFCHSRGVYHRDLKPENLLLD-ENGDLKISDFGLSALQESTRQDGLLHTTC 172
+ QL+ +++ HS V HRDLKP NL ++ E+ LKI DFGL+ + + +
Sbjct: 125 FMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSE- 183
Query: 173 GTPAYV------APEVI-NKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKIT 225
+ +P ++ + Y A D+W+ G + +L G F ++ +E + I
Sbjct: 184 ----GLVTKWYRSPRLLLSPNNYTKA-IDMWAAGCIFAEMLTGKTLFAGAHELEQMQLIL 238
Query: 226 ------RAEF-------------KCPNW--------FP---PEVRKLLSRILDPNPSTRV 255
E P E L +IL +P R+
Sbjct: 239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRL 298
Query: 256 T 256
T
Sbjct: 299 T 299
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-32
Identities = 62/261 (23%), Positives = 109/261 (41%), Gaps = 25/261 (9%)
Query: 13 ELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIK--REISVMRLVRHP 70
+ +G G F V+ G VAIK + R G + + E VM + HP
Sbjct: 11 TFVQEIGSGQFGLVHLGY-WLNKDKVAIKTI------REGAMSEEDFIEEAEVMMKLSHP 63
Query: 71 NIVQLYEVMASKTKIYFAMEYVRGGELFN--KVAKGKLREEVARKYFQQLVDAVEFCHSR 128
+VQLY V + I E++ G L + + +G E + + + +
Sbjct: 64 KLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 123
Query: 129 GVYHRDLKPENLLLDENGDLKISDFGLSALQES----TRQDGLLHTTCGTPA-YVAPEVI 183
V HRDL N L+ EN +K+SDFG++ + P + +PEV
Sbjct: 124 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF------PVKWASPEVF 177
Query: 184 NKRGYDGAKADIWSCGVVLF-VLLAGNLPFYDSNLMELYKKITRAE-FKCPNWFPPEVRK 241
+ Y +K+D+WS GV+++ V G +P+ + + E+ + I+ P V +
Sbjct: 178 SFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQ 236
Query: 242 LLSRILDPNPSTRVTMAKLME 262
+++ P R ++L+
Sbjct: 237 IMNHCWRERPEDRPAFSRLLR 257
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 7e-32
Identities = 61/295 (20%), Positives = 111/295 (37%), Gaps = 54/295 (18%)
Query: 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIK-IVDKEKIRRVGLIDQ-------IKREI 61
+ Y + R + G++ V G + G VAIK + + R I + REI
Sbjct: 22 SPYTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 62 SVMRLVRHPNIVQLYEVMASKTK-----IYFAMEYVRGGELFN--KVAKGKLREEVARKY 114
++ HPNI+ L ++ + +Y E + +L + + + + +
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYF 139
Query: 115 FQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGT 174
++ + H GV HRDL P N+LL +N D+ I DF L+ D
Sbjct: 140 MYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLA---REDTADANKTHYVTH 196
Query: 175 PAYVAPEVI-NKRGYDGAKADIWSCGVVLFVLLAG------------------------- 208
Y APE++ +G+ D+WS G V+ +
Sbjct: 197 RWYRAPELVMQFKGFTKL-VDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI 255
Query: 209 -NLPFYDSNLMELYKKITRAEFKCPNW---FP---PEVRKLLSRILDPNPSTRVT 256
++ + S Y + + + W P P L++++L+ NP R++
Sbjct: 256 EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRIS 310
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 8e-32
Identities = 65/259 (25%), Positives = 121/259 (46%), Gaps = 19/259 (7%)
Query: 13 ELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIK--REISVMRLVRHP 70
+ LG G + +VY G K +VA+K + + ++ + +E +VM+ ++HP
Sbjct: 223 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL------KEDTMEVEEFLKEAAVMKEIKHP 276
Query: 71 NIVQLYEVMASKTKIYFAMEYVRGGELFN---KVAKGKLREEVARKYFQQLVDAVEFCHS 127
N+VQL V + Y E++ G L + + + ++ V Q+ A+E+
Sbjct: 277 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 336
Query: 128 RGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAY--VAPEVINK 185
+ HR+L N L+ EN +K++DFGLS L D APE +
Sbjct: 337 KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAKFPIKWTAPESLAY 393
Query: 186 RGYDGAKADIWSCGVVLF-VLLAGNLPFYDSNLMELYKKITRAE-FKCPNWFPPEVRKLL 243
+ K+D+W+ GV+L+ + G P+ +L ++Y+ + + + P P +V +L+
Sbjct: 394 NKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELM 452
Query: 244 SRILDPNPSTRVTMAKLME 262
NPS R + A++ +
Sbjct: 453 RACWQWNPSDRPSFAEIHQ 471
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 8e-32
Identities = 66/262 (25%), Positives = 122/262 (46%), Gaps = 25/262 (9%)
Query: 13 ELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIK--REISVMRLVRHP 70
+ LG G + +VY G K +VA+K + + ++ + +E +VM+ ++HP
Sbjct: 16 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL------KEDTMEVEEFLKEAAVMKEIKHP 69
Query: 71 NIVQLYEVMASKTKIYFAMEYVRGGELFN---KVAKGKLREEVARKYFQQLVDAVEFCHS 127
N+VQL V + Y E++ G L + + + ++ V Q+ A+E+
Sbjct: 70 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129
Query: 128 RGVYHRDLKPENLLLDENGDLKISDFGLSALQES----TRQDGLLHTTCGTPA-YVAPEV 182
+ HRDL N L+ EN +K++DFGLS L P + APE
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF------PIKWTAPES 183
Query: 183 INKRGYDGAKADIWSCGVVLF-VLLAGNLPFYDSNLMELYKKITRAE-FKCPNWFPPEVR 240
+ + K+D+W+ GV+L+ + G P+ +L ++Y+ + + + P P +V
Sbjct: 184 LAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 242
Query: 241 KLLSRILDPNPSTRVTMAKLME 262
+L+ NPS R + A++ +
Sbjct: 243 ELMRACWQWNPSDRPSFAEIHQ 264
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-31
Identities = 61/260 (23%), Positives = 112/260 (43%), Gaps = 25/260 (9%)
Query: 14 LGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIK--REISVMRLVRHPN 71
L + LG G F V G+ K VA+K++ + G + + + +E M + HP
Sbjct: 12 LLKELGSGQFGVVKLGK-WKGQYDVAVKMI------KEGSMSEDEFFQEAQTMMKLSHPK 64
Query: 72 IVQLYEVMASKTKIYFAMEYVRGGELFN--KVAKGKLREEVARKYFQQLVDAVEFCHSRG 129
+V+ Y V + + IY EY+ G L N + L + + + + F S
Sbjct: 65 LVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ 124
Query: 130 VYHRDLKPENLLLDENGDLKISDFGLSALQES----TRQDGLLHTTCGTPA-YVAPEVIN 184
HRDL N L+D + +K+SDFG++ + P + APEV +
Sbjct: 125 FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKF------PVKWSAPEVFH 178
Query: 185 KRGYDGAKADIWSCGVVLF-VLLAGNLPFYDSNLMELYKKITRAE-FKCPNWFPPEVRKL 242
Y +K+D+W+ G++++ V G +P+ E+ K+++ P+ + ++
Sbjct: 179 YFKYS-SKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQI 237
Query: 243 LSRILDPNPSTRVTMAKLME 262
+ P R T +L+
Sbjct: 238 MYSCWHELPEKRPTFQQLLS 257
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-31
Identities = 64/261 (24%), Positives = 108/261 (41%), Gaps = 15/261 (5%)
Query: 13 ELGRLLGQGTFAKVYHGR-NLKTGQS--VAIKIVDKEKIRRVGLIDQIKREISVMRLVRH 69
L LG G+F V G + +G++ VA+K + + + + +D RE++ M + H
Sbjct: 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80
Query: 70 PNIVQLYEVMASKTKIYFAMEYVRGGELFN--KVAKGKLREEVARKYFQQLVDAVEFCHS 127
N+++LY V + E G L + + +G +Y Q+ + + + S
Sbjct: 81 RNLIRLYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 139
Query: 128 RGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGT--P-AYVAPEVIN 184
+ HRDL NLLL +KI DFGL D P A+ APE +
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ--NDDHYVMQEHRKVPFAWCAPESLK 197
Query: 185 KRGYDGAKADIWSCGVVLF-VLLAGNLPFYDSNLMELYKKITRAEF--KCPNWFPPEVRK 241
R + +D W GV L+ + G P+ N ++ KI + P P ++
Sbjct: 198 TRTFS-HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYN 256
Query: 242 LLSRILDPNPSTRVTMAKLME 262
++ + P R T L +
Sbjct: 257 VMVQCWAHKPEDRPTFVALRD 277
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-31
Identities = 62/261 (23%), Positives = 114/261 (43%), Gaps = 25/261 (9%)
Query: 13 ELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIK--REISVMRLVRHP 70
+ LG G F V +G+ + VAIK++ + G + + + E VM + H
Sbjct: 27 TFLKELGTGQFGVVKYGK-WRGQYDVAIKMI------KEGSMSEDEFIEEAKVMMNLSHE 79
Query: 71 NIVQLYEVMASKTKIYFAMEYVRGGELFN--KVAKGKLREEVARKYFQQLVDAVEFCHSR 128
+VQLY V + I+ EY+ G L N + + + + + + + + +A+E+ S+
Sbjct: 80 KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 139
Query: 129 GVYHRDLKPENLLLDENGDLKISDFGLSALQES----TRQDGLLHTTCGTPA-YVAPEVI 183
HRDL N L+++ G +K+SDFGLS + P + PEV+
Sbjct: 140 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF------PVRWSPPEVL 193
Query: 184 NKRGYDGAKADIWSCGVVLF-VLLAGNLPFYDSNLMELYKKITRAE-FKCPNWFPPEVRK 241
+ +K+DIW+ GV+++ + G +P+ E + I + P+ +V
Sbjct: 194 MYSKFS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYT 252
Query: 242 LLSRILDPNPSTRVTMAKLME 262
++ R T L+
Sbjct: 253 IMYSCWHEKADERPTFKILLS 273
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-30
Identities = 70/259 (27%), Positives = 121/259 (46%), Gaps = 25/259 (9%)
Query: 13 ELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNI 72
+L + +G+G F V G G VA+K + K + E SVM +RH N+
Sbjct: 24 KLLQTIGKGEFGDVMLGD--YRGNKVAVKCI-KNDATAQAFL----AEASVMTQLRHSNL 76
Query: 73 VQLYEV-MASKTKIYFAMEYVRGGELFN---KVAKGKLREEVARKYFQQLVDAVEFCHSR 128
VQL V + K +Y EY+ G L + + L + K+ + +A+E+
Sbjct: 77 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 136
Query: 129 GVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYV---APEVINK 185
HRDL N+L+ E+ K+SDFGL+ ST+ G L P V APE + +
Sbjct: 137 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL------P--VKWTAPEALRE 188
Query: 186 RGYDGAKADIWSCGVVLF-VLLAGNLPFYDSNLMELYKKITRAE-FKCPNWFPPEVRKLL 243
+ + K+D+WS G++L+ + G +P+ L ++ ++ + P+ PP V +++
Sbjct: 189 KKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVM 247
Query: 244 SRILDPNPSTRVTMAKLME 262
+ + R + +L E
Sbjct: 248 KNCWHLDAAMRPSFLQLRE 266
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 6e-30
Identities = 64/285 (22%), Positives = 120/285 (42%), Gaps = 48/285 (16%)
Query: 13 ELGRLLGQGTFAKVYHGR----NLKTGQSVAIKIVDKEKIRRVGLIDQIK---REISVMR 65
+ + LG+G F V R TG+ VA+K + + + ++ REI +++
Sbjct: 13 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL------QHSTEEHLRDFEREIEILK 66
Query: 66 LVRHPNIVQLYEVMASKTK--IYFAMEYVRGGEL--FNKVAKGKLREEVARKYFQQLVDA 121
++H NIV+ V S + + MEY+ G L + + K ++ +Y Q+
Sbjct: 67 SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 126
Query: 122 VEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLS-ALQES-----TRQDGLLHTTCGTP 175
+E+ ++ HRDL N+L++ +KI DFGL+ L + ++ G P
Sbjct: 127 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGES------P 180
Query: 176 -AYVAPEVINKRGYDGAKADIWSCGVVL----------------FVLLAGNLPFYDSNLM 218
+ APE + + + +D+WS GVVL F+ + GN +
Sbjct: 181 IFWYAPESLTESKFS-VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 239
Query: 219 ELYKKITRAE-FKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262
L + + P+ P E+ +++ + N + R + L
Sbjct: 240 HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-29
Identities = 64/285 (22%), Positives = 120/285 (42%), Gaps = 48/285 (16%)
Query: 13 ELGRLLGQGTFAKVYHGR----NLKTGQSVAIKIVDKEKIRRVGLIDQIK---REISVMR 65
+ + LG+G F V R TG+ VA+K + + + ++ REI +++
Sbjct: 44 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL------QHSTEEHLRDFEREIEILK 97
Query: 66 LVRHPNIVQLYEVMASKTK--IYFAMEYVRGGEL--FNKVAKGKLREEVARKYFQQLVDA 121
++H NIV+ V S + + MEY+ G L + + K ++ +Y Q+
Sbjct: 98 SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 157
Query: 122 VEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLS-ALQEST-----RQDGLLHTTCGTP 175
+E+ ++ HRDL N+L++ +KI DFGL+ L + ++ G P
Sbjct: 158 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGES------P 211
Query: 176 -AYVAPEVINKRGYDGAKADIWSCGVVL----------------FVLLAGNLPFYDSNLM 218
+ APE + + + +D+WS GVVL F+ + GN +
Sbjct: 212 IFWYAPESLTESKFS-VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 270
Query: 219 ELYKKITRAE-FKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262
L + + P+ P E+ +++ + N + R + L
Sbjct: 271 HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 114 bits (289), Expect = 2e-29
Identities = 67/266 (25%), Positives = 118/266 (44%), Gaps = 30/266 (11%)
Query: 13 ELGRLLGQGTFAKVYHGR-NLKTGQS--VAIKIVDKEKIRRVGLIDQIK----REISVMR 65
L R+LG+G F +VY G G+ VA+K + K E +M+
Sbjct: 15 VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC------KKDCTLDNKEKFMSEAVIMK 68
Query: 66 LVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFN--KVAKGKLREEVARKYFQQLVDAVE 123
+ HP+IV+L ++ + + ME GEL + + K L+ Y Q+ A+
Sbjct: 69 NLDHPHIVKLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMA 127
Query: 124 FCHSRGVYHRDLKPENLLLDENGDLKISDFGLS-ALQES---TRQDGLLHTTCGTP-AYV 178
+ S HRD+ N+L+ +K+ DFGLS +++ L P ++
Sbjct: 128 YLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL------PIKWM 181
Query: 179 APEVINKRGYDGAKADIWSCGVVLF-VLLAGNLPFYDSNLMELYKKITRAE-FKCPNWFP 236
+PE IN R + +D+W V ++ +L G PF+ ++ + + + P+ P
Sbjct: 182 SPESINFRRFT-TASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCP 240
Query: 237 PEVRKLLSRILDPNPSTRVTMAKLME 262
P + L++R D +PS R +L+
Sbjct: 241 PVLYTLMTRCWDYDPSDRPRFTELVC 266
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 71/263 (26%), Positives = 110/263 (41%), Gaps = 29/263 (11%)
Query: 13 ELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIK--REISVMRLVRHP 70
L LGQG F +V+ G VAIK + + G + +E VM+ +RH
Sbjct: 187 RLEVKLGQGCFGEVWMGT-WNGTTRVAIKTL------KPGTMSPEAFLQEAQVMKKLRHE 239
Query: 71 NIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKY-FQQLVD-------AV 122
+VQLY V S+ IY EY+ G L + L+ E + QLVD +
Sbjct: 240 KLVQLYAV-VSEEPIYIVTEYMSKGSLLDF-----LKGETGKYLRLPQLVDMAAQIASGM 293
Query: 123 EFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTP-AYVAPE 181
+ HRDL+ N+L+ EN K++DFGL+ + + P + APE
Sbjct: 294 AYVERMNYVHRDLRAANILVGENLVCKVADFGLA--RLIEDNEYTARQGAKFPIKWTAPE 351
Query: 182 VINKRGYDGAKADIWSCGVVLF-VLLAGNLPFYDSNLMELYKKITRAE-FKCPNWFPPEV 239
+ K+D+WS G++L + G +P+ E+ ++ R CP P +
Sbjct: 352 AALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL 410
Query: 240 RKLLSRILDPNPSTRVTMAKLME 262
L+ + P R T L
Sbjct: 411 HDLMCQCWRKEPEERPTFEYLQA 433
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-29
Identities = 65/264 (24%), Positives = 114/264 (43%), Gaps = 23/264 (8%)
Query: 13 ELGRLLGQGTFAKVYHGRNLKTGQ---SVAIKIVDKEKIRRVGLIDQIK----REISVMR 65
+ +++G G +V +GR GQ VAIK + + G ++ + E S+M
Sbjct: 52 HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL------KAGYTERQRRDFLSEASIMG 105
Query: 66 LVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFN--KVAKGKLREEVARKYFQQLVDAVE 123
HPNI++L V+ EY+ G L + G+ + + +
Sbjct: 106 QFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMR 165
Query: 124 FCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYV---AP 180
+ G HRDL N+L+D N K+SDFGLS + E +TT G + AP
Sbjct: 166 YLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED--DPDAAYTTTGGKIPIRWTAP 223
Query: 181 EVINKRGYDGAKADIWSCGVVLF-VLLAGNLPFYDSNLMELYKKITRAE-FKCPNWFPPE 238
E I R + + +D+WS GVV++ VL G P+++ ++ + P P
Sbjct: 224 EAIAFRTFS-SASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHA 282
Query: 239 VRKLLSRILDPNPSTRVTMAKLME 262
+ +L+ + + R ++++
Sbjct: 283 LHQLMLDCWHKDRAQRPRFSQIVS 306
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-29
Identities = 63/257 (24%), Positives = 111/257 (43%), Gaps = 13/257 (5%)
Query: 14 LGRLLGQGTFAKVYHG--RNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPN 71
+ LG G F V G + K ++VA+KI+ K + L D++ E +VM+ + +P
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPY 79
Query: 72 IVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGK-LREEVARKYFQQLVDAVEFCHSRGV 130
IV++ + ME G L + + + ++++ + Q+ +++
Sbjct: 80 IVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 138
Query: 131 YHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGT--P-AYVAPEVINKRG 187
HRDL N+LL KISDFGLS + + P + APE IN
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRA--DENYYKAQTHGKWPVKWYAPECINYYK 196
Query: 188 YDGAKADIWSCGVVLF-VLLAGNLPFYDSNLMELYKKITRAE-FKCPNWFPPEVRKLLSR 245
+ +K+D+WS GV+++ G P+ E+ + + E CP P E+ L++
Sbjct: 197 FS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNL 255
Query: 246 ILDPNPSTRVTMAKLME 262
+ R A +
Sbjct: 256 CWTYDVENRPGFAAVEL 272
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-29
Identities = 77/266 (28%), Positives = 122/266 (45%), Gaps = 30/266 (11%)
Query: 13 ELGRLLGQGTFAKVYHGR---NLKTGQSVAIKIVDKEKIRRVGLIDQIK----REISVMR 65
ELGR +G+G F V+ G +VAIK + D ++ +E MR
Sbjct: 18 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC------KNCTSDSVREKFLQEALTMR 71
Query: 66 LVRHPNIVQLYEVMASKTKIYFAMEYVRGGEL--FNKVAKGKLREEVARKYFQQLVDAVE 123
HP+IV+L V ++ ++ ME GEL F +V K L Y QL A+
Sbjct: 72 QFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 130
Query: 124 FCHSRGVYHRDLKPENLLLDENGDLKISDFGLS-ALQES---TRQDGLLHTTCGTPA-YV 178
+ S+ HRD+ N+L+ N +K+ DFGLS +++S G L P ++
Sbjct: 131 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL------PIKWM 184
Query: 179 APEVINKRGYDGAKADIWSCGVVLF-VLLAGNLPFYDSNLMELYKKITRAE-FKCPNWFP 236
APE IN R + + +D+W GV ++ +L+ G PF ++ +I E P P
Sbjct: 185 APESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCP 243
Query: 237 PEVRKLLSRILDPNPSTRVTMAKLME 262
P + L+++ +PS R +L
Sbjct: 244 PTLYSLMTKCWAYDPSRRPRFTELKA 269
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-29
Identities = 64/264 (24%), Positives = 117/264 (44%), Gaps = 24/264 (9%)
Query: 14 LGRLLGQGTFAKVYHGR----NLKTGQSVAIKIVDKEKIRRVGLIDQIK----REISVMR 65
+++G G F +VY G + K VAIK + + G ++ + E +M
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL------KAGYTEKQRVDFLGEAGIMG 101
Query: 66 LVRHPNIVQLYEVMASKTKIYFAMEYVRGGEL--FNKVAKGKLREEVARKYFQQLVDAVE 123
H NI++L V++ + EY+ G L F + G+ + + ++
Sbjct: 102 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMK 161
Query: 124 FCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYV---AP 180
+ + HRDL N+L++ N K+SDFGLS + E +TT G + AP
Sbjct: 162 YLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED--DPEATYTTSGGKIPIRWTAP 219
Query: 181 EVINKRGYDGAKADIWSCGVVLF-VLLAGNLPFYDSNLMELYKKITRAE-FKCPNWFPPE 238
E I+ R + + +D+WS G+V++ V+ G P+++ + E+ K I P P
Sbjct: 220 EAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSA 278
Query: 239 VRKLLSRILDPNPSTRVTMAKLME 262
+ +L+ + + R A ++
Sbjct: 279 IYQLMMQCWQQERARRPKFADIVS 302
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 5e-29
Identities = 60/241 (24%), Positives = 107/241 (44%), Gaps = 24/241 (9%)
Query: 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIV-DKEKIRRVGLIDQIKREISVMR 65
+ +YE+ +++G+G+F +V + K Q VA+K+V ++++ R Q EI ++
Sbjct: 94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHR-----QAAEEIRILE 148
Query: 66 LVRH------PNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLR---EEVARKYFQ 116
+R N++ + E + I E + L+ + K K + + RK+
Sbjct: 149 HLRKQDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAH 207
Query: 117 QLVDAVEFCHSRGVYHRDLKPENLLLDENG--DLKISDFGLSALQESTRQDGLLHTTCGT 174
++ ++ H + H DLKPEN+LL + G +K+ DFG S+ E R ++T +
Sbjct: 208 SILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG-SSCYEHQR----VYTYIQS 262
Query: 175 PAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNW 234
Y APEVI Y D+WS G +L LL G + + +
Sbjct: 263 RFYRAPEVILGARYGMP-IDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQK 321
Query: 235 F 235
Sbjct: 322 L 322
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 5e-29
Identities = 69/265 (26%), Positives = 107/265 (40%), Gaps = 33/265 (12%)
Query: 13 ELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIK--REISVMRLVRHP 70
L LGQG F +V+ G VAIK + + G + +E VM+ +RH
Sbjct: 270 RLEVKLGQGCFGEVWMGT-WNGTTRVAIKTL------KPGTMSPEAFLQEAQVMKKLRHE 322
Query: 71 NIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFC----- 125
+VQLY V S+ IY EY+ G L L+ E + +L V+
Sbjct: 323 KLVQLYAV-VSEEPIYIVTEYMSKGSL-----LDFLKGE--TGKYLRLPQLVDMAAQIAS 374
Query: 126 -----HSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTP-AYVA 179
HRDL+ N+L+ EN K++DFGL+ + + P + A
Sbjct: 375 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA--RLIEDNEYTARQGAKFPIKWTA 432
Query: 180 PEVINKRGYDGAKADIWSCGVVLF-VLLAGNLPFYDSNLMELYKKITRAE-FKCPNWFPP 237
PE + K+D+WS G++L + G +P+ E+ ++ R CP P
Sbjct: 433 PEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE 491
Query: 238 EVRKLLSRILDPNPSTRVTMAKLME 262
+ L+ + P R T L
Sbjct: 492 SLHDLMCQCWRKEPEERPTFEYLQA 516
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 6e-29
Identities = 68/264 (25%), Positives = 115/264 (43%), Gaps = 31/264 (11%)
Query: 13 ELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIK--REISVMRLVRHP 70
+L LG G F +V+ G VA+K + + G + E ++M+ ++H
Sbjct: 16 KLVERLGAGQFGEVWMGY-YNGHTKVAVKSL------KQGSMSPDAFLAEANLMKQLQHQ 68
Query: 71 NIVQLYEVMASKTKIYFAMEYVRGGELFN---KVAKGKLREEVARKYFQQLVDAVEFCHS 127
+V+LY V ++ IY EY+ G L + + KL Q+ + + F
Sbjct: 69 RLVRLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 128 RGVYHRDLKPENLLLDENGDLKISDFGLSALQE----STRQDGLLHTTCGTPA-YVAPEV 182
R HRDL+ N+L+ + KI+DFGL+ L E + R+ P + APE
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF------PIKWTAPEA 181
Query: 183 INKRGYDGAKADIWSCGVVLF-VLLAGNLPFYDSNLMELYKKIT---RAEFKCPNWFPPE 238
IN + K+D+WS G++L ++ G +P+ E+ + + R P+ P E
Sbjct: 182 INYGTFT-IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV--RPDNCPEE 238
Query: 239 VRKLLSRILDPNPSTRVTMAKLME 262
+ +L+ P R T L
Sbjct: 239 LYQLMRLCWKERPEDRPTFDYLRS 262
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 7e-29
Identities = 71/279 (25%), Positives = 116/279 (41%), Gaps = 38/279 (13%)
Query: 13 ELGRLLGQGTFAKVYHGR----NLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR 68
+ R LG+G F KV N TG+ VA+K + K K+EI ++R +
Sbjct: 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL-KADAGPQHRSG-WKQEIDILRTLY 91
Query: 69 HPNIVQLYEVMASKTK--IYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCH 126
H +I++ + MEYV G L + + + + + QQ+ + + + H
Sbjct: 92 HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLH 151
Query: 127 SRGVYHRDLKPENLLLDENGDLKISDFGLS-ALQES-----TRQDGLLHTTCGTP-AYVA 179
++ HRDL N+LLD + +KI DFGL+ A+ E R+DG P + A
Sbjct: 152 AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS------PVFWYA 205
Query: 180 PEVINKRGYDGAKADIWSCGVVL---------------FVLLAGNLPFYDSNLMELYKKI 224
PE + + + +D+WS GV L L + ++ L + +
Sbjct: 206 PECLKEYKFY-YASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL 264
Query: 225 TRAE-FKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262
R E P+ P EV L+ + S R T L+
Sbjct: 265 ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 7e-29
Identities = 71/257 (27%), Positives = 122/257 (47%), Gaps = 21/257 (8%)
Query: 13 ELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNI 72
+L + +G+G F V G + G VA+K + K + E SVM +RH N+
Sbjct: 196 KLLQTIGKGEFGDVMLGD-YR-GNKVAVKCI-KNDATAQAFL----AEASVMTQLRHSNL 248
Query: 73 VQLYEV-MASKTKIYFAMEYVRGGELFN---KVAKGKLREEVARKYFQQLVDAVEFCHSR 128
VQL V + K +Y EY+ G L + + L + K+ + +A+E+
Sbjct: 249 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308
Query: 129 GVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPA-YVAPEVINKRG 187
HRDL N+L+ E+ K+SDFGL+ ST+ G L P + APE + ++
Sbjct: 309 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL------PVKWTAPEALREKK 362
Query: 188 YDGAKADIWSCGVVLF-VLLAGNLPFYDSNLMELYKKITRAE-FKCPNWFPPEVRKLLSR 245
+ K+D+WS G++L+ + G +P+ L ++ ++ + P+ PP V ++
Sbjct: 363 FS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVMKN 421
Query: 246 ILDPNPSTRVTMAKLME 262
+ +TR T +L E
Sbjct: 422 CWHLDAATRPTFLQLRE 438
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 7e-29
Identities = 71/288 (24%), Positives = 129/288 (44%), Gaps = 26/288 (9%)
Query: 14 LGRLLGQGTFAKVYHGR-NLKTGQ--SVAIKIVDKEKIRRVGLIDQIKR----EISVMRL 66
+ +++G G F +V GR L + + SVAIK + +VG ++ +R E S+M
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL------KVGYTEKQRRDFLGEASIMGQ 102
Query: 67 VRHPNIVQLYEVMASKTKIYFAMEYVRGGEL--FNKVAKGKLREEVARKYFQQLVDAVEF 124
HPNI++L V+ + EY+ G L F + + + + +++
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 125 CHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYV---APE 181
G HRDL N+L++ N K+SDFGL + E +TT G + +PE
Sbjct: 163 LSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED--DPEAAYTTRGGKIPIRWTSPE 220
Query: 182 VINKRGYDGAKADIWSCGVVLF-VLLAGNLPFYDSNLMELYKKITRAE-FKCPNWFPPEV 239
I R + + +D+WS G+VL+ V+ G P+++ + ++ K + P P +
Sbjct: 221 AIAYRKFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAAL 279
Query: 240 RKLLSRILDPNPSTRVTMAKLME--NYWFRK-GYKKIETPESPRGQDR 284
+L+ + + R +++ + R G KI T + R +
Sbjct: 280 YQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNL 327
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 8e-29
Identities = 58/260 (22%), Positives = 113/260 (43%), Gaps = 16/260 (6%)
Query: 13 ELGRLLGQGTFAKVYHGR----NLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR 68
+ ++LG G F VY G K VAIK + + + +I E VM V
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA--NKEILDEAYVMASVD 75
Query: 69 HPNIVQLYEVMASKTKIYFAMEYVRGGELFN--KVAKGKLREEVARKYFQQLVDAVEFCH 126
+P++ +L + + + + + G L + + K + + + Q+ + +
Sbjct: 76 NPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 127 SRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCG-TP-AYVAPEVIN 184
R + HRDL N+L+ +KI+DFGL+ L + ++ H G P ++A E I
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKWMALESIL 192
Query: 185 KRGYDGAKADIWSCGVVLF-VLLAGNLPFYDSNLMELYKKITRAE-FKCPNWFPPEVRKL 242
R Y ++D+WS GV ++ ++ G+ P+ E+ + + E P +V +
Sbjct: 193 HRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 251
Query: 243 LSRILDPNPSTRVTMAKLME 262
+ + + +R +L+
Sbjct: 252 MRKCWMIDADSRPKFRELII 271
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-28
Identities = 77/266 (28%), Positives = 123/266 (46%), Gaps = 30/266 (11%)
Query: 13 ELGRLLGQGTFAKVYHGRNLKTGQ---SVAIKIVDKEKIRRVGLIDQIK----REISVMR 65
ELGR +G+G F V+ G + +VAIK + D ++ +E MR
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC------KNCTSDSVREKFLQEALTMR 446
Query: 66 LVRHPNIVQLYEVMASKTKIYFAMEYVRGGEL--FNKVAKGKLREEVARKYFQQLVDAVE 123
HP+IV+L V ++ ++ ME GEL F +V K L Y QL A+
Sbjct: 447 QFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALA 505
Query: 124 FCHSRGVYHRDLKPENLLLDENGDLKISDFGLS-ALQES---TRQDGLLHTTCGTPA-YV 178
+ S+ HRD+ N+L+ N +K+ DFGLS +++S G L P ++
Sbjct: 506 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL------PIKWM 559
Query: 179 APEVINKRGYDGAKADIWSCGVVLF-VLLAGNLPFYDSNLMELYKKITRAE-FKCPNWFP 236
APE IN R + + +D+W GV ++ +L+ G PF ++ +I E P P
Sbjct: 560 APESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCP 618
Query: 237 PEVRKLLSRILDPNPSTRVTMAKLME 262
P + L+++ +PS R +L
Sbjct: 619 PTLYSLMTKCWAYDPSRRPRFTELKA 644
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 8e-28
Identities = 72/281 (25%), Positives = 117/281 (41%), Gaps = 40/281 (14%)
Query: 13 ELGRLLGQGTFAKVYHGR----NLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR 68
+ R LG+G F KV R TG+ VA+K + K + + D +K+EI ++R +
Sbjct: 24 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGNHIAD-LKKEIEILRNLY 81
Query: 69 HPNIVQLYEVMASKTK--IYFAMEYVRGGEL--FNKVAKGKLREEVARKYFQQLVDAVEF 124
H NIV+ + I ME++ G L + K K+ + KY Q+ +++
Sbjct: 82 HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDY 141
Query: 125 CHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQES------TRQDGLLHTTCGTP-AY 177
SR HRDL N+L++ +KI DFGL+ E+ + D P +
Sbjct: 142 LGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDS------PVFW 195
Query: 178 VAPEVINKRGYDGAKADIWSCGVVL---------------FVLLAGNLPFYDSNLMELYK 222
APE + + + +D+WS GV L L + L
Sbjct: 196 YAPECLMQSKFY-IASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN 254
Query: 223 KITRAE-FKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262
+ + CP P EV +L+ + + PS R + L+E
Sbjct: 255 TLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-27
Identities = 58/260 (22%), Positives = 113/260 (43%), Gaps = 16/260 (6%)
Query: 13 ELGRLLGQGTFAKVYHGR----NLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR 68
+ ++LG G F VY G K VAIK + + + +I E VM V
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA--NKEILDEAYVMASVD 75
Query: 69 HPNIVQLYEVMASKTKIYFAMEYVRGGELFN--KVAKGKLREEVARKYFQQLVDAVEFCH 126
+P++ +L + + + + + G L + + K + + + Q+ + +
Sbjct: 76 NPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 127 SRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCG-TP-AYVAPEVIN 184
R + HRDL N+L+ +KI+DFGL+ L + ++ H G P ++A E I
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKWMALESIL 192
Query: 185 KRGYDGAKADIWSCGVVLF-VLLAGNLPFYDSNLMELYKKITRAE-FKCPNWFPPEVRKL 242
R Y ++D+WS GV ++ ++ G+ P+ E+ + + E P +V +
Sbjct: 193 HRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 251
Query: 243 LSRILDPNPSTRVTMAKLME 262
+ + + +R +L+
Sbjct: 252 MVKCWMIDADSRPKFRELII 271
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-27
Identities = 65/276 (23%), Positives = 109/276 (39%), Gaps = 36/276 (13%)
Query: 13 ELGRLLGQGTFAKVYHGR---NLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRH 69
LGR+LG+G F V + + VA+K++ K I I++ RE + M+ H
Sbjct: 26 TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASSDIEEFLREAACMKEFDH 84
Query: 70 PNIVQLYEV------MASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLV---- 119
P++ +L V + +++ G+L + ++ E Q LV
Sbjct: 85 PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV 144
Query: 120 ---DAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQEST-----RQDGLLHTT 171
+E+ SR HRDL N +L E+ + ++DFGLS S L
Sbjct: 145 DIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKL--- 201
Query: 172 CGTPAYV---APEVINKRGYDGAKADIWSCGVVLF-VLLAGNLPFYDSNLMELYKKITRA 227
P V A E + Y +D+W+ GV ++ ++ G P+ E+Y +
Sbjct: 202 ---P--VKWLALESLADNLYT-VHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGG 255
Query: 228 E-FKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262
K P EV L+ + +P R + L
Sbjct: 256 NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRM 291
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 52/264 (19%), Positives = 111/264 (42%), Gaps = 24/264 (9%)
Query: 13 ELGRLLGQGTFAKVYHGR----NLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR 68
++LG G F V+ G V IK++ ++K R + + + +
Sbjct: 16 RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI-EDKSGRQSFQA-VTDHMLAIGSLD 73
Query: 69 HPNIVQLYEVMASKTKIYFAMEYVRGGEL--FNKVAKGKLREEVARKYFQQLVDAVEFCH 126
H +IV+L + + + +Y+ G L + +G L ++ + Q+ + +
Sbjct: 74 HAHIVRLLGL-CPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE 132
Query: 127 SRGVYHRDLKPENLLLDENGDLKISDFGLSAL-----QESTRQDGLLHTTCGTP-AYVAP 180
G+ HR+L N+LL ++++DFG++ L ++ + P ++A
Sbjct: 133 EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKT------PIKWMAL 186
Query: 181 EVINKRGYDGAKADIWSCGVVLF-VLLAGNLPFYDSNLMELYKKITRAE-FKCPNWFPPE 238
E I+ Y ++D+WS GV ++ ++ G P+ L E+ + + E P +
Sbjct: 187 ESIHFGKYT-HQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTID 245
Query: 239 VRKLLSRILDPNPSTRVTMAKLME 262
V ++ + + + R T +L
Sbjct: 246 VYMVMVKCWMIDENIRPTFKELAN 269
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 64/262 (24%), Positives = 113/262 (43%), Gaps = 27/262 (10%)
Query: 13 ELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIK--REISVMRLVRHP 70
+L + LG G F +V+ VA+K + + G + E +VM+ ++H
Sbjct: 191 KLEKKLGAGQFGEVWMAT-YNKHTKVAVKTM------KPGSMSVEAFLAEANVMKTLQHD 243
Query: 71 NIVQLYEVMASKTKIYFAMEYVRGGELFN---KVAKGKLREEVARKYFQQLVDAVEFCHS 127
+V+L+ V +K IY E++ G L + K + Q+ + + F
Sbjct: 244 KLVKLHAV-VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 302
Query: 128 RGVYHRDLKPENLLLDENGDLKISDFGLSALQES----TRQDGLLHTTCGTPA-YVAPEV 182
R HRDL+ N+L+ + KI+DFGL+ + E R+ P + APE
Sbjct: 303 RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF------PIKWTAPEA 356
Query: 183 INKRGYDGAKADIWSCGVVLF-VLLAGNLPFYDSNLMELYKKITRAE-FKCPNWFPPEVR 240
IN + K+D+WS G++L ++ G +P+ + E+ + + R P P E+
Sbjct: 357 INFGSFT-IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELY 415
Query: 241 KLLSRILDPNPSTRVTMAKLME 262
++ R P R T +
Sbjct: 416 NIMMRCWKNRPEERPTFEYIQS 437
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-27
Identities = 56/269 (20%), Positives = 111/269 (41%), Gaps = 31/269 (11%)
Query: 13 ELGRLLGQGTFAKVYHGR---NLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRH 69
++G+G F VYHG N A+K + + E +M+ H
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQ-FLTEGIIMKDFSH 85
Query: 70 PNIVQLYEVMA-SKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLV-------DA 121
PN++ L + S+ + Y++ G+L + +R E + L+
Sbjct: 86 PNVLSLLGICLRSEGSPLVVLPYMKHGDL-----RNFIRNETHNPTVKDLIGFGLQVAKG 140
Query: 122 VEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCG------TP 175
+++ S+ HRDL N +LDE +K++DFGL+ + + T
Sbjct: 141 MKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM- 199
Query: 176 AYVAPEVINKRGYDGAKADIWSCGVVLF-VLLAGNLPFYDSNLMELYKKITRAE-FKCPN 233
A E + + + K+D+WS GV+L+ ++ G P+ D N ++ + + P
Sbjct: 200 ---ALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPE 255
Query: 234 WFPPEVRKLLSRILDPNPSTRVTMAKLME 262
+ P + +++ + P R + ++L+
Sbjct: 256 YCPDPLYEVMLKCWHPKAEMRPSFSELVS 284
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-27
Identities = 70/259 (27%), Positives = 109/259 (42%), Gaps = 25/259 (9%)
Query: 18 LGQGTFAKVYHGR-NLKTGQ-SVAIKIVDKEKIRRVGLIDQIK----REISVMRLVRHPN 71
LG G F V G ++ Q VAIK++ + G RE +M + +P
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVL------KQGTEKADTEEMMREAQIMHQLDNPY 71
Query: 72 IVQLYEVMASKTKIYFAMEYVRGGEL--FNKVAKGKLREEVARKYFQQLVDAVEFCHSRG 129
IV+L V ++ + ME GG L F + ++ + Q+ +++ +
Sbjct: 72 IVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN 130
Query: 130 VYHRDLKPENLLLDENGDLKISDFGLS-ALQESTRQDGLLHTTCGT--P-AYVAPEVINK 185
HRDL N+LL KISDFGLS AL D P + APE IN
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGA---DDSYYTARSAGKWPLKWYAPECINF 187
Query: 186 RGYDGAKADIWSCGVVLF-VLLAGNLPFYDSNLMELYKKITRAE-FKCPNWFPPEVRKLL 243
R + +++D+WS GV ++ L G P+ E+ I + + +CP PPE+ L+
Sbjct: 188 RKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALM 246
Query: 244 SRILDPNPSTRVTMAKLME 262
S R + +
Sbjct: 247 SDCWIYKWEDRPDFLTVEQ 265
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 9e-27
Identities = 70/284 (24%), Positives = 114/284 (40%), Gaps = 47/284 (16%)
Query: 13 ELGRLLGQGTFAKVYHGR----NLKTGQSVAIKIVDKEKIRRVGLIDQIK---REISVMR 65
+ LG+G F V R TG VA+K + + DQ + REI +++
Sbjct: 26 KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL------QHSGPDQQRDFQREIQILK 79
Query: 66 LVRHPNIVQLYEVMASKTK--IYFAMEYVRGGEL--FNKVAKGKLREEVARKYFQQLVDA 121
+ IV+ V + + MEY+ G L F + + +L Y Q+
Sbjct: 80 ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 139
Query: 122 VEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLS-ALQES-----TRQDGLLHTTCGTP 175
+E+ SR HRDL N+L++ +KI+DFGL+ L R+ G P
Sbjct: 140 MEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS------P 193
Query: 176 -AYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDS--------------NLME 219
+ APE ++ + ++D+WS GVVL+ L + S L
Sbjct: 194 IFWYAPESLSDNIFS-RQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR 252
Query: 220 LYKKITRAE-FKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262
L + + + P P EV +L+ P+P R + + L
Sbjct: 253 LLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGP 296
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 58/269 (21%), Positives = 112/269 (41%), Gaps = 31/269 (11%)
Query: 13 ELGRLLGQGTFAKVYHGR---NLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRH 69
++G+G F VYHG N A+K + + E +M+ H
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQ-FLTEGIIMKDFSH 149
Query: 70 PNIVQLYEVMA-SKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLV-------DA 121
PN++ L + S+ + Y++ G+L + +R E + L+
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDL-----RNFIRNETHNPTVKDLIGFGLQVAKG 204
Query: 122 VEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCG------TP 175
++F S+ HRDL N +LDE +K++DFGL+ D + + T
Sbjct: 205 MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM- 263
Query: 176 AYVAPEVINKRGYDGAKADIWSCGVVLF-VLLAGNLPFYDSNLMELYKKITRAE-FKCPN 233
A E + + + K+D+WS GV+L+ ++ G P+ D N ++ + + P
Sbjct: 264 ---ALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPE 319
Query: 234 WFPPEVRKLLSRILDPNPSTRVTMAKLME 262
+ P + +++ + P R + ++L+
Sbjct: 320 YCPDPLYEVMLKCWHPKAEMRPSFSELVS 348
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 54/238 (22%), Positives = 98/238 (41%), Gaps = 56/238 (23%)
Query: 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR- 68
+Y L R LG G F+ V+ +++ VA+KIV +K+ + + EI +++ V
Sbjct: 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT----EAAEDEIKLLQRVND 74
Query: 69 ----------HPNIVQLYEVMASKTKIYFAMEYVRGG-----------------ELFNKV 101
+I++L + +F +G L K
Sbjct: 75 ADNTKEDSMGANHILKLLD--------HF---NHKGPNGVHVVMVFEVLGENLLALIKKY 123
Query: 102 AKGKLREEVARKYFQQLVDAVEFCHSR-GVYHRDLKPENLLLDENGD------LKISDFG 154
+ ++ +QL+ +++ H R G+ H D+KPEN+L++ +KI+D G
Sbjct: 124 EHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG 183
Query: 155 LSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPF 212
+ D + T Y +PEV+ + ADIWS ++F L+ G+ F
Sbjct: 184 -----NACWYDEHYTNSIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLF 235
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-26
Identities = 68/255 (26%), Positives = 110/255 (43%), Gaps = 17/255 (6%)
Query: 18 LGQGTFAKVYHG--RNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQL 75
LG G F V G R K VAIK++ + + +++ RE +M + +P IV+L
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD--TEEMMREAQIMHQLDNPYIVRL 401
Query: 76 YEVMASKTKIYFAMEYVRGGELFN--KVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHR 133
V ++ + ME GG L + ++ + Q+ +++ + HR
Sbjct: 402 IGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 460
Query: 134 DLKPENLLLDENGDLKISDFGLS-ALQESTRQDGLLHTTCGT--P-AYVAPEVINKRGYD 189
+L N+LL KISDFGLS AL D P + APE IN R +
Sbjct: 461 NLAARNVLLVNRHYAKISDFGLSKALGA---DDSYYTARSAGKWPLKWYAPECINFRKFS 517
Query: 190 GAKADIWSCGVVLF-VLLAGNLPFYDSNLMELYKKITRAE-FKCPNWFPPEVRKLLSRIL 247
+++D+WS GV ++ L G P+ E+ I + + +CP PPE+ L+S
Sbjct: 518 -SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCW 576
Query: 248 DPNPSTRVTMAKLME 262
R + +
Sbjct: 577 IYKWEDRPDFLTVEQ 591
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-26
Identities = 61/273 (22%), Positives = 114/273 (41%), Gaps = 39/273 (14%)
Query: 13 ELGRLLGQGTFAKVYHGRNLKTGQS---VAIKIVDKEKIRRVGLIDQIKREISVMRLVRH 69
R++G+G F VYHG + Q+ AIK + + RE +MR + H
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL-SRITEMQQVEA-FLREGLLMRGLNH 81
Query: 70 PNIVQLYEV-MASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVD-------A 121
PN++ L + + + + + Y+ G+L +R + L+
Sbjct: 82 PNVLALIGIMLPPEGLPHVLLPYMCHGDL-----LQFIRSPQRNPTVKDLISFGLQVARG 136
Query: 122 VEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQEST-------RQDGLLHTTCGT 174
+E+ + HRDL N +LDE+ +K++DFGL+ + L
Sbjct: 137 MEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARL------ 190
Query: 175 PAYV---APEVINKRGYDGAKADIWSCGVVLF-VLLAGNLPFYDSNLMELYKKITRAE-F 229
P V A E + + K+D+WS GV+L+ +L G P+ + +L + +
Sbjct: 191 P--VKWTALESLQTYRFT-TKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL 247
Query: 230 KCPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262
P + P + +++ + + +P+ R T L+
Sbjct: 248 PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 5e-26
Identities = 64/246 (26%), Positives = 107/246 (43%), Gaps = 32/246 (13%)
Query: 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIV-DKEKIRRVGLIDQIKREISVMR 65
M++YE+ L+G+G+F +V + + VAIKI+ +K+ +Q + E+ ++
Sbjct: 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFL-----NQAQIEVRLLE 105
Query: 66 LVRHP------NIVQLYEVMASKTKIYFAME------YVRGGELFNKVAKGKLREEVARK 113
L+ IV L + + E Y +L + + RK
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLY----DLLRNTNFRGVSLNLTRK 161
Query: 114 YFQQLVDAVEFCHSR--GVYHRDLKPENLLL--DENGDLKISDFGLSALQESTRQDGLLH 169
+ QQ+ A+ F + + H DLKPEN+LL + +KI DFG S+ Q R ++
Sbjct: 162 FAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG-SSCQLGQR----IY 216
Query: 170 TTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF 229
+ Y +PEV+ YD A D+WS G +L + G F +N ++ KI
Sbjct: 217 QYIQSRFYRSPEVLLGMPYDLA-IDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG 275
Query: 230 KCPNWF 235
P
Sbjct: 276 IPPAHI 281
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 9e-26
Identities = 69/350 (19%), Positives = 122/350 (34%), Gaps = 100/350 (28%)
Query: 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIV-DKEKIRRVGLIDQIKREISVMR 65
+L N + + R +G GTF +V +++ + A+K+V + +K R I E +++
Sbjct: 32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKI-----EADILK 86
Query: 66 LVRH-----PNIVQ---------------------LYEVMASKTKIYFAMEYVRGGELFN 99
+++ NIV+ LYE++ F +E ++
Sbjct: 87 KIQNDDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIK------ 140
Query: 100 KVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENG------------- 146
Y +++ A+ + + H DLKPEN+LLD+
Sbjct: 141 -------------LYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTD 187
Query: 147 ------------DLKISDFGLSALQE--------STRQDGLLHTTCGTPAYVAPEVINKR 186
+K+ DFG A + +TRQ Y APEVI
Sbjct: 188 GKKIQIYRTKSTGIKLIDFG-CATFKSDYHGSIINTRQ------------YRAPEVILNL 234
Query: 187 GYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRI 246
G+D + +D+WS G VL L G+L F ME + P E K
Sbjct: 235 GWDVS-SDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSK 293
Query: 247 LDPNPSTRVTMAKLMENYWFRKGYKKIETPESPRGQDRNKLISDIHAVFE 296
++ + + K KK + ++++ +
Sbjct: 294 YVNKDELKLAWPENASSINSIKHVKK--CLPLYKIIKHELFCDFLYSILQ 341
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 75/376 (19%), Positives = 129/376 (34%), Gaps = 134/376 (35%)
Query: 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQS-VAIKIV-DKEKIRRVGLIDQIKREISVM 64
L +YE+ LG+GTF KV + G+S VA+KI+ + K R + EI+V+
Sbjct: 16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARL-----EINVL 70
Query: 65 RLVRHP------NIVQ---------------------LYEVMASKTKIYFAMEYVRGGEL 97
+ ++ V +E + + + +VR
Sbjct: 71 KKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVR---- 126
Query: 98 FNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENG----------- 146
QL A+ F H + H DLKPEN+L +
Sbjct: 127 ---------------HMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSC 171
Query: 147 --------DLKISDFGLSALQESTRQDGLLHTTCGTPAYV------APEVINKRGYDGAK 192
++++DFG SA + HTT V PEVI + G+
Sbjct: 172 EEKSVKNTSIRVADFG-SATFDHEH-----HTT-----IVATRHYRPPEVILELGWAQP- 219
Query: 193 ADIWSCGVVLFVL---------------LA------GNLP------------FYDSNL-- 217
D+WS G +LF L G +P FY L
Sbjct: 220 CDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVW 279
Query: 218 ---------MELYKKITRAEFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRK 268
++ K ++ + ++ L+ R+L+ +P+ R+T+A+ + + +F
Sbjct: 280 DENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAG 339
Query: 269 GYKKIETPESPRGQDR 284
+ + + R R
Sbjct: 340 LTPEERSFHTSRNPSR 355
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 64/278 (23%), Positives = 112/278 (40%), Gaps = 35/278 (12%)
Query: 10 NKYELGRLLGQGTFAKVYHGR---NLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRL 66
N LG++LG+G F V G T VA+K + K I++ E + M+
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KLDNSSQREIEEFLSEAACMKD 92
Query: 67 VRHPNIVQLYEV-----MASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLV-- 119
HPN+++L V K + +++ G+L + +L Q L+
Sbjct: 93 FSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKF 152
Query: 120 -----DAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQEST-----RQDGLLH 169
+E+ +R HRDL N +L ++ + ++DFGLS S + +
Sbjct: 153 MVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKM- 211
Query: 170 TTCGTPAYV---APEVINKRGYDGAKADIWSCGVVLF-VLLAGNLPFYDSNLMELYKKIT 225
P V A E + R Y +K+D+W+ GV ++ + G P+ E+Y +
Sbjct: 212 -----P--VKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL 263
Query: 226 RAE-FKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262
K P E+ +++ +P R T + L
Sbjct: 264 HGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRL 301
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 72/365 (19%), Positives = 128/365 (35%), Gaps = 134/365 (36%)
Query: 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTG-QSVAIKIV-DKEKIRRVGLIDQIKREISVM 64
+L +YE+ LG+G F KV + K G + VA+KIV + ++ + + EI V+
Sbjct: 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYC-----EAARSEIQVL 65
Query: 65 RLVRHP------NIVQ---------------------LYEVMASKTKIYFAMEYVRGGEL 97
+ VQ Y+ + + F ++++R
Sbjct: 66 EHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIR---- 121
Query: 98 FNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENG----------- 146
K Q+ +V F HS + H DLKPEN+L ++
Sbjct: 122 ---------------KMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKR 166
Query: 147 --------DLKISDFGLSALQESTRQDGLLHTTCGTPAYV------APEVINKRGYDGAK 192
D+K+ DFG SA + H+T V APEVI G+
Sbjct: 167 DERTLINPDIKVVDFG-SATYDDEH-----HST-----LVSTRHYRAPEVILALGWSQP- 214
Query: 193 ADIWSCGVVLFVLLAGNLPFYDSN------LME---------LYKKITRAEF-------- 229
D+WS G +L G F + +ME + +K + ++
Sbjct: 215 CDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDW 274
Query: 230 ---------------------KCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRK 268
+ + L+ ++L+ +P+ R+T+ + +++ +F
Sbjct: 275 DEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDL 334
Query: 269 GYKKI 273
K I
Sbjct: 335 LKKSI 339
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 6e-25
Identities = 79/282 (28%), Positives = 119/282 (42%), Gaps = 42/282 (14%)
Query: 10 NKYELGRLLGQGTFAKVYHGRNLKTGQS--VAIKIVDKEKIRRVGLIDQIKREISVM-RL 66
N + ++G+G F +V R K G AIK + KE + D E+ V+ +L
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRD-FAGELEVLCKL 82
Query: 67 VRHPNIVQLYEVMASKTKIYFAMEYVRGGEL--F---NKVAKGKLREEVARKYFQQL--V 119
HPNI+ L + +Y A+EY G L F ++V + +A L
Sbjct: 83 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142
Query: 120 DAVEFCH----------SRGVYHRDLKPENLLLDENGDLKISDFGLSALQE--STRQDGL 167
+ F + HRDL N+L+ EN KI+DFGLS QE + G
Sbjct: 143 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR 202
Query: 168 LHTTCGTPAYV---APEVINKRGYDGAKADIWSCGVVLF-VLLAGNLPFYDSNLMELYKK 223
L P V A E +N Y +D+WS GV+L+ ++ G P+ ELY+K
Sbjct: 203 L------P--VRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 253
Query: 224 IT---RAEFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262
+ R E P EV L+ + P R + A+++
Sbjct: 254 LPQGYRLE--KPLNCDDEVYDLMRQCWREKPYERPSFAQILV 293
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 68/291 (23%), Positives = 110/291 (37%), Gaps = 51/291 (17%)
Query: 10 NKYELGRLLGQGTFAKVYHG--RNLKTGQS---VAIKIVDKEKIRRVGLIDQIKREISVM 64
N+ G+ LG G F KV L + VA+K++ K + E+ V+
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML-KPSAHLTEREA-LMSELKVL 80
Query: 65 -RLVRHPNIVQLYEVMASKTKIYFAMEYVRGGEL------------FNKVAKGKLREEVA 111
L H NIV L EY G+L +K + + ++
Sbjct: 81 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 112 RKYFQQLVD-------AVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQEST-- 162
+ L+ + F S+ HRDL N+LL KI DFGL+ ++
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200
Query: 163 ---RQDGLLHTTCGTPAYV---APEVINKRGYDGAKADIWSCGVVLF-VLLAGNLPFYD- 214
+ + L P V APE I Y ++D+WS G+ L+ + G+ P+
Sbjct: 201 YVVKGNARL------P--VKWMAPESIFNCVYT-FESDVWSYGIFLWELFSLGSSPYPGM 251
Query: 215 SNLMELYKKIT---RAEFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262
+ YK I R P P E+ ++ D +P R T ++++
Sbjct: 252 PVDSKFYKMIKEGFRML--SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 55/276 (19%), Positives = 92/276 (33%), Gaps = 44/276 (15%)
Query: 13 ELGRLLGQGTFAKVYHGR-------NLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMR 65
LGQGTF K++ G V +K++DK + S+M
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYS---ESFFEAASMMS 67
Query: 66 LVRHPNIVQLYEVMASKTKIYFAMEYVRGGEL--FNKVAKGKLREEVARKYFQQLVDAVE 123
+ H ++V Y V + E+V+ G L + K K + + +QL A+
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMH 127
Query: 124 FCHSRGVYHRDLKPENLLLDENGDL--------KISDFGLSALQESTRQDGLLHTTCGTP 175
F + H ++ +N+LL D K+SD G+S
Sbjct: 128 FLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK------------- 174
Query: 176 AY-------VAPEVINKRGYDGAKADIWSCGVVLF-VLLAGNLPFYDSNLMELYKKITRA 227
V PE I D WS G L+ + G+ P + +
Sbjct: 175 DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDR 234
Query: 228 E-FKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262
P E+ L++ +D P R + ++
Sbjct: 235 HQLPAPK--AAELANLINNCMDYEPDHRPSFRAIIR 268
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 63/279 (22%), Positives = 111/279 (39%), Gaps = 37/279 (13%)
Query: 10 NKYELGRLLGQGTFAKVYHG--RNLKTGQS---VAIKIVDKEKIRRVGLIDQIKREISVM 64
K + R LGQG+F VY G + + + VAIK V E I+ E SVM
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-NEAASMRERIE-FLNEASVM 82
Query: 65 RLVRHPNIVQLYEVMASKTKIYFAMEYVRGGEL-----------FNKVAKGKLREEVARK 113
+ ++V+L V++ ME + G+L N +
Sbjct: 83 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 142
Query: 114 YFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQEST-----RQDGLL 168
++ D + + ++ HRDL N ++ E+ +KI DFG++ T GLL
Sbjct: 143 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 202
Query: 169 HTTCGTPAYV---APEVINKRGYDGAKADIWSCGVVLF-VLLAGNLPFYDSNLMELYKKI 224
P V +PE + + +D+WS GVVL+ + P+ + ++ + +
Sbjct: 203 ------P--VRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 253
Query: 225 TRAE-FKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262
P+ P + +L+ NP R + +++
Sbjct: 254 MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 292
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 79/270 (29%), Positives = 117/270 (43%), Gaps = 65/270 (24%)
Query: 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRH 69
N ++ L+G G F KVY G L+ G VA+K E + G I++ + EI + RH
Sbjct: 39 NNFDHKFLIGHGVFGKVYKGV-LRDGAKVALKRRTPESSQ--G-IEEFETEIETLSFCRH 94
Query: 70 PNIVQLY-------EVMASKTKIYFAMEYVRGGE----LFNKVAKG-----KLREEVARK 113
P++V L E++ IY +Y+ G L+ + R E+
Sbjct: 95 PHLVSLIGFCDERNEMIL----IY---KYMENGNLKRHLYGSDLPTMSMSWEQRLEIC-- 145
Query: 114 YFQQLVDA---VEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHT 170
+ A + + H+R + HRD+K N+LLDEN KI+DFG+S Q H
Sbjct: 146 -----IGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQT---HL 197
Query: 171 T---CGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAG------NLPFYDSNLMELY 221
+ GT Y+ PE +G K+D++S GVVLF +L +LP NL E
Sbjct: 198 STVVKGTLGYIDPEYFI-KGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAE-- 254
Query: 222 KKITRAEFKCPNWFPPEVRK-LLSRILDPN 250
W L +I+DPN
Sbjct: 255 ------------WAVESHNNGQLEQIVDPN 272
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 71/290 (24%), Positives = 117/290 (40%), Gaps = 50/290 (17%)
Query: 10 NKYELGRLLGQGTFAKVYHGR-------NLKTGQSVAIKIVDKEKIRRVGLIDQIKREIS 62
+K LG+ LG+G F +V K +VA+K++ K+ L D + E+
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLV-SEME 92
Query: 63 VM-RLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFN-------KVAKGKLREEVARKY 114
+M + +H NI+ L +Y +EY G L + +
Sbjct: 93 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 115 FQQLVDAVEFCH----------SRGVYHRDLKPENLLLDENGDLKISDFGLSALQEST-- 162
D V + S+ HRDL N+L+ EN +KI+DFGL+ +
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDY 212
Query: 163 ---RQDGLLHTTCGTPAYV---APEVINKRGYDGAKADIWSCGVVLF-VLLAGNLPFYDS 215
+G L P V APE + R Y ++D+WS GV+++ + G P+
Sbjct: 213 YKKTTNGRL------P--VKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGI 263
Query: 216 NLMELYKKIT---RAEFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262
+ EL+K + R + P E+ ++ PS R T +L+E
Sbjct: 264 PVEELFKLLKEGHRMD--KPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 71/290 (24%), Positives = 117/290 (40%), Gaps = 50/290 (17%)
Query: 10 NKYELGRLLGQGTFAKVYHGR-------NLKTGQSVAIKIVDKEKIRRVGLIDQIKREIS 62
+K LG+ LG+G F +V K +VA+K++ K+ L D + E+
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLV-SEME 138
Query: 63 VM-RLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFN-------KVAKGKLREEVARKY 114
+M + +H NI+ L +Y +EY G L + +
Sbjct: 139 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 198
Query: 115 FQQLVDAVEFCH----------SRGVYHRDLKPENLLLDENGDLKISDFGLSALQEST-- 162
D V + S+ HRDL N+L+ EN +KI+DFGL+ +
Sbjct: 199 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDY 258
Query: 163 ---RQDGLLHTTCGTPAYV---APEVINKRGYDGAKADIWSCGVVLF-VLLAGNLPFYDS 215
+G L P V APE + R Y ++D+WS GV+++ + G P+
Sbjct: 259 YKKTTNGRL------P--VKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGI 309
Query: 216 NLMELYKKIT---RAEFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262
+ EL+K + R + P E+ ++ PS R T +L+E
Sbjct: 310 PVEELFKLLKEGHRMD--KPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 357
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 2e-23
Identities = 68/284 (23%), Positives = 106/284 (37%), Gaps = 47/284 (16%)
Query: 13 ELGRLLGQGTFAKVYHGR--NLKTGQS---VAIKIVDKEKIRRVGLIDQIKREISVMRLV 67
LG+ F KVY G G+ VAIK + K+K + + E + +
Sbjct: 12 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL-KDKAEGPLREE-FRHEAMLRARL 69
Query: 68 RHPNIVQLYEVMASKTKIYFAMEYVRGGELFN-------KVAKGKLREEVARKYFQQLVD 120
+HPN+V L V+ + Y G+L G ++ K + D
Sbjct: 70 QHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPD 129
Query: 121 AVEFCH----------SRGVYHRDLKPENLLLDENGDLKISDFGLS-ALQES----TRQD 165
V S V H+DL N+L+ + ++KISD GL + + +
Sbjct: 130 FVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 189
Query: 166 GLLHTTCGTPAYV---APEVINKRGYDGAKADIWSCGVVLF-VLLAGNLPFYDSNLMELY 221
LL P + APE I + +DIWS GVVL+ V G P+ + ++
Sbjct: 190 SLL------P--IRWMAPEAIMYGKFS-IDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVV 240
Query: 222 KKIT---RAEFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262
+ I CP+ P V L+ + PS R +
Sbjct: 241 EMIRNRQVLP--CPDDCPAWVYALMIECWNEFPSRRPRFKDIHS 282
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 4e-23
Identities = 67/269 (24%), Positives = 100/269 (37%), Gaps = 73/269 (27%)
Query: 15 GRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKR----EISVMRLVRHP 70
G +G+G F VY G + +VA+K + ++K+ EI VM +H
Sbjct: 36 GNKMGEGGFGVVYKGY-VN-NTTVAVKKLAAMVDITTE---ELKQQFDQEIKVMAKCQHE 90
Query: 71 NIVQL-------------YEVMASKTKIYFAMEYVRGGELFNKVAKGKL----REEVARK 113
N+V+L Y M + + + L L R ++A
Sbjct: 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDR---------LSCLDGTPPLSWHMRCKIA-- 139
Query: 114 YFQQLVDA---VEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHT 170
A + F H HRD+K N+LLDE KISDFGL+ E
Sbjct: 140 -----QGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEK---FAQTVM 191
Query: 171 T---CGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDS----NLMELYKK 223
T GT AY+APE + RG K+DI+S GVVL ++ G + L++
Sbjct: 192 TSRIVGTTAYMAPEAL--RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD---- 245
Query: 224 ITRAEFKCPNWFPP--EVRKLLSRILDPN 250
+ K + +D
Sbjct: 246 ----------IKEEIEDEEKTIEDYIDKK 264
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 1e-22
Identities = 70/290 (24%), Positives = 118/290 (40%), Gaps = 50/290 (17%)
Query: 10 NKYELGRLLGQGTFAKVYHGR-----NLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVM 64
++ +LG+ LG+G F +V T ++VA+K++ KE + E+ ++
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHRA-LMSELKIL 84
Query: 65 -RLVRHPNIVQLYEV-MASKTKIYFAMEYVRGGELFN-------KVAKGKLREEVARKYF 115
+ H N+V L + +E+ + G L + K+ E K F
Sbjct: 85 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 144
Query: 116 QQLVDAVEFCH----------SRGVYHRDLKPENLLLDENGDLKISDFGLSALQEST--- 162
L + + SR HRDL N+LL E +KI DFGL+
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 204
Query: 163 --RQDGLLHTTCGTPAYV---APEVINKRGYDGAKADIWSCGVVLF-VLLAGNLPFYD-S 215
+ D L P + APE I R Y ++D+WS GV+L+ + G P+
Sbjct: 205 VRKGDARL------P--LKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVK 255
Query: 216 NLMELYKKIT---RAEFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262
E +++ R P++ PE+ + + PS R T ++L+E
Sbjct: 256 IDEEFCRRLKEGTRMR--APDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 303
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 71/290 (24%), Positives = 118/290 (40%), Gaps = 50/290 (17%)
Query: 10 NKYELGRLLGQGTFAKVYHGR-------NLKTGQSVAIKIVDKEKIRRVGLIDQIKREIS 62
++ LG+ LG+G F +V VA+K++ K L D I E+
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLI-SEME 126
Query: 63 VM-RLVRHPNIVQLYEVMASKTKIYFAMEYVRGGEL----------FNKVAKGKLREEVA 111
+M + +H NI+ L +Y +EY G L + +
Sbjct: 127 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 186
Query: 112 RKYFQQLVD-------AVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQEST-- 162
+ + LV +E+ S+ HRDL N+L+ E+ +KI+DFGL+
Sbjct: 187 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 246
Query: 163 ---RQDGLLHTTCGTPAYV---APEVINKRGYDGAKADIWSCGVVLF-VLLAGNLPFYDS 215
+G L P V APE + R Y ++D+WS GV+L+ + G P+
Sbjct: 247 YKKTTNGRL------P--VKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGV 297
Query: 216 NLMELYKKIT---RAEFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262
+ EL+K + R + P+ E+ ++ PS R T +L+E
Sbjct: 298 PVEELFKLLKEGHRMD--KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 345
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-22
Identities = 67/281 (23%), Positives = 111/281 (39%), Gaps = 45/281 (16%)
Query: 13 ELGRLLGQGTFAKVYHG--RNLKTGQS---VAIKIVDKEKIRRVGLIDQIKREISVMRLV 67
L R LG G F +VY G + S VA+K + E +D + E ++
Sbjct: 33 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFL-MEALIISKF 90
Query: 68 RHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLRE---EVARKYFQQLVDAVEF 124
H NIV+ V + ME + GG+L K LRE ++ ++D +
Sbjct: 91 NHQNIVRCIGVSLQSLPRFILMELMAGGDL-----KSFLRETRPRPSQPSSLAMLDLLHV 145
Query: 125 CH----------SRGVYHRDLKPENLLLDENGD---LKISDFGLSALQESTRQDGLLHTT 171
HRD+ N LL G KI DFG++ ++ R +
Sbjct: 146 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA--RDIYRAS---YYR 200
Query: 172 CGTPAYV-----APEVINKRGYDGAKADIWSCGVVLF-VLLAGNLPFYDSNLMELYKKIT 225
G A + PE + + +K D WS GV+L+ + G +P+ + E+ + +T
Sbjct: 201 KGGCAMLPVKWMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 259
Query: 226 ---RAEFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMEN 263
R + P P V +++++ P R A ++E
Sbjct: 260 SGGRMD--PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILER 298
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 2e-22
Identities = 61/215 (28%), Positives = 96/215 (44%), Gaps = 43/215 (20%)
Query: 17 LLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQL- 75
+LG+G F KVY GR L G VA+K + +E R G Q + E+ ++ + H N+++L
Sbjct: 37 ILGRGGFGKVYKGR-LADGTLVAVKRLKEE--RTQGGELQFQTEVEMISMAVHRNLLRLR 93
Query: 76 ------------YEVMASKTKIYFAMEYVRGGELFN-----KVAKGKLREEVAR--KYFQ 116
Y MA+ + E + ++A G AR Y
Sbjct: 94 GFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG-----SARGLAYLH 148
Query: 117 QLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTT---CG 173
+ C + + HRD+K N+LLDE + + DFGL+ L + H T G
Sbjct: 149 ------DHCDPK-IIHRDVKAANILLDEEFEAVVGDFGLAKLMD----YKDTHVTTAVRG 197
Query: 174 TPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAG 208
T ++APE ++ G K D++ GV+L L+ G
Sbjct: 198 TIGHIAPEYLS-TGKSSEKTDVFGYGVMLLELITG 231
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 2e-22
Identities = 68/286 (23%), Positives = 117/286 (40%), Gaps = 52/286 (18%)
Query: 13 ELGRLLGQGTFAKVYHG--RNLKTGQS---VAIKIVDKEKIRRVGLIDQIK--REISVMR 65
L R LG+G F KV+ NL + VA+K + K+ + RE ++
Sbjct: 18 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL-KDPTLA----ARKDFQREAELLT 72
Query: 66 LVRHPNIVQLYEVMASKTKIYFAMEYVRGGEL----------FNKVAKGKLREEVARKYF 115
++H +IV+ Y V + EY++ G+L + G+ R+
Sbjct: 73 NLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 132
Query: 116 QQLV-------DAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQEST-----R 163
Q++ + + S+ HRDL N L+ N +KI DFG+S ST
Sbjct: 133 SQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVG 192
Query: 164 QDGLLHTTCGTPAYV---APEVINKRGYDGAKADIWSCGVVL---FVLLAGNLPFYDSNL 217
+L P + PE I R + ++D+WS GV+L F G P++ +
Sbjct: 193 GHTML------P--IRWMPPESIMYRKFT-TESDVWSFGVILWEIFTY--GKQPWFQLSN 241
Query: 218 MELYKKITRA-EFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262
E+ + IT+ + P P EV ++ P R+ + ++ +
Sbjct: 242 TEVIECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYK 287
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 4e-22
Identities = 64/288 (22%), Positives = 102/288 (35%), Gaps = 49/288 (17%)
Query: 10 NKYELGRLLGQGTFAKVYHG-----RNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVM 64
N + G+ LG G F KV VA+K++ K + E+ +M
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML-KSTAHADEKEALM-SELKIM 103
Query: 65 -RLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFN--------KVAKGKLREEVARKYF 115
L +H NIV L + EY G+L N +
Sbjct: 104 SHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAST 163
Query: 116 QQLVD-------AVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQEST-----R 163
+ L+ + F S+ HRD+ N+LL KI DFGL+ + +
Sbjct: 164 RDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVK 223
Query: 164 QDGLLHTTCGTPAYV---APEVINKRGYDGAKADIWSCGVVLF--VLLAGN-LPFYDSNL 217
+ L P V APE I Y ++D+WS G++L+ L N P N
Sbjct: 224 GNARL------P--VKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGLNPYPGILVN- 273
Query: 218 MELYKKIT---RAEFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262
+ YK + + P + P + ++ P+ R T ++
Sbjct: 274 SKFYKLVKDGYQMA--QPAFAPKNIYSIMQACWALEPTHRPTFQQICS 319
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 6e-22
Identities = 68/295 (23%), Positives = 114/295 (38%), Gaps = 55/295 (18%)
Query: 10 NKYELGRLLGQGTFAKVYHGR-----NLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVM 64
LG+ LG+G F KV +VA+K++ KE L D + E +V+
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML-KENASPSELRD-LLSEFNVL 80
Query: 65 RLVRHPNIVQLYEVMASKTKIYFAMEYVRGGEL-------------FNKVAKGKLREEVA 111
+ V HP++++LY + + +EY + G L + + +
Sbjct: 81 KQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140
Query: 112 RKYFQQL--VDAVEFCH----------SRGVYHRDLKPENLLLDENGDLKISDFGLSALQ 159
+ L D + F + HRDL N+L+ E +KISDFGLS
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDV 200
Query: 160 EST-----RQDGLLHTTCGTPAYV---APEVINKRGYDGAKADIWSCGVVLF-VLLAGNL 210
R G + P V A E + Y ++D+WS GV+L+ ++ G
Sbjct: 201 YEEDSYVKRSQGRI------P--VKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGN 251
Query: 211 PFYDSNLMELYKKIT---RAEFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262
P+ L+ + R E P+ E+ +L+ + P R A + +
Sbjct: 252 PYPGIPPERLFNLLKTGHRME--RPDNCSEEMYRLMLQCWKQEPDKRPVFADISK 304
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 1e-21
Identities = 68/285 (23%), Positives = 111/285 (38%), Gaps = 49/285 (17%)
Query: 10 NKYELGRLLGQGTFAKVYHG--RNLKTGQS---VAIKIVDKEKIRRVGLIDQIKREISVM 64
L R LG G F +VY G + S VA+K + E +D + E ++
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFL-MEALII 128
Query: 65 RLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQ-----LV 119
H NIV+ V + +E + GG+L K LRE R Q ++
Sbjct: 129 SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDL-----KSFLRE--TRPRPSQPSSLAML 181
Query: 120 DAVEFCH----------SRGVYHRDLKPENLLLDENGD---LKISDFGLSALQESTRQDG 166
D + HRD+ N LL G KI DFG++ ++ R
Sbjct: 182 DLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA--RDIYRAG- 238
Query: 167 LLHTTCGTPAYV-----APEVINKRGYDGAKADIWSCGVVLF-VLLAGNLPFYDSNLMEL 220
+ G A + PE + + +K D WS GV+L+ + G +P+ + E+
Sbjct: 239 --YYRKGGCAMLPVKWMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV 295
Query: 221 YKKIT---RAEFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262
+ +T R + P P V +++++ P R A ++E
Sbjct: 296 LEFVTSGGRMD--PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 338
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 70/296 (23%), Positives = 107/296 (36%), Gaps = 56/296 (18%)
Query: 10 NKYELGRLLGQGTFAKVYHGR-----NLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVM 64
E G++LG G F KV + VA+K++ KEK + E+ +M
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML-KEKADSSEREA-LMSELKMM 102
Query: 65 -RLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFN--------------KVAKGKLREE 109
+L H NIV L IY EY G+L N + K EE
Sbjct: 103 TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 162
Query: 110 VARKYFQQLVDAVEFCH----------SRGVYHRDLKPENLLLDENGDLKISDFGLSALQ 159
D + F + + HRDL N+L+ +KI DFGL+
Sbjct: 163 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDI 222
Query: 160 EST-----RQDGLLHTTCGTPAYV---APEVINKRGYDGAKADIWSCGVVLF-VLLAGNL 210
S R + L P V APE + + Y K+D+WS G++L+ + G
Sbjct: 223 MSDSNYVVRGNARL------P--VKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGVN 273
Query: 211 PFYD-SNLMELYKKIT---RAEFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262
P+ YK I + + P + E+ ++ + R + L
Sbjct: 274 PYPGIPVDANFYKLIQNGFKMD--QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 327
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 3e-21
Identities = 68/294 (23%), Positives = 109/294 (37%), Gaps = 59/294 (20%)
Query: 13 ELGRLLGQGTFAKVYHGR--NLKTGQS---VAIKIVDKEKIRRVGLIDQIKREISVMRLV 67
E R +G+G F +V+ R L + VA+K++ KE+ D +RE ++M
Sbjct: 50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML-KEEASADMQAD-FQREAALMAEF 107
Query: 68 RHPNIVQLYEVMASKTKIYFAMEYVRGGEL---------------FNKVAKGKLREEVAR 112
+PNIV+L V A + EY+ G+L + + R
Sbjct: 108 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 167
Query: 113 KYFQQLVDAVEFCH----------SRGVYHRDLKPENLLLDENGDLKISDFGLS-ALQES 161
+ + R HRDL N L+ EN +KI+DFGLS + +
Sbjct: 168 PPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227
Query: 162 ----TRQDGLLHTTCGTPAYV---APEVINKRGYDGAKADIWSCGVVL---FVLLAGNLP 211
+ + P + PE I Y ++D+W+ GVVL F G P
Sbjct: 228 DYYKADGNDAI------P--IRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSY--GLQP 276
Query: 212 FYDSNLMELYKKIT---RAEFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262
+Y E+ + CP P E+ L+ P+ R + +
Sbjct: 277 YYGMAHEEVIYYVRDGNILA--CPENCPLELYNLMRLCWSKLPADRPSFCSIHR 328
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 4e-21
Identities = 66/259 (25%), Positives = 110/259 (42%), Gaps = 38/259 (14%)
Query: 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRH 69
N+Y LGR +G G+F +Y G ++ G+ VAIK+ + K + Q+ E + ++++
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL-ECVKTKH----PQLHIESKIYKMMQG 63
Query: 70 -PNIVQLYEVMASKTKIYFAMEYVRG---GELFNKVAKGKLREEVARKYFQQLVDAVEFC 125
I + A ME + G +LFN ++ K + Q++ +E+
Sbjct: 64 GVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSR-KFSLKTVLLLADQMISRIEYI 121
Query: 126 HSRGVYHRDLKPENLLLDENGD---LKISDFGLSALQESTRQDGLLHTT-------CGTP 175
HS+ HRD+KP+N L+ + I DFGL+ ++ H GT
Sbjct: 122 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA--KKYRDARTHQHIPYRENKNLTGTA 179
Query: 176 AYVAPEVINK-RGYD-GAKADIWSCGVVLFVLLAGNLP---FYDSNLMELYKKI------ 224
Y + IN G + + D+ S G VL G+LP + + Y++I
Sbjct: 180 RYAS---INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 236
Query: 225 TRAEFKCPNWFPPEVRKLL 243
T E C +P E L
Sbjct: 237 TPIEVLCKG-YPSEFATYL 254
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 4e-21
Identities = 67/284 (23%), Positives = 110/284 (38%), Gaps = 49/284 (17%)
Query: 13 ELGRLLGQGTFAKVYHG--RNLKTGQS---VAIKIV----DKEKIRRVGLIDQIKREISV 63
L LG+G F KV+ NL Q VA+K + + + +RE +
Sbjct: 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQ-------DFQREAEL 96
Query: 64 MRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGEL---------FNKVAKGKLREEVARKY 114
+ +++H +IV+ + V + EY+R G+L K+ G
Sbjct: 97 LTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLG 156
Query: 115 FQQLV-------DAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGL 167
QL+ + + HRDL N L+ + +KI DFG+S ++ D
Sbjct: 157 LGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS--RDIYSTD-- 212
Query: 168 LHTTCGTPAYV-----APEVINKRGYDGAKADIWSCGVVLF-VLLAGNLPFYDSNLMELY 221
+ G + PE I R + ++D+WS GVVL+ + G P+Y + E
Sbjct: 213 -YYRVGGRTMLPIRWMPPESILYRKFT-TESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI 270
Query: 222 KKIT---RAEFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262
IT E P PPEV ++ P R ++ +
Sbjct: 271 DCITQGRELE--RPRACPPEVYAIMRGCWQREPQQRHSIKDVHA 312
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 5e-21
Identities = 58/237 (24%), Positives = 101/237 (42%), Gaps = 35/237 (14%)
Query: 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRH 69
+ +G+ +G G F ++ G+NL T + VAIK+ E ++ Q+ E + +
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKL---EPMKSRA--PQLHLEYRFYKQLGS 63
Query: 70 -PNIVQLYEVMASKTKIYFAMEYVRGG----ELFNKVAKGKLREEVARKYFQQLVDAVEF 124
I Q+Y +E + G +LF+ + + QL+ +E+
Sbjct: 64 GDGIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDR-TFSLKTVLMIAIQLISRMEY 120
Query: 125 CHSRGVYHRDLKPENLLLDENGDLK-----ISDFGLSALQESTRQDGLLH-------TTC 172
HS+ + +RD+KPEN L+ G+ I DF L+ +E + H +
Sbjct: 121 VHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA--KEYIDPETKKHIPYREHKSLT 178
Query: 173 GTPAYVAPEVINK-RGYD-GAKADIWSCGVVLFVLLAGNLP---FYDSNLMELYKKI 224
GT Y++ IN G + + D+ + G + L G+LP L E Y+KI
Sbjct: 179 GTARYMS---INTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKI 232
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 93.5 bits (232), Expect = 9e-21
Identities = 71/266 (26%), Positives = 114/266 (42%), Gaps = 37/266 (13%)
Query: 1 MEKKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKRE 60
ME + G NK+ LGR +G G+F ++Y G N++T + VAIK+ + + Q+ E
Sbjct: 1 MEPRVG---NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP-----QLLYE 52
Query: 61 ISVMRLVR-HPNIVQLYEVMASKTKIYFAMEYVRG---GELFNKVAKGKLREEVARKYFQ 116
+ R+++ I + M+ + G +LFN ++ KL +
Sbjct: 53 SKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSR-KLSLKTVLMLAD 110
Query: 117 QLVDAVEFCHSRGVYHRDLKPENLLLDENGD---LKISDFGLSALQESTRQDGLL----- 168
Q+++ VEF HS+ HRD+KP+N L+ + I DFGL+ T +
Sbjct: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 170
Query: 169 HTTCGTPAYVAPEVINK-RGYD-GAKADIWSCGVVLFVLLAGNLP---FYDSNLMELYKK 223
GT Y + +N G + + D+ S G VL L G+LP + Y+K
Sbjct: 171 KNLTGTARYAS---VNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK 227
Query: 224 I------TRAEFKCPNWFPPEVRKLL 243
I T E C +P E
Sbjct: 228 ISEKKVATSIEALCRG-YPTEFASYF 252
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 1e-20
Identities = 51/245 (20%), Positives = 99/245 (40%), Gaps = 33/245 (13%)
Query: 1 MEKKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKRE 60
M + ++ Y++GR +G+G+F ++ G NL Q VAIK + + Q++ E
Sbjct: 1 MSGQNNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF-EPRRSDA----PQLRDE 55
Query: 61 ISVMRLVRH-PNIVQLYEVMASKTKIYFAMEYVRG---GELFNKVAKGKLREEVARKYFQ 116
+L+ I +Y ++ + G +L + + K + +
Sbjct: 56 YRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGR-KFSVKTVAMAAK 113
Query: 117 QLVDAVEFCHSRGVYHRDLKPENLLLDENGDLK-----ISDFGLSALQESTRQDGLLH-- 169
Q++ V+ H + + +RD+KP+N L+ + DFG+ + H
Sbjct: 114 QMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV--KFYRDPVTKQHIP 171
Query: 170 -----TTCGTPAYVAPEVINK-RGYD-GAKADIWSCGVVLFVLLAGNLP---FYDSNLME 219
GT Y++ IN G + + D+ + G V L G+LP + +
Sbjct: 172 YREKKNLSGTARYMS---INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ 228
Query: 220 LYKKI 224
Y++I
Sbjct: 229 KYERI 233
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 7e-19
Identities = 41/278 (14%), Positives = 90/278 (32%), Gaps = 56/278 (20%)
Query: 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRH 69
N++ LG+ +G G F +Y + A +V K + + G + E+ + V
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVV-KVEYQENG---PLFSELKFYQRVAK 92
Query: 70 PNIVQLYEVMASKTK------IYFAMEYVRGGE---------------LFNKVAKGKLRE 108
+ ++ + + +G + + G ++
Sbjct: 93 KDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQ--NGTFKK 150
Query: 109 EVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKI--SDFGLS-------ALQ 159
+ +++D +E+ H H D+K NLLL ++ +D+GLS +
Sbjct: 151 STVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHK 210
Query: 160 ESTRQDGLLHTTCGTPAYVAPEVINK-RGYD-GAKADIWSCGVVLFVLLAGNLP------ 211
+ H GT + + ++ +G ++D+ G + L G LP
Sbjct: 211 QYQENPRKGHN--GTIEFTS---LDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLK 265
Query: 212 FYDSNLMELYKKI------TRAEFKCPNWFPPEVRKLL 243
+ + + E+ + L
Sbjct: 266 DPVAVQTAKTNLLDELPQSVLKWAPSGS-SCCEIAQFL 302
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 2e-18
Identities = 56/281 (19%), Positives = 94/281 (33%), Gaps = 96/281 (34%)
Query: 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRL 66
+ +Y + R LG G F+ V+ +++ + VA+K+V + EI +++
Sbjct: 34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVV----KSAEHYTETALDEIRLLKS 89
Query: 67 VR-----HPN---IVQLYEVMASKTKIYFAMEYVRG-----------------GELFNKV 101
VR PN +VQL + F + G + K
Sbjct: 90 VRNSDPNDPNREMVVQLLD--------DF---KISGVNGTHICMVFEVLGHHLLKWIIKS 138
Query: 102 AKGKLREEVARKYFQQLVDAVEFCHSR-GVYHRDLKPENLLL------------------ 142
L +K QQ++ +++ H++ + H D+KPEN+LL
Sbjct: 139 NYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQ 198
Query: 143 -------------------------------DENGDLKISDFGLSALQESTRQDGLLHTT 171
E +KI+D G +
Sbjct: 199 RSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLG-----NACWVHKHFTED 253
Query: 172 CGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPF 212
T Y + EV+ GY+ ADIWS + F L G+ F
Sbjct: 254 IQTRQYRSLEVLIGSGYN-TPADIWSTACMAFELATGDYLF 293
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 83.0 bits (204), Expect = 1e-17
Identities = 32/192 (16%), Positives = 58/192 (30%), Gaps = 47/192 (24%)
Query: 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGL-----IDQIKREISVM 64
K + +G+G F +V+ VAIKI+ E V ++I EI +
Sbjct: 20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 65 RLV---------RHPNIVQLYEV------------------------------MASKTKI 85
+ + R + L V ++
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 86 YFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSR-GVYHRDLKPENLLLDE 144
+ +E+ GG ++ A+ QL ++ + HRDL N+LL +
Sbjct: 138 FIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKK 197
Query: 145 NGDLKISDFGLS 156
K+
Sbjct: 198 TSLKKLHYTLNG 209
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 8e-17
Identities = 38/283 (13%), Positives = 89/283 (31%), Gaps = 57/283 (20%)
Query: 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTG--------QSVAIKI--------VDKEKIRR 50
+++L + +Y T Q ++K+ ++ +R
Sbjct: 39 KSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQR 98
Query: 51 VGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYF-AMEYVRGGELFNKVAKGKLREE 109
Q+ + + I + K F + + G L +
Sbjct: 99 AAKPLQVNKWKKLYST-PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSL------QSALDV 150
Query: 110 VARKYF---------QQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKI--SDFGLSAL 158
+ +L+DA+EF H H ++ EN+ +D ++ + +G +
Sbjct: 151 SPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFR 210
Query: 159 QESTRQ-----DGLLHTTCGTPAYVAPEVINK-RGYDGA-KADIWSCGVVLFVLLAGNLP 211
+ + +G G +++ ++ +G + ++D+ S G + L G LP
Sbjct: 211 YCPSGKHVAYVEGSRSPHEGDLEFIS---MDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267
Query: 212 ---FYDSNLMELYKKI------TRAEFKCPNW--FPPEVRKLL 243
+ + +K C +W ++K L
Sbjct: 268 WTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYL 310
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 44/282 (15%), Positives = 88/282 (31%), Gaps = 61/282 (21%)
Query: 10 NKYELGRLLGQGTFAKVYHGR-----NLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVM 64
+++G +GQG F +Y ++ + +K+ + + E+
Sbjct: 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN-------GPLFTELKFY 87
Query: 65 RLVRHPNIVQLYEVMASKTKI------YFAMEYVRGGE---------------LFNKVAK 103
+ P +Q + + + G ++ AK
Sbjct: 88 QRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAK 147
Query: 104 GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKI--SDFGLS----- 156
+ + + +++D +E+ H H D+K NLLL+ ++ D+GL+
Sbjct: 148 -RFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCP 206
Query: 157 --ALQESTRQDGLLHTTCGTPAYVAPEVINK-RGYD-GAKADIWSCGVVLFVLLAGNLP- 211
+ H GT + + I+ G + D+ G + L G+LP
Sbjct: 207 EGVHKAYAADPKRCHD--GTIEFTS---IDAHNGVAPSRRGDLEILGYCMIQWLTGHLPW 261
Query: 212 --FYDSNLMELYKKI------TRAEFKCPNW--FPPEVRKLL 243
KI KC P E+ K +
Sbjct: 262 EDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYM 303
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 7e-11
Identities = 49/157 (31%), Positives = 74/157 (47%), Gaps = 20/157 (12%)
Query: 117 QLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQEST-----RQDGLLHTT 171
Q+ +EF SR HRDL N+LL E +KI DFGL+ + D L
Sbjct: 201 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL--- 257
Query: 172 CGTPA-YVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPF----YDSNLMELYKKIT 225
P ++APE I R Y ++D+WS GV+L+ + + G P+ D K+ T
Sbjct: 258 ---PLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 313
Query: 226 RAEFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262
R P++ PE+ + + PS R T ++L+E
Sbjct: 314 RMR--APDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 348
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 9e-07
Identities = 28/151 (18%), Positives = 54/151 (35%), Gaps = 12/151 (7%)
Query: 13 ELGRLLGQGTFAKVYHGR-----NLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVM-RL 66
+LG+ LG+G F +V T ++VA+K++ KE + E+ ++ +
Sbjct: 25 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHRA-LMSELKILIHI 82
Query: 67 VRHPNIVQLYEVM-ASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFC 125
H N+V L + +E+ + G L + + + Y + +
Sbjct: 83 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL---RSKRNEFVPYKTKGARFRQGK 139
Query: 126 HSRGVYHRDLKPENLLLDENGDLKISDFGLS 156
G DLK + + S F
Sbjct: 140 DYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* Length = 258 | Back alignment and structure |
|---|
Score = 51.6 bits (123), Expect = 1e-07
Identities = 34/168 (20%), Positives = 60/168 (35%), Gaps = 27/168 (16%)
Query: 12 YELGRLLGQGTFAKVYHGRNLKTGQ--SVAIKI-------VDKEKIRRVGLIDQIKREIS 62
+G ++ G A V++ + G+ ++A+KI DK G R IS
Sbjct: 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRIS 108
Query: 63 VMRLVR------HPNIVQLYEVMASKTKIYF------AMEYVRGGELFN---KVAKGKLR 107
V N+ + E S + Y ME++ EL +L+
Sbjct: 109 PKEKVFIWTEKEFRNLERAKEAGVSVPQPYTYMKNVLLMEFIGEDELPAPTLVELGRELK 168
Query: 108 EEVARKYFQQLVDAVEFCHSR-GVYHRDLKPENLLLDENGDLKISDFG 154
E F +V+ V+ + + H DL N++ + + D G
Sbjct: 169 ELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYIDK--VYFIDMG 214
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 49.6 bits (118), Expect = 8e-07
Identities = 28/154 (18%), Positives = 55/154 (35%), Gaps = 19/154 (12%)
Query: 12 YELGRLLGQGTFAKVYHGRNLKTGQSVAIKI-------VDKEKIRRVGLIDQIKREISVM 64
+G+L+G+G + V++ + + +K K K +R
Sbjct: 92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 150
Query: 65 RLVRHPNIVQLYEVMASKTKIYF----AMEYVRGGELFNKVAKGKLREEVARKYFQQLVD 120
+ +L + K + ME + EL+ +R E + +++
Sbjct: 151 ARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYR------VRVENPDEVLDMILE 204
Query: 121 AVEFCHSRGVYHRDLKPENLLLDENGDLKISDFG 154
V + RG+ H DL N+L+ + I DF
Sbjct: 205 EVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFP 237
|
| >3ose_A Serine/threonine-protein kinase MARK1; kinase associated-1(Ka1) domain, transferase, lipid binding membrane association; 1.70A {Homo sapiens} PDB: 1ul7_A Length = 120 | Back alignment and structure |
|---|
Score = 42.7 bits (100), Expect = 2e-05
Identities = 8/80 (10%), Positives = 38/80 (47%), Gaps = 2/80 (2%)
Query: 352 TTTKPASAIVSKFEEIAVTESCKFNKKDGTVKLQHNR-QGRKGQLAVDAEIFEVT-PAFH 409
T++ + ++ + ++ +C + +K+ + + + + + E+ ++ + +
Sbjct: 34 TSSMDPNDMMREIRKVLDANNCDYEQKERFLLFCVHGDARQDSLVQWEMEVCKLPRLSLN 93
Query: 410 VVELKKAAGDTMEYKDFCNQ 429
V K+ +G ++ +K+ ++
Sbjct: 94 GVRFKRISGTSIAFKNIASK 113
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.9 bits (100), Expect = 2e-04
Identities = 48/445 (10%), Positives = 117/445 (26%), Gaps = 157/445 (35%)
Query: 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRL 66
+L +L + ++ H N+K + ++RR+ + + V+
Sbjct: 198 VLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSI-----QAELRRLLKSKPYENCLLVLLN 252
Query: 67 VRHPNIV----------------QLYEVMASKTKIYFAMEYVRGG-------ELFNKVAK 103
V++ Q+ + +++ T + ++++ L K
Sbjct: 253 VQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLD 312
Query: 104 GK----------------------LREEVAR-KYFQQL-VDAVEFCHSRGVYHRDLKPEN 139
+ +R+ +A ++ + D + L+P
Sbjct: 313 CRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLT--TIIESSLNVLEPAE 370
Query: 140 L--------LLDENGDLKISDFGLSAL-QESTRQDGLLHTTCGTPAYVAPEVINKRGYDG 190
+ I LS + + + D V ++
Sbjct: 371 YRKMFDRLSVFPP--SAHIPTILLSLIWFDVIKSD---------VMVVVNKLHKYS---- 415
Query: 191 AKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEV-RKLLS----- 244
L+ ++ +Y ++ K N + R ++
Sbjct: 416 --------------LVEKQPKESTISIPSIYLELKV---KLEN--EYALHRSIVDHYNIP 456
Query: 245 RILDPNPSTRVTMAKLME-NYW-------------------FRKGY-------KKIE--- 274
+ D + + Y+ FR + +KI
Sbjct: 457 KTFDSD-----DLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDS 511
Query: 275 TPESPRGQDRNKL---------ISDIHAVFECESSSSRD--TDPPTNSCRSPVRPSSFNA 323
T + G N L I D +E ++ D N S
Sbjct: 512 TAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYT------ 565
Query: 324 FDIISLSKGFNLSGLFEGDANSKLE 348
D++ ++ +FE +A+ +++
Sbjct: 566 -DLLRIALMAEDEAIFE-EAHKQVQ 588
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 448 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2ehb_D | 143 | CBL-interacting serine/threonine-protein kinase 2; | 100.0 | |
| 2zfd_B | 123 | Putative uncharacterized protein T20L15_90; calciu | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.94 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.88 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.79 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.48 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.34 | |
| 3ose_A | 120 | Serine/threonine-protein kinase MARK1; kinase asso | 99.28 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.26 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.21 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.93 | |
| 1v5s_A | 126 | MAP/microtubule affinity-regulating kinase 3; Ka1 | 98.84 | |
| 4eai_A | 106 | 5'-AMP-activated protein kinase catalytic subunit | 98.77 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.76 | |
| 2v8q_A | 157 | 5'-AMP-activated protein kinase catalytic subunit; | 98.67 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.64 | |
| 2y8l_A | 173 | 5'-AMP-activated protein kinase catalytic subunit; | 98.6 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.59 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.46 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.43 | |
| 4eag_A | 130 | EG:132E8.2 protein; AMPK, transferase; HET: ATP TA | 98.4 | |
| 2qrd_A | 137 | SNF1-like protein kinase SSP2; AMPK, ADP, ATP-bind | 98.39 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.38 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.23 | |
| 3t4n_A | 179 | Carbon catabolite-derepressing protein kinase; CBS | 98.0 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.94 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.94 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.77 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.7 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.7 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.66 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.62 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.48 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.46 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.42 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.35 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.22 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.14 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.72 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.16 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.19 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 88.79 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 87.41 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 80.74 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-69 Score=528.47 Aligned_cols=261 Identities=32% Similarity=0.624 Sum_probs=242.7
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIY 86 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 86 (448)
...++|++++.||+|+||+||+|+++.+|+.||||++++....+....+.+.+|+.+|+.++|||||++++++.+++.+|
T Consensus 29 ~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~y 108 (311)
T 4aw0_A 29 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY 108 (311)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 34578999999999999999999999999999999999876655556788999999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccC
Q 037702 87 FAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQD 165 (448)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~ 165 (448)
||||||+||+|++++.+ +.++|.+++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+........
T Consensus 109 ivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 109 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence 99999999999999976 78999999999999999999999999999999999999999999999999999876544444
Q ss_pred CCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHHHHh
Q 037702 166 GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSR 245 (448)
Q Consensus 166 ~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 245 (448)
....+.|||+.|||||++.+.+|+ .++|||||||+||+|++|++||.+.+..+++.+|....+.+|..+|+++++||.+
T Consensus 189 ~~~~~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~ 267 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPELLTEKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEK 267 (311)
T ss_dssp CCBCCCCSCGGGCCHHHHHHSCBC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHHHH
T ss_pred ccccCcccCcccCCHHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHHHH
Confidence 556778999999999999988875 8999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCcCCCCCHHH------HHhhhhccc
Q 037702 246 ILDPNPSTRVTMAK------LMENYWFRK 268 (448)
Q Consensus 246 ~L~~dP~~Rpt~~e------il~hp~~~~ 268 (448)
||..||.+|||++| |++||||+.
T Consensus 268 lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~ 296 (311)
T 4aw0_A 268 LLVLDATKRLGCEEMEGYGPLKAHPFFES 296 (311)
T ss_dssp HSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred HccCCHhHCcChHHHcCCHHHHCCCCcCC
Confidence 99999999999987 689999975
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-68 Score=516.57 Aligned_cols=261 Identities=43% Similarity=0.850 Sum_probs=223.6
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKI 85 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 85 (448)
|...++|++.+.||+|+||+||+|++..+|+.||||++++....+....+.+.+|+.+|+.++|||||++++++.+++.+
T Consensus 9 G~~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~ 88 (275)
T 3hyh_A 9 GAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEI 88 (275)
T ss_dssp -----CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCEeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence 44568999999999999999999999999999999999987766656667899999999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccccc
Q 037702 86 YFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQ 164 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~ 164 (448)
|+||||| +|+|.+++.+ +++++.+++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 89 ~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~--- 164 (275)
T 3hyh_A 89 IMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD--- 164 (275)
T ss_dssp EEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred EEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCC---
Confidence 9999999 6799999865 7899999999999999999999999999999999999999999999999999986432
Q ss_pred CCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 037702 165 DGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLS 244 (448)
Q Consensus 165 ~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 244 (448)
.....+.+||+.|||||++.+..|++.++|||||||+||+|++|+.||.+.+..++++.+..+.+.+|..+|+++++||.
T Consensus 165 ~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 244 (275)
T 3hyh_A 165 GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIK 244 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHH
T ss_pred CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 23345789999999999999888888899999999999999999999999999999999999999999999999999999
Q ss_pred hccCCCcCCCCCHHHHHhhhhccccc
Q 037702 245 RILDPNPSTRVTMAKLMENYWFRKGY 270 (448)
Q Consensus 245 ~~L~~dP~~Rpt~~eil~hp~~~~~~ 270 (448)
+||+.||++|||++|+++||||+...
T Consensus 245 ~~L~~dP~~R~s~~eil~hpw~k~~~ 270 (275)
T 3hyh_A 245 RMLIVNPLNRISIHEIMQDDWFKVDL 270 (275)
T ss_dssp HHSCSSGGGSCCHHHHHHCHHHHTTC
T ss_pred HHccCChhHCcCHHHHHcCcccccCC
Confidence 99999999999999999999998654
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-66 Score=515.54 Aligned_cols=256 Identities=27% Similarity=0.487 Sum_probs=232.3
Q ss_pred cCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFA 88 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 88 (448)
...|++.+.||+|+||+||+|+++.+|+.||||++++..... .+.+.+|+.+|+.++|||||++++++.+++.+|||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iv 149 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 149 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 467999999999999999999999999999999998765443 35678999999999999999999999999999999
Q ss_pred EeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCc
Q 037702 89 MEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLL 168 (448)
Q Consensus 89 ~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 168 (448)
||||+||+|++++.++++++.+++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+..... ....
T Consensus 150 mEy~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~--~~~~ 227 (346)
T 4fih_A 150 MEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VPRR 227 (346)
T ss_dssp ECCCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS--SCCB
T ss_pred EeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCC--CCcc
Confidence 99999999999999899999999999999999999999999999999999999999999999999999865332 2334
Q ss_pred cccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccC---CCCCCCCHHHHHHHHh
Q 037702 169 HTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF---KCPNWFPPEVRKLLSR 245 (448)
Q Consensus 169 ~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~li~~ 245 (448)
.+.|||+.|||||++.+.+|+ .++|||||||+||||++|++||.+.+..+.+..|..... ..+..+|+++++||.+
T Consensus 228 ~~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~ 306 (346)
T 4fih_A 228 KSLVGTPYWMAPELISRLPYG-PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDR 306 (346)
T ss_dssp CCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHH
T ss_pred cccccCcCcCCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHH
Confidence 678999999999999888874 899999999999999999999999999888888876533 3344589999999999
Q ss_pred ccCCCcCCCCCHHHHHhhhhccccc
Q 037702 246 ILDPNPSTRVTMAKLMENYWFRKGY 270 (448)
Q Consensus 246 ~L~~dP~~Rpt~~eil~hp~~~~~~ 270 (448)
||..||++|||++|+|+||||++..
T Consensus 307 ~L~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 307 LLVRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp HSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HcCCChhHCcCHHHHhcCHhhcCCC
Confidence 9999999999999999999998754
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-66 Score=517.01 Aligned_cols=259 Identities=29% Similarity=0.561 Sum_probs=229.7
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYF 87 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 87 (448)
.+++|++++.||+|+||+||+|+++.+|+.||||++.+..... ...+.+.+|+.+|+.++|||||++++++.+++.+||
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yi 100 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS-KEREESRREVAVLANMKHPNIVQYRESFEENGSLYI 100 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCH-HHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence 3579999999999999999999999999999999998876544 346789999999999999999999999999999999
Q ss_pred EEeecCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccccc
Q 037702 88 AMEYVRGGELFNKVAK---GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQ 164 (448)
Q Consensus 88 V~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~ 164 (448)
|||||+||+|++++.. ..++|.+++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+......
T Consensus 101 VmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~- 179 (350)
T 4b9d_A 101 VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV- 179 (350)
T ss_dssp EEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-
T ss_pred EEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc-
Confidence 9999999999999964 357999999999999999999999999999999999999999999999999998654321
Q ss_pred CCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccC-CCCCCCCHHHHHHH
Q 037702 165 DGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF-KCPNWFPPEVRKLL 243 (448)
Q Consensus 165 ~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li 243 (448)
....+.|||+.|||||++.+..|+ .++|||||||+||+|++|+.||.+.+..+++.++..+.+ +.+..+|+++++||
T Consensus 180 -~~~~~~~GT~~YmAPE~l~~~~y~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li 257 (350)
T 4b9d_A 180 -ELARACIGTPYYLSPEICENKPYN-NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLV 257 (350)
T ss_dssp -HHHHHHHSCCTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHH
T ss_pred -ccccccCCCccccCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHH
Confidence 123467899999999999988885 889999999999999999999999999999999988876 46678999999999
Q ss_pred HhccCCCcCCCCCHHHHHhhhhccccc
Q 037702 244 SRILDPNPSTRVTMAKLMENYWFRKGY 270 (448)
Q Consensus 244 ~~~L~~dP~~Rpt~~eil~hp~~~~~~ 270 (448)
.+||+.||.+|||++|+|+||||++..
T Consensus 258 ~~~L~~dP~~R~s~~e~l~hp~~~~~~ 284 (350)
T 4b9d_A 258 SQLFKRNPRDRPSVNSILEKGFIAKRI 284 (350)
T ss_dssp HHHTCSSGGGSCCHHHHHTSHHHHTTG
T ss_pred HHHccCChhHCcCHHHHhcCHHhhcCC
Confidence 999999999999999999999998654
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-66 Score=504.13 Aligned_cols=256 Identities=35% Similarity=0.644 Sum_probs=226.9
Q ss_pred cCCeEEEeeeeecCceEEEEEEEC---CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNL---KTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKI 85 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 85 (448)
.++|++++.||+|+||+||+|++. .+++.||||++.+....... ...+.+|+.+|+.++|||||++++++.+++.+
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 101 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-RVRTKMERDILVEVNHPFIVKLHYAFQTEGKL 101 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE-CC------CCCCCCCCTTEECEEEEEEETTEE
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH-HHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence 367999999999999999999984 46889999999876554322 24678899999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccccc
Q 037702 86 YFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQ 164 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~ 164 (448)
|||||||+||+|++++.+ +.+++.+++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.....
T Consensus 102 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-- 179 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH-- 179 (304)
T ss_dssp EEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC------
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC--
Confidence 999999999999999976 78999999999999999999999999999999999999999999999999999854322
Q ss_pred CCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 037702 165 DGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLS 244 (448)
Q Consensus 165 ~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 244 (448)
.....+.|||+.|||||++.+.+|+ .++|||||||+||+|++|++||.+.+..+++.+|.+..+.+|..+|+++++||.
T Consensus 180 ~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 258 (304)
T 3ubd_A 180 EKKAYSFCGTVEYMAPEVVNRRGHT-QSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLR 258 (304)
T ss_dssp -CCCCSCCCCGGGCCHHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred CccccccccCcccCCHHHhccCCCC-CCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHHHHHH
Confidence 2334578999999999999888886 889999999999999999999999999999999999999999999999999999
Q ss_pred hccCCCcCCCCC-----HHHHHhhhhccc
Q 037702 245 RILDPNPSTRVT-----MAKLMENYWFRK 268 (448)
Q Consensus 245 ~~L~~dP~~Rpt-----~~eil~hp~~~~ 268 (448)
+||+.||.+||| ++|+++||||+.
T Consensus 259 ~~L~~dP~~R~ta~~~~~~eil~Hp~f~~ 287 (304)
T 3ubd_A 259 MLFKRNPANRLGAGPDGVEEIKRHSFFST 287 (304)
T ss_dssp HHTCSSGGGSTTCSTTTHHHHHTSGGGTT
T ss_pred HHcccCHHHCCCCCcCCHHHHHcCccccC
Confidence 999999999998 589999999975
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-65 Score=516.54 Aligned_cols=256 Identities=27% Similarity=0.494 Sum_probs=232.9
Q ss_pred cCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFA 88 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 88 (448)
.++|++.+.||+|+||.||+|+++.+|+.||||++++..... .+.+.+|+.+|+.++|||||++++++.+++.+|||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iV 226 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 226 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS---GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEE
Confidence 467999999999999999999999999999999998765433 35678999999999999999999999999999999
Q ss_pred EeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCc
Q 037702 89 MEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLL 168 (448)
Q Consensus 89 ~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 168 (448)
||||+||+|++++..+++++.+++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+..... ....
T Consensus 227 mEy~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~--~~~~ 304 (423)
T 4fie_A 227 MEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VPRR 304 (423)
T ss_dssp EECCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSS--CCCB
T ss_pred EeCCCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCC--Cccc
Confidence 99999999999999899999999999999999999999999999999999999999999999999999865332 2334
Q ss_pred cccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhcc---CCCCCCCCHHHHHHHHh
Q 037702 169 HTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAE---FKCPNWFPPEVRKLLSR 245 (448)
Q Consensus 169 ~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~li~~ 245 (448)
.+.|||+.|||||++.+..|+ .++|||||||+||||++|++||.+.+..+.+..|.... +..+..+|+++++||.+
T Consensus 305 ~~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~ 383 (423)
T 4fie_A 305 KSLVGTPYWMAPELISRLPYG-PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDR 383 (423)
T ss_dssp CCCEECTTTCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHH
T ss_pred cccccCcCcCCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHH
Confidence 678999999999999888874 89999999999999999999999999988888887653 33455689999999999
Q ss_pred ccCCCcCCCCCHHHHHhhhhccccc
Q 037702 246 ILDPNPSTRVTMAKLMENYWFRKGY 270 (448)
Q Consensus 246 ~L~~dP~~Rpt~~eil~hp~~~~~~ 270 (448)
||..||.+|||++|+|+||||++..
T Consensus 384 ~L~~dP~~R~ta~ell~Hp~~~~~~ 408 (423)
T 4fie_A 384 LLVRDPAQRATAAELLKHPFLAKAG 408 (423)
T ss_dssp HSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HcCCChhHCcCHHHHhcCHHhcCCC
Confidence 9999999999999999999998753
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-64 Score=519.01 Aligned_cols=415 Identities=32% Similarity=0.605 Sum_probs=318.5
Q ss_pred ccccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 037702 4 KAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKT 83 (448)
Q Consensus 4 ~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~ 83 (448)
.+.+..++|++++.||+|+||.||+|++..+|+.||||++.+.........+.+.+|+.+++.++||||+++++++.+.+
T Consensus 10 ~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~ 89 (476)
T 2y94_A 10 DGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPS 89 (476)
T ss_dssp CSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred CCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 45678999999999999999999999999999999999998765544445678999999999999999999999999999
Q ss_pred EEEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccc
Q 037702 84 KIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQEST 162 (448)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~ 162 (448)
.+|+||||++||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||++.....
T Consensus 90 ~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~- 168 (476)
T 2y94_A 90 DIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD- 168 (476)
T ss_dssp EEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCT-
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccc-
Confidence 99999999999999999976 6899999999999999999999999999999999999999999999999999986432
Q ss_pred ccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHH
Q 037702 163 RQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKL 242 (448)
Q Consensus 163 ~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 242 (448)
.....+.+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+.+...++.++..+.+..|..+++++.+|
T Consensus 169 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~L 246 (476)
T 2y94_A 169 --GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISL 246 (476)
T ss_dssp --TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHHHHH
T ss_pred --cccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHHHHH
Confidence 233457799999999999988777778999999999999999999999999999999999999889999999999999
Q ss_pred HHhccCCCcCCCCCHHHHHhhhhccccccccCCCCCCCCccc---cccccchhhhhcccC--------------------
Q 037702 243 LSRILDPNPSTRVTMAKLMENYWFRKGYKKIETPESPRGQDR---NKLISDIHAVFECES-------------------- 299 (448)
Q Consensus 243 i~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~-------------------- 299 (448)
|.+||..||.+|||++++++||||+........+..+..... .....+....+.+..
T Consensus 247 i~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~y 326 (476)
T 2y94_A 247 LKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKFECSEEEVLSCLYNRNHQDPLAVAY 326 (476)
T ss_dssp HHHHTCSSTTTSCCHHHHHTCHHHHTTCCTTTTTSSSCSSCSHHHHHHHHSCCCC-------------------------
T ss_pred HHHHcCCCchhCcCHHHHHhCHHhhhcCccccCCCCcccccccCCHHHHHHHHHHcCCCHHHHHHHHhCCCCCCHHHHHH
Confidence 999999999999999999999999876543322221110000 000000000000000
Q ss_pred ------CCCCCC--------CCCC----CCCCCCCCCCCC------CchhhcccCC--CCCCCCCCcccccCcccceEEe
Q 037702 300 ------SSSRDT--------DPPT----NSCRSPVRPSSF------NAFDIISLSK--GFNLSGLFEGDANSKLEARFTT 353 (448)
Q Consensus 300 ------~~~~~~--------~~~~----~~~~~~~~~~~~------~~~~~~~~s~--~~~~~~~~~~~~~~~~~~rf~~ 353 (448)
...... .++. ........|... .+-...++++ +......+ ....+|.+++.|
T Consensus 327 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~w~lgi~s 404 (476)
T 2y94_A 327 HLIIDNRRIMNEAKDFYLATSPPDSFLDDHHLTRPHPERVPFLVAETPRARHTLDELNPQKSKHQG--VRKAKWHLGIRS 404 (476)
T ss_dssp ------CCTTCCSSHHHHHHHHHHSCGGGTSCCCCSSCTTTTCSCCCCCCSTTCTTTSSSTTTCSC--CCCCCEEESEEE
T ss_pred HHHHhchhhhhhhhccccccCCccccccccccccCCcccCCcccccCCcccccccccccccccccc--cccceeeecCcc
Confidence 000000 0000 000000000000 0000001110 00111112 234688999999
Q ss_pred CCCHHHHHHHHHHHhhhcCcEEEeec-cEEEEEEeeCCCcccEEEEEEEEEEcCceEEEEEEecCCCchhH
Q 037702 354 TKPASAIVSKFEEIAVTESCKFNKKD-GTVKLQHNRQGRKGQLAVDAEIFEVTPAFHVVELKKAAGDTMEY 423 (448)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~v~~~~~~~~~ve~~~~~Gd~~e~ 423 (448)
+.++.+||..|..+++.+||.|++.+ +.|+++.........+.|.+++|++.++.+|||||+..|+.++|
T Consensus 405 ~~~p~~im~ev~~al~~lg~~Wk~~~~~~i~~r~~~~~~~~~~k~~lqly~~~~~~~llDf~~~~~~~~~~ 475 (476)
T 2y94_A 405 QSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEILEV 475 (476)
T ss_dssp CSCHHHHHHHHHHHHHTTTCBCCEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC----
T ss_pred CCCHHHHHHHHHHHHHHcCCeeccCCCEEEEEEECCCCCCceEEEEEEEEEecCCcEEEEeeecCCCcccc
Confidence 99999999999999999999999988 99999874443345677999999999999999999999999987
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-64 Score=486.00 Aligned_cols=254 Identities=25% Similarity=0.526 Sum_probs=221.7
Q ss_pred ccCCe-EEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe----C
Q 037702 8 LMNKY-ELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMAS----K 82 (448)
Q Consensus 8 ~~~~y-~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~----~ 82 (448)
..++| ++.+.||+|+||.||+|.+..+|..||||++.+..... ...+.+.+|+.+|+.++|||||++++++.+ +
T Consensus 23 ~~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~ 101 (290)
T 3fpq_A 23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK 101 (290)
T ss_dssp TTSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTE
T ss_pred CCCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH-HHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCC
Confidence 45676 78889999999999999999999999999998765543 345789999999999999999999999875 3
Q ss_pred CEEEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CEeecCCCCceEEcC-CCCeEEeecccccc
Q 037702 83 TKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRG--VYHRDLKPENLLLDE-NGDLKISDFGLSAL 158 (448)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~g--ivHrDLkp~NILl~~-~g~lkl~DFGla~~ 158 (448)
..+|||||||+||+|.+++.+ +.+++..++.|+.||+.||+|||++| |+||||||+||||+. +|.+||+|||+|+.
T Consensus 102 ~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 102 KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred cEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence 568999999999999999976 78999999999999999999999999 999999999999985 79999999999985
Q ss_pred ccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCC-cHHHHHHHHhhccC--CCCCCC
Q 037702 159 QESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDS-NLMELYKKITRAEF--KCPNWF 235 (448)
Q Consensus 159 ~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~-~~~~~~~~i~~~~~--~~p~~~ 235 (448)
.. .....+.||||.|||||++.+ .| +.++|||||||+||+|+||+.||.+. +...++..+..+.. .++..+
T Consensus 182 ~~----~~~~~~~~GTp~YmAPE~~~~-~y-~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~ 255 (290)
T 3fpq_A 182 KR----ASFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVA 255 (290)
T ss_dssp CC----TTSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCC
T ss_pred CC----CCccCCcccCccccCHHHcCC-CC-CcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccC
Confidence 32 234467899999999999864 46 58999999999999999999999764 45566666665543 345668
Q ss_pred CHHHHHHHHhccCCCcCCCCCHHHHHhhhhccc
Q 037702 236 PPEVRKLLSRILDPNPSTRVTMAKLMENYWFRK 268 (448)
Q Consensus 236 s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 268 (448)
++++++||.+||+.||++|||++|+++||||++
T Consensus 256 ~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 256 IPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 899999999999999999999999999999975
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-63 Score=491.69 Aligned_cols=246 Identities=27% Similarity=0.380 Sum_probs=217.4
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYF 87 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 87 (448)
..+.|++.+.||+|+||.||+|+++.+|+.||||++.++... .+|+.+|+.++|||||++++++.+++.+||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~--------~~E~~il~~l~HpnIV~l~~~~~~~~~~~i 127 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACAGLSSPRIVPLYGAVREGPWVNI 127 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--------THHHHTTTTCCCTTBCCEEEEEEETTEEEE
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH--------HHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 346799999999999999999999999999999999876432 369999999999999999999999999999
Q ss_pred EEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCC-CeEEeeccccccccccccC
Q 037702 88 AMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENG-DLKISDFGLSALQESTRQD 165 (448)
Q Consensus 88 V~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g-~lkl~DFGla~~~~~~~~~ 165 (448)
|||||+||+|++++.+ +++++.+++.|+.||+.||+|||++||+||||||+||||+.+| ++||+|||+|+........
T Consensus 128 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 128 FMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 9999999999999976 7899999999999999999999999999999999999999998 5999999999865432211
Q ss_pred ---CCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccC---CCCCCCCHHH
Q 037702 166 ---GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF---KCPNWFPPEV 239 (448)
Q Consensus 166 ---~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~ 239 (448)
....+.|||+.|||||++.+..|+ .++|||||||+||+|++|++||.+.+..+++.+|..... ..|+.+|+++
T Consensus 208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~ 286 (336)
T 4g3f_A 208 KSLLTGDYIPGTETHMAPEVVMGKPCD-AKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLT 286 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHH
T ss_pred cceecCCccccCccccCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHH
Confidence 112346899999999999988875 889999999999999999999998887777777777654 4678899999
Q ss_pred HHHHHhccCCCcCCCCCHHHHHh
Q 037702 240 RKLLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 240 ~~li~~~L~~dP~~Rpt~~eil~ 262 (448)
++||.+||+.||.+|||+.|+++
T Consensus 287 ~~li~~~L~~dP~~R~sa~el~~ 309 (336)
T 4g3f_A 287 AQAIQEGLRKEPVHRASAMELRR 309 (336)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHccCCHhHCcCHHHHHH
Confidence 99999999999999999999854
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-61 Score=489.58 Aligned_cols=261 Identities=26% Similarity=0.386 Sum_probs=225.3
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe------
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMAS------ 81 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~------ 81 (448)
+.++|++++.||+|+||.||+|+++.+|+.||||++.+.... ....+.+.+|+.+|+.++|||||++++++..
T Consensus 52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 130 (398)
T 4b99_A 52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDV-VTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGE 130 (398)
T ss_dssp CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSS-HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTT
T ss_pred CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccc-hHHHHHHHHHHHHHHhcCCCCcceEeeeeeccccccc
Confidence 346899999999999999999999999999999999765432 2345678899999999999999999999764
Q ss_pred CCEEEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccc
Q 037702 82 KTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQE 160 (448)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~ 160 (448)
...+|||||||+ |+|++++.. +++++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 131 ~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 131 FKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp CCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred CCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 367999999996 689999976 789999999999999999999999999999999999999999999999999998654
Q ss_pred cc--ccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCC-------
Q 037702 161 ST--RQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKC------- 231 (448)
Q Consensus 161 ~~--~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~------- 231 (448)
.. .......+.|||+.|||||++.+..+++.++||||+|||+|||++|++||.+.+..+.+..|.......
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~ 289 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQA 289 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-
T ss_pred cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 32 223345678999999999999887777899999999999999999999999999888887775432211
Q ss_pred ------------------------CCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccccc
Q 037702 232 ------------------------PNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGY 270 (448)
Q Consensus 232 ------------------------p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 270 (448)
.+.+|+++.+||.+||..||.+|||++|+|+||||++..
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 352 (398)
T 4b99_A 290 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 352 (398)
T ss_dssp ----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred hhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence 123689999999999999999999999999999998643
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-60 Score=506.56 Aligned_cols=259 Identities=32% Similarity=0.519 Sum_probs=229.6
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHH---HHHHHhCCCCCcceEEEEEEeC
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKRE---ISVMRLVRHPNIVQLYEVMASK 82 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~E---i~~l~~l~hpnIv~l~~~~~~~ 82 (448)
.+.+++|++++.||+|+||+||+|+++.+|+.||||++.+..+........+.+| +.+++.++|||||++++++.+.
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~ 264 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 264 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC
Confidence 5678899999999999999999999999999999999987765433333444444 5666777999999999999999
Q ss_pred CEEEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccc
Q 037702 83 TKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQES 161 (448)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~ 161 (448)
+.+|||||||+||+|++++.+ +.++|..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+....
T Consensus 265 ~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 265 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 999999999999999999976 7899999999999999999999999999999999999999999999999999986432
Q ss_pred cccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCC---cHHHHHHHHhhccCCCCCCCCHH
Q 037702 162 TRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDS---NLMELYKKITRAEFKCPNWFPPE 238 (448)
Q Consensus 162 ~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~---~~~~~~~~i~~~~~~~p~~~s~~ 238 (448)
....+.||||.|||||++.+...++.++|||||||+||+|++|.+||.+. +...+...+....+.+|..+|++
T Consensus 345 ----~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~~ 420 (689)
T 3v5w_A 345 ----KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPE 420 (689)
T ss_dssp ----CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCHH
T ss_pred ----CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCCHH
Confidence 23467899999999999965433458999999999999999999999764 34567778888889999999999
Q ss_pred HHHHHHhccCCCcCCCCC-----HHHHHhhhhccc
Q 037702 239 VRKLLSRILDPNPSTRVT-----MAKLMENYWFRK 268 (448)
Q Consensus 239 ~~~li~~~L~~dP~~Rpt-----~~eil~hp~~~~ 268 (448)
+++||.+||..||.+|++ ++||++||||+.
T Consensus 421 a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~ 455 (689)
T 3v5w_A 421 LRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455 (689)
T ss_dssp HHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTT
T ss_pred HHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccC
Confidence 999999999999999998 799999999976
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-60 Score=465.74 Aligned_cols=256 Identities=27% Similarity=0.404 Sum_probs=223.3
Q ss_pred cccCCeEEEeeeeecCceEEEEEEEC-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNL-----KTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMAS 81 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~ 81 (448)
+..++|.+.+.||+|+||+||+|++. .+|..||||++.... ....+.+.+|+.+|++++|||||++++++.+
T Consensus 10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~ 86 (299)
T 4asz_A 10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVE 86 (299)
T ss_dssp CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC---HHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC---hHHHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence 45578999999999999999999875 367899999997542 2345789999999999999999999999999
Q ss_pred CCEEEEEEeecCCCchHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCC
Q 037702 82 KTKIYFAMEYVRGGELFNKVAK--------------GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGD 147 (448)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~--------------~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~ 147 (448)
++.+|||||||+||+|.+++.. ..+++.++..++.||++||+|||+++|+||||||+||||+.++.
T Consensus 87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~ 166 (299)
T 4asz_A 87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL 166 (299)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCc
Confidence 9999999999999999999964 25999999999999999999999999999999999999999999
Q ss_pred eEEeeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhh
Q 037702 148 LKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITR 226 (448)
Q Consensus 148 lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~ 226 (448)
+||+|||+|+..............+||+.|||||++.+..|+ .++|||||||+||||+| |+.||.+.+..++...+..
T Consensus 167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~-~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~ 245 (299)
T 4asz_A 167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ 245 (299)
T ss_dssp EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHH
T ss_pred EEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 999999999865443322223345799999999999887775 89999999999999998 9999999999999988887
Q ss_pred cc-CCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccc
Q 037702 227 AE-FKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRK 268 (448)
Q Consensus 227 ~~-~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 268 (448)
+. .+.|..+|+++.+||.+||+.||++|||+++| ++|+++
T Consensus 246 ~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~ 286 (299)
T 4asz_A 246 GRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQN 286 (299)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHH
T ss_pred CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHH
Confidence 75 46788899999999999999999999999999 457754
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-60 Score=464.58 Aligned_cols=252 Identities=29% Similarity=0.481 Sum_probs=201.6
Q ss_pred cCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKT----- 83 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~----- 83 (448)
.++|++.+.||+|+||+||+|+++.+|+.||||++.... .....+.+.+|+.+|+.++|||||++++++.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 81 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKL 81 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-----
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccc
Confidence 467999999999999999999999999999999997653 2334577899999999999999999999987544
Q ss_pred -------EEEEEEeecCCCchHHHHhc-CC---CCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEee
Q 037702 84 -------KIYFAMEYVRGGELFNKVAK-GK---LREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISD 152 (448)
Q Consensus 84 -------~~~lV~E~~~gg~L~~~i~~-~~---l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~D 152 (448)
.+|+|||||+||+|.+++.. +. .++..++.++.||++||+|||++||+||||||+||||+.+|.+||+|
T Consensus 82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEcc
Confidence 47999999999999999976 32 45677899999999999999999999999999999999999999999
Q ss_pred ccccccccccccC----------CCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcH-HHHH
Q 037702 153 FGLSALQESTRQD----------GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNL-MELY 221 (448)
Q Consensus 153 FGla~~~~~~~~~----------~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~-~~~~ 221 (448)
||+|+........ ....+.|||+.|||||++.+..|+ .++|||||||+||||++ ||..... ....
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyell~---Pf~~~~~~~~~~ 237 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYS-HKVDIFSLGLILFELLY---PFSTQMERVRTL 237 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCC-THHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCC-CHHHHHHHHHHHHHHcc---CCCCccHHHHHH
Confidence 9999865432211 122356899999999999888775 89999999999999996 8865432 2333
Q ss_pred HHHhhccCCCCC---CCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccc
Q 037702 222 KKITRAEFKCPN---WFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRK 268 (448)
Q Consensus 222 ~~i~~~~~~~p~---~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 268 (448)
..+... .+|+ ..++.+.+||.+||++||.+|||++|+++||||+.
T Consensus 238 ~~~~~~--~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~ 285 (299)
T 4g31_A 238 TDVRNL--KFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED 285 (299)
T ss_dssp HHHHTT--CCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCC
T ss_pred HHHhcC--CCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCC
Confidence 333333 3332 24678899999999999999999999999999975
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-59 Score=469.68 Aligned_cols=255 Identities=26% Similarity=0.480 Sum_probs=210.6
Q ss_pred cccCCeEEEeeeeecCceEEEEEEEC---CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNL---KTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEVMASK 82 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~ 82 (448)
.+.++|++.+.||+|+||+||+|+++ .+++.||||.+.+.. ...++.+|+.+|+.+ +||||+++++++.++
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKN 92 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence 35688999999999999999999875 467899999986542 235678999999998 699999999999999
Q ss_pred CEEEEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCC-CCeEEeeccccccccc
Q 037702 83 TKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDEN-GDLKISDFGLSALQES 161 (448)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~-g~lkl~DFGla~~~~~ 161 (448)
+.+|||||||+||+|.+++. ++++.+++.|+.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+....
T Consensus 93 ~~~~lvmE~~~g~~L~~~~~--~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~ 170 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDILN--SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD 170 (361)
T ss_dssp TEEEEEEECCCCCCHHHHHT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred CEEEEEEeCCCcccHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence 99999999999999999984 59999999999999999999999999999999999999877 7999999999975432
Q ss_pred cc--------------------------cCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 037702 162 TR--------------------------QDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDS 215 (448)
Q Consensus 162 ~~--------------------------~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~ 215 (448)
.. ......+.|||+.|||||++.+..+++.++||||+|||+|+|++|+.||...
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 11 1122345689999999999987766678999999999999999999999643
Q ss_pred -cHHHHHHHHhh--------------------------------------ccC----------------CCCCCCCHHHH
Q 037702 216 -NLMELYKKITR--------------------------------------AEF----------------KCPNWFPPEVR 240 (448)
Q Consensus 216 -~~~~~~~~i~~--------------------------------------~~~----------------~~p~~~s~~~~ 240 (448)
+..+....|.. ... .....+|++++
T Consensus 251 ~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~ 330 (361)
T 4f9c_A 251 SDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAY 330 (361)
T ss_dssp SSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHH
T ss_pred CCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHH
Confidence 33333333211 000 11134789999
Q ss_pred HHHHhccCCCcCCCCCHHHHHhhhhccc
Q 037702 241 KLLSRILDPNPSTRVTMAKLMENYWFRK 268 (448)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~eil~hp~~~~ 268 (448)
+||.+||..||.+|||++|+|+||||++
T Consensus 331 DLl~~lL~~dP~~R~ta~eaL~Hp~f~~ 358 (361)
T 4f9c_A 331 DLLDKLLDLNPASRITAEEALLHPFFKD 358 (361)
T ss_dssp HHHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred HHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 9999999999999999999999999974
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-59 Score=462.31 Aligned_cols=253 Identities=26% Similarity=0.397 Sum_probs=215.2
Q ss_pred cccCCeEEEeeeeecCceEEEEEEEC-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNL-----KTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMAS 81 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~ 81 (448)
+...+|.+.+.||+|+||+||+|++. .++..||||++.... ....+.+.+|+.+|++++|||||++++++.+
T Consensus 38 i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~ 114 (329)
T 4aoj_A 38 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTMLQHQHIVRFFGVCTE 114 (329)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred cCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 34568999999999999999999864 368899999997542 3345789999999999999999999999999
Q ss_pred CCEEEEEEeecCCCchHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCC
Q 037702 82 KTKIYFAMEYVRGGELFNKVAK----------------GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDEN 145 (448)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~----------------~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~ 145 (448)
...+|||||||++|+|.+++.. +++++.++..++.|++.||+|||+++|+||||||+||||+.+
T Consensus 115 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~ 194 (329)
T 4aoj_A 115 GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQG 194 (329)
T ss_dssp SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCC
Confidence 9999999999999999999854 358999999999999999999999999999999999999999
Q ss_pred CCeEEeeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHH
Q 037702 146 GDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKI 224 (448)
Q Consensus 146 g~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i 224 (448)
+.+||+|||+|+............+.+||+.|||||++.+..|+ .++|||||||+||||+| |+.||.+.+..++...+
T Consensus 195 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~-~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i 273 (329)
T 4aoj_A 195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT-TESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI 273 (329)
T ss_dssp TEEEECCCC----------------CCCCGGGCCHHHHTTCCCC-HHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHH
T ss_pred CcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCC-ccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 99999999999865443333334457899999999999887775 89999999999999999 99999999988888888
Q ss_pred hhc-cCCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 225 TRA-EFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 225 ~~~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
..+ .+..|..+|+++.+||.+||+.||++|||++||+++
T Consensus 274 ~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 274 TQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred HcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 776 467888999999999999999999999999999875
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-59 Score=493.46 Aligned_cols=258 Identities=29% Similarity=0.549 Sum_probs=234.1
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIY 86 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 86 (448)
.++++|++++.||+|+||.||+|+++.+|+.||||++.+.... ..+.+.+|+.+|+.++|||||++++++.++..+|
T Consensus 154 ~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~---~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 230 (573)
T 3uto_A 154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES---DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV 230 (573)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH---HHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEE
T ss_pred cCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchh---hHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 4568999999999999999999999999999999999765432 3467889999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCC--CCeEEeecccccccccc
Q 037702 87 FAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDEN--GDLKISDFGLSALQEST 162 (448)
Q Consensus 87 lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~--g~lkl~DFGla~~~~~~ 162 (448)
||||||+||+|++++.. +.+++.+++.|+.||+.||+|||++||+||||||+|||++.+ |.+||+|||+|+....
T Consensus 231 iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~- 309 (573)
T 3uto_A 231 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP- 309 (573)
T ss_dssp EEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT-
T ss_pred EEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccC-
Confidence 99999999999999954 679999999999999999999999999999999999999854 8999999999986532
Q ss_pred ccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCC----CCCCHH
Q 037702 163 RQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCP----NWFPPE 238 (448)
Q Consensus 163 ~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~ 238 (448)
.....+.|||+.|||||++.+..|. .++|||||||+||+|++|.+||.+.+..+.+..|....+.++ ..+|++
T Consensus 310 --~~~~~~~~GT~~y~APEv~~~~~y~-~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 386 (573)
T 3uto_A 310 --KQSVKVTTGTAEFAAPEVAEGKPVG-YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED 386 (573)
T ss_dssp --TSEEEEECSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHH
T ss_pred --CCceeeeEECccccCHHHhCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence 2334677999999999999988874 889999999999999999999999999999999988876654 458999
Q ss_pred HHHHHHhccCCCcCCCCCHHHHHhhhhcccccc
Q 037702 239 VRKLLSRILDPNPSTRVTMAKLMENYWFRKGYK 271 (448)
Q Consensus 239 ~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~ 271 (448)
+++||.+||..||.+|||++|+|+||||+....
T Consensus 387 ~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~ 419 (573)
T 3uto_A 387 GKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 419 (573)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence 999999999999999999999999999987653
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-59 Score=456.32 Aligned_cols=255 Identities=25% Similarity=0.400 Sum_probs=225.0
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEEC-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNL-----KTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMA 80 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~ 80 (448)
.+...++++.+.||+|+||+||+|+.. .+++.||||++.... .....+.+.+|+.+|++++|||||++++++.
T Consensus 22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~ 99 (308)
T 4gt4_A 22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVVT 99 (308)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEEE
Confidence 456778999999999999999999863 467899999996543 2234578999999999999999999999999
Q ss_pred eCCEEEEEEeecCCCchHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEc
Q 037702 81 SKTKIYFAMEYVRGGELFNKVAK-----------------GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLD 143 (448)
Q Consensus 81 ~~~~~~lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~ 143 (448)
+++.+|||||||++|+|.+++.. +.+++..+..++.||+.||+|||+++|+||||||+||||+
T Consensus 100 ~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY 179 (308)
T ss_dssp SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEEC
Confidence 99999999999999999999953 3589999999999999999999999999999999999999
Q ss_pred CCCCeEEeeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHH
Q 037702 144 ENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYK 222 (448)
Q Consensus 144 ~~g~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~ 222 (448)
+++++||+|||+|+............+.+||+.|||||++.+..|+ .++|||||||+||||+| |..||.+.+..++..
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s-~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~ 258 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFS-IDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE 258 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH
T ss_pred CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCC-ccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999876554444445567899999999999887775 89999999999999998 899999999888888
Q ss_pred HHhhcc-CCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 223 KITRAE-FKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 223 ~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
.+..+. .+.|..+|+++.+|+.+||+.||.+|||++||+++
T Consensus 259 ~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 259 MIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 887765 46788899999999999999999999999999875
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-59 Score=455.65 Aligned_cols=255 Identities=23% Similarity=0.406 Sum_probs=208.7
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKI 85 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 85 (448)
.+..+++++++.||+|+||+||+|++. ..||||++...... ....+.+.+|+.+|++++|||||++++++.+ +.+
T Consensus 32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~-~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~ 106 (307)
T 3omv_A 32 EIEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPT-PEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNL 106 (307)
T ss_dssp BCCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred EEcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeE
Confidence 455678999999999999999999863 35999998754433 3456789999999999999999999998754 568
Q ss_pred EEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccc
Q 037702 86 YFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTR 163 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~ 163 (448)
|||||||+||+|.+++.. +++++.++..++.||+.||+|||++||+||||||+||||+.++++||+|||+|+......
T Consensus 107 ~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 107 AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp EEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence 999999999999999964 679999999999999999999999999999999999999999999999999998765433
Q ss_pred cCCCccccCCCCcccchhhhhccC--CCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccC------CCCCCC
Q 037702 164 QDGLLHTTCGTPAYVAPEVINKRG--YDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF------KCPNWF 235 (448)
Q Consensus 164 ~~~~~~~~~Gt~~Y~APEvl~~~~--~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~------~~p~~~ 235 (448)
......+.+||+.|||||++.+.. .++.++|||||||+||||+||+.||.+.+.......+..... ..+..+
T Consensus 187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 266 (307)
T 3omv_A 187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNC 266 (307)
T ss_dssp -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTS
T ss_pred cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccc
Confidence 334456679999999999996432 235899999999999999999999988665544443333322 234568
Q ss_pred CHHHHHHHHhccCCCcCCCCCHHHHHhhhh
Q 037702 236 PPEVRKLLSRILDPNPSTRVTMAKLMENYW 265 (448)
Q Consensus 236 s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 265 (448)
|+++.+||.+||+.||++|||++||+++-.
T Consensus 267 ~~~l~~li~~cl~~dP~~RPs~~ei~~~Le 296 (307)
T 3omv_A 267 PKAMKRLVADCVKKVKEERPLFPQILSSIE 296 (307)
T ss_dssp CHHHHHHHHHHTCSSSTTSCCHHHHHHHHH
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 999999999999999999999999987643
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-56 Score=444.81 Aligned_cols=261 Identities=40% Similarity=0.800 Sum_probs=241.2
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKI 85 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 85 (448)
....++|++.+.||+|+||.||+|++..+|+.||||++.+..... ...+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus 11 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 89 (328)
T 3fe3_A 11 QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNP-TSLQKLFREVRIMKILNHPNIVKLFEVIETEKTL 89 (328)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEE
Confidence 456889999999999999999999999999999999998765433 4457788999999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccccc
Q 037702 86 YFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQ 164 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~ 164 (448)
|+||||++||+|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||++.....
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~--- 166 (328)
T 3fe3_A 90 YLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV--- 166 (328)
T ss_dssp EEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS---
T ss_pred EEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCC---
Confidence 999999999999999865 7899999999999999999999999999999999999999999999999999975432
Q ss_pred CCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 037702 165 DGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLS 244 (448)
Q Consensus 165 ~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 244 (448)
.....+.+||+.|+|||++.+..+++.++|||||||++|+|++|+.||.+.+..++...+..+.+..|..+|+++.+||+
T Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 246 (328)
T 3fe3_A 167 GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLK 246 (328)
T ss_dssp SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred CCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 23346779999999999999888887899999999999999999999999999999999999999999999999999999
Q ss_pred hccCCCcCCCCCHHHHHhhhhccccc
Q 037702 245 RILDPNPSTRVTMAKLMENYWFRKGY 270 (448)
Q Consensus 245 ~~L~~dP~~Rpt~~eil~hp~~~~~~ 270 (448)
+||..||.+|||++|+++||||+...
T Consensus 247 ~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 247 RFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp HHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred HHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 99999999999999999999998654
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-57 Score=452.08 Aligned_cols=255 Identities=25% Similarity=0.420 Sum_probs=217.7
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCC-----CcEEEEEEeecccccchhHHHHHHHHHHHHHhCCC-CCcceEEEEE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKT-----GQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRH-PNIVQLYEVM 79 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~-----g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~h-pnIv~l~~~~ 79 (448)
.+..++|++++.||+|+||+||+|.+..+ ++.||||.+...... ...+.+.+|+.+|+.++| ||||+++++|
T Consensus 60 Ei~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~--~~~~~~~~E~~il~~l~hhpnIV~l~g~~ 137 (353)
T 4ase_A 60 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNLLGAC 137 (353)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred EecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccCh--HHHHHHHHHHHHHHHcCCCCcEEEEEEEE
Confidence 45568999999999999999999997654 367999999765332 335678999999999976 8999999998
Q ss_pred Ee-CCEEEEEEeecCCCchHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceE
Q 037702 80 AS-KTKIYFAMEYVRGGELFNKVAK-----------------GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLL 141 (448)
Q Consensus 80 ~~-~~~~~lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NIL 141 (448)
.+ +..+|||||||++|+|.+++.. ..+++..+..|+.||+.||+|||+++|+||||||+|||
T Consensus 138 ~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NIL 217 (353)
T 4ase_A 138 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 217 (353)
T ss_dssp CCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred EecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcccee
Confidence 66 4678999999999999999963 23889999999999999999999999999999999999
Q ss_pred EcCCCCeEEeeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHH-H
Q 037702 142 LDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLM-E 219 (448)
Q Consensus 142 l~~~g~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~-~ 219 (448)
++.++.+||+|||+|+............+.+||+.|||||++.+..|+ .++|||||||+||||+| |..||.+.+.. .
T Consensus 218 l~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~-~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~ 296 (353)
T 4ase_A 218 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 296 (353)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred eCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCC-CcccEeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999999865433222233456899999999999887775 89999999999999998 99999886643 4
Q ss_pred HHHHHhhc-cCCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 220 LYKKITRA-EFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 220 ~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
+...+..+ .+..|..+|+++.+||.+||+.||.+|||+++|++|
T Consensus 297 ~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 297 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 44555544 457888999999999999999999999999999998
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-56 Score=442.40 Aligned_cols=260 Identities=31% Similarity=0.614 Sum_probs=231.9
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEVMASKTK 84 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~ 84 (448)
.+..++|++.+.||+|+||.||+|++..+|+.||||++.+.........+.+.+|+.+++.+ +||||+++++++.+.+.
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 98 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR 98 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence 45678999999999999999999999999999999999876554445567788999999988 79999999999999999
Q ss_pred EEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccc
Q 037702 85 IYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTR 163 (448)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~ 163 (448)
+|+||||++||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|.....
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~-- 176 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC-- 176 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeeccc--
Confidence 9999999999999999976 7899999999999999999999999999999999999999999999999999975322
Q ss_pred cCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 037702 164 QDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLL 243 (448)
Q Consensus 164 ~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 243 (448)
......+.|||+.|+|||++.+..|. .++|||||||++|+|++|..||.+.+..+++.++......+|.++++++.+||
T Consensus 177 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li 255 (353)
T 3txo_A 177 NGVTTATFCGTPDYIAPEILQEMLYG-PAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGIL 255 (353)
T ss_dssp ---------CCGGGCCHHHHHHHHCT-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred CCccccccCCCcCeEChhhcCCCCcC-CccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 12234567999999999999887775 88999999999999999999999999999999999999999999999999999
Q ss_pred HhccCCCcCCCCCH------HHHHhhhhccc
Q 037702 244 SRILDPNPSTRVTM------AKLMENYWFRK 268 (448)
Q Consensus 244 ~~~L~~dP~~Rpt~------~eil~hp~~~~ 268 (448)
++||..||.+||++ +++++||||+.
T Consensus 256 ~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~ 286 (353)
T 3txo_A 256 KSFMTKNPTMRLGSLTQGGEHAILRHPFFKE 286 (353)
T ss_dssp HHHTCSSGGGSTTSGGGTCTHHHHTSGGGTT
T ss_pred HHHhhhCHHHccCCcccCCHHHHhhCCcccC
Confidence 99999999999999 89999999976
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-55 Score=436.26 Aligned_cols=259 Identities=38% Similarity=0.670 Sum_probs=236.8
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIY 86 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 86 (448)
+..++|++.+.||+|+||.||+|++..+|+.||||++.+...........+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 81 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence 45789999999999999999999999999999999998765433445677889999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccC
Q 037702 87 FAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQD 165 (448)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~ 165 (448)
+||||++||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++..... ..
T Consensus 82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~--~~ 159 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DG 159 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--TT
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhccc--CC
Confidence 99999999999999976 6899999999999999999999999999999999999999999999999999975322 22
Q ss_pred CCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHHHHh
Q 037702 166 GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSR 245 (448)
Q Consensus 166 ~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 245 (448)
....+.+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+...++..+......+|..+|+++.+||.+
T Consensus 160 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 238 (337)
T 1o6l_A 160 ATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAG 238 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCB-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred CcccccccChhhCChhhhcCCCC-CchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 23456789999999999987776 48899999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCcCCCC-----CHHHHHhhhhccc
Q 037702 246 ILDPNPSTRV-----TMAKLMENYWFRK 268 (448)
Q Consensus 246 ~L~~dP~~Rp-----t~~eil~hp~~~~ 268 (448)
||..||.+|| +++++++||||+.
T Consensus 239 lL~~dP~~R~g~~~~~~~ei~~h~~f~~ 266 (337)
T 1o6l_A 239 LLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp HTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred HhhcCHHHhcCCCCCCHHHHHcCCCcCC
Confidence 9999999999 9999999999975
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-56 Score=441.98 Aligned_cols=264 Identities=39% Similarity=0.814 Sum_probs=236.9
Q ss_pred cccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 037702 5 AGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTK 84 (448)
Q Consensus 5 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 84 (448)
++...++|++.+.||+|+||.||+|.+..+|+.||||++.+...........+.+|+.+++.++||||+++++++.+.+.
T Consensus 4 ~~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 83 (336)
T 3h4j_B 4 SKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTD 83 (336)
T ss_dssp CCSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence 34578999999999999999999999999999999999987654443445678999999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccc
Q 037702 85 IYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTR 163 (448)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~ 163 (448)
+|+||||+ +|+|.+++.. +++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 84 ~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~-- 160 (336)
T 3h4j_B 84 IVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD-- 160 (336)
T ss_dssp EEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT--
T ss_pred EEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccC--
Confidence 99999999 7899888865 7899999999999999999999999999999999999999999999999999986432
Q ss_pred cCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 037702 164 QDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLL 243 (448)
Q Consensus 164 ~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 243 (448)
.....+.+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+.+...++.++....+..|..+|+++.+||
T Consensus 161 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 239 (336)
T 3h4j_B 161 -GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLI 239 (336)
T ss_dssp -SBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHHH
T ss_pred -CcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHHH
Confidence 2234567899999999999887776789999999999999999999999887777766777777788999999999999
Q ss_pred HhccCCCcCCCCCHHHHHhhhhccccccc
Q 037702 244 SRILDPNPSTRVTMAKLMENYWFRKGYKK 272 (448)
Q Consensus 244 ~~~L~~dP~~Rpt~~eil~hp~~~~~~~~ 272 (448)
++||..||.+|||++|+++||||+...+.
T Consensus 240 ~~~L~~dP~~Rpt~~eil~hp~~~~~~~~ 268 (336)
T 3h4j_B 240 RRMIVADPMQRITIQEIRRDPWFNVNLPD 268 (336)
T ss_dssp HTTSCSSGGGSCCHHHHTTCHHHHTTCCG
T ss_pred HHHcCCChhHCcCHHHHHhChhhccCCcc
Confidence 99999999999999999999999876543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-55 Score=429.66 Aligned_cols=256 Identities=36% Similarity=0.719 Sum_probs=236.4
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIY 86 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 86 (448)
...++|++.+.||+|+||.||+|++..+|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.+...+|
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 82 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 82 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence 46789999999999999999999999999999999998765444445677889999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccC
Q 037702 87 FAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQD 165 (448)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~ 165 (448)
+||||++||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~---- 158 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---- 158 (318)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS----
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC----
Confidence 99999999999999976 6799999999999999999999999999999999999999999999999999975432
Q ss_pred CCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHHHHh
Q 037702 166 GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSR 245 (448)
Q Consensus 166 ~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 245 (448)
...+.+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+....+.++......+|..+++++.+||.+
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~ 236 (318)
T 1fot_A 159 -VTYTLCGTPDYIAPEVVSTKPYN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSR 236 (318)
T ss_dssp -CBCCCCSCTTTCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred -ccccccCCccccCHhHhcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 23467899999999999877765 8899999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCcCCCC-----CHHHHHhhhhccc
Q 037702 246 ILDPNPSTRV-----TMAKLMENYWFRK 268 (448)
Q Consensus 246 ~L~~dP~~Rp-----t~~eil~hp~~~~ 268 (448)
||..||.+|| +++++++||||+.
T Consensus 237 lL~~dp~~R~~~~~~~~~~i~~hp~f~~ 264 (318)
T 1fot_A 237 LITRDLSQRLGNLQNGTEDVKNHPWFKE 264 (318)
T ss_dssp HTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred HhccCHHHcCCCcCCCHHHHhcCccccC
Confidence 9999999999 9999999999975
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-55 Score=435.19 Aligned_cols=260 Identities=31% Similarity=0.593 Sum_probs=235.2
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEVMASKTK 84 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~ 84 (448)
.+..++|++.+.||+|+||.||+|++..+|+.||||++.+.........+.+.+|..++..+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 46788999999999999999999999999999999999876543334456788899999876 99999999999999999
Q ss_pred EEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccc
Q 037702 85 IYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTR 163 (448)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~ 163 (448)
+|+||||++||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++.....
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~-- 170 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML-- 170 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC--
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhccc--
Confidence 9999999999999999976 7899999999999999999999999999999999999999999999999999975322
Q ss_pred cCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 037702 164 QDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLL 243 (448)
Q Consensus 164 ~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 243 (448)
......+.+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+..+++..+......+|.++++++++||
T Consensus 171 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 249 (345)
T 1xjd_A 171 GDAKTNTFCGTPDYIAPEILLGQKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLL 249 (345)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred CCCcccCCCCCcccCChhhhcCCCC-CChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHHHHHHH
Confidence 1223456799999999999988776 488999999999999999999999999999999999999999999999999999
Q ss_pred HhccCCCcCCCCCHH-HHHhhhhccc
Q 037702 244 SRILDPNPSTRVTMA-KLMENYWFRK 268 (448)
Q Consensus 244 ~~~L~~dP~~Rpt~~-eil~hp~~~~ 268 (448)
.+||..||.+||++. ++++||||+.
T Consensus 250 ~~lL~~dp~~R~~~~~~i~~hp~f~~ 275 (345)
T 1xjd_A 250 VKLFVREPEKRLGVRGDIRQHPLFRE 275 (345)
T ss_dssp HHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred HHHhcCCHhHcCCChHHHHcCccccC
Confidence 999999999999998 9999999976
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-54 Score=430.03 Aligned_cols=260 Identities=33% Similarity=0.586 Sum_probs=233.7
Q ss_pred cccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccch---hHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 037702 5 AGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRV---GLIDQIKREISVMRLVRHPNIVQLYEVMAS 81 (448)
Q Consensus 5 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~---~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~ 81 (448)
...+.++|++++.||+|+||.||+|++..+|+.||+|++.+...... ...+.+.+|+.+++.++||||+++++++.+
T Consensus 7 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 86 (361)
T 2yab_A 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN 86 (361)
T ss_dssp CSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CCChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe
Confidence 45677899999999999999999999999999999999987654321 134778999999999999999999999999
Q ss_pred CCEEEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCC----CeEEeecccc
Q 037702 82 KTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENG----DLKISDFGLS 156 (448)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g----~lkl~DFGla 156 (448)
...+|+||||++||+|++++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 9999999999999999999976 6799999999999999999999999999999999999998877 7999999999
Q ss_pred ccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCC----
Q 037702 157 ALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCP---- 232 (448)
Q Consensus 157 ~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p---- 232 (448)
...... ....+.+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+..+.+..+....+.++
T Consensus 167 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 242 (361)
T 2yab_A 167 HEIEDG---VEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFF 242 (361)
T ss_dssp EECCTT---CCCCCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHH
T ss_pred eEcCCC---CccccCCCCccEECchHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhc
Confidence 865332 23356789999999999987766 4889999999999999999999999999999999988877665
Q ss_pred CCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccc
Q 037702 233 NWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRK 268 (448)
Q Consensus 233 ~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 268 (448)
..+|+++++||.+||..||.+|||++|+++||||+.
T Consensus 243 ~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 278 (361)
T 2yab_A 243 SQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (361)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred cCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence 468999999999999999999999999999999974
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-54 Score=431.32 Aligned_cols=257 Identities=32% Similarity=0.648 Sum_probs=237.7
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKI 85 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 85 (448)
....++|++.+.||+|+||.||+|++..+|+.||||++.+.........+.+.+|+.+++.++||||+++++++.+...+
T Consensus 37 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 116 (350)
T 1rdq_E 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL 116 (350)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 45678999999999999999999999999999999999876554444567889999999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccccc
Q 037702 86 YFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQ 164 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~ 164 (448)
|+||||++||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 117 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~--- 193 (350)
T 1rdq_E 117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG--- 193 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS---
T ss_pred EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC---
Confidence 999999999999999976 7899999999999999999999999999999999999999999999999999985432
Q ss_pred CCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 037702 165 DGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLS 244 (448)
Q Consensus 165 ~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 244 (448)
...+.+||+.|+|||++.+..|. .++|||||||++|+|++|..||.+.+..+++.++..+...+|..+++++.+||.
T Consensus 194 --~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~ 270 (350)
T 1rdq_E 194 --RTWTLCGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270 (350)
T ss_dssp --CBCCCEECGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHH
T ss_pred --CcccccCCccccCHHHhcCCCCC-CcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 12456899999999999887764 889999999999999999999999999999999999999999999999999999
Q ss_pred hccCCCcCCCCC-----HHHHHhhhhccc
Q 037702 245 RILDPNPSTRVT-----MAKLMENYWFRK 268 (448)
Q Consensus 245 ~~L~~dP~~Rpt-----~~eil~hp~~~~ 268 (448)
+||..||.+||+ +++|++||||+.
T Consensus 271 ~lL~~dp~~R~~~~~~~~~ei~~h~~f~~ 299 (350)
T 1rdq_E 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp HHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred HHhhcCHHhccCCccCCHHHHHhCcCcCC
Confidence 999999999998 999999999975
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-54 Score=432.13 Aligned_cols=261 Identities=30% Similarity=0.550 Sum_probs=235.3
Q ss_pred cccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 037702 5 AGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEVMASKT 83 (448)
Q Consensus 5 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~ 83 (448)
..+..++|++.+.||+|+||.||+|++..+|+.||||++.+.........+.+.+|..++..+ +||||+++++++.+.+
T Consensus 15 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~ 94 (353)
T 2i0e_A 15 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 94 (353)
T ss_dssp ----CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSS
T ss_pred CCCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCC
Confidence 346788999999999999999999999999999999999876544444567788999999987 8999999999999999
Q ss_pred EEEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccc
Q 037702 84 KIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQEST 162 (448)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~ 162 (448)
.+|+||||++||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++.....
T Consensus 95 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~- 173 (353)
T 2i0e_A 95 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW- 173 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc-
Confidence 99999999999999999976 7899999999999999999999999999999999999999999999999999975321
Q ss_pred ccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHH
Q 037702 163 RQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKL 242 (448)
Q Consensus 163 ~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 242 (448)
......+.+||+.|+|||++.+..| +.++|||||||++|+|++|+.||.+.+..+++..+......+|..+|+++.+|
T Consensus 174 -~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 251 (353)
T 2i0e_A 174 -DGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAI 251 (353)
T ss_dssp -TTCCBCCCCSCGGGCCHHHHTTCCB-STHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred -CCcccccccCCccccChhhhcCCCc-CCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 1223456799999999999988777 48899999999999999999999999999999999999999999999999999
Q ss_pred HHhccCCCcCCCC-----CHHHHHhhhhccc
Q 037702 243 LSRILDPNPSTRV-----TMAKLMENYWFRK 268 (448)
Q Consensus 243 i~~~L~~dP~~Rp-----t~~eil~hp~~~~ 268 (448)
|.+||..||.+|| +++++++||||+.
T Consensus 252 i~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~ 282 (353)
T 2i0e_A 252 CKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 282 (353)
T ss_dssp HHHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred HHHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence 9999999999999 4799999999975
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-54 Score=427.20 Aligned_cols=260 Identities=32% Similarity=0.583 Sum_probs=233.9
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEVMASKTK 84 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~ 84 (448)
.+..++|++.+.||+|+||.||+|++..+|+.||||++.+.........+.+.+|+.+++.+ +||||+++++++.+...
T Consensus 5 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 84 (345)
T 3a8x_A 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 84 (345)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCE
Confidence 45678999999999999999999999999999999999987766666677889999999988 89999999999999999
Q ss_pred EEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccc
Q 037702 85 IYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTR 163 (448)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~ 163 (448)
+|+||||++||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++.....
T Consensus 85 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~-- 162 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR-- 162 (345)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC--
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccC--
Confidence 9999999999999999976 7899999999999999999999999999999999999999999999999999975322
Q ss_pred cCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCC---------CcHHHHHHHHhhccCCCCCC
Q 037702 164 QDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYD---------SNLMELYKKITRAEFKCPNW 234 (448)
Q Consensus 164 ~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~---------~~~~~~~~~i~~~~~~~p~~ 234 (448)
......+.+||+.|+|||++.+..| +.++|||||||++|+|++|+.||.. .+...++..+......+|..
T Consensus 163 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~ 241 (345)
T 3a8x_A 163 PGDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 241 (345)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTT
T ss_pred CCCcccccCCCccccCccccCCCCC-ChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCC
Confidence 1223456799999999999988777 4889999999999999999999975 33456677788888889999
Q ss_pred CCHHHHHHHHhccCCCcCCCCCH------HHHHhhhhccc
Q 037702 235 FPPEVRKLLSRILDPNPSTRVTM------AKLMENYWFRK 268 (448)
Q Consensus 235 ~s~~~~~li~~~L~~dP~~Rpt~------~eil~hp~~~~ 268 (448)
+|+++++||.+||..||.+||++ +++++||||+.
T Consensus 242 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~ 281 (345)
T 3a8x_A 242 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281 (345)
T ss_dssp SCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred CCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence 99999999999999999999995 89999999975
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-54 Score=437.55 Aligned_cols=260 Identities=31% Similarity=0.575 Sum_probs=230.3
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEVMASKTK 84 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~ 84 (448)
.+..++|++.+.||+|+||+||+|++..+|+.||||++.+.........+.+.+|..++..+ +||||+++++++.+.+.
T Consensus 48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 127 (396)
T 4dc2_A 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 127 (396)
T ss_dssp -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence 45678999999999999999999999999999999999887665545556788999999877 89999999999999999
Q ss_pred EEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccc
Q 037702 85 IYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTR 163 (448)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~ 163 (448)
+|+||||++||+|..++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 128 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~-- 205 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR-- 205 (396)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC--
T ss_pred EEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeeccc--
Confidence 9999999999999999976 7899999999999999999999999999999999999999999999999999974221
Q ss_pred cCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCC---------cHHHHHHHHhhccCCCCCC
Q 037702 164 QDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDS---------NLMELYKKITRAEFKCPNW 234 (448)
Q Consensus 164 ~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~---------~~~~~~~~i~~~~~~~p~~ 234 (448)
......+.|||+.|+|||++.+..|. .++|||||||++|+|++|+.||... ....++..+......+|..
T Consensus 206 ~~~~~~~~~gt~~Y~aPE~l~~~~~~-~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~ 284 (396)
T 4dc2_A 206 PGDTTSTFCGTPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 284 (396)
T ss_dssp TTCCBCCCCBCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTT
T ss_pred CCCccccccCCcccCCchhhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCc
Confidence 22334578999999999999887774 8899999999999999999999632 2345777888888999999
Q ss_pred CCHHHHHHHHhccCCCcCCCCCH------HHHHhhhhccc
Q 037702 235 FPPEVRKLLSRILDPNPSTRVTM------AKLMENYWFRK 268 (448)
Q Consensus 235 ~s~~~~~li~~~L~~dP~~Rpt~------~eil~hp~~~~ 268 (448)
+|+++++||++||+.||.+||++ +++++||||+.
T Consensus 285 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~ 324 (396)
T 4dc2_A 285 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324 (396)
T ss_dssp SCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred CCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccC
Confidence 99999999999999999999984 89999999975
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-53 Score=415.84 Aligned_cols=258 Identities=31% Similarity=0.537 Sum_probs=229.2
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKI 85 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 85 (448)
+...++|++.+.||+|+||.||+|.+..+|+.||||++....... .+.+.+|+.+++.++||||+++++++...+.+
T Consensus 16 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 92 (297)
T 3fxz_A 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDEL 92 (297)
T ss_dssp SCGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred CChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH---HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEE
Confidence 446789999999999999999999999999999999997654333 36788999999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccC
Q 037702 86 YFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQD 165 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~ 165 (448)
|+||||++||+|.+++....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 93 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~ 170 (297)
T 3fxz_A 93 WVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--Q 170 (297)
T ss_dssp EEEEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST--T
T ss_pred EEEEECCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCc--c
Confidence 99999999999999999888999999999999999999999999999999999999999999999999998754332 2
Q ss_pred CCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhc---cCCCCCCCCHHHHHH
Q 037702 166 GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA---EFKCPNWFPPEVRKL 242 (448)
Q Consensus 166 ~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~l 242 (448)
....+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+... ....|..+++.+.+|
T Consensus 171 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 249 (297)
T 3fxz_A 171 SKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF 249 (297)
T ss_dssp CCBCCCCSCGGGCCHHHHHCSCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHH
T ss_pred cccCCccCCcCccChhhhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHH
Confidence 22345689999999999988776 48999999999999999999999988776665555443 334566789999999
Q ss_pred HHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 243 LSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 243 i~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
|.+||+.||.+|||++++++||||+..
T Consensus 250 i~~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 250 LNRCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp HHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHHccCChhHCcCHHHHhhChhhccc
Confidence 999999999999999999999999754
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-54 Score=424.01 Aligned_cols=249 Identities=24% Similarity=0.361 Sum_probs=197.2
Q ss_pred cCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----E
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKT----K 84 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~----~ 84 (448)
..+|.+.+.||+|+||+||+|++ +|+.||||+++..... ......|+..+..++|||||++++++.+++ .
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~----~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~ 75 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER----SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHH----HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchh----hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceE
Confidence 45799999999999999999987 6899999999754321 123345677778899999999999997653 6
Q ss_pred EEEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CCEeecCCCCceEEcCCCCeEEeecccc
Q 037702 85 IYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSR--------GVYHRDLKPENLLLDENGDLKISDFGLS 156 (448)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~--------givHrDLkp~NILl~~~g~lkl~DFGla 156 (448)
+|||||||+||+|.+++...+++++.+.+++.|++.||+|||++ ||+||||||+||||+.++++||+|||+|
T Consensus 76 ~~lV~Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 76 LWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEecCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 89999999999999999988999999999999999999999987 9999999999999999999999999999
Q ss_pred cccccccc--CCCccccCCCCcccchhhhhccCC-----CCCcchHHHHHHHHHHHHhCCCCCCC---------------
Q 037702 157 ALQESTRQ--DGLLHTTCGTPAYVAPEVINKRGY-----DGAKADIWSCGVVLFVLLAGNLPFYD--------------- 214 (448)
Q Consensus 157 ~~~~~~~~--~~~~~~~~Gt~~Y~APEvl~~~~~-----~~~~sDiwSlGvil~elltG~~Pf~~--------------- 214 (448)
+....... .....+.+||+.|||||++.+... ++.++|||||||+||||+||.+||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 86543322 122335689999999999965421 24689999999999999999776532
Q ss_pred CcHHHHHHHHhhccC--CCCCC-----CCHHHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 215 SNLMELYKKITRAEF--KCPNW-----FPPEVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 215 ~~~~~~~~~i~~~~~--~~p~~-----~s~~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
.....+...+..... .+|.. .++.+.+|+.+||+.||++|||+.||++.
T Consensus 236 ~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred chHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 122344444433322 23332 22468899999999999999999999874
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-53 Score=421.78 Aligned_cols=263 Identities=35% Similarity=0.651 Sum_probs=225.8
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIY 86 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 86 (448)
.+.++|++.+.||+|+||.||+|++..+|+.||||++...... ...+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 4 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 81 (323)
T 3tki_A 4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQY 81 (323)
T ss_dssp TTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc--chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 3678999999999999999999999999999999999765432 22366889999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccC
Q 037702 87 FAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQD 165 (448)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~ 165 (448)
+||||++||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 99999999999999976 57999999999999999999999999999999999999999999999999999866544444
Q ss_pred CCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHH-HHHHHHhhccCCCC--CCCCHHHHHH
Q 037702 166 GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLM-ELYKKITRAEFKCP--NWFPPEVRKL 242 (448)
Q Consensus 166 ~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~~~~~p--~~~s~~~~~l 242 (448)
......+||+.|+|||++.+..+.+.++|||||||++|+|++|..||...+.. ..+..+.......+ ..+++++.+|
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHH
Confidence 44556789999999999988777678899999999999999999999875543 33333333333322 4589999999
Q ss_pred HHhccCCCcCCCCCHHHHHhhhhcccccc
Q 037702 243 LSRILDPNPSTRVTMAKLMENYWFRKGYK 271 (448)
Q Consensus 243 i~~~L~~dP~~Rpt~~eil~hp~~~~~~~ 271 (448)
|.+||..||.+|||++|+++||||++...
T Consensus 242 i~~~L~~dP~~R~t~~eil~h~~~~~~~~ 270 (323)
T 3tki_A 242 LHKILVENPSARITIPDIKKDRWYNKPLK 270 (323)
T ss_dssp HHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred HHHHccCChhhCcCHHHHhhChhhccccc
Confidence 99999999999999999999999987543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-54 Score=437.63 Aligned_cols=262 Identities=31% Similarity=0.565 Sum_probs=231.3
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIY 86 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 86 (448)
+..++|++.+.||+|+||.||+|++..+|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.+...+|
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 145 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 145 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 45689999999999999999999999999999999998754333233355789999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCC
Q 037702 87 FAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDG 166 (448)
Q Consensus 87 lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 166 (448)
+||||++||+|.+++..+++++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|........ .
T Consensus 146 lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~-~ 224 (410)
T 3v8s_A 146 MVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-V 224 (410)
T ss_dssp EEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE-E
T ss_pred EEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCc-c
Confidence 999999999999999888999999999999999999999999999999999999999999999999999975432211 1
Q ss_pred CccccCCCCcccchhhhhccC---CCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhcc--CCCCC--CCCHHH
Q 037702 167 LLHTTCGTPAYVAPEVINKRG---YDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAE--FKCPN--WFPPEV 239 (448)
Q Consensus 167 ~~~~~~Gt~~Y~APEvl~~~~---~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~--~~s~~~ 239 (448)
...+.+||+.|+|||++.+.+ +++.++|||||||++|+|++|+.||.+.+..+.+.+|.... +.+|. .+|+++
T Consensus 225 ~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~ 304 (410)
T 3v8s_A 225 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEA 304 (410)
T ss_dssp ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHH
T ss_pred cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHHH
Confidence 234678999999999997654 23588999999999999999999999999999999887653 44554 689999
Q ss_pred HHHHHhccCCCcCC--CCCHHHHHhhhhcccc
Q 037702 240 RKLLSRILDPNPST--RVTMAKLMENYWFRKG 269 (448)
Q Consensus 240 ~~li~~~L~~dP~~--Rpt~~eil~hp~~~~~ 269 (448)
++||.+||..+|.+ ||+++||++||||+..
T Consensus 305 ~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~ 336 (410)
T 3v8s_A 305 KNLICAFLTDREVRLGRNGVEEIKRHLFFKND 336 (410)
T ss_dssp HHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred HHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence 99999999999998 9999999999999863
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-53 Score=426.13 Aligned_cols=260 Identities=33% Similarity=0.670 Sum_probs=232.0
Q ss_pred cccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 037702 5 AGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTK 84 (448)
Q Consensus 5 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 84 (448)
+..+.++|++.+.||+|+||.||+|.+..+|+.||+|++....... ...+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 24 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~ 102 (362)
T 2bdw_A 24 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHPNIVRLHDSIQEESF 102 (362)
T ss_dssp CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred CCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence 3455678999999999999999999999999999999998765443 345778999999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCC---CeEEeecccccccc
Q 037702 85 IYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENG---DLKISDFGLSALQE 160 (448)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g---~lkl~DFGla~~~~ 160 (448)
.|+||||++||+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 103 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp EEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 9999999999999999875 6799999999999999999999999999999999999998654 59999999997654
Q ss_pred ccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCC----CCC
Q 037702 161 STRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPN----WFP 236 (448)
Q Consensus 161 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s 236 (448)
. .......+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+...++..+..+.+.+|. .++
T Consensus 183 ~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 258 (362)
T 2bdw_A 183 D---SEAWHGFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVT 258 (362)
T ss_dssp T---CCSCCCSCSCTTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSC
T ss_pred C---CcccccCCCCccccCHHHHccCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCC
Confidence 2 2233467899999999999877664 8899999999999999999999999988999988888776553 479
Q ss_pred HHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 237 PEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 237 ~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
+++++||.+||..||.+|||++++++||||+..
T Consensus 259 ~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 291 (362)
T 2bdw_A 259 PEAKSLIDSMLTVNPKKRITADQALKVPWICNR 291 (362)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence 999999999999999999999999999999753
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-53 Score=408.67 Aligned_cols=263 Identities=37% Similarity=0.713 Sum_probs=235.7
Q ss_pred cccccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 037702 3 KKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASK 82 (448)
Q Consensus 3 ~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~ 82 (448)
++.....++|++.+.||+|+||.||+|.+..++..||+|++.+...........+.+|+.+++.++||||+++++++.+.
T Consensus 2 k~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 81 (279)
T 3fdn_A 2 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA 81 (279)
T ss_dssp --CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred CcceeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecC
Confidence 45677889999999999999999999999999999999999876554444567789999999999999999999999999
Q ss_pred CEEEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccc
Q 037702 83 TKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQES 161 (448)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~ 161 (448)
...|+||||+++|+|.+++.. +++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 82 TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp SEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 999999999999999999976 7899999999999999999999999999999999999999999999999999864332
Q ss_pred cccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHH
Q 037702 162 TRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRK 241 (448)
Q Consensus 162 ~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ 241 (448)
. .....+||+.|+|||++.+..+ +.++||||||+++|+|++|..||...+..+....+.......|..+++++.+
T Consensus 162 ~----~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (279)
T 3fdn_A 162 S----RRTDLCGTLDYLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 236 (279)
T ss_dssp ----------CCCCTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHH
T ss_pred c----cccccCCCCCccCHhHhccCCC-CccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHH
Confidence 2 2245689999999999977655 4889999999999999999999999999999999999899999999999999
Q ss_pred HHHhccCCCcCCCCCHHHHHhhhhccccc
Q 037702 242 LLSRILDPNPSTRVTMAKLMENYWFRKGY 270 (448)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 270 (448)
||.+||..||.+|||++++++||||+...
T Consensus 237 li~~~l~~~p~~Rps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 237 LISRLLKHNPSQRPMLREVLEHPWITANS 265 (279)
T ss_dssp HHHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred HHHHHhccChhhCCCHHHHhhCccccCCc
Confidence 99999999999999999999999998754
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-53 Score=428.86 Aligned_cols=260 Identities=32% Similarity=0.567 Sum_probs=227.2
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHH-HHhCCCCCcceEEEEEEeCCE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISV-MRLVRHPNIVQLYEVMASKTK 84 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~-l~~l~hpnIv~l~~~~~~~~~ 84 (448)
....++|++.+.||+|+||.||+|++..+++.||||++.+...........+.+|..+ ++.++||||+++++++.+.+.
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~ 113 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK 113 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE
T ss_pred CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE
Confidence 4567899999999999999999999999999999999988766544445667777776 577899999999999999999
Q ss_pred EEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccc
Q 037702 85 IYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTR 163 (448)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~ 163 (448)
+|+||||++||+|.+++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++.....
T Consensus 114 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~-- 191 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE-- 191 (373)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC--
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccccc--
Confidence 9999999999999999976 7899999999999999999999999999999999999999999999999999975322
Q ss_pred cCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 037702 164 QDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLL 243 (448)
Q Consensus 164 ~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 243 (448)
......+.+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+..+++..+......+|+.+++++++||
T Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li 270 (373)
T 2r5t_A 192 HNSTTSTFCGTPEYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLL 270 (373)
T ss_dssp CCCCCCSBSCCCCCCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHHHHHH
T ss_pred CCCccccccCCccccCHHHhCCCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Confidence 22234567999999999999887775 88999999999999999999999999999999999998899999999999999
Q ss_pred HhccCCCcCCCCCH----HHHHhhhhccc
Q 037702 244 SRILDPNPSTRVTM----AKLMENYWFRK 268 (448)
Q Consensus 244 ~~~L~~dP~~Rpt~----~eil~hp~~~~ 268 (448)
.+||+.||.+||++ .++++||||+.
T Consensus 271 ~~lL~~dp~~R~~~~~~~~~i~~h~~f~~ 299 (373)
T 2r5t_A 271 EGLLQKDRTKRLGAKDDFMEIKSHVFFSL 299 (373)
T ss_dssp HHHTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred HHHcccCHHhCCCCCCCHHHHhCCccccC
Confidence 99999999999986 69999999975
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-53 Score=418.69 Aligned_cols=256 Identities=26% Similarity=0.474 Sum_probs=230.3
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYF 87 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 87 (448)
+.++|++.+.||+|+||.||+|.+..+|+.||+|.+.... .....+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 78 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEE
Confidence 5789999999999999999999999999999999997542 234668899999999999999999999999999999
Q ss_pred EEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcC--CCCeEEeeccccccccccc
Q 037702 88 AMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDE--NGDLKISDFGLSALQESTR 163 (448)
Q Consensus 88 V~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~--~g~lkl~DFGla~~~~~~~ 163 (448)
||||++||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++......
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~- 157 (321)
T 1tki_A 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG- 157 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred EEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC-
Confidence 9999999999999976 36999999999999999999999999999999999999987 789999999999865322
Q ss_pred cCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCC----CCCCHHH
Q 037702 164 QDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCP----NWFPPEV 239 (448)
Q Consensus 164 ~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~ 239 (448)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+....+.++ +.+|+++
T Consensus 158 --~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 234 (321)
T 1tki_A 158 --DNFRLLFTAPEYYAPEVHQHDVV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234 (321)
T ss_dssp --CEEEEEESCGGGSCHHHHTTCEE-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred --CccccccCChhhcCcHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHH
Confidence 22345689999999999976555 5899999999999999999999999998898888888877665 3689999
Q ss_pred HHHHHhccCCCcCCCCCHHHHHhhhhcccccc
Q 037702 240 RKLLSRILDPNPSTRVTMAKLMENYWFRKGYK 271 (448)
Q Consensus 240 ~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~ 271 (448)
.+||.+||..||.+|||+.|+++||||+....
T Consensus 235 ~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~ 266 (321)
T 1tki_A 235 MDFVDRLLVKERKSRMTASEALQHPWLKQKIE 266 (321)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSHHHHSCGG
T ss_pred HHHHHHHcCCChhHCcCHHHHhcChhhccCcc
Confidence 99999999999999999999999999987544
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-53 Score=428.04 Aligned_cols=262 Identities=26% Similarity=0.523 Sum_probs=234.4
Q ss_pred ccccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 037702 4 KAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKT 83 (448)
Q Consensus 4 ~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~ 83 (448)
.+.+..++|++.+.||+|+||.||+|++..+|+.||+|++.+.........+.+.+|+.+|+.++||||+++++++.+..
T Consensus 9 ~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 88 (384)
T 4fr4_A 9 NEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE 88 (384)
T ss_dssp CCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred CCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 45677899999999999999999999999999999999998766544455678899999999999999999999999999
Q ss_pred EEEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccc
Q 037702 84 KIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQEST 162 (448)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~ 162 (448)
.+|+||||+.||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~- 167 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR- 167 (384)
T ss_dssp EEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT-
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccC-
Confidence 99999999999999999976 5799999999999999999999999999999999999999999999999999986432
Q ss_pred ccCCCccccCCCCcccchhhhhcc--CCCCCcchHHHHHHHHHHHHhCCCCCCC---CcHHHHHHHHhhccCCCCCCCCH
Q 037702 163 RQDGLLHTTCGTPAYVAPEVINKR--GYDGAKADIWSCGVVLFVLLAGNLPFYD---SNLMELYKKITRAEFKCPNWFPP 237 (448)
Q Consensus 163 ~~~~~~~~~~Gt~~Y~APEvl~~~--~~~~~~sDiwSlGvil~elltG~~Pf~~---~~~~~~~~~i~~~~~~~p~~~s~ 237 (448)
.....+.+||+.|+|||++... ..++.++|||||||++|+|++|..||.. .........+......+|..+|+
T Consensus 168 --~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~ 245 (384)
T 4fr4_A 168 --ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQ 245 (384)
T ss_dssp --TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSCH
T ss_pred --CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCCH
Confidence 2334567999999999998642 2235889999999999999999999974 34566777777788889999999
Q ss_pred HHHHHHHhccCCCcCCCCC-HHHHHhhhhccc
Q 037702 238 EVRKLLSRILDPNPSTRVT-MAKLMENYWFRK 268 (448)
Q Consensus 238 ~~~~li~~~L~~dP~~Rpt-~~eil~hp~~~~ 268 (448)
++.+||.+||..||.+||+ ++++++||||+.
T Consensus 246 ~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~ 277 (384)
T 4fr4_A 246 EMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND 277 (384)
T ss_dssp HHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTT
T ss_pred HHHHHHHHHhcCCHhHhcccHHHHHcChhhhc
Confidence 9999999999999999998 999999999975
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-53 Score=413.78 Aligned_cols=261 Identities=34% Similarity=0.658 Sum_probs=223.9
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccc-----------------------hhHHHHHHHHHH
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRR-----------------------VGLIDQIKREIS 62 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~-----------------------~~~~~~~~~Ei~ 62 (448)
.+..++|++.+.||+|+||.||+|++..+|+.||||++.+..... ....+.+.+|+.
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 88 (298)
T 2zv2_A 9 CVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIA 88 (298)
T ss_dssp -CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHH
T ss_pred ceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHH
Confidence 356799999999999999999999999999999999997654321 112356889999
Q ss_pred HHHhCCCCCcceEEEEEEe--CCEEEEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCce
Q 037702 63 VMRLVRHPNIVQLYEVMAS--KTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENL 140 (448)
Q Consensus 63 ~l~~l~hpnIv~l~~~~~~--~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NI 140 (448)
+++.++||||+++++++.+ ...+|+||||+++++|.+++..+.+++..++.++.||+.||+|||++||+||||||+||
T Consensus 89 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni 168 (298)
T 2zv2_A 89 ILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNL 168 (298)
T ss_dssp HHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred HHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence 9999999999999999986 67899999999999999988778899999999999999999999999999999999999
Q ss_pred EEcCCCCeEEeeccccccccccccCCCccccCCCCcccchhhhhccCC--CCCcchHHHHHHHHHHHHhCCCCCCCCcHH
Q 037702 141 LLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGY--DGAKADIWSCGVVLFVLLAGNLPFYDSNLM 218 (448)
Q Consensus 141 Ll~~~g~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~--~~~~sDiwSlGvil~elltG~~Pf~~~~~~ 218 (448)
|++.++.+||+|||++...... .......+||+.|+|||++.+... .+.++|||||||++|+|++|..||.+.+..
T Consensus 169 l~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 246 (298)
T 2zv2_A 169 LVGEDGHIKIADFGVSNEFKGS--DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246 (298)
T ss_dssp EECTTSCEEECCCTTCEECSSS--SCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred EECCCCCEEEecCCCccccccc--cccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH
Confidence 9999999999999999864322 222345689999999999876542 357899999999999999999999998888
Q ss_pred HHHHHHhhccCCCC--CCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccc
Q 037702 219 ELYKKITRAEFKCP--NWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRK 268 (448)
Q Consensus 219 ~~~~~i~~~~~~~p--~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 268 (448)
.....+.......| ..+++++.+||.+||+.||.+|||+.|+++||||++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~ 298 (298)
T 2zv2_A 247 CLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298 (298)
T ss_dssp HHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred HHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence 88877777665554 468999999999999999999999999999999963
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-53 Score=435.64 Aligned_cols=260 Identities=35% Similarity=0.678 Sum_probs=231.2
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKI 85 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 85 (448)
..+.++|++.+.||+|+||.||+|.+..+|+.||+|++.+..... ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 7 ~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 85 (444)
T 3soa_A 7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSA-RDHQKLEREARICRLLKHPNIVRLHDSISEEGHH 85 (444)
T ss_dssp CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHH-HHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEE
T ss_pred ccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEE
Confidence 456789999999999999999999999999999999998765543 3356789999999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEc---CCCCeEEeeccccccccc
Q 037702 86 YFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLD---ENGDLKISDFGLSALQES 161 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~---~~g~lkl~DFGla~~~~~ 161 (448)
|+||||++||+|++.+.. +.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.....
T Consensus 86 ~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~ 165 (444)
T 3soa_A 86 YLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165 (444)
T ss_dssp EEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence 999999999999999865 6799999999999999999999999999999999999998 467899999999976543
Q ss_pred cccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCC----CCCH
Q 037702 162 TRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPN----WFPP 237 (448)
Q Consensus 162 ~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~ 237 (448)
. .......+||+.|+|||++.+..| +.++|||||||++|+|++|.+||.+.+..+.+..+..+.+.+|. .+|+
T Consensus 166 ~--~~~~~~~~gt~~Y~APE~l~~~~~-~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 242 (444)
T 3soa_A 166 E--QQAWFGFAGTPGYLSPEVLRKDPY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTP 242 (444)
T ss_dssp T--CCBCCCSCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred C--CceeecccCCcccCCHHHhcCCCC-CCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCH
Confidence 2 222345789999999999987766 48899999999999999999999999999999999888766553 5799
Q ss_pred HHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 238 EVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 238 ~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
++++||.+||+.||.+|||++|+++||||+..
T Consensus 243 ~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 243 EAKDLINKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred HHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence 99999999999999999999999999999764
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-53 Score=434.55 Aligned_cols=261 Identities=27% Similarity=0.512 Sum_probs=228.6
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIY 86 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 86 (448)
+..++|++.+.||+|+||+||+|++..+|+.||+|++.+...........+.+|+.++..++||||+++++++.+.+.+|
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~ 150 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLY 150 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEE
Confidence 45689999999999999999999999999999999998754433333345789999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccccc
Q 037702 87 FAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQ 164 (448)
Q Consensus 87 lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~ 164 (448)
+||||++||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|.......
T Consensus 151 lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~- 229 (437)
T 4aw2_A 151 LVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG- 229 (437)
T ss_dssp EEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS-
T ss_pred EEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCC-
Confidence 99999999999999976 689999999999999999999999999999999999999999999999999997543221
Q ss_pred CCCccccCCCCcccchhhhhc----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhc--cCCCCCC---C
Q 037702 165 DGLLHTTCGTPAYVAPEVINK----RGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA--EFKCPNW---F 235 (448)
Q Consensus 165 ~~~~~~~~Gt~~Y~APEvl~~----~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~---~ 235 (448)
.......+||+.|+|||++.. .+.++.++|||||||++|+|++|+.||.+.+..+.+.++... .+.+|.. +
T Consensus 230 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 309 (437)
T 4aw2_A 230 TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDV 309 (437)
T ss_dssp CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCS
T ss_pred CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccC
Confidence 112234689999999999962 333468999999999999999999999999999998888653 3555554 8
Q ss_pred CHHHHHHHHhccCCCcCC--CCCHHHHHhhhhccc
Q 037702 236 PPEVRKLLSRILDPNPST--RVTMAKLMENYWFRK 268 (448)
Q Consensus 236 s~~~~~li~~~L~~dP~~--Rpt~~eil~hp~~~~ 268 (448)
|+++++||++||..+|++ |++++|+++||||+.
T Consensus 310 s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~ 344 (437)
T 4aw2_A 310 SENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSG 344 (437)
T ss_dssp CHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTT
T ss_pred CHHHHHHHHHHhcccccccCCCCHHHHhCCCccCC
Confidence 999999999999998888 999999999999975
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-53 Score=404.96 Aligned_cols=267 Identities=45% Similarity=0.842 Sum_probs=231.7
Q ss_pred cccccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 037702 3 KKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASK 82 (448)
Q Consensus 3 ~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~ 82 (448)
..+.+..++|++++.||+|+||.||+|.+..+|+.||||++...........+.+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 83 (276)
T 2h6d_A 4 HDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP 83 (276)
T ss_dssp ---CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred ccCcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 34667889999999999999999999999999999999999876544444567889999999999999999999999999
Q ss_pred CEEEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccc
Q 037702 83 TKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQES 161 (448)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~ 161 (448)
+..|+||||+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 84 TDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 999999999999999999975 6899999999999999999999999999999999999999999999999999976432
Q ss_pred cccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHH
Q 037702 162 TRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRK 241 (448)
Q Consensus 162 ~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ 241 (448)
. ......+||+.|+|||++.+..+.+.++||||||+++|+|++|..||...+.......+.......|..+++++.+
T Consensus 164 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 240 (276)
T 2h6d_A 164 G---EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVAT 240 (276)
T ss_dssp ----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred C---cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHH
Confidence 2 2234567999999999998776666889999999999999999999999988888888888888889999999999
Q ss_pred HHHhccCCCcCCCCCHHHHHhhhhccccccc
Q 037702 242 LLSRILDPNPSTRVTMAKLMENYWFRKGYKK 272 (448)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~ 272 (448)
+|.+||+.||.+|||++++++||||++....
T Consensus 241 li~~~l~~~p~~Rps~~~~l~h~~~~~~~~~ 271 (276)
T 2h6d_A 241 LLMHMLQVDPLKRATIKDIREHEWFKQDLPS 271 (276)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHSHHHHTTCCG
T ss_pred HHHHHccCChhhCCCHHHHHhChhhccCchh
Confidence 9999999999999999999999999876543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=415.27 Aligned_cols=260 Identities=33% Similarity=0.609 Sum_probs=224.0
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEEC---CCCcEEEEEEeeccccc-chhHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNL---KTGQSVAIKIVDKEKIR-RVGLIDQIKREISVMRLVRHPNIVQLYEVMAS 81 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~ 81 (448)
.+..++|++.+.||+|+||.||+|++. .+|+.||+|++.+.... .......+.+|+.+++.++||||+++++++.+
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 92 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT 92 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence 467789999999999999999999985 68999999999876432 22234567899999999999999999999999
Q ss_pred CCEEEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccc
Q 037702 82 KTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQE 160 (448)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~ 160 (448)
.+.+|+||||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 93 GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172 (327)
T ss_dssp SSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred CCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence 9999999999999999999975 789999999999999999999999999999999999999999999999999987532
Q ss_pred ccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHH
Q 037702 161 STRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVR 240 (448)
Q Consensus 161 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~ 240 (448)
.. .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+.......|+.+++++.
T Consensus 173 ~~--~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 249 (327)
T 3a62_A 173 HD--GTVTHTFCGTIEYMAPEILMRSGH-NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEAR 249 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTTSCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCHHHH
T ss_pred cC--CccccccCCCcCccCHhhCcCCCC-CCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 22 122346789999999999987766 488999999999999999999999999999999999988999999999999
Q ss_pred HHHHhccCCCcCCCC-----CHHHHHhhhhccc
Q 037702 241 KLLSRILDPNPSTRV-----TMAKLMENYWFRK 268 (448)
Q Consensus 241 ~li~~~L~~dP~~Rp-----t~~eil~hp~~~~ 268 (448)
+||.+||..||.+|| +++++++||||+.
T Consensus 250 ~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~ 282 (327)
T 3a62_A 250 DLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH 282 (327)
T ss_dssp HHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSS
T ss_pred HHHHHHHhcCHhhccCCCCCCHHHHHcCCcccC
Confidence 999999999999999 8999999999975
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-53 Score=421.71 Aligned_cols=262 Identities=32% Similarity=0.662 Sum_probs=225.5
Q ss_pred ccccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccch--hHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 037702 4 KAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRV--GLIDQIKREISVMRLVRHPNIVQLYEVMAS 81 (448)
Q Consensus 4 ~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~ 81 (448)
....+.++|++.+.||+|+||.||+|.+..+|+.||||++........ ...+.+.+|+.+++.++||||+++++++.+
T Consensus 18 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 97 (351)
T 3c0i_A 18 DDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS 97 (351)
T ss_dssp --CCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred CCCccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 344567899999999999999999999999999999999976543211 134778999999999999999999999999
Q ss_pred CCEEEEEEeecCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCC---eEEeec
Q 037702 82 KTKIYFAMEYVRGGELFNKVAK-----GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGD---LKISDF 153 (448)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~---lkl~DF 153 (448)
.+.+|+||||++||+|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+||
T Consensus 98 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Df 177 (351)
T 3c0i_A 98 DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGF 177 (351)
T ss_dssp TTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred CCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecC
Confidence 9999999999999999888753 24899999999999999999999999999999999999987665 999999
Q ss_pred cccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCC-
Q 037702 154 GLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCP- 232 (448)
Q Consensus 154 Gla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p- 232 (448)
|++...... .......+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+ ...+..+..+.+..+
T Consensus 178 g~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~ 253 (351)
T 3c0i_A 178 GVAIQLGES--GLVAGGRVGTPHFMAPEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNP 253 (351)
T ss_dssp TTCEECCTT--SCBCCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCH
T ss_pred cceeEecCC--CeeecCCcCCcCccCHHHHcCCCC-CchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCc
Confidence 999865432 122345689999999999987766 489999999999999999999998754 456667776666554
Q ss_pred ---CCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 233 ---NWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 233 ---~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
..+|+++++||.+||..||.+|||+.++++||||+..
T Consensus 254 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 254 RQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 4689999999999999999999999999999999763
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-52 Score=414.33 Aligned_cols=259 Identities=32% Similarity=0.589 Sum_probs=230.4
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccch---hHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRV---GLIDQIKREISVMRLVRHPNIVQLYEVMASK 82 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~---~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~ 82 (448)
..+.++|++.+.||+|+||.||+|.+..+|+.||+|++.+...... ...+.+.+|+.+++.++||||+++++++.+.
T Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 86 (326)
T 2y0a_A 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK 86 (326)
T ss_dssp SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 4567789999999999999999999999999999999987543221 1357789999999999999999999999999
Q ss_pred CEEEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCC----CeEEeeccccc
Q 037702 83 TKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENG----DLKISDFGLSA 157 (448)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g----~lkl~DFGla~ 157 (448)
...|+||||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 87 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp SEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred CEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 999999999999999999976 6799999999999999999999999999999999999999888 89999999998
Q ss_pred cccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCC----C
Q 037702 158 LQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCP----N 233 (448)
Q Consensus 158 ~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~ 233 (448)
..... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+....+.++ .
T Consensus 167 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (326)
T 2y0a_A 167 KIDFG---NEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 242 (326)
T ss_dssp ECCTT---SCCCCCCSCTTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHT
T ss_pred ECCCC---CccccccCCcCcCCceeecCCCC-CcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccc
Confidence 65322 22345689999999999977666 4889999999999999999999999888888888877666554 4
Q ss_pred CCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccc
Q 037702 234 WFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRK 268 (448)
Q Consensus 234 ~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 268 (448)
.+|+.+.+||.+||..||.+|||++++++||||+.
T Consensus 243 ~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 277 (326)
T 2y0a_A 243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277 (326)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSC
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccC
Confidence 68999999999999999999999999999999975
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-53 Score=436.50 Aligned_cols=260 Identities=37% Similarity=0.657 Sum_probs=226.2
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKI 85 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 85 (448)
.+..++|++.+.||+|+||.||+|.+..+|+.||||++.+...........+.+|+.+++.++||||+++++++.+.+.+
T Consensus 144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 223 (446)
T 4ejn_A 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL 223 (446)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEE
T ss_pred CCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEE
Confidence 34678999999999999999999999999999999999876544444456778999999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCCEeecCCCCceEEcCCCCeEEeeccccccccccc
Q 037702 86 YFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHS-RGVYHRDLKPENLLLDENGDLKISDFGLSALQESTR 163 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~-~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~ 163 (448)
|+||||++||+|.+++.. +.+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+|.....
T Consensus 224 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~-- 301 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK-- 301 (446)
T ss_dssp EEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred EEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC--
Confidence 999999999999999875 679999999999999999999998 9999999999999999999999999999975322
Q ss_pred cCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 037702 164 QDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLL 243 (448)
Q Consensus 164 ~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 243 (448)
......+.+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+...++..+......+|..+++++.+||
T Consensus 302 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li 380 (446)
T 4ejn_A 302 DGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLL 380 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHTSCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred CCcccccccCCccccCHhhcCCCCC-CCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHH
Confidence 1223456789999999999987776 489999999999999999999999999999999999999999999999999999
Q ss_pred HhccCCCcCCCC-----CHHHHHhhhhccc
Q 037702 244 SRILDPNPSTRV-----TMAKLMENYWFRK 268 (448)
Q Consensus 244 ~~~L~~dP~~Rp-----t~~eil~hp~~~~ 268 (448)
.+||..||.+|| |++++++||||+.
T Consensus 381 ~~~L~~dP~~R~~~~~~t~~ell~hp~f~~ 410 (446)
T 4ejn_A 381 SGLLKKDPKQRLGGGSEDAKEIMQHRFFAG 410 (446)
T ss_dssp HHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred HHHcccCHHHhCCCCCCCHHHHHhCccccC
Confidence 999999999999 9999999999975
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=421.18 Aligned_cols=258 Identities=38% Similarity=0.700 Sum_probs=217.0
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIY 86 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 86 (448)
...++|++.+.||+|+||.||+|++..+|+.||||++....... +.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 92 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLA 92 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC----HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc----HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEE
Confidence 45689999999999999999999999999999999997654332 56789999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCC--eEEeeccccccccccc
Q 037702 87 FAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGD--LKISDFGLSALQESTR 163 (448)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~--lkl~DFGla~~~~~~~ 163 (448)
+||||++||+|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++......
T Consensus 93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~- 171 (361)
T 3uc3_A 93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 171 (361)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc-
Confidence 99999999999999865 78999999999999999999999999999999999999987775 999999998743221
Q ss_pred cCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCc----HHHHHHHHhhccCCCCC--CCCH
Q 037702 164 QDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSN----LMELYKKITRAEFKCPN--WFPP 237 (448)
Q Consensus 164 ~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~----~~~~~~~i~~~~~~~p~--~~s~ 237 (448)
......+||+.|+|||++.+..+++.++|||||||++|+|++|+.||.+.+ .......+....+..|. .+++
T Consensus 172 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 249 (361)
T 3uc3_A 172 --SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISP 249 (361)
T ss_dssp -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCH
T ss_pred --CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCH
Confidence 223456899999999999888887666999999999999999999998743 34555566666666655 4799
Q ss_pred HHHHHHHhccCCCcCCCCCHHHHHhhhhcccccc
Q 037702 238 EVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYK 271 (448)
Q Consensus 238 ~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~ 271 (448)
++.+||.+||..||.+|||++++++||||.+...
T Consensus 250 ~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~ 283 (361)
T 3uc3_A 250 ECCHLISRIFVADPATRISIPEIKTHSWFLKNLP 283 (361)
T ss_dssp HHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTCC
T ss_pred HHHHHHHHHccCChhHCcCHHHHHhCcchhcCCc
Confidence 9999999999999999999999999999987543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-52 Score=404.37 Aligned_cols=257 Identities=30% Similarity=0.498 Sum_probs=218.2
Q ss_pred cCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFA 88 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 88 (448)
+++|++.+.||+|+||.||+|.+..+|+.||||++...... ......+.+|+.+++.++||||+++++++.+++.+|+|
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 79 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS-TTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCc-CCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEE
Confidence 47899999999999999999999999999999999876533 34457788999999999999999999999999999999
Q ss_pred EeecCCCchHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCC
Q 037702 89 MEYVRGGELFNKVA--KGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDG 166 (448)
Q Consensus 89 ~E~~~gg~L~~~i~--~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 166 (448)
|||+++ +|.+.+. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 80 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~ 156 (292)
T 3o0g_A 80 FEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP--VR 156 (292)
T ss_dssp EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC--CS
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCc--cc
Confidence 999986 5555553 368999999999999999999999999999999999999999999999999999865322 22
Q ss_pred CccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCC-CCCCcHHHHHHHHhhccC----------------
Q 037702 167 LLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLP-FYDSNLMELYKKITRAEF---------------- 229 (448)
Q Consensus 167 ~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~P-f~~~~~~~~~~~i~~~~~---------------- 229 (448)
.....+||+.|+|||++.+....+.++|||||||++|+|++|..| |.+.+..+....+.....
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T 3o0g_A 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccc
Confidence 334568999999999998776557899999999999999988777 555665566555543110
Q ss_pred -------------CCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 230 -------------KCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 230 -------------~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
..++.+++++++||.+||+.||.+|||++|+++||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 1123478999999999999999999999999999999763
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-52 Score=403.49 Aligned_cols=262 Identities=33% Similarity=0.693 Sum_probs=237.0
Q ss_pred cccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 037702 5 AGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTK 84 (448)
Q Consensus 5 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 84 (448)
.....++|++.+.||+|+||.||+|.+..++..||||++...........+.+.+|+.+++.++||||+++++++.+...
T Consensus 9 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 88 (284)
T 2vgo_A 9 RKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKR 88 (284)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred cchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCE
Confidence 45678899999999999999999999999999999999987654444445778999999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccc
Q 037702 85 IYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTR 163 (448)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~ 163 (448)
.|+||||+++|+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~- 167 (284)
T 2vgo_A 89 IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL- 167 (284)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-
T ss_pred EEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc-
Confidence 9999999999999999976 68999999999999999999999999999999999999999999999999998654322
Q ss_pred cCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 037702 164 QDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLL 243 (448)
Q Consensus 164 ~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 243 (448)
.....+||+.|+|||++.+..+ +.++||||||+++|+|++|..||...+..+....+......+|..+++++.++|
T Consensus 168 ---~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 243 (284)
T 2vgo_A 168 ---RRRTMCGTLDYLPPEMIEGKTH-DEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLI 243 (284)
T ss_dssp ---CBCCCCSCGGGCCHHHHTTCCB-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHH
T ss_pred ---ccccccCCCCcCCHHHhccCCC-CcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHHHHHH
Confidence 2245689999999999987666 488999999999999999999999998888888888888889999999999999
Q ss_pred HhccCCCcCCCCCHHHHHhhhhcccccc
Q 037702 244 SRILDPNPSTRVTMAKLMENYWFRKGYK 271 (448)
Q Consensus 244 ~~~L~~dP~~Rpt~~eil~hp~~~~~~~ 271 (448)
.+||..||.+|||++++++||||+....
T Consensus 244 ~~~l~~~p~~Rps~~~ll~h~~~~~~~~ 271 (284)
T 2vgo_A 244 SKLLRYHPPQRLPLKGVMEHPWVKANSR 271 (284)
T ss_dssp HHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred HHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence 9999999999999999999999986543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-52 Score=423.34 Aligned_cols=263 Identities=26% Similarity=0.409 Sum_probs=213.7
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCC-
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR-HPNIVQLYEVMASKT- 83 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~- 83 (448)
..+.++|++.+.||+|+||.||+|.+..+|+.||||++.+.. ........+.+|+.+++.+. ||||+++++++...+
T Consensus 5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 83 (388)
T 3oz6_A 5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADND 83 (388)
T ss_dssp HHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTS
T ss_pred CcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCC
Confidence 356789999999999999999999999999999999996543 23344567889999999997 999999999997544
Q ss_pred -EEEEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccc
Q 037702 84 -KIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQEST 162 (448)
Q Consensus 84 -~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~ 162 (448)
.+|+||||++ ++|.+++..+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 84 ~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 162 (388)
T 3oz6_A 84 RDVYLVFDYME-TDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162 (388)
T ss_dssp SCEEEEEECCS-EEHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred CEEEEEecccC-cCHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence 7999999997 58999998889999999999999999999999999999999999999999999999999999754321
Q ss_pred -------------------ccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH
Q 037702 163 -------------------RQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKK 223 (448)
Q Consensus 163 -------------------~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~ 223 (448)
.........+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~ 242 (388)
T 3oz6_A 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER 242 (388)
T ss_dssp CCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 1112234568999999999998755556899999999999999999999999887777666
Q ss_pred HhhccC-----------------------------------------------CCCCCCCHHHHHHHHhccCCCcCCCCC
Q 037702 224 ITRAEF-----------------------------------------------KCPNWFPPEVRKLLSRILDPNPSTRVT 256 (448)
Q Consensus 224 i~~~~~-----------------------------------------------~~p~~~s~~~~~li~~~L~~dP~~Rpt 256 (448)
+...-. ..+..+++++.+||.+||..||.+|||
T Consensus 243 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t 322 (388)
T 3oz6_A 243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS 322 (388)
T ss_dssp HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC
Confidence 542100 011257899999999999999999999
Q ss_pred HHHHHhhhhccccc
Q 037702 257 MAKLMENYWFRKGY 270 (448)
Q Consensus 257 ~~eil~hp~~~~~~ 270 (448)
++|+++||||+...
T Consensus 323 ~~e~l~Hp~~~~~~ 336 (388)
T 3oz6_A 323 ANDALKHPFVSIFH 336 (388)
T ss_dssp HHHHTTSTTTTTTC
T ss_pred HHHHhCCHHHHHhc
Confidence 99999999997643
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-52 Score=428.74 Aligned_cols=261 Identities=30% Similarity=0.527 Sum_probs=227.3
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKI 85 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 85 (448)
.+..++|++.+.||+|+||.||+|++..+|+.||||++.+.........+.+.+|+.++..++||||+++++++.+.+.+
T Consensus 57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~ 136 (412)
T 2vd5_A 57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYL 136 (412)
T ss_dssp SCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred cCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence 35678999999999999999999999999999999999875443333445688999999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccc
Q 037702 86 YFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTR 163 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~ 163 (448)
|+||||++||+|.+++.+ ..+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++.......
T Consensus 137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~ 216 (412)
T 2vd5_A 137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG 216 (412)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCC
Confidence 999999999999999976 479999999999999999999999999999999999999999999999999997643221
Q ss_pred cCCCccccCCCCcccchhhhhc------cCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhc--cCCCC---
Q 037702 164 QDGLLHTTCGTPAYVAPEVINK------RGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA--EFKCP--- 232 (448)
Q Consensus 164 ~~~~~~~~~Gt~~Y~APEvl~~------~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p--- 232 (448)
. ....+.+||+.|+|||++.. .+.++.++|||||||++|+|++|+.||.+.+..+.+.+|... ...+|
T Consensus 217 ~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 295 (412)
T 2vd5_A 217 T-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVD 295 (412)
T ss_dssp C-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC---
T ss_pred c-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccc
Confidence 1 11235689999999999974 223358899999999999999999999999998888888753 24444
Q ss_pred CCCCHHHHHHHHhccCCCcCCC---CCHHHHHhhhhccc
Q 037702 233 NWFPPEVRKLLSRILDPNPSTR---VTMAKLMENYWFRK 268 (448)
Q Consensus 233 ~~~s~~~~~li~~~L~~dP~~R---pt~~eil~hp~~~~ 268 (448)
..+|+++++||++||. +|.+| |+++++++||||+.
T Consensus 296 ~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~ 333 (412)
T 2vd5_A 296 EGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFG 333 (412)
T ss_dssp -CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTT
T ss_pred cCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCC
Confidence 5799999999999999 99998 59999999999976
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-52 Score=407.64 Aligned_cols=260 Identities=29% Similarity=0.438 Sum_probs=217.0
Q ss_pred cccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 037702 5 AGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTK 84 (448)
Q Consensus 5 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 84 (448)
+..+.++|++.+.||+|+||.||+|++. +|+.||+|++...... ......+.+|+.+++.++||||+++++++.++..
T Consensus 16 ~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 93 (311)
T 3niz_A 16 FQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAED-EGIPSTAIREISLLKELHHPNIVSLIDVIHSERC 93 (311)
T ss_dssp EECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSC
T ss_pred ecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEeccccc-chhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCE
Confidence 4568899999999999999999999985 6999999999765432 2445778899999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccc
Q 037702 85 IYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQEST 162 (448)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~ 162 (448)
+|+||||+++ +|.+.+.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 94 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 94 LTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp EEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred EEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 9999999985 78887765 45999999999999999999999999999999999999999999999999999865322
Q ss_pred ccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccC-------------
Q 037702 163 RQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF------------- 229 (448)
Q Consensus 163 ~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~------------- 229 (448)
.......+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 173 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 250 (311)
T 3niz_A 173 --VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL 250 (311)
T ss_dssp --CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTS
T ss_pred --cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhcc
Confidence 12234568999999999997755556899999999999999999999987766555544432100
Q ss_pred -----------------CCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 230 -----------------KCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 230 -----------------~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
...+.+++++.+||.+||..||.+|||++|+++||||+.-
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 307 (311)
T 3niz_A 251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307 (311)
T ss_dssp HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence 0123467899999999999999999999999999999864
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-52 Score=418.99 Aligned_cols=260 Identities=22% Similarity=0.405 Sum_probs=219.5
Q ss_pred ccCCeEEEeeeeec--CceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 037702 8 LMNKYELGRLLGQG--TFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKI 85 (448)
Q Consensus 8 ~~~~y~~~~~LG~G--~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 85 (448)
..++|++.+.||+| +||.||+|++..+|+.||||++....... ...+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 101 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN-EMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL 101 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccCh-HHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence 56799999999999 99999999999999999999998765433 4567889999999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccc
Q 037702 86 YFAMEYVRGGELFNKVAK---GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQEST 162 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~ 162 (448)
|+||||+++|+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~ 181 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISH 181 (389)
T ss_dssp EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEET
T ss_pred EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeeccc
Confidence 999999999999999865 57999999999999999999999999999999999999999999999999998643221
Q ss_pred c-----cCCCccccCCCCcccchhhhhc--cCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccC------
Q 037702 163 R-----QDGLLHTTCGTPAYVAPEVINK--RGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF------ 229 (448)
Q Consensus 163 ~-----~~~~~~~~~Gt~~Y~APEvl~~--~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~------ 229 (448)
. ........+||+.|+|||++.+ ..| +.++|||||||++|+|++|+.||.+.+..+....+..+..
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 260 (389)
T 3gni_B 182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGY-DAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT 260 (389)
T ss_dssp TEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCB-CTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred cccccccccccccccccccccCHHHHhccCCCC-CcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccc
Confidence 1 1122334589999999999976 344 5889999999999999999999987655444333322111
Q ss_pred ----------------------------------------CCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 230 ----------------------------------------KCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 230 ----------------------------------------~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
..+..+++++.+||.+||+.||.+|||++|+++||||+..
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~ 340 (389)
T 3gni_B 261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 340 (389)
T ss_dssp ---------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC
T ss_pred cccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHH
Confidence 2345578999999999999999999999999999999764
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-51 Score=394.66 Aligned_cols=260 Identities=33% Similarity=0.669 Sum_probs=231.5
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKI 85 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 85 (448)
..+.++|++.+.||+|+||.||+|.+..+|+.||+|++....... ...+.+.+|+.+++.++||||+++++++.+....
T Consensus 2 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (284)
T 3kk8_A 2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHPNIVRLHDSIQEESFH 80 (284)
T ss_dssp CTTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred chhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCH-HHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEE
Confidence 456789999999999999999999999999999999998765443 3457788999999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCC---eEEeeccccccccc
Q 037702 86 YFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGD---LKISDFGLSALQES 161 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~---lkl~DFGla~~~~~ 161 (448)
|+||||++|++|.+.+.. +.+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||++.....
T Consensus 81 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 81 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 999999999999888865 67999999999999999999999999999999999999987665 99999999975432
Q ss_pred cccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCC----CCCCH
Q 037702 162 TRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCP----NWFPP 237 (448)
Q Consensus 162 ~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~ 237 (448)
. .......||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+.+.......+.......| ..+++
T Consensus 161 ~---~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T 3kk8_A 161 S---EAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTP 236 (284)
T ss_dssp S---CBCCCSCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred C---ccccCCCCCcCCcCchhhcCCCC-CcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCH
Confidence 2 22345689999999999987666 4889999999999999999999999998888888887766554 35789
Q ss_pred HHHHHHHhccCCCcCCCCCHHHHHhhhhccccc
Q 037702 238 EVRKLLSRILDPNPSTRVTMAKLMENYWFRKGY 270 (448)
Q Consensus 238 ~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 270 (448)
++.+||.+||+.||.+|||++++++||||+...
T Consensus 237 ~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (284)
T 3kk8_A 237 EAKSLIDSMLTVNPKKRITADQALKVPWICNRE 269 (284)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred HHHHHHHHHcccChhhCCCHHHHhcCccccCCh
Confidence 999999999999999999999999999997643
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-52 Score=402.08 Aligned_cols=255 Identities=31% Similarity=0.515 Sum_probs=215.5
Q ss_pred cCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFA 88 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 88 (448)
+++|++.+.||+|+||.||+|++ .+|+.||+|++....... ...+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDE-GIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGG-CCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccccc-ccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEE
Confidence 47899999999999999999998 689999999997654322 2346788999999999999999999999999999999
Q ss_pred EeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCC
Q 037702 89 MEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDG 166 (448)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 166 (448)
|||+++ +|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~ 155 (288)
T 1ob3_A 79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV--R 155 (288)
T ss_dssp EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc--c
Confidence 999986 89888865 679999999999999999999999999999999999999999999999999997653221 1
Q ss_pred CccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccC-----------------
Q 037702 167 LLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF----------------- 229 (448)
Q Consensus 167 ~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~----------------- 229 (448)
.....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccc
Confidence 234567999999999997655556899999999999999999999998877666655533100
Q ss_pred ------------CCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccc
Q 037702 230 ------------KCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRK 268 (448)
Q Consensus 230 ------------~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 268 (448)
..+..+++++.+||.+||..||.+|||++|+++||||+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 112347899999999999999999999999999999975
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-52 Score=413.38 Aligned_cols=255 Identities=33% Similarity=0.605 Sum_probs=222.2
Q ss_pred cccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 037702 5 AGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEVMASKT 83 (448)
Q Consensus 5 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~ 83 (448)
+..+.++|++.+.||+|+||.||+|.+..+|+.||||++.+.... ..+|+.++.++ +||||+++++++.+..
T Consensus 17 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~~ 89 (342)
T 2qr7_A 17 SIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDGK 89 (342)
T ss_dssp --CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECSS
T ss_pred ccCccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcCC
Confidence 445678999999999999999999999999999999999866422 23688888877 7999999999999999
Q ss_pred EEEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCC-C---CeEEeecccccc
Q 037702 84 KIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDEN-G---DLKISDFGLSAL 158 (448)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~-g---~lkl~DFGla~~ 158 (448)
.+|+||||++||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||+..+ + .+||+|||++..
T Consensus 90 ~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 90 YVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp EEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 99999999999999999876 679999999999999999999999999999999999998543 3 499999999986
Q ss_pred ccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCC---CcHHHHHHHHhhccCCCC---
Q 037702 159 QESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYD---SNLMELYKKITRAEFKCP--- 232 (448)
Q Consensus 159 ~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~---~~~~~~~~~i~~~~~~~p--- 232 (448)
.... .....+.+||+.|+|||++.+.+|+ .++|||||||++|+|++|..||.. .+..++...+..+.+..+
T Consensus 170 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 246 (342)
T 2qr7_A 170 LRAE--NGLLMTPCYTANFVAPEVLERQGYD-AACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGY 246 (342)
T ss_dssp CBCT--TCCBCCSSCCSSCCCHHHHHHHHHH-HHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTT
T ss_pred CcCC--CCceeccCCCccccCHHHhcCCCCC-CccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccc
Confidence 4332 2334567999999999999877665 789999999999999999999975 456678888888776654
Q ss_pred -CCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 233 -NWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 233 -~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
..+|+++++||.+||..||.+|||++++++||||...
T Consensus 247 ~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 247 WNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp TTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred cccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence 4589999999999999999999999999999999753
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=417.02 Aligned_cols=260 Identities=27% Similarity=0.547 Sum_probs=229.7
Q ss_pred cccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 037702 5 AGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTK 84 (448)
Q Consensus 5 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 84 (448)
.+.+.++|++.+.||+|+||.||+|.+..+|+.||+|++...... ....+.+|+.+|+.++||||+++++++.+...
T Consensus 46 ~~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~---~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~ 122 (387)
T 1kob_A 46 QGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL---DKYTVKNEISIMNQLHHPKLINLHDAFEDKYE 122 (387)
T ss_dssp CSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH---HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSE
T ss_pred CCccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchh---hHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCE
Confidence 345678999999999999999999999999999999999765322 23578899999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcC--CCCeEEeecccccccc
Q 037702 85 IYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDE--NGDLKISDFGLSALQE 160 (448)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~--~g~lkl~DFGla~~~~ 160 (448)
+|+||||++||+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++....
T Consensus 123 ~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~ 202 (387)
T 1kob_A 123 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 202 (387)
T ss_dssp EEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred EEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecC
Confidence 9999999999999999975 36999999999999999999999999999999999999974 4779999999998643
Q ss_pred ccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCC----CCCC
Q 037702 161 STRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCP----NWFP 236 (448)
Q Consensus 161 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s 236 (448)
. .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+....+.++ ..+|
T Consensus 203 ~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 278 (387)
T 1kob_A 203 P---DEIVKVTTATAEFAAPEIVDREPV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVS 278 (387)
T ss_dssp T---TSCEEEECSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSC
T ss_pred C---CcceeeeccCCCccCchhccCCCC-CCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCC
Confidence 2 223345689999999999987666 4889999999999999999999999988888888877765443 3579
Q ss_pred HHHHHHHHhccCCCcCCCCCHHHHHhhhhcccccc
Q 037702 237 PEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYK 271 (448)
Q Consensus 237 ~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~ 271 (448)
+++.+||.+||..||.+|||++++++||||+....
T Consensus 279 ~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 313 (387)
T 1kob_A 279 PEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS 313 (387)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHhhCccccCCcc
Confidence 99999999999999999999999999999987543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-52 Score=437.72 Aligned_cols=260 Identities=27% Similarity=0.459 Sum_probs=233.1
Q ss_pred cccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 037702 5 AGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTK 84 (448)
Q Consensus 5 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 84 (448)
..+..++|++.+.||+|+||.||+|++..+|+.||||++.+...........+.+|+.+|+.++||||+++++++.+.+.
T Consensus 179 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 258 (576)
T 2acx_A 179 QPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDA 258 (576)
T ss_dssp SCCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cCccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCE
Confidence 34677899999999999999999999999999999999987655444455778899999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHhc-C--CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccc
Q 037702 85 IYFAMEYVRGGELFNKVAK-G--KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQES 161 (448)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~--~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~ 161 (448)
+|+||||++||+|.+++.. + .+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|.....
T Consensus 259 l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 259 LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp EEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 9999999999999999875 2 499999999999999999999999999999999999999999999999999976432
Q ss_pred cccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCC----cHHHHHHHHhhccCCCCCCCCH
Q 037702 162 TRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDS----NLMELYKKITRAEFKCPNWFPP 237 (448)
Q Consensus 162 ~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~----~~~~~~~~i~~~~~~~p~~~s~ 237 (448)
.....+.+||+.|+|||++.+..|. .++|||||||++|+|++|..||... ....+...+......+|..+|+
T Consensus 339 ---~~~~~~~~GT~~Y~APEvl~~~~~~-~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~ 414 (576)
T 2acx_A 339 ---GQTIKGRVGTVGYMAPEVVKNERYT-FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSP 414 (576)
T ss_dssp ---TCCEECCCSCGGGCCHHHHTTCEES-SHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCH
T ss_pred ---CccccccCCCccccCHHHHcCCCCC-ccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCH
Confidence 2223456999999999999877664 8899999999999999999999875 3456777777777788899999
Q ss_pred HHHHHHHhccCCCcCCCC-----CHHHHHhhhhccc
Q 037702 238 EVRKLLSRILDPNPSTRV-----TMAKLMENYWFRK 268 (448)
Q Consensus 238 ~~~~li~~~L~~dP~~Rp-----t~~eil~hp~~~~ 268 (448)
++++||.+||..||.+|| +++|+++||||+.
T Consensus 415 ~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~ 450 (576)
T 2acx_A 415 QARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450 (576)
T ss_dssp HHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred HHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence 999999999999999999 8999999999975
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-51 Score=398.29 Aligned_cols=262 Identities=33% Similarity=0.579 Sum_probs=238.1
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIY 86 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 86 (448)
...++|++.+.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 91 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence 45679999999999999999999999999999999998776555556678999999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccC
Q 037702 87 FAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQD 165 (448)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~ 165 (448)
+||||+++++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-- 169 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-- 169 (294)
T ss_dssp EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT--
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCc--
Confidence 99999999999999876 679999999999999999999999999999999999999999999999999998643221
Q ss_pred CCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHHHHh
Q 037702 166 GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSR 245 (448)
Q Consensus 166 ~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 245 (448)
......+||+.|+|||++.+..+ +.++||||||+++|+|++|..||...+..+.+..+.......|..+++.+.++|.+
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 248 (294)
T 2rku_A 170 ERKKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK 248 (294)
T ss_dssp CCBCCCCSCCSSCCHHHHTTSCB-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHH
T ss_pred cccccccCCCCcCCcchhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHHHHHHHH
Confidence 22345679999999999977665 48899999999999999999999999888888888888888899999999999999
Q ss_pred ccCCCcCCCCCHHHHHhhhhcccccc
Q 037702 246 ILDPNPSTRVTMAKLMENYWFRKGYK 271 (448)
Q Consensus 246 ~L~~dP~~Rpt~~eil~hp~~~~~~~ 271 (448)
||..||.+|||++++++||||+....
T Consensus 249 ~l~~~p~~Rps~~~ll~~~~~~~~~~ 274 (294)
T 2rku_A 249 MLQTDPTARPTINELLNDEFFTSGYI 274 (294)
T ss_dssp HTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred HcccChhhCcCHHHHhhChheecCCc
Confidence 99999999999999999999987653
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-52 Score=408.77 Aligned_cols=259 Identities=31% Similarity=0.510 Sum_probs=207.7
Q ss_pred cCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFA 88 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 88 (448)
.++|++.+.||+|+||.||+|.+..+|+.||||++...... ...+.+.+|+.+++.++||||+++++++.+++.+|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 81 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE--GTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV 81 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTT--CSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccc--ccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence 57899999999999999999999999999999999765422 2236678999999999999999999999999999999
Q ss_pred EeecCCCchHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccc
Q 037702 89 MEYVRGGELFNKVAK-------GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQES 161 (448)
Q Consensus 89 ~E~~~gg~L~~~i~~-------~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~ 161 (448)
|||++ |+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 99998 499888854 3589999999999999999999999999999999999999999999999999986532
Q ss_pred cccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhcc-------------
Q 037702 162 TRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAE------------- 228 (448)
Q Consensus 162 ~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~------------- 228 (448)
.. ......+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 161 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (317)
T 2pmi_A 161 PV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK 238 (317)
T ss_dssp CC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGG
T ss_pred Cc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhh
Confidence 21 223456899999999999765555689999999999999999999999988777666654310
Q ss_pred ---------------------CCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccccccc
Q 037702 229 ---------------------FKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYKK 272 (448)
Q Consensus 229 ---------------------~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~ 272 (448)
...+..+++++.+||.+||..||.+|||++|+++||||++.+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 303 (317)
T 2pmi_A 239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHH 303 (317)
T ss_dssp CTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred hhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccch
Confidence 01122478899999999999999999999999999999876543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-51 Score=429.38 Aligned_cols=263 Identities=32% Similarity=0.604 Sum_probs=230.5
Q ss_pred ccccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccch----------hHHHHHHHHHHHHHhCCCCCcc
Q 037702 4 KAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRV----------GLIDQIKREISVMRLVRHPNIV 73 (448)
Q Consensus 4 ~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~----------~~~~~~~~Ei~~l~~l~hpnIv 73 (448)
..+.+.++|++++.||+|+||.||+|.+..+++.||||++.+...... ...+.+.+|+.+++.++||||+
T Consensus 30 ~~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv 109 (504)
T 3q5i_A 30 KEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNII 109 (504)
T ss_dssp ECSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBC
T ss_pred cCCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCC
Confidence 346678999999999999999999999999999999999987653321 3357789999999999999999
Q ss_pred eEEEEEEeCCEEEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCC---CeE
Q 037702 74 QLYEVMASKTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENG---DLK 149 (448)
Q Consensus 74 ~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g---~lk 149 (448)
++++++.+...+|+|||||+||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+|
T Consensus 110 ~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 110 KLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp CEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEE
T ss_pred eEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEE
Confidence 999999999999999999999999998865 7899999999999999999999999999999999999999876 699
Q ss_pred EeeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccC
Q 037702 150 ISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF 229 (448)
Q Consensus 150 l~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~ 229 (448)
|+|||++...... ......+||+.|+|||++.+ .| +.++|||||||++|+|++|..||.+.+..++...+..+.+
T Consensus 190 l~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~ 264 (504)
T 3q5i_A 190 IVDFGLSSFFSKD---YKLRDRLGTAYYIAPEVLKK-KY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKY 264 (504)
T ss_dssp ECCCTTCEECCTT---SCBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred EEECCCCEEcCCC---CccccccCCcCCCCHHHhcc-CC-CchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC
Confidence 9999999865332 23456789999999999864 44 5899999999999999999999999999999999988877
Q ss_pred CCC----CCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccccc
Q 037702 230 KCP----NWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYK 271 (448)
Q Consensus 230 ~~p----~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~ 271 (448)
.++ ..+|+++++||.+||..||.+|||++++++||||+....
T Consensus 265 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 310 (504)
T 3q5i_A 265 YFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN 310 (504)
T ss_dssp CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred CCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence 655 568999999999999999999999999999999987543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-52 Score=431.56 Aligned_cols=259 Identities=25% Similarity=0.443 Sum_probs=215.0
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC----
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASK---- 82 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~---- 82 (448)
.+.++|++++.||+|+||.||+|.+..+|+.||||++.+.. ......+.+.+|+.+|+.++||||+++++++...
T Consensus 59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 137 (464)
T 3ttj_A 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLE 137 (464)
T ss_dssp EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTT
T ss_pred eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccc
Confidence 35689999999999999999999999999999999998653 2334457788999999999999999999999654
Q ss_pred --CEEEEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccc
Q 037702 83 --TKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQE 160 (448)
Q Consensus 83 --~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~ 160 (448)
..+|+||||+++ +|.+.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|....
T Consensus 138 ~~~~~~lv~E~~~~-~l~~~~~~-~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 215 (464)
T 3ttj_A 138 EFQDVYLVMELMDA-NLCQVIQM-ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215 (464)
T ss_dssp TCCEEEEEEECCSE-EHHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred cCCeEEEEEeCCCC-CHHHHHhh-cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence 468999999976 46666654 59999999999999999999999999999999999999999999999999998643
Q ss_pred ccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCC----------
Q 037702 161 STRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFK---------- 230 (448)
Q Consensus 161 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---------- 230 (448)
. .......+||+.|+|||++.+..|+ .++|||||||++|+|++|++||.+.+..+.+.++......
T Consensus 216 ~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~ 291 (464)
T 3ttj_A 216 T---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291 (464)
T ss_dssp ----CCCC----CCCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred C---CcccCCCcccccccCHHHHcCCCCC-HHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence 2 2234567899999999999888775 8899999999999999999999998887777666442110
Q ss_pred -----------------C----CCC-----------CCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccccccc
Q 037702 231 -----------------C----PNW-----------FPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYKK 272 (448)
Q Consensus 231 -----------------~----p~~-----------~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~ 272 (448)
+ |.. .++++++||.+||..||.+|||++|+|+||||+..+..
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~ 365 (464)
T 3ttj_A 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDP 365 (464)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCH
T ss_pred hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccCc
Confidence 0 000 14679999999999999999999999999999876543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-52 Score=448.51 Aligned_cols=260 Identities=30% Similarity=0.554 Sum_probs=236.2
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEVMASKTK 84 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~ 84 (448)
.+..++|++.+.||+|+||.||+|++..+|+.||||++.+.........+.+.+|..++..+ +||||+++++++.+.+.
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~ 416 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 416 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence 35678999999999999999999999999999999999876544444457788999999987 79999999999999999
Q ss_pred EEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccc
Q 037702 85 IYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTR 163 (448)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~ 163 (448)
+||||||++||+|.+++.. +.+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|.....
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~-- 494 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW-- 494 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC--
T ss_pred EEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecccc--
Confidence 9999999999999999976 7899999999999999999999999999999999999999999999999999985322
Q ss_pred cCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 037702 164 QDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLL 243 (448)
Q Consensus 164 ~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 243 (448)
......+.+||+.|+|||++.+..| +.++|||||||+||||++|.+||.+.+..+++..|......+|..+++++.+||
T Consensus 495 ~~~~~~~~~GT~~Y~APE~l~~~~~-~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 573 (674)
T 3pfq_A 495 DGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAIC 573 (674)
T ss_dssp TTCCBCCCCSCSSSCCHHHHTCCCB-STHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHHHHHH
T ss_pred CCcccccccCCCcccCHhhhcCCCC-CccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHH
Confidence 2223456799999999999988777 489999999999999999999999999999999999999999999999999999
Q ss_pred HhccCCCcCCCCCH-----HHHHhhhhccc
Q 037702 244 SRILDPNPSTRVTM-----AKLMENYWFRK 268 (448)
Q Consensus 244 ~~~L~~dP~~Rpt~-----~eil~hp~~~~ 268 (448)
++||..||.+||++ ++|++||||+.
T Consensus 574 ~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~ 603 (674)
T 3pfq_A 574 KGLMTKHPGKRLGCGPEGERDIKEHAFFRY 603 (674)
T ss_dssp HHHSCSSSTTCTTCSTTHHHHHHSSGGGSS
T ss_pred HHHccCCHHHCCCCCCCcHHHHhcCccccC
Confidence 99999999999997 99999999976
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-52 Score=400.43 Aligned_cols=261 Identities=30% Similarity=0.673 Sum_probs=209.1
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKI 85 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 85 (448)
+...++|++.+.||+|+||.||+|.+..+|+.||||++...........+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 7 g~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (278)
T 3cok_A 7 GEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYV 86 (278)
T ss_dssp CSSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEE
T ss_pred ccccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeE
Confidence 34568899999999999999999999999999999999866544444567889999999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccc
Q 037702 86 YFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTR 163 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~ 163 (448)
|+||||+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 87 YLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp EEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 999999999999999976 579999999999999999999999999999999999999999999999999997653222
Q ss_pred cCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 037702 164 QDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLL 243 (448)
Q Consensus 164 ~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 243 (448)
. .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+..+....+....+..|..+++++.+||
T Consensus 167 ~--~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 243 (278)
T 3cok_A 167 E--KHYTLCGTPNYISPEIATRSAH-GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLI 243 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHHHH
T ss_pred C--cceeccCCCCcCCcchhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHHHH
Confidence 1 2235679999999999976655 588999999999999999999998877767777776677778888999999999
Q ss_pred HhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 244 SRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 244 ~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
.+||..||.+|||++++++||||...
T Consensus 244 ~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 244 HQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp HHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred HHHcccCHhhCCCHHHHhcCccccCC
Confidence 99999999999999999999999753
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-51 Score=406.79 Aligned_cols=262 Identities=33% Similarity=0.581 Sum_probs=238.7
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYF 87 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 87 (448)
..++|++.+.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 46789999999999999999999999999999999987765555666889999999999999999999999999999999
Q ss_pred EEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCC
Q 037702 88 AMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDG 166 (448)
Q Consensus 88 V~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 166 (448)
||||+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 119 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~--~ 196 (335)
T 2owb_A 119 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG--E 196 (335)
T ss_dssp EECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT--C
T ss_pred EEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc--c
Confidence 9999999999999876 679999999999999999999999999999999999999999999999999998653221 2
Q ss_pred CccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHHHHhc
Q 037702 167 LLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRI 246 (448)
Q Consensus 167 ~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 246 (448)
.....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+..+.+..+....+..|..+++++.+||.+|
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 275 (335)
T 2owb_A 197 RKKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKM 275 (335)
T ss_dssp CBCCCCSCCSSCCHHHHHTSCB-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHH
T ss_pred cccccCCCccccCHHHhccCCC-CchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHH
Confidence 2345679999999999987666 488999999999999999999999998888888888888889999999999999999
Q ss_pred cCCCcCCCCCHHHHHhhhhccccccc
Q 037702 247 LDPNPSTRVTMAKLMENYWFRKGYKK 272 (448)
Q Consensus 247 L~~dP~~Rpt~~eil~hp~~~~~~~~ 272 (448)
|+.||.+|||++++++||||+..+..
T Consensus 276 l~~dp~~Rps~~ell~~~~~~~~~~~ 301 (335)
T 2owb_A 276 LQTDPTARPTINELLNDEFFTSGYIP 301 (335)
T ss_dssp TCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred ccCChhHCcCHHHHhcCccccCCCcc
Confidence 99999999999999999999887643
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-51 Score=395.03 Aligned_cols=258 Identities=36% Similarity=0.651 Sum_probs=230.9
Q ss_pred cccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 037702 5 AGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTK 84 (448)
Q Consensus 5 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 84 (448)
.+.+.++|++.+.||+|+||.||+|.+..++..||+|++....... .+.+.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (277)
T 3f3z_A 4 KGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRLYETFEDNTD 80 (277)
T ss_dssp --CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred hhhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCe
Confidence 3456789999999999999999999999999999999997654332 4678899999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEE---cCCCCeEEeecccccccc
Q 037702 85 IYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLL---DENGDLKISDFGLSALQE 160 (448)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl---~~~g~lkl~DFGla~~~~ 160 (448)
.|+||||++|++|.+++.. +.+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 81 IYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 9999999999999998865 679999999999999999999999999999999999999 788999999999997543
Q ss_pred ccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCC----CCC
Q 037702 161 STRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPN----WFP 236 (448)
Q Consensus 161 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s 236 (448)
. .......+||+.|+|||++.+. .+.++|||||||++|+|++|..||...+..+....+..+....|. .++
T Consensus 161 ~---~~~~~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (277)
T 3f3z_A 161 P---GKMMRTKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVS 235 (277)
T ss_dssp T---TSCBCCCCSCTTTCCHHHHTTC--BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSC
T ss_pred C---ccchhccCCCCCccChHHhccc--CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCC
Confidence 2 2233566899999999998643 468999999999999999999999999988888888888777765 589
Q ss_pred HHHHHHHHhccCCCcCCCCCHHHHHhhhhccccc
Q 037702 237 PEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGY 270 (448)
Q Consensus 237 ~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 270 (448)
+++.+||.+||+.||.+|||+.++++||||++..
T Consensus 236 ~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~ 269 (277)
T 3f3z_A 236 PQAESLIRRLLTKSPKQRITSLQALEHEWFEKQL 269 (277)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence 9999999999999999999999999999998754
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-52 Score=431.49 Aligned_cols=262 Identities=32% Similarity=0.637 Sum_probs=234.3
Q ss_pred cccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 037702 5 AGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTK 84 (448)
Q Consensus 5 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 84 (448)
...+.++|++.+.||+|+||.||+|.+..+|+.||||++.+.........+.+.+|+.+++.++||||+++++++.+...
T Consensus 21 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 100 (484)
T 3nyv_A 21 TAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGY 100 (484)
T ss_dssp CCCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred CCcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 35677899999999999999999999999999999999987765544556889999999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEE---cCCCCeEEeecccccccc
Q 037702 85 IYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLL---DENGDLKISDFGLSALQE 160 (448)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl---~~~g~lkl~DFGla~~~~ 160 (448)
+|+||||+.||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 101 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 101 FYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180 (484)
T ss_dssp EEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence 9999999999999999865 689999999999999999999999999999999999999 567899999999998653
Q ss_pred ccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCC----CCCC
Q 037702 161 STRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCP----NWFP 236 (448)
Q Consensus 161 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s 236 (448)
.. ......+||+.|+|||++.+ .| +.++|||||||++|+|++|.+||.+.+..+....+..+.+.++ ..+|
T Consensus 181 ~~---~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 255 (484)
T 3nyv_A 181 AS---KKMKDKIGTAYYIAPEVLHG-TY-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVS 255 (484)
T ss_dssp CC---CSHHHHTTGGGTCCHHHHHT-CC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSC
T ss_pred cc---cccccCCCCccccCceeecC-CC-CCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCC
Confidence 22 23456789999999999865 45 5899999999999999999999999999999999888766543 3489
Q ss_pred HHHHHHHHhccCCCcCCCCCHHHHHhhhhcccccc
Q 037702 237 PEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYK 271 (448)
Q Consensus 237 ~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~ 271 (448)
+++++||.+||..||.+|||++++++||||+....
T Consensus 256 ~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~ 290 (484)
T 3nyv_A 256 ESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK 290 (484)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence 99999999999999999999999999999987543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=433.56 Aligned_cols=261 Identities=27% Similarity=0.445 Sum_probs=233.7
Q ss_pred cccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 037702 5 AGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTK 84 (448)
Q Consensus 5 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 84 (448)
.++..++|++.+.||+|+||.||+|++..+|+.||||++.+.........+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 180 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 259 (543)
T 3c4z_A 180 QPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTD 259 (543)
T ss_dssp SCCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred ccCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCE
Confidence 34667899999999999999999999999999999999987765544456788899999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccc
Q 037702 85 IYFAMEYVRGGELFNKVAK-----GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQ 159 (448)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~ 159 (448)
+|+||||++||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++...
T Consensus 260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 9999999999999999864 25999999999999999999999999999999999999999999999999999864
Q ss_pred cccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCC----cHHHHHHHHhhccCCCCCCC
Q 037702 160 ESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDS----NLMELYKKITRAEFKCPNWF 235 (448)
Q Consensus 160 ~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~----~~~~~~~~i~~~~~~~p~~~ 235 (448)
.... ....+.+||+.|+|||++.+.+|+ .++|||||||++|+|++|+.||... ...++...+......+|..+
T Consensus 340 ~~~~--~~~~~~~GT~~Y~APE~l~~~~~~-~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~ 416 (543)
T 3c4z_A 340 KAGQ--TKTKGYAGTPGFMAPELLLGEEYD-FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKF 416 (543)
T ss_dssp CTTC--CCBCCCCSCTTTSCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTS
T ss_pred cCCC--cccccccCCccccChhhhcCCCCC-hHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCccc
Confidence 3221 223456999999999999887775 8899999999999999999999875 34677888888888899999
Q ss_pred CHHHHHHHHhccCCCcCCCCC-----HHHHHhhhhccc
Q 037702 236 PPEVRKLLSRILDPNPSTRVT-----MAKLMENYWFRK 268 (448)
Q Consensus 236 s~~~~~li~~~L~~dP~~Rpt-----~~eil~hp~~~~ 268 (448)
|+++.+||.+||..||.+||+ +++|++||||+.
T Consensus 417 s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~ 454 (543)
T 3c4z_A 417 SPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454 (543)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred CHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence 999999999999999999996 589999999975
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-51 Score=400.52 Aligned_cols=259 Identities=28% Similarity=0.437 Sum_probs=216.2
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYF 87 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 87 (448)
++++|++.+.||+|+||.||+|.+..+|+.||||++..... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 1 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (311)
T 4agu_A 1 MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED-DPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHL 79 (311)
T ss_dssp --CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CcccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEE
Confidence 36899999999999999999999999999999999876543 23445678899999999999999999999999999999
Q ss_pred EEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCC
Q 037702 88 AMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDG 166 (448)
Q Consensus 88 V~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 166 (448)
||||+++++|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~ 157 (311)
T 4agu_A 80 VFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGP--SD 157 (311)
T ss_dssp EEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred EEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc--cc
Confidence 9999999999998875 67999999999999999999999999999999999999999999999999999765422 22
Q ss_pred CccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhcc------------------
Q 037702 167 LLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAE------------------ 228 (448)
Q Consensus 167 ~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~------------------ 228 (448)
.....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
T 4agu_A 158 YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237 (311)
T ss_dssp --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGT
T ss_pred ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccc
Confidence 23456899999999999775555689999999999999999999999887766554443210
Q ss_pred ---CCCC----------CCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 229 ---FKCP----------NWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 229 ---~~~p----------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
.+.+ +.+++++.+||.+||..||.+|||++++++||||++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 291 (311)
T 4agu_A 238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENI 291 (311)
T ss_dssp TCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhc
Confidence 0111 3478899999999999999999999999999999753
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-51 Score=401.22 Aligned_cols=260 Identities=32% Similarity=0.575 Sum_probs=231.0
Q ss_pred cccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccch---hHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 037702 5 AGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRV---GLIDQIKREISVMRLVRHPNIVQLYEVMAS 81 (448)
Q Consensus 5 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~---~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~ 81 (448)
...+.++|++.+.||+|+||.||+|.+..+|+.||+|++........ ...+.+.+|+.+++.++||||+++++++.+
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 86 (321)
T 2a2a_A 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN 86 (321)
T ss_dssp CSCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred chhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 35577899999999999999999999999999999999986543321 135778999999999999999999999999
Q ss_pred CCEEEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCC----CeEEeecccc
Q 037702 82 KTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENG----DLKISDFGLS 156 (448)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g----~lkl~DFGla 156 (448)
....|+||||++|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 9999999999999999999976 5799999999999999999999999999999999999999888 7999999999
Q ss_pred ccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCC----
Q 037702 157 ALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCP---- 232 (448)
Q Consensus 157 ~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p---- 232 (448)
...... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+.......+
T Consensus 167 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 242 (321)
T 2a2a_A 167 HEIEDG---VEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFF 242 (321)
T ss_dssp EECCTT---CCCCCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHH
T ss_pred eecCcc---ccccccCCCCCccCcccccCCCC-CCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhh
Confidence 764332 22345679999999999977666 4889999999999999999999999888888888877766554
Q ss_pred CCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccc
Q 037702 233 NWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRK 268 (448)
Q Consensus 233 ~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 268 (448)
..+++.+.+||.+||..||.+|||++++++||||+.
T Consensus 243 ~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~ 278 (321)
T 2a2a_A 243 SHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (321)
T ss_dssp TTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSC
T ss_pred cccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccC
Confidence 468999999999999999999999999999999964
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-51 Score=400.41 Aligned_cols=260 Identities=27% Similarity=0.439 Sum_probs=213.8
Q ss_pred cccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeeccccc--chhHHHHHHHHHHHHHhCC---CCCcceEEEEE
Q 037702 5 AGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIR--RVGLIDQIKREISVMRLVR---HPNIVQLYEVM 79 (448)
Q Consensus 5 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~--~~~~~~~~~~Ei~~l~~l~---hpnIv~l~~~~ 79 (448)
+.+..++|++.+.||+|+||.||+|++..+|+.||||++...... .......+.+|+.+++.++ ||||+++++++
T Consensus 4 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~ 83 (308)
T 3g33_A 4 GSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVC 83 (308)
T ss_dssp ------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred CcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeee
Confidence 456789999999999999999999999999999999999754321 1112245667888877764 99999999999
Q ss_pred EeCC-----EEEEEEeecCCCchHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEe
Q 037702 80 ASKT-----KIYFAMEYVRGGELFNKVAKG---KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKIS 151 (448)
Q Consensus 80 ~~~~-----~~~lV~E~~~gg~L~~~i~~~---~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~ 151 (448)
.... .+++||||+. ++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 84 ATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp EECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEEC
T ss_pred eccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEe
Confidence 8765 5899999997 5999999763 39999999999999999999999999999999999999999999999
Q ss_pred eccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCC-
Q 037702 152 DFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFK- 230 (448)
Q Consensus 152 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~- 230 (448)
|||++..... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+...++......
T Consensus 163 Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 238 (308)
T 3g33_A 163 DFGLARIYSY---QMALTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP 238 (308)
T ss_dssp SCSCTTTSTT---CCCSGGGGCCCSSCCHHHHHTSCC-CSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred eCccccccCC---CcccCCccccccccCchHHcCCCC-CchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9999976432 223356789999999999987776 48899999999999999999999998887777666442110
Q ss_pred --------------------------CCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 231 --------------------------CPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 231 --------------------------~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
..+.+++++.+||.+||+.||.+|||++|+++||||++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 113478999999999999999999999999999999864
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-51 Score=400.54 Aligned_cols=253 Identities=28% Similarity=0.524 Sum_probs=224.3
Q ss_pred CeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 037702 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAME 90 (448)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (448)
.|+..+.||+|+||.||+|++..+|+.||||++...... ..+.+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ---RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC---SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh---HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 488999999999999999999999999999999765432 24678899999999999999999999999999999999
Q ss_pred ecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCccc
Q 037702 91 YVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHT 170 (448)
Q Consensus 91 ~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~ 170 (448)
|++|++|.+++...++++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....... .....
T Consensus 123 ~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~ 200 (321)
T 2c30_A 123 FLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRKS 200 (321)
T ss_dssp CCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--CCBCC
T ss_pred cCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCc--ccccc
Confidence 9999999999988889999999999999999999999999999999999999999999999999997653321 22345
Q ss_pred cCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccC---CCCCCCCHHHHHHHHhcc
Q 037702 171 TCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF---KCPNWFPPEVRKLLSRIL 247 (448)
Q Consensus 171 ~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~li~~~L 247 (448)
.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+..+....+..... ..+..+++++.+||.+||
T Consensus 201 ~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 279 (321)
T 2c30_A 201 LVGTPYWMAPEVISRSLY-ATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERML 279 (321)
T ss_dssp CCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHS
T ss_pred ccCCccccCHhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHc
Confidence 689999999999977665 4889999999999999999999998888777777665433 223457899999999999
Q ss_pred CCCcCCCCCHHHHHhhhhcccc
Q 037702 248 DPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 248 ~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
..||.+|||++++++||||...
T Consensus 280 ~~dp~~Rps~~ell~hp~~~~~ 301 (321)
T 2c30_A 280 VRDPQERATAQELLDHPFLLQT 301 (321)
T ss_dssp CSSTTTSCCHHHHHTSGGGGGC
T ss_pred cCChhhCcCHHHHhcChhhccC
Confidence 9999999999999999999753
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-51 Score=400.38 Aligned_cols=261 Identities=30% Similarity=0.581 Sum_probs=218.0
Q ss_pred cccccCCeEEE-eeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 037702 5 AGILMNKYELG-RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEVMASK 82 (448)
Q Consensus 5 ~~~~~~~y~~~-~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~ 82 (448)
++.+.++|++. +.||+|+||.||+|.+..+|+.||||++..... ...+.+.+|+.+++++ +||||+++++++.+.
T Consensus 7 ~~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~ 83 (316)
T 2ac3_A 7 SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG---HIRSRVFREVEMLYQCQGHRNVLELIEFFEEE 83 (316)
T ss_dssp CCCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS---CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred CcccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence 35567899995 789999999999999999999999999976532 2346788999999885 799999999999999
Q ss_pred CEEEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCC---eEEeecccccc
Q 037702 83 TKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGD---LKISDFGLSAL 158 (448)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~---lkl~DFGla~~ 158 (448)
+.+|+||||++||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++..
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 84 DRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp TEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred CEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 999999999999999999976 67999999999999999999999999999999999999998876 99999999875
Q ss_pred ccccc-----cCCCccccCCCCcccchhhhhc-----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCc------------
Q 037702 159 QESTR-----QDGLLHTTCGTPAYVAPEVINK-----RGYDGAKADIWSCGVVLFVLLAGNLPFYDSN------------ 216 (448)
Q Consensus 159 ~~~~~-----~~~~~~~~~Gt~~Y~APEvl~~-----~~~~~~~sDiwSlGvil~elltG~~Pf~~~~------------ 216 (448)
..... ........+||+.|+|||++.. ..+ +.++|||||||++|+|++|+.||.+.+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 242 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIY-DKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC 242 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHHHHHH-TTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CC
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccccccCC-CcccccHhHHHHHHHHHHCCCCCcccccccccccccccc
Confidence 43221 1122335679999999999864 234 478999999999999999999997653
Q ss_pred ---HHHHHHHHhhccCCCC----CCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 217 ---LMELYKKITRAEFKCP----NWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 217 ---~~~~~~~i~~~~~~~p----~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
...++..+....+.+| ..+++++++||.+||..||.+|||++++++||||+..
T Consensus 243 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 302 (316)
T 2ac3_A 243 PACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302 (316)
T ss_dssp HHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred hhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence 2445666777766666 3589999999999999999999999999999999764
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-51 Score=415.92 Aligned_cols=253 Identities=32% Similarity=0.624 Sum_probs=210.9
Q ss_pred ccccCCeEEE-eeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHH-HhCCCCCcceEEEEEEe--
Q 037702 6 GILMNKYELG-RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVM-RLVRHPNIVQLYEVMAS-- 81 (448)
Q Consensus 6 ~~~~~~y~~~-~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l-~~l~hpnIv~l~~~~~~-- 81 (448)
+...++|.+. +.||+|+||.||+|.+..+|+.||||++... ..+.+|+.++ +..+||||+++++++..
T Consensus 57 ~~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~ 128 (400)
T 1nxk_A 57 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLY 128 (400)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred CcccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecc
Confidence 4567788887 7899999999999999999999999999643 3466888887 45689999999999876
Q ss_pred --CCEEEEEEeecCCCchHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcC---CCCeEEeec
Q 037702 82 --KTKIYFAMEYVRGGELFNKVAKG---KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDE---NGDLKISDF 153 (448)
Q Consensus 82 --~~~~~lV~E~~~gg~L~~~i~~~---~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~---~g~lkl~DF 153 (448)
...+|+||||++||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+||
T Consensus 129 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DF 208 (400)
T 1nxk_A 129 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 208 (400)
T ss_dssp TTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred cCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEec
Confidence 66799999999999999999762 5999999999999999999999999999999999999998 789999999
Q ss_pred cccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHH----HHHHHHhhccC
Q 037702 154 GLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLM----ELYKKITRAEF 229 (448)
Q Consensus 154 Gla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~----~~~~~i~~~~~ 229 (448)
|++..... .....+.+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+.. .....+..+.+
T Consensus 209 G~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~ 284 (400)
T 1nxk_A 209 GFAKETTS---HNSLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 284 (400)
T ss_dssp TTCEECC--------------CTTCCGGGSCCCCSS-SHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCC
T ss_pred ccccccCC---CCccccCCCCCCccCHhhcCCCCCC-CcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcc
Confidence 99985432 2234567899999999999777665 8899999999999999999999875432 24455666665
Q ss_pred CCC----CCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccccc
Q 037702 230 KCP----NWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGY 270 (448)
Q Consensus 230 ~~p----~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 270 (448)
.+| ..+++++.+||.+||..||.+|||++++++||||....
T Consensus 285 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 285 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329 (400)
T ss_dssp CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence 544 35899999999999999999999999999999998643
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-51 Score=393.84 Aligned_cols=257 Identities=34% Similarity=0.622 Sum_probs=221.3
Q ss_pred cccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 037702 5 AGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTK 84 (448)
Q Consensus 5 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 84 (448)
.|.+.++|++.+.||+|+||.||+|.+..+|..||+|++...... ...+.+.+|+.+++.++||||+++++++.+...
T Consensus 17 ~g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 94 (285)
T 3is5_A 17 QGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ--VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHN 94 (285)
T ss_dssp SSCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CCChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc--hhHHHHHHHHHHHHhCCCchHHhHHHheecCCe
Confidence 456788999999999999999999999999999999999876432 235778999999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEE---cCCCCeEEeecccc
Q 037702 85 IYFAMEYVRGGELFNKVAK-----GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLL---DENGDLKISDFGLS 156 (448)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl---~~~g~lkl~DFGla 156 (448)
.|+||||+++|+|.+.+.. ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a 174 (285)
T 3is5_A 95 MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA 174 (285)
T ss_dssp EEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred EEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence 9999999999999998843 579999999999999999999999999999999999999 45678999999999
Q ss_pred ccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCC---C
Q 037702 157 ALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCP---N 233 (448)
Q Consensus 157 ~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p---~ 233 (448)
...... ......+||+.|+|||++.+ .+ +.++|||||||++|+|++|+.||.+.+..+....+.......+ .
T Consensus 175 ~~~~~~---~~~~~~~~t~~y~aPE~~~~-~~-~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (285)
T 3is5_A 175 ELFKSD---EHSTNAAGTALYMAPEVFKR-DV-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECR 249 (285)
T ss_dssp CC-------------CTTGGGCCHHHHTT-CC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--C
T ss_pred eecCCc---ccCcCcccccCcCChHHhcc-CC-CcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccC
Confidence 764432 22345689999999999853 44 5889999999999999999999999888887777665554433 2
Q ss_pred CCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccc
Q 037702 234 WFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRK 268 (448)
Q Consensus 234 ~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 268 (448)
.+++++.+||.+||+.||.+|||++|+++||||++
T Consensus 250 ~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 250 PLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp CCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 37899999999999999999999999999999975
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-51 Score=427.27 Aligned_cols=260 Identities=32% Similarity=0.655 Sum_probs=228.9
Q ss_pred cccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 037702 5 AGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTK 84 (448)
Q Consensus 5 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 84 (448)
.+.+.++|++.+.||+|+||.||+|.+..+|+.||||++.+..... .....+.+|+.+++.++||||+++++++.+...
T Consensus 17 ~g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 95 (486)
T 3mwu_A 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSS 95 (486)
T ss_dssp CCHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cCChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc-hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCE
Confidence 3567889999999999999999999999999999999997654333 234778899999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEc---CCCCeEEeecccccccc
Q 037702 85 IYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLD---ENGDLKISDFGLSALQE 160 (448)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~---~~g~lkl~DFGla~~~~ 160 (448)
+|+||||++||+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 96 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 9999999999999998865 7899999999999999999999999999999999999995 45679999999998653
Q ss_pred ccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCC----CCCC
Q 037702 161 STRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCP----NWFP 236 (448)
Q Consensus 161 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s 236 (448)
.. ......+||+.|+|||++.+ .| +.++|||||||++|+|++|.+||.+.+..+....+..+.+.++ ..+|
T Consensus 176 ~~---~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 250 (486)
T 3mwu_A 176 QN---TKMKDRIGTAYYIAPEVLRG-TY-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTIS 250 (486)
T ss_dssp CC-------CCTTGGGGCCGGGGGS-CC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSC
T ss_pred CC---CccCCCcCCCCCCCHHHhCC-CC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCC
Confidence 32 22346789999999999865 34 5899999999999999999999999999999888888765443 3479
Q ss_pred HHHHHHHHhccCCCcCCCCCHHHHHhhhhccccc
Q 037702 237 PEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGY 270 (448)
Q Consensus 237 ~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 270 (448)
+++++||.+||..||.+|||+.++++||||+...
T Consensus 251 ~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~ 284 (486)
T 3mwu_A 251 DDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (486)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence 9999999999999999999999999999998754
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-51 Score=392.77 Aligned_cols=261 Identities=35% Similarity=0.650 Sum_probs=226.0
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYF 87 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 87 (448)
..++|++.+.||+|+||.||+|.+..+|+.||||++...... ...+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT--THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch--hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEE
Confidence 467899999999999999999999999999999999765432 345778999999999999999999999999999999
Q ss_pred EEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCC
Q 037702 88 AMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDG 166 (448)
Q Consensus 88 V~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 166 (448)
||||+++++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++..........
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (276)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred EEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence 9999999999999976 579999999999999999999999999999999999999999999999999998654333333
Q ss_pred CccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHH-HHHHHHhhccCCC--CCCCCHHHHHHH
Q 037702 167 LLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLM-ELYKKITRAEFKC--PNWFPPEVRKLL 243 (448)
Q Consensus 167 ~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~~~~~--p~~~s~~~~~li 243 (448)
.....+||+.|+|||++.+..+.+.++|||||||++|+|++|..||...+.. ..+..+....... +..+++.+.+||
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (276)
T 2yex_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242 (276)
T ss_dssp CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHH
Confidence 3456789999999999987776667899999999999999999999876543 3333333332222 245899999999
Q ss_pred HhccCCCcCCCCCHHHHHhhhhccccc
Q 037702 244 SRILDPNPSTRVTMAKLMENYWFRKGY 270 (448)
Q Consensus 244 ~~~L~~dP~~Rpt~~eil~hp~~~~~~ 270 (448)
.+||..||.+|||++++++||||++..
T Consensus 243 ~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (276)
T 2yex_A 243 HKILVENPSARITIPDIKKDRWYNKPL 269 (276)
T ss_dssp HHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HHHCCCCchhCCCHHHHhcCccccChh
Confidence 999999999999999999999998654
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-51 Score=426.57 Aligned_cols=259 Identities=34% Similarity=0.614 Sum_probs=224.6
Q ss_pred cccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 037702 5 AGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTK 84 (448)
Q Consensus 5 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 84 (448)
.+.+.++|++.+.||+|+||.||+|++..++..||||++.+...... ....+.+|+.+++.++||||+++++++.+...
T Consensus 32 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 110 (494)
T 3lij_A 32 KGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTS-SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRN 110 (494)
T ss_dssp BCCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----C-TTHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred CCchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCch-HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence 44566789999999999999999999999999999999987654332 24678899999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCC---CCeEEeecccccccc
Q 037702 85 IYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDEN---GDLKISDFGLSALQE 160 (448)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~---g~lkl~DFGla~~~~ 160 (448)
+|+|||||+||+|.+.+.. +++++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|....
T Consensus 111 ~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 111 YYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 9999999999999998865 789999999999999999999999999999999999999764 459999999998654
Q ss_pred ccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCC----CCCC
Q 037702 161 STRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCP----NWFP 236 (448)
Q Consensus 161 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s 236 (448)
.. ......+||+.|+|||++.+ .| +.++|||||||++|+|++|.+||.+.+..++...+..+.+.++ ..+|
T Consensus 191 ~~---~~~~~~~gt~~y~aPE~l~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 265 (494)
T 3lij_A 191 NQ---KKMKERLGTAYYIAPEVLRK-KY-DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVS 265 (494)
T ss_dssp TT---BCBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSC
T ss_pred CC---ccccccCCCcCeeCHHHHcc-cC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCC
Confidence 32 22356789999999999863 44 5899999999999999999999999999999999988876554 3489
Q ss_pred HHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 237 PEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 237 ~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
+++++||.+||..||.+|||+.++++||||+..
T Consensus 266 ~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 266 EGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred HHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 999999999999999999999999999999874
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-51 Score=406.16 Aligned_cols=256 Identities=34% Similarity=0.632 Sum_probs=209.5
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKI 85 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 85 (448)
..+.++|++.+.||+|+||.||+|++..+++.||||++.... ..+.+.+|+.+++.++||||+++++++.+...+
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 123 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEI 123 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeE
Confidence 356778999999999999999999999999999999997543 225678899999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcC---CCCeEEeeccccccccc
Q 037702 86 YFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDE---NGDLKISDFGLSALQES 161 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~---~g~lkl~DFGla~~~~~ 161 (448)
|+||||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus 124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 124 SLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp EEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 999999999999999976 67999999999999999999999999999999999999975 88999999999986432
Q ss_pred cccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHH-HHHHHHhhccCCCC----CCCC
Q 037702 162 TRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLM-ELYKKITRAEFKCP----NWFP 236 (448)
Q Consensus 162 ~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~~~~~p----~~~s 236 (448)
. ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.... ..+..+.......+ ..++
T Consensus 204 ~---~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 279 (349)
T 2w4o_A 204 Q---VLMKTVCGTPGYCAPEILRGCAY-GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVS 279 (349)
T ss_dssp ------------CGGGSCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSC
T ss_pred c---cccccccCCCCccCHHHhcCCCC-CcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCC
Confidence 2 22345789999999999987666 48999999999999999999999876554 36666766655433 3578
Q ss_pred HHHHHHHHhccCCCcCCCCCHHHHHhhhhccccc
Q 037702 237 PEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGY 270 (448)
Q Consensus 237 ~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 270 (448)
+++.+||.+||..||.+|||+.++++||||+...
T Consensus 280 ~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 280 LNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 9999999999999999999999999999998644
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-51 Score=406.26 Aligned_cols=261 Identities=28% Similarity=0.443 Sum_probs=212.2
Q ss_pred cccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 037702 5 AGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTK 84 (448)
Q Consensus 5 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 84 (448)
.....++|++.+.||+|+||.||+|++..+|+.||||++....... ...+.+.+|+.+++.++||||+++++++.++..
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (329)
T 3gbz_A 29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEE-GVPGTAIREVSLLKELQHRNIIELKSVIHHNHR 107 (329)
T ss_dssp ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTE
T ss_pred cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccccc-ccchhHHHHHHHHHHcCCCCcceEEEEEecCCE
Confidence 3567889999999999999999999999999999999997654322 334667899999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEc-----CCCCeEEeecccccc
Q 037702 85 IYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLD-----ENGDLKISDFGLSAL 158 (448)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~-----~~g~lkl~DFGla~~ 158 (448)
+|+||||++| +|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 108 ~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 108 LHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp EEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred EEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 9999999985 99999876 5799999999999999999999999999999999999995 444599999999986
Q ss_pred ccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCC--------
Q 037702 159 QESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFK-------- 230 (448)
Q Consensus 159 ~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-------- 230 (448)
..... ......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+......
T Consensus 187 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (329)
T 3gbz_A 187 FGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPG 264 (329)
T ss_dssp HC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred cCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhh
Confidence 54321 22345678999999999987665568999999999999999999999988877766665432110
Q ss_pred ---CC-------------------CCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 231 ---CP-------------------NWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 231 ---~p-------------------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
.+ ..+++++.+||.+||..||.+|||++|+++||||+..
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 325 (329)
T 3gbz_A 265 VTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325 (329)
T ss_dssp GGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred hhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence 01 1167899999999999999999999999999999763
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-51 Score=406.50 Aligned_cols=263 Identities=35% Similarity=0.570 Sum_probs=223.0
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeeccccc--chhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIR--RVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKI 85 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~--~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 85 (448)
+.++|++.+.||+|+||.||+|.+..+++.||+|++.+.... .....+.+.+|+.+++.++||||+++++++.+....
T Consensus 24 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 103 (345)
T 3hko_A 24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYI 103 (345)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeE
Confidence 467899999999999999999999999999999999865432 224457899999999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHhc-----------------------------------------CCCCHHHHHHHHHHHHHHHHH
Q 037702 86 YFAMEYVRGGELFNKVAK-----------------------------------------GKLREEVARKYFQQLVDAVEF 124 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-----------------------------------------~~l~e~~~~~~~~qll~aL~y 124 (448)
|+||||++||+|.+++.. ..+++..++.++.||+.||+|
T Consensus 104 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~ 183 (345)
T 3hko_A 104 CLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY 183 (345)
T ss_dssp EEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHH
Confidence 999999999999998851 124678899999999999999
Q ss_pred HHHCCCEeecCCCCceEEcCCC--CeEEeeccccccccccccC--CCccccCCCCcccchhhhhcc-CCCCCcchHHHHH
Q 037702 125 CHSRGVYHRDLKPENLLLDENG--DLKISDFGLSALQESTRQD--GLLHTTCGTPAYVAPEVINKR-GYDGAKADIWSCG 199 (448)
Q Consensus 125 LH~~givHrDLkp~NILl~~~g--~lkl~DFGla~~~~~~~~~--~~~~~~~Gt~~Y~APEvl~~~-~~~~~~sDiwSlG 199 (448)
||++||+||||||+|||++.++ .+||+|||++......... ......+||+.|+|||++.+. ...+.++||||||
T Consensus 184 LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG 263 (345)
T 3hko_A 184 LHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG 263 (345)
T ss_dssp HHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHH
T ss_pred HHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHH
Confidence 9999999999999999998777 8999999999865432221 123456899999999999652 3345899999999
Q ss_pred HHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCC----CCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccccc
Q 037702 200 VVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPN----WFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGY 270 (448)
Q Consensus 200 vil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 270 (448)
|++|+|++|+.||.+.+..+....+.......+. .+++++.+||.+||..||.+|||+.++++||||+...
T Consensus 264 ~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 264 VLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS 338 (345)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred HHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence 9999999999999998888888877776654432 3789999999999999999999999999999998644
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-51 Score=406.66 Aligned_cols=254 Identities=27% Similarity=0.435 Sum_probs=219.4
Q ss_pred cccccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-----CCCcceEEE
Q 037702 3 KKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR-----HPNIVQLYE 77 (448)
Q Consensus 3 ~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-----hpnIv~l~~ 77 (448)
+.+.++.++|++.+.||+|+||.||+|++..+|+.||||++.... .......+|+.+++.+. ||||+++++
T Consensus 28 ~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~ 103 (360)
T 3llt_A 28 KKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK----KYTRSAKIEADILKKIQNDDINNNNIVKYHG 103 (360)
T ss_dssp CTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH----HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred ecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch----hhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence 345678899999999999999999999999999999999996432 33466778999999996 999999999
Q ss_pred EEEeCCEEEEEEeecCCCchHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcC----------
Q 037702 78 VMASKTKIYFAMEYVRGGELFNKVAKG---KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDE---------- 144 (448)
Q Consensus 78 ~~~~~~~~~lV~E~~~gg~L~~~i~~~---~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~---------- 144 (448)
++...+..|+||||+ +++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~ 182 (360)
T 3llt_A 104 KFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITV 182 (360)
T ss_dssp EEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEE
T ss_pred eeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccch
Confidence 999999999999999 89999999763 4999999999999999999999999999999999999975
Q ss_pred ---------------CCCeEEeeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCC
Q 037702 145 ---------------NGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGN 209 (448)
Q Consensus 145 ---------------~g~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~ 209 (448)
++.+||+|||+|..... .....+||+.|+|||++.+..++ .++|||||||++|+|++|+
T Consensus 183 ~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~ 256 (360)
T 3llt_A 183 RRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD-----YHGSIINTRQYRAPEVILNLGWD-VSSDMWSFGCVLAELYTGS 256 (360)
T ss_dssp ECTTTCCEEEEEEESCCCEEECCCTTCEETTS-----CCCSCCSCGGGCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSS
T ss_pred hcccccccccccccCCCCEEEEeccCceecCC-----CCcCccCcccccCcHHHcCCCCC-CccchHHHHHHHHHHHHCC
Confidence 78999999999975332 22456899999999999887765 8899999999999999999
Q ss_pred CCCCCCcHHHHHHHHhhccCCCCC----------------------------------------------CCCHHHHHHH
Q 037702 210 LPFYDSNLMELYKKITRAEFKCPN----------------------------------------------WFPPEVRKLL 243 (448)
Q Consensus 210 ~Pf~~~~~~~~~~~i~~~~~~~p~----------------------------------------------~~s~~~~~li 243 (448)
.||...+..+....+.......|. ..++.+.+||
T Consensus 257 ~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 336 (360)
T 3llt_A 257 LLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFL 336 (360)
T ss_dssp CSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHH
T ss_pred CCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHH
Confidence 999988877666655443222221 1236788999
Q ss_pred HhccCCCcCCCCCHHHHHhhhhcc
Q 037702 244 SRILDPNPSTRVTMAKLMENYWFR 267 (448)
Q Consensus 244 ~~~L~~dP~~Rpt~~eil~hp~~~ 267 (448)
.+||+.||.+|||++|+|+||||+
T Consensus 337 ~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 337 YSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred HHHhcCChhhCCCHHHHhcCcccC
Confidence 999999999999999999999995
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-51 Score=399.54 Aligned_cols=263 Identities=35% Similarity=0.643 Sum_probs=227.5
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccc-hhHHHHHHHHHHHHHhCCCCCcceEEEEE--EeCCE
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRR-VGLIDQIKREISVMRLVRHPNIVQLYEVM--ASKTK 84 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~--~~~~~ 84 (448)
+.++|++++.||+|+||.||+|.+..+|..||+|++....... ....+.+.+|+.+++.++||||+++++++ .+...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 5789999999999999999999999999999999997654322 23457789999999999999999999998 45568
Q ss_pred EEEEEeecCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccc
Q 037702 85 IYFAMEYVRGGELFNKVAK---GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQES 161 (448)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~ 161 (448)
.|+||||++++ |.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence 99999999887 6666643 5799999999999999999999999999999999999999999999999999986543
Q ss_pred cccCCCccccCCCCcccchhhhhccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHH
Q 037702 162 TRQDGLLHTTCGTPAYVAPEVINKRG-YDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVR 240 (448)
Q Consensus 162 ~~~~~~~~~~~Gt~~Y~APEvl~~~~-~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~ 240 (448)
...........||+.|+|||++.+.. +.+.++|||||||++|+|++|..||.+.+..+....+....+..|..+++++.
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~ 241 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLS 241 (305)
T ss_dssp TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSCHHHH
T ss_pred cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccCHHHH
Confidence 33333344667999999999987533 33578999999999999999999999999889999998888889999999999
Q ss_pred HHHHhccCCCcCCCCCHHHHHhhhhcccccc
Q 037702 241 KLLSRILDPNPSTRVTMAKLMENYWFRKGYK 271 (448)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~ 271 (448)
+||.+||..||.+|||++++++||||++...
T Consensus 242 ~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 242 DLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272 (305)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred HHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence 9999999999999999999999999987543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-51 Score=409.44 Aligned_cols=257 Identities=27% Similarity=0.418 Sum_probs=216.8
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC----
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASK---- 82 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~---- 82 (448)
.+.++|++.+.||+|+||.||+|.+..+|+.||||++.... ......+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 100 (367)
T 1cm8_A 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD 100 (367)
T ss_dssp CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTT
T ss_pred eecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccc
Confidence 35689999999999999999999999999999999996543 2334457789999999999999999999999765
Q ss_pred --CEEEEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccc
Q 037702 83 --TKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQE 160 (448)
Q Consensus 83 --~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~ 160 (448)
..+|+||||+ +++|.+++..+++++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 101 ~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 101 DFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179 (367)
T ss_dssp TCCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred cCceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence 3569999999 8899999988899999999999999999999999999999999999999999999999999998643
Q ss_pred ccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccC-----------
Q 037702 161 STRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF----------- 229 (448)
Q Consensus 161 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~----------- 229 (448)
. .....+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+.+..+.....
T Consensus 180 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 254 (367)
T 1cm8_A 180 S-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 254 (367)
T ss_dssp S-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred c-----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 2 234568999999999998744456899999999999999999999998887766665543211
Q ss_pred --------------------CCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccccc
Q 037702 230 --------------------KCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGY 270 (448)
Q Consensus 230 --------------------~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 270 (448)
..++.+++++.+||.+||..||.+|||++++++||||+...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 255 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 12245789999999999999999999999999999997643
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-51 Score=406.34 Aligned_cols=255 Identities=36% Similarity=0.693 Sum_probs=204.5
Q ss_pred cccCCeEEE---eeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeC
Q 037702 7 ILMNKYELG---RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR-HPNIVQLYEVMASK 82 (448)
Q Consensus 7 ~~~~~y~~~---~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~ 82 (448)
...++|++. +.||+|+||.||+|.+..+|+.||||++.+. ....+.+|+.+++.+. ||||+++++++.+.
T Consensus 5 ~f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~ 78 (325)
T 3kn6_A 5 PFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQ 78 (325)
T ss_dssp HHHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred cchhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcC
Confidence 356788886 7899999999999999999999999999654 2356778999999997 99999999999999
Q ss_pred CEEEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCC---CeEEeecccccc
Q 037702 83 TKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENG---DLKISDFGLSAL 158 (448)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g---~lkl~DFGla~~ 158 (448)
...|+||||++||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~ 158 (325)
T 3kn6_A 79 LHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL 158 (325)
T ss_dssp SEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred CEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEecccccee
Confidence 999999999999999999976 5799999999999999999999999999999999999998766 799999999985
Q ss_pred ccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCc-------HHHHHHHHhhccCCC
Q 037702 159 QESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSN-------LMELYKKITRAEFKC 231 (448)
Q Consensus 159 ~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~-------~~~~~~~i~~~~~~~ 231 (448)
.... .....+.+||+.|+|||++.+..|+ .++|||||||++|+|++|..||...+ ..+....+..+.+.+
T Consensus 159 ~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~ 235 (325)
T 3kn6_A 159 KPPD--NQPLKTPCFTLHYAAPELLNQNGYD-ESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF 235 (325)
T ss_dssp CCC------------------------CCCC-HHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCC
T ss_pred cCCC--CCcccccCCCcCccCHHHhcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCC
Confidence 4322 2234567899999999999877775 88999999999999999999997643 356777787777665
Q ss_pred CC----CCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccccc
Q 037702 232 PN----WFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGY 270 (448)
Q Consensus 232 p~----~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 270 (448)
+. .+|+++++||.+||..||.+|||++++++||||+...
T Consensus 236 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~ 278 (325)
T 3kn6_A 236 EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS 278 (325)
T ss_dssp CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence 53 4899999999999999999999999999999998653
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=403.35 Aligned_cols=266 Identities=27% Similarity=0.461 Sum_probs=224.0
Q ss_pred cccccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 037702 3 KKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASK 82 (448)
Q Consensus 3 ~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~ 82 (448)
..+..+.++|++.+.||+|+||.||+|++..+|+.||||++.............+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 84 (311)
T 3ork_A 5 TTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAE 84 (311)
T ss_dssp CCCSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEE
T ss_pred CCcceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeecc
Confidence 44567889999999999999999999999999999999999877665556667899999999999999999999998764
Q ss_pred C----EEEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccc
Q 037702 83 T----KIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSA 157 (448)
Q Consensus 83 ~----~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~ 157 (448)
. ..|+||||++|++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 85 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 85 TPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp ETTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred CCCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 3 45999999999999999975 789999999999999999999999999999999999999999999999999998
Q ss_pred cccccccC-CCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCC----C
Q 037702 158 LQESTRQD-GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKC----P 232 (448)
Q Consensus 158 ~~~~~~~~-~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~----p 232 (448)
........ ......+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+..+....+....... +
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 243 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHS
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCccccc
Confidence 65432211 222345799999999999877664 88999999999999999999999988877766665554433 2
Q ss_pred CCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 233 NWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 233 ~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
..+|+++.++|.+||+.||.+||++.+++.|+|++..
T Consensus 244 ~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 244 EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 4589999999999999999999999999999999753
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=403.88 Aligned_cols=260 Identities=25% Similarity=0.411 Sum_probs=220.2
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe------
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMAS------ 81 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~------ 81 (448)
..++|++.+.||+|+||.||+|++..+|+.||||++....... .....+.+|+.+++.++||||+++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPYN 93 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-----
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc-cchHHHHHHHHHHHhccCCCcccHhheeeccccccc
Confidence 5689999999999999999999999999999999997654332 233567799999999999999999999987
Q ss_pred --CCEEEEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccc
Q 037702 82 --KTKIYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSA 157 (448)
Q Consensus 82 --~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~ 157 (448)
.+.+|+||||+++ +|.+.+.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 94 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 94 RCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp ---CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred cCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 4578999999986 77777755 579999999999999999999999999999999999999999999999999998
Q ss_pred cccccc--cCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCC-
Q 037702 158 LQESTR--QDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNW- 234 (448)
Q Consensus 158 ~~~~~~--~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~- 234 (448)
...... ........+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+.......++.
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 252 (351)
T 3mi9_A 173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 252 (351)
T ss_dssp ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence 654221 22233456899999999999765555689999999999999999999999988877776665432222211
Q ss_pred -------------------------------CCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 235 -------------------------------FPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 235 -------------------------------~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
.++++.+||.+||..||.+|||++|+++||||+..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 318 (351)
T 3mi9_A 253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 318 (351)
T ss_dssp STTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSS
T ss_pred ccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCC
Confidence 26789999999999999999999999999999764
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-51 Score=403.59 Aligned_cols=259 Identities=25% Similarity=0.432 Sum_probs=213.0
Q ss_pred cCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFA 88 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 88 (448)
+++|++.+.||+|+||.||+|.+..+|+.||||++....... ....+.+|+.+++.++||||+++++++.+....|+|
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 78 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccc--cchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEE
Confidence 478999999999999999999999999999999997543221 112345799999999999999999999999999999
Q ss_pred EeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCC
Q 037702 89 MEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDG 166 (448)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 166 (448)
|||++| +|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~--~~ 155 (324)
T 3mtl_A 79 FEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP--TK 155 (324)
T ss_dssp EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred eccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCC--cc
Confidence 999974 88888865 45999999999999999999999999999999999999999999999999999754322 22
Q ss_pred CccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccC-----------------
Q 037702 167 LLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF----------------- 229 (448)
Q Consensus 167 ~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~----------------- 229 (448)
.....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 235 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhc
Confidence 234568999999999997755556899999999999999999999999887776666544211
Q ss_pred --C-----------CCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccccccc
Q 037702 230 --K-----------CPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYKK 272 (448)
Q Consensus 230 --~-----------~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~ 272 (448)
. .++.+++++.+||.+||+.||.+|||++|+++||||......
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 291 (324)
T 3mtl_A 236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER 291 (324)
T ss_dssp HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence 0 112468899999999999999999999999999999876544
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-51 Score=409.87 Aligned_cols=255 Identities=31% Similarity=0.549 Sum_probs=219.3
Q ss_pred ccCCeEE--EeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 037702 8 LMNKYEL--GRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKI 85 (448)
Q Consensus 8 ~~~~y~~--~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 85 (448)
..+.|.+ .+.||+|+||.||+|.+..+|+.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus 85 ~~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 161 (373)
T 2x4f_A 85 VNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDI 161 (373)
T ss_dssp GGGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred cccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 4455666 6789999999999999999999999999976543 2346788999999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEE--cCCCCeEEeeccccccccc
Q 037702 86 YFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLL--DENGDLKISDFGLSALQES 161 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl--~~~g~lkl~DFGla~~~~~ 161 (448)
|+||||++||+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 162 ~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~ 241 (373)
T 2x4f_A 162 VLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP 241 (373)
T ss_dssp EEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCT
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCC
Confidence 999999999999998864 469999999999999999999999999999999999999 5677899999999986533
Q ss_pred cccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCC----CCCCH
Q 037702 162 TRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCP----NWFPP 237 (448)
Q Consensus 162 ~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~ 237 (448)
. ......+||+.|+|||++....+ +.++|||||||++|+|++|..||.+.+..+....+....+..+ ..+++
T Consensus 242 ~---~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 317 (373)
T 2x4f_A 242 R---EKLKVNFGTPEFLAPEVVNYDFV-SFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISE 317 (373)
T ss_dssp T---CBCCCCCSSCTTCCHHHHTTCBC-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCH
T ss_pred c---cccccccCCCcEeChhhccCCCC-CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCH
Confidence 2 22345689999999999976555 5889999999999999999999999998888888887765544 45899
Q ss_pred HHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 238 EVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 238 ~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
++.+||.+||..||.+|||++++++||||+..
T Consensus 318 ~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 318 EAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred HHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 99999999999999999999999999999753
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=409.25 Aligned_cols=255 Identities=31% Similarity=0.551 Sum_probs=223.4
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccch-----hHHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRV-----GLIDQIKREISVMRLVRHPNIVQLYEVMA 80 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~-----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~ 80 (448)
+...++|++.+.||+|+||.||+|++..+|+.||||++.+...... ...+.+.+|+.+++.++||||+++++++.
T Consensus 20 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~ 99 (335)
T 3dls_A 20 GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFE 99 (335)
T ss_dssp THHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 3466799999999999999999999999999999999987653221 12345678999999999999999999999
Q ss_pred eCCEEEEEEeecCCC-chHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccc
Q 037702 81 SKTKIYFAMEYVRGG-ELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSAL 158 (448)
Q Consensus 81 ~~~~~~lV~E~~~gg-~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~ 158 (448)
+.+.+|+||||+.+| +|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 100 ~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 179 (335)
T 3dls_A 100 NQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY 179 (335)
T ss_dssp CSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred eCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceE
Confidence 999999999999777 99999977 5799999999999999999999999999999999999999999999999999986
Q ss_pred ccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHH
Q 037702 159 QESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPE 238 (448)
Q Consensus 159 ~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~ 238 (448)
... .....+.+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.... .........|..++++
T Consensus 180 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~~~~~~~~~~ 250 (335)
T 3dls_A 180 LER---GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE------ETVEAAIHPPYLVSKE 250 (335)
T ss_dssp CCT---TCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGG------GGTTTCCCCSSCCCHH
T ss_pred CCC---CCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHH------HHHhhccCCCcccCHH
Confidence 533 2233567899999999999888776788999999999999999999997632 2333445667779999
Q ss_pred HHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 239 VRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 239 ~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
+.+||.+||.+||.+|||++++++||||+..
T Consensus 251 l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 251 LMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 9999999999999999999999999999764
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-50 Score=392.28 Aligned_cols=260 Identities=25% Similarity=0.423 Sum_probs=221.5
Q ss_pred cccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 037702 5 AGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTK 84 (448)
Q Consensus 5 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 84 (448)
+.++.++|++.+.||+|+||.||+|++..+|..||+|++...........+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 85 (294)
T 4eqm_A 6 GKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDC 85 (294)
T ss_dssp SSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSE
T ss_pred hhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCe
Confidence 45778899999999999999999999999999999999977665555667889999999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccc
Q 037702 85 IYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTR 163 (448)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~ 163 (448)
.|+||||++|++|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 86 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 86 YYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS 165 (294)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence 9999999999999999976 679999999999999999999999999999999999999999999999999998654322
Q ss_pred cCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccC-----CCCCCCCHH
Q 037702 164 QDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF-----KCPNWFPPE 238 (448)
Q Consensus 164 ~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-----~~p~~~s~~ 238 (448)
. ......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+......+...... ..+..+|+.
T Consensus 166 ~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (294)
T 4eqm_A 166 L-TQTNHVLGTVQYFSPEQAKGEAT-DECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQS 243 (294)
T ss_dssp ----------CCSSCCHHHHHTCCC-CTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHH
T ss_pred c-cccCccccCccccCHhHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHH
Confidence 1 22234679999999999987666 4889999999999999999999998887666555444332 234568999
Q ss_pred HHHHHHhccCCCcCCCCCHHHHHhhhhc
Q 037702 239 VRKLLSRILDPNPSTRVTMAKLMENYWF 266 (448)
Q Consensus 239 ~~~li~~~L~~dP~~Rpt~~eil~hp~~ 266 (448)
+.++|.+||..||.+||+..+.+.+.|.
T Consensus 244 l~~li~~~l~~dp~~R~~~~~~l~~~l~ 271 (294)
T 4eqm_A 244 LSNVILRATEKDKANRYKTIQEMKDDLS 271 (294)
T ss_dssp HHHHHHHHSCSSGGGSCSSHHHHHHHHH
T ss_pred HHHHHHHHhcCCHhHccccHHHHHHHHH
Confidence 9999999999999999966666666664
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-50 Score=403.81 Aligned_cols=261 Identities=24% Similarity=0.409 Sum_probs=222.6
Q ss_pred cCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----C
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASK-----T 83 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~-----~ 83 (448)
.++|++.+.||+|+||.||+|.+..++..||||++.... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 469999999999999999999999999999999997532 234457788999999999999999999999765 4
Q ss_pred EEEEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccc
Q 037702 84 KIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTR 163 (448)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~ 163 (448)
..|+||||+.+ +|.+++..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 104 ~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 182 (364)
T 3qyz_A 104 DVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182 (364)
T ss_dssp CEEEEEECCSE-EHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred eEEEEEcccCc-CHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence 78999999974 99999988899999999999999999999999999999999999999999999999999998654332
Q ss_pred c-CCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccC-------------
Q 037702 164 Q-DGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF------------- 229 (448)
Q Consensus 164 ~-~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~------------- 229 (448)
. .......+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 262 (364)
T 3qyz_A 183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 262 (364)
T ss_dssp CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence 2 22235568999999999986655556899999999999999999999998776665555432100
Q ss_pred ------------------CCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccccccc
Q 037702 230 ------------------KCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYKK 272 (448)
Q Consensus 230 ------------------~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~ 272 (448)
..++.+++++.+||.+||+.||.+|||++++++||||+..+..
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~ 323 (364)
T 3qyz_A 263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 323 (364)
T ss_dssp HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred hHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCc
Confidence 0124578999999999999999999999999999999876543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-50 Score=388.16 Aligned_cols=259 Identities=33% Similarity=0.637 Sum_probs=226.0
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccch---hHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRV---GLIDQIKREISVMRLVRHPNIVQLYEVMASKT 83 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~---~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~ 83 (448)
++.++|++.+.||+|+||.||+|.+..+|+.||+|++........ ...+.+.+|+.+++.++||||+++++++.+..
T Consensus 2 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 81 (283)
T 3bhy_A 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKT 81 (283)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred chhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCC
Confidence 456789999999999999999999999999999999986643321 13577899999999999999999999999999
Q ss_pred EEEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCC----CeEEeecccccc
Q 037702 84 KIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENG----DLKISDFGLSAL 158 (448)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g----~lkl~DFGla~~ 158 (448)
..|+||||+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++..
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 82 DVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred eEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 99999999999999999975 6799999999999999999999999999999999999999877 899999999975
Q ss_pred ccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCC----CC
Q 037702 159 QESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCP----NW 234 (448)
Q Consensus 159 ~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~ 234 (448)
..... ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+.+..+....+.......+ ..
T Consensus 162 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T 3bhy_A 162 IEAGN---EFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSN 237 (283)
T ss_dssp CC-----------CCCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred ccCCC---cccccCCCcCccCcceecCCCC-CcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhccc
Confidence 43321 2235679999999999977665 4889999999999999999999999888888877776665544 46
Q ss_pred CCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 235 FPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 235 ~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
+++.+.+||.+||..||.+|||++++++||||+..
T Consensus 238 ~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 238 TSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp CCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred CCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence 88999999999999999999999999999999864
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=419.52 Aligned_cols=262 Identities=24% Similarity=0.368 Sum_probs=200.0
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe-----
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMAS----- 81 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~----- 81 (448)
.+.++|++.+.||+|+||.||+|++..+|+.||||++.+.. .+....+.+.+|+.+|+.++||||+++++++..
T Consensus 50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 128 (458)
T 3rp9_A 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEK 128 (458)
T ss_dssp CSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCccc
Confidence 35689999999999999999999999999999999996543 333445778999999999999999999999843
Q ss_pred CCEEEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccc
Q 037702 82 KTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQE 160 (448)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~ 160 (448)
...+|+||||+ +++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+...
T Consensus 129 ~~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 129 FDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp CCCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred CceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 35799999998 5699999876 579999999999999999999999999999999999999999999999999998654
Q ss_pred ccccC-------------------------CCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh--------
Q 037702 161 STRQD-------------------------GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-------- 207 (448)
Q Consensus 161 ~~~~~-------------------------~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-------- 207 (448)
..... ......+||+.|+|||++.....++.++||||||||||||++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~ 287 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY 287 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSS
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccc
Confidence 22110 123456899999999987555545689999999999999998
Q ss_pred ---CCCCCCCCcH--------------------HHHHHHHhhc----------------------c---------CCCCC
Q 037702 208 ---GNLPFYDSNL--------------------MELYKKITRA----------------------E---------FKCPN 233 (448)
Q Consensus 208 ---G~~Pf~~~~~--------------------~~~~~~i~~~----------------------~---------~~~p~ 233 (448)
|+++|.+.+. .+....|... . ....+
T Consensus 288 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (458)
T 3rp9_A 288 HADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFP 367 (458)
T ss_dssp GGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGST
T ss_pred cccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCC
Confidence 7777766431 1111111110 0 00123
Q ss_pred CCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccccc
Q 037702 234 WFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGY 270 (448)
Q Consensus 234 ~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 270 (448)
.+++++.+||.+||..||.+|||++|+|+||||+...
T Consensus 368 ~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~ 404 (458)
T 3rp9_A 368 ASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR 404 (458)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred CCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcC
Confidence 4689999999999999999999999999999998753
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=398.74 Aligned_cols=260 Identities=29% Similarity=0.506 Sum_probs=224.6
Q ss_pred cccccCCeEEE-eeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 037702 5 AGILMNKYELG-RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEVMASK 82 (448)
Q Consensus 5 ~~~~~~~y~~~-~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~ 82 (448)
...+.++|.+. +.||+|+||.||+|.+..+|+.||+|++....... .....+.+|+.+++.+ .||||+++++++.+.
T Consensus 23 ~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~ 101 (327)
T 3lm5_A 23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ-DCRAEILHEIAVLELAKSCPRVINLHEVYENT 101 (327)
T ss_dssp HHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE-ECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred HHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC
Confidence 34567789998 89999999999999999999999999998764433 3346788999999999 569999999999999
Q ss_pred CEEEEEEeecCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcC---CCCeEEeecccc
Q 037702 83 TKIYFAMEYVRGGELFNKVAK---GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDE---NGDLKISDFGLS 156 (448)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~---~g~lkl~DFGla 156 (448)
...|+||||++||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++
T Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a 181 (327)
T 3lm5_A 102 SEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMS 181 (327)
T ss_dssp SEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGC
T ss_pred CeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccc
Confidence 999999999999999999854 57999999999999999999999999999999999999998 789999999999
Q ss_pred ccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCC----
Q 037702 157 ALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCP---- 232 (448)
Q Consensus 157 ~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p---- 232 (448)
...... ......+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+..+.+..+.......+
T Consensus 182 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 257 (327)
T 3lm5_A 182 RKIGHA---CELREIMGTPEYLAPEILNYDPIT-TATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETF 257 (327)
T ss_dssp EEC------------CCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTT
T ss_pred cccCCc---cccccccCCcCccCCeeecCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhh
Confidence 865432 223456899999999999877664 889999999999999999999999888888777776554433
Q ss_pred CCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 233 NWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 233 ~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
..+++.+.+||.+||..||.+|||++++++||||+..
T Consensus 258 ~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~ 294 (327)
T 3lm5_A 258 SSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQW 294 (327)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCC
T ss_pred cccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccc
Confidence 3578999999999999999999999999999999764
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-50 Score=402.83 Aligned_cols=258 Identities=33% Similarity=0.635 Sum_probs=226.3
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeeccccc-----chhHHHHHHHHHHHHHhC-CCCCcceEEEEEEe
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIR-----RVGLIDQIKREISVMRLV-RHPNIVQLYEVMAS 81 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~-----~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~ 81 (448)
+.++|++.+.||+|+||.||+|.+..+|+.||||++...... .....+.+.+|+.+++.+ +||||+++++++..
T Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 171 (365)
T 2y7j_A 92 FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES 171 (365)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB
T ss_pred hhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee
Confidence 457899999999999999999999999999999999765321 122346788999999999 89999999999999
Q ss_pred CCEEEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccc
Q 037702 82 KTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQE 160 (448)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~ 160 (448)
.+..|+||||++|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 172 ~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~ 251 (365)
T 2y7j_A 172 SSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE 251 (365)
T ss_dssp SSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence 9999999999999999999976 689999999999999999999999999999999999999999999999999997654
Q ss_pred ccccCCCccccCCCCcccchhhhhcc-----CCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCC---
Q 037702 161 STRQDGLLHTTCGTPAYVAPEVINKR-----GYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCP--- 232 (448)
Q Consensus 161 ~~~~~~~~~~~~Gt~~Y~APEvl~~~-----~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p--- 232 (448)
.. ......+||+.|+|||++.+. ...+.++|||||||++|+|++|..||...+.......+..+.+..+
T Consensus 252 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 328 (365)
T 2y7j_A 252 PG---EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPE 328 (365)
T ss_dssp TT---CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHH
T ss_pred CC---cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence 22 223467899999999998642 2235789999999999999999999999888888888877766543
Q ss_pred -CCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccc
Q 037702 233 -NWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRK 268 (448)
Q Consensus 233 -~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 268 (448)
..+++.+.+||.+||..||.+|||++++++||||++
T Consensus 329 ~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 329 WDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 357899999999999999999999999999999963
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=402.84 Aligned_cols=266 Identities=27% Similarity=0.407 Sum_probs=214.5
Q ss_pred CccccccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccc--hhHHHHHHHHHHHHHhCCCCCcceEEEE
Q 037702 1 MEKKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRR--VGLIDQIKREISVMRLVRHPNIVQLYEV 78 (448)
Q Consensus 1 m~~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~ 78 (448)
|.-..+...++|++.+.||+|+||.||+|.+..+|+.||||++....... ......+.+|+.+++.++||||++++++
T Consensus 1 m~l~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 80 (346)
T 1ua2_A 1 MALDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDA 80 (346)
T ss_dssp ------------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CchhhHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEE
Confidence 33344567889999999999999999999999999999999997543221 1122467899999999999999999999
Q ss_pred EEeCCEEEEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccc
Q 037702 79 MASKTKIYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLS 156 (448)
Q Consensus 79 ~~~~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla 156 (448)
+.+....|+||||+++ +|.+.+.. ..+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||++
T Consensus 81 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (346)
T 1ua2_A 81 FGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLA 159 (346)
T ss_dssp ECCTTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred EeeCCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccc
Confidence 9999999999999986 88888865 36999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccC-----CC
Q 037702 157 ALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF-----KC 231 (448)
Q Consensus 157 ~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-----~~ 231 (448)
...... .......+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+..+.+..+..... .+
T Consensus 160 ~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 237 (346)
T 1ua2_A 160 KSFGSP--NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQW 237 (346)
T ss_dssp STTTSC--CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred eeccCC--cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhh
Confidence 865332 22334678999999999997655556899999999999999999999999888777776654211 00
Q ss_pred -----------------------CCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 232 -----------------------PNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 232 -----------------------p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
...+++++.+||.+||..||.+|||++|+++||||++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~ 298 (346)
T 1ua2_A 238 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 298 (346)
T ss_dssp SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred hhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcC
Confidence 13457899999999999999999999999999999764
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-50 Score=411.12 Aligned_cols=262 Identities=26% Similarity=0.402 Sum_probs=210.7
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC----
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASK---- 82 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~---- 82 (448)
.+.++|++.+.||+|+||.||+|.+..+|+.||||++.... ......+.+.+|+.+|+.++||||+++++++...
T Consensus 23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 101 (432)
T 3n9x_A 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLK 101 (432)
T ss_dssp CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCc
Confidence 46789999999999999999999999999999999997543 3334457889999999999999999999999766
Q ss_pred -CEEEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccc
Q 037702 83 -TKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQE 160 (448)
Q Consensus 83 -~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~ 160 (448)
..+|+||||+. |+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 102 ~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 102 FDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180 (432)
T ss_dssp CCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred CCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence 57999999996 599999987 569999999999999999999999999999999999999999999999999998654
Q ss_pred ccccC--------------------CCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhC-----------C
Q 037702 161 STRQD--------------------GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAG-----------N 209 (448)
Q Consensus 161 ~~~~~--------------------~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG-----------~ 209 (448)
..... ....+.+||+.|+|||++.....++.++|||||||++|+|++| .
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~ 260 (432)
T 3n9x_A 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRF 260 (432)
T ss_dssp ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCC
T ss_pred ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccccc
Confidence 32211 1235678999999999975555556899999999999999984 4
Q ss_pred CCCCCCc-----------------HHHHHHHHh------------------------hccCCCC-------CCCCHHHHH
Q 037702 210 LPFYDSN-----------------LMELYKKIT------------------------RAEFKCP-------NWFPPEVRK 241 (448)
Q Consensus 210 ~Pf~~~~-----------------~~~~~~~i~------------------------~~~~~~p-------~~~s~~~~~ 241 (448)
++|.+.+ ..+....+. ......+ +.+++++.+
T Consensus 261 p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 340 (432)
T 3n9x_A 261 PLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGIN 340 (432)
T ss_dssp CSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHH
T ss_pred ccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHH
Confidence 4444332 011111111 1111111 347999999
Q ss_pred HHHhccCCCcCCCCCHHHHHhhhhccccc
Q 037702 242 LLSRILDPNPSTRVTMAKLMENYWFRKGY 270 (448)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 270 (448)
||.+||..||.+|||++|+|+||||+...
T Consensus 341 Ll~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 369 (432)
T 3n9x_A 341 LLESMLKFNPNKRITIDQALDHPYLKDVR 369 (432)
T ss_dssp HHHHHSCSSTTTSCCHHHHHTCGGGTTTC
T ss_pred HHHHHhcCCcccCCCHHHHhcChhhhhcc
Confidence 99999999999999999999999998643
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=393.86 Aligned_cols=257 Identities=35% Similarity=0.680 Sum_probs=225.3
Q ss_pred cccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 037702 5 AGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTK 84 (448)
Q Consensus 5 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 84 (448)
...+.++|++.+.||+|+||.||+|++..+|+.||+|++....... .+.+.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (304)
T 2jam_A 4 TTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR---DSSLENEIAVLKKIKHENIVTLEDIYESTTH 80 (304)
T ss_dssp --CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred ccchhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccc---hHHHHHHHHHHHhCCCCCeeehhhhcccCCE
Confidence 3456789999999999999999999999999999999998654322 3568899999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEE---cCCCCeEEeecccccccc
Q 037702 85 IYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLL---DENGDLKISDFGLSALQE 160 (448)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl---~~~g~lkl~DFGla~~~~ 160 (448)
.|+||||++|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 81 YYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred EEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 9999999999999999865 789999999999999999999999999999999999999 788999999999987532
Q ss_pred ccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCC----CCCC
Q 037702 161 STRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCP----NWFP 236 (448)
Q Consensus 161 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s 236 (448)
. ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+..+.+.++ ..++
T Consensus 161 ~----~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 235 (304)
T 2jam_A 161 N----GIMSTACGTPGYVAPEVLAQKPY-SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDIS 235 (304)
T ss_dssp C----BTTHHHHSCCCBCCTTTBSSCSC-CHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSC
T ss_pred C----CccccccCCCCccChHHhccCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCC
Confidence 2 22345679999999999977666 4889999999999999999999999888888888877755433 4578
Q ss_pred HHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 237 PEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 237 ~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
+++.+||.+||..||.+|||++++++||||+..
T Consensus 236 ~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 236 ESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp HHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 999999999999999999999999999999764
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-50 Score=398.84 Aligned_cols=260 Identities=28% Similarity=0.437 Sum_probs=218.7
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIY 86 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 86 (448)
..+++|++.+.||+|+||.||+|++..+|+.||||++...... ....+.+.+|+.+++.++||||+++++++.+....|
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 100 (331)
T 4aaa_A 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDD-KMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWY 100 (331)
T ss_dssp BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCc-hHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEE
Confidence 3578999999999999999999999999999999999765432 234566889999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccC
Q 037702 87 FAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQD 165 (448)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~ 165 (448)
+||||+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 101 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 178 (331)
T 4aaa_A 101 LVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-- 178 (331)
T ss_dssp EEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred EEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc--
Confidence 99999999999888764 679999999999999999999999999999999999999999999999999997543322
Q ss_pred CCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhcc-----------------
Q 037702 166 GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAE----------------- 228 (448)
Q Consensus 166 ~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~----------------- 228 (448)
......+||+.|+|||++.+....+.++|||||||++|+|++|..||...+..+....+....
T Consensus 179 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (331)
T 4aaa_A 179 EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF 258 (331)
T ss_dssp -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence 223456899999999999776555689999999999999999999999887665554443210
Q ss_pred --CCC------------CCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 229 --FKC------------PNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 229 --~~~------------p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
... .+.+++++.+||.+||..||.+|||++|+++||||+..
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence 111 12478999999999999999999999999999999753
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=395.91 Aligned_cols=253 Identities=23% Similarity=0.385 Sum_probs=207.5
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHH-hCCCCCcceEEEEEEeCCE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMR-LVRHPNIVQLYEVMASKTK 84 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~-~l~hpnIv~l~~~~~~~~~ 84 (448)
.++.++|++.+.||+|+||.||+|++..+|+.||||++.......... .....|+..+. ..+||||+++++++.+...
T Consensus 53 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~-~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~ 131 (311)
T 3p1a_A 53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDR-ARKLAEVGSHEKVGQHPCCVRLEQAWEEGGI 131 (311)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHH-HHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred chhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHH-HHHHHHHHHHHHhcCCCcEEEEEEEEEeCCE
Confidence 345578999999999999999999999999999999987654333333 33444555554 4599999999999999999
Q ss_pred EEEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccc
Q 037702 85 IYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQEST 162 (448)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~ 162 (448)
+|+||||+ +++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 132 LYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp EEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred EEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 99999999 6688888765 46999999999999999999999999999999999999999999999999998764332
Q ss_pred ccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccC--CCCCCCCHHHH
Q 037702 163 RQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF--KCPNWFPPEVR 240 (448)
Q Consensus 163 ~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--~~p~~~s~~~~ 240 (448)
......+||+.|+|||++.+ .+ +.++|||||||++|+|++|..||..... ...+..... ..+..+++++.
T Consensus 211 ---~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~ 282 (311)
T 3p1a_A 211 ---GAGEVQEGDPRYMAPELLQG-SY-GTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGYLPPEFTAGLSSELR 282 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT-CC-STHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTCCCHHHHTTSCHHHH
T ss_pred ---CCCcccCCCccccCHhHhcC-CC-CchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccCCCcccccCCCHHHH
Confidence 22345679999999999875 44 5899999999999999999776655332 223333222 23456899999
Q ss_pred HHHHhccCCCcCCCCCHHHHHhhhhccc
Q 037702 241 KLLSRILDPNPSTRVTMAKLMENYWFRK 268 (448)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~eil~hp~~~~ 268 (448)
+||.+||++||.+|||++++++||||++
T Consensus 283 ~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 283 SVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 9999999999999999999999999975
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=386.88 Aligned_cols=261 Identities=31% Similarity=0.559 Sum_probs=227.4
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeeccccc------chhHHHHHHHHHHHHHhCC-CCCcceEEEE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIR------RVGLIDQIKREISVMRLVR-HPNIVQLYEV 78 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~------~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~ 78 (448)
..+.++|++.+.||+|+||.||+|.+..+|+.||||++...... .....+.+.+|+.+++.+. ||||++++++
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (298)
T 1phk_A 13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT 92 (298)
T ss_dssp --CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred cchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence 45788999999999999999999999999999999999765321 1233467889999999995 9999999999
Q ss_pred EEeCCEEEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccc
Q 037702 79 MASKTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSA 157 (448)
Q Consensus 79 ~~~~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~ 157 (448)
+......|+||||+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 93 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 172 (298)
T 1phk_A 93 YETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC 172 (298)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred eccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchh
Confidence 9999999999999999999999976 689999999999999999999999999999999999999999999999999997
Q ss_pred cccccccCCCccccCCCCcccchhhhhc-----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCC
Q 037702 158 LQESTRQDGLLHTTCGTPAYVAPEVINK-----RGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCP 232 (448)
Q Consensus 158 ~~~~~~~~~~~~~~~Gt~~Y~APEvl~~-----~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p 232 (448)
..... ......+||+.|+|||++.. ....+.++|||||||++|+|++|..||...+.......+.......+
T Consensus 173 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (298)
T 1phk_A 173 QLDPG---EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG 249 (298)
T ss_dssp ECCTT---CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred hcCCC---cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccC
Confidence 64322 22345689999999999852 22335789999999999999999999999888888888877765543
Q ss_pred ----CCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 233 ----NWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 233 ----~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
..+++++.+||.+||..||.+|||++++++||||++.
T Consensus 250 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (298)
T 1phk_A 250 SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 290 (298)
T ss_dssp TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred cccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhc
Confidence 2478999999999999999999999999999999764
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-50 Score=398.41 Aligned_cols=253 Identities=26% Similarity=0.439 Sum_probs=221.5
Q ss_pred CCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 037702 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAM 89 (448)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (448)
++|++.+.||+|+||.||+|++..+|+.||||++...........+.+.+|+.+++.++||||+++++++.+++..|+||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 46999999999999999999999999999999998765544455678899999999999999999999999999999999
Q ss_pred eecCCCchHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCC
Q 037702 90 EYVRGGELFNKVA--KGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGL 167 (448)
Q Consensus 90 E~~~gg~L~~~i~--~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 167 (448)
||+. |+|.+.+. .+.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~------ 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ 206 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC------
Confidence 9997 57878774 36799999999999999999999999999999999999999999999999999975432
Q ss_pred ccccCCCCcccchhhhhc--cCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCC--CCCCCCHHHHHHH
Q 037702 168 LHTTCGTPAYVAPEVINK--RGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFK--CPNWFPPEVRKLL 243 (448)
Q Consensus 168 ~~~~~Gt~~Y~APEvl~~--~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~--~p~~~s~~~~~li 243 (448)
....+||+.|+|||++.. .+..+.++|||||||++|+|++|..||.+.+.......+.....+ .+..+++.+.+||
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 286 (348)
T 1u5q_A 207 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV 286 (348)
T ss_dssp BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHH
T ss_pred CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Confidence 234689999999999852 233458899999999999999999999988877666666554432 3456899999999
Q ss_pred HhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 244 SRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 244 ~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
.+||+.||.+|||++++++||||...
T Consensus 287 ~~~l~~dP~~Rps~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 287 DSCLQKIPQDRPTSEVLLKHRFVLRE 312 (348)
T ss_dssp HHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred HHHcccChhhCcCHHHHhhChhhhcc
Confidence 99999999999999999999999764
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-50 Score=398.66 Aligned_cols=261 Identities=25% Similarity=0.452 Sum_probs=214.9
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCC--CCcceEEEEEEeCC
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRH--PNIVQLYEVMASKT 83 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~h--pnIv~l~~~~~~~~ 83 (448)
.+..++|++.+.||+|+||.||+|.+ .+++.||||++....... ...+.+.+|+.+++.++| |||+++++++.+..
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 82 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADN-QTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 82 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccch-HHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCC
Confidence 45667899999999999999999997 578999999998665432 445778999999999987 99999999999999
Q ss_pred EEEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccc
Q 037702 84 KIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQEST 162 (448)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~ 162 (448)
.+|+||| +.+++|.+++.. +.+++.+++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++......
T Consensus 83 ~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 83 YIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp EEEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred EEEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 9999999 568899999976 6799999999999999999999999999999999999996 688999999999865443
Q ss_pred ccCCCccccCCCCcccchhhhhc----------cCCCCCcchHHHHHHHHHHHHhCCCCCCCCc-HHHHHHHHhh--ccC
Q 037702 163 RQDGLLHTTCGTPAYVAPEVINK----------RGYDGAKADIWSCGVVLFVLLAGNLPFYDSN-LMELYKKITR--AEF 229 (448)
Q Consensus 163 ~~~~~~~~~~Gt~~Y~APEvl~~----------~~~~~~~sDiwSlGvil~elltG~~Pf~~~~-~~~~~~~i~~--~~~ 229 (448)
.........+||+.|+|||++.+ ....+.++|||||||++|+|++|..||.... .......+.. ...
T Consensus 161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 240 (343)
T 3dbq_A 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 240 (343)
T ss_dssp ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCC
T ss_pred cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCccc
Confidence 33333446789999999999865 1334578999999999999999999998643 2333333332 344
Q ss_pred CCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccccc
Q 037702 230 KCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGY 270 (448)
Q Consensus 230 ~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 270 (448)
.+|...++++.+||.+||..||.+|||+.++++||||+...
T Consensus 241 ~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 281 (343)
T 3dbq_A 241 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 281 (343)
T ss_dssp CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence 67777889999999999999999999999999999998654
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-50 Score=391.92 Aligned_cols=265 Identities=27% Similarity=0.406 Sum_probs=216.4
Q ss_pred CccccccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 037702 1 MEKKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMA 80 (448)
Q Consensus 1 m~~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~ 80 (448)
|.-.+..+.++|++.+.||+|+||.||+|.+..+|+.||||++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 2 m~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 78 (320)
T 2i6l_A 2 MNIHGFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVFEILG 78 (320)
T ss_dssp ----CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CccccCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC---hHHHHHHHHHHHHHHhcCCCCeeEEEEecc
Confidence 45566778899999999999999999999999999999999997543 344577889999999999999999999873
Q ss_pred --------------eCCEEEEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEc-CC
Q 037702 81 --------------SKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLD-EN 145 (448)
Q Consensus 81 --------------~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~-~~ 145 (448)
+....|+||||++ |+|.+++..+++++..++.++.||+.||+|||++||+||||||+|||++ .+
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~ 157 (320)
T 2i6l_A 79 PSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTED 157 (320)
T ss_dssp TTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT
T ss_pred ccccccccccccccccCceeEEeeccC-CCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC
Confidence 4478999999998 5999999988999999999999999999999999999999999999997 56
Q ss_pred CCeEEeeccccccccccc-cCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHH
Q 037702 146 GDLKISDFGLSALQESTR-QDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKI 224 (448)
Q Consensus 146 g~lkl~DFGla~~~~~~~-~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i 224 (448)
+.+||+|||++....... .........||+.|+|||++......+.++|||||||++|+|++|+.||.+.+..+....+
T Consensus 158 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 237 (320)
T 2i6l_A 158 LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI 237 (320)
T ss_dssp TEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 789999999998654321 1222345578999999999876555568999999999999999999999988876666555
Q ss_pred hhccC------------------------------CCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 225 TRAEF------------------------------KCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 225 ~~~~~------------------------------~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
..... ..++.+++++.+||.+||+.||.+|||++++++||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (320)
T 2i6l_A 238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY 312 (320)
T ss_dssp HHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTT
T ss_pred HHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccc
Confidence 43211 0124589999999999999999999999999999999753
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-50 Score=384.88 Aligned_cols=253 Identities=20% Similarity=0.330 Sum_probs=215.3
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEVMASKTKI 85 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~ 85 (448)
...++|++.+.||+|+||.||+|.+..+|+.||||++....... .....+.+|+..+..+ +||||+++++++.+.+..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~ 86 (289)
T 1x8b_A 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS-VDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHM 86 (289)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTS-HHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEE
T ss_pred cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccccc-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeE
Confidence 35678999999999999999999999999999999998654433 2346778899999999 999999999999999999
Q ss_pred EEEEeecCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCC--------------
Q 037702 86 YFAMEYVRGGELFNKVAK-----GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENG-------------- 146 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g-------------- 146 (448)
|+||||++|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-----------------
T ss_pred EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999999999999864 5699999999999999999999999999999999999998544
Q ss_pred -----CeEEeeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHH
Q 037702 147 -----DLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELY 221 (448)
Q Consensus 147 -----~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~ 221 (448)
.+||+|||++...... ...+||+.|+|||++.+....+.++|||||||++|+|++|.+|+..... .
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~ 237 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---W 237 (289)
T ss_dssp ---CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---H
T ss_pred cCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---H
Confidence 7999999998764322 2356999999999997664555789999999999999999988765533 3
Q ss_pred HHHhhcc-CCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 222 KKITRAE-FKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 222 ~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
..+.... ...|..+++++.+||.+||+.||.+|||+.++++||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 238 HEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp HHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred HHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 3333333 35677899999999999999999999999999999999864
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-50 Score=404.71 Aligned_cols=258 Identities=26% Similarity=0.410 Sum_probs=204.1
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC----
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASK---- 82 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~---- 82 (448)
.+.++|++.+.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+++.++||||+++++++...
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 104 (367)
T 2fst_X 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 104 (367)
T ss_dssp EEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred CCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccc
Confidence 35689999999999999999999999999999999997543 2234457788999999999999999999998654
Q ss_pred --CEEEEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccc
Q 037702 83 --TKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQE 160 (448)
Q Consensus 83 --~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~ 160 (448)
..+|+|||++ +++|.+++..+++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 105 ~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 105 EFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183 (367)
T ss_dssp GCCCCEEEEECC-CEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC--------
T ss_pred cCCeEEEEeccc-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence 5689999999 7899999988889999999999999999999999999999999999999999999999999997543
Q ss_pred ccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccC-----------
Q 037702 161 STRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF----------- 229 (448)
Q Consensus 161 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~----------- 229 (448)
.. ....+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 184 ~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 258 (367)
T 2fst_X 184 DE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 258 (367)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCC
T ss_pred cc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 21 24568999999999997755556899999999999999999999999887766665543100
Q ss_pred ------------CC--------CCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccccc
Q 037702 230 ------------KC--------PNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYK 271 (448)
Q Consensus 230 ------------~~--------p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~ 271 (448)
.. .+..++++.+||.+||..||.+|||++++++||||+....
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~ 320 (367)
T 2fst_X 259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 320 (367)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred hHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccC
Confidence 00 1246889999999999999999999999999999986543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=386.40 Aligned_cols=258 Identities=29% Similarity=0.526 Sum_probs=229.6
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYF 87 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 87 (448)
..++|++.+.||+|+||.||+|.+..+|+.||||++...... ...+.+.+|+.+++.++||||+++++++.+....|+
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 97 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWI 97 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS--TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH--HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE
Confidence 456899999999999999999999999999999999866433 335788999999999999999999999999999999
Q ss_pred EEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCC
Q 037702 88 AMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGL 167 (448)
Q Consensus 88 V~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 167 (448)
||||+++++|.+++..+++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 98 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 175 (303)
T 3a7i_A 98 IMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IK 175 (303)
T ss_dssp EEECCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB--CC
T ss_pred EEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccc--cc
Confidence 9999999999999998899999999999999999999999999999999999999999999999999997653321 12
Q ss_pred ccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccC-CCCCCCCHHHHHHHHhc
Q 037702 168 LHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF-KCPNWFPPEVRKLLSRI 246 (448)
Q Consensus 168 ~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~ 246 (448)
....+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+.......+..... ..+..+++.+.+||.+|
T Consensus 176 ~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 254 (303)
T 3a7i_A 176 RNTFVGTPFWMAPEVIKQSAYD-SKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEAC 254 (303)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHHH
T ss_pred cCccCCCcCccCHHHHhcCCCC-chhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHHHH
Confidence 3456799999999999876664 789999999999999999999998887776666655443 45667899999999999
Q ss_pred cCCCcCCCCCHHHHHhhhhccccc
Q 037702 247 LDPNPSTRVTMAKLMENYWFRKGY 270 (448)
Q Consensus 247 L~~dP~~Rpt~~eil~hp~~~~~~ 270 (448)
|..||.+|||+.++++||||....
T Consensus 255 l~~dp~~Rps~~~ll~~~~~~~~~ 278 (303)
T 3a7i_A 255 LNKEPSFRPTAKELLKHKFILRNA 278 (303)
T ss_dssp CCSSGGGSCCHHHHTTCHHHHHHC
T ss_pred cCCChhhCcCHHHHhhChhhhcCC
Confidence 999999999999999999997654
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=398.28 Aligned_cols=257 Identities=26% Similarity=0.462 Sum_probs=209.9
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC---
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKT--- 83 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~--- 83 (448)
...++|++.+.||+|+||.||+|++..+|+.||||++.... .....+.+.+|+.+++.++||||+++++++.+..
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 80 (332)
T 3qd2_B 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEK 80 (332)
T ss_dssp HHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCH
T ss_pred hhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccch
Confidence 45678999999999999999999999999999999997654 2234578899999999999999999999986543
Q ss_pred ------------------------------------------------------EEEEEEeecCCCchHHHHhcC----C
Q 037702 84 ------------------------------------------------------KIYFAMEYVRGGELFNKVAKG----K 105 (448)
Q Consensus 84 ------------------------------------------------------~~~lV~E~~~gg~L~~~i~~~----~ 105 (448)
..|+||||++||+|.+++... .
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~ 160 (332)
T 3qd2_B 81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160 (332)
T ss_dssp HHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGG
T ss_pred hhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccc
Confidence 389999999999999999763 3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccC----------CCccccCCCC
Q 037702 106 LREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQD----------GLLHTTCGTP 175 (448)
Q Consensus 106 l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~----------~~~~~~~Gt~ 175 (448)
.++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......... ......+||+
T Consensus 161 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 161 REHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred hhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 566779999999999999999999999999999999999999999999999865433211 1224467999
Q ss_pred cccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCC-CCCCCCHHHHHHHHhccCCCcCCC
Q 037702 176 AYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFK-CPNWFPPEVRKLLSRILDPNPSTR 254 (448)
Q Consensus 176 ~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~li~~~L~~dP~~R 254 (448)
.|+|||++.+..+ +.++|||||||++|+|++|..|+.. .......+.....+ .+...++++.+||.+||+.||.+|
T Consensus 241 ~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 317 (332)
T 3qd2_B 241 LYMSPEQIHGNNY-SHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTER 317 (332)
T ss_dssp GGSCHHHHHCCCC-CTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGS
T ss_pred CccChHHhcCCCC-cchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcC
Confidence 9999999987766 4899999999999999998877532 12233333332221 112356889999999999999999
Q ss_pred CCHHHHHhhhhccc
Q 037702 255 VTMAKLMENYWFRK 268 (448)
Q Consensus 255 pt~~eil~hp~~~~ 268 (448)
||++++++||||++
T Consensus 318 ps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 318 PEATDIIENAIFEN 331 (332)
T ss_dssp CCHHHHHHSTTCCC
T ss_pred CCHHHHhhchhhhc
Confidence 99999999999974
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-50 Score=405.10 Aligned_cols=258 Identities=25% Similarity=0.443 Sum_probs=215.3
Q ss_pred cCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC--CCCcceEEEEEEeCCEEE
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR--HPNIVQLYEVMASKTKIY 86 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~--hpnIv~l~~~~~~~~~~~ 86 (448)
..+|++.+.||+|+||.||+|.+.. |+.||||++...... ....+.+.+|+.+|+.++ ||||+++++++...+.+|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~ 132 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 132 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEeccccc-HHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEE
Confidence 4569999999999999999999764 999999999876543 345678899999999996 599999999999999999
Q ss_pred EEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccC
Q 037702 87 FAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQD 165 (448)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~ 165 (448)
+||| +.+++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.........
T Consensus 133 lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 210 (390)
T 2zmd_A 133 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 210 (390)
T ss_dssp EEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred EEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence 9999 668899999976 6799999999999999999999999999999999999995 689999999999865433332
Q ss_pred CCccccCCCCcccchhhhhcc----------CCCCCcchHHHHHHHHHHHHhCCCCCCCCc-HHHHHHHHhhc--cCCCC
Q 037702 166 GLLHTTCGTPAYVAPEVINKR----------GYDGAKADIWSCGVVLFVLLAGNLPFYDSN-LMELYKKITRA--EFKCP 232 (448)
Q Consensus 166 ~~~~~~~Gt~~Y~APEvl~~~----------~~~~~~sDiwSlGvil~elltG~~Pf~~~~-~~~~~~~i~~~--~~~~p 232 (448)
....+.+||+.|+|||++.+. ...+.++|||||||++|+|++|+.||.... .......+... ...+|
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 290 (390)
T 2zmd_A 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 290 (390)
T ss_dssp ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCC
T ss_pred ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCC
Confidence 334567899999999998652 234588999999999999999999998753 33444444433 34567
Q ss_pred CCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccccc
Q 037702 233 NWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGY 270 (448)
Q Consensus 233 ~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 270 (448)
.+.++++.+||.+||..||.+|||+.++++||||+...
T Consensus 291 ~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 291 DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred ccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 88899999999999999999999999999999998643
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-50 Score=403.32 Aligned_cols=257 Identities=26% Similarity=0.439 Sum_probs=209.8
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC---
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKT--- 83 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~--- 83 (448)
.+.++|++.+.||+|+||.||+|.+..+|+.||||++..... .....+.+.+|+.+++.++||||+++++++....
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 100 (371)
T 2xrw_A 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 100 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTT
T ss_pred chhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccC-ChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccc
Confidence 357899999999999999999999999999999999976532 2344577889999999999999999999997665
Q ss_pred ---EEEEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccc
Q 037702 84 ---KIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQE 160 (448)
Q Consensus 84 ---~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~ 160 (448)
.+|+||||+++ +|.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 101 ~~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 101 EFQDVYIVMELMDA-NLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178 (371)
T ss_dssp TCCEEEEEEECCSE-EHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred cccceEEEEEcCCC-CHHHHHh-hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence 78999999975 7888875 469999999999999999999999999999999999999999999999999998543
Q ss_pred ccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCC----------
Q 037702 161 STRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFK---------- 230 (448)
Q Consensus 161 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---------- 230 (448)
.. ......+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..+.+..+......
T Consensus 179 ~~---~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 254 (371)
T 2xrw_A 179 TS---FMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254 (371)
T ss_dssp --------------CTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred cc---cccCCceecCCccCHHHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 22 223456899999999999887765 8899999999999999999999998877776665432110
Q ss_pred --------------------------CCC------CCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccccc
Q 037702 231 --------------------------CPN------WFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGY 270 (448)
Q Consensus 231 --------------------------~p~------~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 270 (448)
+|. ..++++++||.+||..||.+|||++|+++||||+..+
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 326 (371)
T 2xrw_A 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 326 (371)
T ss_dssp HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhc
Confidence 000 0156789999999999999999999999999998644
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=394.06 Aligned_cols=262 Identities=26% Similarity=0.419 Sum_probs=219.3
Q ss_pred cccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--
Q 037702 5 AGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASK-- 82 (448)
Q Consensus 5 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~-- 82 (448)
...+.++|++.+.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus 6 ~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 83 (353)
T 2b9h_A 6 VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPDSF 83 (353)
T ss_dssp CCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCS
T ss_pred ccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeeccccc
Confidence 3457789999999999999999999999999999999996432 233456788999999999999999999988654
Q ss_pred ---CEEEEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccc
Q 037702 83 ---TKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQ 159 (448)
Q Consensus 83 ---~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~ 159 (448)
...|+||||+. ++|.+++..+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 84 ~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 84 ENFNEVYIIQELMQ-TDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp TTCCCEEEEECCCS-EEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred CccceEEEEEeccC-ccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 67999999997 59999998889999999999999999999999999999999999999999999999999999865
Q ss_pred cccccC--------CCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhcc---
Q 037702 160 ESTRQD--------GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAE--- 228 (448)
Q Consensus 160 ~~~~~~--------~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--- 228 (448)
...... ......+||+.|+|||++......+.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence 432111 112345799999999998765555689999999999999999999999887655544332210
Q ss_pred ---------------------CC--------CCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 229 ---------------------FK--------CPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 229 ---------------------~~--------~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
.. .++.+++++.+||.+||..||.+|||++++++||||+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (353)
T 2b9h_A 243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTY 312 (353)
T ss_dssp CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 00 123578999999999999999999999999999999764
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=402.49 Aligned_cols=252 Identities=28% Similarity=0.434 Sum_probs=211.8
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe-----
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMAS----- 81 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~----- 81 (448)
...++|++++.||+|+||.||+|.+..+|+.||||++..+... ..+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-------KNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-------HHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 4568999999999999999999999999999999998755322 2379999999999999999999843
Q ss_pred ---------------------------------CCEEEEEEeecCCCchHHHHh----c-CCCCHHHHHHHHHHHHHHHH
Q 037702 82 ---------------------------------KTKIYFAMEYVRGGELFNKVA----K-GKLREEVARKYFQQLVDAVE 123 (448)
Q Consensus 82 ---------------------------------~~~~~lV~E~~~gg~L~~~i~----~-~~l~e~~~~~~~~qll~aL~ 123 (448)
...+++||||++| +|.+.+. . +.+++..++.++.||+.||.
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 3458999999985 7766654 2 57999999999999999999
Q ss_pred HHHHCCCEeecCCCCceEEc-CCCCeEEeeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHH
Q 037702 124 FCHSRGVYHRDLKPENLLLD-ENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVL 202 (448)
Q Consensus 124 yLH~~givHrDLkp~NILl~-~~g~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil 202 (448)
|||++||+||||||+|||++ .++.+||+|||+|...... ......+||+.|+|||++.+....+.++|||||||++
T Consensus 156 ~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 156 FIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS---EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp HHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT---SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC---CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 99999999999999999998 6889999999999854322 2234568999999999998766556899999999999
Q ss_pred HHHHhCCCCCCCCcHHHHHHHHhhc-----------------cC------------CCCCCCCHHHHHHHHhccCCCcCC
Q 037702 203 FVLLAGNLPFYDSNLMELYKKITRA-----------------EF------------KCPNWFPPEVRKLLSRILDPNPST 253 (448)
Q Consensus 203 ~elltG~~Pf~~~~~~~~~~~i~~~-----------------~~------------~~p~~~s~~~~~li~~~L~~dP~~ 253 (448)
|+|++|+.||.+.+..+....+... .. .+|..+|+++.+||.+||..||.+
T Consensus 233 ~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 312 (383)
T 3eb0_A 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL 312 (383)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence 9999999999998877766655431 00 135568899999999999999999
Q ss_pred CCCHHHHHhhhhcccc
Q 037702 254 RVTMAKLMENYWFRKG 269 (448)
Q Consensus 254 Rpt~~eil~hp~~~~~ 269 (448)
|||+.|+++||||+..
T Consensus 313 R~t~~e~l~hp~f~~~ 328 (383)
T 3eb0_A 313 RINPYEAMAHPFFDHL 328 (383)
T ss_dssp SCCHHHHHTSGGGHHH
T ss_pred CCCHHHHhcCHHHHHH
Confidence 9999999999999753
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-50 Score=399.92 Aligned_cols=261 Identities=30% Similarity=0.557 Sum_probs=223.4
Q ss_pred cccCCeEEEeeeeecCceEEEEEEEC---CCCcEEEEEEeeccccc-chhHHHHHHHHHHHHHhC-CCCCcceEEEEEEe
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNL---KTGQSVAIKIVDKEKIR-RVGLIDQIKREISVMRLV-RHPNIVQLYEVMAS 81 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~-~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~ 81 (448)
+..++|++.+.||+|+||.||+|++. .+|+.||||++.+.... .....+.+.+|+.+++.+ +||||+++++++..
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 130 (355)
T 1vzo_A 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 130 (355)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence 44589999999999999999999984 58999999999764321 112235567899999999 69999999999999
Q ss_pred CCEEEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccc
Q 037702 82 KTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQE 160 (448)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~ 160 (448)
...+|+||||+++|+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 131 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 131 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 210 (355)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred CceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence 9999999999999999999975 689999999999999999999999999999999999999999999999999997543
Q ss_pred ccccCCCccccCCCCcccchhhhhcc-CCCCCcchHHHHHHHHHHHHhCCCCCCCC----cHHHHHHHHhhccCCCCCCC
Q 037702 161 STRQDGLLHTTCGTPAYVAPEVINKR-GYDGAKADIWSCGVVLFVLLAGNLPFYDS----NLMELYKKITRAEFKCPNWF 235 (448)
Q Consensus 161 ~~~~~~~~~~~~Gt~~Y~APEvl~~~-~~~~~~sDiwSlGvil~elltG~~Pf~~~----~~~~~~~~i~~~~~~~p~~~ 235 (448)
.... ......+||+.|+|||++.+. ...+.++|||||||++|+|++|..||... ....+...+......+|..+
T Consensus 211 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (355)
T 1vzo_A 211 ADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM 289 (355)
T ss_dssp GGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTS
T ss_pred cCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCccc
Confidence 2221 223456899999999999753 23458899999999999999999999743 34556666777777888899
Q ss_pred CHHHHHHHHhccCCCcCCCC-----CHHHHHhhhhccc
Q 037702 236 PPEVRKLLSRILDPNPSTRV-----TMAKLMENYWFRK 268 (448)
Q Consensus 236 s~~~~~li~~~L~~dP~~Rp-----t~~eil~hp~~~~ 268 (448)
++.+.+||.+||..||.+|| |++++++||||+.
T Consensus 290 ~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~ 327 (355)
T 1vzo_A 290 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327 (355)
T ss_dssp CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred CHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence 99999999999999999999 9999999999975
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=383.41 Aligned_cols=253 Identities=25% Similarity=0.515 Sum_probs=218.0
Q ss_pred cCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe----CCE
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMAS----KTK 84 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~----~~~ 84 (448)
...|++.+.||+|+||.||+|.+..++..||+|++....... ...+.+.+|+.+++.++||||+++++++.. ...
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCH-HHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence 345999999999999999999999999999999998665443 345778999999999999999999999875 456
Q ss_pred EEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CEeecCCCCceEEc-CCCCeEEeecccccccc
Q 037702 85 IYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRG--VYHRDLKPENLLLD-ENGDLKISDFGLSALQE 160 (448)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~g--ivHrDLkp~NILl~-~~g~lkl~DFGla~~~~ 160 (448)
+|+||||+++|+|.+++.. +.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++....
T Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 8999999999999999986 78999999999999999999999999 99999999999998 78999999999997533
Q ss_pred ccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCc-HHHHHHHHhhccC--CCCCCCCH
Q 037702 161 STRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSN-LMELYKKITRAEF--KCPNWFPP 237 (448)
Q Consensus 161 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~-~~~~~~~i~~~~~--~~p~~~s~ 237 (448)
. ......+||+.|+|||++.+ .+ +.++|||||||++|+|++|..||.... ....+..+..... ..+...++
T Consensus 184 ~----~~~~~~~~t~~y~aPE~~~~-~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (290)
T 1t4h_A 184 A----SFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 257 (290)
T ss_dssp T----TSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCH
T ss_pred c----cccccccCCcCcCCHHHHhc-cC-CCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCH
Confidence 2 23345679999999998864 34 589999999999999999999998744 4455555544322 34556789
Q ss_pred HHHHHHHhccCCCcCCCCCHHHHHhhhhccc
Q 037702 238 EVRKLLSRILDPNPSTRVTMAKLMENYWFRK 268 (448)
Q Consensus 238 ~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 268 (448)
++.+||.+||..||.+|||++++++||||+.
T Consensus 258 ~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 258 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 9999999999999999999999999999975
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=398.28 Aligned_cols=259 Identities=27% Similarity=0.472 Sum_probs=221.2
Q ss_pred cccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 037702 5 AGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTK 84 (448)
Q Consensus 5 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 84 (448)
+.+..++|++.+.||+|+||.||+|.+..+|+.||+|++.... .....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 28 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 105 (360)
T 3eqc_A 28 GELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE 105 (360)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTE
T ss_pred cccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCE
Confidence 4567889999999999999999999999999999999997653 23445788999999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC-CCEeecCCCCceEEcCCCCeEEeecccccccccc
Q 037702 85 IYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSR-GVYHRDLKPENLLLDENGDLKISDFGLSALQEST 162 (448)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~-givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~ 162 (448)
.|+||||++|++|.+++.. +.+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++......
T Consensus 106 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 106 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred EEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 9999999999999999976 6899999999999999999999996 9999999999999999999999999999754322
Q ss_pred ccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH-------------------
Q 037702 163 RQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKK------------------- 223 (448)
Q Consensus 163 ~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~------------------- 223 (448)
.....+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+..+....
T Consensus 186 ----~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (360)
T 3eqc_A 186 ----MANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260 (360)
T ss_dssp ----C----CCCCTTCCHHHHTTCCCS-HHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------
T ss_pred ----cccCCCCCCCeECHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccC
Confidence 12356899999999999876664 889999999999999999999987665443221
Q ss_pred -----------------------HhhccC-CCC-CCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccccc
Q 037702 224 -----------------------ITRAEF-KCP-NWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGY 270 (448)
Q Consensus 224 -----------------------i~~~~~-~~p-~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 270 (448)
+..... ..+ ..+++++.+||.+||..||.+|||++++++||||+...
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 332 (360)
T 3eqc_A 261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 332 (360)
T ss_dssp -------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred CCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence 111111 112 23789999999999999999999999999999998643
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=389.38 Aligned_cols=256 Identities=27% Similarity=0.470 Sum_probs=215.6
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKI 85 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 85 (448)
.+..++|++.+.||+|+||.||+|++ +|..||||++....... ...+.+.+|+.+++.++||||+++++++.+....
T Consensus 33 ~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 3p86_A 33 DIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHA-ERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL 109 (309)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSH-HHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred cCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence 46778999999999999999999987 68899999997665433 4457788999999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCC--CEeecCCCCceEEcCCCCeEEeeccccccc
Q 037702 86 YFAMEYVRGGELFNKVAKGK----LREEVARKYFQQLVDAVEFCHSRG--VYHRDLKPENLLLDENGDLKISDFGLSALQ 159 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~~~----l~e~~~~~~~~qll~aL~yLH~~g--ivHrDLkp~NILl~~~g~lkl~DFGla~~~ 159 (448)
|+||||+++|+|.+++.... +++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++...
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence 99999999999999997643 999999999999999999999999 999999999999999999999999999754
Q ss_pred cccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHh--hccCCCCCCCCH
Q 037702 160 ESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKIT--RAEFKCPNWFPP 237 (448)
Q Consensus 160 ~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~ 237 (448)
.... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+. ......|..+++
T Consensus 190 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (309)
T 3p86_A 190 ASTF--LSSKSAAGTPEWMAPEVLRDEPS-NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNP 266 (309)
T ss_dssp --------------CCTTSCHHHHTTCCC-CTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCH
T ss_pred cccc--cccccCCCCccccChhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCH
Confidence 3221 22345689999999999987766 488999999999999999999999988877776663 345567888999
Q ss_pred HHHHHHHhccCCCcCCCCCHHHHHh--hhhcc
Q 037702 238 EVRKLLSRILDPNPSTRVTMAKLME--NYWFR 267 (448)
Q Consensus 238 ~~~~li~~~L~~dP~~Rpt~~eil~--hp~~~ 267 (448)
++.+||.+||..||.+|||++++++ +++++
T Consensus 267 ~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 267 QVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 9999999999999999999999998 44543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-50 Score=410.13 Aligned_cols=258 Identities=33% Similarity=0.598 Sum_probs=209.4
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccc-----hhHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRR-----VGLIDQIKREISVMRLVRHPNIVQLYEVMAS 81 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~-----~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~ 81 (448)
.+.++|++.+.||+|+||.||+|.+..+++.||||++.+..... ......+.+|+.+|+.++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 45689999999999999999999999999999999998764321 122235789999999999999999999985
Q ss_pred CCEEEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCC---CeEEeeccccc
Q 037702 82 KTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENG---DLKISDFGLSA 157 (448)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g---~lkl~DFGla~ 157 (448)
....|+||||+++|+|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~ 290 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred cCceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccce
Confidence 4568999999999999999875 6799999999999999999999999999999999999997654 59999999998
Q ss_pred cccccccCCCccccCCCCcccchhhhhc--cCCCCCcchHHHHHHHHHHHHhCCCCCCCCcH-HHHHHHHhhccCCCC--
Q 037702 158 LQESTRQDGLLHTTCGTPAYVAPEVINK--RGYDGAKADIWSCGVVLFVLLAGNLPFYDSNL-MELYKKITRAEFKCP-- 232 (448)
Q Consensus 158 ~~~~~~~~~~~~~~~Gt~~Y~APEvl~~--~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~~~~~~p-- 232 (448)
.... .....+.+||+.|+|||++.+ ....+.++|||||||++|+|++|..||..... ..+...+..+.+..+
T Consensus 291 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~ 367 (419)
T 3i6u_A 291 ILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPE 367 (419)
T ss_dssp SCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHH
T ss_pred ecCC---CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCch
Confidence 6532 223456789999999999853 22334789999999999999999999976543 234445555554433
Q ss_pred --CCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccc
Q 037702 233 --NWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRK 268 (448)
Q Consensus 233 --~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 268 (448)
..+++.+.+||.+||..||.+|||++++++||||+.
T Consensus 368 ~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 368 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred hhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 357999999999999999999999999999999975
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=407.85 Aligned_cols=254 Identities=26% Similarity=0.435 Sum_probs=215.4
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC------CCCCcceEEEEE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV------RHPNIVQLYEVM 79 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l------~hpnIv~l~~~~ 79 (448)
..+.++|++.+.||+|+||.||+|.+..+|+.||||++.... .....+.+|+.+++.+ +|+||+++++++
T Consensus 93 ~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~ 168 (429)
T 3kvw_A 93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENF 168 (429)
T ss_dssp CEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEE
T ss_pred CcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc----chHHHHHHHHHHHHHHhhccccCCcCEEEEEeec
Confidence 346778999999999999999999999999999999997542 3346677899888887 577999999999
Q ss_pred EeCCEEEEEEeecCCCchHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCC--eEEeecc
Q 037702 80 ASKTKIYFAMEYVRGGELFNKVAKG---KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGD--LKISDFG 154 (448)
Q Consensus 80 ~~~~~~~lV~E~~~gg~L~~~i~~~---~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~--lkl~DFG 154 (448)
.....+|+||||+. ++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||
T Consensus 169 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 169 TFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp EETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred ccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecc
Confidence 99999999999996 5899988753 4999999999999999999999999999999999999999987 9999999
Q ss_pred ccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCC----
Q 037702 155 LSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFK---- 230 (448)
Q Consensus 155 la~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---- 230 (448)
+|..... ...+.+||+.|+|||++.+..| +.++|||||||++|+|++|.+||.+.+..+....+......
T Consensus 248 ~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~ 321 (429)
T 3kvw_A 248 SSCYEHQ-----RVYTYIQSRFYRAPEVILGARY-GMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQK 321 (429)
T ss_dssp TCEETTC-----CCCSSCSCGGGCCHHHHHTBCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred cceecCC-----cccccCCCCCccChHHHhCCCC-CchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHH
Confidence 9975322 2346789999999999988777 48899999999999999999999988876665554321000
Q ss_pred -------------------------------------------------------CCCCCCHHHHHHHHhccCCCcCCCC
Q 037702 231 -------------------------------------------------------CPNWFPPEVRKLLSRILDPNPSTRV 255 (448)
Q Consensus 231 -------------------------------------------------------~p~~~s~~~~~li~~~L~~dP~~Rp 255 (448)
.+...++++.+||.+||+.||.+||
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rp 401 (429)
T 3kvw_A 322 LLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRM 401 (429)
T ss_dssp HHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSC
T ss_pred HHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCC
Confidence 0112378899999999999999999
Q ss_pred CHHHHHhhhhccccc
Q 037702 256 TMAKLMENYWFRKGY 270 (448)
Q Consensus 256 t~~eil~hp~~~~~~ 270 (448)
|++|+|+||||++..
T Consensus 402 ta~e~L~Hpw~~~~~ 416 (429)
T 3kvw_A 402 TPGQALRHPWLRRRL 416 (429)
T ss_dssp CHHHHHTSTTTC---
T ss_pred CHHHHhCChhhccCC
Confidence 999999999998754
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-50 Score=400.05 Aligned_cols=258 Identities=26% Similarity=0.512 Sum_probs=227.1
Q ss_pred cccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchh--------------HHHHHHHHHHHHHhCCCC
Q 037702 5 AGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVG--------------LIDQIKREISVMRLVRHP 70 (448)
Q Consensus 5 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~--------------~~~~~~~Ei~~l~~l~hp 70 (448)
.....++|++.+.||+|+||.||+|.+ +|+.||||++......... ..+.+.+|+.+++.++||
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 103 (348)
T 2pml_X 26 KDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNE 103 (348)
T ss_dssp SCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCT
T ss_pred cccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCC
Confidence 456779999999999999999999998 9999999999765433221 127788999999999999
Q ss_pred CcceEEEEEEeCCEEEEEEeecCCCchHHH------Hhc---CCCCHHHHHHHHHHHHHHHHHHHH-CCCEeecCCCCce
Q 037702 71 NIVQLYEVMASKTKIYFAMEYVRGGELFNK------VAK---GKLREEVARKYFQQLVDAVEFCHS-RGVYHRDLKPENL 140 (448)
Q Consensus 71 nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~------i~~---~~l~e~~~~~~~~qll~aL~yLH~-~givHrDLkp~NI 140 (448)
||+++++++.+.+..|+||||+++|+|.++ +.. +.+++..++.++.||+.||.|||+ +||+||||||+||
T Consensus 104 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Ni 183 (348)
T 2pml_X 104 YCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNI 183 (348)
T ss_dssp TBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGE
T ss_pred CcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhE
Confidence 999999999999999999999999999998 653 579999999999999999999999 9999999999999
Q ss_pred EEcCCCCeEEeeccccccccccccCCCccccCCCCcccchhhhhcc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCcH-H
Q 037702 141 LLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKR-GYDGAKADIWSCGVVLFVLLAGNLPFYDSNL-M 218 (448)
Q Consensus 141 Ll~~~g~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~-~~~~~~sDiwSlGvil~elltG~~Pf~~~~~-~ 218 (448)
|++.++.+||+|||++...... ......||+.|+|||++.+. .+.+.++|||||||++|+|++|..||...+. .
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 259 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV 259 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH
T ss_pred EEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence 9999999999999999864332 23456799999999999776 4443389999999999999999999988776 7
Q ss_pred HHHHHHhhccCCCC-------------------CCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccc
Q 037702 219 ELYKKITRAEFKCP-------------------NWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRK 268 (448)
Q Consensus 219 ~~~~~i~~~~~~~p-------------------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 268 (448)
+....+.......| ..+++++.+||.+||..||.+|||++++++||||+.
T Consensus 260 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 328 (348)
T 2pml_X 260 ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLAD 328 (348)
T ss_dssp HHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTT
T ss_pred HHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccC
Confidence 78888877777666 668999999999999999999999999999999975
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=386.02 Aligned_cols=259 Identities=31% Similarity=0.476 Sum_probs=219.5
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKI 85 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 85 (448)
....++|++.+.||+|+||.||+|.+..+|+.||+|++..... ...+.+.+|+.+++.++||||+++++++...+..
T Consensus 15 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 91 (302)
T 2j7t_A 15 LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE---EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKL 91 (302)
T ss_dssp SCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CE
T ss_pred cCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH---HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeE
Confidence 3567899999999999999999999999999999999975532 2347788999999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccc
Q 037702 86 YFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTR 163 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~ 163 (448)
|+||||+++++|.+++.. +.+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||++.......
T Consensus 92 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 92 WIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp EEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred EEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence 999999999999998864 679999999999999999999999999999999999999999999999999986432221
Q ss_pred cCCCccccCCCCcccchhhhh----ccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccC---CCCCCCC
Q 037702 164 QDGLLHTTCGTPAYVAPEVIN----KRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF---KCPNWFP 236 (448)
Q Consensus 164 ~~~~~~~~~Gt~~Y~APEvl~----~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s 236 (448)
. .....+||+.|+|||++. .....+.++|||||||++|+|++|..||...+.......+..... ..+..++
T Consensus 172 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (302)
T 2j7t_A 172 Q--KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWS 249 (302)
T ss_dssp H--C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSC
T ss_pred c--ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccC
Confidence 1 123457999999999984 223345889999999999999999999999887777766665543 2355688
Q ss_pred HHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 237 PEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 237 ~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
.++.++|.+||..||.+|||++++++||||+..
T Consensus 250 ~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 282 (302)
T 2j7t_A 250 VEFRDFLKIALDKNPETRPSAAQLLEHPFVSSI 282 (302)
T ss_dssp HHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTC
T ss_pred HHHHHHHHHHcccChhhCCCHHHHhcChHHhhh
Confidence 999999999999999999999999999999753
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=384.68 Aligned_cols=259 Identities=26% Similarity=0.381 Sum_probs=203.7
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKI 85 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 85 (448)
.+..++|++.+.||+|+||.||+|++..+|+.||||++....... ...+.+.++...++.++||||+++++++.+++..
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQ-EQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcH-HHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence 356789999999999999999999999999999999997653322 2334455666668889999999999999999999
Q ss_pred EEEEeecCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CCEeecCCCCceEEcCCCCeEEeeccccccc
Q 037702 86 YFAMEYVRGGELFNKVAK-----GKLREEVARKYFQQLVDAVEFCHSR-GVYHRDLKPENLLLDENGDLKISDFGLSALQ 159 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~aL~yLH~~-givHrDLkp~NILl~~~g~lkl~DFGla~~~ 159 (448)
|+||||++| +|.+++.. +.+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||++...
T Consensus 82 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 82 WICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999999975 87766642 5799999999999999999999998 9999999999999999999999999999765
Q ss_pred cccccCCCccccCCCCcccchhhhh---ccCCCCCcchHHHHHHHHHHHHhCCCCCCCC-cHHHHHH-HHhhccCCCC-C
Q 037702 160 ESTRQDGLLHTTCGTPAYVAPEVIN---KRGYDGAKADIWSCGVVLFVLLAGNLPFYDS-NLMELYK-KITRAEFKCP-N 233 (448)
Q Consensus 160 ~~~~~~~~~~~~~Gt~~Y~APEvl~---~~~~~~~~sDiwSlGvil~elltG~~Pf~~~-~~~~~~~-~i~~~~~~~p-~ 233 (448)
... ......+||+.|+|||++. .....+.++|||||||++|+|++|..||... ....... .+.......+ .
T Consensus 161 ~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (290)
T 3fme_A 161 VDD---VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPAD 237 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTT
T ss_pred ccc---ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccc
Confidence 332 2223457999999999972 2333458899999999999999999999853 3333333 3333333333 4
Q ss_pred CCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 234 WFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 234 ~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
.+++++.+||.+||+.||.+|||++++++||||+..
T Consensus 238 ~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 238 KFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred cCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 689999999999999999999999999999999764
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=383.58 Aligned_cols=259 Identities=32% Similarity=0.660 Sum_probs=227.4
Q ss_pred cccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 037702 5 AGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTK 84 (448)
Q Consensus 5 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 84 (448)
.+.+.++|++.+.||+|+||.||+|.+..+|+.||||++....... ...+.+.+|+.+++.++||||+++++++.+...
T Consensus 17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 95 (287)
T 2wei_A 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSS 95 (287)
T ss_dssp THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccch-HHHHHHHHHHHHHHhccCCCccEEEEEEeCCCe
Confidence 3567789999999999999999999999999999999997664433 335778899999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCC---CeEEeecccccccc
Q 037702 85 IYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENG---DLKISDFGLSALQE 160 (448)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g---~lkl~DFGla~~~~ 160 (448)
.|+||||+++++|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 9999999999999998865 7899999999999999999999999999999999999997644 69999999998653
Q ss_pred ccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCC----CCCC
Q 037702 161 STRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCP----NWFP 236 (448)
Q Consensus 161 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s 236 (448)
.. .......||+.|+|||++.+. + +.++||||||+++|+|++|..||.+.+..+....+..+.+..+ ..+|
T Consensus 176 ~~---~~~~~~~~~~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (287)
T 2wei_A 176 QN---TKMKDRIGTAYYIAPEVLRGT-Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTIS 250 (287)
T ss_dssp CC---SSCSCHHHHHTTCCHHHHTTC-C-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSC
T ss_pred CC---CccccccCcccccChHHhcCC-C-CCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcC
Confidence 32 122345689999999998653 4 5889999999999999999999999988888888877765433 4589
Q ss_pred HHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 237 PEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 237 ~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
+++.++|.+||..||.+|||++++++||||++.
T Consensus 251 ~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 251 DDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred HHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 999999999999999999999999999999764
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=392.66 Aligned_cols=264 Identities=33% Similarity=0.600 Sum_probs=216.3
Q ss_pred CccccccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeeccccc-----chhHHHHHHHHHHHHHhCCCCCcceE
Q 037702 1 MEKKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIR-----RVGLIDQIKREISVMRLVRHPNIVQL 75 (448)
Q Consensus 1 m~~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~-----~~~~~~~~~~Ei~~l~~l~hpnIv~l 75 (448)
|.--+..+.++|++.+.||+|+||.||+|.+..+|+.||||++...... .......+.+|+.+++.++||||+++
T Consensus 1 M~~~~~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 80 (322)
T 2ycf_A 1 MSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKI 80 (322)
T ss_dssp -CCCCHHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCE
T ss_pred CccchhhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceE
Confidence 4444556778999999999999999999999999999999999765431 11223457899999999999999999
Q ss_pred EEEEEeCCEEEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCC---eEEe
Q 037702 76 YEVMASKTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGD---LKIS 151 (448)
Q Consensus 76 ~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~---lkl~ 151 (448)
++++..+. .|+||||+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+
T Consensus 81 ~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~ 159 (322)
T 2ycf_A 81 KNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKIT 159 (322)
T ss_dssp EEEEESSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEEC
T ss_pred eeEEcCCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEc
Confidence 99997765 8999999999999999875 67999999999999999999999999999999999999987665 9999
Q ss_pred eccccccccccccCCCccccCCCCcccchhhhhc--cCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHH-HHHHHHhhcc
Q 037702 152 DFGLSALQESTRQDGLLHTTCGTPAYVAPEVINK--RGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLM-ELYKKITRAE 228 (448)
Q Consensus 152 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~--~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~~ 228 (448)
|||++...... ......+||+.|+|||++.. ....+.++|||||||++|+|++|..||...... .+...+..+.
T Consensus 160 Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 236 (322)
T 2ycf_A 160 DFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK 236 (322)
T ss_dssp CCTTCEECCCC---HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTC
T ss_pred cCccceecccc---cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCc
Confidence 99999764322 12235679999999999842 233358899999999999999999999765432 3344444444
Q ss_pred CCCC----CCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccc
Q 037702 229 FKCP----NWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRK 268 (448)
Q Consensus 229 ~~~p----~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 268 (448)
...+ ..+++++.+||.+||..||.+|||++++++||||+.
T Consensus 237 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 237 YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred cccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 4332 457899999999999999999999999999999975
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=383.17 Aligned_cols=258 Identities=31% Similarity=0.568 Sum_probs=225.1
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE--eCCEE
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMA--SKTKI 85 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~--~~~~~ 85 (448)
..++|++.+.||+|+||.||+|.+..+|+.||+|++....... ...+.+.+|+.+++.++||||+++++++. ....+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCH-HHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence 4679999999999999999999999999999999998765433 34577899999999999999999999875 46789
Q ss_pred EEEEeecCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-----CEeecCCCCceEEcCCCCeEEeeccc
Q 037702 86 YFAMEYVRGGELFNKVAK-----GKLREEVARKYFQQLVDAVEFCHSRG-----VYHRDLKPENLLLDENGDLKISDFGL 155 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~aL~yLH~~g-----ivHrDLkp~NILl~~~g~lkl~DFGl 155 (448)
|+||||+++++|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 999999999999999864 24999999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccC-CCCCC
Q 037702 156 SALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF-KCPNW 234 (448)
Q Consensus 156 a~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~ 234 (448)
+....... ......+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+..+....+..+.. ..|..
T Consensus 163 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 239 (279)
T 2w5a_A 163 ARILNHDT--SFAKTFVGTPYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR 239 (279)
T ss_dssp HHHC---C--HHHHHHHSCCTTCCHHHHHCC-CC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCTT
T ss_pred heeecccc--ccccccCCCccccChHHhccCCCC-chhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCcc
Confidence 97543221 112345799999999999876664 889999999999999999999999888888888877665 56778
Q ss_pred CCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 235 FPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 235 ~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
+++++.++|.+||..||.+|||++++++|+|+...
T Consensus 240 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 240 YSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred cCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 99999999999999999999999999999999754
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=398.18 Aligned_cols=255 Identities=25% Similarity=0.431 Sum_probs=221.0
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEEC-------CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNL-------KTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYE 77 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~-------~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~ 77 (448)
.+..++|++++.||+|+||.||+|++. .++..||||++.... .....+.+.+|+.+++.+ +||||+++++
T Consensus 77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 154 (370)
T 2psq_A 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG 154 (370)
T ss_dssp BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 455689999999999999999999874 345679999997553 234457789999999999 8999999999
Q ss_pred EEEeCCEEEEEEeecCCCchHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCce
Q 037702 78 VMASKTKIYFAMEYVRGGELFNKVAKG-----------------KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENL 140 (448)
Q Consensus 78 ~~~~~~~~~lV~E~~~gg~L~~~i~~~-----------------~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NI 140 (448)
++.+.+.+|+||||++||+|.+++... .+++..++.++.||+.||+|||++||+||||||+||
T Consensus 155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI 234 (370)
T 2psq_A 155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 234 (370)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred EEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhE
Confidence 999999999999999999999999752 378999999999999999999999999999999999
Q ss_pred EEcCCCCeEEeeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHH
Q 037702 141 LLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLME 219 (448)
Q Consensus 141 Ll~~~g~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~ 219 (448)
|++.+|.+||+|||++................||+.|+|||++.+..| +.++|||||||++|+|++ |..||.+.+..+
T Consensus 235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslG~il~ellt~g~~p~~~~~~~~ 313 (370)
T 2psq_A 235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 313 (370)
T ss_dssp EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCC-CcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 999999999999999986543332222334567899999999987666 488999999999999999 999999988877
Q ss_pred HHHHHhhcc-CCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 220 LYKKITRAE-FKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 220 ~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
+...+..+. ...|..+++++.++|.+||..||.+|||+.+++++
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 314 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp HHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 777776654 45677899999999999999999999999999975
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-51 Score=411.19 Aligned_cols=248 Identities=18% Similarity=0.271 Sum_probs=205.6
Q ss_pred cCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHH---HHHhCCCCCcceEE-------EE
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREIS---VMRLVRHPNIVQLY-------EV 78 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~---~l~~l~hpnIv~l~-------~~ 78 (448)
.++|++.+.||+|+||.||+|.+..+|+.||||++.+.........+.+.+|+. +++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 578999999999999999999999999999999998765555556688999994 55556899999998 77
Q ss_pred EEeCCE-----------------EEEEEeecCCCchHHHHhc-CCCCH-------HHHHHHHHHHHHHHHHHHHCCCEee
Q 037702 79 MASKTK-----------------IYFAMEYVRGGELFNKVAK-GKLRE-------EVARKYFQQLVDAVEFCHSRGVYHR 133 (448)
Q Consensus 79 ~~~~~~-----------------~~lV~E~~~gg~L~~~i~~-~~l~e-------~~~~~~~~qll~aL~yLH~~givHr 133 (448)
+.+.+. .|+||||+ +|+|.+++.. +.+++ ..++.++.||+.||+|||++||+||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 766542 89999999 6799999975 44555 7888899999999999999999999
Q ss_pred cCCCCceEEcCCCCeEEeeccccccccccccCCCccccCCCCcccchhhhhcc-----------CCCCCcchHHHHHHHH
Q 037702 134 DLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKR-----------GYDGAKADIWSCGVVL 202 (448)
Q Consensus 134 DLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~-----------~~~~~~sDiwSlGvil 202 (448)
||||+|||++.+|.+||+|||+|..... ...+.+| +.|+|||++.+. .| +.++|||||||++
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~-~~~~DvwSlG~il 303 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLM-TFSFDAWALGLVI 303 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEEC-CHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccC-ChhhhHHHHHHHH
Confidence 9999999999999999999999985322 2345678 999999999876 55 5899999999999
Q ss_pred HHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccc
Q 037702 203 FVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRK 268 (448)
Q Consensus 203 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 268 (448)
|+|++|+.||.+.+.......+ ...+..+++++.+||.+||..||.+|||+.++++||||+.
T Consensus 304 ~elltg~~Pf~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 304 YWIWCADLPITKDAALGGSEWI----FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp HHHHHSSCCC------CCSGGG----GSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred HHHHHCCCCCcccccccchhhh----hhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 9999999999876544333322 2334678999999999999999999999999999999975
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-49 Score=387.69 Aligned_cols=251 Identities=25% Similarity=0.486 Sum_probs=211.5
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEe--CCE
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR-HPNIVQLYEVMAS--KTK 84 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~--~~~ 84 (448)
..++|++.+.||+|+||.||+|++..+|+.||||++.... .+.+.+|+.+++.++ ||||+++++++.+ ...
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 107 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT 107 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence 3578999999999999999999999999999999986432 366889999999997 9999999999987 678
Q ss_pred EEEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCC-CeEEeeccccccccccc
Q 037702 85 IYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENG-DLKISDFGLSALQESTR 163 (448)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g-~lkl~DFGla~~~~~~~ 163 (448)
.++||||+++++|.+++.. +++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 108 ~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~- 184 (330)
T 3nsz_A 108 PALVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG- 184 (330)
T ss_dssp EEEEEECCCCCCHHHHGGG--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT-
T ss_pred eEEEEeccCchhHHHHHHh--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC-
Confidence 9999999999999998854 89999999999999999999999999999999999999777 8999999999764332
Q ss_pred cCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCc-HHHHHHH-------------HhhccC
Q 037702 164 QDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSN-LMELYKK-------------ITRAEF 229 (448)
Q Consensus 164 ~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~-~~~~~~~-------------i~~~~~ 229 (448)
......+||+.|+|||++.+....+.++|||||||++|+|++|..||.... ..+.... +.....
T Consensus 185 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 262 (330)
T 3nsz_A 185 --QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 262 (330)
T ss_dssp --CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred --CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcc
Confidence 223456899999999999775555689999999999999999999995432 2222111 111111
Q ss_pred CC------------------------CCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 230 KC------------------------PNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 230 ~~------------------------p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
.. +..+++++.+||.+||..||.+|||++|+++||||+..
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 326 (330)
T 3nsz_A 263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326 (330)
T ss_dssp CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence 11 12278999999999999999999999999999999864
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-49 Score=400.91 Aligned_cols=254 Identities=30% Similarity=0.457 Sum_probs=209.9
Q ss_pred cccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-
Q 037702 5 AGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKT- 83 (448)
Q Consensus 5 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~- 83 (448)
+.....+|++.+.||+|+||.||+|++..+++ ||+|.+...... ..+|+.+++.++||||+++++++....
T Consensus 35 ~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~~~~ 106 (394)
T 4e7w_A 35 GEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYSNGD 106 (394)
T ss_dssp CCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEESS
T ss_pred CCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEecCC
Confidence 34567789999999999999999999877766 888887654322 237999999999999999999985543
Q ss_pred -----EEEEEEeecCCCchHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEc-CCCCeEEeec
Q 037702 84 -----KIYFAMEYVRGGELFNKVA----KGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLD-ENGDLKISDF 153 (448)
Q Consensus 84 -----~~~lV~E~~~gg~L~~~i~----~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~-~~g~lkl~DF 153 (448)
.+|+||||++++.+..... .+.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+||
T Consensus 107 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DF 186 (394)
T 4e7w_A 107 KKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDF 186 (394)
T ss_dssp SSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred CCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeC
Confidence 3889999998754433321 36799999999999999999999999999999999999999 7999999999
Q ss_pred cccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhc------
Q 037702 154 GLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA------ 227 (448)
Q Consensus 154 Gla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~------ 227 (448)
|+|...... ......+||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+....+.+.
T Consensus 187 G~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~ 263 (394)
T 4e7w_A 187 GSAKILIAG---EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSR 263 (394)
T ss_dssp TTCEECCTT---CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred CCcccccCC---CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 999864322 22345689999999999977655568999999999999999999999998876666555431
Q ss_pred -----------cCC------------CCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 228 -----------EFK------------CPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 228 -----------~~~------------~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
... +++.+++++.+||.+||+.||.+|||+.++++||||+..
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (394)
T 4e7w_A 264 EQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL 328 (394)
T ss_dssp HHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred HHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence 011 234578999999999999999999999999999999764
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=399.65 Aligned_cols=261 Identities=21% Similarity=0.301 Sum_probs=224.5
Q ss_pred ccccCCeEEEeeeeecCceEEEEEE-----ECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGR-----NLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMA 80 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~-----~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~ 80 (448)
.+..++|++.+.||+|+||.||+|. +..++..||||++.... .......+.+|+.+++.++||||+++++++.
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 144 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSL 144 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 4567899999999999999999999 45578899999986432 2233467889999999999999999999999
Q ss_pred eCCEEEEEEeecCCCchHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCC---CeE
Q 037702 81 SKTKIYFAMEYVRGGELFNKVAK--------GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENG---DLK 149 (448)
Q Consensus 81 ~~~~~~lV~E~~~gg~L~~~i~~--------~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g---~lk 149 (448)
+....|+||||++||+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.+| .+|
T Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEE
Confidence 99999999999999999999965 2489999999999999999999999999999999999999655 499
Q ss_pred EeeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhcc
Q 037702 150 ISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAE 228 (448)
Q Consensus 150 l~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~ 228 (448)
|+|||++................||+.|+|||++.+..++ .++|||||||++|+|++ |..||...+..+....+..+.
T Consensus 225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~ 303 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG 303 (367)
T ss_dssp ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999865443333333456789999999999877664 88999999999999998 999999998888888777654
Q ss_pred -CCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 229 -FKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 229 -~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
...|..+++.+.+||.+||+.||.+|||+++++++.|+...
T Consensus 304 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 304 RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 45677899999999999999999999999999999987543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-50 Score=388.92 Aligned_cols=262 Identities=30% Similarity=0.527 Sum_probs=198.3
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKI 85 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 85 (448)
.+..++|++.+.||+|+||.||+|.+..+|+.||||++...... ...+.+.+|+.+++.++||||+++++++...+..
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 88 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ--TSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL 88 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcc--hhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCc
Confidence 46678999999999999999999999999999999998765332 2346788999999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccc
Q 037702 86 YFAMEYVRGGELFNKVAK---------GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLS 156 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~---------~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla 156 (448)
|+||||++|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence 999999999999999862 45999999999999999999999999999999999999999999999999998
Q ss_pred ccccccc---cCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccC----
Q 037702 157 ALQESTR---QDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF---- 229 (448)
Q Consensus 157 ~~~~~~~---~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---- 229 (448)
....... ........+||+.|+|||++.+....+.++|||||||++|+|++|..||...+.............
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 248 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLE 248 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTT
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccc
Confidence 7543321 112234567999999999997633345899999999999999999999988665544443333221
Q ss_pred ------CCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 230 ------KCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 230 ------~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
..+..+++++.+||.+||..||.+|||++++++||||++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 294 (303)
T 2vwi_A 249 TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA 294 (303)
T ss_dssp C-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred cccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence 1234578999999999999999999999999999999764
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=382.49 Aligned_cols=255 Identities=29% Similarity=0.515 Sum_probs=217.2
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIY 86 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 86 (448)
...++|++.+.||+|+||.||+|.+..+|+.||||++..... .+.+.+|+.+++.++||||+++++++.....+|
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLW 100 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence 456789999999999999999999999999999999976532 256889999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccccc
Q 037702 87 FAMEYVRGGELFNKVA--KGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQ 164 (448)
Q Consensus 87 lV~E~~~gg~L~~~i~--~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~ 164 (448)
+||||+++++|.+++. .+.+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||++.......
T Consensus 101 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~- 179 (314)
T 3com_A 101 IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM- 179 (314)
T ss_dssp EEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB-
T ss_pred EEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc-
Confidence 9999999999999986 3679999999999999999999999999999999999999999999999999997543321
Q ss_pred CCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhcc---CCCCCCCCHHHHH
Q 037702 165 DGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAE---FKCPNWFPPEVRK 241 (448)
Q Consensus 165 ~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~ 241 (448)
.......||+.|+|||++.+..+. .++|||||||++|+|++|..||...+.......+.... +..|..+++.+.+
T Consensus 180 -~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 257 (314)
T 3com_A 180 -AKRNTVIGTPFWMAPEVIQEIGYN-CVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTD 257 (314)
T ss_dssp -SCBCCCCSCGGGCCHHHHSSSCBC-TTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHH
T ss_pred -cccCccCCCCCccChhhcCCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHH
Confidence 123456799999999999876664 88999999999999999999999877665555444332 3345568999999
Q ss_pred HHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 242 LLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
||.+||..||.+|||+.++++||||+..
T Consensus 258 li~~~l~~dp~~Rpt~~~ll~~~~~~~~ 285 (314)
T 3com_A 258 FVKQCLVKSPEQRATATQLLQHPFVRSA 285 (314)
T ss_dssp HHHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred HHHHHccCChhhCcCHHHHHhCHHHhcC
Confidence 9999999999999999999999999864
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-49 Score=394.05 Aligned_cols=254 Identities=26% Similarity=0.440 Sum_probs=215.2
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE--
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKI-- 85 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~-- 85 (448)
+.++|++.+.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+++.++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 118 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ-SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN 118 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTT
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEeccccc-chhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccc
Confidence 56899999999999999999999999999999999976543 234457788999999999999999999999877654
Q ss_pred ----EEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccc
Q 037702 86 ----YFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQES 161 (448)
Q Consensus 86 ----~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~ 161 (448)
|+||||+. ++|.+.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 119 ~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 196 (371)
T 4exu_A 119 FYDFYLVMPFMQ-TDLQKIMGM-EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 196 (371)
T ss_dssp CCCCEEEEECCC-EEHHHHTTS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred ceeEEEEEcccc-ccHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc
Confidence 99999997 588877744 599999999999999999999999999999999999999999999999999975432
Q ss_pred cccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccC------------
Q 037702 162 TRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF------------ 229 (448)
Q Consensus 162 ~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~------------ 229 (448)
. ....+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 197 ~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 271 (371)
T 4exu_A 197 E-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 271 (371)
T ss_dssp --------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSC
T ss_pred C-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhh
Confidence 2 23568999999999997744556899999999999999999999998887766665533110
Q ss_pred -------------------CCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 230 -------------------KCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 230 -------------------~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
..++.+++++.+||.+||+.||.+|||++|+++||||+..
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 330 (371)
T 4exu_A 272 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 330 (371)
T ss_dssp HHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence 0123468999999999999999999999999999999753
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=384.42 Aligned_cols=257 Identities=30% Similarity=0.494 Sum_probs=215.4
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEe----
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEVMAS---- 81 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~---- 81 (448)
...++|++.+.||+|+||.||+|.+..+|+.||||++...... .+.+.+|+.+++.+ +||||+++++++..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST----THHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc----HHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 4678999999999999999999999999999999999765322 36788999999999 89999999999977
Q ss_pred --CCEEEEEEeecCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccc
Q 037702 82 --KTKIYFAMEYVRGGELFNKVAK---GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLS 156 (448)
Q Consensus 82 --~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla 156 (448)
...+|+||||+++|+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 176 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS 176 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTT
T ss_pred cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCc
Confidence 5689999999999999999975 46999999999999999999999999999999999999999999999999998
Q ss_pred ccccccccCCCccccCCCCcccchhhhhc----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCC--
Q 037702 157 ALQESTRQDGLLHTTCGTPAYVAPEVINK----RGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFK-- 230 (448)
Q Consensus 157 ~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~----~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-- 230 (448)
....... ......+||+.|+|||++.. ....+.++|||||||++|+|++|..||.+.+.......+......
T Consensus 177 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 254 (326)
T 2x7f_A 177 AQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRL 254 (326)
T ss_dssp C---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC
T ss_pred eecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccC
Confidence 7653221 12345679999999999862 223358899999999999999999999988777666655554332
Q ss_pred CCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 231 CPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 231 ~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
.+..+++.+.+||.+||..||.+|||++++++||||+..
T Consensus 255 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 255 KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred CccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 245689999999999999999999999999999999864
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-49 Score=388.63 Aligned_cols=256 Identities=26% Similarity=0.439 Sum_probs=213.1
Q ss_pred cccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-
Q 037702 5 AGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKT- 83 (448)
Q Consensus 5 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~- 83 (448)
+.+..++|++.+.||+|+||.||+|.+..+|+.||||++....... ..+.+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 81 (319)
T 4euu_A 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKLFAIEEETTT 81 (319)
T ss_dssp EECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS--CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTT
T ss_pred ccCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCCCcceEEEEeecCCC
Confidence 3467789999999999999999999999999999999997654332 2467789999999999999999999998765
Q ss_pred -EEEEEEeecCCCchHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEE----cCCCCeEEeecc
Q 037702 84 -KIYFAMEYVRGGELFNKVAKG----KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLL----DENGDLKISDFG 154 (448)
Q Consensus 84 -~~~lV~E~~~gg~L~~~i~~~----~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl----~~~g~lkl~DFG 154 (448)
..|+||||++|++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg 161 (319)
T 4euu_A 82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (319)
T ss_dssp CCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCT
T ss_pred ceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCC
Confidence 789999999999999999752 39999999999999999999999999999999999999 778889999999
Q ss_pred ccccccccccCCCccccCCCCcccchhhhhc-------cCCCCCcchHHHHHHHHHHHHhCCCCCCCC----cHHHHHHH
Q 037702 155 LSALQESTRQDGLLHTTCGTPAYVAPEVINK-------RGYDGAKADIWSCGVVLFVLLAGNLPFYDS----NLMELYKK 223 (448)
Q Consensus 155 la~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~-------~~~~~~~sDiwSlGvil~elltG~~Pf~~~----~~~~~~~~ 223 (448)
++...... ......+||+.|+|||++.. ....+.++|||||||++|+|++|..||... ...+...+
T Consensus 162 ~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 238 (319)
T 4euu_A 162 AARELEDD---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK 238 (319)
T ss_dssp TCEECCTT---CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHH
T ss_pred CceecCCC---CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHH
Confidence 99865332 22345679999999999863 234458899999999999999999999642 23444445
Q ss_pred HhhccC-------------------CCC------CCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhh
Q 037702 224 ITRAEF-------------------KCP------NWFPPEVRKLLSRILDPNPSTRVTMAKLMENYW 265 (448)
Q Consensus 224 i~~~~~-------------------~~p------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 265 (448)
+..+.. ..| ..+++.+.+||.+||+.||.+|||++|+++||-
T Consensus 239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp HHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred HhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 444322 111 123467889999999999999999999999983
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-49 Score=387.60 Aligned_cols=256 Identities=28% Similarity=0.447 Sum_probs=216.5
Q ss_pred cccccccCCeEEEeeeeecCceEEEEEEE-CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC------cceE
Q 037702 3 KKAGILMNKYELGRLLGQGTFAKVYHGRN-LKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPN------IVQL 75 (448)
Q Consensus 3 ~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~-~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpn------Iv~l 75 (448)
+.+.++.++|++.+.||+|+||.||+|.+ ..+|+.||||++.... ...+.+.+|+.+++.++|++ |+++
T Consensus 7 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~ 82 (339)
T 1z57_A 7 QSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD----RYCEAARSEIQVLEHLNTTDPNSTFRCVQM 82 (339)
T ss_dssp STTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHHCTTCTTCBCCE
T ss_pred ecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC----chhHHHHHHHHHHHHhhhcCCCCceeeEee
Confidence 45677889999999999999999999998 5588999999996432 33467889999999987654 9999
Q ss_pred EEEEEeCCEEEEEEeecCCCchHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcC--------
Q 037702 76 YEVMASKTKIYFAMEYVRGGELFNKVAKG---KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDE-------- 144 (448)
Q Consensus 76 ~~~~~~~~~~~lV~E~~~gg~L~~~i~~~---~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~-------- 144 (448)
++++...+.+|+||||+ +++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 83 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~ 161 (339)
T 1z57_A 83 LEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYN 161 (339)
T ss_dssp EEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC
T ss_pred ecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccC
Confidence 99999999999999999 88999998753 5899999999999999999999999999999999999987
Q ss_pred -----------CCCeEEeeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCC
Q 037702 145 -----------NGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFY 213 (448)
Q Consensus 145 -----------~g~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~ 213 (448)
++.+||+|||++..... .....+||+.|+|||++.+..++ .++|||||||++|+|++|..||.
T Consensus 162 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~ 235 (339)
T 1z57_A 162 PKIKRDERTLINPDIKVVDFGSATYDDE-----HHSTLVSTRHYRAPEVILALGWS-QPCDVWSIGCILIEYYLGFTVFP 235 (339)
T ss_dssp ----CEEEEESCCCEEECCCSSCEETTS-----CCCSSCSCGGGCCHHHHTTSCCC-THHHHHHHHHHHHHHHHSSCSCC
T ss_pred CccccccccccCCCceEeeCcccccCcc-----ccccccCCccccChHHhhCCCCC-cchhhHHHHHHHHHHHhCCCCCC
Confidence 67899999999975332 22456899999999999877764 88999999999999999999999
Q ss_pred CCcHHHHHHHHhhccCCCC--------------------------------------------CCCCHHHHHHHHhccCC
Q 037702 214 DSNLMELYKKITRAEFKCP--------------------------------------------NWFPPEVRKLLSRILDP 249 (448)
Q Consensus 214 ~~~~~~~~~~i~~~~~~~p--------------------------------------------~~~s~~~~~li~~~L~~ 249 (448)
..+..+....+.......| ...++++.+||.+||+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 315 (339)
T 1z57_A 236 THDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEY 315 (339)
T ss_dssp CSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred CCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCc
Confidence 8776655544432211111 11246789999999999
Q ss_pred CcCCCCCHHHHHhhhhcccc
Q 037702 250 NPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 250 dP~~Rpt~~eil~hp~~~~~ 269 (448)
||.+|||++|+++||||+..
T Consensus 316 dP~~Rpt~~ell~hp~f~~~ 335 (339)
T 1z57_A 316 DPAKRITLREALKHPFFDLL 335 (339)
T ss_dssp STTTSCCHHHHTTSGGGGGG
T ss_pred CcccccCHHHHhcCHHHHHH
Confidence 99999999999999999753
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=388.75 Aligned_cols=262 Identities=22% Similarity=0.376 Sum_probs=202.4
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCc---EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQ---SVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASK 82 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~---~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~ 82 (448)
.+..++|++.+.||+|+||.||+|.+..++. .||||++....... ...+.+.+|+.+++.++||||+++++++...
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS-SDIEEFLREAACMKEFDHPHVAKLVGVSLRS 97 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C-HHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH-HHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence 4567899999999999999999999887765 89999997654333 3457889999999999999999999999877
Q ss_pred CEE------EEEEeecCCCchHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeE
Q 037702 83 TKI------YFAMEYVRGGELFNKVAKG-------KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLK 149 (448)
Q Consensus 83 ~~~------~lV~E~~~gg~L~~~i~~~-------~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lk 149 (448)
... ++||||+++|+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEE
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEE
Confidence 655 9999999999999998541 599999999999999999999999999999999999999999999
Q ss_pred EeeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhcc
Q 037702 150 ISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAE 228 (448)
Q Consensus 150 l~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~ 228 (448)
|+|||++................||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+..+....+....
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~ 256 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLY-TVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN 256 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCC-CCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCC
Confidence 999999986543332222334567889999999987766 489999999999999999 999999888777777766554
Q ss_pred -CCCCCCCCHHHHHHHHhccCCCcCCCCC-------HHHHHhhhhcccc
Q 037702 229 -FKCPNWFPPEVRKLLSRILDPNPSTRVT-------MAKLMENYWFRKG 269 (448)
Q Consensus 229 -~~~p~~~s~~~~~li~~~L~~dP~~Rpt-------~~eil~hp~~~~~ 269 (448)
...|..+++++.+||.+||..||.+||| +++++.|||+...
T Consensus 257 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 257 RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305 (323)
T ss_dssp CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence 5677789999999999999999999999 7778899998653
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-49 Score=401.62 Aligned_cols=252 Identities=31% Similarity=0.445 Sum_probs=208.7
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASK----- 82 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~----- 82 (448)
...+|++.+.||+|+||.||+|++..+|+.||||++..... ...+|+.+|+.++||||+++++++...
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~ 124 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKD 124 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTT
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCc
Confidence 34579999999999999999999999999999999975432 123799999999999999999988532
Q ss_pred -CEEEEEEeecCCCchHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCC-CCeEEeeccc
Q 037702 83 -TKIYFAMEYVRGGELFNKVA-----KGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDEN-GDLKISDFGL 155 (448)
Q Consensus 83 -~~~~lV~E~~~gg~L~~~i~-----~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~-g~lkl~DFGl 155 (448)
..+++||||+++ +|.+.+. ...+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+
T Consensus 125 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~ 203 (420)
T 1j1b_A 125 EVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS 203 (420)
T ss_dssp EEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred ceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchh
Confidence 246799999986 5655543 2579999999999999999999999999999999999999965 5689999999
Q ss_pred cccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhc--------
Q 037702 156 SALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA-------- 227 (448)
Q Consensus 156 a~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-------- 227 (448)
++..... ......+||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+.++.+.
T Consensus 204 a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~ 280 (420)
T 1j1b_A 204 AKQLVRG---EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 280 (420)
T ss_dssp CEECCTT---CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred hhhcccC---CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 9864322 22345689999999999976544568999999999999999999999988776655554331
Q ss_pred ---------cCC------------CCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccccc
Q 037702 228 ---------EFK------------CPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGY 270 (448)
Q Consensus 228 ---------~~~------------~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 270 (448)
.+. +++.+++++.+||.+||..||.+|||+.|+++||||+...
T Consensus 281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 112 2345689999999999999999999999999999997643
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=373.62 Aligned_cols=252 Identities=24% Similarity=0.412 Sum_probs=221.4
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKI 85 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 85 (448)
.+..++|++.+.||+|+||.||+|.+. +++.||+|++...... .+.+.+|+.+++.++||||+++++++.+....
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (269)
T 4hcu_A 6 VIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI 80 (269)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred EeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCce
Confidence 455679999999999999999999986 5778999999765433 25688999999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccc
Q 037702 86 YFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTR 163 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~ 163 (448)
|+||||+++++|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 160 (269)
T 4hcu_A 81 CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 160 (269)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred EEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccc
Confidence 999999999999999965 469999999999999999999999999999999999999999999999999998653322
Q ss_pred cCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhc-cCCCCCCCCHHHHH
Q 037702 164 QDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EFKCPNWFPPEVRK 241 (448)
Q Consensus 164 ~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 241 (448)
. .......||+.|+|||++.+..++ .++|||||||++|+|++ |..||...+..+....+... ....|..+++++.+
T Consensus 161 ~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T 4hcu_A 161 Y-TSSTGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQ 238 (269)
T ss_dssp H-HSTTSTTCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHH
T ss_pred c-ccccCcccccccCCHHHhcCCCCC-chhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHH
Confidence 1 122345678899999999877664 88999999999999999 99999999888888877765 44567778999999
Q ss_pred HHHhccCCCcCCCCCHHHHHhhh
Q 037702 242 LLSRILDPNPSTRVTMAKLMENY 264 (448)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~hp 264 (448)
+|.+||+.||.+|||+.+++++-
T Consensus 239 li~~~l~~~p~~Rps~~~ll~~l 261 (269)
T 4hcu_A 239 IMNHCWRERPEDRPAFSRLLRQL 261 (269)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHccCCcccCcCHHHHHHHH
Confidence 99999999999999999999863
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-49 Score=396.89 Aligned_cols=252 Identities=26% Similarity=0.440 Sum_probs=207.9
Q ss_pred cccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC--------CCCcceEE
Q 037702 5 AGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR--------HPNIVQLY 76 (448)
Q Consensus 5 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~--------hpnIv~l~ 76 (448)
+.++.++|++.+.||+|+||.||+|++..+|+.||||++.... ...+.+.+|+.+++.++ ||||++++
T Consensus 32 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~ 107 (397)
T 1wak_A 32 GDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE----HYTETALDEIRLLKSVRNSDPNDPNREMVVQLL 107 (397)
T ss_dssp TCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEE
T ss_pred hhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC----cchHHHHHHHHHHHHHhhcCCCCCCcceeeeee
Confidence 4567789999999999999999999999999999999997542 33467889999999985 78899999
Q ss_pred EEEE----eCCEEEEEEeecCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC-CCEeecCCCCceEEcCCC--
Q 037702 77 EVMA----SKTKIYFAMEYVRGGELFNKVAK---GKLREEVARKYFQQLVDAVEFCHSR-GVYHRDLKPENLLLDENG-- 146 (448)
Q Consensus 77 ~~~~----~~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~yLH~~-givHrDLkp~NILl~~~g-- 146 (448)
+++. ....+|+||||+ +++|.+.+.. +.+++..++.++.||+.||+|||++ ||+||||||+|||++.++
T Consensus 108 ~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~ 186 (397)
T 1wak_A 108 DDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQY 186 (397)
T ss_dssp EEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHH
T ss_pred cceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchh
Confidence 9987 566899999999 5566666543 4699999999999999999999999 999999999999999776
Q ss_pred -----------------------------------------------CeEEeeccccccccccccCCCccccCCCCcccc
Q 037702 147 -----------------------------------------------DLKISDFGLSALQESTRQDGLLHTTCGTPAYVA 179 (448)
Q Consensus 147 -----------------------------------------------~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~A 179 (448)
.+||+|||++...... ....+||+.|+|
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~a 261 (397)
T 1wak_A 187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRS 261 (397)
T ss_dssp HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCC
T ss_pred hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccC
Confidence 8999999999865322 245689999999
Q ss_pred hhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCc------HHHHHHHHhhc--------------------------
Q 037702 180 PEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSN------LMELYKKITRA-------------------------- 227 (448)
Q Consensus 180 PEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~------~~~~~~~i~~~-------------------------- 227 (448)
||++.+..+. .++|||||||++|+|++|..||...+ ..+....+...
T Consensus 262 PE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 340 (397)
T 1wak_A 262 LEVLIGSGYN-TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLK 340 (397)
T ss_dssp HHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBS
T ss_pred ChhhcCCCCC-cHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccc
Confidence 9999887765 88999999999999999999997643 12222222110
Q ss_pred ----------------cCCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcc
Q 037702 228 ----------------EFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFR 267 (448)
Q Consensus 228 ----------------~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~ 267 (448)
.+..+...++++.+||.+||+.||.+|||++|+++||||+
T Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 341 HITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp SCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred cccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence 0111222346788999999999999999999999999996
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=386.69 Aligned_cols=255 Identities=24% Similarity=0.385 Sum_probs=219.6
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCc---EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQ---SVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASK 82 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~---~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~ 82 (448)
.+..++|++.+.||+|+||.||+|.+..+|+ .||||++.... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 122 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG 122 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 4677899999999999999999999986665 49999997543 223457789999999999999999999999999
Q ss_pred CEEEEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccc
Q 037702 83 TKIYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQE 160 (448)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~ 160 (448)
...|+||||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 123 RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 999999999999999999964 579999999999999999999999999999999999999999999999999998654
Q ss_pred ccccCC-CccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhc-cCCCCCCCCH
Q 037702 161 STRQDG-LLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EFKCPNWFPP 237 (448)
Q Consensus 161 ~~~~~~-~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~ 237 (448)
...... ......||+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..+....+... ....|..+++
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFS-SASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPH 281 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCC-cHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcCH
Confidence 332211 12234568899999999876664 88999999999999999 99999998888888777665 4566778999
Q ss_pred HHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 238 EVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 238 ~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
++.+||.+||..||.+|||+.++++.
T Consensus 282 ~l~~li~~~l~~dp~~Rps~~eil~~ 307 (325)
T 3kul_A 282 ALHQLMLDCWHKDRAQRPRFSQIVSV 307 (325)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999999999873
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-49 Score=388.09 Aligned_cols=255 Identities=26% Similarity=0.387 Sum_probs=222.7
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEEC-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNL-----KTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMA 80 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~ 80 (448)
.+..++|++.+.||+|+||.||+|++. .+++.||||++.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 456789999999999999999999987 456899999997553 2244578899999999999999999999999
Q ss_pred eCCEEEEEEeecCCCchHHHHhc-------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecC
Q 037702 81 SKTKIYFAMEYVRGGELFNKVAK-------------------------GKLREEVARKYFQQLVDAVEFCHSRGVYHRDL 135 (448)
Q Consensus 81 ~~~~~~lV~E~~~gg~L~~~i~~-------------------------~~l~e~~~~~~~~qll~aL~yLH~~givHrDL 135 (448)
+.+..|+||||+++|+|.+++.. +.+++.+++.++.||+.||.|||++||+||||
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dl 200 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 200 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 99999999999999999999865 46899999999999999999999999999999
Q ss_pred CCCceEEcCCCCeEEeeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCC
Q 037702 136 KPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYD 214 (448)
Q Consensus 136 kp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~ 214 (448)
||+|||++.++.+||+|||++................||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcC-cccccHHHHHHHHHHHhcCCCcCCC
Confidence 999999999999999999999865433322233456789999999999877664 89999999999999999 9999999
Q ss_pred CcHHHHHHHHhhccC-CCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 215 SNLMELYKKITRAEF-KCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 215 ~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
.+..+....+..+.. ..|..+++++.++|.+||+.||.+|||+.+++++
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 280 MAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp SCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 888888877776654 5678899999999999999999999999999874
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=388.23 Aligned_cols=254 Identities=26% Similarity=0.444 Sum_probs=214.6
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE---
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTK--- 84 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~--- 84 (448)
+.++|.+.+.||+|+||.||+|.+..+|+.||||++..... .....+.+.+|+.+++.++||||+++++++.....
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 100 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ-SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN 100 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccc
Confidence 56899999999999999999999999999999999976532 33445778899999999999999999999987654
Q ss_pred ---EEEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccc
Q 037702 85 ---IYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQES 161 (448)
Q Consensus 85 ---~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~ 161 (448)
.|+||||+. ++|.+++.. ++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 101 ~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 178 (353)
T 3coi_A 101 FYDFYLVMPFMQ-TDLQKIMGL-KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 178 (353)
T ss_dssp CCCCEEEEECCS-EEGGGTTTS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred ceeEEEEecccc-CCHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence 599999997 588887754 599999999999999999999999999999999999999999999999999975432
Q ss_pred cccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhcc-------------
Q 037702 162 TRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAE------------- 228 (448)
Q Consensus 162 ~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~------------- 228 (448)
. ....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 179 ~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 253 (353)
T 3coi_A 179 E-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 253 (353)
T ss_dssp ----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSC
T ss_pred C-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhh
Confidence 1 2346799999999999774455689999999999999999999999887766555543210
Q ss_pred ------------------CCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 229 ------------------FKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 229 ------------------~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
...++.+++++.+||.+||..||.+|||++++++||||+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 312 (353)
T 3coi_A 254 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312 (353)
T ss_dssp HHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred HHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 11234578999999999999999999999999999999753
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=382.49 Aligned_cols=263 Identities=30% Similarity=0.463 Sum_probs=216.3
Q ss_pred Ccccccc-ccCCeEEEeeeeecCceEEEEEEEC-CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC---CCCCcceE
Q 037702 1 MEKKAGI-LMNKYELGRLLGQGTFAKVYHGRNL-KTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV---RHPNIVQL 75 (448)
Q Consensus 1 m~~~~~~-~~~~y~~~~~LG~G~fg~Vy~a~~~-~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l---~hpnIv~l 75 (448)
|++.+-. ..++|++.+.||+|+||.||+|.+. .+|+.||+|++....... .....+.+|+.+++.+ +||||+++
T Consensus 1 m~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~ 79 (326)
T 1blx_A 1 MEKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRL 79 (326)
T ss_dssp ----CCCCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCE
T ss_pred CCCccccCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEee
Confidence 5555533 3589999999999999999999995 678999999997654322 1123456777777766 89999999
Q ss_pred EEEEE-----eCCEEEEEEeecCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCC
Q 037702 76 YEVMA-----SKTKIYFAMEYVRGGELFNKVAK---GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGD 147 (448)
Q Consensus 76 ~~~~~-----~~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~ 147 (448)
++++. .....++||||+. |+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 80 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~ 158 (326)
T 1blx_A 80 FDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ 158 (326)
T ss_dssp EEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC
T ss_pred eeeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCC
Confidence 99987 5678999999998 599999865 34999999999999999999999999999999999999999999
Q ss_pred eEEeeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhc
Q 037702 148 LKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA 227 (448)
Q Consensus 148 lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~ 227 (448)
+||+|||++....... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 159 ~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 234 (326)
T 1blx_A 159 IKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 234 (326)
T ss_dssp EEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred EEEecCcccccccCCC---CccccccccceeCHHHHhcCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 9999999997654222 2345689999999999987666 48899999999999999999999988877766665431
Q ss_pred c---------------------------CCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 228 E---------------------------FKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 228 ~---------------------------~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
. ..++..+++.+.+||.+||..||.+|||+.++++||||+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 303 (326)
T 1blx_A 235 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 303 (326)
T ss_dssp HCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcccccc
Confidence 0 01234578999999999999999999999999999999753
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=390.65 Aligned_cols=262 Identities=24% Similarity=0.383 Sum_probs=211.7
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeeccccc--------chhHHHHHHHHHHHHHhCCCCCcceEEE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIR--------RVGLIDQIKREISVMRLVRHPNIVQLYE 77 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~--------~~~~~~~~~~Ei~~l~~l~hpnIv~l~~ 77 (448)
..+.++|++.+.||+|+||.||+|.+. +|..||||++...... +....+.+.+|+.+++.++||||+++++
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 96 (362)
T 3pg1_A 18 HAMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRD 96 (362)
T ss_dssp HHTTCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSE
T ss_pred HHhccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceee
Confidence 457789999999999999999999975 4999999999654321 2233578899999999999999999999
Q ss_pred EEEe-----CCEEEEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEE
Q 037702 78 VMAS-----KTKIYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKI 150 (448)
Q Consensus 78 ~~~~-----~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl 150 (448)
++.. ...+|+||||++ |+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 97 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl 175 (362)
T 3pg1_A 97 IFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITI 175 (362)
T ss_dssp EEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEE
T ss_pred eEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEE
Confidence 9844 347899999998 588888765 36999999999999999999999999999999999999999999999
Q ss_pred eeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccC-
Q 037702 151 SDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF- 229 (448)
Q Consensus 151 ~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~- 229 (448)
+|||++...... ......+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 176 ~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 252 (362)
T 3pg1_A 176 CDFNLAREDTAD---ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGT 252 (362)
T ss_dssp CCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred EecCcccccccc---cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence 999999743322 2234568999999999997745556899999999999999999999998887666665532100
Q ss_pred -------------------------------CCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccccccc
Q 037702 230 -------------------------------KCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYKK 272 (448)
Q Consensus 230 -------------------------------~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~ 272 (448)
..++.+++.+.+||.+||..||.+|||++++++||||+..+.+
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 326 (362)
T 3pg1_A 253 PKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDP 326 (362)
T ss_dssp CCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred CChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCc
Confidence 1123468899999999999999999999999999999876543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-49 Score=389.29 Aligned_cols=257 Identities=31% Similarity=0.580 Sum_probs=222.1
Q ss_pred ccccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccch---hHHHHHHHHHHHHHhCC--CCCcceEEEE
Q 037702 4 KAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRV---GLIDQIKREISVMRLVR--HPNIVQLYEV 78 (448)
Q Consensus 4 ~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~---~~~~~~~~Ei~~l~~l~--hpnIv~l~~~ 78 (448)
.+..+.++|++.+.||+|+||.||+|.+..+|+.||||++........ ...+.+.+|+.+++.++ ||||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 345678899999999999999999999999999999999987644321 11234668999999996 5999999999
Q ss_pred EEeCCEEEEEEeecCC-CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEc-CCCCeEEeeccc
Q 037702 79 MASKTKIYFAMEYVRG-GELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLD-ENGDLKISDFGL 155 (448)
Q Consensus 79 ~~~~~~~~lV~E~~~g-g~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~-~~g~lkl~DFGl 155 (448)
+...+..++|||++.+ ++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+
T Consensus 117 ~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~ 196 (320)
T 3a99_A 117 FERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS 196 (320)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred EecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence 9999999999999986 899999875 7899999999999999999999999999999999999999 788999999999
Q ss_pred cccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCC
Q 037702 156 SALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWF 235 (448)
Q Consensus 156 a~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~ 235 (448)
+..... ......+||+.|+|||++.+..+.+.++|||||||++|+|++|..||...+ .+.......+..+
T Consensus 197 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~~~~~ 266 (320)
T 3a99_A 197 GALLKD----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRV 266 (320)
T ss_dssp CEECCS----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSSCC
T ss_pred cccccc----ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcccccccccC
Confidence 986542 223456799999999999887776788999999999999999999997643 2344566677889
Q ss_pred CHHHHHHHHhccCCCcCCCCCHHHHHhhhhccccc
Q 037702 236 PPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGY 270 (448)
Q Consensus 236 s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 270 (448)
++++.+||.+||..||.+|||++++++||||+...
T Consensus 267 ~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 267 SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 99999999999999999999999999999997643
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-49 Score=392.62 Aligned_cols=255 Identities=25% Similarity=0.427 Sum_probs=215.7
Q ss_pred ccccCCeEEEeeeeecCceEEEEEE-----ECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGR-----NLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEVM 79 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~-----~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~ 79 (448)
.+..++|++++.||+|+||.||+|+ +..+++.||||++..... ....+.+.+|+.+++.+ +||||+++++++
T Consensus 18 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hpniv~~~~~~ 95 (359)
T 3vhe_A 18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGAC 95 (359)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCC--HHHHHHHHHHHHHHHhhcCCcceeeeeeee
Confidence 4567899999999999999999999 556778999999975432 23356789999999999 789999999999
Q ss_pred EeCC-EEEEEEeecCCCchHHHHhcCC-----------------------------------------------------
Q 037702 80 ASKT-KIYFAMEYVRGGELFNKVAKGK----------------------------------------------------- 105 (448)
Q Consensus 80 ~~~~-~~~lV~E~~~gg~L~~~i~~~~----------------------------------------------------- 105 (448)
.+.+ .+|+||||++||+|.+++....
T Consensus 96 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (359)
T 3vhe_A 96 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD 175 (359)
T ss_dssp CSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred ecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence 8755 4899999999999999997532
Q ss_pred --------------CCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCcccc
Q 037702 106 --------------LREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTT 171 (448)
Q Consensus 106 --------------l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~ 171 (448)
+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...............
T Consensus 176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 255 (359)
T 3vhe_A 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 255 (359)
T ss_dssp --------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--C
T ss_pred hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhcccc
Confidence 899999999999999999999999999999999999999999999999999865433222233456
Q ss_pred CCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHH-HHHHHhhc-cCCCCCCCCHHHHHHHHhccC
Q 037702 172 CGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLME-LYKKITRA-EFKCPNWFPPEVRKLLSRILD 248 (448)
Q Consensus 172 ~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~-~~~~i~~~-~~~~p~~~s~~~~~li~~~L~ 248 (448)
.||+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..+ ....+... ....|..+++++.++|.+||.
T Consensus 256 ~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 334 (359)
T 3vhe_A 256 RLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 334 (359)
T ss_dssp EECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred CCCceeEChhhhcCCCCC-chhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcc
Confidence 789999999999877664 89999999999999998 999998866443 33333333 456778899999999999999
Q ss_pred CCcCCCCCHHHHHhh
Q 037702 249 PNPSTRVTMAKLMEN 263 (448)
Q Consensus 249 ~dP~~Rpt~~eil~h 263 (448)
.||.+|||++++++|
T Consensus 335 ~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 335 GEPSQRPTFSELVEH 349 (359)
T ss_dssp SSGGGSCCHHHHHHH
T ss_pred CChhhCCCHHHHHHH
Confidence 999999999999987
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=391.66 Aligned_cols=257 Identities=24% Similarity=0.416 Sum_probs=224.1
Q ss_pred cccccCCeEEEeeeeecCceEEEEEEECCC-------CcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEE
Q 037702 5 AGILMNKYELGRLLGQGTFAKVYHGRNLKT-------GQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLY 76 (448)
Q Consensus 5 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~-------g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~ 76 (448)
..+..++|++++.||+|+||.||+|++..+ +..||||++.... .......+.+|+.+++.+ +||||++++
T Consensus 64 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 141 (382)
T 3tt0_A 64 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLL 141 (382)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhhe
Confidence 356678999999999999999999997543 3579999997653 224457788999999999 999999999
Q ss_pred EEEEeCCEEEEEEeecCCCchHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCc
Q 037702 77 EVMASKTKIYFAMEYVRGGELFNKVAKG-----------------KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPEN 139 (448)
Q Consensus 77 ~~~~~~~~~~lV~E~~~gg~L~~~i~~~-----------------~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~N 139 (448)
+++.+.+..|+||||+++|+|.+++... .+++..++.++.||+.||+|||++||+||||||+|
T Consensus 142 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 221 (382)
T 3tt0_A 142 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 221 (382)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred eeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcce
Confidence 9999999999999999999999999753 38999999999999999999999999999999999
Q ss_pred eEEcCCCCeEEeeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHH
Q 037702 140 LLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLM 218 (448)
Q Consensus 140 ILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~ 218 (448)
||++.++.+||+|||++................||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+..
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~ellt~g~~p~~~~~~~ 300 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPVE 300 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999986544333233345578899999999987666 488999999999999999 99999999888
Q ss_pred HHHHHHhhc-cCCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhh
Q 037702 219 ELYKKITRA-EFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENY 264 (448)
Q Consensus 219 ~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 264 (448)
++...+... ....|..+++++.+||.+||+.||.+|||+.+++++-
T Consensus 301 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 347 (382)
T 3tt0_A 301 ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 347 (382)
T ss_dssp HHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 888877665 3456778999999999999999999999999999863
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=389.07 Aligned_cols=259 Identities=28% Similarity=0.363 Sum_probs=203.7
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE-
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTK- 84 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~- 84 (448)
....++|++.+.||+|+||.||+|++..+|+.||||++....... ....+|+..++.++||||+++++++.....
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR----NRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC----CHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc----HHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 456789999999999999999999999999999999986553222 345578888899999999999999865433
Q ss_pred ------EEEEEeecCCCchH---HHHhc-CCCCHHHHHHHHHHHHHHHHHHH--HCCCEeecCCCCceEEcC-CCCeEEe
Q 037702 85 ------IYFAMEYVRGGELF---NKVAK-GKLREEVARKYFQQLVDAVEFCH--SRGVYHRDLKPENLLLDE-NGDLKIS 151 (448)
Q Consensus 85 ------~~lV~E~~~gg~L~---~~i~~-~~l~e~~~~~~~~qll~aL~yLH--~~givHrDLkp~NILl~~-~g~lkl~ 151 (448)
+++||||++++.+. ..... ..+++..++.++.|++.||.||| ++||+||||||+|||++. ++.+||+
T Consensus 95 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~ 174 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLC 174 (360)
T ss_dssp CTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEEC
T ss_pred cccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEe
Confidence 88999999875332 22223 57999999999999999999999 999999999999999997 8999999
Q ss_pred eccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccC--
Q 037702 152 DFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF-- 229 (448)
Q Consensus 152 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-- 229 (448)
|||++....... .....+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+....+..+.+...
T Consensus 175 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 251 (360)
T 3e3p_A 175 DFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCP 251 (360)
T ss_dssp CCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred eCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCC
Confidence 999998654322 234567999999999997666556899999999999999999999999887776666543210
Q ss_pred ------------------------------CCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccccc
Q 037702 230 ------------------------------KCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYK 271 (448)
Q Consensus 230 ------------------------------~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~ 271 (448)
..+...++++.+||.+||+.||.+|||+.|+++||||+....
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 252 SREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD 323 (360)
T ss_dssp CHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred CHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence 111225688999999999999999999999999999987543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=400.07 Aligned_cols=254 Identities=16% Similarity=0.171 Sum_probs=196.3
Q ss_pred cCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC--CCCCcceEE-------EEE
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV--RHPNIVQLY-------EVM 79 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l--~hpnIv~l~-------~~~ 79 (448)
..+|++.+.||+|+||.||+|.+..+|+.||||++...........+.+.+|+.+++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 34599999999999999999999999999999999887654445567788886555555 699988865 555
Q ss_pred EeC-----------------CEEEEEEeecCCCchHHHHhc--CCCCHHHH------HHHHHHHHHHHHHHHHCCCEeec
Q 037702 80 ASK-----------------TKIYFAMEYVRGGELFNKVAK--GKLREEVA------RKYFQQLVDAVEFCHSRGVYHRD 134 (448)
Q Consensus 80 ~~~-----------------~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~------~~~~~qll~aL~yLH~~givHrD 134 (448)
... ..+|+||||++ |+|.+++.. ..+++... ..++.||+.||+|||++||+|||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD 219 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH 219 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence 443 34899999998 899999975 24544444 56679999999999999999999
Q ss_pred CCCCceEEcCCCCeEEeeccccccccccccCCCccccCCCCcccchhhhhc--cCCCCCcchHHHHHHHHHHHHhCCCCC
Q 037702 135 LKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINK--RGYDGAKADIWSCGVVLFVLLAGNLPF 212 (448)
Q Consensus 135 Lkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~--~~~~~~~sDiwSlGvil~elltG~~Pf 212 (448)
|||+|||++.+|.+||+|||+|...... .....||+.|+|||++.+ ..| +.++|||||||++|+|++|+.||
T Consensus 220 ikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~-~~~~DiwSlG~il~elltg~~Pf 293 (371)
T 3q60_A 220 FTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATF-THALNAWQLGLSIYRVWCLFLPF 293 (371)
T ss_dssp CSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEEC-CHHHHHHHHHHHHHHHHHSSCST
T ss_pred CCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCc-CccccHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999854322 124567799999999976 445 58999999999999999999999
Q ss_pred CCCcHHH--HHHH-----HhhccCC--CCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 213 YDSNLME--LYKK-----ITRAEFK--CPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 213 ~~~~~~~--~~~~-----i~~~~~~--~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
.+..... .+.. .....+. .+..+|+++.+||.+||+.||.+|||++++++||||+..
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 359 (371)
T 3q60_A 294 GLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL 359 (371)
T ss_dssp TBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred CCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence 8763221 1110 0111222 234689999999999999999999999999999999763
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-49 Score=400.96 Aligned_cols=259 Identities=26% Similarity=0.437 Sum_probs=197.1
Q ss_pred ccccCCeEE-EeeeeecCceEEEEEEEC--CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe-
Q 037702 6 GILMNKYEL-GRLLGQGTFAKVYHGRNL--KTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMAS- 81 (448)
Q Consensus 6 ~~~~~~y~~-~~~LG~G~fg~Vy~a~~~--~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~- 81 (448)
..+.+.|++ ++.||+|+||.||+|++. .+++.||||++...... ..+.+|+.+|+.++||||+++++++..
T Consensus 16 ~~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~hpniv~~~~~~~~~ 90 (405)
T 3rgf_A 16 ERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSH 90 (405)
T ss_dssp CCHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC-----HHHHHHHHHHHHCCCTTBCCCCEEEEET
T ss_pred hhhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC-----HHHHHHHHHHHhcCCCCeeeEeeEEecC
Confidence 345667887 668999999999999976 57899999999755332 457799999999999999999999954
Q ss_pred -CCEEEEEEeecCCCchHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEE----cCCC
Q 037702 82 -KTKIYFAMEYVRGGELFNKVAK----------GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLL----DENG 146 (448)
Q Consensus 82 -~~~~~lV~E~~~gg~L~~~i~~----------~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl----~~~g 146 (448)
...+|+||||+.+ +|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++
T Consensus 91 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~ 169 (405)
T 3rgf_A 91 ADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERG 169 (405)
T ss_dssp TTTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTT
T ss_pred CCCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCC
Confidence 7789999999975 78777752 149999999999999999999999999999999999999 7788
Q ss_pred CeEEeecccccccccccc-CCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcH--------
Q 037702 147 DLKISDFGLSALQESTRQ-DGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNL-------- 217 (448)
Q Consensus 147 ~lkl~DFGla~~~~~~~~-~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~-------- 217 (448)
.+||+|||+|........ .......+||+.|+|||++.+..+++.++|||||||++|+|++|.+||.+.+.
T Consensus 170 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~ 249 (405)
T 3rgf_A 170 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY 249 (405)
T ss_dssp CEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCC
T ss_pred cEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccc
Confidence 999999999986543221 12334578999999999998766567899999999999999999999976543
Q ss_pred -HHHHHHHhhc-cCCC-------------------------------------CCCCCHHHHHHHHhccCCCcCCCCCHH
Q 037702 218 -MELYKKITRA-EFKC-------------------------------------PNWFPPEVRKLLSRILDPNPSTRVTMA 258 (448)
Q Consensus 218 -~~~~~~i~~~-~~~~-------------------------------------p~~~s~~~~~li~~~L~~dP~~Rpt~~ 258 (448)
.+....+... ..+. ....++++.+||.+||..||.+|||++
T Consensus 250 ~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~ 329 (405)
T 3rgf_A 250 HHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSE 329 (405)
T ss_dssp CHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHH
T ss_pred hHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHH
Confidence 1222222211 0000 011267899999999999999999999
Q ss_pred HHHhhhhccccc
Q 037702 259 KLMENYWFRKGY 270 (448)
Q Consensus 259 eil~hp~~~~~~ 270 (448)
|+|+||||+...
T Consensus 330 e~L~hp~f~~~~ 341 (405)
T 3rgf_A 330 QAMQDPYFLEDP 341 (405)
T ss_dssp HHHTSGGGTSSS
T ss_pred HHhcChhhccCC
Confidence 999999998653
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=375.63 Aligned_cols=256 Identities=21% Similarity=0.322 Sum_probs=215.2
Q ss_pred CccccccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEE
Q 037702 1 MEKKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEVM 79 (448)
Q Consensus 1 m~~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~ 79 (448)
|...+.++.++|++.+.||+|+||.||+|.+..+|+.||||++...... +.+.+|+.+++.+ +|+||+++++++
T Consensus 1 Ms~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~ 75 (298)
T 1csn_A 1 MSGQNNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFG 75 (298)
T ss_dssp -----CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEE
T ss_pred CCCcCcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc-----HHHHHHHHHHHHHhcCCCCCeEEeec
Confidence 6777888999999999999999999999999999999999998754322 3477899999999 899999999999
Q ss_pred EeCCEEEEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCC-----eEEee
Q 037702 80 ASKTKIYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGD-----LKISD 152 (448)
Q Consensus 80 ~~~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~-----lkl~D 152 (448)
......|+||||+ +++|.+++.. .++++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|
T Consensus 76 ~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~D 154 (298)
T 1csn_A 76 QEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVD 154 (298)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECC
T ss_pred CCCceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEE
Confidence 9999999999999 9999999975 46999999999999999999999999999999999999988776 99999
Q ss_pred ccccccccccccC-----CCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCC---cHHHHHHHH
Q 037702 153 FGLSALQESTRQD-----GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDS---NLMELYKKI 224 (448)
Q Consensus 153 FGla~~~~~~~~~-----~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~---~~~~~~~~i 224 (448)
||++......... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+. .....+..+
T Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 233 (298)
T 1csn_A 155 FGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI 233 (298)
T ss_dssp CTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH
T ss_pred CccccccccccccccccccCccCCCCCcccCCchhhcCCCC-ChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHH
Confidence 9999865433221 12345679999999999987666 58999999999999999999999873 344444444
Q ss_pred hhccCC-----CCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 225 TRAEFK-----CPNWFPPEVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 225 ~~~~~~-----~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
...... .+..+|+++.++|.+||..||.+|||+++|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 234 GEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp HHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred HhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 433221 234689999999999999999999999999874
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=378.57 Aligned_cols=255 Identities=27% Similarity=0.507 Sum_probs=209.0
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe------
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMAS------ 81 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~------ 81 (448)
+.++|++.+.||+|+||.||+|++..+|+.||||++... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK 79 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhh
Confidence 457899999999999999999999999999999999643 2345778899999999999999999998865
Q ss_pred -------CCEEEEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEee
Q 037702 82 -------KTKIYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISD 152 (448)
Q Consensus 82 -------~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~D 152 (448)
....|+||||++||+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus 80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 80 PMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp ------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECC
T ss_pred hhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEee
Confidence 4578999999999999999975 3578899999999999999999999999999999999999999999999
Q ss_pred ccccccccccc------------cCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCC-CcHHH
Q 037702 153 FGLSALQESTR------------QDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYD-SNLME 219 (448)
Q Consensus 153 FGla~~~~~~~------------~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~-~~~~~ 219 (448)
||++....... ........+||+.|+|||++.+.+..+.++|||||||++|+|++ ||.. .+...
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~ 236 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN 236 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence 99997543211 01223456799999999999876555689999999999999998 6653 23345
Q ss_pred HHHHHhhccCCCCC----CCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 220 LYKKITRAEFKCPN----WFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 220 ~~~~i~~~~~~~p~----~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
....+......+|+ ..++.+.++|.+||..||.+|||++++++||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 237 ILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp HHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred HHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 55555555444443 456789999999999999999999999999999753
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-48 Score=370.05 Aligned_cols=250 Identities=28% Similarity=0.533 Sum_probs=207.6
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccc-hhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRR-VGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKI 85 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 85 (448)
+..++|++.+.||+|+||.||+|.+ +|..||||++....... ....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL 81 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--C
T ss_pred cchhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence 4578999999999999999999998 58999999987653322 23357788999999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CEeecCCCCceEEcC--------CCCeEEeecc
Q 037702 86 YFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRG---VYHRDLKPENLLLDE--------NGDLKISDFG 154 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~g---ivHrDLkp~NILl~~--------~g~lkl~DFG 154 (448)
|+||||++|++|.+++..+++++..++.++.|++.||.|||++| |+||||||+|||++. ++.+||+|||
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp EEEEECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EEEEEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 99999999999999998889999999999999999999999999 999999999999986 7789999999
Q ss_pred ccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhcc--CCCC
Q 037702 155 LSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAE--FKCP 232 (448)
Q Consensus 155 la~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p 232 (448)
++....... .....||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+.+.......+.... ...|
T Consensus 162 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 236 (271)
T 3dtc_A 162 LAREWHRTT----KMSAAGAYAWMAPEVIRASMF-SKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIP 236 (271)
T ss_dssp C-----------------CCGGGSCHHHHHHCCC-SHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCC
T ss_pred ccccccccc----ccCCCCccceeCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCC
Confidence 997543322 234579999999999987666 488999999999999999999999888776666655543 4566
Q ss_pred CCCCHHHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 233 NWFPPEVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 233 ~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
..+++++.++|.+||+.||.+|||+.+++++
T Consensus 237 ~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 237 STCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 7899999999999999999999999999985
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=382.11 Aligned_cols=250 Identities=26% Similarity=0.438 Sum_probs=212.0
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIY 86 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 86 (448)
+..++|++++.||+|+||.||+|.+..+|+.||+|++... +....+.+.+|+.+++.++||||+++++++.++...|
T Consensus 7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 83 (310)
T 3s95_A 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLN 83 (310)
T ss_dssp ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeE
Confidence 4578999999999999999999999999999999998543 2344578899999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccccc
Q 037702 87 FAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQ 164 (448)
Q Consensus 87 lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~ 164 (448)
+||||++||+|.+++.. +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp EEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred EEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 99999999999999976 6799999999999999999999999999999999999999999999999999986533221
Q ss_pred C------------CCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHH-----HHHHHhhc
Q 037702 165 D------------GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLME-----LYKKITRA 227 (448)
Q Consensus 165 ~------------~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~-----~~~~i~~~ 227 (448)
. ....+.+||+.|+|||++.+..++ .++|||||||++|+|++|..||....... ..... .
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~--~ 240 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYD-EKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGF--L 240 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHH--H
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCC-cHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcc--c
Confidence 1 111256899999999999876664 88999999999999999999986532110 00011 1
Q ss_pred cCCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHh
Q 037702 228 EFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 228 ~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 262 (448)
....|..+|+.+.++|.+||+.||.+|||++++++
T Consensus 241 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 241 DRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp HHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 12346778999999999999999999999999987
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-48 Score=369.21 Aligned_cols=252 Identities=23% Similarity=0.385 Sum_probs=219.5
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKI 85 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 85 (448)
.+..++|++.+.||+|+||.||+|.+. ++..||+|++...... .+.+.+|+.+++.++||||+++++++.+....
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI 78 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred EechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence 456789999999999999999999875 6778999999765433 25688999999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccc
Q 037702 86 YFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTR 163 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~ 163 (448)
|+||||+++++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 79 YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred EEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 999999999999999975 359999999999999999999999999999999999999999999999999997543321
Q ss_pred cCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhccC-CCCCCCCHHHHH
Q 037702 164 QDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAEF-KCPNWFPPEVRK 241 (448)
Q Consensus 164 ~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~ 241 (448)
. .......||+.|+|||++.+..+. .++||||||+++|+|++ |..||...+..+....+..... ..|..+++.+.+
T Consensus 159 ~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 236 (268)
T 3sxs_A 159 Y-VSSVGTKFPVKWSAPEVFHYFKYS-SKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQ 236 (268)
T ss_dssp E-EECCSCCCCGGGCCHHHHHHSEEE-TTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHH
T ss_pred h-hcccCCCcCcccCCHHHHhccCCc-hhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHH
Confidence 1 112344577889999999876664 88999999999999999 9999999888877777766543 456678999999
Q ss_pred HHHhccCCCcCCCCCHHHHHhhh
Q 037702 242 LLSRILDPNPSTRVTMAKLMENY 264 (448)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~hp 264 (448)
+|.+||+.||.+|||+.+++++-
T Consensus 237 li~~~l~~~p~~Rps~~~ll~~L 259 (268)
T 3sxs_A 237 IMYSCWHELPEKRPTFQQLLSSI 259 (268)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHHHHH
Confidence 99999999999999999999863
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=371.52 Aligned_cols=253 Identities=22% Similarity=0.383 Sum_probs=219.7
Q ss_pred CccccccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 037702 1 MEKKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMA 80 (448)
Q Consensus 1 m~~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~ 80 (448)
|.+..++..++|++.+.||+|+||.||+|++ +|+.||||++....... ...+.+.+|+.+++.++||||+++++++.
T Consensus 1 m~~~~~i~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 77 (271)
T 3kmu_A 1 MNKHSGIDFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWST-RKSRDFNEECPRLRIFSHPNVLPVLGACQ 77 (271)
T ss_dssp ---CCCCCGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCH-HHHHHHHHHGGGGCCCSCTTEECEEEEEC
T ss_pred CCCcCCCCHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCH-HHHHHHHHHHHHHHhcCCCchhheEEEEc
Confidence 7788899999999999999999999999998 58999999998764333 34567899999999999999999999998
Q ss_pred eC--CEEEEEEeecCCCchHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--CEeecCCCCceEEcCCCCeEEeec
Q 037702 81 SK--TKIYFAMEYVRGGELFNKVAKG---KLREEVARKYFQQLVDAVEFCHSRG--VYHRDLKPENLLLDENGDLKISDF 153 (448)
Q Consensus 81 ~~--~~~~lV~E~~~gg~L~~~i~~~---~l~e~~~~~~~~qll~aL~yLH~~g--ivHrDLkp~NILl~~~g~lkl~DF 153 (448)
+. ...++||||+++|+|.+++... .+++..++.++.||+.||.|||++| |+||||||+|||++.++.++|+||
T Consensus 78 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~ 157 (271)
T 3kmu_A 78 SPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMA 157 (271)
T ss_dssp TTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGG
T ss_pred cCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEec
Confidence 77 7889999999999999999874 4899999999999999999999999 999999999999999999999999
Q ss_pred cccccccccccCCCccccCCCCcccchhhhhccCCCC--CcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhc--cC
Q 037702 154 GLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDG--AKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA--EF 229 (448)
Q Consensus 154 Gla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~--~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~ 229 (448)
|++.... .....||+.|+|||++.+..+.. .++|||||||++|+|++|..||.+.+..+....+... ..
T Consensus 158 ~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 230 (271)
T 3kmu_A 158 DVKFSFQ-------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP 230 (271)
T ss_dssp GSCCTTS-------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCC
T ss_pred cceeeec-------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCC
Confidence 9875421 13457899999999997655442 2799999999999999999999988887776666544 34
Q ss_pred CCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 230 KCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 230 ~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
..|..+++++.++|.+||+.||.+|||++++++.
T Consensus 231 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 264 (271)
T 3kmu_A 231 TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPI 264 (271)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 5677899999999999999999999999999873
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=380.41 Aligned_cols=255 Identities=22% Similarity=0.384 Sum_probs=220.6
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEEC-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNL-----KTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMA 80 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~ 80 (448)
.+..++|++.+.||+|+||.||+|.+. .++..||||++.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 96 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGACS 96 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEEEEe
Confidence 456789999999999999999999983 456899999997543 2344577899999999999999999999999
Q ss_pred eCCEEEEEEeecCCCchHHHHhcC-------------------------CCCHHHHHHHHHHHHHHHHHHHHCCCEeecC
Q 037702 81 SKTKIYFAMEYVRGGELFNKVAKG-------------------------KLREEVARKYFQQLVDAVEFCHSRGVYHRDL 135 (448)
Q Consensus 81 ~~~~~~lV~E~~~gg~L~~~i~~~-------------------------~l~e~~~~~~~~qll~aL~yLH~~givHrDL 135 (448)
+.+..|+||||++||+|.+++... .+++..++.++.||+.||.|||++||+||||
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~di 176 (314)
T 2ivs_A 97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDL 176 (314)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccccc
Confidence 999999999999999999999752 2899999999999999999999999999999
Q ss_pred CCCceEEcCCCCeEEeeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCC
Q 037702 136 KPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYD 214 (448)
Q Consensus 136 kp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~ 214 (448)
||+|||++.++.+||+|||++................||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+
T Consensus 177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~ 255 (314)
T 2ivs_A 177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIY-TTQSDVWSFGVLLWEIVTLGGNPYPG 255 (314)
T ss_dssp SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCc-CchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999976543222222234567899999999987665 488999999999999999 9999998
Q ss_pred CcHHHHHHHHhhcc-CCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 215 SNLMELYKKITRAE-FKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 215 ~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
.+.......+.... ...|..+++++.++|.+||..||.+|||+++++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 256 IPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp CCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 88777777666553 45677899999999999999999999999999886
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-48 Score=390.72 Aligned_cols=254 Identities=28% Similarity=0.444 Sum_probs=213.9
Q ss_pred cccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CC-----CcceEEEE
Q 037702 5 AGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR-HP-----NIVQLYEV 78 (448)
Q Consensus 5 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-hp-----nIv~l~~~ 78 (448)
+..+.++|++.+.||+|+||.||+|.+..+|+.||||++.... .....+.+|+.+++.++ |+ +|++++++
T Consensus 49 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~ 124 (382)
T 2vx3_A 49 GEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK----AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRH 124 (382)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEE
T ss_pred CCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH----HHHHHHHHHHHHHHHHHhcccccceeEEEeeee
Confidence 4567899999999999999999999999999999999997542 33467788999998885 54 49999999
Q ss_pred EEeCCEEEEEEeecCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH--HCCCEeecCCCCceEEc--CCCCeEEe
Q 037702 79 MASKTKIYFAMEYVRGGELFNKVAK---GKLREEVARKYFQQLVDAVEFCH--SRGVYHRDLKPENLLLD--ENGDLKIS 151 (448)
Q Consensus 79 ~~~~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~yLH--~~givHrDLkp~NILl~--~~g~lkl~ 151 (448)
+...+.+|+||||+++ +|.+++.. +.+++..++.++.||+.||.||| +.||+||||||+|||++ .++.+||+
T Consensus 125 ~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~ 203 (382)
T 2vx3_A 125 FMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIV 203 (382)
T ss_dssp EEETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred eccCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEE
Confidence 9999999999999965 99999875 35999999999999999999999 57999999999999995 47889999
Q ss_pred eccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCC
Q 037702 152 DFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKC 231 (448)
Q Consensus 152 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~ 231 (448)
|||+|..... .....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+..+....+.......
T Consensus 204 DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~ 277 (382)
T 2vx3_A 204 DFGSSCQLGQ-----RIYQYIQSRFYRSPEVLLGMPYD-LAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIP 277 (382)
T ss_dssp CCTTCEETTC-----CCCSSCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSC
T ss_pred eccCceeccc-----ccccccCCccccChHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9999976532 23456899999999999887765 89999999999999999999999988777766654321100
Q ss_pred C------------------C-------------------C---------------------------CCHHHHHHHHhcc
Q 037702 232 P------------------N-------------------W---------------------------FPPEVRKLLSRIL 247 (448)
Q Consensus 232 p------------------~-------------------~---------------------------~s~~~~~li~~~L 247 (448)
| . . .++++.+||.+||
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL 357 (382)
T 2vx3_A 278 PAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRML 357 (382)
T ss_dssp CHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHT
T ss_pred CHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhc
Confidence 0 0 0 0037899999999
Q ss_pred CCCcCCCCCHHHHHhhhhcccc
Q 037702 248 DPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 248 ~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
+.||.+|||++|+|+||||+..
T Consensus 358 ~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 358 DYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp CSCTTTSCCHHHHTTSGGGCC-
T ss_pred CCChhhCCCHHHHhcCcccccC
Confidence 9999999999999999999764
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-49 Score=384.29 Aligned_cols=256 Identities=31% Similarity=0.606 Sum_probs=211.7
Q ss_pred cccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccch---hHHHHHHHHHHHHHhC----CCCCcceEEE
Q 037702 5 AGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRV---GLIDQIKREISVMRLV----RHPNIVQLYE 77 (448)
Q Consensus 5 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~---~~~~~~~~Ei~~l~~l----~hpnIv~l~~ 77 (448)
...+.++|++.+.||+|+||.||+|.+..+|+.||||++........ .....+.+|+.+++.+ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 45678899999999999999999999999999999999976543221 1123456799999998 8999999999
Q ss_pred EEEeCCEEEEEEee-cCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEc-CCCCeEEeecc
Q 037702 78 VMASKTKIYFAMEY-VRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLD-ENGDLKISDFG 154 (448)
Q Consensus 78 ~~~~~~~~~lV~E~-~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~-~~g~lkl~DFG 154 (448)
++...+..++|||+ +.+++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg 185 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFG 185 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCS
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcc
Confidence 99999999999999 789999999975 6799999999999999999999999999999999999999 88999999999
Q ss_pred ccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCC
Q 037702 155 LSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNW 234 (448)
Q Consensus 155 la~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~ 234 (448)
++...... ......||+.|+|||++.+..+.+.++|||||||++|+|++|+.||.... .+......++..
T Consensus 186 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~~~ 255 (312)
T 2iwi_A 186 SGALLHDE----PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELHFPAH 255 (312)
T ss_dssp SCEECCSS----CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCCCCCTT
T ss_pred hhhhcccC----cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhccCCccc
Confidence 99865432 23456799999999999877776668999999999999999999997542 244556677888
Q ss_pred CCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccccc
Q 037702 235 FPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGY 270 (448)
Q Consensus 235 ~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 270 (448)
+++++.+||.+||..||.+|||++++++||||+...
T Consensus 256 ~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 256 VSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence 999999999999999999999999999999997643
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=384.94 Aligned_cols=255 Identities=26% Similarity=0.411 Sum_probs=213.2
Q ss_pred ccccccCCeEEEeeeeecCceEEEEEEECCCC-cEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC------cceEE
Q 037702 4 KAGILMNKYELGRLLGQGTFAKVYHGRNLKTG-QSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPN------IVQLY 76 (448)
Q Consensus 4 ~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g-~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpn------Iv~l~ 76 (448)
.+..+.++|++.+.||+|+||.||+|.+..++ ..||+|++.... ...+.+.+|+.+++.++|++ ++.++
T Consensus 13 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~ 88 (355)
T 2eu9_A 13 IGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG----KYREAARLEINVLKKIKEKDKENKFLCVLMS 88 (355)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEE
T ss_pred cCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc----cchhHHHHHHHHHHHHhhcCCCCceeEEEee
Confidence 35578899999999999999999999998877 689999996532 33467888999999997766 99999
Q ss_pred EEEEeCCEEEEEEeecCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEE-----------
Q 037702 77 EVMASKTKIYFAMEYVRGGELFNKVAK---GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLL----------- 142 (448)
Q Consensus 77 ~~~~~~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl----------- 142 (448)
+++......|+||||+ +++|.+.+.. ..+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 89 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~ 167 (355)
T 2eu9_A 89 DWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNE 167 (355)
T ss_dssp EEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECC
T ss_pred eeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccc
Confidence 9999999999999999 5667676654 369999999999999999999999999999999999999
Q ss_pred --------cCCCCeEEeeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 037702 143 --------DENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYD 214 (448)
Q Consensus 143 --------~~~g~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~ 214 (448)
+.++.+||+|||++..... .....+||+.|+|||++.+..++ .++|||||||++|+|++|..||..
T Consensus 168 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~ 241 (355)
T 2eu9_A 168 HKSCEEKSVKNTSIRVADFGSATFDHE-----HHTTIVATRHYRPPEVILELGWA-QPCDVWSIGCILFEYYRGFTLFQT 241 (355)
T ss_dssp C-CCCEEEESCCCEEECCCTTCEETTS-----CCCSSCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccccCCCcEEEeecCccccccc-----cccCCcCCCcccCCeeeecCCCC-CccchHHHHHHHHHHHhCCCCCCC
Confidence 6788999999999975332 12456899999999999877764 889999999999999999999998
Q ss_pred CcHHHHHHHHhhccCCCC--------------------------------------------CCCCHHHHHHHHhccCCC
Q 037702 215 SNLMELYKKITRAEFKCP--------------------------------------------NWFPPEVRKLLSRILDPN 250 (448)
Q Consensus 215 ~~~~~~~~~i~~~~~~~p--------------------------------------------~~~s~~~~~li~~~L~~d 250 (448)
.+..+....+.......| ...++++.+||.+||+.|
T Consensus 242 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 321 (355)
T 2eu9_A 242 HENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFD 321 (355)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred CCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCC
Confidence 776655444333211111 112357889999999999
Q ss_pred cCCCCCHHHHHhhhhcccc
Q 037702 251 PSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 251 P~~Rpt~~eil~hp~~~~~ 269 (448)
|.+|||++++++||||+..
T Consensus 322 P~~Rpt~~e~l~hp~f~~~ 340 (355)
T 2eu9_A 322 PAQRITLAEALLHPFFAGL 340 (355)
T ss_dssp TTTSCCHHHHTTSGGGGGC
T ss_pred hhhCcCHHHHhcChhhcCC
Confidence 9999999999999999753
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=393.38 Aligned_cols=254 Identities=26% Similarity=0.459 Sum_probs=218.7
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIY 86 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 86 (448)
+..++|++.+.||+|+||.||+|.+..+|+.||||++.... .....+.+.+|+.+|+.++||||+++++++...+.+|
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 188 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIY 188 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcE
Confidence 45678999999999999999999999999999999987542 2233456889999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccccc
Q 037702 87 FAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQ 164 (448)
Q Consensus 87 lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~ 164 (448)
+||||++||+|.+++.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 189 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 189 IVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY 268 (377)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence 99999999999999975 3699999999999999999999999999999999999999999999999999975332211
Q ss_pred CCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhc-cCCCCCCCCHHHHHH
Q 037702 165 DGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EFKCPNWFPPEVRKL 242 (448)
Q Consensus 165 ~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~l 242 (448)
........+|+.|+|||++....+ +.++|||||||++|||++ |..||.+.+..+....+..+ ..+.|..+|+++.+|
T Consensus 269 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 347 (377)
T 3cbl_A 269 AASGGLRQVPVKWTAPEALNYGRY-SSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRL 347 (377)
T ss_dssp ECCSSCCEEEGGGSCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred eecCCCCCCCcCcCCHhHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 111112335778999999987665 488999999999999998 99999998877777666554 456788899999999
Q ss_pred HHhccCCCcCCCCCHHHHHhh
Q 037702 243 LSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 243 i~~~L~~dP~~Rpt~~eil~h 263 (448)
|.+||+.||.+|||++++++.
T Consensus 348 i~~cl~~dP~~Rps~~~i~~~ 368 (377)
T 3cbl_A 348 MEQCWAYEPGQRPSFSTIYQE 368 (377)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCchhCcCHHHHHHH
Confidence 999999999999999999863
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-48 Score=371.25 Aligned_cols=252 Identities=25% Similarity=0.399 Sum_probs=218.3
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKI 85 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 85 (448)
.+..++|++.+.||+|+||.||+|.+. ++..||||++...... .+.+.+|+.+++.++||||+++++++.+....
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (283)
T 3gen_A 20 EIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPI 94 (283)
T ss_dssp BCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred cCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC----HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCe
Confidence 456779999999999999999999875 6778999999765433 25688999999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccc
Q 037702 86 YFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTR 163 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~ 163 (448)
|+||||+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 174 (283)
T 3gen_A 95 FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174 (283)
T ss_dssp EEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence 999999999999999976 679999999999999999999999999999999999999999999999999998653322
Q ss_pred cCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhcc-CCCCCCCCHHHHH
Q 037702 164 QDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAE-FKCPNWFPPEVRK 241 (448)
Q Consensus 164 ~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~ 241 (448)
. .......||+.|+|||++.+..+ +.++||||||+++|+|++ |..||...+..+....+.... ...|..+++.+.+
T Consensus 175 ~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 252 (283)
T 3gen_A 175 Y-TSSVGSKFPVRWSPPEVLMYSKF-SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYT 252 (283)
T ss_dssp H-HSTTSTTSCGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred c-ccccCCccCcccCCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHHHH
Confidence 1 11234457889999999987766 488999999999999998 999999988888877777653 4566778999999
Q ss_pred HHHhccCCCcCCCCCHHHHHhhh
Q 037702 242 LLSRILDPNPSTRVTMAKLMENY 264 (448)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~hp 264 (448)
+|.+||+.||.+|||++++++|-
T Consensus 253 li~~~l~~~p~~Rps~~~ll~~L 275 (283)
T 3gen_A 253 IMYSCWHEKADERPTFKILLSNI 275 (283)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHccCChhHCcCHHHHHHHH
Confidence 99999999999999999999874
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=385.02 Aligned_cols=255 Identities=30% Similarity=0.569 Sum_probs=187.2
Q ss_pred cccccCCeEEEe-eeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe--
Q 037702 5 AGILMNKYELGR-LLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMAS-- 81 (448)
Q Consensus 5 ~~~~~~~y~~~~-~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~-- 81 (448)
...+.++|++.+ .||+|+||.||+|.+..+|+.||||++.... ....+....++.++||||+++++++..
T Consensus 23 ~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~ 95 (336)
T 3fhr_A 23 KYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-------KARQEVDHHWQASGGPHIVCILDVYENMH 95 (336)
T ss_dssp CSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-------HHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred CccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-------HHHHHHHHHHHhcCCCChHHHHHHHhhcc
Confidence 356789999965 6999999999999999999999999996532 122233344677899999999999876
Q ss_pred --CCEEEEEEeecCCCchHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCC---CCeEEeec
Q 037702 82 --KTKIYFAMEYVRGGELFNKVAKG---KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDEN---GDLKISDF 153 (448)
Q Consensus 82 --~~~~~lV~E~~~gg~L~~~i~~~---~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~---g~lkl~DF 153 (448)
...+|+||||++||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+||
T Consensus 96 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Df 175 (336)
T 3fhr_A 96 HGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDF 175 (336)
T ss_dssp TTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred CCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecc
Confidence 55689999999999999999763 59999999999999999999999999999999999999864 45999999
Q ss_pred cccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHH----HHHHhhccC
Q 037702 154 GLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMEL----YKKITRAEF 229 (448)
Q Consensus 154 Gla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~----~~~i~~~~~ 229 (448)
|++..... ......+||+.|+|||++....+ +.++|||||||++|+|++|..||........ ...+.....
T Consensus 176 g~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 250 (336)
T 3fhr_A 176 GFAKETTQ----NALQTPCYTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQY 250 (336)
T ss_dssp TTCEEC--------------------------CHH-HHHHHHHHHHHHHHHHHHSSCCC---------------------
T ss_pred ccceeccc----cccccCCCCcCccChhhhCCCCC-CchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcccc
Confidence 99975432 22346689999999999876655 4789999999999999999999977654433 223333333
Q ss_pred CCC----CCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccccc
Q 037702 230 KCP----NWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYK 271 (448)
Q Consensus 230 ~~p----~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~ 271 (448)
..| ..+++++.+||.+||..||.+|||++++++||||+....
T Consensus 251 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 296 (336)
T 3fhr_A 251 GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMV 296 (336)
T ss_dssp CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGG
T ss_pred ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccccc
Confidence 333 358999999999999999999999999999999987543
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=375.80 Aligned_cols=257 Identities=25% Similarity=0.404 Sum_probs=210.3
Q ss_pred ccccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 037702 4 KAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKT 83 (448)
Q Consensus 4 ~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~ 83 (448)
+.+...++|++.+.||+|+||.||+|.+..+|+.||||++......+....+.+.+|+.+++.++||||+++++++...+
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 2h34_A 28 REGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG 107 (309)
T ss_dssp ------CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred CCCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCC
Confidence 35677899999999999999999999999999999999998765555555678999999999999999999999999999
Q ss_pred EEEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccc
Q 037702 84 KIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQEST 162 (448)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~ 162 (448)
..|+||||++|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 108 QLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 99999999999999999976 67999999999999999999999999999999999999999999999999998765432
Q ss_pred ccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccC---CCCCCCCHHH
Q 037702 163 RQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF---KCPNWFPPEV 239 (448)
Q Consensus 163 ~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~ 239 (448)
. .......+||+.|+|||++.+..+ +.++||||||+++|+|++|..||...+...+...+..... ..++.+|+++
T Consensus 188 ~-~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 265 (309)
T 2h34_A 188 K-LTQLGNTVGTLYYMAPERFSESHA-TYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAF 265 (309)
T ss_dssp ----------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHH
T ss_pred c-cccccccCCCcCccCHHHHcCCCC-CchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHH
Confidence 2 122235679999999999977655 4889999999999999999999998876655444443322 3456789999
Q ss_pred HHHHHhccCCCcCCCC-CHHHHHh
Q 037702 240 RKLLSRILDPNPSTRV-TMAKLME 262 (448)
Q Consensus 240 ~~li~~~L~~dP~~Rp-t~~eil~ 262 (448)
.++|.+||..||.+|| |++++++
T Consensus 266 ~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 266 DAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred HHHHHHhccCCHHHHHHhHHHHHH
Confidence 9999999999999999 7888775
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=383.25 Aligned_cols=253 Identities=21% Similarity=0.393 Sum_probs=215.1
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcE----EEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQS----VAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASK 82 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~----vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~ 82 (448)
+..++|++.+.||+|+||.||+|.+..+|+. ||+|.+...... .....+.+|+.+++.++||||+++++++. .
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~ 86 (325)
T 3kex_A 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR--QSFQAVTDHMLAIGSLDHAHIVRLLGLCP-G 86 (325)
T ss_dssp CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSC--SCBCSCCHHHHHHHTCCCTTBCCEEEEEC-B
T ss_pred cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccH--HHHHHHHHHHHHHhcCCCCCcCeEEEEEc-C
Confidence 4567999999999999999999999888886 677776543211 12245678999999999999999999886 4
Q ss_pred CEEEEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccc
Q 037702 83 TKIYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQE 160 (448)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~ 160 (448)
...++||||+.+|+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 87 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence 568999999999999999975 479999999999999999999999999999999999999999999999999998765
Q ss_pred ccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhc-cCCCCCCCCHH
Q 037702 161 STRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EFKCPNWFPPE 238 (448)
Q Consensus 161 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~ 238 (448)
............||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+..+....+... ....|..++++
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHFGKY-THQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTID 245 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCTT
T ss_pred cccccccccCCCCcccccChHHhccCCC-ChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcHH
Confidence 4433334455678899999999987766 489999999999999999 99999988877777766665 45667788999
Q ss_pred HHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 239 VRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 239 ~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
+.++|.+||..||.+|||+.+++++
T Consensus 246 ~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 246 VYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp TTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999999987
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=372.51 Aligned_cols=253 Identities=29% Similarity=0.491 Sum_probs=210.6
Q ss_pred eEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 037702 12 YELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAMEY 91 (448)
Q Consensus 12 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 91 (448)
|.....||+|+||.||+|.+..++..||||.+..... ...+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 100 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS---RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ 100 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC------HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch---HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEe
Confidence 3334489999999999999999999999999976532 3346788999999999999999999999999999999999
Q ss_pred cCCCchHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcC-CCCeEEeeccccccccccccCC
Q 037702 92 VRGGELFNKVAKG----KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDE-NGDLKISDFGLSALQESTRQDG 166 (448)
Q Consensus 92 ~~gg~L~~~i~~~----~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~-~g~lkl~DFGla~~~~~~~~~~ 166 (448)
+++++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++....... .
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~--~ 178 (295)
T 2clq_A 101 VPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN--P 178 (295)
T ss_dssp CSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----
T ss_pred CCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC--C
Confidence 9999999999753 4678999999999999999999999999999999999988 8999999999997643221 2
Q ss_pred CccccCCCCcccchhhhhccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCcHH--HHHH-HHhhccCCCCCCCCHHHHHH
Q 037702 167 LLHTTCGTPAYVAPEVINKRG-YDGAKADIWSCGVVLFVLLAGNLPFYDSNLM--ELYK-KITRAEFKCPNWFPPEVRKL 242 (448)
Q Consensus 167 ~~~~~~Gt~~Y~APEvl~~~~-~~~~~sDiwSlGvil~elltG~~Pf~~~~~~--~~~~-~i~~~~~~~p~~~s~~~~~l 242 (448)
......||+.|+|||++.+.. ..+.++|||||||++|+|++|..||...+.. .... .........|..+++++.+|
T Consensus 179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 258 (295)
T 2clq_A 179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAF 258 (295)
T ss_dssp --CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHH
T ss_pred cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHH
Confidence 234567999999999997543 2358899999999999999999999754322 2222 12233446677899999999
Q ss_pred HHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 243 LSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 243 i~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
|.+||..||.+|||++++++||||+..
T Consensus 259 i~~~l~~dp~~Rps~~~ll~~~~~~~~ 285 (295)
T 2clq_A 259 ILKCFEPDPDKRACANDLLVDEFLKVS 285 (295)
T ss_dssp HHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred HHHHccCChhhCCCHHHHhcChhhhhc
Confidence 999999999999999999999999754
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-48 Score=381.68 Aligned_cols=253 Identities=22% Similarity=0.373 Sum_probs=209.8
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEE----EEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSV----AIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASK 82 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~v----AiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~ 82 (448)
+..++|++.+.||+|+||.||+|++..+|+.+ |+|.+.... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 89 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 45678999999999999999999998888765 677665332 223347788999999999999999999999876
Q ss_pred CEEEEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccc
Q 037702 83 TKIYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQE 160 (448)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~ 160 (448)
. .++||||+.+|+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|....
T Consensus 90 ~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp S-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred C-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 5 7899999999999999975 579999999999999999999999999999999999999999999999999998765
Q ss_pred ccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhc-cCCCCCCCCHH
Q 037702 161 STRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EFKCPNWFPPE 238 (448)
Q Consensus 161 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~ 238 (448)
............||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+..++...+... ....|..++.+
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID 247 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHH
T ss_pred CCcccccccCCCccccccChHHhccCCCC-chhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCHH
Confidence 44333333445678899999999877664 89999999999999999 99999988777766666554 34667789999
Q ss_pred HHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 239 VRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 239 ~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
+.+++.+||+.||.+|||+.+++++
T Consensus 248 ~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 248 VYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhhCCCHHHHHHH
Confidence 9999999999999999999999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=375.28 Aligned_cols=248 Identities=23% Similarity=0.328 Sum_probs=212.6
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCC-------cEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTG-------QSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEV 78 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g-------~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~ 78 (448)
.+..++|++.+.||+|+||.||+|.+..++ ..||+|++..... ...+.+.+|+.+++.++||||++++++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~ 80 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR---NYSESFFEAASMMSKLSHKHLVLNYGV 80 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGG---GGHHHHHHHHHHHHTSCCTTBCCEEEE
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccH---HHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 356789999999999999999999998877 4699999965432 334778999999999999999999999
Q ss_pred EEeCCEEEEEEeecCCCchHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCC--------e
Q 037702 79 MASKTKIYFAMEYVRGGELFNKVAKG--KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGD--------L 148 (448)
Q Consensus 79 ~~~~~~~~lV~E~~~gg~L~~~i~~~--~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~--------l 148 (448)
+.+.+..|+||||++||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++. +
T Consensus 81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 81 CVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp ECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred EEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence 99999999999999999999999763 3999999999999999999999999999999999999999887 9
Q ss_pred EEeeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCC-CCCCCCcHHHHHHHHhhc
Q 037702 149 KISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGN-LPFYDSNLMELYKKITRA 227 (448)
Q Consensus 149 kl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~-~Pf~~~~~~~~~~~i~~~ 227 (448)
||+|||++...... ....||+.|+|||++.+....+.++|||||||++|+|++|. +||...+.. ........
T Consensus 161 kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~-~~~~~~~~ 233 (289)
T 4fvq_A 161 KLSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ-RKLQFYED 233 (289)
T ss_dssp EECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-HHHHHHHT
T ss_pred eeccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH-HHHHHhhc
Confidence 99999998643221 23568999999999987454568999999999999999954 555544443 33444455
Q ss_pred cCCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 228 EFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 228 ~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
....|...++++.+||.+||+.||.+|||+++++++
T Consensus 234 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 234 RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 666777789999999999999999999999999986
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-48 Score=383.06 Aligned_cols=257 Identities=23% Similarity=0.355 Sum_probs=216.1
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEE-----CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRN-----LKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEVM 79 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~-----~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~ 79 (448)
.+..++|++++.||+|+||.||+|.+ ..++..||||++...... ...+.+.+|+.+++.+ +||||+++++++
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS--SEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCH--HHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 45668999999999999999999997 346678999999754322 2346788999999999 999999999999
Q ss_pred EeCCEEEEEEeecCCCchHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHHCCCEeecC
Q 037702 80 ASKTKIYFAMEYVRGGELFNKVAKG------------------------KLREEVARKYFQQLVDAVEFCHSRGVYHRDL 135 (448)
Q Consensus 80 ~~~~~~~lV~E~~~gg~L~~~i~~~------------------------~l~e~~~~~~~~qll~aL~yLH~~givHrDL 135 (448)
...+..|+||||+++|+|.+++... .+++..++.++.||+.||+|||++||+||||
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Di 198 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL 198 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 9999999999999999999999752 2789999999999999999999999999999
Q ss_pred CCCceEEcCCCCeEEeeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCC
Q 037702 136 KPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYD 214 (448)
Q Consensus 136 kp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~ 214 (448)
||+|||++.++.+||+|||++................||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~ 277 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY-TIKSDVWSYGILLWEIFSLGVNPYPG 277 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCC-ChhHhHHHHHHHHHHHHcCCCCCccc
Confidence 99999999999999999999986544332222334568899999999987666 489999999999999998 9999988
Q ss_pred CcHHHHHHHHhhc--cCCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhh
Q 037702 215 SNLMELYKKITRA--EFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYW 265 (448)
Q Consensus 215 ~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 265 (448)
.+.......+... ....|..+++++.+||.+||..||.+|||+.+++++..
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 330 (344)
T 1rjb_A 278 IPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 330 (344)
T ss_dssp CCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 7654444443333 34567789999999999999999999999999999764
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-48 Score=378.86 Aligned_cols=256 Identities=21% Similarity=0.317 Sum_probs=222.3
Q ss_pred cccccCCeEEEeeeeecCceEEEEEEEC-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEE
Q 037702 5 AGILMNKYELGRLLGQGTFAKVYHGRNL-----KTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVM 79 (448)
Q Consensus 5 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~ 79 (448)
..+..++|++.+.||+|+||.||+|.+. .+++.||||++..... ......+.+|+.+++.++||||+++++++
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 20 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS--MRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC--HHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccC--HHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 4566789999999999999999999876 4678899999975432 23346788999999999999999999999
Q ss_pred EeCCEEEEEEeecCCCchHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCe
Q 037702 80 ASKTKIYFAMEYVRGGELFNKVAK-----------GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDL 148 (448)
Q Consensus 80 ~~~~~~~lV~E~~~gg~L~~~i~~-----------~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~l 148 (448)
.+....|+||||+++|+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeE
Confidence 999999999999999999999864 357999999999999999999999999999999999999999999
Q ss_pred EEeeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhc
Q 037702 149 KISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA 227 (448)
Q Consensus 149 kl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~ 227 (448)
||+|||++................||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+..+....+...
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 256 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG 256 (322)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT
T ss_pred EECcCccccccccccccccccCCCCCCCccChhhhccCCC-CchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcC
Confidence 9999999986543322222234567899999999987666 488999999999999999 89999998888887777665
Q ss_pred cC-CCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 228 EF-KCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 228 ~~-~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
.. ..|..+++.+.+||.+||..||.+|||+.+++++
T Consensus 257 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 257 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 43 5677899999999999999999999999999987
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=383.46 Aligned_cols=249 Identities=23% Similarity=0.336 Sum_probs=212.5
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEVMASKTK 84 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~ 84 (448)
-++.++|++.+.||+|+||.||+|.+..+|+.||||++...... +.+.+|+.+++.+ +||||+++++++.....
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 79 (330)
T 2izr_A 5 LMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKY 79 (330)
T ss_dssp CEETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS-----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTE
T ss_pred EEEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch-----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCc
Confidence 35668899999999999999999999999999999998765322 3577899999999 99999999999999999
Q ss_pred EEEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCC-----eEEeeccccc
Q 037702 85 IYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGD-----LKISDFGLSA 157 (448)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~-----lkl~DFGla~ 157 (448)
.|+||||+ +++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++.
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 80 NAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred cEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 99999999 9999999974 68999999999999999999999999999999999999999887 9999999998
Q ss_pred cccccccCC-----CccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCC---CcHHHHHHHHhhccC
Q 037702 158 LQESTRQDG-----LLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYD---SNLMELYKKITRAEF 229 (448)
Q Consensus 158 ~~~~~~~~~-----~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~---~~~~~~~~~i~~~~~ 229 (448)
......... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+ .+..+.+..+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~ 237 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQ-SRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKR 237 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHH
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcCCCC-CchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhc
Confidence 654322211 1246789999999999988776 4899999999999999999999987 344555666654443
Q ss_pred CCC-----CCCCHHHHHHHHhccCCCcCCCCCHHHHHh
Q 037702 230 KCP-----NWFPPEVRKLLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 230 ~~p-----~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 262 (448)
..| ..+| ++.++|.+||..||.+||++++|++
T Consensus 238 ~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 238 ATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred cCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 333 2244 9999999999999999999999876
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-48 Score=377.63 Aligned_cols=256 Identities=24% Similarity=0.382 Sum_probs=217.6
Q ss_pred cccccCCeEEEeeeeecCceEEEEEEE-----CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEE
Q 037702 5 AGILMNKYELGRLLGQGTFAKVYHGRN-----LKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEV 78 (448)
Q Consensus 5 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~-----~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~ 78 (448)
..+..++|++.+.||+|+||.||+|.+ ..+++.||||++..... ....+.+.+|+.+++.+ +||||++++++
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 95 (313)
T 1t46_A 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLLGA 95 (313)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh--HHHHHHHHHHHHHHhhcccCCCeeeEEEE
Confidence 345678999999999999999999985 45788999999975532 23357789999999999 99999999999
Q ss_pred EEeCCEEEEEEeecCCCchHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCc
Q 037702 79 MASKTKIYFAMEYVRGGELFNKVAKG-------------------KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPEN 139 (448)
Q Consensus 79 ~~~~~~~~lV~E~~~gg~L~~~i~~~-------------------~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~N 139 (448)
+.+.+..|+||||+++|+|.+++... .+++..++.++.||+.||.|||++||+||||||+|
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N 175 (313)
T 1t46_A 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175 (313)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccce
Confidence 99999999999999999999999753 38999999999999999999999999999999999
Q ss_pred eEEcCCCCeEEeeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHH
Q 037702 140 LLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLM 218 (448)
Q Consensus 140 ILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~ 218 (448)
||++.++.+||+|||++................||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+..
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~ 254 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred EEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence 9999999999999999986544332222334567889999999987666 488999999999999999 99999886654
Q ss_pred HHHHHHhhc--cCCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 219 ELYKKITRA--EFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 219 ~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
......... ....+..+++++.++|.+||..||.+|||+++++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 255 SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 444333333 234467789999999999999999999999999985
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-48 Score=387.25 Aligned_cols=253 Identities=26% Similarity=0.455 Sum_probs=208.3
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-----------CCCcceE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR-----------HPNIVQL 75 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-----------hpnIv~l 75 (448)
...++|++.+.||+|+||.||+|.+..+|+.||||++.... ...+.+.+|+.+++.++ ||||+++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~ 91 (373)
T 1q8y_A 16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 91 (373)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc----cchhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence 45679999999999999999999999999999999997543 23466789999999886 8999999
Q ss_pred EEEEEeCC----EEEEEEeecCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC-CCEeecCCCCceEEcC---
Q 037702 76 YEVMASKT----KIYFAMEYVRGGELFNKVAK---GKLREEVARKYFQQLVDAVEFCHSR-GVYHRDLKPENLLLDE--- 144 (448)
Q Consensus 76 ~~~~~~~~----~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~yLH~~-givHrDLkp~NILl~~--- 144 (448)
++++.... .+++||||+ +++|.+++.. +.+++..++.++.||+.||+|||++ ||+||||||+|||++.
T Consensus 92 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 92 LDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp CEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEET
T ss_pred HHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCC
Confidence 99987654 789999999 8899999865 4699999999999999999999998 9999999999999953
Q ss_pred ---CCCeEEeeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcH----
Q 037702 145 ---NGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNL---- 217 (448)
Q Consensus 145 ---~g~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~---- 217 (448)
.+.+||+|||++...... ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 244 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFEPDEGHSYT 244 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCC-CTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred CcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCcccccC
Confidence 347999999999765322 234589999999999987766 4899999999999999999999986541
Q ss_pred --HHHHHHHh------------------------------------------hccCCCCCCCCHHHHHHHHhccCCCcCC
Q 037702 218 --MELYKKIT------------------------------------------RAEFKCPNWFPPEVRKLLSRILDPNPST 253 (448)
Q Consensus 218 --~~~~~~i~------------------------------------------~~~~~~p~~~s~~~~~li~~~L~~dP~~ 253 (448)
.+....+. ...+.++..+++++.+||.+||+.||.+
T Consensus 245 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 324 (373)
T 1q8y_A 245 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK 324 (373)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred ChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccc
Confidence 12222211 1122333445678999999999999999
Q ss_pred CCCHHHHHhhhhccccc
Q 037702 254 RVTMAKLMENYWFRKGY 270 (448)
Q Consensus 254 Rpt~~eil~hp~~~~~~ 270 (448)
|||++|+++||||+...
T Consensus 325 Rpt~~ell~hp~f~~~~ 341 (373)
T 1q8y_A 325 RADAGGLVNHPWLKDTL 341 (373)
T ss_dssp CBCHHHHHTCGGGTTCT
T ss_pred cCCHHHHhhChhhhccc
Confidence 99999999999998754
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-48 Score=371.21 Aligned_cols=254 Identities=28% Similarity=0.428 Sum_probs=208.2
Q ss_pred cccccCCeEEEeeeeecCceEEEEEEECCC---CcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 037702 5 AGILMNKYELGRLLGQGTFAKVYHGRNLKT---GQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMAS 81 (448)
Q Consensus 5 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~ 81 (448)
..+..++|++.+.||+|+||.||+|.+..+ +..||+|++.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 86 (281)
T 1mp8_A 10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 86 (281)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-
Confidence 456788999999999999999999998654 4569999986542 2344577899999999999999999999984
Q ss_pred CCEEEEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccc
Q 037702 82 KTKIYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQ 159 (448)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~ 159 (448)
.+..|+||||+++|+|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 87 ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcccccccc
Confidence 5678999999999999999975 36999999999999999999999999999999999999999999999999999865
Q ss_pred cccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhcc-CCCCCCCCH
Q 037702 160 ESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAE-FKCPNWFPP 237 (448)
Q Consensus 160 ~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~ 237 (448)
..... .......||+.|+|||++....++ .++|||||||++|+|++ |..||.+.+..+....+.... ...|..+++
T Consensus 167 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (281)
T 1mp8_A 167 EDSTY-YKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 244 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCH
T ss_pred Ccccc-cccccCCCcccccChhhcccCCCC-CccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCCH
Confidence 43221 122344678899999999877664 88999999999999996 999999887777777776553 467788999
Q ss_pred HHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 238 EVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 238 ~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
++.++|.+||..||.+|||+.+++++
T Consensus 245 ~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 245 TLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999999999875
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=378.69 Aligned_cols=255 Identities=25% Similarity=0.432 Sum_probs=219.6
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEEC-------CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNL-------KTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYE 77 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~-------~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~ 77 (448)
.+..++|++++.||+|+||.||+|.+. .++..||||++.... .....+.+.+|+.+++.+ +||||+++++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 108 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG 108 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEEE
Confidence 456789999999999999999999975 467789999997553 223457789999999999 9999999999
Q ss_pred EEEeCCEEEEEEeecCCCchHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCce
Q 037702 78 VMASKTKIYFAMEYVRGGELFNKVAKG-----------------KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENL 140 (448)
Q Consensus 78 ~~~~~~~~~lV~E~~~gg~L~~~i~~~-----------------~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NI 140 (448)
++.+.+..|+||||+++|+|.+++... .+++..++.++.||+.||.|||++||+||||||+||
T Consensus 109 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 188 (334)
T 2pvf_A 109 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 188 (334)
T ss_dssp EECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred EEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceE
Confidence 999999999999999999999999753 389999999999999999999999999999999999
Q ss_pred EEcCCCCeEEeeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHH
Q 037702 141 LLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLME 219 (448)
Q Consensus 141 Ll~~~g~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~ 219 (448)
|++.++.+||+|||++................||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+..+
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 267 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 267 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCc-ChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH
Confidence 999999999999999986543222122234567899999999977665 488999999999999999 999999988888
Q ss_pred HHHHHhhcc-CCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 220 LYKKITRAE-FKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 220 ~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
....+.... ...|..+++++.++|.+||..||.+|||+.+++++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 268 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 877776654 45677799999999999999999999999999985
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=379.21 Aligned_cols=261 Identities=21% Similarity=0.292 Sum_probs=218.6
Q ss_pred cccccCCeEEEeeeeecCceEEEEEE-----ECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEE
Q 037702 5 AGILMNKYELGRLLGQGTFAKVYHGR-----NLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVM 79 (448)
Q Consensus 5 ~~~~~~~y~~~~~LG~G~fg~Vy~a~-----~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~ 79 (448)
..+..++|++.+.||+|+||.||+|+ +..++..||||++.... .......+.+|+.+++.++||||+++++++
T Consensus 25 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 102 (327)
T 2yfx_A 25 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVS 102 (327)
T ss_dssp CBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEE
Confidence 35678899999999999999999999 55688899999996432 223446788999999999999999999999
Q ss_pred EeCCEEEEEEeecCCCchHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCC---CCe
Q 037702 80 ASKTKIYFAMEYVRGGELFNKVAKG--------KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDEN---GDL 148 (448)
Q Consensus 80 ~~~~~~~lV~E~~~gg~L~~~i~~~--------~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~---g~l 148 (448)
.+....|+||||++|++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+
T Consensus 103 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 103 LQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred cCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceE
Confidence 9999999999999999999999753 38999999999999999999999999999999999999954 469
Q ss_pred EEeeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhc
Q 037702 149 KISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA 227 (448)
Q Consensus 149 kl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~ 227 (448)
||+|||++................||+.|+|||++.+..+ +.++|||||||++|+|++ |..||...+..+....+...
T Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~ 261 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIF-TSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 261 (327)
T ss_dssp EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred EECccccccccccccccccCCCcCCCcceeCHhHhcCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcC
Confidence 9999999975543332222345578999999999987666 489999999999999998 99999988887777777665
Q ss_pred c-CCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccc
Q 037702 228 E-FKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRK 268 (448)
Q Consensus 228 ~-~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 268 (448)
. ...+..+++.+.++|.+||..||.+|||+.+++++.|+..
T Consensus 262 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 262 GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 3 4566779999999999999999999999999999998754
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=374.41 Aligned_cols=261 Identities=25% Similarity=0.438 Sum_probs=212.2
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC--CCCcceEEEEEEeCC
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR--HPNIVQLYEVMASKT 83 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~--hpnIv~l~~~~~~~~ 83 (448)
.+..++|++.+.||+|+||.||+|.+. +|+.||||++...... ....+.+.+|+.+++.++ ||||+++++++.+..
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 101 (313)
T 3cek_A 24 SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 101 (313)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCC-HHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSS
T ss_pred eeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEecccccc-ccchHHHHHHHHHHHhccccCCceEEEEEEeecCC
Confidence 345678999999999999999999975 5899999999765443 244578899999999997 599999999999999
Q ss_pred EEEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccc
Q 037702 84 KIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQEST 162 (448)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~ 162 (448)
..|+||| +.+++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++......
T Consensus 102 ~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~ 179 (313)
T 3cek_A 102 YIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 179 (313)
T ss_dssp EEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC----
T ss_pred EEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCc
Confidence 9999999 668899999976 6799999999999999999999999999999999999996 589999999999865443
Q ss_pred ccCCCccccCCCCcccchhhhhcc----------CCCCCcchHHHHHHHHHHHHhCCCCCCCCc-HHHHHHHHhhc--cC
Q 037702 163 RQDGLLHTTCGTPAYVAPEVINKR----------GYDGAKADIWSCGVVLFVLLAGNLPFYDSN-LMELYKKITRA--EF 229 (448)
Q Consensus 163 ~~~~~~~~~~Gt~~Y~APEvl~~~----------~~~~~~sDiwSlGvil~elltG~~Pf~~~~-~~~~~~~i~~~--~~ 229 (448)
.........+||+.|+|||++.+. ...+.++|||||||++|+|++|..||.... .......+... ..
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 259 (313)
T 3cek_A 180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 259 (313)
T ss_dssp ----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCC
T ss_pred cccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhccccc
Confidence 332233456799999999998652 234578999999999999999999998653 23333333332 34
Q ss_pred CCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccccc
Q 037702 230 KCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGY 270 (448)
Q Consensus 230 ~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 270 (448)
.+|...++++.++|.+||..||.+|||++++++||||+...
T Consensus 260 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 300 (313)
T 3cek_A 260 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 300 (313)
T ss_dssp CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred CCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence 56777899999999999999999999999999999998643
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=367.78 Aligned_cols=259 Identities=25% Similarity=0.374 Sum_probs=220.9
Q ss_pred cccccccCCeEEEe-eeeecCceEEEEEEEC--CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEE
Q 037702 3 KKAGILMNKYELGR-LLGQGTFAKVYHGRNL--KTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVM 79 (448)
Q Consensus 3 ~~~~~~~~~y~~~~-~LG~G~fg~Vy~a~~~--~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~ 79 (448)
++..+..++|.+.+ .||+|+||.||+|.+. .++..||||++.... .....+.+.+|+.+++.++||||+++++++
T Consensus 2 ~~~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 79 (287)
T 1u59_A 2 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC 79 (287)
T ss_dssp CCCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CcccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEe
Confidence 34455677899988 9999999999999864 467889999997653 234457889999999999999999999999
Q ss_pred EeCCEEEEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccc
Q 037702 80 ASKTKIYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSA 157 (448)
Q Consensus 80 ~~~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~ 157 (448)
..+..|+||||+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 80 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~ 158 (287)
T 1u59_A 80 -QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSK 158 (287)
T ss_dssp -ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred -cCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECccccee
Confidence 55669999999999999999964 569999999999999999999999999999999999999999999999999998
Q ss_pred ccccccc-CCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhcc-CCCCCC
Q 037702 158 LQESTRQ-DGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAE-FKCPNW 234 (448)
Q Consensus 158 ~~~~~~~-~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~ 234 (448)
....... ........||+.|+|||++.+..+ +.++|||||||++|+|++ |..||...+..+....+..+. ...|..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 237 (287)
T 1u59_A 159 ALGADDSYYTARSAGKWPLKWYAPECINFRKF-SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPE 237 (287)
T ss_dssp ECTTCSCEECCCCSSCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTT
T ss_pred eeccCcceeeccccccccccccCHHHhccCCC-CchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCC
Confidence 6533211 112234467899999999977666 488999999999999998 999999888877777776654 467788
Q ss_pred CCHHHHHHHHhccCCCcCCCCCHHHHHhhhh
Q 037702 235 FPPEVRKLLSRILDPNPSTRVTMAKLMENYW 265 (448)
Q Consensus 235 ~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 265 (448)
+++++.++|.+||..||.+|||+.+++++.+
T Consensus 238 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 238 CPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred cCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 9999999999999999999999999998764
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=362.90 Aligned_cols=250 Identities=24% Similarity=0.411 Sum_probs=219.4
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIY 86 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 86 (448)
+-.++|++.+.||+|+||.||+|.+. ++..||+|++...... .+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (267)
T 3t9t_A 5 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC 79 (267)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred EchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeE
Confidence 44678999999999999999999986 6789999999865433 267889999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccccc
Q 037702 87 FAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQ 164 (448)
Q Consensus 87 lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~ 164 (448)
+||||+++++|.+++.. +.+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||++........
T Consensus 80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 159 (267)
T 3t9t_A 80 LVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 159 (267)
T ss_dssp EEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred EEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccccc
Confidence 99999999999999975 4699999999999999999999999999999999999999999999999999986532211
Q ss_pred CCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhcc-CCCCCCCCHHHHHH
Q 037702 165 DGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAE-FKCPNWFPPEVRKL 242 (448)
Q Consensus 165 ~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~l 242 (448)
.......||+.|+|||++.+..+ +.++||||||+++|+|++ |..||...+..+....+..+. ...|..+++.+.++
T Consensus 160 -~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 237 (267)
T 3t9t_A 160 -TSSTGTKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQI 237 (267)
T ss_dssp -HSTTSTTCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHH
T ss_pred -cccccccccccccChhhhcCCCc-cchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHH
Confidence 11234567889999999987666 488999999999999999 999999988888887776653 44567789999999
Q ss_pred HHhccCCCcCCCCCHHHHHhh
Q 037702 243 LSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 243 i~~~L~~dP~~Rpt~~eil~h 263 (448)
|.+||+.||.+|||+++++++
T Consensus 238 i~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 238 MNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999985
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=379.35 Aligned_cols=253 Identities=23% Similarity=0.379 Sum_probs=209.9
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEE----EEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSV----AIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASK 82 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~v----AiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~ 82 (448)
+..++|++.+.||+|+||.||+|.+..+|+.+ |+|.+.... .....+.+.+|+.+++.++||||+++++++...
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence 45689999999999999999999999888866 555554322 223457788999999999999999999999876
Q ss_pred CEEEEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccc
Q 037702 83 TKIYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQE 160 (448)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~ 160 (448)
. .++||||+.+|+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 90 ~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp S-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred C-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 5 8899999999999999965 579999999999999999999999999999999999999999999999999998764
Q ss_pred ccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhcc-CCCCCCCCHH
Q 037702 161 STRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAE-FKCPNWFPPE 238 (448)
Q Consensus 161 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~ 238 (448)
............||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+..+....+.... ...|..++++
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID 247 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHH
T ss_pred CccccccccCCCccccccCHHHHcCCCCC-hHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHH
Confidence 43333333445678899999999877664 89999999999999999 999999888777776665553 5667789999
Q ss_pred HHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 239 VRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 239 ~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
+.++|.+||..||.+|||+.++++.
T Consensus 248 l~~li~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 248 VYMIMRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHH
Confidence 9999999999999999999999974
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=372.20 Aligned_cols=255 Identities=23% Similarity=0.382 Sum_probs=209.5
Q ss_pred cccccCCeEEEeeeeecCceEEEEEE----ECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 037702 5 AGILMNKYELGRLLGQGTFAKVYHGR----NLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMA 80 (448)
Q Consensus 5 ~~~~~~~y~~~~~LG~G~fg~Vy~a~----~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~ 80 (448)
..+..++|++.+.||+|+||.||+|+ +..+|+.||||++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 81 (295)
T 3ugc_A 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCY 81 (295)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 45678899999999999999999998 56789999999997542 234577899999999999999999999985
Q ss_pred e--CCEEEEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccc
Q 037702 81 S--KTKIYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLS 156 (448)
Q Consensus 81 ~--~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla 156 (448)
. ...+|+||||+++|+|.+++.. .++++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 82 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 82 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp HHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred cCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccc
Confidence 4 4568999999999999999976 35999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccC-CCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHH----------------H
Q 037702 157 ALQESTRQD-GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLM----------------E 219 (448)
Q Consensus 157 ~~~~~~~~~-~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~----------------~ 219 (448)
......... .......||+.|+|||++.+..++ .++|||||||++|+|++|..||...... .
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFS-VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240 (295)
T ss_dssp C-------------CTTCGGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred ccccCCcceeeeccCCCCccceeCcHHhcCCCCC-hHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence 865433221 222345678889999999877764 8999999999999999999998653221 1
Q ss_pred HHHHHh-hccCCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 220 LYKKIT-RAEFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 220 ~~~~i~-~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
....+. ....+.|..+|+++.+||.+||..||.+|||+.++++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~ 285 (295)
T 3ugc_A 241 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR 285 (295)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 122222 22456677899999999999999999999999999873
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-47 Score=371.73 Aligned_cols=259 Identities=27% Similarity=0.436 Sum_probs=200.8
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKI 85 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 85 (448)
....++|++.+.||+|+||.||+|.+..+|+.||||++....... ...+.+.++..+++.++||||+++++++.+.+.+
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~ 99 (318)
T 2dyl_A 21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKE-ENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDV 99 (318)
T ss_dssp ECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHH-HHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccch-HHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcE
Confidence 346789999999999999999999999999999999998654322 2334455566678889999999999999999999
Q ss_pred EEEEeecCCCchHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CCEeecCCCCceEEcCCCCeEEeecccccccccc
Q 037702 86 YFAMEYVRGGELFNKVA--KGKLREEVARKYFQQLVDAVEFCHSR-GVYHRDLKPENLLLDENGDLKISDFGLSALQEST 162 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~--~~~l~e~~~~~~~~qll~aL~yLH~~-givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~ 162 (448)
|+||||+ ++.+..+.. .+.+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++......
T Consensus 100 ~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 100 FIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp EEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred EEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 9999999 555555554 36799999999999999999999995 9999999999999999999999999999754332
Q ss_pred ccCCCccccCCCCcccchhhhhc----cCCCCCcchHHHHHHHHHHHHhCCCCCCCC-cHHHHHHHHhhccCC-CC--CC
Q 037702 163 RQDGLLHTTCGTPAYVAPEVINK----RGYDGAKADIWSCGVVLFVLLAGNLPFYDS-NLMELYKKITRAEFK-CP--NW 234 (448)
Q Consensus 163 ~~~~~~~~~~Gt~~Y~APEvl~~----~~~~~~~sDiwSlGvil~elltG~~Pf~~~-~~~~~~~~i~~~~~~-~p--~~ 234 (448)
......+||+.|+|||++.. ....+.++|||||||++|+|++|..||... +..+....+...... .| ..
T Consensus 179 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (318)
T 2dyl_A 179 ---KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMG 255 (318)
T ss_dssp -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSC
T ss_pred ---ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCC
Confidence 12235679999999999852 223358899999999999999999999873 444555555554432 23 35
Q ss_pred CCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 235 FPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 235 ~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
+++++.+||.+||..||.+|||++++++||||+..
T Consensus 256 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 256 FSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY 290 (318)
T ss_dssp CCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence 79999999999999999999999999999999753
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=369.81 Aligned_cols=254 Identities=26% Similarity=0.442 Sum_probs=222.7
Q ss_pred ccccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 037702 4 KAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKT 83 (448)
Q Consensus 4 ~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~ 83 (448)
...+..++|++.+.||+|+||.||+|.+..++..||+|++.... ...+.+.+|+.+++.++||||+++++++.+..
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 82 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 82 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS----THHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 45567889999999999999999999999999999999997543 23477889999999999999999999999999
Q ss_pred EEEEEEeecCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccc
Q 037702 84 KIYFAMEYVRGGELFNKVAK---GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQE 160 (448)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~ 160 (448)
..|+||||++|++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 83 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 83 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 99999999999999999975 459999999999999999999999999999999999999999999999999998654
Q ss_pred ccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhc-cCCCCCCCCHH
Q 037702 161 STRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EFKCPNWFPPE 238 (448)
Q Consensus 161 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~ 238 (448)
.... .......||+.|+|||++.+..+ +.++||||||+++|+|++ |..||...+.......+... ....|..+|+.
T Consensus 163 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T 3kfa_A 163 GDTY-TAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEK 240 (288)
T ss_dssp SSSS-EEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHH
T ss_pred CCcc-ccccCCccccCcCChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCHH
Confidence 2211 12233457889999999987766 488999999999999999 99999988877776666554 45667789999
Q ss_pred HHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 239 VRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 239 ~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
+.+||.+||..||.+|||++++++.
T Consensus 241 l~~li~~~l~~dp~~Rps~~~~~~~ 265 (288)
T 3kfa_A 241 VYELMRACWQWNPSDRPSFAEIHQA 265 (288)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhCCChhhCcCHHHHHHH
Confidence 9999999999999999999999873
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=377.13 Aligned_cols=256 Identities=22% Similarity=0.379 Sum_probs=217.3
Q ss_pred cccccCCeEEEeeeeecCceEEEEEEECCCCc-----EEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEE
Q 037702 5 AGILMNKYELGRLLGQGTFAKVYHGRNLKTGQ-----SVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEV 78 (448)
Q Consensus 5 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~-----~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~ 78 (448)
..+..++|++.+.||+|+||.||+|.+..+++ .||+|++..... ....+.+.+|+.+++.+ +||||++++++
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 118 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH--ADEKEALMSELKIMSHLGQHENIVNLLGA 118 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccC--hHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 34567899999999999999999999987665 799999975532 23457789999999999 89999999999
Q ss_pred EEeCCEEEEEEeecCCCchHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEc
Q 037702 79 MASKTKIYFAMEYVRGGELFNKVAK---------------GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLD 143 (448)
Q Consensus 79 ~~~~~~~~lV~E~~~gg~L~~~i~~---------------~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~ 143 (448)
+.+.+..|+||||+++|+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT 198 (333)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEE
T ss_pred EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEEC
Confidence 9999999999999999999999863 3579999999999999999999999999999999999999
Q ss_pred CCCCeEEeeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHH
Q 037702 144 ENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYK 222 (448)
Q Consensus 144 ~~g~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~ 222 (448)
.++.+||+|||++................||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+........
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 277 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY 277 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH
T ss_pred CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCC-hHHHHHHHHHHHHHHHcCCCCCCcccchhHHHH
Confidence 9999999999999865433222223345678899999999876664 89999999999999998 999998866544444
Q ss_pred HHhhc--cCCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 223 KITRA--EFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 223 ~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
.+... ....|..+++++.++|.+||+.||.+|||+.+++++
T Consensus 278 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 278 KLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 44333 334567789999999999999999999999999874
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=378.71 Aligned_cols=251 Identities=20% Similarity=0.267 Sum_probs=204.8
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC---
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKT--- 83 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~--- 83 (448)
+..++|++.+.||+|+||.||+|++ +|+.||||++.... .......+|+.+++.++||||+++++++....
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVD 94 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred cchhhchhhheecccCceEEEEEEE--CCCEEEEEEeecCc----hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCC
Confidence 4567999999999999999999987 48999999996543 22345667999999999999999999998743
Q ss_pred -EEEEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC----------CCEeecCCCCceEEcCCCCeEEee
Q 037702 84 -KIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSR----------GVYHRDLKPENLLLDENGDLKISD 152 (448)
Q Consensus 84 -~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~----------givHrDLkp~NILl~~~g~lkl~D 152 (448)
.+|+||||+++|+|.+++..+.+++..++.++.|++.||+|||++ ||+||||||+|||++.++.+||+|
T Consensus 95 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D 174 (322)
T 3soc_A 95 VDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174 (322)
T ss_dssp EEEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred ceEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence 479999999999999999988899999999999999999999999 999999999999999999999999
Q ss_pred ccccccccccccCCCccccCCCCcccchhhhhccCC----CCCcchHHHHHHHHHHHHhCCCCCCCCc------------
Q 037702 153 FGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGY----DGAKADIWSCGVVLFVLLAGNLPFYDSN------------ 216 (448)
Q Consensus 153 FGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~----~~~~sDiwSlGvil~elltG~~Pf~~~~------------ 216 (448)
||++...............+||+.|+|||++.+... .+.++|||||||++|+|++|+.||.+..
T Consensus 175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 254 (322)
T 3soc_A 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254 (322)
T ss_dssp CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence 999986554433333445689999999999976322 2357899999999999999999997532
Q ss_pred ----HHHHHHHHhhccC--CCCCC-----CCHHHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 217 ----LMELYKKITRAEF--KCPNW-----FPPEVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 217 ----~~~~~~~i~~~~~--~~p~~-----~s~~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
.......+..... ..+.. .++++.+||.+||+.||.+|||+.++++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 312 (322)
T 3soc_A 255 QHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER 312 (322)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 2222222222221 11111 23459999999999999999999999874
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=374.91 Aligned_cols=252 Identities=26% Similarity=0.432 Sum_probs=216.6
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEE--EEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSV--AIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEVMASKT 83 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~v--AiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~ 83 (448)
+..++|++.+.||+|+||.||+|++..+|..+ |+|.+.... .....+.+.+|+.+++.+ +||||+++++++.+.+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 99 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 99 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence 45689999999999999999999999898865 999887432 223346788999999999 9999999999999999
Q ss_pred EEEEEEeecCCCchHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCC
Q 037702 84 KIYFAMEYVRGGELFNKVAKG-----------------KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENG 146 (448)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~~-----------------~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g 146 (448)
..|+||||+++|+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence 999999999999999999753 599999999999999999999999999999999999999999
Q ss_pred CeEEeeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHh
Q 037702 147 DLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKIT 225 (448)
Q Consensus 147 ~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~ 225 (448)
.+||+|||++....... ......+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+..+....+.
T Consensus 180 ~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~ 255 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 255 (327)
T ss_dssp CEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred eEEEcccCcCccccccc---cccCCCCCccccChhhhccccC-CchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhh
Confidence 99999999987432221 1234567899999999977665 488999999999999998 999999998888888776
Q ss_pred hc-cCCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhh
Q 037702 226 RA-EFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENY 264 (448)
Q Consensus 226 ~~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 264 (448)
.+ ....|..+++++.+||.+||..||.+|||+++++++-
T Consensus 256 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 295 (327)
T 1fvr_A 256 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 295 (327)
T ss_dssp GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 65 3456777899999999999999999999999999864
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-47 Score=365.65 Aligned_cols=252 Identities=25% Similarity=0.445 Sum_probs=212.0
Q ss_pred cccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhH----HHHHHHHHHHHHhCCCCCcceEEEEEE
Q 037702 5 AGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGL----IDQIKREISVMRLVRHPNIVQLYEVMA 80 (448)
Q Consensus 5 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~----~~~~~~Ei~~l~~l~hpnIv~l~~~~~ 80 (448)
+.+..++|++.+.||+|+||.||+|++..+++.||||++.......... .+.+.+|+.+++.++||||+++++++.
T Consensus 14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 93 (287)
T 4f0f_A 14 PTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH 93 (287)
T ss_dssp CBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEET
T ss_pred hhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeec
Confidence 3567789999999999999999999999999999999997654332211 267889999999999999999999997
Q ss_pred eCCEEEEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--CEeecCCCCceEEcCCCC-----eEEe
Q 037702 81 SKTKIYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRG--VYHRDLKPENLLLDENGD-----LKIS 151 (448)
Q Consensus 81 ~~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~g--ivHrDLkp~NILl~~~g~-----lkl~ 151 (448)
+.. ++||||+++|+|.+.+.. ..+++..++.++.|++.||+|||++| |+||||||+|||++.++. +||+
T Consensus 94 ~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 94 NPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp TTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred CCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 766 699999999999998854 47999999999999999999999999 999999999999998886 9999
Q ss_pred eccccccccccccCCCccccCCCCcccchhhhhcc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHH--HHHHHhhc-
Q 037702 152 DFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKR-GYDGAKADIWSCGVVLFVLLAGNLPFYDSNLME--LYKKITRA- 227 (448)
Q Consensus 152 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~-~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~--~~~~i~~~- 227 (448)
|||++..... .....+||+.|+|||++... ...+.++|||||||++|+|++|..||...+... ....+...
T Consensus 172 Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 246 (287)
T 4f0f_A 172 DFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG 246 (287)
T ss_dssp CCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSC
T ss_pred CCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccC
Confidence 9999974322 23456899999999998432 223578999999999999999999998654332 23333333
Q ss_pred -cCCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 228 -EFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 228 -~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
....|..+++++.++|.+||+.||.+|||++++++.
T Consensus 247 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 283 (287)
T 4f0f_A 247 LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283 (287)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 345677899999999999999999999999999873
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=373.97 Aligned_cols=256 Identities=25% Similarity=0.424 Sum_probs=215.6
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEE-----CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRN-----LKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEVM 79 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~-----~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~ 79 (448)
.+..++|++.+.||+|+||.||+|.+ ..+++.||||++..... ....+.+.+|+.+++.+ +||||+++++++
T Consensus 23 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 100 (316)
T 2xir_A 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGAC 100 (316)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCC--cHHHHHHHHHHHHHHhcccCCCeeeEEEEE
Confidence 45678999999999999999999985 45778999999976532 23446788999999999 799999999998
Q ss_pred EeCC-EEEEEEeecCCCchHHHHhcCC-----------------CCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceE
Q 037702 80 ASKT-KIYFAMEYVRGGELFNKVAKGK-----------------LREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLL 141 (448)
Q Consensus 80 ~~~~-~~~lV~E~~~gg~L~~~i~~~~-----------------l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NIL 141 (448)
...+ .+|+||||+++|+|.+++.... +++..++.++.||+.||.|||++||+||||||+|||
T Consensus 101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil 180 (316)
T 2xir_A 101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 180 (316)
T ss_dssp CCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred ecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEE
Confidence 7754 5899999999999999997632 889999999999999999999999999999999999
Q ss_pred EcCCCCeEEeeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHH-H
Q 037702 142 LDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLM-E 219 (448)
Q Consensus 142 l~~~g~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~-~ 219 (448)
++.++.+||+|||++................||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+.. .
T Consensus 181 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~t~g~~p~~~~~~~~~ 259 (316)
T 2xir_A 181 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 259 (316)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred ECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhcccccc-chhHHHHHHHHHHHHHhCCCCCCcccchhHH
Confidence 999999999999999865432222222345688999999999877664 89999999999999998 99999876543 3
Q ss_pred HHHHHhhc-cCCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhh
Q 037702 220 LYKKITRA-EFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENY 264 (448)
Q Consensus 220 ~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 264 (448)
....+..+ ....|..+++++.++|.+||..||.+|||++++++|-
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 305 (316)
T 2xir_A 260 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305 (316)
T ss_dssp HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 33344333 3456778999999999999999999999999999874
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=366.08 Aligned_cols=255 Identities=30% Similarity=0.577 Sum_probs=207.7
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKI 85 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 85 (448)
....++|++.+.||+|+||.||+|.+..+|+.||||++...........+.+.+|+.+++.++||||+++++++...+..
T Consensus 28 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 107 (310)
T 2wqm_A 28 YNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL 107 (310)
T ss_dssp TSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred cccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcE
Confidence 34678999999999999999999999999999999999875555555667889999999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccc
Q 037702 86 YFAMEYVRGGELFNKVAK-----GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQE 160 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~ 160 (448)
++||||+++++|.+++.. ..+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||++....
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999999998853 469999999999999999999999999999999999999999999999999987653
Q ss_pred ccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCC--cHHHHHHHHhhccCCC--CCCCC
Q 037702 161 STRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDS--NLMELYKKITRAEFKC--PNWFP 236 (448)
Q Consensus 161 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~--~~~~~~~~i~~~~~~~--p~~~s 236 (448)
... .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+. +.......+....+.. +..++
T Consensus 188 ~~~--~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (310)
T 2wqm_A 188 SKT--TAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYS 264 (310)
T ss_dssp -------------CCSSCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSC
T ss_pred CCC--ccccccCCCeeEeChHHhCCCCC-CchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccC
Confidence 322 22335579999999999987666 48899999999999999999999764 3345555555544332 25689
Q ss_pred HHHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 237 PEVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 237 ~~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
+++.+||.+||..||.+|||+++++++
T Consensus 265 ~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 265 EELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 999999999999999999999999974
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=368.10 Aligned_cols=254 Identities=23% Similarity=0.456 Sum_probs=200.0
Q ss_pred cccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 037702 5 AGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTK 84 (448)
Q Consensus 5 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 84 (448)
+.+..++|++.+.||+|+||.||+|++. ..||+|++...... ....+.+.+|+.+++.++||||++++++. ....
T Consensus 19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~ 93 (289)
T 3og7_A 19 WEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPT-PQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQ 93 (289)
T ss_dssp CBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSS
T ss_pred CccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCC-HHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCc
Confidence 4678899999999999999999999863 35999999765433 34457789999999999999999999965 5566
Q ss_pred EEEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccc
Q 037702 85 IYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQEST 162 (448)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~ 162 (448)
.++||||++|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 94 LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp CEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred cEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccc
Confidence 8999999999999999964 57999999999999999999999999999999999999999999999999999865433
Q ss_pred ccCCCccccCCCCcccchhhhhc--cCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHH-HHHHHhhccCC-----CCCC
Q 037702 163 RQDGLLHTTCGTPAYVAPEVINK--RGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLME-LYKKITRAEFK-----CPNW 234 (448)
Q Consensus 163 ~~~~~~~~~~Gt~~Y~APEvl~~--~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~-~~~~i~~~~~~-----~p~~ 234 (448)
.........+||+.|+|||++.. ....+.++|||||||++|+|++|..||.+.+..+ ....+...... .+..
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (289)
T 3og7_A 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSN 253 (289)
T ss_dssp ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTT
T ss_pred cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhcccc
Confidence 33333455679999999999862 2223478999999999999999999998765443 33444333322 2346
Q ss_pred CCHHHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 235 FPPEVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 235 ~s~~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
+|+++.+||.+||..||.+|||++++++.
T Consensus 254 ~~~~l~~li~~~l~~~p~~Rps~~ell~~ 282 (289)
T 3og7_A 254 CPKRMKRLMAECLKKKRDERPSFPRILAE 282 (289)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 78999999999999999999999999874
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=370.89 Aligned_cols=255 Identities=24% Similarity=0.373 Sum_probs=207.4
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECC---CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLK---TGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKT 83 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~---~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~ 83 (448)
+..++|++++.||+|+||.||+|.+.. ++..||+|++....... ...+.+.+|+.+++.++||||+++++++.+..
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 109 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQ-REIEEFLSEAACMKDFSHPNVIRLLGVCIEMS 109 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCH-HHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccch-hHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence 456799999999999999999998765 55689999997654332 34577899999999999999999999987655
Q ss_pred -----EEEEEEeecCCCchHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEe
Q 037702 84 -----KIYFAMEYVRGGELFNKVAK-------GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKIS 151 (448)
Q Consensus 84 -----~~~lV~E~~~gg~L~~~i~~-------~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~ 151 (448)
..|+||||+++|+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~ 189 (313)
T 3brb_A 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVA 189 (313)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEEC
T ss_pred ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEe
Confidence 35999999999999999831 469999999999999999999999999999999999999999999999
Q ss_pred eccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhc-cC
Q 037702 152 DFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EF 229 (448)
Q Consensus 152 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~ 229 (448)
|||++................|++.|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+... ..
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 268 (313)
T 3brb_A 190 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY-TSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRL 268 (313)
T ss_dssp SCSCC----------------CCGGGSCHHHHHSSCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC
T ss_pred ecCcceecccccccCcccccCCCccccCchhhcCCCc-cchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCC
Confidence 9999986543322222234568899999999987666 488999999999999999 99999988877777766655 34
Q ss_pred CCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 230 KCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 230 ~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
..|..+++++.++|.+||..||.+|||+.+++++
T Consensus 269 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 269 KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 5677899999999999999999999999999985
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=365.68 Aligned_cols=254 Identities=25% Similarity=0.357 Sum_probs=214.8
Q ss_pred ccccCCeEEEe-eeeecCceEEEEEEE--CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 037702 6 GILMNKYELGR-LLGQGTFAKVYHGRN--LKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASK 82 (448)
Q Consensus 6 ~~~~~~y~~~~-~LG~G~fg~Vy~a~~--~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~ 82 (448)
.+..++|++.+ .||+|+||.||+|.+ ..+++.||||++..... .....+.+.+|+.+++.++||||+++++++ ..
T Consensus 12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~ 89 (291)
T 1xbb_A 12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGIC-EA 89 (291)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ES
T ss_pred eecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CC
Confidence 34567899999 999999999999954 56788999999976533 224457899999999999999999999999 56
Q ss_pred CEEEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccc
Q 037702 83 TKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQES 161 (448)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~ 161 (448)
+..|+||||+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 90 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (291)
T 1xbb_A 90 ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 169 (291)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred CCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence 778999999999999999976 5699999999999999999999999999999999999999999999999999976533
Q ss_pred cccC-CCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhcc-CCCCCCCCHH
Q 037702 162 TRQD-GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAE-FKCPNWFPPE 238 (448)
Q Consensus 162 ~~~~-~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~ 238 (448)
.... .......||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+..+....+.... ...|..++++
T Consensus 170 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (291)
T 1xbb_A 170 DENYYKAQTHGKWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPRE 248 (291)
T ss_dssp TCSEEEC----CCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred CCCcccccccCCCCceeeChHHhccCCCC-hhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence 2211 111234578999999999776654 78999999999999999 999999988888777776654 4567789999
Q ss_pred HHHHHHhccCCCcCCCCCHHHHHh
Q 037702 239 VRKLLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 239 ~~~li~~~L~~dP~~Rpt~~eil~ 262 (448)
+.++|.+||..||.+|||+.++++
T Consensus 249 l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 249 MYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999999986
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=382.96 Aligned_cols=255 Identities=23% Similarity=0.391 Sum_probs=207.8
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEEC---CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNL---KTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASK 82 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~ 82 (448)
.+..++|++.+.||+|+||.||+|++. .++..||||++.... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 118 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS 118 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence 345678999999999999999999976 467789999997543 223457789999999999999999999999999
Q ss_pred CEEEEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccc
Q 037702 83 TKIYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQE 160 (448)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~ 160 (448)
...|+||||+++|+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 119 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 119 KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred CceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 999999999999999999976 369999999999999999999999999999999999999999999999999998654
Q ss_pred ccccCC-CccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhc-cCCCCCCCCH
Q 037702 161 STRQDG-LLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EFKCPNWFPP 237 (448)
Q Consensus 161 ~~~~~~-~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~ 237 (448)
...... ......+|+.|+|||++.+..+. .++|||||||++|+|++ |..||...+..+....+... ..+.|..+++
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~ 277 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPA 277 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCBH
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcC-chhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccccH
Confidence 322111 11223467889999999877664 88999999999999998 99999988888777776654 3455667899
Q ss_pred HHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 238 EVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 238 ~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
++.++|.+||+.||.+||++.++++.
T Consensus 278 ~l~~li~~cl~~dp~~RPs~~~i~~~ 303 (373)
T 2qol_A 278 ALYQLMLDCWQKDRNNRPKFEQIVSI 303 (373)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHhCcChhhCcCHHHHHHH
Confidence 99999999999999999999999873
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=363.83 Aligned_cols=249 Identities=23% Similarity=0.360 Sum_probs=208.8
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEE-EeCCEE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVM-ASKTKI 85 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~-~~~~~~ 85 (448)
.+.++|++.+.||+|+||.||+|++..+|+.||||++...... +.+.+|+.+++.++|++++..+..+ ......
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (296)
T 3uzp_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 80 (296)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-----hHHHHHHHHHHHhhcCCCCCccccccCCCCce
Confidence 3568999999999999999999999999999999998765432 3578999999999998876665554 677889
Q ss_pred EEEEeecCCCchHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEE---cCCCCeEEeecccccccc
Q 037702 86 YFAMEYVRGGELFNKVA--KGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLL---DENGDLKISDFGLSALQE 160 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~--~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl---~~~g~lkl~DFGla~~~~ 160 (448)
|+||||+ +++|.+++. .+.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 81 VMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 9999999 899999997 3679999999999999999999999999999999999999 588999999999998654
Q ss_pred ccccC-----CCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCc---HHHHHHHHhhccCCCC
Q 037702 161 STRQD-----GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSN---LMELYKKITRAEFKCP 232 (448)
Q Consensus 161 ~~~~~-----~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~---~~~~~~~i~~~~~~~p 232 (448)
..... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+ ....+..+.......|
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred ccccccccccccccccccccccCChhhhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence 43221 11245689999999999987666 489999999999999999999998632 2233444444333333
Q ss_pred -----CCCCHHHHHHHHhccCCCcCCCCCHHHHHh
Q 037702 233 -----NWFPPEVRKLLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 233 -----~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 262 (448)
..+|+++.++|.+||+.||.+|||++++++
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 678999999999999999999999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=375.12 Aligned_cols=258 Identities=24% Similarity=0.403 Sum_probs=193.4
Q ss_pred cccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHH-HHHhCCCCCcceEEEEEEeCC
Q 037702 5 AGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREIS-VMRLVRHPNIVQLYEVMASKT 83 (448)
Q Consensus 5 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~-~l~~l~hpnIv~l~~~~~~~~ 83 (448)
..+..++|++.+.||+|+||.||+|.+..+|+.||||++...... .....+.+|+. +++.++||||+++++++...+
T Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~ 94 (327)
T 3aln_A 17 WDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE--KEQKQLLMDLDVVMRSSDCPYIVQFYGALFREG 94 (327)
T ss_dssp ECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCH--HHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSS
T ss_pred cccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCc--hHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCC
Confidence 346678999999999999999999999999999999999765322 22344555665 777889999999999999999
Q ss_pred EEEEEEeecCCCchHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHC-CCEeecCCCCceEEcCCCCeEEeecccc
Q 037702 84 KIYFAMEYVRGGELFNKVA------KGKLREEVARKYFQQLVDAVEFCHSR-GVYHRDLKPENLLLDENGDLKISDFGLS 156 (448)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~------~~~l~e~~~~~~~~qll~aL~yLH~~-givHrDLkp~NILl~~~g~lkl~DFGla 156 (448)
..|+||||+++ +|.+++. .+.+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++
T Consensus 95 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~ 173 (327)
T 3aln_A 95 DCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGIS 173 (327)
T ss_dssp EEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSS
T ss_pred ceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCc
Confidence 99999999986 7777765 46799999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccccCCCccccCCCCcccchhhhh----ccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcH-HHHHHHHhhccC-C
Q 037702 157 ALQESTRQDGLLHTTCGTPAYVAPEVIN----KRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNL-MELYKKITRAEF-K 230 (448)
Q Consensus 157 ~~~~~~~~~~~~~~~~Gt~~Y~APEvl~----~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~~~~-~ 230 (448)
....... .....+||+.|+|||++. +..+ +.++|||||||++|+|++|..||...+. .+....+..+.. .
T Consensus 174 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 249 (327)
T 3aln_A 174 GQLVDSI---AKTRDAGCRPYMAPERIDPSASRQGY-DVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQ 249 (327)
T ss_dssp CC---------------------------------C-CSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCC
T ss_pred eeccccc---ccccCCCCccccCceeeccccCcCCC-CchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCC
Confidence 7643221 223447999999999983 3334 5889999999999999999999987543 222222322222 1
Q ss_pred C----CCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 231 C----PNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 231 ~----p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
. +..+++++.+||.+||..||.+|||+.++++||||...
T Consensus 250 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 250 LSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292 (327)
T ss_dssp CCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred CCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence 2 23578999999999999999999999999999999764
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=371.03 Aligned_cols=255 Identities=23% Similarity=0.368 Sum_probs=212.7
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCC----cEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTG----QSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMAS 81 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g----~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~ 81 (448)
.+..++|++.+.||+|+||.||+|.+..++ ..||||++.... .......+.+|+.+++.++||||+++++++..
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 117 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 117 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence 456679999999999999999999986553 359999997543 22344678899999999999999999999999
Q ss_pred CCEEEEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccc
Q 037702 82 KTKIYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQ 159 (448)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~ 159 (448)
....|+||||+++|+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 118 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 118 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 9999999999999999999975 57999999999999999999999999999999999999999999999999999865
Q ss_pred cccccCC-CccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhc-cCCCCCCCC
Q 037702 160 ESTRQDG-LLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EFKCPNWFP 236 (448)
Q Consensus 160 ~~~~~~~-~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s 236 (448)
....... ......||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+..+....+..+ ..+.|..++
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCP 276 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCB
T ss_pred ccccccccccCCCCccccccCchhcccCCCC-chhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccCC
Confidence 4322111 11233568899999999876664 88999999999999998 99999988888887777665 445667789
Q ss_pred HHHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 237 PEVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 237 ~~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
+.+.++|.+||+.||.+||++.+++++
T Consensus 277 ~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 277 SAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999999875
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=366.82 Aligned_cols=254 Identities=28% Similarity=0.417 Sum_probs=210.2
Q ss_pred ccccCCeEEEeeeeecCceEEEEEE----ECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGR----NLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMAS 81 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~----~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~ 81 (448)
.....+|++.+.||+|+||.||+|+ +..+|+.||||++..... ....+.+.+|+.+++.++||||+++++++..
T Consensus 17 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (302)
T 4e5w_A 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--GNHIADLKKEIEILRNLYHENIVKYKGICTE 94 (302)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc--chhHHHHHHHHHHHHhCCCCCeeeeeeEEec
Confidence 3456789999999999999999999 567899999999976542 2335778999999999999999999999987
Q ss_pred C--CEEEEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccc
Q 037702 82 K--TKIYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSA 157 (448)
Q Consensus 82 ~--~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~ 157 (448)
. ..+|+||||+++|+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 95 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 95 DGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp ---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred CCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccc
Confidence 6 678999999999999999954 579999999999999999999999999999999999999999999999999998
Q ss_pred cccccccC-CCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCc---------------HHHHH
Q 037702 158 LQESTRQD-GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSN---------------LMELY 221 (448)
Q Consensus 158 ~~~~~~~~-~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~---------------~~~~~ 221 (448)
........ .......||+.|+|||++.+..+. .++|||||||++|+|++|..|+.... .....
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFY-IASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV 253 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCC-cchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence 65432211 223356789999999999876664 88999999999999999999864321 12222
Q ss_pred HHHhh-ccCCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHh
Q 037702 222 KKITR-AEFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 222 ~~i~~-~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 262 (448)
..+.. .....|..+++++.+||.+||..||.+|||++++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 254 NTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 22322 234567789999999999999999999999999987
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=362.70 Aligned_cols=247 Identities=25% Similarity=0.463 Sum_probs=212.5
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe-----
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMAS----- 81 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~----- 81 (448)
.+.++|++.+.||+|+||.||+|.+..+|+.||+|++.... +.+.+|+.+++.++||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (284)
T 2a19_B 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDP 80 (284)
T ss_dssp HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-
T ss_pred hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCc
Confidence 45678999999999999999999999999999999997543 245689999999999999999998864
Q ss_pred -----------CCEEEEEEeecCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCC
Q 037702 82 -----------KTKIYFAMEYVRGGELFNKVAK---GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGD 147 (448)
Q Consensus 82 -----------~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~ 147 (448)
...+|+||||+++|+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 81 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 81 ETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp --------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE
T ss_pred ccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCC
Confidence 4568999999999999999964 57999999999999999999999999999999999999999999
Q ss_pred eEEeeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhc
Q 037702 148 LKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA 227 (448)
Q Consensus 148 lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~ 227 (448)
+||+|||++...... .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||... ......+..
T Consensus 161 ~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~- 233 (284)
T 2a19_B 161 VKIGDFGLVTSLKND---GKRTRSKGTLRYMSPEQISSQDY-GKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRD- 233 (284)
T ss_dssp EEECCCTTCEESSCC---SCCCCCCSCCTTSCHHHHHCSCC-CTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHT-
T ss_pred EEECcchhheecccc---ccccccCCcccccChhhhccCCC-cchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhc-
Confidence 999999999765332 22345679999999999987666 48999999999999999999987532 233333333
Q ss_pred cCCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccc
Q 037702 228 EFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRK 268 (448)
Q Consensus 228 ~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 268 (448)
...+..+++++.++|.+||..||.+|||+.++++++|.-.
T Consensus 234 -~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 234 -GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp -TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred -ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 2356678999999999999999999999999999998654
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=361.92 Aligned_cols=254 Identities=26% Similarity=0.433 Sum_probs=213.6
Q ss_pred cccccCCeEEEeeeeecCceEEEEEEECC---CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 037702 5 AGILMNKYELGRLLGQGTFAKVYHGRNLK---TGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMAS 81 (448)
Q Consensus 5 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~---~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~ 81 (448)
.++..++|++.+.||+|+||.||+|.+.. ++..||+|++..... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 84 (281)
T 3cc6_A 7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCT--LDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE 84 (281)
T ss_dssp CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSC--HHHHHHHHHHHHHHHHHCCTTBCCEEEEECS
T ss_pred ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccC--chHHHHHHHHHHHHHhCCCCCcceEEEEEcC
Confidence 45678899999999999999999998654 344699999976532 2345778999999999999999999999865
Q ss_pred CCEEEEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccc
Q 037702 82 KTKIYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQ 159 (448)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~ 159 (448)
+ ..|+||||+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 85 ~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 85 E-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp S-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred C-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 4 56899999999999999965 46999999999999999999999999999999999999999999999999999865
Q ss_pred cccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhc-cCCCCCCCCH
Q 037702 160 ESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EFKCPNWFPP 237 (448)
Q Consensus 160 ~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~ 237 (448)
..... .......||+.|+|||++.+..+. .++|||||||++|+|++ |+.||...+..+....+... ....|..+++
T Consensus 164 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (281)
T 3cc6_A 164 EDEDY-YKASVTRLPIKWMSPESINFRRFT-TASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPP 241 (281)
T ss_dssp ----------CCCCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCCH
T ss_pred ccccc-cccccCCCCcceeCchhhccCCCC-chhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCCH
Confidence 43221 122345678999999999776664 88999999999999998 99999877666666655544 3456777999
Q ss_pred HHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 238 EVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 238 ~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
.+.++|.+||..||.+|||+.+++++
T Consensus 242 ~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 242 VLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHccCCchhCcCHHHHHHH
Confidence 99999999999999999999999985
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=385.62 Aligned_cols=244 Identities=28% Similarity=0.523 Sum_probs=212.8
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-E
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKT-K 84 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~-~ 84 (448)
.+..++|++.+.||+|+||.||+|.+ +|+.||||++.... ..+.+.+|+.+|+.++||||+++++++.... .
T Consensus 189 ~i~~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 261 (450)
T 1k9a_A 189 ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 261 (450)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSC
T ss_pred ccChHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCc
Confidence 35568999999999999999999988 47899999997553 2367889999999999999999999987665 7
Q ss_pred EEEEEeecCCCchHHHHhc-C--CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccc
Q 037702 85 IYFAMEYVRGGELFNKVAK-G--KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQES 161 (448)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~--~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~ 161 (448)
+|+||||+++|+|.+++.. + .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 262 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 341 (450)
T 1k9a_A 262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341 (450)
T ss_dssp EEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence 9999999999999999975 3 379999999999999999999999999999999999999999999999999974322
Q ss_pred cccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhc-cCCCCCCCCHHH
Q 037702 162 TRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EFKCPNWFPPEV 239 (448)
Q Consensus 162 ~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~ 239 (448)
. .....+|+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..+....+..+ ....|..+|+++
T Consensus 342 ~-----~~~~~~~~~y~aPE~~~~~~~~-~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l 415 (450)
T 1k9a_A 342 T-----QDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAV 415 (450)
T ss_dssp ----------CCCTTTSCHHHHHSSCCC-HHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHH
T ss_pred c-----ccCCCCCcceeCHHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHH
Confidence 1 1234678999999999877664 89999999999999998 99999988777777776655 456788899999
Q ss_pred HHHHHhccCCCcCCCCCHHHHHh
Q 037702 240 RKLLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 240 ~~li~~~L~~dP~~Rpt~~eil~ 262 (448)
.+||.+||..||.+|||+.++++
T Consensus 416 ~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 416 YDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999999986
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=363.77 Aligned_cols=249 Identities=23% Similarity=0.362 Sum_probs=204.1
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEE-EeCCEE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVM-ASKTKI 85 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~-~~~~~~ 85 (448)
.+.++|++.+.||+|+||.||+|++..+|+.||||++...... ..+.+|+.+++.++|++++..+..+ ......
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 80 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCce
Confidence 3568999999999999999999999999999999987655332 3467899999999988877666654 778889
Q ss_pred EEEEeecCCCchHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEE---cCCCCeEEeecccccccc
Q 037702 86 YFAMEYVRGGELFNKVA--KGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLL---DENGDLKISDFGLSALQE 160 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~--~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl---~~~g~lkl~DFGla~~~~ 160 (448)
++||||+ +++|.+++. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 81 VMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 9999999 999999997 3679999999999999999999999999999999999999 789999999999998654
Q ss_pred ccccC-----CCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcH---HHHHHHHhhccCCCC
Q 037702 161 STRQD-----GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNL---MELYKKITRAEFKCP 232 (448)
Q Consensus 161 ~~~~~-----~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~---~~~~~~i~~~~~~~p 232 (448)
..... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+. ...+..+.......|
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCC-CchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence 33221 12235689999999999987766 4899999999999999999999976432 233333333333333
Q ss_pred -----CCCCHHHHHHHHhccCCCcCCCCCHHHHHh
Q 037702 233 -----NWFPPEVRKLLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 233 -----~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 262 (448)
..+|+++.+||.+||+.||.+|||++++++
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 568999999999999999999999999987
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-48 Score=378.68 Aligned_cols=254 Identities=26% Similarity=0.374 Sum_probs=210.0
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIY 86 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 86 (448)
...++|++.+.||+|+||.||+|.+ .+|+.||||++..... ...+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 111 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESS---QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMI 111 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCS---SHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCE
T ss_pred HHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccCh---HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence 4568999999999999999999996 4789999999875532 33577899999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccc
Q 037702 87 FAMEYVRGGELFNKVAKG-----KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQES 161 (448)
Q Consensus 87 lV~E~~~gg~L~~~i~~~-----~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~ 161 (448)
+||||+++|+|.+++... .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 191 (321)
T 2qkw_B 112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTE 191 (321)
T ss_dssp EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSS
T ss_pred EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 999999999999998652 489999999999999999999999999999999999999999999999999986443
Q ss_pred cccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHH------H-HHHhhccC-----
Q 037702 162 TRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMEL------Y-KKITRAEF----- 229 (448)
Q Consensus 162 ~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~------~-~~i~~~~~----- 229 (448)
..........+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......+. . .......+
T Consensus 192 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (321)
T 2qkw_B 192 LDQTHLSTVVKGTLGYIDPEYFIKGRL-TEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD 270 (321)
T ss_dssp SSCCCCBCCCEEETTTCCHHHHHHCBC-CTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSS
T ss_pred ccccccccccCCCccccCHHHhcCCCC-CcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcC
Confidence 333333345579999999999987666 4889999999999999999999976432111 0 11111111
Q ss_pred -C----CCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhh
Q 037702 230 -K----CPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYW 265 (448)
Q Consensus 230 -~----~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 265 (448)
. .++..+..+.+++.+||+.||.+|||+.+++++..
T Consensus 271 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 311 (321)
T 2qkw_B 271 PNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311 (321)
T ss_dssp SSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred hhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 1 11223467899999999999999999999998764
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=359.12 Aligned_cols=251 Identities=26% Similarity=0.433 Sum_probs=216.1
Q ss_pred ccccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 037702 4 KAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKT 83 (448)
Q Consensus 4 ~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~ 83 (448)
...+..++|++.+.||+|+||.||+|.+. ++..||||.+...... .+.+.+|+.+++.++||||+++++++.. +
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~ 80 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQ-E 80 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCccc----HHHHHHHHHHHHhCCCcCcceEEEEEcC-C
Confidence 44567789999999999999999999974 5678999999755322 3678899999999999999999999864 5
Q ss_pred EEEEEEeecCCCchHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccc
Q 037702 84 KIYFAMEYVRGGELFNKVAKG---KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQE 160 (448)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~~---~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~ 160 (448)
..|+||||+++++|.+++... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 81 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (279)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence 589999999999999999752 69999999999999999999999999999999999999999999999999998654
Q ss_pred ccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhc-cCCCCCCCCHH
Q 037702 161 STRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EFKCPNWFPPE 238 (448)
Q Consensus 161 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~ 238 (448)
.... .......||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+..+....+... ....|..++++
T Consensus 161 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (279)
T 1qpc_A 161 DNEY-TAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEE 238 (279)
T ss_dssp SSCE-ECCTTCCCCTTTSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred Cccc-ccccCCCCccCccChhhhccCCC-CchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHH
Confidence 3211 11234467889999999976655 488999999999999999 99999998887777777655 34566778999
Q ss_pred HHHHHHhccCCCcCCCCCHHHHHh
Q 037702 239 VRKLLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 239 ~~~li~~~L~~dP~~Rpt~~eil~ 262 (448)
+.++|.+||..||.+|||++++++
T Consensus 239 l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 239 LYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhccChhhCCCHHHHHH
Confidence 999999999999999999999986
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=386.88 Aligned_cols=249 Identities=25% Similarity=0.430 Sum_probs=216.4
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKI 85 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 85 (448)
.+..++|++.+.||+|+||.||+|.+. ++..||||++..... ..+.+.+|+.+|+.++||||+++++++. .+.+
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~ 257 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPI 257 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred eechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCc----cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCcc
Confidence 456678999999999999999999985 577899999976532 2477899999999999999999999986 6678
Q ss_pred EEEEeecCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccc
Q 037702 86 YFAMEYVRGGELFNKVAK---GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQEST 162 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~ 162 (448)
|+||||+++|+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 258 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 258 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 337 (454)
T ss_dssp EEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence 999999999999999975 26999999999999999999999999999999999999999999999999999865332
Q ss_pred ccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhc-cCCCCCCCCHHHH
Q 037702 163 RQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EFKCPNWFPPEVR 240 (448)
Q Consensus 163 ~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 240 (448)
.. .......+|+.|+|||++....+ +.++|||||||+||+|++ |..||.+.+..++...+..+ ..+.|..+|+++.
T Consensus 338 ~~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~ 415 (454)
T 1qcf_A 338 EY-TAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELY 415 (454)
T ss_dssp HH-HTTCSSSSCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHHH
T ss_pred ce-eccCCCcccccccCHHHhccCCC-CcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence 11 11123457889999999987666 489999999999999999 99999998888887777655 3466778999999
Q ss_pred HHHHhccCCCcCCCCCHHHHHh
Q 037702 241 KLLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~eil~ 262 (448)
+||.+||..||.+|||+++|++
T Consensus 416 ~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 416 NIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHccCChhHCcCHHHHHH
Confidence 9999999999999999999986
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-47 Score=394.13 Aligned_cols=251 Identities=25% Similarity=0.453 Sum_probs=219.6
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKI 85 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 85 (448)
.+...+|++.+.||+|+||.||+|.+..++..||||++..... ..+.+.+|+.+|+.++||||+++++++.....+
T Consensus 216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 291 (495)
T 1opk_A 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 291 (495)
T ss_dssp BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc----chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcE
Confidence 3456789999999999999999999999999999999975532 246788999999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccc
Q 037702 86 YFAMEYVRGGELFNKVAK---GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQEST 162 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~ 162 (448)
|+||||+++|+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 292 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 371 (495)
T 1opk_A 292 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371 (495)
T ss_dssp EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred EEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence 999999999999999975 45899999999999999999999999999999999999999999999999999865322
Q ss_pred ccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhc-cCCCCCCCCHHHH
Q 037702 163 RQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EFKCPNWFPPEVR 240 (448)
Q Consensus 163 ~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 240 (448)
.. .......+|+.|+|||++....+ +.++|||||||+||+|++ |..||.+.+..++...+... ....|..+++++.
T Consensus 372 ~~-~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 449 (495)
T 1opk_A 372 TY-TAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 449 (495)
T ss_dssp CE-ECCTTCCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHH
T ss_pred ce-eecCCCcCCcceeCHhHHhcCCC-CcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence 11 11223457789999999987666 488999999999999999 99999988877777666554 3466788999999
Q ss_pred HHHHhccCCCcCCCCCHHHHHh
Q 037702 241 KLLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~eil~ 262 (448)
+||.+||+.||.+|||+.+|++
T Consensus 450 ~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 450 ELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHcCcChhHCcCHHHHHH
Confidence 9999999999999999999987
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=373.15 Aligned_cols=254 Identities=17% Similarity=0.220 Sum_probs=201.3
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECC---CCcEEEEEEeecccccchh--------HHHHHHHHHHHHHhCCCCCcceEE
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLK---TGQSVAIKIVDKEKIRRVG--------LIDQIKREISVMRLVRHPNIVQLY 76 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~---~g~~vAiK~i~~~~~~~~~--------~~~~~~~Ei~~l~~l~hpnIv~l~ 76 (448)
..++|++.+.||+|+||.||+|.+.. ++..||||++......... ....+.+|+..++.++||||++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 44689999999999999999999987 7889999999765321100 113466889999999999999999
Q ss_pred EEEEe----CCEEEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCC--CeE
Q 037702 77 EVMAS----KTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENG--DLK 149 (448)
Q Consensus 77 ~~~~~----~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g--~lk 149 (448)
+++.. ....|+||||+ |++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+|
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~k 193 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVY 193 (345)
T ss_dssp EEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEE
T ss_pred cccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEE
Confidence 99988 78899999999 9999999976 5799999999999999999999999999999999999999887 999
Q ss_pred EeeccccccccccccC-----CCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCC--CcHHHHHH
Q 037702 150 ISDFGLSALQESTRQD-----GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYD--SNLMELYK 222 (448)
Q Consensus 150 l~DFGla~~~~~~~~~-----~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~--~~~~~~~~ 222 (448)
|+|||++......... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+ .+......
T Consensus 194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~ 272 (345)
T 2v62_A 194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVAL-SRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQT 272 (345)
T ss_dssp ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHH
T ss_pred EEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCccccccccHHHHH
Confidence 9999999765432211 11245689999999999987655 5899999999999999999999965 22222222
Q ss_pred HHhhccCCCC---------CCCCHHHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 223 KITRAEFKCP---------NWFPPEVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 223 ~i~~~~~~~p---------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
.........| ..+|+++.++|.+||..||.+|||++++++.
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 273 AKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp HHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 2111111222 2688999999999999999999999999873
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=364.03 Aligned_cols=255 Identities=25% Similarity=0.428 Sum_probs=207.7
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECC-CCc--EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLK-TGQ--SVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKT 83 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~-~g~--~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~ 83 (448)
+..++|++.+.||+|+||.||+|.+.. ++. .||||++...........+.+.+|+.+++.++||||+++++++.+..
T Consensus 15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 94 (291)
T 1u46_A 15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP 94 (291)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC
Confidence 456789999999999999999998643 333 68999998765555556688999999999999999999999998765
Q ss_pred EEEEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccc
Q 037702 84 KIYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQES 161 (448)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~ 161 (448)
.++||||+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 95 -~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 95 -MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp -CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred -ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccc
Confidence 8999999999999999875 5699999999999999999999999999999999999999999999999999986543
Q ss_pred cccC-CCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhcc--CCCCCCCCH
Q 037702 162 TRQD-GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAE--FKCPNWFPP 237 (448)
Q Consensus 162 ~~~~-~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~ 237 (448)
.... .......||+.|+|||++.+..+ +.++||||||+++|+|++ |..||...+..+....+.... ...+..+++
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (291)
T 1u46_A 174 NDDHYVMQEHRKVPFAWCAPESLKTRTF-SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQ 252 (291)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCH
T ss_pred cccchhhhccCCCCceeeCchhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcCH
Confidence 2211 12234568889999999987665 488999999999999999 999999988888887776653 345567899
Q ss_pred HHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 238 EVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 238 ~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
++.++|.+||..||.+|||+.+++++
T Consensus 253 ~l~~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 253 DIYNVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHccCCcccCcCHHHHHHH
Confidence 99999999999999999999999984
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-46 Score=359.73 Aligned_cols=250 Identities=24% Similarity=0.416 Sum_probs=211.2
Q ss_pred CeEEEeeeeecCceEEEEEEECCCCc---EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE-E
Q 037702 11 KYELGRLLGQGTFAKVYHGRNLKTGQ---SVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKI-Y 86 (448)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~g~---~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~-~ 86 (448)
.|++.+.||+|+||.||+|.+..++. .||+|++.... .....+.+.+|+.+++.++||||+++++++.+.+.. +
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT--EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH 99 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc--cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence 57778999999999999999766554 79999986532 334457888999999999999999999999876655 9
Q ss_pred EEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccc-
Q 037702 87 FAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTR- 163 (448)
Q Consensus 87 lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~- 163 (448)
+||||+.+|+|.+++.. +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 100 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179 (298)
T ss_dssp EEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred EEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence 99999999999999976 568999999999999999999999999999999999999999999999999997543322
Q ss_pred -cCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhcc-CCCCCCCCHHHH
Q 037702 164 -QDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAE-FKCPNWFPPEVR 240 (448)
Q Consensus 164 -~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~ 240 (448)
.........||+.|+|||++.+..+. .++|||||||++|+|++ |.+||...+..+....+.... ...|..+++.+.
T Consensus 180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 258 (298)
T 3pls_A 180 YSVQQHRHARLPVKWTALESLQTYRFT-TKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLY 258 (298)
T ss_dssp GCSCCSSCTTCGGGGSCHHHHTTCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHHH
T ss_pred cccccCcCCCCCccccChhhhccCCCC-hhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHHHH
Confidence 12223455789999999999876664 88999999999999999 555666666666666555543 456778999999
Q ss_pred HHHHhccCCCcCCCCCHHHHHhh
Q 037702 241 KLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~eil~h 263 (448)
++|.+||..||.+|||+.++++.
T Consensus 259 ~li~~~l~~~p~~Rps~~~ll~~ 281 (298)
T 3pls_A 259 QVMQQCWEADPAVRPTFRVLVGE 281 (298)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999999874
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=362.08 Aligned_cols=253 Identities=23% Similarity=0.387 Sum_probs=210.1
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCC---cEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEE-EeCC
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTG---QSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVM-ASKT 83 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g---~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~-~~~~ 83 (448)
...+|++.+.||+|+||.||+|.+..++ ..||+|.+.... .....+.+.+|+.+++.++||||+++++++ ..+.
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 100 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 100 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC--CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCC
Confidence 4457999999999999999999976543 358999987532 334457789999999999999999999985 4566
Q ss_pred EEEEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccc
Q 037702 84 KIYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQES 161 (448)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~ 161 (448)
..|+||||+++|+|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 101 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 101 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp CCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred ceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence 88999999999999999975 4689999999999999999999999999999999999999999999999999975533
Q ss_pred ccc--CCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhccC-CCCCCCCH
Q 037702 162 TRQ--DGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAEF-KCPNWFPP 237 (448)
Q Consensus 162 ~~~--~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~ 237 (448)
... ........||+.|+|||++.+..+. .++|||||||++|+|++ |.+||...+..+....+..... ..|..+++
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD 259 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCCH
T ss_pred cchhccccccCCCCCccccChHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCCH
Confidence 221 1222345688999999999877664 88999999999999999 6778877776666666655543 45677899
Q ss_pred HHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 238 EVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 238 ~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
.+.++|.+||+.||.+|||+.++++.
T Consensus 260 ~l~~li~~~l~~~p~~Rps~~ell~~ 285 (298)
T 3f66_A 260 PLYEVMLKCWHPKAEMRPSFSELVSR 285 (298)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999999873
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=367.72 Aligned_cols=254 Identities=25% Similarity=0.369 Sum_probs=211.1
Q ss_pred ccccCCe-EEEeeeeecCceEEEEEEE----CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 037702 6 GILMNKY-ELGRLLGQGTFAKVYHGRN----LKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMA 80 (448)
Q Consensus 6 ~~~~~~y-~~~~~LG~G~fg~Vy~a~~----~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~ 80 (448)
.++.++| ++++.||+|+||.||+|.. ..+|+.||||++.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 26 ~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (318)
T 3lxp_A 26 TVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCE 103 (318)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEe
Confidence 4566777 9999999999999988754 4578999999997653 2234577899999999999999999999998
Q ss_pred e--CCEEEEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccc
Q 037702 81 S--KTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSAL 158 (448)
Q Consensus 81 ~--~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~ 158 (448)
+ ...+|+||||+++|+|.+++...++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 104 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 104 DAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA 183 (318)
T ss_dssp ETTTTEEEEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred cCCCceEEEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccc
Confidence 7 46899999999999999999988899999999999999999999999999999999999999999999999999986
Q ss_pred ccccccC-CCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHH---------------HHHH
Q 037702 159 QESTRQD-GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLM---------------ELYK 222 (448)
Q Consensus 159 ~~~~~~~-~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~---------------~~~~ 222 (448)
....... .......||+.|+|||++.+..++ .++|||||||++|+|++|..||...... ....
T Consensus 184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (318)
T 3lxp_A 184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKFY-YASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE 262 (318)
T ss_dssp CCTTCSEEEC---CCCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHH
T ss_pred ccccccccccccCCCCCceeeChHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHH
Confidence 5432211 122345689999999999876664 8899999999999999999999764321 1112
Q ss_pred HHhh-ccCCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHh
Q 037702 223 KITR-AEFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 223 ~i~~-~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 262 (448)
.+.. .....|..+++++.+||.+||..||.+|||++++++
T Consensus 263 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 263 LLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 2222 234567789999999999999999999999999986
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=361.07 Aligned_cols=250 Identities=25% Similarity=0.426 Sum_probs=201.5
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHh--CCCCCcceEEEEEEe--
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRL--VRHPNIVQLYEVMAS-- 81 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~--l~hpnIv~l~~~~~~-- 81 (448)
..+.++|++.+.||+|+||.||+|++ +|+.||||++.... .....+|..++.. ++||||+++++++..
T Consensus 4 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~ 75 (301)
T 3q4u_A 4 RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTSR 75 (301)
T ss_dssp CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE
T ss_pred ccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeecccc
Confidence 45788999999999999999999987 79999999986542 2445567777776 799999999998654
Q ss_pred --CCEEEEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HCCCEeecCCCCceEEcCCCCeEEe
Q 037702 82 --KTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCH--------SRGVYHRDLKPENLLLDENGDLKIS 151 (448)
Q Consensus 82 --~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH--------~~givHrDLkp~NILl~~~g~lkl~ 151 (448)
...+|+||||+++|+|.+++..+.+++..++.++.||+.||+||| ++||+||||||+|||++.++.+||+
T Consensus 76 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 76 HSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp TTEEEEEEEECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred CCCceeEEehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEe
Confidence 356899999999999999998889999999999999999999999 9999999999999999999999999
Q ss_pred eccccccccccccC--CCccccCCCCcccchhhhhccCCC-----CCcchHHHHHHHHHHHHhC----------CCCCCC
Q 037702 152 DFGLSALQESTRQD--GLLHTTCGTPAYVAPEVINKRGYD-----GAKADIWSCGVVLFVLLAG----------NLPFYD 214 (448)
Q Consensus 152 DFGla~~~~~~~~~--~~~~~~~Gt~~Y~APEvl~~~~~~-----~~~sDiwSlGvil~elltG----------~~Pf~~ 214 (448)
|||++......... ......+||+.|+|||++.+.... +.++|||||||++|+|++| ..||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 99999754432211 112345899999999999765332 2579999999999999999 889865
Q ss_pred Cc----HHHHHHHHhhccC---CCCC-----CCCHHHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 215 SN----LMELYKKITRAEF---KCPN-----WFPPEVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 215 ~~----~~~~~~~i~~~~~---~~p~-----~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
.. ............. ..|. .+++++.+||.+||+.||.+|||++++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~ 296 (301)
T 3q4u_A 236 VVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKT 296 (301)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 32 2222233222221 2221 134779999999999999999999999873
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-47 Score=382.67 Aligned_cols=255 Identities=26% Similarity=0.446 Sum_probs=210.3
Q ss_pred cccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-
Q 037702 5 AGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKT- 83 (448)
Q Consensus 5 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~- 83 (448)
+.+..++|++.+.||+|+||.||+|++..+|+.||||++....... ..+.+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 81 (396)
T 4eut_A 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKLFAIEEETTT 81 (396)
T ss_dssp EECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS--CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTT
T ss_pred CCCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCCCCCeEEEeeccCCC
Confidence 4467789999999999999999999999999999999997654332 2467789999999999999999999998755
Q ss_pred -EEEEEEeecCCCchHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEE----cCCCCeEEeecc
Q 037702 84 -KIYFAMEYVRGGELFNKVAKG----KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLL----DENGDLKISDFG 154 (448)
Q Consensus 84 -~~~lV~E~~~gg~L~~~i~~~----~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl----~~~g~lkl~DFG 154 (448)
..|+||||++||+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG 161 (396)
T 4eut_A 82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (396)
T ss_dssp CCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGG
T ss_pred CeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCC
Confidence 789999999999999999752 39999999999999999999999999999999999999 777889999999
Q ss_pred ccccccccccCCCccccCCCCcccchhhhhcc-------CCCCCcchHHHHHHHHHHHHhCCCCCCC----CcHHHHHHH
Q 037702 155 LSALQESTRQDGLLHTTCGTPAYVAPEVINKR-------GYDGAKADIWSCGVVLFVLLAGNLPFYD----SNLMELYKK 223 (448)
Q Consensus 155 la~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~-------~~~~~~sDiwSlGvil~elltG~~Pf~~----~~~~~~~~~ 223 (448)
++....... .....+||+.|+|||++... ...+.++|||||||++|+|++|+.||.. ....+...+
T Consensus 162 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~ 238 (396)
T 4eut_A 162 AARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK 238 (396)
T ss_dssp GCEECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHH
T ss_pred CceEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHH
Confidence 998654322 23456899999999998652 2234789999999999999999999964 223444445
Q ss_pred HhhccCC-------------------CC------CCCCHHHHHHHHhccCCCcCCCCCHHHHHhhh
Q 037702 224 ITRAEFK-------------------CP------NWFPPEVRKLLSRILDPNPSTRVTMAKLMENY 264 (448)
Q Consensus 224 i~~~~~~-------------------~p------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 264 (448)
+..+... .| ..+++.+.++|.+||..||.+|||+++++++-
T Consensus 239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l 304 (396)
T 4eut_A 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (396)
T ss_dssp HHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred HhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHH
Confidence 5443221 11 11346788999999999999999999987654
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=360.18 Aligned_cols=245 Identities=27% Similarity=0.506 Sum_probs=207.2
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-CE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASK-TK 84 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~-~~ 84 (448)
.+..++|++.+.||+|+||.||+|.+ +|+.||||++.... ..+.+.+|+.+++.++||||+++++++.+. ..
T Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (278)
T 1byg_A 17 ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 89 (278)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--C
T ss_pred cCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCc
Confidence 45678999999999999999999987 58999999987542 346788999999999999999999987544 57
Q ss_pred EEEEEeecCCCchHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccc
Q 037702 85 IYFAMEYVRGGELFNKVAKG---KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQES 161 (448)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~~---~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~ 161 (448)
.|+||||+++++|.+++... .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred eEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 89999999999999999763 389999999999999999999999999999999999999999999999999875432
Q ss_pred cccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhc-cCCCCCCCCHHH
Q 037702 162 TRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EFKCPNWFPPEV 239 (448)
Q Consensus 162 ~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~ 239 (448)
. .....+|+.|+|||++.+..+ +.++||||||+++|+|++ |..||...+..+....+..+ ....|..+++.+
T Consensus 170 ~-----~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 243 (278)
T 1byg_A 170 T-----QDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAV 243 (278)
T ss_dssp -----------CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHH
T ss_pred c-----ccCCCccccccCHHHhCCCCC-CchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHH
Confidence 2 224468999999999987666 488999999999999998 99999988777777766554 345677899999
Q ss_pred HHHHHhccCCCcCCCCCHHHHHhh
Q 037702 240 RKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 240 ~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
.++|.+||..||.+|||+.++++.
T Consensus 244 ~~li~~~l~~~p~~Rps~~~l~~~ 267 (278)
T 1byg_A 244 YEVMKNCWHLDAAMRPSFLQLREQ 267 (278)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhcCChhhCCCHHHHHHH
Confidence 999999999999999999999863
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-46 Score=382.60 Aligned_cols=249 Identities=28% Similarity=0.430 Sum_probs=211.4
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKI 85 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 85 (448)
.+..++|++.+.||+|+||.||+|.+.. +..||||++...... .+.+.+|+.+|+.++||||+++++++.+ ..+
T Consensus 180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~ 253 (452)
T 1fmk_A 180 EIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 253 (452)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cce
Confidence 3556789999999999999999999864 467999999765422 3678899999999999999999999876 678
Q ss_pred EEEEeecCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccc
Q 037702 86 YFAMEYVRGGELFNKVAK---GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQEST 162 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~ 162 (448)
|+||||+++|+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 254 ~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 254 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 333 (452)
T ss_dssp EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred EEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence 999999999999999964 46999999999999999999999999999999999999999999999999999865422
Q ss_pred ccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhc-cCCCCCCCCHHHH
Q 037702 163 RQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EFKCPNWFPPEVR 240 (448)
Q Consensus 163 ~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 240 (448)
. ........+|+.|+|||++....+ +.++|||||||++|+|++ |..||.+.+..+....+..+ ..+.|..+|+.+.
T Consensus 334 ~-~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~ 411 (452)
T 1fmk_A 334 E-YTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH 411 (452)
T ss_dssp ----------CCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHH
T ss_pred c-eecccCCcccccccCHhHHhcCCC-CccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence 1 111233457889999999987666 489999999999999999 99999998888887777655 3567788999999
Q ss_pred HHHHhccCCCcCCCCCHHHHHh
Q 037702 241 KLLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~eil~ 262 (448)
+||.+||..||.+|||++++++
T Consensus 412 ~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 412 DLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHccCChhhCcCHHHHHH
Confidence 9999999999999999999987
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=368.26 Aligned_cols=252 Identities=25% Similarity=0.379 Sum_probs=212.3
Q ss_pred ccCCeEEEeeeeecCceEEEEEE----ECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE--e
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGR----NLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMA--S 81 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~----~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~--~ 81 (448)
..++|++.+.||+|+||.||+|+ +..+|+.||||++.... ....+.+.+|+.+++.++||||+++++++. +
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 97 (327)
T 3lxl_A 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---PDQQRDFQREIQILKALHSDFIVKYRGVSYGPG 97 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence 45799999999999999999999 56789999999997653 234467899999999999999999999886 5
Q ss_pred CCEEEEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccc
Q 037702 82 KTKIYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQ 159 (448)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~ 159 (448)
...+|+||||+++++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 98 RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp SCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred CceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceec
Confidence 6779999999999999999975 56999999999999999999999999999999999999999999999999999865
Q ss_pred cccccC-CCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHH---------------HHHHH
Q 037702 160 ESTRQD-GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLM---------------ELYKK 223 (448)
Q Consensus 160 ~~~~~~-~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~---------------~~~~~ 223 (448)
...... .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||...... .....
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIF-SRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL 256 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred ccCCccceeeccCCccccccCHHHhccCCC-ChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 432211 12234568999999999977665 48899999999999999999998654322 22222
Q ss_pred Hhhc-cCCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 224 ITRA-EFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 224 i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
+... ....|..+++++.+||.+||..||.+|||+++++++
T Consensus 257 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 257 LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2222 345677899999999999999999999999999875
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=367.07 Aligned_cols=254 Identities=23% Similarity=0.360 Sum_probs=205.2
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE----eCC
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMA----SKT 83 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~----~~~ 83 (448)
..++|++.+.||+|+||.||+|.+..+|+.||||++.... ....+.+.+|+.+++.++||||+++++++. ...
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE---QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKH 103 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC---HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCc
Confidence 4568999999999999999999999999999999986542 234577889999999999999999999986 344
Q ss_pred EEEEEEeecCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccc
Q 037702 84 KIYFAMEYVRGGELFNKVAK-----GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSAL 158 (448)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~ 158 (448)
..|+||||+++|+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 78999999999999998864 5699999999999999999999999999999999999999999999999999875
Q ss_pred ccccccC-------CCccccCCCCcccchhhhhccCC--CCCcchHHHHHHHHHHHHhCCCCCCCCcH--HHHHHHHh-h
Q 037702 159 QESTRQD-------GLLHTTCGTPAYVAPEVINKRGY--DGAKADIWSCGVVLFVLLAGNLPFYDSNL--MELYKKIT-R 226 (448)
Q Consensus 159 ~~~~~~~-------~~~~~~~Gt~~Y~APEvl~~~~~--~~~~sDiwSlGvil~elltG~~Pf~~~~~--~~~~~~i~-~ 226 (448)
....... .......||+.|+|||++....+ .+.++|||||||++|+|++|..||..... ......+. .
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~ 263 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQ 263 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhcc
Confidence 4321111 01123468999999999865432 25789999999999999999999953211 01111111 1
Q ss_pred ccCCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhh
Q 037702 227 AEFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENY 264 (448)
Q Consensus 227 ~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 264 (448)
...+.+..+++++.++|.+||..||.+|||+++++++-
T Consensus 264 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 301 (317)
T 2buj_A 264 LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301 (317)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHh
Confidence 22344456899999999999999999999999999864
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=375.82 Aligned_cols=253 Identities=15% Similarity=0.216 Sum_probs=200.2
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCC-----CcEEEEEEeecccccchhH--------HHHHHHHHHHHHhCCCCCcce
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKT-----GQSVAIKIVDKEKIRRVGL--------IDQIKREISVMRLVRHPNIVQ 74 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~-----g~~vAiK~i~~~~~~~~~~--------~~~~~~Ei~~l~~l~hpnIv~ 74 (448)
..++|++++.||+|+||.||+|.+..+ ++.||||++.......... .....+|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 345999999999999999999998765 5889999987653211000 122345666777888999999
Q ss_pred EEEEEEeC----CEEEEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEc--CCC
Q 037702 75 LYEVMASK----TKIYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLD--ENG 146 (448)
Q Consensus 75 l~~~~~~~----~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~--~~g 146 (448)
+++++... ...||||||+ |++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++ .++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~ 191 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD 191 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTT
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCC
Confidence 99998764 5689999999 9999999975 5799999999999999999999999999999999999999 889
Q ss_pred CeEEeeccccccccccccC-----CCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHH
Q 037702 147 DLKISDFGLSALQESTRQD-----GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELY 221 (448)
Q Consensus 147 ~lkl~DFGla~~~~~~~~~-----~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~ 221 (448)
.+||+|||++......... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+......+
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~ 270 (364)
T 3op5_A 192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAP-SRRGDLEILGYCMIQWLTGHLPWEDNLKDPKY 270 (364)
T ss_dssp CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH
T ss_pred eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCC-CchhhHHHHHHHHHHHHhCCCCccccccCHHH
Confidence 9999999999765433221 11234569999999999987766 58999999999999999999999853221111
Q ss_pred HHHhh----cc-------CCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHh
Q 037702 222 KKITR----AE-------FKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 222 ~~i~~----~~-------~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 262 (448)
..... .. .-.+..+|+++.++|.+||..||.+||++++|++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 271 VRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 11111 00 0112567999999999999999999999999987
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=359.97 Aligned_cols=235 Identities=29% Similarity=0.592 Sum_probs=195.7
Q ss_pred cccccCCeEEE-eeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHH-HhCCCCCcceEEEEEEe-
Q 037702 5 AGILMNKYELG-RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVM-RLVRHPNIVQLYEVMAS- 81 (448)
Q Consensus 5 ~~~~~~~y~~~-~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l-~~l~hpnIv~l~~~~~~- 81 (448)
.+.+.++|.+. +.||+|+||.||+|.+..+|+.||||++... ....+|+.++ +.++||||+++++++..
T Consensus 12 ~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~ 83 (299)
T 3m2w_A 12 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENL 83 (299)
T ss_dssp CSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred ccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhh
Confidence 35677889888 7899999999999999999999999998643 4566888888 66799999999999987
Q ss_pred ---CCEEEEEEeecCCCchHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcC---CCCeEEee
Q 037702 82 ---KTKIYFAMEYVRGGELFNKVAKG---KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDE---NGDLKISD 152 (448)
Q Consensus 82 ---~~~~~lV~E~~~gg~L~~~i~~~---~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~---~g~lkl~D 152 (448)
...+|+||||++||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~D 163 (299)
T 3m2w_A 84 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD 163 (299)
T ss_dssp ETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred cCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEec
Confidence 77899999999999999999752 5999999999999999999999999999999999999998 78899999
Q ss_pred ccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHH----HHhhcc
Q 037702 153 FGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYK----KITRAE 228 (448)
Q Consensus 153 FGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~----~i~~~~ 228 (448)
||++..... ..+ +.++|||||||++|+|++|..||.+.+...... .+....
T Consensus 164 fg~a~~~~~------------------------~~~-~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 218 (299)
T 3m2w_A 164 FGFAKETTG------------------------EKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 218 (299)
T ss_dssp CTTCEECTT------------------------CGG-GGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTC
T ss_pred ccccccccc------------------------ccC-CchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhcc
Confidence 999864211 123 478999999999999999999998765444322 122223
Q ss_pred CCCC----CCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccccccc
Q 037702 229 FKCP----NWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYKK 272 (448)
Q Consensus 229 ~~~p----~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~ 272 (448)
...| ..+++++.+||.+||..||.+|||++++++||||++....
T Consensus 219 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~ 266 (299)
T 3m2w_A 219 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 266 (299)
T ss_dssp CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGS
T ss_pred ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccC
Confidence 3333 4689999999999999999999999999999999876543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-46 Score=366.15 Aligned_cols=251 Identities=24% Similarity=0.406 Sum_probs=199.7
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHh--CCCCCcceEEEEEEeC-
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRL--VRHPNIVQLYEVMASK- 82 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~--l~hpnIv~l~~~~~~~- 82 (448)
..+.++|++.+.||+|+||.||+|++ +|+.||||++.... .....+|..++.. ++||||+++++++...
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 104 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKGT 104 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred cccccceEEEeEeecCCCeEEEEEEE--CCceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence 45668999999999999999999998 48999999986432 1334455555554 4999999999999887
Q ss_pred ---CEEEEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CCEeecCCCCceEEcCCCCeEEe
Q 037702 83 ---TKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSR--------GVYHRDLKPENLLLDENGDLKIS 151 (448)
Q Consensus 83 ---~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~--------givHrDLkp~NILl~~~g~lkl~ 151 (448)
..+|+||||+++|+|.+++..+.+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+
T Consensus 105 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~ 184 (337)
T 3mdy_A 105 GSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA 184 (337)
T ss_dssp GGGCEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred CCCCceEEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence 7899999999999999999888999999999999999999999999 99999999999999999999999
Q ss_pred eccccccccccccC--CCccccCCCCcccchhhhhccCCCCC-----cchHHHHHHHHHHHHhC----------CCCCCC
Q 037702 152 DFGLSALQESTRQD--GLLHTTCGTPAYVAPEVINKRGYDGA-----KADIWSCGVVLFVLLAG----------NLPFYD 214 (448)
Q Consensus 152 DFGla~~~~~~~~~--~~~~~~~Gt~~Y~APEvl~~~~~~~~-----~sDiwSlGvil~elltG----------~~Pf~~ 214 (448)
|||++......... ....+.+||+.|+|||++.+..+... ++|||||||++|+|++| ..||..
T Consensus 185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~ 264 (337)
T 3mdy_A 185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264 (337)
T ss_dssp CCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence 99999754332221 11235689999999999977655422 38999999999999999 777754
Q ss_pred Cc-----HHHHHHHHhhc--cCCCCC-----CCCHHHHHHHHhccCCCcCCCCCHHHHHhhh
Q 037702 215 SN-----LMELYKKITRA--EFKCPN-----WFPPEVRKLLSRILDPNPSTRVTMAKLMENY 264 (448)
Q Consensus 215 ~~-----~~~~~~~i~~~--~~~~p~-----~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 264 (448)
.. .......+... ....|. .+++++.+||.+||+.||.+|||+.+++++-
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 326 (337)
T 3mdy_A 265 LVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL 326 (337)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred hcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHH
Confidence 21 12222222221 222332 2456799999999999999999999999863
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=377.36 Aligned_cols=253 Identities=28% Similarity=0.407 Sum_probs=197.5
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEVMASKTK 84 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~ 84 (448)
..+.+.|.+.+.||+|+||+||.+. ..+|+.||||++..+. .+.+.+|+.+++.+ +||||+++++++.+...
T Consensus 11 ~~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~ 83 (434)
T 2rio_A 11 QSLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRF 83 (434)
T ss_dssp CSCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSE
T ss_pred hhhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCe
Confidence 4566778888999999999998754 4689999999986542 24577899999876 89999999999999999
Q ss_pred EEEEEeecCCCchHHHHhcCCC--------CHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCC-----------
Q 037702 85 IYFAMEYVRGGELFNKVAKGKL--------REEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDEN----------- 145 (448)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~~~l--------~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~----------- 145 (448)
+|+|||||. |+|.+++..... ++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 84 ~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~ 162 (434)
T 2rio_A 84 LYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGA 162 (434)
T ss_dssp EEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCC
T ss_pred EEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCC
Confidence 999999996 599999976432 223457899999999999999999999999999999754
Q ss_pred --CCeEEeeccccccccccccC--CCccccCCCCcccchhhhhc------cCCCCCcchHHHHHHHHHHHHh-CCCCCCC
Q 037702 146 --GDLKISDFGLSALQESTRQD--GLLHTTCGTPAYVAPEVINK------RGYDGAKADIWSCGVVLFVLLA-GNLPFYD 214 (448)
Q Consensus 146 --g~lkl~DFGla~~~~~~~~~--~~~~~~~Gt~~Y~APEvl~~------~~~~~~~sDiwSlGvil~ellt-G~~Pf~~ 214 (448)
+.+||+|||++......... ......+||+.|+|||++.+ ....+.++|||||||++|+|++ |..||.+
T Consensus 163 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~ 242 (434)
T 2rio_A 163 ENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242 (434)
T ss_dssp CSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred CceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCC
Confidence 47999999999865432211 12235689999999999965 1334688999999999999999 9999977
Q ss_pred CcHHHHHHHHhhccCCCCC-------CCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccc
Q 037702 215 SNLMELYKKITRAEFKCPN-------WFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRK 268 (448)
Q Consensus 215 ~~~~~~~~~i~~~~~~~p~-------~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 268 (448)
..... ..+.......+. .+++++.+||.+||..||.+|||+.++++||||..
T Consensus 243 ~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 243 KYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp TTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred chhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 65433 233333333222 23578999999999999999999999999999964
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=358.74 Aligned_cols=242 Identities=29% Similarity=0.509 Sum_probs=199.7
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIY 86 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 86 (448)
+-.++|++.+.||+|+||.||+|.+ .++.||||.+... ...+.+.+|+.+++.++||||+++++++.+ ..|
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~ 75 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVC 75 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTE
T ss_pred CCHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcE
Confidence 3467899999999999999999987 5789999998643 234678899999999999999999998864 479
Q ss_pred EEEeecCCCchHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCCEeecCCCCceEEcCCCC-eEEeecccccc
Q 037702 87 FAMEYVRGGELFNKVAKG----KLREEVARKYFQQLVDAVEFCHS---RGVYHRDLKPENLLLDENGD-LKISDFGLSAL 158 (448)
Q Consensus 87 lV~E~~~gg~L~~~i~~~----~l~e~~~~~~~~qll~aL~yLH~---~givHrDLkp~NILl~~~g~-lkl~DFGla~~ 158 (448)
+||||++||+|.+++... .+++..+..++.|++.||.|||+ +||+||||||+|||++.++. +||+|||++..
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~ 155 (307)
T 2eva_A 76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD 155 (307)
T ss_dssp EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence 999999999999999763 37899999999999999999999 89999999999999999887 79999999975
Q ss_pred ccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCc--HHHHHHHHhh-ccCCCCCCC
Q 037702 159 QESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSN--LMELYKKITR-AEFKCPNWF 235 (448)
Q Consensus 159 ~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~--~~~~~~~i~~-~~~~~p~~~ 235 (448)
.... .....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.... .......+.. .....+..+
T Consensus 156 ~~~~-----~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (307)
T 2eva_A 156 IQTH-----MTNNKGSAAWMAPEVFEGSNY-SEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNL 229 (307)
T ss_dssp --------------CCTTSSCHHHHTCCCC-CTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTC
T ss_pred cccc-----cccCCCCCceEChhhhCCCCC-CcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCccccc
Confidence 4321 234579999999999987666 488999999999999999999997543 2233333333 334556778
Q ss_pred CHHHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 236 PPEVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 236 s~~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
++.+.++|.+||..||.+|||+++++++
T Consensus 230 ~~~l~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 230 PKPIESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 9999999999999999999999999985
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-46 Score=371.06 Aligned_cols=247 Identities=15% Similarity=0.248 Sum_probs=201.4
Q ss_pred cccCCeEEEeeeeecCceEEEEE-----EECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC---CCCcceEEEE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHG-----RNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR---HPNIVQLYEV 78 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a-----~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~---hpnIv~l~~~ 78 (448)
+..++|++.+.||+|+||.||+| .+..+++.||||++.... ...+.+|+.+++.++ |+||++++++
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~~~ 135 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFYSA 135 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence 34578999999999999999999 467789999999996542 245778888988887 9999999999
Q ss_pred EEeCCEEEEEEeecCCCchHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcC--------
Q 037702 79 MASKTKIYFAMEYVRGGELFNKVA------KGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDE-------- 144 (448)
Q Consensus 79 ~~~~~~~~lV~E~~~gg~L~~~i~------~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~-------- 144 (448)
+...+..|+||||++||+|.+++. .+.+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC---
T ss_pred eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccc
Confidence 999999999999999999999995 356999999999999999999999999999999999999998
Q ss_pred ---CCCeEEeeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHH
Q 037702 145 ---NGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELY 221 (448)
Q Consensus 145 ---~g~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~ 221 (448)
++.+||+|||+|...............+||+.|+|||++.+..| +.++|||||||++|+|++|+.||........
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~- 293 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPW-NYQIDYFGVAATVYCMLFGTYMKVKNEGGEC- 293 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCB-STHHHHHHHHHHHHHHHHSSCCCEEEETTEE-
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCC-CccccHHHHHHHHHHHHhCCCccccCCCCce-
Confidence 89999999999976543333334456789999999999988776 4899999999999999999999965432100
Q ss_pred HHHhhccCCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhh
Q 037702 222 KKITRAEFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENY 264 (448)
Q Consensus 222 ~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 264 (448)
.........+.++.+.+++.+||..+|.+|++..+.+.+.
T Consensus 294 ---~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~ 333 (365)
T 3e7e_A 294 ---KPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQK 333 (365)
T ss_dssp ---EECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHH
T ss_pred ---eechhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHH
Confidence 0001111123567899999999999999997655555443
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=368.20 Aligned_cols=245 Identities=16% Similarity=0.233 Sum_probs=202.5
Q ss_pred cCCeEEEeeeeecCceEEEEEEECCC--------CcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcce------
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNLKT--------GQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQ------ 74 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~--------g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~------ 74 (448)
.++|++.+.||+|+||.||+|++..+ ++.||||++... +.+.+|+.+++.++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 47999999999999999999999874 889999998754 34678999999999999988
Q ss_pred ---------EEEEEEe-CCEEEEEEeecCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceE
Q 037702 75 ---------LYEVMAS-KTKIYFAMEYVRGGELFNKVAK---GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLL 141 (448)
Q Consensus 75 ---------l~~~~~~-~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NIL 141 (448)
+++++.. ....|+||||+ +++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl 191 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF 191 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence 6677765 78899999999 9999999975 57999999999999999999999999999999999999
Q ss_pred EcCCC--CeEEeeccccccccccccC-----CCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 037702 142 LDENG--DLKISDFGLSALQESTRQD-----GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYD 214 (448)
Q Consensus 142 l~~~g--~lkl~DFGla~~~~~~~~~-----~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~ 214 (448)
++.++ .+||+|||++......... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||..
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGP-SRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCccc
Confidence 99998 8999999999765433211 12234589999999999987666 4899999999999999999999986
Q ss_pred Cc--HHHHHHHHh---hccCCCC------CCCCHHHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 215 SN--LMELYKKIT---RAEFKCP------NWFPPEVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 215 ~~--~~~~~~~i~---~~~~~~p------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
.. ...+..... .....++ ..+++++.+||.+||..||.+|||++++++.
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 330 (352)
T 2jii_A 271 CLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN 330 (352)
T ss_dssp GTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred CCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence 53 333332222 2212111 2468999999999999999999999999873
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-46 Score=373.35 Aligned_cols=251 Identities=24% Similarity=0.411 Sum_probs=202.3
Q ss_pred CCeEEEeeeeecCceEEEEEEECCCC---cEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE-eCCEE
Q 037702 10 NKYELGRLLGQGTFAKVYHGRNLKTG---QSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMA-SKTKI 85 (448)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~g---~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~-~~~~~ 85 (448)
..|++.+.||+|+||.||+|.+..++ ..||+|.+... ......+.+.+|+.+++.++||||+++++++. .++..
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 166 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 166 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence 35899999999999999999976443 36899998643 23344678899999999999999999999864 45688
Q ss_pred EEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccc
Q 037702 86 YFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTR 163 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~ 163 (448)
|+||||+++|+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 999999999999999976 468999999999999999999999999999999999999999999999999997543322
Q ss_pred cC--CCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhcc-CCCCCCCCHHH
Q 037702 164 QD--GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAE-FKCPNWFPPEV 239 (448)
Q Consensus 164 ~~--~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~ 239 (448)
.. .......||+.|+|||++.+..+. .++|||||||++|+|++ |.+||.+.+..+....+..+. ...|..+++.+
T Consensus 247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~l 325 (373)
T 3c1x_A 247 FDSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPL 325 (373)
T ss_dssp -----------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHHH
T ss_pred cccccccCCCCCcccccChHHhcCCCCC-cHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence 11 112334678899999999877664 89999999999999999 788898776655555555543 45677899999
Q ss_pred HHHHHhccCCCcCCCCCHHHHHhh
Q 037702 240 RKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 240 ~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
.++|.+||..||.+|||+++++++
T Consensus 326 ~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 326 YEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999975
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-46 Score=364.69 Aligned_cols=253 Identities=28% Similarity=0.420 Sum_probs=188.9
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEE------
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR-HPNIVQLYEVMA------ 80 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~------ 80 (448)
...+|++.+.||+|+||.||+|++..+|+.||||++.... ....+.+.+|+.+++.+. ||||+++++++.
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 102 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE---EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES 102 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc---hHHHHHHHHHHHHHHHhccCCChhhcccccccccccc
Confidence 4458999999999999999999999999999999985542 233467889999999996 999999999984
Q ss_pred --eCCEEEEEEeecCCCchHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--CEeecCCCCceEEcCCCCeEEee
Q 037702 81 --SKTKIYFAMEYVRGGELFNKVAK----GKLREEVARKYFQQLVDAVEFCHSRG--VYHRDLKPENLLLDENGDLKISD 152 (448)
Q Consensus 81 --~~~~~~lV~E~~~gg~L~~~i~~----~~l~e~~~~~~~~qll~aL~yLH~~g--ivHrDLkp~NILl~~~g~lkl~D 152 (448)
....+++||||+. |+|.+++.. +.+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|
T Consensus 103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~D 181 (337)
T 3ll6_A 103 DTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCD 181 (337)
T ss_dssp TTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred ccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEec
Confidence 3456899999996 688888753 57999999999999999999999999 99999999999999999999999
Q ss_pred ccccccccccccC----------CCccccCCCCcccchhhhh--ccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHH
Q 037702 153 FGLSALQESTRQD----------GLLHTTCGTPAYVAPEVIN--KRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMEL 220 (448)
Q Consensus 153 FGla~~~~~~~~~----------~~~~~~~Gt~~Y~APEvl~--~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~ 220 (448)
||++......... ......+||+.|+|||++. .....+.++|||||||++|+|++|..||.+......
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~ 261 (337)
T 3ll6_A 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI 261 (337)
T ss_dssp CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh
Confidence 9999865432111 1112457999999999983 222335789999999999999999999987654433
Q ss_pred HHHHhhccCCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhc
Q 037702 221 YKKITRAEFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWF 266 (448)
Q Consensus 221 ~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 266 (448)
.... .....+...++.+.+||.+||+.||.+|||+.+++++.+-
T Consensus 262 ~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 305 (337)
T 3ll6_A 262 VNGK--YSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQE 305 (337)
T ss_dssp ------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred hcCc--ccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 3221 1233445678899999999999999999999999998653
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=378.91 Aligned_cols=250 Identities=23% Similarity=0.363 Sum_probs=196.5
Q ss_pred CeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEE
Q 037702 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEVMASKTKIYFAM 89 (448)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~ 89 (448)
+|++.+.||+|+||.|+. ....+|+.||||++...... .+.+|+.+|+.+ +||||+++++++.+....|+||
T Consensus 25 ~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~------~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFS------FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp EEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEE------ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred EEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHH------HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 599999999999999764 33468999999999765432 245799999999 8999999999999999999999
Q ss_pred eecCCCchHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCC-----CCeEEeecccccccccc
Q 037702 90 EYVRGGELFNKVAKG--KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDEN-----GDLKISDFGLSALQEST 162 (448)
Q Consensus 90 E~~~gg~L~~~i~~~--~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~-----g~lkl~DFGla~~~~~~ 162 (448)
|||. |+|.+++... .+.+..++.++.||+.||.|||++||+||||||+|||++.+ ..+||+|||+|......
T Consensus 98 E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~ 176 (432)
T 3p23_A 98 ELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176 (432)
T ss_dssp ECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred ECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence 9996 5999999763 46666788999999999999999999999999999999532 35889999999865432
Q ss_pred cc-CCCccccCCCCcccchhhhhcc--CCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhccCCC---CCCC
Q 037702 163 RQ-DGLLHTTCGTPAYVAPEVINKR--GYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAEFKC---PNWF 235 (448)
Q Consensus 163 ~~-~~~~~~~~Gt~~Y~APEvl~~~--~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~---p~~~ 235 (448)
.. .......+||+.|+|||++.+. ...+.++|||||||++|+|++ |..||...........+....... +...
T Consensus 177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (432)
T 3p23_A 177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHE 256 (432)
T ss_dssp ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTCHH
T ss_pred CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCccccc
Confidence 21 1223456899999999999742 233568999999999999999 999997665544433332222221 1223
Q ss_pred CHHHHHHHHhccCCCcCCCCCHHHHHhhhhccc
Q 037702 236 PPEVRKLLSRILDPNPSTRVTMAKLMENYWFRK 268 (448)
Q Consensus 236 s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 268 (448)
+..+.+||.+||+.||.+|||++++++||||..
T Consensus 257 ~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 257 DVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp HHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred cHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 566899999999999999999999999999965
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-46 Score=362.23 Aligned_cols=248 Identities=28% Similarity=0.390 Sum_probs=203.7
Q ss_pred eEEEeeeeecCceEEEEEEECCCCcEEEEEEeeccc-ccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 037702 12 YELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEK-IRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAME 90 (448)
Q Consensus 12 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~-~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (448)
|..++.||+|+||.||+|.+ ++..||||++.... .......+.+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence 44458999999999999986 68899999997543 2333456789999999999999999999999999999999999
Q ss_pred ecCCCchHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCC
Q 037702 91 YVRGGELFNKVAK----GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDG 166 (448)
Q Consensus 91 ~~~gg~L~~~i~~----~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 166 (448)
|+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 190 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCE
T ss_pred ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccc
Confidence 9999999999863 469999999999999999999999999999999999999999999999999998654332222
Q ss_pred CccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHH----HHHHHhhccC-----------CC
Q 037702 167 LLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLME----LYKKITRAEF-----------KC 231 (448)
Q Consensus 167 ~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~----~~~~i~~~~~-----------~~ 231 (448)
.....+||+.|+|||++.+. + +.++|||||||++|+|++|..||...+... ....+..... ..
T Consensus 191 ~~~~~~g~~~y~aPE~~~~~-~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (307)
T 2nru_A 191 MTSRIVGTTAYMAPEALRGE-I-TPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDA 268 (307)
T ss_dssp ECSSCCSCGGGCCHHHHTTE-E-CTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCC
T ss_pred cccccCCCcCcCChHHhcCC-C-CccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccccccc
Confidence 23346799999999998653 3 588999999999999999999998654322 2222211111 11
Q ss_pred CCCCCHHHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 232 PNWFPPEVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 232 p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
+...++.+.++|.+||..||.+|||+.+++++
T Consensus 269 ~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 269 DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp CHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred chHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 22245778999999999999999999999975
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=389.65 Aligned_cols=251 Identities=25% Similarity=0.372 Sum_probs=210.3
Q ss_pred ccCCeEEEe-eeeecCceEEEEEEECC--CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 037702 8 LMNKYELGR-LLGQGTFAKVYHGRNLK--TGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTK 84 (448)
Q Consensus 8 ~~~~y~~~~-~LG~G~fg~Vy~a~~~~--~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 84 (448)
..++|.+.+ .||+|+||.||+|.+.. ++..||||++..... ....+.+.+|+.+|+.++||||+++++++.. +.
T Consensus 333 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~ 409 (613)
T 2ozo_A 333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--KADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA 409 (613)
T ss_dssp CTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCS--STTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SS
T ss_pred cccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CC
Confidence 345667776 89999999999998753 566799999976532 2345788999999999999999999999976 56
Q ss_pred EEEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccc
Q 037702 85 IYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQEST 162 (448)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~ 162 (448)
+|+||||+++|+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 410 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~ 489 (613)
T 2ozo_A 410 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489 (613)
T ss_dssp EEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred eEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence 9999999999999999964 56999999999999999999999999999999999999999999999999999865332
Q ss_pred ccC-CCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhcc-CCCCCCCCHHH
Q 037702 163 RQD-GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAE-FKCPNWFPPEV 239 (448)
Q Consensus 163 ~~~-~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~ 239 (448)
... .......+|+.|+|||++....++ .++|||||||+||||++ |..||.+.+..++...+..+. ...|..+++++
T Consensus 490 ~~~~~~~~~~~~~~~y~APE~~~~~~~~-~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l 568 (613)
T 2ozo_A 490 DSYYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPEL 568 (613)
T ss_dssp ------------CCTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred CceeeeccCCCCccceeCHhhhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHH
Confidence 211 111233467899999999877764 89999999999999998 999999988888888777654 46788899999
Q ss_pred HHHHHhccCCCcCCCCCHHHHHh
Q 037702 240 RKLLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 240 ~~li~~~L~~dP~~Rpt~~eil~ 262 (448)
.+||.+||..||.+|||++++++
T Consensus 569 ~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 569 YALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp HHHHHHTTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999999854
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=390.28 Aligned_cols=248 Identities=25% Similarity=0.382 Sum_probs=209.1
Q ss_pred eEEE-eeeeecCceEEEEEEE--CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 037702 12 YELG-RLLGQGTFAKVYHGRN--LKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFA 88 (448)
Q Consensus 12 y~~~-~~LG~G~fg~Vy~a~~--~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 88 (448)
+.+. +.||+|+||.||+|.+ ..+++.||||++..... .....+.+.+|+.+|+.++||||+++++++.. +..++|
T Consensus 370 ~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv 447 (635)
T 4fl3_A 370 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLV 447 (635)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGG-CGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred ccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEE
Confidence 4443 4799999999999955 45678999999976533 23445789999999999999999999999965 458899
Q ss_pred EeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccC-C
Q 037702 89 MEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQD-G 166 (448)
Q Consensus 89 ~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~-~ 166 (448)
|||+++|+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|......... .
T Consensus 448 ~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 448 MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred EEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 999999999999976 57999999999999999999999999999999999999999999999999999865432211 1
Q ss_pred CccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhcc-CCCCCCCCHHHHHHHH
Q 037702 167 LLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAE-FKCPNWFPPEVRKLLS 244 (448)
Q Consensus 167 ~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~ 244 (448)
......||+.|+|||++....+. .++|||||||+||+|++ |..||.+.+..++...+..+. ..+|..+|+++.+||.
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~-~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~ 606 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMN 606 (635)
T ss_dssp -------CGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred cccCCCCceeeeChhhhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 22334578899999999877764 89999999999999998 999999998888888777664 4678889999999999
Q ss_pred hccCCCcCCCCCHHHHHh
Q 037702 245 RILDPNPSTRVTMAKLME 262 (448)
Q Consensus 245 ~~L~~dP~~Rpt~~eil~ 262 (448)
+||..||.+|||++++++
T Consensus 607 ~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 607 LCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp HHTCSSTTTSCCHHHHHH
T ss_pred HHcCCCHhHCcCHHHHHH
Confidence 999999999999999976
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=385.86 Aligned_cols=250 Identities=28% Similarity=0.426 Sum_probs=216.2
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKI 85 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 85 (448)
.+..++|++.+.||+|+||.||+|.+.. +..||||++...... .+.+.+|+.+|+.++||||+++++++.+ ..+
T Consensus 263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~ 336 (535)
T 2h8h_A 263 EIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 336 (535)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccc
Confidence 4566789999999999999999999864 467999999765432 3678899999999999999999999876 678
Q ss_pred EEEEeecCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccc
Q 037702 86 YFAMEYVRGGELFNKVAK---GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQEST 162 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~ 162 (448)
||||||+++|+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 337 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 416 (535)
T 2h8h_A 337 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 416 (535)
T ss_dssp EEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred eEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence 999999999999999964 46999999999999999999999999999999999999999999999999999865322
Q ss_pred ccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhc-cCCCCCCCCHHHH
Q 037702 163 RQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EFKCPNWFPPEVR 240 (448)
Q Consensus 163 ~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 240 (448)
.. .......+|+.|+|||++....+ +.++|||||||+||+|++ |..||.+....++...+..+ ....|..+++++.
T Consensus 417 ~~-~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~ 494 (535)
T 2h8h_A 417 EY-TARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH 494 (535)
T ss_dssp HH-HTTCSTTSCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred ce-ecccCCcCcccccCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence 11 11123457889999999987666 489999999999999999 99999998888887777655 3466788999999
Q ss_pred HHHHhccCCCcCCCCCHHHHHhh
Q 037702 241 KLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~eil~h 263 (448)
+||.+||..||++|||+++|++.
T Consensus 495 ~li~~cl~~dP~~RPt~~~l~~~ 517 (535)
T 2h8h_A 495 DLMCQCWRKEPEERPTFEYLQAF 517 (535)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHHHHH
Confidence 99999999999999999999873
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=367.09 Aligned_cols=255 Identities=22% Similarity=0.362 Sum_probs=206.1
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKI 85 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 85 (448)
....++|++.+.||+|+||.||+|.+ .+|+.||||++........ ...+.+|+.+++.++||||+++++++.+.+..
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 102 (326)
T 3uim_A 26 QVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGG--ELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 102 (326)
T ss_dssp HTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----C--CCHHHHHHHGGGTCCCTTBCCCCEEECCSSCC
T ss_pred HHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchH--HHHHHHHHHHHHhccCCCccceEEEEecCCce
Confidence 35678999999999999999999985 4799999999976543321 23578999999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCEeecCCCCceEEcCCCCeEEeeccccc
Q 037702 86 YFAMEYVRGGELFNKVAKG-----KLREEVARKYFQQLVDAVEFCHSR---GVYHRDLKPENLLLDENGDLKISDFGLSA 157 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~~-----~l~e~~~~~~~~qll~aL~yLH~~---givHrDLkp~NILl~~~g~lkl~DFGla~ 157 (448)
++||||+++|+|.+++... .+++..++.++.|++.||+|||++ ||+||||||+|||++.++.+||+|||++.
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~ 182 (326)
T 3uim_A 103 LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 182 (326)
T ss_dssp EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCE
T ss_pred EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcccc
Confidence 9999999999999999752 399999999999999999999999 99999999999999999999999999998
Q ss_pred cccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCc--------HHHHHHHHhhcc-
Q 037702 158 LQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSN--------LMELYKKITRAE- 228 (448)
Q Consensus 158 ~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~--------~~~~~~~i~~~~- 228 (448)
...... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.... ..+.........
T Consensus 183 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (326)
T 3uim_A 183 LMDYKD-THVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 260 (326)
T ss_dssp ECCSSS-SCEECCCCSCGGGCCHHHHHHSEE-CHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCC
T ss_pred ccCccc-ccccccccCCcCccCHHHhccCCC-CccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchh
Confidence 654322 222344569999999999977665 589999999999999999999995211 111111111110
Q ss_pred ------C----CCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhh
Q 037702 229 ------F----KCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYW 265 (448)
Q Consensus 229 ------~----~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 265 (448)
. ..+...++.+.+++.+||+.||.+|||+.++++|-+
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 261 LEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp STTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred hhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 0 111112367899999999999999999999999875
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=363.76 Aligned_cols=250 Identities=21% Similarity=0.372 Sum_probs=193.6
Q ss_pred cccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHH--HHHHHHHhCCCCCcceEEEEEEe-
Q 037702 5 AGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIK--REISVMRLVRHPNIVQLYEVMAS- 81 (448)
Q Consensus 5 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~--~Ei~~l~~l~hpnIv~l~~~~~~- 81 (448)
.++..++|++.+.||+|+||.||+|++ +|+.||||++..... ..+. .|+..+..++||||+++++.+..
T Consensus 8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~------~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 79 (336)
T 3g2f_A 8 PSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR------QNFINEKNIYRVPLMEHDNIARFIVGDERV 79 (336)
T ss_dssp -CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGH------HHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred CCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccch------hhHHHHHHHHHHHhccCcchhhheeccccc
Confidence 457789999999999999999999987 789999999975431 2233 34444556899999999986542
Q ss_pred ----CCEEEEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---------CCEeecCCCCceEEcCCCCe
Q 037702 82 ----KTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSR---------GVYHRDLKPENLLLDENGDL 148 (448)
Q Consensus 82 ----~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~---------givHrDLkp~NILl~~~g~l 148 (448)
...+|+||||+++|+|.+++.....++..++.++.||+.||.|||++ ||+||||||+|||++.++.+
T Consensus 80 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~ 159 (336)
T 3g2f_A 80 TADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTC 159 (336)
T ss_dssp CTTSCEEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCE
T ss_pred ccCCCceEEEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcE
Confidence 33678999999999999999888889999999999999999999999 99999999999999999999
Q ss_pred EEeeccccccccccc------cCCCccccCCCCcccchhhhhcc------CCCCCcchHHHHHHHHHHHHhCCCCCCCCc
Q 037702 149 KISDFGLSALQESTR------QDGLLHTTCGTPAYVAPEVINKR------GYDGAKADIWSCGVVLFVLLAGNLPFYDSN 216 (448)
Q Consensus 149 kl~DFGla~~~~~~~------~~~~~~~~~Gt~~Y~APEvl~~~------~~~~~~sDiwSlGvil~elltG~~Pf~~~~ 216 (448)
||+|||++....... ........+||+.|+|||++.+. ...+.++|||||||++|+|++|..||....
T Consensus 160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 239 (336)
T 3g2f_A 160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239 (336)
T ss_dssp EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTS
T ss_pred EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCcc
Confidence 999999997653221 11222355799999999999752 122367999999999999999977764321
Q ss_pred ------------------HHHHHHHHhhc--cCCCCCC------CCHHHHHHHHhccCCCcCCCCCHHHHHh
Q 037702 217 ------------------LMELYKKITRA--EFKCPNW------FPPEVRKLLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 217 ------------------~~~~~~~i~~~--~~~~p~~------~s~~~~~li~~~L~~dP~~Rpt~~eil~ 262 (448)
.......+... ...+|.. +++++.+||.+||..||.+|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~ 311 (336)
T 3g2f_A 240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE 311 (336)
T ss_dssp CCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred chhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence 11111111111 2233333 2357999999999999999999999965
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=359.22 Aligned_cols=253 Identities=23% Similarity=0.381 Sum_probs=209.7
Q ss_pred ccccCCeEEEeeeeecCceEEEEEE----ECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGR----NLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMAS 81 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~----~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~ 81 (448)
.+..++|++.+.||+|+||.||+|+ +..+|+.||||++.... ....+.+.+|+.+++.++||||+++++++..
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 113 (326)
T 2w1i_A 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS 113 (326)
T ss_dssp CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC---SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC
T ss_pred ccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Confidence 4566789999999999999999998 46689999999997542 2345778999999999999999999999865
Q ss_pred CC--EEEEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccc
Q 037702 82 KT--KIYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSA 157 (448)
Q Consensus 82 ~~--~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~ 157 (448)
.+ .+++||||+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 114 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 114 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp ----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred cCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchh
Confidence 44 78999999999999999976 459999999999999999999999999999999999999999999999999998
Q ss_pred cccccccC-CCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHH----------------HH
Q 037702 158 LQESTRQD-GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLM----------------EL 220 (448)
Q Consensus 158 ~~~~~~~~-~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~----------------~~ 220 (448)
........ .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||...... .+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 272 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred hccccccccccccCCCCceeEECchhhcCCCC-CchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH
Confidence 65432211 11233467889999999987666 48899999999999999999998643110 11
Q ss_pred HHHHhh-ccCCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHh
Q 037702 221 YKKITR-AEFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 221 ~~~i~~-~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 262 (448)
...+.. ...+.|..+++++.++|.+||..||.+|||+.++++
T Consensus 273 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 273 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 122222 234567789999999999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=361.28 Aligned_cols=254 Identities=27% Similarity=0.431 Sum_probs=210.6
Q ss_pred cccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 037702 5 AGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTK 84 (448)
Q Consensus 5 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 84 (448)
..+..++|++.+.||+|+||.||+|.+.. .+|+|++....... ...+.+.+|+.+++.++||||+++++++.+...
T Consensus 28 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (319)
T 2y4i_B 28 WDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNE-DQLKAFKREVMAYRQTRHENVVLFMGACMSPPH 103 (319)
T ss_dssp SSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCC-CCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred ccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCH-HHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence 45678999999999999999999999743 49999997653322 223456789999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccc
Q 037702 85 IYFAMEYVRGGELFNKVAKG--KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQEST 162 (448)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~~--~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~ 162 (448)
+++||||++|++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||++......
T Consensus 104 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~ 182 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL 182 (319)
T ss_dssp EEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred eEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence 99999999999999999863 599999999999999999999999999999999999998 789999999998754321
Q ss_pred ---ccCCCccccCCCCcccchhhhhcc--------CCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCC
Q 037702 163 ---RQDGLLHTTCGTPAYVAPEVINKR--------GYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKC 231 (448)
Q Consensus 163 ---~~~~~~~~~~Gt~~Y~APEvl~~~--------~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~ 231 (448)
..........||+.|+|||++... ...+.++|||||||++|+|++|..||...+.......+.......
T Consensus 183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 262 (319)
T 2y4i_B 183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPN 262 (319)
T ss_dssp -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCC
T ss_pred cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCC
Confidence 112233455799999999998642 223578999999999999999999999988887777776654332
Q ss_pred --CCCCCHHHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 232 --PNWFPPEVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 232 --p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
+..+++++.++|.+||..||.+|||+.++++.
T Consensus 263 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~ 296 (319)
T 2y4i_B 263 LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296 (319)
T ss_dssp CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 23578999999999999999999999999973
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=374.41 Aligned_cols=249 Identities=25% Similarity=0.370 Sum_probs=209.0
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCC-CCcceEEEEEEeCCEE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRH-PNIVQLYEVMASKTKI 85 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~h-pnIv~l~~~~~~~~~~ 85 (448)
.+.++|++.+.||+|+||.||+|++..+|+.||||++...... ..+.+|+.+++.++| ++|..+..++......
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~ 78 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYN 78 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEE
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEE
Confidence 4678999999999999999999999999999999998765432 346789999999987 5566666677888999
Q ss_pred EEEEeecCCCchHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEE---cCCCCeEEeecccccccc
Q 037702 86 YFAMEYVRGGELFNKVA--KGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLL---DENGDLKISDFGLSALQE 160 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~--~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl---~~~g~lkl~DFGla~~~~ 160 (448)
||||||+ +++|.+++. .+.+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++....
T Consensus 79 ~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 9999999 999999997 4689999999999999999999999999999999999999 688999999999998654
Q ss_pred ccccC-----CCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCc---HHHHHHHHhhccC---
Q 037702 161 STRQD-----GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSN---LMELYKKITRAEF--- 229 (448)
Q Consensus 161 ~~~~~-----~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~---~~~~~~~i~~~~~--- 229 (448)
..... ......+||+.|+|||++.+..+ +.++|||||||+||+|++|+.||.+.. ..+.+.++.....
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS 236 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence 33221 11235689999999999987776 488999999999999999999998743 3344444433322
Q ss_pred --CCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHh
Q 037702 230 --KCPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 230 --~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 262 (448)
..+..+++++.+||.+||..||.+||++++|++
T Consensus 237 ~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 223568999999999999999999999998765
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=357.44 Aligned_cols=249 Identities=25% Similarity=0.426 Sum_probs=205.3
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHh--CCCCCcceEEEEEEeCC-
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRL--VRHPNIVQLYEVMASKT- 83 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~--l~hpnIv~l~~~~~~~~- 83 (448)
.+.++|++.+.||+|+||.||+|.+ +|+.||||++.... ...+.+|+.+++. ++||||+++++++....
T Consensus 39 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~ 110 (342)
T 1b6c_B 39 TIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNG 110 (342)
T ss_dssp HHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred cccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence 3557899999999999999999998 68999999986432 2567789999988 79999999999998876
Q ss_pred ---EEEEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HCCCEeecCCCCceEEcCCCCeEEee
Q 037702 84 ---KIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCH--------SRGVYHRDLKPENLLLDENGDLKISD 152 (448)
Q Consensus 84 ---~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH--------~~givHrDLkp~NILl~~~g~lkl~D 152 (448)
.+|+||||+++|+|.+++..+++++..++.++.||+.||.||| ++||+||||||+|||++.++.+||+|
T Consensus 111 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 190 (342)
T 1b6c_B 111 TWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 190 (342)
T ss_dssp SCCCEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECC
T ss_pred ccceeEEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEE
Confidence 8999999999999999999888999999999999999999999 89999999999999999999999999
Q ss_pred ccccccccccccC--CCccccCCCCcccchhhhhccCCC-----CCcchHHHHHHHHHHHHhC----------CCCCCCC
Q 037702 153 FGLSALQESTRQD--GLLHTTCGTPAYVAPEVINKRGYD-----GAKADIWSCGVVLFVLLAG----------NLPFYDS 215 (448)
Q Consensus 153 FGla~~~~~~~~~--~~~~~~~Gt~~Y~APEvl~~~~~~-----~~~sDiwSlGvil~elltG----------~~Pf~~~ 215 (448)
||++......... ......+||+.|+|||++.+.... +.++|||||||++|+|++| ..||...
T Consensus 191 fg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~ 270 (342)
T 1b6c_B 191 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 270 (342)
T ss_dssp CTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcccc
Confidence 9999765432211 022456799999999999754322 1579999999999999999 8898764
Q ss_pred -----cHHHHHHHHhhccC--CCCCC-----CCHHHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 216 -----NLMELYKKITRAEF--KCPNW-----FPPEVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 216 -----~~~~~~~~i~~~~~--~~p~~-----~s~~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
....+...+..... ..|.. .++.+.+||.+||..||.+|||+++++++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 271 VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp SCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred CcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 23344444433322 22221 23578999999999999999999999986
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=375.42 Aligned_cols=249 Identities=19% Similarity=0.254 Sum_probs=196.2
Q ss_pred cCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCC-CCc---------ce----
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRH-PNI---------VQ---- 74 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~h-pnI---------v~---- 74 (448)
...|.+++.||+|+||.||+|.+..+|+.||||++...........+.+.+|+.+++.+.| +|. +.
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 3458899999999999999999999999999999875444333345779999999999987 221 11
Q ss_pred --------EEEEEEe-----CCEEEEEEeecCCCchHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHCCCEee
Q 037702 75 --------LYEVMAS-----KTKIYFAMEYVRGGELFNKVA--------KGKLREEVARKYFQQLVDAVEFCHSRGVYHR 133 (448)
Q Consensus 75 --------l~~~~~~-----~~~~~lV~E~~~gg~L~~~i~--------~~~l~e~~~~~~~~qll~aL~yLH~~givHr 133 (448)
+..++.. ...++++|+++ +++|.+++. .+.+++..+..++.||+.||+|||++||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHr 235 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 235 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 1111111 22467777766 679998884 2347788899999999999999999999999
Q ss_pred cCCCCceEEcCCCCeEEeeccccccccccccCCCccccCCCCcccchhhhh----------ccCCCCCcchHHHHHHHHH
Q 037702 134 DLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVIN----------KRGYDGAKADIWSCGVVLF 203 (448)
Q Consensus 134 DLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~----------~~~~~~~~sDiwSlGvil~ 203 (448)
||||+|||++.++.+||+|||++...... ..+.+| +.|+|||++. ...| +.++|||||||++|
T Consensus 236 DiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~-~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 236 YLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLM-TFAFDTWTLGLAIY 308 (413)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEE-CHHHHHHHHHHHHH
T ss_pred CcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCC-CchhhHHHHHHHHH
Confidence 99999999999999999999998764332 346688 9999999994 2223 47899999999999
Q ss_pred HHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 204 VLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 204 elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
+|++|+.||...+.......+. .....+|+++.+||.+||..||.+|||+.++++||||+.-
T Consensus 309 elltg~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~ 370 (413)
T 3dzo_A 309 WIWCADLPNTDDAALGGSEWIF----RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 370 (413)
T ss_dssp HHHHSSCCCCTTGGGSCSGGGG----SSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred HHHHCCCCCCCcchhhhHHHHH----hhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence 9999999998876544433332 2234678999999999999999999999999999999763
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=372.30 Aligned_cols=245 Identities=19% Similarity=0.288 Sum_probs=199.2
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeeccccc-----chhHHHHHHHHHHHHHhCC---------CCCc
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIR-----RVGLIDQIKREISVMRLVR---------HPNI 72 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~-----~~~~~~~~~~Ei~~l~~l~---------hpnI 72 (448)
+..++|++.+.||+|+||.||+|++ +|+.||||++...... .....+.+.+|+.+++.++ ||||
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni 94 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF 94 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred cccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence 3467899999999999999999998 7899999999876432 2233477889999999886 8888
Q ss_pred ceEEEEEE------------------------------eCCEEEEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHH
Q 037702 73 VQLYEVMA------------------------------SKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAV 122 (448)
Q Consensus 73 v~l~~~~~------------------------------~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL 122 (448)
+++.+++. ....+|+||||+++|++.+.+.++.+++..++.++.||+.||
T Consensus 95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASL 174 (336)
T ss_dssp CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHH
T ss_pred hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence 88877653 267899999999999888888778899999999999999999
Q ss_pred HHHH-HCCCEeecCCCCceEEcCCC--------------------CeEEeeccccccccccccCCCccccCCCCcccchh
Q 037702 123 EFCH-SRGVYHRDLKPENLLLDENG--------------------DLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPE 181 (448)
Q Consensus 123 ~yLH-~~givHrDLkp~NILl~~~g--------------------~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE 181 (448)
+||| ++||+||||||+|||++.++ .+||+|||+|+.... .+.+||+.|+|||
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~aPE 247 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSMDED 247 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTTCSG
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecccChh
Confidence 9999 99999999999999999987 899999999986532 2458999999999
Q ss_pred hhhccCCCCCcchHHHHHHH-HHHHHhCCCCCCCCcH-HHHHHHHhhc-cCC--C----CCCCCHHHHHHHHhccCCCcC
Q 037702 182 VINKRGYDGAKADIWSCGVV-LFVLLAGNLPFYDSNL-MELYKKITRA-EFK--C----PNWFPPEVRKLLSRILDPNPS 252 (448)
Q Consensus 182 vl~~~~~~~~~sDiwSlGvi-l~elltG~~Pf~~~~~-~~~~~~i~~~-~~~--~----p~~~s~~~~~li~~~L~~dP~ 252 (448)
++.+.. +.++||||||++ .+++++|..||.+... ......+... ... . ++.+|+++++||.+||+.|
T Consensus 248 ~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-- 323 (336)
T 2vuw_A 248 LFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-- 323 (336)
T ss_dssp GGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS--
T ss_pred hhcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC--
Confidence 997654 588999998777 7788899999854321 1222233211 111 1 1236789999999999976
Q ss_pred CCCCHHHHH-hhhhcc
Q 037702 253 TRVTMAKLM-ENYWFR 267 (448)
Q Consensus 253 ~Rpt~~eil-~hp~~~ 267 (448)
|++|+| +||||+
T Consensus 324 ---sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 324 ---SATDLLCQHSLFK 336 (336)
T ss_dssp ---SHHHHHHHCGGGC
T ss_pred ---CHHHHHhcCCCcC
Confidence 999999 999995
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=385.88 Aligned_cols=253 Identities=28% Similarity=0.431 Sum_probs=214.6
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCC---CcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKT---GQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASK 82 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~ 82 (448)
.+..++|++++.||+|+||.||+|.+..+ +..||||.+.... .....+.+.+|+.+++.++||||+++++++. .
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 462 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 462 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence 35567899999999999999999998654 4579999886532 2344577899999999999999999999985 4
Q ss_pred CEEEEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccc
Q 037702 83 TKIYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQE 160 (448)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~ 160 (448)
+..|+||||+++|+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence 568999999999999999975 368999999999999999999999999999999999999999999999999998653
Q ss_pred ccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhcc-CCCCCCCCHH
Q 037702 161 STRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAE-FKCPNWFPPE 238 (448)
Q Consensus 161 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~ 238 (448)
.... .......||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+..+....+..+. ...|+.+++.
T Consensus 543 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 620 (656)
T 2j0j_A 543 DSTY-YKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPT 620 (656)
T ss_dssp C-----------CCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCHH
T ss_pred CCcc-eeccCCCCCcceeCHHHhcCCCC-CchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccHH
Confidence 3221 11234567889999999987766 488999999999999997 999999988888887776654 4678889999
Q ss_pred HHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 239 VRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 239 ~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
+.+||.+||..||.+|||+.++++.
T Consensus 621 l~~li~~~l~~dP~~RPs~~el~~~ 645 (656)
T 2j0j_A 621 LYSLMTKCWAYDPSRRPRFTELKAQ 645 (656)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHH
Confidence 9999999999999999999999874
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-44 Score=345.35 Aligned_cols=225 Identities=16% Similarity=0.245 Sum_probs=192.7
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIY 86 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 86 (448)
++.++|++.+.||+|+||.||+|.+..+|+.||||++...........+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 57789999999999999999999999999999999998776555556678999999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCC
Q 037702 87 FAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDG 166 (448)
Q Consensus 87 lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 166 (448)
+||||++|++|.+++..+ ....++..++.||+.||+|||++||+||||||+|||++.+|.+||+++|
T Consensus 108 lv~e~~~g~~L~~~l~~~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~------------ 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADTS-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA------------ 174 (286)
T ss_dssp EEEECCCEEEHHHHHTTC-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC------------
T ss_pred EEEEecCCCCHHHHHhcC-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc------------
Confidence 999999999999999766 4666788999999999999999999999999999999999999998443
Q ss_pred CccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHH---HHhhccC----CCCCCCCHHH
Q 037702 167 LLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYK---KITRAEF----KCPNWFPPEV 239 (448)
Q Consensus 167 ~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~---~i~~~~~----~~p~~~s~~~ 239 (448)
|++| .+.++|||||||++|+|++|+.||.+.+...... +...... ..+..+|+++
T Consensus 175 ----------~~~~--------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (286)
T 3uqc_A 175 ----------TMPD--------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQI 236 (286)
T ss_dssp ----------CCTT--------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHH
T ss_pred ----------ccCC--------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHH
Confidence 3333 3588999999999999999999998765422110 1111111 1235689999
Q ss_pred HHHHHhccCCCcCCCCCHHHHHhh
Q 037702 240 RKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 240 ~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
.++|.+||+.||.+| |++++++.
T Consensus 237 ~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 237 SAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp HHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred HHHHHHHcccCCccC-CHHHHHHH
Confidence 999999999999999 99999974
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=392.01 Aligned_cols=258 Identities=27% Similarity=0.394 Sum_probs=206.2
Q ss_pred cccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe---
Q 037702 5 AGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMAS--- 81 (448)
Q Consensus 5 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--- 81 (448)
++...++|++.+.||+|+||.||+|.+..+|+.||||++.... .....+.+.+|+.+++.++||||+++++++..
T Consensus 9 pg~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~ 86 (676)
T 3qa8_A 9 PTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQK 86 (676)
T ss_dssp --------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCC
T ss_pred CCCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeeccccc
Confidence 3456799999999999999999999999999999999987542 23445778999999999999999999998765
Q ss_pred ---CCEEEEEEeecCCCchHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCC---eEEe
Q 037702 82 ---KTKIYFAMEYVRGGELFNKVAKG----KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGD---LKIS 151 (448)
Q Consensus 82 ---~~~~~lV~E~~~gg~L~~~i~~~----~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~---lkl~ 151 (448)
+...|+||||++||+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+
T Consensus 87 ~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~ 166 (676)
T 3qa8_A 87 LAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKII 166 (676)
T ss_dssp CCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred ccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEc
Confidence 67789999999999999999762 5999999999999999999999999999999999999998775 9999
Q ss_pred eccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH--------
Q 037702 152 DFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKK-------- 223 (448)
Q Consensus 152 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~-------- 223 (448)
|||++...... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||........+..
T Consensus 167 DFG~a~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~-s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~ 242 (676)
T 3qa8_A 167 DLGYAKELDQG---ELCTEFVGTLQYLAPELLEQKKY-TVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNE 242 (676)
T ss_dssp SCCCCCBTTSC---CCCCCCCSCCTTCSSCSSCCSCC-STTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC-----
T ss_pred ccccccccccc---cccccccCCcccCChHHhccCCC-CchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccch
Confidence 99999865332 22345689999999999977666 4889999999999999999999976432221100
Q ss_pred -H-----hhccC------CCC----CCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccc
Q 037702 224 -I-----TRAEF------KCP----NWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRK 268 (448)
Q Consensus 224 -i-----~~~~~------~~p----~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 268 (448)
+ ..+.. +.| ..+++.+.+||.+||..||.+|||++++++||||+.
T Consensus 243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 0 01111 111 125688999999999999999999999999999976
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-44 Score=385.26 Aligned_cols=245 Identities=27% Similarity=0.372 Sum_probs=202.7
Q ss_pred cccccCCeEEEeeeeecCceEEEEEEECC-CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 037702 5 AGILMNKYELGRLLGQGTFAKVYHGRNLK-TGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKT 83 (448)
Q Consensus 5 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~-~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~ 83 (448)
+.++.++|++.+.||+|+||.||+|.+.. +|+.||||++.... .......+.+|+.+++.++||||+++++++...+
T Consensus 75 g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 152 (681)
T 2pzi_A 75 GDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTD 152 (681)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEEC
T ss_pred CCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecC
Confidence 34667999999999999999999999976 78999999986542 2244567889999999999999999999998765
Q ss_pred E-----EEEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccc
Q 037702 84 K-----IYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSAL 158 (448)
Q Consensus 84 ~-----~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~ 158 (448)
. .||||||++|++|.+++.. .+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||++..
T Consensus 153 ~~~~~~~~lv~E~~~g~~L~~~~~~-~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 153 RHGDPVGYIVMEYVGGQSLKRSKGQ-KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp TTSCEEEEEEEECCCCEECC----C-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred CCCCceeEEEEEeCCCCcHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchh
Confidence 5 7999999999999988765 79999999999999999999999999999999999999875 999999999975
Q ss_pred ccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHH
Q 037702 159 QESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPE 238 (448)
Q Consensus 159 ~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~ 238 (448)
.... ...+||+.|+|||++.+. + +.++|||||||++|+|++|..||.+.....+ . ........++.
T Consensus 231 ~~~~------~~~~gt~~y~aPE~~~~~-~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~----~--~~~~~~~~~~~ 296 (681)
T 2pzi_A 231 INSF------GYLYGTPGFQAPEIVRTG-P-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL----P--EDDPVLKTYDS 296 (681)
T ss_dssp TTCC------SCCCCCTTTSCTTHHHHC-S-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC----C--TTCHHHHHCHH
T ss_pred cccC------CccCCCccccCHHHHcCC-C-CCceehhhhHHHHHHHHhCCCCCcccccccc----c--ccccccccCHH
Confidence 4322 456799999999998653 4 5899999999999999999999875321100 0 00000113578
Q ss_pred HHHHHHhccCCCcCCCCCHHHHHhhhhcc
Q 037702 239 VRKLLSRILDPNPSTRVTMAKLMENYWFR 267 (448)
Q Consensus 239 ~~~li~~~L~~dP~~Rpt~~eil~hp~~~ 267 (448)
+.+||.+||.+||.+||+..+.+.|+|+.
T Consensus 297 l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 297 YGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp HHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 99999999999999999999999999975
|
| >2ehb_D CBL-interacting serine/threonine-protein kinase 2; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=279.56 Aligned_cols=130 Identities=35% Similarity=0.600 Sum_probs=116.8
Q ss_pred CCCCCCchhhcccCCCCCCCCCCccccc-CcccceEEeCCCHHHHHHHHHHHhhhcCcEEEeeccEEEEEEeeCCCcccE
Q 037702 317 RPSSFNAFDIISLSKGFNLSGLFEGDAN-SKLEARFTTTKPASAIVSKFEEIAVTESCKFNKKDGTVKLQHNRQGRKGQL 395 (448)
Q Consensus 317 ~~~~~~~~~~~~~s~~~~~~~~~~~~~~-~~~~~rf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 395 (448)
.|..+|||++||+|+|+|||+||+.... +++++||+|+.||++|++|||++|+++||+|++++++|++++..+|+||+|
T Consensus 3 ~p~~lNAFdiIs~S~g~dLSgLFe~~~~~~~r~tRF~s~~~a~~ii~klEe~a~~lg~~V~kk~~~vkl~~~~~grkG~l 82 (143)
T 2ehb_D 3 GPLMMNAFEMITLSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANSMGFKSHTRNFKTRLEGLSSIKAGQL 82 (143)
T ss_dssp CCEECCHHHHHTTCTTTCGGGGGCSCCCSCCCCCEEEECSCHHHHHHHHHHHHHHTTEEEEESSSEEEEEECCSSGGGCC
T ss_pred CccccCHHHHHHHCcCCCchhhhccccccccccceEEeCCCHHHHHHHHHHHHHhcCcEEEEcCcEEEEEEecCCCcceE
Confidence 4667999999999999999999983222 578999999999999999999999999999999889999999999999999
Q ss_pred EEEEEEEEEcCceEEEEEEecCCCchhHHHHhhcCcccccccceeeccCCCC
Q 037702 396 AVDAEIFEVTPAFHVVELKKAAGDTMEYKDFCNQGLRPSLKDIVWTWQGNDE 447 (448)
Q Consensus 396 ~~~~~v~~~~~~~~~ve~~~~~Gd~~e~~~~~~~~~~~~l~~~~~~~~~~~~ 447 (448)
++.+|||||+|+++||||||++||++||++||++ |||+|+||||+|+++.+
T Consensus 83 ~v~~EVfevapsl~vVEvrks~GD~lEy~k~~~~-Lr~~L~diV~~~~~~~~ 133 (143)
T 2ehb_D 83 AVVIEIYEVAPSLFMVDVRKAAGETLEYHKFYKK-LCSKLENIIWRATEGIP 133 (143)
T ss_dssp EEEEEEEEEETTEEEEEEEEEESCHHHHHHHHHH-HHHHSTTTBCC------
T ss_pred EEEEEEEEecCCEEEEEEEecCCChHHHHHHHHH-HHHHhhcceecCCCCCc
Confidence 9999999999999999999999999999998885 99999999999998653
|
| >2zfd_B Putative uncharacterized protein T20L15_90; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=259.47 Aligned_cols=122 Identities=33% Similarity=0.473 Sum_probs=107.6
Q ss_pred CCCCCCchhhcccCCCCCCCCCCcccccCcccceEEeCCCHHHHHHHHHHHhhhcCcEEEeeccEEEEEEeeCCCcccEE
Q 037702 317 RPSSFNAFDIISLSKGFNLSGLFEGDANSKLEARFTTTKPASAIVSKFEEIAVTESCKFNKKDGTVKLQHNRQGRKGQLA 396 (448)
Q Consensus 317 ~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~rf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 396 (448)
.|..+||||+||+|+|+|||+||+.+...++++||+|+.||++|++|||++|+++||+|+++++. ++..+|+||+|+
T Consensus 2 ~~~~lNAFdiIs~S~g~dLSgLFe~~~~~~r~tRF~S~~~a~~ii~klEe~a~~lg~~v~kk~~~---~~~~~g~kG~l~ 78 (123)
T 2zfd_B 2 GARRMNAFDIISGSPGFNLSGLFGDARKYDRVERFVSAWTAERVVERLEEIVSAENLTVAKKETW---GMKIEGQKGNFA 78 (123)
T ss_dssp --CCCCHHHHHHTSTTSSSGGGGGGGCSSCCCEEEEESSCHHHHHHHHHHHHHHTTCEEEEEETT---EEEEEEGGGTEE
T ss_pred CcccccHHHHHHHCcCCCchHhcCcccccccceEEEeCCCHHHHHHHHHHHHHHCCCEEEEcCCc---cccccCCCccEE
Confidence 35679999999999999999999733334789999999999999999999999999999998864 666788999999
Q ss_pred EEEEEEEEcCceEEEEEEecCCCchhHHHHhhcCcccccccceee
Q 037702 397 VDAEIFEVTPAFHVVELKKAAGDTMEYKDFCNQGLRPSLKDIVWT 441 (448)
Q Consensus 397 ~~~~v~~~~~~~~~ve~~~~~Gd~~e~~~~~~~~~~~~l~~~~~~ 441 (448)
+.+|||||+|+++||||||++||++||++||.++|||+|+||||+
T Consensus 79 v~~EVfev~p~l~vVEvrks~GD~lEy~~~~~~~L~~~L~diV~~ 123 (123)
T 2zfd_B 79 MVVEINQLTDELVMIEVRKRQRAAASGRDLWTDTLRPFFVELVHE 123 (123)
T ss_dssp EEEEEEECSSSCEEEEEEEEESCC---CCHHHHTHHHHHHHTBC-
T ss_pred EEEEEEEecCCEEEEEEEecCCChHHHHHHHHHHHHHHHhhhhcC
Confidence 999999999999999999999999999999988899999999985
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=322.59 Aligned_cols=233 Identities=14% Similarity=0.093 Sum_probs=162.6
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEeeccccc-------chhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEE
Q 037702 16 RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIR-------RVGLIDQIKREISVMRLV-RHPNIVQLYEVMASKTKIYF 87 (448)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~-------~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~l 87 (448)
..++.|++|.+..++....|+.||+|++.++... .+...+.+.+|+++|+++ .|+||++++++++++...||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 3467788888888888889999999999875321 123346799999999999 79999999999999999999
Q ss_pred EEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCC
Q 037702 88 AMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDG 166 (448)
Q Consensus 88 V~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 166 (448)
||||++|++|.++|.. +++++. +++.||++||+|||++|||||||||+||||+.+|++||+|||+|+..... ..
T Consensus 320 VMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~--~~ 394 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD--CS 394 (569)
T ss_dssp EEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-----C
T ss_pred EEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCC--Cc
Confidence 9999999999999987 567764 47899999999999999999999999999999999999999999865432 22
Q ss_pred CccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHHHHhc
Q 037702 167 LLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRI 246 (448)
Q Consensus 167 ~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 246 (448)
...+.+||+.|||||++.+. ...++|+||+|+++++|.++..||. ..+.. .|.. ...+..+...+
T Consensus 395 ~~~t~vGTp~YmAPE~l~g~--~~~~~d~~s~g~~~~~l~~~~~~~~--------~~l~~----~~~~-~~~~~~l~~~l 459 (569)
T 4azs_A 395 WPTNLVQSFFVFVNELFAEN--KSWNGFWRSAPVHPFNLPQPWSNWL--------YAVWQ----EPVE-RWNFVLLLALF 459 (569)
T ss_dssp CSHHHHHHHHHHHHHHC-------------------CCCCTTHHHHH--------HHHHT----SCGG-GCSHHHHHHHH
T ss_pred cccCceechhhccHHHhCCC--CCCcccccccccchhhhccccchhH--------HHhhc----CCCC-CCcHHHHHHHH
Confidence 34567999999999999754 3467999999999988877654431 11111 1111 11356677777
Q ss_pred cCCCcCCCCCHHHHHhhhhccc
Q 037702 247 LDPNPSTRVTMAKLMENYWFRK 268 (448)
Q Consensus 247 L~~dP~~Rpt~~eil~hp~~~~ 268 (448)
+..+|..|+.......++|...
T Consensus 460 ~~~~~~~~~~~~~~~~~~~~~~ 481 (569)
T 4azs_A 460 EKKAKLPSAEQQRGATEQWIIA 481 (569)
T ss_dssp HTGGGSCCGGGSSCCHHHHHHH
T ss_pred hCCCCCCCCChhhhccchhHHH
Confidence 7888888888777777777643
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-30 Score=274.51 Aligned_cols=189 Identities=21% Similarity=0.252 Sum_probs=147.0
Q ss_pred EEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccch-----hHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 037702 13 ELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRV-----GLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYF 87 (448)
Q Consensus 13 ~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~-----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 87 (448)
...+.||+|+||.||+|.. .+..+++|.......... ...+.+.+|+.+++.++||||+++..++...+..||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 3466899999999999954 688999998765443322 124568999999999999999955555556777899
Q ss_pred EEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCC-
Q 037702 88 AMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDG- 166 (448)
Q Consensus 88 V~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~- 166 (448)
||||++|++|.+++.. +..++.|+++||+|||++||+||||||+|||++. ++||+|||+|+.........
T Consensus 417 VmE~~~ggsL~~~l~~-------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~ 487 (540)
T 3en9_A 417 MMSYINGKLAKDVIED-------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAV 487 (540)
T ss_dssp EEECCCSEEHHHHSTT-------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHH
T ss_pred EEECCCCCCHHHHHHH-------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCcccccc
Confidence 9999999999999876 6789999999999999999999999999999998 99999999998654322111
Q ss_pred ----CccccCCCCcccchhhhhc--cCCCCCcchHHHHHHHHHHHHhCCCCCC
Q 037702 167 ----LLHTTCGTPAYVAPEVINK--RGYDGAKADIWSCGVVLFVLLAGNLPFY 213 (448)
Q Consensus 167 ----~~~~~~Gt~~Y~APEvl~~--~~~~~~~sDiwSlGvil~elltG~~Pf~ 213 (448)
...+.+||+.|||||++.. .+|. ..+|+||..+-..+.+.++.+|.
T Consensus 488 ~~~~~~~~~~GT~~y~APEv~~~~~~~Y~-~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 488 DLIVFKKAVLSTHHEKFDEIWERFLEGYK-SVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHCGGGHHHHHHHHHHHHH-HHCTTHHHHHHHHHHHHTCSCCC
T ss_pred chhhhhhhhcCCCCcCCHHHHHHHHHHHH-HHHhHHHHHHHHHHHHHhccccC
Confidence 1246689999999999976 5664 67899999998888887776653
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.1e-27 Score=227.73 Aligned_cols=146 Identities=20% Similarity=0.252 Sum_probs=117.5
Q ss_pred eEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccch---------------hHHHHHHHHHHHHHhCCCCCcceEE
Q 037702 12 YELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRV---------------GLIDQIKREISVMRLVRHPNIVQLY 76 (448)
Q Consensus 12 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~---------------~~~~~~~~Ei~~l~~l~hpnIv~l~ 76 (448)
|.+++.||+|+||.||+|.+ .+|+.||||++........ .....+.+|+.+|+.++| +++.
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v~ 167 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAVP 167 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSSC
T ss_pred EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCcC
Confidence 44559999999999999999 8899999999965332110 124678899999999994 5555
Q ss_pred EEEEeCCEEEEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccc
Q 037702 77 EVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLS 156 (448)
Q Consensus 77 ~~~~~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla 156 (448)
+++.. +..|+||||++||+|.+ +.. .....++.|++.||.|||++||+||||||+|||++ +|.+||+|||+|
T Consensus 168 ~~~~~-~~~~lvmE~~~g~~L~~-l~~-----~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a 239 (282)
T 1zar_A 168 KVYAW-EGNAVLMELIDAKELYR-VRV-----ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQS 239 (282)
T ss_dssp CEEEE-ETTEEEEECCCCEEGGG-CCC-----SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTC
T ss_pred eEEec-cceEEEEEecCCCcHHH-cch-----hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCC
Confidence 55544 44699999999999988 422 23557999999999999999999999999999999 999999999998
Q ss_pred ccccccccCCCccccCCCCcccchhhhh
Q 037702 157 ALQESTRQDGLLHTTCGTPAYVAPEVIN 184 (448)
Q Consensus 157 ~~~~~~~~~~~~~~~~Gt~~Y~APEvl~ 184 (448)
.. +..|+|||++.
T Consensus 240 ~~---------------~~~~~a~e~l~ 252 (282)
T 1zar_A 240 VE---------------VGEEGWREILE 252 (282)
T ss_dssp EE---------------TTSTTHHHHHH
T ss_pred eE---------------CCCCCHHHHHH
Confidence 62 44689999874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=7.3e-23 Score=195.22 Aligned_cols=139 Identities=19% Similarity=0.287 Sum_probs=109.9
Q ss_pred eEEEeeeeecCceEEEEEEECCCCcE--EEEEEeeccccc--c-------------------hhHHHHHHHHHHHHHhCC
Q 037702 12 YELGRLLGQGTFAKVYHGRNLKTGQS--VAIKIVDKEKIR--R-------------------VGLIDQIKREISVMRLVR 68 (448)
Q Consensus 12 y~~~~~LG~G~fg~Vy~a~~~~~g~~--vAiK~i~~~~~~--~-------------------~~~~~~~~~Ei~~l~~l~ 68 (448)
|++.+.||+|+||.||+|.+..+|+. ||||++...... . ......+.+|+.+|+.+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 78999999999999999998788999 999997543211 0 011246789999999998
Q ss_pred CCCc--ceEEEEEEeCCEEEEEEeecCC-C----chHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCCEeecCCCCce
Q 037702 69 HPNI--VQLYEVMASKTKIYFAMEYVRG-G----ELFNKVAKGKLREEVARKYFQQLVDAVEFCH-SRGVYHRDLKPENL 140 (448)
Q Consensus 69 hpnI--v~l~~~~~~~~~~~lV~E~~~g-g----~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH-~~givHrDLkp~NI 140 (448)
|++| ..+++. ...+|||||+.+ | +|.+.... .++..+..++.|++.||.||| +.||+||||||+||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NI 202 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNI 202 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSE
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHE
Confidence 8864 444442 246899999942 4 66655432 345678899999999999999 99999999999999
Q ss_pred EEcCCCCeEEeecccccc
Q 037702 141 LLDENGDLKISDFGLSAL 158 (448)
Q Consensus 141 Ll~~~g~lkl~DFGla~~ 158 (448)
|++. .++|+|||+|..
T Consensus 203 Ll~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 203 MYID--KVYFIDMGQAVT 218 (258)
T ss_dssp EESS--SEEECCCTTCEE
T ss_pred EEcC--cEEEEECccccc
Confidence 9988 999999999974
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.79 E-value=2.1e-19 Score=179.60 Aligned_cols=138 Identities=17% Similarity=0.207 Sum_probs=102.3
Q ss_pred eEEEeeeeecCceEEEEEEECCCCcEEEEEEeeccccc------------ch---hH----HHHHHHHHHHHHhCCCCCc
Q 037702 12 YELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIR------------RV---GL----IDQIKREISVMRLVRHPNI 72 (448)
Q Consensus 12 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~------------~~---~~----~~~~~~Ei~~l~~l~hpnI 72 (448)
|++++.||.|+||.||+|.+ .+|+.||||++...... .. .. .-...+|...|.++.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 99999999999999999997 47999999997543211 00 00 1123467788888865554
Q ss_pred ceEEEEEEeCCEEEEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCC-----
Q 037702 73 VQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGD----- 147 (448)
Q Consensus 73 v~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~----- 147 (448)
.-..-+.... .+|||||++|++|..+.. .+.+..++.||+.+|.|||++|||||||||.|||++.+|.
T Consensus 176 ~vp~p~~~~~--~~LVME~i~G~~L~~l~~-----~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~ 248 (397)
T 4gyi_A 176 PVPEPIAQSR--HTIVMSLVDALPMRQVSS-----VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPS 248 (397)
T ss_dssp SCCCEEEEET--TEEEEECCSCEEGGGCCC-----CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTT
T ss_pred CCCeeeeccC--ceEEEEecCCccHhhhcc-----cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCccccc
Confidence 3221111222 279999999998866532 2345678999999999999999999999999999998874
Q ss_pred -----eEEeeccccc
Q 037702 148 -----LKISDFGLSA 157 (448)
Q Consensus 148 -----lkl~DFGla~ 157 (448)
+.|+||+-+.
T Consensus 249 ~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 249 SITLTPIIIXFPQMV 263 (397)
T ss_dssp SEEEEEEECCCTTCE
T ss_pred ccccceEEEEeCCcc
Confidence 8899999765
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.48 E-value=1.4e-13 Score=130.42 Aligned_cols=141 Identities=18% Similarity=0.193 Sum_probs=114.5
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEE
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR-HPNIVQLYEVMASKTKIY 86 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~ 86 (448)
..+.|++...+|.|+++.||++.. .|..+++|+........ ...+.+|+.+++.+. +..+.+++++....+..|
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~ 86 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HhccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence 456799999999999999999975 47899999986532111 135789999999984 677889999999999999
Q ss_pred EEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------
Q 037702 87 FAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHS--------------------------------------- 127 (448)
Q Consensus 87 lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~--------------------------------------- 127 (448)
+||||++|.+|.+.+. +......++.+++.+|..||+
T Consensus 87 lv~e~i~G~~l~~~~~----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T 3tm0_A 87 LLMSEADGVLCSEEYE----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp EEEECCSSEEHHHHCC----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred EEEEecCCeehhhccC----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence 9999999999877632 122345788999999999999
Q ss_pred --------------------CCCEeecCCCCceEEcCCCCeEEeeccccc
Q 037702 128 --------------------RGVYHRDLKPENLLLDENGDLKISDFGLSA 157 (448)
Q Consensus 128 --------------------~givHrDLkp~NILl~~~g~lkl~DFGla~ 157 (448)
..++|+|++|.|||++.++.+.|+||+.+.
T Consensus 163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 458999999999999876556799999875
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.34 E-value=6.4e-12 Score=118.13 Aligned_cols=136 Identities=14% Similarity=0.175 Sum_probs=103.6
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC--cceEEEEEEeCCEE
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPN--IVQLYEVMASKTKI 85 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpn--Iv~l~~~~~~~~~~ 85 (448)
....|.+....+.|..+.||++.. .+|..+++|+..... ...+.+|+.+++.+.+.+ +.+++.+....+..
T Consensus 18 ~~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~ 90 (264)
T 1nd4_A 18 RLFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRD 90 (264)
T ss_dssp TTTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCE
T ss_pred hcCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCC
Confidence 345677766555677799999964 567889999975431 134678999999986544 56688988888889
Q ss_pred EEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC------------------------------------
Q 037702 86 YFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRG------------------------------------ 129 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~g------------------------------------ 129 (448)
|+||||++|.+|. .. ..+ ...++.+++..|..||+..
T Consensus 91 ~~v~e~i~G~~l~--~~--~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (264)
T 1nd4_A 91 WLLLGEVPGQDLL--SS--HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ 163 (264)
T ss_dssp EEEEECCSSEETT--TS--CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred EEEEEecCCcccC--cC--cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence 9999999998884 21 122 2356778888888888754
Q ss_pred ----------------------CEeecCCCCceEEcCCCCeEEeeccccc
Q 037702 130 ----------------------VYHRDLKPENLLLDENGDLKISDFGLSA 157 (448)
Q Consensus 130 ----------------------ivHrDLkp~NILl~~~g~lkl~DFGla~ 157 (448)
++|+|++|.|||++.++.+.|+|||.+.
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999877667799999875
|
| >3ose_A Serine/threonine-protein kinase MARK1; kinase associated-1(Ka1) domain, transferase, lipid binding membrane association; 1.70A {Homo sapiens} SCOP: d.129.6.1 PDB: 1ul7_A | Back alignment and structure |
|---|
Probab=99.28 E-value=1.6e-11 Score=102.00 Aligned_cols=86 Identities=13% Similarity=0.344 Sum_probs=76.5
Q ss_pred eEEeCCCHHHHHHHHHHHhhhcCcEEEeec-cEEEEEEeeCCCcccEEEEEEEEEEc-CceEEEEEEecCCCchhHHHHh
Q 037702 350 RFTTTKPASAIVSKFEEIAVTESCKFNKKD-GTVKLQHNRQGRKGQLAVDAEIFEVT-PAFHVVELKKAAGDTMEYKDFC 427 (448)
Q Consensus 350 rf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~v~~~~-~~~~~ve~~~~~Gd~~e~~~~~ 427 (448)
.-||..+|++|+.+|+.++..+|+.|++++ +.+++.......++.+.|.+||+++. +++++|+|||.+||++.|+++|
T Consensus 32 ~tTS~~~P~eIm~eI~rvL~~~gi~~~~~g~y~l~C~~~~~~~~~~v~fElEVckl~~~~l~gV~~kRi~Gd~~~yk~lc 111 (120)
T 3ose_A 32 KTTSSMDPNDMMREIRKVLDANNCDYEQKERFLLFCVHGDARQDSLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNIA 111 (120)
T ss_dssp CCEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEESCTTTTCCEEEEEEEEEEGGGTEEEEEEEEEESCHHHHHHHH
T ss_pred cCcccCCHHHHHHHHHHHHHHCCCEEEEcCCEEEEEEecCCCCCccEEEEEEEEEecCCCceeEEEEecCCCHHHHHHHH
Confidence 348999999999999999999999999988 89999876555567899999999995 8999999999999999999999
Q ss_pred hcCcccccc
Q 037702 428 NQGLRPSLK 436 (448)
Q Consensus 428 ~~~~~~~l~ 436 (448)
.+ |-+.|+
T Consensus 112 ~~-il~~L~ 119 (120)
T 3ose_A 112 SK-IANELK 119 (120)
T ss_dssp HH-HHHHCC
T ss_pred HH-HHHHhc
Confidence 97 655553
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.26 E-value=1.5e-11 Score=122.14 Aligned_cols=141 Identities=18% Similarity=0.340 Sum_probs=108.0
Q ss_pred EEEeeeeecCceEEEEEEECCCCcEEEEEEee--cccccchhHHHHHHHHHHHHHhCC--CCCcceEEEEEEeC---CEE
Q 037702 13 ELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVD--KEKIRRVGLIDQIKREISVMRLVR--HPNIVQLYEVMASK---TKI 85 (448)
Q Consensus 13 ~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~--~~~~~~~~~~~~~~~Ei~~l~~l~--hpnIv~l~~~~~~~---~~~ 85 (448)
.-.+.|+.|.++.||++.. .+..+++|+.. ..... .....+.+|+.+++.+. +..+.+++.++.+. +..
T Consensus 41 ~~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~ 116 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRA 116 (359)
T ss_dssp CEEEECCC-CCSCEEEEEC--SSCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSC
T ss_pred ceEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCe
Confidence 3467899999999999875 35688999875 33211 11246788999999997 45578899988776 458
Q ss_pred EEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 037702 86 YFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHS-------------------------------------- 127 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~-------------------------------------- 127 (448)
|+||||++|..+.+... ..+++.....++.+++.+|..||+
T Consensus 117 ~~vme~v~G~~l~~~~~-~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 117 FYIMEFVSGRVLWDQSL-PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp EEEEECCCCBCCCCTTC-TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EEEEEecCCeecCCCcc-ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 99999999988754221 347888889999999999999997
Q ss_pred --------------------CCCEeecCCCCceEEcCCCC--eEEeecccccc
Q 037702 128 --------------------RGVYHRDLKPENLLLDENGD--LKISDFGLSAL 158 (448)
Q Consensus 128 --------------------~givHrDLkp~NILl~~~g~--lkl~DFGla~~ 158 (448)
.+++|+|++|.|||++.++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 36899999999999998764 68999999874
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.21 E-value=7.6e-12 Score=121.39 Aligned_cols=185 Identities=17% Similarity=0.231 Sum_probs=124.6
Q ss_pred EeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCC--cceEEEEEEeCC---EEEEE
Q 037702 15 GRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR-HPN--IVQLYEVMASKT---KIYFA 88 (448)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-hpn--Iv~l~~~~~~~~---~~~lV 88 (448)
.+.++.|.+..||++. ..+++|+.... .....+.+|..+|+.+. +.. +.+++....... ..|+|
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 4568999999999863 56899986432 23467889999998883 333 345555443333 34899
Q ss_pred EeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------------
Q 037702 89 MEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHS----------------------------------------- 127 (448)
Q Consensus 89 ~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~----------------------------------------- 127 (448)
||+++|..|..... ..++.++...++.|++..+..||+
T Consensus 95 m~~i~G~~l~~~~~-~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 95 FTKIKGVPLTPLLL-NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp EECCCCEECCHHHH-HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred EcccCCeECCcccc-ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 99999998865432 357888888999999999999996
Q ss_pred -----------------CCCEeecCCCCceEEcC--CCCeEEeeccccccccccccCCCccccCCCCcccchhhhhc--c
Q 037702 128 -----------------RGVYHRDLKPENLLLDE--NGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINK--R 186 (448)
Q Consensus 128 -----------------~givHrDLkp~NILl~~--~g~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~--~ 186 (448)
..++|+|++|.||+++. ++.+.|+||+.+.......+-....... .-..|+.... .
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~---~~~~~~~~~~~l~ 250 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDD---EEYGMEFVSKILN 250 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTT---TSCCHHHHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhc---cccCHHHHHHHHH
Confidence 13699999999999998 4568899999987532211100000000 0022332210 1
Q ss_pred CCCC-----------CcchHHHHHHHHHHHHhCCCCCC
Q 037702 187 GYDG-----------AKADIWSCGVVLFVLLAGNLPFY 213 (448)
Q Consensus 187 ~~~~-----------~~sDiwSlGvil~elltG~~Pf~ 213 (448)
.|.. .-.+.|++|.++|.+.+|..+|.
T Consensus 251 ~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 251 HYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 1111 12689999999999999988764
|
| >1v5s_A MAP/microtubule affinity-regulating kinase 3; Ka1 domain, ELKL motif, MARK3, phosphorylation, structural genomics, NPPSFA; NMR {Mus musculus} SCOP: d.129.6.1 | Back alignment and structure |
|---|
Probab=98.84 E-value=3.4e-09 Score=87.85 Aligned_cols=85 Identities=11% Similarity=0.315 Sum_probs=73.4
Q ss_pred EEeCCCHHHHHHHHHHHhhhcCcEEEeec-cEEEEEEeeCCCcccEEEEEEEEEEc-CceEEEEEEecCCCchhHHHHhh
Q 037702 351 FTTTKPASAIVSKFEEIAVTESCKFNKKD-GTVKLQHNRQGRKGQLAVDAEIFEVT-PAFHVVELKKAAGDTMEYKDFCN 428 (448)
Q Consensus 351 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~v~~~~-~~~~~ve~~~~~Gd~~e~~~~~~ 428 (448)
-||..+|++|+..|..+++.+|+.|++++ +.+++.......+..+.|.+||+.|. .+++.|+|||.+||+..|+++|.
T Consensus 33 tTSsk~P~eIm~EI~rvL~~~~i~~k~~~~y~L~C~~~~~~~~~~vkfEiEVcKvp~l~l~GI~fKRisGd~w~YK~lc~ 112 (126)
T 1v5s_A 33 QGSSGSSGDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAENLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNIAS 112 (126)
T ss_dssp CCCCSSHHHHHHHHHHHHHHTTEEEEEEETTEEEEEECSSSTTTCEEEEEECCCCTTTCSCCCEEEEEESCHHHHHHHHH
T ss_pred eecCCCHHHHHHHHHHHHHHcCCcEEEECCEEEEEEECCCCCCceEEEEEEEEEecCCCceeEEEeeccCchhHHHHHHH
Confidence 36788999999999999999999999866 88888764444456899999999994 79999999999999999999999
Q ss_pred cCcccccc
Q 037702 429 QGLRPSLK 436 (448)
Q Consensus 429 ~~~~~~l~ 436 (448)
+ |-..|+
T Consensus 113 ~-IL~eLk 119 (126)
T 1v5s_A 113 K-IANELK 119 (126)
T ss_dssp H-HHHHTT
T ss_pred H-HHHHHh
Confidence 8 555555
|
| >4eai_A 5'-AMP-activated protein kinase catalytic subunit linker, 5'-AMP-activated protein...; AMPK, transferase; HET: AMP; 2.29A {Rattus norvegicus} PDB: 4eaj_A* 4eak_A* 4eal_A* | Back alignment and structure |
|---|
Probab=98.77 E-value=4.2e-08 Score=78.50 Aligned_cols=90 Identities=9% Similarity=0.197 Sum_probs=76.7
Q ss_pred CcccceEEeCCCHHHHHHHHHHHhhhcCcEEEeec-cEEEEEEeeCCCcccEEEEEEEEEEcCceEEEEEEecCCC----
Q 037702 345 SKLEARFTTTKPASAIVSKFEEIAVTESCKFNKKD-GTVKLQHNRQGRKGQLAVDAEIFEVTPAFHVVELKKAAGD---- 419 (448)
Q Consensus 345 ~~~~~rf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~v~~~~~~~~~ve~~~~~Gd---- 419 (448)
.+|..-..|...|.+||..|..+++.+|+.|++.+ +.|++....+.....+.|.+++|++.+..+|+||++..||
T Consensus 6 ~kW~LGIrS~~~P~eiM~eIyraLk~lg~~Wk~~~~Y~lkcR~~~~~~~~~vK~~lQLYkv~~~~YLLDfq~i~g~~~~~ 85 (106)
T 4eai_A 6 AKWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDGGGGG 85 (106)
T ss_dssp CEEEESEEECSCHHHHHHHHHHHHHHHTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEECCSSCCCS
T ss_pred ccceEcceeCCCHHHHHHHHHHHHHHcCCEEeeCCceEEEEEEcCCCCCceeEEEEEEEEecCCcEEEEEEeccCCCCCC
Confidence 35666688999999999999999999999999888 9999987543334568999999999999999999999994
Q ss_pred ----chhHHHHhhcCccccc
Q 037702 420 ----TMEYKDFCNQGLRPSL 435 (448)
Q Consensus 420 ----~~e~~~~~~~~~~~~l 435 (448)
+++|-++|.+ +-.+|
T Consensus 86 ~~~~~~~F~d~ca~-li~~l 104 (106)
T 4eai_A 86 GGSHTIEFFEMCAN-LIKIL 104 (106)
T ss_dssp SSCHHHHHHHHHHH-HHHHC
T ss_pred CCcCcEeHHHHHHH-HHHHH
Confidence 9999999997 43333
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.76 E-value=1.2e-07 Score=91.81 Aligned_cols=134 Identities=21% Similarity=0.227 Sum_probs=99.2
Q ss_pred EeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCC---CcceEEEEEE-eCCEEEEEEe
Q 037702 15 GRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHP---NIVQLYEVMA-SKTKIYFAME 90 (448)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hp---nIv~l~~~~~-~~~~~~lV~E 90 (448)
.+.++.|....||+. |..+++|+... ......+.+|..+|+.+.+. .+.+++.+.. ..+..|+|||
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 456889999999987 57789998422 13346788999999999753 3566676664 4556789999
Q ss_pred ecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC------------------------------------------
Q 037702 91 YVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSR------------------------------------------ 128 (448)
Q Consensus 91 ~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~------------------------------------------ 128 (448)
+++|..|....- ..++......++.|+...|..||+.
T Consensus 94 ~i~G~~l~~~~~-~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 94 KVQGQILGEDGM-AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp CCCSEECHHHHH-TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred ccCCeECchhhh-hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 999988866322 2356666677777777777777753
Q ss_pred ------------------CCEeecCCCCceEEcC---CCCe-EEeeccccccc
Q 037702 129 ------------------GVYHRDLKPENLLLDE---NGDL-KISDFGLSALQ 159 (448)
Q Consensus 129 ------------------givHrDLkp~NILl~~---~g~l-kl~DFGla~~~ 159 (448)
.++|+|++|.|||++. ++.+ .|+||+.+...
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 2499999999999987 4665 89999988653
|
| >2v8q_A 5'-AMP-activated protein kinase catalytic subunit; phosphorylation, nucleotide-binding, serine/threonine-protei kinase, magnesium, CBS domain; HET: AMP; 2.10A {Rattus norvegicus} SCOP: d.129.6.2 PDB: 2v92_A* 2v9j_A* 2y94_C* | Back alignment and structure |
|---|
Probab=98.67 E-value=1.6e-07 Score=79.51 Aligned_cols=78 Identities=4% Similarity=0.095 Sum_probs=65.9
Q ss_pred CcccceEEeCCCHHHHHHHHHHHhhhcCcEEEeec-cEEEEEEeeCCCcccEEEEEEEEEEcCceEEEEEEecCCCchh
Q 037702 345 SKLEARFTTTKPASAIVSKFEEIAVTESCKFNKKD-GTVKLQHNRQGRKGQLAVDAEIFEVTPAFHVVELKKAAGDTME 422 (448)
Q Consensus 345 ~~~~~rf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~v~~~~~~~~~ve~~~~~Gd~~e 422 (448)
.+|.....|+..|.+||..|..+++.+|+.|++.+ +.|++..........+.|.+++|+|.++.+||||++..||+-|
T Consensus 3 ~kWhLGIrSrs~P~eIM~EVyRALk~Lg~eWK~~~pY~IkcRw~~~~~~~~vKm~LQLYkv~~~~YLLDFk~l~g~~~e 81 (157)
T 2v8q_A 3 MAWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEITE 81 (157)
T ss_dssp CEEEESEEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC---
T ss_pred ccceeecccCCCHHHHHHHHHHHHHHcCCEEeeCCCeEEEEEEcCCCCCceEEEEEEEEEecCCCEEEEEEecCCCccc
Confidence 46777888999999999999999999999999988 9999987543222368999999999999999999999998744
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.64 E-value=3.5e-07 Score=86.36 Aligned_cols=133 Identities=14% Similarity=0.181 Sum_probs=100.0
Q ss_pred eeeecCce-EEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEeecCC
Q 037702 17 LLGQGTFA-KVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR-HPNIVQLYEVMASKTKIYFAMEYVRG 94 (448)
Q Consensus 17 ~LG~G~fg-~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (448)
.+..|..| .||+......+..+++|+-... ....+.+|...|+.+. +--+.+++.++.+.+..|+|||+++|
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G 104 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPG 104 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCS
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCC
Confidence 34455554 6999887667788999986533 2356788999999884 22367889999999999999999999
Q ss_pred CchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC----------------------------------------------
Q 037702 95 GELFNKVAKGKLREEVARKYFQQLVDAVEFCHSR---------------------------------------------- 128 (448)
Q Consensus 95 g~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~---------------------------------------------- 128 (448)
.++.+..... ......+..++...|.-||+.
T Consensus 105 ~~~~~~~~~~---~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 105 KTAFQVLEEY---PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp EEHHHHHHHC---GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred ccccccccCC---HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 8887765432 223345667777888888841
Q ss_pred ------------CCEeecCCCCceEEcCCCCeEEeecccccc
Q 037702 129 ------------GVYHRDLKPENLLLDENGDLKISDFGLSAL 158 (448)
Q Consensus 129 ------------givHrDLkp~NILl~~~g~lkl~DFGla~~ 158 (448)
.++|+|++|.|||++.++.+-|+||+.+..
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 279999999999999877777999998763
|
| >2y8l_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, serine/threonine-protein KI; HET: ADP AMP; 2.50A {Rattus norvegicus} PDB: 2y8q_A* 2ya3_A* | Back alignment and structure |
|---|
Probab=98.60 E-value=2.7e-07 Score=79.20 Aligned_cols=86 Identities=7% Similarity=0.139 Sum_probs=67.6
Q ss_pred CCCCcccccCcccceEEeCCCHHHHHHHHHHHhhhcCcEEEeec-cEEEEEEeeCCCcccEEEEEEEEEEcCceEEEEEE
Q 037702 336 SGLFEGDANSKLEARFTTTKPASAIVSKFEEIAVTESCKFNKKD-GTVKLQHNRQGRKGQLAVDAEIFEVTPAFHVVELK 414 (448)
Q Consensus 336 ~~~~~~~~~~~~~~rf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~v~~~~~~~~~ve~~ 414 (448)
+||-. ....+|.....|+..|.+||..|..+++.+|+.|++.+ +.|+++.........+.|.+++|+|.++.+||||+
T Consensus 9 ~~~~~-~k~~kWhLGIrSrs~P~eIM~EVyRALk~Lg~eWK~i~pY~IkcRw~~~~~~~~vKmeLQLYKv~~~~YLLDFk 87 (173)
T 2y8l_A 9 SGLVP-RGSMAWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFR 87 (173)
T ss_dssp --------CCEEEESEEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEE
T ss_pred cCCcc-cccceeeeecccCCCHHHHHHHHHHHHHHcCCEEeeCCCeEEEEEEcCCCCCeeEEEEEEEEEEcCCCEEEEEE
Confidence 44443 34568888899999999999999999999999999988 99999875332223689999999999999999999
Q ss_pred ecCCCchh
Q 037702 415 KAAGDTME 422 (448)
Q Consensus 415 ~~~Gd~~e 422 (448)
+..||+-|
T Consensus 88 ~l~Gd~~e 95 (173)
T 2y8l_A 88 SIDDEITE 95 (173)
T ss_dssp EECCC---
T ss_pred ecCCCccc
Confidence 99999866
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.43 E-value=4.9e-07 Score=90.67 Aligned_cols=80 Identities=16% Similarity=0.121 Sum_probs=51.1
Q ss_pred EEeeeeecCceEEEEEEECCCCcEEEEEEeecccc-cc---hhHHHHHHHHHHHHHhCCC--C-CcceEEEEEEeCCEEE
Q 037702 14 LGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKI-RR---VGLIDQIKREISVMRLVRH--P-NIVQLYEVMASKTKIY 86 (448)
Q Consensus 14 ~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~---~~~~~~~~~Ei~~l~~l~h--p-nIv~l~~~~~~~~~~~ 86 (448)
-.+.||.|.++.||++....++..++||....... .. ....+.+.+|..+++.+.. | .+.+++.+ +.+..+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 36689999999999997655678999998653211 00 0112456789999988742 3 34456654 344568
Q ss_pred EEEeecCCC
Q 037702 87 FAMEYVRGG 95 (448)
Q Consensus 87 lV~E~~~gg 95 (448)
+|||+++|.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999874
|
| >4eag_A EG:132E8.2 protein; AMPK, transferase; HET: ATP TAM; 2.70A {Drosophila melanogaster} | Back alignment and structure |
|---|
Probab=98.40 E-value=1.4e-06 Score=71.45 Aligned_cols=79 Identities=10% Similarity=0.143 Sum_probs=62.9
Q ss_pred CcccceEEeCCCHHHHHHHHHHHhhhcCcEEEeec-cEEEEEEeeCCCcccEEEEEEEEEEcCceEEEEEEecCCCchhH
Q 037702 345 SKLEARFTTTKPASAIVSKFEEIAVTESCKFNKKD-GTVKLQHNRQGRKGQLAVDAEIFEVTPAFHVVELKKAAGDTMEY 423 (448)
Q Consensus 345 ~~~~~rf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~v~~~~~~~~~ve~~~~~Gd~~e~ 423 (448)
.+|..-..|...|.+||..|..+++.+|+.|++.+ +.|++..........+.|.+++|+|.+..+|+||+...||..|+
T Consensus 6 ~kW~LGIrS~~~P~eIM~EVyrALk~Lg~eWK~~~pY~vkcR~~n~~~~~~vKm~LQLYqv~~~~YLLDfk~~~~~~~~~ 85 (130)
T 4eag_A 6 AKWHLGIRSQSKPNDIMLEVYRAMKALSYEWKIINPYHVRVRRQNVKTGKFSKMSLQLYQVDAKSYLLDFKSLTNDEVEQ 85 (130)
T ss_dssp CCEEESBCCCSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEESSSSCEEEEEEECC------
T ss_pred cceeeeeecCCCHHHHHHHHHHHHHHCCCEEeeCCCEEEEEEecCCCCCceeEEEEEEEEecCCcEEEEeccCCcchhhc
Confidence 35556667888899999999999999999999988 99999865444344688999999999999999999999996443
|
| >2qrd_A SNF1-like protein kinase SSP2; AMPK, ADP, ATP-binding, kinase, nucleotide-binding, serine/T protein kinase, transferase, CBS domain; HET: ADP ATP; 2.41A {Schizosaccharomyces pombe} SCOP: d.129.6.2 PDB: 2ooy_A* 2qr1_A* 2qrc_A* 2oox_A* 2qre_A* | Back alignment and structure |
|---|
Probab=98.39 E-value=4.7e-07 Score=76.11 Aligned_cols=90 Identities=17% Similarity=0.234 Sum_probs=75.1
Q ss_pred CcccceEEeCCCHHHHHHHHHHHhhhcCcEEEee---------c-cEEEEEEeeCCC-----cccEEEEEEEEEEcCceE
Q 037702 345 SKLEARFTTTKPASAIVSKFEEIAVTESCKFNKK---------D-GTVKLQHNRQGR-----KGQLAVDAEIFEVTPAFH 409 (448)
Q Consensus 345 ~~~~~rf~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~-~~~~~~~~~~~~-----~~~l~~~~~v~~~~~~~~ 409 (448)
.+|..-.-|+..|.+||..|..+++.+|+.|++. + +.|++....+.. ...+.|.+++|+|.++.+
T Consensus 11 ~kWhlGIRSrs~P~eIM~EVyrALk~Lg~eWk~~~~~~~~~~~~~y~Ik~R~~~~~~~~~~~~~~vkm~iQLYqv~~~~Y 90 (137)
T 2qrd_A 11 NKWHFGVRCRGDAPEILLAVYRALQRAGAQFTVPKPVNGKYRSDMYTIKSRWEIPHCKREGKNTYAYIELQLYEVMPGCF 90 (137)
T ss_dssp CCCEESEEEESCHHHHHHHHHHHHHHHTCEECCCCCBTTBCCGGGGEEEEEEECHHHHHTTCCEEEEEEEEEEEEETTEE
T ss_pred CccccccccCCCHHHHHHHHHHHHHHCCCEEEeccccccccCCCceEEEEEEecCCCccccCCceEEEEEEEEEecCCcE
Confidence 4677888999999999999999999999999988 7 999988743321 235899999999999999
Q ss_pred EEEEEecCCC---------------c----hhHHHHhhcCccccc
Q 037702 410 VVELKKAAGD---------------T----MEYKDFCNQGLRPSL 435 (448)
Q Consensus 410 ~ve~~~~~Gd---------------~----~e~~~~~~~~~~~~l 435 (448)
||||+...|+ . ++|-++|.. |-.+|
T Consensus 91 LlDFk~~~~~~~~~~~~~~~~~~~~~~~s~~~Fldlca~-Li~eL 134 (137)
T 2qrd_A 91 MLDVKSNGYKDIYSHPERTADHGMDDLKSSFPFLDLCAM-LVCKL 134 (137)
T ss_dssp EEEEEEEEEEESCC-------------CCCTTHHHHHHH-HHHHH
T ss_pred EEEEEecCCccccccCccccccCCccccccccHHHHHHH-HHHHH
Confidence 9999999999 5 889999987 44333
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.38 E-value=3.6e-07 Score=90.14 Aligned_cols=83 Identities=13% Similarity=0.179 Sum_probs=57.1
Q ss_pred EEEeee-eecCceEEEEEEEC--C----CCcEEEEEEeeccc---ccchhHHHHHHHHHHHHHhCCC---CCcceEEEEE
Q 037702 13 ELGRLL-GQGTFAKVYHGRNL--K----TGQSVAIKIVDKEK---IRRVGLIDQIKREISVMRLVRH---PNIVQLYEVM 79 (448)
Q Consensus 13 ~~~~~L-G~G~fg~Vy~a~~~--~----~g~~vAiK~i~~~~---~~~~~~~~~~~~Ei~~l~~l~h---pnIv~l~~~~ 79 (448)
...+.| +.|....+|+.... . +|..+++|+..... ... ...+.+|+.+++.+.. -.+.+++.+.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~---~~~~~~E~~~l~~L~~~~~vpvP~v~~~~ 99 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP---TYRLDHQFEVIRLVGELTDVPVPRVRWIE 99 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS---CCCHHHHHHHHHHHHHHCCSCCCCEEEEE
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc---hhHHHHHHHHHHHHhhcCCCCCCcEEEEc
Confidence 345778 88999999988652 1 26789999865432 111 1346788888888842 3577888877
Q ss_pred EeC---CEEEEEEeecCCCchH
Q 037702 80 ASK---TKIYFAMEYVRGGELF 98 (448)
Q Consensus 80 ~~~---~~~~lV~E~~~gg~L~ 98 (448)
.+. ...|+||||++|..+.
T Consensus 100 ~~~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 100 TTGDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp CSSTTTSSCEEEEECCCCBCCC
T ss_pred cCCCccCCceEEEEecCCCChh
Confidence 655 3568999999987654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.23 E-value=1.1e-05 Score=78.35 Aligned_cols=134 Identities=12% Similarity=0.152 Sum_probs=78.9
Q ss_pred EeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-----CCCcceEE-E--EEEeCCEEE
Q 037702 15 GRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR-----HPNIVQLY-E--VMASKTKIY 86 (448)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-----hpnIv~l~-~--~~~~~~~~~ 86 (448)
.+.|+.|..+.||++.. .+..+++|+..... ..+..|..+++.|. .|.++... + +....+..+
T Consensus 37 ~~~l~gG~~n~~~~v~~--~~~~~vlk~~~~~~-------~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~ 107 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHT--DSGAVCLKRIHRPE-------KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLF 107 (346)
T ss_dssp EEECC----CEEEEEEE--TTEEEEEEEECSCH-------HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEE
T ss_pred eeeccccccCcEEEEEe--CCCCEEEEecCCCH-------HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEE
Confidence 34566678899999875 34469999987521 23344555555542 34444310 0 123467889
Q ss_pred EEEeecCCCchH--------------HHHhc--CCC--C-----------HH--------H-------------------
Q 037702 87 FAMEYVRGGELF--------------NKVAK--GKL--R-----------EE--------V------------------- 110 (448)
Q Consensus 87 lV~E~~~gg~L~--------------~~i~~--~~l--~-----------e~--------~------------------- 110 (448)
++|+|++|..+. ..+.. ..+ + .. .
T Consensus 108 ~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 187 (346)
T 2q83_A 108 VVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQL 187 (346)
T ss_dssp EEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHH
T ss_pred EEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHH
Confidence 999999986541 11110 111 1 00 0
Q ss_pred ----HHHHHHHHHHHHHHHHH-------------CCCEeecCCCCceEEcCCCCeEEeeccccc
Q 037702 111 ----ARKYFQQLVDAVEFCHS-------------RGVYHRDLKPENLLLDENGDLKISDFGLSA 157 (448)
Q Consensus 111 ----~~~~~~qll~aL~yLH~-------------~givHrDLkp~NILl~~~g~lkl~DFGla~ 157 (448)
...+..++..++++|++ .+++|+|++|.|||++.++.+.|+||+.+.
T Consensus 188 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 188 YLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 11122234456666653 579999999999999888899999999775
|
| >3t4n_A Carbon catabolite-derepressing protein kinase; CBS domain, nucleotide binding, cytosol, protein binding; HET: ADP; 2.30A {Saccharomyces cerevisiae} SCOP: d.129.6.2 PDB: 3tdh_A* 3te5_A* 2qlv_A | Back alignment and structure |
|---|
Probab=98.00 E-value=3.3e-05 Score=67.00 Aligned_cols=89 Identities=11% Similarity=0.139 Sum_probs=71.5
Q ss_pred CcccceEEeCCCHHHHHHHHHHHhhhcCcEEEee----ccEEEEEEeeCC---------CcccEEEEEEEEEEcCceEEE
Q 037702 345 SKLEARFTTTKPASAIVSKFEEIAVTESCKFNKK----DGTVKLQHNRQG---------RKGQLAVDAEIFEVTPAFHVV 411 (448)
Q Consensus 345 ~~~~~rf~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~---------~~~~l~~~~~v~~~~~~~~~v 411 (448)
.+|..-..|+..+.+||..|..+++.+|+.|++. -+.|+|+..... ....+.|.+++|++.++.+||
T Consensus 49 ~kW~LGIrS~~~P~eIM~EVyrALk~Lg~~WKk~~~~~pY~IkcRw~~~~~~~~~~~~~~p~~vKmeLQLYkv~~~~YLL 128 (179)
T 3t4n_A 49 TRWHFGIRSRSYPLDVMGEIYIALKNLGAEWAKPSEEDLWTIKLRWKYDIGNKTNTNEKIPDLMKMVIQLFQIETNNYLV 128 (179)
T ss_dssp CCCEESEEECSCHHHHHHHHHHHHHHHTCEEECCCGGGTTEEEEEECC-----------CCCEEEEEEEEEEEETTEEEE
T ss_pred ceeeeccccCCCHHHHHHHHHHHHHHcCCEEeeCCCCCceEEEEEEeCCCCcccccccCCCceeEEEEEEEEecCCceEE
Confidence 4677778899999999999999999999999975 288998853211 123589999999999999999
Q ss_pred EEEecCC----------------------CchhHHHHhhcCccccc
Q 037702 412 ELKKAAG----------------------DTMEYKDFCNQGLRPSL 435 (448)
Q Consensus 412 e~~~~~G----------------------d~~e~~~~~~~~~~~~l 435 (448)
||+ ..| ..+.|-.+|.. |--+|
T Consensus 129 Dfk-~~G~e~~~~~~~~~~~~~~~e~~~~s~~pFLdlca~-LI~eL 172 (179)
T 3t4n_A 129 DFK-FDGWESSYGDDTTVSNISEDEMSTFSAYPFLHLTTK-LIMEL 172 (179)
T ss_dssp EEE-EEEEECC----------------CCCCHHHHHHHHH-HHHHH
T ss_pred EEE-eccccccccccccccccccccccccCCccHHHHHHH-HHHHH
Confidence 999 788 66888888887 43333
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.94 E-value=3.1e-05 Score=78.20 Aligned_cols=81 Identities=14% Similarity=0.074 Sum_probs=46.5
Q ss_pred HHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCccccCCCCcccchhhhhccCC--CCCcchHHHHHHHHH
Q 037702 126 HSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGY--DGAKADIWSCGVVLF 203 (448)
Q Consensus 126 H~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~--~~~~sDiwSlGvil~ 203 (448)
+...++|+|++|.|||++.++ +.|+||+.+.......+-...-. .-...|++|+....... .....++.++...+|
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLG-NLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHH-HHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHH-HHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 356799999999999998877 99999998874322111000000 00134566655421110 011244557777777
Q ss_pred HHHhC
Q 037702 204 VLLAG 208 (448)
Q Consensus 204 elltG 208 (448)
..+++
T Consensus 308 ~~y~~ 312 (420)
T 2pyw_A 308 NLFNK 312 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 77653
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.94 E-value=0.00011 Score=71.27 Aligned_cols=76 Identities=16% Similarity=0.233 Sum_probs=61.1
Q ss_pred EEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEEEEEEe
Q 037702 14 LGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR---HPNIVQLYEVMASKTKIYFAME 90 (448)
Q Consensus 14 ~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~---hpnIv~l~~~~~~~~~~~lV~E 90 (448)
-.+.|+.|.+..+|+... ++..+++|+.... ....+.+|...|+.|. ...+.+++.+....+..|+|||
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme 111 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLE 111 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEE
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEE
Confidence 456789999999999875 5778999987643 1366788999998883 3568889998888889999999
Q ss_pred ecCCCch
Q 037702 91 YVRGGEL 97 (448)
Q Consensus 91 ~~~gg~L 97 (448)
|++|..+
T Consensus 112 ~l~G~~~ 118 (312)
T 3jr1_A 112 ALNKSKN 118 (312)
T ss_dssp CCCCCCC
T ss_pred eccCCCC
Confidence 9998754
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.77 E-value=0.00016 Score=65.78 Aligned_cols=135 Identities=16% Similarity=0.146 Sum_probs=89.8
Q ss_pred chHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH-CCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCccccC
Q 037702 96 ELFNKVAK--GKLREEVARKYFQQLVDAVEFCHS-RGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTC 172 (448)
Q Consensus 96 ~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~-~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~ 172 (448)
+|.+.+.. .+++|+++|.++.|.+.+|.-+-. +.-..+=+.|..|++..+|+|-+.+ +.+. .
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------------~ 98 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD--------------A 98 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc--------------c
Confidence 78888864 689999999999999999877622 2222444567999999999998764 2111 1
Q ss_pred CCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHHHHhccCCC--
Q 037702 173 GTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILDPN-- 250 (448)
Q Consensus 173 Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~d-- 250 (448)
....+.|||... ...+.+.=|||||+++|.-+--.+|= .-+..+|+++.+||..|....
T Consensus 99 ~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~e-----------------~eE~eLS~~LE~LL~~Mt~~~~d 159 (229)
T 2yle_A 99 GEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLKE-----------------NEERELSPPLEQLIDHMANTVEA 159 (229)
T ss_dssp --------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCCT-----------------TEEECCCHHHHHHHHHHTTCCC-
T ss_pred cccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCCc-----------------ccchhhCHHHHHHHHHHHhcccc
Confidence 233567888752 22346778999999999888644431 123458999999999998652
Q ss_pred -----------------------cCCCCCHHHHHhhh
Q 037702 251 -----------------------PSTRVTMAKLMENY 264 (448)
Q Consensus 251 -----------------------P~~Rpt~~eil~hp 264 (448)
+..|++.++|++..
T Consensus 160 ~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C 196 (229)
T 2yle_A 160 DGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLC 196 (229)
T ss_dssp -------------------CCSCCCCCCSHHHHHHHH
T ss_pred cccccccccccccccccccccccccCcCCHHHHHHHH
Confidence 45777787777643
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.70 E-value=6.7e-05 Score=72.01 Aligned_cols=131 Identities=15% Similarity=0.147 Sum_probs=75.7
Q ss_pred EeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEEEEeec-
Q 037702 15 GRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNI-VQLYEVMASKTKIYFAMEYV- 92 (448)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnI-v~l~~~~~~~~~~~lV~E~~- 92 (448)
.+.|+.|....+|++ ..+++|+........ -...+|+.+++.+...++ .+++... .+.-++++||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~----~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~ 90 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEY----INRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIA 90 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----C----CCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCT
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccce----eCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecC
Confidence 788999999999998 568999876432111 112468888877743333 4555543 33457899999
Q ss_pred CCCchHHH---------------Hh---c-C-CCC-----HHHHHHHHHH--------------HHHHHHHHH----H--
Q 037702 93 RGGELFNK---------------VA---K-G-KLR-----EEVARKYFQQ--------------LVDAVEFCH----S-- 127 (448)
Q Consensus 93 ~gg~L~~~---------------i~---~-~-~l~-----e~~~~~~~~q--------------ll~aL~yLH----~-- 127 (448)
+|.+|... +. . + .++ ...+..+..+ +...+..+. .
T Consensus 91 ~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~ 170 (301)
T 3dxq_A 91 GAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHP 170 (301)
T ss_dssp TCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSC
T ss_pred CCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcC
Confidence 66544210 10 0 0 010 1111122111 111122111 1
Q ss_pred --CCCEeecCCCCceEEcCCCCeEEeecccccc
Q 037702 128 --RGVYHRDLKPENLLLDENGDLKISDFGLSAL 158 (448)
Q Consensus 128 --~givHrDLkp~NILl~~~g~lkl~DFGla~~ 158 (448)
..++|+|+.|.||+ ..++.+.|+||..+..
T Consensus 171 ~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 171 LPLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred CCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 23799999999999 6677899999998764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.70 E-value=8.4e-05 Score=72.30 Aligned_cols=135 Identities=15% Similarity=0.179 Sum_probs=72.4
Q ss_pred EeeeeecCceE-EEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCC--CCcceEEEEEEeCCEEEEEEee
Q 037702 15 GRLLGQGTFAK-VYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRH--PNIVQLYEVMASKTKIYFAMEY 91 (448)
Q Consensus 15 ~~~LG~G~fg~-Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~h--pnIv~l~~~~~~~~~~~lV~E~ 91 (448)
.+.|+.|+... +|+... .+|..+++|....... +.+..|+.+++.+.. -.+.+++.+..... +++||+
T Consensus 23 ~~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~~------~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~ 93 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEEG------GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIED 93 (333)
T ss_dssp ECC--------CCEEEEC-TTCCEEEEEECCTTTT------CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECC
T ss_pred eeECCCCCCCceEEEEEc-CCCCeEEEEECCCCCC------ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEee
Confidence 44566665555 666652 2367788876543210 223467777776642 23566776643333 789999
Q ss_pred cCCCchHHHHhcC------------------------C---CCHHHHH-------H-HH------------HHHHHHHHH
Q 037702 92 VRGGELFNKVAKG------------------------K---LREEVAR-------K-YF------------QQLVDAVEF 124 (448)
Q Consensus 92 ~~gg~L~~~i~~~------------------------~---l~e~~~~-------~-~~------------~qll~aL~y 124 (448)
+.+..+.+.+... . ++..... . +. ..+...++.
T Consensus 94 l~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~ 173 (333)
T 3csv_A 94 LGDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQ 173 (333)
T ss_dssp CCSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHH
T ss_pred CCCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHH
Confidence 9776654433211 1 1121110 0 00 011222233
Q ss_pred H------HHCCCEeecCCCCceEEcCC----CCeEEeecccccc
Q 037702 125 C------HSRGVYHRDLKPENLLLDEN----GDLKISDFGLSAL 158 (448)
Q Consensus 125 L------H~~givHrDLkp~NILl~~~----g~lkl~DFGla~~ 158 (448)
+ +...++|+|+.|.|||++.+ +.+.|+||+.+..
T Consensus 174 l~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 174 ILSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HHHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred HHHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 3 13479999999999999875 6799999998864
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.66 E-value=0.00028 Score=67.18 Aligned_cols=81 Identities=12% Similarity=0.040 Sum_probs=57.4
Q ss_pred cCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCC---CcceEEEEEEeCCEE
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHP---NIVQLYEVMASKTKI 85 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hp---nIv~l~~~~~~~~~~ 85 (448)
..+..-.+.+|.|..+.||+... .+|+.|.+|+........ ...+.+|...|+.|.-. -+.+++.+. . -
T Consensus 14 G~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~--~ 85 (288)
T 3f7w_A 14 GREVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPAL---DGLFRAEALGLDWLGRSFGSPVPQVAGWD--D--R 85 (288)
T ss_dssp CCCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCC---TTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T--T
T ss_pred CCCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcch---hhHHHHHHHHHHHHHhhCCCCcceEEecc--C--c
Confidence 34567788899999999999974 688999999875443222 24567899999988422 345555542 2 3
Q ss_pred EEEEeecCCCch
Q 037702 86 YFAMEYVRGGEL 97 (448)
Q Consensus 86 ~lV~E~~~gg~L 97 (448)
++||||++++..
T Consensus 86 ~lv~e~l~~~~~ 97 (288)
T 3f7w_A 86 TLAMEWVDERPP 97 (288)
T ss_dssp EEEEECCCCCCC
T ss_pred eEEEEeecccCC
Confidence 789999987643
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.62 E-value=0.00012 Score=70.76 Aligned_cols=137 Identities=10% Similarity=0.102 Sum_probs=78.5
Q ss_pred EEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC--cceEEEE------EEeCCEE
Q 037702 14 LGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPN--IVQLYEV------MASKTKI 85 (448)
Q Consensus 14 ~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpn--Iv~l~~~------~~~~~~~ 85 (448)
-.+.|+.|....+|+... ++..+++|+..... . .+.+..|..+++.+...+ +.+++.. ....+..
T Consensus 26 ~~~~i~~G~~n~~~~v~~--~~g~~vlk~~~~~~-~----~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~ 98 (322)
T 2ppq_A 26 SYKGIAEGVENSNFLLHT--TKDPLILTLYEKRV-E----KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRP 98 (322)
T ss_dssp EEEEECC---EEEEEEEE--SSCCEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEE
T ss_pred EeeccCCCcccceEEEEe--CCccEEEEEeCCCC-C----HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEE
Confidence 456678888899999875 23478899987531 1 134556777777763222 2333311 1234678
Q ss_pred EEEEeecCCCchHH--------------HHhc--CCC--------CHHHHHHH---------------HHHHHHHHHHHH
Q 037702 86 YFAMEYVRGGELFN--------------KVAK--GKL--------REEVARKY---------------FQQLVDAVEFCH 126 (448)
Q Consensus 86 ~lV~E~~~gg~L~~--------------~i~~--~~l--------~e~~~~~~---------------~~qll~aL~yLH 126 (448)
+++|+|++|..+.. .+.. ..+ ....-... -..+...+++++
T Consensus 99 ~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~ 178 (322)
T 2ppq_A 99 AALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLA 178 (322)
T ss_dssp EEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHH
T ss_pred EEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHH
Confidence 99999999865310 0110 011 10000000 011344556665
Q ss_pred H-------CCCEeecCCCCceEEcCCCCeEEeeccccc
Q 037702 127 S-------RGVYHRDLKPENLLLDENGDLKISDFGLSA 157 (448)
Q Consensus 127 ~-------~givHrDLkp~NILl~~~g~lkl~DFGla~ 157 (448)
+ .+++|+|++|.|||++.++.+.|+||+.+.
T Consensus 179 ~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 179 AHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 3 369999999999999877656899999775
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.48 E-value=0.00027 Score=71.56 Aligned_cols=75 Identities=13% Similarity=0.177 Sum_probs=50.9
Q ss_pred EEeeeeecCceEEEEEEECC-------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEE
Q 037702 14 LGRLLGQGTFAKVYHGRNLK-------TGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNI-VQLYEVMASKTKI 85 (448)
Q Consensus 14 ~~~~LG~G~fg~Vy~a~~~~-------~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnI-v~l~~~~~~~~~~ 85 (448)
-.+.|+.|....||++.... ++..+++|+..... . .+.+.+|..+++.+...++ .++++.+.+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~---- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--T---ESHLVAESVIFTLLSERHLGPKLYGIFSG---- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----
Confidence 35678889999999998642 25789999884321 1 1344579999988854444 567765542
Q ss_pred EEEEeecCCCch
Q 037702 86 YFAMEYVRGGEL 97 (448)
Q Consensus 86 ~lV~E~~~gg~L 97 (448)
.+||||++|.+|
T Consensus 148 g~v~e~l~G~~l 159 (429)
T 1nw1_A 148 GRLEEYIPSRPL 159 (429)
T ss_dssp EEEECCCCEEEC
T ss_pred CEEEEEeCCccc
Confidence 289999987443
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.46 E-value=0.00028 Score=70.27 Aligned_cols=140 Identities=18% Similarity=0.209 Sum_probs=85.4
Q ss_pred CCeEEEeeeeecCceEEEEEEECC-------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC-cceEEEEEEe
Q 037702 10 NKYELGRLLGQGTFAKVYHGRNLK-------TGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPN-IVQLYEVMAS 81 (448)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~-------~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpn-Iv~l~~~~~~ 81 (448)
+..+ .+.|..|....+|++.... ++..+++|+.... . .....+.+|..+++.+...+ ..++++.+.+
T Consensus 51 ~~l~-v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~ 125 (379)
T 3feg_A 51 EELR-VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-L---QGVDSLVLESVMFAILAERSLGPQLYGVFPE 125 (379)
T ss_dssp GGCC-CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT
T ss_pred CceE-EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-c---chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC
Confidence 3344 3567778888999988632 3578999986332 1 12355668999998884323 3566666543
Q ss_pred CCEEEEEEeecCCCchHH--------------HHh---c-----CC-C--CHHHHHHHHHHHHH----------------
Q 037702 82 KTKIYFAMEYVRGGELFN--------------KVA---K-----GK-L--REEVARKYFQQLVD---------------- 120 (448)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~--------------~i~---~-----~~-l--~e~~~~~~~~qll~---------------- 120 (448)
.+||||++|..|.. .+. . ++ . -..++.+|+.|+-.
T Consensus 126 ----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~ 201 (379)
T 3feg_A 126 ----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYS 201 (379)
T ss_dssp ----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTT
T ss_pred ----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHH
Confidence 29999999865421 111 1 11 1 13556666665532
Q ss_pred ---HHHHHHH--------CCCEeecCCCCceEEcCC----CCeEEeecccccc
Q 037702 121 ---AVEFCHS--------RGVYHRDLKPENLLLDEN----GDLKISDFGLSAL 158 (448)
Q Consensus 121 ---aL~yLH~--------~givHrDLkp~NILl~~~----g~lkl~DFGla~~ 158 (448)
.+..|.+ ..++|+|+.+.|||++.+ +.+.|+||..|..
T Consensus 202 l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 202 LKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2344432 258999999999999876 7899999998763
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.42 E-value=0.00054 Score=66.20 Aligned_cols=135 Identities=14% Similarity=0.143 Sum_probs=78.8
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC--cceEEEE-----EEeCCEEEEE
Q 037702 16 RLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPN--IVQLYEV-----MASKTKIYFA 88 (448)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpn--Iv~l~~~-----~~~~~~~~lV 88 (448)
..|+ |....||++.. .+|+.+++|........ .+.+..|..+++.+...+ +++++.. ....+..+++
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~----~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l 105 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERWT----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV 105 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTSC----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCCC----HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence 4566 88889998763 45678999998643221 245667888887774222 3334332 2235677899
Q ss_pred EeecCCCchH----H-------H---Hh---c-CC------CCHHHH----HHHH---------------HHHHHHHHHH
Q 037702 89 MEYVRGGELF----N-------K---VA---K-GK------LREEVA----RKYF---------------QQLVDAVEFC 125 (448)
Q Consensus 89 ~E~~~gg~L~----~-------~---i~---~-~~------l~e~~~----~~~~---------------~qll~aL~yL 125 (448)
|++++|..+. + . +. . .. .+.... ..++ ..+-..++.+
T Consensus 106 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l 185 (328)
T 1zyl_A 106 FPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAV 185 (328)
T ss_dssp EECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHH
T ss_pred EEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHH
Confidence 9999885431 0 0 10 0 00 111110 1111 1111222333
Q ss_pred H-------HCCCEeecCCCCceEEcCCCCeEEeecccccc
Q 037702 126 H-------SRGVYHRDLKPENLLLDENGDLKISDFGLSAL 158 (448)
Q Consensus 126 H-------~~givHrDLkp~NILl~~~g~lkl~DFGla~~ 158 (448)
. ...++|+|++|.|||++ + .+.|+||+.+..
T Consensus 186 ~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 186 TAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 2 24589999999999998 4 899999987753
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.35 E-value=0.00041 Score=68.47 Aligned_cols=75 Identities=15% Similarity=0.115 Sum_probs=45.4
Q ss_pred EeeeeecCceEEEEEEECC--------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC-cceEEEEEEeCCEE
Q 037702 15 GRLLGQGTFAKVYHGRNLK--------TGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPN-IVQLYEVMASKTKI 85 (448)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~--------~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpn-Iv~l~~~~~~~~~~ 85 (448)
.+.|+.|....+|++.... .+..+++|+...... . ......|..+++.+...+ +.+++... .+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~---~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~-- 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD---E-LYNTISEFEVYKTMSKYKIAPQLLNTF--NG-- 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG---G-TSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc---c-eecHHHHHHHHHHHHhcCCCCceEEec--CC--
Confidence 5677888889999998643 136889998754321 1 112357888888875334 44666544 22
Q ss_pred EEEEeecCCCch
Q 037702 86 YFAMEYVRGGEL 97 (448)
Q Consensus 86 ~lV~E~~~gg~L 97 (448)
++||||++|..+
T Consensus 110 ~~v~e~i~G~~l 121 (369)
T 3c5i_A 110 GRIEEWLYGDPL 121 (369)
T ss_dssp EEEEECCCSEEC
T ss_pred cEEEEEecCCcC
Confidence 689999998543
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.22 E-value=0.0046 Score=63.01 Aligned_cols=76 Identities=14% Similarity=0.215 Sum_probs=49.9
Q ss_pred EEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEEEEeec
Q 037702 14 LGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNI-VQLYEVMASKTKIYFAMEYV 92 (448)
Q Consensus 14 ~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnI-v~l~~~~~~~~~~~lV~E~~ 92 (448)
-.+.|+.|....+|++.....+..+++|+...... ... ...+|..+++.|...++ .++++.+. + .+||||+
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~---~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I 183 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD---EII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFM 183 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CC---SCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChh---hhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEee
Confidence 35678889999999998754457899998754321 111 12579999999975555 56777663 2 2599999
Q ss_pred CCCch
Q 037702 93 RGGEL 97 (448)
Q Consensus 93 ~gg~L 97 (448)
+|..|
T Consensus 184 ~G~~l 188 (458)
T 2qg7_A 184 DGYAL 188 (458)
T ss_dssp CSEEC
T ss_pred CCccC
Confidence 88544
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.14 E-value=0.0023 Score=62.51 Aligned_cols=32 Identities=22% Similarity=0.362 Sum_probs=28.2
Q ss_pred CCCEeecCCCCceEEcCCCCeEEeeccccccc
Q 037702 128 RGVYHRDLKPENLLLDENGDLKISDFGLSALQ 159 (448)
Q Consensus 128 ~givHrDLkp~NILl~~~g~lkl~DFGla~~~ 159 (448)
..++|+|+.|.||+++.++.+.|+||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 36999999999999998889999999887643
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.16 E-value=0.012 Score=59.17 Aligned_cols=136 Identities=15% Similarity=0.189 Sum_probs=83.3
Q ss_pred EEeeeeecCceEEEEEEECCC-------CcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC-cceEEEEEEeCCEE
Q 037702 14 LGRLLGQGTFAKVYHGRNLKT-------GQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPN-IVQLYEVMASKTKI 85 (448)
Q Consensus 14 ~~~~LG~G~fg~Vy~a~~~~~-------g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpn-Iv~l~~~~~~~~~~ 85 (448)
-.+.|..|-...+|++..... +..+++++...... .. -...+|..+++.+...+ ..++++.+ .+
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~---~~-idR~~E~~~l~~L~~~gi~P~l~~~~--~~-- 145 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG---KF-YDSKVELDVFRYLSNINIAPNIIADF--PE-- 145 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CC-CCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc---hh-cCHHHHHHHHHHHHhcCCCCCEEEEc--CC--
Confidence 355677788899999986421 57899998654321 11 12357888888884323 35566533 22
Q ss_pred EEEEeecCCCchHH----------H----Hh------c-C-CC---------CHHHHHHHHHHHH---------------
Q 037702 86 YFAMEYVRGGELFN----------K----VA------K-G-KL---------REEVARKYFQQLV--------------- 119 (448)
Q Consensus 86 ~lV~E~~~gg~L~~----------~----i~------~-~-~l---------~e~~~~~~~~qll--------------- 119 (448)
++||||++|..|.. . +. . . .+ ...++..|..++-
T Consensus 146 ~~I~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~ 225 (424)
T 3mes_A 146 GRIEEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELY 225 (424)
T ss_dssp EEEEECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHH
T ss_pred CEEEEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccH
Confidence 78999999865411 0 00 0 0 01 1344444443322
Q ss_pred ----HHHHHHHH------------------------CCCEeecCCCCceEEcCCCCeEEeecccccc
Q 037702 120 ----DAVEFCHS------------------------RGVYHRDLKPENLLLDENGDLKISDFGLSAL 158 (448)
Q Consensus 120 ----~aL~yLH~------------------------~givHrDLkp~NILl~~~g~lkl~DFGla~~ 158 (448)
..+.+|.+ ..++|+|+.+.||+ +.++.+.|+||..|..
T Consensus 226 ~~l~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 226 SKILEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 22333321 24899999999999 8888999999998863
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.19 E-value=0.13 Score=50.99 Aligned_cols=29 Identities=34% Similarity=0.531 Sum_probs=25.1
Q ss_pred CEeecCCCCceEE------cCCCCeEEeecccccc
Q 037702 130 VYHRDLKPENLLL------DENGDLKISDFGLSAL 158 (448)
Q Consensus 130 ivHrDLkp~NILl------~~~g~lkl~DFGla~~ 158 (448)
++|+|+.+.|||+ ++++.+.++||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999999 4567799999998864
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=88.79 E-value=1.5 Score=39.55 Aligned_cols=83 Identities=16% Similarity=0.123 Sum_probs=64.3
Q ss_pred CCCCcceEEEEEEeCCEEEEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHH-HHHHCCCEeecCCCCceEEcCCC
Q 037702 68 RHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVE-FCHSRGVYHRDLKPENLLLDENG 146 (448)
Q Consensus 68 ~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~-yLH~~givHrDLkp~NILl~~~g 146 (448)
.||++ -..+-.+++.+.+.++.-+++.=+..++ .++..+.++++.+|+.... ++ ..-+|--|+|+||++|.++
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~--~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~~~~ 121 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR--KTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFNRAL 121 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH--TSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEECTTC
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH--hcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEeCCC
Confidence 68888 5556678888888888765655555554 4788899998888887665 43 5567888999999999999
Q ss_pred CeEEeecccc
Q 037702 147 DLKISDFGLS 156 (448)
Q Consensus 147 ~lkl~DFGla 156 (448)
.+++.-.|+-
T Consensus 122 ~p~i~hRGi~ 131 (219)
T 4ano_A 122 EPFFLHVGVK 131 (219)
T ss_dssp CEEESCCEET
T ss_pred cEEEEEcCCc
Confidence 9999988863
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=87.41 E-value=1.2 Score=40.19 Aligned_cols=107 Identities=14% Similarity=0.267 Sum_probs=73.9
Q ss_pred EEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCCchHHHHhcCCCCHHHHHHHHHHH
Q 037702 39 AIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQL 118 (448)
Q Consensus 39 AiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~ql 118 (448)
-+..+.++.+...+. .|+.+|.. .||+++.. .+-++.+.+.+.++.-+.+.=+..++ .++....++++.+|
T Consensus 20 ~~~~~~ks~ik~~~~-----~el~LL~~-~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik--~~~~~eKlr~l~ni 90 (215)
T 4ann_A 20 DMREIPKSSIKPEHF-----HLMYLLEQ-HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK--SFTKNEKLRYLLNI 90 (215)
T ss_dssp CEEEEEGGGSCGGGG-----GGGGGGGS-CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG--GSCHHHHHHHHHHG
T ss_pred HHHHhcHhhccccCH-----HHHHHHhc-cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH--hcCHHHHHHHHHHH
Confidence 455566665543322 23333332 68889876 67777777777777655443344443 47888999999999
Q ss_pred HHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccc
Q 037702 119 VDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLS 156 (448)
Q Consensus 119 l~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla 156 (448)
+....++ ..=+|--|+|+||+++.++.+++.-.|+-
T Consensus 91 ~~l~~~~--~~r~tf~L~P~NL~f~~~~~p~i~~RGik 126 (215)
T 4ann_A 91 KNLEEVN--RTRYTFVLAPDELFFTRDGLPIAKTRGLQ 126 (215)
T ss_dssp GGGGGGG--GSSEECCCSGGGEEECTTSCEEESCCEET
T ss_pred HHHHHHh--cCceEEEEecceEEEcCCCCEEEEEccCc
Confidence 9887443 45578889999999999999999987763
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=80.74 E-value=0.1 Score=53.10 Aligned_cols=63 Identities=8% Similarity=0.142 Sum_probs=17.4
Q ss_pred EEeeeeecCceEEEEEEECCCCcEEEE------EEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 037702 14 LGRLLGQGTFAKVYHGRNLKTGQSVAI------KIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMA 80 (448)
Q Consensus 14 ~~~~LG~G~fg~Vy~a~~~~~g~~vAi------K~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~ 80 (448)
+.+.|| ||.||.+.......+||+ |......... +....+.+|..+++.++|||+++.+.+..
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~-e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSE-KRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC------------------------------------CBCCCEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccc-cccccccccccccccccccccCCCcceEE
Confidence 344565 999999998665568888 6554332222 23356778999999999999999988754
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 448 | ||||
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 8e-94 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-89 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-87 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-87 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-84 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-84 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 7e-84 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-83 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-80 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-80 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-79 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-79 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-79 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-78 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-77 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-77 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 8e-77 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-76 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-76 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-75 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-74 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-74 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-73 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-72 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-71 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-70 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-68 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-68 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-68 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-67 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-67 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-67 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-67 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-67 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-67 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 6e-67 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 7e-67 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 9e-67 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-65 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-65 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-65 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-65 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-63 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-63 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-63 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-63 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-63 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-62 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-62 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-62 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 7e-62 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-61 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-60 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-60 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-59 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-59 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-59 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 6e-57 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 9e-57 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-55 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-55 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-43 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 8e-26 | |
| d1ul7a_ | 102 | d.129.6.1 (A:) Map/microtubule affinity-regulating | 3e-13 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 281 bits (721), Expect = 8e-94
Identities = 98/261 (37%), Positives = 154/261 (59%), Gaps = 6/261 (2%)
Query: 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR 68
+ +E+GR LG+G F VY R ++ +A+K++ K ++ + G+ Q++RE+ + +R
Sbjct: 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 64
Query: 69 HPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHS 127
HPNI++LY T++Y +EY G ++ ++ K K E+ Y +L +A+ +CHS
Sbjct: 65 HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 124
Query: 128 RGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRG 187
+ V HRD+KPENLLL G+LKI+DFG S S+R T CGT Y+ PE+I R
Sbjct: 125 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEMIEGRM 180
Query: 188 YDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRIL 247
+D K D+WS GV+ + L G PF + E YK+I+R EF P++ R L+SR+L
Sbjct: 181 HD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLL 239
Query: 248 DPNPSTRVTMAKLMENYWFRK 268
NPS R + +++E+ W
Sbjct: 240 KHNPSQRPMLREVLEHPWITA 260
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 270 bits (691), Expect = 4e-89
Identities = 97/267 (36%), Positives = 152/267 (56%), Gaps = 6/267 (2%)
Query: 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRH 69
++L + LG+G + +V N T ++VA+KIVD ++ V + IK+EI + +++ H
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNH 62
Query: 70 PNIVQLYEVMASKTKIYFAMEYVRGGELFNKV-AKGKLREEVARKYFQQLVDAVEFCHSR 128
N+V+ Y Y +EY GGELF+++ + E A+++F QL+ V + H
Sbjct: 63 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 122
Query: 129 GVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGY 188
G+ HRD+KPENLLLDE +LKISDFGL+ + ++ LL+ CGT YVAPE++ +R +
Sbjct: 123 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182
Query: 189 DGAKADIWSCGVVLFVLLAGNLPFY-DSNLMELYKKITRAEFKCPNW--FPPEVRKLLSR 245
D+WSCG+VL +LAG LP+ S+ + Y + W LL +
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHK 242
Query: 246 ILDPNPSTRVTMAKLMENYWFRKGYKK 272
IL NPS R+T+ + ++ W+ K KK
Sbjct: 243 ILVENPSARITIPDIKKDRWYNKPLKK 269
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 266 bits (682), Expect = 1e-87
Identities = 81/259 (31%), Positives = 144/259 (55%), Gaps = 2/259 (0%)
Query: 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHP 70
++ G++LG+G+F+ V R L T + AIKI++K I + + + RE VM + HP
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 71 NIVQLYEVMASKTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRG 129
V+LY K+YF + Y + GEL + K G E R Y ++V A+E+ H +G
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 128
Query: 130 VYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYD 189
+ HRDLKPEN+LL+E+ ++I+DFG + + + ++ GT YV+PE++ ++
Sbjct: 129 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC 188
Query: 190 GAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRILDP 249
+D+W+ G +++ L+AG PF N +++KI + E+ P F P+ R L+ ++L
Sbjct: 189 -KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 247
Query: 250 NPSTRVTMAKLMENYWFRK 268
+ + R+ ++ +
Sbjct: 248 DATKRLGCEEMEGYGPLKA 266
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 267 bits (684), Expect = 4e-87
Identities = 88/335 (26%), Positives = 158/335 (47%), Gaps = 18/335 (5%)
Query: 1 MEKKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKRE 60
+E K +++ Y++ LG G F V+ TG + A K V + +++E
Sbjct: 17 VEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK---ETVRKE 73
Query: 61 ISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQL 118
I M ++RHP +V L++ ++ E++ GGELF KVA K+ E+ A +Y +Q+
Sbjct: 74 IQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQV 133
Query: 119 VDAVEFCHSRGVYHRDLKPENLLL--DENGDLKISDFGLSALQESTRQDGLLHTTCGTPA 176
+ H H DLKPEN++ + +LK+ DFGL+A + + + T GT
Sbjct: 134 CKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS---VKVTTGTAE 190
Query: 177 YVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFK----CP 232
+ APEV + G D+WS GV+ ++LL+G PF N E + + ++
Sbjct: 191 FAAPEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF 249
Query: 233 NWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGY---KKIETPESPRGQDRNKLIS 289
+ + + + ++L +P+TR+T+ + +E+ W G + + P S + R+ + +
Sbjct: 250 SGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKT 309
Query: 290 DIHAVFECESSSSRDTDPPTNSCRSPVRPSSFNAF 324
A E R ++ + P S +AF
Sbjct: 310 KYDAWPEPLPPLGRISNYSSLRKHRPQEYSIRDAF 344
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 259 bits (663), Expect = 1e-84
Identities = 79/262 (30%), Positives = 134/262 (51%), Gaps = 9/262 (3%)
Query: 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRH 69
KY +GQG VY ++ TGQ VAI+ ++ ++ + + I EI VMR ++
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMRENKN 76
Query: 70 PNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRG 129
PNIV + +++ MEY+ GG L + V + + E ++ + A+EF HS
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 130 VYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYD 189
V HRD+K +N+LL +G +K++DFG A + T + T GTP ++APEV+ ++ Y
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAYG 194
Query: 190 GAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA---EFKCPNWFPPEVRKLLSRI 246
K DIWS G++ ++ G P+ + N + I E + P R L+R
Sbjct: 195 -PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253
Query: 247 LDPNPSTRVTMAKLMENYWFRK 268
LD + R + +L+++ + +
Sbjct: 254 LDMDVEKRGSAKELLQHQFLKI 275
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 257 bits (659), Expect = 3e-84
Identities = 76/270 (28%), Positives = 133/270 (49%), Gaps = 14/270 (5%)
Query: 12 YELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPN 71
+E+ LG G F KVY +N +T A K++D + + + EI ++ HPN
Sbjct: 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEEL---EDYMVEIDILASCDHPN 70
Query: 72 IVQLYEVMASKTKIYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRG 129
IV+L + + ++ +E+ GG + + + L E + +Q +DA+ + H
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK 130
Query: 130 VYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVI----NK 185
+ HRDLK N+L +GD+K++DFG+SA T Q + GTP ++APEV+ +K
Sbjct: 131 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--RRDSFIGTPYWMAPEVVMCETSK 188
Query: 186 RGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAE---FKCPNWFPPEVRKL 242
KAD+WS G+ L + P ++ N M + KI ++E P+ + +
Sbjct: 189 DRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDF 248
Query: 243 LSRILDPNPSTRVTMAKLMENYWFRKGYKK 272
L + L+ N R T ++L+++ + K
Sbjct: 249 LKKCLEKNVDARWTTSQLLQHPFVTVDSNK 278
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 259 bits (663), Expect = 7e-84
Identities = 76/333 (22%), Positives = 151/333 (45%), Gaps = 16/333 (4%)
Query: 1 MEKKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKRE 60
+E K G + + Y++ LG G F V+ TG+ K ++ +K E
Sbjct: 20 VEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK---YTVKNE 76
Query: 61 ISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQL 118
IS+M + HP ++ L++ K ++ +E++ GGELF+++A K+ E Y +Q
Sbjct: 77 ISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQA 136
Query: 119 VDAVEFCHSRGVYHRDLKPENLLLD--ENGDLKISDFGLSALQESTRQDGLLHTTCGTPA 176
+ ++ H + H D+KPEN++ + + +KI DFGL+ D ++ T T
Sbjct: 137 CEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP---DEIVKVTTATAE 193
Query: 177 YVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCP---- 232
+ APE++++ D+W+ GV+ +VLL+G PF + +E + + R +++
Sbjct: 194 FAAPEIVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAF 252
Query: 233 NWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIETPESPRGQDRNKLISDIH 292
+ PE + + +L P R+T+ +E+ W + + + + ++ +
Sbjct: 253 SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEK 312
Query: 293 AVFECESSSSRDTDPPTNSCRSPVRPSSFNAFD 325
+ +S R RP + +D
Sbjct: 313 YADWPAPQPAIGRIANFSSLRKH-RPQEYQIYD 344
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 257 bits (657), Expect = 1e-83
Identities = 69/287 (24%), Positives = 121/287 (42%), Gaps = 12/287 (4%)
Query: 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHP 70
+ R +G G+F VY R+++ + VAIK + + I +E+ ++ +RHP
Sbjct: 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 75
Query: 71 NIVQLYEVMASKTKIYFAMEYVRGGELF-NKVAKGKLREEVARKYFQQLVDAVEFCHSRG 129
N +Q + + MEY G +V K L+E + + + HS
Sbjct: 76 NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN 135
Query: 130 VYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVI--NKRG 187
+ HRD+K N+LL E G +K+ DFG +++ ++ GTP ++APEVI G
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NSFVGTPYWMAPEVILAMDEG 189
Query: 188 YDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNW--FPPEVRKLLSR 245
K D+WS G+ L P ++ N M I + E + R +
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS 249
Query: 246 ILDPNPSTRVTMAKLMENYWFRKGYKK-IETPESPRGQDRNKLISDI 291
L P R T L+++ + + + R +D + + ++
Sbjct: 250 CLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDNL 296
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 248 bits (634), Expect = 1e-80
Identities = 81/268 (30%), Positives = 138/268 (51%), Gaps = 17/268 (6%)
Query: 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHP 70
YE+ +G G++ + R G+ + K +D + + E++++R ++HP
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKHP 63
Query: 71 NIVQLYEVMASKT--KIYFAMEYVRGGELFNKVAKGK-----LREEVARKYFQQLVDAVE 123
NIV+ Y+ + +T +Y MEY GG+L + + KG L EE + QL A++
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 124 FCHSRG-----VYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYV 178
CH R V HRDLKP N+ LD ++K+ DFGL+ + GTP Y+
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS--FAKAFVGTPYYM 181
Query: 179 APEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF-KCPNWFPP 237
+PE +N+ Y+ K+DIWS G +L+ L A PF + EL KI +F + P +
Sbjct: 182 SPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSD 240
Query: 238 EVRKLLSRILDPNPSTRVTMAKLMENYW 265
E+ ++++R+L+ R ++ +++EN
Sbjct: 241 ELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 249 bits (637), Expect = 2e-80
Identities = 75/320 (23%), Positives = 142/320 (44%), Gaps = 18/320 (5%)
Query: 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV 67
L KY + LG+G F V+ + ++ K V + +V +K+EIS++ +
Sbjct: 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV----LVKKEISILNIA 58
Query: 68 RHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFC 125
RH NI+ L+E S ++ E++ G ++F ++ +L E Y Q+ +A++F
Sbjct: 59 RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFL 118
Query: 126 HSRGVYHRDLKPENLLLD--ENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVI 183
HS + H D++PEN++ + +KI +FG + + P Y APEV
Sbjct: 119 HSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN---FRLLFTAPEYYAPEVH 175
Query: 184 NKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCP----NWFPPEV 239
D+WS G +++VLL+G PF ++ + I AE+ E
Sbjct: 176 QHDVVS-TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234
Query: 240 RKLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIETPESPRGQDRNKLISDIHAVFECES 299
+ R+L +R+T ++ +++ W ++ +++ T + R + I
Sbjct: 235 MDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKKDLNMVV 294
Query: 300 SSSRDTDPPTNSCRSPVRPS 319
S++R + + RS S
Sbjct: 295 SAARIS--CGGAIRSQKGVS 312
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 247 bits (631), Expect = 1e-79
Identities = 86/281 (30%), Positives = 150/281 (53%), Gaps = 12/281 (4%)
Query: 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV- 67
+ + L ++LG+G+F KV+ KT Q AIK + K+ + ++ E V+ L
Sbjct: 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60
Query: 68 RHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKV-AKGKLREEVARKYFQQLVDAVEFCH 126
HP + ++ +K ++F MEY+ GG+L + + K A Y +++ ++F H
Sbjct: 61 EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 120
Query: 127 SRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKR 186
S+G+ +RDLK +N+LLD++G +KI+DFG+ +E+ D +T CGTP Y+APE++ +
Sbjct: 121 SKGIVYRDLKLDNILLDKDGHIKIADFGMC--KENMLGDAKTNTFCGTPDYIAPEILLGQ 178
Query: 187 GYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRI 246
Y+ D WS GV+L+ +L G PF+ + EL+ I P W E + LL ++
Sbjct: 179 KYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKL 237
Query: 247 LDPNPSTRVTMAK-LMENYWFRK------GYKKIETPESPR 280
P R+ + + ++ FR+ K+I+ P P+
Sbjct: 238 FVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRPK 278
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 246 bits (630), Expect = 1e-79
Identities = 102/306 (33%), Positives = 168/306 (54%), Gaps = 20/306 (6%)
Query: 3 KKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREIS 62
K+A + + Y+ +LG G F++V + +T + VAIK + K+ + G ++ EI+
Sbjct: 2 KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE--GKEGSMENEIA 59
Query: 63 VMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKV-AKGKLREEVARKYFQQLVDA 121
V+ ++HPNIV L ++ S +Y M+ V GGELF+++ KG E A + Q++DA
Sbjct: 60 VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDA 119
Query: 122 VEFCHSRGVYHRDLKPENLLL---DENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYV 178
V++ H G+ HRDLKPENLL DE+ + ISDFGLS +++ +L T CGTP YV
Sbjct: 120 VKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP---GSVLSTACGTPGYV 176
Query: 179 APEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAE--FKCPNW-- 234
APEV+ ++ Y D WS GV+ ++LL G PFYD N +L+++I +AE F P W
Sbjct: 177 APEVLAQKPYS-KAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDD 235
Query: 235 FPPEVRKLLSRILDPNPSTRVTMAKLMENYWFR------KGYKKIETPESPRGQDRNKLI 288
+ + +++ +P R T + +++ W K + + + + ++K
Sbjct: 236 ISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKKNFAKSKWK 295
Query: 289 SDIHAV 294
+A
Sbjct: 296 QAFNAT 301
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 244 bits (624), Expect = 5e-79
Identities = 85/275 (30%), Positives = 144/275 (52%), Gaps = 20/275 (7%)
Query: 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRV------GLIDQIKREISVM 64
YE +LG+G + V + T + A+KI+D L + +E+ ++
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 65 RLVR-HPNIVQLYEVMASKTKIYFAMEYVRGGELFNKV-AKGKLREEVARKYFQQLVDAV 122
R V HPNI+QL + + T + + ++ GELF+ + K L E+ RK + L++ +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 123
Query: 123 EFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEV 182
H + HRDLKPEN+LLD++ ++K++DFG S + + L CGTP+Y+APE+
Sbjct: 124 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEI 180
Query: 183 I-----NKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA--EFKCPNW- 234
I + G + D+WS GV+++ LLAG+ PF+ M + + I +F P W
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 240
Query: 235 -FPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRK 268
+ V+ L+SR L P R T + + + +F++
Sbjct: 241 DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 244 bits (624), Expect = 2e-78
Identities = 101/312 (32%), Positives = 173/312 (55%), Gaps = 18/312 (5%)
Query: 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR 68
+ +++ R LG G+F +V+ R+ G+ A+K++ KE + R+ ++ E ++ +V
Sbjct: 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 62
Query: 69 HPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREE-VARKYFQQLVDAVEFCHS 127
HP I++++ +I+ M+Y+ GGELF+ + K + VA+ Y ++ A+E+ HS
Sbjct: 63 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 122
Query: 128 RGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRG 187
+ + +RDLKPEN+LLD+NG +KI+DFG + +T CGTP Y+APEV++ +
Sbjct: 123 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-----YTLCGTPDYIAPEVVSTKP 177
Query: 188 YDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRIL 247
Y+ D WS G++++ +LAG PFYDSN M+ Y+KI AE + P +F +V+ LLSR++
Sbjct: 178 YN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLI 236
Query: 248 DPNPSTRV-----TMAKLMENYWFRK------GYKKIETPESPRGQDRNKLISDIHAVFE 296
+ S R+ + + WF++ + IETP P Q S E
Sbjct: 237 TRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQFDKYPE 296
Query: 297 CESSSSRDTDPP 308
+ + + P
Sbjct: 297 EDINYGVQGEDP 308
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 240 bits (614), Expect = 1e-77
Identities = 84/278 (30%), Positives = 135/278 (48%), Gaps = 18/278 (6%)
Query: 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLID---QIKREISVM 64
L ++Y++G LLG G F VY G + VAIK V+K++I G + ++ E+ ++
Sbjct: 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 65 RLVR--HPNIVQLYEVMASKTKIYFAMEYVRGGELFNKV--AKGKLREEVARKYFQQLVD 120
+ V +++L + +E + +G L+EE+AR +F Q+++
Sbjct: 62 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 121
Query: 121 AVEFCHSRGVYHRDLKPENLLLDEN-GDLKISDFGLSALQESTRQDGLLHTTCGTPAYVA 179
AV CH+ GV HRD+K EN+L+D N G+LK+ DFG AL + T GT Y
Sbjct: 122 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSP 177
Query: 180 PEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEV 239
PE I Y G A +WS G++L+ ++ G++PF +I R + E
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSEC 231
Query: 240 RKLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIETPE 277
+ L+ L PS R T ++ + W + ET E
Sbjct: 232 QHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 269
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 240 bits (613), Expect = 2e-77
Identities = 58/266 (21%), Positives = 120/266 (45%), Gaps = 15/266 (5%)
Query: 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRL 66
I + +G+ +G G+F VY G+ VA+K+++ + K E+ V+R
Sbjct: 5 IPDGQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQ-LQAFKNEVGVLRK 60
Query: 67 VRHPNIVQLYEVMASKTKIYFAMEYVRGGELFN--KVAKGKLREEVARKYFQQLVDAVEF 124
RH NI+ + ++ ++ G L++ + + K +Q +++
Sbjct: 61 TRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDY 119
Query: 125 CHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVIN 184
H++ + HRDLK N+ L E+ +KI DFGL+ ++ G+ ++APEVI
Sbjct: 120 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 185 --KRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF------KCPNWFP 236
+ ++D+++ G+VL+ L+ G LP+ + N + + + K + P
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP 239
Query: 237 PEVRKLLSRILDPNPSTRVTMAKLME 262
+++L++ L R +++
Sbjct: 240 KAMKRLMAECLKKKRDERPLFPQILA 265
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 240 bits (613), Expect = 8e-77
Identities = 67/308 (21%), Positives = 126/308 (40%), Gaps = 53/308 (17%)
Query: 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRL 66
+ + +E LG G V+ + +G +A K++ E + + +QI RE+ V+
Sbjct: 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHE 60
Query: 67 VRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFC 125
P IV Y S +I ME++ GG L + K G++ E++ K ++ + +
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 120
Query: 126 HSR-GVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVIN 184
+ + HRD+KP N+L++ G++K+ DFG+S + ++ GT +Y++PE +
Sbjct: 121 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQ 176
Query: 185 KRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPP------- 237
Y ++DIWS G+ L + G P + EL PP
Sbjct: 177 GTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235
Query: 238 -------------------------------------EVRKLLSRILDPNPSTRVTMAKL 260
E + +++ L NP+ R + +L
Sbjct: 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
Query: 261 MENYWFRK 268
M + + ++
Sbjct: 296 MVHAFIKR 303
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 237 bits (607), Expect = 1e-76
Identities = 64/267 (23%), Positives = 130/267 (48%), Gaps = 18/267 (6%)
Query: 12 YELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPN 71
+ +G+G+F VY G + +T VA + K+ + + K E +++ ++HPN
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPN 69
Query: 72 IVQLYEVMASKTK----IYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCH 126
IV+ Y+ S K I E + G L + + ++ +V R + +Q++ ++F H
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 127 SRG--VYHRDLKPENLLL-DENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVI 183
+R + HRDLK +N+ + G +KI D GL+ L+ ++ GTP ++APE+
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAPEMY 185
Query: 184 NKRGYDGAKADIWSCGVVLFVLLAGNLPFYDS-NLMELYKKITRA--EFKCPNWFPPEVR 240
YD D+++ G+ + + P+ + N ++Y+++T PEV+
Sbjct: 186 E-EKYD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK 243
Query: 241 KLLSRILDPNPSTRVTMAKLMENYWFR 267
+++ + N R ++ L+ + +F+
Sbjct: 244 EIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 239 bits (611), Expect = 3e-76
Identities = 107/321 (33%), Positives = 162/321 (50%), Gaps = 20/321 (6%)
Query: 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRL 66
+ MN ++ +LLG+GTF KV R TG+ A+KI+ KE I + E V++
Sbjct: 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 67 VRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKG-KLREEVARKYFQQLVDAVEFC 125
RHP + L + ++ F MEY GGELF +++ EE AR Y ++V A+E+
Sbjct: 62 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 126 HSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINK 185
HSR V +RD+K ENL+LD++G +KI+DFGL S + T CGTP Y+APEV+
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLED 179
Query: 186 RGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSR 245
Y D W GVV++ ++ G LPFY+ + L++ I E + P PE + LL+
Sbjct: 180 NDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAG 238
Query: 246 ILDPNPSTRVTMAK-----LMENYWFRK------GYKKIETPESPRGQDRNKLISDIHAV 294
+L +P R+ +ME+ +F KK+ P P+ D
Sbjct: 239 LLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTS----EVDTRY- 293
Query: 295 FECESSSSRDTDPPTNSCRSP 315
F+ E ++ T P + S
Sbjct: 294 FDDEFTAQSITITPPDRYDSL 314
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 235 bits (600), Expect = 2e-75
Identities = 73/270 (27%), Positives = 128/270 (47%), Gaps = 11/270 (4%)
Query: 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV 67
L ++YELG +LG G ++V+ R+L+ + VA+K++ + R + +RE +
Sbjct: 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL 64
Query: 68 RHPNIVQLYEVMASKTK----IYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAV 122
HP IV +Y+ ++T Y MEYV G L + V G + + A + A+
Sbjct: 65 NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQAL 124
Query: 123 EFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSA-LQESTRQDGLLHTTCGTPAYVAPE 181
F H G+ HRD+KP N+++ +K+ DFG++ + +S GT Y++PE
Sbjct: 125 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 184
Query: 182 VINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPN----WFPP 237
D A++D++S G VL+ +L G PF + + + + R + P+
Sbjct: 185 QARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSA 243
Query: 238 EVRKLLSRILDPNPSTRVTMAKLMENYWFR 267
++ ++ + L NP R A M R
Sbjct: 244 DLDAVVLKALAKNPENRYQTAAEMRADLVR 273
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (596), Expect = 1e-74
Identities = 84/271 (30%), Positives = 143/271 (52%), Gaps = 16/271 (5%)
Query: 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKI---RRVGLIDQIKREISVMRL 66
+ Y+ G LG G FA V R TG A K + K + RR + I+RE+S+++
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 67 VRHPNIVQLYEVMASKTKIYFAMEYVRGGELFN-KVAKGKLREEVARKYFQQLVDAVEFC 125
++HPN++ L+EV +KT + +E V GGELF+ K L EE A ++ +Q+++ V +
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 129
Query: 126 HSRGVYHRDLKPENLLLDENGD----LKISDFGLSALQESTRQDGLLHTTCGTPAYVAPE 181
HS + H DLKPEN++L + +KI DFGL+ + + GTP +VAPE
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPE 186
Query: 182 VINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPP---- 237
++N +AD+WS GV+ ++LL+G PF E ++ ++ + +
Sbjct: 187 IVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 245
Query: 238 EVRKLLSRILDPNPSTRVTMAKLMENYWFRK 268
+ + R+L +P R+T+ +++ W +
Sbjct: 246 LAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 235 bits (599), Expect = 3e-74
Identities = 84/271 (30%), Positives = 139/271 (51%), Gaps = 16/271 (5%)
Query: 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR 68
MN + + R++G+G F +VY R TG+ A+K +DK++I+ E ++ LV
Sbjct: 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 62
Query: 69 ---HPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEF 124
P IV + + K+ F ++ + GG+L +++ G E R Y +++ +E
Sbjct: 63 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 122
Query: 125 CHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVIN 184
H+R V +RDLKP N+LLDE+G ++ISD GL+ + H + GT Y+APEV+
Sbjct: 123 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQ 178
Query: 185 KRGYDGAKADIWSCGVVLFVLLAGNLPFYDSN---LMELYKKITRAEFKCPNWFPPEVRK 241
K + AD +S G +LF LL G+ PF E+ + + P+ F PE+R
Sbjct: 179 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 238
Query: 242 LLSRILDPNPSTRVTMAK-----LMENYWFR 267
LL +L + + R+ + E+ +FR
Sbjct: 239 LLEGLLQRDVNRRLGCLGRGAQEVKESPFFR 269
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (591), Expect = 2e-73
Identities = 87/296 (29%), Positives = 149/296 (50%), Gaps = 32/296 (10%)
Query: 1 MEKKAGILMNKYE-LGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKR 59
++ K +++ Y+ ++LG G KV N +T + A+K++ + +R
Sbjct: 2 LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARR 53
Query: 60 EISVM-RLVRHPNIVQLYEV----MASKTKIYFAMEYVRGGELFNKVAK---GKLREEVA 111
E+ + R + P+IV++ +V A + + ME + GGELF+++ E A
Sbjct: 54 EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREA 113
Query: 112 RKYFQQLVDAVEFCHSRGVYHRDLKPENLLLD---ENGDLKISDFGLSALQESTRQDGLL 168
+ + + +A+++ HS + HRD+KPENLL N LK++DFG + + T L
Sbjct: 114 SEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KETTSHNSL 170
Query: 169 HTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA- 227
T C TP YVAPEV+ YD D+WS GV++++LL G PFY ++ + + +
Sbjct: 171 TTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI 229
Query: 228 -----EFKCPNW--FPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIETP 276
EF P W EV+ L+ +L P+ R+T+ + M + W + K +TP
Sbjct: 230 RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 285
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (575), Expect = 5e-72
Identities = 67/262 (25%), Positives = 123/262 (46%), Gaps = 19/262 (7%)
Query: 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRL 66
+ M + +L + +G+G F V G G VA+K + + + E SVM
Sbjct: 4 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQ-----AFLAEASVMTQ 56
Query: 67 VRHPNIVQLYEVMA-SKTKIYFAMEYVRGGELFN---KVAKGKLREEVARKYFQQLVDAV 122
+RH N+VQL V+ K +Y EY+ G L + + L + K+ + +A+
Sbjct: 57 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 116
Query: 123 EFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEV 182
E+ HRDL N+L+ E+ K+SDFGL+ ST+ T + APE
Sbjct: 117 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEA 171
Query: 183 INKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAE-FKCPNWFPPEVR 240
+ ++ + K+D+WS G++L+ + + G +P+ L ++ ++ + P+ PP V
Sbjct: 172 LREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVY 230
Query: 241 KLLSRILDPNPSTRVTMAKLME 262
+++ + + R + +L E
Sbjct: 231 EVMKNCWHLDAAMRPSFLQLRE 252
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (578), Expect = 3e-71
Identities = 68/318 (21%), Positives = 125/318 (39%), Gaps = 38/318 (11%)
Query: 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRH 69
+Y +G+G + V + VAIK + + + + REI ++ RH
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ--TYCQRTLREIKILLRFRH 65
Query: 70 PNIVQLYEVMASKT----KIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFC 125
NI+ + +++ + T K + + ++ G +L+ + L + + Q++ +++
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYI 125
Query: 126 HSRGVYHRDLKPENLLLDENGDLKISDFGLS-ALQESTRQDGLLHTTCGTPAYVAPEVIN 184
HS V HRDLKP NLLL+ DLKI DFGL+ G L T Y APE++
Sbjct: 126 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 185
Query: 185 KRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA----------------- 227
DIWS G +L +L+ F + ++ I
Sbjct: 186 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 245
Query: 228 ---EFKCPNW-----------FPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYKKI 273
P+ + LL ++L NP R+ + + + + + + Y
Sbjct: 246 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 305
Query: 274 ETPESPRGQDRNKLISDI 291
+ P + + + D+
Sbjct: 306 DEPIAEAPFKFDMELDDL 323
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 225 bits (574), Expect = 1e-70
Identities = 87/284 (30%), Positives = 158/284 (55%), Gaps = 18/284 (6%)
Query: 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR 68
+++++ + LG G+F +V ++ ++G A+KI+DK+K+ ++ I+ E +++ V
Sbjct: 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 69 HPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHS 127
P +V+L + +Y MEYV GGE+F+ + + G+ E AR Y Q+V E+ HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 128 RGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRG 187
+ +RDLKPENLL+D+ G ++++DFG + R G T CGTP +APE+I +G
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGF-----AKRVKGRTWTLCGTPEALAPEIILSKG 214
Query: 188 YDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRIL 247
Y+ D W+ GV+++ + AG PF+ +++Y+KI + + P+ F +++ LL +L
Sbjct: 215 YN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLL 273
Query: 248 DPNPSTRV-----TMAKLMENYWFRK------GYKKIETPESPR 280
+ + R + + + WF +K+E P P+
Sbjct: 274 QVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPK 317
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (553), Expect = 1e-68
Identities = 63/261 (24%), Positives = 115/261 (44%), Gaps = 11/261 (4%)
Query: 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRL 66
I + LG G F V +G+ + VAIK++ + + D+ E VM
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMN 55
Query: 67 VRHPNIVQLYEVMASKTKIYFAMEYVRGGELFN--KVAKGKLREEVARKYFQQLVDAVEF 124
+ H +VQLY V + I+ EY+ G L N + + + + + + + + +A+E+
Sbjct: 56 LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEY 115
Query: 125 CHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVIN 184
S+ HRDL N L+++ G +K+SDFGLS + + PEV+
Sbjct: 116 LESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLM 174
Query: 185 KRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EFKCPNWFPPEVRKL 242
+ +K+DIW+ GV+++ + + G +P+ E + I + P+ +V +
Sbjct: 175 YSKFS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTI 233
Query: 243 LSRILDPNPSTRVTMAKLMEN 263
+ R T L+ N
Sbjct: 234 MYSCWHEKADERPTFKILLSN 254
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (553), Expect = 2e-68
Identities = 61/264 (23%), Positives = 102/264 (38%), Gaps = 9/264 (3%)
Query: 7 ILMNKYELGRLLGQGTFAKVYHGRNLKT---GQSVAIKIVDKEKIRRVGLIDQIKREISV 63
I L LG G+F V G SVA+K + + + + +D RE++
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 64 MRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDA 121
M + H N+++LY V+ + + E G L +++ K G +Y Q+ +
Sbjct: 65 MHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123
Query: 122 VEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPE 181
+ + S+ HRDL NLLL +KI DFGL ++ P
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 182 VINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAE--FKCPNWFPPE 238
K +D W GV L+ + G P+ N ++ KI + P P +
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 243
Query: 239 VRKLLSRILDPNPSTRVTMAKLME 262
+ ++ + P R T L +
Sbjct: 244 IYNVMVQCWAHKPEDRPTFVALRD 267
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (549), Expect = 6e-68
Identities = 66/260 (25%), Positives = 117/260 (45%), Gaps = 12/260 (4%)
Query: 16 RLLGQGTFAKVYHG--RNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIV 73
+ LG G F V G + K ++VA+KI+ E L D++ E +VM+ + +P IV
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP-ALKDELLAEANVMQQLDNPYIV 71
Query: 74 QLYEVMASKTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYH 132
++ + ++ ME G L + + ++++ + Q+ +++ H
Sbjct: 72 RMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 130
Query: 133 RDLKPENLLLDENGDLKISDFGLS-ALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGA 191
RDL N+LL KISDFGLS AL+ + APE IN + +
Sbjct: 131 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS-S 189
Query: 192 KADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAE-FKCPNWFPPEVRKLLSRILDP 249
K+D+WS GV+++ + G P+ E+ + + E CP P E+ L++
Sbjct: 190 KSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTY 249
Query: 250 NPSTRVTMAKL---MENYWF 266
+ R A + + NY++
Sbjct: 250 DVENRPGFAAVELRLRNYYY 269
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (550), Expect = 2e-67
Identities = 64/295 (21%), Positives = 113/295 (38%), Gaps = 36/295 (12%)
Query: 1 MEKKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQS-----VAIKIVDKEKIRRVGLID 55
+ K E G++LG G F KV + ++ VA+K++ ++ +
Sbjct: 28 YDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS--SERE 85
Query: 56 QIKREISVM-RLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAK----------- 103
+ E+ +M +L H NIV L IY EY G+L N +
Sbjct: 86 ALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIE 145
Query: 104 -------------GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKI 150
L E + Q+ +EF + HRDL N+L+ +KI
Sbjct: 146 YENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKI 205
Query: 151 SDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GN 209
DFGL+ S + ++APE + + Y K+D+WS G++L+ + + G
Sbjct: 206 CDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGV 264
Query: 210 LPFYDSNLMELYKKITRAEFK--CPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262
P+ + + K+ + FK P + E+ ++ + R + L
Sbjct: 265 NPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 214 bits (545), Expect = 3e-67
Identities = 65/261 (24%), Positives = 123/261 (47%), Gaps = 11/261 (4%)
Query: 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRL 66
+ + LG G + +VY G K +VA+K + ++ + ++ +E +VM+
Sbjct: 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV----EEFLKEAAVMKE 69
Query: 67 VRHPNIVQLYEVMASKTKIYFAMEYVRGGELFN---KVAKGKLREEVARKYFQQLVDAVE 123
++HPN+VQL V + Y E++ G L + + + ++ V Q+ A+E
Sbjct: 70 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 129
Query: 124 FCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVI 183
+ + HRDL N L+ EN +K++DFGLS L + APE +
Sbjct: 130 YLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESL 188
Query: 184 NKRGYDGAKADIWSCGVVLFVLL-AGNLPFYDSNLMELYKKITR-AEFKCPNWFPPEVRK 241
+ K+D+W+ GV+L+ + G P+ +L ++Y+ + + + P P +V +
Sbjct: 189 AYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYE 247
Query: 242 LLSRILDPNPSTRVTMAKLME 262
L+ NPS R + A++ +
Sbjct: 248 LMRACWQWNPSDRPSFAEIHQ 268
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 4e-67
Identities = 69/268 (25%), Positives = 113/268 (42%), Gaps = 12/268 (4%)
Query: 3 KKAGILMNKYELGRL-LGQGTFAKVYHG--RNLKTGQSVAIKIVDKEKIRRVGLIDQIKR 59
KK + + + + LG G F V G R K VAIK++ + + +++ R
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK--ADTEEMMR 58
Query: 60 EISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFN--KVAKGKLREEVARKYFQQ 117
E +M + +P IV+L V + ME GG L + ++ + Q
Sbjct: 59 EAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 117
Query: 118 LVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLS-ALQESTRQDGLLHTTCGTPA 176
+ +++ + HRDL N+LL KISDFGLS AL
Sbjct: 118 VSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 177
Query: 177 YVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAE-FKCPNW 234
+ APE IN R + +++D+WS GV ++ L+ G P+ E+ I + + +CP
Sbjct: 178 WYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPE 236
Query: 235 FPPEVRKLLSRILDPNPSTRVTMAKLME 262
PPE+ L+S R + +
Sbjct: 237 CPPELYALMSDCWIYKWEDRPDFLTVEQ 264
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (547), Expect = 5e-67
Identities = 67/306 (21%), Positives = 129/306 (42%), Gaps = 10/306 (3%)
Query: 12 YELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKE--KIRRVGLIDQIKREISVMRLVRH 69
++ ++LG G F VY G + G+ V I + KE + +I E VM V +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 70 PNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLR--EEVARKYFQQLVDAVEFCHS 127
P++ +L + + T + + + G L + V + K + + Q+ + +
Sbjct: 71 PHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 129
Query: 128 RGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRG 187
R + HRDL N+L+ +KI+DFGL+ L + ++ ++A E I R
Sbjct: 130 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 189
Query: 188 YDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAE-FKCPNWFPPEVRKLLSR 245
Y ++D+WS GV ++ L+ G+ P+ E+ + + E P +V ++ +
Sbjct: 190 YT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVK 248
Query: 246 ILDPNPSTRVTMAKLMENYWFRKGYKKIETPESPRGQDRNKLISDIHAVFECESSSSRDT 305
+ +R +L+ F K + + +G +R L S + F D
Sbjct: 249 CWMIDADSRPKFRELIIE--FSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDM 306
Query: 306 DPPTNS 311
D ++
Sbjct: 307 DDVVDA 312
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 214 bits (545), Expect = 5e-67
Identities = 59/266 (22%), Positives = 112/266 (42%), Gaps = 13/266 (4%)
Query: 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQS---VAIKIVDKEKIRRVGLIDQIKREISV 63
I ++ ++ +++G G F +V G G+ VAIK + + E S+
Sbjct: 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQ--RRDFLSEASI 80
Query: 64 MRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGEL--FNKVAKGKLREEVARKYFQQLVDA 121
M HPN++ L V+ T + E++ G L F + G+ + +
Sbjct: 81 MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAG 140
Query: 122 VEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTT---CGTPAYV 178
+++ HRDL N+L++ N K+SDFGLS E D + +
Sbjct: 141 MKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWT 200
Query: 179 APEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAE-FKCPNWFP 236
APE I R + +D+WS G+V++ +++ G P++D ++ I + P P
Sbjct: 201 APEAIQYRKFTS-ASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCP 259
Query: 237 PEVRKLLSRILDPNPSTRVTMAKLME 262
+ +L+ + + R +++
Sbjct: 260 SALHQLMLDCWQKDRNHRPKFGQIVN 285
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (543), Expect = 5e-67
Identities = 67/261 (25%), Positives = 114/261 (43%), Gaps = 13/261 (4%)
Query: 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRL 66
+ +L LG G F +V+ G VA+K + + + D E ++M+
Sbjct: 10 VPRETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSP----DAFLAEANLMKQ 64
Query: 67 VRHPNIVQLYEVMASKTKIYFAMEYVRGGELFN---KVAKGKLREEVARKYFQQLVDAVE 123
++H +V+LY V+ ++ IY EY+ G L + + KL Q+ + +
Sbjct: 65 LQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 124 FCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVI 183
F R HRDL+ N+L+ + KI+DFGL+ L E + + APE I
Sbjct: 124 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN-EYTAREGAKFPIKWTAPEAI 182
Query: 184 NKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EFKCPNWFPPEVRK 241
N G K+D+WS G++L ++ G +P+ E+ + + R P+ P E+ +
Sbjct: 183 N-YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQ 241
Query: 242 LLSRILDPNPSTRVTMAKLME 262
L+ P R T L
Sbjct: 242 LMRLCWKERPEDRPTFDYLRS 262
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 6e-67
Identities = 72/299 (24%), Positives = 115/299 (38%), Gaps = 33/299 (11%)
Query: 13 ELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRV--GLIDQIKREISVMRLVRHP 70
E LG+G FA VY R+ T Q VAIK + G+ REI +++ + HP
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 71 NIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGK-LREEVARKYFQQLVDAVEFCHSRG 129
NI+ L + K+ I +++ L + Y + +E+ H
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 130 VYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYD 189
+ HRDLKP NLLLDENG LK++DFGL+ S + T Y APE++
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMY 178
Query: 190 GAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF-------------------- 229
G D+W+ G +L LL + ++ +I
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238
Query: 230 --------KCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIETPESPR 280
+ ++ L+ + NP R+T + ++ +F + PR
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLPR 297
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 7e-67
Identities = 60/260 (23%), Positives = 111/260 (42%), Gaps = 11/260 (4%)
Query: 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRL 66
I ++ + +G G F V+ G VAIK + + + + E VM
Sbjct: 2 IDPSELTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSE----EDFIEEAEVMMK 56
Query: 67 VRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLR--EEVARKYFQQLVDAVEF 124
+ HP +VQLY V + I E++ G L + + + E + + + +
Sbjct: 57 LSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAY 116
Query: 125 CHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVIN 184
V HRDL N L+ EN +K+SDFG++ Q T + +PEV +
Sbjct: 117 LEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-QYTSSTGTKFPVKWASPEVFS 175
Query: 185 KRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EFKCPNWFPPEVRKL 242
Y +K+D+WS GV+++ + + G +P+ + + E+ + I+ P V ++
Sbjct: 176 FSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQI 234
Query: 243 LSRILDPNPSTRVTMAKLME 262
++ P R ++L+
Sbjct: 235 MNHCWKERPEDRPAFSRLLR 254
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 213 bits (542), Expect = 9e-67
Identities = 80/290 (27%), Positives = 135/290 (46%), Gaps = 34/290 (11%)
Query: 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR 68
M KY +G+GT+ VY +N G++ A+K + EK G+ REIS+++ ++
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDE-GIPSTTIREISILKELK 58
Query: 69 HPNIVQLYEVMASKTKIYFAMEYVRGGELFN-KVAKGKLREEVARKYFQQLVDAVEFCHS 127
H NIV+LY+V+ +K ++ E++ V +G L A+ + QL++ + +CH
Sbjct: 59 HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 128 RGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRG 187
R V HRDLKP+NLL++ G+LKI+DFGL+ + T Y AP+V+
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK--YTHEIVTLWYRAPDVLMGSK 176
Query: 188 YDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA--EFKCPNW----------- 234
DIWS G + ++ G F + + +I R NW
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 235 ----------------FPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRK 268
LLS++L +P+ R+T + +E+ +F++
Sbjct: 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 1e-65
Identities = 77/296 (26%), Positives = 136/296 (45%), Gaps = 34/296 (11%)
Query: 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR 68
M ++ +G+GT+ VY RN TG+ VA+K + + G+ REIS+++ +
Sbjct: 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELN 59
Query: 69 HPNIVQLYEVMASKTKIYFAMEYVRGG--ELFNKVAKGKLREEVARKYFQQLVDAVEFCH 126
HPNIV+L +V+ ++ K+Y E++ + + A + + + Y QL+ + FCH
Sbjct: 60 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 127 SRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKR 186
S V HRDLKP+NLL++ G +K++DFGL+ + T Y APE++
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPEILLGC 177
Query: 187 GYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA------------------E 228
Y DIWS G + ++ F + ++ +I R +
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 229 FKCPNW-----------FPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYKKI 273
P W + R LLS++L +P+ R++ + + +F+ K +
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 293
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 2e-65
Identities = 65/303 (21%), Positives = 117/303 (38%), Gaps = 44/303 (14%)
Query: 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR 68
++KYE +GQGTF +V+ R+ KTGQ VA+K V E + G REI +++L++
Sbjct: 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLK 67
Query: 69 HPNIVQLYEVMASKT--------KIYFAMEYVRGGEL-FNKVAKGKLREEVARKYFQQLV 119
H N+V L E+ +K IY ++ K ++ Q L+
Sbjct: 68 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL 127
Query: 120 DAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQD--GLLHTTCGTPAY 177
+ + + H + HRD+K N+L+ +G LK++DFGL+ + T Y
Sbjct: 128 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 187
Query: 178 VAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPP 237
PE++ G D+W G ++ + + + I++ P
Sbjct: 188 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 247
Query: 238 EVRK--------------------------------LLSRILDPNPSTRVTMAKLMENYW 265
V L+ ++L +P+ R+ + + +
Sbjct: 248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 307
Query: 266 FRK 268
F
Sbjct: 308 FWS 310
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (534), Expect = 3e-65
Identities = 63/276 (22%), Positives = 112/276 (40%), Gaps = 24/276 (8%)
Query: 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVM-R 65
+ N + ++G+G F +V R K G + I ++ E+ V+ +
Sbjct: 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCK 66
Query: 66 LVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFN-----------------KVAKGKLRE 108
L HPNI+ L + +Y A+EY G L + L
Sbjct: 67 LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 126
Query: 109 EVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLL 168
+ + + +++ + HRDL N+L+ EN KI+DFGLS QE +
Sbjct: 127 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--- 183
Query: 169 HTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA 227
++A E +N +D+WS GV+L+ +++ G P+ ELY+K+ +
Sbjct: 184 TMGRLPVRWMAIESLN-YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 242
Query: 228 E-FKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262
+ P EV L+ + P R + A+++
Sbjct: 243 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 278
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 4e-65
Identities = 68/261 (26%), Positives = 107/261 (40%), Gaps = 13/261 (4%)
Query: 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRL 66
I L LGQG F +V+ G VAIK + + + +E VM+
Sbjct: 14 IPRESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKK 68
Query: 67 VRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLR---EEVARKYFQQLVDAVE 123
+RH +VQLY V+ S+ IY EY+ G L + + + Q+ +
Sbjct: 69 LRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 127
Query: 124 FCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVI 183
+ HRDL+ N+L+ EN K++DFGL+ L E + + APE
Sbjct: 128 YVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN-EYTARQGAKFPIKWTAPEAA 186
Query: 184 NKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EFKCPNWFPPEVRK 241
+ K+D+WS G++L L G +P+ E+ ++ R CP P +
Sbjct: 187 LYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 245
Query: 242 LLSRILDPNPSTRVTMAKLME 262
L+ + P R T L
Sbjct: 246 LMCQCWRKEPEERPTFEYLQA 266
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 205 bits (522), Expect = 1e-63
Identities = 66/285 (23%), Positives = 108/285 (37%), Gaps = 35/285 (12%)
Query: 10 NKYELGRLLGQGTFAKVYHGR-----NLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVM 64
N E R +G+G F +V+ R + VA+K++ +E + +RE ++M
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALM 70
Query: 65 RLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFN------------------------- 99
+PNIV+L V A + EY+ G+L
Sbjct: 71 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 130
Query: 100 KVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQ 159
L +Q+ + + R HRDL N L+ EN +KI+DFGLS
Sbjct: 131 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 190
Query: 160 ESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNL-PFYDSNLM 218
S ++ PE I Y ++D+W+ GVVL+ + + L P+Y
Sbjct: 191 YSADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYYGMAHE 249
Query: 219 ELYKKITRAEF-KCPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262
E+ + CP P E+ L+ P+ R + +
Sbjct: 250 EVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (526), Expect = 1e-63
Identities = 73/308 (23%), Positives = 128/308 (41%), Gaps = 44/308 (14%)
Query: 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRH 69
Y + +G G + V + +TG VAIK + + + RE+ +++ +RH
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSE-LFAKRAYRELRLLKHMRH 76
Query: 70 PNIVQLYEVMASK------TKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVE 123
N++ L +V T Y M ++ G +L + KL E+ + Q++ +
Sbjct: 77 ENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLR 135
Query: 124 FCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVI 183
+ H+ G+ HRDLKP NL ++E+ +LKI DFGL+ + D + T Y APEVI
Sbjct: 136 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA-----RQADSEMTGYVVTRWYRAPEVI 190
Query: 184 NKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWF-------- 235
DIWS G ++ ++ G F S+ ++ K+I + P F
Sbjct: 191 LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250
Query: 236 -----------------------PPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYKK 272
P LL ++L + RVT + + + +F +
Sbjct: 251 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT 310
Query: 273 IETPESPR 280
+ P+ +
Sbjct: 311 EDEPQVQK 318
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 2e-63
Identities = 84/316 (26%), Positives = 134/316 (42%), Gaps = 52/316 (16%)
Query: 12 YELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPN 71
Y +++G G+F VY + +G+ VAIK V ++K + RE+ +MR + H N
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-------NRELQIMRKLDHCN 74
Query: 72 IVQLYEVMAS------KTKIYFAMEYVRGGEL----FNKVAKGKLREEVARKYFQQLVDA 121
IV+L S + + ++YV AK L + Y QL +
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 122 VEFCHSRGVYHRDLKPENLLLDENG-DLKISDFGLSALQESTRQDGLLHTTCGTPAYVAP 180
+ + HS G+ HRD+KP+NLLLD + LK+ DFG + + + + + Y AP
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA---KQLVRGEPNVSYICSRYYRAP 191
Query: 181 EVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITR-------------- 226
E+I + D+WS G VL LL G F + ++ +I +
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 227 ---AEFKCPNW------------FPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYK 271
EFK P PPE L SR+L+ P+ R+T + + +F +
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311
Query: 272 KIETPESPRGQDRNKL 287
+ P G+D L
Sbjct: 312 --PNVKLPNGRDTPAL 325
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 3e-63
Identities = 71/263 (26%), Positives = 116/263 (44%), Gaps = 12/263 (4%)
Query: 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQS---VAIKIVDKEKIRRVGLIDQIKREISV 63
I + ELGR +G+G F V+ G + VAIK + ++ +E
Sbjct: 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD--SVREKFLQEALT 61
Query: 64 MRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDA 121
MR HP+IV+L V+ ++ ++ ME GEL + + L Y QL A
Sbjct: 62 MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 120
Query: 122 VEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPE 181
+ + S+ HRD+ N+L+ N +K+ DFGLS E + ++APE
Sbjct: 121 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-TYYKASKGKLPIKWMAPE 179
Query: 182 VINKRGYDGAKADIWSCGVVLF-VLLAGNLPFYDSNLMELYKKITRAE-FKCPNWFPPEV 239
IN R + +D+W GV ++ +L+ G PF ++ +I E P PP +
Sbjct: 180 SINFRRFTS-ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL 238
Query: 240 RKLLSRILDPNPSTRVTMAKLME 262
L+++ +PS R +L
Sbjct: 239 YSLMTKCWAYDPSRRPRFTELKA 261
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 3e-63
Identities = 77/295 (26%), Positives = 139/295 (47%), Gaps = 21/295 (7%)
Query: 7 ILMNKYELGRLLGQGTFAKVYHGRNL---KTGQSVAIKIVDKEKI-RRVGLIDQIKREIS 62
+ + +EL ++LG G + KV+ R + TG+ A+K++ K I ++ + + E
Sbjct: 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQ 80
Query: 63 VMRLVRH-PNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKG-KLREEVARKYFQQLVD 120
V+ +R P +V L+ ++TK++ ++Y+ GGELF +++ + E + Y ++V
Sbjct: 81 VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVL 140
Query: 121 AVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAP 180
A+E H G+ +RD+K EN+LLD NG + ++DFGLS + +
Sbjct: 141 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 200
Query: 181 EVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSN----LMELYKKITRAEFKCPNWFP 236
V D WS GV+++ LL G PF E+ ++I ++E P
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 260
Query: 237 PEVRKLLSRILDPNPSTRVTMAK-----LMENYWFRK------GYKKIETPESPR 280
+ L+ R+L +P R+ + E+ +F+K KK+ P P
Sbjct: 261 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPV 315
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 2e-62
Identities = 67/306 (21%), Positives = 128/306 (41%), Gaps = 42/306 (13%)
Query: 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRH 69
+Y+ +G G + V + KTG VA+K + + + + RE+ +++ ++H
Sbjct: 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH-AKRTYRELRLLKHMKH 76
Query: 70 PNIVQLYEVMASKTKI-----YFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEF 124
N++ L +V + + + ++ G +L N V KL ++ + Q++ +++
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 125 CHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVIN 184
HS + HRDLKP NL ++E+ +LKI DFGL+ + T Y APE++
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYVATRWYRAPEIML 191
Query: 185 KRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFP-------- 236
+ DIWS G ++ LL G F ++ ++ K I R
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251
Query: 237 -----------------------PEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYKKI 273
P LL ++L + R+T A+ + + +F + +
Sbjct: 252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311
Query: 274 ETPESP 279
+ P +
Sbjct: 312 DEPVAD 317
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 5e-62
Identities = 75/291 (25%), Positives = 129/291 (44%), Gaps = 34/291 (11%)
Query: 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR 68
M KYE +G+GT+ V+ +N +T + VA+K V + G+ REI +++ ++
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELK 59
Query: 69 HPNIVQLYEVMASKTKIYFAMEYVRGGEL-FNKVAKGKLREEVARKYFQQLVDAVEFCHS 127
H NIV+L++V+ S K+ E+ + G L E+ + + QL+ + FCHS
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 128 RGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRG 187
R V HRDLKP+NLL++ NG+LK+++FGL+ + T Y P+V+
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC--YSAEVVTLWYRPPDVLFGAK 177
Query: 188 YDGAKADIWSCGVVLFVLLAGNLPFYD-SNLMELYKKITRAEF----------------- 229
D+WS G + L P + +++ + K+I R
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237
Query: 230 ------------KCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRK 268
R LL +L NP R++ + +++ +F
Sbjct: 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 201 bits (511), Expect = 6e-62
Identities = 63/292 (21%), Positives = 107/292 (36%), Gaps = 30/292 (10%)
Query: 1 MEKKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKRE 60
ME + G N+Y LGR +G G+F +Y G ++ G+ VAIK+ + Q+ E
Sbjct: 1 MELRVG---NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIE 52
Query: 61 ISVMRLVRHPN-IVQLYEVMASKTKIYFAMEYVRGGELF-NKVAKGKLREEVARKYFQQL 118
+ ++++ I + A ME + K + Q+
Sbjct: 53 SKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQM 112
Query: 119 VDAVEFCHSRGVYHRDLKPENLL---LDENGDLKISDFGLSALQESTRQDGLLH-----T 170
+ +E+ HS+ HRD+KP+N L + + I DFGL+ R +
Sbjct: 113 ISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKN 172
Query: 171 TCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFK 230
GT Y + + D+ S G VL G+LP+ +K R K
Sbjct: 173 LTGTARYASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK 231
Query: 231 --------CPNWFPPEVRKLLSRILDPNPSTRVTMA---KLMENYWFRKGYK 271
+P E L+ + + +L N + R+G+
Sbjct: 232 KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 283
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 7e-62
Identities = 75/296 (25%), Positives = 129/296 (43%), Gaps = 43/296 (14%)
Query: 10 NKYELGRLLGQGTFAKVYHGRNLKT-GQSVAIKIVDKEKIRRVGLIDQIKREISVMRL-- 66
+YE +G+G + KV+ R+LK G+ VA+K V + G+ RE++V+R
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLE 65
Query: 67 -VRHPNIVQLYEVMAS-----KTKIYFAMEYVRGG--ELFNKVAKGKLREEVARKYFQQL 118
HPN+V+L++V +TK+ E+V +KV + + E + QL
Sbjct: 66 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 125
Query: 119 VDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYV 178
+ ++F HS V HRDLKP+N+L+ +G +K++DFGL+ + + T Y
Sbjct: 126 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVVVTLWYR 182
Query: 179 APEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF--------- 229
APEV+ + Y D+WS G + + F S+ ++ KI
Sbjct: 183 APEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 241
Query: 230 ------------------KCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFR 267
K + LL + L NP+ R++ + + +F+
Sbjct: 242 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 6e-61
Identities = 63/284 (22%), Positives = 109/284 (38%), Gaps = 31/284 (10%)
Query: 7 ILMNKYELGRLLGQGTFAKVYHGR-----NLKTGQSVAIKIVDKEKIRRVGLIDQIKREI 61
N+ G+ LG G F KV +VA+K++ + + + E+
Sbjct: 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSEL 77
Query: 62 SVM-RLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAK----------------- 103
V+ L H NIV L EY G+L N + +
Sbjct: 78 KVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137
Query: 104 --GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQES 161
L E + Q+ + F S+ HRDL N+LL KI DFGL+ ++
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 197
Query: 162 TRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMEL 220
+ ++APE I ++D+WS G+ L+ L + G+ P+ +
Sbjct: 198 DSNYVVKGNARLPVKWMAPESI-FNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256
Query: 221 YKKITRAEFK--CPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262
+ K+ + F+ P P E+ ++ D +P R T ++++
Sbjct: 257 FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 1e-60
Identities = 62/283 (21%), Positives = 116/283 (40%), Gaps = 30/283 (10%)
Query: 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQS-------VAIKIVDKEKIRRVGLIDQIKR 59
+ ++ LG+ LG+G F +V + + VA+K++ + + + +
Sbjct: 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLIS 67
Query: 60 EISVM-RLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFN-----------------KV 101
E+ +M + +H NI+ L +Y +EY G L
Sbjct: 68 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 127
Query: 102 AKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQES 161
+ +L + Q+ +E+ S+ HRDL N+L+ E+ +KI+DFGL+
Sbjct: 128 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 187
Query: 162 TRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMEL 220
++APE + R Y ++D+WS GV+L+ + G P+ + EL
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 246
Query: 221 YKKITRAE-FKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262
+K + P+ E+ ++ PS R T +L+E
Sbjct: 247 FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 6e-60
Identities = 61/262 (23%), Positives = 118/262 (45%), Gaps = 13/262 (4%)
Query: 11 KYELGRLLGQGTFAKVYHGRNLK---TGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV 67
++G+G F VYHG L A+K +++ I +G + Q E +M+
Sbjct: 28 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDF 85
Query: 68 RHPNIVQLYEV-MASKTKIYFAMEYVRGGEL--FNKVAKGKLREEVARKYFQQLVDAVEF 124
HPN++ L + + S+ + Y++ G+L F + + + Q+ ++F
Sbjct: 86 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKF 145
Query: 125 CHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTT--CGTPAYVAPEV 182
S+ HRDL N +LDE +K++DFGL+ D + + T ++A E
Sbjct: 146 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 205
Query: 183 INKRGYDGAKADIWSCGVVLFVLLAGNLPFY-DSNLMELYKKITRAE-FKCPNWFPPEVR 240
+ + K+D+WS GV+L+ L+ P Y D N ++ + + P + P +
Sbjct: 206 L-QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY 264
Query: 241 KLLSRILDPNPSTRVTMAKLME 262
+++ + P R + ++L+
Sbjct: 265 EVMLKCWHPKAEMRPSFSELVS 286
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 195 bits (497), Expect = 1e-59
Identities = 66/301 (21%), Positives = 128/301 (42%), Gaps = 53/301 (17%)
Query: 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVM-RLV 67
+ Y+L R LG+G +++V+ N+ + V +KI+ K ++ IKREI ++ L
Sbjct: 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK------IKREIKILENLR 87
Query: 68 RHPNIVQLYEVMASKTK--IYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFC 125
PNI+ L +++ E+V + L + R Y +++ A+++C
Sbjct: 88 GGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY--QTLTDYDIRFYMYEILKALDYC 145
Query: 126 HSRGVYHRDLKPENLLLD-ENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVIN 184
HS G+ HRD+KP N+++D E+ L++ D+GL+ ++ + + + PE++
Sbjct: 146 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPELLV 202
Query: 185 KRGYDGAKADIWSCGVVLFVLLAGNLPFYDSN--------------LMELYKKITRAEFK 230
D+WS G +L ++ PF+ + +LY I + +
Sbjct: 203 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262
Query: 231 CPNWFP------------------------PEVRKLLSRILDPNPSTRVTMAKLMENYWF 266
F PE L ++L + +R+T + ME+ +F
Sbjct: 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 322
Query: 267 R 267
Sbjct: 323 Y 323
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 2e-59
Identities = 58/265 (21%), Positives = 111/265 (41%), Gaps = 12/265 (4%)
Query: 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQS----VAIKIVDKEKIRRVGLIDQIKREIS 62
I + +++G G F +VY G + VAIK + + E
Sbjct: 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ--RVDFLGEAG 61
Query: 63 VMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVD 120
+M H NI++L V++ + EY+ G L + + G+ + +
Sbjct: 62 IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAA 121
Query: 121 AVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHT-TCGTPAYVA 179
+++ + HRDL N+L++ N K+SDFGLS + E + + + A
Sbjct: 122 GMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181
Query: 180 PEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EFKCPNWFPP 237
PE I+ R + +D+WS G+V++ ++ G P+++ + E+ K I P P
Sbjct: 182 PEAISYRKFTS-ASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPS 240
Query: 238 EVRKLLSRILDPNPSTRVTMAKLME 262
+ +L+ + + R A ++
Sbjct: 241 AIYQLMMQCWQQERARRPKFADIVS 265
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 193 bits (492), Expect = 3e-59
Identities = 56/292 (19%), Positives = 106/292 (36%), Gaps = 28/292 (9%)
Query: 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRL 66
++ Y++GR +G+G+F ++ G NL Q VAIK + Q++ E +L
Sbjct: 2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKL 56
Query: 67 VRH-PNIVQLYEVMASKTKIYFAMEYV-RGGELFNKVAKGKLREEVARKYFQQLVDAVEF 124
+ I +Y ++ + E + K + +Q++ V+
Sbjct: 57 LAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQS 116
Query: 125 CHSRGVYHRDLKPENLLLDE-----NGDLKISDFGLSALQESTRQDGLLH-----TTCGT 174
H + + +RD+KP+N L+ + + DFG+ + GT
Sbjct: 117 IHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176
Query: 175 PAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDS---NLMELYKKITRAEFKC 231
Y++ R + D+ + G V L G+LP+ + Y++I +
Sbjct: 177 ARYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235
Query: 232 PNW-----FPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYKKIETPES 278
P FP E K + + L F K +++ T E
Sbjct: 236 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG--LFSKVLERLNTTED 285
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 6e-57
Identities = 57/274 (20%), Positives = 108/274 (39%), Gaps = 21/274 (7%)
Query: 7 ILMNKYELGRLLGQGTFAKVYHGRN-----LKTGQSVAIKIVDKEKIRRVGLIDQIKREI 61
+ K + R LGQG+F VY G + VAIK V++ R + E
Sbjct: 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE--RIEFLNEA 74
Query: 62 SVMRLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELF-----------NKVAKGKLREEV 110
SVM+ ++V+L V++ ME + G+L N
Sbjct: 75 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134
Query: 111 ARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHT 170
+ ++ D + + ++ HRDL N ++ E+ +KI DFG++ T
Sbjct: 135 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 194
Query: 171 TCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAG-NLPFYDSNLMELYKKITRAE- 228
+++PE + + +D+WS GVVL+ + P+ + ++ + +
Sbjct: 195 GLLPVRWMSPESLKDGVFTT-YSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL 253
Query: 229 FKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262
P+ P + +L+ NP R + +++
Sbjct: 254 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 9e-57
Identities = 63/294 (21%), Positives = 118/294 (40%), Gaps = 47/294 (15%)
Query: 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRH 69
L +G+G F +V+ G+ G+ VA+KI + R + EI ++RH
Sbjct: 3 RTIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFSSREERSW----FREAEIYQTVMLRH 56
Query: 70 PNIVQLYEVM----ASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFC 125
NI+ + T+++ +Y G LF+ + + + E K +
Sbjct: 57 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHL 116
Query: 126 HS--------RGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQ--DGLLHTTCGTP 175
H + HRDLK +N+L+ +NG I+D GL+ +S D + GT
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 176 AYVAPEVIN-----KRGYDGAKADIWSCGVVLFVLLAGNLPFY---------------DS 215
Y+APEV++ K +ADI++ G+V + + D
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236
Query: 216 NLMELYKKITRAEFK--CPNWF-----PPEVRKLLSRILDPNPSTRVTMAKLME 262
++ E+ K + + + PN + + K++ N + R+T ++ +
Sbjct: 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (469), Expect = 3e-55
Identities = 68/320 (21%), Positives = 126/320 (39%), Gaps = 55/320 (17%)
Query: 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV 67
++ +Y+ + +G G V + ++VAIK + + + + RE+ +M+ V
Sbjct: 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKCV 73
Query: 68 RHPNIVQLYEVMASK------TKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDA 121
H NI+ L V + +Y ME + +V + +L E Q++
Sbjct: 74 NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLC--QVIQMELDHERMSYLLYQMLCG 131
Query: 122 VEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPE 181
++ HS G+ HRDLKP N+++ + LKI DFGL+ + ++ T Y APE
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPE 188
Query: 182 VINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWF------ 235
VI GY DIWS G ++ ++ + F + ++ + K+ F
Sbjct: 189 VILGMGYKE-NVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247
Query: 236 ------------------------------------PPEVRKLLSRILDPNPSTRVTMAK 259
+ R LLS++L +P+ R+++
Sbjct: 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 307
Query: 260 LMENYWFRKGYKKIETPESP 279
+++ + Y E P
Sbjct: 308 ALQHPYINVWYDPAEVEAPP 327
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 6e-55
Identities = 64/282 (22%), Positives = 114/282 (40%), Gaps = 28/282 (9%)
Query: 7 ILMNKYELGRLLGQGTFAKVYHGRNLK-----TGQSVAIKIVDKEKIRRVGLIDQIKREI 61
++ +LG+ LG+G F +V T ++VA+K++ + +
Sbjct: 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELK 68
Query: 62 SVMRLVRHPNIVQLYEVMASK-TKIYFAMEYVRGGELF-----------------NKVAK 103
++ + H N+V L + +E+ + G L + K
Sbjct: 69 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 128
Query: 104 GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTR 163
L E Y Q+ +EF SR HRDL N+LL E +KI DFGL+
Sbjct: 129 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 188
Query: 164 QDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGN-LPFYDSNLMELYK 222
++APE I R Y ++D+WS GV+L+ + + P+ + E +
Sbjct: 189 DYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247
Query: 223 KITRA--EFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262
+ + + P++ PE+ + + PS R T ++L+E
Sbjct: 248 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 289
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 153 bits (387), Expect = 4e-43
Identities = 59/347 (17%), Positives = 118/347 (34%), Gaps = 74/347 (21%)
Query: 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRH 69
+Y L R LG G F+ V+ +++ VA+KIV +K+ + + EI +++ V
Sbjct: 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT----EAAEDEIKLLQRVND 68
Query: 70 PNIVQL-------------YEVMASKTKIYFAMEYVRGG----ELFNKVAKGKLREEVAR 112
+ + + ++ M + G L K + +
Sbjct: 69 ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVK 128
Query: 113 KYFQQLVDAVEFC-HSRGVYHRDLKPENLLLDENG-DLKISDFGLSALQESTRQDGLLHT 170
+ +QL+ +++ G+ H D+KPEN+L++ + ++ L + D
Sbjct: 129 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN 188
Query: 171 TCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYK-------- 222
+ T Y +PEV+ + ADIWS ++F L+ G+ F K
Sbjct: 189 SIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247
Query: 223 ----------------------------------------KITRAEFKCPNWFPPEVRKL 242
+ ++K E+
Sbjct: 248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF 307
Query: 243 LSRILDPNPSTRVTMAKLMENYWFRKGY--KKIETPESPRGQDRNKL 287
LS +L +P R L+ + W + ++I P+ + +
Sbjct: 308 LSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDI 354
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 101 bits (253), Expect = 8e-26
Identities = 38/204 (18%), Positives = 69/204 (33%), Gaps = 25/204 (12%)
Query: 12 YELGRLLGQGTFAKVYHGRNLKTGQSVAIKIV-------DKEKIRRVGLIDQIKREISVM 64
+G+L+G+G + V++ + + +K K K +R
Sbjct: 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 65 RLVRHPNIVQLYEVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEF 124
+ +L + K+Y EL + ++R E + +++ V
Sbjct: 61 ARNEFRALQKLQGLAV--PKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAK 118
Query: 125 CHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVIN 184
+ RG+ H DL N+L+ E G + I DF S +L I
Sbjct: 119 FYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREILERDV--------RNII 169
Query: 185 ---KRGYDGAKADIWSCGVVLFVL 205
R Y + DI S + +L
Sbjct: 170 TYFSRTY-RTEKDINS--AIDRIL 190
|
| >d1ul7a_ d.129.6.1 (A:) Map/microtubule affinity-regulating kinase 3 {Mouse (Mus musculus) [TaxId: 10090]} Length = 102 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Kinase associated domain 1, KA1 domain: Map/microtubule affinity-regulating kinase 3 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 63.6 bits (155), Expect = 3e-13
Identities = 9/83 (10%), Positives = 38/83 (45%), Gaps = 2/83 (2%)
Query: 352 TTTKPASAIVSKFEEIAVTESCKFNKKDG-TVKLQHNRQGRKGQLAVDAEIFEV-TPAFH 409
T++ S ++ + ++ +C + +++ + H + + + E+ ++ + +
Sbjct: 16 TSSMDPSDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAENLVQWEMEVCKLPRLSLN 75
Query: 410 VVELKKAAGDTMEYKDFCNQGLR 432
V K+ +G ++ +K+ ++
Sbjct: 76 GVRFKRISGTSIAFKNIASKIAN 98
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 448 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1ul7a_ | 102 | Map/microtubule affinity-regulating kinase 3 {Mous | 99.52 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.75 | |
| d2v8qa1 | 153 | 5'-AMP-activated protein kinase catalytic subunit | 98.49 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.2 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.11 | |
| d2qrda1 | 127 | Snf1-like protein kinase ssp2 {Schizosaccharomyces | 97.95 | |
| d2qlva1 | 171 | Carbon catabolite-derepressing protein kinase SNF1 | 97.59 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.31 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.17 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.85 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-66 Score=492.99 Aligned_cols=258 Identities=38% Similarity=0.730 Sum_probs=239.5
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIY 86 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 86 (448)
..+++|++++.||+|+||.||+|+++.+|+.||||++.+....+....+.+.+|+.+++.++||||+++++++.+++.+|
T Consensus 3 ~~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 82 (263)
T d2j4za1 3 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY 82 (263)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred cchhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEE
Confidence 34689999999999999999999999999999999998776655556678999999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccC
Q 037702 87 FAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQD 165 (448)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~ 165 (448)
+|||||+||+|.+++.. +.+++..++.++.||++||+|||++||+||||||+|||++.+|.+||+|||+|.....
T Consensus 83 ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~---- 158 (263)
T d2j4za1 83 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS---- 158 (263)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC----
T ss_pred EEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCC----
Confidence 99999999999999976 7899999999999999999999999999999999999999999999999999975432
Q ss_pred CCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHHHHh
Q 037702 166 GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSR 245 (448)
Q Consensus 166 ~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 245 (448)
......+||+.|||||++.+..|+ .++|||||||+||+|++|+.||.+.+..+++.++.+..+.+|..+|+++++||.+
T Consensus 159 ~~~~~~~Gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 237 (263)
T d2j4za1 159 SRRTTLCGTLDYLPPEMIEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISR 237 (263)
T ss_dssp CCCEETTEEGGGCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHH
T ss_pred CcccccCCCCcccCHHHHcCCCCC-chhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence 233567899999999999887775 8999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCcCCCCCHHHHHhhhhcccc
Q 037702 246 ILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 246 ~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
||++||.+|||++|+++||||+..
T Consensus 238 ~L~~dp~~R~t~~eil~hp~~~~~ 261 (263)
T d2j4za1 238 LLKHNPSQRPMLREVLEHPWITAN 261 (263)
T ss_dssp HTCSSGGGSCCHHHHHTCHHHHHH
T ss_pred HccCCHhHCcCHHHHHcCcCcCCc
Confidence 999999999999999999999754
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-65 Score=491.04 Aligned_cols=261 Identities=35% Similarity=0.650 Sum_probs=226.3
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYF 87 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 87 (448)
..++|++++.||+|+||+||+|+++.+|+.||||++.+.... +..+.+.+|+.+|+.++||||+++++++.+++.+||
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~i 80 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 80 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEE
Confidence 467899999999999999999999999999999999876433 234668899999999999999999999999999999
Q ss_pred EEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCC
Q 037702 88 AMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDG 166 (448)
Q Consensus 88 V~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 166 (448)
|||||+||+|++++.. +.+++.+++.++.||++||+|||++||+||||||+|||++.+|++||+|||+|+.........
T Consensus 81 vmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 81 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred EEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 9999999999999976 679999999999999999999999999999999999999999999999999998765544444
Q ss_pred CccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHH-HHHHHHhhccCCC--CCCCCHHHHHHH
Q 037702 167 LLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLM-ELYKKITRAEFKC--PNWFPPEVRKLL 243 (448)
Q Consensus 167 ~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~~~~~--p~~~s~~~~~li 243 (448)
...+.+||+.|||||++.+..+++.++|||||||+||+|++|++||...+.. ..+..+....... +..+|+++.+||
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 240 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 240 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHH
Confidence 5567899999999999988888778899999999999999999999775543 3333333333222 245899999999
Q ss_pred HhccCCCcCCCCCHHHHHhhhhccccc
Q 037702 244 SRILDPNPSTRVTMAKLMENYWFRKGY 270 (448)
Q Consensus 244 ~~~L~~dP~~Rpt~~eil~hp~~~~~~ 270 (448)
.+||+.||++|||++|+++||||++..
T Consensus 241 ~~~L~~dP~~R~t~~eil~hpwf~~~l 267 (271)
T d1nvra_ 241 HKILVENPSARITIPDIKKDRWYNKPL 267 (271)
T ss_dssp HHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HHHcCCChhHCcCHHHHhcCHhhCcCC
Confidence 999999999999999999999998654
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-65 Score=493.13 Aligned_cols=261 Identities=32% Similarity=0.631 Sum_probs=234.8
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIY 86 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 86 (448)
...++|++++.||+|+||+||+|+++.+|+.||||++.+....+....+.+.+|+.+|++++||||+++++++.+++.+|
T Consensus 5 ~~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 84 (288)
T d1uu3a_ 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY 84 (288)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEE
T ss_pred CCCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEE
Confidence 34578999999999999999999999999999999998776555555678999999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccC
Q 037702 87 FAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQD 165 (448)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~ 165 (448)
+|||||+||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+........
T Consensus 85 ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 85 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence 99999999999999875 78999999999999999999999999999999999999999999999999999876544444
Q ss_pred CCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHHHHh
Q 037702 166 GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSR 245 (448)
Q Consensus 166 ~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 245 (448)
....+.+||+.|+|||++.+..|+ .++|||||||+||+|++|+.||.+.+..+++.++.+..+.+|..+|+++++||.+
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~~~~~-~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 243 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTEKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 243 (288)
T ss_dssp -----CCCCGGGCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHHHHT
T ss_pred cccccccCCccccCceeeccCCCC-cccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence 445667899999999999887775 8999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCcCCCCCHHH------HHhhhhccc
Q 037702 246 ILDPNPSTRVTMAK------LMENYWFRK 268 (448)
Q Consensus 246 ~L~~dP~~Rpt~~e------il~hp~~~~ 268 (448)
||+.||.+|||++| +++||||+.
T Consensus 244 ~L~~dP~~R~t~~e~~~~~~i~~Hpff~~ 272 (288)
T d1uu3a_ 244 LLVLDATKRLGCEEMEGYGPLKAHPFFES 272 (288)
T ss_dssp TSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred HccCCHhHCcCHHHHcCCHHHHcCCccCC
Confidence 99999999999987 578888864
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-63 Score=483.78 Aligned_cols=254 Identities=31% Similarity=0.538 Sum_probs=228.6
Q ss_pred cCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFA 88 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 88 (448)
.++|++.+.||+|+||+||+|+++.+|+.||||++....... .+.+.+|+.+|+.++||||+++++++.+++.+|+|
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 95 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH---HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEE
Confidence 458999999999999999999999999999999998664433 36789999999999999999999999999999999
Q ss_pred EeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCc
Q 037702 89 MEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLL 168 (448)
Q Consensus 89 ~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 168 (448)
||||+||+|.+++.++++++.+++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+..... ....
T Consensus 96 mEy~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~--~~~~ 173 (293)
T d1yhwa1 96 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKR 173 (293)
T ss_dssp EECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST--TCCB
T ss_pred EEecCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccc--cccc
Confidence 99999999999998889999999999999999999999999999999999999999999999999999865332 2234
Q ss_pred cccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhc---cCCCCCCCCHHHHHHHHh
Q 037702 169 HTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA---EFKCPNWFPPEVRKLLSR 245 (448)
Q Consensus 169 ~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~li~~ 245 (448)
...+||+.|+|||++.+..|+ .++|||||||++|+|++|+.||.+.+..+....+... .+..|..+|+++++||.+
T Consensus 174 ~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 252 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252 (293)
T ss_dssp CCCCSCGGGCCHHHHSSSCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHH
T ss_pred cccccCCCccChhhhcCCCCC-chhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHH
Confidence 567899999999999887775 8999999999999999999999988877666665544 334567799999999999
Q ss_pred ccCCCcCCCCCHHHHHhhhhccc
Q 037702 246 ILDPNPSTRVTMAKLMENYWFRK 268 (448)
Q Consensus 246 ~L~~dP~~Rpt~~eil~hp~~~~ 268 (448)
||++||.+|||++|+++||||+.
T Consensus 253 ~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 253 CLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp HTCSSTTTSCCHHHHTTCGGGGG
T ss_pred HccCChhHCcCHHHHhcCHhhCC
Confidence 99999999999999999999974
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-63 Score=491.45 Aligned_cols=259 Identities=37% Similarity=0.661 Sum_probs=240.5
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIY 86 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 86 (448)
+.+++|++++.||+|+||.||+|+++.+|+.||||++.++........+.+.+|+.+|+.++||||+++++++.+++.+|
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence 45789999999999999999999999999999999999876655556688999999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccC
Q 037702 87 FAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQD 165 (448)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~ 165 (448)
+|||||+||+|++++.+ +.++|..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.... ..
T Consensus 82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~--~~ 159 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DG 159 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--TT
T ss_pred cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeeccccccccc--CC
Confidence 99999999999999976 7899999999999999999999999999999999999999999999999999985432 22
Q ss_pred CCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHHHHh
Q 037702 166 GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSR 245 (448)
Q Consensus 166 ~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 245 (448)
....+.|||+.|+|||++.+.+|+ .++|||||||++|+|++|++||.+.+..+++.++....+.+|..+|+++++||++
T Consensus 160 ~~~~~~~GT~~Y~aPE~~~~~~y~-~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~ 238 (337)
T d1o6la_ 160 ATMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAG 238 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred cccccceeCHHHhhhhhccCCCCC-hhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHh
Confidence 334568999999999999988885 8999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCcCCCCC-----HHHHHhhhhccc
Q 037702 246 ILDPNPSTRVT-----MAKLMENYWFRK 268 (448)
Q Consensus 246 ~L~~dP~~Rpt-----~~eil~hp~~~~ 268 (448)
||++||.+|++ ++|+++||||+.
T Consensus 239 ~L~~dP~~R~~~~~~~~~eil~Hp~f~~ 266 (337)
T d1o6la_ 239 LLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp HTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred hccCCchhhcccccccHHHHHcCccccc
Confidence 99999999994 999999999975
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-62 Score=480.65 Aligned_cols=261 Identities=36% Similarity=0.692 Sum_probs=217.7
Q ss_pred cccccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 037702 3 KKAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASK 82 (448)
Q Consensus 3 ~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~ 82 (448)
++..-+.++|++.+.||+|+||+||+|+++.+|+.||||++.++.... ....+.+|+.+|+.++||||+++++++.++
T Consensus 2 ~~~edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 79 (307)
T d1a06a_ 2 KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESG 79 (307)
T ss_dssp EECSCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred CCCCCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 455667788999999999999999999999999999999998765443 235688999999999999999999999999
Q ss_pred CEEEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEc---CCCCeEEeecccccc
Q 037702 83 TKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLD---ENGDLKISDFGLSAL 158 (448)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~---~~g~lkl~DFGla~~ 158 (448)
+.+|||||||+||+|.+++.. +.+++.+++.++.||+.||+|||++||+||||||+|||+. .++.+||+|||+|..
T Consensus 80 ~~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~ 159 (307)
T d1a06a_ 80 GHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 159 (307)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred CEEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEE
Confidence 999999999999999999975 6899999999999999999999999999999999999995 578999999999986
Q ss_pred ccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCC----CC
Q 037702 159 QESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCP----NW 234 (448)
Q Consensus 159 ~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~ 234 (448)
... .....+.+||+.|||||++.+..|+ .++|||||||+||+|++|+.||.+.+..+++..+.......+ +.
T Consensus 160 ~~~---~~~~~~~~GT~~y~APE~~~~~~~~-~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (307)
T d1a06a_ 160 EDP---GSVLSTACGTPGYVAPEVLAQKPYS-KAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDD 235 (307)
T ss_dssp ----------------CTTSCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTT
T ss_pred ccC---CCeeeeeeeCccccCcHHHcCCCCC-cHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccC
Confidence 432 2334567899999999999887775 899999999999999999999999999999999888766543 46
Q ss_pred CCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 235 FPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 235 ~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
+|+++++||.+||+.||.+|||++|+++||||+..
T Consensus 236 ~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 236 ISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred CCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 89999999999999999999999999999999753
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.6e-62 Score=478.44 Aligned_cols=255 Identities=36% Similarity=0.723 Sum_probs=236.9
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYF 87 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 87 (448)
.+++|++++.||+|+||+||+|+++.+|+.||||++.++...+....+.+.+|+.+|+.++||||+++++++.+++.+|+
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 81 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 81 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence 35789999999999999999999999999999999987765555556889999999999999999999999999999999
Q ss_pred EEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCC
Q 037702 88 AMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDG 166 (448)
Q Consensus 88 V~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 166 (448)
|||||+||+|..++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|.....
T Consensus 82 vmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~----- 156 (316)
T d1fota_ 82 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----- 156 (316)
T ss_dssp EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS-----
T ss_pred EeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc-----
Confidence 9999999999999876 6789999999999999999999999999999999999999999999999999986532
Q ss_pred CccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHHHHhc
Q 037702 167 LLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRI 246 (448)
Q Consensus 167 ~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 246 (448)
...+.+||+.|||||++.+..|+ .++|||||||+||+|++|+.||.+.+..+++.++..+...+|+.+|++++++|.+|
T Consensus 157 ~~~~~~Gt~~Y~APE~l~~~~y~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 235 (316)
T d1fota_ 157 VTYTLCGTPDYIAPEVVSTKPYN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRL 235 (316)
T ss_dssp CBCCCCSCTTTCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred ccccccCcccccCHHHHcCCCCC-chhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence 23467999999999999887775 78999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCcCCCC-----CHHHHHhhhhccc
Q 037702 247 LDPNPSTRV-----TMAKLMENYWFRK 268 (448)
Q Consensus 247 L~~dP~~Rp-----t~~eil~hp~~~~ 268 (448)
|.+||.+|+ |++++++||||+.
T Consensus 236 L~~dp~~R~~~~r~t~~~il~Hp~f~~ 262 (316)
T d1fota_ 236 ITRDLSQRLGNLQNGTEDVKNHPWFKE 262 (316)
T ss_dssp TCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred hhhCHHhccccchhhHHHHHcCccccc
Confidence 999999996 9999999999976
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-62 Score=474.52 Aligned_cols=255 Identities=29% Similarity=0.500 Sum_probs=225.9
Q ss_pred cCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFA 88 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 88 (448)
.+.|++.+.||+|+||.||+|++..+|+.||||++.+.... ..+.+.+|+.+|+.++|||||++++++.+++.+|+|
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv 87 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE---ELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWIL 87 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSG---GGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHH---HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEE
Confidence 45799999999999999999999999999999999865432 346788999999999999999999999999999999
Q ss_pred EeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCC
Q 037702 89 MEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDG 166 (448)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 166 (448)
||||+||+|.+++.+ +.+++.+++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|....... .
T Consensus 88 mEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--~ 165 (288)
T d2jfla1 88 IEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--Q 165 (288)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--H
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc--c
Confidence 999999999998754 569999999999999999999999999999999999999999999999999997543321 1
Q ss_pred CccccCCCCcccchhhhh-----ccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccC---CCCCCCCHH
Q 037702 167 LLHTTCGTPAYVAPEVIN-----KRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF---KCPNWFPPE 238 (448)
Q Consensus 167 ~~~~~~Gt~~Y~APEvl~-----~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~ 238 (448)
...+.+||+.|+|||++. ...| +.++|||||||++|+|++|+.||.+.+..+.+.++..... ..|..+|++
T Consensus 166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y-~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~ 244 (288)
T d2jfla1 166 RRDSFIGTPYWMAPEVVMCETSKDRPY-DYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSN 244 (288)
T ss_dssp HHTCCCSCCTTCCHHHHTTCSTTTSST-TTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHH
T ss_pred cccccccccccCCHHHHhhcccCCCCC-ChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHH
Confidence 234678999999999984 2334 5889999999999999999999999888888888877653 345678999
Q ss_pred HHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 239 VRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 239 ~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
+++||.+||++||.+|||++|+++||||+..
T Consensus 245 ~~~li~~~L~~dp~~R~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 245 FKDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275 (288)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 9999999999999999999999999999753
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-62 Score=470.77 Aligned_cols=254 Identities=31% Similarity=0.579 Sum_probs=217.6
Q ss_pred cCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEEE
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMAS--KTKIY 86 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~~~~~ 86 (448)
.++|++.+.||+|+||.||+|+++.+|+.||||++.+....+ ...+.+.+|+.+|++++||||+++++++.+ +..+|
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCH-HHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCH-HHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence 478999999999999999999999999999999998776543 345778999999999999999999999864 45689
Q ss_pred EEEeecCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-----CEeecCCCCceEEcCCCCeEEeecccc
Q 037702 87 FAMEYVRGGELFNKVAK-----GKLREEVARKYFQQLVDAVEFCHSRG-----VYHRDLKPENLLLDENGDLKISDFGLS 156 (448)
Q Consensus 87 lV~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~aL~yLH~~g-----ivHrDLkp~NILl~~~g~lkl~DFGla 156 (448)
+|||||+||+|.+++.+ +.+++..++.++.||+.||+|||++| |+||||||+|||++.+|.+||+|||+|
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 99999999999999853 56999999999999999999999976 999999999999999999999999999
Q ss_pred ccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccC-CCCCCC
Q 037702 157 ALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF-KCPNWF 235 (448)
Q Consensus 157 ~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~ 235 (448)
+..... .....+.+||+.|||||++.+..|+ .++|||||||++|+|++|..||.+.+..++..++..+.+ ..|..+
T Consensus 162 ~~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~-~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 238 (269)
T d2java1 162 RILNHD--TSFAKAFVGTPYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY 238 (269)
T ss_dssp HHC-------------CCCSCCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTS
T ss_pred eecccC--CCccccCCCCcccCCHHHHcCCCCC-hHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccc
Confidence 875432 2234567899999999999887775 899999999999999999999999999999999888776 467789
Q ss_pred CHHHHHHHHhccCCCcCCCCCHHHHHhhhhc
Q 037702 236 PPEVRKLLSRILDPNPSTRVTMAKLMENYWF 266 (448)
Q Consensus 236 s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 266 (448)
|+++.+||.+||++||.+|||++|+++|||+
T Consensus 239 s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 239 SDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 9999999999999999999999999999995
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-61 Score=467.56 Aligned_cols=259 Identities=32% Similarity=0.589 Sum_probs=232.9
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccch---hHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRV---GLIDQIKREISVMRLVRHPNIVQLYEVMASK 82 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~---~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~ 82 (448)
..+.++|++++.||+|+||+||+|+++.+|+.||||++.+...... ...+.+.+|+.+|+.++|||||++++++.++
T Consensus 6 ~~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 85 (293)
T d1jksa_ 6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK 85 (293)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 3457889999999999999999999999999999999987654322 2357899999999999999999999999999
Q ss_pred CEEEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCC----CeEEeeccccc
Q 037702 83 TKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENG----DLKISDFGLSA 157 (448)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g----~lkl~DFGla~ 157 (448)
+.+|||||||+||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+| .+||+|||+|.
T Consensus 86 ~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 86 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred CEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhh
Confidence 999999999999999999976 7899999999999999999999999999999999999998877 59999999998
Q ss_pred cccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCC----C
Q 037702 158 LQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCP----N 233 (448)
Q Consensus 158 ~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~ 233 (448)
..... ....+.+||+.|+|||++.+..| +.++|||||||++|+|++|+.||.+.+..+.+..+......++ +
T Consensus 166 ~~~~~---~~~~~~~~t~~y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (293)
T d1jksa_ 166 KIDFG---NEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 241 (293)
T ss_dssp ECTTS---CBCSCCCCCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred hcCCC---ccccccCCCCcccCHHHHcCCCC-CCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcC
Confidence 65332 23456789999999999987666 5899999999999999999999999999999999888776654 5
Q ss_pred CCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccc
Q 037702 234 WFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRK 268 (448)
Q Consensus 234 ~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 268 (448)
.+|+++++||++||+.||.+|||++|+++||||+.
T Consensus 242 ~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 276 (293)
T d1jksa_ 242 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276 (293)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 68999999999999999999999999999999974
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.4e-61 Score=479.54 Aligned_cols=258 Identities=29% Similarity=0.551 Sum_probs=232.2
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKI 85 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 85 (448)
+.++++|++++.||+|+||.||+|+++.+|+.||||++.+... ...+.+.+|+.+|+.++|||||++++++.+++.+
T Consensus 22 ~~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 98 (350)
T d1koaa2 22 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM 98 (350)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEE
T ss_pred CCCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch---hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 3466899999999999999999999999999999999976543 2346788999999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcC--CCCeEEeeccccccccc
Q 037702 86 YFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDE--NGDLKISDFGLSALQES 161 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~--~g~lkl~DFGla~~~~~ 161 (448)
|||||||+||+|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||++. +|.+||+|||+|+....
T Consensus 99 ~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 99 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp EEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred EEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 999999999999999953 67999999999999999999999999999999999999964 67899999999986533
Q ss_pred cccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCC----CCCCH
Q 037702 162 TRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCP----NWFPP 237 (448)
Q Consensus 162 ~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~ 237 (448)
.....+.+||+.|||||++.+..|+ .++|||||||++|+|++|+.||.+.+..+.+..+....+..+ ..+|+
T Consensus 179 ---~~~~~~~~gT~~Y~aPEv~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 254 (350)
T d1koaa2 179 ---KQSVKVTTGTAEFAAPEVAEGKPVG-YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE 254 (350)
T ss_dssp ---TSCEEEECSCTTTCCHHHHHTCCBC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCH
T ss_pred ---ccccceecCcccccCHHHHcCCCCC-hhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCH
Confidence 2334567899999999999887775 889999999999999999999999999999999988776654 35899
Q ss_pred HHHHHHHhccCCCcCCCCCHHHHHhhhhccccc
Q 037702 238 EVRKLLSRILDPNPSTRVTMAKLMENYWFRKGY 270 (448)
Q Consensus 238 ~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 270 (448)
++++||.+||..||.+|||++|+|+||||+...
T Consensus 255 ~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~ 287 (350)
T d1koaa2 255 DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN 287 (350)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 999999999999999999999999999998754
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.4e-61 Score=479.94 Aligned_cols=260 Identities=27% Similarity=0.542 Sum_probs=233.9
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKI 85 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 85 (448)
+.+.++|++.+.||+|+||.||+|++..+|+.||||++.+.... ..+.+.+|+.+|++++|||||++++++.+++.+
T Consensus 25 ~~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~ 101 (352)
T d1koba_ 25 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL---DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM 101 (352)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH---HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEE
T ss_pred CCcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 45678899999999999999999999999999999999865432 236788999999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEc--CCCCeEEeeccccccccc
Q 037702 86 YFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLD--ENGDLKISDFGLSALQES 161 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~--~~g~lkl~DFGla~~~~~ 161 (448)
|||||||+||+|++++.. .++++.+++.++.||+.||+|||++||+||||||+||||+ .+|.+||+|||+|.....
T Consensus 102 ~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 102 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred EEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCC
Confidence 999999999999998865 4699999999999999999999999999999999999998 578999999999986543
Q ss_pred cccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCC----CCCCH
Q 037702 162 TRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCP----NWFPP 237 (448)
Q Consensus 162 ~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~ 237 (448)
.....+.+||+.|+|||++.+..|+ .++|||||||+||+|++|..||.+.+..+.+..+....+.+| ..+|+
T Consensus 182 ---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 257 (352)
T d1koba_ 182 ---DEIVKVTTATAEFAAPEIVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP 257 (352)
T ss_dssp ---TSCEEEECSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCH
T ss_pred ---CCceeeccCcccccCHHHHcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCH
Confidence 2344677899999999999887774 899999999999999999999999999999999988876655 46899
Q ss_pred HHHHHHHhccCCCcCCCCCHHHHHhhhhccccccc
Q 037702 238 EVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYKK 272 (448)
Q Consensus 238 ~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~ 272 (448)
++++||.+||+.||.+|||++|+|+||||+.....
T Consensus 258 ~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~~~ 292 (352)
T d1koba_ 258 EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSN 292 (352)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCTT
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCHhhCCCcch
Confidence 99999999999999999999999999999875543
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.7e-61 Score=480.80 Aligned_cols=257 Identities=32% Similarity=0.648 Sum_probs=238.4
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKI 85 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 85 (448)
...+++|++++.||+|+||.||+|+++.+|+.||||++.+....+....+.+.+|+.+|+.++||||+++++++.+...+
T Consensus 37 ~~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 116 (350)
T d1rdqe_ 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL 116 (350)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CCCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccc
Confidence 34568999999999999999999999999999999999877655555567899999999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccccc
Q 037702 86 YFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQ 164 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~ 164 (448)
|+||||+.||+|..++.+ +.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 117 ~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~--- 193 (350)
T d1rdqe_ 117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG--- 193 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS---
T ss_pred ccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc---
Confidence 999999999999999876 7899999999999999999999999999999999999999999999999999986532
Q ss_pred CCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 037702 165 DGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLS 244 (448)
Q Consensus 165 ~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 244 (448)
...+.+||+.|||||++.+..|+ .++|||||||+||+|++|+.||.+.+...++.++....+..|..+|+++.+||+
T Consensus 194 --~~~~~~Gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 270 (350)
T d1rdqe_ 194 --RTWTLCGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270 (350)
T ss_dssp --CBCCCEECGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHH
T ss_pred --ccccccCccccCCHHHHcCCCCC-ccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHH
Confidence 23467899999999999887775 889999999999999999999999999999999999999999999999999999
Q ss_pred hccCCCcCCCC-----CHHHHHhhhhccc
Q 037702 245 RILDPNPSTRV-----TMAKLMENYWFRK 268 (448)
Q Consensus 245 ~~L~~dP~~Rp-----t~~eil~hp~~~~ 268 (448)
+||.+||.+|+ |++++++||||+.
T Consensus 271 ~~L~~dP~kR~~~~r~t~~ell~Hp~f~~ 299 (350)
T d1rdqe_ 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp HHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred HHhhhCHHhccccccccHHHHHcCccccC
Confidence 99999999995 9999999999975
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.8e-61 Score=471.27 Aligned_cols=253 Identities=26% Similarity=0.417 Sum_probs=226.7
Q ss_pred CeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 037702 11 KYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAME 90 (448)
Q Consensus 11 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (448)
.|++.+.||+|+||.||+|++..+|+.||||++.+.........+.+.+|+.+|+.++|||||++++++.+++.+|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 49999999999999999999999999999999988766665666789999999999999999999999999999999999
Q ss_pred ecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCcc
Q 037702 91 YVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLH 169 (448)
Q Consensus 91 ~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~ 169 (448)
||.||+|..++.. +++++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|..... ..
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~------~~ 169 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------AN 169 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------BC
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC------CC
Confidence 9999999876654 6899999999999999999999999999999999999999999999999999975432 23
Q ss_pred ccCCCCcccchhhhhcc--CCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCC--CCCCCCHHHHHHHHh
Q 037702 170 TTCGTPAYVAPEVINKR--GYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFK--CPNWFPPEVRKLLSR 245 (448)
Q Consensus 170 ~~~Gt~~Y~APEvl~~~--~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~--~p~~~s~~~~~li~~ 245 (448)
+.+||+.|||||++.+. +.++.++|||||||++|+|++|..||.+.+..+...++.....+ .+..+|+++++||.+
T Consensus 170 ~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~ 249 (309)
T d1u5ra_ 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS 249 (309)
T ss_dssp CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHH
T ss_pred ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHH
Confidence 56899999999998642 23357899999999999999999999998888877777766543 234589999999999
Q ss_pred ccCCCcCCCCCHHHHHhhhhcccc
Q 037702 246 ILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 246 ~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
||+.||.+|||++|+++||||.+.
T Consensus 250 ~L~~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 250 CLQKIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp HTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred HCcCChhHCcCHHHHHhCHHhcCC
Confidence 999999999999999999999764
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-61 Score=459.90 Aligned_cols=254 Identities=25% Similarity=0.524 Sum_probs=220.5
Q ss_pred cccCCe-EEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe----
Q 037702 7 ILMNKY-ELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMAS---- 81 (448)
Q Consensus 7 ~~~~~y-~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~---- 81 (448)
...++| ++.+.||+|+||+||+|++..++..||+|.+....... ...+.+.+|+++|++++|||||++++++.+
T Consensus 5 ~~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 83 (270)
T d1t4ha_ 5 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG 83 (270)
T ss_dssp CTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSS
T ss_pred CCCCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH-HHHHHHHHHHHHHHhCCCCCeeeEEEEEeecccc
Confidence 345667 78889999999999999999999999999998765443 345778999999999999999999999865
Q ss_pred CCEEEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CEeecCCCCceEEc-CCCCeEEeeccccc
Q 037702 82 KTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRG--VYHRDLKPENLLLD-ENGDLKISDFGLSA 157 (448)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~g--ivHrDLkp~NILl~-~~g~lkl~DFGla~ 157 (448)
+..+|+|||||+||+|.+++.+ +.+++..++.++.||+.||+|||++| |+||||||+|||++ .++.+||+|||+|+
T Consensus 84 ~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~ 163 (270)
T d1t4ha_ 84 KKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 163 (270)
T ss_dssp CEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred CCEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence 4568999999999999999976 78999999999999999999999999 99999999999996 57899999999997
Q ss_pred cccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCC-cHHHHHHHHhhccC--CCCCC
Q 037702 158 LQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDS-NLMELYKKITRAEF--KCPNW 234 (448)
Q Consensus 158 ~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~-~~~~~~~~i~~~~~--~~p~~ 234 (448)
.... ....+.+||+.|||||++.+ .| +.++|||||||++|+|++|+.||.+. +...+++.+..+.. .++..
T Consensus 164 ~~~~----~~~~~~~GT~~Y~aPE~~~~-~~-~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~ 237 (270)
T d1t4ha_ 164 LKRA----SFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKV 237 (270)
T ss_dssp GCCT----TSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGC
T ss_pred eccC----CccCCcccCccccCHHHhCC-CC-CCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCcc
Confidence 5332 23456789999999999865 45 58999999999999999999999765 45566666665433 34556
Q ss_pred CCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcc
Q 037702 235 FPPEVRKLLSRILDPNPSTRVTMAKLMENYWFR 267 (448)
Q Consensus 235 ~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~ 267 (448)
+++++++||.+||++||++|||++|+++||||+
T Consensus 238 ~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 238 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred CCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 889999999999999999999999999999995
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-61 Score=472.52 Aligned_cols=257 Identities=31% Similarity=0.592 Sum_probs=233.6
Q ss_pred cCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHH-hCCCCCcceEEEEEEeCCEEEE
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMR-LVRHPNIVQLYEVMASKTKIYF 87 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~-~l~hpnIv~l~~~~~~~~~~~l 87 (448)
+++|++++.||+|+||+||+|+++.+|+.||||++.++........+.+.+|+.++. .++||||+++++++.+++.+||
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 478999999999999999999999999999999998765544444566667777665 6899999999999999999999
Q ss_pred EEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCC
Q 037702 88 AMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDG 166 (448)
Q Consensus 88 V~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 166 (448)
|||||+||+|.+++.. +++++.+++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+..... ..
T Consensus 81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~--~~ 158 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG--DA 158 (320)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT--TC
T ss_pred EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc--cc
Confidence 9999999999999976 78999999999999999999999999999999999999999999999999999854322 23
Q ss_pred CccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHHHHHHHhc
Q 037702 167 LLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEVRKLLSRI 246 (448)
Q Consensus 167 ~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 246 (448)
.....+||+.|+|||++.+..|+ .++|||||||++|+|++|+.||.+.+..+++.++....+.+|..+|+++++||.+|
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~ 237 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKL 237 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred cccccCCCCCcCCHHHHcCCCCC-chhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHh
Confidence 34557899999999999988875 89999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCcCCCCCHH-HHHhhhhccc
Q 037702 247 LDPNPSTRVTMA-KLMENYWFRK 268 (448)
Q Consensus 247 L~~dP~~Rpt~~-eil~hp~~~~ 268 (448)
|.+||.+|||+. ++++||||+.
T Consensus 238 L~~dP~~R~s~~~~l~~hpff~~ 260 (320)
T d1xjda_ 238 FVREPEKRLGVRGDIRQHPLFRE 260 (320)
T ss_dssp SCSSGGGSBTTBSCGGGSGGGTT
T ss_pred cccCCCCCcCHHHHHHhCchhcc
Confidence 999999999995 8999999975
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-61 Score=475.55 Aligned_cols=256 Identities=27% Similarity=0.478 Sum_probs=218.2
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIY 86 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 86 (448)
+..++|++.+.||+|+||.||+|+++.+|+.||+|++.++. +....+.+.+|+.+|+.++|||||++++++.+++.+|
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 45689999999999999999999999999999999997653 2344578899999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCCEeecCCCCceEEcCCCCeEEeecccccccccccc
Q 037702 87 FAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHS-RGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQ 164 (448)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~-~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~ 164 (448)
+|||||+||+|.+++.+ +.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|++||+|||+|......
T Consensus 81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-- 158 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 158 (322)
T ss_dssp EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC--
Confidence 99999999999999975 789999999999999999999997 59999999999999999999999999999865432
Q ss_pred CCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHH----------------------
Q 037702 165 DGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYK---------------------- 222 (448)
Q Consensus 165 ~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~---------------------- 222 (448)
...+.+||+.|+|||++.+..|+ .++|||||||++|||++|+.||.+.+..+...
T Consensus 159 --~~~~~~GT~~Y~APEvl~~~~y~-~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
T d1s9ja_ 159 --MANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235 (322)
T ss_dssp --TC---CCSSCCCCHHHHHCSCCC-TTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred --ccccccCCccccCchHHcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence 23467999999999999887775 88999999999999999999997654322110
Q ss_pred --------------------HHhhcc-CCCC-CCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 223 --------------------KITRAE-FKCP-NWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 223 --------------------~i~~~~-~~~p-~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
.+.... ...| ..+|+++.+||.+||..||.+|||++|+|+||||++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp ----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred cccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 001100 1111 1257899999999999999999999999999999864
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-60 Score=468.50 Aligned_cols=258 Identities=26% Similarity=0.476 Sum_probs=232.3
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIY 86 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 86 (448)
.+.++|++++.||+|+||+||+|++..+|+.||||++.+.... ...+.+|+.+|+.++||||+++++++.+++.+|
T Consensus 2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~----~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 77 (321)
T d1tkia_ 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD----QVLVKKEISILNIARHRNILHLHESFESMEELV 77 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH----HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEE
T ss_pred CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc----HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 3678999999999999999999999999999999999765422 356789999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCC--CCeEEeecccccccccc
Q 037702 87 FAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDEN--GDLKISDFGLSALQEST 162 (448)
Q Consensus 87 lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~--g~lkl~DFGla~~~~~~ 162 (448)
||||||+||+|++++.. +++++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++.....
T Consensus 78 lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~- 156 (321)
T d1tkia_ 78 MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP- 156 (321)
T ss_dssp EEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT-
T ss_pred EEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhcccc-
Confidence 99999999999999975 369999999999999999999999999999999999999854 4799999999986432
Q ss_pred ccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCC----CCCHH
Q 037702 163 RQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPN----WFPPE 238 (448)
Q Consensus 163 ~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~ 238 (448)
.....+.+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+..+.+.+|....+.+|. .+|++
T Consensus 157 --~~~~~~~~~t~~y~ape~~~~~~~~-~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 233 (321)
T d1tkia_ 157 --GDNFRLLFTAPEYYAPEVHQHDVVS-TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIE 233 (321)
T ss_dssp --TCEEEEEESCGGGSCHHHHTTCEEC-HHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHH
T ss_pred --CCcccccccccccccchhccCCCCC-chhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHH
Confidence 2334567899999999999877664 8999999999999999999999999999999999988877664 68999
Q ss_pred HHHHHHhccCCCcCCCCCHHHHHhhhhccccccc
Q 037702 239 VRKLLSRILDPNPSTRVTMAKLMENYWFRKGYKK 272 (448)
Q Consensus 239 ~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~ 272 (448)
+++||.+||..||.+|||++|+++||||++....
T Consensus 234 ~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~~~ 267 (321)
T d1tkia_ 234 AMDFVDRLLVKERKSRMTASEALQHPWLKQKIER 267 (321)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCGGG
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCHhhccCccc
Confidence 9999999999999999999999999999875443
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.3e-60 Score=455.93 Aligned_cols=257 Identities=32% Similarity=0.577 Sum_probs=229.5
Q ss_pred cCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccc------hhHHHHHHHHHHHHHhCC-CCCcceEEEEEEe
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRR------VGLIDQIKREISVMRLVR-HPNIVQLYEVMAS 81 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~------~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~ 81 (448)
.++|++.+.||+|+||+||+|++..+|+.||||++.+..... ....+.+.+|+.+|+.++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 579999999999999999999999999999999998765432 223456889999999997 9999999999999
Q ss_pred CCEEEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccc
Q 037702 82 KTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQE 160 (448)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~ 160 (448)
++.+|||||||+||+|.+++.. +++++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence 9999999999999999999965 789999999999999999999999999999999999999999999999999998654
Q ss_pred ccccCCCccccCCCCcccchhhhhcc-----CCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCC--
Q 037702 161 STRQDGLLHTTCGTPAYVAPEVINKR-----GYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPN-- 233 (448)
Q Consensus 161 ~~~~~~~~~~~~Gt~~Y~APEvl~~~-----~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~-- 233 (448)
.. ......+||+.|+|||++.+. ...+.++||||+||+||+|++|+.||.+.+..+....+..+....+.
T Consensus 162 ~~---~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 238 (277)
T d1phka_ 162 PG---EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 238 (277)
T ss_dssp TT---CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred CC---CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence 32 233557899999999998642 22357899999999999999999999999999988888887665443
Q ss_pred --CCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccc
Q 037702 234 --WFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRK 268 (448)
Q Consensus 234 --~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 268 (448)
.+|+++++||.+||++||.+|||++|+++||||++
T Consensus 239 ~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 239 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 58999999999999999999999999999999975
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.1e-60 Score=474.15 Aligned_cols=257 Identities=32% Similarity=0.522 Sum_probs=224.0
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHH---HHHHHhCCCCCcceEEEEEEeCCE
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKRE---ISVMRLVRHPNIVQLYEVMASKTK 84 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~E---i~~l~~l~hpnIv~l~~~~~~~~~ 84 (448)
.+++|++.+.||+|+||.||+|++..+|+.||||++.+...........+.+| +.+++.++||||+++++++.+.+.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence 46899999999999999999999999999999999987655433333334444 666777789999999999999999
Q ss_pred EEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccc
Q 037702 85 IYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTR 163 (448)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~ 163 (448)
+|+|||||+||+|.+++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~- 160 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK- 160 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS-
T ss_pred EEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC-
Confidence 9999999999999999975 78999999999999999999999999999999999999999999999999999865332
Q ss_pred cCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcH---HHHHHHHhhccCCCCCCCCHHHH
Q 037702 164 QDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNL---MELYKKITRAEFKCPNWFPPEVR 240 (448)
Q Consensus 164 ~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~---~~~~~~i~~~~~~~p~~~s~~~~ 240 (448)
...+.+||+.|+|||++.....++.++|||||||+||+|++|+.||.+.+. ..+...+.......|..+|++++
T Consensus 161 ---~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 237 (364)
T d1omwa3 161 ---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 237 (364)
T ss_dssp ---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHH
T ss_pred ---cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHH
Confidence 235678999999999997554446899999999999999999999986543 34555556667778888999999
Q ss_pred HHHHhccCCCcCCCCC-----HHHHHhhhhccc
Q 037702 241 KLLSRILDPNPSTRVT-----MAKLMENYWFRK 268 (448)
Q Consensus 241 ~li~~~L~~dP~~Rpt-----~~eil~hp~~~~ 268 (448)
+||.+||+.||.+||| ++|+++||||+.
T Consensus 238 ~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~ 270 (364)
T d1omwa3 238 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270 (364)
T ss_dssp HHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTT
T ss_pred HHHHHHcccCHHHhCCCcccCHHHHHcCccccC
Confidence 9999999999999999 799999999975
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-60 Score=455.04 Aligned_cols=252 Identities=33% Similarity=0.606 Sum_probs=222.4
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchh---HHHHHHHHHHHHHhCC--CCCcceEEEEEEeC
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVG---LIDQIKREISVMRLVR--HPNIVQLYEVMASK 82 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~---~~~~~~~Ei~~l~~l~--hpnIv~l~~~~~~~ 82 (448)
+.++|++++.||+|+||.||+|++..+|+.||||++.+....+.. ...++.+|+.+|+.++ ||||+++++++.+.
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 467999999999999999999999999999999999876543221 1233568999999996 89999999999999
Q ss_pred CEEEEEEeecCC-CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCC-CCeEEeeccccccc
Q 037702 83 TKIYFAMEYVRG-GELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDEN-GDLKISDFGLSALQ 159 (448)
Q Consensus 83 ~~~~lV~E~~~g-g~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~-g~lkl~DFGla~~~ 159 (448)
+..|+||||+.+ +++.+++.. +.+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|...
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 161 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceec
Confidence 999999999986 578888865 789999999999999999999999999999999999999855 78999999999864
Q ss_pred cccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCCCCHHH
Q 037702 160 ESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNWFPPEV 239 (448)
Q Consensus 160 ~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~ 239 (448)
.. ....+.+||+.|+|||++.+..+++.++|||||||++|+|++|+.||.+.+ .+.+....+++.+|+++
T Consensus 162 ~~----~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~~~~~~~s~~~ 231 (273)
T d1xwsa_ 162 KD----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSEC 231 (273)
T ss_dssp CS----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSSCCCHHH
T ss_pred cc----ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcccCCCCCCCHHH
Confidence 32 234567899999999999888887788999999999999999999997642 45667788899999999
Q ss_pred HHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 240 RKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 240 ~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
++||++||..||++|||++|+++||||++.
T Consensus 232 ~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 232 QHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred HHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 999999999999999999999999999764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-59 Score=453.63 Aligned_cols=254 Identities=27% Similarity=0.391 Sum_probs=215.2
Q ss_pred EEeeeeecCceEEEEEEECCCCcEEEEEEeecccccc--hhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 037702 14 LGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRR--VGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAMEY 91 (448)
Q Consensus 14 ~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 91 (448)
.++.||+|+||+||+|++..+|+.||||++....... ....+.+.+|+.+|+.++|||||++++++.+++.+|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 5689999999999999999999999999997654322 12235688999999999999999999999999999999999
Q ss_pred cCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCCccc
Q 037702 92 VRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGLLHT 170 (448)
Q Consensus 92 ~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~ 170 (448)
+.|+++..+... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|...... .....+
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~--~~~~~~ 159 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP--NRAYTH 159 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC--CCCCCC
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCC--cccccc
Confidence 999888777764 57999999999999999999999999999999999999999999999999999754332 223456
Q ss_pred cCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCC--------------------
Q 037702 171 TCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFK-------------------- 230 (448)
Q Consensus 171 ~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-------------------- 230 (448)
.+||+.|+|||++....+++.++|||||||++|+|++|.+||.+.+..+...+|.+....
T Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (299)
T d1ua2a_ 160 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239 (299)
T ss_dssp SCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCC
T ss_pred eecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhcc
Confidence 789999999999976666678999999999999999999999998888877776542100
Q ss_pred C--------CCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 231 C--------PNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 231 ~--------p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
. .+.+++++.+||.+||+.||++|||++|+|+||||++.
T Consensus 240 ~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286 (299)
T ss_dssp CCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred CCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence 0 12467899999999999999999999999999999753
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-58 Score=449.26 Aligned_cols=259 Identities=29% Similarity=0.467 Sum_probs=218.9
Q ss_pred cCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFA 88 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 88 (448)
+++|++.+.||+|+||+||+|++..+|+.||||++...... ....+++.+|+.+|+.++||||+++++++.+++.+|+|
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence 47999999999999999999999999999999999765433 23347788999999999999999999999999999999
Q ss_pred EeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCC
Q 037702 89 MEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDG 166 (448)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 166 (448)
|||+.++.+...... +++++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|...... ..
T Consensus 80 ~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~--~~ 157 (298)
T d1gz8a_ 80 FEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VR 157 (298)
T ss_dssp EECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC--SB
T ss_pred EeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCC--cc
Confidence 999976544433332 57999999999999999999999999999999999999999999999999999865332 22
Q ss_pred CccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccC-----------------
Q 037702 167 LLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF----------------- 229 (448)
Q Consensus 167 ~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~----------------- 229 (448)
.....+||+.|+|||++....+.+.++|||||||++|+|++|+.||.+.+..+...++.....
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccc
Confidence 345668999999999998888888999999999999999999999998887766655533210
Q ss_pred -CC-----------CCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccccc
Q 037702 230 -KC-----------PNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGY 270 (448)
Q Consensus 230 -~~-----------p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 270 (448)
.. .+.+|+++++||.+||..||.+|||++|+++||||++-.
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~ 290 (298)
T d1gz8a_ 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290 (298)
T ss_dssp TTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred cccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCC
Confidence 01 123678999999999999999999999999999997654
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-59 Score=458.88 Aligned_cols=256 Identities=32% Similarity=0.619 Sum_probs=217.3
Q ss_pred ccccccCCeEEEe-eeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHH-hCCCCCcceEEEEEEe
Q 037702 4 KAGILMNKYELGR-LLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMR-LVRHPNIVQLYEVMAS 81 (448)
Q Consensus 4 ~~~~~~~~y~~~~-~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~-~l~hpnIv~l~~~~~~ 81 (448)
+...+.++|++.. .||+|+||.||+|++..+|+.||||++.+. ..+.+|+.++. .++||||+++++++.+
T Consensus 5 ~~~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~ 76 (335)
T d2ozaa1 5 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYEN 76 (335)
T ss_dssp BCSCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred CCCCcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEee
Confidence 4456788999875 699999999999999999999999998643 45678999865 4589999999999876
Q ss_pred ----CCEEEEEEeecCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcC---CCCeEEe
Q 037702 82 ----KTKIYFAMEYVRGGELFNKVAK---GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDE---NGDLKIS 151 (448)
Q Consensus 82 ----~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~---~g~lkl~ 151 (448)
+..+|||||||+||+|++++.. .++++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+
T Consensus 77 ~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~ 156 (335)
T d2ozaa1 77 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLT 156 (335)
T ss_dssp EETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEEC
T ss_pred cccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccc
Confidence 4678999999999999999975 26999999999999999999999999999999999999985 5679999
Q ss_pred eccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHH----HHHHHhhc
Q 037702 152 DFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLME----LYKKITRA 227 (448)
Q Consensus 152 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~----~~~~i~~~ 227 (448)
|||+|+.... .....+.+||+.|||||++.+..|+ .++|||||||+||+|++|++||.+.+... +...+...
T Consensus 157 DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~y~-~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~ 232 (335)
T d2ozaa1 157 DFGFAKETTS---HNSLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG 232 (335)
T ss_dssp CCTTCEECCC---CCCCCCCSCCCSSCCCCCCCGGGGS-HHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSC
T ss_pred ccceeeeccC---CCccccccCCcccCCcHHHcCCCCC-HHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcC
Confidence 9999986543 2334567899999999999887775 88999999999999999999998765433 33444555
Q ss_pred cCCCCC----CCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccccc
Q 037702 228 EFKCPN----WFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYK 271 (448)
Q Consensus 228 ~~~~p~----~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~ 271 (448)
.+.+|. .+|+++++||.+||+.||++|||++|+++||||++...
T Consensus 233 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 280 (335)
T d2ozaa1 233 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 280 (335)
T ss_dssp SSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTS
T ss_pred CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCC
Confidence 555553 37999999999999999999999999999999986543
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=7.1e-58 Score=440.50 Aligned_cols=261 Identities=27% Similarity=0.467 Sum_probs=220.2
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC--
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKT-- 83 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~-- 83 (448)
..+.++|++.+.||+|+||.||+|++..+|+.||||++.++...+....+.+.+|+.+++.++||||+++++++...+
T Consensus 3 ~~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~ 82 (277)
T d1o6ya_ 3 SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA 82 (277)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSS
T ss_pred cCccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCC
Confidence 457789999999999999999999999999999999998877766666788999999999999999999999987654
Q ss_pred --EEEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccc
Q 037702 84 --KIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQE 160 (448)
Q Consensus 84 --~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~ 160 (448)
.+|+|||||+||+|.+++.. +++++.+++.++.||+.||+|||++||+||||||+|||++.++..+|+|||++....
T Consensus 83 ~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~ 162 (277)
T d1o6ya_ 83 GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 162 (277)
T ss_dssp SEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred CceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhc
Confidence 48999999999999998865 789999999999999999999999999999999999999999999999999987543
Q ss_pred ccc-cCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCC----CCCC
Q 037702 161 STR-QDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKC----PNWF 235 (448)
Q Consensus 161 ~~~-~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~----p~~~ 235 (448)
... ......+.+||+.|+|||++.+..|+ .++|||||||++|+|++|.+||.+.+..+...++....... ++.+
T Consensus 163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (277)
T d1o6ya_ 163 DSGNSVTQTAAVIGTAQYLSPEQARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 241 (277)
T ss_dssp ----------------TTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSC
T ss_pred cccccccccccccCcccccCHHHHcCCCCC-cceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCC
Confidence 322 22234567899999999999877775 88999999999999999999999998888887777665433 3568
Q ss_pred CHHHHHHHHhccCCCcCCCCCHHHHHhhhhcc
Q 037702 236 PPEVRKLLSRILDPNPSTRVTMAKLMENYWFR 267 (448)
Q Consensus 236 s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~ 267 (448)
|+++.+||.+||++||.+||+..+.+.|+|.+
T Consensus 242 s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 242 SADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 99999999999999999999555555677764
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.6e-57 Score=438.40 Aligned_cols=256 Identities=30% Similarity=0.479 Sum_probs=219.6
Q ss_pred cCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFA 88 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 88 (448)
+++|++.+.||+|+||.||+|++. +|+.||||++...... ....+.+.+|+.+|+.++||||+++++++.+.+..|++
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~ 78 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence 479999999999999999999985 8899999999776543 23457889999999999999999999999999999999
Q ss_pred EeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCC
Q 037702 89 MEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGL 167 (448)
Q Consensus 89 ~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 167 (448)
||++.++.+..+... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|....... ..
T Consensus 79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~--~~ 156 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV--RK 156 (286)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCc--cc
Confidence 999998888777764 789999999999999999999999999999999999999999999999999998654322 22
Q ss_pred ccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccC------------------
Q 037702 168 LHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF------------------ 229 (448)
Q Consensus 168 ~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~------------------ 229 (448)
.....||+.|+|||++.+..+.+.++|||||||++|+|++|+.||.+.+..+...++.....
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccc
Confidence 34567999999999998777778999999999999999999999998887776665543110
Q ss_pred -----------CCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccc
Q 037702 230 -----------KCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRK 268 (448)
Q Consensus 230 -----------~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 268 (448)
..+..+++++.+||++||++||++|||++|+++||||++
T Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 123446899999999999999999999999999999974
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-57 Score=437.36 Aligned_cols=255 Identities=23% Similarity=0.433 Sum_probs=209.7
Q ss_pred cccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 037702 5 AGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTK 84 (448)
Q Consensus 5 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 84 (448)
.++..++|++++.||+|+||.||+|++ +..||||++....... ...+.+.+|+.+|++++|||||++++++. .+.
T Consensus 3 wei~~~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~ 77 (276)
T d1uwha_ 3 WEIPDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHVNILLFMGYST-APQ 77 (276)
T ss_dssp CBCCTTCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSCCT-THHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred cccccccEEEEEEEeeCCCcEEEEEEE---CCEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccE
Confidence 356678999999999999999999985 3469999997664443 44678999999999999999999999875 456
Q ss_pred EEEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccc
Q 037702 85 IYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQEST 162 (448)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~ 162 (448)
+|+|||||+||+|.+++.. +++++..+..++.||++||+|||++||+||||||+||||+.++.+||+|||+|+.....
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp CEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 8999999999999999964 57999999999999999999999999999999999999999999999999999876544
Q ss_pred ccCCCccccCCCCcccchhhhhccC--CCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHH-HHHhhccC-----CCCCC
Q 037702 163 RQDGLLHTTCGTPAYVAPEVINKRG--YDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELY-KKITRAEF-----KCPNW 234 (448)
Q Consensus 163 ~~~~~~~~~~Gt~~Y~APEvl~~~~--~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~-~~i~~~~~-----~~p~~ 234 (448)
.......+.+||+.|||||++.... .++.++|||||||+||||+||+.||.+.+..... ..+..+.. ..+..
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 237 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSN 237 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTT
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhcccc
Confidence 4444455678999999999996432 2358899999999999999999999886655443 33333321 24566
Q ss_pred CCHHHHHHHHhccCCCcCCCCCHHHHHhhh
Q 037702 235 FPPEVRKLLSRILDPNPSTRVTMAKLMENY 264 (448)
Q Consensus 235 ~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 264 (448)
+|+++.+||.+||+.||++|||+++|+++-
T Consensus 238 ~~~~l~~li~~cl~~dp~~RPt~~~il~~L 267 (276)
T d1uwha_ 238 CPKAMKRLMAECLKKKRDERPLFPQILASI 267 (276)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred chHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 899999999999999999999999999874
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-57 Score=445.59 Aligned_cols=255 Identities=24% Similarity=0.369 Sum_probs=217.0
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCc-----EEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQ-----SVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEVM 79 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~-----~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~ 79 (448)
.+..++|++++.||+|+||+||+|++..+++ .||+|.+...... .....+.+|+.+|+.+ +|||||++++++
T Consensus 33 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~HpnIv~l~~~~ 110 (325)
T d1rjba_ 33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS--SEREALMSELKMMTQLGSHENIVNLLGAC 110 (325)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCH--HHHHHHHHHHHHHHHhcCCCcEeEEEEEE
Confidence 3455789999999999999999999876554 6999998654322 2346788999999988 899999999999
Q ss_pred EeCCEEEEEEeecCCCchHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHHCCCEeecC
Q 037702 80 ASKTKIYFAMEYVRGGELFNKVAKG------------------------KLREEVARKYFQQLVDAVEFCHSRGVYHRDL 135 (448)
Q Consensus 80 ~~~~~~~lV~E~~~gg~L~~~i~~~------------------------~l~e~~~~~~~~qll~aL~yLH~~givHrDL 135 (448)
.+.+.+|+|||||+||+|.+++... .+++..++.++.||+.||+|||++||+||||
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDl 190 (325)
T d1rjba_ 111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL 190 (325)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 9999999999999999999999642 3889999999999999999999999999999
Q ss_pred CCCceEEcCCCCeEEeeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCC
Q 037702 136 KPENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYD 214 (448)
Q Consensus 136 kp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~ 214 (448)
||+|||++.++++||+|||+|+............+.+||+.|||||++.+..|+ .++|||||||+||||+| |..||.+
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~~DiwS~Gvil~emlt~g~~Pf~~ 269 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGVNPYPG 269 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCC-cceeccchhHHHHHHHhCCCCCCCC
Confidence 999999999999999999999865544333333456789999999999877764 89999999999999997 8999988
Q ss_pred CcHHHHHHHHhhc--cCCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 215 SNLMELYKKITRA--EFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 215 ~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
.+..+.+.++... .+..|..+|+++++||.+||+.||++|||++||++|
T Consensus 270 ~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 270 IPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp CCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 7665555555444 345678899999999999999999999999999986
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-56 Score=437.72 Aligned_cols=255 Identities=29% Similarity=0.447 Sum_probs=214.2
Q ss_pred cCCeEEEeeeeecCceEEEEEEECCC-CcEEEEEEeecccccchhHHHHHHHHHHHHHhC---CCCCcceEEEEEEe---
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNLKT-GQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV---RHPNIVQLYEVMAS--- 81 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~-g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l---~hpnIv~l~~~~~~--- 81 (448)
.++|++++.||+|+||.||+|++..+ ++.||||++....... .....+.+|+.+|+.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc-hHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 47999999999999999999999776 5679999997654332 2223456788887766 79999999999853
Q ss_pred --CCEEEEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccc
Q 037702 82 --KTKIYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSA 157 (448)
Q Consensus 82 --~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~ 157 (448)
...+|++|||++++.+...... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence 3578999999999877554433 579999999999999999999999999999999999999999999999999988
Q ss_pred cccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhcc---------
Q 037702 158 LQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAE--------- 228 (448)
Q Consensus 158 ~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--------- 228 (448)
..... ....+.+||+.|+|||++.+..|+ .++|||||||++|+|++|++||.+.+..+...++....
T Consensus 165 ~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~-~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 240 (305)
T d1blxa_ 165 IYSFQ---MALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240 (305)
T ss_dssp CCCGG---GGGCCCCCCCTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred hhccc---ccCCCcccChhhcCcchhcCCCCC-hhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccc
Confidence 64332 234567899999999999888775 89999999999999999999999988877776664310
Q ss_pred ------------------CCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccc
Q 037702 229 ------------------FKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRK 268 (448)
Q Consensus 229 ------------------~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 268 (448)
..++..+++.+++||.+||+.||.+|||++|+|+||||+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~ 298 (305)
T d1blxa_ 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298 (305)
T ss_dssp TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred ccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcC
Confidence 0123457899999999999999999999999999999975
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-56 Score=430.46 Aligned_cols=257 Identities=26% Similarity=0.419 Sum_probs=221.1
Q ss_pred ccccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 037702 4 KAGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKT 83 (448)
Q Consensus 4 ~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~ 83 (448)
+..+..++|++++.||+|+||.||+|++. ++..||||++...... .+.+.+|+.+|++++|||||++++++.+ +
T Consensus 7 ~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~ 80 (272)
T d1qpca_ 7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQ-E 80 (272)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred CeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCC----HHHHHHHHHHHHhCCCCCEeEEEeeecc-C
Confidence 34566789999999999999999999974 6788999999765432 3678999999999999999999998754 5
Q ss_pred EEEEEEeecCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccc
Q 037702 84 KIYFAMEYVRGGELFNKVAK---GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQE 160 (448)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~ 160 (448)
.+|+||||+++|+|.+++.. .++++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+...
T Consensus 81 ~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (272)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEcc
Confidence 67999999999999998754 369999999999999999999999999999999999999999999999999998654
Q ss_pred ccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhC-CCCCCCCcHHHHHHHHhhc-cCCCCCCCCHH
Q 037702 161 STRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAG-NLPFYDSNLMELYKKITRA-EFKCPNWFPPE 238 (448)
Q Consensus 161 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG-~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~ 238 (448)
.... .......||+.|+|||++....| +.++|||||||++|||+|| .+||...+..+....+..+ ....|..+|++
T Consensus 161 ~~~~-~~~~~~~gt~~y~APE~~~~~~~-~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~ 238 (272)
T d1qpca_ 161 DNEY-TAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEE 238 (272)
T ss_dssp SSCE-ECCTTCCCCTTTSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred CCcc-ccccccCCcccccChHHHhCCCC-CchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHH
Confidence 3221 22345679999999999987666 4899999999999999994 6667777777777777665 45678889999
Q ss_pred HHHHHHhccCCCcCCCCCHHHHHh--hhhccc
Q 037702 239 VRKLLSRILDPNPSTRVTMAKLME--NYWFRK 268 (448)
Q Consensus 239 ~~~li~~~L~~dP~~Rpt~~eil~--hp~~~~ 268 (448)
+.+||.+||+.||++|||+++|++ |+||..
T Consensus 239 l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 239 LYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 999999999999999999999998 788864
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.4e-57 Score=435.57 Aligned_cols=251 Identities=25% Similarity=0.447 Sum_probs=218.4
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKI 85 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 85 (448)
++..++|++.+.||+|+||.||+|++..+|+.||||++..+... .+++.+|+.+|+.++|||||++++++.+++.+
T Consensus 13 ei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (287)
T d1opja_ 13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 88 (287)
T ss_dssp BCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred EecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch----HHHHHHHHHHHHhCCCCCEecCCccEeeCCee
Confidence 45667899999999999999999999999999999999765432 36788999999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccc
Q 037702 86 YFAMEYVRGGELFNKVAK---GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQEST 162 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~ 162 (448)
|+|||||++|+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+.....
T Consensus 89 ~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (287)
T d1opja_ 89 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168 (287)
T ss_dssp EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred EEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCC
Confidence 999999999999999864 46899999999999999999999999999999999999999999999999999865432
Q ss_pred ccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCC-CCCCcHHHHHHHHhhc-cCCCCCCCCHHHH
Q 037702 163 RQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLP-FYDSNLMELYKKITRA-EFKCPNWFPPEVR 240 (448)
Q Consensus 163 ~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~P-f~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 240 (448)
.. .......||+.|+|||++.+..|+ .++|||||||++|||++|..| |.+.+...++..+..+ ....|..+|+++.
T Consensus 169 ~~-~~~~~~~g~~~y~aPE~~~~~~~~-~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~ 246 (287)
T d1opja_ 169 TY-TAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 246 (287)
T ss_dssp SS-EEETTEEECGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred Cc-eeeccccccccccChHHHcCCCCC-chhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHH
Confidence 11 112334589999999999887775 899999999999999996555 5566666666666554 4567788999999
Q ss_pred HHHHhccCCCcCCCCCHHHHHh
Q 037702 241 KLLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~eil~ 262 (448)
+||.+||+.||++|||++++++
T Consensus 247 ~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 247 ELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHcCCCHhHCcCHHHHHH
Confidence 9999999999999999999976
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-56 Score=430.70 Aligned_cols=256 Identities=25% Similarity=0.396 Sum_probs=220.0
Q ss_pred ccCCeEEEee-eeecCceEEEEEEECCC--CcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 037702 8 LMNKYELGRL-LGQGTFAKVYHGRNLKT--GQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTK 84 (448)
Q Consensus 8 ~~~~y~~~~~-LG~G~fg~Vy~a~~~~~--g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 84 (448)
..++|.+.+. ||+|+||.||+|.++.+ +..||||++.... .....+.+.+|+.+|+.++|||||++++++.+ +.
T Consensus 6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~ 82 (285)
T d1u59a_ 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA 82 (285)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SS
T ss_pred cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-Ce
Confidence 3467899986 99999999999987644 4579999997543 23445788999999999999999999999865 45
Q ss_pred EEEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccccc
Q 037702 85 IYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQEST 162 (448)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~ 162 (448)
+|+|||||+||+|.+++.. +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 83 ~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 83 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccc
Confidence 8999999999999999754 57999999999999999999999999999999999999999999999999999865433
Q ss_pred cc-CCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhcc-CCCCCCCCHHH
Q 037702 163 RQ-DGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAE-FKCPNWFPPEV 239 (448)
Q Consensus 163 ~~-~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~ 239 (448)
.. .......+||+.|+|||++....|+ .++|||||||++|||+| |..||.+.+..++...+..+. +..|+.+|+++
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l 241 (285)
T d1u59a_ 163 DSYYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPEL 241 (285)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred ccccccccccccCccccChHHHhCCCCC-ccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHH
Confidence 22 1223456799999999999877664 89999999999999998 999999988888888887764 56788999999
Q ss_pred HHHHHhccCCCcCCCCCHHHH---Hhhhhcc
Q 037702 240 RKLLSRILDPNPSTRVTMAKL---MENYWFR 267 (448)
Q Consensus 240 ~~li~~~L~~dP~~Rpt~~ei---l~hp~~~ 267 (448)
.+||.+||+.||++|||+.+| |+|+|+.
T Consensus 242 ~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 242 YALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp HHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 999999999999999999988 6778764
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-56 Score=442.22 Aligned_cols=255 Identities=27% Similarity=0.420 Sum_probs=216.7
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKT---- 83 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~---- 83 (448)
+-++|++++.||+|+||+||+|.+..+|+.||||++.+... .....+.+.+|+.+|+.++|||||++++++...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~ 94 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 94 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccc
Confidence 57899999999999999999999999999999999976543 3345678899999999999999999999997654
Q ss_pred --EEEEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccc
Q 037702 84 --KIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQES 161 (448)
Q Consensus 84 --~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~ 161 (448)
.+|+||||+ |.+|...+..+++++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||+|.....
T Consensus 95 ~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~ 173 (346)
T d1cm8a_ 95 FTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 173 (346)
T ss_dssp CCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred cceEEEEEecc-cccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCC
Confidence 579999999 66888888888999999999999999999999999999999999999999999999999999975432
Q ss_pred cccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccC------------
Q 037702 162 TRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEF------------ 229 (448)
Q Consensus 162 ~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~------------ 229 (448)
.....+||+.|+|||++.+..+.+.++||||+||++|+|++|++||.+.+.......+.....
T Consensus 174 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (346)
T d1cm8a_ 174 -----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 248 (346)
T ss_dssp -----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred -----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcc
Confidence 234678999999999998777777999999999999999999999998876665544332111
Q ss_pred -------------------CCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 230 -------------------KCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 230 -------------------~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
..+..+++++.+||.+||..||.+|||++|+|+||||+.-
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred hhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 1234578999999999999999999999999999999864
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-56 Score=426.51 Aligned_cols=247 Identities=24% Similarity=0.424 Sum_probs=209.0
Q ss_pred CCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 037702 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAM 89 (448)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (448)
.+|++++.||+|+||.||+|++. +++.||||++...... .+.+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~ 79 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF 79 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc----HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEE
Confidence 58999999999999999999975 6788999999765433 267889999999999999999999999999999999
Q ss_pred eecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCC
Q 037702 90 EYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGL 167 (448)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 167 (448)
||+++|+|.+++.. ..+++..+..++.||+.||+|||+++|+||||||+|||++.++++||+|||+|+....... ..
T Consensus 80 E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~~ 158 (263)
T d1sm2a_ 80 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TS 158 (263)
T ss_dssp ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred EecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCc-ee
Confidence 99999999999865 5689999999999999999999999999999999999999999999999999986543322 22
Q ss_pred ccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhcc-CCCCCCCCHHHHHHHHh
Q 037702 168 LHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAE-FKCPNWFPPEVRKLLSR 245 (448)
Q Consensus 168 ~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~ 245 (448)
.....||+.|+|||++.+..|+ .++|||||||++|||+| |.+||...+..++...+..+. ...|..+++++.+||.+
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~-~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~ 237 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNH 237 (263)
T ss_dssp ------CTTSCCHHHHTTCCCC-HHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHH
T ss_pred ecceecCcccCChHHhcCCCCC-chhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHH
Confidence 2346799999999999887775 89999999999999999 677788888888888877653 45677889999999999
Q ss_pred ccCCCcCCCCCHHHHHhh
Q 037702 246 ILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 246 ~L~~dP~~Rpt~~eil~h 263 (448)
||+.||++|||+++|++|
T Consensus 238 cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 238 CWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HccCCHhHCcCHHHHHHH
Confidence 999999999999999986
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-56 Score=436.26 Aligned_cols=261 Identities=25% Similarity=0.379 Sum_probs=216.0
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe------
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMAS------ 81 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~------ 81 (448)
..++|++++.||+|+||+||+|++..+|+.||||++.++.... .....+.+|+.+|+.++||||+++++++..
T Consensus 8 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~ 86 (318)
T d3blha1 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPYN 86 (318)
T ss_dssp BGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTT-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEC------
T ss_pred ccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHHhcCCCccceEeeeeccccccc
Confidence 3689999999999999999999999999999999997765433 334678899999999999999999998855
Q ss_pred --CCEEEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccc
Q 037702 82 --KTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSAL 158 (448)
Q Consensus 82 --~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~ 158 (448)
+..+|+||||+.++.+...... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 87 ~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~ 166 (318)
T d3blha1 87 RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA 166 (318)
T ss_dssp ----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeee
Confidence 3468999999988776655443 6799999999999999999999999999999999999999999999999999975
Q ss_pred ccccc--cCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCCCCC--
Q 037702 159 QESTR--QDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKCPNW-- 234 (448)
Q Consensus 159 ~~~~~--~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~-- 234 (448)
..... ......+.+||+.|+|||++.+...++.++||||+||++|+|++|+.||.+.+.......+.......++.
T Consensus 167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 246 (318)
T d3blha1 167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246 (318)
T ss_dssp CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence 54322 22334567899999999999776555689999999999999999999999888777666654432221110
Q ss_pred ------------------------------CCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccc
Q 037702 235 ------------------------------FPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKG 269 (448)
Q Consensus 235 ------------------------------~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 269 (448)
.++++.+||.+||+.||++|||++|+|+||||+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~ 311 (318)
T d3blha1 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 311 (318)
T ss_dssp TTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred cccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence 26788999999999999999999999999999853
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3e-56 Score=433.82 Aligned_cols=254 Identities=23% Similarity=0.392 Sum_probs=209.9
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCc---EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQ---SVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKT 83 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~---~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~ 83 (448)
+..++|++.+.||+|+||+||+|++..+|+ .||||.+..... ....+.+.+|+.+|++++|||||++++++.+++
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~ 100 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT--EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST 100 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccC--HHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 456789999999999999999999987765 588998865432 234567899999999999999999999999999
Q ss_pred EEEEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccc
Q 037702 84 KIYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQES 161 (448)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~ 161 (448)
.+|+|||||+||+|.+++.. +.+++.++..++.||++||.|||++||+||||||+||||+.++.+||+|||+|+....
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccC
Confidence 99999999999999998875 5799999999999999999999999999999999999999999999999999986543
Q ss_pred cccCCC---ccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhcc-CCCCCCCC
Q 037702 162 TRQDGL---LHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAE-FKCPNWFP 236 (448)
Q Consensus 162 ~~~~~~---~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s 236 (448)
...... .....||+.|||||++.+..|+ .++|||||||+||||+| |..||.+.+..++...+..+. .+.|..+|
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 259 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCP 259 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCC
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCC-cccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccch
Confidence 322111 1124589999999999877665 88999999999999998 899999998888888887653 56777899
Q ss_pred HHHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 237 PEVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 237 ~~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
+++.+||.+||+.||++|||++||+++
T Consensus 260 ~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 260 SALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999999999875
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-56 Score=430.49 Aligned_cols=248 Identities=26% Similarity=0.419 Sum_probs=210.4
Q ss_pred eeeeecCceEEEEEEEC--CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecC
Q 037702 16 RLLGQGTFAKVYHGRNL--KTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAMEYVR 93 (448)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~--~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 93 (448)
+.||+|+||.||+|.+. .+++.||||++..+.. +....+.+.+|+.+|++++|||||++++++.++ ..|||||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCC
Confidence 46999999999999864 4567899999975543 334557899999999999999999999999654 5789999999
Q ss_pred CCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccC-CCcccc
Q 037702 94 GGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQD-GLLHTT 171 (448)
Q Consensus 94 gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~-~~~~~~ 171 (448)
+|+|.+++.. +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+........ ......
T Consensus 91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 170 (277)
T d1xbba_ 91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 170 (277)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----
T ss_pred CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccccc
Confidence 9999999976 67999999999999999999999999999999999999999999999999999865432211 122345
Q ss_pred CCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhcc-CCCCCCCCHHHHHHHHhccCC
Q 037702 172 CGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAE-FKCPNWFPPEVRKLLSRILDP 249 (448)
Q Consensus 172 ~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~ 249 (448)
.||+.|+|||++.+..| +.++|||||||++|||++ |.+||.+.+..++...+..+. ++.|..+|+++.+||.+||+.
T Consensus 171 ~gt~~y~APE~l~~~~~-~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~ 249 (277)
T d1xbba_ 171 KWPVKWYAPECINYYKF-SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTY 249 (277)
T ss_dssp CCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCCceecCchhhcCCCC-CchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCC
Confidence 79999999999987766 489999999999999998 899999998888888887754 567888999999999999999
Q ss_pred CcCCCCCHHHH---Hhhhhc
Q 037702 250 NPSTRVTMAKL---MENYWF 266 (448)
Q Consensus 250 dP~~Rpt~~ei---l~hp~~ 266 (448)
||.+|||+++| |+|+|+
T Consensus 250 dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 250 DVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp STTTSCCHHHHHHHHHHHHH
T ss_pred CHhHCcCHHHHHHHhhCHHh
Confidence 99999999998 466665
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-55 Score=438.60 Aligned_cols=263 Identities=25% Similarity=0.408 Sum_probs=218.1
Q ss_pred cCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----E
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKT----K 84 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~----~ 84 (448)
..+|++++.||+|+||+||+|++..+|+.||||++.+.. .....+.+.+|+.+|+.++||||+++++++.... .
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~ 84 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 84 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccc
Confidence 478999999999999999999999999999999997643 2344577889999999999999999999997653 2
Q ss_pred EEEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccc-
Q 037702 85 IYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTR- 163 (448)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~- 163 (448)
.+++|+++.||+|++++..+++++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|.......
T Consensus 85 ~~~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~ 164 (345)
T d1pmea_ 85 DVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 164 (345)
T ss_dssp CEEEEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred eEEEEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence 3444556679999999988899999999999999999999999999999999999999999999999999998654332
Q ss_pred cCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhcc---------------
Q 037702 164 QDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAE--------------- 228 (448)
Q Consensus 164 ~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--------------- 228 (448)
........+||+.|+|||++.....++.++||||+||++|+|++|..||.+.+..+.........
T Consensus 165 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (345)
T d1pmea_ 165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244 (345)
T ss_dssp BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhh
Confidence 22334567899999999999766666789999999999999999999999877655544432210
Q ss_pred -------C---------CCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccccccc
Q 037702 229 -------F---------KCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYKKI 273 (448)
Q Consensus 229 -------~---------~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~ 273 (448)
. ...+.+|+++++||.+||+.||.+|||++|+|+||||+......
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~ 305 (345)
T d1pmea_ 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 305 (345)
T ss_dssp HHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGG
T ss_pred hhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCc
Confidence 0 01234788999999999999999999999999999998765443
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-56 Score=422.34 Aligned_cols=247 Identities=25% Similarity=0.416 Sum_probs=221.5
Q ss_pred CCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 037702 10 NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFAM 89 (448)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (448)
++|++++.||+|+||+||+|+++ ++..||||++.+.... .+.+.+|+.++++++||||+++++++.+++.+|+||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~ 78 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 78 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCC----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Confidence 68999999999999999999984 7889999999876543 257889999999999999999999999999999999
Q ss_pred eecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCC
Q 037702 90 EYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGL 167 (448)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 167 (448)
||+++|+|.+++.. ..+++..+.+++.|+++||+|||++||+||||||+|||++.++.+||+|||+|....... ...
T Consensus 79 Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~-~~~ 157 (258)
T d1k2pa_ 79 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTS 157 (258)
T ss_dssp ECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS-CCC
T ss_pred EccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCC-cee
Confidence 99999999998754 579999999999999999999999999999999999999999999999999998654322 222
Q ss_pred ccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhc-cCCCCCCCCHHHHHHHHh
Q 037702 168 LHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EFKCPNWFPPEVRKLLSR 245 (448)
Q Consensus 168 ~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~ 245 (448)
....+||+.|+|||++.+..|+ .++|||||||++|||+| |+.||.+.+..++..++..+ ....|..+++++.+||.+
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~-~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~ 236 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYS 236 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred ecccCCCCCcCCcHHhcCCCCC-cceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHHH
Confidence 3346799999999999888775 89999999999999998 89999999998988888776 346778899999999999
Q ss_pred ccCCCcCCCCCHHHHHhh
Q 037702 246 ILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 246 ~L~~dP~~Rpt~~eil~h 263 (448)
||+.||++|||+++|++|
T Consensus 237 cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 237 CWHEKADERPTFKILLSN 254 (258)
T ss_dssp TTCSSGGGSCCHHHHHHH
T ss_pred HccCCHhHCcCHHHHHHH
Confidence 999999999999999997
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-55 Score=422.01 Aligned_cols=257 Identities=29% Similarity=0.474 Sum_probs=222.6
Q ss_pred cCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKIYFA 88 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 88 (448)
+++|++++.||+|+||+||+|++..+|+.||||++..... ......++.+|+.+|+.++||||+++++++.+....++|
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence 4799999999999999999999999999999999977653 335568899999999999999999999999999999999
Q ss_pred EeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccCCC
Q 037702 89 MEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQDGL 167 (448)
Q Consensus 89 ~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 167 (448)
||++.|++|..++.. +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.|....... ..
T Consensus 80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~--~~ 157 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV--RC 157 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC--SC
T ss_pred eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCC--cc
Confidence 999999999888876 689999999999999999999999999999999999999999999999999998654322 22
Q ss_pred ccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCC-CCCcHHHHHHHHhhccC-----------------
Q 037702 168 LHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPF-YDSNLMELYKKITRAEF----------------- 229 (448)
Q Consensus 168 ~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf-~~~~~~~~~~~i~~~~~----------------- 229 (448)
.....+++.|+|||++....+.+.++|||||||++|+|++|+.|| .+.+..+...++.....
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence 334568899999999988777779999999999999999999986 44555555555432111
Q ss_pred ------------CCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccc
Q 037702 230 ------------KCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRK 268 (448)
Q Consensus 230 ------------~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 268 (448)
..+..+++.+.+||++||++||.+|||++|+|+||||++
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence 122346889999999999999999999999999999975
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-55 Score=436.52 Aligned_cols=256 Identities=26% Similarity=0.385 Sum_probs=218.7
Q ss_pred cCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----C
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASK-----T 83 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~-----~ 83 (448)
.++|++.+.||+|+||+||+|++..+|+.||||++.+.... ....+.+.+|+.+|+.++||||+++++++... .
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcC-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 47999999999999999999999999999999999866433 23456788999999999999999999998643 3
Q ss_pred EEEEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccc
Q 037702 84 KIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTR 163 (448)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~ 163 (448)
..+++|+|+.||+|.+++..+++++.+++.++.||+.||+|||++||+||||||+|||++.+|.+|++|||+|......
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~- 174 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE- 174 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTGG-
T ss_pred ceEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCcc-
Confidence 4466677888999999998889999999999999999999999999999999999999999999999999999754322
Q ss_pred cCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCCC------------
Q 037702 164 QDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFKC------------ 231 (448)
Q Consensus 164 ~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~------------ 231 (448)
..+.+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+.+.......+.......
T Consensus 175 ----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 250 (348)
T d2gfsa1 175 ----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250 (348)
T ss_dssp ----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHH
T ss_pred ----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchh
Confidence 3467899999999998887777899999999999999999999999988777666664432111
Q ss_pred -------------------CCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccccc
Q 037702 232 -------------------PNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGY 270 (448)
Q Consensus 232 -------------------p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 270 (448)
...+++++++||++||..||.+|||++|+|+||||++..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp HHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 124789999999999999999999999999999998643
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-54 Score=431.33 Aligned_cols=252 Identities=31% Similarity=0.425 Sum_probs=211.3
Q ss_pred cCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe------C
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMAS------K 82 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~------~ 82 (448)
.-+|+.+++||+|+||+||+|++..+|+.||||++.++... ..+|+.+|+.++||||+++++++.. .
T Consensus 19 ~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~ 91 (350)
T d1q5ka_ 19 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 91 (350)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSC
T ss_pred cCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCc
Confidence 44799999999999999999999999999999999765422 2379999999999999999999853 3
Q ss_pred CEEEEEEeecCCCchHHHH---h-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCC-CeEEeeccccc
Q 037702 83 TKIYFAMEYVRGGELFNKV---A-KGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENG-DLKISDFGLSA 157 (448)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i---~-~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g-~lkl~DFGla~ 157 (448)
.++|||||||+++.+.... . ...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 92 ~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~ 171 (350)
T d1q5ka_ 92 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171 (350)
T ss_dssp CEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred eEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchh
Confidence 4689999999876443332 2 25799999999999999999999999999999999999999876 89999999998
Q ss_pred cccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhc----------
Q 037702 158 LQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRA---------- 227 (448)
Q Consensus 158 ~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---------- 227 (448)
.... .....+.+||+.|+|||++.+..+++.++||||+||++|||++|+.||...+..+.+..+.+.
T Consensus 172 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~ 248 (350)
T d1q5ka_ 172 QLVR---GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 248 (350)
T ss_dssp ECCT---TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred hccC---CcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhh
Confidence 6432 223456789999999999877666679999999999999999999999988877666655421
Q ss_pred -------cCC------------CCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccccc
Q 037702 228 -------EFK------------CPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGY 270 (448)
Q Consensus 228 -------~~~------------~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 270 (448)
... ....+++++.+||.+||..||.+|||++|+|+||||+...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 011 1234789999999999999999999999999999997643
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-55 Score=430.14 Aligned_cols=261 Identities=30% Similarity=0.560 Sum_probs=224.1
Q ss_pred cccCCeEEEeeeeecCceEEEEEEEC---CCCcEEEEEEeeccccc-chhHHHHHHHHHHHHHhCCC-CCcceEEEEEEe
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNL---KTGQSVAIKIVDKEKIR-RVGLIDQIKREISVMRLVRH-PNIVQLYEVMAS 81 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~-~~~~~~~~~~Ei~~l~~l~h-pnIv~l~~~~~~ 81 (448)
+-+++|++++.||+|+||+||+|++. .+|+.||||++.+.... +....+.+.+|+.+|++++| |||+++++++.+
T Consensus 21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~ 100 (322)
T d1vzoa_ 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 100 (322)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence 45688999999999999999999974 47899999999765432 22334667899999999977 899999999999
Q ss_pred CCEEEEEEeecCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccc
Q 037702 82 KTKIYFAMEYVRGGELFNKVAK-GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQE 160 (448)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~ 160 (448)
...+|++|||+.||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|....
T Consensus 101 ~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 101 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180 (322)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred CCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence 9999999999999999999976 689999999999999999999999999999999999999999999999999997654
Q ss_pred ccccCCCccccCCCCcccchhhhhccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCcH----HHHHHHHhhccCCCCCCC
Q 037702 161 STRQDGLLHTTCGTPAYVAPEVINKRG-YDGAKADIWSCGVVLFVLLAGNLPFYDSNL----MELYKKITRAEFKCPNWF 235 (448)
Q Consensus 161 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~-~~~~~sDiwSlGvil~elltG~~Pf~~~~~----~~~~~~i~~~~~~~p~~~ 235 (448)
... .....+.+||+.|+|||++.+.. +.+.++|||||||+||+|++|+.||.+.+. ..+.........+.|..+
T Consensus 181 ~~~-~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 259 (322)
T d1vzoa_ 181 ADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM 259 (322)
T ss_dssp GGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTS
T ss_pred ccc-cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccC
Confidence 322 22345678999999999997544 446789999999999999999999977543 344455556667788889
Q ss_pred CHHHHHHHHhccCCCcCCCC-----CHHHHHhhhhccc
Q 037702 236 PPEVRKLLSRILDPNPSTRV-----TMAKLMENYWFRK 268 (448)
Q Consensus 236 s~~~~~li~~~L~~dP~~Rp-----t~~eil~hp~~~~ 268 (448)
|+++.+||.+||++||.+|| |++|+++||||+.
T Consensus 260 s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~ 297 (322)
T d1vzoa_ 260 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297 (322)
T ss_dssp CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred CHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence 99999999999999999999 5899999999974
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-55 Score=418.38 Aligned_cols=253 Identities=28% Similarity=0.430 Sum_probs=209.3
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCC---cEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTG---QSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASK 82 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g---~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~ 82 (448)
++..++|++++.||+|+||.||+|++..++ ..||||.+.... .....+.+.+|+.+|+.++||||+++++++. +
T Consensus 3 ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 79 (273)
T d1mp8a_ 3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 79 (273)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred CcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 355679999999999999999999987654 468888875432 3344577899999999999999999999985 5
Q ss_pred CEEEEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccccccc
Q 037702 83 TKIYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQE 160 (448)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~ 160 (448)
+.+|+||||+++|+|.+++.. +.+++..++.++.||++||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheecc
Confidence 678999999999999998754 579999999999999999999999999999999999999999999999999998654
Q ss_pred ccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhcc-CCCCCCCCHH
Q 037702 161 STRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAE-FKCPNWFPPE 238 (448)
Q Consensus 161 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~ 238 (448)
... .......+||+.|+|||++.+..|+ .++|||||||++|||++ |.+||.+.+..+++.++..+. .+.|+.+|++
T Consensus 160 ~~~-~~~~~~~~gt~~y~apE~l~~~~~~-~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 237 (273)
T d1mp8a_ 160 DST-YYKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPT 237 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHH
T ss_pred CCc-ceeccceecCcccchhhHhccCCCC-CccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence 322 2223456789999999999877775 88999999999999998 899999998888888887765 5678889999
Q ss_pred HHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 239 VRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 239 ~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
+.+||.+||..||.+|||++||++|
T Consensus 238 ~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 238 LYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999999999986
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-54 Score=417.68 Aligned_cols=256 Identities=27% Similarity=0.423 Sum_probs=214.2
Q ss_pred cccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 037702 5 AGILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTK 84 (448)
Q Consensus 5 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 84 (448)
..+-.++|++++.||+|+||+||+|++..+ +.||||++...... .+.+.+|+.+|++++|||||++++++.+ +.
T Consensus 12 ~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~----~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~ 85 (285)
T d1fmka3 12 WEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP 85 (285)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred eEcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCC----HHHHHHHHHHHHhcccCCEeEEEEEEec-CC
Confidence 356678999999999999999999998654 67999999765432 3678899999999999999999999854 55
Q ss_pred EEEEEeecCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccc
Q 037702 85 IYFAMEYVRGGELFNKVAK---GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQES 161 (448)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~ 161 (448)
+|+||||+++|+|..++.. +.+++.+++.++.||+.||+|||++||+||||||+||||+.++++||+|||+|+....
T Consensus 86 ~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~ 165 (285)
T d1fmka3 86 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 165 (285)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred eEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccC
Confidence 8999999999999988753 5799999999999999999999999999999999999999999999999999986543
Q ss_pred cccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhC-CCCCCCCcHHHHHHHHhhc-cCCCCCCCCHHH
Q 037702 162 TRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAG-NLPFYDSNLMELYKKITRA-EFKCPNWFPPEV 239 (448)
Q Consensus 162 ~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG-~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~ 239 (448)
... ......+||+.|+|||++....++ .++|||||||++|||++| .+||...+..++...+..+ ..+.|..+|+++
T Consensus 166 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~-~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 243 (285)
T d1fmka3 166 NEY-TARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL 243 (285)
T ss_dssp -----------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHH
T ss_pred CCc-eeeccccccccccChHHHhCCCCC-cHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHH
Confidence 221 223446799999999999877775 899999999999999995 5666777777777777655 456788899999
Q ss_pred HHHHHhccCCCcCCCCCHHHHHh--hhhccc
Q 037702 240 RKLLSRILDPNPSTRVTMAKLME--NYWFRK 268 (448)
Q Consensus 240 ~~li~~~L~~dP~~Rpt~~eil~--hp~~~~ 268 (448)
++||.+||+.||++|||+++|++ ++||+.
T Consensus 244 ~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 244 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred HHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 99999999999999999999987 777754
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-54 Score=425.17 Aligned_cols=252 Identities=22% Similarity=0.379 Sum_probs=212.1
Q ss_pred CCeEEEeeeeecCceEEEEEEECCCCc----EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 037702 10 NKYELGRLLGQGTFAKVYHGRNLKTGQ----SVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKI 85 (448)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~----~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 85 (448)
.+|++++.||+|+||+||+|.+..+|+ .||+|.+.... .....+.+.+|+.+|+.++|||||++++++.++ ..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~ 85 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 85 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence 579999999999999999999988887 47788775432 223457789999999999999999999999865 56
Q ss_pred EEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccc
Q 037702 86 YFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTR 163 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~ 163 (448)
+++|||+.+|+|.+.+.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|+......
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~ 165 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence 788999999999988864 579999999999999999999999999999999999999999999999999998765443
Q ss_pred cCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhcc-CCCCCCCCHHHHH
Q 037702 164 QDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAE-FKCPNWFPPEVRK 241 (448)
Q Consensus 164 ~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~ 241 (448)
.........||+.|+|||++.+..| +.++|||||||+||||+| |.+||.+.+..++...+..+. ++.|+.+|+++.+
T Consensus 166 ~~~~~~~~~gt~~y~APE~l~~~~~-~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~ 244 (317)
T d1xkka_ 166 KEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 244 (317)
T ss_dssp C--------CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHHH
T ss_pred ccccccccccCccccChHHHhcCCC-ChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHH
Confidence 3333344579999999999988776 489999999999999998 899999888878877777654 5678889999999
Q ss_pred HHHhccCCCcCCCCCHHHHHhhhh
Q 037702 242 LLSRILDPNPSTRVTMAKLMENYW 265 (448)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~hp~ 265 (448)
||.+||..||.+|||+.+|++|..
T Consensus 245 li~~cl~~dP~~RPs~~eil~~l~ 268 (317)
T d1xkka_ 245 IMVKCWMIDADSRPKFRELIIEFS 268 (317)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHhCCCChhhCcCHHHHHHHHH
Confidence 999999999999999999999853
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-54 Score=414.85 Aligned_cols=254 Identities=22% Similarity=0.358 Sum_probs=209.5
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCC----cEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTG----QSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMAS 81 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g----~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~ 81 (448)
++....|++.++||+|+||.||+|.+..++ ..||||++...... .....+.+|+.+|+.++|||||++++++.+
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~E~~il~~l~H~nIv~~~g~~~~ 80 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE--KQRVDFLGEAGIMGQFSHHNIIRLEGVISK 80 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccCh--HHHHHHHHHHHHHHhcCCCCEeeeeEEEec
Confidence 345568999999999999999999987655 36999999754322 334678899999999999999999999999
Q ss_pred CCEEEEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccc
Q 037702 82 KTKIYFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQ 159 (448)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~ 159 (448)
....++||||+.+|+|.+.+.. +.+++.++..++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+..
T Consensus 81 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 81 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred CCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcc
Confidence 9999999999999999998865 57999999999999999999999999999999999999999999999999999865
Q ss_pred cccccC-CCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhC-CCCCCCCcHHHHHHHHhhc-cCCCCCCCC
Q 037702 160 ESTRQD-GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAG-NLPFYDSNLMELYKKITRA-EFKCPNWFP 236 (448)
Q Consensus 160 ~~~~~~-~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG-~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s 236 (448)
...... .......||+.|+|||++.+..|+ .++|||||||++|||++| .+||...+..+++..+..+ ..+.|..+|
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~-~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 239 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCP 239 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCB
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCC-CcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhH
Confidence 433221 222345789999999999877665 899999999999999995 5556666777777777655 346677899
Q ss_pred HHHHHHHHhccCCCcCCCCCHHHHHh
Q 037702 237 PEVRKLLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 237 ~~~~~li~~~L~~dP~~Rpt~~eil~ 262 (448)
+++.+||.+||+.||++|||+.+|++
T Consensus 240 ~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 240 SAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 99999999999999999999999987
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=6.6e-54 Score=422.38 Aligned_cols=250 Identities=25% Similarity=0.488 Sum_probs=209.1
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEe--CCE
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR-HPNIVQLYEVMAS--KTK 84 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~--~~~ 84 (448)
..++|++++.||+|+||+||+|++..+|+.||||++.+.. .+.+.+|+.+|+.++ ||||+++++++.. ...
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~ 106 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT 106 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCS
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCc
Confidence 3468999999999999999999999999999999996542 356889999999995 9999999999974 456
Q ss_pred EEEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCC-CeEEeeccccccccccc
Q 037702 85 IYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENG-DLKISDFGLSALQESTR 163 (448)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g-~lkl~DFGla~~~~~~~ 163 (448)
+|+|||||++++|.... +.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|......
T Consensus 107 ~~~v~e~~~~~~L~~~~--~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~- 183 (328)
T d3bqca1 107 PALVFEHVNNTDFKQLY--QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG- 183 (328)
T ss_dssp EEEEEECCCSCBGGGTT--TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT-
T ss_pred eeEEEeecCCCcHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCC-
Confidence 99999999999998764 4699999999999999999999999999999999999999766 5999999999865432
Q ss_pred cCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHH-HHHHHHhh-------------ccC
Q 037702 164 QDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLM-ELYKKITR-------------AEF 229 (448)
Q Consensus 164 ~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~-------------~~~ 229 (448)
......+||+.|+|||++.+...++.++||||+||++|+|++|..||...+.. +....+.. ...
T Consensus 184 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 261 (328)
T d3bqca1 184 --QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261 (328)
T ss_dssp --CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred --CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence 23456789999999999887666678999999999999999999999764322 21111110 000
Q ss_pred ------------------------CCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhccc
Q 037702 230 ------------------------KCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRK 268 (448)
Q Consensus 230 ------------------------~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 268 (448)
.....+|+++.+||++||..||.+|||++|+|+||||+.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~ 324 (328)
T d3bqca1 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 324 (328)
T ss_dssp CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 011236899999999999999999999999999999975
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-54 Score=417.02 Aligned_cols=257 Identities=24% Similarity=0.424 Sum_probs=220.6
Q ss_pred cccccccCCeEEEeeeeecCceEEEEEEECCCC-------cEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcce
Q 037702 3 KKAGILMNKYELGRLLGQGTFAKVYHGRNLKTG-------QSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQ 74 (448)
Q Consensus 3 ~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g-------~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~ 74 (448)
++..+..++|++++.||+|+||.||+|++..++ ..||||++.++... .....+.+|...+.++ +|||||+
T Consensus 6 ~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~e~~~l~~~~~HpnIv~ 83 (299)
T d1fgka_ 6 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE--KDLSDLISEMEMMKMIGKHKNIIN 83 (299)
T ss_dssp TTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCH--HHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccCh--HHHHHHHHHHHHHHHhcCCCeEEe
Confidence 344566799999999999999999999976554 37999999765432 3346778888888888 8999999
Q ss_pred EEEEEEeCCEEEEEEeecCCCchHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCC
Q 037702 75 LYEVMASKTKIYFAMEYVRGGELFNKVAKG-----------------KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKP 137 (448)
Q Consensus 75 l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-----------------~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp 137 (448)
+++++.++..+|+||||+++|+|.+++... .+++.+++.++.||+.||+|||++||+||||||
T Consensus 84 ~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp 163 (299)
T d1fgka_ 84 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA 163 (299)
T ss_dssp EEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred cccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecc
Confidence 999999999999999999999999999642 489999999999999999999999999999999
Q ss_pred CceEEcCCCCeEEeeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCc
Q 037702 138 ENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSN 216 (448)
Q Consensus 138 ~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~ 216 (448)
+|||++.++.+||+|||++...............+||+.|+|||++.+..|+ .++|||||||++|||++ |.+||.+.+
T Consensus 164 ~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~-~k~DiwS~Gvvl~ell~~g~~p~~~~~ 242 (299)
T d1fgka_ 164 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVP 242 (299)
T ss_dssp GGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCC-chhhhHHhHHHHHHhccCCCCCCCCCC
Confidence 9999999999999999999977655444445567899999999999887775 89999999999999998 799999999
Q ss_pred HHHHHHHHhhc-cCCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHh
Q 037702 217 LMELYKKITRA-EFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 217 ~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 262 (448)
..+++..+..+ .+..|.++|+++.+||.+||+.||.+|||+.||++
T Consensus 243 ~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 243 VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 88888887665 45678889999999999999999999999999987
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-54 Score=429.51 Aligned_cols=257 Identities=25% Similarity=0.430 Sum_probs=206.7
Q ss_pred ccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe------
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMAS------ 81 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~------ 81 (448)
+.++|++++.||+|+||+||+|++..+|+.||||++.+.... ......+.+|+.+++.++||||+++++++..
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~ 93 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 93 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcC-HHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccccc
Confidence 568999999999999999999999999999999999876543 3445678999999999999999999999953
Q ss_pred CCEEEEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccc
Q 037702 82 KTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQES 161 (448)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~ 161 (448)
...+|+|||||.++.+ +.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||++.....
T Consensus 94 ~~~~~iv~Ey~~~~l~-~~~-~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~ 171 (355)
T d2b1pa1 94 FQDVYLVMELMDANLC-QVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_dssp CCEEEEEEECCSEEHH-HHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred CceeEEEEeccchHHH-Hhh-hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccc
Confidence 4789999999977544 444 35699999999999999999999999999999999999999999999999999875443
Q ss_pred cccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhhccCC-----------
Q 037702 162 TRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKITRAEFK----------- 230 (448)
Q Consensus 162 ~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~----------- 230 (448)
. ......+||+.|+|||++.+..++ .++||||+||++|+|++|++||.+.+......++......
T Consensus 172 ~---~~~~~~~~t~~y~aPE~l~~~~~~-~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 247 (355)
T d2b1pa1 172 S---FMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_dssp ------------CCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred c---cccccccccccccChhhhcCCCCC-CCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh
Confidence 2 233466899999999999887664 8899999999999999999999988766655544321100
Q ss_pred -----------C--------------C------CCCCHHHHHHHHhccCCCcCCCCCHHHHHhhhhcccccc
Q 037702 231 -----------C--------------P------NWFPPEVRKLLSRILDPNPSTRVTMAKLMENYWFRKGYK 271 (448)
Q Consensus 231 -----------~--------------p------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~ 271 (448)
. + ...|+++.+||++||..||++|||++|+|+||||+....
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~ 319 (355)
T d2b1pa1 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD 319 (355)
T ss_dssp HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCC
T ss_pred hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCC
Confidence 0 0 013578999999999999999999999999999987553
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.5e-54 Score=417.68 Aligned_cols=252 Identities=26% Similarity=0.384 Sum_probs=220.6
Q ss_pred ccCCeEEEeeeeecCceEEEEEEEC-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 037702 8 LMNKYELGRLLGQGTFAKVYHGRNL-----KTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASK 82 (448)
Q Consensus 8 ~~~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~ 82 (448)
..++|++.+.||+|+||.||+|++. .+++.||||++..... ....+.+.+|+.+|+.++||||+++++++.+.
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 88 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALMAEFDNPNIVKLLGVCAVG 88 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcC--hHHHHHHHHHHHHHHhcCCCCcccceeeeccC
Confidence 4578999999999999999999975 3567899999975432 23457789999999999999999999999999
Q ss_pred CEEEEEEeecCCCchHHHHhcC-------------------------CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCC
Q 037702 83 TKIYFAMEYVRGGELFNKVAKG-------------------------KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKP 137 (448)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~~-------------------------~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp 137 (448)
...++||||+++|+|.+++... .+++..+..++.||+.||+|||++||+||||||
T Consensus 89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp 168 (301)
T d1lufa_ 89 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT 168 (301)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcc
Confidence 9999999999999999998531 378999999999999999999999999999999
Q ss_pred CceEEcCCCCeEEeeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCC-CCCCCCc
Q 037702 138 ENLLLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGN-LPFYDSN 216 (448)
Q Consensus 138 ~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~-~Pf~~~~ 216 (448)
+|||++.++++||+|||+|+............+.+||+.|+|||++.+..|+ .++|||||||++|||++|. +||.+.+
T Consensus 169 ~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t-~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCC-hhhhhccchhhHHHHHccCCCCCCCCC
Confidence 9999999999999999999866554444444567899999999999887775 8999999999999999985 7899999
Q ss_pred HHHHHHHHhhccC-CCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHh
Q 037702 217 LMELYKKITRAEF-KCPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 217 ~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 262 (448)
..++...+..+.. ..|..+|+++.+||.+||+.||++|||+.||++
T Consensus 248 ~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 248 HEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 8888888887764 467789999999999999999999999999975
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-54 Score=416.68 Aligned_cols=255 Identities=25% Similarity=0.412 Sum_probs=204.4
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLK-----TGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEVM 79 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~ 79 (448)
.+..++|++++.||+|+||.||+|.+.. +++.||||++...... ...+.+.+|+.++.++ +||||+.+++++
T Consensus 9 ei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~--~~~~~~~~e~~~l~~~~~h~~iv~~~~~~ 86 (299)
T d1ywna1 9 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNLLGAC 86 (299)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CH--HHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCc--HHHHHHHHHHHHHHhhcCCCeEEEeeeee
Confidence 3556889999999999999999999754 4568999998754322 2345677777777766 689999999987
Q ss_pred EeC-CEEEEEEeecCCCchHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceE
Q 037702 80 ASK-TKIYFAMEYVRGGELFNKVAK-----------------GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLL 141 (448)
Q Consensus 80 ~~~-~~~~lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NIL 141 (448)
... ..+++|||||++|+|.+++.. ..+++..++.++.||++||.|||++||+||||||+|||
T Consensus 87 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NIL 166 (299)
T d1ywna1 87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 166 (299)
T ss_dssp CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred ccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCcccee
Confidence 654 568999999999999999853 24889999999999999999999999999999999999
Q ss_pred EcCCCCeEEeeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhC-CCCCCCCcHHHH
Q 037702 142 LDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAG-NLPFYDSNLMEL 220 (448)
Q Consensus 142 l~~~g~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG-~~Pf~~~~~~~~ 220 (448)
|+.++++||+|||+|+............+.+||+.|+|||++.+..| +.++|||||||++|||++| .+||.+.+..+.
T Consensus 167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~ 245 (299)
T d1ywna1 167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 245 (299)
T ss_dssp ECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred ECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCC-CcccceeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence 99999999999999986554444334456789999999999988766 5899999999999999986 568877654443
Q ss_pred H-HHHhhc-cCCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 221 Y-KKITRA-EFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 221 ~-~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
+ ..+..+ .+..|..+|+++.+||.+||+.||++|||++|+++|
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 246 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 3 444433 456778899999999999999999999999999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-54 Score=413.64 Aligned_cols=252 Identities=25% Similarity=0.426 Sum_probs=207.1
Q ss_pred cCCeEEEeeeeecCceEEEEEEECC-CC--cEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNLK-TG--QSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKTKI 85 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~-~g--~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 85 (448)
.++|++.+.||+|+||.||+|++.. ++ ..||||++.+....+.+..+.+.+|+.+|+.++||||+++++++.+ ..+
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 4679999999999999999998653 33 3689999987766666667889999999999999999999999965 467
Q ss_pred EEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccc
Q 037702 86 YFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTR 163 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~ 163 (448)
++||||+++|+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~ 165 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCC
Confidence 899999999999988754 579999999999999999999999999999999999999999999999999998654432
Q ss_pred cC-CCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhccC--CCCCCCCHHH
Q 037702 164 QD-GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRAEF--KCPNWFPPEV 239 (448)
Q Consensus 164 ~~-~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~--~~p~~~s~~~ 239 (448)
.. .......||+.|+|||++.+..+ +.++|||||||++|||+| |..||.+.+..+....+.+... +.|..+|+++
T Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l 244 (273)
T d1u46a_ 166 DHYVMQEHRKVPFAWCAPESLKTRTF-SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDI 244 (273)
T ss_dssp CEEEC-----CCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHH
T ss_pred CcceecCccccCcccCCHHHHhCCCC-CcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHHH
Confidence 22 22234568889999999987665 588999999999999998 8999999999999888877644 5567799999
Q ss_pred HHHHHhccCCCcCCCCCHHHHHh
Q 037702 240 RKLLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 240 ~~li~~~L~~dP~~Rpt~~eil~ 262 (448)
.+||.+||..||++|||+++|++
T Consensus 245 ~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 245 YNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999999974
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-53 Score=407.74 Aligned_cols=245 Identities=27% Similarity=0.508 Sum_probs=209.5
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe-CCE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMAS-KTK 84 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~-~~~ 84 (448)
.+-.++|++++.||+|+||.||+|++ +|..||||++.++. ..+.+.+|+.++++++||||+++++++.+ ++.
T Consensus 3 ~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~ 75 (262)
T d1byga_ 3 ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 75 (262)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--C
T ss_pred ccCHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCc
Confidence 45678999999999999999999998 57899999996543 33678899999999999999999999854 566
Q ss_pred EEEEEeecCCCchHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccc
Q 037702 85 IYFAMEYVRGGELFNKVAKG---KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQES 161 (448)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~~---~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~ 161 (448)
+|+||||+++|+|.+++... .+++..++.++.||+.||.|||+++|+||||||+|||++.+|.+||+|||+++....
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 76 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCC
Confidence 89999999999999999652 489999999999999999999999999999999999999999999999999986432
Q ss_pred cccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhhc-cCCCCCCCCHHH
Q 037702 162 TRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLMELYKKITRA-EFKCPNWFPPEV 239 (448)
Q Consensus 162 ~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~ 239 (448)
. ..+.++|+.|+|||++.+..+ +.++|||||||++|||+| |++||...+..++...+..+ .++.|..+++++
T Consensus 156 ~-----~~~~~~~~~y~aPE~l~~~~~-t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (262)
T d1byga_ 156 T-----QDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAV 229 (262)
T ss_dssp -----------CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHH
T ss_pred C-----CccccccccCCChHHHhCCCC-ChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHH
Confidence 2 245678999999999987776 589999999999999998 79999988888888888764 457788899999
Q ss_pred HHHHHhccCCCcCCCCCHHHHHhh
Q 037702 240 RKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 240 ~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
.+||.+||+.||.+|||+.+++++
T Consensus 230 ~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 230 YEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcccCHhHCcCHHHHHHH
Confidence 999999999999999999999885
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-53 Score=414.26 Aligned_cols=251 Identities=26% Similarity=0.416 Sum_probs=215.9
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcE--EEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQS--VAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEVMASKT 83 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~--vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~ 83 (448)
+-.++|++.+.||+|+||.||+|.+..+|.. ||||.+..... ....+.+.+|+.+|+++ +||||+++++++.+++
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 84 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS--KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 84 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccC--hHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence 4567999999999999999999999888875 67777654322 23346789999999998 7999999999999999
Q ss_pred EEEEEEeecCCCchHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCC
Q 037702 84 KIYFAMEYVRGGELFNKVAK-----------------GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENG 146 (448)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g 146 (448)
.+|+||||++||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence 99999999999999999853 4689999999999999999999999999999999999999999
Q ss_pred CeEEeeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhC-CCCCCCCcHHHHHHHHh
Q 037702 147 DLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAG-NLPFYDSNLMELYKKIT 225 (448)
Q Consensus 147 ~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG-~~Pf~~~~~~~~~~~i~ 225 (448)
.+||+|||+|+...... .....+||+.|+|||.+.+..|+ .++|||||||++|||++| .+||.+.+..+++..+.
T Consensus 165 ~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~-~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~ 240 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 240 (309)
T ss_dssp CEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred ceEEccccccccccccc---cccceecCCcccchHHhccCCCC-ccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 99999999997544322 22456799999999999887774 889999999999999996 56899999999988887
Q ss_pred hc-cCCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 226 RA-EFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 226 ~~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
.+ .+..|..+|+++.+||.+||+.||++|||+++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 241 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 65 456778899999999999999999999999999987
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-53 Score=412.01 Aligned_cols=257 Identities=21% Similarity=0.309 Sum_probs=223.3
Q ss_pred ccccccCCeEEEeeeeecCceEEEEEEECC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEE
Q 037702 4 KAGILMNKYELGRLLGQGTFAKVYHGRNLK-----TGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEV 78 (448)
Q Consensus 4 ~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~ 78 (448)
+..+..++|++++.||+|+||.||+|.+.. ++..||||++++... ......+.+|+.++++++||||++++++
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~ 91 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS--MRERIEFLNEASVMKEFNCHHVVRLLGV 91 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC--HHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccC--hHHHHHHHHHHHHHHHcCCCCEeeeeeE
Confidence 345667899999999999999999998753 457899999975432 2334678999999999999999999999
Q ss_pred EEeCCEEEEEEeecCCCchHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCC
Q 037702 79 MASKTKIYFAMEYVRGGELFNKVAK-----------GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGD 147 (448)
Q Consensus 79 ~~~~~~~~lV~E~~~gg~L~~~i~~-----------~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~ 147 (448)
+..++..++||||+++|+|.+++.. ..+++..+..++.|+++||.|||+++|+||||||+|||++.+++
T Consensus 92 ~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~ 171 (308)
T d1p4oa_ 92 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 171 (308)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC
T ss_pred EecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCce
Confidence 9999999999999999999998753 23688999999999999999999999999999999999999999
Q ss_pred eEEeeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhC-CCCCCCCcHHHHHHHHhh
Q 037702 148 LKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAG-NLPFYDSNLMELYKKITR 226 (448)
Q Consensus 148 lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG-~~Pf~~~~~~~~~~~i~~ 226 (448)
+||+|||+|+..............+||+.|+|||.+.+..++ .++|||||||++|||++| .+||.+.+..+.+..+..
T Consensus 172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~-~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~ 250 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 250 (308)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCC-cccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence 999999999876544333333455799999999999877665 889999999999999998 588999998888888877
Q ss_pred ccC-CCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 227 AEF-KCPNWFPPEVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 227 ~~~-~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
+.. ..|..+|+.+.++|.+||+.||++|||+++|+++
T Consensus 251 ~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~ 288 (308)
T d1p4oa_ 251 GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288 (308)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 554 5678899999999999999999999999999983
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-52 Score=409.13 Aligned_cols=254 Identities=24% Similarity=0.396 Sum_probs=216.8
Q ss_pred ccccCCeEEEeeeeecCceEEEEEEEC-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEE
Q 037702 6 GILMNKYELGRLLGQGTFAKVYHGRNL-----KTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLV-RHPNIVQLYEVM 79 (448)
Q Consensus 6 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~ 79 (448)
.+..++|++++.||+|+||.||+|++. .+++.||||++..... ......+.+|+.+++.+ +|||||++++++
T Consensus 19 ~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~ 96 (311)
T d1t46a_ 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (311)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC--HHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 455689999999999999999999863 4677899999976543 23456788999999999 699999999999
Q ss_pred EeCCEEEEEEeecCCCchHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCce
Q 037702 80 ASKTKIYFAMEYVRGGELFNKVAKG-------------------KLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENL 140 (448)
Q Consensus 80 ~~~~~~~lV~E~~~gg~L~~~i~~~-------------------~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NI 140 (448)
.++..+|+|||||++|+|.+++... .+++..+..++.||+.||+|||++|++||||||+||
T Consensus 97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NI 176 (311)
T d1t46a_ 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI 176 (311)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccc
Confidence 9999999999999999999998642 489999999999999999999999999999999999
Q ss_pred EEcCCCCeEEeeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHH
Q 037702 141 LLDENGDLKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLA-GNLPFYDSNLME 219 (448)
Q Consensus 141 Ll~~~g~lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~ 219 (448)
|++.++.+|++|||+++..............+||+.|+|||++....+ +.++|||||||++|||+| |.+||...+..+
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~ 255 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCC-CCcccccchHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999999987654433333345689999999999987665 589999999999999998 677777766655
Q ss_pred HHHHHhhc--cCCCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHh
Q 037702 220 LYKKITRA--EFKCPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 220 ~~~~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 262 (448)
.+.++... ....|..+|+++.+||.+||+.||++|||+++|++
T Consensus 256 ~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 256 KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 55554443 33556778999999999999999999999999986
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-50 Score=393.73 Aligned_cols=248 Identities=23% Similarity=0.408 Sum_probs=205.0
Q ss_pred EEEeeeeecCceEEEEEEECCCC---cEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe-CCEEEEE
Q 037702 13 ELGRLLGQGTFAKVYHGRNLKTG---QSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMAS-KTKIYFA 88 (448)
Q Consensus 13 ~~~~~LG~G~fg~Vy~a~~~~~g---~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~-~~~~~lV 88 (448)
.+.++||+|+||+||+|.+..++ ..||||.+++. .+....+.+.+|+++|++++||||+++++++.+ +...++|
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 107 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 107 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEE
Confidence 34678999999999999987653 36899999643 233456789999999999999999999999865 5689999
Q ss_pred EeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeeccccccccccccC-
Q 037702 89 MEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALQESTRQD- 165 (448)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla~~~~~~~~~- 165 (448)
||||++|+|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+||||++++.+||+|||+++........
T Consensus 108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 999999999999875 45788999999999999999999999999999999999999999999999999865432211
Q ss_pred -CCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCC-CcHHHHHHHHhhc-cCCCCCCCCHHHHHH
Q 037702 166 -GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYD-SNLMELYKKITRA-EFKCPNWFPPEVRKL 242 (448)
Q Consensus 166 -~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~~-~~~~p~~~s~~~~~l 242 (448)
.......||+.|+|||++....+ +.++|||||||++|||++|..||.. .+..+....+..+ .+..|..+++++.+|
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~l 266 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEV 266 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred ceecccccccccccChHHHhcCCC-CChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHH
Confidence 12233569999999999987666 5899999999999999997777654 4444555555554 446778899999999
Q ss_pred HHhccCCCcCCCCCHHHHHhh
Q 037702 243 LSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 243 i~~~L~~dP~~Rpt~~eil~h 263 (448)
|.+||+.||++|||+.||++|
T Consensus 267 i~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 267 MLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999987
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-50 Score=393.85 Aligned_cols=255 Identities=23% Similarity=0.336 Sum_probs=203.8
Q ss_pred cCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcc-eEEEEEEeCCEEEE
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIV-QLYEVMASKTKIYF 87 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv-~l~~~~~~~~~~~l 87 (448)
.++|++++.||+|+||.||+|++..+|+.||||++..+... +.+.+|+.+++.++|+|++ .+..+..+.+..++
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~i 80 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 80 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEE
Confidence 36899999999999999999999999999999998765322 3467899999999877654 55666788899999
Q ss_pred EEeecCCCchHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcC---CCCeEEeecccccccccc
Q 037702 88 AMEYVRGGELFNKVA--KGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDE---NGDLKISDFGLSALQEST 162 (448)
Q Consensus 88 V~E~~~gg~L~~~i~--~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~---~g~lkl~DFGla~~~~~~ 162 (448)
||||+.+ +|.+.+. .+.+++..+..++.|++.||+|||++||+||||||+|||++. +..+||+|||+|+.....
T Consensus 81 vme~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 81 VMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp EEECCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred EEEEcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 9999954 5655554 367999999999999999999999999999999999999864 557999999999876543
Q ss_pred ccC-----CCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHH---hhccC-----
Q 037702 163 RQD-----GLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLMELYKKI---TRAEF----- 229 (448)
Q Consensus 163 ~~~-----~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i---~~~~~----- 229 (448)
... ....+.+||+.|||||++.+..|+ .++|||||||++|||++|..||...........+ .....
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCC-HHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCC-ChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh
Confidence 221 223456899999999999887775 8999999999999999999999875544332222 11111
Q ss_pred CCCCCCCHHHHHHHHhccCCCcCCCCCHHH---HHhhhhccccc
Q 037702 230 KCPNWFPPEVRKLLSRILDPNPSTRVTMAK---LMENYWFRKGY 270 (448)
Q Consensus 230 ~~p~~~s~~~~~li~~~L~~dP~~Rpt~~e---il~hp~~~~~~ 270 (448)
..+..+|+++.+||.+||..||++||++++ +|+|+|.+.++
T Consensus 239 ~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~ 282 (299)
T d1ckia_ 239 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 282 (299)
T ss_dssp HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCC
Confidence 124568999999999999999999999874 57888876654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.6e-49 Score=385.07 Aligned_cols=249 Identities=21% Similarity=0.323 Sum_probs=208.5
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCC-CCcceEEEEEEeCCEE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRH-PNIVQLYEVMASKTKI 85 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~h-pnIv~l~~~~~~~~~~ 85 (448)
++.++|++++.||+|+||.||+|++..+|+.||||++...... ..+.+|++.++.++| +||+.+++++......
T Consensus 2 vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 76 (293)
T d1csna_ 2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN 76 (293)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred CCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc-----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCcc
Confidence 5678999999999999999999999999999999998765322 346789999999976 8999999999999999
Q ss_pred EEEEeecCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcC-----CCCeEEeecccccc
Q 037702 86 YFAMEYVRGGELFNKVAK--GKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDE-----NGDLKISDFGLSAL 158 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~-----~g~lkl~DFGla~~ 158 (448)
|+||||+ |++|.+++.. +.+++..+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||+|+.
T Consensus 77 ~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 77 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 9999999 6799888865 47999999999999999999999999999999999999974 57899999999986
Q ss_pred cccccc-----CCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCc---HHHHHHHHhhccC-
Q 037702 159 QESTRQ-----DGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSN---LMELYKKITRAEF- 229 (448)
Q Consensus 159 ~~~~~~-----~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~---~~~~~~~i~~~~~- 229 (448)
...... .....+.+||+.|||||++.+..++ .++|||||||++|+|++|..||.+.. ....+.++.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~-~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCC-hHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence 543211 1223456899999999999887764 88999999999999999999997543 3333444332221
Q ss_pred ----CCCCCCCHHHHHHHHhccCCCcCCCCCHHHHHh
Q 037702 230 ----KCPNWFPPEVRKLLSRILDPNPSTRVTMAKLME 262 (448)
Q Consensus 230 ----~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 262 (448)
..++.+|+++.+++..|+..+|++||+++.+.+
T Consensus 235 ~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 235 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 123568899999999999999999999887754
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=387.42 Aligned_cols=249 Identities=24% Similarity=0.358 Sum_probs=195.7
Q ss_pred cCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----E
Q 037702 9 MNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIVQLYEVMASKT----K 84 (448)
Q Consensus 9 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~----~ 84 (448)
..+|.+.+.||+|+||.||+|++ +|+.||||++..+... ......|+..+..++||||+++++++.+.+ .
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~----~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~ 75 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER----SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHH----HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchh----HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceE
Confidence 46799999999999999999986 7899999999654321 122334566667789999999999987654 6
Q ss_pred EEEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------CCCEeecCCCCceEEcCCCCeEEeecccc
Q 037702 85 IYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHS--------RGVYHRDLKPENLLLDENGDLKISDFGLS 156 (448)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~--------~givHrDLkp~NILl~~~g~lkl~DFGla 156 (448)
+|+|||||++|+|.+++.+.++++.....++.|++.||+|||+ +||+||||||+||||+.++.+||+|||++
T Consensus 76 ~~lv~Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 76 LWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 8999999999999999998889999999999999999999996 59999999999999999999999999999
Q ss_pred cccccccc--CCCccccCCCCcccchhhhhccCC-----CCCcchHHHHHHHHHHHHhCCCCCCCC--------------
Q 037702 157 ALQESTRQ--DGLLHTTCGTPAYVAPEVINKRGY-----DGAKADIWSCGVVLFVLLAGNLPFYDS-------------- 215 (448)
Q Consensus 157 ~~~~~~~~--~~~~~~~~Gt~~Y~APEvl~~~~~-----~~~~sDiwSlGvil~elltG~~Pf~~~-------------- 215 (448)
+....... .......+||+.|+|||++.+... .+.++|||||||+||||+||..||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence 86543322 122345689999999999865432 246799999999999999998876321
Q ss_pred -cHHHHHHHHhhccC--CCCCC-----CCHHHHHHHHhccCCCcCCCCCHHHHHhh
Q 037702 216 -NLMELYKKITRAEF--KCPNW-----FPPEVRKLLSRILDPNPSTRVTMAKLMEN 263 (448)
Q Consensus 216 -~~~~~~~~i~~~~~--~~p~~-----~s~~~~~li~~~L~~dP~~Rpt~~eil~h 263 (448)
........+..... .+|.. .+..+.+|+.+||+.||++|||+.||+++
T Consensus 236 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred chHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 22233333332222 22221 12458899999999999999999999874
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.3e-47 Score=381.65 Aligned_cols=255 Identities=24% Similarity=0.423 Sum_probs=199.1
Q ss_pred ccccc-CCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-----------CCCc
Q 037702 5 AGILM-NKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR-----------HPNI 72 (448)
Q Consensus 5 ~~~~~-~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-----------hpnI 72 (448)
|.++. +||++++.||+|+||+||+|++..+|+.||||++.++.. ..+.+.+|+.+++.++ ||||
T Consensus 7 g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~----~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~i 82 (362)
T d1q8ya_ 7 GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDADNTKEDSMGANHI 82 (362)
T ss_dssp TCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred CCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc----chHHHHHHHHHHHHhcchhhhhhhhcCcCce
Confidence 34443 579999999999999999999999999999999976532 2356778999988875 5789
Q ss_pred ceEEEEEEe--CCEEEEEEeecCCCchHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCEeecCCCCceEEcCC
Q 037702 73 VQLYEVMAS--KTKIYFAMEYVRGGELFNKVA----KGKLREEVARKYFQQLVDAVEFCHS-RGVYHRDLKPENLLLDEN 145 (448)
Q Consensus 73 v~l~~~~~~--~~~~~lV~E~~~gg~L~~~i~----~~~l~e~~~~~~~~qll~aL~yLH~-~givHrDLkp~NILl~~~ 145 (448)
+++++++.. ....+++|+++..+....... ...+++..++.++.||+.||+|||+ .||+||||||+|||++.+
T Consensus 83 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~ 162 (362)
T d1q8ya_ 83 LKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV 162 (362)
T ss_dssp CCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEE
T ss_pred EEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeecc
Confidence 999988754 467778888776665433322 2579999999999999999999998 899999999999999877
Q ss_pred CC------eEEeeccccccccccccCCCccccCCCCcccchhhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHH-
Q 037702 146 GD------LKISDFGLSALQESTRQDGLLHTTCGTPAYVAPEVINKRGYDGAKADIWSCGVVLFVLLAGNLPFYDSNLM- 218 (448)
Q Consensus 146 g~------lkl~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~- 218 (448)
+. ++++|||.|..... .....+||+.|+|||++....|+ .++||||+||++++|++|+.||...+..
T Consensus 163 ~~~~~~~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~g~~pF~~~~~~~ 236 (362)
T d1q8ya_ 163 DSPENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEGHS 236 (362)
T ss_dssp ETTTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCC-THHHHHHHHHHHHHHHHSSCCC-------
T ss_pred CcccccceeeEeeccccccccc-----ccccccccccccChhhccccCCC-ccccccchHHHHHHHHHCCCCCCCCcccc
Confidence 64 99999999875432 22457899999999999888775 8899999999999999999999754321
Q ss_pred -----HHHHHHhh------------------------------------------ccCCCCCCCCHHHHHHHHhccCCCc
Q 037702 219 -----ELYKKITR------------------------------------------AEFKCPNWFPPEVRKLLSRILDPNP 251 (448)
Q Consensus 219 -----~~~~~i~~------------------------------------------~~~~~p~~~s~~~~~li~~~L~~dP 251 (448)
+....... .....+...++++.+||.+||..||
T Consensus 237 ~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP 316 (362)
T d1q8ya_ 237 YTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 316 (362)
T ss_dssp --CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred ccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCCh
Confidence 11111000 0011112245789999999999999
Q ss_pred CCCCCHHHHHhhhhcccc
Q 037702 252 STRVTMAKLMENYWFRKG 269 (448)
Q Consensus 252 ~~Rpt~~eil~hp~~~~~ 269 (448)
.+|||++|+|+||||+..
T Consensus 317 ~~Rpta~e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 317 RKRADAGGLVNHPWLKDT 334 (362)
T ss_dssp TTCBCHHHHHTCGGGTTC
T ss_pred hHCcCHHHHhcCcccCCC
Confidence 999999999999999843
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=1.7e-26 Score=208.11 Aligned_cols=136 Identities=21% Similarity=0.318 Sum_probs=108.8
Q ss_pred eEEEeeeeecCceEEEEEEECCCCcEEEEEEeeccccc---------------chhHHHHHHHHHHHHHhCCCCCcceEE
Q 037702 12 YELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIR---------------RVGLIDQIKREISVMRLVRHPNIVQLY 76 (448)
Q Consensus 12 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~---------------~~~~~~~~~~Ei~~l~~l~hpnIv~l~ 76 (448)
|.+++.||+|+||.||+|++ .+|+.||||++...... .........+|...+.++.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 56899999999999999997 47999999987532110 001123456789999999999999988
Q ss_pred EEEEeCCEEEEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecCCCCceEEcCCCCeEEeecccc
Q 037702 77 EVMASKTKIYFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHSRGVYHRDLKPENLLLDENGDLKISDFGLS 156 (448)
Q Consensus 77 ~~~~~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~~givHrDLkp~NILl~~~g~lkl~DFGla 156 (448)
++.. .+++|||+++..+.+ +++..+..++.|++.+|.|||++||+||||||+|||++++ .++|+|||+|
T Consensus 81 ~~~~----~~lvme~~~~~~~~~------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~a 149 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELYR------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQS 149 (191)
T ss_dssp EEET----TEEEEECCCCEEGGG------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTTC
T ss_pred EecC----CEEEEEeeccccccc------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCCc
Confidence 7532 279999999876543 4556678899999999999999999999999999999865 4999999998
Q ss_pred ccc
Q 037702 157 ALQ 159 (448)
Q Consensus 157 ~~~ 159 (448)
...
T Consensus 150 ~~~ 152 (191)
T d1zara2 150 VEV 152 (191)
T ss_dssp EET
T ss_pred ccC
Confidence 754
|
| >d1ul7a_ d.129.6.1 (A:) Map/microtubule affinity-regulating kinase 3 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Kinase associated domain 1, KA1 domain: Map/microtubule affinity-regulating kinase 3 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.52 E-value=1.6e-14 Score=114.32 Aligned_cols=86 Identities=12% Similarity=0.320 Sum_probs=78.5
Q ss_pred ceEEeCCCHHHHHHHHHHHhhhcCcEEEeec-cEEEEEEeeCCCcccEEEEEEEEEEc-CceEEEEEEecCCCchhHHHH
Q 037702 349 ARFTTTKPASAIVSKFEEIAVTESCKFNKKD-GTVKLQHNRQGRKGQLAVDAEIFEVT-PAFHVVELKKAAGDTMEYKDF 426 (448)
Q Consensus 349 ~rf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~v~~~~-~~~~~ve~~~~~Gd~~e~~~~ 426 (448)
..-||..+|++||.+|+++++.+|+.|++++ +.++++...+++++.+.|.+||++|. +++++|+|||.+||+++|+++
T Consensus 13 v~tTS~~~P~eIm~eI~rvL~~lgv~~~~~g~y~l~c~~~~~~~~~~v~fEieV~kv~~~~l~gv~~kR~~Gd~~~yk~l 92 (102)
T d1ul7a_ 13 MKTTSSMDPSDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAENLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNI 92 (102)
T ss_dssp CCCCBCSCHHHHHHHHHHHHHHTTCEEEECSTTCEEEEECSSCGGGCEEEEEEEEECSSSSSEEEEEEEEESCHHHHHHH
T ss_pred eecCcCCCHHHHHHHHHHHHHHcCcEEEEcCCEEEEEEecCCCCCceEEEEEEEEEcCCCceEEEEEEEccCCHHHHHHH
Confidence 3458999999999999999999999999876 99999998889999999999999995 799999999999999999999
Q ss_pred hhcCccccc
Q 037702 427 CNQGLRPSL 435 (448)
Q Consensus 427 ~~~~~~~~l 435 (448)
|.+ |-..|
T Consensus 93 ~~~-il~~l 100 (102)
T d1ul7a_ 93 ASK-IANEL 100 (102)
T ss_dssp HHH-HHHHC
T ss_pred HHH-HHHhc
Confidence 998 54444
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.75 E-value=1.6e-08 Score=92.91 Aligned_cols=143 Identities=17% Similarity=0.168 Sum_probs=102.8
Q ss_pred cccCCeEEEeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEE
Q 037702 7 ILMNKYELGRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVR-HPNIVQLYEVMASKTKI 85 (448)
Q Consensus 7 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~ 85 (448)
.+.+.|++.+..+.++.+.||+.. .++..+.+|......... ...+.+|...++.+. +--+.+++.+...++..
T Consensus 11 ~~~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 11 KLIEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HhhhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 356788888877666678999886 366778899886543222 234678888888774 33367788888889999
Q ss_pred EEEEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 037702 86 YFAMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCHS-------------------------------------- 127 (448)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH~-------------------------------------- 127 (448)
|+||++++|..+.+..... .....++.++...+..||+
T Consensus 86 ~lv~~~l~G~~~~~~~~~~----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDE----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp EEEEECCSSEEHHHHTTTC----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTT
T ss_pred EEEEEeccccccccccccc----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccc
Confidence 9999999998876554322 1223345556666666664
Q ss_pred ---------------------CCCEeecCCCCceEEcCCCCeEEeecccccc
Q 037702 128 ---------------------RGVYHRDLKPENLLLDENGDLKISDFGLSAL 158 (448)
Q Consensus 128 ---------------------~givHrDLkp~NILl~~~g~lkl~DFGla~~ 158 (448)
..++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 1279999999999998776667999998763
|
| >d2v8qa1 d.129.6.2 (A:396-548) 5'-AMP-activated protein kinase catalytic subunit alpha-1, AMPK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: 5'-AMP-activated protein kinase catalytic subunit alpha-1, AMPK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.49 E-value=3.7e-07 Score=74.68 Aligned_cols=73 Identities=4% Similarity=0.117 Sum_probs=63.3
Q ss_pred eEEeCCCHHHHHHHHHHHhhhcCcEEEeec-cEEEEEEeeCCCcccEEEEEEEEEEcCceEEEEEEecCCCchh
Q 037702 350 RFTTTKPASAIVSKFEEIAVTESCKFNKKD-GTVKLQHNRQGRKGQLAVDAEIFEVTPAFHVVELKKAAGDTME 422 (448)
Q Consensus 350 rf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~v~~~~~~~~~ve~~~~~Gd~~e 422 (448)
-+.|+..+.+||..|..+++.||+.|++.+ +.|+++.........+.|.+++|+|.+..||||||...|+..|
T Consensus 4 GIrS~s~P~dIM~eVyrALk~L~~eWk~~~~y~ir~R~~~~~~~~~~Km~lQLYqv~~~~YLLDfk~i~~~~~e 77 (153)
T d2v8qa1 4 GIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEITE 77 (153)
T ss_dssp SEEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC---
T ss_pred ccccCCCHHHHHHHHHHHHHHcCCeEEecCceEEEEEEECCCCCceeEEEEEEEEEcCCceEEEeeecCcchhc
Confidence 356888999999999999999999999988 9999998655555678999999999999999999999998665
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.20 E-value=3.1e-06 Score=76.70 Aligned_cols=132 Identities=16% Similarity=0.203 Sum_probs=86.1
Q ss_pred CeEEEeeeeecC-ceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCC--CcceEEEEEEeCCEEEE
Q 037702 11 KYELGRLLGQGT-FAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHP--NIVQLYEVMASKTKIYF 87 (448)
Q Consensus 11 ~y~~~~~LG~G~-fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hp--nIv~l~~~~~~~~~~~l 87 (448)
.++.. .+..|. .+.||+... .+|..+++|....... ..+.+|...++.+... .+.+++.+..+++..++
T Consensus 12 g~~~~-~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~ 83 (255)
T d1nd4a_ 12 GYDWA-QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWL 83 (255)
T ss_dssp TCEEE-ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEE
T ss_pred CCceE-EcCCcccCCeEEEEEe-CCCCEEEEEeCCccCH------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEE
Confidence 34443 444554 468998874 5677788997654322 3466788888877433 35778888888889999
Q ss_pred EEeecCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-----------------------------------------
Q 037702 88 AMEYVRGGELFNKVAKGKLREEVARKYFQQLVDAVEFCH----------------------------------------- 126 (448)
Q Consensus 88 V~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yLH----------------------------------------- 126 (448)
||++++|.++.+. ...... .+.++...|.-||
T Consensus 84 v~~~i~G~~~~~~----~~~~~~---~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (255)
T d1nd4a_ 84 LLGEVPGQDLLSS----HLAPAE---KVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 156 (255)
T ss_dssp EEECCSSEETTTS----CCCHHH---HHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred EEEeeeccccccc----cccHHH---HHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhh
Confidence 9999998765331 111111 1123333333333
Q ss_pred ----------HC-------CCEeecCCCCceEEcCCCCeEEeeccccc
Q 037702 127 ----------SR-------GVYHRDLKPENLLLDENGDLKISDFGLSA 157 (448)
Q Consensus 127 ----------~~-------givHrDLkp~NILl~~~g~lkl~DFGla~ 157 (448)
++ .++|+|+.|.|||++.++.+-|+||+.+.
T Consensus 157 ~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 157 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 21 37999999999999887667899999875
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.11 E-value=4.3e-06 Score=81.49 Aligned_cols=81 Identities=16% Similarity=0.150 Sum_probs=51.0
Q ss_pred EeeeeecCceEEEEEEECCCCcEEEEEEeeccc-ccc---hhHHHHHHHHHHHHHhCC-C--CCcceEEEEEEeCCEEEE
Q 037702 15 GRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEK-IRR---VGLIDQIKREISVMRLVR-H--PNIVQLYEVMASKTKIYF 87 (448)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~-~~~---~~~~~~~~~Ei~~l~~l~-h--pnIv~l~~~~~~~~~~~l 87 (448)
.+.||.|....||++.+..+|+.+++|.-.... ... ....++...|...|+.+. + ..+.+++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 557899999999999887778899999754311 000 012345667888887763 2 345666654 3445578
Q ss_pred EEeecCCCch
Q 037702 88 AMEYVRGGEL 97 (448)
Q Consensus 88 V~E~~~gg~L 97 (448)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987543
|
| >d2qrda1 d.129.6.2 (A:450-576) Snf1-like protein kinase ssp2 {Schizosaccharomyces pombe [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: Snf1-like protein kinase ssp2 species: Schizosaccharomyces pombe [TaxId: 4896]
Probab=97.95 E-value=1e-05 Score=64.69 Aligned_cols=69 Identities=16% Similarity=0.242 Sum_probs=57.0
Q ss_pred cccceEEeCCCHHHHHHHHHHHhhhcCcEEEeec----------cEEEEEEeeC-----CCcccEEEEEEEEEEcCceEE
Q 037702 346 KLEARFTTTKPASAIVSKFEEIAVTESCKFNKKD----------GTVKLQHNRQ-----GRKGQLAVDAEIFEVTPAFHV 410 (448)
Q Consensus 346 ~~~~rf~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~-----~~~~~l~~~~~v~~~~~~~~~ 410 (448)
||..-.-|+..|-+||..|..+.+.+|+.|++.+ +.|+++-..+ +....+.|.+++|+|.++.+|
T Consensus 2 KWhfGIRSrs~P~eiM~eVYrALk~Lg~eWk~~~~~~~~~~~d~y~Ir~R~~~~~~~~~~~~~~vkm~iQLYqve~~~YL 81 (127)
T d2qrda1 2 KWHFGVRCRGDAPEILLAVYRALQRAGAQFTVPKPVNGKYRSDMYTIKSRWEIPHCKREGKNTYAYIELQLYEVMPGCFM 81 (127)
T ss_dssp CCEESEEEESCHHHHHHHHHHHHHHHTCEECCCCCBTTBCCGGGGEEEEEEECHHHHHTTCCEEEEEEEEEEEEETTEEE
T ss_pred CceeccccCCChHHHHHHHHHHHHHcCCEEeecCcccccccCCceEEEEEeecCCccccCCCceEEEEEEEEEEcCCcEE
Confidence 4556678999999999999999999999998755 6888874322 223458899999999999999
Q ss_pred EEEE
Q 037702 411 VELK 414 (448)
Q Consensus 411 ve~~ 414 (448)
||||
T Consensus 82 lDFK 85 (127)
T d2qrda1 82 LDVK 85 (127)
T ss_dssp EEEE
T ss_pred EEEc
Confidence 9998
|
| >d2qlva1 d.129.6.2 (A:460-630) Carbon catabolite-derepressing protein kinase SNF1 {Saccharomyces cerevisiae [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: Carbon catabolite-derepressing protein kinase SNF1 species: Saccharomyces cerevisiae [TaxId: 4932]
Probab=97.59 E-value=7.2e-05 Score=62.75 Aligned_cols=71 Identities=10% Similarity=0.127 Sum_probs=55.0
Q ss_pred CcccceEEeCCCHHHHHHHHHHHhhhcCcEEEeec----cEEEEEEeeC---------CCcccEEEEEEEEEEcCceEEE
Q 037702 345 SKLEARFTTTKPASAIVSKFEEIAVTESCKFNKKD----GTVKLQHNRQ---------GRKGQLAVDAEIFEVTPAFHVV 411 (448)
Q Consensus 345 ~~~~~rf~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~---------~~~~~l~~~~~v~~~~~~~~~v 411 (448)
.||..-.-|+..|-+||..|..+++.+|+.|++.+ +.|+++...+ .....+.|.+++|+|.++.+||
T Consensus 44 ~kWhfGIRSrs~P~eiM~evykALk~Lg~eWk~~~~~~~~~ir~Rwk~~~~~~~~~~~~~~~~vk~~iQLYqv~~~~YLl 123 (171)
T d2qlva1 44 TRWHFGIRSRSYPLDVMGEIYIALKNLGAEWAKPSEEDLWTIKLRWKYDIGNKTNTNEKIPDLMKMVIQLFQIETNNYLV 123 (171)
T ss_dssp CCCEESEEECSCHHHHHHHHHHHHHHHTCEECCCC---CCEEEEEEC--------------CEEEEEEEEEC---CCEEE
T ss_pred ceeeeecccCCCHHHHHHHHHHHHHHcCCEEeecCCCCceEEEEEeecCCCcccccCCCCCceEEEEEEEEEEcCCceEE
Confidence 46778899999999999999999999999998764 8888875321 1113478999999999999999
Q ss_pred EEEe
Q 037702 412 ELKK 415 (448)
Q Consensus 412 e~~~ 415 (448)
|||-
T Consensus 124 DFK~ 127 (171)
T d2qlva1 124 DFKF 127 (171)
T ss_dssp EEEE
T ss_pred EEec
Confidence 9984
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.31 E-value=0.00027 Score=66.31 Aligned_cols=71 Identities=14% Similarity=0.173 Sum_probs=47.4
Q ss_pred cCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcc--eEE-----EEEEeCCEEEEEEeecC
Q 037702 21 GTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNIV--QLY-----EVMASKTKIYFAMEYVR 93 (448)
Q Consensus 21 G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv--~l~-----~~~~~~~~~~lV~E~~~ 93 (448)
+..-.||++.. .+|..|++|+....... .+++..|...+..|...+|. ... ..+......+.++++++
T Consensus 33 s~EN~vy~v~~-~dg~~~VlK~~rp~~~s----~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~ 107 (325)
T d1zyla1 33 SYENRVYQFQD-EDRRRFVVKFYRPERWT----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 107 (325)
T ss_dssp CSSSEEEEECC-TTCCCEEEEEECTTTSC----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred cccceeEEEEc-CCCCEEEEEEeCCCCCC----HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecC
Confidence 33468999974 68899999998654322 36677899888887532221 111 12345778899999998
Q ss_pred CCc
Q 037702 94 GGE 96 (448)
Q Consensus 94 gg~ 96 (448)
|..
T Consensus 108 G~~ 110 (325)
T d1zyla1 108 GRQ 110 (325)
T ss_dssp CEE
T ss_pred CcC
Confidence 743
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.17 E-value=0.00069 Score=65.21 Aligned_cols=78 Identities=13% Similarity=0.181 Sum_probs=52.4
Q ss_pred CCeEEEeeeeecCceEEEEEEECC-------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc-ceEEEEEEe
Q 037702 10 NKYELGRLLGQGTFAKVYHGRNLK-------TGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPNI-VQLYEVMAS 81 (448)
Q Consensus 10 ~~y~~~~~LG~G~fg~Vy~a~~~~-------~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpnI-v~l~~~~~~ 81 (448)
+..+ ++.|+.|-.-.+|++.... .++.|.+++.... . . .....+|..+++.+.-.++ .++++++..
T Consensus 43 ~~l~-v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~--~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~ 116 (395)
T d1nw1a_ 43 EHLR-ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--E--T-ESHLVAESVIFTLLSERHLGPKLYGIFSG 116 (395)
T ss_dssp GGEE-EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--C--C-HHHHHHHHHHHHHHHHTTSSSCEEEEETT
T ss_pred cceE-EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--c--h-hhHHHHHHHHHHHHHhCCCCCeEEEEcCC
Confidence 3444 4678889999999998643 2456778876521 1 1 2345689999998853444 577777643
Q ss_pred CCEEEEEEeecCCCch
Q 037702 82 KTKIYFAMEYVRGGEL 97 (448)
Q Consensus 82 ~~~~~lV~E~~~gg~L 97 (448)
.+||||++|..|
T Consensus 117 ----g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 ----GRLEEYIPSRPL 128 (395)
T ss_dssp ----EEEECCCCEEEC
T ss_pred ----ceEEEEeccccC
Confidence 689999987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.85 E-value=0.001 Score=61.63 Aligned_cols=136 Identities=13% Similarity=0.120 Sum_probs=72.6
Q ss_pred EeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC-----cceEE---EEEEeCCEEE
Q 037702 15 GRLLGQGTFAKVYHGRNLKTGQSVAIKIVDKEKIRRVGLIDQIKREISVMRLVRHPN-----IVQLY---EVMASKTKIY 86 (448)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~~l~~l~hpn-----Iv~l~---~~~~~~~~~~ 86 (448)
.+.|..|---+.|+... ++..+++|++.... . .+.+..|+.++..|...+ .+... .+........
T Consensus 23 ~~~i~~G~~N~ny~v~t--~~g~yVLri~~~~~--~---~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~ 95 (316)
T d2ppqa1 23 YKGIAEGVENSNFLLHT--TKDPLILTLYEKRV--E---KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPA 95 (316)
T ss_dssp EEEECC---EEEEEEEE--SSCCEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEE
T ss_pred eecCCCCcccCeEEEEE--CCCcEEEEEcCCCC--C---HHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccc
Confidence 33445666688899875 34469999986532 1 134556777777764322 22110 1123355677
Q ss_pred EEEeecCCCchHH--------------HHh---c---CC----CCH------------------HHHHHHHHHHHHHHHH
Q 037702 87 FAMEYVRGGELFN--------------KVA---K---GK----LRE------------------EVARKYFQQLVDAVEF 124 (448)
Q Consensus 87 lV~E~~~gg~L~~--------------~i~---~---~~----l~e------------------~~~~~~~~qll~aL~y 124 (448)
.++.+..|..... .+. . .. ... ......+..+...+.-
T Consensus 96 ~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 175 (316)
T d2ppqa1 96 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA 175 (316)
T ss_dssp EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred eeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhc
Confidence 7777776643310 000 0 00 000 0111222222222222
Q ss_pred HH----HCCCEeecCCCCceEEcCCCCeEEeeccccc
Q 037702 125 CH----SRGVYHRDLKPENLLLDENGDLKISDFGLSA 157 (448)
Q Consensus 125 LH----~~givHrDLkp~NILl~~~g~lkl~DFGla~ 157 (448)
.+ ..|+||+|+.+.||+++.+...-|.||+.+.
T Consensus 176 ~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 176 HWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 22 2479999999999999988777899999875
|